<SEC-DOCUMENT>0000950170-21-003800.txt : 20211109
<SEC-HEADER>0000950170-21-003800.hdr.sgml : 20211109
<ACCEPTANCE-DATETIME>20211109171049
ACCESSION NUMBER:		0000950170-21-003800
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		53
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211109
DATE AS OF CHANGE:		20211109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kodiak Sciences Inc.
		CENTRAL INDEX KEY:			0001468748
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				270476525
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38682
		FILM NUMBER:		211393203

	BUSINESS ADDRESS:	
		STREET 1:		1200 PAGE MILL RD
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		650-281-0850

	MAIL ADDRESS:	
		STREET 1:		1200 PAGE MILL RD
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oligasis, LLC
		DATE OF NAME CHANGE:	20090721
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>kod-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2021-11-09T17:02:55.1078+00:00 --><!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:kod="http://kodiak.com/20210930" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-Q</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonFraction id="F_525f0a1b-b4ec-4a72-98ab-f7443ab418bc" name="us-gaap:CommitmentsAndContingencies" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_43297c36-5cca-4992-b552-762d25eb323d" name="dei:CurrentFiscalYearEndDate" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1">--12-31</ix:nonNumeric><ix:nonNumeric id="F_bfb17daa-e5bf-42a6-b0e6-f4661e6df9c3" name="dei:DocumentFiscalPeriodFocus" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1">Q3</ix:nonNumeric><ix:nonFraction id="F_96f66858-c650-49ce-8733-f803beb8d6ee" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_0b201eed-5ccd-4cf8-8b7d-2c8eacd321e0" name="us-gaap:CommitmentsAndContingencies" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_6c610b87-5e64-4ad8-a4d1-e933dce4fa66" name="dei:EntityCentralIndexKey" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1">0001468748</ix:nonNumeric><ix:nonFraction id="F_50422e85-346c-4b9e-a26d-7837cf373b79" name="us-gaap:PreferredStockValue" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_2f1ee712-59aa-4bc8-a15c-9f4c6b71c5bf" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_cfc22e00-db77-4e36-b02a-b9cbdc4da455" name="us-gaap:PreferredStockValue" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_491b1780-c8cb-4dfa-9022-3e9b148a4ea6" name="dei:AmendmentFlag" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" format="ixt:booleanfalse">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="kod-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_cbd92a0e-372f-48a4-b6d5-ce7f82ea665f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8cafabb9-2fa4-4282-a961-4356c77480d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-13</xbrli:startDate><xbrli:endDate>2021-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9b59a0e5-e47e-4121-b018-a86d491ac673"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bdfa9aa-1ba9-4af1-8101-e5969ff5eae8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a23868ac-4d18-4080-b770-dd5c05f2ac9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c25a3452-9b30-4001-9008-cd10e3278714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_76b97688-4be3-49e7-81df-21713ee340ae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68a9be7d-3755-49bf-a2da-42390bcb4eec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_90a0890e-113a-4768-a4d5-8086e659ebe1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e0805aa0-1dc9-4338-83a1-9f7dc9b4a4d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f61b024-5ca7-4987-be9f-a79fc65f9ac7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60ee5be9-fce8-4ec2-9433-83baa13390dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58d71972-cf16-407c-92c6-ce1dbf2b12b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-13</xbrli:startDate><xbrli:endDate>2021-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df61c764-a534-4f0b-8ca0-21e84f617033"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb793a10-451f-4b36-8cb8-5154d0eba3cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cccca9ea-943c-426b-a949-a6fa3e183830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_132bd18c-61d8-48f7-809f-8bb8b165fbc1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8ca588ac-2ea8-47e2-9e1e-0d5c0f7bdd04"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_28f3dc2d-2645-40d1-8f72-dba22572cd4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_975902bf-d85c-41cd-863e-84e008163d3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a54f3b91-0dde-44ee-ba4b-942ccb719672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bba9d155-8973-4881-b4f4-889287f1e62c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a2ce11da-0bb4-4016-be57-12f7208128b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_195d5ffe-0492-4de0-b82c-488c9ea38019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31399e52-c5e0-47e5-a93a-23ef7ff40786"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kod:ClinicalAndCommercialSupplyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kod:LonzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e95e0f4c-377f-4358-8d44-eaa863f82dcd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f286752f-3bc4-47a6-a27d-666daa7a6ec9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e740a6d-5b59-4139-b143-25fb54883059"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5328f00-e330-42c1-80c1-8421c3606923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_93d12b66-9ce5-4317-ac9a-15a39b2600d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e32f672d-5f84-455b-8c7b-12ed7c65984c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c938c6fd-25b2-418a-ad6d-7089541a671c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kod:LonzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kod:ClinicalAndCommercialSupplyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_20bef648-9662-4045-ac10-f374a4e6dd4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_88e8f9d6-793b-4b92-a798-5c12f7a88303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_458e6e92-7030-4315-9600-616198160fdb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kod:ClinicalAndCommercialSupplyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kod:LonzaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e5c59142-312f-4066-abfc-c35cb8d948e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_47fd8490-2f13-4a75-8942-c29752532c90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8656501a-52be-4d70-8809-9957b36d4bee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32f5b3f4-2926-4a41-a753-0315ed597699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f7a3a9d0-55f0-4f98-bd8e-f8ff83d37aef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72724aca-fdbc-4107-8023-8e92c79546de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0bf9017-3374-4d04-9d4e-2d55c59dd283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c0f0042-303e-4491-b1dc-68acfaccacc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_86dc39fd-f86e-42e3-9bd9-ba7b697a9ddf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_baaf78fe-4b36-48dc-ba7a-9a0cd9f14b1c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9ffaaef7-e461-404c-aa29-30c8c1054bbb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12553a8d-237a-4ea4-b220-6b9e18798500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7ae9458-f493-45a2-8df8-95b502b2f850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_263b39c0-fc6e-4304-804c-806e5d34aa8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0f217839-80a3-4a6a-bdfd-679c49f63892"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5c21659f-1cec-4a85-8710-24968233ef93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0ec927f1-50c6-4660-8fa6-d7393ce25571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3bb54cbe-545d-4fe0-bcd2-19e483d491f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4882ce6c-ab65-4041-9b2e-170bdcd25b73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_158eae8b-5b6c-4683-b5fa-33c0622853f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEmployeeSharePurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_63179ee0-98f3-437f-a39f-263cdaf44426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35c1b8b0-ef41-45be-a72a-9abe398ca0e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a00f1dc8-2c72-4c4b-a537-1e6bd1510eb4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2bbe6b4-f70f-4f1f-81ce-fdcefcfcd7b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_43f639e8-9157-46d6-99bf-779d020c83ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca5ad689-4bf0-49c6-bbdf-99985e3228a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d4d3bdd1-f4a5-411e-b2cd-de5f19a1571b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_add76d56-e3aa-4160-be48-644dc3f7d81b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a2edcb3-cdb8-4ae3-8ba8-ad3566e86572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8945418-7878-462f-88bb-8634543ad049"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0509b27f-2c96-45a2-b3c6-bd0c582464ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be29e469-1e89-4c7e-9ad6-caa85930c9fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d5599e4-af21-4a80-b2fa-9f50ffb8ff68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a051b042-5e1d-45e2-b954-e74131ddd0b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b596f86d-2557-4336-bacd-b0ddf9d1d545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_463882b0-53f7-46b3-9143-d473f7db2d44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9bb106de-f5c9-411f-80cc-5611a5510340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7d6f728e-e9d4-4671-bc36-35fc3079d423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fad684c8-cc78-4067-ab73-24cb363807a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_66006d13-4030-4015-b889-1afb6b097dca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_52fd169e-6778-4b75-87b8-41bfa51538a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_282bfd4f-0e6c-4f01-ad36-409ab1c8d1c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4724a75b-6bfd-4f43-a79e-256b1d3309c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-13</xbrli:startDate><xbrli:endDate>2021-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbe6d2e0-e108-4f31-b4a9-aabc9eee0627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b2909d7-cea1-4df1-9529-fa4f0d2242dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00c91e92-2084-4178-8614-66b75d51a63e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f799a588-4775-46ae-b373-fdba49e2b7b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f2795d1-2d93-4f05-944e-15b9e4c3cfa8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ccfa3f6d-89ca-4e36-8c0f-12d38600ca8b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7b002c3-ab22-4669-b768-13dd644c4c23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4bf07dd0-aa9f-4e17-a6bc-9b077b5eb34f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4ed3c78d-73cb-40d0-9e64-ce6ba2494412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e739ae0c-05c8-4c3a-9039-0e4e7b4f6746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7dbc5e36-5dc0-495f-8dc7-02933e453b0d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f3d83275-b94c-473f-9d84-d4f80ce062b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b4b42d07-b554-47fb-9b37-295ad99f4b05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_508f6cdf-9b62-49da-86b7-10e38cc856c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d52ced4e-2cc6-4467-a7c6-7247dd7a8166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_63e78694-19d8-46fd-86b4-4a74be843c5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_91bbf1c7-f25d-4226-96c0-0fe81b4ea717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEmployeeSharePurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_83602e3b-403a-43a4-ae96-ae8d95713283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb27358c-ef23-4137-acfd-472379d7d8fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be8eee73-1f79-40e1-81dc-2113994bd9a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3632781-f643-46dc-88ab-1cd6c0123800"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9576e5b4-2d98-4b0c-b5ce-11be9a69984a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f8f672c-7b89-45db-8898-94025bfd6f08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b41ae94c-ea21-43b0-b06e-03ad6d4cf023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d417aa44-069d-45f0-a7f5-d98db662cdba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94d38241-9b26-4db5-b401-ca5bf21d7968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9aef3e3a-3ea0-45c0-bd9f-ebf158d52e18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a1e4b7dd-9d0f-43db-9195-97483937350d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEmployeeSharePurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94e0829a-4192-4195-b797-aa8cc430a181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7dc99746-dd99-4798-80e9-33bcb72d7ab3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_520836e4-6ccf-4a48-aec5-56fdd89596cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5ab89046-dcd8-48bc-ba35-9efd3fc2e6e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e870a142-80e3-4e6a-82c5-2362dbf0e897"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f34844dd-a0dc-4745-aaa5-323fb87a0df9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ca048f5-d8ec-4b11-8cd8-2132a593856e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b726a636-8b47-460e-ae59-7f6272c15d60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e681ec89-e92b-43ad-b6d0-5e7aad790ff7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_99a56596-b12a-4053-a88d-44e605f7dfab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a99bad54-886c-4f22-a572-c4f604a8eef5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61ad6d79-e0a3-4c3a-9112-71b6fcbfb724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c04dde98-cf3c-4935-9b98-35dde0c8ff28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-13</xbrli:startDate><xbrli:endDate>2021-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b45963b2-ae18-48d6-8992-a6e27e535c56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3cf9ac24-3ded-44bb-ae89-f866105b17ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_abb4f15e-cec6-4695-bd11-ddd8693c1243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb05ac74-574d-4580-b0cf-bb252f7fa760"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c60273c5-32a1-4ece-91e4-ddb660a10670"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001468748</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Days"><xbrli:measure>kod:Days</xbrli:measure></xbrli:unit><xbrli:unit id="U_CHF"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="U_PurchasePeriod"><xbrli:measure>kod:PurchasePeriod</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">WASHINGTON, DC 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a306f65-f061-480d-a93e-9adf1883d095" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">10-Q</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Mark One)</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b3d4a040-1736-4ad4-bb39-7792d7a25cb7" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">For the quarterly period ended </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f94fe6f8-80ba-480b-b898-f8f7d70e1f15" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0be4b659-12f7-4c55-8dc6-58f7d2610e00" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></ix:nonNumeric></span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">OR</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_23267274-8055-48f5-b48f-2fc054c2dca6" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">For the transition period from __________ to _________</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Commission File Number: </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_87f1435a-7bf9-42fb-a4ca-49bd3099af5e" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">001-38682</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb9e5051-01cb-4efe-8767-52e22ff9ef43" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:Times New Roman;">KODIAK SCIENCES INC.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Exact Name of Registrant as Specified in its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c32408b5-0fd1-4442-9573-b54da7eb2872" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ed8a1601-fce0-4e87-a620-1bccff212085" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">27-0476525</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_737180e5-3380-4703-b900-0f881c912164" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1200 Page Mill Road</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_15940d3f-3b6e-4dec-aac8-a03d6773461b" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Palo Alto</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b7497849-b3ff-4f8a-a69d-1107b734bd0d" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CA</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6493c0e4-fa17-424b-847f-7eadef5a1f5a" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">94304</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Registrant&#x2019;s telephone number, including area code: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ec45d39c-9dda-47c3-ba54-a056219028d9" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">650</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">) </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4f2f56e7-2b36-4f60-bbd9-53433c2d5a63" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">281-0850</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.327%;"></td>
    <td style="width:33.336%;"></td>
    <td style="width:33.336%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Title of each class</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Trading Symbol(s)</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_39543fcd-1499-4030-9b4b-d90b46488102" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Common stock, par value $0.0001</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2c633fe4-12ef-4bca-b89a-70903abb4157" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">KOD</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_491c43c2-55c6-4d7d-88ab-d92614d92ba3" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_588a19eb-ee1b-475c-87c1-40e572fa20b6" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> &#9746;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No &#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fcf0ca00-9afc-4204-890b-7c5f157c6f4f" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> &#9746;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No &#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.565%;"></td>
    <td style="width:3.021%;"></td>
    <td style="width:55.368%;"></td>
    <td style="width:0.963%;"></td>
    <td style="width:19.061%;"></td>
    <td style="width:3.021%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6f89b6eb-f64b-4cd0-9c73-ca2381383ad0" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Large accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Non-accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3eaaabac-5ed1-4c68-ba71-0a5c86d09b5b" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Wingdings;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Wingdings;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Wingdings;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_856768ee-69f7-4f84-8fe2-c3d863c1cdd5" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8cfd0c21-d6e9-4ec2-bd4d-af5e07078686" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">No &#9746;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">As of October 29, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">, the registrant had </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f09ac071-1680-41ac-b6e5-3afa3ed93651" contextRef="C_8656501a-52be-4d70-8809-9957b36d4bee" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,717,286</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> shares of common stock, $0.0001 par value per share, outstanding.</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Quarterly Report on Form 10-Q contains &#x201c;forward-looking statements&#x201d; within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, or Exchange Act. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management&#x2019;s good faith beliefs as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;objective,&#x201d; &#x201c;intend,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;project,&#x201d; &#x201c;target,&#x201d; &#x201c;design,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;plan&#x201d;, &#x201c;hope&#x201d; or the negative of these terms, or similar expressions and comparable terminology intended to identify forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties, including those set forth under the section of this Quarterly Report on Form 10-Q titled &#x201c;Part II, Item 1A &#x2014; Risk Factors&#x201d; and elsewhere in this report. Forward-looking statements include, but are not limited to, statements about:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the success, cost and timing of our development activities, preclinical studies, clinical trials and regulatory filings;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the translation of our preclinical results and data and early clinical trial results in particular relating to safety, efficacy and durability into future clinical trials in humans;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the continued durability, efficacy and safety of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the portfolio of clinical trials planned for submission in our Biologics License Application, or BLA, of KSI-301;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to present clinical data across our pivotal trials beginning in early 2022;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our and Lonza&#x2019;s ability to successfully execute on our manufacturing development plan; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number, size and design of clinical trials that regulatory authorities may require to obtain marketing approval, including the order and number of clinical studies required to support a BLA in wet age-related macular degeneration, or wet AMD, diabetic macular edema, or DME, retinal vein occlusion, or RVO, and diabetic retinopathy, or DR;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our expectations regarding chemistry manufacturing and controls, or CMC, requirements of the United States Food and Drug Administration, or FDA, and other regulatory bodies to support our BLA submission and potential commercial launch;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing or likelihood of regulatory filings and approvals, including the potential to achieve FDA approval of KSI-301 in wet AMD, DME, RVO and DR;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain and maintain regulatory approval of our product candidates, and any related restrictions, limitations and/or warnings in the label of any approved product candidate;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain funding for our operations, including funding necessary to develop, manufacture and commercialize our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the rate and degree of market acceptance of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the success of competing products or platform technologies that are or may become available;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our plans and ability to establish sales, marketing and distribution infrastructure to commercialize any product candidates for which we obtain approval;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our expectation as to the concentration of retinal specialists in the United States and its impact on our sales and marketing plans;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our expectations regarding our ability to enter into manufacturing-related commitments, and the timing thereof;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">future agreements with third parties in connection with the commercialization of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size and growth potential of the markets for our product candidates, if approved for commercial use, and our ability to serve those markets;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">existing regulations and regulatory developments in the United States and foreign countries;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">i</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the expected potential benefits of strategic collaboration agreements and our ability to attract collaborators with development, regulatory and commercialization expertise;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential claims relating to our intellectual property and third-party intellectual property;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the pricing and reimbursement of our product candidates, if approved;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our estimates regarding the impact of the novel coronavirus, or COVID-19, pandemic on our business and operations, the business and operations of our collaborators, and on the global economy; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our aspirational goals and objectives related to our human capital resources and workforce objectives; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to attract and retain key managerial, scientific and medical personnel;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the accuracy of our estimates regarding the sufficiency of our cash resources, expenses, future revenue, capital requirements and needs for additional financing; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our financial performance.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All forward-looking statements are based on information available to us on the date of this Quarterly Report on Form 10-Q and we will not update any of the forward-looking statements after the date of this Quarterly Report on Form 10-Q, except as required by law. Our actual results could differ materially from those discussed in this Quarterly Report on Form 10-Q. The forward-looking statements contained in this Quarterly Report on Form 10-Q, and other written and oral forward-looking statements made by us from time to time, are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, and you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Factors that might cause such a difference include, but are not limited to, those discussed in the following discussion and within the section of this Quarterly Report on Form 10-Q titled &#x201c;Part II, Item 1A &#x2014; Risk Factors&#x201d;.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, statements that &#x201c;we believe&#x201d; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">All brand names or trademarks appearing in this report are the property of their respective holders. Unless the context requires otherwise, references in this report to &#x201c;Kodiak&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d; refer to Kodiak Sciences Inc. and its subsidiaries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ii</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SELECTED RISKS AFFECTING OUR BUSINESS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investing in our common stock involves numerous risks, including the risks described in &#x201c;Part II&#x2014;Other Information, Item 1A. Risk Factors&#x201d; of this Quarterly Report on Form 10-Q, any one of which could materially adversely affect our business, financial condition, results of operations, and prospects. These risks include, among others, the following:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are in the clinical stage of drug development and have a very limited operating history and no products approved for commercial sale, which may make it difficult to evaluate our current business and predict our future success and viability. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have incurred significant net losses in each period since our inception and anticipate that we will continue to incur significant and increasing net losses for the foreseeable future. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Drug development is a highly uncertain undertaking and involves a substantial degree of risk. We have never generated any revenue from product sales, and we may never generate revenue or be profitable. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our prospects are heavily dependent on our KSI-301 product candidate, which is currently in clinical development for multiple indications. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A failure of KSI-301 in clinical development may require us to discontinue development of other product candidates based on our ABC Platform. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development of biopharmaceutical products is inherently risky. We cannot give any assurance that any of our product candidates will receive regulatory, including marketing, approval, which is necessary before they can be commercialized. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may encounter substantial delays in our clinical trials, or may not be able to conduct or complete our clinical trials on the timelines we expect, if at all. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may encounter difficulties enrolling patients in our clinical trials, and our clinical development activities could thereby be delayed or otherwise adversely affected. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our clinical trials may fail to demonstrate substantial evidence of the durability, efficacy and safety of our product candidates, which would prevent, delay or limit the scope of regulatory approval and commercialization. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may retain their market share with existing drugs or achieve regulatory approval before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize any product candidates we may develop and ultimately harm our financial condition.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The manufacture of our product candidates is highly complex and requires substantial lead time to produce. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have no experience manufacturing any of our product candidates at a commercial scale. If we or any of our third-party manufacturers encounter difficulties in production or fail to meet rigorously enforced regulatory standards, our ability to provide supply of our product candidates for clinical trials or our ability to provide the information needed in the regulatory dossiers for our BLA filing, or our ability to supply our products for patients, if approved, could be delayed or stopped, or we may be unable to establish a commercially viable cost structure. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The regulatory approval processes of the FDA, EMA, NMPA and comparable foreign regulatory authorities are lengthy, time consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates, we will be unable to generate product revenue and our business will be substantially harmed. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We plan to conduct clinical trials for our product candidates outside the United States, and the FDA, EMA, NMPA and applicable foreign regulatory authorities may not accept data from such trials. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to complex and evolving U.S. and foreign laws and regulations relating to privacy and data protection. These laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, or monetary penalties, and otherwise may harm our business.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we or any contract manufacturers and suppliers we engage fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to rely on third parties to conduct many aspects of our clinical trials and some aspects of our research and preclinical testing, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">iii</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to obtain and maintain patent protection for any product candidates we develop or for our ABC Platform, our competitors could develop and commercialize products or technology similar or identical to ours, and our ability to successfully commercialize any product candidates we may develop, and our technology may be adversely affected. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If the scope of any patent protection we obtain is not sufficiently broad, or if we lose any of our patent protection, our ability to prevent our competitors from commercializing similar or identical technology and product candidates would be adversely affected. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party claims of intellectual property infringement, misappropriation or other violation against us or our collaborators may prevent or delay the development and commercialization of our ABC Platform, product candidates and other technologies. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time consuming and unsuccessful. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are highly dependent on our key personnel, and if we are not successful in attracting, motivating and retaining highly qualified personnel, we may not be able to successfully implement our business strategy. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is currently affected and could be materially and adversely affected in the future by the effects of disease outbreaks, epidemics and pandemics, including the ongoing effects of the COVID-19 pandemic. The COVID-19 pandemic continues to impact our business and could materially and adversely affect our operations, as well as the business or operations of our manufacturers, CROs or other third parties with whom we conduct business. Our manufacturers are also engaged in the manufacturing of COVID-19 related vaccines and therapeutic treatments, and the success of and demand for these vaccines and therapeutic treatments means we and our programs are competing for scarce manufacturing resources.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">iv</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.0%;"></td>
    <td style="width:81.583%;"></td>
    <td style="width:10.417%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART I.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ifinancial_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">FINANCIAL INFORMATION</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Financial Statements (Unaudited)</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_statements_operat"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_statements_stockh"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Stockholders&#x2019; Equity</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_statements_cash_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_unaudited_condensed_consolidate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_quantitative_qualitative_disclosu"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART II.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iior_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">OTHER INFORMATION</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_unregistered_sales_equity_securit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_defaults_upon_senior_securities"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Defaults Upon Senior Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_exhibits"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibits</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Signatures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">v</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ifinancial_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART I&#x2014;FINANCI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AL INFORMATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. Financi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">al Statements (Unaudited).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolida</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ted Balance Sheets</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.497%;"></td>
    <td style="width:1.605%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.67%;"></td>
    <td style="width:0.946%;"></td>
    <td style="width:1.605%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.67%;"></td>
    <td style="width:0.946%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30,<br />2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31,<br />2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current assets:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_66e6b67c-557d-46e1-ab4e-cda30959c832" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">799,247</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9183104e-300a-424d-944d-3d254a128f04" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">944,396</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_96f66858-c650-49ce-8733-f803beb8d6ee;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8273ff4a-cbb8-406a-9d56-b50b123a0024" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,578</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_060b81ad-5932-49db-8d4d-aac1f4a567c3" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,259</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_127c16b7-f27c-4379-95a3-f241c780f728" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,031</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f84620b2-6394-465d-956a-a2fce72106c3" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">805,506</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e378dcfb-5b52-4e98-a1c6-f48fa7e9a579" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">972,005</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fad4ced4-5c74-439e-9a98-5033489239a6" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,324</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e5204813-03f7-4f56-b2a3-12df7028162e" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,324</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef9e9043-0716-4bf4-bfa4-ce478e379093" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,939</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3240d88f-f46b-47b4-abb2-51f0ac99ad1c" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease right-of-use asset</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_826fdec1-e27c-487e-88b7-bb7772828b3d" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">68,450</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_033a98e2-738f-4a2f-b3d0-7ea46ab9526f" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">73,672</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c9ec90d7-45fc-47b1-97bd-34d575d14391" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,987</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c0a8b782-d5e5-47c3-b843-7c325c906bc9" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,210</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee50e1c5-de96-4d5b-93e8-72c040a8e14b" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">958,206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3d0a618-36c9-48e8-b3e8-e1be0fb4286d" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,067,347</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liabilities and stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee0e1854-8d3b-4856-a28a-0326721a190c" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,761</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a8e5c56-152e-47fe-b3d1-2a540564e5d7" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,646</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e4004e5f-d934-4b66-a1e4-a64f91e5d1a7" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,016</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2ede3df7-04d6-4c67-8d24-251851e25012" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,402</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liability</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e8efc659-b8c3-4909-9427-ace7832d6169" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,619</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9fde576-ab9d-41a1-a2a3-3ad5ffdc3388" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,374</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6b40e12-d41d-49a3-9b32-5ea36f2dc228" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,396</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83c75ea1-faa7-406e-b880-0f8b8191eb90" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,422</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liability, net of current portion</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_40805e5d-71d1-4e77-8b1c-5e21aee2507d" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">77,338</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee3c7b08-d310-434c-bc81-f8641ea0dc4c" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,028</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Liability related to sale of future royalties</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_325ae013-ef92-44b1-b6a8-c8e156d3b575" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="kod:LiabilityRelatedToSaleOfFutureRoyalties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,929</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_481a935f-55f4-41e5-a5a6-047ccc6473b5" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:LiabilityRelatedToSaleOfFutureRoyalties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,890</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e52ef9fd-7763-4acf-9f2b-fe0e10cd12a8" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">223</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_efe8e892-1c52-4beb-863a-3cd1ed2f66ba" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">256</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5d52716f-4b5c-478e-b697-0f28d1c32eca" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">231,886</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4c968098-ed84-4d03-9313-bbeb78a2f7b6" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">206,596</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Commitments and contingencies (Note 6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stockholders&#x2019; equity:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfff1a42-fdb4-44d1-afc4-97af41334fb7" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_a7233710-d205-46a4-8113-ba636eb31c59" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;par value, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c2502c61-12c2-43bc-a004-256f68c76458" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1a6cc49b-5f34-4cfa-958a-b84a9bed708b" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares authorized;<br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50916c3d-d7d9-4780-a686-ff9e3f35956a" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_cbbb80d1-8001-419a-9ffd-e7c3daf2c4bd" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_00100896-3d95-48c1-9370-8e532a501c02" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_32230284-6045-4095-b52f-3e7583e89f17" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding at September 30, 2021 and <br />&#160;&#160;&#160;December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_cfc22e00-db77-4e36-b02a-b9cbdc4da455;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_50422e85-346c-4b9e-a26d-7837cf373b79;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c4631a55-6414-4517-b70c-3fbe44cf0ae3" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_ed899a50-0e25-449e-aa03-0254e34cd905" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;par value, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_90b998ad-fe86-4d33-b805-4371d57cc233" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_2117ea6a-0a8a-4ce0-9ef9-99d25ffe1663" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">490,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares authorized <br />&#160;&#160;&#160;at September 30, 2021 and December 31, 2020; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9603a737-4bfa-4312-8b59-0c7caf6f695f" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_975df73f-7752-4c63-9c49-08bf592d44c2" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,698,775</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and <br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d1da0f2-bafe-4c95-8415-66484cd96c95" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_019ba8c6-2da2-48d9-8801-267530664c80" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,112,302</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding at September 30, 2021 and <br />&#160;&#160;&#160;December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3e2c8b77-2775-41b4-9f83-3e9a977038d9" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0a9dc88e-4f43-4082-a598-65acbc0da54f" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7fc8aae7-6669-4b04-9770-d1fd67df87ae" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,191,367</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a59589c6-7b4a-4868-96f9-187285aac15f" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,151,920</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated other comprehensive income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2f1ee712-59aa-4bc8-a15c-9f4c6b71c5bf;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aeb35704-123c-4448-af00-a60af770c075" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d2dbe90f-e0eb-40a8-81db-adb7b6a0c869" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">465,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f0a319c-5750-46e7-9d9d-3a276bf8dbdd" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">291,227</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_deedcf78-1a98-4863-9cd7-dfe657dd7a92" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">726,320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4395df54-c7fe-4069-ba75-290baedf501b" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">860,751</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities and stockholders&#x2019; equity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7fda42ed-49b3-4a40-90bb-758073fdf525" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">958,206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f07d9939-4f80-4972-919b-2528cfc96716" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,067,347</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_statements_operat"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statements o</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">f Operations and Comprehensive Loss</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.789%;"></td>
    <td style="width:1.169%;"></td>
    <td style="width:1.512%;"></td>
    <td style="width:9.138%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.169%;"></td>
    <td style="width:1.512%;"></td>
    <td style="width:9.138%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.169%;"></td>
    <td style="width:1.512%;"></td>
    <td style="width:9.138%;"></td>
    <td style="width:0.983%;"></td>
    <td style="width:1.169%;"></td>
    <td style="width:1.512%;"></td>
    <td style="width:9.138%;"></td>
    <td style="width:0.983%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6993fbc9-4ea1-4c26-9729-44382853ace9" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">56,002</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c7c5ea0-7e08-467d-a5b3-39e75204ba7c" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,306</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c67554a-89ec-426e-bf39-32cd5b0db03d" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,743</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fc3a287c-bb6f-4ac7-8b4a-db57661018bb" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">70,033</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc6c6afc-b2f1-4656-aa2c-2ec7c46c59dc" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,533</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50669ace-1303-4619-a848-cc58b459986a" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,357</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50991de3-f35f-4c73-af42-51db0ec457cd" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,259</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_218ace46-6f8a-4707-a916-944e0de6f83e" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,132</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aac0af49-648f-4127-83c3-bee96ce4a941" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">67,535</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_074fe34a-fdc4-4dd6-8e22-c7f34f7c47e0" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,663</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_61d54eb6-ff0f-4c60-86c7-59679eec8716" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">174,002</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3462d9f7-ff57-451f-8ae7-aa35e48f0e03" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">89,165</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e4062dc-b261-4b3b-ba5d-f4eee490b4be" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,535</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1b08b0d8-dd34-410e-90f6-99ffb80200d8" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,663</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2c61b710-4421-436e-a8c5-1d904bdd79d6" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">174,002</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_245aacdc-248c-4de5-9d29-ebf41a2e14d7" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">89,165</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2facd6b8-51d1-43b6-abe7-4583c9f3a35a" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad7affb9-ee57-47b7-9a33-ea174489e204" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">645</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fbc36954-4f4f-4aad-a212-bda614d93643" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">270</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_56311302-963e-4b23-87e6-7da110262169" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e4522fd8-0049-4bcf-839c-98b30d0931b6" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7ce03ab7-c61b-40b7-94bf-13365481d8c6" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c2c3614d-c5ed-43e5-a327-cf94406609d3" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a65c5a2e-7d52-4674-9b4d-512e54994f66" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_99133f17-6a53-457e-a06d-540008405dcd" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_30aa48bf-5cef-46ec-b3fe-2fbca3da2551" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">98</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_672b2efd-765c-4109-bc4a-ea5195e2ff52" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">76</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b67d5586-167e-496b-9be1-5bf1b1345af0" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f60d510-fa53-4d38-8338-e234d87888b6" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b6e628e-2644-413f-ab94-1717a9dd4729" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_15c03310-6b69-4d33-881e-9f8525f69708" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">173,825</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4dbe3215-5a73-42d8-8776-1a7844c4fbca" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">86,513</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per common share, basic and diluted</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f6d24125-d340-40a9-a6de-a1608fe3afdd" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">1.30</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a6d607ee-7930-46da-863e-91a4d0ed6138" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">0.80</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e49fc7d-2f0a-4a38-a5ed-c1f27d1ea8e2" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">3.36</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f6fef830-67f1-4dd2-b877-2684bae0d1ff" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">1.92</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average common shares outstanding used in <br />&#160;&#160;&#160;computing net loss per common share, basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f5d12f5-e1a9-4fe3-b87c-7d1d08954355" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">51,875,315</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_311c6475-64c4-4586-b7aa-9d0a58d69c1c" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">45,119,885</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b453503-317f-4f72-95ef-61f99ccd0f12" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">51,722,611</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2df12904-7b77-4679-a6ed-b44993add364" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">44,972,085</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other comprehensive income (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in unrealized gains related to available-for-sale <br />&#160;&#160;&#160;debt securities, net of tax</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c25afc90-f5d1-4357-a755-f84b78f0381f" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_527c2f39-4917-4ef3-b6db-c819e45c78f8" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">349</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_51a53219-ec23-48f2-bd5e-3a095ed69ddb" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9b728d84-e211-42af-ae9f-425d1d7d1182" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total other comprehensive income (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4928147d-6d23-4d66-8712-5daedb356d61" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d2905ada-5c44-4443-aea8-6052b44f35b7" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">349</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8a14376f-b405-4575-ad76-eb305d51ff15" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07c98062-3969-4f9d-83c3-63ee8548179d" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c6117fc6-e425-49fd-997e-5870f32268e4" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_39aca8c2-44a6-4aed-8261-5e377ff8c19f" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,471</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e8f841fa-c139-4ba6-a25a-5ccf1461efda" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">173,878</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_33dd01bd-5c85-495c-b2de-832f4e5a989d" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">86,278</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_statements_stockh"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated Statem</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ents of Stockholders&#x2019; Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:23.256%;"></td>
    <td style="width:1.197%;"></td>
    <td style="width:0.538%;"></td>
    <td style="width:10.464%;"></td>
    <td style="width:0.538%;"></td>
    <td style="width:1.197%;"></td>
    <td style="width:1.085%;"></td>
    <td style="width:9.907%;"></td>
    <td style="width:0.538%;"></td>
    <td style="width:1.197%;"></td>
    <td style="width:1.085%;"></td>
    <td style="width:9.796%;"></td>
    <td style="width:0.659%;"></td>
    <td style="width:1.197%;"></td>
    <td style="width:1.085%;"></td>
    <td style="width:10.13%;"></td>
    <td style="width:0.659%;"></td>
    <td style="width:1.197%;"></td>
    <td style="width:1.085%;"></td>
    <td style="width:9.796%;"></td>
    <td style="width:0.659%;"></td>
    <td style="width:1.197%;"></td>
    <td style="width:1.085%;"></td>
    <td style="width:9.796%;"></td>
    <td style="width:0.659%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Additional<br />Paid-In</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated<br />Other<br />Comprehensive</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total<br />Stockholders&#x2019;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Income (Loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Equity</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8fce2638-3770-4593-898f-6d71a1733d0d" contextRef="C_43f639e8-9157-46d6-99bf-779d020c83ec" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,112,302</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3fa5f83a-43e2-4ce1-b619-f008c4adf168" contextRef="C_43f639e8-9157-46d6-99bf-779d020c83ec" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0baf3ac-14fd-46a5-b91d-b8b0c307848b" contextRef="C_88e8f9d6-793b-4b92-a798-5c12f7a88303" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,151,920</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc6df689-7261-4dc8-81eb-7c648540ee26" contextRef="C_e2bbe6b4-f70f-4f1f-81ce-fdcefcfcd7b0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4274756b-06f9-4886-a46b-f9b83eb1ef2f" contextRef="C_cbd92a0e-372f-48a4-b6d5-ce7f82ea665f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">291,227</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e783910-df2a-4834-8af1-eafc08ba2740" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">860,751</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c00c2e19-d47f-4383-9d29-11c45a235b4e" contextRef="C_52fd169e-6778-4b75-87b8-41bfa51538a8" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">113,559</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f476eef6-5892-4773-a84e-0e1d35656315" contextRef="C_94e0829a-4192-4195-b797-aa8cc430a181" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,483</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5eefa4a5-1783-4eed-b044-bd2e1dafe9cc" contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,483</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d2fa0da-bbae-4c4f-9743-9f7c7b406947" contextRef="C_94e0829a-4192-4195-b797-aa8cc430a181" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,925</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_77182f56-d5df-42d0-b589-445d8bc4f5ea" contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,925</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ca6d097-8180-434d-bbb5-5d94541cc1bc" contextRef="C_2ca048f5-d8ec-4b11-8cd8-2132a593856e" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_718a9e4f-70ec-4325-8d9c-6c320209db7f" contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b13cf4a-4db1-4e69-b4a0-01da14a870ec" contextRef="C_e3632781-f643-46dc-88ab-1cd6c0123800" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">50,447</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_300d4627-d15f-48fc-b57c-dd7fd1d6642d" contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">50,447</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at March 31, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a0538bab-73cc-4649-9ce1-1d55120b21e9" contextRef="C_9ffaaef7-e461-404c-aa29-30c8c1054bbb" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,225,861</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3427678-63cc-4d59-ba67-050cbb9529a2" contextRef="C_9ffaaef7-e461-404c-aa29-30c8c1054bbb" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5fef65f8-ff2e-47c1-9254-b7996b31907c" contextRef="C_e95e0f4c-377f-4358-8d44-eaa863f82dcd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,163,328</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ac9ee461-25a2-414d-b8ce-9e8a91e5a776" contextRef="C_e681ec89-e92b-43ad-b6d0-5e7aad790ff7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_217d7d71-deda-4c41-9a8d-ec72fb5045ae" contextRef="C_a0bf9017-3374-4d04-9d4e-2d55c59dd283" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">341,674</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_13d8d845-890d-490d-bb68-fd88111a0b9e" contextRef="C_ccfa3f6d-89ca-4e36-8c0f-12d38600ca8b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">821,677</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f766e3c1-824a-4492-880a-512bd5d809fb" contextRef="C_a99bad54-886c-4f22-a572-c4f604a8eef5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">131,276</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c62866aa-7519-4836-818c-445bb2018e7e" contextRef="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa4a3678-f6d6-41c2-a825-3d66c90a37e3" contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;vesting of restricted stock units, <br />&#160;&#160;&#160;net of taxes withheld</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3f355c5-2cd8-4a97-91aa-a3d4390d84f8" contextRef="C_a99bad54-886c-4f22-a572-c4f604a8eef5" name="kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">72,976</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock pursuant <br />&#160;&#160;&#160;to employee stock purchase plans</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d29f80a-44ad-4270-92af-d1cd603bc9ca" contextRef="C_a99bad54-886c-4f22-a572-c4f604a8eef5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">4,295</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4e0c4fd6-b52f-4101-943d-bfe6a2ce0a76" contextRef="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">305</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fce88acd-5ff3-44c0-a36a-795481408f79" contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">305</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a058887b-8e96-4f53-8c12-3d7f95cfd9ab" contextRef="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,087</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b9a6f4b-32b3-49e3-9038-bd06899a4c3d" contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,087</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa768a4a-2f07-4d5f-a132-25be32f81dec" contextRef="C_61ad6d79-e0a3-4c3a-9112-71b6fcbfb724" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_72ce3ae4-2a9a-45b8-bed1-801e4764b49d" contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c1777cfb-1084-4370-a139-ef6b78ec580b" contextRef="C_8ca588ac-2ea8-47e2-9e1e-0d5c0f7bdd04" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">55,852</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa6e668e-748d-4142-a8ff-023cce434358" contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">55,852</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at June 30, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_60b785c8-836a-4b18-810b-20a86ed9192d" contextRef="C_8cafabb9-2fa4-4282-a961-4356c77480d5" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">51,434,408</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ff20ec1-c674-4117-90a7-b863aa336a6e" contextRef="C_8cafabb9-2fa4-4282-a961-4356c77480d5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4cfc3679-9f45-452f-81af-a5c9bddf5fdd" contextRef="C_282bfd4f-0e6c-4f01-ad36-409ab1c8d1c5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,176,948</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3f349dc-3864-4eac-9622-c60810a1539e" contextRef="C_a2ce11da-0bb4-4016-be57-12f7208128b8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f9b588e-9c8d-44cf-a643-5becb50cf28c" contextRef="C_66006d13-4030-4015-b889-1afb6b097dca" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">397,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59a1897f-8e28-4b1c-a4f0-eef99765e5b3" contextRef="C_20bef648-9662-4045-ac10-f374a4e6dd4a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">779,427</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eb208561-e29d-46c5-b407-198f4d7c4f18" contextRef="C_1e740a6d-5b59-4139-b143-25fb54883059" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">103,585</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74ddde03-e730-44da-b56a-c9e69609f38f" contextRef="C_7b2909d7-cea1-4df1-9529-fa4f0d2242dd" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,042</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_745a4aa6-3978-46a1-ada4-76c9d486e166" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,042</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;vesting of restricted stock units, <br />&#160;&#160;&#160;net of taxes withheld</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_245f3589-2232-4d23-90f0-5cd13f81e807" contextRef="C_1e740a6d-5b59-4139-b143-25fb54883059" name="kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">10,799</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of common stock warrants</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e620079a-0cbf-4994-ad8f-3f35d994ac3d" contextRef="C_1e740a6d-5b59-4139-b143-25fb54883059" name="kod:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">149,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3fbb225e-e882-4b34-992f-b04b5a8e6f7f" contextRef="C_7b2909d7-cea1-4df1-9529-fa4f0d2242dd" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,377</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_79ed73a3-5c9e-418d-ae33-a4fc597b3a35" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,377</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_805cb883-64b5-4fd4-82c6-fb55e368fe72" contextRef="C_d8945418-7878-462f-88bb-8634543ad049" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a9530c25-7079-48bc-af68-1a299df0ea60" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at September 30, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fc9f3630-73f3-4787-9811-1ccf049b770e" contextRef="C_a00f1dc8-2c72-4c4b-a537-1e6bd1510eb4" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,698,775</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9592aa4e-43e7-4fd8-93ae-0378d3b39287" contextRef="C_a00f1dc8-2c72-4c4b-a537-1e6bd1510eb4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_21746f78-db09-4c8c-9b51-7132a7b6cbfd" contextRef="C_f3d83275-b94c-473f-9d84-d4f80ce062b9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,191,367</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5425fbd1-6229-4570-bce2-dea283594eb1" contextRef="C_463882b0-53f7-46b3-9143-d473f7db2d44" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6dda53d6-ed74-4ba5-ba01-52823ffdcbb0" contextRef="C_3d5599e4-af21-4a80-b2fa-9f50ffb8ff68" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">465,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_95c78717-066f-422c-a572-3a6080641c97" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">726,320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Additional<br />Paid-In</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated<br />Other<br />Comprehensive</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total<br />Stockholders&#x2019;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Income (Loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Equity</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at December 31, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_949a0ccb-6c23-4f3c-a7dd-c203fdf47290" contextRef="C_9aef3e3a-3ea0-45c0-bd9f-ebf158d52e18" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,413,404</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e4f3c12-7f7e-46bb-adf4-25a17ea34758" contextRef="C_9aef3e3a-3ea0-45c0-bd9f-ebf158d52e18" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fad37c05-d461-4fe4-a0f5-5eb03eebbb57" contextRef="C_86dc39fd-f86e-42e3-9bd9-ba7b697a9ddf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">503,475</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7a3941f3-4435-41b2-9550-396a9456005d" contextRef="C_94d38241-9b26-4db5-b401-ca5bf21d7968" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e9195abf-2259-460b-b574-ff999c73a9ef" contextRef="C_7d6f728e-e9d4-4671-bc36-35fc3079d423" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">158,131</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c51c4c3c-fa35-41e6-ac78-90df270dbcff" contextRef="C_5c21659f-1cec-4a85-8710-24968233ef93" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">345,359</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a0144f3d-6c36-4edf-aa8c-807a38675572" contextRef="C_3bb54cbe-545d-4fe0-bcd2-19e483d491f6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">39,297</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f1fd432-67e2-4d5d-80d5-88fb67061732" contextRef="C_3bb54cbe-545d-4fe0-bcd2-19e483d491f6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ddc3caba-9873-46c2-9873-567cb4c32681" contextRef="C_9b59a0e5-e47e-4121-b018-a86d491ac673" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">159</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b9487edd-f499-463e-abad-8d3af2d43489" contextRef="C_12553a8d-237a-4ea4-b220-6b9e18798500" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_31859ea7-4441-457c-81bf-f58990aa5799" contextRef="C_fad684c8-cc78-4067-ab73-24cb363807a6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_399141e5-e2b2-4e9f-b350-080dea5d8cfb" contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">159</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b09f2cb2-40ec-4f59-84b2-cb2385ba2eaa" contextRef="C_9b59a0e5-e47e-4121-b018-a86d491ac673" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_00302626-db3a-4a23-9589-2e2863fda742" contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Other comprehensive income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da17cbe4-afea-4d56-bb3f-30f5bcc8dfb5" contextRef="C_9b59a0e5-e47e-4121-b018-a86d491ac673" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b863cacc-37dd-414a-b961-533961fe2ac4" contextRef="C_12553a8d-237a-4ea4-b220-6b9e18798500" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">479</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ec18cfe-5c47-4ed0-8c7d-6a1182f603ea" contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">479</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d3a5c09-4836-426a-bee5-8617904b36e6" contextRef="C_fad684c8-cc78-4067-ab73-24cb363807a6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">24,392</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_95d6b559-ddbc-45ce-853b-e8f90191c1be" contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">24,392</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at March 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9a5de393-44c7-4337-8c1a-74a311315ff1" contextRef="C_508f6cdf-9b62-49da-86b7-10e38cc856c3" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,452,701</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa4e1afe-1c57-4981-b3f8-4c6dda8f5ab1" contextRef="C_508f6cdf-9b62-49da-86b7-10e38cc856c3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c46c202-2303-4fe1-a04e-ef1062ca7a50" contextRef="C_9bb106de-f5c9-411f-80cc-5611a5510340" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">509,716</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5841283e-51a5-4f80-9344-74af393073ef" contextRef="C_60ee5be9-fce8-4ec2-9433-83baa13390dd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">489</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7660caf-d45e-4e68-ba64-c029d7ff817b" contextRef="C_dbe6d2e0-e108-4f31-b4a9-aabc9eee0627" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">182,523</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ccbbb980-f372-43db-9da9-eddac9c3dcbb" contextRef="C_68a9be7d-3755-49bf-a2da-42390bcb4eec" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">327,687</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b37b4ca4-ac7c-4e87-b997-cabf0f769adc" contextRef="C_4ed3c78d-73cb-40d0-9e64-ce6ba2494412" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">203,373</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e0ace173-75b0-4cc6-afa7-92af4a5664a9" contextRef="C_c60273c5-32a1-4ece-91e4-ddb660a10670" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">720</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_773ec649-a624-4571-ba1e-fc6af24f8d6a" contextRef="C_99a56596-b12a-4053-a88d-44e605f7dfab" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_31069858-316a-4aba-a0a0-6c50956ce949" contextRef="C_132bd18c-61d8-48f7-809f-8bb8b165fbc1" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48b6f12e-fcee-4062-a3c3-c345456ac9c7" contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">720</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;vesting of restricted stock units, <br />&#160;&#160;&#160;net of taxes withheld</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed5f4981-42ba-4d57-92e2-69f34955d680" contextRef="C_4ed3c78d-73cb-40d0-9e64-ce6ba2494412" name="kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,942</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e71d0a1c-fb2e-401e-a2ca-2950127f384b" contextRef="C_c60273c5-32a1-4ece-91e4-ddb660a10670" name="kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a8afb9a-346f-46ad-9efe-a7c362f93296" contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672" name="kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_66355f45-b401-4682-be11-90bfb3afc3dd" contextRef="C_c60273c5-32a1-4ece-91e4-ddb660a10670" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,890</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8603b7e7-6f9a-4fbe-965e-76dc10d0ba38" contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,890</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Other comprehensive income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_583b627c-f25d-4c93-b24f-9f8f8a8946d3" contextRef="C_99a56596-b12a-4053-a88d-44e605f7dfab" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">105</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6ca8713-51bc-47fc-8198-33f3558f09ad" contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">105</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dae84e3e-3f1f-452b-b5de-61f85b659e79" contextRef="C_132bd18c-61d8-48f7-809f-8bb8b165fbc1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">25,999</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c72264d9-32cd-4c46-bf43-39f0ab164de1" contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">25,999</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at June 30, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_093fd6e6-bdba-455d-8774-e437c9471ade" contextRef="C_63e78694-19d8-46fd-86b4-4a74be843c5f" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,667,016</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0b749c87-f2c0-4ef4-9230-d055a98cb1f9" contextRef="C_63e78694-19d8-46fd-86b4-4a74be843c5f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7e91fd6-5e49-4225-a099-457e36c180de" contextRef="C_5ab89046-dcd8-48bc-ba35-9efd3fc2e6e4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">517,120</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f63116c1-a680-4001-8355-8ec85dcdf38e" contextRef="C_b41ae94c-ea21-43b0-b06e-03ad6d4cf023" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">594</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_39292583-01b8-488b-8b85-5e4155735c6b" contextRef="C_7dbc5e36-5dc0-495f-8dc7-02933e453b0d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">208,522</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8babbafc-8cbc-4bdb-a400-12f2064851fc" contextRef="C_1f61b024-5ca7-4987-be9f-a79fc65f9ac7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">309,197</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon <br />&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_113423f5-bb68-46e0-8468-82de59cd04d2" contextRef="C_be29e469-1e89-4c7e-9ad6-caa85930c9fc" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">93,497</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc8675be-c90d-4eb7-a11c-8e675bdff743" contextRef="C_f799a588-4775-46ae-b373-fdba49e2b7b8" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">813</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_674db454-f6e3-4468-81ae-1b39fa14fa43" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">813</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d160dc6-70f9-452a-a92c-78c33d2fd53c" contextRef="C_f799a588-4775-46ae-b373-fdba49e2b7b8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,241</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f480208-6efd-4411-b6fe-abe14b3b7263" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,241</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c16f876c-1657-4b86-8aaa-15f09293d82b" contextRef="C_b726a636-8b47-460e-ae59-7f6272c15d60" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">349</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3682616d-1c52-405c-b1e0-0c1c6063c0af" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">349</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_619f63cd-2341-4adc-ba20-63e5c8adc57e" contextRef="C_b596f86d-2557-4336-bacd-b0ddf9d1d545" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f5048304-4c72-4870-9f99-67065fdbbe14" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Balances at September 30, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_144e2c8a-05a5-4ba6-add8-f6c428760acf" contextRef="C_be8eee73-1f79-40e1-81dc-2113994bd9a8" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,760,513</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20052142-0d69-463d-9187-1bd64617aea7" contextRef="C_be8eee73-1f79-40e1-81dc-2113994bd9a8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19caf882-a2f1-45ad-a3fe-439a5ad434ef" contextRef="C_8f8f672c-7b89-45db-8898-94025bfd6f08" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">526,174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_66b1b4f1-de1d-4a1b-81ea-3112ae99390e" contextRef="C_f34844dd-a0dc-4745-aaa5-323fb87a0df9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">245</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5ff4cdef-80d1-4646-8fb3-533c41e70426" contextRef="C_a7ae9458-f493-45a2-8df8-95b502b2f850" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">244,644</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b84e934f-34f1-45c5-9d8a-5528c64cd6a1" contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">281,780</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_statements_cash_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Condensed Consolidated S</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">tatements of Cash Flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Unaudited)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:65.94%;"></td>
    <td style="width:1.595%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.735%;"></td>
    <td style="width:0.992%;"></td>
    <td style="width:1.966%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.717%;"></td>
    <td style="width:0.992%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9fde0a87-b6df-48f6-8d60-4dec15aea4d8" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">173,825</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4de1c213-0313-4911-8bd9-18b3132f1601" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">86,513</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_69423c0e-99e1-426b-95f6-73aa7f73ec19" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">722</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4e79b431-d646-4164-b0ba-350bf6dea6d4" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">317</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eed26ceb-2016-4d50-8080-7e0c3b16e1d9" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,389</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9a314945-e4f2-4d36-94b0-e49c5cf5bb80" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,213</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization (accretion) of premium (discount) on marketable securities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_906bafce-fe3d-47c2-a112-00e338066036" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1feb9db1-9d82-4ddf-a8be-b27b928c6a04" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">145</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization of operating lease right-of-use asset</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_29cf547f-faba-434c-98db-97add1d43566" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:OperatingLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,811</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6beb249c-0ae0-4fc2-bc0b-6b83bcbbcb86" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="kod:OperatingLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,793</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization of issuance costs</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0feb38a4-7606-4b26-989a-7a21808ca0ef" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:AmortizationOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44b938a4-d55f-4db2-88ca-9a767386f7be" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="kod:AmortizationOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in assets and liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_522025a8-979b-4216-a0fa-d47a37639580" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87a6448f-935a-481f-856d-aff875a2c678" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,518</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6ec7e3f-d91a-45d2-871c-0f5519bda65b" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">936</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0f8ec88-e312-41dc-a556-214f064aefed" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,654</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e359072-2b69-44fb-b7c2-1a7fb0943ef6" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,255</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aba87f53-cffa-42ed-9729-4084a1f1ae89" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,616</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17c8d5bc-cf53-455b-969e-50057f2f8d9d" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,547</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f3c5396-8670-4dcb-9794-858c5f81b0f6" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,566</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liability</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb228352-bfed-4272-8cdc-840259a5e48b" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">966</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ea250a6-1925-411b-9f9c-0cdf71a8fdae" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="kod:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">156</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c3c0dd6-1227-4a19-a493-683446bc8afe" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">123,235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f5462b6-04fd-4daf-9f91-9307f4b54798" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">56,409</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from investing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchase of property and equipment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_84fec07a-7b9a-426c-93cf-4627db5fefcf" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,598</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b85dc14-3edc-44d1-9e05-ac0294ca63a2" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,855</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deposits on property and equipment</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c07ee7da-eb71-4456-b91c-bf6e3343871b" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:DepositsOnPropertyAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,841</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f74cb3a3-f286-4f41-9a8a-e66c69c4f0e1" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="kod:DepositsOnPropertyAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchase of marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_88e8e4c2-b657-4059-8faf-a16f78eacdc8" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf4ae4f3-91d1-48fc-afdc-fff6be100870" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">86,317</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Maturities of marketable securities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1c7c061-628c-4e0f-b7bc-9d65752b269a" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,500</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46de79ca-c381-45d4-976d-34dba01d1506" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,148</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by (used in) investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07953ae9-4313-4589-b0c0-3996dbb20de0" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27,939</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4400157a-9095-42a1-a1b5-6c13126d635f" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,976</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from financing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from issuance of common stock upon options exercise</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6dc660c7-6f9a-4948-9531-d60e9bbfed62" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,753</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0598dc6d-a571-46ee-af29-54c3a95b9896" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,692</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payments for restricted stock units, net of taxes withheld</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7a8acc47-231c-4a68-a11c-d47cae272956" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d749ae71-8fe8-4a7b-9f62-9bb554971cca" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from issuance of common stock pursuant to employee stock purchase plans</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9c05444f-4574-4eab-a510-01d9e1feb3da" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">305</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f4eda1a-8535-462f-8486-3ac64187584d" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from sale of future royalties, net of issuance costs</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7fc441b9-ebc0-456d-a152-ba0388ab5261" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47d679b9-6ae9-403f-b8bf-e5e0b9cca385" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="kod:ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,643</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Principal payments of capital lease</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b1c8bda6-82a1-4438-8b55-82afda4eff60" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71abf6fa-798a-4247-9a7e-70333cce5014" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Principal payments of tenant improvement allowance payable</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_38b85174-0568-4741-a6a9-8fb8dfb0e2c7" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:PrincipalPaymentsOfTenantImprovementAllowancePayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_41ddfab1-03ec-46c9-8e78-9243cac1cb39" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="kod:PrincipalPaymentsOfTenantImprovementAllowancePayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cd3958e2-4321-48be-9ccb-2dcccd607536" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,025</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a2a6cbc6-07a1-4f91-b694-5aca5b0fb36c" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">101,096</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7a103223-0cc0-45fc-8826-fec8fee38b90" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">145,149</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ebe5516-862e-41f3-b336-f599bc880d5f" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90,663</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash, at beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f6558e3-cc7d-4b7c-82f6-13e041b85de9" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">950,720</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6da4dda5-dd77-4b97-8936-5897c345d01f" contextRef="C_5c21659f-1cec-4a85-8710-24968233ef93" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">211,937</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash, at end of period</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9b0561f3-5949-497b-9086-658e69d42bed" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">805,571</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e10c4e7-723f-4c04-a834-d895ddda255a" contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">302,600</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0af06cbd-2e65-41f0-8c15-df688ba4c5a8" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">799,247</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb001218-103c-44b2-9e5f-9f153c93df6f" contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">291,585</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cdc09aad-5934-4984-ae77-fd7abd84caef" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,324</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e455171a-3c37-4d9f-a389-d7825f7d5316" contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,015</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash in consolidated balance sheets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80322ea3-3216-4177-9994-58e4847622c4" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">805,571</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7dc9019-6001-47ac-b37f-5a727cf9b2b3" contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">302,600</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Supplemental disclosures of non-cash investing and financing information:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease right-of-use asset obtained in exchange for operating lease liability</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4d83aba5-f79a-4d7c-bd8e-9a9682fdc3ba" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">583</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc04fd85-0584-43c8-9e11-d262b6edf96b" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,545</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchase of property and equipment under accounts payable and accruals</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ac5beb9-f066-4433-8b21-c8ad6fc7f0ab" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,730</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f4a57188-32f1-466c-893c-43de81ff11fa" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,034</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_unaudited_condensed_consolidate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Co</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">nsolidated Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share data)</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6be47d45-35e2-40a4-9780-c5682380cd12" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:TheCompanyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. The Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) is a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases in the United States and additional international markets. The Company devotes substantially all of its resources to the research and development of its product platforms and product candidates including activities to conduct clinical studies of its product candidates, manufacture product candidates and provide general and administrative support for these operations.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, the Company had cash and cash equivalents of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8f078100-f0ed-46ec-ae10-de9f84903101" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">799.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. Although the Company has incurred significant operating losses since inception and expects to continue to incur operating losses and negative operating cash flows for the foreseeable future, the Company believes that the cash and cash equivalents will be sufficient to meet the anticipated operating and capital expenditure requirements for the 12 months following the date of this Form 10-Q.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_908d9b1e-feef-467c-8901-4379b414b6e8" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b6efd9e-57ed-4548-bf2d-f56e2a67777e" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_90ac75e4-8acf-4c11-9a4c-b5594c043c3b" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd111f8c-fe0d-4a22-a26a-51634773c499" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements (Continued)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82b4196d-6dbd-42d8-821b-9e236d3aec55" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:RiskAndUncertaintiesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company&#x2019;s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company&#x2019;s product candidates, and begin to commercialize any approved products.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2021, respectively, are consistent with those discussed in Note 2 to the consolidated financial statements in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020, except as noted within the &#x201c;Recent Accounting Pronouncements &#x2013; Recently Adopted Accounting Pronouncements&#x201d; section.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_17871a5b-b86c-4b33-a068-c33a05c90335" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true" continuedAt="F_17871a5b-b86c-4b33-a068-c33a05c90335_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ccounting </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">p</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the FASB issued Accounting Standards Update 2020-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Codification Improvements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_17871a5b-b86c-4b33-a068-c33a05c90335_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">New Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:continuation></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ca0a9c3-0093-4898-807e-4cfca0d08a78" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. Accrued and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3524c049-7742-4ab9-ba3f-270273a9a475" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.562%;"></td>
        <td style="width:1.605%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:12.832%;"></td>
        <td style="width:0.752%;"></td>
        <td style="width:1.605%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:12.832%;"></td>
        <td style="width:0.752%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30,<br />2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31,<br />2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued clinical trial and related costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df762753-0892-4c37-913b-563f969a5639" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="kod:AccruedClinicalTrialAndRelatedCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,762</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c2eea3c4-4c94-44ab-a7c3-af536118e014" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:AccruedClinicalTrialAndRelatedCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued leasehold improvements</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81badbde-d0c5-42bb-951c-fe85c1370127" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="kod:AccruedLeaseholdImprovements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,470</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5875fa0-b97c-4bec-80a9-10d0875e9b61" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:AccruedLeaseholdImprovements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued salaries and benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_885df295-5dbd-4f69-86ca-1a2af21cba3c" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,790</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_67f3c3cc-0488-4422-82a6-ed62f7bb21df" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,094</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7afdd3f0-638d-4a59-a936-e343d4947b99" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="kod:AccruedResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,392</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3e265db-d80b-4de9-969e-d0c3e775f298" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:AccruedResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,082</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued legal fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c4797107-f418-41c2-855f-906f1a98186e" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="kod:AccruedLegalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">582</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59623464-5808-4087-bc6e-b919743a30a1" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:AccruedLegalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">252</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued professional fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_16773924-5e8b-494f-965a-db3c9c04edee" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">223</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19b7d38b-333b-4b03-a38b-a84ac495fe2f" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">253</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued other liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f95ea5d2-8d0d-4397-b16b-814bd8adf3c2" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">797</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a53312fa-efa2-49b4-a831-f21b01f98d04" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">583</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued and other current liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_afad6bd3-0f72-426d-a24f-ce1a2d1c8615" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,016</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_68e01038-2318-40f6-b61f-14e03a66147d" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,402</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements (Continued)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e42f243-dbf4-4b0f-be40-49ea3fd2f1e7" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a90867ad-1e27-46b7-a026-c360bc2874bd" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present the Company&#x2019;s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.096%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.521%;"></td>
        <td style="width:9.072%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.521%;"></td>
        <td style="width:9.044%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.521%;"></td>
        <td style="width:8.988%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.521%;"></td>
        <td style="width:9.072%;"></td>
        <td style="width:0.974%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b2ef6511-3bc6-43dc-a1fe-ef7233651059" contextRef="C_f286752f-3bc4-47a6-a27d-666daa7a6ec9" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">762,550</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87ede2c8-15e3-4d9d-a25c-24cd9b977949" contextRef="C_b45963b2-ae18-48d6-8992-a6e27e535c56" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">762,550</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4e67c375-3cf3-455e-9d55-cf6115ad0010" contextRef="C_e739ae0c-05c8-4c3a-9039-0e4e7b4f6746" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">762,550</ix:nonFraction></span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c60fafa-cc92-4e3c-b310-63e1ec5c8f37" contextRef="C_263b39c0-fc6e-4304-804c-806e5d34aa8e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">762,550</ix:nonFraction></span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_572c9b13-3b73-4379-b04c-cba144292737" contextRef="C_f7a3a9d0-55f0-4f98-bd8e-f8ff83d37aef" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">917,485</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f58119a6-a9b9-4d34-95cb-bf2ddbb58783" contextRef="C_3cf9ac24-3ded-44bb-ae89-f866105b17ab" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">917,485</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9272f959-a2a2-445b-93b1-c09a73744f3b" contextRef="C_abb4f15e-cec6-4695-bd11-ddd8693c1243" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e878beb-a826-4c39-804b-0c7c9314e306" contextRef="C_cb05ac74-574d-4580-b0cf-bb252f7fa760" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7c20a4e-0a30-443f-a738-b86342c99779" contextRef="C_e870a142-80e3-4e6a-82c5-2362dbf0e897" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,572</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a89ea449-866e-4975-88a0-fe0d67260472" contextRef="C_76b97688-4be3-49e7-81df-21713ee340ae" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,572</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c48da24-83c8-498a-befa-c1f0201180f2" contextRef="C_7f2795d1-2d93-4f05-944e-15b9e4c3cfa8" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">917,485</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83c13c3f-64ee-488c-bd34-17e51b675f6f" contextRef="C_63179ee0-98f3-437f-a39f-263cdaf44426" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,578</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5e31074-2b84-4e6a-ad38-7aec2190dc5a" contextRef="C_d7b002c3-ab22-4669-b768-13dd644c4c23" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">942,063</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (&#x201c;BBA&#x201d;), which are considered Level 3 inputs.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_925f6ca4-5729-4228-bc66-60671b1da8a0" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Marketable Securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The marketable securities are classified as available-for-sale and consist of U.S. treasury securities and corporate notes. The fair value measurement data for marketable securities is obtained from independent pricing services. The Company validates the prices provided by the third-party pricing services by understanding the valuation methods and data sources used and analyzing the pricing data in certain instances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7cbe1d0-e260-4397-ac6d-3166f91c1218" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:MarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> marketable securities at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d0533254-922a-4979-97a1-efa2f7248d67" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:MarketableSecuritiesTextBlock" escape="true" continuedAt="F_d0533254-922a-4979-97a1-efa2f7248d67_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the marketable securities (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_d0533254-922a-4979-97a1-efa2f7248d67_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.91%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.53%;"></td>
        <td style="width:9.098%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.53%;"></td>
        <td style="width:9.107%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.53%;"></td>
        <td style="width:9.107%;"></td>
        <td style="width:0.974%;"></td>
        <td style="width:1.187%;"></td>
        <td style="width:1.521%;"></td>
        <td style="width:9.023%;"></td>
        <td style="width:0.974%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized<br />Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br />Gains</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br />Losses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair<br />Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_be8b3a12-4687-455b-923d-094b1a12f3a0" contextRef="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b" name="kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,003</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f378d7f3-6c95-44e6-b1af-3afd8dc30788" contextRef="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b" name="kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_76e677b7-39a0-4b88-8dd8-fdc587a9b63b" contextRef="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1814528-27ce-4295-87ce-478c0b502f65" contextRef="C_00c91e92-2084-4178-8614-66b75d51a63e" name="kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,522</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c7c65538-722c-4113-8982-e95bcf8f25a9" contextRef="C_00c91e92-2084-4178-8614-66b75d51a63e" name="kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8a03fd40-0c6c-4947-831d-2348d8111342" contextRef="C_00c91e92-2084-4178-8614-66b75d51a63e" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,572</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total marketable securities, current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e4368cba-a662-408a-8ec1-437d92a90200" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,525</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a97b57b1-b88f-4f3e-8d7c-78300d398996" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ddbe9698-979c-4ee6-927e-887c6debcef9" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,578</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All marketable securities held at December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> had effective maturities of less than </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a16567c2-3631-4094-a814-0cd143788c0f" contextRef="C_4882ce6c-ab65-4041-9b2e-170bdcd25b73" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_adbb875a-1b93-4fb3-b165-a62df0f47e43" contextRef="C_c25a3452-9b30-4001-9008-cd10e3278714" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one year</span></ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dcf0d132-6094-46a3-a015-eb0fd07592d7" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0f2b2167-4b30-4a02-babd-ba5a089e0fb9" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> realized gains or losses recognized on the sale or maturity of available-for-sale debt securities during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three and nine months ended September 30, 2021, respectively and, as a result, the Company did not reclassify any amounts out of accumulated comprehensive loss. As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_42056f4b-dde1-4cec-a3dd-f88272a6bcfc" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_3545ce05-4364-4fac-92e9-6570a9308338" contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> allowance for credit losses for available-for-sale debt securities. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b9430c2-9a32-484d-986b-1bb47cef6b98" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0e61ce1e-22a6-440a-b706-241bb915b9a1" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> impairment charges or recoveries recorded during each of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021 and September 30, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cfdeca1-bb26-429d-8d62-d54da0c79a89" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_7cfdeca1-bb26-429d-8d62-d54da0c79a89_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Embedded Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the Company and its wholly-owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd (&#x201c;Lonza&#x201d;) for the clinical and commercial supply of drug substance for KSI-301. A custom-built manufacturing facility is planned to be completed and dedicated to the manufacture of the Company&#x2019;s drug substance. The manufacturing agreement has an initial term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9c9dd2f-66a4-4505-82e1-fb3c3dee57de" contextRef="C_458e6e92-7030-4315-9600-616198160fdb" name="kod:ManufacturingAgreementInitialTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eight years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the Company has the right to extend the term up to a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3814bd34-21e5-4c04-a8a8-30d5ad6a384a" contextRef="C_31399e52-c5e0-47e5-a93a-23ef7ff40786" name="kod:ManufacturingAgreementTermThatCanBeExtended" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company and Lonza each have the ability to terminate this agreement upon the occurrence of certain conditions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements (Continued)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2021, the agreement was amended to provide for higher annual manufacturing capacity. The Company expanded and finalized the design and scope of the bioconjugate manufacturing facility with a revised estimated capital contribution of approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_98a7d114-e677-49b4-940c-6d6a46bf2ff8" contextRef="C_c938c6fd-25b2-418a-ad6d-7089541a671c" name="kod:EstimatedCapitalContributions" unitRef="U_CHF" scale="6" decimals="-5" format="ixt:numdotdecimal">75.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs of which the Company has paid </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b5b273c-54fb-44e1-b2c3-cc4a1b926d35" contextRef="C_a5328f00-e330-42c1-80c1-8421c3606923" name="kod:ManufacturingAgreementExpense" unitRef="U_CHF" scale="6" decimals="-5" format="ixt:numdotdecimal">35.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs of the capital contribution, equivalent to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ead942a3-3022-4fb4-b4f1-b03bcfbfeb54" contextRef="C_a5328f00-e330-42c1-80c1-8421c3606923" name="kod:ManufacturingAgreementExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">38.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million U.S. Dollars, which is recorded in other assets on the consolidated balance sheet as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Over the period from 2022 through 2029, manufacturing payments totaling approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6a3cbc6-550e-4722-958c-d023d01af072" contextRef="C_c938c6fd-25b2-418a-ad6d-7089541a671c" name="us-gaap:ContractualObligation" unitRef="U_CHF" scale="6" decimals="-5" format="ixt:numdotdecimal">150.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs may be incurred for potential commercial supply of KSI-301 drug substance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company concluded that this agreement contains an embedded lease as the custom-built manufacturing suite will be dedicated for the Company&#x2019;s use. As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company did not have control of this manufacturing space and therefore, did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b543980e-b078-4066-9cf4-e4a211fb3501" contextRef="C_b4b42d07-b554-47fb-9b37-295ad99f4b05" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_bdf38936-674d-4666-9328-2ce5d024f9de" contextRef="C_b4b42d07-b554-47fb-9b37-295ad99f4b05" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t record a right-of-use asset and corresponding lease liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Manufacturing Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into service and equipment purchase agreements in the normal course of business with various providers, pursuant to which such providers agreed to perform activities in connection with the manufacturing process of certain materials. These agreements, and any related amendments, state that planned activities and purchases that are included in the signed work orders are, in some cases, binding and, hence, obligate the Company to pay the full price of the work order upon satisfactory delivery of products and services or obligate the Company to the binding amount regardless of whether such planned activities are in fact performed. Per the terms of the agreements, the Company has the option to cancel signed orders at any time upon written notice, which may or may not be subject to payment of a cancellation fee. The level of cancellation fees may be dependent on the timing of the written notice in relation to the commencement date of the work, with the maximum cancellation amount dependent on the agreement or the work order.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Funding Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the normal course of business, the Company enters into agreements with third-parties for services to be provided to the Company. Generally, these agreements provide for termination upon notice, with specified amounts due upon termination based on the timing of termination and the terms of the applicable agreement. The actual amounts and timing of payments under these agreements are uncertain and contingent upon the initiation and completion of services to be provided to the Company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has also entered into various cancellable license agreements for certain technology. The Company may be obligated to make payments on future sales of specified products associated with such license agreements. Such payments are dependent on future product sales and are not estimable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Indemnification</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_7cfdeca1-bb26-429d-8d62-d54da0c79a89_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at the Company&#x2019;s request in such capacity. The indemnification period covers all pertinent events and occurrences during the director&#x2019;s or officer&#x2019;s service. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not specified in the agreements; however, the Company has director and officer insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements (Continued)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3152fdb3-7e92-4524-9d0f-2c32efbe317c" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In January 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the number of shares of common stock available for issuance under the 2018 Equity Incentive Plan (the &#34;2018 Plan&#34;) was increased by approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9143cf37-a135-4d2f-853f-c864a613b2e7" contextRef="C_a23868ac-4d18-4080-b770-dd5c05f2ac9d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:numdotdecimal">2.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9723244e-81af-477e-876b-ca16b04f3748" contextRef="C_add76d56-e3aa-4160-be48-644dc3f7d81b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" scale="6" decimals="-5" format="ixt:numdotdecimal">1.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million shares, respectively, as a result of the automatic increase provision in the 2018 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d65e0367-e1b6-4007-90de-8f77eb9381ee" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the &#34;2015 Plan&#34;) is summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.581%;"></td>
        <td style="width:1.475%;"></td>
        <td style="width:0.983%;"></td>
        <td style="width:11.651%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.475%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:11.596%;"></td>
        <td style="width:0.983%;"></td>
        <td style="width:1.475%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:11.679%;"></td>
        <td style="width:0.983%;"></td>
        <td style="width:1.475%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:11.614%;"></td>
        <td style="width:0.983%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number<br />of<br />Options</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br />Average<br />Exercise<br />Price</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br />Average<br />Remaining<br />Contractual<br />Term<br />(in years)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">  </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br />Intrinsic<br />Value<br />(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9241058-4acc-412c-9262-f2048d5e0318" contextRef="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,897,276</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_179af3b5-c2b6-463d-b923-c35c854732ab" contextRef="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">24.52</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f1193f78-c376-44dd-a631-f14b691576ad" contextRef="C_df61c764-a534-4f0b-8ca0-21e84f617033" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.07</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3bc30fbf-dae0-4b12-a163-d75618c1eead" contextRef="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">841,704</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a781319d-7c15-4111-9980-fb96a9c9199c" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,478,994</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0cada8e-6f0e-46d6-9ef9-e2d5866565df" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">94.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercised</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_57066a75-360a-4761-8a57-c857bcffc2a4" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">348,420</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4d99cd0c-dfd5-4d21-8a5d-a20943d64f07" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">17.06</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited or canceled</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6e769720-3f49-4313-a4df-0220c0ad3a6f" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">228,118</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b4949fd-0431-4043-8332-3cb5c137783a" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">41.86</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c13b317b-afca-474a-a656-ad5f162ad464" contextRef="C_a051b042-5e1d-45e2-b954-e74131ddd0b7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,799,732</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb999492-99ba-496d-b36f-062c9eca25c5" contextRef="C_a051b042-5e1d-45e2-b954-e74131ddd0b7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">37.62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b98ccaa-1ad9-4eb4-8838-eacf75455f80" contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.74</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ac7fa92-3244-4efd-ac42-a511243c7eec" contextRef="C_a051b042-5e1d-45e2-b954-e74131ddd0b7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">431,288</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Shares</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5896d029-10f0-4c0a-af24-42fa6e3f1454" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.942%;"></td>
        <td style="width:2.125%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:17.673%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:2.125%;"></td>
        <td style="width:1.531%;"></td>
        <td style="width:17.618%;"></td>
        <td style="width:0.993%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of<br />Restricted<br />Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br />Average<br />Grant Date<br />Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6fff2b2-2d95-4fd5-b956-328f8ba94d3f" contextRef="C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">359,945</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7075e91c-1706-4e0d-8afa-acdfc11f0687" contextRef="C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">59.54</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e95f2ed-f52d-4e70-b498-1fa74d818e7f" contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">170,150</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59325d84-b1d3-499b-9508-fca2b2cce95c" contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">90.75</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f0b4cf6-49bb-4ed5-9f9c-f6015d4e890d" contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">83,775</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6a28fa3d-3a54-4623-b964-44ad68b7a816" contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">57.98</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Canceled</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ff01a12-64b9-44c7-8d6f-e0d9420b0d12" contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,033</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b2447d50-8d0d-43fd-9bcb-9d7022ffb4f5" contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">61.24</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d499d88-5d79-4469-b8da-0933216eedd6" contextRef="C_9a2edcb3-cdb8-4ae3-8ba8-ad3566e86572" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">412,287</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_db1934cd-da6b-471e-9309-9db801522762" contextRef="C_9a2edcb3-cdb8-4ae3-8ba8-ad3566e86572" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">72.59</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Performance-Based Stock Options and Restricted Stock Units</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0bacd10d-f783-4458-8dc5-b5ae7fa67ac8" contextRef="C_d4d3bdd1-f4a5-411e-b2cd-de5f19a1571b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">669,581</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based stock options during the nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#34;2021 PSAs&#34;). The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45901ea5-4e4b-436c-bfc4-06865befbcc7" contextRef="C_4bf07dd0-aa9f-4e17-a6bc-9b077b5eb34f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t grant any performance-based equity awards during </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.  The Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8950b8e5-6d41-4a5b-9f1e-dc4abcd51d5e" contextRef="C_ca5ad689-4bf0-49c6-bbdf-99985e3228a2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">170,150</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based options and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1b4873cd-af1f-4f78-8fe2-2c55bff69d86" contextRef="C_0ec927f1-50c6-4660-8fa6-d7393ce25571" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">128,900</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based restricted stock units to employees in 2019 (the &#34;2019 PSAs&#34;).</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The performance-based equity awards granted will vest </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_28eeb5dd-0467-4d91-8eb3-bd77314ea9cf" contextRef="C_7dc99746-dd99-4798-80e9-33bcb72d7ab3" name="kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one-quarter</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the achievement of specific clinical development milestones. The remaining shares will then vest ratably over three years thereafter. Performance-based stock options and performance-based restricted stock units are recorded as expense beginning when vesting events are determined to be probable.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The milestone for the 2019 PSAs was achieved during the second quarter of 2021. As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_846d77cf-3ed6-4e2f-a63e-005ab55ebaed" contextRef="C_d4d3bdd1-f4a5-411e-b2cd-de5f19a1571b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">42,536</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based stock options and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c54c3345-47dd-469e-9dab-e3806ea03e65" contextRef="C_e0805aa0-1dc9-4338-83a1-9f7dc9b4a4d2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">28,905</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based restricted stock units granted during 2019 have vested. The Company believes that the achievement of the requisite performance condition for 2021 PSAs granted in the first quarter of 2021 continues to be probable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense recognized was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a0500ecd-d1f6-40fc-8c01-af05310eeb37" contextRef="C_9576e5b4-2d98-4b0c-b5ce-11be9a69984a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8ba3bd2-4746-4702-b52c-915e6fe21005" contextRef="C_7dc99746-dd99-4798-80e9-33bcb72d7ab3" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2021, respectively, and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8550edb7-a247-4f88-bcf9-2ae6639fd0ed" contextRef="C_93d12b66-9ce5-4317-ac9a-15a39b2600d5" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a256f5e-0439-47fd-8340-3443618a02a3" contextRef="C_35c1b8b0-ef41-45be-a72a-9abe398ca0e3" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2020, respectively.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements (Continued)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2018 Employee Share Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:5.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.62%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the Company adopted the 2018 Employee Share Purchase Plan (&#x201c;ESPP&#x201d;), which became effective on the business day prior to the effectiveness of the registration statement relating to the Company's initial public offering. A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c2d7d72e-5a50-4b27-be3c-02e813576ebe" contextRef="C_158eae8b-5b6c-4683-b5fa-33c0622853f2" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">460,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were initially reserved for issuance under the ESPP. The initial offering period of the ESPP was authorized by the Company&#x2019;s board of directors and commenced on January 4, 2021. Each offering period is approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_653715a6-27b2-4133-b60d-ffc8da61c329" contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d" name="kod:TermOfOfferingPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">twelve months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> long, with </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b74b73a-1a8f-4142-8aa6-8b896b36ee5d" contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d" name="kod:NumberOfPurchasePeriods" unitRef="U_PurchasePeriod" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> purchase periods. ESPP participants will purchase shares of common stock at a price per share equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81881639-bafc-4d09-87ef-7d6891bc4870" contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the lesser of (1) the fair market value per share of the common stock on the enrollment date or (2) the fair market value of the common stock on the exercise date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.62%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company issued </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_11f0c1ee-023c-4d0b-a31b-a213a7c36b69" contextRef="C_91bbf1c7-f25d-4226-96c0-0fe81b4ea717" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5f8cbed9-e311-4813-a9a7-695235155093" contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">4,295</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares under the ESPP during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three and nine months ended September 30, 2021, respectively. The stock-based compensation expense related to the ESPP was less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_263ba75e-6985-4575-8e29-f10ea068e630" contextRef="C_91bbf1c7-f25d-4226-96c0-0fe81b4ea717" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_625d385f-8cd7-4a38-a5d1-8b630a8e5ddf" contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e0f335ad-301b-48e9-8e33-8ba5d9d4f3d3" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.745%;"></td>
        <td style="width:1.425%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:11.258%;"></td>
        <td style="width:0.975%;"></td>
        <td style="width:1.425%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:11.22%;"></td>
        <td style="width:0.975%;"></td>
        <td style="width:0.975%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:11.258%;"></td>
        <td style="width:0.975%;"></td>
        <td style="width:1.425%;"></td>
        <td style="width:1.528%;"></td>
        <td style="width:11.258%;"></td>
        <td style="width:0.975%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br />&#160;&#160;September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br />&#160;&#160;September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_64182c89-d726-4e46-bf52-689a3efdd049" contextRef="C_9bdfa9aa-1ba9-4af1-8101-e5969ff5eae8" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,429</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d5777989-5fc1-4b79-85cd-2ccbd8ff668b" contextRef="C_28f3dc2d-2645-40d1-8f72-dba22572cd4a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,759</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_232d4b4d-7f26-43d0-bc7c-474af6585ad6" contextRef="C_bba9d155-8973-4881-b4f4-889287f1e62c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,598</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7b338af-89e1-460c-99c8-427923fe6ed4" contextRef="C_0509b27f-2c96-45a2-b3c6-bd0c582464ba" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,983</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3a0b31c-754f-4f65-9bb1-8c8de2630837" contextRef="C_32f5b3f4-2926-4a41-a753-0315ed597699" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,948</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d5819cca-1136-45aa-b1a8-3da88693edca" contextRef="C_0f217839-80a3-4a6a-bdfd-679c49f63892" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,482</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c5b9489-4331-4d22-93b5-46d47f383ed0" contextRef="C_7c0f0042-303e-4491-b1dc-68acfaccacc3" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,791</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35bbac8a-ad38-44fb-bc1b-4a89f9bae7c6" contextRef="C_bb793a10-451f-4b36-8cb8-5154d0eba3cb" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,230</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9dd906e-c134-42f1-a784-1c5fe84c0c31" contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,377</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b71da40c-1199-4458-96fe-82801f9d3e2d" contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,241</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ec51137f-40dc-4443-a7ac-0f07ee342f43" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,389</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed29dc2f-67fa-434e-a85a-32ca9e797ee6" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,213</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, total unrecognized compensation cost related to the unvested share-based awards and ESPP was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_add5a595-e76a-4fb6-92f1-047183155697" contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">122.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_929777e7-b000-4f39-b33a-224aa12e5beb" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.8</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3070f6b5-3c34-46ea-8ab0-d237922d22a6" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Net Loss per Common Share</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3414bae1-a268-42c4-b717-387be535d899" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.859%;"></td>
        <td style="width:2.338%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:17.729%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:2.338%;"></td>
        <td style="width:1.002%;"></td>
        <td style="width:17.729%;"></td>
        <td style="width:1.002%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_af2eef8e-2b4c-4a15-85c2-5f7a0c34c89f" contextRef="C_d417aa44-069d-45f0-a7f5-d98db662cdba" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,799,732</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_53b535ea-515b-4ba0-a075-7ea0854a2c5b" contextRef="C_72724aca-fdbc-4107-8023-8e92c79546de" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,238,363</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb8c34a8-bf81-4174-81f1-752c2b95ec79" contextRef="C_baaf78fe-4b36-48dc-ba7a-9a0cd9f14b1c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">412,287</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_41756690-952f-4259-857f-c253b893638f" contextRef="C_47fd8490-2f13-4a75-8942-c29752532c90" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">363,195</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_49f666ca-b7a3-4fd4-8089-928ded1777bc" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,212,019</ix:nonFraction></span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70e21e7d-4ac4-4ee2-b911-fcc5b016dc68" contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,601,558</ix:nonFraction></span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ce997ca-1431-4564-9414-439ac9104fcf" contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On October 13, 2021, stockholders of the Company approved the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the &#x201c;LTPIP&#x201d;) as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on September 13, 2021. Stock options were granted under the LTPIP, contingent on stockholder approval of the LTPIP, to named executive officers and other eligible employees at the vice president level who made a one-time election to participate in the LTPIP and agreed to forgo a portion of their annual long-term incentive awards over the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_69b670ba-d8f5-412f-afcd-527102948be4" contextRef="C_fb27358c-ef23-4137-acfd-472379d7d8fd" name="kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seven-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance period ending on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2ddba57c-c7d3-4de1-b582-51b3a60e8d18" contextRef="C_d52ced4e-2cc6-4467-a7c6-7247dd7a8166" name="kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">August 11, 2028</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f62922bf-1cc0-404a-bbe2-2d5fae586276" contextRef="C_fb27358c-ef23-4137-acfd-472379d7d8fd" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,502,334</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were reserved for issuance under the LTPIP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The options can be earned based on the achievement of the performance-based requirement and/or certain operational milestones. The performance-based requirement consists of seven tranches of options that are earned based on meeting or exceeding stock price goals between $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f2bb472c-07fb-424d-8cf6-2d5eea28b167" contextRef="C_195d5ffe-0492-4de0-b82c-488c9ea38019" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0">200</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f51bfa4b-a623-46c9-9312-9eac40047447" contextRef="C_e32f672d-5f84-455b-8c7b-12ed7c65984c" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0">800</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_101e51ac-e62f-4b52-ae9c-bfd0e5b93623" contextRef="C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b" name="kod:ConsecutiveTradingDays" unitRef="U_Days" decimals="0" format="ixt:numdotdecimal">90</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive trading days.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_22ba30f8-5ee2-4eee-b2b5-ca47028f5113" contextRef="C_4724a75b-6bfd-4f43-a79e-256b1d3309c8" name="kod:LongTermPerformanceIncentivePlanDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5729954a-98a8-4f2e-85a6-bcff8d40dc54" contextRef="C_c04dde98-cf3c-4935-9b98-35dde0c8ff28" name="kod:SalesForecasting" unitRef="U_USD" scale="9" decimals="-8" format="ixt:numdotdecimal">2.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> billion in a fiscal year.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Once earned, options are subject to a service-based requirement and will vest through the remainder of the seven-year performance period in equal monthly installments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Unaudited Condensed Consolidated Financial Statements (Continued)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Performance-based stock options totaling </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6e757256-ff66-4be7-9c30-6235aeb4fb7f" contextRef="C_58d71972-cf16-407c-92c6-ce1dbf2b12b5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,920,625</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> with the same terms and conditions as the LTPIP were also granted to employees below the vice president level under the 2018 Plan. These stock option awards were also contingent on stockholder approval of the LTPIP. As discussed above, the LTPIP was approved by the stockholders of the Company on October 13, 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is currently evaluating the LTPIP approved in October 2021 and its accounting impact as a modification of the portion of the annual long-term incentive awards granted in 2021 that were foregone.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="i_item2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2. Management&#x2019;s Discussion and Analysis of </span><span id="item_2_managements_discussion_analysis_f"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this report and with our audited financial statements and related notes thereto and management&#x2019;s discussion and analysis of financial condition and results of operations for the year ended December 31, 2020, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on March 1, 2021. This discussion and analysis and other parts of this report contain forward-looking statements based upon current beliefs, plans and expectations related to future events and our future financial performance that involve risks, uncertainties and assumptions, such as statements regarding our intentions, plans, objectives, expectations, forecasts and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under the section of this report titled &#x201c;Part II, Item 1A &#x2014; Risk Factors&#x201d; and elsewhere in this report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since its founding in 2009, Kodiak Sciences Inc. (&#x201c;Kodiak,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we&#x201d; or &#x201c;our&#x201d;) has developed a new technology platform for retinal medicines. Our goal is to prevent and treat the major causes of blindness by developing and commercializing next-generation therapeutics for chronic, high-prevalence retinal diseases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak has progressed its lead investigational therapy, KSI-301, into six registrational clinical trials. The comprehensive clinical program targets high prevalence anti-VEGF dependent retinal diseases with studies designed as a package to support a broad product label, which we hope will include the key diseases and the longest dosing intervals. KSI-301 is being developed as a first line therapy for use in any patient who may benefit from anti-VEGF therapy. At the same time, Kodiak is investing in commercial scale manufacturing with a capacity goal to supply 100% of today&#x2019;s branded anti-VEGF market. We hope to be able to provide a pre-filled syringe early in commercialization, with a stretch goal of having this available at launch. Combining these ambitious clinical and manufacturing efforts sets the stage for early market share capture when and if KSI-301 is approved.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, Kodiak is investing in its pipeline. The Company is progressing its Antibody Biopolymer Conjugate (or ABC) Platform</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> towards suboptimal anti-VEGF responder patients, a group as large as 30% of treated patients, with its bispecific conjugate KSI-501. And beyond today&#x2019;s anti-VEGF market, Kodiak&#x2019;s new triplet medicines are being designed on its ABC Platform in an effort to bring new capabilities to treat the retina in the even higher prevalence diseases of dry AMD and glaucoma.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notably, up to this point, Kodiak has retained all global rights to make, use and sell its products, preserving future value and allowing for agile decision-making.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While engaged in these research and development efforts, the Company has also demonstrated a disciplined and creative approach to building and financing the company, so Kodiak today is well capitalized with more than $799.2 million in cash as of September 30, 2021.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our objective is to develop our retina-focused product candidates, seek FDA and worldwide health authority marketing authorization approvals, and ultimately commercialize our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following from these efforts, we believe Kodiak has the potential to achieve our ambition of becoming a significant incumbent retinal development and commercialization franchise on a global basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent Updates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">KSI-301 Clinical Program Highlights</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are engaged in a broad development program for KSI-301 with concurrent late-stage development activities across all of the major disease indications for which intravitreal anti-VEGF therapies are used and have made considerable progress in prosecuting the KSI-301 pivotal study program over this past quarter. We expect to include the results of all our pivotal clinical trials in wet AMD, DME and RVO in a single initial BLA. The ambitious program for KSI-301 reflects our conviction in KSI-301 (and our ABC Platform) and seeks labeling at launch that is supportive of a broad range of individualized dosing intervals, from every 4-week dosing up to once every 20-week dosing for wet AMD patients; from every 4-week dosing up to once every 24-week dosing for DME patients; and from every 4-week dosing up to once every 8-week dosing for RVO patients.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">DAZZLE &#x2013; Phase 2b/3 Study in Patients with Treatment-Na&#xef;ve Wet Age-Related Macular Degeneration (Wet AMD)</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Phase 2b/3 DAZZLE study is a global, multi-center, randomized pivotal study designed to evaluate the durability efficacy and safety of KSI-301 in patients with treatment-na&#xef;ve wet AMD. Patients are randomized to receive either KSI-301 on an individualized dosing regimen as infrequently as every five months and no more often than every three months or to receive aflibercept on its labeled every eight-week dosing regimen, each after three monthly initiating doses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We initiated the DAZZLE pivotal study in October 2019 and completed enrollment in November 2020 with over 550 patients enrolled globally. We expect the last patient&#x2019;s primary endpoint visit to occur in the fourth quarter of 2021 and to announce topline data in the first quarter of 2022.</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">BEACON &#x2013; Phase 3 Study in Patients with Treatment-Na&#xef;ve Retinal Vein Occlusion (RVO)</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We began enrolling patients into BEACON in the third quarter of 2020. With over 475 patients randomized, we believe we are on track to complete enrollment into BEACON before the end of this year. Based on the 24-week primary endpoint for BEACON, we expect to announce topline data in mid-2022.</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">GLEAM / GLIMMER &#x2013; Paired Phase 3 Studies in Patients with Treatment-Na&#xef;ve Diabetic Macular Edema (DME)</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Phase 3 GLEAM and GLIMMER studies are global, multi-center, randomized pivotal studies designed to evaluate the durability, efficacy and safety of KSI-301 in patients with treatment-na&#xef;ve diabetic macular edema (DME). In each study, patients are randomized to receive either intravitreal KSI-301 on an individualized dosing regimen every eight to 24 weeks after only three loading doses or intravitreal aflibercept every eight weeks after five loading doses per its label. Each study is expected to enroll approximately 450 patients worldwide. The primary endpoint for both studies is at one year, and patients will be treated and followed for a total of two years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We initiated GLEAM and GLIMMER in the third quarter of 2020. Continued elevated COVID-19 transmission rates globally have impacted enrollment rates for patients with treatment na&#xef;ve DME. With GLEAM more than two-thirds enrolled and GLIMMER more than three-quarters enrolled, we expect to complete enrollment in the first quarter of 2022.</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">DAYLIGHT &#x2013; Phase 3 Study in Patients with Treatment-Na&#xef;ve Wet AMD</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Phase 3 DAYLIGHT study is a global, multi-center, randomized pivotal study designed to evaluate the efficacy and safety of high-frequency KSI-301 in patients with treatment-na&#xef;ve wet AMD. Patients are randomized to receive either KSI-301 on a monthly dosing regimen or to receive standard-of-care aflibercept. The study is expected to enroll approximately 500 patients worldwide. The primary endpoint is at 40 weeks, and the study is being planned and executed to allow for inclusion of its results in the initial BLA for KSI-301.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2021, we randomized the first patients into DAYLIGHT. Study enrollment has been strong with recruitment now underway both in the US and EU. Additional global study sites will be activated through the fourth quarter of 2021, and we believe we can complete enrollment in the first half of 2022.</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">GLOW &#x2013; Phase 3 Study in Patients with Non-Proliferative Diabetic Retinopathy without DME</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We began screening patients into GLOW in the second quarter of 2021 and randomized the first patients in September. We are not planning for this study and indication to be included in our initial BLA filing given our expectations for a longer recruitment timeframe. We are excited to be recruiting patients in this chronic, more preventive disease indication and believe KSI-301 can be a new longest-interval therapeutic option for patients with diabetic retinopathy.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To date, we are pleased with the continued operational progress across our pivotal program. We believe we are on track for a series of KSI-301 topline data readouts beginning in early 2022 with DAZZLE in the first quarter of 2022, BEACON in mid-2022 and then DAYLIGHT and GLEAM/GLIMMER tracking towards early 2023.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img6467664_0.jpg" alt="img6467664_0.jpg" style="width:720px;height:405px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our KSI-301 pivotal program is designed to support a full range of individualized dosing regimens and we hope to position KSI-301 to be the therapy of choice for all patients with retinal vascular disease and which can meet the distinct needs of patients, physicians, caregivers and payors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img6467664_1.jpg" alt="img6467664_1.jpg" style="width:718px;height:404px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Kodiak Stockholder Approval of the Kodiak 2021 Long-term Performance Incentive Plan (LTPIP)</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On August 12, 2021, the Board of Directors of Kodiak Sciences Inc. approved the Kodiak 2021 Long-Term Performance Incentive Plan (LTPIP), subject to approval by Kodiak stockholders. The LTPIP was approved by Kodiak&#x2019;s stockholders on October 13, 2021, with 75% of all votes cast voting in favor of approving the LTPIP, excluding votes cast by any participant in the LTPIP.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe the LTPIP aligns management incentives to significant value creation. The plan covers the next seven years and was open to a significant number of our existing employees &#x2013; not just senior management. Employees had a one-time opportunity to &#x201c;opt-in&#x201d; to the plan by agreeing to forego up to 75% of their annual equity incentive compensation for the next seven years via a one-time election. Shares can be earned based on significant stock price appreciation over the seven-year performance period, with the possibility to earn up to 35% of the award based on achieving substantive operational goals. Earned awards begin vesting once earned and vest through the remainder of the seven-year period in equal monthly increments, ensuring what we believe is a true long-term incentive program.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">China INDs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2021, our investigational new drug (IND) applications for KSI-301 in RVO and DME were approved by China&#x2019;s National Medicinal Products Administration (NMPA). The IND approval allows Kodiak to enroll patients from China into the BEACON and GLIMMER studies; we believe that inclusion of patients from China in these studies could be beneficial for the potential future approval of KSI-301 in China.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The first Chinese patients are expected to be randomized in the fourth quarter of 2021. We are excited to embark on this important milestone in China as we believe there is substantial clinical unmet need in China for the type of long-interval dosing which KSI-301 and our ABC Platform may provide.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">KSI-301 Phase 1b Study</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2021, we presented Year 1 durability, efficacy and safety data from our ongoing Phase 1b trial of KSI-301 in patients with treatment na&#xef;ve wet AMD, DME or RVO at the Angiogenesis, Exudation, and Degeneration 2021 &#x2013; Virtual Edition meeting. The data showed 2 in every 3 patients are on a 6-month or longer treatment-free interval at Year 1 in each of the three major retinal vascular diseases after only three loading doses. Robust vision gains (particularly notable in the context of very good baseline vision) and robust retinal drying (when baseline anatomical characteristics are considered) were seen across all three diseases being studied. Strong anti-VEGF efficacy (achieving at Year 1 approximately 20/40 eye chart vision on average in wet AMD and approximately 20/32 vision on average in DME and RVO) and an encouraging safety profile continued to be observed across all three diseases. We believe the data support the &#x201c;anti-VEGF Generation 2.0&#x201d; profile of KSI-301.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Track Record of KSI-301 Safety</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe the safety profile of KSI-301 continues to be very encouraging. In the pivotal study program, in which the data remain masked (blinded) as the studies are ongoing, we estimate that over 4,500 KSI-301 injections have been given. Additionally, more than 750 injections have been given in the open-label Phase 1a/1b program. The total safety database now includes an estimated &gt;800 patient-years of exposure to KSI-301. Our ongoing reviews of safety data from the open-label Phase 1b study and the masked pivotal studies continue to suggest that the safety of KSI-301 is tracking with the expectations set by the safety profile of the current standard of care intravitreal medicines.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">COVID-19</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are continuing to monitor the global ongoing COVID-19 pandemic. We and our key clinical and manufacturing partners have been able to continue to advance our operations. Through this pandemic, we continue to work closely with our clinical sites towards patient safety and low number of missed visits and study discontinuations. The overall rate of missed study visits remains &lt;5%.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In response to the COVID-19 pandemic with regards to business operations, clinical trials, and manufacturing activities, we have taken steps in line with guidance from the U.S. Centers for Disease Control and Prevention, or CDC, and the State of California to protect the health and safety of our employees and our community.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will continue to monitor the COVID-19 situation closely. The ultimate impact of the ongoing COVID-19 pandemic on our business operations remains uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, healthcare systems or the global economy as a whole. See also the section titled &#x201c;Risk Factors&#x201d; for additional information on risks and uncertainties related to the evolving COVID-19 pandemic.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Components of Operating Results</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Substantially all of our research and development expenses consist of expenses incurred in connection with the development of our ABC Platform and product candidates. These expenses include certain payroll and personnel expenses, including stock-based compensation, for our research and product development employees; laboratory supplies and facility costs; consulting costs; contract manufacturing and fees paid to CROs to conduct certain research and development activities on our behalf; and allocated overhead, including rent, equipment, depreciation and utilities. We expense both internal and external research and development expenses as they are incurred. Costs of certain activities, such as manufacturing and preclinical and clinical studies, are generally recognized based on an evaluation of the progress to completion of specific tasks. Nonrefundable payments made prior to the receipt of goods or services that will be used or rendered for future research and development activities are deferred and capitalized. The capitalized amounts are recognized as expense as the goods are delivered or the related services are performed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are focusing substantially all of our resources and development efforts on the development of our product candidates, in particular KSI-301. We expect our research and development expenses to increase substantially during the next few years as we conduct our Phase 3 clinical studies, complete our clinical program, pursue regulatory approval of our drug candidates and prepare for a possible commercial launch. Predicting the timing or the final cost to complete our clinical program or validation of our commercial manufacturing and supply processes is difficult and delays may occur because of many factors, including factors outside of our control. For example, if the FDA or other regulatory authorities were to require us to conduct clinical trials beyond those that we currently anticipate, or if we experience significant delays in enrollment in any of our clinical trials, we could be required to expend significant additional financial resources and time on the completion of clinical development. Furthermore, we are unable to predict when or if our drug candidates will receive regulatory approval with any certainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses consist principally of payroll and personnel expenses, including stock-based compensation; professional fees for legal, consulting, accounting and tax services; allocated overhead, including rent, equipment, depreciation and utilities; and other general operating expenses not otherwise classified as research and development expenses.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We anticipate that our general and administrative expenses will increase as a result of increased personnel costs, including stock-based compensation, expanded infrastructure and higher consulting, legal and accounting services associated with maintaining compliance with requirements of the stock exchange listing and Securities and Exchange Commission, or SEC, investor relations costs and director and officer insurance premiums associated with being a public company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest Income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income consists primarily of interest income earned on our cash, cash equivalents and marketable securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income (Expense), Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income (expense), net consists primarily of accretion income and amortization expense on marketable debt securities net of amortized issuance costs from the liability related to the future sale of royalties to BBA in 2019.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the results of our operations for the periods indicated, in thousands:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:38.444%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.845%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.845%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.845%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.91%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.845%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:0.927%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.845%;"></td>
    <td style="width:0.974%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56,002</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29,306</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,696</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">141,743</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70,033</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">71,710</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,533</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,357</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,176</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32,259</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19,132</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,127</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(67,535</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(36,663</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(30,872</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(174,002</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(89,165</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(84,837</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">645</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(605</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">270</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,551</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2,281</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(17</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(25</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(98</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">73</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(76</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">120</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(196</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(67,526</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(36,122</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(31,404</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(173,825</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(86,513</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(87,312</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our research and development expenses for the periods indicated, in thousands:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:38.673%;"></td>
    <td style="width:0.928%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.821%;"></td>
    <td style="width:0.947%;"></td>
    <td style="width:0.928%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.821%;"></td>
    <td style="width:0.947%;"></td>
    <td style="width:0.928%;"></td>
    <td style="width:1.513%;"></td>
    <td style="width:6.821%;"></td>
    <td style="width:0.974%;"></td>
    <td style="width:0.928%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.877%;"></td>
    <td style="width:0.947%;"></td>
    <td style="width:0.928%;"></td>
    <td style="width:1.503%;"></td>
    <td style="width:6.821%;"></td>
    <td style="width:0.947%;"></td>
    <td style="width:0.928%;"></td>
    <td style="width:1.513%;"></td>
    <td style="width:6.821%;"></td>
    <td style="width:0.974%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KSI-301 program expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,371</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,415</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22,956</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89,557</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37,587</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51,970</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KSI-501 program expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">951</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">453</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">498</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,357</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">922</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,435</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ABC Platform and other program expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,745</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,174</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(429</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,173</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,345</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(172</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payroll and personnel expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,679</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,575</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,483</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,850</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,633</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Facilities and other research and development expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,256</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,160</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,096</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,173</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,329</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,844</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total research and development expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56,002</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29,306</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,696</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">141,743</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70,033</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">71,710</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KSI-301 program expenses increased $23.0 million and $52.0 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020. The increase was primarily due to clinical trial costs to support ongoing trials, as well as manufacturing progress for KSI-301. We initiated two pivotal Phase 3 clinical studies in DME (GLEAM and GLIMMER) and one pivotal Phase 3 clinical study in RVO (BEACON) in the third quarter of 2020. In June 2021, we randomized the first patients into an additional Phase 3 study in wet AMD (DAYLIGHT) designed to broaden KSI-301&#x2019;s product labeling.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KSI-501 program increased $0.5 million and $3.4 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, primarily due to increased research and development activities for KSI-501.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payroll and personnel expenses increased $2.6 million and $9.6 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, due to increased headcount and stock-based compensation expense.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Facilities and other research and development expenses increased $1.1 million and $6.8 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, primarily due to lease costs for our Palo Alto and Switzerland facilities expansion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses increased $4.2 million and $13.1 million during the three and nine months ended September 30, 2021, respectively, as compared to 2020, primarily driven by increased headcount and stock-based compensation expense, professional services related to consulting, legal and accounting, and lease costs for Palo Alto facilities expansion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liquidity and Capital Resources; Plan of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sources of Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have funded our operations primarily through the sale and issuance of common stock, redeemable convertible preferred stock, convertible notes, warrants and the sale of royalties. As of September 30, 2021, we had cash and cash equivalents of $799.2 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Future Funding Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have incurred net losses since our inception. For the three and nine months ended September 30, 2021, we had net loss of $67.5 million and $173.8 million, respectively, and we expect to continue to incur additional losses in future periods. As of September 30, 2021, we had an accumulated deficit of $465.1 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have based these estimates on assumptions that may prove to be wrong, and we could deplete our available capital resources sooner than we expect. Because of the risks and uncertainties associated with research, development and commercialization of product candidates, we are unable to estimate the exact amount of our working capital requirements. Our future funding requirements will depend on and could increase significantly as a result of many factors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To date, we have not generated any product revenue. We do not expect to generate any product revenue unless and until we obtain regulatory approval of and commercialize any of our product candidates or enter into collaborative agreements with third parties, and we do not know when, or if, either will occur. We expect to continue to incur significant losses for the foreseeable future, and we expect our losses to increase as we continue the development of, and seek regulatory approvals for, our product candidates, and begin to commercialize any approved products. We are subject to all of the risks typically related to the development of new product candidates, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have based these estimates on assumptions that may prove to be wrong, and we could deplete our capital resources sooner than we expect. The timing and amount of our operating expenditures and capital requirements will depend on many factors, including:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope, timing, rate of progress and costs of our drug discovery, preclinical development activities, laboratory testing and clinical trials for our product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number and scope of clinical programs we decide to pursue; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope and costs of manufacturing development and commercial manufacturing activities; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we acquire or in-license other product candidates and technologies; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost, timing and outcome of regulatory review of our product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to establish and maintain collaborations on favorable terms, if at all; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of our product candidates; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost and timing associated with commercializing our product candidates, if they receive marketing approval.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A change in the outcome of any of these or other variables with respect to the development of any of our product candidates could significantly change the costs and timing associated with the development of that product candidate. Furthermore, our operating plans may change in the future, and we will continue to require additional capital to meet operational needs and capital requirements associated with such operating plans. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we are unable to raise additional funds when needed, we may be required to delay, reduce, or terminate some or all of our development programs and clinical trials. We may also be required to sell or license rights to our product candidates in certain territories or indications to others that we would prefer to develop and commercialize ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The significant uncertainties caused by the evolving effects of the ongoing COVID-19 pandemic may also negatively impact our operations and capital resources. We and our key clinical and manufacturing partners have been able to continue to advance our operations, and we continue to monitor the impact of COVID-19 on our ability to continue the development of, and seek regulatory approvals for, our product candidates, and begin to commercialize any approved products. This pandemic may ultimately have a material adverse effect on our liquidity and operating plans, although we are unable to make any prediction with certainty given the spread and rapidly changing nature of the pandemic and the evolving global actions taken to contain and treat the novel coronavirus.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adequate additional funding may not be available to us on acceptable terms or at all. Our failure to raise capital as and when needed could have a negative impact on our financial condition and our ability to pursue our business strategies. See the section of this report titled &#x201c;Part II, Item 1A &#x2014; Risk Factors&#x201d; for additional risks associated with our substantial capital requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary Statement of Cash Flows</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth the primary sources and uses of cash for each of the periods presented below, in thousands:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.209%;"></td>
    <td style="width:1.605%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.772%;"></td>
    <td style="width:0.992%;"></td>
    <td style="width:1.605%;"></td>
    <td style="width:1.53%;"></td>
    <td style="width:12.763%;"></td>
    <td style="width:0.992%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br />&#160;&#160;September 30,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash (used in) provided by:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(123,235</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(56,409</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(27,939</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45,976</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,025</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101,096</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(145,149</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90,663</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Flows from Operating Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities was $123.2 million for the nine months ended September 30, 2021, primarily attributable to a net loss during this period due to increased payroll and personnel expenses and manufacturing and clinical trial costs to support overall growth. Cash used in operating activities was also driven by changes in operating assets and liabilities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Flows from Investing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in investing activities was $27.9 million for the nine months ended September 30, 2021, primarily related to maturities of marketable securities net of purchases of and deposits related to property and equipment during the quarter.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Flows from Financing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities was $6.0 million for the nine months ended September 30, 2021, primarily due to the proceeds from stock option exercises and proceeds from issuances of common stock pursuant to employee stock purchase plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Contractual Obligations and Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The disclosure of our contractual obligations and commitments is set forth under the heading &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations &#x2014; Contractual Obligations&#x201d; in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021. There have been no material changes in our contractual obligations and commitments since December 31, 2020, except as otherwise described in Note 6 to our unaudited condensed consolidated financial statements included in this report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Critical Accounting Policies, Significant Judgments and Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#x2019;s judgments and estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the nine months ended September 30, 2021, there were no material changes to our critical accounting policies as reported in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021, except as otherwise described in Note 2 to our unaudited condensed consolidated financial statements included in this report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Off-Balance Sheet Arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception, we have not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is discussed under Note 2 to our unaudited condensed consolidated financial statements included in this report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="i_item3"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3. Quantitative and Qualitati</span><span id="item_3_quantitative_qualitative_disclosu"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ve Disclosures About Market Risk.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="s161692780"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the nine months ended September 30, 2021, there were no material changes to our market risk disclosures as reported in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4. Controls</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> and Procedures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Management&#x2019;s Evaluation of our Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We maintain &#x201c;disclosure controls and procedures,&#x201d; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC&#x2019;s rules and forms and (2) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the Company&#x2019;s disclosure controls and procedures as of September 30, 2021. Based upon such evaluation, our principal executive officer and principal financial officer concluded that the design and operation of our disclosure controls and procedures were effective at a reasonable assurance level as of September 30, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There has been no change in our internal control over financial reporting during the quarter ended September 30, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="i_item4t"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART II&#x2014;OTHER</span><span id="part_iior_information"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> INFORMATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. Legal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Proceedings.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may become involved in litigation relating to claims arising from the ordinary course of business. As of the date of this report, there are no claims or actions pending against us, the ultimate disposition of which could have a material adverse effect on our results of operations or financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1A. Ris</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">k Factors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">You should consider carefully the following risk factors, together with all the other information in this report, including the section of this report titled &#x201c;Part I, Item 2 &#x2014; Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and our unaudited condensed financial statements and notes thereto. The occurrence of any events described in the following risk factors and the risks described elsewhere in this report could harm our business, operating results, financial condition, and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements that we have made in this report and those we may make from time to time. You should consider all of the risk factors described when evaluating our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to the Discovery, Development and Commercialization of Our Product Candidates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our prospects are heavily dependent on our KSI-301 product candidate, which is currently in clinical development for multiple indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KSI-301 is our only product candidate currently in clinical trials. It may be years before a registrational-type trial is completed, if at all. Further, we cannot be certain that either KSI-301 or any of our product candidates will be successful in clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our early encouraging preclinical and Phase 1/1b clinical trial results for KSI-301 in the respective indications are not necessarily predictive of the results of our ongoing or future discovery programs or any future preclinical or clinical studies. Our ability to demonstrate efficacy, safety and clinical durability in pivotal studies may be affected by the patient populations sampled and the design of our pivotal studies. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical studies after achieving positive results in early-stage development, including early-stage clinical studies, and we cannot be certain that we will not face similar setbacks. These setbacks have been caused by, among other things, preclinical findings made while clinical studies were underway or safety or efficacy observations made in preclinical studies and clinical studies, including previously unreported or unobserved adverse events as more patients are treated with KSI-301 and followed for longer periods of time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There can be significant variability in safety or efficacy results between different clinical studies of the same product candidate due to numerous factors, including changes in study procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical study protocols and the rate of dropout among clinical study participants. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical studies nonetheless failed to obtain FDA approval. If approved, KSI-301 clinical study designs and data are not necessarily predictive of KSI-301&#x2019;s final marketed product label. FDA may not approve a label for once every five or six months even if we believe the data demonstrate that type of durability.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may in the future advance product candidates into clinical trials and terminate such trials prior to their completion. While we have certain preclinical programs such as KSI-501 and KSI-601 in development and intend to develop other product candidates, it will take additional investment and time for such programs to reach the same stage of development as KSI-301.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">A failure of KSI-301 in clinical development may require us to discontinue development of other product candidates based on our ABC Platform.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If KSI-301 fails in development as a result of any underlying problem with our platform, then we may discontinue development of some or all of our product candidates that are based on our ABC Platform. If we discontinue development of KSI-301, or if KSI-301 were to fail to receive regulatory approval or were to fail to receive regulatory approval in one or more of our four planned key clinical indications or were to fail to achieve sufficient market acceptance, we could be prevented from or significantly delayed in achieving profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development of biopharmaceutical products is inherently risky. We cannot give any assurance that any of our product candidates will receive regulatory, including marketing, approval, which is necessary before they can be commercialized.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are at an early stage of development of our product candidates. Our future success is dependent on our ability to successfully develop, obtain regulatory approval for, and then successfully commercialize our product candidates, and we may fail to do so for many reasons, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our product candidates may not successfully complete preclinical studies or clinical trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a product candidate obtains regulatory approval, approval may be for indications, dosage and administration or patient populations that are not as broad as intended or desired;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a product candidate may, on further study, be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria, for example a positive benefit-risk profile; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors may develop therapeutics that render our product candidates obsolete or less attractive; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors may develop platform technologies that render our ABC Platform obsolete or less attractive; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the product candidates and ABC Platform that we develop may not be sufficiently covered by intellectual property for which we hold exclusive rights or may be covered by third party patents or other intellectual property or exclusive rights; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the market for a product candidate may change so that the continued development of that product candidate is no longer reasonable or commercially attractive; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">if a product candidate obtains regulatory approval, we may be unable to establish sales and marketing capabilities, or successfully market such approved product candidate, to gain market acceptance; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2241666666666668;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors, if applicable. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any of these events occurs, we may be forced to abandon our development efforts for a product candidate or candidates, which would have a material adverse effect on our business and could potentially cause us to cease operations. Failure of a product candidate may occur at any stage of preclinical or clinical development, and, because our product candidates and our ABC Platform are in development, there is a relatively higher risk of failure and we may never succeed in developing marketable products or generating product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be successful in our efforts to further develop our ABC Platform and current product candidates in time to meet the current and identified market opportunity. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the FDA or comparable foreign regulatory authorities, and we may never receive such regulatory approval for any of our product candidates. Each of our product candidates is in the early stages of development and will require significant additional clinical development, management of preclinical, clinical, and manufacturing activities, regulatory approval, adequate manufacturing supply, a commercial organization, and significant marketing efforts before we generate any revenue from product sales, if at all. Any clinical studies that we may conduct may not demonstrate the efficacy and safety necessary to obtain regulatory approval to market our product candidates. If the results of our ongoing or future clinical studies are inconclusive with respect to the efficacy of our product candidates or if we do not meet the clinical endpoints with statistical significance or if there are safety concerns or adverse events associated with our product candidates, we may be prevented or delayed in obtaining marketing approval for our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any of our product candidates successfully completes clinical trials, we generally plan to seek regulatory approval to market our product candidates in the United States, the EU, and in additional foreign countries where we believe there is a viable commercial opportunity. We have never commenced, compiled or submitted an application seeking regulatory approval to market any product candidate. We may never receive regulatory approval to market any product candidates even if such product candidates successfully complete clinical trials, which would adversely affect our viability. To obtain regulatory approval in countries outside the United States, we must comply with numerous and varying regulatory requirements of such other countries regarding safety, efficacy, chemistry, manufacturing and controls, clinical trials, commercial sales, pricing, and distribution of our product candidates. We may also rely on our collaborators or partners to conduct the required activities to support an application for regulatory approval, and to seek approval, for one or more of our product candidates. We cannot be sure that our collaborators or partners will conduct these activities successfully or do so within the timeframe we desire. Even if we (or our collaborators or partners) are successful in obtaining approval in one jurisdiction, we cannot ensure that we will obtain approval in any other jurisdictions. If we are unable to obtain approval for our product candidates in multiple jurisdictions, our revenue and results of operations could be negatively affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we receive regulatory approval to market any of our product candidates, we cannot assure you that any such product candidate will be successfully commercialized, widely accepted in the marketplace or more effective than other commercially available alternatives. That approval may be for indications, dosage and administration or patient populations that are not as broad as intended or desired or may require labeling that includes significant use or distribution restrictions or safety warnings. We may also be required to perform additional or unanticipated clinical studies to obtain approval or be subject to additional post-marketing testing requirements to maintain regulatory approval. In addition, regulatory authorities may withdraw their approval of a product or impose restrictions on its distribution, such as in the form of a modified Risk Evaluation and Mitigation Strategy, or REMS. The failure to obtain timely regulatory approval of product candidates, any product marketing limitations or a product withdrawal would negatively impact our business, results of operations and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investment in biopharmaceutical product development involves significant risk that any product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval, and become commercially viable. We cannot provide any assurance that we will be able to successfully advance any of our product candidates through the development process or, if approved, successfully commercialize any of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may encounter substantial delays in our clinical trials, or may not be able to conduct or complete our clinical trials on the timelines we expect, if at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.235;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical testing is expensive, time consuming, and subject to uncertainty. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all. We cannot be sure that submission of an IND application or a clinical trial application, or CTA, will result in the FDA, European Medicines Agency, or EMA, China National Medical Products Administration, or NMPA, or any other regulatory authority as applicable, allowing clinical trials to begin in a timely manner, if at all. Moreover, even if these trials begin, issues may arise that could suspend or terminate such clinical trials. A failure of one or more clinical trials can occur at any stage of testing, and our future clinical trials may not be successful. Events that may prevent successful or timely initiation or completion of clinical trials include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to generate sufficient preclinical, toxicology, or other </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> data to support the initiation or continuation of clinical trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in reaching a consensus with regulatory agencies on study design or, in the case of China, the registration category for the drug candidate to be studied in the clinical trial; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the determination by the reviewing regulatory authority to require more costly or lengthy clinical trials than we currently anticipate; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in reaching agreement on acceptable terms with prospective CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in identifying, recruiting and training suitable clinical investigators; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in obtaining required Institutional Review Board, or IRB, approval at each clinical trial site; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.235;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">imposition of a temporary or permanent clinical hold by regulatory agencies for a number of reasons, including after review of an IND or amendment, CTA or amendment, or equivalent application or amendment; as a result of a new safety finding that presents unreasonable risk to clinical trial participants; a negative finding from an inspection of our clinical trial operations or study sites; developments on trials conducted by competitors for related technology that raises FDA, EMA, NMPA or any other regulatory authority concerns about risk to patients of the technology broadly; or if the FDA, EMA, NMPA or any other regulatory authority finds that the investigational protocol or plan is clearly deficient to meet its stated objectives; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in identifying, recruiting and enrolling suitable patients to participate in our clinical trials, and delays caused by patients withdrawing from clinical trials or failing to return for post-treatment follow-up; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulty collaborating with patient groups and investigators; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure by our CROs, other third parties, or us to adhere to clinical trial requirements; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to perform in accordance with the FDA&#x2019;s or any other regulatory authority&#x2019;s current good clinical practices, or cGCPs, requirements, or applicable EMA, NMPA or other regulatory guidelines in other countries; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">occurrence of adverse events associated with the product candidate that are viewed to outweigh its potential benefits; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in the standard of care on which a clinical development plan was based, which may require new or additional trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of clinical trials of our product candidates being greater than we anticipate; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinical trials of our product candidates producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon development of such product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">transfer of manufacturing processes to larger-scale facilities operated by CMOs or by us, and delays or failure by our CMOs or us to make any necessary changes to such manufacturing process; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2079166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in manufacturing, testing, releasing, validating, or importing/exporting sufficient stable quantities of our product candidates for use in clinical trials and for use in regulatory filings or the inability to do any of the foregoing. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any inability to successfully initiate or complete clinical trials could result in additional costs to us or impair our ability to generate revenue. In addition, if we make manufacturing or formulation changes to our product candidates, we may be required to or we may elect to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays could also shorten any periods during which our products have patent protection and may allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We could also encounter delays if a clinical trial is suspended or terminated by us, by the data safety monitoring board for such trial or by the FDA, EMA, NMPA or any other regulatory authority, or if the IRBs of the institutions in which such trials are being conducted suspend or terminate the participation of their clinical investigators and sites subject to their review. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA, EMA, NMPA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product candidate, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. We may also face delays if we are unable to reach agreement with the FDA, EMA, NMPA or other regulatory authorities regarding CMC matters, including methodologies for, and assessment of, comparability of manufacturing procedures and lots.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Delays in the commencement or completion of any clinical trial of our product candidates will increase our costs, slow down our product candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our product candidates may cause undesirable side effects or have other properties that could halt their clinical development, prevent their regulatory approval, limit their commercial potential or result in significant negative consequences.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adverse events or other undesirable side effects caused by our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA, EMA, NMPA or other comparable foreign regulatory authorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the conduct of clinical trials, patients report changes in their health, including illnesses, injuries, and discomforts, to their study doctor. Often, it is not possible to determine whether or not the product candidate being studied caused these conditions. It is possible that as we test our product candidates in larger, longer and more extensive clinical trials, or as use of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts and other adverse events that were not observed in earlier trials, as well as conditions that did not occur or went undetected in previous trials, will be reported by patients. Many times, side effects are only detectable after investigational products are tested in large-scale Phase 3 clinical trials or, in some cases, after they are made available to patients on a commercial scale after approval. If additional clinical experience indicates that any of our product candidates has side effects or causes serious or life-threatening side effects, the development of the product candidate may fail or be delayed, or, if the product candidate has received regulatory approval, such approval may be revoked, which would severely harm our business, prospects, operating results and financial condition. For example, the safety profile we have observed in the Phase 1a/1b study of KSI-301 and in the masked (blinded) pivotal data thus far may not be representative of the safety profile we observe when data is unmasked. We may still observe significant safety events that may negatively impact the KSI-301 program and the ABC platform. Even with a safety database through pivotal studies of approximately 1,500 patients, a safety profile for KSI-301 in line with today&#x2019;s standard of care agents may not be sustained when administered to 100,000s of patients at varying dose intervals after commercialization.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our most advanced product candidate, KSI-301, is an anti-VEGF biologic that we are studying in wet AMD, DME/DR and RVO. There are some potential side effects associated with intravitreal anti-VEGF therapies such as intraocular hemorrhage, intraocular pressure elevation, retinal detachment, inflammation, vasculitis, artery occlusion or infection inside the eye and over-inhibition of VEGF, as well as the potential for potential systemic side effects such as heart attack, stroke, wound healing problems, and high blood pressure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recent trends in the development of anti-VEGF therapies have favored increased molar dosages, as compared to currently marketed treatments. To date these heightened dosages have not exhibited a safety profile significantly worse than that of current treatments, as attributable to molar dose. However, anti-VEGF product candidates featuring higher molar dosages, including KSI-301, may heighten the risk of adverse effects associated with anti-VEGF treatments generally, both in the eye and in the rest of the body. There are risks inherent in the intravitreal injection procedure of drugs like KSI-301 which can cause injury to the eye and other complications including conjunctival hemorrhage, punctate keratitis, eye pain, conjunctival hyperemia, intra-ocular inflammation, and endophthalmitis. KSI-301 is also being explored clinically with higher frequency dosing</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">not predicated with today&#x2019;s standard of care agents historically, higher frequency dosing may increase the risk of potential adverse events. Our expectation is for KSI-301 to be used at high frequency (for example, monthly dosing) in a minority of patients, yet any additional toxicology signal observed, be it real or perceived, may negatively impact perceptions of KSI-301 in broader populations and impact clinical trial enrollment, regulatory approval and commercial success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Drug-related side effects could affect patient recruitment, the ability of enrolled patients to complete the study and/or result in potential product liability claims. We may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses due to liability. A successful product liability claim or series of claims brought against us could cause our stock price to decline and, if judgments exceed our insurance coverage, could adversely affect our results of operations and business. In addition, regardless of merit or eventual outcome, product liability claims may result in impairment of our business reputation, withdrawal of clinical trial participants, costs due to related litigation, distraction of management&#x2019;s attention from our primary business, initiation of investigations by regulators, substantial monetary awards to patients or other claimants, the inability to commercialize our product candidates and decreased demand for our product candidates, if approved for commercial sale.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects or adverse events caused by such products, a number of potentially significant negative consequences could result, including but not limited to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may withdraw approvals of such product; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may require additional warnings on the label; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to change the way the product is administered or conduct additional clinical trials or post-approval studies; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to create a REMS plan, which could include a medication guide outlining the risks of such side effects for distribution to patients, a communication plan for healthcare providers and/or other elements to assure safe use; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we could be sued and held liable for harm caused to patients; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our reputation may suffer. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and could significantly harm our business, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may encounter difficulties enrolling patients in our clinical trials, and our clinical development activities could thereby be delayed or otherwise adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the trial until its conclusion. We may experience difficulties in patient enrollment in our clinical trials for a variety of reasons, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size and nature of the patient population; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patient eligibility criteria defined in the protocol, including certain highly-specific criteria related to stage of disease progression, which may limit the patient populations eligible for our clinical trials to a greater extent than competing clinical trials for the same indication that do not have such patient eligibility criteria; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size of the study population required for analysis of the trial&#x2019;s primary endpoints; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the proximity of patients to a trial site; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the effects of health epidemics, including the ongoing COVID-19 pandemic and the resulting shelter-in-place, travel or similar restrictions;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the design of the trial; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">new safety events may cause physicians to decrease patient enrollment in our studies;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to recruit clinical trial investigators with the appropriate competencies and experience; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">competing clinical trials for similar therapies or targeting patient populations meeting our patient eligibility criteria; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinicians&#x2019; and patients&#x2019; perceptions as to the potential advantages and side effects of the product candidate being studied in relation to other available therapies and product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain and maintain patient consents; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the risk that patients enrolled in clinical trials will not complete such trials, for any reason. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, because patients with early stages of DR often lack symptoms, it may be challenging to identify and enroll patients at early stages of disease that may be required for a clinical trial. Our inability to enroll a sufficient number of patients for our clinical trials could result in significant delays or may require us to abandon one or more clinical trials altogether. Enrollment delays in our clinical trials may result in increased development costs for our product candidates, delay or halt the development of and approval processes for our product candidates and jeopardize our ability to commence sales of and generate revenues from our product candidates, which may harm our business and results of operation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our clinical trials may fail to demonstrate substantial evidence of the safety and efficacy or durability of our product candidates, which would prevent, delay or limit the scope of regulatory approval and commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before obtaining regulatory approvals for the commercial sale of any of our product candidates, we must demonstrate through lengthy, complex and expensive preclinical studies and clinical trials that our product candidates are both safe and effective for use in each target indication. For those product candidates that are subject to regulation as biological drug products, we will need to demonstrate that they are safe, pure, and potent for use in their target indications. Each product candidate must demonstrate an adequate risk versus benefit profile in its intended patient population and for its intended use. This is especially true for anti-VEGF biologic agents, where Lucentis and Eylea are established products with accepted safety profiles.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies of our product candidates may not be predictive of the results of early-stage or later-stage clinical trials, and results of early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. The results of clinical trials in one set of patients or disease indications may not be predictive of those obtained in another. In some instances, there can be significant variability in safety, efficacy or durability results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the dosing regimen and other clinical trial protocols and the rate of dropout among clinical trial participants. Product candidates in later stages of clinical trials may fail to show the desired safety, efficacy and durability profile despite having progressed through preclinical studies and initial clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that begin clinical trials are never approved by regulatory authorities for commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be unable to design and execute clinical trials that support marketing approval. We cannot be certain that our planned clinical trials or any other future clinical trials will be successful. Additionally, any safety concerns observed in any one of our clinical trials in our targeted indications could limit the prospects for regulatory approval of our product candidates in those and other indications, which could have a material adverse effect on our business, financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA or foreign regulatory authorities will interpret the results as we do, and more trials or trials of a different design could be required before we submit our product candidates for approval. Our KSI-301 pivotal study program relies on a single active arm in each study at a single dose (5 mg), such that if a safety observation is observed there is no fallback position at a lower dose to rely on. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates. Even if regulatory approval is secured for any of our product candidates, the terms of such approval may limit the scope and use of our product candidate, which may also limit its commercial potential. Even if trial results are successful at the primary endpoint, clinical trial results may be different or worse in the extended treatment periods following the primary endpoint, and such data may negatively impact perceptions by regulatory authorities, the clinical community or commercial payors of the benefits of our product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be successful in our efforts to continue to create a pipeline of product candidates or to develop commercially successful products. If we fail to successfully identify and develop additional product candidates, our commercial opportunity may be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">One of our strategies is to identify and pursue clinical development of additional product candidates through our ABC Platform. Our ABC Platform may not produce a pipeline of viable product candidates, or our competitors may develop platform technologies that render our ABC Platform obsolete or less attractive. Our research methodology may be unsuccessful in identifying potential product candidates, or our potential product candidates may be shown to have harmful side effects or may have other characteristics that may make them unmarketable or unlikely to receive marketing approval. Identifying, developing, obtaining regulatory approval and commercializing additional product candidates for the treatment of retinal diseases will require substantial additional funding and is prone to the risks of failure inherent in drug development. If we are unable to successfully identify, acquire, develop and commercialize additional product candidates, our commercial opportunity may be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We face significant competition in an environment of rapid technological and scientific change, and there is a possibility that our competitors may retain their market share with existing drugs, or achieve regulatory approval before us or develop therapies that are safer, more advanced or more effective than ours, which may negatively impact our ability to successfully market or commercialize any product candidates we may develop and ultimately harm our financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The development and commercialization of new drug products is highly competitive. We may face competition with respect to any product candidates that we seek to develop or commercialize in the future from major pharmaceutical companies, specialty pharmaceutical companies, and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are a number of large pharmaceutical and biotechnology companies that are currently pursuing the development of products for the treatment of the retinal disease indications for which we have product candidates, including wet AMD, DME/DR, and RVO. Certain of our competitors have commercially approved products for the treatment of retinal diseases that we are pursuing or may pursue in the future, including Roche, Regeneron and Novartis for the treatment of wet AMD, DME/DR, and RVO. These drugs are well established therapies and are widely accepted by physicians, patients and third-party payors, which may make it difficult to educate these parties on the benefits of switching to KSI-301. Companies that we are aware are developing therapeutics in the retinal disease area include large companies with significant financial resources, such as Roche, Novartis, Bayer and Regeneron, AbbVie/Allergan, Mylan, Momenta, and Samsung Bioepis. In addition to competition from other companies targeting retinal indications, any products we may develop may also face competition from other types of therapies, such as gene-editing therapies and drug delivery devices.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The first Lucentis biosimilar was approved this year in the USA, and its approval may impact market dynamics and payor policies negatively for KSI-301. Roche&#x2019;s product candidate, faricimab, was filed for approval in May 2021 for wet AMD and DME and is currently enrolling pivotal studies in RVO. We believe faricimab&#x2019;s clinical profile together with physician enthusiasm for a new branded anti-VEGF will make it an important product in the marketplace. Even if KSI-301 presents a compelling clinical profile, we may not be able to market our product candidates as effectively as our competitors. For example, entrenched franchises may seek to impede adoption of KSI-301 through significant discounts or rebates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many of our current or potential competitors, either alone or with their strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our product candidates. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Furthermore, currently approved products could be discovered to have application for treatment of retinal disease indications, which could give such products significant regulatory and market timing advantages over any of our product candidates. Our competitors also may obtain FDA, EMA, NMPA or other regulatory approval for their products more rapidly than we may obtain approval for ours. Additionally, products or technologies developed by our competitors may render our potential product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates we may develop against competitors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we could face litigation or other proceedings with respect to the scope, ownership, validity and/or enforceability of our patents relating to our competitors&#x2019; products and our competitors may allege that our products infringe, misappropriate or otherwise violate their intellectual property. For more information regarding potential disputes concerning intellectual property, see the subsection of this report titled &#x201c;Risks Related to Our Intellectual Property.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The manufacture of our product candidates is highly complex and requires substantial lead time to produce.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Manufacturing our product candidates involves complex processes, including developing cells or cell systems to produce the biologic, growing large quantities of such cells, and harvesting and purifying the biologic produced by them. These processes require specialized facilities, highly specific raw materials and other production constraints. As a result, the cost to manufacture a biologic is generally far higher than traditional small molecule chemical compounds, and the biologics manufacturing process is less reliable and is difficult to reproduce. Because of the complex nature of our products, we need to oversee the manufacture of multiple components that require a diverse knowledge base and specialized personnel. Commercial manufacturing scale-up timelines may be negatively affected by material shortages, construction delays and supply chain challenges due to, among other factors, global supply chain shortages due to COVID-19 or other reasons.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, unlike chemical pharmaceuticals, the physical and chemical properties of a biologic such as our product candidates generally cannot be adequately characterized prior to manufacturing the final product. As a result, an assay of the finished product is not sufficient to ensure that the product will perform in the intended manner. Accordingly, we expect to employ multiple steps to attempt to control our manufacturing process to assure that the process works, and the product or product candidate is made strictly and consistently in compliance with the process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Manufacturing biologics is highly susceptible to product loss due to contamination, equipment failure, improper installation or operation of equipment, vendor or operator error, improper storage or transfer, inconsistency in yields and variability in product characteristics. Even minor deviations from normal manufacturing, distribution or storage processes could result in reduced production yields, product defects and other supply disruptions. Some of the raw materials required in our manufacturing process are derived from biological sources. Such raw materials are difficult to procure and may also be subject to contamination or recall. A material shortage, contamination, recall or restriction on the use of biologically derived substances in the manufacture of our product candidates could adversely impact or disrupt commercialization. Production of additional drug substance and drug product for any of our product candidates may require substantial lead time. For example, currently any new large-scale batches of KSI-301 would require at least 12 months to manufacture. In the event of significant product loss and materials shortages, we may be unable to produce adequate amounts of our product candidates or products for our operational needs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, as product candidates are developed through preclinical studies to late-stage clinical trials towards approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods, are altered along the way in an effort to optimize processes and results. Such changes carry the risk that they will not achieve these intended objectives, and any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other future clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on third parties for raw materials needed for manufacturing KSI-301. We may not be able to obtain adequate amounts in the future. These challenges are magnified by the international nature of our supply chain, which, for KSI-301, requires drug substance and drug product sourced from single source suppliers from China, Japan, the United Kingdom, the United States and Switzerland. For example, the effects of health epidemics, including the ongoing COVID-19 pandemic and the resulting shelter-in-place, travel or similar restrictions may impact the timing of clinical resupply facing and BLA facing manufacturing activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have no experience manufacturing any of our product candidates at a commercial scale. If we or any of our third-party manufacturers encounter difficulties in production, or fail to meet rigorously enforced regulatory standards, our ability to provide supply of our product candidates for clinical trials and regulatory applications or our products for patients, if approved, could be delayed or stopped, or we may be unable to establish a commercially viable cost structure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to conduct clinical trials of our product candidates, or supply commercial products, if approved, we will need to manufacture them in small and large quantities. Our third-party manufacturer has made only a limited number of lots of KSI-301 to date and has not made any commercial lots. The manufacturing processes for KSI-301 have never been tested at commercial scale and the process validation requirement (the requirement to consistently produce the active pharmaceutical ingredient used in KSI-301 in commercial quantities and of specified quality on a repeated basis and document its ability to do so) has not yet been satisfied. Our manufacturing partners may be unable to successfully increase the manufacturing capacity for any of our product candidates in a timely or cost-effective manner, or at all. In addition, quality issues may arise during scale-up activities. If our manufacturing partners are unable to successfully scale up the manufacture of our product candidates in sufficient quality and quantity, the development, testing and clinical trials of our product candidates may be delayed or become infeasible, and regulatory approval or commercial launch of any resulting product may be delayed or not obtained, which could significantly harm our business. The same risks would apply to any internal manufacturing facilities, should we in the future decide to build internal manufacturing capacity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the manufacturing process for any products that we may develop is subject to FDA, EMA, NMPA and foreign regulatory authority approval processes and continuous oversight. We will need to contract with manufacturers who can meet all applicable FDA, EMA, NMPA and foreign regulatory authority requirements, including complying with current good manufacturing practices, or cGMPs, on an ongoing basis. If we or our third-party manufacturers are unable to reliably produce products to specifications acceptable to the FDA, EMA, NMPA or other regulatory authorities, we may not obtain or maintain the approvals we need to commercialize such products. Even if we obtain regulatory approval for any of our product candidates, there is no assurance that either we or our CMOs will be able to manufacture the approved product to specifications acceptable to the FDA, EMA, NMPA or other regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential launch of the product, or to meet potential future demand. Our manufacturers are also engaged in the manufacturing of COVID-19 related vaccines and therapeutic treatments, and the success of and demand for these vaccines and therapeutic treatments means we and our programs are competing for scarce manufacturing resources. We aim to distribute KSI-301 in a prefilled syringe early in our commercial rollout. We may not be able to complete our prefilled syringe activities in a timely manner, or we may fail technically to design and develop a prefilled syringe for KSI-301. If we require large volumes of glass vials, we may not be able to secure a sufficient supply due to COVID-19 related shortages of glass and vials. Any of these challenges could delay completion of clinical trials, require bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidate, impair commercialization efforts, increase our cost of goods, and have an adverse effect on our business, financial condition, results of operations and growth prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If, in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market any product candidates we may develop, we may not be successful in commercializing those product candidates if and when they are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not have a sales or marketing infrastructure and have no experience in the sale, marketing or distribution of pharmaceutical products. To achieve commercial success for any approved product for which we retain sales and marketing responsibilities, we must either develop a sales and marketing organization or outsource these functions to third parties. In the future, we may choose to build a focused sales, marketing and commercial support infrastructure to sell, or participate in sales activities with our collaborators for, some of our product candidates if and when they are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are risks involved with both establishing our own commercial capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force or reimbursement specialists is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and other commercialization capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our commercialization personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Factors that may inhibit our efforts to commercialize any approved product on our own include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer service, medical affairs and other support personnel; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability of sales personnel to obtain access to physicians or educate adequate numbers of physicians on the benefits of prescribing any future approved products; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement, and other acceptance by payors; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability to price our products at a sufficient price point to ensure an adequate and attractive level of profitability; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restricted or closed distribution channels that make it difficult to distribute our products to segments of the patient population; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unforeseen costs and expenses associated with creating an independent commercialization organization. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we enter into arrangements with third parties to perform sales, marketing, commercial support and distribution services, our product revenue or the profitability of product revenue may be lower than if we were to market and sell any products we may develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to commercialize our product candidates or may be unable to do so on terms that are favorable to us. We may have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish commercialization capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates if approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if any product candidates we develop receive marketing approval, they may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors and others in the medical community necessary for commercial success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The commercial success of any of our product candidates will depend upon its degree of market acceptance by physicians, patients, third-party payors and others in the medical community. Even if any product candidates we may develop receive marketing approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors, and others in the medical community. The degree of market acceptance of any product candidates we may develop, if approved for commercial sale, will depend on a number of factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the efficacy and safety of such product candidates as demonstrated in pivotal clinical trials and published in peer-reviewed journals; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the potential and perceived advantages of our product or product label as compared to alternative treatments; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability to offer our products for sale at competitive prices; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability to offer appropriate patient access programs, such as co-pay assistance; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which physicians recommend our products to their patients; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">convenience and ease of dosing and administration compared to alternative treatments; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the clinical indications for which the product candidate is approved by FDA, EMA, NMPA or other regulatory agencies; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product labeling or product insert requirements of the FDA, EMA, NMPA or other comparable foreign regulatory authorities, including any limitations, contraindications or warnings contained in a product&#x2019;s approved labeling; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on how the product is distributed; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing of market introduction of competitive products; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">publicity concerning our products or competing products and treatments; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the strength of marketing and distribution support; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sufficient third-party coverage or reimbursement; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the prevalence and severity of any side effects. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any product candidates we develop do not achieve an adequate level of acceptance, we may not generate significant product revenue, and we may not become profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we are able to commercialize any product candidates, such products may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, which would harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Drug pricing and access policies in the U.S. and abroad may change and negatively impact KSI-301&#x2019;s commercial viability. Proposed policy changes, including the potential for Medicare to negotiate with drug manufacturers, may limit our ability to competitively price KSI-301. Further, commercial insurers may limit patient access to KSI-301 and other branded therapies. The regulations that govern marketing approvals, pricing and reimbursement for new drugs vary widely from country to country. In the United States, recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our ability to successfully commercialize any products that we may develop also will depend in part on the extent to which reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers, and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Government authorities currently impose mandatory discounts for certain patient groups, such as Medicare, Medicaid and Veterans Affairs, or VA, hospitals, and may seek to increase such discounts at any time. Future regulation may negatively impact the price of our products, if approved. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, that the level of reimbursement will be sufficient.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. In order to get reimbursement, physicians may need to show that patients have superior treatment outcomes with our products compared to standard of care drugs, including lower-priced generic versions of standard of care drugs. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval. In the United States, no uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There may be significant delays in obtaining reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the medicine is approved by the FDA, EMA, NMPA or other comparable foreign regulatory authorities. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies. Further, coverage policies and third-party payor reimbursement rates may change at any time. Therefore, even if favorable coverage and reimbursement status is attained, less favorable coverage policies and reimbursement rates may be implemented in the future. Our inability to promptly obtain and maintain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates, and our overall financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our product candidates may face competition from biological products that are biosimilar to or interchangeable with our product candidates sooner than anticipated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing the sponsor&#x2019;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of their product. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation and meaning are subject to uncertainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that any of our product candidates approved as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider our product candidates to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face an inherent risk of product liability as a result of the clinical testing of our product candidates and will face an even greater risk when and if we commercialize any products. For example, we may be sued if our product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit testing and commercialization of our product candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">decreased or interrupted demand for our products; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injury to our reputation; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">withdrawal of clinical trial participants and inability to continue clinical trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiation of investigations by regulators; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs to defend the related litigation; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a diversion of management&#x2019;s time and our resources; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">substantial monetary awards to trial participants or patients; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product recalls, withdrawals or labeling, marketing or promotional restrictions; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">loss of revenue; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">exhaustion of any available insurance and our capital resources; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability to commercialize any product candidate; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a decline in our share price. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our inability to obtain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent or inhibit the commercialization of products we develop, alone or with collaborators. Our insurance policies may have various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or adequate should any claim arise.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Regulatory Approval and Other Legal Compliance Matters</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The regulatory approval processes of the FDA, EMA, NMPA and comparable foreign regulatory authorities are lengthy, time consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates, we will be unable to generate product revenue and our business will be substantially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The time required to obtain approval by the FDA, EMA, NMPA and comparable foreign regulatory authorities is unpredictable, typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the type, complexity and novelty of the product candidates involved. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#x2019;s clinical development and may vary among jurisdictions, which may cause delays in the approval or the decision not to approve an application. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. We have not submitted for or obtained regulatory approval for any product candidate, and it is possible that none of our existing product candidates or any product candidates we may seek to develop in the future will ever obtain regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Applications for our product candidates could fail to receive regulatory approval for many reasons, including but not limited to the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA, EMA, NMPA or comparable foreign regulatory authorities may disagree with the design, implementation or results of our clinical trials or the portfolio of clinical trials planned for submission in our BLA; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA, EMA, NMPA or comparable foreign regulatory authorities may determine that our product candidates are not safe and effective, only moderately effective or have undesirable or unintended side effects, toxicities or other characteristics that preclude our obtaining marketing approval or prevent or limit commercial use of our products; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the population studied in the clinical program may not be sufficiently broad or representative to assure efficacy and safety in the full population for which we seek approval; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be unable to demonstrate to the FDA, EMA, NMPA or comparable foreign regulatory authorities that a product candidate&#x2019;s risk-benefit ratio for its proposed indication(s), when compared to the standard of care, is acceptable; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA, EMA, NMPA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the data collected from clinical trials of our product candidates may not be sufficient to support the submission of a BLA or other submission or to obtain regulatory approval in the United States or elsewhere; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">study data may not be positive in all clinical trials demonstrating a mix of positive and negative clinical trial results;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA, EMA, NMPA or comparable foreign regulatory authorities may fail to approve the chemistry, manufacturing and controls processes, test procedures and specifications, or facilities or third-party manufacturers with which we contract for clinical and commercial supplies; and </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.1700000000000002;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the approval policies or regulations of the FDA, EMA, NMPA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This lengthy approval process, as well as the unpredictability of the results of clinical trials, may result in our failing to obtain regulatory approval to market any of our product candidates, which would significantly harm our business, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We plan to conduct clinical trials for our product candidates outside the United States (or the respective jurisdictions of other regulatory authorities), and the FDA, (or EMA, NMPA and applicable foreign regulatory authorities) may not accept data from such trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We plan to conduct one or more of our clinical trials outside the United States, including Europe, China and other foreign countries. The acceptance of study data from global clinical trials by the FDA, EMA, NMPA or applicable foreign regulatory authority may be subject to certain conditions. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (1) the data are applicable to the U.S. population and U.S. medical practice and (2) the trials were performed by clinical investigators of recognized competence and pursuant to cGCP regulations. Additionally, the FDA&#x2019;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory bodies have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, EMA, NMPA or any applicable foreign regulatory authority will accept data from trials conducted outside of their respective jurisdictions. If the FDA, EMA, NMPA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming, would delay aspects of our business plan and which may result in our product candidates not receiving approval or clearance for commercialization in the applicable jurisdiction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, but a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA, EMA or NMPA grants marketing approval of a product candidate, we would not be permitted to manufacture, market or promote the product candidate in other countries unless and until comparable regulatory authorities in foreign jurisdictions had approved the candidate for use in their countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional preclinical studies or clinical trials. There can be no assurance that any clinical trials conducted in one jurisdiction will be accepted by regulatory authorities in other jurisdictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we or any collaborator we work with fail to comply with the regulatory requirements in international markets or fail to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we obtain regulatory approval for a product candidate, our products will remain subject to extensive regulatory scrutiny.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market information, including both federal and state requirements in the United States and requirements of comparable foreign regulatory authorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Manufacturers and manufacturers&#x2019; facilities are required to comply with extensive requirements imposed by the FDA, EMA, NMPA and comparable foreign regulatory authorities, including ensuring that quality control and manufacturing procedures conform to cGMP regulations. As such, we and our contract manufacturers will be subject to continual review and inspections to assess compliance with cGMP and adherence to commitments made in any BLA or marketing authorization application, or MAA. Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production and quality control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any regulatory approvals that we receive for our product candidates will be subject to limitations on the approved indicated uses for which the product may be marketed and promoted or to the conditions of approval (including the requirement to implement a REMS), or contain requirements for potentially costly post-marketing testing. We will be required to report certain adverse reactions and production problems, if any, to the FDA, EMA, NMPA and comparable foreign regulatory authorities. Any new legislation addressing drug safety issues could result in delays in product development or commercialization, or increased costs to assure compliance. The FDA and other agencies, including the Department of Justice, closely regulate and monitor the post-approval marketing and promotion of products to ensure that they are manufactured, marketed and distributed only for the approved indications and in accordance with the provisions of the approved labeling. We will have to comply with requirements concerning advertising and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">promotion for our products. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#x2019;s approved label. As such, we may not promote our products for indications or uses for which they do not have approval. The holder of an approved BLA or MAA must submit new or supplemental applications and obtain approval for certain changes to the approved product, product labeling or manufacturing process. We could also be asked to conduct post-marketing clinical trials to verify the safety and efficacy of our products in general or in specific patient subsets. If original marketing approval was obtained via the accelerated approval pathway, we could be required to conduct a successful post-marketing clinical trial to confirm clinical benefit for our products. An unsuccessful post-marketing study or failure to complete such a study could result in the withdrawal of marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a regulatory agency discovers previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, or disagrees with the promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal of the product from the market. If we fail to comply with applicable regulatory requirements, a regulatory agency or enforcement authority may, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issue warning letters that would result in adverse publicity; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impose civil or criminal penalties; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">suspend or withdraw regulatory approvals; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">suspend any of our ongoing clinical trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refuse to approve pending applications or supplements to approved applications submitted by us; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impose restrictions on our operations, including closing our contract manufacturers&#x2019; facilities; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seize or detain products; or </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require a product recall. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our company and our operating results will be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Healthcare legislative measures aimed at reducing healthcare costs may have a material adverse effect on our business and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party payors, whether domestic or foreign, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In both the United States and certain international jurisdictions, there have been a number of legislative and regulatory changes to the health care system that could impact our ability to sell our products profitably. In particular, in 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively the ACA, was enacted, which, among other things, subjected biologic products to potential competition by lower-cost biosimilars, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate Program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and provided incentives to programs that increase the federal government&#x2019;s comparative effectiveness research.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since the ACA&#x2019;s enactment, there have been numerous challenges to the ACA. For example, President Trump signed several Executive Orders and other directives designed to delay the implementation of certain provisions of the ACA. Concurrently, Congress considered legislation that would repeal or repeal and replace all or part of the ACA.  While Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the ACA such as removing penalties, starting January 1, 2019, for not complying with the ACA&#x2019;s individual mandate to carry health insurance and delaying the implementation of certain ACA-mandated fees. On June 17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued that the ACA is unconstitutional in its entirety because the individual mandate was repealed by Congress. Thus, the ACA will remain in effect in its current form. Further, prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace, which began on February 15, 2021 and remained open through August 15, 2021. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is possible that the ACA will be subject to judicial or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Congressional challenges in the future. It is unclear how such challenges and the healthcare reform measures of the Biden administration will impact the ACA and our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#x2019;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in 2013, and due to subsequent legislative amendments to the statute, will remain in effect through 2030 unless additional Congressional action is taken. However, COVID-19 relief support legislation suspended the 2% Medicare sequester from May 1, 2020 through December 31, 2021. The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Further, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap for single source and innovator multiple source drugs, beginning January 1, 2024. In addition, Congress is considering additional health reform measures as part of the budget reconciliation process. In addition, Congress is considering additional health reform measures, such as capping the costs for prescription drugs covered by Medicare Part D and by setting the annual out-of-pocket limit at $2,000 beginning in 2024, as part of the budget reconciliation process.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the demand for our product candidates, if we obtain regulatory approval; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to receive or set a price that we believe is fair for our products; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to generate revenue and achieve or maintain profitability; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the level of taxes that we are required to pay; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the availability of capital. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies. At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals, executive orders and policy initiatives. For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to prescription drug pricing that attempt to implement several of the administration&#x2019;s proposals. The FDA also released a final rule, effective November 30, 2020, implementing a portion of the importation executive order providing guidance for states to build and submit importation plans for drugs from Canada. Further, on November 20, 2020, the Department of Health and Human Services, or HHS, finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January 1, 2022 to January 1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which have also been delayed until January 1, 2023. On November 20, 2020, the Centers for Medicare &amp; Medicaid Services, or CMS, issued an interim final rule implementing President Trump&#x2019;s Most Favored Nation, or MFN, executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries, effective January 1, 2021. As a result of litigation challenging the MFN Model, on August 10, 2021, CMS published a proposed rule that seeks to rescind the MFN Model interim final rule. In July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. No legislation or administrative actions have been finalized to implement these principles. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, lower reimbursement and new payment methodologies. This could lower the price that we receive for any approved product. Any denial in coverage or reduction in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reimbursement from Medicare or other government-funded programs may result in a similar denial or reduction in payments from private payors, which may prevent us from being able to generate sufficient revenue, attain profitability or commercialize our product candidates, if approved. Further, it is possible that additional governmental action is taken in response to the COVID-19 pandemic.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our employees, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements or insider trading violations, which could significantly harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to the risk of fraud, misconduct or other illegal activity by our employees, independent contractors, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless and negligent conduct that fails to: comply with the laws of the FDA, EMA, NMPA and other comparable foreign regulatory authorities; provide true, complete and accurate information to the FDA, EMA, NMPA and other comparable foreign regulatory authorities; comply with manufacturing standards we have established; comply with healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws; or report financial information or data accurately or to disclose unauthorized activities to us. If we obtain FDA approval of any of our product candidates and begin commercializing those products in the United States, our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws are also likely to increase. In particular, research, sales, marketing, education and other business arrangements in the healthcare industry are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, educating, marketing and promotion, sales and commission, certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. Employee misconduct could also involve the improper use of, including improper trading based upon, information obtained in the course of clinical studies, which could result in regulatory sanctions and serious harm to our reputation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with our IPO, we adopted a code of business conduct and ethics that applies to all our employees, including management, and our directors. However, it is not always possible to identify and deter misconduct by employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we fail to comply with healthcare laws, we could face substantial penalties and our business, operations and financial conditions could be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our current and future arrangements with healthcare providers, third-party payors, customers, and others may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, which may constrain the business or financial arrangements and relationships through which we research, as well as, sell, market and distribute any products for which we obtain marketing approval. The laws that may impact our operations include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">federal civil and criminal false claims laws, including the False Claims Act, which can be enforced by private citizens on behalf of the government through civil whistleblower or qui tam actions, and civil monetary penalty laws, which impose criminal and civil penalties against individuals or entities from knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid or other third-party payors that are false or fraudulent or knowingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;visibility:hidden;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and healthcare clearinghouses and their respective business associates that perform services for them that involve the use, or disclosure of, individually identifiable health information as well as their covered subcontractors, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which require manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program to report annually to the CMS under the Open Payments Program, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers also will be required to report such information related to payments or other transfers of value made during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists and certified nurse midwives; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws that require the registration of pharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could, despite our efforts to comply, be subject to challenge under one or more of such laws. Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. It is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, disgorgement, monetary fines, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. In addition, the approval and commercialization of any of our product candidates outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned above, among other foreign laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business is subject to complex and evolving U.S. and foreign laws and regulations relating to privacy and data protection. These laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, or monetary penalties, and otherwise may harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A wide variety of provincial, state, national, and foreign laws and regulations, as well as policies, contracts and other obligations apply to the collection, use, retention, protection, disclosure and transfer of personal data. These data protection and privacy-related laws and regulations are evolving and may result in ever-increasing regulatory and public scrutiny and escalating levels of enforcement and sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, the European Union&#x2019;s General Data Protection Regulation, or GDPR, which took effect on May 25, 2018, imposes stringent data protection requirements and provides for material penalties for noncompliance. The GDPR applies to processing operations carried out in the context of the activities of an establishment in the European Economic Area, or EEA, and any processing relating to the offering of goods or services to individuals in the EEA and/or the monitoring of their behavior in the EEA. Also, notwithstanding the United Kingdom&#x2019;s withdrawal from the EU, by operation of the so-called UK GDPR, the GDPR continues to apply in substantially equivalent form to processing operations carried out in the context of the activities of an establishment in the United Kingdom and any processing relating to the offering of goods or services to individuals in the United Kingdom and/or monitoring of their behavior in the United Kingdom&#x2014;so, when we refer to the GDPR in this section, we are also making reference to the UK GDPR in the context of the United Kingdom, unless the context requires otherwise. These laws may apply in the context of our processing of personal data related to the conduct of clinical trials in the EEA and/or UK.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The GDPR requires organizations to give detailed disclosures about how they collect, use and share personal information; in certain cases, obtain explicit consent to process special categories of personal data, such as the health or genetic information referred to above; contractually require vendors to meet data protection requirements; maintain adequate data security measures; notify regulators and affected individuals of certain data breaches; meet extensive privacy governance and documentation requirements; and honor individuals&#x2019; data protection rights, including their rights to access, correct and delete their personal information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">European data protection laws, including the GDPR, also restrict transfers of personal data from Europe, including the EEA, the United Kingdom and Switzerland, to the United States and most other countries unless the parties to the transfer have implemented specific safeguards to protect the transferred personal data. One of the primary safeguards that allowed U.S. companies to import personal data from Europe had been certification to the EU-U.S. Privacy Shield and Swiss-U.S. Privacy Shield frameworks administered by the U.S. Department of Commerce. However, the Court of Justice of the European Union, or CJEU, adopted a decision in July 2020 that invalidated the EU U.S. Privacy Shield. Following this decision, the United Kingdom government has similarly invalidated use of the EU U.S. Privacy Shield as a mechanism for lawful personal data transfers from the United Kingdom to the United States under the UK GDPR; and the Swiss Federal Data Protection and Information Commissioner announced that the Swiss-U.S. Privacy Shield does not provide adequate safeguards for the purposes of personal data transfers from Switzerland to the United States. The CJEU&#x2019;s decision in this case also raised questions about whether one of the primary alternatives to the EU-U.S. Privacy Shield, namely, the European Commission&#x2019;s Standard Contractual Clauses, can lawfully be used for personal data transfers from Europe to the United States or other third countries that are not the subject of an adequacy decision of the European Commission. While the CJEU upheld the adequacy of the Standard Contractual Clauses in principle, it made clear that reliance on the Standard Contractual Clauses alone may not necessarily be sufficient in all circumstances. Despite updated forms of the Standard Contractual Clauses having been issued by the European Commission following this case, use of the Standard Contractual Clauses must be assessed on a case-by-case basis. In the context of any given transfer, where the legal regime applicable in the destination country may or does conflict with the intended operation of the Standard Contractual Clauses and/or applicable European data protection laws, the CJEU&#x2019;s decision in this case, subsequent guidance from the European Data Protection Board, or EDPB, and those updated Standard Contractual Clauses, would require the parties to that transfer to implement supplementary technical, organizational and/or contractual measures in order to rely on the Standard Contractual Clauses as a compliant &#x2018;transfer mechanism.&#x2019; However, the EDPB draft guidance appears to conclude that no combination of supplementary measures could be sufficient to allow effective reliance on the Standard Contractual Clauses in the context of transfers of personal data &#x2018;in the clear&#x2019; to recipients in countries where the power granted to public authorities to access the transferred personal data goes beyond that which is &#x2018;necessary and proportionate in a democratic society&#x2019; &#x2013; which may, following the CJEU&#x2019;s conclusions in this case on relevant powers of United States public authorities and commentary in that EDPB guidance, include the United States in certain circumstances.  At present, there are few, if any, viable alternatives to the Standard Contractual Clauses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 28, 2021, the European Commission issued an adequacy decision under the GDPR which allows transfers (other than those carried out for the purposes of United Kingdom immigration control) of personal data from the EEA to the United Kingdom to continue without restriction for a period of four years ending June 27, 2025. After that period, the adequacy decision may be renewed only if the United Kingdom continues to ensure an adequate level of data protection. During these four years, the European Commission will continue to monitor the legal situation in the United Kingdom and could intervene at any point if the United Kingdom deviates from the level of data protection in place at the time of issuance of the adequacy decision. If the adequacy decision is withdrawn or not renewed, transfers of personal data from the EEA to the United Kingdom will require a valid &#x2018;transfer mechanism&#x2019; and we may be required to implement new processes and put new agreements in place, such as Standard Contractual Clauses, to enable transfers of personal data from the EEA to the United Kingdom to continue, which could disrupt our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to implement a valid solution for personal data transfers from Europe, including, for example, obtaining individuals&#x2019; explicit consent to transfer their personal data from Europe to the United States or other countries, we will face increased exposure to regulatory actions, substantial fines and injunctions against processing personal data from Europe. Inability to import personal data from Europe, including the EEA, United Kingdom or Switzerland, may also (i) restrict our activities in Europe; (ii) limit our ability to collaborate with partners as well as other service providers, contractors and other companies subject to European data protection laws; or (iii) require us to increase our data processing capabilities in Europe at significant expense or otherwise cause us to change the geographical location or segregation of our relevant systems and operations&#x2014;any or all of which could adversely affect our financial results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, other countries outside of Europe have enacted or are considering enacting similar cross-border data transfer restrictions and laws requiring local data residency, which could increase the cost and complexity of operating our business. The type of challenges we face in Europe will likely also arise in other jurisdictions that adopt laws similar in construction to the GDPR or regulatory frameworks of equivalent complexity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As noted above, the GDPR also provides for more robust regulatory enforcement and greater penalties for noncompliance than previously applicable data protection laws, including fines of up to &#x20ac;20 million or 4% of an undertaking&#x2019;s total worldwide annual turnover for the preceding financial year, whichever is higher. In addition to administrative fines, supervisory authorities have extensive audit and inspection rights, and powers to order temporary or permanent bans on all or some processing of personal data carried out by noncompliant actors. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies and obtain compensation for damages resulting from violations of the GDPR. Additionally, as noted above, the United Kingdom has transposed the GDPR into the laws of the United Kingdom, which could expose us to two parallel regimes, each of which potentially authorizes similar fines, with the UK GDPR permitting fines of up to the higher of &#163;17.5 million or 4% of global annual revenue of any noncompliant organizations for the preceding financial year, as well as other potentially divergent enforcement actions for certain violations.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Privacy laws in the U.S. are also increasingly complex and changing rapidly. For example, the California legislature enacted the California Consumer Privacy Act, or CCPA, which took effect on January 1, 2020. The CCPA requires covered companies to provide new disclosures to California residents, and honor their requests to access, delete and opt-out of certain sharing of their personal information. The CCPA provides for civil penalties for violations. Since the enactment of the CCPA, new privacy and data security laws have been proposed in more than half of the states and in the U.S. Congress, reflecting a trend toward more stringent privacy legislation in the U.S. The CCPA itself will expand substantially as a result of California voters approving a November 2020 ballot measure that adopted the California Privacy Rights Act of 2020, or CPRA, which will, among other things, create a new administrative agency to implement and enforce California&#x2019;s privacy laws effective January 1, 2023. While certain clinical trial activities are exempt from the CCPA&#x2019;s requirements, other personal information that we handle may be subject to the CCPA, which may increase our compliance costs, exposure to regulatory enforcement action and other liabilities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The GDPR, CCPA and many other laws and regulations relating to privacy and data protection are still being tested in courts, and they are subject to new and differing interpretations by courts and regulatory officials. We are working to comply with the privacy and data protection laws and regulations that apply to us, and we anticipate needing to devote significant additional resources to complying with these laws and regulations. It is possible that the GDPR, CCPA or other laws and regulations relating to privacy and data protection may be interpreted and applied in a manner that is inconsistent from jurisdiction to jurisdiction or inconsistent with our current policies and practices.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our actual or perceived failure to adequately comply with applicable laws, regulations, policies, contracts and other obligations relating to privacy and data protection, or to protect personal data and other data we process or maintain, could result in regulatory fines and bans on processing personal information, investigations and enforcement actions, penalties and other liabilities, interruptions to our development process, claims for damages by affected individuals, and damage to our reputation, any of which could materially affect our business, financial condition, results of operations and growth prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we or any contract manufacturers and suppliers we engage fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and any contract manufacturers and suppliers we engage are subject to numerous federal, state and local environmental, health, and safety laws, regulations, and permitting requirements, including those governing laboratory procedures; the generation, handling, use, storage, treatment and disposal of hazardous and regulated materials and wastes; the emission and discharge of hazardous materials into the ground, air and water; and employee health and safety. Our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Our operations also produce hazardous waste. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. Under certain environmental laws, we could be held responsible for costs relating to any contamination at our current or past facilities and at third-party facilities. We also could incur significant costs associated with civil or criminal fines and penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Compliance with applicable environmental laws and regulations may be expensive, and current or future environmental laws and regulations may impair our research, product development and manufacturing efforts. In addition, we cannot entirely eliminate the risk of accidental injury or contamination from these materials or wastes. Although we maintain workers&#x2019; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not carry specific biological or hazardous waste insurance coverage, and our property, casualty, and general liability insurance policies specifically exclude coverage for damages and fines arising from biological or hazardous waste exposure or contamination. Accordingly, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources, and our clinical trials or regulatory approvals could be suspended, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business activities may be subject to the Foreign Corrupt Practices Act, or FCPA, and similar anti-bribery and anti-corruption laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate or may operate in the future, including the UK Bribery Act. The FCPA generally prohibits offering, promising, giving or authorizing others to give anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action, or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, the health care providers who prescribe pharmaceuticals are employed by their government, and the purchasers of pharmaceuticals are government entities; therefore, our dealings with these prescribers and purchasers are subject to regulation under the FCPA. Recently the SEC and Department of Justice have increased their FCPA enforcement activities with respect to biotechnology and pharmaceutical companies. There can be no assurance that all of our employees, agents, contractors or collaborators, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers, or our employees, the closing down of our facilities, requirements to obtain export licenses, cessation of business activities in sanctioned countries, implementation of compliance programs and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our ability to attract and retain employees, and our business, prospects, operating results, and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Reliance on Third Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We expect to rely on third parties to conduct our clinical trials and some aspects of our research and preclinical testing, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently rely and expect to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions and clinical investigators, to conduct some aspects of our research, preclinical testing and clinical trials. Any of these third parties may terminate their engagements with us or be unable to fulfill their contractual obligations. If we need to enter into alternative arrangements, it would delay our product development activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our reliance on these third parties for research and development activities reduces our control over these activities, but does not relieve us of our responsibilities. For example, we remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with cGCPs for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible, reproducible and accurate and that the rights, integrity and confidentiality of trial participants are protected. We are also required to register ongoing clinical trials and to post the results of completed clinical trials on a government-sponsored database within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for any product candidates we may develop and will not be able to, or may be delayed in our efforts to, successfully commercialize our medicines.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also expect to rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of any product candidates we may develop or commercialization of our medicines, producing additional losses and depriving us of potential product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We contract with third parties for the manufacture of materials for our product candidates and preclinical studies and clinical trials and for commercialization of any product candidates that we may develop. This reliance on third parties carries and may increase the risk that we will not have sufficient quantities of such materials, product candidates or any medicines that we may develop and commercialize, or that such supply will not be available to us at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not have any manufacturing facilities. We currently rely exclusively on a third-party manufacturer, Lonza AG, for the manufacture of our materials for preclinical studies and clinical trials and expect to continue to do so for preclinical studies, clinical trials and for commercial supply of any product candidates that we may develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be unable to establish any further agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the possible breach of the manufacturing agreement by the third party or us; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the possible early termination of the agreement by us at a time that requires us to pay a cancellation fee; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reliance on the third party for regulatory compliance, quality assurance, safety and pharmacovigilance and related reporting; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability to produce required volume in a timely manner and to quality standards. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in clinical holds on our trials, sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocations, seizures or recalls of product candidates or medicines, operating restrictions, and criminal prosecutions, any of which could significantly and adversely affect supplies of our medicines and harm our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any medicines that we may develop may compete with other product candidates and products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any performance failure on the part of our existing or future manufacturers could delay clinical development or marketing approval. We do not currently have arrangements in place for redundant supply for any of our product candidates. If any one of our current contract manufacturers cannot perform as agreed, we may be required to replace that manufacturer and may incur added costs and delays in identifying and qualifying any such replacement. Furthermore, securing and reserving production capacity with contract manufacturers may result in significant costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our current and anticipated future reliance upon others for the manufacture of any product candidates we may develop or medicines may adversely affect our future profit margins and our ability to commercialize any medicines that receive marketing approval on a timely and competitive basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Reliance on third parties to conduct clinical trials, assist in research and development and to manufacture our product candidates, will at times require us to share trade secrets with them. We seek to protect our proprietary technology by in part entering into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar agreements with our advisors, employees, third-party contractors and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#x2019;s independent discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We rely on third-party suppliers for key raw materials used in our manufacturing processes, and the loss of these third-party suppliers or their inability to supply us with adequate raw materials could harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on third-party suppliers for the raw materials required for the production of our product candidates. Our reliance on these third-party suppliers and the challenges we may face in obtaining adequate supplies of raw materials involve several risks, including limited control over pricing, availability, quality and delivery schedules. As a small company, our negotiation leverage is limited and we are likely to get lower priority than our competitors who are larger than we are. We cannot be certain that our suppliers will continue to provide us with the quantities of these raw materials that we require or satisfy our anticipated specifications and quality requirements. Any supply interruption in limited or sole sourced raw materials could materially harm our ability to manufacture our product candidates until a new source of supply, if any, could be identified and qualified. We may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reasonable terms. Any performance failure on the part of our suppliers could delay the development and potential commercialization of our product candidates, including limiting supplies necessary for clinical trials and regulatory approvals, which would have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may depend on collaborations with third parties for the research, development and commercialization of certain of the product candidates we may develop. If any such collaborations are not successful, we may not be able to realize the market potential of those product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may seek third-party collaborators for the research, development and commercialization of certain of the product candidates we may develop. Our likely collaborators for any other collaboration arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies, biotechnology companies and academic institutions. If we enter into any such arrangements with any third parties, we will likely have shared or limited control over the amount and timing of resources that our collaborators dedicate to the development or potential commercialization of any product candidates we may seek to develop with them. Our ability to generate revenue from these arrangements with commercial entities will depend on our collaborators&#x2019; abilities to successfully perform the functions assigned to them in these arrangements. We cannot predict the success of any collaboration that we enter into.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborations involving our product candidates we may develop, pose the following risks to us:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators generally have significant discretion in determining the efforts and resources that they will apply to these collaborations; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may not properly obtain, maintain, enforce or defend intellectual property or proprietary rights relating to our product candidates or may use our proprietary information in such a way as to expose us to potential litigation or other intellectual property related proceedings, including proceedings challenging the scope, ownership, validity and enforceability of our intellectual property;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may own or co-own intellectual property covering our product candidates that result from our collaboration with them, and in such cases, we may not have the exclusive right to commercialize such intellectual property or such product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">disputes may arise with respect to the ownership of intellectual property developed pursuant to collaborations; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may need the cooperation of our collaborators to enforce or defend any intellectual property we contribute to or that arises out of our collaborations, which may not be provided to us; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">disputes may arise between the collaborators and us that result in the delay or termination of the research, development, or commercialization of our product candidates or that result in costly litigation or arbitration that diverts management attention and resources; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may decide not to pursue development and commercialization of any product candidates we develop or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborator&#x2019;s strategic focus or available funding or external factors such as an acquisition that diverts resources or creates competing priorities; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials, or require a new formulation of a product candidate for clinical testing; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators with marketing and distribution rights to one or more product candidates may not commit sufficient resources to the marketing and distribution of such product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may lose certain valuable rights under circumstances identified in our collaborations, including if we undergo a change of control; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may undergo a change of control and the new owners may decide to take the collaboration in a direction which is not in our best interest; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may become party to a business combination transaction and the continued pursuit and emphasis on our development or commercialization program by the resulting entity under our existing collaboration could be delayed, diminished or terminated; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborators may become bankrupt, which may significantly delay our research or development programs, or may cause us to lose access to valuable technology, know-how or intellectual property of the collaborator relating to our products, product candidates; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">key personnel at our collaborators may leave, which could negatively impact our ability to productively work with our collaborators; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborations may require us to incur short and long-term expenditures, issue securities that dilute our stockholders, or disrupt our management and business; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates or our ABC Platform; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may face significant competition in seeking appropriate collaborations. Recent business combinations among biotechnology and pharmaceutical companies have resulted in a reduced number of potential collaborators. In addition, the negotiation process is time-consuming and complex, and we may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate or delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop product candidates or bring them to market and generate product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we enter into collaborations to develop and potentially commercialize any product candidates, we may not be able to realize the benefit of such transactions if we or our collaborator elect not to exercise the rights granted under the agreement or if we or our collaborator are unable to successfully integrate a product candidate into existing operations and company culture. In addition, if our agreement with any of our collaborators terminates, our access to technology and intellectual property licensed to us by that collaborator may be restricted or terminate entirely, which may delay our continued development of our product candidates utilizing the collaborator&#x2019;s technology or intellectual property or require us to stop development of those product candidates completely. We may also find it more difficult to find a suitable replacement collaborator or attract new collaborators, and our development programs may be delayed or the perception of us in the business and financial communities could be adversely affected. Any collaborator may also be subject to many of the risks relating to product development, regulatory approval, and commercialization described in this &#x201c;Risk Factors&#x201d; section, and any negative impact on our collaborators may adversely affect us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to obtain and maintain patent protection for any product candidates we develop or for our ABC Platform, our competitors could develop and commercialize products or technology similar or identical to ours, and our ability to successfully commercialize any product candidates we may develop, and our technology may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect to our ABC Platform and any proprietary product candidates and other technologies we may develop. We seek to protect our proprietary position by in-licensing intellectual property and filing patent applications in the United States and abroad relating to our ABC Platform, product candidates and other technologies that are important to our business. Given that the development of our technology and product candidates is at an early stage, our intellectual property portfolio directed to certain aspects of our technology and product candidates is also at an early stage. We have filed or intend to file patent applications on core aspects of our technology and product candidates; however, there can be no assurance that any such patent applications will issue as granted patents. Furthermore, in some cases, we only have filed provisional patent applications on certain aspects of our technology and product candidates, and none of these provisional patent applications is eligible to become an issued patent until, among other things, we file a non-provisional patent application within 12 months of the filing date of the applicable provisional patent application. Any failure to file a non-provisional patent application within this timeline could cause us to lose the ability to obtain patent protection for the inventions disclosed in the associated provisional patent applications. Furthermore, in some cases, we may not be able to obtain issued claims covering compositions relating to our ABC Platform and product candidates, as well as other technologies that are important to our business, and instead may need to rely on filing patent applications with claims covering a method of use and/or method of manufacture for protection of such ABC Platform, product candidates and other technologies. There can be no assurance that any such patent applications will issue as granted patents, and even if they do issue, such patent claims may be insufficient to prevent third parties, such as our competitors, from utilizing our technology. Any failure to obtain or maintain patent protection with respect to our ABC Platform and product candidates could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If any of our patent applications does not issue as a patent in any jurisdiction, we may not be able to compete effectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in either the patent laws or their interpretation in the United States and other countries may diminish our ability to protect our inventions, and obtain, maintain and enforce our intellectual property rights and, more generally, could affect the value of our intellectual property or narrow the scope of our owned and licensed patents. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors or other third parties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. In addition, our ability to obtain and maintain valid and enforceable patents depends on whether the differences between our inventions and the prior art allow our inventions to be patentable over the prior art. In addition, our own fixed applications may become prior art against our current or future patent applications. Furthermore, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, and in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in any of our patents or pending patent applications, or that we were the first to file for patent protection of such inventions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If the scope of any patent protection we obtain is not sufficiently broad, or if we lose any of our patent protection, our ability to prevent our competitors from commercializing similar or identical technology and product candidates would be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions, and has been the subject of much litigation in recent years. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued that protect our ABC Platform, product candidates or other technologies or that effectively prevent others from commercializing competitive technologies and product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if patent applications we license or own currently or in the future issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with any competitive advantage. Any patents may be challenged, narrowed, circumvented, rendered unenforceable or invalidated by third parties. Consequently, we do not know whether our ABC Platform, product candidates or other technologies will be protectable or remain protected by valid and enforceable patents. Our competitors or other third parties may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner which could materially adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. We may be subject to a third party preissuance submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or become involved in opposition, derivation, revocation, reexamination, post-grant and inter partes review, or interference proceedings or other similar proceedings challenging our patent rights. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate or render unenforceable, our patent rights, allow third parties to commercialize our ABC Platform, product candidates or other technologies and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Moreover, we may have to participate in interference proceedings declared by the USPTO to determine priority of invention or in post-grant challenge proceedings, such as oppositions and other challenges in a foreign patent office or administrative tribunal, that challenge our or our licensor&#x2019;s priority of invention or other features of patentability with respect to our owned or in-licensed patents and patent applications. Such challenges may result in loss of patent rights, loss of exclusivity, or in patent claims being narrowed, invalidated, or held unenforceable, which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our ABC Platform, product candidates and other technologies. Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect our intellectual property and proprietary rights throughout the world.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Filing, prosecuting and defending patents relating to our ABC Platform, product candidates and other technologies in all countries throughout the world would be prohibitively expensive, and the laws of foreign countries may not protect our rights to the same extent as U.S. laws. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection but enforcement is not as strong as that in the United States. These products may compete with our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult, costly or impossible for us to stop the infringement of our patents or marketing of competing products in violation of our intellectual property and proprietary rights generally. Proceedings to enforce our intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, could put our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and applications will be due to be paid to the USPTO and various government patent agencies outside of the United States over the lifetime of our owned or licensed patents and applications. The USPTO and various non-U.S. government agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. In some cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. Payment within these late fee windows may be employed in order to simplify the payment of these fees generally. There are situations, however, in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in a partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential competitors might be able to enter the market with similar or identical products or technology, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, while not relevant for KSI-301, if we rely on a different product, its development could involve the use of government funds, which can require additional compliance aspects to make certain all rights are transferred to or remain with us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Issued patents may be challenged or invalidated, and recent changes in U.S. patent law have diminished and may further diminish the value of patents in general. We rely on patents to protect our products, and any diminishment in the scope or value of our patents would adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we initiated legal proceedings against a third party to enforce a patent directed to our ABC Platform, product candidates or other technologies, the defendant could allege that such patent is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and unenforceability are commonplace. Grounds for a validity challenge include alleged failures to meet any of several statutory requirements, including obviousness, lack of novelty, lack of written description, or non-enablement. Grounds for an unenforceability challenge include an allegation that someone connected with prosecution of the patent withheld material information from the USPTO with an intent to deceive the USPTO, or made a misleading statement, during prosecution. The filing of a legal proceeding could also result in the third party challenging the patent at the USPTO, such as in post-grant and inter partes review.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For patent filings beginning in March 2013, the United States employs a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. Under the current patent laws, a third party that files a patent application in the USPTO before us could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant going forward of the time from invention to filing of a patent application. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we were the first to either (1) file any patent application related to our ABC Platform, product candidates or other technologies or (2) invent any of the inventions claimed in our or our licensor&#x2019;s patents or patent applications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes to U.S. patent laws since 2011 also include allowing third party submissions of prior art to the USPTO during patent prosecution and additional procedures for attacking the validity of a patent through USPTO administered post-grant proceedings, including re-examination, post-grant review, inter partes review, interference proceedings and derivation proceedings. Some of these changes apply to patents issued prior to 2011. These and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings) could result in the revocation of, cancellation of or amendment to our patents in such a way that they no longer cover our ABC Platform, product candidates or other technologies. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standards applied in United States federal courts that apply to actions seeking to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if challenged in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not otherwise have been invalidated if first challenged by the third party as a defendant in a district court action.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As compared to intellectual property-reliant companies generally, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. These rulings have created uncertainty with respect to the validity and enforceability of patents, even once obtained. Depending on future actions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any future changes to patent laws could increase the uncertainties and costs surrounding the prosecution of our owned or in-licensed patent applications and the enforcement or defense of our owned or in-licensed issued patents. If a third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our ABC Platform, product candidates or other technologies. Increased uncertainty with respect to, or loss of, patent protection would have a material adverse impact on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we do not obtain patent term extension and data exclusivity for any product candidates we may develop, our business may be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of our owned or in-licensed U.S. patents may be eligible for limited patent term extension under the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term extension of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar extensions as compensation for patent term lost during regulatory review processes are also available in certain foreign countries and territories, such as in Europe under a Supplementary Patent Certificate. Patent term extension in the United States and/or foreign countries and territories may not be available if, among other things, we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to the expiration of relevant patents, or otherwise fail to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension received is shorter than what we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations and prospects could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor or owner or co-owner. For example, we may have inventorship disputes arise from conflicting obligations of employees, collaborators, consultants or others who are involved in developing our ABC Platform, product candidates or other technologies. Litigation may be necessary to defend against these and other claims challenging inventorship or our ownership of our owned or in-licensed patents, trade secrets or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our ABC Platform, product candidates and other technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to seeking patents for our ABC Platform, product candidates and other technologies, we also rely on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other proprietary information and to maintain our competitive position. Trade secrets and know-how can be difficult to protect. Over time, we expect our trade secrets and know-how to be disseminated within the industry through independent development, the publication of journal articles describing the methodology and the movement of personnel from academic to industry scientific positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We seek to protect these trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants, train our employees not to bring or use proprietary information or technology from former employers to us or in their work and remind former employees when they leave their employment of their confidentiality obligations to us. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technology and processes. Despite our efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to contain such breaches or disclosures or obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed without the protection of a confidentiality agreement found unenforceable by relevant courts or independently developed by a competitor or other third party, our competitive position would be materially and adversely harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many of our employees, consultants and advisors are currently or were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors and potential competitors. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these individuals have improperly used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#x2019;s current or former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, while it is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects. Where post-filing date patent assignments are not executed by an inventor, it is our practice to employ and record the assignment provision that can be found in the employee&#x2019;s employment agreement. This is done when possible, and when the intellectual property is of interest to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Third-party claims of intellectual property infringement, misappropriation or other violation against us or our collaborators may prevent or delay the development and commercialization of our ABC Platform, product candidates and other technologies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The field of discovering treatments for retinal diseases is highly competitive and dynamic. Due to the focused research and development that is taking place in this field by several companies, including us and our competitors, the intellectual property landscape is in flux, and it may remain uncertain in the future. As such, there may be significant intellectual property related litigation and proceedings relating to our owned, and other third party, intellectual property and proprietary rights in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends in part on our and our collaborators&#x2019; ability to avoid infringing, misappropriating and otherwise violating the patents and other intellectual property rights of third parties. There is a substantial amount of complex litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings challenging patents, including interference, derivation and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. As discussed above, due to changes in U.S. law referred to as patent reform, new procedures including </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">inter partes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> review and post-grant review have been implemented. As stated above, this reform adds uncertainty to the possibility of challenge to our patents in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerous U.S. and foreign issued patents and pending patent applications owned by third parties exist relating to ABC technology and in the fields in which we are developing our product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our ABC Platform, product candidates and other technologies may give rise to claims of infringement of the patent rights of others. We cannot assure you that our ABC Platform, product candidates and other technologies that we have developed, are developing or may develop in the future will not infringe existing or future patents owned by third parties. We may not be aware of patents that have already been issued or that a third party, including a competitor in the fields in which we are developing our ABC Platform, product candidates and other technologies, might assert are infringed by our current or future ABC Platform, product candidates or other technologies. Such a dispute may concern claims to compositions, formulations, methods of manufacture or methods of use or treatment that cover our ABC Platform, product candidates or other technologies. It is also possible that patents owned by third parties of which we are aware, but which we do not believe are relevant to our ABC Platform, product candidates or other technologies, could be found to be infringed by our ABC Platform, product candidates or other technologies. In addition, because patent applications can take many years to issue, there may be currently pending patent applications that later result in issued patents that our ABC Platform, product candidates or other technologies may infringe.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third parties may have patents or obtain patents in the future and claim that the manufacture, use or sale of our ABC Platform, product candidates or other technologies infringes these patents. If a third party alleges that we infringe their patents or that we are otherwise employing their proprietary technology without authorization and initiates litigation against us, a court of competent jurisdiction could hold that such patents are valid, enforceable and infringed by our ABC Platform, product candidates or other technologies, even if we believe such claims are without merit. In that event, the successful plaintiff may be able to impede our ability to commercialize the applicable product candidate or technology unless we obtain a license under the applicable patents, or such patents expire or are finally determined to be invalid or unenforceable. Such a license may not be available on commercially reasonable terms or at all. Even if we are able to obtain a license, the license would likely obligate us to pay license fees, royalties or both. Any license granted to us might be nonexclusive, which could result in our competitors gaining access to the same intellectual property. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, we may be unable to commercialize our ABC Platform, product candidates or other technologies, or our commercialization efforts may be significantly delayed, which could in turn significantly harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are aware of a number of patents and applications that are directed to one or more aspects of KSI-301. Our intent is to maintain our development efforts under 35 U.S.C. Section 271(e)(1) (which provides a safe harbor from patent infringement claims related to certain drug development activities) through to at least the launch of any KSI-301 product. As such, we do not intend to launch KSI-301 when any valid patent is still in force. We are aware of at least one pending application with claims that are directed to some aspect of KSI-301, and that could, if issued, result in a patent term beyond our intended launch date of KSI-301. If this were to occur, we may challenge the validity of the claims, obtain a license, modify KSI-301, or delay launch.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we choose to further the pipeline and develop a different product, such a product would be delayed until the expiration of any valid patent that is still in force on such product. Alternatively, our options for addressing any such patents relating to these non-KSI-301 products would include the following: challenge the validity of the claims, obtain a license, or modify the non-KSI-301 product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Defending against infringement claims, regardless of their merit, would involve substantial litigation expense, would be a substantial diversion of management and other employee resources from our business and may adversely impact our reputation. We may be subject to an injunction that prevents or delays us from commercializing our ABC Platform technology, product candidates or other technologies during ongoing litigation even if we ultimately prevail in the litigation proceedings or the litigation is settled in our favor. We may be subject to an injunction that prevents or delays us from commercializing our ABC Platform, product candidates or other technologies during ongoing litigation even if we ultimately prevail in the litigation proceedings or the litigation is settled in our favor. In the event of a successful claim of infringement against us, we may be enjoined from further developing or commercializing our infringing ABC Platform, product candidates or other technologies. In addition, we may have to pay substantial damages (including treble damages and attorneys&#x2019; fees for willful infringement) obtain one or more licenses from third parties, pay royalties and/or redesign our infringing product candidates or technologies, which may be impossible or require substantial time and monetary expenditure. If we were unable to further develop and commercialize our ABC Platform, product candidates or other technologies, it would harm our business significantly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Engaging in litigation to defend against third parties alleging that we have infringed, misappropriated or otherwise violated their patents or other intellectual property rights is very expensive, particularly for a company of our size, and time-consuming. Some of our competitors may be able to sustain the costs of litigation or administrative proceedings more effectively than we can because of greater financial resources. Patent litigation and other proceedings may also absorb significant management time. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings against us could impair our ability to compete in the marketplace. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time consuming and unsuccessful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2241666666666668;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Competitors may infringe our patents or the patents of our licensing partners, or we may be required to defend against claims of infringement. If we assert our intellectual property against others, it could increase the likelihood that our patents or the patents of our licensing partners become involved in inventorship, priority or validity disputes. As discussed above, countering or defending against such claims can be expensive and time consuming. In an infringement proceeding, a court may decide that a patent owned or in-licensed by us is invalid or unenforceable, the other party&#x2019;s use of our patented technology falls under the safe harbor to patent infringement under 35 U.S.C. &#167;271(e)(1), or may refuse to stop the other party from using the technology at issue on the grounds that our owned and in-licensed patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our owned or in-licensed patents at risk of being invalidated, rendered unenforceable or interpreted narrowly. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we prevail in asserting our intellectual property, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately or to assert all claims we believe to be viable. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on trademarks, service marks, tradenames and brand names. We cannot assure you that our trademark applications will be approved. During trademark registration proceedings, we may receive rejections. Although we are given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, any registered or unregistered trademarks or trade names that we currently have or may in the future acquire may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. We own a registered trademark for the mark &#x201c;KODIAK&#x201d; and &#x201c;KODIAK SCIENCES&#x201d; in the United States. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. We engage a third party watching service to monitor use by third parties of names that are identical or similar to our name. We have identified at least two companies that are using names that we continue to monitor. We have sent cease and desist letters to two companies and filed a trademark opposition proceeding against one company. If we deem it appropriate, we may decide to take further action with respect to those companies. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property rights do not necessarily address all potential threats.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may be able to make products that are similar to our product candidates or utilize similar technology but that are not covered by the claims of the patents that we may license or own; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our current or future licensors or collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or own now or in the future;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our current or future licensors or collaborators, might not have been the first to file patent applications covering certain of our or their inventions; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our owned or licensed intellectual property rights; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our current or future pending owned or licensed patent applications will not lead to issued patents; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors or other third parties; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors or other third parties might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not develop additional proprietary technologies that are patentable; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patents of others may harm our business; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are highly dependent on our key personnel, and if we are not successful in attracting, motivating and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Developing and commercializing new medicines is a challenging exercise and requires diverse expertise in a variety of scientific, clinical, manufacturing, commercial, financial, people and legal functions. Failure to adequately develop these functions at Kodiak will hurt our ability to compete effectively.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract, motivate and retain highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, particularly our Chief Executive Officer, Dr. Victor Perlroth, and our scientific and medical personnel. The loss of the services provided by any of our executive officers, other key employees, and other scientific and medical advisors, and our inability to find suitable replacements, could result in delays in the development of our product candidates and harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We conduct our U.S. operations at our facilities in Palo Alto, California, in a region that is headquarters to many other biopharmaceutical companies and many academic and research institutions. Competition for skilled personnel is intense and the turnover rate can be high, which may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all. We expect that we may need to recruit talent from outside of our region and doing so may be costly and difficult.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have provided restricted stock and stock option grants, including early exercise stock options exercisable for restricted stock that vest over time. The value to employees of these equity grants that vest over time may be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to counteract more lucrative offers from other companies. Although we have employment agreements with our key employees, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. We do not maintain &#x201c;key man&#x201d; insurance policies on the lives of all of these individuals or the lives of any of our other employees. If we are unable to attract, incentivize and retain quality personnel on acceptable terms, or at all, it may cause our business and operating results to suffer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will need to grow the size and capabilities of our organization, and we may experience difficulties in managing this growth.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, we had 85 employees, all of whom were full-time. As our development plans and strategies develop, and as we continue operating as a public company, we must add a significant number of additional managerial, operational, financial and other personnel. Future growth will impose significant added responsibilities on members of management, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">identifying, recruiting, integrating, retaining and motivating additional employees; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.2458333333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">managing our internal development efforts effectively, including the clinical and FDA review process for our current and future product candidates, while complying with our contractual obligations to contractors and other third parties; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expanding our operational, financial and management controls, reporting systems and procedures; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">managing increasing operational and managerial complexity. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our future financial performance and our ability to continue to develop and, if approved, commercialize our product candidates will depend, in part, on our ability to effectively manage any future growth. Our management may also have to divert a disproportionate amount of its attention away from day-to-day activities in order to manage these growth activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services. There can be no assurance that the services of these independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be extended, delayed, or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, if at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop our product candidates and, accordingly, may not achieve our research, development, and commercialization goals.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we engage in acquisitions, in-licensing or strategic partnerships, this may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities and subject us to other risks.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may engage in various acquisitions and strategic partnerships in the future, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any acquisition or strategic partnership may entail numerous risks, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">increased operating expenses and cash requirements; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the assumption of indebtedness or contingent liabilities; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the issuance of our equity securities which would result in dilution to our stockholders; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">assimilation of operations, intellectual property, products and product candidates of an acquired company, including difficulties associated with integrating new personnel; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the diversion of our management&#x2019;s attention from our existing product candidates and initiatives in pursuing such an acquisition or strategic partnership; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">retention of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or product candidates and regulatory approvals; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our inability to generate revenue from acquired intellectual property, technology and/or products sufficient to meet our objectives or even to offset the associated transaction and maintenance costs. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, if we undertake such a transaction, we may incur large one-time expenses and acquire intangible assets that could result in significant future amortization expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If our security measures, or those maintained on our behalf by CROs, service providers or other third parties, are compromised now, or in the future, or the security, confidentiality, integrity or availability of our information technology, software, services, networks, communications or data is compromised, limited or fails, this could result in significant fines or other liability, interrupt our development programs, harm our reputation, or otherwise adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the course of our business, we collect, store and transmit proprietary, confidential and sensitive information, including personal information. The information and data processed and stored in our technology systems, and those of our research collaborators, CROs, contractors, consultants, and other third parties on which we depend to operate our business, may be vulnerable to security breaches, loss, damage, corruption, unauthorized access, use or disclosure, or misappropriation. Such incidents may also result from errors or malfeasance by our personnel or the personnel of the third parties with which we work, malware, viruses, software vulnerabilities, hacking, denial of service attacks, social engineering (including phishing), ransomware, credential stuffing or other cyberattacks, including attacks by state-sponsored organizations or sophisticated groups of hackers.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While we have developed systems and processes designed to protect the integrity, confidentiality and security of the confidential and personal information under our control, we cannot assure you that our security measures or those of the third parties we depend on will be effective in preventing cybersecurity incidents. There are many different and rapidly evolving cybercrime and hacking techniques, and we may be unable to anticipate attempted security breaches, identify them before our information is exploited, or react in a timely manner.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, as a result of the ongoing COVID-19 pandemic, certain employees remain in a remote work environment and outside of our corporate network security protection boundaries, which imposes additional risks to our business, including increased risk of industrial espionage, phishing and other cybersecurity attacks, and unauthorized dissemination of proprietary or confidential information, any of which could have a material adverse effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be required to expend significant resources, fundamentally change our business activities and practices, or modify our operations, including our clinical trial activities, or information technology in an effort to protect against security breaches and to mitigate, detect and remediate actual or potential vulnerabilities. Although to our knowledge, we have not experienced a material system failure or cybersecurity incident to date, if such an event were to occur, it could result in a material disruption of our development programs and our business operations, whether due to a loss of trade secrets or other proprietary information or other similar disruptions. For example, the loss of clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on third-party research institution collaborators, CROs, other contractors and consultants for many aspects of our business, including research and development activities and manufacturing of our product candidates, and similar events relating to their computer systems could also have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cybersecurity incidents and any unauthorized access or disclosure of our information or intellectual property could also compromise our intellectual property, expose sensitive business information, expose the personal information of our employees, require us to incur significant remediation costs, disrupt key business operations and divert attention of management and key information technology resources. Such incidents could also subject us to significant liability, harm our competitive position and delay the further development and commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, applicable data protection requirements, including, without limitation, laws, regulations, guidance as well as our internal and external policies and our contractual obligations, may require us to notify relevant stakeholders of security breaches, including affected individuals, partners, collaborators, regulators, law enforcement agencies, and others. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to litigation or other liability, fines, harm to our reputation, significant costs, or other materially adverse effects. There can be no assurance that any limitations or exclusions of liability in our contracts would be enforceable or adequate or protect us from liability or damages.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot be certain that our insurance coverage will be adequate for cybersecurity liabilities, will continue to be available to us on economically reasonable terms, or at all, or that any insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect our reputation, business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operations, and those of our CROs, CMOs, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are partly uninsured. In addition, we rely on our third-party research institution collaborators for conducting research and development of our product candidates, and they may be affected by government shutdowns or withdrawn funding. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. For example, in connection to the ongoing COVID-19 pandemic, the various quarantines, shelter-in-place and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, could adversely affect our business, financial condition or results of operations by limiting our ability to manufacture product, forcing temporary closure of facilities that we rely upon or increasing the costs associated with obtaining clinical supplies of our product candidates. The extent to which the ongoing COVID-19 pandemic impacts our results will depend on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the COVID-19 pandemic and the actions to contain the coronavirus or treat its impact, among others.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operations are located at facilities in Palo Alto, California and Switzerland. Damage or extended periods of interruption to our corporate, development or research facilities due to fire, natural disaster, power loss, communications failure, unauthorized entry or other events could cause us to cease or delay development of some or all of our product candidates. Although we maintain property damage and business interruption insurance coverage on these facilities, our insurance might not cover all losses under such circumstances and our business may be seriously harmed by such delays and interruption.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We implemented a new enterprise resource planning, or ERP, system as well as other systems as part of our ongoing technology and process improvements. Our ERP system is critical to our ability to accurately maintain books and records and prepare our financial statements. If we encounter unforeseen problems with our ERP system or other systems and infrastructure, our business, operations, and financial results could be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business is subject to economic, political, regulatory and other risks associated with international operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to risks associated with conducting business internationally. Some of our suppliers and collaborative relationships are located outside the United States. Accordingly, our future results could be harmed by a variety of factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">economic weakness, including inflation or political instability in particular non-U.S. economies and markets; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">differing and changing regulatory requirements, pricing and reimbursement regimes in non-U.S. countries; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulties in compliance with non-U.S. laws and regulations; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in non-U.S. regulations and customs, tariffs and trade barriers; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in non-U.S. currency exchange rates and currency controls; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in a specific country&#x2019;s or region&#x2019;s political or economic environment; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">trade protection measures, import or export licensing requirements or other restrictive actions by U.S. or non-U.S. governments; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negative consequences from changes in tax laws; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">workforce uncertainty in countries where labor unrest is more common than in the United States; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulties associated with staffing and managing international operations, including differing labor relations; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential liability under the FCPA or comparable foreign laws; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">business interruptions resulting from geo-political actions, including war and terrorism or natural disasters. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following the result of a referendum in 2016, the United Kingdom, or UK, left the European Union, or EU, on January 31, 2020, commonly referred to as Brexit.  Pursuant to the formal withdrawal arrangements agreed between the UK and the EU, the UK was subject to a transition period until December 31, 2020, or the Transition Period, during which EU rules continued to apply.  A trade and cooperation agreement, or the Trade and Cooperation Agreement, that outlines the future trading relationship between the United Kingdom and the European Union applied provisionally from January 1, 2021, and formally entered into force on May 1, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since a significant proportion of the regulatory framework in the UK, is derived from EU directives and regulations, Brexit may have a material impact upon the regulatory regime applicable to our operations, including with respect to our ability to obtain regulatory approvals of our product candidates in the EU. For example, Great Britain is no longer covered by the centralized procedures for obtaining EU-wide marketing authorization from the European Medicines Agency, or EMA, and a separate marketing authorization will be required to market our product candidates in Great Britain. Any delay in obtaining, or an inability to obtain, any marketing approvals, would restrict our ability to generate revenue and achieve and sustain profitability.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While the Trade and Cooperation Agreement provides for the tariff-free trade of medicinal products between the UK and the EU there are additional non-tariff costs to such trade which did not exist prior to the end of the Transition Period.  Further, should the UK diverge from the EU from a regulatory perspective in relation to medicinal products, tariffs could be put into place in the future.  We could therefore, both now and in the future, face significant additional expenses (when compared to the position prior to the end of the Transition Period) to operate our business, which could significantly and materially harm or delay our ability to generate revenues or achieve profitability of our business. Any further changes in international trade, tariff and import/export regulations as a result of Brexit or otherwise may impose unexpected duty costs or other non-tariff barriers on us. These developments, or the perception that any of them could occur, may significantly reduce global trade and, in particular, trade between the impacted nations and the UK It is also possible that Brexit may negatively affect our ability to attract and retain employees, particularly those from the EU.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These and other risks associated with our planned international operations may materially adversely affect our ability to attain profitable operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business is currently affected and could be materially and adversely affected in the future by the effects of disease outbreaks, epidemics and pandemics, including the ongoing effects of the COVID-19 pandemic. The COVID-19 pandemic continues to impact our business and could materially and adversely affect our operations, as well as the business or operations of our manufacturers, CROs or other third parties with whom we conduct business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business could be materially and adversely affected by health epidemics in regions where we have concentrations of clinical trial sites or other business operations and could cause significant disruption in the operations of third-party manufacturers and CROs upon whom we rely. For example, in March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. In response, we delayed initiation of the next set of KSI-301 pivotal studies by one quarter from June to September 2020 in order to assess how best to minimize the impact of COVID-19 on clinical trial conduct. We implemented and continue to implement various enhancements into our ongoing study execution to help ensure the safety of patients, physicians, study site staff and Kodiak operations team members during the ongoing COVID-19 pandemic, including the use of remote study monitoring.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic continues to unfold, and we will continue to monitor our operations in response. We continue to observe government recommendations. Quarantines for COVID-19 or other viruses could impact personnel at third party manufacturing facilities, or the availability or cost of materials, which would disrupt our supply chain. While many of these materials may be obtained by more than one supplier, port closures and other restrictions resulting from the coronavirus outbreak in the region may disrupt our supply chain or limit our ability to obtain sufficient materials for our drug products. As we work towards commercial scale-up and manufacturing activities to support BLA submission, there is increasing competition with COVID-19 related vaccine and therapeutic programs for manufacturing related (i) materials such as resins, filters, sterile tubesets, pipette tips; (ii) personnel such as facility engineering and construction as well as plant engineers and workers; and (iii) production slots in cGMP facilities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our current and future clinical trials may be materially and adversely affected by the COVID-19 outbreak in the future. Site initiation and patient enrollment may be further delayed due to prioritization of hospital resources toward the COVID-19 outbreak. Some patients may not be able to comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. Our ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19, and may adversely impact our clinical trial operations. Kodiak staff and/or our CRO partners may not be able to travel to study sites, impacting further site initiations and in-person monitoring of study data quality. Other Kodiak vendors on whom we depend, such as supply chain and logistics partners and our image reading centers may be disrupted, and our operations could be affected. Our clinical studies enroll patients who have underlying risk factors such as advanced age, hypertension and/or diabetes which could lead to higher than expected study discontinuation rates and/or missed visit rates if these patients are adversely affected by the COVID-19 outbreak. To date, we continue to see low levels of patient missed visits. Additionally, the pandemic could result in delayed recruitment in some or all of our clinical studies that are currently recruiting patients, for example if as a consequence of the pandemic patients are not willing to be seen by their physician as frequently as our study protocols require.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The global outbreak of COVID-19 continues to rapidly evolve. The ultimate impact of the COVID-19 outbreak or a similar health epidemic is highly uncertain and subject to change.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The extent to which the risks and evolving effects of the COVID-19 pandemic impact our business and our clinical development and regulatory efforts will depend on future developments that are highly uncertain and cannot be predicted with confidence, such as the ultimate duration and severity of the pandemic, government actions, such as travel restrictions, quarantines and social distancing requirements, business closures or business disruptions and the effectiveness of actions taken in the U.S. and in other countries to contain and treat the disease, including the effectiveness and timing of vaccine programs in the U.S. and worldwide. The COVID-19 pandemic may also have the effect of heightening many of the other risks described in this &#x201c;Risk Factors&#x201d; section.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, the Company had $50.1 million of federal and $171.0 million of state net operating loss, or NOLs, that may be available to offset future taxable income. A portion of the federal NOL carryforwards begin to expire in 2035 and the state NOL carryforwards begin to expire in 2035, if not utilized. Under Sections 382 and 383 of the United States Internal Revenue Code of 1986, as amended, or the Code, if a corporation undergoes an &#x201c;ownership change&#x201d; (generally defined as a greater than 50-percentage-point cumulative change (by value) in the equity ownership of certain stockholders over a rolling three-year period), the corporation&#x2019;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change taxable income or taxes may be limited. We may also experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which are outside our control. As a result, our ability to use our pre-change net operating loss carryforwards and other pre-change tax attributes to offset post-change taxable income or taxes may be subject to limitation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Tax Act, as modified by the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;) enacted in March 2020, among other things, includes changes to U.S. federal tax rates and the rules governing NOL carryforwards. Federal NOLs arising in tax years beginning after December 31, 2017 are permitted to be carried forward indefinitely, but carryback of such NOLs is generally permitted to the prior five taxable years only for NOLs arising in taxable years beginning before 2021. In addition, under the Tax Act, as modified by the CARES Act, the deductibility of federal NOLs incurred in taxable years beginning after December 31, 2017 is limited in taxable years beginning after December 31, 2020. For state income tax purposes, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. For example, California recently imposed limits on the usability of California state net operating losses to offset taxable income in tax years beginning after 2019 and before 2023. The new limitations on use of NOLs may significantly impact our ability to utilize our NOLs to offset taxable income in the future. <br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Tax Act enacted many significant changes to the U.S. tax laws. Future guidance from the Internal Revenue Service and other tax authorities with respect to the Tax Act may affect us, and certain aspects of the Tax Act could be repealed or modified in future legislation. For example, the CARES Act, modified certain provisions of the Tax Act and proposals have recently been made in Congress (which have not yet been enacted) to increase the federal income tax rate applicable to corporate income and make other tax law changes that could have a material adverse impact on us. In addition, it is uncertain if and to what extent various states will conform to the Tax Act, the CARES Act or any newly enacted federal tax legislation. Changes in corporate tax rates, the realization of net deferred tax assets relating to our operations, the taxation of foreign earnings, and the deductibility of expenses under the Tax Act or future reform legislation could have a material impact on the value of our net deferred tax assets, could result in significant one-time charges, and could increase our future U.S. tax expense.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Business, Financial Condition and Capital Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are in the clinical stage of drug development and have a very limited operating history and no products approved for commercial sale, which may make it difficult to evaluate our current business and predict our future success and viability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We commenced operations in June 2009, have no products approved for commercial sale and have not generated any revenue. Drug development is a highly uncertain undertaking and involves a substantial degree of risk. Except for KSI-301, we have not initiated clinical trials for any of our other product candidates. To date, we have not completed a pivotal clinical trial, obtained marketing approval for any product candidates, manufactured a commercial scale product, or conducted sales and marketing activities necessary for successful product commercialization. Our limited operating history as a company and early stage of drug development make any assessment of our future success and viability subject to significant uncertainty. We will encounter risks and difficulties frequently experienced by early-stage biopharmaceutical companies in rapidly evolving fields, and we have not yet demonstrated an ability to successfully overcome such risks and difficulties. If we do not address these risks and difficulties successfully, our business will suffer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have incurred significant net losses in each period since our inception and anticipate that we will continue to incur significant and increasing net losses for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have incurred net losses in each reporting period since our inception, including net losses of $173.8 million for the nine months ended September 30, 2021. As of September 30, 2021, we had an accumulated deficit of $465.1 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have invested significant financial resources in research and development activities, including for our product candidates and our ABC Platform. We do not expect to generate revenue from product sales for several years, if at all. The amount of our future net losses will depend, in part, on the level of our future expenditures and our ability to generate revenue. Moreover, our net losses may fluctuate significantly from quarter to quarter and year to year, such that a period-to-period comparison of our results of operations may not be a good indication of our future performance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to continue to incur significant and increasingly higher expenses and operating losses for the foreseeable future. We anticipate that our expenses will increase substantially if and as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">progress our current and any future product candidates through preclinical and clinical development; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">work with our contract manufacturers to scale up the manufacturing processes for our product candidates or, in the future, establish and operate a manufacturing facility; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue our research and discovery activities; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue the development of our ABC Platform; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiate and conduct additional preclinical, clinical or other studies for our current and any future product candidates;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">change or add additional contract manufacturers or suppliers; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek regulatory approvals and marketing authorizations for our product candidates, including KSI-301; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish sales, marketing and distribution infrastructure to commercialize any products for which we obtain approval; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquire or in-license product candidates, intellectual property and technologies; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">make milestone, royalty or other payments due under any current or future collaboration or license agreements; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtain, maintain, expand, protect and enforce our intellectual property portfolio; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">attract, hire and retain qualified personnel; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">experience any delays or encounter other issues related to our operations; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">meet the requirements and demands of being a public company; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">defend against any product liability claims or other lawsuits related to our products. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders&#x2019; equity and working capital. In any particular quarter or quarters, our operating results could be below the expectations of securities analysts or investors, which could cause our stock price to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Drug development is a highly uncertain undertaking and involves a substantial degree of risk. We have never generated any revenue from product sales, and we may never generate revenue or be profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have no products approved for commercial sale and have not generated any revenue from product sales. We do not anticipate generating any revenue from product sales until after we have successfully completed clinical development and received regulatory approval for the commercial sale of a product candidate, if ever.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our ability to generate revenue and achieve profitability depends significantly on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">successfully completing research and preclinical and clinical development of our product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining regulatory approvals and marketing authorizations for product candidates for which we successfully complete clinical development and clinical trials; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developing a sustainable and scalable manufacturing process for our product candidates, as well as establishing and maintaining commercially viable supply relationships with third parties that can provide adequate products and services to support clinical activities and any commercial demand for our product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">identifying, assessing, acquiring and/or developing new product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negotiating favorable terms in any collaboration, licensing or other arrangements into which we may enter; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">launching and successfully commercializing product candidates for which we obtain regulatory and marketing approval, either by collaborating with a partner or, if launched independently, by establishing a sales, marketing and distribution infrastructure;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining and maintaining an adequate price for our product candidates, both in the United States and in foreign countries where our products are commercialized; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining adequate reimbursement for our product candidates from payors; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining market acceptance of our product candidates as viable treatment options; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">addressing any competing technological and market developments; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintaining, protecting, expanding and enforcing our portfolio of intellectual property rights, including patents, trade secrets and know-how; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">attracting, hiring and retaining qualified personnel. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because of the numerous risks and uncertainties associated with drug development, we are unable to predict the timing or amount of our expenses, or when we will be able to generate any meaningful revenue or achieve or maintain profitability, if ever. In addition, our expenses could increase beyond our current expectations if we are required by the FDA or foreign regulatory agencies, to perform studies in addition to those that we currently anticipate, or if there are any delays in any of our or our future collaborators&#x2019; clinical trials or the development of any of our product candidates. Even if one or more of our product candidates is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate and ongoing compliance efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we are able to generate revenue from the sale of any approved products, we may not become profitable, and we will need to obtain additional funding through one or more debt or equity financings in order to continue operations. Revenue from the sale of any product candidate for which regulatory approval is obtained will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to get reimbursement at any price and whether we own the commercial rights for that territory. If the number of addressable patients is not as significant as we anticipate, the indication approved by regulatory authorities is narrower than we expect, or the reasonably accepted population for treatment is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our failure to become and remain profitable could decrease the value of our company and could impair our ability to raise capital, expand our business, maintain our research and development efforts, diversify our pipeline of product candidates or continue our operations and cause a decline in the value of our common stock, all or any of which may adversely affect our viability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we fail to obtain additional financing, we may be unable to complete the development and, if approved, commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operations have required substantial amounts of cash since inception. To date, we have funded our operations primarily through the sale of equity securities. Developing our product candidates is expensive, and we expect to continue to increase our spending as we conduct the Phase 3 clinical trials for our KSI-301 product candidate. Even if we are successful in developing our product candidates, obtaining regulatory approvals and launching and commercializing any product candidate will require substantial additional funding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our estimate as to how long we expect our existing cash, cash equivalents and marketable securities to be available to fund our operations is based on assumptions that may prove inaccurate, and we could deplete our available capital resources sooner than we currently expect. In addition, changing circumstances may cause us to increase our spending significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. We may need to raise additional funds sooner than we anticipate if we choose to expand more rapidly than we presently anticipate.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will require additional capital for the further development and, if approved, commercialization of our product candidates. Additional capital may not be available when we need it, on terms acceptable to us or at all. We currently have no committed source of additional capital. If adequate capital is not available to us on a timely basis, we may be required to significantly delay, scale back or discontinue our research and development programs or the commercialization of any product candidates, if approved, or be unable to continue or expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations and cause the price of our common stock to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Due to the significant resources required for the development of our product candidates, and depending on our ability to access capital, we must prioritize development of certain product candidates. Moreover, we may expend our limited resources on product candidates that do not yield a successful product and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Due to the significant resources required for the development of our product candidates, we must decide which product candidates and indications to pursue and advance and the amount of resources to allocate to each. Our decisions concerning the allocation of research, development, collaboration, management and financial resources toward particular product candidates or therapeutic areas may not lead to the development of any viable commercial product and may divert resources away from better opportunities. Similarly, our potential decisions to delay, terminate or collaborate with third parties in respect of certain product candidates may subsequently also prove to be suboptimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the viability or market potential of any of our product candidates or misread trends in the biopharmaceutical industry, in particular for retinal diseases, our business, financial condition and results of operations could be materially adversely affected. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Ownership of Our Common Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The market price of our common stock may be volatile, which could result in substantial losses for investors purchasing shares.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The market price of our common stock may be volatile. As a result, you may not be able to sell your common stock at or above the price that you paid for such shares. Some of the factors that may cause the market price of our common stock to fluctuate include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the success of existing or new competitive products or technologies; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and results of clinical trials for our current product candidates and any future product candidates that we may develop; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">commencement or termination of collaborations for our product candidates;  </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure or discontinuation of any of our product candidates; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to develop our ABC Platform; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">results of preclinical studies, clinical trials or regulatory approvals of product candidates of our competitors, or announcements about new research programs or product candidates of our competitors; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory or legal developments in the United States and other countries; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developments or disputes concerning patent applications, issued patents or other proprietary rights; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the recruitment or departure of key personnel; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the commencement of litigation; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the level of expenses related to any of our research programs, product candidates that we may develop; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the results of our efforts to develop additional product candidates or products; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">announcement or expectation of additional financing efforts; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sales of our common stock by us, our insiders, or other stockholders; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expiration of market standoff or lock-up agreements; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">variations in our financial results or those of companies that are perceived to be similar to us; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in estimates or recommendations by securities analysts, if any, that cover our stock; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in the structure of healthcare payment systems; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">market conditions in the pharmaceutical and biotechnology sectors; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">general economic, industry, and market conditions, including fluctuations attributable to the ongoing COVID-19 pandemic and other unforeseeable circumstances; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the other factors described in this &#x201c;Risk Factors&#x201d; section. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In recent years, the stock market in general, and the market for pharmaceutical and biotechnology companies in particular, has experienced significant price and volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Broad market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance. Following periods of such volatility in the market price of a company&#x2019;s securities, securities class action litigation has often been brought against that company. Because of the potential volatility of our stock price, we may become the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management&#x2019;s attention and resources from our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will seek additional capital through one or a combination of public and private equity offerings, debt financings, strategic partnerships and alliances and licensing arrangements. We, and indirectly, our stockholders, will bear the cost of issuing and servicing such securities. Because our decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of any future offerings. To the extent that we raise additional capital through the sale of equity securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a stockholder. The incurrence of indebtedness would result in increased fixed payment obligations and could involve restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. Additionally, any future collaborations we enter into with third parties may provide capital in the near term but limit our potential cash flow and revenue in the future. If we raise additional funds through strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or product candidates, or grant licenses on terms unfavorable to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our principal stockholders own a significant percentage of our common stock, which could limit your ability to affect the outcome of key transactions, including a change of control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our directors, executive officers, significant holders of outstanding common stock and their respective affiliates beneficially own a significant amount of our common stock. As a result, these stockholders, if they act together, will be able to influence our management and affairs and all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change in control of our company and might affect the market price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Delaware law and provisions in our certificate of incorporation and bylaws might discourage, delay, or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Provisions in our certificate of incorporation and bylaws may discourage, delay, or prevent a merger, acquisition, or other change in control that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares of our common stock. These provisions may also prevent or frustrate attempts by our stockholders to replace or remove our management. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our charter documents:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eliminate cumulative voting in the election of directors; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">authorize our board of directors to issue shares of preferred stock and determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide our board of directors with the exclusive right to elect a director to fill a vacancy or newly created directorship; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">permit stockholders to only take actions at a duly called annual or special meeting and not by written consent; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">prohibit stockholders from calling a special meeting of stockholders; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require that stockholders give advance notice to nominate directors or submit proposals for consideration at stockholder meetings; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">authorize our board of directors, by a majority vote, to amend the bylaws; and </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require the affirmative vote of at least 66 2/3% or more of the outstanding shares of common stock to amend many of the provisions described above. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, Section 203 of the General Corporation Law of the State of Delaware, or DGCL, prohibits a publicly-held Delaware corporation from engaging in a business combination with an interested stockholder, generally a person which together with its affiliates owns, or within the last three years has owned, 15% of our voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any provision of our certificate of incorporation, bylaws, or Delaware law that has the effect of delaying or preventing a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock and could also affect the price that some investors are willing to pay for our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our bylaws provide that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any derivative action or proceeding brought on our behalf; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim of breach of fiduciary duty; </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim against us arising under the DGCL, our certificate of incorporation, or our bylaws; and </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim against us that is governed by the internal-affairs doctrine. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our bylaws further provide that the U.S. federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These exclusive-forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find either exclusive-forum provision in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business. Our bylaws further provide that unless we otherwise consent in writing, the U.S. federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">General Risk Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The trading market for our common stock will rely in part on the research and reports that industry or financial analysts publish about us or our business. If one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Future sales of our common stock in the public market could cause our share price to decline, even if our business is doing well.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales, particularly sales by our directors, executive officers and significant stockholders, may have on the prevailing market price of our common stock. All of our outstanding shares of common stock are available for sale in the public market, subject only to the restrictions of Rule 144 under the Securities Act in the case of our affiliates. In addition, the shares of common stock subject to outstanding options under our equity incentive plans and the shares reserved for future issuance under our equity incentive plans, as well as shares issuable upon vesting of restricted stock unit awards, will become eligible for sale in the public market in the future, subject to certain legal and contractual limitations. In addition, certain holders of our common stock have the right, subject to various conditions and limitations, to request we include their shares of our common stock in registration statements we may file relating to our securities.  If any of these additional shares are sold, or if it is perceived that they will be sold, in the public market, the market price of our common stock could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">A failure to maintain an effective system of internal control over financial reporting could result in material misstatements of our financial statements in future periods and may impair our ability to comply with the accounting and reporting requirements applicable to public companies. Furthermore, our business, financial position, and results of operations could be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a public company, we are subject to reporting and other obligations under the Exchange Act, including the requirements of SOX Section 404, which require annual management assessments of the effectiveness of our internal control over financial reporting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The rules governing the standards that must be met for management to determine that our internal control over financial reporting is effective are complex and require significant documentation, testing and possible remediation to meet the detailed standards under the rules. During the course of its testing, our management may identify material weaknesses or deficiencies which may not be remedied in time to meet the deadline imposed by SOX. These reporting and other obligations place significant demands on our management and administrative and operational resources, including accounting resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Any failure to maintain effective internal controls could also have an adverse effect on our business, financial position and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2. Unregistered Sales of Equi</span><span id="item_2_unregistered_sales_equity_securit"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ty Securities and Use of Proceeds.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_defaults_upon_senior_securities"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3. Defaults Upo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">n Senior Securities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4. Mine Safe</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ty Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 5. Other </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="ii_item6"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 6. E</span><span id="item_6_exhibits"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">xhibits.</span></p>
  <div style="margin-left:4.533%;display:flex;margin-top:6.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.25in;">(a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Exhibits.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:59.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.537%;"></td>
    <td style="width:0.741%;"></td>
    <td style="width:5.944%;"></td>
    <td style="width:0.741%;"></td>
    <td style="width:8.037%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Incorporated by Reference</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Description</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;border-bottom:0.250pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Form</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;border-bottom:0.250pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">File No.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;border-bottom:0.250pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;border-bottom:0.250pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filing Date</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;10.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kod-ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">2021 Long-Term Performance Incentive Plan</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;10.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1468748/000095017021000510/kod-20210721ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Letter Agreement, dated July 22, 2021, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Edison ICAV, as assignee of Baker Bros. Advisors, LP</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-38682</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/23/2021</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;31.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kod-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;31.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kod-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Accounting and Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;32.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kod-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;32.2*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kod-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Accounting and Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.INS</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.SCH</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.CAL</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.DEF</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.LAB</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.PRE</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:86.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* The certifications attached as Exhibits 32.1 and 32.2 are deemed &#x201c;furnished&#x201d; and not deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNAT</span><span id="signature"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">URES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KODIAK SCIENCES INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 9, 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Victor Perlroth</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Victor Perlroth, M.D.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Chairman and Chief Executive Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Principal Executive Officer)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 9, 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ John Borgeson</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">John Borgeson</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Senior Vice President and Chief Financial Officer</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Principal Accounting and Financial Officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>kod-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 10.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021 Long-Term Performance Incentive Plan</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1.	General.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	Purpose.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> As part of its employee compensation program, Kodiak Sciences Inc. (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) has adopted this 2021 Long-Term Performance Incentive Plan (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), effective as of August 12, 2021 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), subject to Section 2 below. The purpose of the Plan is to help attract and retain key employees by providing them with additional incentives and to encourage such employees to contribute maximum effort towards supporting the Company&#x2019;s next phase of transformational performance and growth.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	Eligible Employees.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> An employee of the Company shall be eligible to participate in the Plan if (i) such employee is at Grade Level 10 or above at the Company and (ii) such employee has agreed to participate in the Plan by executing and returning an Election Form to the Company within the time period required therein. Notwithstanding the foregoing, the determination of whether an employee may participate in the Plan shall be made by the Administrator, in its sole discretion, and such determination shall be binding and conclusive on all persons.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2.	Stockholder Approval Required. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Plan shall be subject to stockholder approval at a special meeting of the Company&#x2019;s stockholders to be held as soon as practicable following the Effective Date. If such stockholder approval is not obtained, then each Award granted under the Plan will be forfeited and each Participant will receive 100% of his or her Annual LTI Awards for fiscal year 2021. If such stockholder approval is obtained, each Participant will forego a portion of each Annual LTI Award that may be granted by the Company to the Participant during the Performance Period, with such foregone portion being specified in his or her Election Form.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3.	Administration of the Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	Powers of the Administrator.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Administrator shall have the authority, in its discretion:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(1)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to select the employees to whom Awards may be granted </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursuant to the Plan</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(2)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to determine the number of Shares to be covered by each Award granted </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursuant to the Plan</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(3)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to approve the forms of Award Agreements for use under the Plan;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(4)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursuant to the Plan</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator shall determine;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(5)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to construe and interpret the terms of the Plan and the Awards granted </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursuant to the Plan</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(6)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to modify or amend each Award, including but not limited to the discretionary authority to extend the post-termination exercisability period of Awards and to extend the maximum term of Awards;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(7)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(8)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to make all other determinations deemed necessary or advisable for administering the Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	Rule 16b-3.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)	Effect of Administrator&#x2019;s Decision.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Administrator&#x2019;s decisions, determinations and interpretations shall be final and binding on all Participants.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4.	</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stock Subject to the Plan. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to the provisions of Section 6 of the Plan, the maximum aggregate number of Shares that may be issued under the Plan is 5,502,334 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5.	Awards.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each Award granted under the Plan will be a Nonstatutory Stock Option.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The term of each Award will be stated in the Award Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)	Exercise Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(1)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The per Share exercise price of each Award will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(2)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the time an Award is granted, the Administrator will fix the period within which the Award may be exercised and will determine any conditions that must be satisfied before the Award may be exercised.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(3)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Administrator will determine the acceptable form of consideration for exercising an Award, including the method of payment. Such consideration may consist entirely of: (1) cash; (2) check; (3) promissory note, to the extent permitted by Applicable Laws, (4) other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Award will be exercised and provided that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (5) consideration received by the Company under a broker-assisted (or other) cashless exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (6) by net exercise; (7) such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws; or (8) any combination of the foregoing methods of payment.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(d)	Exercise of Award.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(1)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any Award granted hereunder will be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Award may not be exercised for a fraction of a Share.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(2)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">An Award will be deemed exercised when the Company receives: (i) a notice of exercise (in such form as the Administrator may specify from time to time) from the person entitled to exercise the Award, and (ii) full payment for the Shares with respect to which the Award is exercised (together with applicable withholding taxes). Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Award will be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse, or, if approved by the Administrator, in the name of an estate planning vehicle established for the exclusive benefit of the Participant and the Participant&#x2019;s family members within the meaning of Instruction A.1.(a)(5) of Form S-8 under the Securities Act. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to an Award, notwithstanding the exercise of the Award. The Company will issue (or cause to be issued) such Shares promptly after the Award is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 6 of the Plan.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(3)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercising an Award in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Award, by the number of Shares as to which the Award is exercised.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(4)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a Participant ceases to be a Service Provider, the Participant may exercise his or her Award, to the extent vested, within such period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Award as set forth in the Award Agreement). If after termination the Participant does not exercise his or her Award within the time specified by the Administrator, the Award will terminate, and the Shares covered by such Award will revert to the Plan.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(e)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Vesting of Award</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. A Participant&#x2019;s Award shall be subject to the vesting requirements set forth in the Award Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6.	Adjustments; Dissolution or Liquidation; Merger or Change in Control.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Adjustments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of Shares that may be delivered under the Plan and/or the number, class, and price of Shares covered by each outstanding Award, and the numerical Share limits in Section 4 of the Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	Dissolution or Liquidation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)	Change in Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of a Change in Control, each outstanding Award will be treated as set forth in the applicable Award Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7.	Tax.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	Withholding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax withholding obligations are due, the Company will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or local taxes, non-U.S. taxes, or other taxes (including the Participant&#x2019;s FICA obligation) required to be withheld with respect to such Award (or exercise thereof).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	Withholding Arrangements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares having a fair market value not in excess of the maximum statutory amount required to be withheld, or (iii) delivering to the Company already-owned Shares having a fair market value not in excess of the maximum statutory amount required to be withheld. The fair market value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)	Compliance With Section 409A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Section 409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement under the Plan is intended to meet the requirements of Section 409A and will be construed and interpreted in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Section 409A the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Section 409A, such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A. In no event will the Company (or any Parent or Subsidiary of the Company, as applicable) reimburse a Participant for any taxes imposed or other costs incurred as a result of Section 409A.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8.	</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amendment and Termination of the Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to Section 2 above, the Plan is effective as of the Effective Date and will continue in effect for a term of ten (10) years following the Effective Date, unless terminated earlier in accordance with this Section 8. The Board may modify, amend, or terminate the Plan at any time, provided that such modification, amendment or termination shall not cancel, reduce, or otherwise adversely affect the amount of any Award previously determined and granted to any Participant as of the date of any such modification, amendment, or termination, without the consent of the Participant unless such modification, amendment or termination is required to conform the Plan to Applicable Laws.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9.	No Guarantee of Employment. </font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Neither the Plan nor any Award shall confer upon a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Participant </font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any right with respect to continuing the Participant&#x2019;s relationship as a Service Provider, nor shall they interfere in any way with the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Participant&#x2019;s right or the right of the Company to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10.	Choice of Law. </font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of California, without regard to conflict of law principles that would result in any application of any law other than the law of the State of California.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11.	</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Definitions.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> For purposes of the Plan, the following definitions shall apply. Capitalized terms used but not otherwise defined in the Plan will have the meanings ascribed to such terms in the Equity Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Annual LTI Award</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means an annual long-term incentive equity award that may be granted to a Participant with respect to any given fiscal year during the Performance Period.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Award</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; or means each Nonstatutory Stock Option granted to a Participant pursuant to the Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Award Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means an agreement between a Participant and the Company evidencing the terms and conditions of the Award, in substantially the form attached hereto as </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Award Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means the &#x201c;Notice of Stock Option Grant&#x201d; that accompanies the Award Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Election Form</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means the Election Form for Special Equity Award in substantially the form attached hereto as </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Equity Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means the Kodiak Sciences Inc. 2018 Equity Incentive Plan, as amended from time to time, or any successor plan thereto.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Participant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means an Employee of the Company who meets the eligibility requirements set forth in Section 1 hereof to receive, and who has received, an Award.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Performance Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the period commencing as of the Date of Grant and ending on August 11, 2028; provided, that the Performance Period may be extended as set forth in the Award Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Award Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021 LONG-TERM PERFORMANCE INCENTIVE PLAN</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">STOCK OPTION AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unless otherwise defined herein, the terms defined in the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the &#x201c;Plan&#x201d;) will have the same defined meanings in this Stock Option Agreement, which includes the Notice of Stock Option Grant (the &#x201c;Notice of Grant&#x201d;), the Terms and Conditions of Stock Option Grant attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and all appendices and exhibits attached thereto (all together, the &#x201c;Option Agreement&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">NOTICE OF STOCK OPTION GRANT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Participant:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Address:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The undersigned Participant has been granted an Option to purchase Common Stock of Kodiak Sciences Inc. (the &#x201c;Company&#x201d;), subject to the terms and conditions of the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan attached hereto as Exhibit B (the &#x201c;Plan&#x201d;) and this Option Agreement, as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:0.5in;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:43.899%;"></td>
    <td style="width:1.769%;"></td>
    <td style="width:2.1%;"></td>
    <td style="width:52.232%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date of Grant:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Number of Shares Granted:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercise Price per Share:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total Exercise Price:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Type of Option:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nonstatutory Stock Option</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Term/Expiration Date:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1.	Vesting Schedule</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Option will be earned, vest and become exercisable based on the attainment of the Performance-Based Requirement and Service-Based Requirement, as described below. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">[FOR CEO ONLY:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Notwithstanding the foregoing, the Option will be immediately exercisable pursuant to the Restricted Stock Purchase Agreement and related documents attached as Exhibit D hereto.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Performance-Based Requirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Subject to the Participant continuing to be a Service Provider through each applicable date, the Option will be earned as to an applicable percentage of the Option based on the Stock Price meeting or exceeding the corresponding Stock Price Goal for a period of ninety (90) consecutive trading days during the Performance Period (such earned portion of the Option, the &#x201c;Earned Option&#x201d;), in accordance with the table below.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:29.508%;"></td>
    <td style="width:15.476%;"></td>
    <td style="width:27.458%;"></td>
    <td style="width:27.557%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Option Tranche</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock Price Goal</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tranche Earning Percentage</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cumulative Earning</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Percentage</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 1</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$200</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.5%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.5%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$300</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.5%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 3</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$400</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25.0%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 4</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$500</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25.0%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 5</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$600</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20.0%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 6</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$700</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.0%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 7</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$800</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.0%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100%</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Service-Based Requirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Following the attainment of the Stock Price Goal in accordance with Section 1(a) above, the Earned Option will be subject to additional time-based vesting and will vest in substantially equal monthly installments on the first day of each complete calendar month that occurs during the Service-Based Period, subject to the Participant continuing to be a Service Provider through each applicable vesting date.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Operational and Sales Milestones</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i)	Notwithstanding Section 1(a) above, subject to the Participant continuing to be a Service Provider through each applicable date, the Option will be earned as to an applicable percentage of the Option based on the Company&#x2019;s achievement of the corresponding Operational Milestone or Sales Milestone during the Performance Period, in accordance with the table below. Any such portion of the Option that is earned based on the Company&#x2019;s achievement of the corresponding Operational Milestone or Sales Milestone during the Performance Period in accordance with this Section 1(c)(i) shall constitute the &#x201c;Earned Option&#x201d; for purposes of this Option Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:65.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.687%;"></td>
    <td style="width:49.313%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operational/Sales Milestone</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operational/Sales Milestone</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Earning Percentage</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">First Operational Milestone</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Second Operational Milestone</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Third Operational Milestone</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Sales Milestone</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10%</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii)	Following the attainment of the Operational Milestone or Sales Milestone in accordance with Section 1(c)(i) above, the Earned Option will be subject to additional time-based vesting and will vest in substantially equal monthly installments on the first day of each complete calendar month that occurs during the Service-Based Period, subject to the Participant continuing to be a Service Provider through each applicable vesting date.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii)	Notwithstanding anything herein to the contrary, the portion of the Option that is eligible to be earned based on the attainment of an Operational Milestone or Sales Milestone shall be inclusive of, and not in addition to, any portion of the Option that may be earned based on attainment of the Stock Price Goal. To the extent a portion of the Option becomes earned based on the attainment of an Operational Milestone or Sales Milestone, the subsequent tranche(s) of the Option that is eligible to be earned based on attainment of the Stock Price Goal shall be reduced by the excess, if any, of the number of Options earned over the &#x201c;Cumulative Earning Percentage&#x201d; set forth in the table in Section 1(a) above. For purposes of illustration only, (A) if fewer than 25% of the Option has been earned based on the Stock Price Goal, then up to 25% of the Option (inclusive of any portion previously earned based on the Stock Price Goal) shall be eligible to be earned based on attainment of the Operational Milestones and (B) if all three Operational Milestones are achieved following attainment of the Stock Price Goal for tranche 1 (i.e., $200) but prior to attainment of the Stock Price Goal for tranche 2 (i.e., $300) resulting in a Cumulative Earning Percentage equal to 25% of the Option, then (I) the portion of the Option eligible to be earned based on the Stock Price Goal in tranche 2 shall be reduced to zero and (II) the portion of the Option eligible to be earned based on the Stock Price Goal in tranche 3 shall be reduced to 20% in order to account for the 25% of the Option that has previously vested based on achievement of all three Operational Milestones. These principles are further illustrated in the table set forth below.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.309%;"></td>
    <td style="width:24.096%;"></td>
    <td style="width:29.552%;"></td>
    <td style="width:28.042%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Option</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tranche</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock Price Goal</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tranche Earning</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Percentage</font></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cumulative Earning</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Percentage</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 1</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$200</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.5%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.5%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Operational Milestones Achieved</font></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:18.0pt;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:-18.0pt;padding-left:18.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.5%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 2</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$300</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">12.5%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">20%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 3</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$400</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">25.0%</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;20.0%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 4</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$500</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25.0%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 5</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$600</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20.0%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 6</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$700</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.0%</font></p></td>
    <td style="background-color:rgba(204,204,204,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95%</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tranche 7</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$800</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.0%</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100%</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2.	Treatment Upon Termination of Employment.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Termination for Cause</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that the Participant&#x2019;s employment with the Company is terminated by the Company for Cause, the Unvested Option shall immediately terminate and be forfeited without consideration.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Voluntary Resignation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that the Participant&#x2019;s employment with the Company is terminated due to the Participant&#x2019;s voluntary resignation other than for Good Reason, the Unvested Option shall immediately terminate and be forfeited without consideration.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Termination without Cause/for Good Reason</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Subject to the Participant&#x2019;s execution and delivery of a release and waiver of claims agreement drafted by and satisfactory to counsel for the Company, and such release and waiver of claims agreement must be executed and become effective within sixty (60) days following the employment termination date (the date such release and waiver of claims agreement becomes effective, the &#x201c;Release Effective Date&#x201d;), in the event that the Participant&#x2019;s employment with the Company is terminated by the Company without Cause or due to the Participant&#x2019;s resignation for Good Reason, a pro-rata portion of the Option that has been earned as of the date of such termination based on the attainment of the Stock Price Goal, Operational Milestones and/or Sales Milestone, as applicable, shall become vested and exercisable as of the Release Effective Date, based on a fraction the numerator of which is the number of completed Months of Service between the Date of Grant and the date of such termination and the denominator of which is eighty four (84). Any portion of the Option that remains unvested after giving effect to the preceding sentence shall immediately terminate and be forfeited without consideration.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Retirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that the Participant&#x2019;s employment with the Company is terminated due to the Participant&#x2019;s Retirement, the portion of the Option that has been earned as of the date of such termination based on the attainment of the Stock Price Goal, Operational Milestones and/or Sales Milestone, as applicable, shall continue to vest and become exercisable based on the original monthly vesting schedule during the Service-Based Period as if such termination had not occurred. Any portion of the Option that is unearned as of the date of termination shall immediately terminate and be forfeited without consideration.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Death/Severe Disability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that the Participant&#x2019;s employment with the Company is terminated due to the Participant&#x2019;s death or Severe Disability, the portion of the Option that has been earned based on the attainment of the Stock Price Goal, Operational Milestones and/or Sales Milestone, as applicable, prior to the date of such termination shall become vested and exercisable as of the date of such termination. Any portion of the Option that is unearned as of the date of termination shall immediately terminate and be forfeited without consideration.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3.	Post-Termination Exercise Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Option, to the extent earned and vested, will be exercisable for the following periods after the Participant ceases to be a Service Provider.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Death</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of the death of the Participant during the period of continuous Service Provider status since the date of grant of the Option, or within three (3) months following termination of the Participant&#x2019;s continuous Service Provider status, the Vested Option may be exercised by the Participant&#x2019;s estate, or by a person who acquired the right to exercise the Option by bequest or inheritance, at any time within nine (9) months following the date of death or, if earlier, the date the Participant&#x2019;s continuous Service Provider status terminated.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Severe Disability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of termination of Participant&#x2019;s continuous Service Provider status as a result of the Participant&#x2019;s Severe Disability, the Participant may exercise the Vested Option at any time within six (6) months following such termination.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Retirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of termination of Participant&#x2019;s continuous Service Provider status as a result of the Participant&#x2019;s Retirement, the Participant may exercise the Vested Option at any time prior to the first (1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">st</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) anniversary of the end of the Performance Period.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Other Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of termination of the Participant&#x2019;s continuous Service Provider status for any reason other than death, Severe Disability or Retirement, the Participant may exercise the Option at any time within three (3) months following such termination.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e)	Notwithstanding anything to the contrary in this Section 3, in no event may this Option be exercised after the Term/Expiration Date as provided above and may be subject to earlier termination as provided in Section 4 below.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4.	Change in Control.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	In the event that a Change in Control occurs during the Performance Period, the Option will be earned as to an applicable percentage of the Option based on the per Share consideration received by the Company&#x2019;s shareholders in such Change in Control transaction meeting or exceeding the corresponding Stock Price Goal, in accordance with the table set forth in Section 1(a) above, subject to straight-line interpolation to the extent such per Share consideration falls between two Stock Price Goals. For the avoidance of doubt, to the extent that less than thirty five percent (35%) of the Option has vested in such Change in Control based on the Stock Price Goal, then the Option shall remain eligible to be earned based on the attainment of the Operational Milestones and Sales Milestone in accordance with Section 1(c) above. Thereafter, the earned portion of the Option shall vest and become exercisable in accordance with Section 1(b) above; provided, however, that if (i) on the date twenty-four (24) months immediately following the consummation of such Change in Control, the Participant is providing services to the acquiring company (or its subsidiaries or parent) as either an employee or a consultant or (ii) within twenty-four (24) months following the consummation of such Change in Control, the Participant&#x2019;s employment is terminated by the Company without Cause or by the Participant for Good Reason, then in either the case of (i) or (ii), one hundred percent (100%) of the Option that has previously been earned based on the Stock Price Goal, Operational Milestones and/or Sales Milestone but that remains unvested based on the Service-Based Period shall vest and become exercisable in full, subject to the Participant&#x2019;s execution and delivery of a release and waiver of claims agreement drafted by and satisfactory to counsel for the Company, and such release and waiver of claims agreement must be executed and become effective within sixty (60) days following the employment termination date or the second (2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">nd</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) anniversary of the Change in Control, as applicable.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	Notwithstanding the foregoing, in the event that the successor corporation does not assume or substitute for the Option, the Participant will fully vest in and have the right to exercise the portion of the Option that has been earned as of the date of such Change in Control after giving effect to Section 4(a) above. In addition, if an Award is not assumed or substituted in the event of a Change in Control, the Administrator will notify the Participant in writing or electronically that the Award will be exercisable for a period of time determined by the Administrator in its sole discretion, and the Award will terminate upon the expiration of such period.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stockholder Approval Required</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding anything to the contrary in this Option Agreement, the Option is subject to approval of the Plan by the stockholders of the Company at a special meeting of the Company&#x2019;s stockholders to be held as soon as practicable following the Date of Grant. If such stockholder approval of the Plan is not obtained, then the Option granted hereunder will be forfeited and the Participant will receive 100% of the Participant&#x2019;s Annual LTI Award for fiscal year 2021. If such stockholder approval is obtained, the Participant will forego a portion of each Annual LTI Award that may be granted by the Company to the Participant during the Performance Period (including, for the avoidance of doubt, the Annual LTI Award for fiscal year 2021), with such foregone portion being specified in the Participant&#x2019;s Election Form.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6.	Definitions</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> For purposes of this Option Agreement, the following definitions shall apply.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;Annual LTI Award&#x201d; means an annual long-term incentive equity award that may be granted to a Participant with respect to any given fiscal year during the Performance Period.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Cause</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean: (i) the Participant&#x2019;s conviction of, including pleading guilty or nolo contendere to, any felony or any crime involving dishonesty; (ii) the Participant&#x2019;s participation in any fraud or act of dishonesty against the Company that has caused or is reasonably expected to result in injury to the Company; (iii) a material violation by the Participant of any of the Company&#x2019;s written policies or other serious misconduct, in each case that results in or is reasonably likely to result in material harm to Company; (iv) the Participant&#x2019;s willful and continued failure substantially to perform any of the Participant&#x2019;s job duties (other than as a result of total or partial Severe Disability) that is not cured within thirty (30) days following written notice of Cause from the Company; (v) conduct by the Participant which, in the good faith and reasonable determination of the Administrator, demonstrates gross unfitness to serve; or (vi) the Participant&#x2019;s material breach of any agreement with the Company (or its subsidiaries or successors).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Corporate Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any (i) consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization in which the members/shareholders of the Company prior to such consolidation, merger or reorganization shall own less than fifty percent (50%) of the voting equity of the continuing or surviving entity after such consolidation, merger or reorganization, (ii) any transaction or series of related transactions to which the Company is a party, in which in excess of fifty percent (50%) of the Company&#x2019;s voting equity securities is transferred, except for bona fide sales of the Company&#x2019;s equity securities to investors for primarily fundraising purposes, or (iii) a sale of substantially all of the assets of the Company.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Election Form</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means the Election Form for Special Equity Award pursuant to which the Participant elected to forego a portion of each Annual LTI Award that may be granted by the Company to the Participant during the Performance Period.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Employment Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the Executive Employment Agreement by and between the Company and Participant.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">First Operational Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean U.S. Food and Drug Administration approval of a Biologics License Application in respect of a first major indication (RVO, DME and/or wAMD).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Good Reason</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; means the occurrence of any one or more of the following events without the prior written consent of Participant: (i) a material reduction in Base Salary or Targeted Incentive Bonus (as such terms are defined in the Employment Agreement) opportunity or benefits, provided that any reduction in Base Salary (and any reduction in the dollar amount of Participant&#x2019;s Targeted Incentive Bonus opportunity resulting from such reduction in Base Salary) that is related to a cross executive team base salary reduction shall not constitute &#x201c;Good Reason&#x201d;; (ii) a material reduction in Participant&#x2019;s title, duties, or responsibilities or change in reporting line; provided that a reassignment following a Corporate Transaction to a position that is substantially similar to the position held prior to the Corporate Transaction shall not constitute a material reduction in job responsibilities or duties; (iii) a relocation of Participant&#x2019;s primary work location that increases Participant&#x2019;s one-way commute by more than fifty (50) miles; (iv) failure of the successor company to assume obligations contained in this Option Agreement or any other equity compensation agreement in place between Participant and the Company at the time of the Corporate Transaction; (v) any written directive given to Participant by the Chief Executive Officer or the Board, as applicable, that is in conflict with Participant&#x2019;s professional obligations or otherwise in violation of applicable law or regulation, in all cases, of which the Chief Executive Officer or the Board, as applicable, has knowledge of such obligations or law or regulation prior to the issuance of such directive; or (vi) the Company&#x2019;s material breach of any terms of this Option Agreement, any other equity compensation agreement in place between Participant and the Company, or the Employment Agreement; provided, however, that no such event or condition shall constitute Good Reason unless (A) Participant gives the Company a written notice of termination for Good Reason not more than ninety (90) days after the initial existence of the condition, (B) the grounds for termination (if susceptible to correction) are not corrected by the Company within thirty (30) days of its receipt of such notice, and (C) the termination date occurs within ninety (90) days following the Company&#x2019;s receipt of such notice.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Month of Service</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean a consecutive period of 30 calendar days during which the Participant is continuously employed with, and is actively providing service, to the Company or any Parent or Subsidiary of the Company.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Operational Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean each of the First Operational Milestone, Second Operational Milestone and Third Operational Milestone.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(j)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Performance Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the period commencing as of the Date of Grant and ending on August 11, 2028; provided, that the Performance Period may be extended by up to ninety (90) trading days if as of the last day of the Performance Period (without regard to any extension) the Stock Price has reached or exceeded a Stock Price Goal for less than ninety (90) trading days.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(k)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Retirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the Participant&#x2019;s voluntary resignation from the Company on or after the date on which the Participant attains 65 years of age.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(l)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Sales Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the first completed fiscal year of the Company in which the Company has generated sales of at least $2.5 billion.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(m)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Second Operational Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean U.S. Food and Drug Administration approval of a Biologics License Application in respect of a second major indication (RVO, DME and/or wAMD).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(n)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Service-Based Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the period commencing on either (i) the date on which the applicable Stock Price Goal was attained in accordance with this Option Agreement or (ii) the date on which the applicable Operational Milestone or Sales Milestone was attained in accordance with this Option Agreement and ending, in either case, on the last day of the Performance Period.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(o)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Severe Disability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean that the Participant is unable, due to a physical or mental impairment, to perform the essential functions of the Participant&#x2019;s job position, with or without reasonable accommodation, for a period of two hundred seventy (270) consecutive calendar days. Any determination as to Severe Disability will be made by a licensed physician selected by the Administrator.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(p)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Stock Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the closing sales price per share Common Stock as quoted on any established stock exchange or national market system (including without limitation the New York Stock Exchange, NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market of The NASDAQ Stock Market) on which the Common Stock is listed (or the closing bid, if no sales were reported), as reported in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Wall Street Journal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in the Common Stock.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(q)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Stock Price Goal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean each Stock Price target amount based on which the Option will be earned, as indicated in the table set forth in Section 1(a) above.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(r)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Third Operational Milestone</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean U.S. Food and Drug Administration approval of a Biologics License Application in respect of a third major indication (RVO, DME and/or wAMD).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(s)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Unvested Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the portion of the Option other than the Vested Option.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(t)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Vested Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the portion of the Option that has become earned and vested based on attainment of (i) the Stock Price Goal, Operational Milestone and/or Sales Milestone, as applicable, and (ii) the Participant&#x2019;s continued employment with the Company through the Service-Based Period.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">[Signature page follows.]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By Participant&#x2019;s signature and the signature of the representative of the Company below, Participant and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan, attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and this Option Agreement, including the Terms and Conditions of Stock Option Grant, attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, all of which are made a part of this document. Participant acknowledges receipt of a copy of the Plan. Participant has reviewed the Plan and this Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement, and fully understands all provisions of the Plan and this Option Agreement. Participant hereby agrees to accept as binding, conclusive, and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and the Option Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated below.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.54%;"></td>
    <td style="width:4.901%;"></td>
    <td style="width:47.56%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PARTICIPANT</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Address:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TERMS AND CONDITIONS OF STOCK OPTION GRANT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Grant of Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company hereby grants to the individual (the &#x201c;Participant&#x201d;) named in the Notice of Stock Option Grant of this Option Agreement (the &#x201c;Notice of Grant&#x201d;) an option (the &#x201c;Option&#x201d;) to purchase the number of Shares, as set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the &#x201c;Exercise Price&#x201d;), subject to all of the terms and conditions in this Option Agreement and the Plan, each of which is incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Option Agreement, the terms and conditions of the Plan will prevail. The Option will be designated as a Nonstatutory Stock Option.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Vesting Schedule</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Except as provided in Section &#x200e;3, the Option awarded by this Option Agreement will vest in accordance with the vesting provisions set forth in the Notice of Grant. Shares scheduled to vest on a certain date or upon the occurrence of a certain condition will not vest in Participant in accordance with any of the provisions of this Option Agreement, unless Participant will have been continuously a Service Provider from the Date of Grant until the date such vesting occurs.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Administrator Discretion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Administrator, in its discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested Option at any time, subject to the terms of the Plan. If so accelerated, such Option will be considered as having vested as of the date specified by the Administrator.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exercise of Option.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Right to Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Method of Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Option is exercisable by delivery of an exercise notice (the &#x201c;Exercise Notice&#x201d;) in the form attached as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or in a manner and pursuant to such procedures as the Administrator may determine, which will state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the &#x201c;Exercised Shares&#x201d;), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice will be completed by Participant and delivered to the Company. The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares together and of any Tax Obligations (as defined in Section 6(a)). This Option will be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Method of Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the election of Participant:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	cash;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	check;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	consideration received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan; or</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	if Participant is a U.S. employee, surrender of other Shares which have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Exercised Shares and that are owned free and clear of any liens, claims, encumbrances, or security interests, provided that accepting such Shares, in the sole discretion of the Administrator, will not result in any adverse accounting consequences to the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Tax Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	Participant acknowledges that, regardless of any action taken by the Company or, if different, Participant&#x2019;s employer (the &#x201c;Employer&#x201d;) or Parent or Subsidiary to which Participant is providing services (together, the Company, Employer and/or Parent or Subsidiary to which the Participant is providing services, the &#x201c;Service Recipient&#x201d;), the ultimate liability for any tax and/or social insurance liability obligations and requirements in connection with the Option, including, without limitation, (i) all federal, state, and local taxes (including the Participant&#x2019;s Federal Insurance Contributions Act (FICA) obligation) that are required to be withheld by the Company or the Service Recipient or other payment of tax-related items related to Participant&#x2019;s participation in the Plan and legally applicable to Participant, (ii) the Participant&#x2019;s and, to the extent required by the Company (or Service Recipient), the Company&#x2019;s (or Service Recipient&#x2019;s) fringe benefit tax liability, if any, associated with the grant, vesting, or exercise of the Option or sale of Shares, and (iii) any other Company (or Service Recipient) taxes the responsibility for which the Participant has, or has agreed to bear, with respect to the Option (or exercise thereof or issuance of Shares thereunder) (collectively, the &#x201c;Tax Obligations&#x201d;), is and remains Participant&#x2019;s responsibility and may exceed the amount actually withheld by the Company or the Service Recipient. Participant further acknowledges that the Company and/or the Service Recipient (A) make no representations or undertakings regarding the treatment of any Tax Obligations in connection with any aspect of the Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends or other distributions, and (B) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate Participant&#x2019;s liability for Tax Obligations or achieve any particular tax result. Further, if Participant is subject to Tax Obligations in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the Company and/or the Service Recipient (or former employer, as applicable) may be required to withhold or account for Tax Obligations in more than one jurisdiction. If Participant fails to make satisfactory arrangements for the payment of any required Tax Obligations hereunder at the time of the applicable taxable event, Participant acknowledges and agrees that the Company may refuse to issue or deliver the Shares.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Tax Withholding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. When the Option is exercised, Participant generally will recognize immediate U.S. taxable income if Participant is a U.S. taxpayer. If Participant is a non-U.S. taxpayer, Participant will be subject to applicable taxes in his or her jurisdiction. Pursuant to such procedures as the Administrator may specify from time to time, the Company and/or Service Recipient shall withhold the amount required to be withheld for the payment of Tax Obligations. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit Participant to satisfy such Tax Obligations, in whole or in part (without limitation), if permissible by applicable local law, by (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable Shares having a fair market value equal to the minimum amount that is necessary to meet the withholding requirement for such Tax Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences), (iii) withholding the amount of such Tax Obligations from Participant&#x2019;s wages or other cash compensation paid to Participant by the Company and/or the Service Recipient, (iv) delivering to the Company already vested and owned Shares having a fair market value equal to such Tax Obligations, or (v) selling a sufficient number of such Shares otherwise deliverable to Participant through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) equal to the minimum amount that is necessary to meet the withholding requirement for such Tax Obligations (or such greater amount as Participant may elect if permitted by the Administrator, if such greater amount would not result in adverse financial accounting consequences). To the extent determined appropriate by the Company in its discretion, it will have the right (but not the obligation) to satisfy any Tax Obligations by reducing the number of Shares otherwise deliverable to Participant. Further, if Participant is subject to tax in more than one jurisdiction between the Date of Grant and a date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges and agrees that the Company and/or the Service Recipient (and/or former employer, as applicable) may be required to withhold or account for tax in more than one jurisdiction. If Participant fails to make satisfactory arrangements for the payment of any required Tax Obligations hereunder at the time of the Option exercise, Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such amounts are not delivered at the time of exercise.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notice of Disqualifying Disposition of ISO Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If the Option granted to Participant herein is an ISO, and if Participant sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i) the date two (2) years after the Date of Grant, or (ii) the date one (1) year after the date of exercise, Participant will immediately notify the Company in writing of such disposition. Participant agrees that Participant may be subject to income tax withholding by the Company on the compensation income recognized by Participant.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Code Section 409A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Under Code Section 409A, a stock right (such as the Option) that vests after December 31, 2004 (or that vested on or prior to such date but which was materially modified after October 3, 2004) that was granted with a per share exercise price that is determined by the Internal Revenue Service (the &#x201c;IRS&#x201d;) to be less than the fair market value of an underlying share on the date of grant (a &#x201c;discount option&#x201d;) may be considered &#x201c;deferred compensation.&#x201d; A stock right that is a &#x201c;discount option&#x201d; may result in (i) income recognition by the recipient of the stock right prior to the exercise of the stock right, (ii) an additional twenty percent (20%) federal income tax, and (iii) potential penalty and interest charges. The &#x201c;discount option&#x201d; may also result in additional state income, penalty and interest tax to the recipient of the stock right. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the fair market value of a Share on the date of grant in a later examination. Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the fair market value of a Share on the date of grant, Participant shall be solely responsible for Participant&#x2019;s costs related to such a determination.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Rights as Stockholder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book entry form) will have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant (including through electronic delivery to a brokerage account). After such issuance, recordation, and delivery, Participant will have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">No Guarantee of Continued Service</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER, WHICH UNLESS PROVIDED OTHERWISE UNDER APPLICABLE LAW IS AT THE WILL OF THE COMPANY (OR THE SERVICE RECIPIENT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS OPTION AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#x2019;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE SERVICE RECIPIENT) TO TERMINATE PARTICIPANT&#x2019;S RELATIONSHIP AS A SERVICE PROVIDER, SUBJECT TO APPLICABLE LAW, WHICH TERMINATION, UNLESS PROVIDED OTHERWISE UNDER APPLICABLE LAW, MAY BE AT ANY TIME, WITH OR WITHOUT CAUSE.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Nature of Grant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In accepting the Option, Participant acknowledges, understands and agrees that:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	the grant of the Option is voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	all decisions with respect to future option or other grants, if any, will be at the sole discretion of the Company;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	Participant is voluntarily participating in the Plan;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	the Option and any Shares acquired under the Plan are not intended to replace any pension rights or compensation;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e)	the Option and Shares acquired under the Plan and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(f)	the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(g)	if the underlying Shares do not increase in value, the Option will have no value;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(h)	if Participant exercises the Option and acquires Shares, the value of such Shares may increase or decrease in value, even below the Exercise Price;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i)	for purposes of the Option, Participant&#x2019;s engagement as a Service Provider will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Parent or Subsidiary (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is a Service Provider or the terms of Participant&#x2019;s employment or service agreement, if any), and unless otherwise expressly provided in this Option Agreement (including by reference in the Notice of Grant to other arrangements or contracts) or determined by the Administrator, (i) Participant&#x2019;s right to vest in the Option under the Plan, if any, will terminate as of such date and will not be extended by any notice period (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">e.g</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">., Participant&#x2019;s period of service would not include any contractual notice period or any period of &#x201c;garden leave&#x201d; or similar period mandated under employment laws in the jurisdiction where Participant is a Service Provider or Participant&#x2019;s employment or service agreement, if any, unless Participant is providing bona fide services during such time); and (ii) the period (if any) during which Participant may exercise the Option after such termination of Participant&#x2019;s engagement as a Service Provider will commence on the date Participant ceases to actively provide services and will not be extended by any notice period mandated under employment laws in the jurisdiction where Participant is employed or terms of Participant&#x2019;s engagement agreement, if any; the Administrator shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Option grant (including whether Participant may still be considered to be providing services while on a leave of absence and consistent with local law);</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(j)	unless otherwise provided in the Plan or by the Company in its discretion, the Option and the benefits evidenced by this Option Agreement do not create any entitlement to have the Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(k)	the following provisions apply only if Participant is providing services outside the United States:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i)	the Option and the Shares subject to the Option are not part of normal or expected compensation or salary for any purpose;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii)	Participant acknowledges and agrees that none of the Company, the Service Recipient, or any Parent or Subsidiary shall be liable for any foreign exchange rate fluctuation between Participant&#x2019;s local currency and the United States Dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the exercise of the Option or the subsequent sale of any Shares acquired upon exercise; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii)	no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from the termination of Participant&#x2019;s engagement as a Service Provider (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is a Service Provider or the terms of Participant&#x2019;s employment or service agreement, if any), and in consideration of the grant of the Option to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Company, any Parent, any Subsidiary or the Service Recipient, waives his or her ability, if any, to bring any such claim, and releases the Company, any Parent or Subsidiary and the Service Recipient from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">No Advice Regarding Grant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#x2019;s participation in the Plan, or Participant&#x2019;s acquisition or sale of the underlying Shares. Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Data Privacy</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#x2019;s personal data as described in this Option Agreement and any other Option grant materials by and among, as applicable, the Employer or other Service Recipient, the Company and any Parent or Subsidiary for the exclusive purpose of implementing, administering and managing Participant&#x2019;s participation in the Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant&#x2019;s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all Options or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#x2019;s favor (&#x201c;Data&#x201d;), for the exclusive purpose of implementing, administering and managing the Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Participant understands that Data will be transferred to a stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration, and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#x2019;s country of operation (e.g., the United States) may have different data privacy laws and protections than Participant&#x2019;s country. Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purposes of implementing, administering and managing Participant&#x2019;s participation in the Plan. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant&#x2019;s participation in the Plan. Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her engagement as a Service Provider and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant&#x2019;s consent is that the Company would not be able to grant Participant Options or other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect Participant&#x2019;s ability to participate in the Plan. For more information on the consequences of Participant&#x2019;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Address for Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Any notice to be given to the Company under the terms of this Option Agreement will be addressed to the Company at Kodiak Sciences Inc., 1200 Page Mill Road, Palo Alto, CA 94304, or at such other address as the Company may hereafter designate in writing.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Non-Transferability of Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant; provided, that, if approved by the Administrator, the Option may be transferred to an estate planning vehicle established for the exclusive benefit of Participant and Participant&#x2019;s family members within the meaning of Instruction A.1.(a)(5) of Form S-8 under the Securities Act.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company may assign any of its rights under this Option Agreement to single or multiple assignees, and this Option Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Option Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns. The rights and obligations of Participant under this Option Agreement may only be assigned with the prior written consent of the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Additional Conditions to Issuance of Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If at any time the Company will determine, in its discretion, that the listing, registration, qualification or rule compliance of the Shares upon any securities exchange or under any state, federal or non-U.S. law, the tax code and related regulations or under the rulings or regulations of the United States Securities and Exchange Commission or any other governmental regulatory body or the clearance, consent or approval of the United States Securities and Exchange Commission or any other governmental regulatory authority is necessary or desirable as a condition to the purchase by, or issuance of Shares, to Participant (or his or her estate) hereunder, such purchase or issuance will not occur unless and until such listing, registration, qualification, rule compliance, clearance, consent or approval will have been completed, effected or obtained free of any conditions not acceptable to the Company. Subject to the terms of the Option Agreement and the Plan, the Company shall not be required to issue any certificate or certificates for Shares hereunder prior to the lapse of such reasonable period of time following the date of exercise of the Option as the Administrator may establish from time to time for reasons of administrative convenience.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Language</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If Participant has received this Option Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Interpretation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Administrator will have the power to interpret the Plan and this Option Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Shares subject to the Option have vested). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons. Neither the Administrator nor any person acting on behalf of the Administrator will be personally liable for any action, determination, or interpretation made in good faith with respect to the Plan or this Option Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Electronic Delivery and Acceptance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company may, in its sole discretion, decide to deliver any documents related to the Option awarded under the Plan or future options that may be awarded under the Plan by electronic means or request Participant&#x2019;s consent to participate in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Captions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Option Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Agreement Severable</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that any provision in this Option Agreement will be held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of this Option Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amendment, Suspension or Termination of the Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. By accepting this Option, Participant expressly warrants that he or she has received an Option under the Plan, and has received, read, and understood a description of the Plan. Participant understands that the Plan is discretionary in nature and may be amended, suspended or terminated by the Company at any time.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Governing Law and Venue</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Option Agreement will be governed by the laws of California, without giving effect to the conflict of law principles thereof. For purposes of litigating any dispute that arises under this Option or this Option Agreement, the parties hereby submit to and consent to the jurisdiction of the State of California, and agree that such litigation will be conducted in the courts of Santa Clara County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this Option is made and/or to be performed.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Country Addendum</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Notwithstanding any provisions in this Option Agreement, this Option shall be subject to any special terms and conditions set forth in the appendix (if any) to this Option Agreement for Participant&#x2019;s country (the &#x201c;Country Addendum&#x201d;). Moreover, if Participant relocates to one of the countries included in the Country Addendum (if any), the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Country Addendum constitutes part of this Option Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Modifications to the Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Option Agreement constitutes the entire understanding of the parties on the subjects covered. Participant expressly warrants that he or she is not accepting this Option Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Option Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company. Notwithstanding anything to the contrary in the Plan or this Option Agreement, the Company reserves the right to revise this Option Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Section 409A of the Code in connection with the Option.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">No Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Either party&#x2019;s failure to enforce any provision or provisions of this Option Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party from thereafter enforcing each and every other provision of this Option Agreement. The rights granted both parties herein are cumulative and shall not constitute a waiver of either party&#x2019;s right to assert all other legal remedies available to it under the circumstances.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Tax Consequences</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Participant has reviewed with its own tax advisors the U.S. federal, state, local and non-U.S. tax consequences of this investment and the transactions contemplated by this Option Agreement. With respect to such matters, Participant relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral. Participant understands that Participant (and not the Company) shall be responsible for Participant&#x2019;s own tax liability that may arise as a result of this investment or the transactions contemplated by this Option Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021 LONG-TERM PERFORMANCE INCENTIVE PLAN</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">STOCK OPTION AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">COUNTRY ADDENDUM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">TERMS AND CONDITIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Country Addendum includes additional terms and conditions that govern the Option granted to Participant under the Plan if Participant works in one of the countries listed below. If Participant is a citizen or resident of a country (or is considered as such for local law purposes) other than the one in which he or she is currently working or if Participant relocates to another country after receiving the Option, the Company will, in its discretion, determine the extent to which the terms and conditions contained herein will be applicable to Participant.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain capitalized terms used but not defined in this Country Addendum shall have the meanings set forth in the Plan, and/or the Stock Option Agreement to which this Country Addendum is attached.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">NOTIFICATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Country Addendum also includes notifications relating to exchange control and other issues of which Participant should be aware with respect to his or her participation in the Plan. The information is based on the exchange control, securities and other laws in effect in the countries listed in this Country Addendum, as of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">            </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(except as otherwise noted below). Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the notifications herein as the only source of information relating to the consequences of his or her participation in the Plan because the information may be outdated when Participant exercises the Option or sells Shares acquired under the Plan.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the notifications are general in nature and may not apply to Participant&#x2019;s particular situation, and the Company is not in a position to assure Participant of any particular result. Accordingly, Participant is advised to seek appropriate professional advice as to how the relevant laws in Participant&#x2019;s country may apply to Participant&#x2019;s situation.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Finally, if Participant is a citizen or resident of a country other than the one in which Participant is currently working (or is considered as such for local law purposes) or if Participant moves to another country after the Option is granted, the information contained herein may not be applicable to Participant.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021 LONG-TERM PERFORMANCE INCENTIVE PLAN</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">EXERCISE NOTICE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1200 Page Mill Road</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Palo Alto, CA 94304</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Attention: Stock Administration</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exercise of Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Effective as of today, ________________, _____, the undersigned (&#x201c;Purchaser&#x201d;) hereby elects to purchase ______________ shares (the &#x201c;Shares&#x201d;) of the Common Stock of Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) under and pursuant to the 2021 Long-Term Performance Incentive Plan (the &#x201c;Plan&#x201d;) and the Stock Option Agreement, dated ________ and including the Notice of Grant, the Terms and Conditions of Stock Option Grant, and exhibits attached thereto (the &#x201c;Option Agreement&#x201d;). The purchase price for the Shares will be $_____________, as required by the Option Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">FOR CEO ONLY:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Exercise of Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Effective as of today, ________________, _____, the undersigned (&#x201c;Purchaser&#x201d;) hereby elects to purchase ______________ shares (the &#x201c;Shares&#x201d;) of the Common Stock of Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) under and pursuant to the 2021 Long-Term Performance Incentive Plan (the &#x201c;Plan&#x201d;) and the Stock Option Agreement, dated ________ and including the Notice of Grant, the Terms and Conditions of Stock Option Grant, the Restricted Stock Purchase Agreement and exhibits attached thereto (the &#x201c;Option Agreement&#x201d;). The Purchaser further acknowledges and agrees that the purchase of the Shares hereunder shall be subject to and conditioned upon the Participant entering into the Restricted Stock Purchase Agreement (in the form attached to the Option Agreement as Exhibit D) with respect to any Shares acquired by the Participant hereunder, and such Shares shall be subject to, and shall become vested and non-forfeitable in accordance with, the vesting schedule set forth in the Notice of Grant. The purchase price for the Shares will be $_____________, as required by the Option Agreement.]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Delivery of Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Purchaser herewith delivers to the Company the full purchase price of the Shares and any Tax Obligations (as defined in Section 6(a) of the Option Agreement) to be paid in connection with the exercise of the Option.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Representations of Purchaser</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Purchaser acknowledges that Purchaser has received, read and understood the Plan and the Option Agreement and agrees to abide by and be bound by their terms and conditions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Rights as Stockholder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the Shares, no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to the Option, notwithstanding the exercise of the Option. The Shares so acquired will be issued to Purchaser as soon as practicable after exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date of issuance, except as provided in Section 6 of the Plan.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Tax Consultation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser&#x2019;s purchase or disposition of the Shares. Purchaser represents that Purchaser has consulted with any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that Purchaser is not relying on the Company for any tax advice.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Entire Agreement; Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Plan and the Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser&#x2019;s interest except by means of a writing signed by the Company and Purchaser. This Option Agreement is governed by the internal substantive laws, but not the choice of law rules, of California.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Submitted by:		Accepted by:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.54%;"></td>
    <td style="width:4.901%;"></td>
    <td style="width:47.56%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PURCHASER</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Address:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date Received</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT D-1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">KODIAK SCIENCES INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021 LONG-TERM PERFORMANCE INCENTIVE PLAN</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RESTRICTED STOCK PURCHASE AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">THIS RESTRICTED STOCK PURCHASE AGREEMENT (the &#x201c;Agreement&#x201d;) is made between Victor Perlroth (the &#x201c;Purchaser&#x201d;) and Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) or its assignees of rights hereunder as of __________________, ____.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unless otherwise defined herein, capitalized terms used in this Agreement shall have the meanings ascribed to such terms defined in the Company&#x2019;s 2021 Long-Term Performance Incentive Plan (the &#x201c;Plan&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">RECITALS</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A.	Pursuant to the exercise of the Option granted to Purchaser under the Plan and pursuant to the Stock Option Agreement (the &#x201c;Option Agreement&#x201d;) dated as of _______, 2021 by and between the Company and Purchaser, which Plan and Option Agreement are hereby incorporated by reference, Purchaser has elected to purchase _________ of those Shares of Common Stock which have not become vested under the vesting schedule set forth in the Option Agreement (&#x201c;Unvested Shares&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">B.	As required by the Option Agreement, as a condition to Purchaser&#x2019;s election to exercise the Option, Purchaser must execute this Agreement, which sets forth the rights and obligations of the parties with respect to Shares acquired upon exercise of the Option.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Repurchase Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	If Purchaser&#x2019;s status as a Service Provider is terminated for any reason, the Company shall have the right and option for one hundred and eighty (180) days from such date to purchase from Purchaser, or Purchaser&#x2019;s personal representative, as the case may be, all of the Purchaser&#x2019;s Unvested Shares as of the date of such termination at the price paid by the Purchaser for such Shares (the &#x201c;Repurchase Option&#x201d;).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	Upon the occurrence of such termination, the Company may exercise its Repurchase Option by delivering personally or by registered mail, to Purchaser (or his or her transferee or legal representative, as the case may be) with a copy to the escrow agent described in Section 2 below, a notice in writing indicating the Company&#x2019;s intention to exercise the Repurchase Option and by delivering to the Purchaser (or the Purchaser&#x2019;s transferee or legal representative) a check in the amount of the aggregate repurchase price. Upon delivery of such notice and payment of the aggregate repurchase price, the Company shall become the legal and beneficial owner of the Unvested Shares being repurchased and the rights and interests therein or relating thereto, and the Company shall have the right to retain and transfer to its own name the number of Unvested Shares being repurchased by the Company.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	Whenever the Company shall have the right to repurchase Unvested Shares hereunder, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations to exercise all or a part of the Company&#x2019;s Repurchase Option under this Agreement and purchase all or a part of such Unvested Shares.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	If the Company does not elect to exercise the Repurchase Option conferred above by giving the requisite notice within one hundred and eighty (180) days following the termination, the Repurchase Option shall terminate.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e)	The Repurchase Option shall terminate in accordance with the vesting schedule contained in Purchaser&#x2019;s Option Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Transferability of the Shares; Escrow</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)	Purchaser hereby authorizes and directs the Secretary of the Company, or such other person designated by the Company, to transfer the Unvested Shares as to which the Repurchase Option has been exercised from Purchaser to the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)	To insure the availability for delivery of Purchaser&#x2019;s Unvested Shares upon repurchase by the Company pursuant to the Repurchase Option under Section 1, Purchaser hereby appoints the Secretary, or any other person designated by the Company as escrow agent (the &#x201c;Escrow Agent&#x201d;), as its attorney-in-fact to sell, assign and transfer unto the Company, such Unvested Shares, if any, repurchased by the Company pursuant to the Repurchase Option and shall, upon execution of this Agreement, deliver and deposit with the Escrow Agent, the share certificates representing the Unvested Shares, together with the stock assignment duly endorsed in blank, attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibit D-2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Unvested Shares and stock assignment shall be held by the Escrow Agent in escrow, pursuant to the Joint Escrow Instructions of the Company and Purchaser attached as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibit D-3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> hereto, until the Company exercises its Repurchase Option, until such Unvested Shares are vested, or until such time as this Agreement no longer is in effect. Upon vesting of the Unvested Shares, the Escrow Agent shall promptly deliver to the Purchaser the certificate or certificates representing such Shares in the Escrow Agent&#x2019;s possession belonging to the Purchaser, and the Escrow Agent shall be discharged of all further obligations hereunder; provided, however, that the Escrow Agent shall nevertheless retain such certificate or certificates as Escrow Agent if so required pursuant to other restrictions imposed pursuant to this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)	Neither the Company nor the Escrow Agent shall be liable for any act it may do or omit to do with respect to holding the Shares in escrow and while acting in good faith and in the exercise of its judgment.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)	Transfer or sale of the Shares is subject to restrictions on transfer imposed by any applicable state and federal securities laws. Any transferee shall hold such Shares subject to all the provisions hereof and the Exercise Notice executed by the Purchaser with respect to any Unvested Shares purchased by Purchaser and shall acknowledge the same by signing a copy of this Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Ownership, Voting Rights, Duties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Agreement shall not affect in any way the ownership, voting rights or other rights or duties of Purchaser, except as specifically provided herein.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Legends</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The share certificate evidencing the Shares issued hereunder shall be endorsed with the following legend (in addition to any legend required under applicable federal and state securities laws):</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS UPON TRANSFER AND RIGHTS OF REPURCHASE AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Adjustment for Stock Split</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. All references to the number of Shares and the purchase price of the Shares in this Agreement shall be appropriately adjusted to reflect any stock split, stock dividend or other change in the Shares, which may be made by the Company pursuant to Section 6 of the Plan after the date of this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Notices required hereunder shall be given in person or by registered mail to the address of Purchaser shown on the records of the Company, and to the Company at their respective principal executive offices.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Survival of Terms</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Agreement shall apply to and bind Purchaser and the Company and their respective permitted assignees and transferees, heirs, legatees, executors, administrators and legal successors.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Section 83(b) Election</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Purchaser hereby acknowledges that he has been informed that, with respect to the exercise of an Option for Unvested Shares, an election (the &#x201c;Election&#x201d;) may be filed by the Purchaser with the Internal Revenue Service, within thirty (30) days of the purchase of the exercised Shares, electing pursuant to Section 83(b) of the Code to be taxed currently on any difference between the purchase price of the exercised Shares and their Fair Market Value on the date of purchase. A form of Election under Section 83(b) is attached hereto as Exhibit D-4 for reference.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PURCHASER ACKNOWLEDGES THAT IT IS PURCHASER&#x2019;S SOLE RESPONSIBILITY AND NOT THE COMPANY&#x2019;S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b) OF THE CODE, EVEN IF PURCHASER REQUESTS THE COMPANY OR ITS REPRESENTATIVE TO MAKE THIS FILING ON PURCHASER&#x2019;S BEHALF.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Representations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Purchaser has reviewed with his or her own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Purchaser is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Purchaser understands that he or she (and not the Company) shall be responsible for his or her own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Entire Agreement; Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Plan and Option Agreement are incorporated herein by reference. The Plan, the Option Agreement, the Exercise Notice, and this Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser&#x2019;s interest except by means of a writing signed by the Company and Purchaser. This Agreement is governed by the internal substantive laws but not the choice of law rules of California.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchaser represents that he has read this Agreement and is familiar with its terms and provisions. Purchaser hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">[Signature page follows]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IN WITNESS WHEREOF, this Agreement is deemed made as of the date first set forth above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:51.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:45.711%;"></td>
    <td style="width:6.4%;"></td>
    <td style="width:47.89%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PURCHASER</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KODIAK SCIENCES INC.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Residence Address</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dated: _________________________, ____</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT D-2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ASSIGNMENT SEPARATE FROM CERTIFICATE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FOR VALUE RECEIVED I, Victor Perlroth, hereby sell, assign and transfer unto Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) _____________ shares of the common stock of the Company standing in my name of the books of the Company and represented by Certificate No. ___ herewith and do hereby irrevocably constitute and appoint the Company&#x2019;s Secretary to transfer the said stock on the books of the Company with full power of substitution in the premises.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Stock Assignment may be used only in accordance with the Restricted Stock Purchase Agreement between the Company and the undersigned dated ______________, _____ (the &#x201c;Agreement&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dated: ___________________	Signature:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">             </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	Name: Victor Perlroth</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:36.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">INSTRUCTIONS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Please do not fill in any blanks other than the signature line. The purpose of this assignment is to enable the Company to exercise its &#x201c;repurchase option,&#x201d; as set forth in the Agreement, without requiring additional signatures on the part of the Purchaser.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT D-3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">JOINT ESCROW INSTRUCTIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">_________________, ____</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate Secretary</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">____________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">____________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dear _________________:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As Escrow Agent for both Kodiak Sciences. (the &#x201c;Company&#x201d;), and the undersigned purchaser of stock of the Company (the &#x201c;Purchaser&#x201d;), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Purchase Agreement (the &#x201c;Agreement&#x201d;) between the Company and the undersigned, in accordance with the following instructions:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.	In the event the Company and/or any assignee of the Company (referred to collectively for convenience herein as the &#x201c;Company&#x201d;) exercises the Company&#x2019;s repurchase option set forth in the Agreement, the Company shall give to Purchaser and you a written notice specifying the number of shares of stock to be purchased, the purchase price, and the time for a closing hereunder at the principal office of the Company. Purchaser and the Company hereby irrevocably authorize and direct you to close the transaction contemplated by such notice in accordance with the terms of said notice.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.	At the closing, you are directed (a) to date the stock assignments necessary for the transfer in question, (b) to fill in the number of shares being transferred, and (c) to deliver the stock assignments, together with the certificate evidencing the shares of stock to be transferred, to the Company or its assignee, against the simultaneous delivery to you of the purchase price (by cash, a check, or some combination thereof) for the number of shares of stock being purchased pursuant to the exercise of the Company&#x2019;s repurchase option.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.	Purchaser irrevocably authorizes the Company to deposit with you any certificates evidencing shares of stock to be held by you hereunder and any additions and substitutions to said shares as defined in the Agreement. Purchaser does hereby irrevocably constitute and appoint you as Purchaser&#x2019;s attorney-in-fact and agent for the term of this escrow to execute with respect to such securities all documents necessary or appropriate to make such securities negotiable and to complete any transaction herein contemplated, including but not limited to the filing with any applicable state blue sky authority of any required applications for consent to, or notice of transfer of, the securities. Subject to the provisions of this paragraph 3, Purchaser shall exercise all rights and privileges of a stockholder of the Company while the stock is held by you.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.	Upon written request of the Purchaser, but no more than once per calendar year, unless the Company&#x2019;s repurchase option has been exercised, you shall deliver to Purchaser a certificate or certificates representing so many shares of stock as are not then subject to the Company&#x2019;s repurchase option. Within two hundred (200) days after cessation of Purchaser&#x2019;s continuous employment by or services to the Company, or any parent or subsidiary of the Company, you shall deliver to Purchaser a certificate or certificates representing the aggregate number of shares held or issued pursuant to the Agreement and not purchased by the Company or its assignees pursuant to exercise of the Company&#x2019;s repurchase option.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.	If at the time of termination of this escrow you should have in your possession any documents, securities, or other property belonging to Purchaser, you shall deliver all of the same to Purchaser and shall be discharged of all further obligations hereunder.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.	Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties hereto.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.	You shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Purchaser while acting in good faith, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.	You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or corporation, excepting only orders or process of courts of law and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree, you shall not be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have been entered without jurisdiction.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.	You shall not be liable in any respect on account of the identity, authorities or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.	You shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these Joint Escrow Instructions or any documents deposited with you.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.	You shall be entitled to employ such legal counsel and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefor.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.	Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be an officer or agent of the Company or if you shall resign by written notice to each party. In the event of any such termination, the Company shall appoint a successor Escrow Agent.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.	If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.	It is understood and agreed that should any dispute arise with respect to the delivery and/or ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to anyone all or any part of said securities until such disputes shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.	Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto entitled at the following addresses or at such other addresses as a party may designate by ten (10) days&#x2019; advance written notice to each of the other parties hereto.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16.	By signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow Instructions; you do not become a party to the Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.	This instrument shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.	These Joint Escrow Instructions shall be governed by the internal substantive laws, but not the choice of law rules, of California.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">[Signature page follows]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.917%;"></td>
    <td style="width:4.167%;"></td>
    <td style="width:47.917%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PARTICIPANT</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KODIAK SCIENCES INC.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Print Name</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Residence Address</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ESCROW AGENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">               </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate Secretary</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dated:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT D-4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ELECTION UNDER SECTION 83(b)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">OF THE INTERNAL REVENUE CODE OF 1986</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The undersigned taxpayer hereby elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in taxpayer&#x2019;s gross income or alternative minimum taxable income, as the case may be, for the current taxable year the amount of any compensation taxable to taxpayer in connection with taxpayer&#x2019;s receipt of the property described below.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.	The name, address and taxpayer identification (social security) number of the undersigned, and the taxable year in which this election is being made, are:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TAXPAYER&#x2019;S NAME:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TAXPAYER&#x2019;S SOCIAL SECURITY NUMBER:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ADDRESS:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TAXABLE YEAR:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                 </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The name, address and taxpayer identification (social security) number of the undersigned&#x2019;s spouse are (complete if applicable):</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">SPOUSE&#x2019;S NAME:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">SPOUSE&#x2019;S SOCIAL SECURITY NUMBER:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ADDRESS:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.	The property with respect to which the election is made is described as follows: __________ shares (the &#x201c;Shares&#x201d;) of the Common Stock of Kodiak Sciences Inc. (the &#x201c;Company&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.	The date on which the property was transferred is:___________________ ,______.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.	The property is subject to the following restrictions:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Shares may not be transferred and are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.	The Fair Market Value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms shall never lapse, of such property is: $_________________.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.	The amount (if any) paid for such property is: $_________________.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned&#x2019;s receipt of the above-described property. The transferee of such property is the person performing the services in connection with the transfer of said property.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">[Signature page follows]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">The undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dated: ___________________	</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">        </font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Taxpayer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Exhibit B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Election Form</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Election Form for Special Equity Award</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Compensation Committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) of the Board of Directors (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Board</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) of Kodiak Sciences Inc. (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) is providing you the opportunity to receive a one-time special equity award in the form of a stock option under the Kodiak Sciences Inc. 2018 Equity Incentive Plan (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), pursuant to the terms and conditions set forth in this Election Form for Special Equity Award (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Election Form</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) and as described in the attached Q&amp;A (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Special Award</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Specifically, the Committee is giving you the opportunity in this Election Form to (1) elect whether you wish to receive the Special Award (such election, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Opt-In Election</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), which would be granted to you in lieu of a portion of each annual long term incentive award that may be granted by the Company to you during fiscal year 2021 and continuing through and including fiscal year 2027 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Election Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), in each case subject to your continued status as a Service Provider (as defined in the Plan) on the applicable grant date (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Annual Long Term Incentive Awards</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), and, to the extent you make the Opt-In Election, (2) indicate your preference regarding the portion of the Annual Long Term Incentive Awards that you wish to forego (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Percentage Election</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will be sending a DocuSign to complete this Election Form. Please complete the DocuSign before 5:00 p.m., Pacific Time on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">__________</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. To the extent that your completed Election Form is not received by such time, you will be deemed to have declined the Special Award.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Opt-In Election.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> I hereby make the following election with respect to the Special Award:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.004%;"></td>
    <td style="width:2.996%;"></td>
    <td style="width:3.998%;"></td>
    <td style="width:86.002%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Accept.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;I wish to accept the Special Award and forego a percentage of my Annual Long Term Incentive Award for each of the next seven years. I have indicated my Percentage Election below.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Decline.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;I wish to decline the Special Award.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Percentage Election.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> I hereby elect to forego the following percentage of each Annual Long Term Incentive Award in exchange for the Special Award:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.004%;"></td>
    <td style="width:2.996%;"></td>
    <td style="width:3.998%;"></td>
    <td style="width:86.002%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0% of the Annual Long Term Incentive Awards in the form of the Special Award; or</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25% of the Annual Long Term Incentive Awards in the form a Special Award of _____non-qualified stock options; or</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50% of the Annual Long Term Incentive Awards in the form of a Special Award of _____non-qualified stock options; or</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75% of the Annual Long Term Incentive Awards in the form of a Special Award of ____non-qualified stock options.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">By signing below, you acknowledge that you understand that, after 5:00 p.m., Pacific Time on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">__________</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">, you may not withdraw or change your elections.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.54%;"></td>
    <td style="width:4.901%;"></td>
    <td style="width:47.56%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Signature</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name (please print)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(Exhibit A). &#x2013; Special Award Q&amp;A</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Special Award Q&amp;A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following information in this Special Award Q&amp;A (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Q&amp;A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) is intended as a summary. It may not answer all of the questions you may have about the Special Award and is not intended to go into every detail regarding the Special Award. Please note that if there are any inconsistencies between the information in this Q&amp;A and the terms of the Special Award (as set forth in the documentation evidencing the Special Award that will, in the event you make the Opt-In Election, be provided to you upon grant), the terms of the Special Award will control. Capitalized terms not explicitly defined in this Q&amp;A or the Election Form will have the same meanings ascribed to them in the Plan.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Why am I receiving the Election Form?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To motivate and reward the next phase of transformational performance and growth, the Committee is considering approving a new long-term incentive compensation program (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">KSO Program</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;), pursuant to which each participant will be granted a Special Award that will vest subject to both time-based and performance-based vesting conditions (as described further below). You are receiving the Election Form because you are grade-level six or above and the Committee believes you are in a position to lead and influence the Company&#x2019;s next phase of performance and growth, and therefore wants you to be a participant in the KSO Program. By electing to receive the Special Award, you will confirm your wish to participate in the KSO Program.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Is there an overview document to review details of KSO Program?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Eligible participants should read the &#x201c;KSO Program 7-year Performance Award Participant Overview&#x201d; . Please note that the KSO Program is subject to modification or cancellation based on shareholder voting from special proxy filing.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">What is the potential value of the Special Award?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Special Award is designed to provide approximately </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">three</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> times the value at the end of the seven year performance measurement period, based on assumptions used prior to grant date, as compared to the foregone portion of the Annual Long Term Incentive Awards.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">How will the Special Award vest?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to certain exceptions, the Special Award will be earned based upon the achievement of stock price performance objectives ranging from $200 to $800 over the next seven years. These performance objectives will need to be achieved, and sustained, over ninety (90) consecutive trading days at any time during the Election Period. Once earned, the Special Award will also be subject to time-based vesting conditions. Specifically, upon the achievement of any performance objective under the KSO Program, the underlying tranche of options will vest in equal monthly installments between the date of achievement of such performance objective and the end of the Election Period, subject to your continued status as a Service Provider through each such vesting date. Subject to certain exceptions, any stock price performance objectives that are not achieved by the end of the Election Period will result in the cancellation of any relevant tranches of the Special Award.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Are there any other ways for the Special Award to be earned and to vest?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A threshold level of the Special Award will be earned upon the attainment of certain operational performance objectives. Up to 25% of the Special Award will be earned upon the attainment of regulatory milestones tied to KSI-301. An additional 10% of the Special Award will be earned in the first fiscal year in which KSI-301 and/or KSI-501 has sales of $2.5 billion. To prevent double counting, the KSOs that are earned based on (Exhibit A). Please note that attainment of the stock price performance objectives (that is, the same KSOs cannot be earned twice).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Are there any other conditions applicable to the Special Award?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Special Award will be subject to stockholder approval at a special meeting of the Company&#x2019;s stockholders to be held as soon as practicable following the Committee&#x2019;s approval of the KSO Program and the Special Award. If such shareholder approval is not obtained, then the Special Award will be forfeited and you will receive 100% of the value of your Annual Long Term Incentive Award for fiscal year 2021.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Who can I contact to answer any questions regarding the Special Award?</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">You are encouraged to direct questions to </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KSOQuestions@InfiniteEquity.com</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or contact John Borgeson at the Company to the extent you have any questions regarding the Special Award.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>kod-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Victor Perlroth, M.D., certify that:</font></p>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I have reviewed this Quarterly Report on Form 10-Q of Kodiak Sciences Inc.;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.009%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.917%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 9, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Victor Perlroth</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Victor Perlroth, M.D.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Chairman and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>kod-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, John Borgeson, certify that:</font></p>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I have reviewed this Quarterly Report on Form 10-Q of Kodiak Sciences Inc.;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.009%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.917%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 9, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ John Borgeson</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">John Borgeson</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Senior Vice President and Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Principal Accounting and Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>kod-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the Quarterly Report of Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</font></p>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.321%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:3.996%;"></td>
    <td style="width:49.679%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 9, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Victor Perlroth</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Victor Perlroth, M.D.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Chairman and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>kod-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the Quarterly Report of Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</font></p>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.533%;display:flex;margin-top:12.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-block;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:0.3402777777777778in;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.321%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:3.996%;"></td>
    <td style="width:49.679%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: November 9, 2021</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ John Borgeson</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">John Borgeson</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Senior Vice President and Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Principal Accounting and Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Kodiak Sciences Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img6467664_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img6467664_1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" :8"[@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI.DZKJ\]S;_;#-$5D?S'8( BR98 MS@?>R #]L:*_!3XK?MS_&KXM:E//?\
MC?4-$L7?<FF>'YGL;>,=E_=D,X'7YV8^]><:1\;/B'X?O%NM,\=^);"X4@B2
MWU>X1N/H] ']&5%?D[^R;_P5$\3>'=?L/#?Q=N_[>\.W,BPKX@:,+=V.3@/+
MM&)8QW.-X&3EL;:_5ZWN(KRWBG@E2:"50\<D;!E=2,@@CJ".] $E%(6"@DG
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M_A27O_QV@#^AFBOR-^+7_!4+Q9#\/?"GA#X<W<EO?6NAV,&L>+-03S[RXO!
M@G$0DR/O[@9&!9CDC'#'R']FGXW?$+QU^U-\,_\ A(?''B'64N/$5GYL5[J<
MTD; R $;"VW&.,8QB@#]T**\>_:L_:";]F?X1W?C1?#=UXE,=Q':K!!(L<<+
M29"R3.<E8]P"Y522S*.,Y'Y*_%#_ (*-?'/XF74AC\5-X2L&SLL?#:?90O\
MVUR92?\ @>/0"@#]RZ*_G)O_ (Q>/M5G\Z]\<>)+R;_GI<:M<.W7/4OZD_G7
M3^"/VK/C!\.[J.;0OB-XA@$9!%O<7SW-OQTS%*60_P#?- ']!]%?"G[$O_!1
MV/XW:W:>!?B%;VFD>+YP5L-3M?W=KJ+#_ED4)/ERD=,':YR %.%/W70 45^<
M/_!6;XJ^-?AQXA^&\?A+QAKWA>.[M;YKA-%U.>T$Q5X=I<1LNXC)QGIDU\9_
M!_\ :[^(WAGXJ^$-7\4_$WQOJ7AJQU6VN=2LY-<NKA9[9)%:1#&TNU]R@C:>
M#G!H _>JBOQ2^/G_  4N^*_Q7U:Y@\,ZI-\/_#09E@M='?9=NF>&EN!\^['_
M #S*CV.,U\ZM\8?'KWGVMO&_B-KO(/GG5KC?D# ^;?GI0!_1O17XB? ;_@H]
M\6_A#K%LFMZU<^/?#>X"XT[7)C+/L[F*X;+JV.FXLO\ L]Z_8KX1_%?P]\;/
MA[I'C'PO=?:M)U*+>JN )(7'#Q2+GY75L@CIQD$@@D [&BBOA[]L[_@I!IWP
M-U2^\$^ [6WU_P ;6Y\N\O+GYK+3F(R4(!!EE'=00%)Y)(*T ?<-%?S\>//V
MN_C+\1]0FNM:^(_B#;)UM;"]>SM@/00PE4Z'&<9]ZP/#/[0?Q.\&WD=UHOQ!
M\2Z?*C;P(]5FV,>/O(6*L.!P01P* /Z)J*_'RR_X*;^,O%7P#\8>#?%=]<6/
MC&2RC_L3Q9H9:TN&D6:-F27RB-C% ^'3:.Q'.:^:?^&H/C)_T5KQU_X4E[_\
M=H _H9HKR+]D?7-1\2?LS_#?5-7O[K5=3N]&@EN+V]F:::9R.6=V)9B?4FO4
M-:UJP\.:/>ZKJEW#8:;90O<7-U<.$CAC4%F=B>@ !- %VBORM_:6_P""L&O:
MGJUSHWP=ABTG1X\H?$6H6PDNK@]-T43Y6-/3>K,>#A.E?%WB3]HKXI^+II9=
M8^(WBF_\QBQCEU>?RP2<_*@?:HSV  H _HCHK^>[P9^U5\8/A_>P7.B?$GQ)
M!Y.-EO<:A)<V_& ,PREHVX '*FOT)_8^_P""GT/Q$UJQ\&_%:*UTG6[R58+'
M7[1/+M;AV.%CG3)\MR> X^4YP0N,D _0BBBB@ HHHH **\E_:/\ VFO!O[,/
M@U-<\57$DMU=%H].TFT :YO9% )"@\*HR-SMP,CJ2 ?R?^,O_!2KXS_%2XN8
M=,UK_A!-%=CY=GX?)BG"]MUS_K"P'4H4!_NCC !^W5%?SG7GQM^(FH7RWEUX
M]\3W-XIW"XFUFY>0'.<[B^>M>C_#/]NOXX?"Z]66Q\>ZGK5MD;K'Q#,VHPLH
MP H\TED''\#+0!^]5%?*/['?[?GAK]IKR?#FJVR>&OB"D)D;3@Q-M>A1EWMG
M// RQC;Y@,D%PK$=W^V[\2O$?PA_9?\ &GBWPEJ/]D^(=/\ L7V6\\B.;R_,
MO8(G^2160Y1V'(/7(YP: /G_ /X*]^/KS0/@CX8\+VLC11>(-6+W15L>9#;I
MO\LCN#(\3?6,5^2-K;27EU#;PKOEE<1HH[L3@#\Z]*^,_P"TQ\2?VA(])C^(
M'B3^WTTDRM9C[#;6WE&39O\ ]3&F[/EI][.,<=Z\XL+Z?2[ZVO+9_*N;>19H
MGP#M92"#@\'D#K0!^OO@3_@DS\)]-\%V=IXIN-9UCQ&\(-WJ%M>^1&DI'S")
M N H/3=N)QD^E?27[.?P!T+]FOX9P>#- N+B]M4NY[N6\NPHFG>1\@OM !*H
M(TR ,A <"OR"_P"'DW[1W_11?_*'IO\ \CU^L'[%_P 1?$/Q9_9E\$^+/%>H
M?VKX@U&.Y:ZO/(CA\PI=31K\D:JHPJ*. .GK0![91110 45E^*/$VE^"_#NI
M:]K=[%IND:= ]S=7<YPD4:C+,?P[#D]!7Y1_M)?\%5O&7B[6+K2OA4?^$2\.
M)F-=4G@234+KU<;MRPJ>P +=]P/  /UPHK^='6OCI\2/$4WFZK\0/%&HR9SN
MNM9N),?3+\5Z%\)_VY/C1\(=2@GT_P ;:AK5BC9?2_$$SWUM(.ZX=MR#_<93
M[]: .I_X*9?\GF>./^N.G_\ I#!1_P $S?\ D\SP/_UQU#_TAGKS3]J+XU6_
M[0WQGU;QY;Z;)I U.VLUELI'#^5+';1Q2 ,/O+N0D' .",@'BO2_^"9O_)YG
M@?\ ZXZA_P"D,] '[AT45\^?M9?MG>$/V5M%BCOT?6_%U]"9=/T&W;:SKD@2
MS/@^7'N!&<$D@[0<,0 ?0=%?A7\5O^"A7QP^*ETQ/C"X\)V&[='8^%V:Q"<_
M\]5/FMV^\Y'M7D'_  NCXA?;?MG_  G?B;[7C'VC^V+CS,?[V_- ']&=%?A9
M\*?^"AGQQ^%=TG_%7W'BRPW;I+'Q06O@_/\ SU8^:OX.![5^J?[*'[97@_\
M:JT69=-1]%\5V,2RZAH-R^YXU)QYD3X ECS@9P""0& RN0#Z HHK\ZOVR/\
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M+#_ED4)/ERD=,':YR %.%(!]UU^7/_!9G_D9OA;_ ->>H?\ H<%?J-7Y<_\
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MO+JPM69HX2XW*!NY!VE25.=I)&3C-=K0 445^;__  4A_:X^+/P#^.&A^'_
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M![4 ?NG17S_^RA^V5X/_ &JM%F734?1?%=C$LNH:#<ON>-2<>9$^ )8\X&<
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M7&K7#MUSU+^I/YUT_@C]JSXP?#NZCFT+XC>(8!&01;W%\]S;\=,Q2ED/_?-
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M77GB6&;6/"6HWTK37<6C31"VFD8DM)Y<D;;6).3M(7K\N3FO5?V<?V2OA_\
MLOZ;>P^$;2ZN-1O@%N]8U259;N90<JF55550>RJ,\$Y(!K\?_C1^TA\6]+^,
M7CNRLOBEXTL[.VUZ_A@M[?Q#=I'%&MQ(%15$F%4   #@ 5]<_P#!*#XM>./B
M-\0O'=MXL\9^(/$]O;:7!)!#K.J3W:1,92"RB1V"DCC(H _2ZBL[Q'*\'A[5
M)(W:.1+65E=3@J0AP0>QK^??_AJ#XR?]%:\=?^%)>_\ QV@#^AFBOQI^&O\
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MP?G7'(P5&1GY/L+^YTN^M[VSN)+2\MI%FAN(7*/&ZD%65AR"" 01Z4 ?T?\
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M7\J_36OS6_X(RZ*8]+^*NK,AVS3:;:H^/[BW#,/_ !]/TK]*: /Q0_X*D_\
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M[E28YT'LLJ.![ 5_.[7[2?\ !*F\GNOV2[*.92L=OK%[%"3W0LKDC_@3M^5
M'Q=_P5J_Y.FM/^Q=M/\ T;/7Q97VG_P5J_Y.FM/^Q=M/_1L]> _LJ^%8/&G[
M27PTT>[BCGLY]?M&GAF4,DD22"1T(/4,JD8]Z /J[]G?_@D_K'Q \*6/B/XB
M>(I?"L-_%'<6VD6$ DNQ$P# S,_RQ-@CY,,1GG!!%?>7[+_[)/A?]E*R\0VO
MAC5M7U2+6GMY9_[6>)V1HE<?*8XTX.\\$'MS7N-,E9DC=E3>P!(7.,GTH _$
M'_@HA^T->?&[X_:OIEK?--X3\+S/IFFVZM^[:1<+<3^A+R*0&_NJE>1?L^_
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M/V:_A)9>"Y/$UYXH\F:2X\ZYC6.. O@M'"@R5CW;FPS,=SL>,X'KU% 'X/\
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M[*/B7Q7K&FZU<>(;C5TCMK2:^MU2:RME)9HMRG#EVV$L O\ JUX'?\N/ _\
MP4"^/?@5HEM_B!>ZM;IP8-<CCOMX]"\BF3\0P-?>O['O_!3"Q^-OB6P\$^/M
M,MO#GBJ](BL-0L6;[%?2]HBK$M%(?X<LP8\9!V@@'W31110 5\]_MN?LQG]J
M'X0?V)IS6MMXITZZ2\TF[NR5C5B0LJ.P!(1D)Z _,J'M7T)7SE^UY^VMX8_9
M3TJTMI[1O$'B_48S+9:+#*(PL>2/.F?!V)N! P"6(( X) !Y+\)?^"2OPO\
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M_NS.* /%OV/_ (N?\*1_:,\%^)YIO)TU;P6>HDG"_99AY4C'UVAM_P!4%?T
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MZA=X_B-?NK7\SMO<26MQ%/$Q26-@Z,.H(.0:_I9TRZ:^TVTN7C\IYHDD:/\
MNDJ"1^M %FBBB@#Y2_X*??\ )G7BK_K\L/\ TJCK\1J_;G_@I]_R9UXJ_P"O
MRP_]*HZ_$:@#Z!_9-_8U\6?M7:S>'3;F'0_#.FR)'J&M72%PK,"?+B08\R3
MSC( !&2,C/Z(?"/_ ()9^ _A3XT\.>+8_%WB+4M;T2_AOX0P@CMI&C;=M9/+
M+8.!T?UKT/\ X)U^%8/"O['_ ("6**-)]0BN-1N)$4 RO+<2%6;U(3RUSZ(!
MVKZ2H YOXD> =*^*7@+7O".N1>=I6L6DEI. /F4,.'7T93A@>Q4&O@7X)_\
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M_? KXO\ VM+*+3_VGOBK# NR/_A);]]OH6G=C^&2:^CO^"/K'_AI7Q,,\?\
M"(W/'_;Y94 ?HI^V1\:I/@+^SOXK\46<ACUEH18:8PZK=3'8C_\   6DYZ[,
M=Z_ FZNI[ZZFN;F:2XN9G:26:5BSNQ.2S$\DDG))K]@/^"O7VO\ X9GT+R/^
M/?\ X2BV^T8Z[?LUUM_#=C\<5^/5 'W%^Q'_ ,$Z7^/WA^'QUXYU"[T;PA+*
MR65C9J%N=1"G!DWL"(XMV5S@EMK8VC!/VA>_\$N?V?[K25LXO#VJ6=P%(-_#
MJ\YF/'4AV://_ .]>S_LQ-I[?LX_"\Z5Q8?\(UIWEYQG_CV3.['\6<Y]\UZ;
M0!^%_P"VA^Q;J_[*.OV-Q;WTFO\ @W579+'4WBV212#DP3 <;]O(88#@,0!@
M@?--?M-_P54;3U_9)U 7O_'R=7LA8]/]=O;/_D+S>E?BS0!^_G[%O_)J/PM_
M[ 5O_*OD'_@KC^T%=Z;#H7PFT6^:!+R'^T]=6(X+Q[L6\+'T+*[E?:,U]??L
M6_\ )J/PM_[ 5O\ RK\H_P#@I9?7%Y^V9XZ2=2JV\=A%$#_<^Q0-D?4LQ_&@
M#PKX5_#76?C#\1-!\&:!&DFK:Q<BWA\PX1!@L[L?[JJK,<<X4U^RWPE_X)O?
M!7X:Z%;0:GX;C\::PH!N-3UPF3S&XR%A!\M5R.!@G!Y8U^,OPY^)7B7X2^*K
M?Q+X2U-M&URW1XX;R.*.1HPZE6P'5@,J2,XZ$UZ__P /!/V@_P#HI5]_X!VO
M_P :H _0?]H[_@F#\.?'GA.]N_AUIB^#?%UO$SVL=O,QLKMQR(Y4<D)GH&3;
MC.2& Q7X]ZAI]SI&H7-E>0O;7EK*T,T+C#1NI(93[@@BO??^'@G[0?\ T4J^
M_P# .U_^-5X7XD\1:AXN\0:EKFK7'VO5-2N9+N[N-BIYLKL6=R%  )8D\#O0
M!^V/_!.GX]77QR_9XL1K%ZU[XE\.S'2;Z:4YDF50&@E8]R8R%+'DM&Q-?4=?
MF/\ \$8]2F^U?%>PP6MRFF3ANRL#<K^H/_CM?IQ0 5#>7<-A:S75S*D%O"C2
M2RR'"HH&2Q/8 "IJ\X_:3OKC3?V=_BA=VBEKJ'POJ<D>WJ&%K(0?PZ_A0!^'
MO[5'QZU+]HKXSZ[XIN[F632A,]MH]M)PMM9*Q\I0O8D?,WJS-6I^R7^RKKO[
M5?Q FT73[I=)T73HUN-5U:2,N+>-FPJ*O&Z1\-M4D#"L<\5X=7[ _P#!(72[
M.U_9Q\07\++)>77B6=+A@.4V6]OL0_0,6_X'0!V6B_\ !+O]G_2]%6RNO#FH
MZQ=;0IU*[U>X28G^]MB=(_\ QROAW]N3_@GW)^SCIG_":^$+^XUCP1)<+!<6
M]VNZYTUGX0LZ@!XRWRAL @LH.<Y/[*UY7^U5I=GK'[,_Q3MKXJEO_P (UJ$N
M]AD*R6[NC?@RJ?PH _ #PUXDU3P=X@T[7-%OIM-U;3YTN;6[@;#Q2*<JP_'\
M#7[F^&W\._M[?LAZ?#K5U=V-AXFM;==4_LF1(Y[>ZMYT>5$+HX \V'C*G*,#
MQD&OP?K]BO\ @D7?7%U^S#JT,RL(K7Q-=10L>A4V]LYQ_P "9J /CO\ X*!?
ML<^"_P!E*S\#R^$M3U[46UR2]6Y_MJXAE""$0%=GEPQXSYK9SGH.E?']G"MQ
M>01,2%DD53CK@G%?IO\ \%G?^09\)?\ KMJG_H-I7YF:7_R$[3_KLG_H0H _
M7;_AS]\&_P#H9?'7_@?9?_(E?6'P7^$ND? OX9Z)X&T&YOKO2=)658)M1='G
M8/*\IW,B(I^:0XPHX ^M=M10 4444 ?F=_P5[^.=U;-X9^%6EWKPV\\/]L:S
M%&V!*-^VVC;'8%)'*GOY9["OS4TO2[O6]3M-.L+:2\O[R9+>WMX5+/+([!51
M0.I)( 'O7T__ ,%.;ZXNOVR/&$4RD1VMMI\4!/=#9Q.2/^!._P"58G_!.W3;
M35?VR/AS%>LHCCGNIT##.9([.=T'UW*#^% 'VY^S_P#\$G?!'A_P];WOQ5EG
M\4^()U5Y=-LKJ2VLK7C)C#QE9)&]6W*/0=S9^.__  2=\ >)?#T]Q\,);CPA
MX@A4M#:7=U+=65QQ]QC(6D0GC#AB!W4]1]YT4 ?S3ZWHM_X;UF^TG5+62QU*
MQG>VN;69</%(C%65AZ@@BOI7_@F;_P GF>!_^N.H?^D,]1?\%*-)L])_;&\<
M"S9?](2RN9HU&/+E:TB+#ZGAO^!U+_P3-_Y/,\#_ /7'4/\ TAGH _:+XA>.
M--^&G@77_%>KOY>FZ-92WL^#RRHI;:O^T2  .Y(K^>;XJ?$[7OC'X_UGQAXD
MNVN]6U2<RN2?EC7HD2#LB* H'H!7[3?\%&[ZXL/V,_B(]LI+NEE$Q'\*/?0*
MQ_(D?C7X6T ?4/[$W[$NI?M5ZS>ZEJ%])H?@C29EAO;Z%,S7,I&[R(,C:&"X
M+,<[0Z\-G%?HM_PZ_P#V??[%^P_\(OJ'VG;C^TO[8N?/SC&<;_+SW^YBM;_@
MF]I=GIG[&_@)K-ED-T+RXGD48W2F\F5@?==H7_@-?3- 'X;_ +:W[$^I_LI:
MU87]EJ$FO>"M6E>*ROI8]LUO(!N\B?'R[BN2K#&X*W"XQ7B7PC^*FN_!7XB:
M)XQ\.7+6^IZ9.) H;"SQ]'A?U1URI]CZXK]E/^"EFEV>I?L;^-Y;HJCV<EC<
M6[,,XD^V0I@>Y5V7\:_#J@#^A'QM\58]8_9?\1?$7PG+)*LWA.ZUK39(R ZM
M]D>5,^C*<9'4$$=:_GPDD:61G=B[L<LS'))/4DU^Y/[ MLGC#]AWP/I^LVYF
MM+NRO[":%R1YL'VNXBQD<@%.*_+K]JS]C'QK^S7XJU%WTRZU;P.TK/8>(+>,
MR1"(M\B3L!B.4# (; )Y7(H ^J_^";_[*?P5^*WPI?Q1XFM;7QAXN^U317.E
MW5T=FG1JQ6,&!6&=ZX;>X(YP,8.?KS7OV$_@'XDC*7?PQT:$$8S8>99G\X76
MOP;T_4KO2+R.[L;J:RNHSE)[>0QNOT8'(KV#P9^V?\</ 3)_9/Q,U]XU/RPZ
ME<?;XQ[!;@. /8"@#]-?A_\ \$Q?A_\ #'XZZ!X_T36-1ETO296NH_#^I(LZ
MBXVGRG68;6"QL0X#!CE1\W8_9%?EI^S_ /\ !6_7+?6K32_BUI-I>Z3,XC;7
MM(A,4]MGC?)""5D4=]FT@9P&/!_4'2]4M-;TRTU&PN8[RPO(4N+>XA8,DL;J
M&5U(Z@@@@^] 'X4_\%!/^3Q?B5_U^0?^DL-=U_P2K_Y.VT__ +!%[_Z M<+_
M ,%!/^3Q?B5_U^0?^DL-=U_P2K_Y.VT__L$7O_H"T ?M-7\Z?QX_Y+A\0_\
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M.[/OF@#YS\,^&M4\9>(M-T+1;*74=6U&X2UM;6$9>61R JC\3U/ K]8/@O\
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MHH \?_;"_P"36?BK_P!B[>?^BFK^?FOZ!OVPO^36?BK_ -B[>?\ HIJ_GYH
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MZ)T1<JI(W*P) RV[ (K]9Z\\_:*T^+5OV?\ XEV<XS%-X:U)#[?Z+)S]1UH
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M4]/N)+._LIDN;>XB.'BD1@R.I[$$ _A7]%?P>\<#XF?"CP?XLP%?6M)M;^1
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M]G#X.A\+WK(!#J6@NUO+"P& =F3&WON4Y^O-?EK_ ,/!/V@_^BE7W_@':_\
MQJC_ (>"?M!_]%*OO_ .U_\ C5 'G_[07P1UK]GGXJZSX)UMTN)K)@]O>1C"
M75NXS'*!VR.H[$$<XK[D_P""1/QZN_[3U_X3:K>O+9M"=5T6.4Y$3*V+B)?9
M@RR!>@VR'J37P1\5/C%XQ^-FO6^M^-M:DU[5;>V6TCNI88HV$09F"?(JY 9V
M//J:]B_X)QZE-IO[97P],(+B9[R!U'=6LIP?RX/X4 ?NC1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
MSD_&/_DKWCC_ +#M]_Z4/7T+_P $V_V?/#'QZ^-5[_PED;7NE^';-=2&FD#R
MKN3S%55E]4!.2O\ %@ \9!^>OC'_ ,E>\<?]AV^_]*'K[3_X(Y?\E>\>?]@)
M/_2A* /U2UOP[IGB30;S1-4L(+[2+RW:UN+*9 8I(F7:4*^F.*_#G]MK]D?4
M?V7?B*RV:S7G@?5W:71]0;+%!U:VE/\ ST3/7^)<-UW!?W7KA_C1\'?#OQX^
M'.J^#?$]MY^G7R?),@'FVLPSLFB)Z.IY'J,@Y!((!^!/P7^,'B'X$?$;2/&7
MAFX\G4;"3YX7)\JYA/WX9 .J,.#W'!&" 1^]GP'^-WA[]H3X9Z7XR\-RYM;I
M=EQ:.P,MG<*!YD$F/XE)'/<%6'!%?A#\?O@7XB_9W^)>I>#_ !'%F:W/F6MZ
MBD17MN2=DT?L<'(_A(8'D5Z#^Q7^UAJ/[+OQ,2ZN&FN_!FK,D&M:>G)V@_+<
M1C_GI'DG_:4LO<$ '[A^./&6F?#WP=K7B;69Q;:5I%I+>W,A[(BEB!ZDXP!W
M) KXR^ O_!5SP!X[5-/^(EH_@/5R^U+M0]QI\H)^7+@;XSV.X%>^[L/3_P!M
M+P'XN_:7_9G73_A1J6GZA;ZJ]OJ$BFX\L:G9@>8D<3GY06?RV^<@?)@D5^*G
MC;X>^)_AMK#:5XJ\/ZEX=U!<_P"CZE:O"S =UW ;A[C(YH _HJ\*^-_#OCK3
MQ?>&]>TW7[(@$7&F7<=PG/3YD)%;$LJ01O)(ZQQH"S.QP% ZDGL*_FCL[ZYT
M^7S;6XEMI<8WPN4./3(K0U+Q?KVLQ^7J&M:C?1[=FRYNY)!M],,3Q0!]H?\
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M_D[;X7_]A=/_ $!J /WSHHHH *\?_;"_Y-9^*O\ V+MY_P"BFKV"O'_VPO\
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MU_05\6OA-X9^-O@74?"/BVP%_H]Z!N"MMDB<'*R1M_"ZGH?J#D$@_DU\>?\
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M?\G36G_8NVG_ *-GK]DZ_&S_ (*U?\G36G_8NVG_ *-GH \?_8<_Y.V^%_\
MV%T_] :OWSK\#/V'/^3MOA?_ -A=/_0&K]\Z /P?_P""@G_)XOQ*_P"OR#_T
MEAKNO^"5?_)VVG_]@B]_] 6N%_X*"?\ )XOQ*_Z_(/\ TEAKNO\ @E7_ ,G;
M:?\ ]@B]_P#0%H _::N%^/'_ "0_XA_]B[J/_I-)7=5POQX_Y(?\0_\ L7=1
M_P#2:2@#^=.OV _X(_?\FT^)?^QNN?\ TCLJ_'^OV _X(_?\FT^)?^QNN?\
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MR3H ]>_9+^$)^./[0G@WPI)"9=.FO%NM1XX%I#^\E!]-RJ4'NXK^@< *  ,
M=!7YK?\ !'GX0>38^,OB;>08:9ET+3G8<[5VRW##V)\@9']UA7Z54 ?*7_!3
M[_DSKQ5_U^6'_I5'7XC5^W/_  4^_P"3.O%7_7Y8?^E4=?B-0!^^?[#G_)I/
MPO\ ^P0G_H;5^?O_  5T^&-UX?\ C;H7C5%+:=XBTU;=GQ]VXMSM8$^\;Q$?
M1O2OT"_8<_Y-)^%__8(3_P!#:NA_:1^ .A?M)?"S4O"&M*L,SCS]/U +N>RN
ME!V2KZCDAAW5F''4 'X,_"7XE:E\'OB5X<\::0D<M_HMXETD,OW)5'#QMZ!E
M+*2.1NXYK]]/@E\?/!?[0'A&UU[PAK-O>AXU>YL#(HNK)SUCFCSE2#D9Z'J"
M00:_"GX[?LZ^./V=/%<FB>,=)>V4L?LNI0 O9WB]FBDP ?=3AAW KSFUO)[&
M836TTEO*O22)RK#\10!_1%\9/CEX,^ WA*Z\0>,-:M]-@CC9H+4R W-VX'$<
M,><NQ/IP.I( )K\#?C5\5-1^-GQ4\2^.-5C6&\UF[,_DIRL,8 2.,'OM147/
M?;FN4W7^O:A%'FXU&]F98HU^:61V)PJ@<DG/ %=-\3_A-XE^#NL:=I/BNQ.E
MZK>Z?#J7V&0_O8(Y2VQ9!_"^%R5ZC(!P<@ 'N7_!,W_D\SP/_P!<=0_](9Z_
M7O\ :.^&4OQD^!?C7P;;L$O-5TV2.U+8V^>N'BSGH/,1,^U?D)_P3-_Y/,\#
M_P#7'4/_ $AGK]PZ /YGKJUFL;J:VN(G@N(7,<D4BD,C X(([$&OTB_X)P?M
M(?"YO!</PT^(EEH.G:U8S2-I>K:Q;0"*[A=]WDM*XXD5F;&X\J5 Y7%=A^WK
M_P $[;WXC:U??$?X76L!UR=3-J_A]2(S>R=YX#]WS2/O(<;B,@[B0WY;:UH>
MH^'-3GT[5K"ZTS4+=MDUI>0M%+&P[,K $'ZT ?T8+\,O!<BAE\)Z"RL,AAIL
M)!'_ 'S7D7Q\^+GP'_9QTEKGQ9IOA\ZD0#!H=CIUO+?S9(Y$6!M7'.YB%XZD
MX!_#K3/'/B31;86^G^(-4L+<=(K6]DC3\E8"LAFFO+@DEYYY7R2<LSL3^9)-
M ']#_@G1?AE\1O">F>)?#FA^'=5T34H1/;7<&G0E74]C\N0P((*GD$$$ @UZ
M" %  & .@KX(_P""6GP=^+GPU\/:U?\ BUIM"\$ZFHDL?#FI0L+EI^,W*J2#
M"I7Y2",OP<#:"?OB@ HHHH ^4O\ @I]_R9UXJ_Z_+#_TJCK\1J_;G_@I]_R9
MUXJ_Z_+#_P!*HZ_$:@#]\_V'/^32?A?_ -@A/_0VKW.O#/V'/^32?A?_ -@A
M/_0VKW.@#\K/^"R'B749?'WP]\/F1QI,&F37ZQCA6FDEV,3ZD+$N/3<?4U\3
M? KPCI'C_P",_@CPUK]R;31=6UBUL[R57"-Y3RJK ,?ND@X![$YK]9/^"DO[
M*.K?M!?#_2_$/A.V^V>+/#/FLMBG^LOK5P"\:>LBE RKWRX') K\:;ZQN](O
MY[.\MYK*]MY#'+!.ACDB=3@JRGD$'L: /Z'O"W[/OPR\$Z;%8:)X!\.V%O&N
MP;=-B9V'^T[*6<^[$FOE?_@J)_P@7@7]FV?28=+T?3?$FMW]M'I\=I:11SLL
M<@DE?Y0&"!5VD],NH[U\"^'_ /@H!^T#X9T&+2++XDWSV<2>6K7EI:W4^W&/
M]=+$TA^I;(KD?^$>^)G[1D?B[Q]J]YJ7B&V\/V+7>IZ[JDKO'$JXV0*QXW$L
M-L:] 2<  T >4U^^?[#G_)I/PO\ ^P0G_H;5^!E?OG^PY_R:3\+_ /L$)_Z&
MU 'Q9_P69_Y&;X6_]>>H?^AP5\#?"_\ Y*7X2_["]I_Z.2OOG_@LS_R,WPM_
MZ\]0_P#0X*^!OA?_ ,E+\)?]A>T_]')0!_1_1110!_/S^V%_R=-\5?\ L8KS
M_P!&M7T-_P $?O\ DY;Q+_V*-S_Z665?//[87_)TWQ5_[&*\_P#1K5]#?\$?
MO^3EO$O_ &*-S_Z665 'Z,?MB?!9_CW^SSXK\*VL?F:QY OM, .";J$[XTR>
M!OP8\GH'-?@/>6=QIUY/:74$EM=02-%+#,I5XW4X96!Y!!!!!K^F"OB?]LS_
M ()QZ5\>M2O?&?@FZM_#WCF;Y[J"XR++4F  W-M!,<F!]\ AL<C)+4 ?)'[$
M_P#P43NOV>=#B\$^,M.NM>\%I,SVEQ:.#=Z=N.6158A9(]V6VY4@LQ!/W:^S
M;S_@JM\![;2ENXKW7KNX(S]AATIA,/8EF"?DU?F'X\_8S^-?PYU"6UU3X;Z_
M<K'S]KTFS>_MRN< ^9 &49]&(/M7/^&?V;?BMXPO8K72/ASXGNY).C?V5,D8
MYQEI&4*HSQDD"@#T7]L?]LW7?VK_ !%9(;(Z#X1TIF-AI(E\QF<\&>9N TA7
M@ #"@D#.6)^<J^K_ (J?L'ZS^S_^SA>^/_B#?QV?B6ZO;6RTW0;*19!!O)9S
M/(.&?8C85"0.NX]!\H4 ?OY^Q;_R:C\+?^P%;_RK\]/^"N7PHNO#?QJT;QW&
MC/IGB2P6W>3'W+JW 0J?K&8B,]<-Z5^B7['-F]C^RO\ "N.3[S>'K27\'C#C
M]&%='\=/@GX;_:"^&^I^#O$UOYEG=+O@ND \VSG .R:,]F4GZ$$J>"10!^#'
MP%^)T7P<^+GAOQ=<Z9#K5AI]QF\TZ>-76XMW4I*F&!7=M8E2>C!3VK]R/A+K
MGP8^.7AJ'6_!ECX7UBV9%>6".QM_M%J6&=DT6W=&WL1VXR.:_&G]I#]CWXA?
MLSZU)'KVG-J7A]V_T7Q#I\;/:3+V#G'[I_5'QT."PYKQ:PU&[TNY6XLKJ:SN
M%^[+;R%''T(.: /Z+=4\"^ -#T^XO]2\/>&]/L;==\UU=65O%%&HZLS,H 'N
M:\:^%_Q\_9Y^,7Q2U;P%X7LM!OM7L8_,AG.EP+;ZA@$R"V<K^\* 9/ R,E=R
M@D?B+K/BW7/$4<<>K:SJ&J1QG<B7EU),%/J Q.#7=_L\_"3XD_%3XAZ7'\-;
M&^_MBRN8YAK%ONCATY@V1+),!A ,9]3C !/% '] .B^%M%\-F8Z3I%AI9FQY
MALK9(=^,XW;0,XR>OJ:U*R_"UKJUCX:TJWUZ^AU36X;6-+V]MH/(CGF"@/(L
M>3M!;)QGC-:E !65XL\.V_B[PMK.A7;%;75+*:RE91DA)$*,1^#&M6B@#^;C
MQ_X)U+X;^.->\*ZQ'Y6IZ/>RV-PN."T;%=P]5.,@]P0:^PO^"9O[6^C_  /\
M2ZKX(\97T.E^%-?E6YM]2G^6.SO0 G[QOX8W0*"QX4HN< L1]8?M[_L%G]H9
M5\:>"%M;+Q[:Q>7<V\S"*/5HE'R*6Z+,N-JLV 1@,0 "/R'\7>#==\ Z]=:)
MXCTB\T35K9BDMI?0M%(I!QG!ZCC@C@]J /Z1K&_MM4LX;NSN(KNUF4/%/ X=
M'4]"K#@CZ5\'?\%*/VQ?#OAKX:ZI\,/"FK6FK^*-<4VFJ&TD$JZ?:_\ +1'8
M9 E?&W9U"EB<?+G\G;?6+^TMVMX+VYA@;.8HY653GKP#BJ]O;RW=Q'!!$\TT
MC!$CC4LS,3@  =2: (Z_=W]@+X2W?P?_ &7O"FG:BICU35%;6;J)EP8FGPR(
M1ZB,1@Y[@U\:_L+_ /!./6=7U[2?B!\5M+_L[0K8K=6'AN\0_:+R0<H]Q&?N
M1@\[&^9L#("_>_5+IP* /S7_ ."SO_(,^$O_ %VU3_T&TK\S-+_Y"=I_UV3_
M -"%?IG_ ,%G?^09\)?^NVJ?^@VE?F9I?_(3M/\ KLG_ *$* /Z7**** "BB
MB@#\BO\ @KI\,;KP_P#&W0O&J*6T[Q%IJV[/C[MQ;G:P)]XWB(^C>E?'GPE^
M)6I?![XE>'/&FD)'+?Z+>)=)#+]R51P\;>@92RDCD;N.:_>;]I'X Z%^TE\+
M-2\(:TJPS.//T_4 NY[*Z4'9*OJ.2&'=68<=1^&_QV_9U\<?LZ>*Y-$\8Z2]
MLI8_9=2@!>SO%[-%)@ ^ZG##N!0!^ZWP2^/G@O\ : \(VNO>$-9M[T/&KW-@
M9%%U9.>L<T><J0<C/0]02"#4WQD^.7@SX#>$KKQ!XPUJWTV".-F@M3(#<W;@
M<1PQYR[$^G ZD@ FOYW;6\GL9A-;326\J])(G*L/Q%2[K_7M0BCS<:C>S,L4
M:_-+([$X50.23G@"@#J_C5\5-1^-GQ4\2^.-5C6&\UF[,_DIRL,8 2.,'OM1
M47/?;FO;?^"9O_)YG@?_ *XZA_Z0SUX;\3_A-XE^#NL:=I/BNQ.EZK>Z?#J7
MV&0_O8(Y2VQ9!_"^%R5ZC(!P<@>Y?\$S?^3S/ __ %QU#_TAGH _7O\ :.^&
M4OQD^!?C7P;;L$O-5TV2.U+8V^>N'BSGH/,1,^U?SS75K-8W4UM<1/!<0N8Y
M(I%(9&!P01V(-?TPU^=?[?'_  3OO_B#KE]\2/A=9PR:S<*9M8\/H1&UW)WG
M@_A\PC[R$C<1D98D, <M_P $O_VPM \*>'Y?A-XUU2UT6)+AKC0=0O'$4+&1
MBTEL[G 5MYW(3]XNRYR%!_3G[1%Y'G>8GD[=_F;AMVXSG/IBOYJ-5TF^T+4)
M[#4K*XTZ^MVV36MU$T4L;>C*P!!^M+_;%_\ 8_LGVVY^RXV^1YK;,>FW.* /
MT7_X*@?MA:!XQT.#X4>"=4M=:M_M"W6NZC9N)(0T9S';(XX8AOF<CH549SN
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MG7BK_K\L/_2J.OQ&K]N?^"GW_)G7BK_K\L/_ $JCK\1J /WS_8<_Y-)^%_\
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M;'M7QI^P+_P3RO\ X<:U9?$CXGVD*:Y"HET?0&(D-DYZ3S]O- ^Z@SL)R?F
M"_H=0 4444 >/_MA?\FL_%7_ +%V\_\ 135_/S7] W[87_)K/Q5_[%V\_P#1
M35_/S0!^TW_!*O\ Y-)T_P#["][_ .AK7V!7Q_\ \$J_^32=/_["][_Z&M?8
M% 'X_P#_  6!_P"3EO#7_8HVW_I9>UX'^Q;_ ,G7?"W_ +#MO_.O?/\ @L#_
M ,G+>&O^Q1MO_2R]KP/]BW_DZ[X6_P#8=M_YT ?OY7"_'C_DA_Q#_P"Q=U'_
M -)I*[JN%^/'_)#_ (A_]B[J/_I-)0!_.G7[$_\ !(G_ )-AUC_L:+K_ -)K
M6OQVK]B?^"1/_)L.L?\ 8T77_I-:T >$_P#!9#Q+J,OC[X>^'S(XTF#3)K]8
MQPK322[&)]2%B7'IN/J:^)O@5X1TCQ_\9_!'AK7[DVFBZMK%K9WDJN$;RGE5
M6 8_=)!P#V)S7ZR?\%)?V4=6_:"^'^E^(?"=M]L\6>&?-9;%/]9?6K@%XT]9
M%*!E7OEP.2!7XTWUC=Z1?SV=Y;S65[;R&.6"=#')$ZG!5E/((/8T ?T/>%OV
M??AEX)TV*PT3P#X=L+>-=@VZ;$SL/]IV4LY]V)-?*_\ P5$_X0+P+^S;/I,.
MEZ/IOB36[^VCT^.TM(HYV6.022O\H#! J[2>F74=Z^!?#_\ P4 _:!\,Z#%I
M%E\2;Y[.)/+5KRTM;J?;C'^NEB:0_4MD5R/_  CWQ,_:,C\7>/M7O-2\0VWA
M^Q:[U/7=4E=XXE7&R!6/&XEAMC7H"3@ &@#RFOWS_8<_Y-)^%_\ V"$_]#:O
MP,K]\OV'>/V2?A@3_P! A/\ T-J /5_'7CC1?AOX0U;Q/XBOH]-T72X&N+FX
MDZ*H[ =V)P HY)( Y-?@Q^U1^TCK?[3OQ4O?$^H[[32H<V^D:66RMG; _*#V
M+M]YV[D\<  >Z?\ !1W]L?\ X7AXO/@3PG>[O NA7!\ZXA;Y-4NUR#)D=8DY
M"=B<MSE<?/?[-OP!UW]I+XJ:9X0T96A@<^?J.H;=R65JI'F2GU/("CNS*..H
M ,W1?@3XU\0_"/7/B78:++/X1T>[CL[J\'4,PY95[HA*!F[&1??&+\-?B-KO
MPE\=:/XM\-7C6.LZ7.)X)!RK=F1Q_$C*2K#N"17]"/@_X3>%? _PSL_ &F:1
M /"MO9&P-A,H=9HF!$GF<?.7W,6)ZEB>]?B;^VO^RS>_LO\ Q6FL+9)IO!^K
M%[K0[V3+?NP1N@=N\D9(!]04;^+  /V-_9K_ &@M"_:4^%FG>+M&*P7#?N-1
MTXON>RNE WQ'U'(96[JRG@Y ]4K\%/V-_P!J/4OV7?BI!JV9;KPKJ6VVUO3H
MSGS(<\2H.GF1DEE]067(#$U^[7AWQ%IOB[0=/UO1KV'4=*U"!+FUNX&RDL;@
M,K ^A!H _GD^/'_)</B'_P!C%J/_ *4R5]I_\$;O^2E_$/\ [!%O_P"CC7Q9
M\>/^2X?$/_L8M1_]*9*^T_\ @C=_R4OXA_\ 8(M__1QH _47Q1_R+.K_ /7G
M-_Z :_FMK^E+Q1_R+.K_ /7G-_Z :_FMH _5G_@C=_R33XA_]A>W_P#1)K]#
M:_/+_@C=_P DT^(?_87M_P#T2:_0V@#\S/\ @M#_ ,T=_P"XQ_[8U^=/@/\
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MJ@G_  K]W_V,O GQ%^&_P%T+0_B9JL>HZW /]'@'SRV-M@>7;22Y(D9.>1P
M0H+!0: /<J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#R;4/V3?@SJM]<WMY\,?"]S=W,C3332Z;$S2.
MQ)9B<<DDDUT/@'X'_#_X5WUS>^#_  =HWAJ[NH_)GFTVS2%I$!SM8J.1D UW
M%% !1110!QWQ ^#O@;XK&R/C'PGI'B9K+<+9M3LTF,.[&X*6' .U<_05R'_#
M'OP0_P"B5>%/_!7%_A7L%% &+X0\&Z'X T"WT/PWI5KHNCVY8PV-E&(X8]S%
MFVJ.!DDGCN34OB3PGHGC+36T[Q!HVGZYI['+6NI6J7$1/NC@C]*U:* /GSQ%
M^P#^S]XHNC<7GPTTZ&0G.W3KBYL4_P"^()47]*P]-_X)I_L[Z>^]O LEXP8,
MOVG6+T@8[8$P!'U!KZ?HH X3X<_ GX>?".%4\'>#='T"15V_:;6T47##I\TQ
M!=OQ8UW=%% !7DVH?LF_!G5;ZYO;SX8^%[F[N9&FFFETV)FD=B2S$XY)))KU
MFB@#AO /P,^'OPLU*XU#PAX-T7PW?7$7D37&FV:0O)'N#;25'(R <>U=S110
M 4444 %(RAE*L 5(P0>AI:* /&?''[&_P3^(LDDNM_#;0GN)26DN+& V,KD]
M2SP%&)]R<UP?_#L[]G;[9Y__  @TWE8_X]O[:OO+Z8Z^=N]_O5]144 >1?#W
M]D?X.?"R\6\\-?#W1K.^0@QW=Q$;N>,CH4DF+LI]U(S7KM%% !1110!S_C;X
M>^&/B3H[:5XK\/Z;XBTYCG[-J5JDZ*?[R[@=K>XP17@&K_\ !-7]GK5KLW \
M#R63,<LEGJMVB'_@/FD#\,5]/T4 >/\ PV_9!^#?PCOH[[PO\/\ 2;*_B;=%
M>72O>3Q-G.4DG9V4^ZD5[!110 4444 >=^-/V=_AC\1M>EUOQ1X#T'7M7D18
MWO;^Q265E484%B,X XJKX;_9A^$O@_7+/6=$^'7AS2M6LY/-MKRUT^..6)_[
MRL!D'FO3J* "BBB@ KQ_]L+_ )-9^*O_ &+MY_Z*:O8*\?\ VPO^36?BK_V+
MMY_Z*:@#^?FOV?\ ^"7>GVNJ_L>VUG>VT-Y9SZI?1S6]Q&'CD4L 593P01V-
M?C!7[3?\$J_^32=/_P"PO>_^AK0!Z!XC_8'_ &?_ !3>/<WOPSTN&1F#%=-F
MGL4R/1()$4#GH!BNL^'?[+/PE^%.IQZEX5\ Z-I>I1_ZN^\CSIX^2<I)(693
MSU!';TKU2B@ HHHH X#QQ\ /AM\3-:75_%G@?0_$.J+$L O-1LDFD$:DD+N(
MS@%CQ[FJ'AO]F'X2^#]<L]9T3X=>'-*U:SD\VVO+73XXY8G_ +RL!D'FO3J*
M "BBB@ K(\4^#]"\<:/+I7B+1K#7=,E^_9ZE;)/$WOM<$9]ZUZ* /GO5O^"?
M_P"S[K5PDUQ\--/C=6#@6EU<VRY&>JQRJ".>A&*[+P!^RY\)?A?J$=_X8^'^
MAZ9J$0 CO?LHEGCQW623<RGW!YKU*B@ HHHH \<_:R_:!M/V;/@KK/BU_*FU
M<C['I%I-R)[QP?+!&02J@,[8(^5#@Y(KYV^!?_!6'X>>,-.MK/XCVT_@C70H
M66[AA>YT^5O52@:2//\ =92!_?/6NI_X*"?L=>+_ -J#3]#U'PKXDBBNM"AD
M6+P[?#R[>X9R"TBRC[LA"JN&!7Y1RG)/Y2_$;]F[XH?"6ZF@\5^!M:TM(OO7
M7V5I;4]?NSQ[HVZ=FH _<?3OVL/@MJEJMQ#\6/!J1MT6XURV@?\ %'<,/Q%>
M3_'O_@HY\)OA5X9U'_A'/$5GXW\4^4ZV5AH[?:+?S<85I9U_=A <9VL6(Z"O
MQ'JUINEWNLWD=GI]I/?7<APD%M$TDC'V4 DT 6/$GB+4/%WB+5-<U:Y:\U74
M[J6\N[A^LLTCEW8X]6)-?I9_P1Y^$MW9V/C7XD7D!BMKP1Z+ITC#!D56\RX(
M_P!G<(0#ZJP[5X-^S7_P31^(WQ>U2SU#QG8W7@+P?Q)+-?($O[A?[D4#?,A/
M]^0 #.0&QBOV$\#^"=$^&_A'2O#/ARPBTS1=,@6WMK6(<*H[D]2Q.26/)))/
M)H W:\HU+]D_X-ZSJ5WJ%]\,O#%W?7<KSSW$VFQL\LC,69F..2222?>O5Z*
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M//@-\.OBCK$.J^+O!6B>(]2A@6UCNM2LDFD6(,S! 6'W0SN<>K&LOP]^R_\
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MW;_9+O5-+M;Z:W QY;RQ*[+C)Z%B/PH Z*BBB@ HHHH **** "BBB@ HHHH
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M53@^=P<$T ?KU1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#I/@_P +6?V/1M-CV1JQW22,3EY)&Q\SLQ+$^IX &!7XP?\ #R;]H[_HHO\
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M_P#!2/3?CMK5GX*\=6-MX<\97/R65W:DBRU!P/N ,28I#CA22&/ ()"G[?H
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MK^/'O? L-O=RWMK%H]FDDS+;R&%$,4*ON,OE@?,!D\D#- 'Z_P!%?CI\9O\
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M2-7L=?TNTU/3+R#4-.O(EGM[NUD$D4T;#*NC#AE((((H MT5YO\ M(^+M6\
M_ /X@>(]!N_L&M:7HMS=V=SY:2>5*D9*MM<%3@CH017X]_\ #R;]H[_HHO\
MY0]-_P#D>@#]S**_,6/_ (*M7O@[]G_PE;E(_''Q8O+>X?5+V[B6VL[)OM$H
MBWI$J"1O+"'8FT8();.17S%XJ_X*(?'[Q5?/.WCZXTJ(G*6VE6L%O&G7@$)N
M(Y/WF/;T% '[KT5^('@'_@I;\>/!-]#)=^*(?%-BC O8ZU91.''<>8BK(/\
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M]J^N_@C_ ,%2_BM\2OC'X(\)ZGX?\&P:=KFLVFG7,MI97:S)'+*J,4+7+ ,
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M(^'M%&O^-I;^[N'-YN2SLD=AL9\8:5CC.U2!CJP/% '[!T5^%/BK_@HA\?\
MQ5>O.WCZXTJ(ME+;2K6"WC3KP"$W$<_Q,?T%:_@'_@I;\>/!-]#)=^*(?%-B
MC O8ZU91.''<>8BK(/\ OJ@#]OZ*^?\ ]DG]L3PM^U9X;N'L(6T7Q3IR*VI:
M'-('9 >!+$V!YD9/&< J<!@,J3H_MF:M\0O#'P \0^(_AGK;Z+XCT,+J3E+2
M"Y^T6J9\^/;+&X&$)DR!G,8&<$T >WT5^&?_  \F_:._Z*+_ .4/3?\ Y'K]
M5/V)OCY-^T3^S_H?B/4KA+CQ':L^FZPR(J9NH\?/M4 +O1HY,   N0!@4 >\
M445X_P#M:?&P?L__  #\4^+X94CU:*#[+I:NH;=>2G9$=IX8*27(/54:@#V"
MBOPS_P"'DW[1W_11?_*'IO\ \CU^M?[,>L>,A^SSX>\1_%77UO?$-Y9-JU]=
MW4$%HEI X,B(PC1%4)%M+$C();)P. #V&BOS2_:*_P""MDFFZQ=:)\(M'M+V
MWMY&C?Q%K*,Z38XS! "I"YZ,YY'\ ZU\GZY_P4&_: UZXEDE^(U[:*[;A'8V
MMO;JOH!LC!Q^//?- '[NT5^$F@_\%"OV@O#TP>'XBW=VO>._L[:Y4YQQ\\9(
MZ=B/U-?8'[(?_!2[QQ\7OB?X?\ >*/!MCJUWJTODIJFB,UN\*JI=Y98G+*RJ
MJLQVE>!P">* /T-US1+#Q+HM_I&J6D5_IE_!):W5K,NY)HG4JZ,.X()'XU^<
MOCC_ ((WVE[XEFN/"?Q%;2]#FD++9:GIIN)K93_")%D42<],JIQU)/)_1G7K
MJ6RT/4;B%MDT-M)(C8!PP4D'!]Z_$+_AY-^T=_T47_RAZ;_\CT ?JS^RI^R/
MX5_93\*W=CHT\VL:WJ)5M2UJZC"23[0=J(@SY<8RQ"Y)RQR3QCW.OC7_ ()I
M_M ^/OV@/ _C/4/'VO?V]>:?J,,%M)]CM[;RT:+<1B&- >>Y!-?95 !17S'^
MU5^WMX$_9G\[1P/^$J\;A5(T&SF""WR 0UQ+@B+(.0N"QR/E .ZOSN^('_!4
M;XZ^,-0DDTC6-/\ !M@<JMGI.GQ2<=BTDZR/N]U*CVH _:VBOP<TW]O_ /:!
MTFY:>#XEZB[L<D7-M;3IWZ+)$P'7H!Z>@KZ<^ 7_  5RUBWU*QTGXLZ+:WNG
M2,(Y/$&CQF*>$?\ /22 9609Z^7L('16/! /U'KY%_:X_P""=OAK]ICQ,/%N
MFZX_A#Q:\:17=RMJ+BWO51=J&1-RD. %7>&^ZH!4X!'U-X9\3Z3XT\/V&N:%
MJ-OJVD7T0FMKRUD#QRH>X(_+V((/-?G+_P %$/VPOB[\"_CY;^'/ _BW^Q-%
M;1;>[-M_9MG<9E:24,VZ6%VY"KQG'% 'H'[-_P#P2O\ #_PD\;Z=XL\8^)O^
M$QOM-D6XLM-ALOL]I',O*O(6=FEVG! PHR!G/2ONZOR)_95_;P^.?Q(_:(\!
M^&/$?CC^T=#U/45@N[7^R;&+S$*L<;D@5AT'((-?KM0 45\&?M0?\%2M-^$?
MBO6/!W@GPO)KOB#2YY+2[OM9WVUI!,C;658@!)* 0><H#U4L#FOBOQ7_ ,%)
MOV@/%$SLGC./1(&SBWTG3K>)5SQPS(S_ /CU '[CT5^"EC^WC\?=/N%GB^)N
MKNZ]!.L,R_\ ?+H0?RKZ+^!O_!7#Q?HFJ6UE\4-(M?$>CNX675-+A%M>PCNW
ME@B.0#^Z AY//:@#]8**P_!'C;1/B-X3TOQ+X<U"+5-$U*$3VMU">'4]B#R&
M!!!4\@@@@$5=UZZELM#U&XA;9-#;22(V <,%)!P?>@"_17X9_P##R;]H[_HH
MO_E#TW_Y'KZ)^%O_  50U+P;\ ;B[\:7+>/OB=<ZO<1V=IY$5E#;V8BAV23&
M&-5QO,F% +-@Y*C!H _4.BOPV\;?\%(OCYXSO))8_&"^';5ONV>B644*)SGA
MV5I#T'5S^IJ#PA_P48^/WA&\27_A.'UJ!3EK76+.&=']BVT./^ L* /W0HKY
M2_8U_;VT#]J#=X>U2SC\->/((3,VGK(6M[V-?O/;L><CJ8SR!R"P!(^K: "B
MO"OVIOVO_!O[*_A^";6M^K^(KY2UAH%G(%FF49'F.QSY<8(QN(.3D -@X_,[
MXB?\%3/C?XRN)1HU_IO@RQ9\I#I5DDL@7/ :28.2?4J%SZ#I0!^TU%?@E_PW
M=\?/M7VC_A9VL>9NW[<1;,_[FS;CVQBO1O ?_!4[XY^$[B/^U]1TGQA:J IA
MU73DB;:/1X/+.?=MWOF@#]IZ*\E_9<^.ES^T9\'M,\<7'AN;PQ]LEEB2VEG$
MRRB-MC2QL "4+AU&0#E#U&"?6J "BBLSQ-XBLO"'AO5==U-Y(].TRUEO+EX8
MGE=8HT+N0B LQP#P 2: -.BORW^,_P#P5_UB[NKFQ^&'A6VT^S5BJ:OK^9IY
M%_O+ A"Q_P# F?CL*^:M>_X*$?M ^()FDF^(MY:*3D1V%I;VZK[#9&#CGN30
M!^[M%?A'X=_X*$?M >&[M9HOB)>7R@Y:'4;:"X1O8[XR1^!%?9W[+O\ P56L
M_&^N6/ACXK:;9Z!>W3K!;^(=/)6S:0G $\;$F+)Q\X8KD\A ,T ?H=12=>17
MS]^W=\4_%'P9_9K\0>*O!VI_V/KUK<V<<-W]GBGVJ]PB.-DJLIRI(Y'>@#Z"
MHK\,_P#AY-^T=_T47_RAZ;_\CU],?%'_ (*PW7ASP'X8T;P3:6WB+QBVC6;Z
MSXBU*/;;1WC0(9UC@0+O8.6R<J@(P%84 ?II17X/:[_P4 ^/_B"]>XF^(^H6
MN6)$5C!!;QKG' "1C@8'7)_,UV_PQ_X*B?&SP-J4#:[J=GXWTI6_>6>J6L<4
MA7OMFB56!]VW#V- '[545Y1^SA^TEX3_ &G/ :^(_#$LD,T#B#4-+N2/M%E-
MC.U@.JD<JXX8 ]"& ]7H **\W^._[0/@S]G/P8_B/QCJ/V:%B4M+* ![J]D
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M^(7BK7M)GBOC+8:GK5S<P2%;.9EW1NY4X8 C(X(!K]BJ_G6^!GQFUO\ 9_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KS+]I3X+_P##0WP5\1_#_P#MC^P/[8^S?\3'[+]I\KRK
MF*?_ %>]-V?*V_>&-V><8/IM% 'X<?MG?L4?\,B6OA*;_A,O^$L_MY[I-O\
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MO2OE!/\ @K1\;8T5$L_":HHP%73)0 /3_74O_#VKXW_\^GA3_P %LO\ \>H
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M_P"32?A?_P!@A/\ T-J /GC_ (+$_P#)#_!7_8Q#_P!)IJ_).OUL_P""Q/\
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M\9/BEX8\%:9N%UK5[';>8J[O*CSF24CT1 [GV4U_1#X9\.:?X/\ #>E:%I4
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M6/B!XITOPYX?L9-3UK4[A;:TM8L R2,< 9)  [DD@  DD 5T/QX_Y+A\0_\
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M=VD_9_\ AD[$LS>&-,))ZD_9(J /S[_X+,_\C-\+?^O/4/\ T."OS?K](/\
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M#_&O_8Q'_P!)H:^^J^!?^".W_)#_ !J/^IB/_I-#7WU0!\"_\%B?^2'^"O\
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M=0U2PTR+S[_0M1VRSK"HR\L,BA=P4?,4*YP&(8XVUPG_  ]J^-__ #Z>%/\
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M,,<:1H3Z*QF('^V?6ON.@#^>'X_? 3Q1^SC\1+GPCXJBA^U+&+BVN[9BT-W
MQ8+*A(!P2K#! (*D5I_LH?%>\^#'[07@KQ+;3M!;+J$5I?J.DEI*PCF4CO\
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MK<?7=GO0![?_ ,$D_P!HJ^_MC4_A!K-[YVGM;R:EH0E.3%(K SP*?1@3(%Z
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M2DK_ -MZ_+KPEXHU'P3XHTCQ#I$YMM4TJ[BO;68?P21N&4_F!0!_2A7Y0_\
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MTQ:JQD[<892O;^[W/MCP_P"*/_!'2/[3#-\.O'+K;EU66S\31AG5<C<ZS0J
MQ SA3&.GWJ^9O!__  4B^/WA#RT/C-=<MD_Y8:Q8P3Y^L@42'_ONOHSX3_\
M!8B_6^M[7XD>"K:2T8[9-2\-NR/'[^1*S!O?$@]AVH _2+P-X-TSX=^#=$\,
M:- +?2M(M(K*VC'78BA03ZDXR3W))K<KGOA_\0/#_P 4O".F^)_"VJ0ZQH>H
M1^9;W4!.#S@J0>58$$%2 0001FNAH *;)&LL;(ZAT8896&00>H(IU,EE2"-Y
M)'6.- 69V. H'4D]A0!^4GB;_@E#XN\2?'[Q39Z->V7AKX;?:/M5AJMS^^?R
MI/F\B*%2&9HR2F6*@A0<DG%>Y>'_ /@D!\)[&S"ZOXF\6:K>%2K20SV]O%G^
M\J>2Q!^K$5G_ ![_ ."M'A7P/K%UHOPZT'_A-+BW8QR:Q<SF"QW X/E@ M,.
M/O?(#U!8<U\X:A_P5R^-%U=226^E^$;.$GY(4T^=]H[9+3DD_P"<"@#K/VK/
M^"6J_"OP%J?C+X=:]J.NV6DPM<WVD:LB-<^2O+RQR1JJMM7+%2@.%)!)XK\^
M*^R-8_X*K?&;7=)O=-O+'PI):7D#V\R?V;+\R.I5A_KO0FOC>@#]P?\ @FW\
M7[OXM_LPZ.-3N/M.J>'+A]"FE8Y=TB5&A8^I\J1%SW*$]<U7_P""GW_)G7BK
M_K\L/_2J.O(_^"-\[M\+?B!"3^[3687 ]S  ?_01^5>N?\%/O^3.O%7_ %^6
M'_I5'0!^(U>[?LL_L?\ C+]JK7+N+0W@TG0-/95U#6[T$QPE@2$1!S(Y )VC
M '&XKD9\)K]T/^"<OA"V\(_L@^!S#!'%<ZHMQJ5U)&H!F>2=]K-ZD1K$OT04
M ?,FL?\ !&54T1O[+^*9EU=%)47FB^7;RMCA25F9HQG^+Y_H:_/+XG?#77_A
M!X[U?PAXGL_L.MZ7+Y4\2L&4Y4,KJPZJRLK ^A%?T?5^0O\ P5_T>WL_VAO#
M-_$@26\\-Q";:,;F2YG 8^IVD#Z** /._P#@FO\ %>\^&W[4GA[3UG9-)\3A
MM'O8>H=F4M V/[PE5!GT9AWK]O2P4$DX ZFOYZ?V6Y&B_:8^$I4X/_"6Z2OX
M&\B!_0U^[WQWUB7P[\#_ (AZK &,]CX=U&ZCV]=R6TC#'XB@#\2/VSOVA-0_
M:(^.6N:NUX9_#NG3R6&AP*?W:6J.0) /[TF-['KR!T4 <A\!?@'XL_:-\?0>
M$_"-M%)=F,W%S=7+E(+2 $!I9& )QEE& "22 !7G%?K5_P $>/"MG:?!7QEX
MC6.(ZA?:^;%Y0!O\J&WB=5)ZXW3N<>^>] &?H?\ P1P\&1:+LUCX@:[=:L4'
M[^QMH88%?O\ NV#L1_P(5\A?M>?L)>*?V6!!K*W\?B;P7=3+;Q:M%%Y4L,I!
M(CFBR=N=K88$J<=B0*_<FO+/VIO"=GXW_9Q^).DWT<3QR:#>31M, 5CFCB:2
M)^>FUT5L^U '\]E?L3_P2)_Y-AUC_L:+K_TFM:_':OV)_P""1/\ R;#K'_8T
M77_I-:T ?;M%%% !7Y<_\%F?^1F^%O\ UYZA_P"AP5^HU?ES_P %F?\ D9OA
M;_UYZA_Z'!0!^;]?:O[)O_!-/7_CYX5MO&/BG66\(^%KU-^GK#")KR\7<1OV
MD@1QG!PQR6ZA<$$_(/A'15\2>+-%TAY!"FH7L%H9&. @>15S^&:_I&TW3;71
M].M;"QMX[2RM8E@@MX5"I%&H"JJ@=    /:@#\ZOB#_P1ST-M$N)/ _CO48M
M72/,-OKT,<D$S@=&>)5* G/.UL>AK\V/B#X!UWX6^--6\*^);%M.US2YC!<V
M[$-AL @@CAE((8,.""#7](M?D]_P6*\*V>G?%3P)X@@CACN]4TJ:VN"@ =_(
ME!5F]>)MH)[+CM0!RO\ P2X_:*OOAU\98/AYJ%[_ ,4KXL=HXX93\MO?A,Q.
MOH9 OED#J3'_ ':_8F2-98V1U#HPPRL,@@]017\XGPIU:30/BAX/U.'=YMEK
M-G<IMZ[DG1AC\17]'4LJ01O)(ZQQH"S.QP% ZDGL* /RD\3?\$H?%WB3X_>*
M;/1KVR\-?#;[1]JL-5N?WS^5)\WD10J0S-&24RQ4$*#DDXKW+P__ ,$@/A/8
MV875_$WBS5;PJ5:2&>WMXL_WE3R6(/U8BL_X]_\ !6CPKX'UBZT7X=:#_P )
MI<6[&.36+F<P6.X'!\L %IAQ][Y >H+#FOG#4/\ @KE\:+JZDDM]+\(V<)/R
M0II\[[1VR6G))_S@4 =9^U9_P2U7X5^ M3\9?#K7M1UVRTF%KF^TC5D1KGR5
MY>6.2-55MJY8J4!PI()/%?GQ7V1K'_!5;XS:[I-[IMY8^%)+2\@>WF3^S9?F
M1U*L/]=Z$U\;T ?N#_P3;^+]W\6_V8='&IW'VG5/#EP^A32L<NZ1*C0L?4^5
M(BY[E">N:^=OVEO^"8'VFZ^*GQ5_X67M\Q]5\3_V3_8.<9,MSY'F_:?^ []G
MOM[5TO\ P1OG=OA;\0(2?W::S"X'N8 #_P"@C\J^QOVC/^3>_B?_ -BOJG_I
M)+0!_.Y7V+^R)_P3T_X:J^&%YXP_X3__ (1?[/JDNF_8_P"QOM>[9'$^_?\
M:(\9\W&,?P]>>/CJOV)_X)$_\FPZQ_V-%U_Z36M '1?L>_L _P##)_Q"U;Q1
M_P )W_PE/V_2VTW[+_8_V/9NEBDW[_/DS_JL8P/O9SQ7K?[87_)K/Q5_[%V\
M_P#135[!7C_[87_)K/Q5_P"Q=O/_ $4U '\_-?M-_P $J_\ DTG3_P#L+WO_
M *&M?BS7[3?\$J_^32=/_P"PO>_^AK0!H?\ !1O]I2]_9_\ @M'9>'KP6GBW
MQ/*]C9S*?WEM %S/.GHP#(@/8R CI7XGV]O<:C>100127-U/($CCC4L\CL<
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M3MOA?_V%T_\ 0&KV#_@K5_R=-:?]B[:?^C9Z\?\ V'/^3MOA?_V%T_\ 0&H
M_?.OP?\ ^"@G_)XOQ*_Z_(/_ $EAK]X*_!__ (*"?\GB_$K_ *_(/_26&@#D
M?V5_C0O[/_QX\*>-IX&NM/L9WBOH4^\UO+&T4A4=V57+@=RH%?OOX3\7:+X[
M\.V.O>'M4M=9T>]C\RWO;.021R+[$=P<@@\@@@X(K^<OP[X*USQ;9ZW=:/IL
M^HPZ+9'4=0-NNXP6X=$:4CKM#2+DCH#D\ D:G@?XP>.OAF'7PEXQUWPW'(Q=
MXM+U"6WC=B "616"L>!U'8>E ']!GQ.^*'AKX/>#=0\4>*]4@TK2;.-F+S.
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M])20&6QN,8967KL)!*,?O+[@@>K7U];Z;9SW=Y<16EI C22SSN$2- ,EF8\
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M_P!LCXH:[\5OVCO%VMZU97VD/!=&RL=/OX7@FM;6(E85:-@&1B/G(/\ $[4
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M?L[_ ,$H/^344_[#MY_*.@#[)K\D_P#@L3_R7#P5_P!BZ/\ TIFK];*_)/\
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MM(T:QGU/4[HE8+2V0O)*0I;"J.2< \#D]JT_!_Q$\7?#/4)I_"_B36?"]XQ
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M*9J_6ROR3_X+$_\ )</!7_8NC_TIFH ^4OV7_P#DY;X2_P#8W:1_Z615^_\
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MB\6ME%?^)?$5^S2,SNTTTFU2SN[L>BJI)9C@ $DX% '.5^Q/_!(G_DV'6/\
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MY .,C-?/>K:7<:'JM[IUV@CN[.9[>90P8!T8JPR.O(- 'ZG?\$;O^2:?$/\
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MGTZU_0A\$=0\;ZI\*?#=S\1K"UTWQG):*=1M[-PR!^Q.!A7(P65<A6) ) H
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M! [4 >@T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMA/^QMKV6BB@#YV^(O[ OP<^+'C/4_%7BG1M2U77-2D\RXN9-7N5S@ *JJ'
M554 !0,  "CX=?L _!+X6^,],\4Z%X5E76--D\ZUDN[^>X2.3! ?8[E2PSD$
MC@@$<@&OHFB@ KG_ !]X#T+XG>#M5\+>)M/CU30]3A,%S:R$@,N0001RK @,
M&'((!'(KH** /E+_ (=@_L^?]"K??^#BZ_\ CE>N? []F[P/^SK9ZG9^!K2^
MTZRU*19;BUN+^:XB,BC =5D8A6(X)&,@#.<#'J-% 'AOQF_8O^%/Q]\7)XF\
M::'=:CK"6J68FAU"> >4A8J-J,!U=N?>L3X?_P#!/WX*?#'QGI/BKP_X=O+7
M6M+F%Q:S2:I<2*C@$9*LY!ZGJ*^C:* "OGCXE?L#_!GXM>.-5\6^)?#UW>:Y
MJ;K)=3QZG<1*S*BH,*K@#Y5'05]#T4 >*?!3]COX7?L^>(K[7/!6B7&GZC>V
M;6$[W%]-<*T+.CE=KL1]Y%Y]JX_XG?\ !.7X&_$_5)=3F\-3>'-0F??--X>N
M3:I(>IS%AHQ]50$U]-T4 ?&&@_\ !)GX':/,KW<OBC7%#9,=_J:*I&0<'R8H
MSCC'7/)]L?4/PW^$?@SX0:/_ &7X,\-:=X<LVQYBV, 5YB.AD?[TA&3RQ)KK
MJ* "N.^+7PE\-?&[P/>>$O%MG)?Z'=O')+!%.\+%HW#K\R$$?,H[UV-% 'RE
M_P .P?V?/^A5OO\ P<77_P <KZ,^'_@/1OACX,TGPKX?MWM=%TN$6]K#)*TC
M(@)."S$D]3U-=#10!YS\;OV?O!7[1'A^PT7QQITVI:?8W7VR".&ZD@*R[&3.
M4()X8\&O&/\ AV#^SY_T*M]_X.+K_P".5]6T4 5-)TNWT/2K+3K1#':6<*6\
M*EBQ"(H51D]> *\N^.?[*_PY_:-NM(N?'6DW&IRZ4DD=H8;V6WV+(5+9V,,Y
M*+U]*]<HH ^7=)_X)J_ 30]5LM1M/"]]'=V<R7$+'5[E@'1@RG!?GD"OJ*BB
M@ KPSXT?L4_"#X\:A+JGB7PK'%KDO^LU;2Y6M+F0XQERGRR'IRZL>!7N=% '
MQ39_\$D?@E:WS3R7_BV[B)R+:;4H1&OL"L"M^;5]%?!?]F_X=?L^V$]MX&\-
M6^D2W"A;F]9FFNIP.</*Y+$9YV@A0>@%>F5YO^T9XO\ %'@3X)>+];\%Z+<Z
M]XHM;%OL%I:1B1Q(Q"^;LZN(P2Y49)V8QS0!+X3_ &@_AWXW\7:[X6T?Q;IM
MQXBT6[>QO-->41S+*IPP16QY@!R"4R 00>:\@_X*#_'#P5\.?V>_%GAW7)[/
M4M>\06+V%AH9E!G9W&%G*CYE2(_O-QP,HHSDBOQ#U!KJ34+EKXS&]:5C.;C/
MF&3)W;L\[LYSGG-5Z "OW._X)Z_ T_!']F[0UO;?R-?\0_\ $ZU#</F7S5'D
MQGN-L03*]F+U\&?L&?L':]\5O&6F>-?'6C7&E^ =.D6ZBM[^(QOJ\BD,B*C#
M)AS@LY&&'RKG)*_L5TX% "T444 %%%% &%XT\#^'_B-X=N=!\3Z/9Z[H]R/W
MMG?1"2,D=" >C#LPY'8U\J>*/^"4?P,\07LT]DGB/PXDA!%OI>IJT<?KM\^.
M4\^Y/MBOLBB@#Y0\!_\ !,7X$>!]2BOI]#U#Q3-$0T:Z]?&6(,.YCC"(^?1P
MP]J](^,W[(/PN^/=WHUQXPT&2Z;1[8V=E'9W<MK'#$3G8%C8#' QQQ7L]% '
MSE\/_P#@G[\%/ACXSTGQ5X?\.WEKK6ES"XM9I-4N)%1P",E6<@]3U%?1M%%
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M!0^ "S$X' KL_@?^R/\ #/\ 9VUK4=6\#:/<:;>ZA;BUN'FOIK@-&&#  .Q
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MB@ KBOB/\%? ?Q>LQ;^,_"6D^(E5=B2WMJK31C_8E^^G_ 2*[6B@#X_\2?\
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MO_L__#[X\Z7'8^.?#%GK@A!$%RX:.Y@SU\N9"'49P2 <' R#7H=% 'Q3>_\
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M$/PCK'AG7(&N='U:UDL[N%)&C+Q.,, RD$<'J*^;?^'8/[/G_0JWW_@XNO\
MXY7U;10!Q/P?^#GA;X$^#(_"O@^RDT_18YI+A89;AYFWN<L=SDGMZUVU%% '
MEWQS_9K\!?M&VND6WCK2Y]3BTIY)+00W<MOL:0*&SL89R$7KZ5Y'_P .P?V?
M/^A5OO\ P<77_P <KZMHH *\K^.G[,O@#]HZ'1H_'>ESZFFD-,UF(;R6WV&7
M9OSL89SY:]>F*]4HH ^58?\ @F/^S]!,DB>%;X.C!@?[8NNH_P"!U]5444 0
MWEK'?6LUM,-T4R-&XSC*D8/Z&OEC_AV#^SY_T*M]_P"#BZ_^.5]6T4 >9_ [
M]G3P-^SKI6IZ=X&TV;3;34IEN+E9KN2X+.J[0078XX]*],HHH R_$OA?1O&>
MC7&D:_I-EK>E7 Q-9:A;I/"_U1@0:^6O&'_!+;X$>*KVYN;;3-8\-M,=WEZ/
MJ)$:$CJJRK(!SSCIZ#'%?7-% 'R#X-_X)8_ GPI?17-Y8:WXH\L<0ZSJ7[LM
MG.XK L6?H>/:O9?BE^RS\-/C!X-T3PIK_AR./P]HLOG6&GZ7(UE% VTK\JQ%
M1C!/'2O6:* /E6'_ ()C_L_03)(GA6^#HP8'^V+KJ/\ @=?55%% !7 ?%+X!
M?#OXU6I@\:^$-+U]MNQ;J>';<QKSPDZ8D0<_PL*[^B@#XPUS_@DU\#M69C:R
M^*-&!.0MCJ:,!SG \Z*3Z5L^$?\ @EU\!O"]XMS=:-JOB,J<K'J^I.4!]UB$
M8/T.17UM10!D>%/"&A^!="MM%\.Z19:'I-L,165A L,2>I"J ,GN>I[UKT44
M ?/'Q*_8'^#/Q:\<:KXM\2^'KN\US4W62ZGCU.XB5F5%0857 'RJ.@K0^#_[
M$OPE^!/C./Q5X/T*ZT_6HX9+=9I=1GF78XPPVNQ';TKW>B@ K/\ $6@V?BGP
M_J>BZC&9=/U*UEL[F-6*EHI$*. 1R,@GD5H44 ?*7_#L']GS_H5;[_P<77_Q
MRO;/@G\"/!W[/7A6[\.>"-/FTW2KJ]?4)8IKF2<F9HXXRVYR2!MB08Z<>]>@
MT4 %9WB#PWI/BS29]+US2[/6-,G&);._MTGAD'^TC @_B*T:* /E/QG_ ,$R
M/@+XPOYKR+P]?>'99CEET6_>*,'(Y6-]ZKTQA0!STKG]"_X)._ W29 UT?$V
MM@-G9?:FJ@C.<?N8XSCMZU]F44 <;\-?@WX'^#NEG3_!?A?3?#ELP D-G !+
M-CH9)#EY#[L2:[*BB@ KRKXM?LM?"OXW^9)XP\%Z;J-\XYU*%#;WGMF>(JYQ
MCH21[5ZK10!\5ZE_P23^"-],DD%YXLTY58$Q6VI1%6QV/F0L<'V.:ZWP/_P3
M/^ O@JZ6YE\-77B2=#E#KE\\R#GO&FQ&_P"!*:^IZ* *FE:38Z%IMOI^FV=O
MI]A;((X+6UB6**)1T554 */8"K=%% !1110 5\U>,O\ @G=\#O'OBS6?$FL^
M&[RXU?5[N6^NYDU6Y0/+(Q=R%#X&23P.*^E:* /%?@C^Q[\+_P!GGQ+>Z]X(
MT6YTW4[RT:QFDFOYIP8BZ.1M=B!\T:\]>*]JHHH *Y_QM\/?#/Q)T=])\5:!
MIWB'3FY^SZE;),JG^\NX':WN,$5T%% 'R!XH_P""5OP(\03SRVEAKGAXRDD+
MI>IDJF<_=$RR8^GMZ4>%_P#@E=\"/#T\$MW8:YXB\H@E=4U,A7Q_>$*QY]<?
MTXKZ_HH P/!7P_\ #7PWT9-)\*Z!IWA[35Y^S:;;) A/]XA0-Q]SDFM^BB@#
MCOBU\)?#7QN\#WGA+Q;9R7^AW;QR2P13O"Q:-PZ_,A!'S*.]>!_\.P?V?/\
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M ? WPO\ ^2E^$O\ L+VG_HY*_=SXV?LB_"K]H"87?C#PK!<:NJ[%U:R=K:[
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MN#_6RE_SZ?WGZB45^7?_  L;Q9_T,^L_^#"7_P"*H_X6-XL_Z&?6?_!A+_\
M%4?ZK5?^?J^X/];*7_/I_>?J)17Y=_\ "QO%G_0SZS_X,)?_ (JC_A8WBS_H
M9]9_\&$O_P 51_JM5_Y^K[@_ULI?\^G]Y^HE%?EW_P +&\6?]#/K/_@PE_\
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M6J_\_5]P?ZV4O^?3^\_42BOR[_X6-XL_Z&?6?_!A+_\ %4?\+&\6?]#/K/\
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MT,^L_P#@PE_^*H_U6J_\_5]P?ZV4O^?3^\_42BOR[_X6-XL_Z&?6?_!A+_\
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M6J_\_5]P?ZV4O^?3^\_42BOR[_X6-XL_Z&?6?_!A+_\ %4?\+&\6?]#/K/\
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MT,^L_P#@PE_^*H_U6J_\_5]P?ZV4O^?3^\_42BOR[_X6-XL_Z&?6?_!A+_\
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MZS_X,)?_ (JC_5:K_P _5]P?ZV4O^?3^\_42BOR[_P"%C>+/^AGUG_P82_\
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MZS_X,)?_ (JC_5:K_P _5]P?ZV4O^?3^\_42BOR[_P"%C>+/^AGUG_P82_\
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MZS_X,)?_ (JC_5:K_P _5]P?ZV4O^?3^\_42BOR[_P"%C>+/^AGUG_P82_\
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MT,^L_P#@PE_^*H_U6J_\_5]P?ZV4O^?3^\_42BOR[_X6-XL_Z&?6?_!A+_\
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M_6+'_P R^Y!_JWE_\K^]GQ7_ ,,->+/^@_HWYR__ !%'_##7BS_H/Z-^<O\
M\17VI11_K%C_ .9?<@_U;R_^5_>SXK_X8:\6?]!_1OSE_P#B*/\ AAKQ9_T'
M]&_.7_XBOM2BC_6+'_S+[D'^K>7_ ,K^]GQ7_P ,->+/^@_HWYR__$4?\,->
M+/\ H/Z-^<O_ ,17VI11_K%C_P"9?<@_U;R_^5_>SXK_ .&&O%G_ $']&_.7
M_P"(H_X8:\6?]!_1OSE_^(K[4HH_UBQ_\R^Y!_JWE_\ *_O9\5_\,->+/^@_
MHWYR_P#Q%'_##7BS_H/Z-^<O_P 17VI11_K%C_YE]R#_ %;R_P#E?WL^*_\
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M\,->+/\ H/Z-^<O_ ,11_P ,->+/^@_HWYR__$5]J44?ZQ8_^9?<@_U;R_\
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M_P#*_O9\5_\ ##7BS_H/Z-^<O_Q%'_##7BS_ *#^C?G+_P#$5]J44?ZQ8_\
MF7W(/]6\O_E?WL^*_P#AAKQ9_P!!_1OSE_\ B*/^&&O%G_0?T;\Y?_B*^U**
M/]8L?_,ON0?ZMY?_ "O[V?%?_##7BS_H/Z-^<O\ \11_PPUXL_Z#^C?G+_\
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M_P!6\O\ Y7][/BO_ (8:\6?]!_1OSE_^(H_X8:\6?]!_1OSE_P#B*^U**/\
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M_P#E?WL^*_\ AAKQ9_T']&_.7_XBC_AAKQ9_T']&_.7_ .(K[4HH_P!8L?\
MS+[D'^K>7_RO[V?%?_##7BS_ *#^C?G+_P#$4?\ ##7BS_H/Z-^<O_Q%?:E%
M'^L6/_F7W(/]6\O_ )7][/BO_AAKQ9_T']&_.7_XBC_AAKQ9_P!!_1OSE_\
MB*^U**/]8L?_ #+[D'^K>7_RO[V?%?\ PPUXL_Z#^C?G+_\ $4?\,->+/^@_
MHWYR_P#Q%?:E%'^L6/\ YE]R#_5O+_Y7][/BO_AAKQ9_T']&_.7_ .(H_P"&
M&O%G_0?T;\Y?_B*^U**/]8L?_,ON0?ZMY?\ RO[V?%?_  PUXL_Z#^C?G+_\
M11_PPUXL_P"@_HWYR_\ Q%?:E%'^L6/_ )E]R#_5O+_Y7][/BO\ X8:\6?\
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M7_XBOM2BC_6+'_S+[D'^K>7_ ,K^]GQ7_P ,->+/^@_HWYR__$4?\,->+/\
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M']&_.7_XBC_AAKQ9_P!!_1OSE_\ B*^U**/]8L?_ #+[D'^K>7_RO[V?%?\
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M_P!!_1OSE_\ B*^U**/]8L?_ #+[D'^K>7_RO[V?%?\ PPUXL_Z#^C?G+_\
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M)QJ*\0HHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&NS:VF2 =L?R,TA&<$X4 ],UY/\ \%@?#>FZ?XP^'.LV]I%#J.H6E[!=3QH
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MO /PJL/ =KH6GW&AQV:VUU#-;(ZWK;</)*",.SDL23ZU^0/@WP/:?#7_ (*
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M  4:^S_M.#X0_P#"O=V?$B^'O[9_MK'WIQ%YWD_9_?.W?[9[U],>$_@;\/?
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ML1'&TDDCX]%1&8GL%)K]-/\ @E[^TU_PGG@>3X8:]=[]>\.P[],DE;YKBPR
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MS-&KO;11PQ2GRR1\I9IN2.NQ?2N*G1A3IRJU5>SM8ZIU)3FH4W:ZN=3\!_\
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MN*_;VL\72A3<?9K=%X>I*?-S]&%%%%>>=84444 %%%% !1110 4444 %%%%
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MGQ7^&?[6%_X5\,^,;K2?#\?]G[;&.W@91YD4;/RR%N2Q[]Z_3VOQI_X*%?\
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M^&5_B1IOA/\ X03_ (2?[9I,>J?;/[7^R;-\TT7E[/(DSCR<YS_%C'&3A_\
M!)?_ )-GU?\ [&>Z_P#2>UKYA_X*X,&_:2\.@$$KX3M@<=O],O#_ %J:="G+
M%2IM:#G5FJ"FGJ?H9\:OB7I-C^RWJWCG7/"EOXDTF71K?4;CP[=S@13K)Y;>
M4SE&& 7'.SG;T%?/W[(O[3O@K7/AO\:?%G@_X.:7X _X1'28M4NK/3+Y3_:N
MR&[E2-G6W39M\EP#A_\ 6DXXP?0?VBO^4=^J?]BGI_\ *"OGG_@CQ:PWUM\8
M[>XBCN+>9-)CDBE4,CJ1? J0>"".,&IA"/U><GT?^14I2]M&*ZH^-?'GQW_X
M3;]I&7XK_P!A_8M^LVVK?V1]K\S'DF,^7YVP=?+^]LXST.*_63X!_M6V_P"T
ME\!?'/C6\\&II5IHYN[2;1Y-0^U+=I':I,P+^4FT,)"N-IZ9YSBOSG^.&DV-
MK_P40N=.@LK>'3QXOTZ/[)'$JQ;2\&5V 8P<GC'>OUM^)&@Z9X?^#OCF#2].
MM--@?1KYVBLX%B5F^SN,D* ,X Y]JZ,7*#C37+OMY&.'4N:;N?)7[!G[0WP]
M^+7Q?UC2/"7P1T7X;:C#H4UW)JVG7:322Q"XMU,!"V\?REG5L[CS&..XZSX^
M?\%$(?@7\>I/AQ<>!DU&WB>T$FM2:T+946=$8L8S V @?^_SCM7RI_P2-_Y.
M0\2?]BG<_P#I99UQ'_!3#G]K[Q2!_P ^EA_Z2QU7U>G+%.#6EN[)]M.-!23U
MN?4/Q4_X*X:%X>\47.F^"?!K^)],MI&C.K7M\;5)R#C=%&(V.P]F8@G^Z*]V
M_9+_ &W/#7[5#ZEID.E3^&?$^GQ?:9-+GN!<+)!D*9(Y0J[@K,H(*@C<O7/'
MI?AWX ^!_#_PG3X>IX=T]O#[V*V5U"+=1]H^3:TCG&3(22V\\Y.<YK\IO^":
M;26'[8>A6\<A"-::A#)_MJ('.#^*@_A7/&%"M2FX1LXFSE5IU(J3NF?J)^T?
M^TQX1_9E\'Q:SXFDEN+R\+QZ=I5J 9[R10"0,\*JY7<YX&1U) /QUH?_  6&
MMI_$42:Q\-)+/0G?:\UGJPGN8E_O!6B17/7Y<K]?7Q+_ (*D>*+S7OVI)](E
MGD-IHVF6EM!"[$1H9$\YF Z<^8,G_9'I7ZH>"?@CX-\#_"^S\!6F@:?-X>BM
M%M9[6>V1UN_EP[R@C#LQR23U)-+V=&A2C*I&[EYCYJE6I)0=DCY?TG_@IUH_
MB;X]:+\/_#_@Y=7T;5]4L].M?$:ZN4W).8QYAMS;Y!4N04+@Y4@D5]NU^'O@
MGP79_#G]O[0_"^G,S:?I'Q AL[;>VYA$E\ @)[D* #[BOW"K/&4H4G'V:W1>
M'J2J*7/W"BBBO/.L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /QM
M_:X^ OBW]D/X^I\0?"<,L/AJ;4_[4T?4X8]T5G,7+FUD],'( ;AT/<[@/??#
MW_!8'1U\*J=<^']\WB1(@"FGWB"TFDQR=SC?&I/;#D>IK]"M6TFQU[3;G3M3
MLK?4=/N4,<]I=Q++%*IZJR,"&'L17BEU^PS\![S4GOG^&FDK.[;RL32QQ9]H
ME<(![!<5Z?UFE4BE7C=KJCA]C.$FZ4K)GY::/HWC[_@H1^TI/>O;^6]]*CWL
M\(/V;2;!"% R1V7A0>7<^Y(_4C]J[]GW_A;G[,VJ> _#L"Q7NGV\$NC0,^%\
MRWQLBR?[R!D!)X+ GI7KO@[P-X=^'NBQZ1X8T2PT#3$)86NG6ZPQ[CU8A0,D
M^IY-;E95L4YRBX*RCL:4Z"C%J3NWN?CA^Q;^V%+^Q_J_B3PCXV\/:E)H=Y="
M6XMX(@E[I]VB[&S%(5R& 4,I((V CN#;_;6_;/\ ^&MY/#W@CP-H&IQZ';WH
MN4CNHE:\O[LJT<86*,M@ .X #$L7Y P!7Z?_ !*_9W^&OQ?N%N?&'@O2=;O
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M-CIO5T)QP5;TK]JJXWXE?!OP1\8M.ALO&GAC3O$4$.?):\A!DASC/ER##)G
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'XT_L8?\ *132/^PMK?\
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MN(X;J)6O-0O&4QQA8HRV H=P &);S.@QBOU"^)7[._PU^+]PMSXP\%Z3K=X
M%^V2P;+C:!@+YJ8? ],XIGPS_9Q^&7P=NGN_!_@O2]%OG!4WL<1DN #U42N6
M< ^@.*T^M4>?VO)[WX$>PJ<OL^;W3D?V*O@7=_L^_ #1?#FJ*J:]=22:GJ:(
M00EQ+CY,C@E$6-"1P2I(XK\K/VV/ =W\%/VH?'5CIS26-AJ[OJ%OY1VK);W:
MEI$Q_=#F1,?[%?N37#>.O@;\/OB?JD&I>+?!NB^(K^"$6\5SJ-FDTB1ABP0$
MC.,LQQZDUA0Q3IU74GK<UJT.>"A'H?%_P2_9Y_MC_@F%XCTS[,6U;Q';W7B2
M-,?.987#6Z@_[26L?_?P^IKX ^"/@K4/C9\6O 7@:2::>TN;U+01[CB"U\QI
MK@J.V%,K_6OWZT?0]/\ #^BV>D:;906.EV<"VUO9P(%BBB50JHJC@*  ,5Q7
M@_\ 9Y^&7P_UZ'6_#7@30=#U>%66*]L;&.*5 RE6 8#(R"1]#6U/&\G/=;ZH
MSGA>;EL]CO[>WBL[>*""-8H8E")&@PJJ!@ #L *DHHKRCO/Q.^/7_*0C5O\
ML<K3_P!&Q5^T/B'P_IWBS0=0T75[.+4-+U"![:ZM9ERDL;J592/0@FN+U/\
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MI1DY*<'9H_.3XN?MX?$WX]?'#1-.^!]QKGA^UD1;"RTW$32WLS,6::6,[XU
M&!R2%5"21DX^@/\ @IY9:GIO['_A&TUO4?[7UF#7+".]U#RTC^TSBTN1))M1
M55=S9.  !GI7U=\-O@7\/_@^)CX-\(Z7X?EF4++<6L \Z11T5I#ER/8G%;/C
MCX>>&?B9H\>E>*]"L/$.FQS+<):ZC LT:R ,H< ]P&89]S5/$4U.#A&RC][)
M]C-QDI2NW]Q\K?\ !*+_ )-@N_\ L8;O_P!%05TO_!2OP7?^,OV4]<?3K9[J
M71[RVU22.-2S>4C%)& '95D+'T52>U?0W@GX?^&OAKHS:3X5T.Q\/Z8TK3FT
MT^!8HS(P +;1W(4<^PK>=%D1D=0RL,%6&01Z5C*M^^]JEUN:JG^Z]F^Q^2W_
M  3_ /VW/!_[.?@OQ!X1\9VNHQVEWJ)U2TOM/@$PWM%'&\;KN!'$*$$9SELX
MP,^,_MH_&2]_:!^*\/CO^P;[0O#MY9+9Z(+]-LEQ;0NX,O'!S(\GW20/NY)4
MFOUGO/V+?@=?Z]_;$WPST(WN_>52%D@)SGF!2(S]-M=;XL^ ?PX\=_V=_P )
M!X'T'5QIMN+2S6ZL(V6VA'2.,8PJCT'%=RQ=&-7VL8N[W.5X>I*'(Y:(\6_:
M*_Y1WZI_V*>G_P H*^?O^"-__-7O^X/_ .WM?H;JW@O0==\*OX9U'2+.]\//
M MLVF31!H#$N-J%#QM&T8'L*R_ /PB\%?"O[?_PA_A;2_#7V_P O[5_9EJL/
MG;-VS=M'.W>^/]XUR*NE1G2MJV=#I/VD9WV/R%_;.N)OAQ^WEKVMW5K((;75
MM/U>-8S@S1K%!)E2>Y*L/8@^E?H[X1_::\+?M/? 7XG:QX5M-3L[73-/O+.2
M/58HXY&8VA<, CN-OS$<G^$UZ7\4/@#\._C0UL_C7PEIVOSVZE(;B="LR*3G
M:)$(;;GMG%3^ ?@?X#^%_AN_T#PMX7T_1](U $7EM"A87(*E2)&8EG^4D<D\
M$U=3$4ZE.*:?-$F%&<)R:>C/S'_X)&_\G(>)/^Q3N?\ TLLZY'_@IY_R=MKG
M_8.L?_1(K]9? OP+^'OPQU:;5/"7@S1?#NHS0&VDNM.LTAD:(LK%"5'W2R*<
M>JBH/&7[/GPT^(6N2:UXF\#:%KNK2(L;WE_8I+*RJ,*"Q&< 5LL9'V[JVTM8
MS^KR]E[._4]!K\8/^"</_)Y^@_\ 7'4?_2>6OV?KS[PE^SY\-/ ?B"+7?#O@
M;0M%UF(.$OK*Q2.90P(;# 9Y!(/UKDHUE3A.+7Q(WJ4W.49+H?G]_P %8O@7
MJMOXRTCXI:=:S76C75HFG:G)&NX6LT;'RG?'175@H/3,>,_,HK6\"_\ !6@:
M9\,=.TK4_!%YK'CFVMDM$G@N%6UNY NU9&&-ZEC@E%!R2<$9&/6_V[OVJ/B)
M^S;XFT6'3O"V@^(? 6N6!AF;6+.60&Z#2"2$LL@7!C,9VLISAL=#CS/X._MJ
M?LQ>'=#M?%.H?#;3_"7CV'>TMMHF@1R%7RV#;S8 4$8ZE""V.@S7?!.="//#
MFMM8Y)6C5ERRM?>Y\B_!^;Q#=?ML>#KGQ9#+;^)[CQM:7&IQ3+L=+A[M7D#+
M_"=S'CMTK]UZ_&7]F.UU+]I+]O:V\86>F26UB=>G\3W:CYULX5=I8U=L8R6\
MM,]RU?LU668/WHKK8TPGPR?F%%%%>4=X4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?C3
M^QA_RD4TC_L+:W_Z27E=;_P4H_9SN?@_\4+3XI>%4DLM%UZ[$TSVN4-AJ:_/
MN!'W?,P9 ?[RR=/EJ;]DKX*_$+PW^WEI?B#5_ ?B;2]!34]8D;5+W1[B&U57
MM;I48RL@4!BR@'/)88ZU^F?Q=^%VC?&CX<ZYX-UZ/?IVJ0&(R* 7AD!W1RI_
MM(P5A]/2O<K8CV5>,EM97_$\NG2]I2E%[W/P\^+/QDNOCU\9M*\8:A +?5+F
M+3K>]"@!7GB2.)W4#H&*;L=MV.U?IA_P52N+R']EDI;,RPRZY9I=!20#'MD8
M ^HWK'U]!7YRWW[)/Q>\%_$AM*D^'?B?4HM.U)8CJ6G:-<SVDZ+(,2QRJA4H
M1SG/?G!S7[2_&SX3Z5\<?A=X@\$ZP[0V>JP;!<1J"\$JL'CD4'J5=5..^".]
M/%5(0G2<=E_P!4(SE&HGNSY)_P""0]GIJ?!'QA=1+'_:\GB%HKEL#?Y*VT)B
M![XW/-CW+59_X*Y6>FR? /PO=3K'_:D7B...U? W[&MIS*H[[3MC)]U2OEC0
MO O[2G[!7C?5)_#V@W6I:9=82>YL;)]0TN_1,E&<(-T9&6QNV,,MV)R[6_!_
M[27[??C;27\0:%=:;I%F2D5S=V+V&EV",1YCKO\ FD8X7(!=^!T'1^R7M_K'
M.N7</:?NO9<KN?3W_!-CPN?B)^Q=XO\ "^M[FTK4]5U'3HMPSM@EM8 Q7/H[
MR'ZU\B_LI_&>]_96\4?&70-6D-E?OH5]9Q19QC5;5F6$?@6F%?K=\%/A+I/P
M-^&&@^"M%+26>EP;&N'4![B5B6DE;'=G9CCMD#H*_,3_ (*!?LL^-F_:2UG7
M?!O@G7_$6C^(((M2:;1=*GNHX;@@I*C-&A 8M'YF#_STK.A4A6J5(2VEJ75A
M*G"$ENCQ'PS\ Y]>_9,\9_%41N9-(\06=C&W./(V,L_'?,ES:\]MA]ZZC]H#
M]H8_$K]FOX&>!XK@RW>B64YU*%3NP\4C6UH#[B%&/_;05^B7P5_9QFM?V"8_
MAMJ5A)8ZUKFA7,US!<H8Y8KRXW2QB16^Z\9,2D'D>7@]*_/K]E7]D?X@^(/V
M@O!4/BKX?^)=#\.VM^M]?7FK:/<6UOY<(,OEL[H!\[(J8SSNKJA7A4<I2?PN
MZ^XYY4I048Q^TC]7OV9_A@/@W\!_!7A)HQ%=V.GHUXH&/])DS+/_ .1'?\ *
M].HHKYV4G)N3ZGLI<JLC\-?VC-$M_$W[<7BS1[LN+34/%RVDQC.&V23*K8/8
MX)KZ<_:;_P""6^D^$_A_?^)?A=J&L7^HZ;&;BXT34G2=KF)>6,+(BD.HRVT[
MMV,#!P#Y5\7?@9\2-2_;AU;7K/X?>*KK0W\80W2ZG!HMR]LT(N$)D$H3:5P"
M=V<8%?L'7LU\1*DJ;@^AYM*C&ISJ:ZGY*?\ !-7XU_#KPGX^L/"OB?PAI-IX
MEOY6BTCQ@REI_.?@0/O)"%L[5>/;U"D'.:^VO^"BEU=VO['?C]K09++91RL#
MR(VO8 V/7@X^A-?%/[=W[$WB?PC\7#XJ^&7A;5M;T'7W:[>TT"QEN'TV[!!D
M&V)241B=ZGH"648"C/VK\$;K6_VG/V7;[PG\5O#&N>'=>ELWT?5/[8TV:T>X
M.W]W>1>8J[C]UCCHZGC&,Q7Y'*&)B]-+HJES*,J,M^A^>?[$=_\ M":5I?BR
M;X'Z#IVK6\TUNFJR7DEHKHRK(8@!/*AQAI.@(KN_CY^S_P#M??M)7&BS^,_
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M&.#7H?[9?P1U#]H#]G_7_"VC&/\ MT-%?:>LSA$DFB8-Y9)X&]=Z@G !8$\
MU$II8OF;TN6HMX?E78\9_P""2[!OV:-9 .2/$]T#[?Z-:U\P?\%;KA)OVE-
M1&#-%X5MD<>A^UW;8_)A^=8/[._Q*_:+_9/U'5O"6A?#;4]2749Q-)H^J:)=
M2A9PH3S8C$5/(" G)4A5Z=:S/VE?V??VA?&7BK3_ !GXP\)ZUXC\1^(;;[3-
M::#I4UU'ID:MLB@8PJRHVT;MF20""Q+%L>C"FH8EU')6>QQRGS4%!)W1]_\
M[17_ "COU3_L4]/_ )05\_?\$;_^:O?]P?\ ]O:^EOCUX4UO6/V$=1T"PT?4
M+[7F\,6-NNEVUJ\ET9%$.Y!$ 6W#!R,9&#7AW_!*'X9^,/AS_P +2_X2SPIK
MGAC[9_9?V;^V=.FM//V?;-^SS%7=MWKG'3<,]17#&2^JU%?K_D=+3]O!^7^9
M\Q_'D%?^"D5SD8_XK'3/_0[>OUP^,'_))?&W_8#OO_2=Z_+W]O3X%_$GP?\
MM1:E\1M \/:IJ>DWUQ:ZG8ZII]FUREO/%'$"D@4'80\>1N ##IG!Q]<_L[_%
M/XJ_'3]GGXG77Q#\,W6F:NUM=0:5!'I,MH+F)K0@")'RTAWYY&>6P/2M,0N>
MG3J)Z)(FB^6<X-;GR+_P2-_Y.0\2?]BG<_\ I99UR/\ P4\_Y.VUS_L'6/\
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MKG4;-)I$C#%@@)&<99CCU)K"ABG3JNI/6YK5H<\%&.ECXN^#?[//]J?\$O\
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MR3P:NIB*=2G%->]$F%&<)R:>C/S&_P""1O\ R<AXD_[%.Y_]++.N1_X*/?\
M)Y^O?]<=._\ 2>*OUE\"_ OX>_#'5IM4\)>#-%\.ZC- ;:2ZTZS2&1HBRL4)
M4?=+(IQZJ*@\6_L^?#3QYX@EUWQ%X&T+6M9E"![Z]L4DF8* %RQ&>  !]*V6
M,BJ[JVTM8S^KR]DJ=^IZ#7XP?\$X?^3S]!_ZXZC_ .D\M?L_7GWA+]GSX:>
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M"H@]@H _"KE>:?\ #3GP=_Z*QX'_ /"CL_\ XY1_PTY\'?\ HK'@?_PH[/\
M^.5/L:O\K^X?M(=T>ET5YI_PTY\'?^BL>!__  H[/_XY1_PTY\'?^BL>!_\
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M -%8\#_^%'9__'*/^&G/@[_T5CP/_P"%'9__ !RCV-7^5_<'M(=STNBO-/\
MAISX._\ 16/ _P#X4=G_ /'*/^&G/@[_ -%8\#_^%'9__'*/8U?Y7]P>TAW/
M2Z*\T_X:<^#O_16/ _\ X4=G_P#'*/\ AISX._\ 16/ _P#X4=G_ /'*/8U?
MY7]P>TAW/2Z*\T_X:<^#O_16/ __ (4=G_\ '*/^&G/@[_T5CP/_ .%'9_\
MQRCV-7^5_<'M(=STNBO-/^&G/@[_ -%8\#_^%'9__'*/^&G/@[_T5CP/_P"%
M'9__ !RCV-7^5_<'M(=STNBO-/\ AISX._\ 16/ _P#X4=G_ /'*/^&G/@[_
M -%8\#_^%'9__'*/8U?Y7]P>TAW/2Z*\T_X:<^#O_16/ _\ X4=G_P#'*/\
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M -%8\#_^%'9__'*/^&G/@[_T5CP/_P"%'9__ !RCV-7^5_<'M(=STNBO-/\
MAISX._\ 16/ _P#X4=G_ /'*/^&G/@[_ -%8\#_^%'9__'*/8U?Y7]P>TAW/
M2Z*\T_X:<^#O_16/ _\ X4=G_P#'*/\ AISX._\ 16/ _P#X4=G_ /'*/8U?
MY7]P>TAW/2Z*\T_X:<^#O_16/ __ (4=G_\ '*/^&G/@[_T5CP/_ .%'9_\
MQRCV-7^5_<'M(=STNBO-/^&G/@[_ -%8\#_^%'9__'*/^&G/@[_T5CP/_P"%
M'9__ !RCV-7^5_<'M(=STNBO-/\ AISX._\ 16/ _P#X4=G_ /'*/^&G/@[_
M -%8\#_^%'9__'*/8U?Y7]P>TAW/2Z*\T_X:<^#O_16/ _\ X4=G_P#'*/\
MAISX._\ 16/ _P#X4=G_ /'*/8U?Y7]P>TAW/2Z*\T_X:<^#O_16/ __ (4=
MG_\ '*/^&G/@[_T5CP/_ .%'9_\ QRCV-7^5_<'M(=STNBO-/^&G/@[_ -%8
M\#_^%'9__'*/^&G/@[_T5CP/_P"%'9__ !RCV-7^5_<'M(=STNBO-/\ AISX
M._\ 16/ _P#X4=G_ /'*/^&G/@[_ -%8\#_^%'9__'*/8U?Y7]P>TAW/2Z*\
MT_X:<^#O_16/ _\ X4=G_P#'*/\ AISX._\ 16/ _P#X4=G_ /'*/8U?Y7]P
M>TAW/2Z*\T_X:<^#O_16/ __ (4=G_\ '*/^&G/@[_T5CP/_ .%'9_\ QRCV
M-7^5_<'M(=STNBO-/^&G/@[_ -%8\#_^%'9__'*/^&G/@[_T5CP/_P"%'9__
M !RCV-7^5_<'M(=STNBO-/\ AISX._\ 16/ _P#X4=G_ /'*/^&G/@[_ -%8
M\#_^%'9__'*/8U?Y7]P>TAW/2Z*\T_X:<^#O_16/ _\ X4=G_P#'*/\ AISX
M._\ 16/ _P#X4=G_ /'*/8U?Y7]P>TAW/2Z*\T_X:<^#O_16/ __ (4=G_\
M'*/^&G/@[_T5CP/_ .%'9_\ QRCV-7^5_<'M(=STNBO-/^&G/@[_ -%8\#_^
M%'9__'*/^&G/@[_T5CP/_P"%'9__ !RCV-7^5_<'M(=STNBO-/\ AISX._\
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M%'9__'*/8U?Y7]P>TAW/2Z*\T_X:<^#O_16/ _\ X4=G_P#'*/\ AISX._\
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M_P"&G/@[_P!%8\#_ /A1V?\ \<H]C5_E?W![2'<]+HKS3_AISX._]%8\#_\
MA1V?_P <H_X:<^#O_16/ _\ X4=G_P#'*/8U?Y7]P>TAW/2Z*\T_X:<^#O\
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M>"?^AQT#_P &<'_Q5+ZIB/\ GW+[F/\ M#!_\_H_^!+_ #.JHKE?^%K>"?\
MH<= _P#!G!_\51_PM;P3_P!#CH'_ (,X/_BJ/JF(_P"?<ON8?VA@_P#G]'_P
M)?YG545RO_"UO!/_ $..@?\ @S@_^*H_X6MX)_Z''0/_  9P?_%4?5,1_P ^
MY?<P_M#!_P#/Z/\ X$O\SJJ*Y7_A:W@G_H<= _\ !G!_\51_PM;P3_T..@?^
M#.#_ .*H^J8C_GW+[F']H8/_ )_1_P# E_F=517*_P#"UO!/_0XZ!_X,X/\
MXJC_ (6MX)_Z''0/_!G!_P#%4?5,1_S[E]S#^T,'_P _H_\ @2_S.JHKE?\
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M#)I'_@?%_P#%4?VA@_\ G]'_ ,"7^8?5,1_S[E]S-^BL#_A8'A?_ *&32/\
MP/B_^*H_X6!X7_Z&32/_  /B_P#BJ/[0P?\ S^C_ .!+_,/JF(_Y]R^YF_16
M!_PL#PO_ -#)I'_@?%_\51_PL#PO_P!#)I'_ ('Q?_%4?VA@_P#G]'_P)?YA
M]4Q'_/N7W,WZ*P/^%@>%_P#H9-(_\#XO_BJ/^%@>%_\ H9-(_P# ^+_XJC^T
M,'_S^C_X$O\ ,/JF(_Y]R^YF_16!_P + \+_ /0R:1_X'Q?_ !5'_"P/"_\
MT,FD?^!\7_Q5']H8/_G]'_P)?YA]4Q'_ #[E]S-^BL#_ (6!X7_Z&32/_ ^+
M_P"*H_X6!X7_ .ADTC_P/B_^*H_M#!_\_H_^!+_,/JF(_P"?<ON9OT5@?\+
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MM\>K?XQ?$C3+S1[*WO)]6SJD7DW.H7KEB&$) 9$#OOW$ ': N<Y'ZC5@?\+
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M,/[/QG_/F7_@+_R.RHKC?^%T?#[_ *'OPS_X.+?_ .+H_P"%T?#[_H>_#/\
MX.+?_P"+H^JXC_GV_N8?V?C/^?,O_ 7_ )'945QO_"Z/A]_T/?AG_P '%O\
M_%T?\+H^'W_0]^&?_!Q;_P#Q='U7$?\ /M_<P_L_&?\ /F7_ ("_\CLJ*XW_
M (71\/O^A[\,_P#@XM__ (NC_A='P^_Z'OPS_P"#BW_^+H^JXC_GV_N8?V?C
M/^?,O_ 7_D=E17&_\+H^'W_0]^&?_!Q;_P#Q='_"Z/A]_P!#WX9_\'%O_P#%
MT?5<1_S[?W,/[/QG_/F7_@+_ ,CLJ*XW_A='P^_Z'OPS_P"#BW_^+H_X71\/
MO^A[\,_^#BW_ /BZ/JN(_P"?;^YA_9^,_P"?,O\ P%_Y'945QO\ PNCX??\
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M+-$Q[':P.".Q'([5X7=?\$\OV>[R\-R_P[A60G=MBU2^C3_OA9PN/;%>M?\
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MU?7=%']I8S_GXP^JT/Y3Y$_X=C?"[_H/>+__  ,M?_D:C_AV-\+O^@]XO_\
M RU_^1J^NZ*/[2QG_/QA]5H?RGR)_P .QOA=_P!![Q?_ .!EK_\ (U'_  [&
M^%W_ $'O%_\ X&6O_P C5]=T4?VEC/\ GXP^JT/Y3Y$_X=C?"[_H/>+_ /P,
MM?\ Y&H_X=C?"[_H/>+_ /P,M?\ Y&KZ[HH_M+&?\_&'U6A_*?(G_#L;X7?]
M![Q?_P"!EK_\C4?\.QOA=_T'O%__ (&6O_R-7UW11_:6,_Y^,/JM#^4^1/\
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M+7_Y&H_X=C?"[_H/>+__  ,M?_D:OKNBC^TL9_S\8?5:'\I\B?\ #L;X7?\
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MH_X=C?"[_H/>+_\ P,M?_D:OKNBC^TL9_P _&'U6A_*?(G_#L;X7?]![Q?\
M^!EK_P#(U'_#L;X7?]![Q?\ ^!EK_P#(U?7=%']I8S_GXP^JT/Y3Y$_X=C?"
M[_H/>+__  ,M?_D:C_AV-\+O^@]XO_\  RU_^1J^NZ*/[2QG_/QA]5H?RGR)
M_P .QOA=_P!![Q?_ .!EK_\ (U'_  [&^%W_ $'O%_\ X&6O_P C5]=T4?VE
MC/\ GXP^JT/Y3Y$_X=C?"[_H/>+_ /P,M?\ Y&H_X=C?"[_H/>+_ /P,M?\
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M_L.7/_HN&M_;5*.%K3INSYR/9QJ5:<9*ZY3/_P"'8WPN_P"@]XO_ / RU_\
MD:C_ (=C?"[_ *#WB_\ \#+7_P"1J^NZ*\K^TL9_S\9V?5:'\I\B?\.QOA=_
MT'O%_P#X&6O_ ,C4?\.QOA=_T'O%_P#X&6O_ ,C5]=T4?VEC/^?C#ZK0_E/D
M3_AV-\+O^@]XO_\  RU_^1J/^'8WPN_Z#WB__P #+7_Y&KZ[HH_M+&?\_&'U
M6A_*?(G_  [&^%W_ $'O%_\ X&6O_P C4?\ #L;X7?\ 0>\7_P#@9:__ "-7
MUW11_:6,_P"?C#ZK0_E/D3_AV-\+O^@]XO\ _ RU_P#D:C_AV-\+O^@]XO\
M_ RU_P#D:OKNBC^TL9_S\8?5:'\I\B?\.QOA=_T'O%__ (&6O_R-1_P[&^%W
M_0>\7_\ @9:__(U?7=%']I8S_GXP^JT/Y3Y$_P"'8WPN_P"@]XO_ / RU_\
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MU?7=%']I8S_GXP^JT/Y3Y$_X=C?"[_H/>+__  ,M?_D:C_AV-\+O^@]XO_\
M RU_^1J^NZ*/[2QG_/QA]5H?RGR)_P .QOA=_P!![Q?_ .!EK_\ (U'_  [&
M^%W_ $'O%_\ X&6O_P C5]=T4?VEC/\ GXP^JT/Y3Y$_X=C?"[_H/>+_ /P,
MM?\ Y&H_X=C?"[_H/>+_ /P,M?\ Y&KZ[HH_M+&?\_&'U6A_*?(G_#L;X7?]
M![Q?_P"!EK_\C4?\.QOA=_T'O%__ (&6O_R-7UW11_:6,_Y^,/JM#^4^1/\
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M^-UZM11_;V:?\_Y!_JCD7_0)'^OF>4_\,W^&O^?[5O\ O]%_\;H_X9O\-?\
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MPJ/1_P#GYOO^_B?_ !%=O11_JED7_0+'^OF']OYI_P _Y'$?\*CT?_GYOO\
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M_/\ 8?ZV9Y_T%2_KY'A__#(?@[_H):Y_W_A_^-4?\,A^#O\ H):Y_P!_X?\
MXU7N%%']O9G_ ,_V'^MF>?\ 05+^OD>'_P##(?@[_H):Y_W_ (?_ (U1_P ,
MA^#O^@EKG_?^'_XU7N%%']O9G_S_ &'^MF>?]!4OZ^1X?_PR'X._Z"6N?]_X
M?_C5'_#(?@[_ *"6N?\ ?^'_ .-5[A11_;V9_P#/]A_K9GG_ $%2_KY'A_\
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M '_A_P#C5>X44?V]F?\ S_8?ZV9Y_P!!4OZ^1X?_ ,,A^#O^@EKG_?\ A_\
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MB@ HHHH **** "BBB@ HHHH **** .0^,/\ R2/QO_V [[_TG>OSN_X)<_\
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M]?#GC_'I_P"$^JZ***^>/3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OA[_@J3_R*/@+_K^NO_1:5]PU\/?\%2?^11\!?]?U
MU_Z+2O6RG_?:?S_)G%C/X$OZZGV3\5_^31['_L&:7_.&N:^!O_),]*_WIO\
MT:]=+\5_^31['_L&:7_.&N:^!O\ R3/2O]Z;_P!&O7LS_P"1 _\ K]_[8?$1
M_P"2P7_8-_[D.]HHHKY _1 HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+2O6RG_?:?S_ "9Q8S^!+^NI]D_%?_DT>Q_[!FE_SAKFO@;_ ,DSTK_>F_\
M1KUTOQ7_ .31['_L&:7_ #AKFO@;_P DSTK_ 'IO_1KU[,_^1 _^OW_MA\1'
M_DL%_P!@W_N0[VBBBOD#]$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KY(^-G_!0;3_ (,?%#7/!DW@JYU672VB4WD>H+$LF^))
M.%,9QC?CKVKZWK\=_P!NC_DZOQY_UUM?_2."@#Z9'_!5;2<C/P[O /\ L*I_
M\:KM_!?_  4O^&/B"\2VUNPUGPQN_P"7JXA6X@7GN8R7]/X/6MOP#^PY\$M:
M\"^'-1O?!7G7EWIMM<32?VK?+OD>)68X$P R2> ,5YC^T'_P3AT"/PI>ZU\,
MFO;35K*%I?[$N)3<1W@7DK&S?,LF,XR6!.!QG- 'VYH/B#3/%6CVNJZ/?V^J
M:;=)YD%W:2"2.1?4,.*^1/\ @I!XL^(OA?POX8;PG=:GIGAV22?^U;[27>-U
MD 3RDD=,%4(\P]<$CGH*^;_V OCSJ'PW^+6G^$;J[9O#'B:X6U>WD)*Q7;#;
M#(@[%FVQGU##/W1C[*_;3_:2\3?LXZ#X8O?#5CI-]+JES-#,NJPRR*JHBD;?
M+D3!Y/7- &-_P3S\2?$#Q+\*M4G\:W&H7VGI>*FCWFJ%FGDCV?O &;YFC#;0
M"<\[@#Q@?5->#_L;?'C7_P!H;X8ZGXC\1V>FV5]:ZQ+IZ1Z7%)'&8U@@D!(=
MW.[,K=\8 X]?'OVA/^"B%]\+O'VK^$- \%^9>Z5.8)[S6I2JNP .4B3DH00R
ML7&00<"@#[9HK\R-,_X*B?$B&\+W_AKPQ=VQ8$Q00W$+ <<!C,WH>H/)_"OM
MS]G/]I+P[^T=X7N=2TB&73=2L76._P!*N75I("PRK!A]Y&PP#8'*G(&* /#_
M -N3]J3QU\!?&WAS3/"=Q8PVM]I[7,PNK42DN)&7@D\# KW/]E;XCZS\6_@+
MX7\6>('ADU?4/M7GM;QB-#Y=U-$N%'3Y46OC#_@J9_R4[P;_ -@=_P#T<U8'
MPS_;VNO@I\"?"/@KPOX>M]0UFP2[:\O-5+?9T:2ZFD141&#/\KJ22R\\8/6@
M#]1J*_.7X?\ _!4;Q%#JT4?C7PIIEYIC,%>;0_,@GB7NVV1W5S_LY3ZU]_\
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M_7]%_P"@O7+>#?\ D5=+_P"N"UU/[27_ "3R/_K^B_\ 07KEO!O_ "*NE_\
M7!:_%</_ ,E9B/\ KS'_ -*/VNM_R(:7_7Q_D;-%%%??GR@4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M._V&/B1J7@']H?PY:6T[C3=>F&F7UMN.R4."(V(]5<J0?3<.YH _7ZBOF/\
M;,_:I\0?LV77A*/0](TW5!K"733'4!)\GE&(+MV,.OF'.?05XY?_ /!4*6U\
M Z0]MX8M+[QG<"5KU-\D5C: 2.L8 )+R,4",0" -W7.0 #[_ **\I^!OQF?Q
M_P# '2/B+XI:QT59X+FYO&AW);P1Q3RIGYF)^Z@)YY.<>E?+WQ/_ ."H<-CJ
MTUGX"\+1:C9Q/M&IZQ(Z"8>JPKAE'H6;/JHH ^]Z*_.[P/\ \%3-7CU"&/QC
MX,L9[%B!)/HDKQ21^K".0L&[_+N7ZU]W_#[XA:!\4O"=CXD\-:@FI:3>*2DJ
M@AE8'#(RGE6!X(- 'Q!^TQ^W1\1_A'\</$_A+0X-#?2M->!86N[-WE^>WCD.
MYA( ?F<]NE?5_P 8_%7BS3_V=]<U_P )P&?Q5_9"7-NL$>]E9@ID=$YRRH78
M#G)4<&OS)_;H_P"3J_'G_76U_P#2."OU%\2^+KGP!\ ;_P 36<,5Q=Z/X<:^
MBAGSY;O';[P&P0<$CL: /A+]A7XT?%KQA\>K/3+WQ!K7B;P]-'.^K)J=Q)<Q
M6R"-RC@N3Y1\P(H"XSG&/3[6_:4_:'TG]G/P(NMWUL=2U*[E^SZ?IJR",SR8
MR26P=J*.2<'J!W%>$_LF?MK>)OCM\5F\+:IX=T32K22SGO7FT]91(TB[1SN<
M@YSSQG@5\C_M5?M17_[26I:$+K0XM#AT/[1'''%<F82-(R;F.57'$:^M 'H4
MW_!23XPWUY)>VNF:!'91'YK>/3Y7B [;F,N[/XCK7Z6^"]0U75?!^B7NNVD5
MAK-S90S7EI#G9#,R N@SS\I)'/I7YB?L]_MQ/\#_ (<V'@JU\"66IIY\LES?
M27QC-RTCGED\L]$*IU/"BOT ^/W[1WA3]G?P[%?Z_+)<ZA=[A8:3:X,]RPQD
M\\*@R,L>F>,G (!ZI17YL:K_ ,%3/&DNH,^F^#=!M;'<=L-U)--+M[ NK(,]
M.=M?0/[.'[>WAKXV:Y;>&M;TX^%/$UQ\EJK3>;:W;X^ZCX!5SV5AST#$D"@#
MZFHKPG]L']H#6?V=?A]I.OZ)IUCJ5S>:HMB\5_OV*ABE?(V,#G,8_,U\[:3_
M ,%0I8?A_<76J>&+2[\8/>O%;V-D\D-K';A(R)9'8L22S. J_P!SG;QD ^_Z
M*^=?V>_VH=0^)7P#\3_$CQ/I$<2Z+=W*O9Z%"SNT$,$4A(5W.YOG;N!@#TR?
MG7Q5_P %3]:ENIE\-^!K"UMP<12:K=/,[#L65 @'T#'ZT ?HI17Y\_#_ /X*
ME73:I!#XV\'VZZ>_RR7>ARL)(S_>$4A.X>V\'Z]*^M?BQ\<K/P-\!=0^)NA0
MP^(K".VM[NU3S3&DZ2RQH#NP2N!)G&,Y&#0!7\6?M7?"CP+XBOM!UWQC:Z?J
M]B_EW%J]O.QC; ."50CH1T->K6\Z74$<T3;XY%#JWJ",@U^&?Q@^(LGQ:^)6
MO>+Y;%=-DU:<3-:I(9!'A57 8@9^[Z=Z_0#]F?\ ;PO_ (Q_$SP[X#F\'V^E
MPW,$JF^COVD9?*@=Q\AC'79CKWH \P_X* ?&/XJ>"_C-%IFF:]K'ACPREI#+
MIS:7<26R79*YE9G0C>0^5VDX 53CG)^ROV7?$'BWQ1\"/"FI^.(Y4\17$#F9
MIX_+EDC$CB*1UP,,T80^^<]Z\-_:^_;+\2? 'XG6'AG2O#^BZM:2:;#J(FU%
M9&=9&EE7C:X''E@CC/)JW\7/VN/'G@'X$_#GXCZ;X>T6]M?$,(&HQSK-MMIV
M7=&$PX^5@LG7H5'/- 'UW17@_P"R'^TI)^TAX)U.^U&TM=.U[2[OR+JTLRWE
M^6R[HI!N).#AQUZH:Z[]HKXQ0_ GX2ZUXL:**YO( L-C:S$A9[AVVHIP0<#E
MC@YVJU 'I5%?+7['7[4'CC]I+6M??5]!TC2] TF! US9++ODN';Y$!=R,!5<
MGCCY?6LC]H3_ (*&^'OA;KEWX<\)Z8OBS6[1VBNKIYC'9V\@."F0"96!!! P
M!_>)!  /KRBOS=T'_@J9XMAU)6UOP9HMYI^[YH["::WE XZ,[2 GK_#S[=:^
MW_@?\=O"WQ^\)?VYX9N'S$PBO+"X 6XM)",[74$C!'1@2#@\Y!  /0Z*** "
MBBB@ HHHH **** "BBB@ KYJ_;+_ .9/_P"WS_VA7TK7S5^V7_S)_P#V^?\
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M'.UI+23<8VQG:Z_>1L=F - '24444 %%%% !1110 445\1?\/%M1_P"%R?\
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MWVN_MV?M31P6GG6^E3R^3!NY^P:9$V6D(Z!B"6QT+R =Q0!X?\/?^1_\-?\
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MO^1J\+_C_P"C%KW.O#/V@O\ D:O"_P"/_HQ:^KX8_P"1I#TE_P"DL_/^._\
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MA8,DD; ,K*1U!!!_&K-?,7_!.GQ-<^(OV;+*WN97F.DZC<V$;2$DA!ME51[
M2X'H!BOIV@#Y+_;^_:4U#X/^%;#PIX9NFL_$FO1N\E[$Y66RM0=I9/1W.5#=
M@KD8."/D;]EK]C?6OVD/M?B#4]3DT/PO#.8WOC'YMQ>3<%EC!.,#/+G."< -
MSC5_X*2O<M^TBPG'[I='M1!_N9D)_P#'R]?>G['5O8V_[,OP_73@H@;3][[,
M<REV,O3OYA>@#PWQ)_P2W\$SZ1(N@>+=?LM4V_)+J7D7$!/H42.-@/\ @7'O
M7QQIVJ?$#]C'XV30[VL]7TV55N;99&-KJ-N>0#TWQN.0<94\\,./V=K\U_\
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M^'?PV\.?"?PO#X=\*Z=_96CPR/*EMY\DV&<Y8[I&9N3[UTU% !7EGQ*_9?\
MA?\ %J^>_P#$OA&SNM2?E[ZV9[6=SC +O$RER!_?ST%>IT4 >+>"?V-?@[X
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M>\?_ *"*NU\S+XF?#U/C?J%%%%29A1110 4444 %%%% !1110 4444 %%%%
M'(?&'_DD?C?_ + =]_Z3O7YW?\$N?^1"\;_]A.'_ -%&OT1^,/\ R2/QO_V
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MQ_R;S<_]ARY_]%PUWU/]SK?]?#GC_'I_X3ZKHHHKYX],**** "BBB@ HHHH
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M'_@72_AGX*T;PMHJ.FF:7;K;P^:07;'5W( !9B2Q( R2>!0!^=__  ZW\?\
M_0V>&_SN/_C=>#-:^)/V2_VA+=;K8VL^&;^.1C"2([J$J"=I(!V21.1ZX;UK
M]J:\'^.W[&?@3]H+Q5;>(M?N]9TW4X;5;1GTB>&-9D5F92X>)\L-Q&1CC ["
M@#C?V[O$-CXM_9!EUO3)A<:=J,VGW=O*/XHW=64_D:\I_P""4?\ S5+_ +A?
M_MY7TK=?LG^%[[X$P_":ZUOQ!<>'()Q-#<R7$!NXP)#($#^3MVAB>"I.#C/3
M%O\ 9]_9?\*_LV_V_P#\(SJ&L7W]M?9_M']K312;?)\S;L\N),9\ULYST'3N
M ?GO^VQ^S7=?"+XJ2W^@:=-)X6U\O=V:VT19;:7/[V#@< $[E_V6 YVFONC]
MBW]G\? KX3P'4;<1^*=<V7NIEA\T7'[NW_X "<_[3/VQ7T!10!^-'P1_Y.Z\
M*_\ 8UI_Z45]_P#_  42_P"38=8_Z_[/_P!&BD\*_P#!/_X>>$?B-I_C2SUG
MQ-+JEEJ U*.&>ZMS 9 ^_! @#;<]@P/O7L'QG^#^C?'/P)<^$]>N;ZTTZXEC
MF:73I$28,C;A@NCC&>O% 'YL?L+_ +0'A'X!>(/%=YXLFNX8=1M8(H/LMN9B
M65V)R >."*^J/$G_  4R^%NEV<C:5I^OZW=["8XTM4@C+=@SN^5'N%;KTJO_
M ,.O?A7_ -!_QA_X&6O_ ,C5:T__ ()D_":SEWS:EXIOER#Y=Q?0 <=OD@4\
M_6@#X5^)7Q$\;_M??%^WFCTY[K4[LK9Z;H]CN:.VB!Z GMDEG<X'4G   _5G
M]GGX0P_ WX2:'X31XY[NW1I;VYB!"S7#G=(PSR0"=HSSM5:O?##X(>!_@W9R
M6_@_P[:Z.95"S7"[I)Y0.</*Y+L,\X)P/2NYH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "OA[_ (*D_P#(H^ O^OZZ_P#1:5]P
MU\/?\%2?^11\!?\ 7]=?^BTKULI_WVG\_P F<6,_@2_KJ?9/Q7_Y-'L?^P9I
M?\X:YKX&_P#),]*_WIO_ $:]=+\5_P#DT>Q_[!FE_P X:YKX&_\ ),]*_P!Z
M;_T:]>S/_D0/_K]_[8?$1_Y+!?\ 8-_[D.]HHHKY _1 HHHH **** "BBB@
MHHHH **** "N&^)GQP\#_!V33T\8^((=#;4!(;4312/Y@3;OQL4XQO7KZUW-
M?GO_ ,%6/^0A\-/^N6H_SMJ /NWP7XVT/XB>&[37_#FI0ZMH]WN\FZ@SM;:Q
M5A@@$$$$$$9XK;K\QO\ @G7^T)_P@OC:3X?:S<[-"\02[K%Y&^6WOL  >PE
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M8,Z>7-)$<D<<F,G\:^$/^"IG_)3O!O\ V!W_ /1S5]3_ +!/_)IO@;_M^_\
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M17@7Q:_;@^%GPAU>?2+W4KK7=7MVV7%EH<"SM"W<,[,L>1W7=D8Y KG/ O\
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M^C)J^J?AU_P3L^'?P\\9:;XDBUGQ%J5WIMREW:13W44<:R(P92WEQJQP0.C
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M[>P8X*OCMO5L=J\@TO\ X)A_#"SU 3W>M^)M0ME?<MK)<P(K#/W798@Q_P"
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M45Y<6MW<1SW^H7</DJ4C;<L:*3N)+A6).,!<<YX=_P $L?\ D?O''_8,A_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<)\7O\ D!V?_7Q_[*U=W7"?%[_D!V?_ %\?^RM7QW&'_(AQ7^']4?1<
M/?\ (UH>OZ,[7XS?\FGZE_V [;_VE7E'[+/_ "2>W_Z^YOYBO5_C-_R:?J7_
M & [;_VE7E'[+/\ R2>W_P"ON;^8K]-RW_DEH_XX_P#I"/I:G_),XG_L(_\
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M9_V3O#5C]@U7XAV5_J&-CW+^)(1(CC&X[(_E7GLP/]:^,?B'I]C\'/C)<_\
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M\\9Z;\.;.YDAT>RMH[^^B0X$]PY8H&]0B $#IE\XX!IOP"^"7[-<7P[TV_\
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MG)SR0.: /4_@1\*Y_@O\,=)\(SZ_=>(S8!@MW=1JFU2<^6BC)" YP&+$9QG
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M' V@9Y./1/\ @F'\/K[P[\,_$GB>\A:"+Q!>1):AU(,D,"N/,'^R7E<#_<-
M'P;\:+.;4/CUX[M;=/,N)_$M_%&@_B9KIP!^9K[Y\&?\$R_ %KX1MX/$VIZQ
M?^(9(E-Q=6=PL,44AY(B0H<@=,MG.,\9P/@SXMZI-H?[0WC/4K?'VBS\4WMQ
M'GIN2[=A^HK]2?!?[:/PD\6>$8-:N/&&G:'-Y(>YTW49?+N('Q\R!",R8/=
M<T ?F=\7OA_KW[*/QT?3].U:3[=I4L5_I>J1KL:2-AE&*\\_>5AT.&Z@U^I&
MJ:#I7[5?[.-K#J$:VT/B;2(;N-]NXV=PR!U=>>2DGOR 1GFOS&_:R^,%K^T%
M\<+O6=!@N)=-6*'3=.5D/FSHI.&"8R"SNQ"]<$=^*^I_VMKSQ%\"_P!CGX=^
M";.XDL;BZ2WT[59K=L$A8"\D(;J TG7'4*1T)% #-._91_9B\ V?V#Q?\1K+
M5=;C'E7+3:]#;%).<E88VW)CT8M[DU\C?M&>!?!GPW^(Z0?#OQ7#XF\/3P)=
MP7%O<I-):2;F!B9TQDC:&!P#AAW&3[/^Q3^S#\-_CEX9UG5?%VN7!U2RO# N
MC6MVD!6$1J_G/D%B"2X!& /+/7MY?^UMX,^''P]^)L>@?#>[EO;.SM574)&N
M?M""Z+,2BOT.%V9QT.1U!  /T"\/^!=-_;+_ &5O :>,M2U)&E2*\GN]-DCC
MFEN81+ Q8O&XP27)P.M?F-:>"+&?XV0^#VEN!IC^(5TDRAE\[RC<^5NSMQNV
M\YVXSV[5^J/["_\ R:IX#_ZY77_I9/7YF^(I$\!_M3:A-JK>5#I/C%YKAP"<
M)'>EF8#N-HS0!^FOP%_8[\&?L[^*;[7_  YJ>NWMY>636,B:I<0R1A"Z.2 D
M*'=F,=\8)XK\[/VZ/^3J_'G_ %UM?_2."OU7\(_&3P+X^U)-/\->+M&UV_:W
M:Z^RZ?>QS2+$"H+,JDE<%U&&P>:_*C]NC_DZOQY_UUM?_2."@#Z0^!W_  3=
M\,>)OAMI&N>--:UE=7U:T2[6UTN2*&.U210R*2T;EW (R>!R1@XR?D?XU?#C
M4OV;?C;?Z%9:I(]UH]Q#>:?J<0V2;2%EB?V9<@''&5/:OV7\%J%\':$ , 6$
M  '_ %S6ORQ_X*)?\G/:Q_UX6?\ Z*% 'V]\?O 9_:6_9+M[N&$3:U+I-MXA
MT[8O)G\@2%%_WT9T'NP]*^2/^";'Q;_X1'XL7O@V\FV:=XF@_<!NBW<0+)]-
MR>8ON0@K] /V>O\ D@/PT_[%G3/_ $ECK\P_VJO -]^SG^TS<W^A@V5O)=Q^
M(-&E4':F7W[1[)*KKC/W0OK0!]&?\%/OBW]CT?P]\.K*;$MXW]JZBJ_\\E)6
M%#[%P[8_Z9K7J'_!/;X1_P#"N?@;#KEW#Y>K>*G&H2%A\PM@"+=?H5+2#_KK
M7PQ9RZK^V?\ M56[W43VT6N7RF6%7+?8[")1N4-CJ(D/. "Q]Z_8&SLX-/LX
M+6VB6"V@C6**)!A451@*!Z  4 34444 %%%% !7S5^V7_P R?_V^?^T*^E:^
M:OVR_P#F3_\ M\_]H5]1PS_R-J/_ &]_Z3(^\X%_Y*'#?]O_ /I$C[NT7_D#
M6'_7O'_Z"*NU2T7_ ) UA_U[Q_\ H(J[7S,OB9\/4^-^H4445)F%%%% !111
M0 4444 %%%% !1110 4444 <A\8?^21^-_\ L!WW_I.]?G=_P2Y_Y$+QO_V$
MX?\ T4:_1'XP_P#)(_&__8#OO_2=Z_.[_@ES_P B%XW_ .PG#_Z*->U0_P"1
M?6]8G#4_WFGZ,^VJ***\4[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&JLQD:0%F8@L21U8U]BZ3IRZ5H]E8!_-6V@2#<1C<%4+G'OBKE% 'R=\7/\
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MQ^'?A_PI%>-J$>D6B6BW3Q[#*%_B*Y./SKJ:* "BBB@ HHHH **** "BBB@
MHHHH **** "O#/V@O^1J\+_C_P"C%KW.O#/V@O\ D:O"_P"/_HQ:^KX8_P"1
MI#TE_P"DL_/^._\ D15?6'_I<3Z#_:2_Y)Y'_P!?T7_H+URW@W_D5=+_ .N"
MUU/[27_)/(_^OZ+_ -!>N6\&_P#(JZ7_ -<%K\5P_P#R5F(_Z\Q_]*/VNM_R
M(:7_ %\?Y&S1117WY\H%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/C%_T4'6/^_B_P#Q-'_#7'QB_P"B@ZQ_W\7_ .)H_P!7Z_\ .OQ_R#^TJ?\
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M_M*G_*S]E:*_&K_AKCXQ?]%!UC_OXO\ \31_PUQ\8O\ HH.L?]_%_P#B:/\
M5^O_ #K\?\@_M*G_ "L_96BOQJ_X:X^,7_10=8_[^+_\31_PUQ\8O^B@ZQ_W
M\7_XFC_5^O\ SK\?\@_M*G_*S]E:*_&K_AKCXQ?]%!UC_OXO_P 31_PUQ\8O
M^B@ZQ_W\7_XFC_5^O_.OQ_R#^TJ?\K/V5HK\:O\ AKCXQ?\ 10=8_P"_B_\
MQ-'_  UQ\8O^B@ZQ_P!_%_\ B:/]7Z_\Z_'_ "#^TJ?\K/V5HK\:O^&N/C%_
MT4'6/^_B_P#Q-'_#7'QB_P"B@ZQ_W\7_ .)H_P!7Z_\ .OQ_R#^TJ?\ *S]E
M:*_&K_AKCXQ?]%!UC_OXO_Q-'_#7'QB_Z*#K'_?Q?_B:/]7Z_P#.OQ_R#^TJ
M?\K/V5HK\:O^&N/C%_T4'6/^_B__ !-'_#7'QB_Z*#K'_?Q?_B:/]7Z_\Z_'
M_(/[2I_RL_96OD3_ (*<_P#)!=!_[&6W_P#26ZKXE_X:X^,7_10=8_[^+_\
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MV?\ 7S/UFHK\F?\ AX%\:_\ H8[/_P %=O\ _$4?\/ OC7_T,=G_ ."NW_\
MB*/[!Q7>/WO_ "#^T:/9_P!?,_6:BOR9_P"'@7QK_P"ACL__  5V_P#\11_P
M\"^-?_0QV?\ X*[?_P"(H_L'%=X_>_\ (/[1H]G_ %\S]9J*_)G_ (>!?&O_
M *&.S_\ !7;_ /Q%'_#P+XU_]#'9_P#@KM__ (BC^P<5WC][_P @_M&CV?\
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MV?\ X*[?_P"(H_L'%=X_>_\ (/[1H]G_ %\S]9J*_)G_ (>!?&O_ *&.S_\
M!7;_ /Q%'_#P+XU_]#'9_P#@KM__ (BC^P<5WC][_P @_M&CV?\ 7S/UFHK\
MF?\ AX%\:_\ H8[/_P %=O\ _$4?\/ OC7_T,=G_ ."NW_\ B*/[!Q7>/WO_
M "#^T:/9_P!?,_6:BOR9_P"'@7QK_P"ACL__  5V_P#\11_P\"^-?_0QV?\
MX*[?_P"(H_L'%=X_>_\ (/[1H]G_ %\S]9J*_)G_ (>!?&O_ *&.S_\ !7;_
M /Q%'_#P+XU_]#'9_P#@KM__ (BC^P<5WC][_P @_M&CV?\ 7S/UFHK\F?\
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M+XU_]#'9_P#@KM__ (BC^P<5WC][_P @_M&CV?\ 7S/UFHK\F?\ AX%\:_\
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M_P"'@7QK_P"ACL__  5V_P#\11_P\"^-?_0QV?\ X*[?_P"(H_L'%=X_>_\
M(/[1H]G_ %\S]9J*_)G_ (>!?&O_ *&.S_\ !7;_ /Q%'_#P+XU_]#'9_P#@
MKM__ (BC^P<5WC][_P @_M&CV?\ 7S/UFHK\F?\ AX%\:_\ H8[/_P %=O\
M_$4?\/ OC7_T,=G_ ."NW_\ B*/[!Q7>/WO_ "#^T:/9_P!?,_6:BOR9_P"'
M@7QK_P"ACL__  5V_P#\11_P\"^-?_0QV?\ X*[?_P"(H_L'%=X_>_\ (/[1
MH]G_ %\S]9J*_)G_ (>!?&O_ *&.S_\ !7;_ /Q%'_#P+XU_]#'9_P#@KM__
M (BC^P<5WC][_P @_M&CV?\ 7S/UFKX>_P""I/\ R*/@+_K^NO\ T6E?/7_#
MP+XU_P#0QV?_ (*[?_XBO/\ XN?M&^._CE9:=:>+]3AOX-/D>6W6*TBAVLP
M))11G@#K7=@<HQ&&Q$*LVK+U[>ASXC&TZM)PBG=G['?%?_DT>Q_[!FE_SAKF
MO@;_ ,DSTK_>F_\ 1KUJ>/KR6\_8O\-W$K9EGT;1WD(&,DK"3^M?-&C?$CQ)
MX?TZ*PT_5)+:TCR4B5$(&22>HSU)KULORNMFN3RH49)-56];](VZ)]S\SSO/
ML/P_Q/'%XF,I1=!1]VU[N;?5KL?8%%?)G_"XO&/_ $')?^_<?_Q-'_"XO&/_
M $')?^_<?_Q-8?ZEX[_GY#[W_P#(F_\ Q$_*O^?-3[H__)'UG17R9_PN+QC_
M -!R7_OW'_\ $T?\+B\8_P#0<E_[]Q__ !-'^I>._P"?D/O?_P B'_$3\J_Y
M\U/NC_\ )'UG17R9_P +B\8_]!R7_OW'_P#$T?\ "XO&/_0<E_[]Q_\ Q-'^
MI>._Y^0^]_\ R(?\1/RK_GS4^Z/_ ,D?6=%?)G_"XO&/_0<E_P"_<?\ \31_
MPN+QC_T')?\ OW'_ /$T?ZEX[_GY#[W_ /(A_P 1/RK_ )\U/NC_ /)'UG17
MR9_PN+QC_P!!R7_OW'_\31_PN+QC_P!!R7_OW'_\31_J7CO^?D/O?_R(?\1/
MRK_GS4^Z/_R1]9T5\F?\+B\8_P#0<E_[]Q__ !-'_"XO&/\ T')?^_<?_P 3
M1_J7CO\ GY#[W_\ (A_Q$_*O^?-3[H__ "1]9T5\F?\ "XO&/_0<E_[]Q_\
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M&/\ T')?^_<?_P 31_J7CO\ GY#[W_\ (A_Q$_*O^?-3[H__ "1]9T5\F?\
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M_P#Q-'_"XO&/_0<E_P"_<?\ \31_J7CO^?D/O?\ \B'_ !$_*O\ GS4^Z/\
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MC_-#[W_\B>TT5XM_PLSQ!_S])_WY3_"C_A9GB#_GZ3_ORG^%'_$2LF_DJ?\
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MXB5DW\E3_P !C_\ )!_J9F/\T/O?_P B>TT5XM_PLSQ!_P _2?\ ?E/\*/\
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M )$]IHKQ;_A9GB#_ )^D_P"_*?X4?\+,\0?\_2?]^4_PH_XB5DW\E3_P&/\
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M_$-LY_GI_P#@4O\ Y$^UJ*^*?^&FOB!_T%8/_ .+_P")H_X::^('_05@_P#
M.+_XFC_4[,/YH?>__D0_XAMG/\]/_P "E_\ (GVM17Q3_P --?$#_H*P?^ <
M7_Q-'_#37Q _Z"L'_@'%_P#$T?ZG9A_-#[W_ /(A_P 0VSG^>G_X%+_Y$^UJ
M*^*?^&FOB!_T%8/_  #B_P#B:/\ AIKX@?\ 05@_\ XO_B:/]3LP_FA][_\
MD0_XAMG/\]/_ ,"E_P#(GVM17Q3_ ,--?$#_ *"L'_@'%_\ $T?\--?$#_H*
MP?\ @'%_\31_J=F'\T/O?_R(?\0VSG^>G_X%+_Y$^UJ*^*?^&FOB!_T%8/\
MP#B_^)H_X::^('_05@_\ XO_ (FC_4[,/YH?>_\ Y$/^(;9S_/3_ / I?_(G
MVM17Q3_PTU\0/^@K!_X!Q?\ Q-'_  TU\0/^@K!_X!Q?_$T?ZG9A_-#[W_\
M(A_Q#;.?YZ?_ (%+_P"1/M:BOBG_ (::^('_ $%8/_ .+_XFC_AIKX@?]!6#
M_P  XO\ XFC_ %.S#^:'WO\ ^1#_ (AMG/\ /3_\"E_\B?:U%?%/_#37Q _Z
M"L'_ (!Q?_$T?\--?$#_ *"L'_@'%_\ $T?ZG9A_-#[W_P#(A_Q#;.?YZ?\
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M_P#Y$/\ B&V<_P ]/_P*7_R)]K45\4_\--?$#_H*P?\ @'%_\31_PTU\0/\
MH*P?^ <7_P 31_J=F'\T/O?_ ,B'_$-LY_GI_P#@4O\ Y$^UJ^:OVR_^9/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /?/CI_R9_=_]@C3_P#T
M9!7YUU^BGQT_Y,_N_P#L$:?_ .C(*_.NO]1_#W_D2Q]5_P"D1.7P^_W'$_\
M7Z7Y1"BBBOTP_4@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _7KPC_R*FB_]>4/_ *+6M:LGPC_R*FB_]>4/_HM:UJ_F
M.I\<O4_A:O\ Q9^K_,****S, HHHH **** "BBB@ HHHH **** "BBB@#BOC
M9:I??!GQ[;2Y,4V@7\;8.#@VT@-?EM^P#^R?X _:(\'^*]1\8V]_-<Z=?Q6\
M!L[LP@(T>XY ')S7ZG_&'_DD?C?_ + =]_Z3O7PI_P $C?\ DG7C[_L*P?\
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M/V._AS^SY\(-'\1>$+;4(=2NM=AT^1KN\:9?*:WN)" ".NZ).?K7ZA5\5_\
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M^4^&?^'2OPZ_Z''Q1^=M_P#&J/\ ATK\.O\ H<?%'YVW_P :K[FHH_M3&?\
M/QA]4H?RGPS_ ,.E?AU_T./BC\[;_P"-4?\ #I7X=?\ 0X^*/SMO_C5?<U%'
M]J8S_GXP^J4/Y3X9_P"'2OPZ_P"AQ\4?G;?_ !JC_ATK\.O^AQ\4?G;?_&J^
MYJ*/[4QG_/QA]4H?RGPS_P .E?AU_P!#CXH_.V_^-4?\.E?AU_T./BC\[;_X
MU7W-11_:F,_Y^,/JE#^4^&?^'2OPZ_Z''Q1^=M_\:H_X=*_#K_H<?%'YVW_Q
MJON:BC^U,9_S\8?5*'\I\,_\.E?AU_T./BC\[;_XU1_PZ5^'7_0X^*/SMO\
MXU7W-11_:F,_Y^,/JE#^4^&?^'2OPZ_Z''Q1^=M_\:H_X=*_#K_H<?%'YVW_
M ,:K[FHH_M3&?\_&'U2A_*?#/_#I7X=?]#CXH_.V_P#C5'_#I7X=?]#CXH_.
MV_\ C5?<U%']J8S_ )^,/JE#^4^&?^'2OPZ_Z''Q1^=M_P#&J/\ ATK\.O\
MH<?%'YVW_P :K[FHH_M3&?\ /QA]4H?RGPS_ ,.E?AU_T./BC\[;_P"-4?\
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M+7_$R/\ AE#P5_SUU7_P)7_XBC_AE#P5_P ]=5_\"5_^(KV:BO!_MS,_^?\
M+[SZG_57(_\ H$A]QXS_ ,,H>"O^>NJ_^!*__$4?\,H>"O\ GKJO_@2O_P 1
M7LU%']N9G_S_ )?>'^JN1_\ 0)#[CQG_ (90\%?\]=5_\"5_^(H_X90\%?\
M/75?_ E?_B*]FHH_MS,_^?\ +[P_U5R/_H$A]QXS_P ,H>"O^>NJ_P#@2O\
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MX*_YZZK_ .!*_P#Q%>S44?VYF?\ S_E]X?ZJY'_T"0^X\9_X90\%?\]=5_\
M E?_ (BC_AE#P5_SUU7_ ,"5_P#B*]FHH_MS,_\ G_+[P_U5R/\ Z!(?<>,_
M\,H>"O\ GKJO_@2O_P 11_PRAX*_YZZK_P"!*_\ Q%>S44?VYF?_ #_E]X?Z
MJY'_ - D/N/&?^&4/!7_ #UU7_P)7_XBC_AE#P5_SUU7_P "5_\ B*]FHH_M
MS,_^?\OO#_57(_\ H$A]QXS_ ,,H>"O^>NJ_^!*__$4?\,H>"O\ GKJO_@2O
M_P 17LU%']N9G_S_ )?>'^JN1_\ 0)#[CQG_ (90\%?\]=5_\"5_^(H_X90\
M%?\ /75?_ E?_B*]FHH_MS,_^?\ +[P_U5R/_H$A]QXS_P ,H>"O^>NJ_P#@
M2O\ \11_PRAX*_YZZK_X$K_\17LU%']N9G_S_E]X?ZJY'_T"0^X\9_X90\%?
M\]=5_P# E?\ XBC_ (90\%?\]=5_\"5_^(KV:BC^W,S_ .?\OO#_ %5R/_H$
MA]QXS_PRAX*_YZZK_P"!*_\ Q%'_  RAX*_YZZK_ .!*_P#Q%>S44?VYF?\
MS_E]X?ZJY'_T"0^X\9_X90\%?\]=5_\  E?_ (BC_AE#P5_SUU7_ ,"5_P#B
M*]FHH_MS,_\ G_+[P_U5R/\ Z!(?<>,_\,H>"O\ GKJO_@2O_P 11_PRAX*_
MYZZK_P"!*_\ Q%>S44?VYF?_ #_E]X?ZJY'_ - D/N/&?^&4/!7_ #UU7_P)
M7_XBC_AE#P5_SUU7_P "5_\ B*]FHH_MS,_^?\OO#_57(_\ H$A]QXS_ ,,H
M>"O^>NJ_^!*__$4?\,H>"O\ GKJO_@2O_P 17LU%']N9G_S_ )?>'^JN1_\
M0)#[CQG_ (90\%?\]=5_\"5_^(H_X90\%?\ /75?_ E?_B*]FHH_MS,_^?\
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MWXX?"O1?ASXA\/6FDM=-%>@F7[1('/#J., 8ZU]D5\S_ +5W_(X>#_\ =?\
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M/ZU^</\ \11_PPKX3_Z#^M?G#_\ $5]*T4?ZP9I_S_?X?Y!_KAGW_05+\/\
M(^:O^&%?"?\ T']:_.'_ .(H_P"&%?"?_0?UK\X?_B*^E:*/]8,T_P"?[_#_
M "#_ %PS[_H*E^'^1\U?\,*^$_\ H/ZU^</_ ,11_P ,*^$_^@_K7YP__$5]
M*T4?ZP9I_P _W^'^0?ZX9]_T%2_#_(^:O^&%?"?_ $']:_.'_P"(H_X85\)_
M]!_6OSA_^(KZ5HH_U@S3_G^_P_R#_7#/O^@J7X?Y'S5_PPKX3_Z#^M?G#_\
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MC_AA7PG_ -!_6OSA_P#B*^E:*/\ 6#-/^?[_  _R#_7#/O\ H*E^'^1\U?\
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M^-_^P'??^D[U\*?\$C?^2=>/O^PK!_Z)-?=?QA_Y)'XW_P"P'??^D[U\*?\
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M@48'OR35^!/_  3[\&_ ?XQW_CK3-8U*^C1672--F8H+$.I60.ZG,W!PNX
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MV!TZYXH ^^:*X/XW?&CP[\ _AWJ'C#Q+*ZV5L1'%;P@&:ZF;.R*,$C+'!]@
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ME_CCX8_M">+_  ]JVDZ5JGA+1-4U&QCM;6!HKJ7R_-2W!E+D#]X(]S;3\N[
MS@4 ?I517RO^Q+^T=\2?VAKOQ?>^./#-OX>TJTCM'TDVMA/!',)#-O(DE9O,
MP$CY7 &>G-,_;$_:J^(?P+\4>'/#'@/X>#Q1J>NP-/:7DL<UTLC(V)(5MX=K
MLZ@HQ._ #C@\X /JNBOS#U/_ (*!?M'?!_4-/N_B/\-[2UT>\E^6*^TJYL&D
M 'S)%*7(#=_F5R,]*_0?X,_%G1OCA\-=$\9Z"76PU*+<89?]9!(I*R1/[JP(
MST. 1P10!+X\^,/@?X736<7B[Q7I/AN2\5FMUU*Z6$RA2 Q7<><;A^==-I>J
M6FN:79ZCI]S'>6%Y"EQ;W$+!DEC=0RNI'4$$$'WK\<O^"AGQ8\8_$;XLR:5X
MF\,?V!IWAO4-2T_1[K[--%_:%N)PHES(</E8T.4X^;W%?7/["?[1WQ-\?:AX
M?\#^(O /]B>$=,\.1K9ZY]@NHOM A2&.(^8Y\L[T);CKVXH ^WJ*\V_: ^/7
MAS]G3X=W7BSQ&TDJ!UM[2QM\>=>3L"5C3/ X#,2>@4GG@'X&@_X*#?M'_$R2
M]U?P%\-HI_#]K(0PT_1+O45CP/NR3*<%L,"<!>@.,9H _4*BOC;]C_\ X*#V
MOQZ\2)X+\8:3;^'/&$B,;22U9OLMZRC+1A7):.0 ,0I+ A3R#@'Z?^*WB:[\
M%_"WQCXAT\1F_P!)T:\O[<3*60R10.Z[@",C*C(S0!U5%?E;X1_X*L_$AM'U
M:UO?#&D:[XGN9;>/2$M;:5((Q^\\XR(LA>1B?*"JI7^(D] ?OO\ 9=\?>+OB
M=\$]#\2>.=,&C>);R2Y^T60M)+41JMQ(D>(Y"6 **IY/.<]Z /5Z*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\H_:(_Y%C3?^OS_V1J]7
MKRC]HC_D6--_Z_/_ &1J^.XP_P"1#BO\/ZH^BX>_Y&M#U_1E[XS?\FGZE_V
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M^B37M4/^1?6]8G#4_P!YI^C/O>BBBO%.X**** "BBB@ HHHH **** "BBB@
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MS>ZQ_9+:>JH#<&4F/S/,SA?-Z[><=* /?/CA_P D5\?_ /8OZA_Z325^8?\
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M_*OKC]D&YBNOV7_A@\,BRH-!M8RRG(W*@5A]000?<5!^U/\ LS:/^U!\/8]
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M/&-O<)I]D]QHNHR1QDN;:0@QW"+_ !*2L4G')4G S@5^T5>(?M'_ +(/@/\
M:8LX)/$%O-INOVJ>7;:YIQ5;A$R2(WR"LB9).UAD9.TKDT >A6?Q>\#:AX>3
M7K?QCH,NBN-PU :E#Y'XONP#['I7,?!_]I[X<_';6M=TKP=K\>HWVD2[)870
MQF:/IYT(;EX\\;AWQGAE)^*)O^"/=[]NQ%\4K<V>X?.^AL) O?Y?/QD<]^?:
MOJS]FG]BWP)^S.9=0TH7&M^)YXS%+K>H >8J$\I$@XC4X&>K'NQ'% 'RE_P5
M_P!'U$ZI\-M6V.VD"&\M0X'RI,6B8@^A90,?[A]*^OOV4OB7X,\0?LV^"[O1
MM5T^VL-)T6VM;^)IT3[#-%$J2K+DC:=P)RV-P8-_%FN_^*WPI\,_&GP3>^%?
M%FGKJ.DW6&VABDD4@^[)&PY5U['W(.02#\*:[_P1]MI=69M&^)TUKI;,<17V
MCB::->WSK,BN?^ K0!X;X?U"S^*?_!2FQU3P.!<:9<>,$OHYK9?DEAA8/<3#
M_9=8Y7SW#5^F/[6__)L?Q0_[%^\_]%&N>_9D_8S\$?LQQW%YI+7&M>);N+R;
MC6K\ /Y>03'$@XC0D GJ3@98X&/3_BYX!_X6G\,?%'A#[=_9G]MZ?-8?;/)\
M[R?,4KOV;EW8STR/K0!\%_\ !'O3[=O^%IWQC4W2_P!FP+(1RJ'[2S 'W(7/
M^Z*\\_X*V01Q_M ^&)%15DD\,P[V Y;%U<@9K[8_8\_9!_X9/MO%47_"6_\
M"4_VZ]JV[^S?L?D>2)1_SUDW9\WVQM[YXYO]KC]@_P#X:F\?:5XE_P"$X_X1
MC[#IBZ=]E_LC[7OVRRR;]WGQX_UF,8/3KS0![=!I-I;_ +/\>F1V\:V">&!;
MK %PHC%IMVX],<5^=?\ P2+9O^%T>,UR=I\/Y([<7,7^)_.OT[_X1K_BB?\
MA'_M/_,/^P?:/+_Z9[-^W/XXS^-?-W[(O["O_#*_C76?$'_";_\ "3_VCI_V
M#[/_ &3]D\O]XC[]WGR9^YC&!UZT 6?^"EG_ ":+XH_Z^['_ -*8Z\?_ ."2
MGCGPQ;_#OQ7X5>\M;;Q6^L&^^SRNJS7-LT,2(4!Y8*Z29 SC>/[U>P?\%+/^
M31?%'_7W8_\ I3'7QG^RC^PGH7[47P%N/$(\177AGQ)::Y<67VA8!=02PK#
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M^)/YUYU<_P#!*U-?\-W<?B/XKZKKOB5DBBL]2O+-Y8;%%8%U6)KC+Y4!02X
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M=_R.'@__ '7_ /1B5]7PQ_R-(>DO_26?G_'?_(BJ^L/_ $N)[+^TE_R3R/\
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M5?$=AKB:O;0P(EG"\9C*.S$G=USNKZRH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *^2/V^/^9%_[?\ _P!MZ^MZ^2/V^/\ F1?^W_\
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M$L?^39KK_L8+K_T5!7?4_P!SK?\ 7PYX_P >G_A/L*BBBOGCTPHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .6^*'P[TWXM?#_7/!^KSW5MIFL6YMIY;)U695)!RA96 /'<&N&_9P_9;
M\*?LOZ7K5AX5U#6-0AU::.>=M8FBD9612H"^7%'@88]<U[%10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5^?_\ P5U_Y$OX=?\ 80N__1<=?H!7Y_\
M_!77_D2_AU_V$+O_ -%QUZV4_P"^T_G^3.+&?P)?UU/J7XK_ /)H]C_V#-+_
M )PU<_9K_P"2.:)_OW'_ */>J?Q7_P"31['_ +!FE_SAJY^S7_R1S1/]^X_]
M'O7LS_Y$#_Z_?^V'Q$?^2P7_ &#?^Y#T^BBBOD#]$"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y'XJ
M?"OPY\:/!=WX4\5VDE]HMT\<DL,4SPL61PZ_,A!'('>J7P;^"?A/X"^%9O#O
M@VQET_2IKM[UXIKAYR965%8[G)/2->/:N[HH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *^9_P!J[_D</!_^Z_\ Z,2OIBOF?]J[_D</!_\ NO\ ^C$K
MZOAC_D:0])?^DL_/^._^1%5]8?\ I<3V7]I+_DGD?_7]%_Z"]7OAM_R(>A?]
M>J51_:2_Y)Y'_P!?T7_H+U>^&W_(AZ%_UZI7XKA_^2LQ'_7F/_I1^UUO^1#2
M_P"OC_(Z6BBBOOSY0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#C/C%\*M)^-WPWUGP3KMQ>VFE:JL:
MSS:>Z).NR5)1M+JRCYD&<J>,_6N:_9T_9K\,_LQ^%]3T'PO?:M?V>H7GVZ5]
M7FBDD#[%3"F.-!C"#J"<YYKUBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KRC]HC_D6--_Z_/_ &1J]7KRC]HC_D6--_Z_/_9&KX[C#_D0XK_#^J/H
MN'O^1K0]?T9>^,W_ ":?J7_8#MO_ &E7+?L:_P#)$[7_ *_KC_T(5U/QF_Y-
M/U+_ + =M_[2KEOV-?\ DB=K_P!?UQ_Z$*_3<M_Y):/^./\ Z0CZ6I_R3.)_
M["/_ &T]RHHHKPS\X"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH Y#XN?"_2OC/\.=:\%ZW<7EKI>K1K
M%/-8.B3J%D5QM+JR@Y0=5/&:Y+]G/]F7PO\ LQ>'M5T;PM?ZO?VNI70NYGUB
M:*1U<($PICC0 8'<&O7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Q7_P %8_\
MDW7P[_V-5M_Z1WE?:E?%?_!6/_DW7P[_ -C5;?\ I'>5Z66_[Y3]3DQ7\"1V
M.H?\HLT_[$&+_P!$K6!_P2Q_Y-FNO^Q@NO\ T5!6_J'_ "BS3_L08O\ T2M8
M'_!+'_DV:Z_[&"Z_]%05WU/]SK?]?#GC_'I_X3["HHHKYX],**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/_ /X*Z_\ (E_#
MK_L(7?\ Z+CK] *_/_\ X*Z_\B7\.O\ L(7?_HN.O6RG_?:?S_)G%C/X$OZZ
MGU+\5_\ DT>Q_P"P9I?\X:N?LU_\D<T3_?N/_1[U3^*__)H]C_V#-+_G#5S]
MFO\ Y(YHG^_<?^CWKV9_\B!_]?O_ &P^(C_R6"_[!O\ W(>GT445\@?H@444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\S_M7?
M\CAX/_W7_P#1B5],5\S_ +5W_(X>#_\ =?\ ]&)7U?#'_(TAZ2_])9^?\=_\
MB*KZP_\ 2XGLO[27_)/(_P#K^B_]!>KWPV_Y$/0O^O5*H_M)?\D\C_Z_HO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O*/VB/^18TW_K
M\_\ 9&KU>O*/VB/^18TW_K\_]D:OCN,/^1#BO\/ZH^BX>_Y&M#U_1E[XS?\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\5_P#!6/\ Y-U\._\
M8U6W_I'>5]J5\5_\%8_^3=?#O_8U6W_I'>5Z66_[Y3]3DQ7\"1V.H?\ *+-/
M^Q!B_P#1*U@?\$L?^39KK_L8+K_T5!6_J'_*+-/^Q!B_]$K6!_P2Q_Y-FNO^
MQ@NO_14%=]3_ '.M_P!?#GC_ !Z?^$^PJ***^>/3"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OS_ /\ @KK_ ,B7\.O^PA=_
M^BXZ_0"OS_\ ^"NO_(E_#K_L(7?_ *+CKULI_P!]I_/\F<6,_@2_KJ?4OQ7_
M .31['_L&:7_ #AJY^S7_P D<T3_ '[C_P!'O5/XK_\ )H]C_P!@S2_YPU<_
M9K_Y(YHG^_<?^CWKV9_\B!_]?O\ VP^(C_R6"_[!O_<AZ?1117R!^B!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S/\ M7?\
MCAX/_P!U_P#T8E?3%?,_[5W_ ".'@_\ W7_]&)7U?#'_ "-(>DO_ $EGY_QW
M_P B*KZP_P#2XGLO[27_ "3R/_K^B_\ 07J]\-O^1#T+_KU2J/[27_)/(_\
MK^B_]!>KWPV_Y$/0O^O5*_%</_R5F(_Z\Q_]*/VNM_R(:7_7Q_D=+1117WY\
MH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>4
M?M$?\BQIO_7Y_P"R-7J]>4?M$?\ (L:;_P!?G_LC5\=QA_R(<5_A_5'T7#W_
M "-:'K^C+WQF_P"33]2_[ =M_P"TJY;]C7_DB=K_ -?UQ_Z$*ZGXS?\ )I^I
M?]@.V_\ :5<M^QK_ ,D3M?\ K^N/_0A7Z;EO_)+1_P <?_2$?2U/^29Q/_81
M_P"VGN5%%%>&?G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%% !1110 4444 %?%?_  5C_P"3=?#O_8U6W_I'>5]J5\5_\%8_^3=?#O\
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M/6@#[$^$?@']IKP?\1-)D\:?$?P]XS\&SB0ZE#]@6*X@;82OD[(HR<OM'+8
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M0$ <D*[-@$A>@H ^TJ*S/#/B72_&7A_3]<T2^AU/2;^%;BVN[=MR2HPR"/\
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MLU_\D<T3_?N/_1[U[,_^1 _^OW_MA\1'_DL%_P!@W_N0]/HHHKY _1 HHHH
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MY):/^./_ *0CZ6I_R3.)_P"PC_VT]RHHHKPS\X"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "ODC]OC_F1?^W_ /\ ;>OK>ODC
M]OC_ )D7_M__ /;>OJ.&?^1M1_[>_P#29'WG O\ R4.&_P"W_P#TB1]FZ+_R
M!K#_ *]X_P#T$5=JEHO_ "!K#_KWC_\ 015VOF9?$SX>I\;]0HHHJ3,****
M"BBB@ HHHH **** "BBB@ HHHH Y#XP_\DC\;_\ 8#OO_2=Z^%/^"1O_ "3K
MQ]_V%8/_ $2:^Z_C#_R2/QO_ -@.^_\ 2=Z^%/\ @D;_ ,DZ\??]A6#_ -$F
MO:H?\B^MZQ.&I_O-/T9][T445XIW!1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 5\5_\%8_^3=?#O_8U6W_I'>5]J5\5_P#!6/\
MY-U\._\ 8U6W_I'>5Z66_P"^4_4Y,5_ D=CJ'_*+-/\ L08O_1*U@?\ !+'_
M )-FNO\ L8+K_P!%05OZA_RBS3_L08O_ $2M8'_!+'_DV:Z_[&"Z_P#14%=]
M3_<ZW_7PYX_QZ?\ A/L*BBBOGCTPHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OA+]MC4[G]H3]H'X=?L]:/,XL1<IK'B.2$D&*,*6"D]BL/F,
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M?#R;P)XO\ >%9?B3X9N9[>^AUK0[5KVXC\UV#DNFYRF3&V>5V+GJ* /HZ?\
M;/\ @3=0R0S?$?09H9%*/'([,K*1@@@KR"*^7/V6/&OA3P+^W5XI\(_#;6;;
M5?ASXPL6O;6WLY28;:Z2/S2J@CC;MG4#'W67^[7V7_PS3\(?^B5>"?\ PG;/
M_P"-U6^'7@GX,P^*-2N/ WAKP5;^(= G-G=W&AZ9:QW-E*R<H7C0,I*L0>?[
MP[$4 ?,W_!7%BOP7\&,I((\0@@CM_HTU?2'[+_P1T?X$_!_0M$L+..+5+BUB
MNM7O,9ENKMD!D9VZD!B54'HH ]:^;O\ @KG_ ,D5\&_]C /_ $FFKZ2_9?\
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M;X,^'O$WQ%AU:X\3ZW$=2D6&^:(1Q2G=$I&,EBFUCGG+D=J /O/_ (2;1_\
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M$ZC!. V-K=032_'#]H3P3^SYX9;6?%VJ+ 6P+?3K<J]Y=$G'[J(L"P'))X
MY- 'GG[?WC6Z\ ?LH^,9=-?[-<WT<.E(R#&V.:14D QTS$7'XU\__LO?MM?
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M10 4444 %%%% !115+6M9LO#NCW^JZE<)9Z=8P27-S<2'"Q1(I9V/L "?PH
MNT5^/&L:K\0?%&L:S^V!9+(EEI?BV""TL'+ _8E&S!(_Y9[3# Q'4R2>AK];
M?!7B[3?'WA'1O$FCS"XTO5;2.\MY!W1U# 'T(S@CL010!M5Q'Q4^-G@;X)Z3
M#J7C?Q)9Z!;3,5A6;<\LQ'79$@9WQQG:IQD9ZUV]? [>%]-^//\ P4\\4Z3X
MPM8]:T3P;H$=Q8:;>*)+<L$M3AD/##S+N1\'J0N<XQ0!]+_"7]KKX3?&[7/[
M%\(^+H;[62K.NGW%O-:S2*N22@E1=^%!8A22!R<5TW@[XX^"?'WCGQ)X/T'6
MOM_B/PZY35++[)/']G8.4(WN@1OF&/E8UHZ7\*?!>A^)(?$&F>%-&TW6X8&M
MDO[.QCAE$3;<KN51D?*.O3D#J:^/OV._^3X_VD/^ON7_ -*FH ^O?B=\6O"/
MP9\.IKOC/6X-!TIYUMDGF5WWRL"0BJ@+$X5CP. ">@KH=%UJQ\1Z/8ZKI=U%
M?:;?0)<VUU"VY)8W4,KJ>X((-<9\:O@3X._: \+P:#XSTZ2_L;>Y6[@:&=H9
M(I "N593T*LP(.0<],@$=9X6\,Z9X+\-Z7H&BVBV.DZ9;1VEI;(21'$BA5&2
M23P.I))ZGF@#F/!WQQ\$^/O'/B3P?H.M?;_$?AURFJ67V2>/[.P<H1O= C?,
M,?*QKNZ^%/V._P#D^/\ :0_Z^Y?_ $J:ON::[@MFC6::.)I&V('8 NWH,]30
M!+1110 445%;W4-VK-!-',JL48QL& 8=0<=Z ):*** "BFR2+%&SNP1%&69C
M@ #N:56#J&4AE89!'(- "T4V21(8VDD941069F.  .I)I()X[J%989%EB895
MXV#*1[$4 /HHHH **BM[J&[5F@FCF56*,8V# ,.H..]2T %%%(S!5+,0 !DD
M]J %HJ.WN8;R%9H)4GB;[LD;!E/;@BI* "BOE[]K']H+Q=\'_C%\$?#GAV:T
MCTSQ9JWV/4UN+<2.T?VBUC^0D_*=LS\_3TKZAH **** "BBB@ HHHH ****
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M9;_OE/U.3%?P)'8ZA_RBS3_L08O_ $2M8'_!+'_DV:Z_[&"Z_P#14%;^H?\
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M/WPYX&\:1^-_'?B;4OBEXRCD$T5[K((@BD!RLGEL[L[J>A=R!U"@@$?5M%%
M'SA\?OV&_!GQJ\1KXNTW4+_P)X[C(==?T,[6DD'W7E0$;F']Y61NF6.!CS9_
MV'OC-JL(TK6/VF_$EUH))25(XIQ/-'_=9C<$G( ^\6 R>O.?MBB@#RG]GW]F
MGP5^S9X<GTSPI:S/<WA5[[5+UQ)=7;*.-S  !1DX50 ,D]22>?\ VNOV7_\
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MCHEN^\:5!&T2L>.=SR.JGCDB,GW%?7O@/P#X?^&/A2P\-^%]+@T?1;%-D-K
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M9K_Y(YHG^_<?^CWKV9_\B!_]?O\ VP^(C_R6"_[!O_<AZ?1117R!^B!1110
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MYG_:N_Y'#P?_ +K_ /HQ*^F*^9_VKO\ D</!_P#NO_Z,2OJ^&/\ D:0])?\
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MX)P:YHVOZ+XEU+QW\%[JY2SOM'U)MTM@"> O.U&(!VNFU2PVNOW<_=E]\2-
MT_X;2^/)+U6\,QZ7_;'VM.=UMY7FAE'<E<8'<D"O*/V]?[/_ .&2/B)_:6WR
M?LD/E[L?Z[[1%Y6,]]^VO _$QU0_\$CX,;OM/]D6F=N<_9_[1C_3ROTS0!F^
M _ASX^_X*)SWWC3QYXFU7P?\)FN9(-(\-Z._EM=HC$;R6!1L-P9&5\LKA0H%
M=IKW_!,?P_X8MSJ_PG\<>)O!?C&V7-I=R7H:%B!RKF-%D ;')#$#)^4]*YC]
MFOP[^U'>? GP7-X$\5_#>U\)/8*;"&]BN#.B[CN63%N1O#[MV"><\UZ5_P (
MK^VA_P!#E\+?^_-S_P#(U &]^QC^T9K_ ,5K'Q'X)^(-J+#XE^#IQ:ZFNP(+
MJ/)59@HXW94AMOR\JPX; \@_X*G:\GA:\^"NM20M<)INM7%XT*G!<1FW<J#V
MSC%=K^S[^S'\7O!O[3FM_%CX@ZSX1O9-9TM[&]C\/R7"L[8A",(WA11_J%R<
M]><<UQ7_  5.TR+6KSX*:=<9\B[UJXMY,?W7-NI_0T 2>&_V-O%G[6FFP>/?
MCGXXUNR&KA;S3O"NBNL46FV[ F-2)$95;:5R F[CYF+$X^@?VDOC?IW[)?P(
M75(HO[0OH(XM)T:UN&'[^<1D(9,8RJJA9L8SC QD5[@ %  & *^#/^"G C;Q
MO\ !J6/^$=.MW'V[?]S;YMGG=GC[GF?K0 G@3]AWQ1^TAIEIXW_:!\;Z_<ZA
MJ*_:K7PWI\JPQV$;C*J0RLJ'!^XBKCNQ.:M^,/\ @GMK/P?M3XI_9\\;Z_H_
MBFRQ+_9%_>1F'4-ISY>[:BY/]V4,AZ';UK[JHH XRW\77_@OX2CQ+\0_L6GZ
MAI>E&]UK^S7,D"-'&6D\LL 3G!P/4X!/4_$W@/X<^/O^"B<]]XT\>>)M5\'_
M  F:YD@TCPWH[^6UVB,1O)8%&PW!D97RRN%"@5]"?\%!OM?_  Q_\0OL>?,\
MJTW[>OE_;(-__CN[/MFO"/V:_#O[4=Y\"?!<W@3Q7\-[7PD]@IL(;V*X,Z+N
M.Y9,6Y&\/NW8)YSS0!T^O?\ !,?P_P"&+<ZO\)_''B;P7XQMES:7<EZ&A8@<
MJYC19 &QR0Q R?E/2O0?V,?VC-?^*UCXC\$_$&U%A\2_!TXM=378$%U'DJLP
M4<;LJ0VWY>58<-@8/_"*_MH?]#E\+?\ OS<__(U4_P!GW]F/XO>#?VG-;^+'
MQ!UGPC>R:SI;V-['X?DN%9VQ"$81O"BC_4+DYZ\XYH XK_@J=KR>%KSX*:U)
M$T\>FZU<7C1*<%Q&;=RH/8G&*N^%?V5?&?[7UA!X\^.7B[6-+TO5%%WI7@K1
M)1##96[<QF3<K+N*D'[N_&-S _*,K_@J]]DV_!W^T,?8/[5NOM&[&/+_ -'W
M=?;-??</E^2GE;?*VC9L^[C'&/:@#X7\8?\ !.6]^%MK-XF^ WCSQ#X>\5V:
M>:MC>7:F*^V\B+>BKC/(Q('0DX. 2:]:_9(_:"_X:I^$NN:9XEMCIWBW2]VD
MZ_:PKY1/F*RK,JG.S< X(/1D;C&*^D:^#OV/3#_PW9^T2-)V_P!D^;-YOE_=
M^T?:ANZ<?>\Z@#P_]JK]C3P#\&?B[\%O#6@3:P^G>+]5^Q:B;RZ2201_:+:/
M]V0@VG;,_4'G%?8'PU_X)T_"KX5^.M%\6Z+<>(6U729Q<VZW5]&\18 CYE$0
M)'/K7FO_  4"_P"3COV8/^QA_P#;RQK[KH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *\H_:(_Y%C3?^OS_V1J]7KRC]HC_D6--_Z_/_
M &1J^.XP_P"1#BO\/ZH^BX>_Y&M#U_1E[XS?\FGZE_V [;_VE7+?L:_\D3M?
M^OZX_P#0A74_&;_DT_4O^P';?^TJY;]C7_DB=K_U_7'_ *$*_3<M_P"26C_C
MC_Z0CZ6I_P DSB?^PC_VT]RHHHKPS\X"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BN ^-7QS\'_ 'P@WB+QCJ7V*
MT9_*M[>%/,N+J3&?+B3N<=S@#J2!7S)8_M\?$OQY$M]X _9T\2:UH<GS0ZI=
M321I.N"<KM@*=NSMV'<4 ?;5%?&EI_P4@M_"FM6VG_%?X4>+/AFMPVU+RYB:
MXA!]3NCC9EQW16/M7V-:W4=]:PW$))BF19$+*5)4C(R",CCL>: ):*^3_P!@
MOXX^-OC1_P +-_X3+6O[8_L;65M+'_1((/)B/F?+^Z1=WW1RV3Q7UA0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCD"@#Z#HKPKX*?MK?"CX\:NNC^'M=DL]=D!,6EZM ;::4#D^6<E'.,G:K%L
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MW%3@\@=*]^_9J_;.\!_M->?8Z,;G1O$EM%YTVBZD%$A3@%XF4D2*"0#T8=U
M(R >]T5\F>!_V_K#Q!^T1_PJ/7O!=SX7U3^T)],^W3:@LT?GINV#;Y:DB0J
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M72.1G (/S%54X)#$<UE^'_\ @H]'X?\ %%CH?Q?^&'B#X6/=Y$>H7BR2PG!
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M /O9P"5!&: .U_X*F_!/P3X?^%^@^--(T73]"\0)JT>G,UA D NH9(I7(=5
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M7X;FCLM0N5ED>-;.ZMG=<+YJR.?DW* #G''4 @8 -;_@KM_R5CP-_P!@1_\
MT>]?87P<_9!^%%G\!] T._\ !.BZI-J&DP27^I75FDEW--)$&>03$;U(9FV[
M2-O;%?/G_!1+]G?XH_'/QEX(U;PMX.GU(6^B>5?)!<PXMYS(6,>6==V,]1P:
M^\_ NGW&D^"/#UE=QF&ZMM.MX98R02KK$H8<>A!H _*G_@F?)/X7_:\U/1H)
M6:WDTV_LI<G[ZQR(P)'KF,?F:VOVB/@#\5_@K^U1JGQ6T+P4/B!HMUJLVK6O
M^@-J$ \P'=%<0I\Z;-Y"MP/E5@<C [?]C']F'XG_  T_:POO%7B;PE<Z5X?D
MCU!5OI)X64F1LIPKEN?I76?&"']LSP3\7O%.O^#5AUWPGJ%R7L]/M9[>[@MX
M5&V-1%-MD1]J@OY8VEF/)R* .,\(_P#!1+P-JGC+1X/BM\&;'0;_ $^Y2:+6
M[6W6::PE!RD@A>(2( ><JY..BGO^D=K=0WUK#<V\JSV\R+)'+&<JZD9!![@@
MU^7'B[]FS]IK]LCQQH=]\2='L/"6EV:- M[,L$0MXF8,X6%':5V/8-\N1U7)
M-?I[H&BV_AO0=-TFTW?9;"VCM8=YRVQ%"KD^N * +]%%% !1110 4444 %%%
M% !1110 5\5_\%8_^3=?#O\ V-5M_P"D=Y7VI7Q7_P %8_\ DW7P[_V-5M_Z
M1WE>EEO^^4_4Y,5_ D=CJ'_*+-/^Q!B_]$K6!_P2Q_Y-FNO^Q@NO_14%;^H?
M\HLT_P"Q!B_]$K6!_P $L?\ DV:Z_P"Q@NO_ $5!7?4_W.M_U\.>/\>G_A/L
M*BBBOGCTPHHHH **** "BBB@ HHHH *\Q_:<\=:A\-?V?_'GB326,>J6.ERM
M;2CK%(V$5Q[J6#?A7IU87CSP9IWQ$\%ZYX7U=#)INKV<ME<!?O!74J67T89R
M#V(% 'Y?_P#!-K]FWPA\=-2\8>*_'5J/$2Z7+%!!I]U(Q1Y90[/-+SESP ,\
M9+$Y(&)_^"E'[-'@WX)2>$O%W@:S7P[_ &E<26MQIUJY$8D10Z31@G*'J#CC
M.T\'.<G1?AW^T3^P'\1M5N/"/A^;Q9H%_P#N3-:V$M[8WT8+&)I8XB'BD7)[
MC!+ %E/*>(O O[1G[?GQ"TEO%/AR;PGH.GDQ":YL);*PL4;!D=$E)>:1@%X!
M)R /E7D 'M?[1GCS4OB9_P $Q/#WB36':;5+P:>MS,V=TLD=QY1D/NVS<?=J
MXC_@G%^R-X"^+GP\USQKXYT=?$#_ -I-IME9S3.D42QQQNTF$8;F8R;>>@3W
MKZ!_;,^#-UI/[%,/@#P-H>I:XVEMI]M;6>GVKW-S(D;KND*1J22<%F('4DU:
M_P"":G@OQ#X$_9VN=-\2Z%J?A[43KES,+/5;.2UF*&.$!MDB@X)!YQC@T ?!
M_P"TU\.M-_9A_;(TV#P2)M.T^WN;#5[&W$S,;<LX+1AR=Q7<K8R2<-@YKWK_
M (*Z?$+5K>Y\#^"H)Y(-'GAFU2ZC0D+<2!PD8;U"8<@>KY["N?\ ^"@'P?\
M'OC/]J_3M7\/^"/$>NZ2MC8(U_INDW%Q &61BP,B(5R >>>*^H/V\OV2[O\
M:6\%Z;?>'9(8O&.@F1K.*=@D=Y$^W?"7/W6RH*D\9R#@-D &;\"?V"?@]#\$
M_#T>N^%[;Q)JVJZ;#>7NJW$LGFM)+&KD1,K#RU7.%VXX&3DDUTOP9_90\'?L
M>Z!XQ\4>'+C5=9U=K"XE>34+CY?)C!E2(1)M4D;5&\@MG=@J&(KXV\$?M&?M
M8?!'P?#\/4^'=_J+:<@M+*[O_#UU<W%O'@!$CDC81R*HX7(;L,D "OJ/]AGP
MO\=_[!UZZ^,^IW5QH>HJWV+1M<59;W>[$R.Y^]''@E1$Q[\*@'S 'YR? [XB
M>$;KXP:OXT^+OAK6/B,UP)+K[%9HLJR73N"9)@S#<@&X!>F2.PQ77?M4>-OA
M7\6+/2[WX;?"C6O ?B"WGVW/E:?';V=Q 5/_ "SB8@2*VW!"C(+9SA<>E^*?
MV=?C;^P_\8+WQC\*--N?$WAF;S(X7M;9KS-LS!OL]U GS_*0OSKP=H(93D#N
M]#_:>_:^^+OB?0;/0?AK'X<MH;R-[F:;1;FVM9U&"\<\]PQ"QXY(CP_/!)Q0
M!]=_L>^--6^(/[-/@/6M=:9]7DLFMKF2Y#"61H)7@WOGDLPB#$GJ3GO7'_\
M!0SX@ZK\//V7?$5QH\TEK>:G-#I9N(B0T4<K?O"".A**RY_VJ^CK5IFMHC<)
M''<% 9$B<NBMCD!B 2,]R!GT%<#\?_@YI_Q[^$NO^"M0F^R+J$2F"["[C;SH
MP>.3'<!E&1QD$C/- 'Y1_LH_$KX-_#/PS?7/CGX4ZK\0_$-U<,%N6L(;NS@@
M"@*B)(V-^=Q+%<\@#&.<#Q9X^T7PW^T3HGQ#^#_A'Q!X.TRSG@NWTRZ@("2A
MR)D0(S?N9$X*9_C< !<"O6OAWJ'[3G["FH:EX9L/!$WB7P_=7)G$::?/J%C)
M)@ RPRP$,A90N5;'3E<BOHO]F'XP?M/_ !8^,46I^,?!L/AOX?FU,=S:WFGR
MZ=&F>4EM_-W322$@=24VY^Z2#0!Y5_P5?^#\NC^(/"OQ6TE&@-QMTO4)H<J4
MG3+V\N1W*AUSV\M*ZW]I3]L2+Q%^P=X>U*RN53Q-XZ@_L>ZCC.UHC$-M^V!T
M4XV8_NSJ:^N_VB/A-!\</@QXJ\&RJOGZA:,;.1^!'=)\\+9[ 2*N?;([U^0_
MPA_9'^*GCWXD>%/"?B+P5XLT3PRVHEKNZU'2[F"UM8C@SN'90BLR1!0<_,0@
M]* /K[]G/PCJ'[,O_!/SQE\0;6+[/XM\0:?)JL<Q4[X8F'E6A]PJN9A_UTKY
M _94\>?#'P3K.MZ[\2O &K_$C49&06<4=O'=6T).XR/*DC .[';C<"  >YX_
M9OQ?\/\ 1_&GP_U7P9>VRQZ'J&GOIK0P@+Y<3)L&SL"HQCT(%?E]HGP^_:,_
M8#\>:Q)X1\/R^+O#FH,J--:V$M]9WJ*6\IY$B(DAD +#DCEB,L,$@'D_[17B
M[P7XL\<:'XJ^#_@+Q!\/+^V/F74*VPAB69&5H9H%C8^6PYR!@?*I SDGZB_X
M*3^)KCQI^RW\&?$-W'Y-UJTEO?S1[2NQY;'>PP>F"QXK>^$/[0'[6/QB^+GA
MJ:7X?P^&O!\$K?VC#>Z9/86D\!.'9IIMTAD7^$1<;@,J0#73_P#!4CX?^*/B
M#\,O!MKX6\-ZOXENH-8>6:'1[&6[>-/)8;F6-20,\9- '%_L$_L1_#SQ7\'=
M"^(GC+2I->UO5)Y+FSAEN98H;..*9XTPL;+O9C&7RV1@J  02?,/^"A7@74/
MV?OVGO#GQ8\-)]FCU>:/4T91A%O[=E\U3CLZ^6QS]XO)7W5^Q1X>U7PK^R[X
M"TK6],O-'U2VM9EGL;^!X)XB;B4@,C@,IP0>1T(JA^W+\&D^-/[.?B.QAC5]
M7TA/[9TYCU\V%6+(/]^,R)Z98'M0!\R_\%'OVFK#Q9\"_ 7A[PU<%H_&T$.N
MW,:MEUM%P8XG'J9OR-N17U?^QY\%Q\"?@!X:\/3P"'6)XO[1U3C#?:I@&96]
MT79'_P!LQ7Y=?L(?":Y^.G[0WAFWU/S+WP_X6C_M.X6;+1I%%(7BA /&&GD!
M*]P9#CK7[74 %?./[8'[9.@_LR^'39VWDZQXZOHB;#2=V5A4Y GGQRL8/1>"
MY&!@ LOJ7QV\4>)?!?PA\4ZUX.TF37/$]I9EM/L(;9[AI)20HQ&GS/C); Z[
M:_&J3X7_ !TU7X@GQEXB^%/C#Q;J\ES]KN%USPY?317+CH)%5%RHX^4$+@ 8
MV\4 ?4/[!7[,/B?XG?$M/CU\13+Y#7<FI:='=+B74;IR3]I*_P ,2$DKCJ0N
M/E7G],*_-/1?VM/VO3?6-K)\(+RWLO,CB;;X,OT5(\@''.  /RK]+* /@O\
MX*[?\DG\#?\ 8;?_ -$/5/\ 8?\ V)?A?XZ_9UTGQ3XS\/CQ!K/B'SY#)-<2
MQBUB29XD6/8RX)";BW7+8Z"NJ_X*D?#_ ,4?$'X9>#;7PMX;U?Q+=0:P\LT.
MCV,MV\:>2PW,L:D@9XR:]G_8H\/:KX5_9=\!:5K>F7FCZI;6LRSV-_ \$\1-
MQ*0&1P&4X(/(Z$4 ?E+\/_@'I?BC]LP_"::XN&T.W\37NF22JP$LEM:R2EN>
MS,D)&>Q.:^JO^"A7[(?PU^%GP1LO%?@KP^GAW4;#48;6;R9Y76XAD###!V;+
M!@I#=<;LYXQS7P=^#_CW2_\ @I+?^)[SP1XCM/#;>*]=N%UB?2;A+,Q2"[\N
M03%-FUMRX;.#N&.M?4W_  48\(:]XX_9IO=+\.:)J.OZFVIVD@L]+M)+F8J&
M.6"("<#N<4 >3?LU_%S6_"?_  31\0Z_:3R-JGAZ'4+.PG8EFBRX\MA_N&;(
M] H[5XS_ ,$VOV;?"'QTU+QAXK\=6H\1+I<L4$&GW4C%'EE#L\TO.7/  SQD
ML3D@8^FOV&?@W?7G['>M>!/'>@:GH0U>[O[>XLM2M'M;@12HBB15D4$>JMCJ
M/:OE;1?AW^T3^P'\1M5N/"/A^;Q9H%_^Y,UK82WMC?1@L8FECB(>*1<GN,$L
M 64\@&M_P4H_9H\&_!*3PEXN\#6:^'?[2N)+6XTZU<B,2(H=)HP3E#U!QQG:
M>#G/JG[1GCS4OB9_P3$\/>)-8=IM4O!IZW,S9W2R1W'E&0^[;-Q]VKQ3Q%X%
M_:,_;\^(6DMXI\.3>$]!T\F(37-A+96%BC8,CHDI+S2, O ).0!\J\CZU_;,
M^#-UI/[%,/@#P-H>I:XVEMI]M;6>GVKW-S(D;KND*1J22<%F('4DT ?/W_!.
M+]D;P%\7/AYKGC7QSHZ^('_M)M-LK.:9TBB6..-VDPC#<S&3;ST">]>-?M-?
M#K3?V8?VR--@\$B;3M/M[FPU>QMQ,S&W+."T8<G<5W*V,DG#8.:^\/\ @FIX
M+\0^!/V=KG3?$NA:GX>U$ZY<S"SU6SDM9BACA ;9(H."0><8X-?-/_!0#X/^
M/?&?[5^G:OX?\$>(]=TE;&P1K_3=)N+B ,LC%@9$0KD \\\4 >I?\%4?A7X4
MA^%4?CY-'B7Q?+JMI8/JGF/O,'ES'9MW;<?*.V>*7_@G+^SS\._$GP6\,>/]
M2\,V]UXPM-4N)8-4::4.C13'RSM#A>,#J*]X_;:^".J_'SX ZMX=T%4EUVWG
MBU&Q@D8()Y(R<Q[B0 61G )XSC.!R/AW]E_XP_M"_L^1:;\.(?A3JM_HIUI)
MIUO-#N_M,43NOGI%("L8!4%@S @%B<D$8 .:_P""H-M)>?M7);Q#=++H]E&@
M]26D K[!\3?\$Z?A!I/P.U/2X="9O$EII,CIXB-S+]H:Z2,L)2-VS:6'*;<8
M..O-?/7_  4 ^#_CWQG^U?IVK^'_  1XCUW25L;!&O\ 3=)N+B ,LC%@9$0K
MD \\\5^EGC*"6Z\(:Y##&TTTEC.B1QJ69F,;   =230!^:7_  2'\07D/Q&\
M=Z&)7.GW&E17K1;CM$D<P0-CIG$I&?85Y#XTT'6/V9OVH-;\2?%3X;_\)WH]
MQJ%W<HNJ9^QWZRR,4G60JZ,W.=C@\G! ."/=_P#@EW\)O''P_P#BYXKO/%'@
MSQ!X;LYM#,,5QJ^ESVL<C_:(CM5I$ )P"<#G -;/BC]J;]JSX<^-O$=MK/PC
MFU[P[-?2M:P2:-+<)!;%SLB6YM28W^7 );<<_E0!-\"?VB/V5O'WQ5\,WB_#
M>#X;^,K>X_XEMU]FCAL3.XV*I,+!-WS?*9(P <$$&OT-K\@Q\"_BK^V9\<K'
M7;CX91_"_1!Y,-Y>0Z:^GP1Q(Y9I?G ,\YW8!4=D!V@$C]?* "BBB@ HHHH
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M (* ?%QOVD_BU\.OAKX&N!J-C)%:W,93A9;J^5&BW>R0NASV\Q\]*_2OX:^
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MM_96\$_M<_"SQ9X+\)ZEI$EK\-])OB;RTNKFP:-;:0MYFV56:1]ID9U52?F
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M>)Y+>76+NXNHY6M81$F(YW1<*.G"BO<* "BBB@ HHHH **** "BBB@ HHHH
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MLT3$<$;E)&0>HZB@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@S2_YPU<_9K_ .2.:)_OW'_H]ZI_%?\ Y-'L?^P9I?\ .&KG[-?_ "1S1/\
M?N/_ $>]>S/_ )$#_P"OW_MA\1'_ )+!?]@W_N0]/HHHKY _1 HHHH ****
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MA_\ DK,1_P!>8_\ I1^UUO\ D0TO^OC_ ".EHHHK[\^4"BBB@ HHHH ****
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M /)/A+\1_P!K;]H_P';:;X'UB^.E:'YL%UKC7:03WDSNTH62XE;<SJKJH5"
MJA,]0:Z;]EO]L'XL?#O]H2Q^%GQ9O;S5H;_44TB:/5-KW=C=.0D3+*/OHS%
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M32;>3P0.N%R!6IX0_:H^-?[(_P 9-.\#_'&\/B'PY>&,F^F99GCA=MHN8;@
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MC!QGPS=9_P# BUH ]E_;(_;E\;6OQ6?X2?!Y?*U:*X2PNM2MX5GN9KM\#[/
M&!5=I8*S$;MV0-NW)\R\:VO[9O[._A]?'>M>*-4NM+MRINT?48M2CMPQ _?0
MMN&W)V[E! ]1P:Y&]UB/]FO_ (*/ZCK_ (SADCTN+Q+>7[SM&7_T6\$OES@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;I>J6<7BSP5X_P# .DWDHBM]<\3: ;:R=CTRP=B,\]CP"3BN3\(^ ]-\3?\
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ME=[:;8K1L1U'S-@'^^WJ: /I?QIXVT+X=^&;[Q#XEU2WT;1;%-]Q>7381!G
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M^%_&OPT;4I/+LKSQEHILK:=CT <.V,\<D;1GDU]'S31V\+RRNL44:EG=SA5
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MQ7PA^$OA_P"#/@G3O#N@6,-LEO$HN+I4'G7<V!OFE?&7=CDDGUP,  5VM '
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MJ /*]4_:@^&F@#QDVK>)8M*B\)7<5CJLEW#(H2>0,R1QC;F5B%8X0,>#7-^
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MYKYA_9BTFV^&?[7'Q\^'^B1BS\+@:=K=II\?$-K+-"K2B-.B@F0# XPB#L*
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M!&37R%J'_!)/X8W.K-/;>*/%%G8,V?L@EMW91QPKF+IUZ@GD>G/W'10!Y_\
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M:#H?BKX-WWAQ(H=FM:_=:M;M KK$<-#&F3)O?;P#\H)Y.*Y#Q1\+?B9^S_\
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M%8GYF(V)Y@^\"P[5]RURGPK^&NB_!_X?Z)X/\/Q-%I6E0>3$9""\C$EGD<@
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MC\&>&?%&FR:3KMC]M^T6<CJS1[[V>1,E21RCJ>#WKW&B@#P#]B/X=>(_A?\
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M$CR1\^..#Q7I7[(/PHUKX)_L\^$_"7B&57UFTCFFN8XY Z0-+,\OE!AP=H<
MD9&0<'&*]DHH **** "OS_\ ^"NO_(E_#K_L(7?_ *+CK] *_/\ _P""NO\
MR)?PZ_["%W_Z+CKULI_WVG\_R9Q8S^!+^NI]2_%?_DT>Q_[!FE_SAJY^S7_R
M1S1/]^X_]'O5/XK_ /)H]C_V#-+_ )PU<_9K_P"2.:)_OW'_ */>O9G_ ,B!
M_P#7[_VP^(C_ ,E@O^P;_P!R'I]%%%?('Z(%%%% !1110 4444 %%%% !111
M0!\A_#OPS\8/V4K[Q/X:\/\ PYA^)_@K4M8GU72[^PUF"QNK7SBN89TF^]C
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M45X9^<!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ7_8#MO_ &E7+?L:_P#)$[7_ *_KC_T(5U/QF_Y-/U+_ + =M_[2KEOV-?\
MDB=K_P!?UQ_Z$*_3<M_Y):/^./\ Z0CZ6I_R3.)_["/_ &T]RHHHKPS\X"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\S_ +5W_(X>
M#_\ =?\ ]&)7TQ7S/^U=_P CAX/_ -U__1B5]7PQ_P C2'I+_P!)9^?\=_\
M(BJ^L/\ TN)[+^TE_P D\C_Z_HO_ $%ZO?#;_D0]"_Z]4JC^TE_R3R/_ *_H
MO_07J]\-O^1#T+_KU2OQ7#_\E9B/^O,?_2C]KK?\B&E_U\?Y'2T445]^?*!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E'[1
M'_(L:;_U^?\ LC5ZO7E'[1'_ "+&F_\ 7Y_[(U?'<8?\B'%?X?U1]%P]_P C
M6AZ_HR]\9O\ DT_4O^P';?\ M*N6_8U_Y(G:_P#7]<?^A"NI^,W_ ":?J7_8
M#MO_ &E7+?L:_P#)$[7_ *_KC_T(5^FY;_R2T?\ ''_TA'TM3_DF<3_V$?\
MMI[E1117AGYP%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %?)'[?'_ #(O_;__ .V]?6]?)'[?'_,B_P#;_P#^V]?4<,_\C:C_
M -O?^DR/O.!?^2APW_;_ /Z1(^S=%_Y UA_U[Q_^@BKM4M%_Y UA_P!>\?\
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M"6/_ ";-=?\ 8P77_HJ"N^I_N=;_ *^'/'^/3_PGV%1117SQZ84444 %%%%
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M$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *^2/V^/\ F1?^W_\ ]MZ^MZ^2/V^/^9%_[?\ _P!MZ^HX
M9_Y&U'_M[_TF1]YP+_R4.&_[?_\ 2)'V;HO_ "!K#_KWC_\ 015VJ6B_\@:P
M_P"O>/\ ]!%7:^9E\3/AZGQOU"BBBI,PHHHH **** "BBB@ HHHH **** "B
MBB@#D/C#_P DC\;_ /8#OO\ TG>OA3_@D;_R3KQ]_P!A6#_T2:^Z_C#_ ,DC
M\;_]@.^_])WKX4_X)&_\DZ\??]A6#_T2:]JA_P B^MZQ.&I_O-/T9][T445X
MIW!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF%4?K&,4;[727_MQ^*X3C[,<P<_J>6NIR[\LF[=OL'V'_:EG_P _<'_?Q?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA>:/J5GJMH3@7%C.DT><9QN4D=Q5N,DN9K07,KVN:%%%%0,**** "OS_ /\
M@KK_ ,B7\.O^PA=_^BXZ_0"OS_\ ^"NO_(E_#K_L(7?_ *+CKULI_P!]I_/\
MF<6,_@2_KJ?4OQ7_ .31['_L&:7_ #AJY^S7_P D<T3_ '[C_P!'O5/XK_\
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MOZ8K]$:YN-'>.%=K:2T_\!.WPP7++'J][.&O?X]0HHHK\Q/W4**** "BBB@
MHHHH **** "BBB@ HHHH *^9_P!J[_D</!_^Z_\ Z,2OIBOF?]J[_D</!_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_D#6'_7O'_Z"*NU2T7_ ) UA_U[Q_\ H(J[7S,OB9\/4^-^H4445)F%%%%
M!1110 4444 %%%% !1110 4444 <A\8?^21^-_\ L!WW_I.]?"G_  2-_P"2
M=>/O^PK!_P"B37W7\8?^21^-_P#L!WW_ *3O7PI_P2-_Y)UX^_["L'_HDU[5
M#_D7UO6)PU/]YI^C/O>BBBO%.X**** "BBB@ HHHH *_.+]O+]K;XL?!?X\-
MX=\&^*_['T;^R[>X^S?V=:3_ +QB^YMTL3-S@<9Q7Z.U^0?_  5$_P"3H'_[
M MI_.2O=R:G"KBN6I%-6>^IY^.E*%*\7;4Y/_AXA^T'_ -% _P#*-I__ ,CU
MMZ!_P4P^.FCS1/>:UI>NJA!:._TJ% _/0^2(S[<$5]U?\$[M#TZ\_9(\&S7&
MGVL\K2WV9)(59C_IDPZD5['\0/@#\._BAI-SI_B3P?I-_'.NTSBU6.X3T*3*
M ZD>H(KT:V.P5.K*E/#JR;5U;I\OU.6&'KR@IJJ]?4^??V8_^"C/A?XTZO:>
M&?%=@G@_Q3=.(K1A*9+*]<]%5R 8W)X"MD'@!B2!7V%7X8?M7_ 2?]FOXSWO
MAN"YDN-+EC74M)NF;]Z;9V8(&(_C5D=2>,[=V!G%?JW^Q3\7KSXU?L[^&];U
M25[C6;0/IE_/(<M-+"0HD)[ED*,?=C7'F6!I4Z<<5AO@D;X7$3E)TJOQ(]TK
MYZ_;B_:#N_V>_@K/J.BW26OBO5+A+'2G9%D\MOO22[&!5@J ]01N9<U]"U^.
M7_!1;XU'XL?'^ZT:PG,VB>%0VEVZH<J]QG-PX]]X">XB%<F5X7ZUB4I+W5JS
M;&5O8TFUNRQ\./\ @I!\8M+\>:#=>+/%G]L^&8[R/^TK$:59QF2W+8DVM'"K
M!@I)&".0,\9%?K_9WD&H6<%U:S)<6TZ++%-&P971AD,".H((-?C?^U=^R/<?
ML_\ PS^%_B 12"?4;'[+KNXDB+426F YZ?(S1C''^CYZDD_;_P#P37^-G_"S
M/@5'X:OKCS-;\(NM@P8_,]HP)MV^@ :/_MD/6O4S3#T*E".*PR22=G96Z[_U
MW.3!U*D:CHU7KN?6]?F#^V9^V9\8OA1^TGXP\*^%?&']EZ#8?8_LUI_9EG-L
MWV<$C_/)"S'+NQY)ZXZ5^GU%>%@\13PU1SJ4U-6V?Y[,]"M3E5CRQERGXK_\
M/$/V@_\ HH'_ )1M/_\ D>C_ (>(?M!_]% _\HVG_P#R/7ZW_&CXQ>'O@5\/
M=2\6^)+CR[.U7;#;H1YMU,0=D,8[LQ'T !)P 37XO^+/%'CS]LCXZ)+Y+ZEX
MBUN<6UC81$^39P DK&O]V-%W,S'_ &F/)-?78&I0QBE-X>,8KKI_DCQ<1&I0
M:BJK;?37_,^U/^">?[47Q7^.GQ@UW2/&OB-]<T.ST*6Z5!IMK L=Q]HMU0EX
MHE.=C2X4G!Y.../9O^"A7QF\8_ WX+Z+KW@C6/[$U6X\00V,MQ]EAN-T+6UR
MY7;*C*/FC0Y SQUY->B?LR_LZZ'^S;\.+?P_I@6ZU2?;/JNJ;</>3XZ^R+DA
M5[#GJ6)];KYFOB:'UOVM.FN1=-D_P/5ITJGL.24O>?7L?BO_ ,/$/V@_^B@?
M^4;3_P#Y'H_X>(?M!_\ 10/_ "C:?_\ (]?M1TY-?E#_ ,%!_P!L;_A:VM3?
M#SP=?;O!NG3?Z?>0-\NIW"GH".L*$<=F8;N0%->]@L11QM7V<,+%+J]-/_)3
MSJ]*IAX<SK/^OF><V_\ P4(_:(N[B*"#QV\T\K!(XX]$T]F=B<  "WY)/:OV
MDK\\?^"<W[&XT^&Q^+7C6Q_TJ11+X>TZX3_5J>EXZG^(C_5^@._J5(_0ZO)S
M>IAY553P\4N6]VDE=_\  .W!1JJ#E4;=^Y^5O[5'[;'QH^&_[07C7PUX<\9_
MV=HFG7BQ6MK_ &792^6OEHV-SPLQY)ZDU^B_P%\3:EXT^"7@+7]9N?MFK:IH
M=G>7=QY:IYDLD*L[;5 49))P ![5^._[<'_)UWQ'_P"P@O\ Z)CK]=/V7?\
MDVWX7?\ 8M:?_P"DZ5UYG1I4\'1E"*3=KV7D8X2I.5>HI.Z_X)Z?1117RQZY
M^5O[5'[;'QH^&_[07C7PUX<\9_V=HFG7BQ6MK_9=E+Y:^6C8W/"S'DGJ37E/
M_#Q#]H/_ **!_P"4;3__ )'K$_;@_P"3KOB/_P!A!?\ T3'7Z?\ [/\ ^T!\
M+M%^ WPVT_4/B3X1L;^T\-:;!<6MSKMK'+#(MK&K(ZM("K @@@C((K[NK[#"
MX:E-8=3;2Z+MZ,^>A[2M5G'VCC;_ #]3\V_^'B'[0?\ T4#_ ,HVG_\ R/7Z
M??L9_$3Q#\5_V;/!_BKQ5J']J:]?_;/M-WY,<._9>3QI\D:JHPB*. .F>M='
M_P -)_"/_HJ?@K_PH;/_ ..5Z/7SV.Q5.M34(X=4W??]-D>EAZ,H2<G4YOZ]
M0HHHKQ3O/-OV@?CSX>_9U^'=UXJ\0;YQO%O96$)Q+>7# E8U/884DL>@!/)P
M#^7WCK_@H[\;?'FL.-"U.'PM9NY,.GZ191ROM[!I)%9V('4C:#UP.WOG_!7J
MPU&31OAE>HKG28KB_AF8#Y5F=8#&"?4JDN/]UJ\S_P""<7[0'PM^#,OB.S\:
MO'HFNZE-']DUV>V,D?DA<& NH)C^;YLD!3GD_**^OP.&I4\%]:]G[23Z?.W_
M  =CQ,15G.O['FY4>:6_[;W[17@.X2*^\7:E$2<^1K.F0.7[_P#+2+=W'0CM
M7W_^PC^U!XR_:6\.^()_%.A6%HNCR10+JU@7C2ZD<,2GE-NPRJ%)(;'SK\HK
MWO1_%/@CXO:'<0Z;JN@^,M(F3;/#;SPWL+*>SJ"P_ BI? 'PU\+_  LT>?2?
M"6B6N@Z;-<O=R6MFI5#*X 9L9XX51@<   5YN+QE"M2</8*,^_\ 5CJHT*E.
M:E[2\1_Q*\8?\*]^'7BKQ5]D_M#^P]*NM3^R>9Y?G^3"TFS?@[=VW&<'&<X-
M?(OP'_X*6?\ "[/BUX=\$?\ "N?[&_M>5XOMW]N>?Y6V)Y,^7]F7=]S'WAUK
MG_\ @I/\7?BGX-UR#PSX2NKR'P;J_AR9=9B@TN*XC97:6.7=*T3-'^Z]&7 Y
MXZU^=OPT\5^)_ _CC2M<\&RS0^)K-V>RDM[9;EPQ1E;$;*P;Y2W537H8#*Z=
M;"RJ5$FWMJ]/7Y^ISXC&2IU5&.RW\S^@^BOBK_@G_P#&SXP_%?Q)XOM_B=>7
MUU:6=I!)9"\TB&R =G8-@QQ)NX X.<5[%^VYXTUSX>?LP>-/$'AO4I]'UJS^
MQ?9[VW(#Q[[V!&QGU5F'XUX%3!SIXA89M7;2NMM3T8UHRI.JEIK^![G17YL_
M\$Y_VAOB/\5?CMJ6C^+?%^HZ]ID>@W%REK=LI02K/;J&X Y 9A^-?H_?2-'8
MW#J=K+&Q!]#@TL7A98.K[*;NQT:RK0YTB>BOQF^"W[77QC\0?&+P)I>H_$'6
M+O3[[7K"VN;>1UVRQ/<1JZGY>A!(_&OV9K7&X&>!E&,VG?L1A\1'$)N*V"BO
MBW]MS]O*7X&:LW@CP/%;7GB\1K)?7UR/,BTX, RH$_CE*D-SPH9>&S@?$FA_
MM%?M,?$&\N-6T+Q)XTUPVY)F;1[:22WB/7YHXD\M>O0CTKJP^45Z]/VK:BGM
M<QJXVG3ER)7?D?3?_!7S_D'?"S_KKJ?\K6NC_P""2/\ R2GQO_V&D_\ 1"5\
M/?';]IKQI\=O#/A;0?'$44^K^&9KI?[1\KR9YQ+Y0*S1@!0ZF+&0!G/(R"3]
MP_\ !)'_ ))3XW_[#2?^B$KV<50GALJ]E/=/_P!N.&C4C5QG/'9_Y'W?17PG
M_P %)?&/Q2^$-UX7\6^"_&&JZ-X>O@VG7MK:N/*BN5R\;\@\NF\>G[KWKM/^
M"<_[1FJ_&[X;ZQI/BG5)-5\5:#=Y>YN"/,GM9<M&QP!DJPD7V 3UKYR6!FL*
ML6FG'\4>HL1'VWL6M3ZXHKR;]J?XPI\#/@7XG\4I*J:FD'V735;^*[E^2(X[
M[22Y'HAKXD_8#^*7QC^.WQL UWQWK-_X4T*V:]U"&1U\N9FRD,)('=B6QW$3
M"E1P,ZU">(NE&/?J%3$1A4C2M=L_0CXN?\DI\:?]@6]_]$/7Y[?\$BO^1T^(
MO_8/M/\ T9)7Z1^)=#B\3^'-5T:>1XH-0M);222/&Y5D0H2,\9 ->)_LS_L<
M^&?V7]5UR_T'6]6U635H8X)5U(Q80(Q8%=B+S\W>M</B*=/"5J,OBE:WR)J4
MY2K0FME<]^HHHKR3L"BBB@ HHHH **** "OBO_@K'_R;KX=_[&JV_P#2.\K[
M4KXK_P""L?\ R;KX=_[&JV_]([RO2RW_ 'RGZG)BOX$CL=0_Y19I_P!B#%_Z
M)6L#_@EC_P FS77_ &,%U_Z*@K?U#_E%FG_8@Q?^B5K _P""6/\ R;-=?]C!
M=?\ HJ"N^I_N=;_KX<\?X]/_  GV%1117SQZ84444 0WDK06D\B_>1&89]0,
MU^27_#T[XS?\^WA?_P %TG_QZOUJU+_D'77_ %R;^1K^?GX7V<&H?$SPE:W4
M$=S;3ZO:12PS('21&F0,K*>"""00:^HR7#T:T:KJQ4K6_4\G'U)P<%!VO?\
M0^GH_P#@JA\94D5C9^%I ""4;3Y<-['$P/Y5W_@3_@K?K\-XB>,_ VFWEHW#
M3:#/);R)[A)6D#?3<OUK[J?]FGX12*RGX6>"P&&#M\/V@/YB/BOGO]IC_@G/
MX&\;^$M0U3X>:1'X7\76D+RVUI9-MM+YAEO*>,\(QY"LNT D9R.E0Q665I*$
MZ/+?K_PQ,J.+IKFC.Y]'?!GXZ>#?CYX6&N^#M56^@0JMS:R#9<VCD9V2Q]5/
M!P>5.#@D5WU?AC^R=\;M2^ /QNT/5EN)K?2+BY2PUFU_AEMG8*Y9?[R$[QWR
MN,X)K]SJ\S,L#]1JI1=XO8Z\+B/K$+O=!7PG^VW^WEXD^!OQ0M/!O@6/2;F>
MTM%FU674(&FV2R8:.(!77!"88]<^8/2OLSXA>-].^&O@?7?%.KOLT[2+.2\F
MP>6"*2%'^TQPH'<D5^*WPI\*ZM^UW^U!:6^KO+)+XBU234-6FB)_<VP)DE"D
M_= 0;%ST)0>U=.4X6G4<Z]=7A%&6,K2BHTZ;]YGWI^PK^V]KW[0?B[7?"OC:
M/3+;5TMEO=,;3X6A65%.)D(9VRPW(PQV#^E?:M?A8DFN_L?_ +3A*^8VH>$M
M8((^Y]KML_HLL#_D]?N%X;\06'BSP_IFMZ7.+K3=2MH[NVF7H\4BAE;\012S
M;"PHSC5HKW)(>"K2J1<)_$CS7]J+Q3X_\"_"'5/$WPZCL;K6-(_TNYL[^V:8
M3VJ@^;L"LI#J,/UY"L,9(KY'_95_X*0>)OB%\7M-\+?$6+1[73-8_P!%L[RP
MMWA,5V2/+#EG8%7.4_WF7G&:_1)E#*589!X(-?BY^W/^SG)^SU\8Y9])@:#P
MGKK-?Z2\8(6W;=F2W![&-B"/]ED[YJ\KAA\5&6&JQ7,]GU_I;DXR52BU5@].
MJ/VDKY)_;J_;,O/V;X=$T'PFEA>>+]0/VJ9;Y#+';6@RH)564[G<8'/1&XZ5
M+^S9^VIHGBO]F'4_&/B^^":UX.MA!K29'F7+8Q!(H[M.<*/]O<.G-?G5X>TG
MQ9^VW^TP1<.PU'Q!>&XNYERT>GV:8SC/\,<8"J#U.T=6JL#EUJTY8I>[3W\_
MZW^X6(Q7N15+>1^E'[#GQE^*7Q\\*ZKXO\<PZ39Z TGV72H["S>*2X=3^]E)
M9V^13A!CJV_^[SSW[?7[5GC7]FF[\$1^$8M+D76$O&N?[2MFEP8C"%V[77'^
ML;/7M7U-X-\(Z5X!\*Z3X<T2U6STG2[9+6VA7^%%&!D]R>I)Y)))ZU^>O_!7
MS_D(_"S_ *Y:G_.UK#!JEBLP2Y%R.^GR9I7YZ.&?O:JVOS/H;]@_]HWQ7^TA
MX'\2:OXLCTZ.ZT_45M81IT#1+L,2MR"S9.37T[7PA_P21_Y)3XW_ .PTG_HA
M*^[ZX\QIQI8J<(*R7^1MA9.5&,I/4*^0/V^OVK/&O[--WX(C\(Q:7(NL)>-<
M_P!I6S2X,1A"[=KKC_6-GKVKZ_K\W/\ @KY_R$?A9_URU/\ G:UIE=.%;%PA
M45T[_DR<7*4*,I1=G_P3Z&_8/_:-\5_M(>!_$FK^+(].CNM/U%;6$:= T2[#
M$K<@LV3DU].U\(?\$D?^24^-_P#L-)_Z(2OHK]KSXR3? OX!^)?$MB_EZRT:
MV.FMM!VW,IVJ^#Q\@W/SP=F.]/&8=/'2H4E:[27X!0J?[.JDWT///VG_ -O_
M ,(?L_ZA-X>TJT_X2_Q?$=L]C!/Y4%D<=)I<-\W3Y%!/J5XKXI\0?\%/_C5J
M]S(]C/H>AQ,?EBL].$FT9/&96?/_ -;M7DG[-_P3U7]I[XSVGAQKZ9$N#)J&
MKZFY,DL<"L#+)DYR[,RJ"?XG!/>OU^\!?LG?"3X<Z+#IVF> ]%N=B!7O-3LX
M[NYF('+/)(I/)YP,#T KVZL,!E:5.<.>9Y\)8C%WE&7+$^ _A_\ \%6OB)HN
MH(OBS0=&\2:<SY?[*C6=RJ]]K LGX%/QK]$/@7\?O"'[0WA :_X3O6D6-A'=
MV%R ES9R'.%E0$XS@D$$@X.#P<>9_'?]@?X8?&31YO[-T>S\$^(1S!JNBVJQ
M+GN)8%VI(#Z\-Z-U!]5^"?P0\*_ /P3;^&O"MEY%NOSW-W)@SWDN,&65L<L?
MR X  KR<96P-:DI4(.,^W0[:$,13G:I*\3FOVN?BQK?P0^ ?B+QEX=2U?5[!
M[585O8S)%B2XCC;*A@3\KGOUKYH_8K_;@^(O[0'QI7PKXGAT6/3#IUQ=9L+1
MXI-Z%,<F1N/F/:O9/^"C7_)H7C3_ *ZV'_I;!7P;_P $S]8L-#_:66YU*^MM
M/MO[&NU\ZZE6),DQX&6(&:[,'AZ53+JM24;R5[/Y(PKU9QQ4(IZ:'[$5\B_M
M^?M3^,_V:/\ A!/^$1BTN3^VOM_VK^TK=I<>3]GV;=KKC_6OGKVKZ7_X65X1
M_P"AIT7_ ,&,/_Q5?GM_P5H\2Z1XB_X57_96JV6I^3_:OF?8[A)=F?L>-VTG
M&<'KZ&O/RR@JF+A"I&ZU_)G3BZCC1DX/7_@GT5^P;^TEXM_:2\(^*=2\61Z=
M'<:;?1V\']G0-$NUH]QW LV3FN%_;N_;&\>_LX_$3P_HGA.'1Y+.^TK[;*=1
MM7E?S/.D3@AUP,*.U8G_  2-_P"2=>/O^PK!_P"B37VQXB^'OA;Q?=17.O>&
MM'UNXB3RXYM1L(KAT7).T%U) R2<>];8AT,+CY\T+Q73Y$4_:5L-&TK/N?E7
M_P /3OC-_P ^WA?_ ,%TG_QZC_AZ=\9O^?;PO_X+I/\ X]7U-_P42^&/@[PO
M^S#K%_HWA/0])OEO[-5NK'38890#* 0&50<$5\K_ /!+WPKHOB[X_:_9Z[I%
MAK5HGAFXF2WU&V2>-7%U: ,%<$ X9AGK@GUKW:3P57"RQ2H*T>AYT_K$*RI>
MTW-_P'_P4T^+WB3QQX=TB[MO#8M;_4;>UF,=A(&V/*JM@^;P<$U^JU<=;_!G
MX?V=Q%/!X%\-03Q,'CECTBW5D8'(8$)D$'O78U\MC*]"NXNA3Y+'KT*=2FG[
M25PHHKEOBM-J-O\ "[QC+I!==6CT:\:S,9(83"!S'C'.=V.E<$5S-(Z6[*Y\
M<?M+?\%.+/X?>)+_ ,,?#C2;3Q!?V,C07.LZ@[&S60<,L2(0TF#D;MRC(.-P
MYKYF;_@II\<C>K.-4T@1 8-L-+C\L\]2?O?^/=J^?_A//X8M_B=X7F\:H\OA
M--1A;5%0,2;<.-^0OS$8ZA><9QS7[>_#]?A#X\\-I;^#H/!^LZ+L'^B:7!;2
M1HN, -&H^4@<88 BOM,33PN61C%T>>_5GA4I5L6V_:<OD?%OP%_X*A>*_%'C
M+2/#7B[P7::Q+JMW%96T_ATM!.'D8*N8Y'97Y/9DP*_1ZO([/]D_X5:5\3=*
M\?:7X1LM'\1:<SO$^G@P0,S(R[F@7]WN&XD,%!SSDX%:W[17C[4_A;\$?&'B
MS1EMVU32;%KBW6Z0O&6# ?, 02.?6OG<5*AB:L%A8<M]_4].BJE*#=:5['D'
MQW_X*">#O@%\2M0\%ZQX<US4;^SCAE>XL1#Y3"2-7 &YP> P[5[U\*OB)9?%
MKX=Z#XPTZVN+.QUBV%S%!=;?,122,-M)&>.QK\*_C)\7M=^.?CZ]\8>(TM$U
M:\CBCD6QB,<6(T"+A2Q/11WKWGX)_P#!0#XG> ](\(^!=,@T%M%LWAL(FGLG
M:;RS( <L) ,_,><5[E?)/W$/9+W^NOEK^)Y]/'_O'S_#T/V&HHK\J/V@/V]O
MC-X!^-WCCPYHWB&TM])TO5[BTM8GTRW<I&CD*"S(2>!U-?/8/!5,;)QIM:=S
MTZU>-!)SZGZKT5C>"M2N-:\&Z#J%TP>ZN["WGE8  %VC5F.!TY)KX@_X*!?M
M9?$KX!_%?0=#\&:Q;Z=IUWHB7LL<UC#.3*9YD)RZDCY47CVJ,/A9XJK[&%K^
M8ZM:-*'/+8^^**\&_8E^*_B3XT? +3/%'BN\COM9GO+J%YHH$A4JDA51M0 =
M*].^*7Q.T#X.^!=5\6^);K[+I6GQ[WV@&25CPL<:Y&YV. ![\D#)K*I1G3JN
MCO).VG<N-2,H*?3<ZNN?^(4\EKX!\330R-%-'IERZ21L596$3$$$="#7Y8?%
M#_@J#\5?%&M3GP>UCX+TA7(MXTM(KNY9,\&1YE92V/[J@#/?K4?A#_@I5\3;
M&VU+1O'L=MXITN_LIK61A:1V=W"9(R%D4QJJ$#=G:5Y'0BO;CDF+24W;TOK_
M )?B<#S"BWRZG%?LG_%OQSK/[2/PZL=0\9^(;ZRGUB%)K:YU6>2.12>592Y!
M'L:_:BOPK_8]_P"3H/AG_P!AJ#^=?M!\9E\6?\*M\22>!KL67BV"S:?3G:!)
M@\J?/Y>Q@0=X4ITX+ UOGE./UBG&-E=?J9Y?)^RDWKJ=I17Y>?LQ_P#!0[XC
M>(/CAX9T/X@:S:WGAO5;C[!+ML88##+(-L+[D4' DV@Y.,,3VK]0Z\3%X.K@
MIJ%3KV.^C7A7CS0"L;QGHM_XD\)ZMI>EZS/X=U&\MGA@U6VC622U=A@2*K<$
MC\/8@\U^<W[6'_!0#XA>%/CMKGA?X=:M:VNBZ.ZZ>P-C%<-/=+_KCEU)X<F/
M X_=Y[U^A/PM@\36_P .O#R^,KQ;_P 5-9QR:E,D21KY[#<Z!4 &%)VC YVY
MZFJK8.KA:<*TVO>V745.O"M*4(]#X9\%_P#!*.35IM4O_B/X^N[S4I[EVC?1
MQO:5<\2RR3*27;J5QQ_>->+?  :S^S/^W=!X"T#79-6TN361HE]L!6.[A<=9
M$!(#QELY[,C=B0?JO]MC]NB#X1QW/@3P#,FH^/;@>3<740\Q-*W< 8P0\YSP
MO\/5NRG-_83_ &+=0^'VH+\4OB,LDOC6]5Y;+3[IM\EEYH.^:8GDSN&88_A#
M'.6.%]^.*K+#3JXQ^[-6C&V_GZ?UV/-=*FZL84%JGJS[?HHHKY ]L**** "O
MS_\ ^"NO_(E_#K_L(7?_ *+CK] *_/\ _P""NO\ R)?PZ_["%W_Z+CKULI_W
MVG\_R9Q8S^!+^NI]2_%?_DT>Q_[!FE_SAJY^S7_R1S1/]^X_]'O5/XK_ /)H
M]C_V#-+_ )PU<_9K_P"2.:)_OW'_ */>O9G_ ,B!_P#7[_VP^(C_ ,E@O^P;
M_P!R'I]%%%?('Z(%%%% !1110 4444 %%%% !1110 4444 %>%_'?X OXTN'
MU_P\(TU?;_I%HV%%U@<,#T#XXYX/'(QS[I17H8''U\NKJOAW9K[FNS/'S;*<
M+G6%EA,7&\7]Z?=/O_PST/@:QUSQI\)M0D@AFU'P_.QRUO*A5'/][8PVM]<&
MK>L?%[QWXTMWTVYUJ[NXIU*-;VL21^8IZJ1&HW YY!ZU]V21I,A21%=#U5AD
M&HK:QMK(8M[>* =,1H%_E7VKXKP\W[6K@XNIWNO_ )&_XGY>O#[&4HO#T,RG
M&B_LV?W64TG]WR/F?]G3X/\ B71_%UKXDU2R.EV4,<BK%=?+-(70J,)U &?X
ML5]/T45\AF>95<UQ'UBLDG:R2['Z/D628?(,']4P[;5[MO=MV7Z'YV7EE?V^
ML3S16TZND[.K"(\$-D'I7:_\+J^)G_09OO\ P%3_ .(K[>HKZ^KQ;2KI>VP<
M96[M/\XGYQ0\.\1A')X7,IPYM^6+5_6TT?%%C\9_B3)?6Z/K%\4:10P^RITR
M,_P5]KT45\QFN94<P<'2H*ERWVMK>W9+8^[R#),3DRJK$8N5?FM;FOI:^UY2
MWOY;'YV7EE?V^L3S16TZND[.K"(\$-D'I7:_\+J^)G_09OO_  %3_P"(K[>H
MKZ>KQ;2KI>VP<96[M/\ .)\)0\.\1A')X7,IPYM^6+5_6TT?$/\ PNKXF?\
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MP+XL^#_B!;EX[BT:WDS;ZK:AO*;L"'[9'!4\\\BM6;XL_$CXD0?V##>W-_\
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M^$LUFU\OQ7XIC2<K(N'M;+[T47L6_P!8WU0$92OS!_:!_P"2]?$G_L9=2_\
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M^#.L:+X^_9*^-$8E6;0O%6@W/FVURJDQ7"9(#H2,21.N0?4$@X.17WA\/?\
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M-?>]?!'_  2-_P"2=>/O^PK!_P"B37WO7A9K_OM3^NB/1P?\")\K_P#!2_\
MY-1UO_L(67_HX5\C?\$G/^3BO$7_ &*MS_Z66=?7/_!2_P#Y-1UO_L(67_HX
M5\C?\$G/^3BO$7_8JW/_ *66=>OA/^135]7^APUO]\A\OU/UAHHHKY(]H***
MQ/&WC#3OA_X/UKQ+J\ODZ9I-I+>7##&=B*6('JQQ@#N2!32<G9";LKL^(/VB
MO^"7=GXRUZ^\0_#36+3P_<7;M-+H>HHPM!(3DF*1 3&"<_(58#/!4 "OC_QQ
M^Q;\</A$[ZG/X1OYH+3]X-2T&876P#J_[HF1 /4J,5]+?"O_ (*S7%J\MO\
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MNO"4TTMU#&,M]CE5?-DQU.QHHR?12Y[5PT91AF[<]N9_K8Z)IRP24>R/.?\
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MX6]X*_Z&G2O_  *7_&M8X7$5(J4*<FGY,PJ9A@Z4G"I6BFNCDD_S.NHKD?\
MA;W@K_H:=*_\"E_QK:T'Q3I'BB&672-2MM2CB8+(UM('"DC.#BE/"UZ<>:=-
MI>:8Z6.PE>7)2JQD^RDF_P &:E%5=4U2ST6PFO;^YCL[2$9DFF8*B@G')/N1
M7-_\+>\%?]#3I7_@4O\ C2IX>M67-3@VO)-E5L9AL/+EK58Q?FTOS.NHKDX_
MBUX+E<*OBK203_>NT4?F372V.H6NIVRW%G<PW=NWW98'#H?H1Q2J8>M15ZD&
MO5-#HXO#XAVHU(R]&G^1/1116!UA1110 45SOB+XB^&?"4ABU?6[.RF')A:0
M&0<9SL&6_2LBT^./@2]?9'XFLU/_ $VW1C\V KMA@L54A[2%*3CW2=OR/,J9
MI@*-3V53$0C+LY13^ZYW-%5]/U*TU:U2YL;J&\MF^[-;R"1#]"#BK%<;3B[,
M]&,E)*47=,****104444 %%%% !1110 445QWQ-^)MA\+M)M;^_M;B[CN)_(
M5;;;D':6R<D<<5O0HU,345*DKR>R.7%8JC@J,L1B)<L([OL=C17"_"[XN:;\
M58]2;3[.ZM!8F,/]IV_-OW8QM)_NFM;XC>,!X!\%ZGKIM_M36J+LAS@,S,$7
M)[#+#/M6TL%B*>(6$G&U1M*WF]OS.6GF>$K8)YA3J7HI-\VNT;W\]+,Z2BOF
M[X7?M,ZWXG\:V.CZQI]D;:_E\I)+-'1XF/3JQROKWYSGC%?2-;YAEN(RNHJ6
M(5FU=6=SER?.\'GM"5?!2;2=G=6=PHHHKRSW@HHHH **** "O*OC!J'Q)L]6
ML%\$6WGV1@)G/EPMB3<<??YZ8Z5ZK179A,0L+555PC.W22NCS<PP;Q^'=!59
M4[V]Z#M+3S_,^2O%7Q=^+O@=K==<EAT][@$QH\%NS,!U.%R<>]>^_!G6/$7B
M#P+:ZCXF&+^Y=I(\QK&3"<;#M'3/)^A%?,'C2W\8:?XV;Q=XM\-SW]K'<!O+
MNXV%ML!(1,KP%'& >O?.3GZI^%_Q&L?B=X975+.)K62-S#<6KD$Q2  X![C!
M!!K[G/Z,(8"E.C1AK\4X)63_ )5JWZMGY1PABJM3-J]/$XJKHGR4ZK=VNLW=
M)>B6N_:[ZZBBBOSH_:0KYG_:N_Y'#P?_ +K_ /HQ*^F*^9_VKO\ D</!_P#N
MO_Z,2OJ^&/\ D:0])?\ I+/S_CO_ )$57UA_Z7$]E_:2_P"2>1_]?T7_ *"]
M7OAM_P B'H7_ %ZI5']I+_DGD?\ U_1?^@O5[X;?\B'H7_7JE?BN'_Y*S$?]
M>8_^E'[76_Y$-+_KX_R.EHHHK[\^4"BBB@ HHHH *Y?XG_\ (@:Y_P!>Y_F*
MZBN7^)__ "(&N?\ 7N?YBO(SC_D6XG_!/_TEGH9?_OE'_%'\T?,?AWP_=^*-
M6ATVQ"-<RABH=MHX4L>?H#78_P#"B?%7_/*U_P"_XK"^'/B*U\*^+K+4[T2&
MVA$@;RE!;YD91QD=S7L__"_O#/\ SSO_ /ORO_Q5?S=PWEG#N,P<JF;8CV=3
MF:2YDO=LK/9];G[)G.-SC#XA0P%+FA9:VOK=^?:QXEK7A?5? NJ6QU73XSSO
MC67YX90#R,J>1ZC(/-?1OP[\:V_C;05N(H5M9X"(IK=>B''&W_9(Z?0CM7BW
MQ8^)5IXZ^QV]C;2Q6ULS/YL^ SD@#@ G X]:[7]G;2[BVTG5KZ12MO=21I%G
M^+8&W$>WS ?@:^EX3K4L!Q)/+\JJ>TPTT[MKM&][V6TO=[._S/&SZG/%9-'%
MX^')6B]%ZNUK7>ZU[Z&U\=O^1 F_Z^(OYFO!_"OA'4/&5]+:::L;31Q^:WF/
MM&W('\R*]X^.W_(@3?\ 7Q%_,UY#\*_&ECX'URZO;^*XEBEMC"JVZJS9+*><
ML./E-8\94L)7XHHT\=+EI.,>9[65Y>IIP[4Q%+(ZD\+&\U)V7W%[_A1/BK_G
ME:_]_P 5Z9\'? NJ>"H]674TB4W)B,?ER;ON[\Y_,56_X:&\.?\ /EJG_?J/
M_P".5?T'XVZ'XAUBUTVVM-02>Y?8C2QQA0??#D_I7T638/A++<?2Q.#Q=ZB=
MDG*]W)<O\J[GCYCB.(,9A9T<30M!ZNR[:]_(]!KYZ^/7BC^U/$<6DPOFWT]?
MGQT,K $_D,#ZYKW#Q1KT7ACP_?:G-@K;QEE4_P 3=%7\20/QKY?\,Z%=^/\
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MI-(^Z[MQ]GGYY+*!AOQ&#]2:I_&R%Y/AUJ)3HCQ,P]1YBC^9'Y5Y7\#?%/\
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M:Z[]FSZ+):.8SK2JY;\4%KMMVUT?H^W<XK5_@SXJTDLRV*WT:_\ +2SD#?\
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M<T?\2V^_;YGY[D^/_L[,85F_=O9^CW^[?Y'&_!'Q='>>#9[2[E"OI.=S,?\
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MXLZ?,^3#-I,7EGL,2R@C\^?^!5[K^QKJ%M=_!6V@A93-:WMQ'.H/(8MO&?\
M@++4_P"U-\&[CXI>#H+S28Q)KND%Y88@/FN(V WQCW^4$>XQWKY%^#_QDUSX
M'^(KF2"W^T6DQ$=]I=P3'O*D\@XRCCD9P>I!!K[NC3_MS(HX:@_WE.VGI?\
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ME75K63',,EH"WYJQ'ZU\P_M%?%S3OC!XTM]2TO3I+*SM;86RR7 43388MN8
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M+XNT6YO]7,"6WG17\T(\M,[1M1@.YYKVNBM:=6=&7-3DT_(B4(S5I*Y\P?\
M#MKX#?\ 0L7W_@WN?_BZU]!_X)^? 7P_,D\?@2.]F0Y#7]_=3J>0<%&DV'IW
M6OHBBNAXW%/1U9?>S/ZO27V%]QGZ#X=TKPMID6G:+IEGI&GQ?ZNTL+=((D^B
M* !^5:%%%<;;>K-SYS\3?\$_O@OXQ\1ZIKNKZ#?WFJ:E<R7EU<-JUR#)*[%F
M. ^!R3P.!7T#I.E6F@Z59:;80):V-G"EO;P1C"QQHH55'L  /PJW16U2O5JI
M*I)M+NS.-.$&W%6"O-?C5^SMX$_:"L]+M_&VDOJ2Z9))):O%<20/'O #C<A!
M(.U>#_=%>E45G"<J<E.#LT5**DK25T>7?!7]FSP)^SZVK'P3876G+J@C^U1S
M7LLZN8]VP@.QP1O;D>M<C\0/V%?@_P#$[QCJGBCQ!H%W=:SJ4HFN9H]2GC5F
M"A<A5< < =*]_HK98FO&;J*;YGUOJ1[*FX\KBK'S!_P[:^ W_0L7W_@WN?\
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M_P!B#%_Z)6L#_@EC_P FS77_ &,%U_Z*@K?U#_E%FG_8@Q?^B5K _P""6/\
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MMT:^)G'VR22/8+.T@T^TAM;:)(+:%%CBBC7"HJC 4#L !BI:**^2/:"BBB@
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MIQ_]N/D_]K[_ )';1O\ L'?^U7J?]EGXF?V3JLGA._EQ:7S&2R9CPDV.4^C
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ML?\ \;KU"BN7'9#EF95?;8N@IRM:[[&^&S3&X.'L\/5<8[V1Y?\ \,\^'/\
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M>QQ=-3CV:O\ \,SDP^*KX2?M*$W&7D>9:;\ /#UG<K+<3WEZB\^3(ZJI^NT
M_K4^J? GP]JFH3W;3WUN96W>5;O&L:>RC8<"O1J*\-<+9(J?LEA8VO?;KZ[G
MJ//,R<_:>WE?8;%&(8DC7)"@*,^U<@?BWX6CNKVWFU(6\MK(T;;XV(;'!*D
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M7M[JNK1(<_99I4CC;_>**&Q]"*N^)/V-? WB36[K4GN]8L#<,#]EL98(X8@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/_P#X*Z_\B7\.O^PA=_\
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M@>*DUN>YGLI6"+<Q6ZC$^WN3U!*X7(]!7I]K:Q65M%;P1K#!"@CCC0855 P
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M$57UA_Z7$]E_:2_Y)Y'_ -?T7_H+U>^&W_(AZ%_UZI5']I+_ ))Y'_U_1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#1*U@?\$L?^39KK_L8+K_T5!7?4_W.M_U\.>/\>G_A/L*BBBOGCTPHHHH
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M?J7_ & [;_VE7+?L:_\ )$[7_K^N/_0A7Z;EO_)+1_QQ_P#2$?2U/^29Q/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^*_\
M@K'_ ,FZ^'?^QJMO_2.\K[4KXK_X*Q_\FZ^'?^QJMO\ TCO*]++?]\I^IR8K
M^!(['4/^46:?]B#%_P"B5K _X)8_\FS77_8P77_HJ"M_4/\ E%FG_8@Q?^B5
MK _X)8_\FS77_8P77_HJ"N^I_N=;_KX<\?X]/_"?85%%%?/'IA1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\H_:(_
MY%C3?^OS_P!D:O5Z\H_:(_Y%C3?^OS_V1J^.XP_Y$.*_P_JCZ+A[_D:T/7]&
M7OC-_P FGZE_V [;_P!I5RW[&O\ R1.U_P"OZX_]"%=3\9O^33]2_P"P';?^
MTJY;]C7_ )(G:_\ 7]<?^A"OTW+?^26C_CC_ .D(^EJ?\DSB?^PC_P!M/<J*
M**\,_. HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/\ _P""NO\ R)?P
MZ_["%W_Z+CK] *_/_P#X*Z_\B7\.O^PA=_\ HN.O6RG_ 'VG\_R9Q8S^!+^N
MI]2_%?\ Y-'L?^P9I?\ .&KG[-?_ "1S1/\ ?N/_ $>]4_BO_P FCV/_ &#-
M+_G#5S]FO_DCFB?[]Q_Z/>O9G_R('_U^_P#;#XB/_)8+_L&_]R'I]%%%?('Z
M(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?,
M_P"U=_R.'@__ '7_ /1B5],5\S_M7?\ (X>#_P#=?_T8E?5\,?\ (TAZ2_\
M26?G_'?_ "(JOK#_ -+B>R_M)?\ )/(_^OZ+_P!!>KWPV_Y$/0O^O5*H_M)?
M\D\C_P"OZ+_T%ZO?#;_D0]"_Z]4K\5P__)68C_KS'_TH_:ZW_(AI?]?'^1TM
M%%%??GR@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_DSBQG\"7]=3ZE^*_P#R:/8_]@S2_P"<-7/V:_\ DCFB?[]Q_P"CWJG\5_\
MDT>Q_P"P9I?\X:N?LU_\D<T3_?N/_1[U[,_^1 _^OW_MA\1'_DL%_P!@W_N0
M]/HHHKY _1 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KYG_:N_Y'#P?_ +K_ /HQ*^F*^9_VKO\ D</!_P#NO_Z,2OJ^&/\
MD:0])?\ I+/S_CO_ )$57UA_Z7$]E_:2_P"2>1_]?T7_ *"]7OAM_P B'H7_
M %ZI5']I+_DGD?\ U_1?^@O5[X;?\B'H7_7JE?BN'_Y*S$?]>8_^E'[76_Y$
M-+_KX_R.EHHHK[\^4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0CZ6I_R3.)_["/\ VT]RHHHKPS\X"BBB@ HHHH **** "BBB@ HHHH ****
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M]&?>]%%%>*=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5\5_\%8_^3=?#O\ V-5M_P"D=Y7VI7Q7_P %8_\ DW7P[_V-5M_Z
M1WE>EEO^^4_4Y,5_ D=CJ'_*+-/^Q!B_]$K6!_P2Q_Y-FNO^Q@NO_14%;^H?
M\HLT_P"Q!B_]$K6!_P $L?\ DV:Z_P"Q@NO_ $5!7?4_W.M_U\.>/\>G_A/L
M*BBBOGCTPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K\__P#@KK_R)?PZ_P"PA=_^BXZ_0"OS_P#^"NO_ ")?PZ_["%W_ .BX
MZ];*?]]I_/\ )G%C/X$OZZGU+\5_^31['_L&:7_.&KG[-?\ R1S1/]^X_P#1
M[U3^*_\ R:/8_P#8,TO^<-7/V:_^2.:)_OW'_H]Z]F?_ "('_P!?O_;#XB/_
M "6"_P"P;_W(>GT445\@?H@4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5\S_M7?\ (X>#_P#=?_T8E?3%?,_[5W_(X>#_ /=?
M_P!&)7U?#'_(TAZ2_P#26?G_ !W_ ,B*KZP_]+B>R_M)?\D\C_Z_HO\ T%ZO
M?#;_ )$/0O\ KU2J/[27_)/(_P#K^B_]!>KWPV_Y$/0O^O5*_%</_P E9B/^
MO,?_ $H_:ZW_ "(:7_7Q_D=+1117WY\H%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %>4?M$?\BQIO_7Y_[(U>KUY1^T1_R+&F
M_P#7Y_[(U?'<8?\ (AQ7^']4?1</?\C6AZ_HR]\9O^33]2_[ =M_[2KEOV-?
M^2)VO_7]<?\ H0KJ?C-_R:?J7_8#MO\ VE7+?L:_\D3M?^OZX_\ 0A7Z;EO_
M "2T?\<?_2$?2U/^29Q/_81_[:>Y4445X9^<!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KYG_:N_P"1P\'_ .Z__HQ*^F*^9_VKO^1P
M\'_[K_\ HQ*^KX8_Y&D/27_I+/S_ ([_ .1%5]8?^EQ/9?VDO^2>1_\ 7]%_
MZ"]7OAM_R(>A?]>J51_:2_Y)Y'_U_1?^@O5[X;?\B'H7_7JE?BN'_P"2LQ'_
M %YC_P"E'[76_P"1#2_Z^/\ (Z6BBBOOSY0**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *\H_:(_Y%C3?^OS_V1J]7KRC]HC_D
M6--_Z_/_ &1J^.XP_P"1#BO\/ZH^BX>_Y&M#U_1E[XS?\FGZE_V [;_VE7+?
ML:_\D3M?^OZX_P#0A74_&;_DT_4O^P';?^TJY;]C7_DB=K_U_7'_ *$*_3<M
M_P"26C_CC_Z0CZ6I_P DSB?^PC_VT]RHHHKPS\X"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "ODC]OC_F1?\ M_\ _;>OK>OD
MC]OC_F1?^W__ -MZ^HX9_P"1M1_[>_\ 29'WG O_ "4.&_[?_P#2)'V;HO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M -?O_;#XB/\ R6"_[!O_ '(>GT445\@?H@4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5\S_M7?\CAX/\ ]U__ $8E?3%?,_[5
MW_(X>#_]U_\ T8E?5\,?\C2'I+_TEGY_QW_R(JOK#_TN)[+^TE_R3R/_ *_H
MO_07J]\-O^1#T+_KU2J/[27_ "3R/_K^B_\ 07J]\-O^1#T+_KU2OQ7#_P#)
M68C_ *\Q_P#2C]KK?\B&E_U\?Y'2T445]^?*!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7E'[1'_ "+&F_\ 7Y_[(U>KUY1^
MT1_R+&F_]?G_ +(U?'<8?\B'%?X?U1]%P]_R-:'K^C+WQF_Y-/U+_L!VW_M*
MN6_8U_Y(G:_]?UQ_Z$*ZGXS?\FGZE_V [;_VE7+?L:_\D3M?^OZX_P#0A7Z;
MEO\ R2T?\<?_ $A'TM3_ ))G$_\ 81_[:>Y4445X9^<!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R1^WQ_S(O\ V_\ _MO7
MUO7R1^WQ_P R+_V__P#MO7U'#/\ R-J/_;W_ *3(^\X%_P"2APW_ &__ .D2
M/LW1?^0-8?\ 7O'_ .@BKM4M%_Y UA_U[Q_^@BKM?,R^)GP]3XWZA1114F84
M444 %%%% !1110 4444 %%%% !1110!R'QA_Y)'XW_[ =]_Z3O7PI_P2-_Y)
MUX^_["L'_HDU]U_&'_DD?C?_ + =]_Z3O7PI_P $C?\ DG7C[_L*P?\ HDU[
M5#_D7UO6)PU/]YI^C/O>BBBO%.X**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#DOBM\3=(^#GP_U;QCKRW+Z3IBQM.MG&))?
MGD2,;5) /S.._3-6?ASX^TSXH^!]&\5Z,LZZ7JL N+=;I D@4DCY@"0#QZUY
M#^WY_P FB_$'_KE:?^EL%;7[&/\ R:W\-_\ L%+_ .A-71R+V//UO;\#'F?M
M.7I8]HKR/XA_M/>#OA[\1M&\!-'J7B'QAJA'EZ3H5NMQ+$#RIERZA 1EN3PH
M+' P3Q?[5W[5+_"5K/P/X(LSXC^*FN@1:?IL">9]D#\+-(.YZE4/7&YL*.;?
M[*?[+,?P3L;SQ+XHNAXB^)VN9FU769F,C1[SN:&-CSC/WFZL1Z  .-.,8<]3
MKLN__ $YN4N6'S/H*29(86ED81(J[F9R % Y))KYG^(G_!17X,?#[4IM/35[
M[Q1=0DK+_P (_;">-6'82NR1O]58CWK(_P""F?CG5O!O[-PM=*FDMAKNK0Z7
M=S1$J?LYBEE=,CIN,2J1W4L#P:]2_9O^ ?@GX/\ PYT!/#^D6,E_/90SW.M&
M)7N+N1E#%S+C.W).U1P!C JHPA&FJE36^R%*4I3Y(:6/+O"G_!3?X+>)+M(+
MR;7?#89MHEU;3P4^I,#RX'UKZ<\+^*M&\;:';:SH&J6FL:5<KNAO+*998W_$
M'J.A'4'@U3\9?#SPO\0]/>Q\3^']-UZU9=OEZA:I-@?[)894]P1@@U!\-?AK
MX=^$?A&T\,>%K :;HMJ\CQ6^]I""[L[99B6;ECR23@ =JSFZ35X)I_>7%33]
MYW1R_C+]HKPKX%^,7ACX:ZE'J#>(O$,2S6;00*UN%9Y$&]RP(.8FZ ]J]0KX
M5_:2_P"4CGP/_P"P?!_Z47=?=5.K!0C!KJ@A)R<D^C"JVI:A%I.FW=[,&,-M
M$\S[1D[54DX]\"K-(RAE*L,@\$&N<U/D'_AZ1\&_^?7Q/_X+XO\ X]1_P](^
M#?\ SZ^)_P#P7Q?_ !ZOJW_A&](_Z!5E_P" Z?X5\H?MC?%Y[/4+#X,_#'2K
M2]^)/B;$,LEM"F=-MW'+%@/D=ER<_P " OQ\IKOIJC4ERJ#^_P#X!R3]I!7<
MOP_X)ZY\ /VKO!7[25YK5MX2AU6.324BDN#J-LL0Q(6"[=KMG[A]*]CDD6*-
MG=@B*,LS'  ]37E?[-?[/NB_LY_#:T\.::%N=1DQ/JFI;<-=W!'+>R#HJ]@/
M4DGP?]O[XA^(=>UKP3\"_!]P;35O&DRMJ%PCE62U,FQ4./X&(D9O]F+'(8BL
MO9QJU>6GL:<\H4^:>YUGQ"_X*/?!GP#JTVG0W^I>*IH3MDD\/VR30AL]!)(Z
M*_U4D>]=;\&/VU/A7\<M4CTG0]:ET_7)3B'2]8A^SSS<9_=G)1SP?E5BW'2N
ML^"O[/?@KX#>&;72?#.D6\=Q&@^T:K-$K7=VX!R\DF,]SA1P,D "O*/VQ/V2
M]"^*7@B_\3^&=/BT/XA:)$;ZPU#3E$$ER8AN\IRH&20OR-U5@O(&0;7U>3Y-
M5Y_\ E^VBN;1^1[M\4?B1I/PB\!:OXOUQ;A]*TN-9)UM(P\I#.J#:I(!Y8=Z
M^:O^'I'P;_Y]?$__ (+XO_CU>A_L9?&J3]H;X":=J>M".ZUJPE;2]4W@,)I8
MPI60C_;1D8]MQ;'2N;_X*&:)IUG^R7XQEM["U@E66QQ)'"JL/],A'4"BG3@J
MGLJD=;VW"<I.'M(/2Q]"^"?%UCX^\':)XETP3+IVL64-];"X4+((Y$#KN )P
M<$9&36W7F/[,'_)N/PP_[%K3_P#TG2O3JY9KEDTC>+O%,****@H**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OBO_@K'_P FZ^'?
M^QJMO_2.\K[4KXK_ ."L?_)NOAW_ +&JV_\ 2.\KTLM_WRGZG)BOX$CL=0_Y
M19I_V(,7_HE:P/\ @EC_ ,FS77_8P77_ **@K?U#_E%FG_8@Q?\ HE:P/^"6
M/_)LUU_V,%U_Z*@KOJ?[G6_Z^'/'^/3_ ,)]A4445\\>F%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XS^UE\=[_P#9U^$Y
M\7:=I=OJ]R+^&T^SW4C(F'#9.5YR-M>D^ O$4GB_P+X=UZ:%;>;5--MKYX8R
M2J-)$KE03V!;%?,W_!3[_DV)O^PU:?RDKZ!^"K!?@OX#9C@#P_8$D_\ 7M'7
M3**]C&76[,%)^U<>ECLY)%BC9W8(BC+,QP /4U\S^%?VL=9^,GQTNO!WPO\
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M:WY(TFC>.1%DC<%65AD$'J"/2F6=I!I]K#:VL,=M;0(L44,*!$C11A551P
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M4 %%%% !1110 4444 07FH6NGJK75S#;*QP&F<("?3FIZ^%?^"L__)*O!/\
MV&G_ /1#U]U5M*GRTXSOO?\  SC.\W'M8*K2ZE:0726TMU#'</C;"T@#MGI@
M9R:\9_:C_:@T?]G7PK&$C76/&>J#RM&T*/+/-(3M$CA>1&&XXY8_*O.2.(_9
M7_9EUC1]>N?BW\69CK7Q3UC,B1SD,FDQ,,"- .!)M^7Y>$7Y5[DM4O<]I)V7
M3S$Y^]RQU[^1]35G:MXDTG0=O]IZI9:=N^[]KN$BSUZ;B/0_E7S!^W/\>/%O
M@B3P9\-_A[-]C\8^-;K[*E^#A[:,R)&NQOX6=WQOYVA6(P<$9'A'_@F3X"^R
M)>>/-<U[QGXDG >\O'O#%$[X&=HP7(]V<D^W2KC2BH*=25K[=274DY.,%>Q]
M@6=];:C;K<6EQ%=0-]V6%PZGZ$<5/7Q;XA_X)M:?X7D_MCX0^/O$/@?Q)$=T
M9GNC)!)CD(6C"NH]22XQ_">:^P/#5E?Z;X<TJTU6_.JZI;VL45W?%%0W$RH
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METR"W[QXXV2/"C<=[#"X)P"#7D_[5G[4E_X#U"S^&OPTM?\ A(?BOKF(8+:
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M/B-^Q7\'/B5ILUM=^"=.T6X?)6_T"!+&=&/\68U"L>?XU8>U>J>!O!]C\/\
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ME=8XD4LSN<*H'))/85P'P(^"FA? 'X;Z=X2T%-\</[V[O'7$EY<,!OF?W.
M.RA1VKYB_;%\9>(_C=\;O#?[.G@_4)-+MKQ5N_$E]$>D)7S/+;&/E6(;RI(#
MM)&.,5C&G&I4<8/W>[[&LIN$$Y;_ *GLGBG]NSX&^$=6?3KSQY;7%S')Y<AT
MZUN+N-/4^9%&R$#_ &23[5Z1\-/C-X(^,6G/>^#?$MCKT4?^MCMW(FB]-\3
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MVL?H71117$=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7E'[1'_(L:;_U^?\ LC5ZO7E'[1'_ "+&F_\ 7Y_[(U?'<8?\
MB'%?X?U1]%P]_P C6AZ_HR]\9O\ DT_4O^P';?\ M*N6_8U_Y(G:_P#7]<?^
MA"NI^,W_ ":?J7_8#MO_ &E7+?L:_P#)$[7_ *_KC_T(5^FY;_R2T?\ ''_T
MA'TM3_DF<3_V$?\ MI[E1117AGYP%%%% !1110 4444 %%%% !1110 4444
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MAJ?'+U.J'PH****S+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KXK_X*Q_\FZ^'?^QJMO\ TCO*^U*^*_\ @K'_ ,FZ^'?^QJMO
M_2.\KTLM_P!\I^IR8K^!(['4/^46:?\ 8@Q?^B5K _X)8_\ )LUU_P!C!=?^
MBH*W]0_Y19I_V(,7_HE:P/\ @EC_ ,FS77_8P77_ **@KOJ?[G6_Z^'/'^/3
M_P )]A4445\\>F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!\D_\%/O^38F_P"PU:?RDKQO7_C5XR_:4\+>$O@9\%B5MX-
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M HHHH **** "BBB@ HHHH ^%?^"L_P#R2KP3_P!AI_\ T0]?0/[47[3WA_\
M9I\$MJ%Z8[_Q'>*R:5HP?#W#C^-L<K&N?F;\!R17S]_P5G_Y)5X)_P"PT_\
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M8PW]T/"[ =M_H!C&_9;D'P[_ &]/CIX1OA]GFUIY=5M0>C@S"X51[^7<EO\
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M )'#P?\ [K_^C$KZ8KYG_:N_Y'#P?_NO_P"C$KZOAC_D:0])?^DL_/\ CO\
MY$57UA_Z7$]E_:2_Y)Y'_P!?T7_H+U>^&W_(AZ%_UZI5']I+_DGD?_7]%_Z"
M]7OAM_R(>A?]>J5^*X?_ )*S$?\ 7F/_ *4?M=;_ )$-+_KX_P CI:***^_/
ME HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_"?PMX9\,1C6/B/J6BVIM;.-#*+&,PKB>11U/!*IWQD_*.:W_!5+_DW'2?\
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M0?PO_P!C+%_Z2W-=\6GC+KN<DDUAM>Q]H:;_ ,@^U_ZY+_(58JOIO_(/M?\
MKDO\A5BO,.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KY(_;X_P"9%_[?_P#VWKZWKY(_;X_YD7_M_P#_ &WKZCAG_D;4
M?^WO_29'WG O_)0X;_M__P!(D?9NB_\ (&L/^O>/_P!!%7:I:+_R!K#_ *]X
M_P#T$5=KYF7Q,^'J?&_4****DS"BBB@ HHHH **** "BBB@ HHHH **** .0
M^,/_ "2/QO\ ]@.^_P#2=Z^%/^"1O_).O'W_ &%8/_1)K[K^,/\ R2/QO_V
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M%%% !1110 4444 %%%% !1110 5^?_\ P5U_Y$OX=?\ 80N__1<=?H!7Y_\
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M!H9V'5D69DPO^Z[CT)JGXI_X*/7/Q&L[G0/@K\/O$>N^)KE3#%=WEJFRU+9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF?]J[_ )'#P?\
M[K_^C$KZ8KYG_:N_Y'#P?_NO_P"C$KZOAC_D:0])?^DL_/\ CO\ Y$57UA_Z
M7$]E_:2_Y)Y'_P!?T7_H+U>^&W_(AZ%_UZI5']I+_DGD?_7]%_Z"]7OAM_R(
M>A?]>J5^*X?_ )*S$?\ 7F/_ *4?M=;_ )$-+_KX_P CI:***^_/E HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /ES_ (*(
M?"?Q9\8O@KHNB^#=&EUS4X/$,%Y);PR(A6%;:Y0OEV QND0=<\U]'^%;2;3_
M  OH]K<(8YX;.&.1#_"P0 C\Q6I16KJ-P4.Q"@E)R[E;4M-M=8T^YL+ZVBO+
M*ZB:&>WG0.DJ,,,K*>"""017QCX'^"OQ&_9'^/=P?A_HMYXN^#OB.3S;W3(;
MB/SM,;.-RB1QEDSP1]]/E;YE##[7HITZCIIK=,4H*33ZH^>?VF/V>_&WQ*\1
MZ#XV^'/CVY\(^,-#MWMK>WG8_8IXW;<P8!3@L0N[<KJP105&,UYK'\:OVM_!
M,'V'7/@[I/BF:,[4U+2[A0)A_>94E;!_X"GTK[0HJXUK149132)=.[YDVCX6
M\7:+^U5^U)I;^&=8T32/A/X-O@$OYO.#W$\1Y*$"1G(Q@;0(PW(8XR!];?!W
MX5:-\$_ASHW@W0@YL--B*^=-CS)Y&8M)(^.[,Q/H. . *[.BIJ5G-<J5EV0X
MTU%\U[L^2/"_P;\96/\ P41\7_$*?0YH_!M[I<<%OJIDCV22"SM8RH7=N^]&
MXY'\-?6]%%34J.I:_16^XJ,5"]NNH5YY\?/A*_QN^%^J^$8]?O?#<EV8Y$OK
M'!*NC!U#C@LFX D J>!S7H=%1&3BU);HII25F?$%CJG[8OP.C&F2Z)HWQ<T:
M#Y8M1,P-SL'0$[XY&..[(YS_ !'C-?7O&W[8'QJLYM TSP)IOPTL+L&&?5YI
M@DT2$8;#M(S#@GYHX]P[$$5]ST5T_6%OR*YA['IS.QXS^RS^S7I?[,_P_?1K
M:[_M76K^47.J:F4V>?(!A55<G"*,@ G))8]\"M^U1^S!I?[27A*UA^V-HOBG
M26:?2-8C!S$YQE'QR48JIXY!4$="#[?16/M9\_M+ZFGLX\O);0^'])^)/[8/
MPLM%\/:M\.=,^()MQY%OKT,X9IQ@!7=ED4D<<ET1CU)[E-%_9E^+7[3GCW2O
M%?[05Q::/X9TQ_-LO!FFR@ACD':^TLJJW&YB[2$#;\O;[AHK;ZPUK&*3[HS]
MBOM-M#8XUAC5$5410%55&  .@ KY1_X*+?!_QA\9/AAX:TSP9HDVNWUKK'VF
M:&&2-"D?D2+NR[*.K ?C7UA16-.HZ<U-=#6<%4BXL****R+"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\H_:(_P"18TW_
M *_/_9&KU>O*/VB/^18TW_K\_P#9&KX[C#_D0XK_  _JCZ+A[_D:T/7]&7OC
M-_R:?J7_ & [;_VE7+?L:_\ )$[7_K^N/_0A74_&;_DT_4O^P';?^TJY;]C7
M_DB=K_U_7'_H0K]-RW_DEH_XX_\ I"/I:G_),XG_ +"/_;3W*BBBO#/S@***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YC_X
M*$?"OQ7\8/@?IVB>#]'EUO5(M=@NGMHI$0B)89U+9=@."ZCKWKZ!\#V,^E^"
MO#]E=1F&ZMM/MX98R02KK&H8<>A!K;HK5U&X*'8A02DY=R"^L;;5+&XL[RWC
MNK2XC:*:"9 Z2(PPRLIX(()!!KXM\)_!#XB_LC_'V:Z^&^BW?B[X0^(W\R_T
M>&XC$VG-G&4$CKN9,_*?XDRK<@-7VS13IU'336Z8I04K/JCY]_:7_9^\9_$W
M7/#WC+X=^/;KPAXPT""2&UAF)^Q3(Y#,' 4D%BJAMRNI"*"O&:\QC^,W[7'@
M>#[#KOPATGQ;+&0J:GI=PH$PQ]YE24\Y!_A3Z<BOM"BJC6M%1E%-(F5.[NFT
M?"WBS2_VJ_VHM+D\,:KH6D_";P=? 1W]QYP>XFB/+(0)&D((P-H$8;)5FP2!
M]9?!?X2Z-\#OAOH_@W0M[V>GH=]Q+CS+B5B6DE;W9B3CL, < 5V]%*I6<URI
M679#C347S-W9\D:/\&_&5O\ \%$==^(4FAS)X-N-+6"+5?,CV,XLX8]NW=N^
M\K#IVKZWHHJ:E1U+7Z*Q48*%[==0KS_X\?"=OC;\+]7\(+KM[X<:^"%;ZQP6
M#(P=0PXW(6 R 5)QU%>@45$9.+4ET*:4E9GP_87W[8GP*A&EMI&C?%W1+?Y(
M=0:8-=;!T!)>.1C@=65SGC<>*BUSQ]^V#\9+2;0M)\ Z;\-K.ZS%-K$\P2:%
M" #AGD9AU/S)&6'8@C-?<M%=/UA;\BN8>Q>W,['BW[*O[-&F_LS^ 9M*BO/[
M6U[491<ZKJFTJ)I "%1%).$0$XSR2S'C. S]J;]F+2?VE/!]O:27;:/XETMF
MGTG5XQDPR'&4<#DHVU<XY! (Z8/ME%8^UGS^TOJ:>SCR\EM#X>T?XB?M?_"6
MQ7P[JGP]TWXBBV'DVVO0W 9IAC"LY6120,<ET1CU)YR8]'_9G^+G[4'Q TKQ
M3^T!+::)X5TMS+:>#=.E!W'(.UMC,%5N-S%VD(&WY1C'W+16WUEK6,4GW,_8
MK:3;0R&%+>%(HD6.)%"JB#"J!P !V%?+/_!1/X1^+OC)\(?#^D>#=%EUS4;?
M78[J6"&2-"L0MYU+9=@/O.H_&OJFBL*=1TYJ:Z&LXJ<7%D%C&T5E;HPPRQJ"
M/0XJ>BBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "ODC]OC_ )D7_M__ /;>OK>ODC]OC_F1?^W_ /\ ;>OJ.&?^1M1_
M[>_])D?><"_\E#AO^W__ $B1]FZ+_P @:P_Z]X__ $$5=JEHO_(&L/\ KWC_
M /015VOF9?$SX>I\;]0HHHJ3,**** "BBB@ HHHH **** "BBB@ HHHH Y#X
MP_\ )(_&_P#V [[_ -)WKX4_X)&_\DZ\??\ 85@_]$FONOXP_P#)(_&__8#O
MO_2=Z^%/^"1O_).O'W_85@_]$FO:H?\ (OK>L3AJ?[S3]&?>]%%%>*=P4444
M %%%>=^-OVB/AG\.=1;3_$GCC1-*U!>'LY;M6F3_ 'HURR_B!51BY.T5<3:C
MJST2BN>\%_$+PQ\1M-:_\+>(--\0V:-M>;3;I)@C>C;2=I]CBJ_CKXI>$/AC
M#9R^+?$FF^'8[QF6W;4;A81*5P6"Y/.,C\Z.65^6VH<RM<ZFBO//$W[0WPS\
M'Z?I][K/CK0K"WU"W2[M/,O4+W$+\I*B EF0]F Q73>#O'GASXA:3_:?AC7=
M/U_3]QC-SIURDR*PZJ2I.#['FAQDE=K07,F[)F[15?4-0M=)LIKR^N8;.TA7
M?+<7$@CC11W9B< ?6O+XOVL/@Y-JPTY/B5X;-R6V@_;T$9/3 DSL_6B,92^%
M7!R4=V>L45';W$5U!'-#(DT,BATDC8,K*1D$$=017%^/OCA\/_A=,D'BOQAH
M^A73C<MK=W2B8J>XC!W8YZXQ0HN3LD-M+5G<45R_@7XH^$/B=9R77A/Q+I?B
M&&/'F?V?=)*T>>@=0<J?J!744FFG9@FGJ@HHKS#Q#^U!\)?"NL-I>J?$/P_:
MZ@K;'@^VHYC;T<J2$//\6*<8RE\*N#DH[L]/HK-T3Q+I/B;1XM6T?4[35M+E
M4O'>6,ZS1.!U(920?PKF?!?QP^'_ ,1M7?2O"_C+1M>U)(FG:UL+Q)9!&" 6
MV@YP"R_G1RRUTV#F1W%%4->U_3?"VC7FK:Q?0:;IEG&9;B[NI D<2#JS,> *
MQ_ OQ/\ "7Q-M[JX\)^(M.\106KK'/)IUPLRQL1D!B.A(%+E=KVT"ZO8Z>BO
M.O&O[17PR^'6I-IWB/QSHFE:BIP]G+=JTR?[R+EE_$"NJ\(^./#WC[2QJ7AK
M7-/U[3R=OVG3KE)T#>A*DX/L>:;C)*[6@N9-V3-NBN+\<?&CP)\--0@L?%?B
M[2/#UY<1>?%!J%VD+O'DKN )Y&01^%1^(OCE\/?">M?V/J_C/1+'5A&TKV,E
MZGGQQK&96=T!W(H0%LL ,#-/DD]D',NYW%%<EX%^+?@OXG27J>$O%&E^(GLP
MAN5TZZ68Q!L[2V#QG:WY5I^+_&F@^ -%DUCQ)J]GH>EQNL;7E],L489CA1N/
M<FERN_+;4?,K7-JBL/P;XY\/_$+1AJWAG6+/7=,,C1"[L91+&77&Y=PXR,BO
M+?VN?!OQ/\<?#?3;'X3ZO+HOB*/5HY[BXAOC:%K40S*R[QU^=HCCVSVJHQO+
ME;L3*5H\RU/;J*_*GXJ^$?VJ_@OX-NO$_BSXGWFGZ7 RQ@CQ([R2R,<+'&@Y
M9CR<#L"3@ FO4?\ @FYXI^+_ ,3/&FN>)?%/B36];\$VMB]DC:I>/)$]XTD3
M+Y:M]XJBODCIO [UURPO+3=1332.>.(O-0<6F?H+1117 =8445^??[<_[7OB
M)O'5A\*/A/J-Y%KD=VD6H7^DN1/)<L=J6<3#N"1OQ_%A>,,#O1HRK2Y8F52H
MJ<;L_02BO-_V?O /B3X=_#/3=/\ &'B74/%7BF8?:-1O;ZZ:<)*P&8HBQX1,
M #U.6[X'I%9223:3N:)W5V%%-EE2")Y)'6.- 69V. H'))/85Y5?_M7?!W3-
M5.G7'Q)\.)=*Q5@M^C(I&<@N"5!X[FB,92^%7$Y*.[/5Z*J:3J]CKVFV^H:9
M>V^HV%PN^&ZM)5EBD7U5E)!'N#7*ZS\:_ 7AWQ=%X5U/Q?H]AXDEDBACTNXN
MT6X9Y<>6H0G.6W+CUR*%%O1(=TMSM:*Y32_BOX,USQA/X4TWQ1I.H^)+='DG
MTRSNTFGA",%?>JD[""0"&P>:ZNDTUN%T]@HK\V/V_/C5\1=#_:6TCPGX(\7:
MOH44NF6< L]/O'ACDN)9I<,P!ZD,@SZ**/\ AGO]M'_H?KW_ ,*9J[EA?=4I
M32N<KK^\XJ+=C])Z*Y;X5Z;KNB_#/PK8>*+EKSQ):Z9;PZE<-+YIDN5C42,7
M_BRP)SWKH=1U"VTC3[J^O9X[6SM8FGGGE;:D<:@LS,>P !/X5PM6=CJ3TN6*
M*\_TC]H+X9Z]I6J:G8>//#]SIVEB,WUVNHQ"*VWDA-[$X7<58#/7%2>!_CU\
M.OB5J+:?X8\:Z)K6H+N_T.UO$,S =66,G<RCU (JN22Z"YH]SO**\^\9?M"?
M#3X>ZJ=+\1^.="TG4U8*]G/>IYT9(R-Z DH,$'+ "NP\/>)-*\6Z/;:MHFI6
MFKZ7<KNAO+&99HI!G'RLI(//'X4G&25VM!\R;LF:-%9OB'Q+I'A'29M4US5+
M/1]-A&9+R_G6&)/JS$ 5Y_H?[4OPB\2:LNF:=\1?#T]\[^6D1OD3S&[!2Q 8
MGV)H4925TA.26C9ZE117!:!\?/AOXHOKZTTGQQH-_<V,$EU=QPW\9,$*$!Y'
MY^55+#)/ S0HM[(;:6YWM%>::%^TQ\*/$VO)HNE_$+P]>ZG(XCBMX[^/]ZYZ
M+&<X<GT4FNN\:>-M!\ Z*VI^(=<TW0+,MY4=SJMW';1-*5)5 SL 6(4G&<\'
MTIN$D[-"YDU=,W:*^ ?V1O\ @H'KOQ,^)&I:7\4-9\)^&= ATF2Y@NYF6P#W
M(FA54\R67:24>0[1S\N>QKL_^"F&LZ?XA_95TS4M*OK;4].NM<M)8+RSF66&
M5#%/AD=20P]P:Z?JTXU52EI<Q]O%P<X]#[+HKXQ_81^*G@[X7_LDZ!<>+?$V
ME^'HYK^^,(U"Z2)I<3'.Q2=SXR/N@]:^I/ ?Q5\'?%&TFN?"7B;3/$,4./.^
MP7*R-%GIO4'*Y]P*QJ4I4Y-=%U-(5%))]SJJ*S]>\0Z7X6TN;4M:U*STC3H1
MF6\OYT@A3_>=B /Q->;P_M8?!NXU(V*?$OPT9P0N6U",1DDXXD)VGKV-1&$I
M:I7*<DMV>L45#9WMOJ5K%=6D\5U;3*'CFA<.CJ>A##@CZ5-4%!1110 5\5_\
M%8_^3=?#O_8U6W_I'>5]J5\5_P#!6/\ Y-U\._\ 8U6W_I'>5Z66_P"^4_4Y
M,5_ D=CJ'_*+-/\ L08O_1*U@?\ !+'_ )-FNO\ L8+K_P!%05OZA_RBS3_L
M08O_ $2M8'_!+'_DV:Z_[&"Z_P#14%=]3_<ZW_7PYX_QZ?\ A/L*BBBOGCTP
MHHHH **** "BBB@ HHHH **** "BBB@ HHKYI^,7_!03X3_!_7+G1)+N_P#$
M^L6K&.XM]"A25()!U5Y7=4R#P0I8@\$9!%:0ISJ.T%<B4XP5Y.Q]+45\V?!K
M_@H!\*?C+KUKH5O=7_AO6KIECM[77(4B6XD/\"2([IDG@!BI8\ 9.*]2^.GQ
MMT/]G_P#+XN\0VFH7FFQW$=L8M,CCDFW.2 <.Z#''/-.5*I&2@UJ)5(./,GH
M>@T5\FWO_!33X/6?A&PUK&N375XTBKHL5K$UY$$8KNE E\M Q' +[B.<5U_P
M%_;B^&O[0&NKH.D2ZAHOB"1"\.FZQ"D;7&%+/Y3([*V "<$AL G'!Q;P]6*<
MG%V$JU-NR9]!T5B^,?&>A_#_ ,.7NO\ B/5+?1]'LTWSW=T^U%[ >I). %&2
M20 ":^3]7_X*I?"73]6-M:Z1XHU2T5B&O;>SA1&'8HLDRL0?]H*:FG1J5/@5
MQRJ0A\3L?95%>??!GX]>"OCYX?EU;P;JZWZ6[*EU:R(8[BU8YP)(SR,X.",J
M<'!.#7"?'3]MSX8_ /5GT;6;Z[UC7XP#+I6BPK-+!GD>8S,J(<'.TMNQSCD9
M2I3E+D2U&ZD5'F;T/?**^8/A)_P43^$_Q6UZUT1IM2\*ZG=.(H%UR%(X97/1
M5E1V4$]!OVY) &37T_2G3G3=IJP1G&:O%W"BFR2)#&\DCK'&@+,S'  '4D^E
M?*'Q$_X*8?"'P/K4VF6!U?Q;)"^R2ZT6",VP(."%DDD3?[%05..O>G3ISJ.T
M%<)3C#63L?6-%>+_  '_ &NOAS^T1-+9^&=1GM=9B3S7T?58A!=;.[* S*X'
M?8S8R,XS7.WW[<W@31_CD/A7JFD>(]+\0'4DTL75U;6XM#(Y'E/O$Y;8^Y"I
MV9PXR!SA^QJ7<>75"]I"R=]&?15%4]8U:T\/Z1?:IJ$ZVUA90/<W$[_=CC12
MS,?8 $_A7BW[/'[8'A/]IC6M7T_PKH?B.T72X%GN;S5;:". ;FVH@*3.=S88
M@8QA&Y]84)2BY):(IR2:3>K/=:*^9_C%_P %"/A1\(->N=#>XU#Q1J]JYBN(
M="A22."0=4>5W5<@\$*6(/!P0<:OP._;F^%_QXUJ+0]+O+W0]?FSY&FZW"L+
MW!'41NKLC'T7<&."<<&M/855'GY78CVL.;EOJ?0=%>2?M$?M,>%_V9]%TC4_
M$]AJ]_!J=PUM"ND0Q2,K*NXEA)(@ QZ$UYO>_P#!1KX30R^&K:S_ +8U34M<
M2!DLK2WB9K,RL J7#>;L5AG)568CO2C1J37-&.@Y5(1=FSZCHKYU^&?[<W@/
MXG?%P_#B#2/$6A>)1+<6^S6;:WCC\Z$,9(LI.YW?(V.,';UZ5[+\2OB%I'PI
M\!ZWXNUUY$TK2;=KB80@&1^@5$!(!9F*J 2!EAR*F5.<9*+6K&IQDKIG2T5Y
M)^SO^TIX?_:6T75M6\-:/KFG:?IUPMJ\^L00QK+(5W%8_+E?)4%2<X^^N,\X
M].UO5H=!T6_U.X5W@LK>2YD6, L512Q !(&<#UI2C*,N62U&I*2NMB[17R7H
M/_!3;X.ZUI.KWTZ:_HXT]8REO?VD/G7C.2-D*QS/DC&26VJ,C)Y%6_AK_P %
M(_A)\1?$MMHDK:MX7GNI?*@N-<@BCMV)^Z&D21PA/^U@9[UL\-65WRO0S]M3
M_F/JFBOE3XD?\%)OA%\/?$5QH]NVK>*IK>7RYKG0X(I+=2#\VV1Y$#X]5R">
M_>O7_@7^T5X)_:(T&XU/PA?R2O:,JWEA=Q^5<VI;.W>N2,-M.&4D'!&<@@1*
MC4C'FE'0J-2$GRIZGIE%>=?&C]H+P-\ M%AU#QEK*V)N"1:V4*&6YN2.NR,<
MX'=CA1D9(R*^>M(_X*I?"74-6%M=:1XHTNT9@%O;BSA=%'<NL<S, /\ 9#&G
M"A5J+FC&Z%*K"+M)GV516-X/\8Z)X_\ #=CK_AW4[?5]'O4\R"\MFW(XS@CU
M!!!!!P0000"*^<=-_P""D'PDNO$VM:-J"ZYH#:4LYFO-2MH1#(T3;2D8CF=W
M=C]T!><$G&*F-*<[\JV*E4C&UWN?4]%?'FD_\%2OA#J6O)8W%AXFTRS=U0:E
M=641A7)Y9E25G"CCHI/7BO>?BK^T)X1^$?PSL_'NJ3W&I>&[QX5M[C246<RB
M52T;KE@"I SG/>JE0J1:4H[DJK"2;3V/2JYGXA_$KPU\*/#;Z_XLU6/1M(25
M(6NI4=P'8X480$\_2ORI_9;_ &TM6^'?Q8NM8^(_C'Q?XB\,O8SPQV,M_->J
M)F="C>7++M& &&>HS[U]4?MT?$+2_BO^Q!:^+=$6X32M4O[2:W6Z0)*%$CK\
MR@D Y4]ZZ9825.K&$MGU,5B%*#E'='U9\.?B=X8^+7AW^WO"6K1ZUI/G-!]J
MBC=!YBXW+AU!XR.W>NHK\U_V0/VR/AW^SG^SC:Z7XBGO]0UR;5KJ8:7I,"RS
M)&0@#N79$4$@]6SQTKZE^ O[<7PU_: UU=!TB74-%\02(7ATW6(4C:XPI9_*
M9'96P 3@D-@$XX.,ZN&G3<FD^5%TZT9)7>K/H.BBBN,Z HHHH **** "BBB@
M HHHH **** "BBB@ K\__P#@KK_R)?PZ_P"PA=_^BXZ_0"OS_P#^"NO_ ")?
MPZ_["%W_ .BXZ];*?]]I_/\ )G%C/X$OZZGU+\5_^31['_L&:7_.&KG[-?\
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M^(6E_"CP)K'BW6UN'TK2XA-<+:H'E*E@ORJ2 3EAWKD2<G9'0W979T]%>6?
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M6JVHCBLU279 DYC^?/7,:Y]:N%&512:Z$2J1@TGU/O6BBBL34**** "BBB@
MHHHH **** "OF?\ :N_Y'#P?_NO_ .C$KZ8KYG_:N_Y'#P?_ +K_ /HQ*^KX
M8_Y&D/27_I+/S_CO_D15?6'_ *7$]E_:2_Y)Y'_U_1?^@O5[X;?\B'H7_7JE
M4?VDO^2>1_\ 7]%_Z"]7OAM_R(>A?]>J5^*X?_DK,1_UYC_Z4?M=;_D0TO\
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ML&5U(R""."".]%FMQ7)**R=2\7:'H]XMI?ZSI]C=L 1!<W4<;D'H=I(/-:U
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MVV-QIM];:A;ABAEM9EE0,,$C*DC/(_.@9<HK.\1^(M.\(Z!J&MZQ=QV&EZ?
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M=!\;>'?%1(T77]+U@@9/V"\CGXZ9^1C6U3U6X;A1112 **** "BBB@ HHHH
M**** "ODC]OC_F1?^W__ -MZ^MZ^2/V^/^9%_P"W_P#]MZ^HX9_Y&U'_ +>_
M])D?><"_\E#AO^W_ /TB1]FZ+_R!K#_KWC_]!%7:I:+_ ,@:P_Z]X_\ T$5=
MKYF7Q,^'J?&_4****DS"BBB@ HHHH **** "BBB@ HHHH **** .0^,/_)(_
M&_\ V [[_P!)WKX4_P""1O\ R3KQ]_V%8/\ T2:^Z_C#_P DC\;_ /8#OO\
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MBOKZ'GUN55DZOPV.:^)WAK7?^">_[3FG2>%M:N;[36@BU" 3,%:[LG=D>WN
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M?L]VOP7\:ZMKWB;X^^.]234IKC,-@D-W+)=DC<\TTT43\9.T*&!X)/&*^^O
MUK\0/VNOV1_$&D?$;1+;POJVM6YBTZY"O']HV;)(;F2$@F-3(J]#\P!("@KG
MX3^%/C6T_9+\6:YX4^+WP:TKQ2LL@=?[7TZ![JW901N@DEC821-QP#CN#U!*
M%VJB?QWZ6_ *MDX/[/F97C3Q?X*_9_\ C=HGBWX!>-+S6M*C FEM[J">!HCN
MQ);2&2-/-B=?8D9YY )_9K0M7@\0:)I^J6V?LU];QW,6[KM=0P_0U^=_P?\
MV@OAQ\;/C9HOA;0/V9O"[>'KI62[N(]$M)KJW)(Q.V(@B1+T8$DG<"#D;6_1
MJVMH;.WBM[>)(((D$<<4:A510,!0!P !VKDQDG[JDK-=[?H=&&7Q-/0^./\
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M6MV6Y@96BF9P6D;;*=QR,G(Y')\:_P""LG_)9O"'_8 '_I1-7Z7^"?\ D3-
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M*J4E]H\M_8R_82T7]H;X>W'B_P 8:[JUCIWVJ2ST^STEXT<A,%Y&>1'&TLQ
M4+U!.>:XO1_#NI_L>_MR:1H&F:M-<6EKJ]G:O<8P;JPNO+W(ZC@G9(1Z;D!'
M05]R?\$UO^35-%_["%[_ .CC7R#^V+_RD'LO^PAHG_H,%*G5G4KU*<GI9E2I
MQA2A..^AV7_!66\\2_\ "<>"K67[2/!HT]I(=N?):^\UQ+GL7$8BQGH&;'4U
M@>%O!_[%WCS0K?35\3>)?"&M21A%N]8=U<2''S.P1H ,]>5&">G4?37[9O[5
M=E\%O%&B>%M?^&Z>-O"&I6IFU)]0AQ SE\1I$71HW=0C,RG^\G*\U\+_ !\^
M*/P.^)/ANWM_AU\*;_PKXNFN8_\ 2DGVPA3]Z-84=E<L2 ,*IZ?0K#\\Z4(V
M:7=-?B%;EC.3NGY/]#]=/A7X-T3X>_#GP[X=\-O'+HFGV4<5M/&P83KC)ER.
M"7)+DC@EB:ZJO OV%_ _B3X??LT^%])\4Q36FHDSW*6-R")+6&25G2-@>5.#
MNV]MV#@@BO?:\2HK3:O<].#O%.U@HHHK,L*^*_\ @K'_ ,FZ^'?^QJMO_2.\
MK[4KXK_X*Q_\FZ^'?^QJMO\ TCO*]++?]\I^IR8K^!(['4/^46:?]B#%_P"B
M5K _X)8_\FS77_8P77_HJ"M_4/\ E%FG_8@Q?^B5K _X)8_\FS77_8P77_HJ
M"N^I_N=;_KX<\?X]/_"?85%%%?/'IA1110 4444 %%%% !1110 4444 %%%%
M 'DW[5_C/4OA_P#LY^/==T>1X=3M]-:.":/AXFD98O,4]BH<L#V(KX;_ .":
M/[/O@OXI+XL\4^+]*MO$<^FSPVEI87ZB6!"ZLSRO&>')X W9 PW&<$?I%XV\
M'Z;\0/!^L^&M8B,NF:M:26=PJG#;'4J2I[,,Y![$"OS(LO@?^T;^Q/X]U2]^
M'NF7/BK0[S$9FTVS-[#>QJ24$UNO[Q'7)Y &"2 Q!.?3PTE*E.G&5I,X:R:J
M1FU=(N_\%+?@#X-^$]YX0\3>#],M_#LNK23V]UI]BOEPLT81DEC0<(1N(.W
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M/DGPO\0OVQ/@[X5A\ V7@S6[BWLT%M9W9T)KYK6,# 2.X0-&5 X&[=@  '
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M%*QLI7Y>.".H]"!17E3H*-.&JO=_Y!24ZK<Y:.UD?D!^R+XPTCP)<:WK%_\
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MCYI>J:GX(5;'4?-6;5=/N+9(+M9&&%DE"DB3(7 <,W3&01BO'O@3JG[--O\
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M /\ ;"^*'P9^-T7PN^-%Q-J-K+>1V$MS?E6N;"23'ERB9?\ 6Q-N4DL3\I#
M\8/J'[!O[4OPUTC]GW1?"GB#Q/I?A?6M ^T1S0ZK<+;+,CS22K)&SX#Y#X*@
MEMP/'(S\K_M%^*K/]J[]LK3K?P&)+VVN9K/2;:\C1E\[RSF2XQC(1<N=Q_A3
M-:I>TG.E."45UL0WR1C.,KR9]$_\%./B[XU^&.N^ (O"?BG5?#L=Y;7C7"Z=
M=-")2K1!2VT\XR?SKS/2[7]K_P#:*\&VGC'1=;U#2M#%N%L;?3]5_LY[M8QM
M+@!P\A9E/S2-\Q)Q\N*WO^"N7_(Q?#7_ *]+[_T.&ON;]GBWCM?@#\-8HD"1
MKX:TW"C_ *]8S6'M%1P].2BFW?<UY74K2BV['QY_P3[_ &N/&GC3Q_=?#3Q_
M?3ZS<-;RRZ?>WB@744D63)#*>"X*[B"V6!0CD'CYC_;@\.?$OP]\55_X6/JG
M]I_:OM$VC?Z0LOE61G?8G &WZ&N[_954+_P4=N0!@#6M>  _ZYW5==_P5JT^
M:/XA> KYE_T>;2YX$;U9)@S#\I%_.NJ/+3Q245;F5S"5Y4&V]F>\?L6^!?CW
MX=\1)J/Q)\0?VGX)GT )IMK]M27RY6>!HCL"@C$0D'7OBO@:S\5>,?!_[7/B
M*^\ 0"Y\83>(-4LM.C,0E/F3R30Y"L=N0')!;Y1C)X!K]7/@'\</ ?Q!\'^$
M]*T#Q5I>HZR=$@FDTN&Y1KJ$)'&L@DC!RA5F (/U&1S7YY_LNV\=Q_P4?F\Q
M _EZ[KKKGLPCNL&L*,W>K*<>FQI5BK4U%]1_Q7C_ &L_V=;6Q\:>)_&>MBRF
MN%B+QZQ]LMHI2"RI) 28P#@C[I7C&>1G[4^%O[6#^+OV0]1^*]]IZ2:QHME<
M+?6</RQRW<*\8[JC[D;_ &0QZXR:?_!2!0W[)WB4D9(N[$CV_P!)2O-_^"=(
MT%OV.?&W_"4K WAK^UM0_M,7.?+^S?8[?S=V.<;<].:RE*-:@JDHJZ=M#2*=
M.JX)Z6ZGAOPGUS]I+]M#4]?O-$^*J>&X["16DM8]4ETY5W@[5CCME+E1MQN;
MWY)S7UC^RA\,_P!H+X?^-=<M_BGXS'B'PM%:+]C_ -+%Y]IN&8?,LDB"9%15
M.0P4$NN,X-?+M[^R+\"O'6_7?AK\?]+\/Q,?/AT_6Y8UE@''!+R12H!GJR$]
MLGK5S]A7XX>/M&_:4C^%]UXND\;^%)Y+VW-P;A[J!?(BD=+BWD?YEC8Q@8R%
M(?.,XK>M'VD)>SLDELU9KYF=-\DH\][OK<_3RBBBO"/4"BBB@ HHHH *^9_V
MKO\ D</!_P#NO_Z,2OIBOF?]J[_D</!_^Z__ *,2OJ^&/^1I#TE_Z2S\_P".
M_P#D15?6'_I<3V7]I+_DGD?_ %_1?^@O5[X;?\B'H7_7JE4?VDO^2>1_]?T7
M_H+U>^&W_(AZ%_UZI7XKA_\ DK,1_P!>8_\ I1^UUO\ D0TO^OC_ ".EK\T_
M^"AOQZ\6^+OC!;?!7PG=S6=DAM;:\@MI/+;4+NX"-'&[9'[L+)'\O3<S$YP,
M?I97Y<_\%!OAGXE^$_[1FG_&+2;-[C2;RXLKY+L(6BMKZV$:B.3'W0PB1@3C
M=E@/NU^GX%1=7WM[:>I\3BK^ST^9O>(O^"4.H:7\/9[_ $SQL-1\7V]L9_[/
M^Q;+::0*"8DDW[@<@@,1R<9"\XZO_@F7^TIX@\;7.K?#;Q-?S:LVGV7]H:5>
M73EY4A5TCD@9CRP&]"N>0-PZ8 N>)/\ @JUX0E^'=Q)HOAK68O&<UL4BM;E8
MOLD$Y7&\RA]SHIY V MC!VYR.3_X)8_!'6[77M<^)^JVDUII4UBVF:8TZE3=
ML\B/+*F>2J^6%W="78#E3CKG[25"?UGY'/'D56/L?F?.?CK1/$WB;]MWQAHO
M@Z_ETOQ%J?BO4;"VO(9FA,2RRRQR,77D+Y;/G'.,XKT7]I/_ ()YW_P!^%4O
MCFQ\8CQ"-/EA&H0-8_9C&)'5%DC;S&SAW08(!P<YXQ1\,_\ E*!>?]C?JW\K
MFON+]OS_ )-%^(/_ %RM/_2V"M:E:=.I2A'9I&<*49PG)[JYPW[$?[1%_KW[
M)NN^)?%UW-J=QX+:[CGN97+3W%O#;K.A9CG<VUBF3R=@SD\GX_\ AIX)\>_\
M%%_C%K=_XC\2MINE:<@N)GVF6*QC=B(K>WAW <[6Y)_A8L23S[O_ ,$X_!\?
MQ"_99^*OA>:7R(]:O;G3S-C/E^;91INQ[;L_A7A7[-/QGU7]@_XO^*?#WC[P
MY?"SODCM[^&V \Y&B9S%/%N(61"'?N,A@0>,&8QY9U?9+WN@Y/FC3]I\/4]=
M7_@F_P#$CX5_%30-5^%_CZ.&T#&2;5KL&VELMI'R-&A;SU8=L 'D, .3T/\
MP4L_:/\ $G@*WT'X;:#J;Z=>:E8?;]8O[+="\D3,T:1(<DHK,DI89)P%&<$Y
MEUG_ (*D0ZS\1= T?P!X"U#Q%I=S)Y%Q%>8BOKF1B @MU1G48Y/S9W9Q\F,G
MF_\ @J-\$]=UJ\\._%#3M.N)["#3ETW5HHU#M9;7>2.1]N?E/FNI;H"J\_,*
MB'M)5H?65Z?\$N7(J<O8GFVD_LF_ RZ^'\,FH?M Z+;>-9;82.JW=NUC%.0#
MY9&=[*#\I8,,]<=J]7_X)F_M >(-2\2:S\*O$.IMK%G9VCW>DW,DOG&$1NJ2
M0K)D[HR&#+V&TXX(%>8>!OC-^R5-X,M)/%?PCU"U\20PJMS!I[2S13R #+1L
M;A< GG# 8SCGK7T]^PQ!\'?B+;ZAXV\#_#27P1KVF326+O)-<3H8WY4I*QV.
M2H&Y0,J?8J35>3]E)5$WZVT)I)<\7!K\3Z]K\H?VM/C1J?[0W[2L_P -;CQ9
M!X0^'^E:FVF237<WEVJO"2)[F;D"1MRN$!('"@8+$G]7J_'[]JGX5R? ']JF
M^\2^)?"Y\3>!-:U675HH96:."\CF9GF@\Q?N2(SM@9S\J-@@URX!1]H[[VT.
MC%7Y5VZECXR_L^_"/X<^"SXG^&/QQM-7\3Z6R3BQ:_A$\W(!:W:(JRNO+ <Y
M X((Y]Z\,ZIJG[<?["/B"RUC_B8>.?"UPS6]SM^>ZF@C$D;8'\<D3O$?5LFO
M+?$7QL_8_L_#AN=&^#>IZGK3("FGW,TEO&K=P\HN&P.O*JWT%?>O[,?A?X?:
M5\,['7OAWX8F\*Z5XBC2^DL[E9EEW@;?F$C$\<@,ORL,$$@@UT5ZDH03DG=/
M1NWZ&-*"E)I-6:U2N?+_ /P2G^,']I>&/$?PWO9\W&FR?VKIR,>3!(0LRCV6
M3:WUF->3_$Z>3]M3]O.T\-6SM<>%-)N?[/+(3M%G;$O<R9'3S'WJK?[48KCO
MVB=-U_\ 8W_:NU_4O"3_ -G0:G;W%YIC '8MO=I(CJ /^><A?:.QC0U]*_\
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M4(;B%3 E_9L[*\,T>XC!,;J1D] PP<8^N?\ @DW_ ,D9\8?]A\_^D\5>'_\
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MG^*]8_;:\9:9X(O);#Q1J/BK4K"SN893$T?G2RQ2'>.5'EN^6'(&2.:_1?\
M8Y_9!N?V6_\ A);B\\51^(KK7H[42QQ61@6W:(RDX<R,9,^;U*KT]Z^+_AF
M?^"H%YD9_P"*PU;^5Q7ZR5CC*LHQC36S2-,-33;F]TPKRC]HC_D6--_Z_/\
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M)D>(MAEC,D80DY YPS8-<E1UVE]87NW\CHC[)-^QWL?$/PA\)^&_VG/$6O\
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MV*->_:B^&\>MZSXVGT'PYILTUAI%G]G-W@[O,E94,BK&A=STY8ANF 3]6?\
M!4C_ )-IM?\ L/VO_HJ:MK_@FM_R:IHO_80O?_1QK:G4E2PG-#>YG*$:F(M+
M:Q^=.DV?Q/\ @O\ %[Q!\'O"WBBYTW4-7U)/#]P+&8QPW1>14CDR>4R&4[AA
M@K,,X)!]4_:1_P"">M_^S_\ "5_'-MXP77VT^6%=1M_L)M_+$CK&KQMYC%L2
M.@P0"<YXQBG^+O\ E*#!_P!C?8_RBK[9_P""A7_)G_C[_N'_ /IPMJZJE><:
ME)1^U:_F81I1E";?2]CDOV&?V@+[Q)^RGK.O^+;R;4)O!CW<,]U*Y>::VA@6
M=69CU8*S)D]=@SSS7QS\._!_CS_@HM\:M8N_$'B-M,TNQC-S*V#+#I\+,1%;
MV\.X#)P>21G:S,2>OO\ _P $V?"L7CO]F'XI>&KB0PP:S?7.G22 9*++91QE
ML>P;-> _LX_%[5_V#?C5XET+QYX=O39WD:VM_#; ></+9C%<0[B%D0AGQR 0
MV0>,&(QY9U?9+WNA4GS1I\_P]30_:/\ V6_$_P"Q#?>'O'G@KQE>3V4MW]D6
M^1/L]Q;3[6=4<!BLB.J/U&#M((Y&?J/XI_%Y_CI_P3@U[QC/"EO?WFGQQ7D4
M8PJW$=Y''(5'925W =@PKYN_;/\ VQ+']J?3_#O@3P#H.K26:Z@MVS74 ^TW
M=SL:...**-F. )'ZG))' QD_0/C;X2WOP3_X)GZWX7U4*NL1V"75\BL&$<TM
M['(T>1P=@8)D<';D4I\SC2=;X[K[AQM>:I_#8^1OV1_V7?$G[4FG:OI;>*IO
M#O@G1KE;B5-C3K)=R)MRD.]5W;(QER>!M !R<5OB9X)\7?L!_M!:6VB^(&OV
M2&+4;:ZB5H%O;8R,KP3QACP6C92N3QAA@XQ]9?\ !)C_ ))5XV_[#2?^B$KR
M#_@K)_R6;PA_V !_Z435M&M*6*E1?P]C)TXQH*HMSU7_ (*4_ RR\9^!_P#A
M<L6MRQ-I&F6=E#IGV<%9TENN',F[*G%QTP?N^]>*_L.?L:V?QS\/P_$&?Q3/
MI$VA^(E@6PCLEE6;R4MYP2Y<8R9-O0XQFOLG]K;PM?\ B_\ 8AUVRTV"2ZNX
MM)L+P11KEF2&2&60X]D1S^%?(_["O[9W@G]GKX;ZYX6\66NJ>=<ZNVI6]Q8P
M+*C!XH8F5LN"I7RMW0Y!/< 'GHSJO#-4]T[?(VJ1@JZ<]FB3_@K)_P EF\(?
M]@ ?^E$U:/A__@FGXM^)WPV@\9Z[X^8^,=4L4O8-/N[=IQ@Q@Q12W#29!V[1
MPI"=/F K*_X*N3QW7Q@\&30NLL4GAY721#E64W$I!![C%?IGX)_Y$S0/^P?;
M_P#HM:F=:='#T^0<:<:E:?,?G3_P2S^+FNV_C_7/AOJ%[-/H<FGR7]I:SN6^
MRW$<B!UC!/RJRR,6 [H#W->3?M$>*%^*G[9&O:+\5O$VH>&?"&FZO<:?'-'
M\XL;6,,(6CA&<>;MC8L ?]9NP0,5TW_!.7_D[_4O^P?J'_HQ*]<^._[1W[-G
MQ$^*GB+P]\2_ E]>W&AW#:?;^)=-)WS[,*X8QO&^%<,%!\Q2!D8W8KHE[F)D
MXQO==.ABO>HI-]>IF_"O]B?X+>+/&WAW5/A]\:3K3Z?=QWEUI7G1&[GA1LLJ
M[#')%D#!;:>">E?HS7X=?%.#P WQ-\/+\ )/%4D\A01K=#%PMX7Q&+<KA\].
MO.>A]/VWT$7RZ'IPU,J=2%O&+HIC!EVC?C'&-V:X<9&2Y92E>_?<Z\-)>\DK
M>A>HHHKS#M"BBB@ HHHH **** "BBB@ KY(_;X_YD7_M_P#_ &WKZWKY(_;X
M_P"9%_[?_P#VWKZCAG_D;4?^WO\ TF1]YP+_ ,E#AO\ M_\ ](D?9NB_\@:P
M_P"O>/\ ]!%7:I:+_P @:P_Z]X__ $$5=KYF7Q,^'J?&_4****DS"BBB@ HH
MHH **** "BBB@ HHHH **** .0^,/_)(_&__ & [[_TG>OA3_@D;_P DZ\??
M]A6#_P!$FONOXP_\DC\;_P#8#OO_ $G>OA3_ ()&_P#).O'W_85@_P#1)KVJ
M'_(OK>L3AJ?[S3]&?>]%%%>*=P4444 %8^O^#= \5>7_ &WH>FZQY8PG]H6D
M<^WG/&\''-;%%.[6P%?3].M-)M4M;*UAL[:/[D-O&$1?HH&!5?5_#NE>(%B7
M5-,L]26(DQB\MTE"9ZXW XS@?E5]W6-69F"JHR68X 'K2]>11Y@0V=G;Z?:Q
M6UK!';6T2[8X84"(@] !P!6>GA'0H]4_M-=%TY=1WF3[8MI&)MQZMOQG/OFM
M:BB[ *Y^/X>^%8=6_M2/PSHZ:GG=]M6PB$V<YSOVYSGGKUKH**+M;""L[6_#
MND^)K7[+K&EV>JVW7R;ZW29.1@\,".E:-%(91T?0=-\/VHM=+TZUTVV'2&S@
M6)!_P%0!5ZBB@ K$UKP/X<\274=SJWA_2]4N8R"DU[91S.N,XP64D8R?SK;H
MIW:V CM[>*UA2*")(8E&%CC4*H^@%)=6L-[;RV]Q%'/;RJ4DBE4,KJ1@@@\$
M$=JEHI 9FD>%]&\/R2/I>D6.FO(-KM9VR1%@.@)4#-:=%% &3KWA'0O%2HNM
M:)IVL+']Q;^TCG"\YXW@XY _*KUAIUII5JEM96L-G;K]V&WC"(/H ,58HIW>
MP&5JWA71-?F2;4]'T_49D78LEW:I*RKG. 6!P,FH_%EYJ>C>$=6N= TQ=4U>
MVLY'L-.#K$L\RH?+CW,0%!; SD8%;-%%Q6/RO^(WC+]K?X[^%4^&VN> =5BM
MKB5%N[R+0Y+,7>U@RB6X8B$+N ;Y=HR/PK[L_9/^ ,7[.?P?L/#<CPW.MSR-
M>ZK=09V27#X&%)Y*HH5!Z[2<#)%>R45U5,0ZD>2,4EY&$**A+F;NPI&4.I5@
M&4C!!'!I:*Y#H.4O/A+X&U"Z^TW7@SP_<W.<^=-I<#OUSU*9ZUU$,*6\*11(
ML<2*%5$&%4#@ #L*?13;;W%9+8^4K?\ 9K\5>*_VXKOXK>*8+-?">E6RIHD2
MSB25I$B6-"R8^4!GFD]CMKZMHHJYU'4M?HK$Q@H7MU"F3PQW4,D,T:RPR*4>
M.10RLI&""#U!%/HK,LR])\+Z-X?DDDTO2+#39)!M=K2V2(L/0E0,BM2BB@ K
MG[WX>^%M2U3^TKOPUH]UJ.2WVR:PB>;)ZG>5S^M=!133:V$( %  & *RKSPC
MH6HZ@+^[T73KJ^!4BZFM(WEROW3N(SQ@8^E:U%%[;#"BBBD!G:UX;TGQ);B#
M5]+LM5@&<1WMNDRC(P>&![52\/> ?#'A&>2?0O#>DZ+-(-KR:?8Q0,P]"449
M%;U%.[M85EN%,GACNH9(9HUEAD4H\<BAE92,$$'J"*?12&9FD>%]&\/R2/I>
MDV.FO( ':SMDB+ = =H&:-7\+Z-X@DC?5-)L=2>,$(UY;)*5!Z@;@<5IT4[O
M<5AD$,=K#'##&L4,:A$CC4*JJ!@  = !67I?A#0=#NC<Z;HFG:?<%2AFM;2.
M)]IZC*@'' _*M>BB[&-DC2:-XY$62-P596&00>H(]*P])\ ^&-!OVOM,\.:3
MIUZW+7-I8Q12'C'+*H/2MZBB[$%9.F^$="T>\-W8:+IUC=$$&>VM(XW(/4;@
M >:UJ*!E/5-'T_7+46VI6-MJ%N&#^3=0K*FX=#A@1GD_G3M-TFRT6U6UT^SM
M["V4DB&VB6- 3U.U0!5JBCR R==\(Z%XH\H:SHNGZN(N8_MUK'/LYSQN!QR!
M^52W7AO2+[38M.N-+LKC3X<>7:2VZ-$F!@80C P/05HT478BKINDV6BVJVNG
MV=O86RDD0VT2QH">IVJ *IWGA'0M1U 7]WHNG75\"I%U-:1O+E?NG<1GC Q]
M*UJ*+L""\L;?4;9[>[MXKJW<8:*9 Z-]0>#69HW@GP[X<N))])T'3-+GD)9Y
M+.SCA9B>I)51DUM447>PPHHHI %%%% !7Q7_ ,%8_P#DW7P[_P!C5;?^D=Y7
MVI7Q7_P5C_Y-U\._]C5;?^D=Y7I9;_OE/U.3%?P)'8ZA_P HLT_[$&+_ -$K
M6!_P2Q_Y-FNO^Q@NO_14%;^H?\HLT_[$&+_T2M8'_!+'_DV:Z_[&"Z_]%05W
MU/\ <ZW_ %\.>/\ 'I_X3["HHHKYX],**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D.<
M''!I:* /SB^(/[%'[2WB76O$&G#XE6NI>&M<OI;RYC.KW5O;/O<L=]MM8*.?
MN+N'RCDX%?6G[*O[,^E?LR_#^71K:Z_M36M0E%SJ>I;-@FD PJ(.HC09P"2<
MLQ[X'M-%=53$U*D>1[&$*,(2YEN%%%%<IN%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^?_P#P5U_Y
M$OX=?]A"[_\ 1<=?H!7Y_P#_  5U_P"1+^'7_80N_P#T7'7K93_OM/Y_DSBQ
MG\"7]=3ZE^*__)H]C_V#-+_G#5S]FO\ Y(YHG^_<?^CWJG\5_P#DT>Q_[!FE
M_P X:N?LU_\ )'-$_P!^X_\ 1[U[,_\ D0/_ *_?^V'Q$?\ DL%_V#?^Y#T^
MBBBOD#]$"BBB@ HHHH *\-^.O[&?PS_:"U :IX@TVXT[7=H1]8T>58+B10
M'W*R/@  %E)   (%>Y45<9RIOFB[,F45)6DCY.\ ?\$S_@_X)UJ#4[T:SXKD
MA<.EKK5S&UMD'()CCC3=VR&)4XZ=J^C?'G@+3?B#X!UGPA?--9Z5JED]A*;$
MJDD<3+M_=Y4J"!TR"/:NDHJI5JDVI2=[$QIQBK11XU^SG^RMX3_9CAU^+PMJ
M&LWZZTT#7']KSPR%?*$@79Y<28SYC9SGH.E5?VBOV1O!_P"TU>Z'=>*-2URP
MDTB.6. :1/#&&$A4MO\ ,B?)^08QCO7M]%'M9\_M+ZA[./+R6T,'P]X*TSP]
MX%TSPB(O[1T:QTV+2A'?JLOGP)$(L2C:%;<HYX .3QVKYD\8_P#!,+X/>*-8
MEO[&77_#2RON:RTN\C-N,G)VB6)V7V ; ].U?7-%$*M2F[Q=@E3A-6DCR#X$
M?LI_#S]G:.:3PKIDLFJW$?E3ZQJ,HFNY$R#MW8"HI(!(15!(&<X&+7QQ_9D^
M'_[0MG GB[2#)?VR%+;5;-_)NX5.?E#@?,N23M<,H))QFO5:*/:3YN>^H^2/
M+RVT/CS0?^"6OP@TC4EN;R_\3:U"KAA:7E]$D;*,?*QBB1CDYY##@_C7UEX>
M\.Z9X3T2ST?1K"WTO2[.,16]G:QB..)1V"C_ #S6C114JU*GQNXHTXP^%6"O
MG;XS_L&_"GXV:]/KFH6%]H&M7#;[F^T&=(#<-W9T='0L2<E@H8]R:^B:*F%2
M5-W@[%2C&:M)7/F#X5_\$ZOA'\,-=L]9:VU+Q1J%J0\7]NSI+"D@_C$2(BG!
MZ!MV/J,U]/T44YU)U'>;N*,(P5HJQ\K:Y_P3=^%&O_$:Z\87%SX@CFNM2.IR
MZ5#<P+8LYD\QH]GD;A&QR"H?."0".,?5/3@4443J3J6YG>P1A&%^5'B'QT_8
MY^&?[05Z-2\1:9/8Z[L$9UC2)1!<NHP 'RK))@  %U) & 0*\Z\$_P#!,GX/
M>$=7M]0O3KGB<PR>8MKJ]W&;=L'*ADBC3<!QD$X/<8.*^M**N.(JQCRJ3L2Z
M4)/F:U. ^,7P3\/_ !J^&=QX%U:2[TO0YC!C^R#'#)&(G5D5-R,H7Y0,;>G3
M%4_@!\ ?#W[./@FX\+^&KS4[[3Y[Z2_:3598Y)1(Z(A ,<:#;B->V>3S7I=%
M1[27+R7T+Y8\W-;4^7/BM_P4&^&/PM\=^)O!FM66K:E=:4BQ2/801S0SRLF7
MA^9UP5R%.>,[AVKY!_X)X_!'_A:7QXN/'LFD_8O"/ANX>[MXFR\?VMB3!"K$
M?,8@0Y/4%4S]X5^C?C;]G/X8_$;5FU3Q)X'T75=2;[]Y+:JLLF.FYUP6_'-=
MGX;\+Z/X-T>#2=!TNST;3(!B*SL8%AB3UPJ@"NN.(A3IN--.[W.9TI3FI3>B
M-.J6MZ3#KVBW^F7#.D%[;R6TC1D!@KJ5)!((S@^E7:*X#K/B_P#X=1_"3_H8
MO&G_ ('6G_R+1_PZC^$G_0Q>-/\ P.M/_D6OM"BNOZU7_F9A]7I?RF1X/\,V
MO@KPEHGAZQDFELM)L8+""2X(,C1Q1JBEB  6(49P ,]A6E=6L-]:S6US$D]O
M,ACDBD4,KJ1@J0>H(.,5+17+?6YOY'Q_XA_X)<_!_6M<EO[6\\2:);2.7.G6
M%[$8$]D,L3N!]6/X5]"^(O@CX-\8?#.R\!:_I"ZWX=L[:*V@COG9YHQ&FQ'6
M7.\2!>-X(/)]37=T5K*M4G;FEL9QIPC>RW/C23_@E5\)'U/[0NM>+([7=N^Q
MK>V^WJ#M#&#=MQD=<^]?3/PK^$/A+X*^&$T#P?H\.D6 ;?)M)>6=_P"_)(V6
M=O<G@<# XKLJ*)UJE16G*X1IP@[Q05S_ (\\ >'OB=X7O/#OBC2H-8T:[&);
M:<'&1T96&"K \AE(([&N@HK)-IW1>^C/C#4O^"5/PIO+]9K77?%5A;ELO;)=
M0.,>BLT)(_'=7T9\%_@'X*^ /A^72?!VDBR2X8/=7<SF6XN6&<&1SR<9. ,*
M,G &37H=%;3KU:BY92NC.-*$'>*"OGKXZ?L/^!?V@O'T'B[Q%JWB*RU*&UBM
M%BTNY@CAV1LS*2'A<YRYSSZ5]"T5G"I*F[Q=F7**FK21D>,/#-KXU\):WX>O
MI)HK+5K&>PGDMR!(L<L;(Q4D$!@&.,@C/8UY/^SK^R-X/_9EO=<NO"^I:Y?R
M:O'%'.-7GAD"B,L5V>7$F#\YSG/:O;Z*%.48N*>C!Q3:DUJCPW]HK]D'P=^T
MUJ>C7WBC4M<L)M*AD@@72)X8U978,2WF1/DY4=,5ZMH_@W3-)\$V/A1X1J.C
MVNGQZ88;Y5E\^!(Q'B08"ME1SQ@Y/%;E%-U).*BWH@48IN26K/D7QA_P3!^#
M_B;6);^QF\0>&DE?<UEI=Y&;<<Y.T2Q.RY[?-@=AVKU?X$_LF_#K]GCS;CPO
MI<L^KS)Y4FL:G()[MD[J& "H#W"*N>,YP*]CHJY5ZLH\LI.Q"I0B[I:GB'[1
M7[(W@_\ ::O=#NO%&I:Y82:1'+' -(GAC#"0J6W^9$^3\@QC'>O6/!_AFU\%
M>$M$\/6,DTMEI-C!8027!!D:.*-44L0 "Q"C. !GL*UZ*S<Y2BHMZ(M1BFY)
M:L^>OA_^P_X%^'/QLD^*&FZMXBGU][J[NS;75S UKON%D60;5A5L 2MCY^PS
MFO1/C9\"/!_[0'A5=!\7V#W-O#)YUM<V\ABN+:3!&^-_H>005/&0<"O0:*IU
M9RDI-ZHE4XI.*6A\T_ _]@7X?_ 7Q_;>,-$U?Q)?ZI:I)' FH7<1B570HVY8
MXDW'!/4XZ'&0#6C\/_V'_ OPY^-DGQ0TW5O$4^OO=7=V;:ZN8&M=]PLBR#:L
M*M@"5L?/V&<U]"T53KU)7;EOH)4H*UEL<)\;/@[HWQX^'M]X-U^YO[/3+R2*
M22;39$28&-PZX+HZXRHS\O2N4^&O[)W@;X:_!_6OAG$=3UWPMK%S)<WD>JW(
M\URZQJ5#PK'A?W2GCG.>:]FHJ%4FH\J>A3A%OF:U/C76/^"5OPDU"Z\ZSU?Q
M5I<9<$V\-Y Z!<DD+OA9@>V23TZ&O:?@/^RC\//V=1<3^%=-FEU:XC\J;5]2
ME\ZZ>/(.P$ *BD@$A%7.!G.!CV&BKEB*LURRD[$QI4XNZ04445@:A1110 44
M44 %?,_[5W_(X>#_ /=?_P!&)7TQ7S/^U=_R.'@__=?_ -&)7U?#'_(TAZ2_
M])9^?\=_\B*KZP_]+B>R_M)?\D\C_P"OZ+_T%ZO?#;_D0]"_Z]4JC^TE_P D
M\C_Z_HO_ $%ZO?#;_D0]"_Z]4K\5P_\ R5F(_P"O,?\ TH_:ZW_(AI?]?'^1
MTM5M2TVSUBQGLK^T@OK*==DMO<QB2.1?1E(((^M6:*^_/E#R>U_9/^#EGJHU
M&'X:^&UN@P89L$,8(Q@B,C8.G85ZK##';PQQ11K%%&H5(T "JH&  !T%/HJI
M2E+XG<E14=D</9_ _P"'^G^,F\6VW@[1H/$[3R71U:.S07)E?.]]^,[CN;)]
MS72>*/"VD>-="NM%U[3;;5])N@HGLKR,212!6##<IX.&4'Z@5J44<TF[MCY5
MM8YSP/\ #?PM\--/GL?"F@:?X>L[B7SY8-/@6)'DP%W$#J< #\*@\=?"OP=\
M3K6.W\6>&-+\0QQY$9U"U25H\]=C$97\"*ZJBCFE?FOJ'*K6L<+X#^!?P]^%
M]T;KPKX-T?0[Q@5-W:VBB?!ZCS""V.>F<5W$L23Q/'(BR1N"K(PR&!X(([BG
M44.3D[M@DEHCRJ^_95^#VI:N=3N/AMX;DNRQ=C_9\:HS'J6C VL3GN*]'T30
M]-\-:7;Z9I&GVNE:;;KMAL[&!888ESG"HH  R>PJ]10Y2EHV)12V05G>(/#>
MD^+-+FTS6]+L]8TZ88DM+^!)HG^J,"#6C14E'EFC_LK_  @T'43?67PW\-I=
M;@ZO)I\<H1@<@J'!"G/]T"O4^G HHJI2E+XG<2BH[(Y#QU\(/!/Q.GM)O%GA
M72?$4UHK)!)J-JDS1*Q!(4D< D"M_P /^'M,\)Z+::1HUA;Z7I=HGEV]G:QB
M.*)?15' K0HHYG:U] LKW*^H:=::M936=]:PWMI,NR6WN(Q)&Z^C*1@CZUYA
M#^R?\&X-3:_7X9^&3.?X6TZ-HOPB(V#\J]7HHC*4=G83BI;HBM+2#3[6&UM8
M8[:VA01Q0PH$1% P%4#@ #L*XSP?\#_A_P##W6GU?PUX.T;0M4>-HFO+&S2*
M0HQ!9=P&<$@?E7<44<S6B8[(^=?VP?VD/%G[/.G^&KOPQX,F\3Q7=Q(=0N'@
ME:W@B5<"/>GW)&9@03D8C;@YX^(=.\,>/_\ @H?^T%IOB+5O#1T'PI;I#;WE
MY#$Z006:,7,:S,/WLS[VQCIN!P%%?K11772Q"HQ]V/O=SGJ474?O2T[$-G9P
M:?9P6MK$EO;01K%%%&,*B*,!0.P  %3445Q'2>=^)?V=OACXRUR[UG7/ >@Z
MMJMVP:>\N[%))92 %!9B,G@ ?A69_P ,G_!O_HF7AC_P6Q_X5ZO16GM)K:3(
MY(]CG/ _PW\+?#33Y['PIH&G^'K.XE\^6#3X%B1Y,!=Q ZG  _"NCHHJ&VW=
ME)6T1P_@_P"!_P /_A[K3ZOX:\':-H6J/&T37EC9I%(48@LNX#."0/RK2\<_
M#/PG\3+2UM?%GAW3O$-O:N9((M1MUF6-B,$J".#BNFHI\TKWOJ+E5K6,WP[X
M;TOPCHEIH^B:?;Z7I5HNRWL[6,)%$N2<*HX R3^=<SIWP/\ A_I/C)_%MEX.
MT:U\3O/+=-JT5FBW)EDW>8^_&=S;VR>^XUW%%'-+77<?*NQ6U+3;/6+&>RO[
M2"^LIUV2V]S&)(Y%]&4@@CZUYA:_LG_!RSU4:C#\-?#:W08,,V"&,$8P1&1L
M'3L*]8HHC*4=G83BGNAD,,=O#'%%&L44:A4C0 *J@8  '05Q5G\#_A_I_C)O
M%MMX.T:#Q.T\ET=6CLT%R97SO??C.X[FR?<UW%%"DULQV3W,OQ1X6TCQKH5U
MHNO:;;:OI-T%$]E>1B2*0*P8;E/!PR@_4"J'@?X;^%OAII\]CX4T#3_#UG<2
M^?+!I\"Q(\F NX@=3@ ?A71T4N9VM?0+*]SC/B!\&? WQ5\@^+O"FE^()(%V
MQ37MLK2QJ3DA7^\!GL#3-/\ @EX TKP7=^$K/P=HUMX:O"K7.F1V:"&X96#!
MI!CYR"JG+9/ ]*[:BJYY6M<7*KWL<YX'^&_A;X::?/8^%- T_P /6=Q+Y\L&
MGP+$CR8"[B!U. !^%9OC?X*> OB5J4.H^*O"&C^(+Z&$6\=QJ%HDKI&&+! 2
M.F68X]S7:T4N:5^:^H<JM:QB>(O!'AWQ?I*:7KV@Z;K>FIC;9ZC:1W$2X&!A
M7! P*X33OV4O@[I5^;RW^&GAKSR<_O=.CE4$=PC J/P%>K44U.4=$P<8O=#(
M(8[6&.&&-8H8U")'&H554#   Z "GT45!1RGCOX4^#?B?;1P>+/#&E^(4C!$
M3:A:I(\>>NQB-R]>Q%4? 7P-^'WPON&N?"G@[1]#NV4J;JUM%$Y4]1YA&['/
M3-=S15\\K<M]">57O8R_%'A;2/&NA76BZ]IMMJ^DW043V5Y&)(I K!AN4\'#
M*#]0*H>!_AOX6^&FGSV/A30-/\/6=Q+Y\L&GP+$CR8"[B!U. !^%='14\SM:
M^@[*]PK+\4>%M(\:Z%=:+KVFVVKZ3=!1/97D8DBD"L&&Y3P<,H/U K4HHVU0
MSG/ _P -_"WPTT^>Q\*:!I_AZSN)?/E@T^!8D>3 7<0.IP /PJOX[^%/@WXG
MVT<'BSPQI?B%(P1$VH6J2/'GKL8C<O7L175T4^:5^:^HN56M8X;P%\#?A]\+
M[AKGPIX.T?0[ME*FZM;11.5/4>81NQSTS72^*/"VD>-="NM%U[3;;5])N@HG
MLKR,212!6##<IX.&4'Z@5J44.4F[MZARI*R1SG@?X;^%OAII\]CX4T#3_#UG
M<2^?+!I\"Q(\F NX@=3@ ?A6;XW^"G@+XE:E#J/BKPAH_B"^AA%O'<:A:)*Z
M1ABP0$CIEF./<UVM%'-*_-?47*K6L>0?M0>(_B!X)^#5[<_"O0IM6\3+)#%$
MEK$DS6L(.7D6%O\ 6$!0@0 GY\XP#7Q=#_P4;^(NB21)XC^#VGR^*%7RHKQ[
M:>UD+<@_NV5FYV= P^Z?3C],**Z*=:$(VG"YE.G*3O&5C\P?V;_@3\3?VCOV
MDK;XQ?$/2KG1=)MM0CU5Y[B VXN)H"OV>"")_F\M2B#<01M0C<6-?IY+$D\3
MQR(LD;@JR,,A@>"".XIU%36K.LT[62V'3IJFK;W/*K[]E7X/:EJYU.X^&WAN
M2[+%V/\ 9\:HS'J6C VL3GN*]'T30]-\-:7;Z9I&GVNE:;;KMAL[&!888ESG
M"HH  R>PJ]16+E*6C9HHI;(X>S^!_P /]/\ &3>+;;P=HT'B=IY+HZM'9H+D
MROG>^_&=QW-D^YKN***3DY;L:26P5Y1^T1_R+&F_]?G_ +(U>KUY1^T1_P B
MQIO_ %^?^R-7QO&'_(AQ7^']4?1\/?\ (UH>OZ,O?&;_ )-/U+_L!VW_ +2K
MEOV-?^2)VO\ U_7'_H0KJ?C-_P FGZE_V [;_P!I5RW[&O\ R1.U_P"OZX_]
M"%?IN6_\DM'_ !Q_](1]+4_Y)G$_]A'_ +:>Y4445X9^<!1110 4444 %%%%
M !1110 4444 >=^-OV=_AG\1M1;4/$G@;1-5U!N7O);15F?_ 'I%PS?B371^
M"_A[X8^'.FM8>%O#^F^'[-VW/#IMJD(=O5MH&X^YS70T57-)JS>A/*KWL<MX
MZ^%OA#XG0V<7BWPWIOB*.S9FMUU&W681%L!BN1QG:/RK:T'0=.\+Z/9Z3I%E
M!INF6<8BM[2V0)'$@Z*JCH*OT4N9VM?0=E>YP\'P/^']KXR/BV'P=HT?B<SM
M='5ELT%SYK9W/OQG<<GGWKL-0T^UU:RFL[ZVAO+29=DMO<1B2-U/9E(P1]:L
M44W)O=@DEL>3Q?LG_!R'5AJ*?#7PV+D-N ^P(8P>N1'C9^E>J6]O%:P1PPQI
M##&H1(XU"JJ@8  '0 5)11*4I?$[B45'9'%^//@MX#^*#))XL\(Z/KTZ#:EQ
M>6B-,H]!)C<![ T_P+\'/ OPQ9W\)^$=&\/SR1^5)<6%E''-(F<[6D W,,C.
M"378T4^>5N6^@<JO>P4445!1YGXF_9F^%/C'5FU36/A]H%YJ#-ODN#8HCRMZ
MN5 WG_>S79^%?!N@>!=+&F>&]$T[0-.W&3[+IEJEO%N/5MJ #)P.>IK9HJW.
M35FR5%)W2*6M:+8>)-(O-*U6SAU#3;R)H+BUN4#QRQL,,K*>""*YKP/\&? O
MPSOKF\\*>$M(\/7=Q'Y,T^GVB1.Z9SM) Z9 ./:NRHI<S2LF.RO<*\^\<?L^
M?#7XD7YOO$O@C1-7OV^]>36BB=O9I% 8_B:]!HHC)Q=XNP-*6C.;\%_#;PG\
M-[6:V\*^&M)\.PS$&9=,LXX/-(Z%RH!8C/4YK/\ ''P7\"?$O4(+[Q7X1TCQ
M#>6\7D13ZA:)*Z1Y+;02.!DD_C7:44<TK\U]1<JM:QA^*-4?P=X+U._T[29]
M4DTVQDEMM+L(RTL[(A*0QJ.Y("CZU^77QC_;$^*W[17@-_A;+\.A;:M?RPK>
MK8V<\D\Q1PZJD+ F/YXP2<D_*>G-?K#1711K1I.[C=F52G*IHI61X%^Q3^S[
M+^SW\&;73M4A2/Q1JDIO]6VL&\N0C"0AAP0B  XXW%R.#7OM%%83FZDG*6[-
M8Q4(J*"N \?_  !^''Q2NGN_%7@O1]9OG01M?3VJBY*@8 \U</@=N>.U=_12
MC)Q=T[#:4M&<A\/_ (/^"?A3!-%X1\+Z7X?\[B62RME2249R [_>8#L"3BNO
MHHI-N3NP22T1@^-/ ?AWXBZ.NE>)]%LM>TU95G%K?PK+&) " V#W )_.I/"/
M@O0? .B1Z/X;TBST32HV9TL[&(11*S'+$*.,DUM44<SM:^@65[G#S_ _X?W7
MC(>+9O!VC2>)Q.MT-6:S0W/FKC:^_&=PP.?:NB\5>$]&\<:#=:)X@TRUUG2+
MK;Y]E>1"2*3:X==RG@X95(]P*UJ*?-+1WV#E78YSP/\ #?PM\--/GL?"F@:?
MX>L[B7SY8-/@6)'DP%W$#J< #\*@\=?"OP=\3K6.W\6>&-+\0QQY$9U"U25H
M\]=C$97\"*ZJBCFE?FOJ'*K6L<)X#^!/P\^%]T;OPKX-T?1+TJ5-W:VBB?:>
MH\P@MCGIFNH\2^&=)\9:'=Z-KFG6^K:5=*%GL[N,212@$, RG@\@'\*TZ*'*
M3=V]0Y4E9(YKP/\ #7PK\,[&YL_"GA_3_#UK<2>;-#IUNL*R/C&X@#DX&*H>
M./@OX$^)>H07WBOPCI'B&\MXO(BGU"T25TCR6V@D<#))_&NTHHYI7YKZBY5:
MUB.WMHK6WCMX8UB@C01I&HPJJ!@ #TQ7F5]^RY\(]2UTZQ=?#GP[-J#.96D:
MP3:[DY+,F-K'/J#7J-%$92CL[ XI[HXCQC\$/A_\0KJTN/$O@[1=;GLX!;6[
MWMFDABB!)"+D<*"3P/6NSM[>*SMXH((UBAB4(D:C 50, #VQ4E%#DVK-CLEJ
M</X3^!_P_P# >O/K?AWP=HVBZNZLC7ME9I'*58Y8;@,X) S1XX^!WP^^)5P;
MGQ1X+T/6[PKM^UW=C&T^W'3S<;L>V:[BBGSRO>^HN56M8XGP1\$?A]\-KA;C
MPOX,T/0[M5VB[L[&-)]I&"#+C>1^-=M114N3D[MC22T04444AA1110 4444
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M)'X5?L-8VO9NVI/M=)=TKGT5J'CSPSI%[IMG?>(M)LKO4V1+&WN+Z*.2[9R
M@B4MERQ(QMSG-;M?./[/?[,/AJU\/^&?'GC*R'BKXD7EO;:E-K&I$N;238K1
M10)G;&L0VJN!GY<^@'T=7/448NT7<UBVU=HX?XO_  [U3XF>%X=)TGQEK'@>
MYCNDN#J6BOMF=0KJ8B<_=)8$^ZBOG3XE? K6OA+X)U7Q7XD_:5^(%GI.G1&2
M1O/4O(W18T&[YG8X4#N37V'7RA^T]\)_BU\0?BWX8UO2-%T'Q=X#\-[;RW\+
MW^H-;?:[S:W[V4%=K%3M"@G'7(PS9WH3=^5NR^7ZF56*M>UV=%^Q%X7^(VG_
M  [O?$/Q%\1ZQJUSX@DCN=.TW6;AIIK"U ;87)Z/('#,H P%7.#D#Z-KR+X!
M_M"VOQH&N:3?Z)=^$?&OAV5;?6?#U\P9X&8?*\;C'F1M@X; ^F"I/KM95N9S
M;DK,TIVY5RNYD1^,-!FU?4]*36].?5-,C6:_L5NXS/:1LNY7E3.Y%(Y!8 $<
MUF:!\6/!'BK5'TS1/&/A_6-20D-9Z?JD$\PQURB.3^E?'E_\(8_C5^WY\4=#
MUF[N1X,M]/TR]U;3;>5HEU%DMH1!#(RD-Y>YG<@'DH/8CTK]H?\ 9 ^&B_!_
MQ'JOACPQ9>$O$N@V$VJ:9JVC*;:>*:!#(H+(1N!V8R<XSD<C-;>RIQ<8N3NT
MOQ,_:3:;2VN?17B?QIX>\$V:W?B+7M,T"U8X6?5+R.V0D=0&=@*F\/\ B?1_
M%NGB_P!#U:QUFQ)VBYT^Y2>(GTW(2,U\E_LJ_ G1_CI\/;#XK_%VW7Q]XL\0
M*_D_VN-]O96L;M%'''#]P9V%R<=7]<DM\;?#_1_V8?VHOA1K'@&W'A_1/&UW
M-H6M:);%A:2MA?*E6/.%8,XZ8 V?[397L8<SII^\K^F@>TE93MHS[)KD9OC!
MX#M=:.CS>-O#L6KAMIL'U: 3[LXQY9?=G/'2O#_VLM<UOQU\0OAW\$-"U:YT
M"'Q@;FZUO4K,XF6P@0LT2'MYFUP?HH.06![>V_8U^"MMX7&@_P#"NM$EM?+\
MLW,EONNSQC=]H_UN?<-4*$(Q3F]^Q?-)MJ*V/9^O(K(B\7Z%/K&I:3'K6G2:
MKID:S7UBMW&9[2-EW*\J9W(I'(+  CFOF[]E^ZU;X1_&KQQ\"+_5KK7M"TBQ
MAUOPY=WS[IX+)RB/;L>X1G4#&!\K' ! 'GMW\*6^,G[?'Q6T#5+^ZA\%KIFF
M76LZ?:RM%_:6VVA$,$CKAA'N9G(!&=@'N+5%<TDWHE?\B'4=DTM;V/L#0_BQ
MX(\3ZHVF:-XR\/ZMJ2DJ;.QU2":8$=1L5R<_A6GXH\8:#X(TO^TO$>MZ=H&G
M;Q%]LU2[CMH=YSA=[D#)P>,]J\(^+W[%?PLUSX=:M'H7A.P\+Z[9VLEQINK:
M1&;>>"X1"T;%E(WC(&0WUX."-3]F;5K/]HS]EWP5J'CO3-/\4R30M'=1ZM9I
M<1RS6\TD(E9'!!<A-Q;U8].E0X0Y>>+=KV92E*_*]S&^ 7[9_A3XB>'-=O?&
M?BOP?X6OK/6[FPM+:35XK<SVJ!#'.!+)DAMS?,/E.WBJO[>S!_ ?PU92&4^/
MM)((Z'B:N&_86^#/P_\ %WP]\;W.N^!O#>M7%OXRU&UAFU'2+>=XH56';&I=
M"0@R<*.!DUT?_!2-;]?@SX.71F$&J#QCIXLF"@A)O*N/+."".&QQBNGEA'$*
M,.YCS2=%N1]&>(OBCX,\'ZA'8:]XNT+1+Z3&RVU'4H;>5L\C"NP)KH;.\M]0
MM8KFUGCN;:50\<T+AT=3T((X(KQ+PK^QG\+]*T?;X@\.6OC37[D>9J6O:\IN
M;J\G(^>0LY.S)S@+C''?FO._V>]%'P)_:O\ ''PBT:ZN#X(O-$C\2Z5IUQ(T
MHL7\U(Y(XV8D[278\]=J]P2>?V<))\CU1MS237,M&;?B+_E(IX4_[$";_P!*
MY:^A]%\5Z)XDN-1@TC6-/U6?39S:WL=E=),UK,.L<H4G8X_NM@U\\>(O^4BG
MA3_L0)O_ $KEJEXA'_#/O[9FEZVH^S^$/BI NFWV.(XM7A'[ESSP9%(4>I=S
M5RASV77E(4N6[Z7/JFLOPWXJT7QCIW]H:!K%AKEAYC1?:M-NDN(MZG#+N0D9
M'<=J\H_:\^)5]\/?@[=VF@[I/%WB:>/P]H<,9PYN;@[-ZXZ%$WL#TW!1WKN/
M@U\,['X._"_PWX.T_:T.E6BPO*HQYTI^:63_ ($[,WXUS\MH<SZFW-[W*CLZ
M^8_V-_\ D>OVA?\ L?[W^9KZ<KYC_8W_ .1Z_:%_['^]_F:TI_PY_+\R)?''
MYGT?K&M:=X>T^2^U6_M=,L8_OW-Y,L4:_5F( K+\*_$;PIXY,@\-^)]&\0&,
M9?\ LK4(KG:,XR=C''-?*OPI\"V/[8WQ.\9_$+Q_OUKPCX>UFXT'PWX9F8BS
M01!2]S(@.'9]R]>,Y!R%4#L/CY^R+X0;P=?>*?AWIEM\/?'GA^"34=+U/P[$
MMH'>)"WE2(F%*N!M)QD9SR-RM7LX1?))Z_@A<\FN:*T/INN3U;XN>!=!U(:=
MJ?C3P]IVH%BHM+O58(I=PSD;&<'(P>W:N(^%?B>/]I[]F/2-4U6XN](/B+2W
M@OKC2;@VTL4J,T4S1./NC?&Q .1@X.1G/F$/A?\ 8[\'Z?+H$\OP\F=5\N:2
M]O8+JZW#@YF9F=6SG.&!SZ5,::NXRO==D-S=DU:S[GU?!/'=0QS0R++#(H=)
M(V#*RD9!!'4$53UO7],\,Z>]_K&HVFE6*$!KF^G6&)2>@+,0!7R=^PQXBTS3
M?B!\8/A_X7UT:_X"T6]M;[P_-'<?:(X8KA',D229)*JRJN,]58]22:'PF^']
MA^V)\4/&OQ%^(&_6_"GA_6KC0?#?AJ=C]CC6(+NN'0'#LP9>O&2P.0J@4Z*C
M)\ST7Z["57F2Y5JSZ5NOB%X5\>>"?$C^&?$VC^(DBT^?S&TF_BN@G[MNIC8X
MKS/]@J$7'['_ ("B8LH>"\4LC%6&;R<<$=#6=\=_V3?"<?@O5?$OPZTRU^'_
M (WT:SFNK*^T"%;6.X"1DM;S1( CQR ;3D9Y!Y&0=7]@/_DT7X??]<KO_P!+
M9ZJ2BJ+<'U7Y,2<O:)271_H=9^S3\//"'PT^&[Z9X(\53^,=$FOY[K^TYM1B
MOLRL0'021@+@%>0/XBQ/)KNK?QWX:NX=7F@\0Z5-#H\S6VI21WL3+92K]Z.8
MAOW;#NK8(KY__P""<_\ R;+IW_85O_\ T>U>2_ 7X'V?QH^.WQU7Q=-/J'@C
M2O&5W-'X>$C);7=\TK_O9MI!<1HBX4G&7)]<N5-.<W.6W^8E-J,%%;GVCX7^
M)G@_QO/)!X=\5Z'K\T>2\>EZC#<LN.N0C'%=+7R+^U5^R[X'\(_"36/'7@/1
M;?P/XQ\*1?VK8ZEH:_9S^[(9T=5(5@5!Y(R#CMD'I?C9^T/K'AC]C/3OB%I&
MV+Q-X@TO3UM&1,+#<W2(690<\J&<J#D94=16?LE+E=-[NVI7M'&_/TU/;?$_
MQ3\%^";Q+3Q%XOT'0+I\;8-4U."V=L],*[ G-7+KQWX:L;'2[VY\0Z5;V>JS
MI:Z?<2WL2QWDSYV1PL6Q([8.%7).#BO&?A3^Q1\./!?AQ!XFT&Q\=^*KQ3-J
MNN>(81>RW%P_,C+YF=HR3C'S=R2>:\(_:8^ 5C\&_B5\'[[P=/-I?@O5O'6E
MF[\-*Y:U@OED_=SP*<[-T9E#*,#Y5]L5&G2G+E4F*4YQ7,T??-%%<5\:OB%_
MPJGX2^+/%RQ+/-I&G37,,3_=>4+B-6]BY4'V-<L4Y-)&[=E=FKXJ^(?A7P(L
M;>)?$VC^'ED&4;5;^*U##.,CS&&>:^=/V_=>TSQ-^RG>:AH^HVFJV$NJV'EW
M5C.LT3_OUZ,I(/YTG[-?[+/AGQ%X)TWXA_$RP@^(/CGQ7;1:M=7?B"%;F.W2
M5 \<,<3Y10JD#IUX&  !Y)^WA^SGI7PH^'I\2^ "WAS0M0U&UM==\.6I(L9S
MOW0W*1GB.1755.W&0W;YMW?1A3C6C%2U3^1RU)3=-NVA^@]<IKGQ8\#^&=5&
MEZQXR\/Z3J1.!9WVJ00S$XSC8S@]/:O)OVS/B'XA\-^$_"O@_P (WSZ5XD\=
M:Y!H$&I1YWV<4AQ+*I!R& *C(Y 8D$$ UJ>#?V+?@_X2\*QZ/-X*TO7YC'MN
M=4UBV6YO+A_XI#(PRA)Y^3 &>*YE"*BI3>YLY2<N6*V/;+>XBNH8YH9$FAD4
M,DD;!E93R"".HK+\3>,M \%V:W?B'7--T&U8D+/J=W';(2!D@,Y X'-?+WPO
MTF?]E_\ :GM/A7I5_<W?PZ\::=<:GHVFW4ID.DW<6]Y8HV))\LHK'U.Y<Y*D
MMQ&LW_@#2_VO/'\_[0UC&8YA;)X-N/$%N\VE?8U5C(J @QYR5)+<!MXX).=%
M03EO=6OYLAU=-M;V/M3PQXZ\-^-H7E\.^(=*U^) "[Z7>Q7*J#T)*,<9K4U#
M4;32;*:\OKJ&RM(5WRW%Q((XT7U9B< ?6O'/AW\&_@;J7B[3_'GP_P!,\.'4
M].$BQWGABX00 2*5(>.%O+)P3C*Y&..E>"?$+QQX"^,G[4/B?1?BMXLT_2/
M'@3R+>P\.ZA?"WAU6_92TD\HW#>(SE<=.5]7!F-)3DU&]EY:C=1Q2OU/L/PS
M\2O"/C2ZFMO#WBK1=>N(<^;#IFHPW+I@X.X(Q(P?6NCKXF^*VB_LN^(O"LTO
M@WQ;X+\#>,M/C-QHVM>'KV&RF@N44F/<8RN\$\'=S@D@@\U+\0OBEXW^.?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7Y_P#_  5U_P"1+^'7_80N_P#T7'7Z 5^?_P#P5U_Y$OX=?]A"[_\
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M''Q3\(WVF1_#SX:0>/+::-VNYIM:@L/L[@C:H$A&[(R<CIBO(/%W[2OQ_P#
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MBWXA\=?';XV^%=5DMWTGPG=Z=#IBQ0A'59HYF?>W\7,:X]*]QKY7_9IB\_\
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ME%1VE?[RHR;W5BQ1116985\S_M7?\CAX/_W7_P#1B5],5\S_ +5W_(X>#_\
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MASXB:;X8_8ZFTKQ]\)O%<:>$HKZ&W\1>"1JYO;>>VD<*9X%9V=)59@<Y[CH
MRMU__!234KO3O@OX.O\ 2T6XOX/&.GSVJ,,J\BQ7#(".X) JE0YI12>C)=6T
M6VM4?632*K*&8*6.%!/4X)P/P!_*G5X1\(?V4=%\#^)=.\>^)M3U3QA\3UC=
MKC7M0O9"B221E)$AB!"+& S*JD' Z8XQ[O6$E%.T7<UBVUJK'GGQ>\+_ !%\
M2QZ6/A_XWLO!CPF4WC7FDI??: =NP#<1LVX?IUW>U>#?%QOCA\%_ 6I^+/$7
MQYT6&PLT^2)/"4'F7$I^Y#&-_+L>!Z<DX )KZ\KXI^-]O\3+K]HRV\6>*OA3
MK'C/X8^$P9="T[1+RWF\RX 7_39( Q>1P<[4(7&U>N&W=-!\SY7:R\E^IC55
ME=7_ !/?_P!F*X^).H?"73]2^*EQ%+XHU"1KI;>.V2!K6W95\N*15 &_@L>,
MC?M/(KU>N*^$/Q@\,_'#P7!XG\*WCW-A([0RQ3)Y<UM,N-T4J?PL,CU!!!!(
M(-=K7-4OS.ZL;1MRJSN><_"?X7Z[\/-:\9WNL>.]5\8P:[J1OK.UU($+I<9+
M8ACR[<891P%7"+A1SGT:OF/]C?\ Y'K]H7_L?[W^9KR[4O!.O_$[]O+XM>$[
M#7KOPYX;O=*TV?7;O36\N\F@CMH EO%+@^7O:3YB!DJC#/.#TNES3DI2V5_R
M,54Y8JRW9]UK(CLZJZLR'#*#RO&>?PIMQ&9K>6-9&A9U*B2/&Y<CJ,\9%?*7
MQ!_8+\ ^&_!^HZU\-5U7P1XWTRVDN[#5[#5KIWDF12P60.[#:Q&#M //?H?7
MOV7?B=??&/X!>#?%VIA?[2O[5DNFC& \T4KPN^.VYHRV.V:RE"*CSP=U_7J7
M&3YN62-'X&?#/6_A/X(;0]?\;ZGX_OS=RW/]K:J")0KXQ$-SN=HP3RQY8XP,
M 9_PK^.'_"S/B5\3?"7]B_V;_P (7>V]G]L^U>;]L\U9#NV;%\O'E],MG/48
MKQS]A?P?H_C[]C\>'_$%BNI:/?ZC?QW-K(S*LB_:"<$J01R!T->=?L]_LL_"
MSQA\=/CQH>L>$+:^TKP]JEG!I=L\\RBVC=)BZ@AP3DJO4GI70Z<+U.=ZKR\U
MYF7-*T.5:/\ R/L3XS> =5^)WP[U/PYHGBR_\$ZE=F/R]:TT$S0A75F VNC8
M8 J<,IYZXR#TWAW39]%\/Z9I]U?S:K<VEK%!+?W  DN75 K2OC^)B"Q]S7SY
M^VSX>T[PE^Q/XOT32+9;+2].LK"UM;=6)$427=NJJ"22<  <FO7O[!O?%'P?
MMM)T[6[KPY?7FD0Q0ZK8JK36S&)<.H88S^1YX(.".?E_=IWTN_T-;^^U;6QV
M;2*K*K,H9CA03R>,\4ZOE:Z_8Q_9\L$>#Q1=/K&OLO[W5M<\33"^9\G,AQ*J
MAMV3]W&>H-0_LDZQ/-XB^+WP<U?7Y?&OASPW- FEZA=W'GRRV%U$_P"X:53\
MP10HXQRS 8  %.E%Q<HO;R_X(N=W2DM_,]=TGXX?VI^T=K?PI_L7RO[-T*/6
MO[6^U9\S=)&GE>5LXQYF=V\].E=OXX\/WGBKP;K>C:?K%SX>OK^SEMH-5L_]
M=:.RD+*G(Y4G/!!XX(/-?$'AW]EGX67G[;WBOP3-X0MI/"]GX2AU"#3C/-L2
MX,T*F3=OW9PS#!..:^G?B%X!T#X8_LO^/?#GAC38])T6T\.:J8+2-V=4+P3.
MW+$GEF)Z]ZJI"$91Y'J[=/\ @DPE)J7-YG9?"OP=J/P_^'VB>'M6\1WGBW4=
M/A\J;6M0!$UT=Q(9LLQX!"C+$X49)/-=77D'[(/_ ";%\-?^P+!_*ODW]BGX
M"M\?OA')'X[U.^F^'^DZK=0:?X:L+A[6*\F+"26>Y="'< NJH PQM;U.5[-2
M<Y2EL_\ ,?.URJ*W/T/CD2:-7C=71AD,IR#^-.KX?^.WP<TS]BVQT?XJ?"BX
MU#P]IUCJ5M;Z[X=:_FN+*^M9&VDD2,S;\D#)/&[(P1S[1^UY\5?$?P_\'^'M
M \%R1V_C/QGK$.@Z;=R@%;0R'YYN>,J, 9'&[/.,4O8\SCR.Z8_:63YEL>ZM
M,D<B(SJKOD*I."V!DX]:?7S+H/\ P3Y^%ATI'\8VVI>./%$R WOB#4M5NEGF
MEX)90DH"C/0')QP2><^37/PZ\2_"C]MKX)>&[[Q%>>)/!\9U:Y\/S:FYEN[1
M'M&$UJ\IY=4*1E2>@?':G&E"=U&6U^G;YB=24;.4?Q/O.BBN6^*7CRW^%_PX
M\2^+;J+SX='L)KSR0<&5D4E4SVW-@9]ZYDG)V1LW979TTTT=O&9)76-!U9S@
M#\:^=/V_M>U/PW^SG?WND:C=Z7>KJ=B@N+*=H9 IF4$;E(."*XCX.?LKVOQ^
M\,V/Q*^.=U=^,]<\0Q)J-CI/VR:WL=+MI%#11QQQNO)4J3SCG!!(+'RW]M7X
M!WGP%^&*CP-JUXOPUU34+6WOO"]_<R7*:?<"3S(I[9G8LJL5*,I)^\#SQM[Z
M-."K1CS:I]M/Z^1RU)R=-NVA^B]-:15959E#,<*">3QGBO#OVN/BUK_PV\$:
M)I/@[RU\:^+]6@T#29I@"EM)*<-,001\HP!G(!8$@@$'F=$_X)__  SNM'23
MQQ'JGCOQ;-&#>^(]2U6Z6>27J60+* H!Z Y..I-<T:<>52F[7^?^1LY/FY8H
M^F:1F"J68X Y)-?*OP?U/Q+\ /VB?^%,:WK]YXH\(:]I\NJ^%K[4I#+=VGEE
MC):NYY8!58@G@!5QC<0. U:U\&?&C]J[XB^&OCIK,EM8:&ULGA;PWJ&I26%C
M-"R,7G4JZ>9(?D/7)#D?,%PMJAJ]=+7_ *1/M=-M=C[I1UD565@RL,AE.01Z
MTM>)?#?]DWX>_##QE8>*O LFK:#"B2"32['6)Y=/O0ZD!I(W9MVW.5P< @''
M KRKXAZU#^T=^T%XF^'^N>+W\*?#+P9# FI6=MJ"V4VMWLREO+9R03"B@JRC
MN/\ :!68TXR?NO1>13FXK5:GV!'(DF[8ZOM)4[3G!'4?6G5\<>-/V:?A9X+T
M&ZU[X+^+;;X>^.M/B,]E<6/B%IH;QD&1!/'+*X=&Y'3J<D,,@O\ BU^T9XH\
M9_L%VOQ(\+>?I.K:DD5OJ5SIRGS+%1.8;F2+G*_,A ;.5#@Y!&:KV/-;D>C=
MM="?:\M^9>9]A>8GF>7O7S,;MN><>N/2G5\D^ /V1_V9_B-X>M[KP^T?BF^E
MC$SZU!XAN'OFD(YE<+*-CY.2I08/45])?#GP1%\./!FF^'(-5U36H;%61+[6
MKHW-U("Q8;Y#UP#M&     .*SG&,=F[^:M^I<92ENOQ.DHHHK$T"BBB@ HHH
MH **** "BBB@ KY(_;X_YD7_ +?_ /VWKZWKY(_;X_YD7_M__P#;>OJ.&?\
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MC'PIJ/@_X17/_">>-=:M9;:)=/B<V^GQ.I5[J>4KM54!)QDY.,C!KI?V _\
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MQF^"/A?X[>&8-&\30W"BUN%N[*_L)C#=6<PX$D3X.#SW!'3C@87M8^VY^G_
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M6V5(W9CW)8')KU;]A+QYI'BO]G3PSI-G*L6L>'8?[+U737&R>TF1V'SH>1N
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MMY-$.MZ?X@ALUM;J)!)L\NX1#M'1N>O*G)W8'CO['OP:76M'\4^"+[XI^/\
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ME_V [;_VE7+?L:_\D3M?^OZX_P#0A7Z;EO\ R2T?\<?_ $A'TM3_ ))G$_\
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M0+J0OU^&?A9+E2&&W2H0@(.0=@7;^E>G00QVL,<,,:Q0QJ$2.-0JJH&  !T
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M>\#:%I&K?P7=K9(KQ\8.SCY,CKMQFO0J*I2:5DQ-)ZM!1114C"BBB@ HHHH
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M_P#H(J[5+1?^0-8?]>\?_H(J[7S,OB9\/4^-^H4445)F%%%% !1110 4444
M%%%% !1110 4444 <A\8?^21^-_^P'??^D[U\*?\$C?^2=>/O^PK!_Z)-?=?
MQA_Y)'XW_P"P'??^D[U\*?\ !(W_ ))UX^_["L'_ *)->U0_Y%];UB<-3_>:
M?HS[WHHHKQ3N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OBO_@K'_P FZ^'?^QJMO_2.\K[4KXK_ ."L?_)NOAW_ +&JV_\
M2.\KTLM_WRGZG)BOX$CL=0_Y19I_V(,7_HE:P/\ @EC_ ,FS77_8P77_ **@
MK?U#_E%FG_8@Q?\ HE:P/^"6/_)LUU_V,%U_Z*@KOJ?[G6_Z^'/'^/3_ ,)]
MA4445\\>F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH **** "O*/VB/\ D6--_P"OS_V1J]7KRC]HC_D6--_Z_/\
MV1J^.XP_Y$.*_P /ZH^BX>_Y&M#U_1E[XS?\FGZE_P!@.V_]I5RW[&O_ "1.
MU_Z_KC_T(5U/QF_Y-/U+_L!VW_M*N6_8U_Y(G:_]?UQ_Z$*_3<M_Y):/^./_
M *0CZ6I_R3.)_P"PC_VT]RHHHKPS\X"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH *_/_ /X*Z_\ (E_#K_L(7?\ Z+CK] *_/_\ X*Z_\B7\.O\
ML(7?_HN.O6RG_?:?S_)G%C/X$OZZGU+\5_\ DT>Q_P"P9I?\X:N?LU_\D<T3
M_?N/_1[U3^*__)H]C_V#-+_G#5S]FO\ Y(YHG^_<?^CWKV9_\B!_]?O_ &P^
M(C_R6"_[!O\ W(>GT445\@?H@4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5\S_M7?\CAX/_W7_P#1B5],5\S_ +5W_(X>#_\
M=?\ ]&)7U?#'_(TAZ2_])9^?\=_\B*KZP_\ 2XGLO[27_)/(_P#K^B_]!>KW
MPV_Y$/0O^O5*H_M)?\D\C_Z_HO\ T%ZO?#;_ )$/0O\ KU2OQ7#_ /)68C_K
MS'_TH_:ZW_(AI?\ 7Q_D=+1117WY\H%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %>4?M$?\BQIO\ U^?^R-7J]>4?M$?\BQIO
M_7Y_[(U?'<8?\B'%?X?U1]%P]_R-:'K^C+WQF_Y-/U+_ + =M_[2KEOV-?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "O*/VB/^18TW_K\_\ 9&KU>O*/VB/^18TW_K\_]D:OCN,/
M^1#BO\/ZH^BX>_Y&M#U_1E[XS?\ )I^I?]@.V_\ :5<M^QK_ ,D3M?\ K^N/
M_0A74_&;_DT_4O\ L!VW_M*N6_8U_P"2)VO_ %_7'_H0K]-RW_DEH_XX_P#I
M"/I:G_),XG_L(_\ ;3W*BBBO#/S@**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OS_ /\ @KK_ ,B7\.O^PA=_^BXZ_0"OS_\ ^"NO_(E_#K_L(7?_ *+C
MKULI_P!]I_/\F<6,_@2_KJ?4OQ7_ .31['_L&:7_ #AJY^S7_P D<T3_ '[C
M_P!'O5/XK_\ )H]C_P!@S2_YPU<_9K_Y(YHG^_<?^CWKV9_\B!_]?O\ VP^(
MC_R6"_[!O_<AZ?1117R!^B!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7S/\ M7?\CAX/_P!U_P#T8E?3%?,_[5W_ ".'@_\
MW7_]&)7U?#'_ "-(>DO_ $EGY_QW_P B*KZP_P#2XGLO[27_ "3R/_K^B_\
M07J]\-O^1#T+_KU2J/[27_)/(_\ K^B_]!>KWPV_Y$/0O^O5*_%</_R5F(_Z
M\Q_]*/VNM_R(:7_7Q_D=+1117WY\H%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KXK_ ."L?_)NOAW_ +&JV_\ 2.\K[4KXK_X*Q_\
M)NOAW_L:K;_TCO*]++?]\I^IR8K^!(['4/\ E%FG_8@Q?^B5K _X)8_\FS77
M_8P77_HJ"M_4/^46:?\ 8@Q?^B5K _X)8_\ )LUU_P!C!=?^BH*[ZG^YUO\
MKX<\?X]/_"?85%%%?/'IA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKA_^2LQ'_7F/_I1^UUO^1#2_Z^/\CI:***^_/E HHHH **** "BBB@ HHHH
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M]<?^A"OTW+?^26C_ (X_^D(^EJ?\DSB?^PC_ -M/<J***\,_. HHHH ****
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M_1)KVJ'_ "+ZWK$X:G^\T_1GWO1117BG<%%%% !1110 4444 %%%% !1110
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MBBB@ HHHH **** "BBB@ HHHH *_/_\ X*Z_\B7\.O\ L(7?_HN.OT K\_\
M_@KK_P B7\.O^PA=_P#HN.O6RG_?:?S_ "9Q8S^!+^NI]2_%?_DT>Q_[!FE_
MSAJY^S7_ ,D<T3_?N/\ T>]4_BO_ ,FCV/\ V#-+_G#5S]FO_DCFB?[]Q_Z/
M>O9G_P B!_\ 7[_VP^(C_P E@O\ L&_]R'I]%%%?('Z(%%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSZ$<ZYN7J?0E%%%9%A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRC]HC_D6--_Z_/_ &1J]7KR
MC]HC_D6--_Z_/_9&KX[C#_D0XK_#^J/HN'O^1K0]?T9>^,W_ ":?J7_8#MO_
M &E7+?L:_P#)$[7_ *_KC_T(5U/QF_Y-/U+_ + =M_[2KEOV-?\ DB=K_P!?
MUQ_Z$*_3<M_Y):/^./\ Z0CZ6I_R3.)_["/_ &T]RHHHKPS\X"BBB@ HHHH
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M%M @2.*-1A551P   ,5V3M1INE]I[^7D<T?WDU/HMBU1117$=(4444 %%%%
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M\_\ 9&KU>O*/VB/^18TW_K\_]D:OCN,/^1#BO\/ZH^BX>_Y&M#U_1E[XS?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?R,$+(J[>#\S="<>6<X+ 5Z-52BX[B3OL%%%%2,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "OBO_@K'_P FZ^'?^QJMO_2.\K[4KXK_ ."L?_)NOAW_
M +&JV_\ 2.\KTLM_WRGZG)BOX$CL=0_Y19I_V(,7_HE:P/\ @EC_ ,FS77_8
MP77_ **@K?U#_E%FG_8@Q?\ HE:P/^"6/_)LUU_V,%U_Z*@KOJ?[G6_Z^'/'
M^/3_ ,)]A4445\\>F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?G_P#\%=?^1+^'7_80N_\ T7'7Z 5^?_\ P5U_Y$OX=?\
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M?_DK,1_UYC_Z4?M=;_D0TO\ KX_R.EHHHK[\^4"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /*
MOVG/A_XS^*7P=U?POX%UBST/6-2*0RW5]*\2&V)_>IN1'8%E^7@<@D9YKY6^
M%_[*?[5OP9\,_P!@>#/B-X&T32O.:X:&. 2L\C8RS/)I[.QP .2<  #@ 5]_
M45TTZ\J<>1)->:,94E*7,V[GQ)J_PP_;4CTF]:Z^+O@V2V6!S*BVD663:<@?
M\2X<XSWKPC]B7P9^T3XB^%6JW/PC\>>'_"_AM=:ECN+/5H$>5[H00%I 6M)O
ME*&(?>'*GCN?U&UBU>^TF^MH\>9- \:[N!DJ0,_G7@7[#7P%\3?L[?"75O#?
MBI[&34+K6YM0C.GS-+'Y306\8R2J\YB;C'I73'$?NI72OIT1A*C[ZU=M>I[%
M\,M/\4Z7X!T2T\;:E:ZQXKBMPNHWUDH6&:7)RR@(@ QC^!?I73T45YS=W<[%
MHK!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5Y1^T1_R+&F_]?G_LC5ZO7E'[1'_(L:;_ -?G
M_LC5\=QA_P B'%?X?U1]%P]_R-:'K^C+WQF_Y-/U+_L!VW_M*N6_8U_Y(G:_
M]?UQ_P"A"NI^,W_)I^I?]@.V_P#:5<M^QK_R1.U_Z_KC_P!"%?IN6_\ )+1_
MQQ_](1]+4_Y)G$_]A'_MI[E1117AGYP%%%% !1110 4444 %%%% !1110 44
M44 %? /BC]C?]HFZ^/FL_%#1?''@^'69KJ8Z==:@TEQ):VQ)6)%CDLW1"L>%
MRO3YN>23]_45M2K2I7Y>IE.FJEK]#XO_ .%6_MM_]%@\%_\ @)%_\K:^;_B'
MX4_: @_;&\":3KOCG0;WXIR:<ITC7(8$%I;P?Z40CJ+503Q/UB;[XY]/U@KY
ME^(G[.OBKQ1^VEX$^*EG)IX\,:+IRVMTDL["Y+@77W4VD$?OD_B'>NRCB-7S
M)+1]$<]2CHK-O5=3HOV>?"'Q^\-^(-4F^+WCC0?%6DR6H2R@TF!(WBFW@EF*
MVL/&W(ZGZ5[Q117!.7.[VMZ'7&/*K!1114%!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?(G[3G[3W
MB#6/%B_!GX*(VK?$"^)BU#5;4YCTB/H_S]%< _,YXCZ??("^Y?M#:)\0/$OP
MKU32OAIJ%II/BB\*PK>W<AC\J$G]X4<*=K[> V.,Y&#@CX\^"G[+_P"TQ\ +
M348O",O@&"XU&3S+J^NW>>YEQT4R&/.T<G:.,DGJ:[</"%G.35^B?ZG-6E*_
M+%.W<^H_V8OV8M"_9Q\*/#"XU;Q7J($FKZ[*,R7$G4HI/*Q@DX'4GD\]/::^
M0/[+_;2_Z#'P^_[X;_XW7KO[/]K\;+:;7/\ A;UYX>NXV6'^S/["!!4Y?S=^
M5'_3/'XU%6#=YRFF_4JG)*T5%H]BHHHKE-PHHHH **** "BBB@ HHHH ****
M "BBB@ KY(_;X_YD7_M__P#;>OK>ODC]OC_F1?\ M_\ _;>OJ.&?^1M1_P"W
MO_29'WG O_)0X;_M_P#](D?9NB_\@:P_Z]X__015VJ6B_P#(&L/^O>/_ -!%
M7:^9E\3/AZGQOU"BBBI,PHHHH **** "BBB@ HHHH **** "BBB@#D/C#_R2
M/QO_ -@.^_\ 2=Z^%/\ @D;_ ,DZ\??]A6#_ -$FONOXP_\ )(_&_P#V [[_
M -)WKX4_X)&_\DZ\??\ 85@_]$FO:H?\B^MZQ.&I_O-/T9][T445XIW!1110
M 4444 %?F'\(;74_A)-XM^/&B)<74&B>/]4T7Q1I\1)\_2)/L[>8J]VBD<O[
MY!. IK]/*^4/V$])L]>^&_QATS4;:.\L+SQ[K%O<6\R[DEC>&W5E8=P02/QK
MLH2Y(3?30YJL>:45ZGU)I.K6>O:59ZGIUS'>6%Y"EQ;W$+;DEC=0RLI[@@@_
MC7Y]_M<7EQ^TC9?$S7X)G_X5Y\,;5K*P:-B$U'67=%FDR/O+$C;1[D$9#,*U
M9/B!XV_9ZT_Q!^SCI$5YJ'B?4;M+?P%JS*2J:;=,Y=Y'[&W D^;L>P5*]7^/
M?PNTKX,_L%^*?!^CC=:Z;I"(\[##7$IF1I)6]V<LWMG'05K3BJ,T^[5O3O\
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M+^U@MC->3/$D/V>.## !FDF"\@]1TK&U[_E)+X;_ .R=O_Z67%0?M4645_\
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M7XRAV^//'D3ZC>1L#FQM/+/V6T7/("1XR#SD@'E:A_X)U_\ )HO@S_KK?_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KRC]HC_D6--_Z_/_ &1J]7KRC]HC
M_D6--_Z_/_9&KX[C#_D0XK_#^J/HN'O^1K0]?T9>^,W_ ":?J7_8#MO_ &E7
M+?L:_P#)$[7_ *_KC_T(5U/QF_Y-/U+_ + =M_[2KEOV-?\ DB=K_P!?UQ_Z
M$*_3<M_Y):/^./\ Z0CZ6I_R3.)_["/_ &T]RHHHKPS\X"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "ODC]OC_F1?^W__ -MZ
M^MZ^2/V^/^9%_P"W_P#]MZ^HX9_Y&U'_ +>_])D?><"_\E#AO^W_ /TB1]FZ
M+_R!K#_KWC_]!%7:I:+_ ,@:P_Z]X_\ T$5=KYF7Q,^'J?&_4****DS"BBB@
M HHHH **** "BBB@ HHHH **** .0^,/_)(_&_\ V [[_P!)WKX4_P""1O\
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MOA!X/\-/JD/C32_$-RR?Z+I>B7"W5W<2'A8PB9*$GC+X K._8O\ AQXA\&^
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MSS0XZX<?45UO[3GA6U\#_L8^,] LI[RZM-.T+[/'-?W#3SN%91N=VY8G\NP
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M>ST4E)I-+J-Q3:?8^=OBQ\ ?&UI\73\5_A%KFE:5XKNK1+'6-)U^.1K#5(D
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M)&&?PK:T?6].\1:=%J&E7]KJ=A-GR[JSF6:)\'!PRD@\CM7SS\"_V5O!>H>
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M> O)_P"$F\4:+X<\X9B_M;4(;7?_ +OF,,_A5OPUXPT'QI9&\\/ZWINNVBD
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MOV0_$GAKXN_#BW_X1W3)=5M]+\3>'K,E;*^M921YBQ9VHZ$'&,#+ \8;=/\
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M]HDDMV?4]%> _"WX_>*(/B9'\+_BSH5CH'C2YMVN]*U'1Y6DTW6(D!+^5O\
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MKR?]G7XW3_'+1/%M_/I,>D'0_$EWH*QQSF7SEA6)A*25&"?,Z<XQUHC&\6[
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M-M;2"RA$5O#'!$#D)$@5?R%-U+J2MN[_ )_YB4+.+[+_ "/E_P#X*%?\DU\
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MC6AZ_HR]\9O^33]2_P"P';?^TJY;]C7_ )(G:_\ 7]<?^A"NI^,W_)I^I?\
M8#MO_:5<M^QK_P D3M?^OZX_]"%?IN6_\DM'_''_ -(1]+4_Y)G$_P#81_[:
M>Y4445X9^<!1110 4444 %%%% 'Q-XU^*OA3X/\ _!0S5-;\8:Q%HFER^"([
M5+F6-W!E:=&"X12>0C'IVKUB^_;X^ ]A:R3MX^@FVC(C@L;IW8^@ B_^M7NM
MUH]A?2^;<V-M<28QOEA5CCTR13(O#^EP2))'IMI'(IW*ZP("".X.*ZG4IR2Y
MD]%;?_@&"A.-[/?R_P""?(^I1^)_VY/&GAY)O#>H^%/@CH5ZFI2R:U#Y-UX@
MG3[BK$>1#R1G)!!8YW8"]M^U9X)\2:5XL^'_ ,8?!NE2Z[J_@B>9;[1[<9FO
M-/G39,(QW=5+8 &?G)YV@5](T4O;-25EHNGKN/V>CN]6?/-O^WU\$)O#_P#:
M<WB\V4RC$FEW%C.+R.3',9C"'Y@>,@E<]ZQOV:]!\0?$GXR>,OCKX@T:Z\-V
M.KV,>B^'-*ODVW/]GJRNTTJ_PEV16 ]VZC:3]%R>%=%FU1=2DT>P?45.X7C6
MR&8$=#OQG]:U*3J0BFH+<.63:<GL?,EQ^V!\"O'#76@^/X%T#4;69X9=$\;:
M(P9<'[V&1T 8#(!(/J*\V^"MOX/U[]L*QUCX#VMQ9^ (-*G3Q7-80RP:5<3E
M7$"1H^!O#%#A1C"DC^(G[6U70M-UZ)8M2T^UU&)>52Z@64#Z!@?0?E5BSL[?
M3[=+>U@CMH$&$BA0(J_0#@52JQBFHIZ^>GY"]G*33D]O(^)M-D\/_L?_ !5\
M9:7\1O#$=U\-_%.K2:SHOBPZ:+R.QEEQYEK/A690" %P#TS@[B5[;6/VH/@-
M)<V.F^#?#UK\1O$5[+&D.C^'="$DNQB-TC,\:HH4')R<^N!DCZEN+>*ZA>&>
M))H9!M>.10RL/0@]:JZ5H>FZ#"T.FZ?:Z=$QRT=K"L2D^I"@4.M&6LD[^H*F
MXZ1>GH>=?%[XY>&/V==.T!]=TC5(/#UY(UN]]I6G&:TTU5 (,VS[BG. %!)P
M<#BOG3XX_$_]D[XB^!-5E$>BZWXAN[>1=/\ [#TJ2+5)+D@B(*RQJX._;PYV
MGOD<5]O5EV?A71=.OFO;31["UO&ZW$-LB2'_ ($!FIIU(PL[._D_^ .4)2TT
MMZ'GW[+&E^*]&_9]\$V?C=[E_$T=E_I/VQBTZJ9',22$G.Y8C&ISSD'/->JT
M45C*7-)R[FD5RI(^6O\ @F[_ ,FUQ?\ 8:OO_1@H_8S_ .2E?M&?]CS<_P#H
M4E?4%M:P6<?EV\,<$><[(U"C/K@40VL%LTC0PQQ-(V]RB@%V]3CJ:VE6YG-V
M^(SC3Y5'78\M_:P_Y-I^)O\ V +O_P!%FK/[,'_)N/PP_P"Q:T__ -)TKTN:
M&.XB:.5%DC889'&01Z$4L4201I'&BQQJ-JHHP !V J.?]WR>=R^7WN8=1116
M184444 %%%% !1110 4444 %%%% !1110 4444 %?*7_  4T_P"36[[_ +"M
MG_Z$:^K:BNK."^A,5Q#'<19SLE0,OY&M:<_9S4^Q$X\\7'N>%_\ #=GP(_Z*
M'9?^ ES_ /&JX?QG^V1<?%6UN/"W[/VBZEXQ\1W@-N?$3V4EMIFE!AS,[RJ,
MLN> 0 3_ 'N%;Z?_ .$;TC_H%67_ (#I_A5Z"WBM85BAC2&)>%2-0JCZ 5:E
M2CJHM^K_ . 0XS>C?X'A7A?]E?3O#7[*^H_")+T37.HZ?.EWJK*?WM]+EC.1
MU(5]F!UVHH//-<)\$_VJM$^$_A73/AM\9))? OC/PY;IIWF7T$AM-1@B 2.>
M&95*D% N<D9.2/0?6E4=6T/3=>A6'4]/M=1A4[ECNX5E4'U 8'FA5>:ZJ*]]
M?F'L[6<-+'QY\3_'UK^W!XF\-?#[X>076H^ ]/U6'5/$WBF2V>&U\N+)6VB+
M@%G;)[=0IY4,1[?\7OVGO!7P8\6V/A_QO;:KIVFZC:^:NN-ILDVF[BS*8&=0
M3OP 2 I ##)%>N6=E;Z=:QVUI!%:VT8VI#"@1%'H .!4DL23QO'(BR1L-K(P
MR"#V(H=2+LK>ZO,%"2N[ZL_/O]IKQ1^SW\1?"#1_#"SLM3^+5W- ^A2^#=/D
MM[T7'F*=\CQHHX7.=_S#C&" 1ZA^T%\-?%VDI\)OBJN@Q^-]?\&V0M?$VB>6
MLSW]O)"JSO$G(9T?S& &>6!YVU]2Z7X;TC0Y))-.TNRT^23[[6MND9;ZE0,U
MHUI]8M916B[ON3[*]V^O8^5[+]K3]F"ZT,:C-=:+82 #S-/NM 87<3\Y0QK$
M<D$$':2,]Z]+^%GQ%TC6/A3JOCS2OAWJGAFV5;B6'3!IB17VHPQ M$\<4?+>
M8#\H/<G&1ACZ7_PC>D?VI_:7]E67]H_\_GV=/._[[QG]:TJRE.#5HI_-EQC+
MJ_P/EJ[_ &L?V;/BUI)C\93:7'<QH1/I/BW1F^T6S#JAW1LNX$_P,?;FN:_8
MQT_3IOC=\3-9^&EMJ%C\%+F"!+".X66.UGU#Y/,DMDD^8+@29X_B4< *!]<:
MIX;TC6Y(Y-1TJROY(_N/=6Z2%?H6!Q6A'&D,:1QHL<: *JJ,  = !Z5?M8J+
MC%/7N_\ @$^S;DG)[>0ZOEK7O^4DOAO_ +)V_P#Z67%?4M1&T@:Z%R88S<!=
M@FV#>%],]<5C"?)?S5C24>:Q\O\ [3G_ "=7^S#_ -A#6/\ T3;5]2U%+:03
MS12R0QR2Q$F-V0%DSUP>U2T2GS1BNW^=PC'E;?<^6OV8_P#DZO\ :>_["&C_
M /HFYKZEJ**T@@FEECACCEE(,CJ@#/CID]ZEHJ3YY7]/P5@A'E5@HHHK,L**
M** "BBB@ KY(_;X_YD7_ +?_ /VWKZWKY(_;X_YD7_M__P#;>OJ.&?\ D;4?
M^WO_ $F1]YP+_P E#AO^W_\ TB1]FZ+_ ,@:P_Z]X_\ T$5=JEHO_(&L/^O>
M/_T$5=KYF7Q,^'J?&_4****DS"BBB@ HHHH **** "BBB@ HHHH **** .0^
M,/\ R2/QO_V [[_TG>OA3_@D;_R3KQ]_V%8/_1)K[K^,/_)(_&__ & [[_TG
M>OA3_@D;_P DZ\??]A6#_P!$FO:H?\B^MZQ.&I_O-/T9][T445XIW!1110 4
M444 %%%% 'RS^WDR:?:_![6=3P?"VE^.]/N-6+C,:19;YW_V0-X.?[V.]?4D
M4J3Q))&ZR1N RNIR&!Y!![BL/QUX'T3XE>$M3\->([&/4M&U&+RKBWDR,C((
M((Y# @$$<@@$5\_:-^RS\4_ -C%H/@;]H#4]&\(0Y2VT_5/#]KJ-Q:QXX19W
M(.!T  4*.@KI3C4@HMV:_KH8^]&3:5[F+\5]8TB\_P""BGP0L+62*36++2M3
M^V[""R(]G<F%&]#Q(V#V<'OSH75Q#H?_  4<MI=<=(X]6\#&UT.28@*9EN0S
MQIG^/:LIXYPWO6OX)_8GTCP)\6/!?CZS\37VH:SH\FH7.KW6J0^?=:U/=0&+
M>\V\>6J;B54*PZ]R6/I'QR^ /AGX]:#9V>N?:K'4M-F^TZ7K6FR>5>6$W!WQ
MOZ$JN5/!P#P0"-74IIQBGI:WXLS4)V;:UO<]*KY/_9-%GXG^./[2FJZ:L=WX
M1U#6K6UB=,-!<3I',+HJ>A!+J2>X<'-:M]^S+\8/$EA+H/B+]HK5+WPM,GDW
M%O8^';6TO)H2"&0W*L6!(P"QW;LG(KV/P;\&?"_P_P#AB? ?AVTETC0FMI+=
MFMIBMPQD4AY3+U\PYSN[<8P  ,_=IQ:4KM^OZE^].2;5K'BND_LN?$?X+_:;
M;X.?%"/3?##3-/#X5\4:>+RV@9CDJDX/F*N2> .^26/-:OPM^-WCGQ5XP\:?
M"3QYHFG:/\0M-T=M1M=0T*5VL+R!]L:R()#N0AY$ZGGGA=O,&G_LU_%KP;&+
M#P?^T+JUIHB92"U\0:%;:K-!'SM FD8%BO88 Z<8&*[CX+_L]P_"W7M;\5:U
MXEU#QOX[UN-(=0U[442+]VGW8H84^6*/(!V@GH.< "M)3BTW)IOIIK\_Z9$8
MR37*FEZZ'S3^Q-X)^)GB#X":;%X2^,%GX3MM/O+NTN]"E\)P7DUE<"9F99)6
MF5F)#*W(& P'05ZA\3/V6?BM\7O!MYX7\4?'.TOM'NFC>2./P7!$X9'5U*NM
MP&4AE'0],CH:Z#QQ^R?-+XZO_&OPR\=ZG\+?$FJ-OU,65LEY87SYSYDEJY"F
M3D_-G&23C)8EO@_]F?Q;=^,-'\2?%#XLZMX]N-'G6[T_3;.T32;*&X P)'2%
MOWI SC.!R0002#<JR<G4C)+KMK^7ZDQIM+D:;^>GYF_\:/V;K;XNP^&-3A\2
M:AX7\<^&@?[,\3::H,B,R@2!XR<.C8^[N'4C."P/FGC7Q=^T3^SIX;N?%&OZ
MEX5^*?A+2P)=1:.T?3=4$.X!G0)^Z&,Y/!^E>J?&+X$ZI\1O$&F^(_#GQ#\0
M> O$-C ;5)=/<36DL18L1+;,0KG)ZD]AP<#'!ZM^RW\1OB/9_P!B_$OXY:AX
MD\).P^U:1I&@VVE->!6#*))D+-M.!E0,<<$'FLZ<HV2G)-=FM?E_PY<HN[Y4
M[^I] ^#_ !/:>-O"6B>(M/$@L-7L8-0MQ*,/Y<L:R+D=CAA6%\;/^2,^/?\
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M_OE/U.3%?P)'8ZA_RBS3_L08O_1*U@?\$L?^39KK_L8+K_T5!6_J'_*+-/\
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M ,FCV/\ V#-+_G#5S]FO_DCFB?[]Q_Z/>O9G_P B!_\ 7[_VP^(C_P E@O\
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M9?F8X484<953D88-;^*G[//BB+XF2_%#X2>([3PUXTNH$M]5T[58FDTW6(T
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MYE&]=H.[CKG!]*QO@;^TCHGQXU;Q5I>G>'O$GAK4_#36Z7]GXELDM)E:82%
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M+_KX_P CI:***^_/E HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OEK]IS_ ).K_9A_["&L?^B;:OJ6OEK]IS_DZO\ 9A_[
M"&L?^B;:NC#_ !_)_DS&K\/S7YHSO^"DPU%OA5\/QH\WV?5SXYT\6<V =DWD
M77EM@^C8->D>#_V-_A5X=T!;/5/">G^+-5F7=?ZWKT N[R\F."\K229*EFYP
MI&,_7/$?\% O^1,^%7_91-*_]%W-?4M7*<HT8*+MN2HJ523:['R5^SGHX^"/
M[57Q$^$6CW,__"%S:1#XETK3YY&D%B3)''*B,23M+2=#SA5ZG)/UK7RUH/\
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MY1I5M*)19V\$(BA5Y  'E(W,Y&5!("D@9/I]%0ZC=_,M02MY!1116184444
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M@.^_])WKX4_X)&_\DZ\??]A6#_T2:^Z_C#_R2/QO_P!@.^_])WKX4_X)&_\
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M/RY%?/\ \>OAS\8M(^"/CZ]UWXY:??Z1%H5ZUU8'P?;6XN4\AP81+YY*%\[
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M7:0QP@Y>1CEI'8Y9W8\EV)8GDDU,ZBG=]_P'&#C9=C9HHHKG-@HHHH ****
M"BBB@ KXK_X*Q_\ )NOAW_L:K;_TCO*^U*^*_P#@K'_R;KX=_P"QJMO_ $CO
M*]++?]\I^IR8K^!(['4/^46:?]B#%_Z)6L#_ ()8_P#)LUU_V,%U_P"BH*W]
M0_Y19I_V(,7_ *)6L#_@EC_R;-=?]C!=?^BH*[ZG^YUO^OASQ_CT_P#"?85%
M%%?/'IA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5O#>L1>5=V;-]UL?Q(V.&'MD#(KDX-<_:-M88X8? _P\BAC4(D<>M7*JJ@8
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MKA_^2LQ'_7F/_I1^UUO^1#2_Z^/\CI:***^_/E HHHH **** "BBB@ HHHH
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M 5532;*/4GU!;.W6_DC\I[I8E$K)D':7QDC@<9[5:HH **** "BBB@ HHHH
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M10!G:IX=TG7&B;4M+L]0:+F-KJW24I]-P.*OQQK#&J(JHB@*JJ,  = !3J*
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MKY(_;X_YD7_M_P#_ &WKZCAG_D;4?^WO_29'WG O_)0X;_M__P!(D?9NB_\
M(&L/^O>/_P!!%7:I:+_R!K#_ *]X_P#T$5=KYF7Q,^'J?&_4****DS"BBB@
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MWE?:E?%?_!6/_DW7P[_V-5M_Z1WE>EEO^^4_4Y,5_ D=CJ'_ "BS3_L08O\
MT2M8'_!+'_DV:Z_[&"Z_]%05OZA_RBS3_L08O_1*U@?\$L?^39KK_L8+K_T5
M!7?4_P!SK?\ 7PYX_P >G_A/L*BBBOGCTPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K\_P#_ (*Z_P#(E_#K_L(7?_HN.OT
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MX?\ $3V;W\NL7=\ILI3(GER%2O)4<\'(Q7ME%6I-1<>Y/*FTPHHHJ"@HHHH
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M HHHH **** "BBB@ HHHH *^2/V^/^9%_P"W_P#]MZ^MZ^2/V^/^9%_[?_\
MVWKZCAG_ )&U'_M[_P!)D?><"_\ )0X;_M__ -(D?9NB_P#(&L/^O>/_ -!%
M7:I:+_R!K#_KWC_]!%7:^9E\3/AZGQOU"BBBI,PHHHH **** "BBB@ HHHH
M**** "BBB@#D/C#_ ,DC\;_]@.^_])WKX4_X)&_\DZ\??]A6#_T2:^Z_C#_R
M2/QO_P!@.^_])WKX4_X)&_\ ).O'W_85@_\ 1)KVJ'_(OK>L3AJ?[S3]&?>]
M%%%>*=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7S/^U=_R.'@_P#W7_\ 1B5],5\S_M7?\CAX/_W7_P#1
MB5]7PQ_R-(>DO_26?G_'?_(BJ^L/_2XGLO[27_)/(_\ K^B_]!>KWPV_Y$/0
MO^O5*H_M)?\ )/(_^OZ+_P!!>KWPV_Y$/0O^O5*_%</_ ,E9B/\ KS'_ -*/
MVNM_R(:7_7Q_D=+1117WY\H%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>4?M$?\ (L:;_P!?G_LC5ZO7E'[1'_(L:;_U^?\
MLC5\=QA_R(<5_A_5'T7#W_(UH>OZ,O?&;_DT_4O^P';?^TJY;]C7_DB=K_U_
M7'_H0KJ?C-_R:?J7_8#MO_:5<M^QK_R1.U_Z_KC_ -"%?IN6_P#)+1_QQ_\
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MZ_X>\ZQ_T3.Q_P#!N_\ \9H_X>\ZQ_T3.Q_\&[__ !FOAS_A9WC'_H;-<_\
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M_BJ/[)PG_/I?>P^N5OY_P1]Q_P##WG6/^B9V/_@W?_XS1_P]YUC_ *)G8_\
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MI7ZHN>*;E&4-&E8^X_\ A[SK'_1,['_P;O\ _&:/^'O.L?\ 1,['_P &[_\
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M\51_PL[QC_T-FN?^#*;_ .*H_LG"?\^E][#ZY6_G_!'W'_P]YUC_ *)G8_\
M@W?_ .,T?\/>=8_Z)G8_^#=__C-?#G_"SO&/_0V:Y_X,IO\ XJC_ (6=XQ_Z
M&S7/_!E-_P#%4?V3A/\ GTOO8?7*W\_X(^X_^'O.L?\ 1,['_P &[_\ QFC_
M (>\ZQ_T3.Q_\&[_ /QFOAS_ (6=XQ_Z&S7/_!E-_P#%4?\ "SO&/_0V:Y_X
M,IO_ (JC^R<)_P ^E][#ZY6_G_!'W'_P]YUC_HF=C_X-W_\ C-'_  ]YUC_H
MF=C_ .#=_P#XS7PY_P +.\8_]#9KG_@RF_\ BJ/^%G>,?^ALUS_P93?_ !5'
M]DX3_GTOO8?7*W\_X(^X_P#A[SK'_1,['_P;O_\ &:/^'O.L?]$SL?\ P;O_
M /&:^'/^%G>,?^ALUS_P93?_ !5'_"SO&/\ T-FN?^#*;_XJC^R<)_SZ7WL/
MKE;^?\$?<?\ P]YUC_HF=C_X-W_^,T?\/>=8_P"B9V/_ (-W_P#C-?#G_"SO
M&/\ T-FN?^#*;_XJC_A9WC'_ *&S7/\ P93?_%4?V3A/^?2^]A]<K?S_ ((^
MX_\ A[SK'_1,['_P;O\ _&:/^'O.L?\ 1,['_P &[_\ QFOAS_A9WC'_ *&S
M7/\ P93?_%4?\+.\8_\ 0V:Y_P"#*;_XJC^R<)_SZ7WL/KE;^?\ !'W'_P /
M>=8_Z)G8_P#@W?\ ^,T?\/>=8_Z)G8_^#=__ (S7PY_PL[QC_P!#9KG_ (,I
MO_BJ/^%G>,?^ALUS_P &4W_Q5']DX3_GTOO8?7*W\_X(^X_^'O.L?]$SL?\
MP;O_ /&:/^'O.L?]$SL?_!N__P 9KX<_X6=XQ_Z&S7/_  93?_%4?\+.\8_]
M#9KG_@RF_P#BJ/[)PG_/I?>P^N5OY_P1]Q_\/>=8_P"B9V/_ (-W_P#C-'_#
MWG6/^B9V/_@W?_XS7PY_PL[QC_T-FN?^#*;_ .*H_P"%G>,?^ALUS_P93?\
MQ5']DX3_ )]+[V'URM_/^"/N/_A[SK'_ $3.Q_\ !N__ ,9H_P"'O.L?]$SL
M?_!N_P#\9KX<_P"%G>,?^ALUS_P93?\ Q5'_  L[QC_T-FN?^#*;_P"*H_LG
M"?\ /I?>P^N5OY_P1]Q_\/>=8_Z)G8_^#=__ (S1_P />=8_Z)G8_P#@W?\
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M'_"SO&/_ $-FN?\ @RF_^*H_LG"?\^E][#ZY6_G_  1]Q_\ #WG6/^B9V/\
MX-W_ /C-'_#WG6/^B9V/_@W?_P",U\.?\+.\8_\ 0V:Y_P"#*;_XJC_A9WC'
M_H;-<_\ !E-_\51_9.$_Y]+[V'URM_/^"/N/_A[SK'_1,['_ ,&[_P#QFC_A
M[SK'_1,['_P;O_\ &:^'/^%G>,?^ALUS_P &4W_Q5'_"SO&/_0V:Y_X,IO\
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M/>=8_P"B9V/_ (-W_P#C-?#G_"SO&/\ T-FN?^#*;_XJC_A9WC'_ *&S7/\
MP93?_%4?V3A/^?2^]A]<K?S_ ((^X_\ A[SK'_1,['_P;O\ _&:/^'O.L?\
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M_L^X_P">?_CP_P :/[/N/^>?_CP_QK\XO^$JUO\ Z#%__P"!3_XT?\)5K?\
MT&+_ /\  I_\:/\ 4BI_S_7_ (#_ ,$/^(IT?^@1_P#@:_\ D3]'?[/N/^>?
M_CP_QH_L^X_YY_\ CP_QK\XO^$JUO_H,7_\ X%/_ (T?\)5K?_08O_\ P*?_
M !H_U(J?\_U_X#_P0_XBG1_Z!'_X&O\ Y$_1W^S[C_GG_P"/#_&C^S[C_GG_
M ./#_&OSB_X2K6_^@Q?_ /@4_P#C1_PE6M_]!B__ / I_P#&C_4BI_S_ %_X
M#_P0_P"(IT?^@1_^!K_Y$_1W^S[C_GG_ ./#_&C^S[C_ )Y_^/#_ !K\XO\
MA*M;_P"@Q?\ _@4_^-'_  E6M_\ 08O_ /P*?_&C_4BI_P _U_X#_P $/^(I
MT?\ H$?_ (&O_D3]'?[/N/\ GG_X\/\ &C^S[C_GG_X\/\:_.+_A*M;_ .@Q
M?_\ @4_^-'_"5:W_ -!B_P#_  *?_&C_ %(J?\_U_P" _P#!#_B*='_H$?\
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M/#_&OSB_X2K6_P#H,7__ (%/_C1_PE6M_P#08O\ _P "G_QH_P!2*G_/]?\
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M?_CP_P :/[/N/^>?_CP_QK\XO^$JUO\ Z#%__P"!3_XT?\)5K?\ T&+_ /\
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MW_T&+_\ \"G_ ,:/]2*G_/\ 7_@/_!#_ (BG1_Z!'_X&O_D3]'?[/N/^>?\
MX\/\:/[/N/\ GG_X\/\ &OSB_P"$JUO_ *#%_P#^!3_XT?\ "5:W_P!!B_\
M_ I_\:/]2*G_ #_7_@/_  0_XBG1_P"@1_\ @:_^1/T=_L^X_P">?_CP_P :
M/[/N/^>?_CP_QK\XO^$JUO\ Z#%__P"!3_XT?\)5K?\ T&+_ /\  I_\:/\
M4BI_S_7_ (#_ ,$/^(IT?^@1_P#@:_\ D3]'?[/N/^>?_CP_QH_L^X_YY_\
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M"B_\"3_\37E7_"0:I_T$KS_O^_\ C1_PD&J?]!*\_P"_[_XT?ZZYU_T%R_\
M (!_JUEO_0.O_ I'JO\ PT=<_P#0"B_\"3_\31_PT=<_] *+_P "3_\ $UY5
M_P )!JG_ $$KS_O^_P#C1_PD&J?]!*\_[_O_ (T?ZZYU_P!!<O\ P" ?ZM9;
M_P! Z_\  I'JO_#1US_T HO_  )/_P 31_PT=<_] *+_ ,"3_P#$UY5_PD&J
M?]!*\_[_ +_XT?\ "0:I_P!!*\_[_O\ XT?ZZYU_T%R_\ @'^K66_P#0.O\
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MZYU_T%R_\ @'^K66_P#0.O\ P*1ZK_PT=<_] *+_ ,"3_P#$T?\ #1US_P!
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M?]!*\_[_ +_XT?ZZYU_T%R_\ @'^K66_] Z_\"D>J_\ #1US_P! *+_P)/\
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M"B_\"3_\37E7_"0:I_T$KS_O^_\ C1_PD&J?]!*\_P"_[_XT?ZZYU_T%R_\
M (!_JUEO_0.O_ I'JO\ PT=<_P#0"B_\"3_\31_PT=<_] *+_P "3_\ $UY5
M_P )!JG_ $$KS_O^_P#C1_PD&J?]!*\_[_O_ (T?ZZYU_P!!<O\ P" ?ZM9;
M_P! Z_\  I'JO_#1US_T HO_  )/_P 31_PT=<_] *+_ ,"3_P#$UY5_PD&J
M?]!*\_[_ +_XT?\ "0:I_P!!*\_[_O\ XT?ZZYU_T%R_\ @'^K66_P#0.O\
MP*1ZK_PT=<_] *+_ ,"3_P#$T?\ #1US_P! *+_P)/\ \37E7_"0:I_T$KS_
M +_O_C1_PD&J?]!*\_[_ +_XT?ZZYU_T%R_\ @'^K66_] Z_\"D>J_\ #1US
M_P! *+_P)/\ \31_PT=<_P#0"B_\"3_\37E7_"0:I_T$KS_O^_\ C1_PD&J?
M]!*\_P"_[_XT?ZZYU_T%R_\  (!_JUEO_0.O_ I'JO\ PT=<_P#0"B_\"3_\
M31_PT=<_] *+_P "3_\ $UY5_P )!JG_ $$KS_O^_P#C1_PD&J?]!*\_[_O_
M (T?ZZYU_P!!<O\ P" ?ZM9;_P! Z_\  I'JO_#1US_T HO_  )/_P 31_PT
M=<_] *+_ ,"3_P#$UY5_PD&J?]!*\_[_ +_XT?\ "0:I_P!!*\_[_O\ XT?Z
MZYU_T%R_\ @'^K66_P#0.O\ P*1ZK_PT=<_] *+_ ,"3_P#$T?\ #1US_P!
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M^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\
M]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<
MR[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__
M $)UM_X'M_\ &Z^;?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_
MU<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;
M?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H
M'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)U
MM_X'M_\ &Z^;?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[
M_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![
M?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@
M4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'
MM_\ &Z^;?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7
M_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z
M^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U
M*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\
M&Z^;?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@
M_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^
M$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_
M *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;
M?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2
MLE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0
M_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(
M_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;?^$T
M\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2LE_Z
M!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0_P#0
M=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(_P#@
M<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;?^$T\0_]
M!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2LE_Z!(_^
M!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0_P#0=U/_
M ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(_P#@<SZ2
M_P"&]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;?^$T\0_]!W4_
M_ R3_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I
M+_AO2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)
M/_BJ/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&
M]+__ *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;?^$T\0_]!W4__ R3
M_P"*H_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO
M2_\ ^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ
M/^$T\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__
M *$ZV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;?^$T\0_]!W4__ R3_P"*
MH_X33Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\
M^A.MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T
M\0_]!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$Z
MV_\  ]O_ (W1_P -Z7__ $)UM_X'M_\ &Z^;?^$T\0_]!W4__ R3_P"*H_X3
M3Q#_ -!W4_\ P,D_^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.M
MO_ ]O_C='_#>E_\ ]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]
M!W4__ R3_P"*H_U<R[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\
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M_P -Z7__ $)UM_X'M_\ &Z^;?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\
MP,D_^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>
ME_\ ]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*
MH_U<R[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W1_P -
MZ7__ $)UM_X'M_\ &Z^;?^$T\0_]!W4__ R3_P"*H_X33Q#_ -!W4_\ P,D_
M^*H_U<R[_H'7_@4@_P!2LE_Z!(_^!S/I+_AO2_\ ^A.MO_ ]O_C='_#>E_\
M]"=;?^![?_&Z^;?^$T\0_P#0=U/_ ,#)/_BJ/^$T\0_]!W4__ R3_P"*H_U<
MR[_H'7_@4@_U*R7_ *!(_P#@<SZ2_P"&]+__ *$ZV_\  ]O_ (W7E/QT^/5Q
M\;O[$\_1X])_LSS\>7<&7S/,\OKE1C'E_K7!_P#":>(?^@[J?_@9)_\ %5]
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M&(?@3_T3'0_^_;__ !5>XT4?6J__ #\?WL/8T_Y5]QX=_P ,0_ G_HF.A_\
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MN-%'UJO_ ,_'][#V-/\ E7W'AW_#$/P)_P"B8Z'_ -^W_P#BJ/\ AB'X$_\
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MX\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\
MY^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\
MXJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\
MHF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\
M\51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\
MT3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^
MX\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\
MY^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\
MXJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\
MHF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\
M\51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\
MT3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^
MX\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\
MY^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\
MXJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\
MHF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\
M\51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\
MT3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^
MX\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\
MY^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\
MXJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\
MHF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\ T3'0_P#OV_\
M\51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^X\._X8A^!/\
MT3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\ Y^/[V'L:?\J^
MX\._X8A^!/\ T3'0_P#OV_\ \51_PQ#\"?\ HF.A_P#?M_\ XJO<:*/K5?\
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M ". _P"%"?#[_H5+#_OEO\:/^%"?#[_H5+#_ +Y;_&N_HH_M#&?\_I?^!/\
MS#^Q\M_Z!H?^ 1_R. _X4)\/O^A4L/\ OEO\:/\ A0GP^_Z%2P_[Y;_&N_HH
M_M#&?\_I?^!/_,/['RW_ *!H?^ 1_P C@/\ A0GP^_Z%2P_[Y;_&C_A0GP^_
MZ%2P_P"^6_QKOZ*/[0QG_/Z7_@3_ ,P_L?+?^@:'_@$?\C@/^%"?#[_H5+#_
M +Y;_&C_ (4)\/O^A4L/^^6_QKOZ*/[0QG_/Z7_@3_S#^Q\M_P"@:'_@$?\
M(X#_ (4)\/O^A4L/^^6_QH_X4)\/O^A4L/\ OEO\:[^BC^T,9_S^E_X$_P#,
M/['RW_H&A_X!'_(X#_A0GP^_Z%2P_P"^6_QH_P"%"?#[_H5+#_OEO\:[^BC^
MT,9_S^E_X$_\P_L?+?\ H&A_X!'_ ". _P"%"?#[_H5+#_OEO\:/^%"?#[_H
M5+#_ +Y;_&N_HH_M#&?\_I?^!/\ S#^Q\M_Z!H?^ 1_R. _X4)\/O^A4L/\
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M !KOZ*G^T,9_S^E_X$_\S3^Q\M_Z!H?^ 1_R. _X4)\/O^A4L/\ OEO\:/\
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MV/EO_0-#_P  C_D']H8S_G]+_P "?^9R'_"H_!W_ $+]G_WR?\:/^%1^#O\
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MV/EO_0-#_P  C_D']H8S_G]+_P "?^9R'_"H_!W_ $+]G_WR?\:/^%1^#O\
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M\3F-6_LYS=NSDSIHX[.<0FZ-6K*W:4W^3,S_ (9K^&'_ $)>F?\ ?#?XT?\
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MPW^-'_#-?PP_Z$O3/^^&_P :]+HH_M#&?\_I?^!/_,/[8S+_ *"9_P#@<O\
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MPQ_;,^#/Q?UB+2/#/CJQN-6F;9%8WD4ME+,QZ+&)T3S&]ER:^=?V+?AK\/\
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M[K6O!&M#6M.M;IK*>3[--;M',JJQ1DE1&'#J<XQS[&OE?]BOQ$_PE^/WQ#^
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ML<M7"X2MA9XG"<RY&N92L]'LTTEUW5CTVZNH;&WDGN9H[>",;GEE8*JCU)/
MKB9_CAX)M[@PMKB,P."T<$K+_P!]!<'\*Y?Q7;R?%#XK#PM--)'H.D0K<7<4
M;;?.D(4X)'^\H]L-CK7I=OX.T*TLUM(M&L5MPNWR_LZ$$>^1S^-1''9CF-6J
MLOY(4Z<G'FFI2<I+XK).-DGI=MW=]"GA<'@Z<'B^:4YI2M%I63VNVG=M:VLO
M4MZ3K-CKUDEYIUW#>VS<"2%PPSZ>Q]J75M8L=!LGN]1NX;*V7@RS.%&?3GJ?
M:L'PO\.=*\':UJ.H:69K:.]50UDK_N$([JOK^/&2!Q7G5M]@^)WQ.UF?7[J(
M:)H<GV:UL9Y0B2R9(+'GGE23ZY4=!58K-,9A*%&G5IQ^L5).*7-[FEVY-VOR
MV5[;ZI>8J.!P^(JU)PF_8P2;=O>ULE&VU[NU]NIVUM\;O!-U="!-<C5R<!I(
M9$3_ +Z90!]2:[6&>.ZA2:&198I%#)(C!E8'H01U%<U>:;X-U"Q:SGAT9[8C
M'E_N@!],=#[BN)^&-X/"/Q U;P=!>"^T9X_MNGMY@?R\XW)G/N?Q7/<UE#,L
M9@\12I8Z5.<*CY5*%URRM=)Q<I73M9-/>UUJ7+!X;$4:E3"J4905VI6=UU::
M2U6]K;=3U^FR2)#&TDC+'&HW,S'  '4DTZO(?BWJ#^)/&6A^"C>_V?IMPOVN
M_FW!=R#<0F2?]@_BR^E>QFN8++<-[;EYI-J,5>UY2=DK]%W?17/.P.#>-K>S
MO9)-M[V25WIU\EW.FO/C9X*LKHP2:[&[@X+0Q22)_P!]*I!_ UU6CZYI_B&R
M6[TV\AO;9N/,A<, ?0^A]CS6'INE^#-)L5L[6+1X[<+M*DQL6'^T3DM^->=Z
MTNF_#/X@Z+JWAZY@72M6F%I?V%O*&C4DC#A0>.N?;:<<'%>#4S3,,O4:^-E2
MG3;2ER73C=VOJWS)-ZZ1=M?(]6&!PF,;I893C.S:YK-2LKVT2Y6^FK70]6C\
M6Z5-XDET!;K_ (F\<7G-;M&X^3 .0Q&T]1T/KZ&MBO*/C39S>'=0T+QQ91EI
MM+F6&Z5>KP,<8/XEE_[:5ZA97D.H6<%U;N);>>-98W'1E89!_(U[6"QU2KB\
M1@\0DI4VG&W6$OA>K>J:<7TNNESSL3A84\/1Q-)MQDFG?I);KTM9KR9G^(/%
M>E>%UM#J=U]G-W*((%$;R,[GL H)_P#UBM"\OK?3;62YNYX[:WC&YY9G"JH]
M23TKRRS_ .+B?&>:Y/[S2/#">7'W5KDGD_@0?^_:^M4?%\T'Q!^+ \.:E>+:
M^'M'B$]Q$TGEBXE(4[<Y']\#V ;UKQ:F?U8TZE:G!-2J>SI=.9KXI2>ONIJ6
MRVCUNCTH953<X4Y2::ASSZV3V27>S6[W?D=:WQP\$K=>0=<3=G&X02E,_P"]
MMQ^/2NSL-0M=4M([JSN(KJVD&4FA<.K?0BL!;#P='8_8UAT46N-ODXBVX^E>
M?: UK\.?BQ;Z3I%VDWAW74++;QR^8MO, >G)]!^##^Z*MYGCL#4IO'2ISISD
MHWA=.+EHKIRES*]DWHU>]K$?4L+BH36%4XSBF[2LU)+5[)6=M;:W[GJ7B#Q3
MI?A>.U?5+K[*MU,((CY;ON<]!\H..G4\5GZY\2/#7AO4%L;_ %6**]9@HMXU
M:1P3T!"@[?QQ7"?M+326_AK1983B6/459"!GY@C$?K76>#?A9HWAW3HC=V-O
MJ6K28EN;ZZC$KO*>6(+9P,^GX\T5,RS.OF=?+\'&"5-0?-*^BDGI9/5OILDE
MK<(X/!4L%2Q>(E*\W)<JMT>]VM$NN][]#>TGQ9I6MZIJ.FV=UYM]I[;;F%HW
M0H<D?Q 9''49'3U%:]>1>/Q_PK_XF:+XN0;-.U#_ $#42.@X^5C^ !_[9UZX
M6 7<2 N,Y[5Z^6XZIB*E?#8A)5*4K:;.+UA+5O=:/7=,X,9A8484JU%MPFKZ
M]&M)+Y/;R:,K4O%6EZ3K&GZ5=77EZA?D_9X%C=R^.IRH( ]SCH?2M:O)_API
M\=?$#7?&<HW65N?[/TW/3:/O./J#_P"/M7K%/*<=4S&E/$R24')\EMW%:<S_
M ,33:VTL+'X:&#J1HIOF27-Y2>MEZ*R?G<*\]^*/CFZTLVWASP^//\2ZG\D0
M4_\ 'NAZR'T/7'I@GMSM?$/QU:^ M!:\D7S[R4^7:6H^]-)V'T'4G^I%8WPM
M\"W.CK<^(=>;[1XFU3YYF?K AZ1CT[9], #ISP9EB:N+K_V5@I6DU><E]B#[
M?WY;1[*\NB.K!4:>'I?7\2KQ6D8_S2_^1CU[[&W\/_ ]KX#T&.QA/G7,A\RZ
MNC]Z:0]3].P']<UTU<(_C74%^+T?AD+#_9S6/V@G8?,W<]\]./2NUNKR"QMW
MGN9H[>!/O22N%5><<D^]>CEM7"1H2H85<L*+<.UN7?\ /?J<>-AB'556N[RJ
M)2^_;_AB:LOQ1JSZ%X;U748UWR6EK+.JD9!*J2,^V14?_"8:#_T&]-_\"X_\
M:N7TUC/I%Q)=20MILD#-+(S#RS$5Y)/3&.]=E2M"M2FJ%17L];IV\SGC3E3J
M1=6#M=:6W\CR?X3_  [TOQ7H,?BGQ$G]N:IJ+R.6NF+)& Y7 7.#]WOTZ#&*
MZ#QA\&/#.JZ/<&ST^'2;Z)"\-U:CR]K 9&0.",_CZ$5YUX'UKQ-I%]>V?@&T
MG\0^&ED8Q'4HA$B-GD(Y<9[>G7[HZG2\?>)?B/)I<D&IZ-_8NC296ZNM,"W,
MJQ'[W1^!C/\ =^M?DN%Q>4PR?DKX&4Y)6E)4^92EUG[7:S>O-S:?(^_KX?'R
MS'FI8E13=TN:SBND>3?1:6MJ=O\  [Q/>^*? 4$U^[37-O,]L9G^](% ()]3
MA@,]\5Z!7*_#*/0X?!>GQ^'IOM&G*I'F-]\OG+;QV;)Z?3MBNJK]-R6-2&6X
M>-6HIR4(WDG=/3OU]>NY\3F4H2QE65.'*N9Z;6U[=/3H9/A_Q5I?BJ.Y?2[K
M[2+:4P3 QO&R..H(8 UK5Y3I8_X0CXW7UE]S3O$D'VF+T%PN2P^I^<_\#6NB
M^+WB1O#/@6_DA)^VW6+.V"_>+OQQ[A=Q_"N+#YPXX&OB,8DIT'-22V]W56O=
M^]'E:]3IK9>GBJ5'#ZQJJ+C?SWOZ.Z?H;?AKQAH_C"&XET>]6]2WD\N0JC+M
M;&?X@,CW'%;->(>!]#D^$?Q$TS2I7/V/7M/168GY1=(/F _'./\ KH*]#^*?
MB8^$_ ^IWD;;;IT^SV^.OF/\H(]QRW_ :RR[.:D\NJXG,8J%2CS<Z6RLN96O
M=ZQ::\V7C,NA'&4Z.#;E"I;E;\]-?1W-?P_XGTSQ3!<3:7<_:X8)F@DD$;*
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MXT74C))V<N5J3[.*2<;]^:5NIZ%?ZA:Z59S7E[<PV=I"I>6XN) D<:CJ68\
M>YKRJX_:T^%%MJ!LV\6Q-(&VF2.TN'BSD?QB,J1SU!QQUKSOXQWD'Q>_: T_
MX<ZKJBZ9X0T.U74M4C:80B[E.UEC+9'&'C [C+D=B/8K/1OAA8:2NF06OA5+
M!5"_9\6Y4@#'.>I]SS70L'A\/2A+$J4I35[1LK)[7;3NWO;\3LCEN"P5"E/'
M1J3G4BI6A9*,7M=N,KMK6R2LK:G7Z'K^F^)M,AU'2+^WU*PF&8[BUE$B-Z\C
MN/3M6A7RMHXTKX$_M%:'8>%-0AF\&^,PT,VF6]P)8[2Z7 5E^8XRS)U[,PZ
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M$DE=6DO>49)[JZOH]FFG;H='XF^.?@3P=I&FZEK'B.VLK;4;=+JT4H[32Q.
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MGHU\S6M%3IM-V/D[XQ>+=._;2_: ^$WPV\/SG4/ =A9P^-O$3#.UXV16MX)
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M7+?X(_%SQO87I\K0]6LWU^S7.!YB!C)&ON2'X]$6NF_9MT&YMO!-SXCU%?\
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M-VYK;2C+6TEMJK-=K'NX?$X>MAE@\9=*+;C)*]K[IKJGOIJF=S7D'Q@\9?\
M"0;/ _AUA?:MJ$@CN6B.5@0$$@D=^.?0 YZU9?X(7]TIAO/'6NW-F># TS8Q
MZ<L1T]J[/P?\/]#\"V[1Z5:".208DN)#OE?ZMZ>PP/:N3%1S;.*;PDZ*P].6
MDI.2E)QZJ*CHFUI=O1/:YO0E@,OFL1&I[6<=8KE:5^CDWKIV2U[EG2]$B\-^
M$8=+@YCM;3R@W]XA>3^)R?QKA_V<?^2<C_K\E_DM>G3Q">&2,G =2N?J*Y_P
M#X*A\ Z#_9=O<R7<?FM+YDB@')QQQ]*]"IE\XYEA:U*-J=.$X^E^3E5O2+.2
M.+C+!5Z=1^_.47ZVYK_F=)7DWP,_Y"_CK_L*M_Z$]>LUS'@WP+!X-NM9GANI
M+DZG<FY<2*!L)).!CM\U:XW"5JV88/$07NTW/F^<;+\2,-B*=/"8BE)^]/EM
M\I79PC7D?@'X[7EQJ)$&G:_;*(;E^$60;1@GZJ?IO6O8:R/%/A+2_&6EM8:K
M;+<0YW*W1XV_O*>QK@O^%'W4$?V6U\;:Y;Z;T%KYI( [ $$#]*\RE1S#)ZM6
M&&HJM2G)S5I*,HN3O).^C5]4T[J]K';.IA,PA3E6J>SG%*+T;32T35M4[:-/
M[ST2U\1:9>ZM=:7!?0RZA:J&FME;+H#W(_$?3(]:\0T'PCX=M?BIXCT+Q38Q
MRR7DWVK399F9%969FV@@C)(('U1AUXKUOP5\/M(\!VLL>G1N\\QS-=3MNEE/
MN?3GH *=XS\ Z-X\LT@U2W+/'S%<0G;+'ZX;T]CD5&899B\SP]&O7IP=:G)R
MY'K!IW3BVUO:WO6LI+:Q6#QN'P56I2I3DJ<TES+22:L^9)/:_2^SW,O_ (4K
MX*_Z ,/_ ']D_P#BJE\)^#?!FFZM/=:!:VJW]FQ@E:"=G,1(Y4C<>W]?2N</
MP0O646[>.=<:P''V?S3T],[L?I7<>$/!.D^!]-^QZ5;^6&YDF?YI93ZLW?Z=
M!V%&!P7-B8SEEM.C&.O-[CE?IR\J[]6UZ!BL3RT916,G4;Z>\E;K>[_!)F[7
MA_Q?T;3K'XF>']:UVU^T^'KJ+['<D[L(XW8)((Q]Y3]%:O<*HZUHMCXBTV:P
MU&V2[M)AAXY!^1'H1ZCD5Z^=Y9_:N$]C&W,FI1YE>-XN]I+JGL_)GGY9C?J.
M(]H[V::=M'9JVC[K=')P_!OP-<0I+%HEO+$XW*Z32%6!Z$'=S4*_#/X?VFL0
M60TZSCU,KY\=O]H?S"%/W@N[_.#Z5E_\*+?3]\6B>+]:TBS8_P#'M',2H]0,
M%:Z'P7\*](\&W4E\'GU/5I/O7]\P>0<8POI_/WKY^AE\JE6$)Y52@K^])\C5
MNO*E&[?:]O,]:KBE"$I1QU23Z+WD_G=V];7.EUS1[?Q!H][IMTNZWNHFB?U&
M1C(]QU_"O&/"OQ#F\"_#OQ#I&H.%UG096M;=6_CWDB,CU .X_P"Z!7NM<!XD
M^#>D^)?&EMXAGFD1XS&TMLJC9,R'@M^  /L*[\\P..J3IXO++>U2E!W=O=DM
M_6$DI)>JZG+E>*PT(SP^._AMJ2_Q1Z?]O*Z?R+GPD\)MX1\%VD,X/V^Z_P!+
MNF;[WF/@X/N!@?4&O.?$WA[1-/\ C=.?%%HDND:U K6TTK,J), JG+ CNI_[
M[7ZU[S6/XH\)Z7XRTMK#5;5;B'.Y6Z/&W]Y3V-+,,AA6R^AA,,HMT'%Q4E>,
MN5--2_Q)N[[ZAA,UE3Q=7$5F[5$TW'1J^MUZ-+Y:& /@OX)/(T&$C_KK)_\
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M237R=CB/^%*^"O\ H P_]_9/_BJK?&+37M_A+JEGIJ&**WAB41IDXA1UR/7
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MPT*Y2[C(Z[,@,/IPI/LIK*N-4A^*'Q,\.06Q\S2=*M5U68=O-< QJ?<90_\
M?5>K7UE#J5C<6EPGF07$;12+ZJPP1^1KE?AQ\,['X<6M[':W$EW+=.K/-*H!
MVJ,*O'89/YUX>/RG$5\RC*G;V%3E=3UIW<=.O-[J?E$]/"YA1I8)QG_%AS*'
MI/1_=JUYLSOC=H<U]X0&JV?RZCHLRW\#CJ I^;\,?-_P&N?U#6H?BKXX\'V%
MM\^FVMNNLWBCD!\#8C>X. ?9S7KT\,=S#)#*@DBD4HZMT((P17'?#KX6Z?\
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MZ;IMKH]C#9V5O':VL*[4BB7"J*P='\"P:/XTUCQ$EU))-J2*CPLH"IC;T/\
MP&O8S3(UCJ.#PWLTJ<)IS4?=C;EDG;;1M[;M,\W YF\+4Q%;G;E*-HMZN_,K
M7WU27WG">/?A_)X%FL_%G@VW6VFTU EU91YVS0@<DCN<=>YZ]1SZ1X/\667C
M30;?5+!LQR##QD_-$X^\C>X_7@]ZV:X_PS\-[;PAXDU#4=+O9K>RON9=-VCR
M@WJIZC!S^!QZ8ZZ675<LQWM,!%>PJ?'#1<LK:3BMM=I)>31A4QD,;A>3%/\
M>P^&6]U_*_3=/Y&AK'A7PWXYB\R]LK/5 A:(3*064@X*[U.1@YXS7FGC[X76
M'P]T.Z\1^&-2O-$N[/:XB\\M')E@-O/)//0D@],5T-Y\"],CO)KK1-7U7P]+
M*=S+97!"9SGIU_6B+X)0W]Q%)XB\1:MXBCB;<MM<S%8<^NW)_0BO"S'+\5F$
M9QGE\%6>BJJ:5GTES64]-[6\CU,'BZ&$E%QQ<G36\'%ZKJK7<==KW.P\%:M<
M:]X1TC4;M-ES=6L<L@ P"2!R!Z'K^-;=,BC2&-(XT6.- %5%& H'0 >E/K]
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MF;XT0:QH<'@7Q-)_97C;0A]@DL[QMKW*Q_*K*3]Y@!@C))QNY!KWRO.?BE\
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M'QQ-H0T^)%M+5;#SA!(K%C(K>:N&)V]L_*.>!67_ ,,V_$C_ *+OKG_@&_\
M\DU]%45P0SC&4Z<:2DN6.BO&#M]\3QZ7$F9T:,,/&<>2"LDZ=-V7JXMGPOK'
MPA\76W[3&A^&I/B9J4^N7&DM<1>(FMV$T,8$W[H+YV2/E;G</OGCU^K/A+\/
M_$'P_P!.O[?7_&EYXTFN)5DBGO(C&85 P5&9'R">>HIFH?"&SU#XRZ9\0VU"
M=+VQL#8+9!!Y;*?,^8GKG]X?RKOZZ<RS6>,I4Z2::Y5S>[%>\F]G:]MMM#OS
MOB"IF-"A0C)-<D5+W(KWDVW9J*:6VD6E^(5\\_&#_BU_[0'@7Q_'^ZTS6/\
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M U'_ (F-H ?FMY3'NS@C )B"YS_&*]D^$WPRT_X1^"K7P[ITTEU'%))+)<S
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M.WNDZE<W5GY>^6W$>QM\:R#&6!Z./RH ]HHHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMKZNR[*[=EY*R/1Q&8XK%05.M.Z^6K[NV[\V%%%%>R><%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7Q3^VM_P E4TK_ + L7_H^>OM:OB7]M*0O\5[ ?W=(A _[^S'^
MM ':?'C_ )-3^'_^YIO_ *1O70?L3_\ )-M9_P"PL_\ Z)BK'^/4*K^RQX)4
M XC33<?^ K#^M:G[$LA/P]UQ.RZH3^<4?^% 'T51110 4444 %%%% !1110
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MEBK] *_/_P#:5_TGX]>(U;D-+;)Q_P!>\0H _0"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \]_:"C\WX,^+!S_ ,>>[CV93_2O!/V'Y /$GBA.
MYM(3^3G_ !KZ'^-D/G_"/Q>OIID[?DA/]*^;/V(YMOCO7X<_>TW?^4J#_P!F
MH ^R:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OAW]L>0-\7D _ATV$'
M_OIS_6ON*OA3]KR;S?C-=+_SSL[=?_'2?ZT >O\ [04++^S%H"DC,::?G_OU
MC^M0_L0R ^#_ !&G<7Z'\XQ_A6]^T78^7^S=L(Q]FCL>V,89%_K7*_L.S;M&
M\60Y^[<6[_FKC_V6@#Z>HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *_/_P".?^D?M":VJ\%K^!!GUV1BOT KX!^)G_$P
M_:4U"/[V_7(HNGHZ+_2@#[^HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .;^)5O]L^'/BJ#&?-TJZ3\X6%?)'[%]QY/Q7O8\_P"NTF9,?26)OZ5]
MFZY9_P!H:+J%KC/GV\D6,==RD?UKX;_9+O/LOQKTR/./M-O<1?7$9?\ ]DH
M^\J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@/]J.4WGQVU^->=@MHE
M_P# >,_S)K[\KX ^*A_MS]I#4XOO>;K,5M^3)'_2@#ZN_:2L@_P)\2P(/ECA
M@(^B3QG^E>0?L,W&VZ\8P9^\EHX'T,P_]F%>\?'"S^W?"'Q='C.W39I>G]Q=
M_P#[+7SA^Q'>>7XX\06F>9=.$N/]V51_[/0!]CT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %? -Q_P 37]J0CJK^+0O_
M  $7>/Y"OOZO@#X7G^W/VD--F^]YNM2W/Y,[_P!* /O^BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_/[X3M_PBO[1FE6[?)Y&L2V7_ 'T7BQ_X
M]7Z U^?WQDAD\!_M":M>(I5H-4CU.,@==Q6;(_$G\10!^@-%>?+^T!\.V4'_
M (2S3Q]6;_"E_P"%_?#S_H;-/_[Z/^% 'H%%>?\ _"_OAY_T-FG_ /?1_P *
M/^%_?#S_ *&S3_\ OH_X4 >@45Y__P +^^'G_0V:?_WT?\*/^%_?#S_H;-/_
M .^C_A0!Z!17G_\ PO[X>?\ 0V:?_P!]'_"C_A?WP\_Z&S3_ /OH_P"% 'H%
M%>?_ /"_OAY_T-FG_P#?1_PH_P"%_?#S_H;-/_[Z/^% 'H%%>?\ _"_OAY_T
M-FG_ /?1_P */^%_?#S_ *&S3_\ OH_X4 >@45Y__P +^^'G_0V:?_WT?\*/
M^%_?#S_H;-/_ .^C_A0!Z!17G_\ PO[X>?\ 0V:?_P!]'_"C_A?WP\_Z&S3_
M /OH_P"% 'H%%>?_ /"_OAY_T-FG_P#?1_PH_P"%_?#S_H;-/_[Z/^% 'H%%
M>?\ _"_OAY_T-FG_ /?1_P */^%_?#S_ *&S3_\ OH_X4 >@45Y__P +^^'G
M_0V:?_WT?\*/^%_?#S_H;-/_ .^C_A0!Z!17G_\ PO[X>?\ 0V:?_P!]'_"C
M_A?WP\_Z&S3_ /OH_P"% 'H%%>?_ /"_OAY_T-FG_P#?1_PH_P"%_?#S_H;-
M/_[Z/^% 'H%%>?\ _"_OAY_T-FG_ /?1_P */^%_?#S_ *&S3_\ OH_X4 >@
M45Y__P +^^'G_0V:?_WT?\*/^%_?#S_H;-/_ .^C_A0!Z!17G_\ PO[X>?\
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M45Y__P +^^'G_0V:?_WT?\*/^%_?#S_H;-/_ .^C_A0!Z!17G_\ PO[X>?\
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M0PX\P6=RDVS.<9VDXS@]?0UYK^UU_P FO_%'_L7KS_T4:^+/^".7_(2^*_\
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MG_\ ?1_PH_X7]\//^ALT_P#[Z/\ A0!Z!17G_P#PO[X>?]#9I_\ WT?\*/\
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MG_\ ?1_PH_X7]\//^ALT_P#[Z/\ A0!Z!17G_P#PO[X>?]#9I_\ WT?\*/\
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MG_\ ?1_PH_X7]\//^ALT_P#[Z/\ A0!Z!17G_P#PO[X>?]#9I_\ WT?\*/\
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MWN([<;HX8@Z$'#OO) .?W2]FKDO^";G[2WB^;XM>)/A?\2-?UG5=3O [V/\
MPD%W+<7%M=V^X3V^96++E S;>QB/<UVK"S='VOX',Z\54]F?I/1117$=(45G
MZ_X@T[POI,^IZM=QV.GP;?-N)3A5W,%&?J2!^-<?_P +^^'G_0V:?_WT?\*
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M!KG_ $,VG_\ ?B2OL"B@#X__ .&(-<_Z&;3_ /OQ)1_PQ!KG_0S:?_WXDK[
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MG_\ ?B2OL"B@#X__ .&(-<_Z&;3_ /OQ)1_PQ!KG_0S:?_WXDK[ HH ^/_\
MAB#7/^AFT_\ [\24?\,0:Y_T,VG_ /?B2OL"B@#X_P#^&(-<_P"AFT__ +\2
M4?\ #$&N?]#-I_\ WXDK[ HH ^/_ /AB#7/^AFT__OQ)1_PQ!KG_ $,VG_\
M?B2OL"B@#X__ .&(-<_Z&;3_ /OQ)1_PQ!KG_0S:?_WXDK[ HH ^/_\ AB#7
M/^AFT_\ [\24?\,0:Y_T,VG_ /?B2OL"B@#X_P#^&(-<_P"AFT__ +\24?\
M#$&N?]#-I_\ WXDK[ HH ^/_ /AB#7/^AFT__OQ)1_PQ!KG_ $,VG_\ ?B2O
ML"B@#X__ .&(-<_Z&;3_ /OQ)1_PQ!KG_0S:?_WXDK[ HH ^/_\ AB#7/^AF
MT_\ [\24?\,0:Y_T,VG_ /?B2OL"B@#X_P#^&(-<_P"AFT__ +\24?\ #$&N
M?]#-I_\ WXDK[ HH ^/_ /AB#7/^AFT__OQ)1_PQ!KG_ $,VG_\ ?B2OL"B@
M#X__ .&(-<_Z&;3_ /OQ)1_PQ!KG_0S:?_WXDK[ HH ^/_\ AB#7/^AFT_\
M[\24?\,0:Y_T,VG_ /?B2OL"B@#X_P#^&(-<_P"AFT__ +\24?\ #$&N?]#-
MI_\ WXDK[ HH ^/_ /AB#7/^AFT__OQ)1_PQ!KG_ $,VG_\ ?B2OL"B@#X__
M .&(-<_Z&;3_ /OQ)1_PQ!KG_0S:?_WXDK[ HH ^/_\ AB#7/^AFT_\ [\24
M?\,0:Y_T,VG_ /?B2OL"B@#X_P#^&(-<_P"AFT__ +\24?\ #$&N?]#-I_\
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MGFSO[6T0O)=Q2!6EDB4#+%90S!0,[7/4C!NZBZ2K_%_7_ (U?M/9;'BWP?\
M!O[&=O\ #'3E^('CS5+SQG>6JRWTEO::C&EA,PR8H@EN4;9D*6;>&*DC@XJI
M^Q#\58O@S^UY'X2\*^))?$?P]\17[:8LS1/ MTK _9IS%(H*2*VU3P."X'!%
M2_!']L+X0>#? -CH'Q"^ /AO7=;TR 6RZM:Z-8M)>;>%,XEC!#X'S/EBQR2
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M'4P\Z<-TSKE)0JQG+9HZ'_@K1_R<QI'_ &+%K_Z475>[_P#!5/\ Y-O^&_\
MV%H?_2.6OA+]J+XQ^(_C]\3#XZU_17T&WU*T1=*M"&*"SC9T4I(RCS!O$F7
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M'_\ PQ!KG_0S:?\ ]^)*/^&(-<_Z&;3_ /OQ)7V!10!\?_\ #$&N?]#-I_\
MWXDH_P"&(-<_Z&;3_P#OQ)7V!10!\?\ _#$&N?\ 0S:?_P!^)*/^&(-<_P"A
MFT__ +\25]@44 ?'_P#PQ!KG_0S:?_WXDH_X8@US_H9M/_[\25]@44 ?'_\
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M4 ?'_P#PQ!KG_0S:?_WXDH_X8@US_H9M/_[\25]@44 ?'_\ PQ!KG_0S:?\
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M /OQ)7V!10!\?_\ #$&N?]#-I_\ WXDH_P"&(-<_Z&;3_P#OQ)7V!10!\?\
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M10!\?_\ #$&N?]#-I_\ WXDH_P"&(-<_Z&;3_P#OQ)7V!10!\?\ _#$&N?\
M0S:?_P!^)*/^&(-<_P"AFT__ +\25]@44 ?'_P#PQ!KG_0S:?_WXDH_X8@US
M_H9M/_[\25]@44 ?'_\ PQ!KG_0S:?\ ]^)*/^&(-<_Z&;3_ /OQ)7V!10!\
M?_\ #$&N?]#-I_\ WXDH_P"&(-<_Z&;3_P#OQ)7V!10!\?\ _#$&N?\ 0S:?
M_P!^)*/^&(-<_P"AFT__ +\25]@44 ?'_P#PQ!KG_0S:?_WXDH_X8@US_H9M
M/_[\25]@44 ?'_\ PQ!KG_0S:?\ ]^)*/^&(-<_Z&;3_ /OQ)7V!10!\?_\
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ME]3U[XT_\$N_ 7AOX5ZQK'@G6-<L/$VBV4E]#/?722QW)B0N5<*B[&(& RX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (=U W^E>!O#>F7S$,;JSTBWBE)'0[E0'L/RKL:*XU)K8Z+)A7->*OAGX/\
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M(-2M8[B-7 (#!7! ."1GW-3:'X?TOPOIL>GZ-IMGI-A&24M;&!(8E).20B@
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MM='61596#*PR&4Y!'K5.,HI-K<E3C)M)[#J*CN+B*U@DFGD2&&-2[R2,%55
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M\WZ*9#,EQ&LD3K)&PR&0Y!^AI]9&P444R::.VADFFD6**-2[R.0%50,DDGH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /SW_ &II&7]H#Q* Q S:=_\ IUAK[YT+_D!Z?_U[1_\
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M_88U[['N7Q'IQNL?ZLI($S_O8S^E?4?PU\#V?PZ\%Z9H5G&J_9X@9Y%',LQ
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M.O9TC;)93U!'48H ^@J*\8\'_M+67C2/7-*MO#&L:;X^TNS:[/A'5XQ:W-P
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MPKJGQ"\2V85KZWTHK';V6>BS3M\JO_LX]B0>*=X!_:.MO$'C"+P?XL\,ZIX
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M$[00R/L5Y #M4MV!.!GM0!9HKD_A;J?B[6/!-C=>.='M-!\2N9!<V-C,)8D
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M/+@!F;(SC&$QSZ@5U'[7O[=NO_M/K%X4\/Z9<:#X-\]7%B6WW6H2 _(9MO&
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M4\S5-6MH]3U.]?YI;FXF0.Q=CRV-VT>P]2:]6DC2:-HY$5XV!5E89!!Z@BO
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MF-=A\&O@OJMCK\WQ#^(MS%K/Q$OX]B+'S;:/ 1_Q[VXY ."0SCKD@$Y9F?\
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M/_"?P%\:?!%J]R$TJ.+Q9H</W=0M Q_TA1_SUC'.?09[-N^M?C9_R1GQ[_V
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MHHU"HB#"J ,  =A7SYX*_P"3W/B+_P!BW8_S2O=O#^O67BC0M/UC393/I]_
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M]\J #D.(21QSN!Q0!F?!#]JSPA\+O!MG\/?%D=Q8:[X8C^P3RZ3%_:%I/M)
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M(/3E2: /.OV:KKX=)\-K72_AQJ\&L:;8G%U-\RW,D[?>EG1P'#N03\P' P.
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M' _Y:( "#C.%!YV@-F?L/>([7QA:?%?7[$2"RU7QE>7T E7#B.4*Z[AV.&%
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M((/4$5\]?L=2/H,'Q)\"I(TFG>%O$]U;:>'8DQVSL2J?@0Q^K&O:?&'C[0/
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M1+*FX8.U@",_@:^//VHO!/Q=TGX#^*KOQ+\2M.UW1(T@^TZ?!H,=N\P-Q$%
MD#97#%3^&.]>Y_ _PQ\0]%M+:Y\6>-;/Q'I,NG1"ULK?2DM6@8A2"74DMA<C
M'OF@#D/A-_R>'\=O^O;1?_21:POV??&FA_"?Q]\3_!?C._M]!\27OB2YUFWN
M]2D$*:C:S &-DD; )&UCMSQN..C8W?A-_P GA_';_KVT7_TD6O8?%7@KPC\0
M\V'B'1M)U]K7#>3?01S/#NY!&02N<>V: /FK]MKXK>'?%7PVD\->%=0MO$?B
M2UG35FDTF<3#2XK<EGG>1#MC;^  G)W\#I7T[X!UQ_%'@7PYK,AW2:CIMM=L
M<8R9(E<\?C7SQ^T0/"?A_P $R_"'X<:/I%OXO\73161TW2(4C,$._=)<7&P<
M*%4C+<\D]%-?05I=:'\-_#_A_1KW5K33X(XX-+LC>SI$;AU0*B+N(W.0O0<T
M ='1110!RWQ5N+BU^%_B^:S@EN;N/1[QH88$+R22"%]JJHY))P !ZU\[? _]
MHK0?A7\(?#'AW7?"GC339-+L5CNKJ70)?($F2SX8<XR3SCH*^E/&WCK0OASH
M$FM^(]1CTK2XY8X7N902JM(X1>@)ZL,GH!DG !-:&EZYINNV*WVFZA:ZA9,-
MRW%K,LL9'J&4D8H Q?A[\3?#'Q6T(:QX5UB#6+'=L=HLJ\38!VNC ,C8(X(%
M=17S%\%YM)U?]KKXF:GX,:&7PM_9-O#J,]CC[-+J7F Y4CY2=HER1GDL>]?1
M>B^)=(\2+=G2=4L]3%I.UM<?8YTE\F5?O1OM)VL.X/- &E7PMX5^#,_Q-\4?
M&K5_#MU_9'C[P]XUN+S1-34[?G#.3"Y[QOC!ST..HW _=-?./[*/_)0?CS_V
M.-Q_Z$] 'H'P#^-$/QB\*2O=6W]E>*M)E^Q:WH\@*O:7*Y!^4\[&()!]B.JF
MN&_9)_Y#WQO_ .Q_U+_T(4GQ\\ ZSX!\50_&CP!:F;6]/B\OQ!H\>0NKV(QN
M.!_RT0 $'&<*#SM ;,_8>\1VOC"T^*^OV(D%EJOC*\OH!*N'$<H5UW#L<,*
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M:M=2K;3G:U[;2,'2>,G[X(.>.<%3WH X[]J*Q^)_PQ^#WB.VU7Q$/B'X.U2
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MX8;^V=(TOQ1 ;K7;;Y[-KAL;8(I1P[!=S-MR!E>>N/0/VK(UF\0_!-74,O\
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M0!Q7[,O@&\^&?P,\*>'K^[AO;NW@DEDEMI1+%F65Y=J,.& #@9'!QD<5P/[
MW_) 4_["][_Z&*E_8CD>3X>^*19-.WA%/$U\GASS]W_'@&79L+<E,[O^!;JB
M_8&_Y("G_87O?_0Q0!]'5X'^U9K%WXCL_#/PIT:9HM6\;7H@N9(QEK?3HL/<
MR>W  YZC>*][9@JDDX Y)-?'G@WP[X\^/GQ0\2?%WPCXKLO#&G1RR>']%DO-
M+%YYUE$PW2QAB H>3<<]<EAP.H!UWQDTNU^ 7Q(^'GQ(TF 67AR&./PGKL4?
M"1V38%O*WM&PY)Y.$%>[>/+#7=8\%ZO:>%]3ATC7Y[9EL;^9!)'#(1PQ&#Q[
MX.,YP>E>&>-O@+\8_B%X5U'P[KWQ6T>^TF_C\N> ^&HUW $,""&R"& ((Z$"
MN@_9C^)S7GPEN].\77D6GZ[X(FDT?6I;R4(J"'A)F9L?*4 ^8]2K&@#U;P+I
M^N:5X/T>S\2ZE%J^OPVR)>WT$8C2:4#YF P./P&>N!TJ?Q9KZ>%/"NLZW)"U
MQ'IME->-"GWG$<;.5'N=N*NZ=J5IK%A;WUA<PWME<()8;BWD$D<B$9#*PX((
M[BH];U*PT71[V_U6XAM=,MH7EN9K@@1I& 2Q8GC&,T ?.GPQTGXI_&[P1I_C
M:?XM-X<75D,]KI6AZ3;RV]HFX@(SR99V&.<G@Y'->JZ-;>-?"?PR\0?\)5XB
ML]?UJT@N9+75+.R%JS1K%F-I(P2N_<"3M 7H.>M<):_LS^"M1CEUSX;^+]<\
M&07C?:%?PEJ__$OD8@<F+YD*]/E&!]*A^ /B[Q+\1/#_ ,2_!^OZU;^)FT*\
MET>U\2V\2QB]5XV'S*OR[DXSC^\.N,D [+]F'Q9JWCKX#^$M=UV];4-6O()'
MGN755+D32*#A0!T ' [5G?&3QMK?AOXN?![2=-OWM=.UK4KN'4(%52)T2%64
M$D$C!)/&*P_V)/$UE>_ O2?#C2K!X@\.RW%AJ>F2'$]M()Y"-R'D @CGID,.
MH-<O\:/B%I7B+]JSX,^'-,NH[VXTB^NI;]X3O2&22(!(BPX#X1B5Z@%?6@#K
MOVL/BOKGPCL? >IZ+]HG%QXABM[K3[8+OOHC&Y\@%@<;F"C(YIMK\,OC1XIL
M6U;5?BN?">K7(\V+1=)TBWGM+#/(B9W^:8CH6R,\]1BN?_;AUP^&;/X5:P+2
M2_\ [.\86EY]EA0N\HC5W*J!U)VX%>_^%?&VA^-?#-MXAT74[>_T>XB\U+J-
MQM"XR=V?ND=P<$8YH \R^!OQ7\2ZMXJ\0?#SX@6UK!XVT*-;E;NQ&VWU*S8@
M+<(O8Y*AATRPX!R!YZ/B=\4/%GQY^)'PZ\*WL=LMO<VLD>N7T"2PZ):^2I?9
M%@>;)([#:K$C@]N1L?#76K;XN?M:^)?&N@-]I\+^'_#R^&_[2CSY5W=&X\Y@
MA_C"@D$CT4]"">>^&?Q,T?P3^V'\7]'UF5;!->N=/CM+Z8;8?M$=N2(2_16=
M78J">=A YQ0!U'B[PG\:OA3H\OB;0OB"WQ!73X_.O?#VL:9##]IB7ES%)'AE
M< '"]_<@ [GQ-\?:=\4/V0_%'BK2MPL=3\.W,R(^-T;;&5T;'=6#*?<&N\^+
MGQ4T'X/^";_7]=NHH8XXV%O;,?WEU+CY8D7JQ)Q]!DG !->#^&_!6I> /^"?
M.JZ3J\3V^H'P_?W4EO("&B$S22JI!Z$*ZY'8YH [^/XJ6?P;_95\*>)KNW:]
MEAT#38;2QC.'NKAX(UCC'U)R3@X )P<8K-TOX9?&OQ/IJZOK7Q8_X1;6+E1*
MNC:3H]O-:66>1$6D^:0CH23^)')X[XV^$[_Q-^Q;X$N]/BN+B30;+1]9EAM'
M9)GABMU$FPCD%5<OGMLSVKMO _PP\(_$;PQ:>(/#_P 3/'NH:9<('$L?B^[)
MC.,E'&_Y6'=3R* -SX)_$_Q!K6O>(_ GCF"UA\:^'?+DDN;'(M]1M9!^[N(U
M/W3V9>@)'3.!YQ:?$'XH>-/CU\2_A_X:U>#3+.PN+69=<O;9)UTJW,*DQQ0X
M DDD=B1O. $;VKT+X/>!? -CXX\0:_X9\5:EXK\06<0T;4;C4=9DU!H5W+((
M]SD]".QP#O'4$5@_ F-?^&COV@)-HW_;-)7=WQ]FDXH YWXE:M\5/V:+.T\;
M:AXW?XB^$(KF*'6M-O--@M9X8W8()86CQSN8#:2!DKG(R1M^&_#/QC^+FCVW
MBN\^(?\ PKVVU*);G3_#^EZ5#<_9H6 :,S2R\NY7!*\ $]N0-C]MC_DU_P <
M?]<[7_TKAKU_PW&L/AW2XT4*BVL2JHZ !!@4 >2? /XE>*]3\4>,/A[X]>UO
M/%7AAX7&J6<0BCO[65=T<A0<*WK@ ?,!C(.<WQ1X\\:_%CXHZUX#^'FK6_A?
M2O#JQC7/$\ENMS+Y[@D6UO&WRY SN8]"#TP-U?P5_P GM_$7_L6['^:5Y[X7
M\$Z3I/[27Q'\+>*/%/B3PM?:]J UO1&TO7)]/@U&.7)=!L8!Y$8[0.ORMC@4
M =QXPN_BC^SK9KXMO_%[?$GP9;R(-8L+VPBMKVUA8A3/ \> ^TD$JW&/Q8=+
M^U1\2M1\#_ 2[\6>&-2:WF$UE)#=VZJV^&29,XW C#(Q[=ZR/B!\&_ /AW1Q
M;^,?B1XPM]-U)ULOLVJ>+;EH[DR':(RC,=P.>>, 9)P 35']LK0;3P[^RG/H
MMHKFQL7TVSA61MS>6DT2+D]S@#F@#2TWP7\9/B38Q>(=0^(W_" "]19[3P_I
M.DPW(LXVPRB:67YI)-O# 8 .<<<5H? ;XE>++[QAXL^'7C]K6\\4>'!%/'JU
MG$(H]0M91E)"@X5AQD  ?-C&02?;54*H & . !7SUX5_Y/D\;?\ 8IVO_HV.
M@#SO5/ACXN'[7&F:2?B?K!U.3PG)=)K/V*V\Z.+[4P\@)LVE<_-DC.:^H= T
M+Q!X7\$36+ZZWBG7XHYF@O\ 58UA$LAR8UD$0 "@X&0,X'K7D?B2\ATS]N3P
ML]U(L"7W@V:TMFD8 22BY9R@SU.T9Q7IOQH\:7W@7X3^+_$.C1I=ZGI5C+-%
M'C>$D"YRP]%!W$>@H X*'X4_&;6[4WNK?&1=&U23YUL-$T*W:RMFR/D#2?/*
MHQU8@\_GI?L]?$SQ'XJN?&'A'QE]FF\5^$+Y+2ZOK--D5Y%(I:&8+_"S!6)
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MS#3-8M)+*Y-NX23RW4JVTD'!P?2M^BI3:=T/?1GQS_PZI^"?_/7Q-_X,8_\
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MN0\,_L?_  A\)ZI'J-GX-MY[N-@T;:A<37:IC[H"2NR\<8XSP.:]DHH 0 *
M ,"N>LOA_H&G>-]1\7V]AY?B+4+:.TNKSSI#YD28VKL+;!C Y !KHJ* "O,O
MB'^S7\-_BGJXU7Q'X7@NM5QAKZWFEM9GX ^=HF7?P,?-G X%>FT4 <G\._A3
MX2^$^E2:=X2T*VT6UD8-+Y.YI)2,X+R,2[XR<;B<9KK*** *6MZ-9^(M%O\
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MM\/'5M2AMUM4F^W7,.V-69@NV.15ZNQSC/->F44 >#_\,,_!'_H2?_*M??\
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M:^&/A?HYTOPKHEKHMDS;G2W7YI&Z;G<Y9S[L2:C\"_##PQ\-%U4>&M)CTO\
MM2[:]O-CNWFRMU/S$X'HHP!DX%=310 5S?A/X=^'O ^H:]?:)I_V*ZUV\;4-
M1D\Z23SYV))?#L0O4\+@>U=)10 5S'@?X9^&?AK'JD?AG28](BU.[:^NHH7<
MHTS  LJL2$& /E4!1C@5T]% &/XJ\(:)XXT>72?$&E6FLZ=(<M;7D(D3(Z,
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M7!^&/V7_ (9^$=2M;_3_  T'N;0[K5KZ]N+M;<XZQK+(P4C)((&03G->J44
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ME]%X+AFDC;?'%=7EQ/"O.2/*>0H1GL017L\$$=K#'##&L4,:A$CC4*JJ!@
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M_2=1A^T:??V\EK<0[F7?&ZE77*D$9!(R"#5VB@#P?_AAGX(_]"3_ .5:^_\
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M9$9'4,K#!5AD$>E.HH \;UK]C_X0Z[J4E]-X-M[2YD8L[:==3V:G/4;(I%4
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M$96&<#(!P<#(.*L> ?A;X7^&/A^?1?#>E)8:;<2M//"TKS&:1@ S.TC,S$@
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MKA?'G[*_PN^)GBB[\1>)?#']I:S=!!-<_P!H746X(@1?ECE51A5 X':O6**
M/!_^&&?@C_T)/_E6OO\ X_7I?@'X4^%OAC_:9\-:7_9[ZE*LUW(]Q+.\K*NU
M<M(S$!1P%!P,G KK:* "N;\0?#OP]XH\3:!XAU+3_/UK07D?3KQ)I(GA,@"N
M/D8!@0,%6!'7CDUTE% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
3 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img6467664_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img6467664_0.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" :8"[@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7Y^?\%C?^20^ _P#L.O\ ^D[U^@=?GY_P6-_Y)#X#_P"P
MZ_\ Z3O0!^3E?T;?!S_DD/@?_L!6/_I.E?SDU^YGQ&_:D\-?LM_LQ>"M9U4K
M?ZY=Z%9Q:3HJ2!9;N46R<GNL:Y!9\<9 &20" ;G[7_[7&@?LK^!3=3>5J7B[
M4$9='T;=S(PX,LN.5B4]3U8_*.Y'X=?$+X@Z_P#%3QEJGBGQ/J,NJ:WJ4IFG
MN)3^2J.BJHP%4<   =*M_%;XJ>)?C1XZU/Q=XLU!M0UB_?+-C;'$@X6*-?X4
M4< ?GDDD_7'_  3Y_80D^,VH6OQ"\>6+1^ [27=9:?,I4ZO*IZD?\\%/4_QD
M;1P&H ZC_@G7^P7_ ,)I-IWQ3^(NGY\/1L)]$T6Y3_C_ &!RMQ*I_P"6(/W5
M/WR,GY,;_P!5^G IL,*6\*11(L<2*%5$&%4#@ #L*?0!^0G_  5A^.6H^+/C
M3#\.+:XEAT'PO!%+<6ZN0D]Y-&LOF,!P=L3QJN>A,G]XU\=?#7X=:[\6O'6C
M^$/#-I]NUO59O)MX2P5> 69F)Z*JJS$]@IKW/_@H_P"&[KPY^V%XY:X240ZB
M;6_MI) 1YD;VT8)4]P'5TX_N$=J\Y_9C^-S?L[_&SP[XZ_L[^UK?3VECN+,,
M$:2&6)HWVL0<, ^X>I&#P30!]Z>#O^"-VB1Z;;MXK^(E_/J!YFCT>S2*)>/N
MJTFXG!_B*C/H*C\7_P#!&O2I+61_"WQ)O+>Y7)2'6-.25'] 7C92OUVGZ5]5
M_"W]N+X*?%JWA.E^.=/TR^DP#INNR"PN W]T"0A7/^XS"O=+>XBNH4FAD2:&
M0!DDC8,K ]"".HH _$S5O^":_P 8?#'Q/\-^&]3T=;_1-6U"*U?Q%HKFXM;>
M,M^\DDRH>/:F3\Z@$C )-?M1H.AV/AC0].T?3+=;33=/MX[2VMT^['%&H5%'
ML  *OT4 ?GY_P6-_Y)#X#_[#K_\ I.]?DY7ZQ_\ !8W_ ))#X#_[#K_^D[U^
M3E ']%GP'_Y(?\//^Q=T[_TFCKNJX7X#_P#)#_AY_P!B[IW_ *31UW5 !111
M0!RGQ8\"_P#"T/AAXL\'_;O[,_M[2[G3?MGD^;Y'FQLF_9N7=C=G&1G'45^>
M_P#PY>_ZK%_Y;'_W97Z9T4 ?F9_PY>_ZK%_Y;'_W97RS^UY^RQX:_97U/3M"
M@^)7_"8^*K@>=<:7#HPM5LX"/E>23[1)AF.-J;<D9)(&W=^I'[:W[8&E?LM^
M!=EH8=0\=:M&RZ3ICG(C'0W,P'(C4]!U=AM' 8K^'WB;Q-JOC3Q%J&N:W?3:
MIK&H3M<75W<-N>61CDD_X#@=!0!6TK2[S7-4M-.TZUFOM0NY5@M[6W0O)+(Q
M"JBJ.222  /6OW"_8+_9:O/V8?A//;ZW=>=XIUZ6.]U*WC8-%:$*0D*D?>*@
MG<V<%B<< $^3_P#!.G]AQ?A1I=I\3/'-DK>,[Z'?IFGSKDZ5 X^^P/2=U//=
M%..I8#[QH \Z_:$^,5C\ _@[XF\<7T8G_LRVS;VQ_P"6]P[!(8_7!=ER1T&3
MVK^?SQUXXUOXD^+M5\3^(KZ34M:U.=KBYN)#]YCV [*!@!1P  !P*_33_@L;
MX_N=-\#_  _\&P-MM]5OKC4KG:<$_9T1(U/J";AS]4'I7Y7=>!0!]&_LH_L.
M^-/VJ'N=0LKF'PYX3M)?)GUR]B:0/)P3'#&"/,8 @GE5&>6S@5]#_$?_ (([
M^(-'\/37O@OQY;^(]4ACW?V9J.G_ &+SR!R$E$K@$]@P ]6%?HI\!_AG9_!W
MX.^$?!UE"L*Z5IT44VT?ZR<C=-(?=I&=C_O5WM '\TVM:+?^'-8O=*U2TFL-
M2LIGM[FUN$*20R*2K(P/0@@BOT<_X)._M-7O]K7/P;UZ[>XM)8I+WP^TAR86
M4%Y[<'^Z5S(H[%9/[U>;?\%:OAK:^$?V@M+\2V4*P1^)]+6:Y"C&ZYA8QNWI
MS'Y/X@GO7RW\!_']S\+?C/X+\5VK;9-+U6"9QG >+>%E0GL&0LI^M '[&?MG
M?L4?\-=W7A*;_A,O^$3_ +!2Z3;_ &7]M\_SC$<_ZZ/;M\KWSN[8Y^+/CU_P
M2S_X4C\(?$_CG_A9W]M?V+;"X^P?V!Y'G9=5QYGVEMOWLYVGI7ZXUX%^WI_R
M:%\3?^P<O_HZ.@#\%J_:;_@E7_R:3I__ &%[W_T-:_%FOVF_X)5_\FDZ?_V%
M[W_T-: /L"BBB@ K\K_^"RO_ "//PT_[!UY_Z-CK]4*_*_\ X+*_\CS\-/\
ML'7G_HV.@#\\M,LCJ6I6EH'\LW$J1!B,XW,!G]:_1?\ X<S:S_T5*Q_\$S__
M !ZOSS\+_P#(S:1_U^0_^ABOZ4J /RHU3_@C;XOA5_[.^(VB73;,J+JQF@!;
MT.TO@=.>?I7S%\>OV+_BK^SK;F_\4:$MSH6X)_;>DR_:+0,3@!C@-'DX WJN
M2<#-?OI574],L]:TZZT_4+6&^L;J-H9[:XC$D<L;##*RG@@@D$&@#^:_1]9O
M_#VJ6NIZ7>W&FZC:R"6WN[25HI8G'(964@@CU%?LK_P3S_;,E_:*\*W'A;Q7
M.A\?:'"KR38"_P!I6H(43X' =20K@<996'WB!^<W[=G[.MO^S?\ '>^T?2(V
M3PQJL"ZII*LQ8Q1.S*\))Z['5P,Y.W83R:X7]F?XJ7'P7^._@OQ;#,T4%EJ,
M:W@5L;[60^7.I^L;-U[X/:@#^ABBBOS<_P""@'_!0K5/"6O:A\,_A=J"6M[;
M P:SXBMSNEAEZ-;V[=%91PS]03A=I4F@#[F^(_QZ^'?PA,:>,?&6C^'YY.4M
MKNZ43L,9R(AER/?&*\PM_P#@HA^SS<WQM$^)-J)1_%)IUXD?;_EHT(7OZ^OH
M:_#+.H>(M6'_ !\ZIJ=Y+C^*::>1C^+,Q)^IKM]0_9S^*VDZ.-5O?AIXNM=-
MVES=3:)<JBJ!G<24X7'.3P: /WZ\ _%#PC\4M+_M'PAXDTSQ'9C[\FG722^6
M3V< Y0^S &NHK^;/P?XSUWX?^(K/7?#>K76BZQ:.'AO+.4QNISTR.H/<'@C@
M@U^R/[!/[;B?M,:%<^'?%)M;+XA:7'YDBPKY<>HVXP//1?X6!(#J..01@'"@
M'LWCK]J;X3_#/Q-=>'O%/CG2]#UJU"--97;,KH'4.I^[T*L#^-1^#/VL/A#\
M0O$UEX>\.>/]'U;6KTLMM9P2G?*54L0,@<X4G\*^+O\ @K]\$?/L?"WQ4T^W
M^> _V+JK*/X"6>WD/T/FH3_M(*_-[P1XPU'X?^,M$\3:1+Y.J:/>PWUL_;S(
MW# 'U!Q@CN"10!_2717-_#?QYIOQ0\ ^'_%ND/OT[6;**]A&<E Z@E&_VE.5
M([$&NDH XGXF?&OP-\&H+";QMXGL/#<>H,Z6IO7*^<4 +[0 <XW+GZBN)L/V
MU?@=JE];V5I\2=%N;NXD6&&&-W+2.Q 50-O))(%?EG_P4H^-W_"WOVDM3TVR
MG\W0_":G1K8*?E:96)N9/J9,IGN(EK3_ ."8'P1_X6E^T1!XBO8/-T7P;&-3
MD+#Y6NB2MLGU#!I!_P!<: /VEJMJ&I6FD6,U[?W4-E9PKOEN+B01QQJ.[,3@
M#ZUP7[0'QT\/?L[_  QU/QCXBDW16X\NTLE<++>W# ^7"F>Y())YVJ&8\"OP
M\_:%_:D\>_M*>)'U'Q5JC)IT;$V>B6C,EE:+VVIGYF]7;+'UQ@  _8SQ'^WI
M\ ?"LTL5[\3-*E>-BC?V?'/>C(..#!&X(]QQ6EX+_;2^"'Q OH++1?B1HKW=
MQ@10WKO9LY(&% G5/FYZ=>U?AEX(^$7CGXE!SX3\'Z[XE1&V/)I6G37"(W'#
M,BD+U'4]Q6=XM\!^)? -\EEXG\/:KX<O) 62WU:REM9& ."0LB@D9H _I(5@
MRAE(*D9!'0TM?A[^Q_\ MV>+?V;]<LM(U.ZFU[X>33*MUI4[%WLT)P9;4D_*
MPZ[/NMSP"=P_;#PWXDTSQAX?T[7-%O8=2TG4($N;6[@.4EC895A^!H _,O\
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M_"ZP\6Z*1;W!_<:EIK/NDL;H %XR>XY#*W=2#P<@>3_\%/O^3.O%7_7Y8?\
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M" QX_P!S;GT_BKD?V"?^"@_@/X??"O1OAM\09)?#LFDM)'9:RL+2VT\<DKR
M2!%+1LI?;G!!&"2#FOT,\$_%'P=\2;7[1X4\4Z/XCBQN)TN^CN"O^\%8E3['
M% 'Y<?%3_@D/\0?#-M/=^"/$NF>,XHP6%E<QG3[MO]E0S/&Q]RZ_2O>O^"6?
M[,VM?"?1O&'B_P 8Z'=:)XDO[C^R+6TOX3'-%;1$-(P!'W9)"O/0^2".#D_>
MM% &/K'C+0/#MTMMJNN:;IEPR"18;R[CB<J20& 8@XR",^QK\ OVIKR#4/VE
M/BE<VLT=S;3>)M0>.:%PR.IN'(8$<$$=Q7TK_P %@?\ DY;PU_V*-M_Z67M?
M#- 'W#_P22\0:7X=^/?BJXU74K33('\,RHLMY.L2LWVJV.T%B 3@'CVK]9+3
MXB>%-0NHK:U\3Z-<W,SB..&'4(F=V)P% #9))["OYNJ]7_9/_P"3GOA1_P!C
M1IO_ *4I0!_0?7BVK?MG?!'0=5O=,U#XD:+:W]G,]O<022-NCD1BK*?EZ@@C
M\*]IK^=/X\?\EP^(?_8Q:C_Z4R4 ?OI\,?C=X$^,T>HOX)\3V/B1=.,8NS9,
M3Y)?=LW9 Z[&_(US_P 1/VKOA#\*;^2P\4?$#1M.U"-BDME',;BXB([/%$&9
M#_O 5^'WPW_:&\8?"/X?^+_"WA._?15\42VS7VHVKLETL<(E BC<'Y WFG<1
MSA0,@$Y\T9FD8LQ+,QR6)R2: /Z0OA]\0- ^*G@[3/%7A>__ +4T'4D:2UN_
M)DA\Q5=D)V2*K#YE8<@=*UM7UG3_  _IL^H:I?6VFV$"[I;J\F6**-?5F8@
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MJI''4'T]17X9:3H^I^)M4BL=+L;O5M2N"?+MK2%III#@DX5023C)KKO$_P
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MS<0$K)'I_F7Q5AU'[A'Y'I]?2D\&_MQ? GQY>16FD_$K1UN)>$34O,L-QSC
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MX;^Q;\$?^%!_L[^&/#MQ!Y.M7,?]IZKD8;[5, S*WNB[(_\ MG7N5 !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM_*UKQE,+T%EPRV296W7Z-F23W$B^E 'V?1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPJC.22>K,222Q))))))- &]7@7[>G_)H7Q-_[!R_^CHZ]]KQ;]L[PQJWC/\
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MF.X6SN&FOKA#P4:?"[4(ZJB@]06()%>+?\,>_&__ *)5XK_\%<O^%>C^ _\
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M SXA?%/XO^$]0\(>#=:\265OH0@FN--LWF2.3[1*VTE1P<$''O0!\,_LO_\
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M&&888="<%3S7Y;_%K_@EC\8OA_-+-X<BL?'VE@G;+IDH@N0OJ\$I'/LC/UH
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MF ]N0!GT'2F^#?\ @C?XHN+Y#XK^(.D6%F "ZZ-:RW,C>J@R>6%_WL'Z4 ?
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M=%8>A%?MA_P4@^"B?%[]FG6KVWB5M:\*YURT?H3'&I^T)GT,6YL=VC2OP_H
M]!^ 'PFO/CE\8_"O@FSWK_:MXJ7$R#)AMUR\TG_ 8U<^Y '>OZ&='TFST#2;
M+2]/MTM+"R@2VM[>,86*-%"HH'H  /PK\W_^"07P0\FU\3_%74;?YIC_ &+I
M+.O\(*O<2#ZGRT!']V05^EE !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %?ES_ ,%F?^1F^%O_ %YZ
MA_Z'!7ZC5\/_ /!1G]DOX@?M+ZUX&N?!-O83Q:1;W<=U]MNQ 09&B*XR.?N-
M0!^4'PO_ .2E^$O^PO:?^CDK^C^OQS\$?\$P?CCH/C30-3NK#1!:V>H6]S*5
MU12=B2*S8&.3@&OV,H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BOCW_@I9^TEX@^ /PO\.6W@_5FT;Q3KFI$1W4:([):PIF4@
M.",EGA'3H37@.A^'?V__ !!HNGZI:>()/LM];QW,/G7.F1OL=0R[E*Y4X(R#
MR* /U HK\S/^$&_X*#?]#!_Y.Z7_ /$U[-^R?X1_:NT_XK?:OC-KS3>#X;"8
MK;B>RD\ZY)58U(A&X8!=L]/E]Z /LVBBB@ HHK\K/BU^TE^T'\3/VQ/&7PY^
M#_BF>W@M+V:SL]-1+58H_LT06=C)*G&7CD/)ZM@=J /U3HK\S/\ A!O^"@W_
M $,'_D[I?_Q-4[S4O^"A'P^5[J>*YURRAS*\<,&E7WF +R L8,WX+@DCC- '
MZ?T5^>W[,O\ P5#D\3>,+?P3\8M%MO"^K33"TCUFW1X($GS@)<Q2$F(DX&\'
M )Y"CD?H30!6U+4[/1K">^U"[@L;*W0R37-S((XXU'5F9B  /4U#H>OZ9XFT
MV+4='U*TU;3Y<B.ZL9UFB?!P<.I(.#[UX=^W%\!_$O[1?P(NO"?A748+'55O
MH+WR;J1HX;M(]V878 XY97&1C=&N<=1A_L"_LR>(_P!F'X5ZII/BG4K>[U;5
MM0-\]I8R-)!:+Y:H%#$#+G;EB!C[HYQD@'TY1110 4444 %%%% !1110 444
M4 %%>*?#O]K[X=_%/XO:S\-_#USJ%WXDTEKI;K=9E;<>1)Y<C"3."-Q ![Y%
M>UT %%%% !1110 4444 4=;US3?#6DW6J:OJ%KI6F6J&6XO;Z98884'5G=B%
M4>Y-9_@_Q[X9^(>FRZAX5\1:3XFL(I3!)=:/?17<22!0Q0O&Q 8!E.,YPP]:
M^;O^"GGC3_A$?V1O$-JDGE3Z[>VFE1MGGF3SG ^L<#CZ$U:_X)H^"_\ A#_V
M1?"LKQ^7<ZU/=:K*,==\I2,_C'%&?QH ^I:*** "BBB@ HHHH **\4N/VOOA
MW!\?%^#RW.H3^-#.MOY4-F6@#F$38,F<<(>?0@CM7M= !1110 4444 %%%%
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MO%NJ^,M1L_M>M)!;PZ7IT[2QHL9<^9(Q !8EL #.!GGG ^T* "BBB@ HHHH
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M^T)\7/A%?S$^3YKJK]#-9W)@<K[LLN?<(/2@#].:*** "BBB@ HHHH ****
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MPCT>WT/PC\2K2SCMM9FOO[%O[B/@W*&)Y(2X[E!%(-W7! / 7'V3^R!XNO\
MQU^S'\-]9U25I]0FT>*.:9^6D:/,6]CW+;,D]R37Q)_P5M^+EIXLUSP7\)-
M<ZIK%K=?VA?VMJ/,9)Y%\JVAP.?,(>0[>N'3^]7W]\!?A\_PI^"W@GPC,=US
MI&DV]K<,#D&8(#*1[;RV/:@#S/\ :@_;:\)_LLZ_H&C:YHNKZW?ZQ ]Q''I2
MQ$QHKA!N#NOWCG&,_=->U^,/%7_"'^!M9\23:?<7G]EZ?-J$EA;E3-((XS(8
MTR=I8[2!SC/>OS%_:JS\:O\ @I]X+\(#_2+32+G2M/F0<J8E/VR?\=LK@_3V
MK]5+B".Z@DAF1989%*.C#(92,$$>F* /$_V6_P!K3PQ^U=H^O7_AS3M0TI]&
MN(X+BVU(1^9B12R.-C,,':X^JFO<*_+'_@G/</\ !+]L_P")OPJN7*07"W=G
M!N/,LMG.3$?<&%IF_*OU.H *^<OC_P#MP^$/@+\1]$\!R:-K'BSQ5JBH5T_0
MTC=XFD<+"C;W7YW).%'.,$]1GT?]H/XW:-^SW\)];\:ZT1(EG'LM+/=M:[N6
MR(H5_P!X]2,X4,W0&OB;_@G+\$=9^+7C[7/VD/B*IO=1U"[F_L83+\KS$E9;
ME5/1$&8HQVPW3:IH _1JUDDFM89)H3;RNBL\+,&*,1RN1P<'C(KYO^,__!0S
MX,?!34)=-O-=G\3:Q#(8Y]/\-1+=/"P."'D9TB!!SE=^X8Z5X3_P44_:H\3-
MXNL/@-\+I+L>)]3:*+5;C3SMG;SP/*LXVZJ65U9V&/E*C."U>D?LS_\ !-?X
M<_"+0[.^\::99^//&+#S)YM0C\VQMV(_U<4#?*P']]P23R-O0 '"P?\ !8OX
M<MJ!2;P/XHCL>/WT9MFD[9^0R >O\78=.WTW\!OVM/AG^T=')'X.U[S-5AC\
MV?1[Z,P7D2YQNV'AU&1ED+ 9&3S74:I\!_AKK>GK8ZA\/?"UY9J-JP3:-;LJ
M#_9!3CH.GI7YF?MS?LJ?\,?>*O#/Q:^$UU=:'I)U 1^2)S(VFWF&=/++99HG
M17!5MV-I!)#@  _6VOB_XP?\%1/ 7PC^(7B7P;/X8U_4]2T6X>SDN;;R/(>5
M1R!F0-@-P>.QKZ-_9\^*T7QP^"_A'QQ%$L#ZQ9+)/"ARL<ZDQS(/82(X'L*\
M<_X*#0^&_!/[+'Q UI-"TM=9U"..RBNOL<0F:2XF1';?MSNV-(V<YXH _./]
MB7]JWPU^S?\ $;Q?XQ\7:3JNNZEK-I]FB?31%E=\PEF+;W7JR1],]#7Z%_ /
M_@H]X-_:$^*6D^!M"\)^(K*_U!9G%U>"#R8ECB:0EMLA/.W:,#JPKD_^"7/P
M=T)?V88]=UG0M/U*YUW5[JZBFOK2.5A#&5@"@L#QNAD/U8U]D:5X(\.Z#>"Z
MTW0-+TZZ *B>ULXXG /4;E4'% &W7CWQS_:T^&'[.\31^+_$<4>K>6)(]%L5
M^T7T@/3]VOW ><,Y53CK7#_MY?M6?\,Q?"M#I)5_&GB R6NCJRAE@V@>;<L#
MP1&'7 .<LRY!&:^</V._^"?-O\3M+A^+'QQDOO$6HZ]_IUKHM[-(&=6.5N+I
MP0SLXPRID *1NSG:H!UUY_P6*^&J7RI:^"O%4UGSNFF%M'(..,()6!Y_VJ][
M^ ?[<GPG_:*U%-)\.ZO<:9XA=69-%UN$6]S(!UV$,T<AQD[4<L "2,5Z-9_
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M[F;9CZXMA^?O7M?[+G_!/+3=0L;?XA?'2*7Q?XUU5([H:/J+-Y%@NT!(Y4!
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MK%DV^SU"VBNX&/>.1 RG\B*T*\"_8-\:?\)U^R3\.+UGWS6FG?V7(#U4VSM
MH/\ P&-3]"*]WN[N#3[6:ZN9H[>VA1I)9I6"HB@9+,3P  "<T >-?M0?M8>$
MOV5?#VD:EXD@O-2N=5N6@M=-T[89W55S)+AV4;%R@)SU=:[_ $'X@1:G\,;;
MQKJ6F7F@6LFF?VK-8WX47%M%Y9DQ( 2 VWDC/'0]*_.3X;V<_P#P4._;>O\
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MF?\ X)K_  Y^$6AV=]XTTRS\>>,6'F3S:A'YMC;L1_JXH&^5@/[[@DGD;>@
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MG&06/<FOI#PQX0T'P3IIT[P[HFG:!I^_S/LFEVD=M%NP!NV( ,X51G'0#TH
MUZ**\?\ VJ_VAM._9E^#VI>+[N%;S4&<66EV+' N;MU8HK'LH"L[?[*'')%
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M<F4G/KB"0?B:^WOVX?&G_"!_LG_$K4@^R6;2VTZ,CKNN66WX]QYI/X5\"?\
M!/']K;X5?LS_  Y\2VGB^ZU*'Q!J^J"8K9V+3)]G2)5CRP/7<TW'N* /UNHK
MX_\ ^'JGP&_Z"&N_^"I_\:/^'JGP&_Z"&N_^"I_\: /L"N?\?^.M&^&7@O6?
M%7B"Z%EHVDVS75S-C)"J.BCNQ.% [D@=Z;\/?'6F?$[P3HOBO1?/_LG5[9;N
MU-S$8Y#&WW25/3(Y_&OB'_@L!\3)] ^%7A'P3:RF/_A(K^2[NPI^]#;!"$(]
M#),C?6*@#P'X?>"_%_\ P4^_:*U;Q)XFNKW1OAWH[8V0ME;. G]U:09^7SG
MW.^#W)'W%K]5/AK\+O"WP?\ "EIX;\(:+;:)I%LN%AMU^:1N[R.?F=SW9B2:
M\V_8G^$EO\&?V:?!>C*BB_O+1=5U"11R]Q< 2$'UVJ4C'M&*]SH ***9--';
MQ/+*ZQ1(-S.Y  'J2: /--"_9I^&WAKXM:E\2M.\*V=MXOOX]LEZJG:C'(>6
M-/NI(X.&=0"<'^\V[TZJ]GJ%KJ,;/:7,-TBG:6AD#@'TR*FDD6&-I'8(B@LS
M,<  =30!^4GQ<_XOA_P5AT'1%_TFQT74[&W"]1Y=G"+J93[;Q,*_5VOR(_8'
M\9:!XJ_;4\>?$KQ1KNFZ):O'J.HVTVJ7D=N&FN;@!57>PSB-Y>G3 K]/?^%\
M?#3_ **'X4_\'=M_\70!W5%<+_POCX:?]%#\*?\ @[MO_BZZ/PWXPT'QG:2W
M7A_6].UVUB?RI)M-NX[A$? .TLA(!P0<>XH UZ*** /,OVB/CYH?[-OPTN?&
MFOVEW?V<5Q#:I:V.SSI9)&P NY@. &8\]%-7?@/\8K'X^?"W1_'6EZ9>Z3IV
MJ&;R+?4-@FVQRO$6(4D8+(2.>F*^+_\ @L?XT^Q?#SX?>%$?!U'4Y]2D53VM
MXA&N?8FY/_?/M7V/^S;X+_X5[\ ?A[X>:/RI['0[1)UQC]\8E:7_ ,?9J -O
MXM?$K3/@[\-_$/C36(YIM.T6U:ZEAM]OF28( 1=Q W,Q &3WKRCX:?MP?#SQ
MU\&;[XG:O--X'\-VU_+IZ?VZ\8FN9$1'/DI&S&0_/@*N6RK<8&:X'_@JKXT_
MX1C]E&[TQ'VR>(-6M-.V@\E5+7#?A_HX!^OO7RO^P7^Q9-^T3X<T[Q5\2YKZ
M;X<:0\L&A:(DQA2]D,I,[DKAA'O!4LI#,RXW 1X(![[XI_X*^?"S2KR6#1?#
M7B7743A;EHH;:*3GDC<Y;&/50?:NW^$?_!3KX-?%37H-&NKC4_!=],0L4GB*
M***UD<G 43)(ZK]7V#MFO;]!_9L^$_ABR^RZ9\-?"MK"5V-_Q)[=G<#^^[(6
M;_@1-?&__!1O]BOP#I'P=U3XD^"?#]GX5UG1)(7O+32H1#;7=N\BQ']RN$1E
M+J^Y0,@,#DD$ 'Z'A@P!!R#T-+7RM_P31^)FI?$K]E?1_P"U9GN;O0;R;1!<
M2$EI(HPCQ9/^S'*B?1!7I/[5?[0VG?LR_![4O%]W"MYJ#.++2[%C@7-VZL45
MCV4!6=O]E#CDB@#:^,?[0WP]^ >EI>^./$UIHQF1GM[,YDNKC'_/.% 789P-
MV-H)Y(KY/U;_ (+#?#&WND33O!WBN]@W8>6=+:$X[E5$K9[8!(_"O)/V2?V/
M=8_;"U:Y^,_QNU74-5TJ_G<6E@\C12:D%.-Q92#%;J<JJ1XR5."JCYOT1\/?
ML^_#'PKI:Z=I/P^\,V=H(_**+I4!+KC'SL5)<^I8DGO0!Y'\#_\ @HE\'OCC
MK-IHEKJ-[X8U^Z<1V^G^((%A\]^/ECE1GC))X +*S'HM?,/_  6*\5RZEX@^
M&/@FTS)-Y=SJ,D"]7:1TAAX^J3#\:]\_:J_X)X> /BUX.U'4/!/AZP\(^.K6
M!I+!](B2TMKN0?,(IHE 3YN1Y@ 8$@DD#%?G?\&?$OB;]IS]K+X-:?XME;4+
M[2);+3GDDR7EM;)Y+AO,SU;8KACW.2>2: /VN^'OA2+P)X!\-^&H,>3H^FVV
MGIMZ8BB6,?\ H->9_M1?M6>&OV4_#NBZKXBT[4-5_M:Z:U@MM-$?F#:FYG.]
ME&!\H^K"O;*_+3_@K1JUSXW^./PN^'EBV^X6S\U$'(\Z\N!"H(]?]''X-[T
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M<,.K)NH _8BO$_VHOVK/#7[*?AW1=5\1:=J&J_VM=-:P6VFB/S!M3<SG>RC
M^4?5A7JWA'Q-9^-/"FB^(=.8OI^K64-_;,W4Q2QJZ'\F%?ES_P %C/&9U#XH
M> O"B/N73-)FU!E4\;KB;9@^^+8?]]>] 'W+X]_;2^&'PK\"^'/$/B[5FTB\
MUS3H-1MO#ZJ)]15)8Q( \2$[< XW,0N00":^>[G_ (+%?#9+]4@\%>*9;+<P
M:9_LR28[$)YA!S_O#'O5_P#97_X)\:1>:/#X_P#CE8R^+?'FL*MRVEZHY-O8
M1D 1H\8P'D"  JWR(,*%&W-?53?L[_"M],_LX_#3PA]@_P"?7^PK7R_KM\O&
M>!0!P_[/O[;7PL_:0NCI_AK59].U_#,-#UJ-;>[D4#):,!F23@$D(Q( )( K
MWJOQ[_X*$?L[:9^R;\4?!/CCX:&7P_9:G+)<06L+LPL+VW:-]T;,20KB12%.
M0"C=B /UB^'/BK_A.OA[X8\2&(0'6-+M=1\L=$\Z)9,?ANH 3Q]\1O"_PM\.
MRZ[XNUVQ\/:3&=INK^81JS8)"*#R[$ X502<<"OC[Q9_P5V^$6BW5Q;Z-HGB
M?Q#Y;$)=1VT5O;R^A4R2>8 ?]I ?:O!/VC8[[]KG_@HQIOPHUC4;BQ\*:5<?
M8(H87"E(X[8W-RZY&/,D*LH;!X"=<5^BO@?]FSX6?#G2(M-\/^ = LK>-=N]
M[%)IG]WED#.YX'+,>E 'S/X/_P""N?PBUR[BM];T?Q)X:WXW74MM'<P)ZY,;
ME_R0U]?_  _^(WAGXJ>&;?Q!X2UNSU_1YR56ZLY-RA@ 2C#JK#(RK $9Y%<-
M\0OV2_@_\3]+N+/7/A[H.^8?\?MC9):7:'G!6:(*_4YQG![@UT/P3^#/ASX
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M#MY1=H(W%@G1C0!^E_Q:_P""G'P7^%^J7&EVE]?^--0MW\N3_A'H4EMU;O\
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MO_P4N_8^\)_"CPYIGQ2^'U@GA@C48[34=-L/W<"LX9H[B%1_JB&3:57 ^92
M"#G[G_9!^*%_\9/V:_ ?BW57,VJ7EBT-W,W66:"5X'D/NS1%O^!5\@?\%9/C
MYHVJ>'M%^$&@W*ZIXADU&._U.&T/F&V5598H&Q_RT=I VWJ @R/F&?LO]EGX
M8W?P<_9Z\"^$-0 34=/TY3=HO1)Y&:65/?:\C#/?&: /5:*** /A'_@KYXT_
ML;X"^&_#D<FR?6];61US]Z&")V8?]]O"?PKYB_9]_P""F=Y^S]\(= \!Z?\
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M!_X6E=8T;3;IA_:,))@N;EAB6XST\F&,-A^^9",@KD ^RO\ @F[I<VE_L:^
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M55\/J>K3:BZ@\E;>+9S[9N1^*^U>K_\ !+Z35I?V0_#YU-I&@6^O5L#(2?\
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M8VP^._\ P5JGBU9FO-.T'593''U6,:? ?+7'IY\:D^I8^M??G[)_P3_X9]^
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M1.6'_?<D)_"ON^ORQ_X*I7T_Q(_:2^%OPWLG+S"UC157G;/>W0B QZXAC/\
MP(4 ?<O[&/@P> ?V6/AGI/E^5(VCQ7TJ8P1)<YN'!]PTI'X4?MG^,_\ A ?V
M6/B9JPD\J1M'EL8G[B2XQ;J1[[I17L.GV$&EZ?;65K&(K:VB6&*,=%10 H_
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MT7(W.S$*!ZGL.:L?#WXB^&_BKX3L?$GA35[?6M&O$#Q7%NV<< E77JCC/*L
M0>"* -'6O#.C^)!"-6TFQU00Y\L7MLDVS.,[=P.,X'3T%>/_ !4_8G^#7Q8T
M&XL+[P+H^D7;HPAU31+1+*YA<C"ONB"[\==K[E]J]SKGO'WC[P_\,/">H>)?
M$^IP:1HUC&9)KFX; X'"J.K,>@49)/ % 'Y;?\$__$'B#]GG]M37_@S>W\EW
MI5_<WVF3QX*Q/<6R22172J3\I9(B/I(,] 1^M5?E)^P?INI?M%_MT>+OC)]C
M:UT339[S4/W@SL>Y62&W@ST+")G)/3]V?45^K= !117%?&SQH/AU\'_&WB??
ML?2=&N[R,^LB0L4 ]RP4?C0!^9_[(.EP_'W_ (*0>,_&MP/M.GZ3>:EK=N6&
M5(\W[/;#/JJRJP]XZ_66OS<_X(V^"_+T'XD>+I4R;BYM=*@D(Z>6KRRC/OYL
M7Y"OTCH *_)GXD:+:_M _P#!5^#0Y8_M.E6&IVT4Z'E6CLK59I4;V+Q.OXXZ
MU^L5Q<1VEO+/,ZQ0QJ7=V. J@9)/X5^5_P#P3)MY/BM^UU\3OB3=*SJMO=W8
M9ARL]Y=;E_\ '%F&/>@#]5**** /RE_X*4#_ (6O^VA\./A]:_.?LUAIT@7J
MLMU=-GZ80QG\:_5E5"J%4 *!@ =!7Y4?#G_B]_\ P5JUK56_TBQT/4[N1B.0
M%LH/LL1'MYJ1G/OGO7ZL4 ?E%_P3_LQ\:?V[_'OC_5V:]FT]-0U2VD;D+--.
M(8_P$4D@ [8'I7ZNU^1G['?BBV_91_;M\8^"O%THTRRU26XT..=R%B65ITEM
M)6)Z(Z# /_35<X&<?KG0 5\??\%5KRUM?V2[Z.X"&6XUBRBM]QY$@9G./?8C
M_AFOKV>>.UADFFD6*&-2[R2,%55 R22>@ K\<_\ @I3^UAIOQ\\<:7X-\'W*
MZCX4\.RNQOK<EDU"\<!2R?WD0956'4LY&05- 'W7_P $T?!?_"'_ +(OA65X
M_+N=:GNM5E&.N^4I&?QCBC/XU[)^T)XT_P"%=_ OQ]XD5_+FT[1+N:!O^FWE
M,(A^+E1^-:OPE\&K\._A;X0\+JH7^QM(M;!L=VCB5&/U)!/XU\X_\%2O&G_"
M*_LF:K8+)LE\0:E9Z8N#S@.;AOPVVY!^OO0!Y#_P1M\%_9?!?Q%\6O'_ ,?U
M_;Z7$Y'3R8VD<#Z_:$_[Y%;7_!87QG<Z3\(?!GAN"<Q1:SJTEQ/&O_+5+>,8
M4^P:9#]0*]A_X)M^"_\ A#?V0_!S/'Y=SJ[7&JS<8SYDS",_C$D5>2?\%?OA
M_>^(/@WX3\5VL7FP>'M3>*ZVCF.*Y55#GVWQQK]7% 'TY^R3X#M?AM^S7\.=
M#M8O**Z-;W=P".3<3J)IB?\ MI(WX8KURO!?V(_C1I/QH_9T\(W=C=B75-'L
M(-(U6W8CS(KF&)4+,/1P ZGN&]00/>J "ORE^'MO'X@_X*_ZE-I^([>TUC47
MF:+G#1V$J2?G)D'_ 'C7W9^U=^U)X<_9A^'5WJU_<6]UXEN8F71M%9_WEW-T
M#%1R(E)!9N.!@'<0#\J_\$J?@=K,U[XH^-WBJ%S=Z\)+72YK@?O)P\N^ZN<=
M@SJJAN^).QY /T$\4>(+?PGX9U?6[PXM--LYKV8YQ\D:%V_137Y>?\$E/ K^
M-_C)X\^)6J 37&F6XAB=AUN;MW9W7W"1.OTEK[6_;X\:#P-^R/\ $6[5]DU[
M8C2XUS@M]ID6%@/^ .Y^@->4_P#!)?P7_P (]^S/=ZW)'B;Q!K5Q<+)CK#$J
M0J/P>.7\S0!]KT444 %?EW_P5\\07VN_$CX8^!K>9O)-K)>BW7HTL\PA1B.^
M!$P'^\WK7ZB5^8/_  5^\':IH_C3X;_$2S4BW2!],-PH_P!3/%*9X@?]X/(1
M_N-0!^DO@OPG8> _!^B>&]*C\K3=(LH;"V3N(XT"+GWP.:V:XKX-_%G0OCA\
M-]$\9>';@3:?J4(=H\@O;RCB2%P.C(V0?ID<$&NUH *_)G_@G#X7M?&'[;GC
MOQ/:Q(-,T>+4KNU:/E5:>X\J, ^AC>7\J^M_V^OVNM'^ 7PRU/P[I=_#<?$#
M7+5K6SLHGS)912*5:ZDQ]W:,[,_>;'! ;'CO_!'#P7]C^'OQ!\6/'\VHZG!I
MD;L/X8(C(V/8FY'_ 'S[4 ?HC7Y,^.M)A_:*_P""KT>C3C[3H^EZI#%+&>5\
MNPMA)*C>S2QNO_ \5^L%Y=PV%K-<W$@B@A1I))&Z*H&23] *_+/_ ()>VDOQ
M0_:I^)_Q)NXV8K;7%QEN=D][=;P<^NV.4?B: /U2HHHH _,+_@L;XD.I>)/A
M;X2M5,EVD-W?/&O);S7BBB 'UBD_.OT@\">&QX.\#^'M #!AI6G6]B&7H?*B
M5,C_ +YK\Q/C[CXX?\%5O"WAL?Z59Z+>Z;:,O4-%;I]MG7Z9:4'Z&OU8H ^2
MO^"HGC/_ (13]DG6K)9/+FU[4+/3$/<_O//8#ZK P^AK6_X)L^"_^$-_9#\(
M.\?EW.L/<ZK,,=?,F98S^,215\]?\%F/$4\&@_"[0ES]FNKF_OI/3?$D")^D
MS_G7WI\'- M?"OPC\$Z-8LKV>GZ)96T3IT=4@10WXXSGWH ["O*?VK/&?_"O
M_P!F[XD:X)/*F@T.YB@?TFE0Q1'_ +[D6O5J^,?^"L'C0>&_V6_['1\2^(-9
MM;,H#R8X]UPQ^@:&,?\  A0!Q?\ P1V\&#3?A'XX\4/'MDU;6([%6(Y:.WA#
M CVW7#C\#7TW^UEX_P#B-\.?A2-2^%OAJ3Q3XKEOX;=+1+)[L)$0[/(R(0<
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M-5]1?LT_LXZ!^R_\/I_"?AV]O=1M;B_DU"6ZU#9YKR.B)SL51@+&H'%>L44
M%%%% 'Y4?\%"#_PN+]N[X<?#M#YMM"FFZ;/'UVO<W)>5C[>4\9_"OU6 "@ #
M '05^57P1_XO=_P5=\3^(,?:;+0[[4+G=U!CM8OL4+?3<8F'X5^JU 'YC_\
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MP#7YT_\ !&OP7YFK?$GQ=)'CR8+72H),==[/+*/P\N'\Z]"_X*=?M=:/X5\
MZC\)O#5_#?>*-:40ZPUN^[^SK7(9HV(X$DG"[>R%B0,KGN/^"5/@O_A%_P!E
M.TU1H]LOB'5KO4-Q')5&6W4?3]P2/][WH ^Q*_*OPZO_  N[_@KE?W1_?6&@
MZG,S8Y$?V"V\E<?]MXU_%B:_5&:00PO(02%4L0HR>*_+'_@DRJ^,_C_\4/&=
M^ZG5I-/+;"<G-S=>9(P^AB49_P!KWH _5&BBB@#\J/\ @H0?^%Q?MW?#CX=H
M?-MH4TW39X^NU[FY+RL?;RGC/X5^FWQ!\1?\(9\/_$NO+M0:3IES?#(X'E1,
M_P"7RU^97P1_XO=_P5=\3^(,?:;+0[[4+G=U!CM8OL4+?3<8F'X5^FWQ"\,?
M\)MX!\2^'=ZQ_P!KZ9<Z?N?[H\V)H\GV^:@#\Y?^"/\ X377_%?Q.^(&IE[K
M5T6"PCNI.2QG=YKAB?[Q,<7/N?6OTZK\K?\ @E-\3K7X7_%/QU\*O%#MI>L:
MM-&+.&X(51>6QE2: _[;!A@=_*(ZD _JE0 5^>/_  62O+6/X;?#NU<)]MEU
M:XEB)/S>6L(#X'IEX\_A7W_KNO:=X8T>\U;5[ZWTS3+.)IKF\NY!'%"@&2S,
M> !7Y-_$;7KW_@I-^V7HVB>'+>9OAYX?Q"UV0R 6*RAKBY;/W6E.$0<' CR
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M9F8X  ZDF@!U?D1^VYJTO[4_[=GA_P"&VB'SK33)[?P\98?FPY<R7<I]HPS
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MXK I^AKQK_@LEXT%OX/^'/A)'R;R^N=4E0'IY,:Q(3]?/DQ_NFOM[X#>"_\
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MEM-*MY/]T/+*/_'X?RK]*Z /"I/V&?@+)&R'X8:& PP=J.#^!#9%>'?M'_\
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M$'QFO@WPY='9=(UW:Q[X3C<HBL1\_'&R1E![GG-?IG10!^6'QV_X)F>(=/\
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MDL;*+&;-[W[?=QKW2-$_<19_O*QYY*FOU#HH X?X-_!GPK\!_ MGX2\'Z?\
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M !7PI_P4P_9^^*_[0UYX#T[P#X8.MZ3I274]Y-_:-K;@32&-4!6:5"<+&QR
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MR/MPR0]<9SQTK[VHHH ^,OVQO^"=>F?M :Y)XT\&ZG#X5\=,%-QYZL+._90
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M]*Z* /@W]GW_ ()MZAI_Q"M/B3\;?%C>.?%,4J7:Z=YDEQ%YZX*-//)\TNS
MP@4*"HY9>*^\J** "O-_VE=+;6OV=?BA8IGS)_#&I(F/[WV63'ZXKTBL_P 0
M:-#XBT'4M)N21;W]M):RE>NUT*G]#0!\)_\ !'745D^"?C:P'WX/$/GGZ/;1
M*/\ T6:^_*_,?_@DGKEQX+^)GQ8^&6JJ(M2B5+DQ'@K):S/!./SEC_[YK].*
M /SY_;4_97^*/[1'[5G@K4K#PQ]I^'>FPV-E=ZDVH6J*L9N6DN9/*:42'"/C
M 0D[.,U^@U%% !1110!^4OQ\_P""9GC.\_:2:[\">'X[SX;:Q?PWEQ,E[;PC
M34DE_P!(B\MY%=E3YF4(I^5E49(-?JPB+&BHBA448"J, #TIU% '@W[<'@CQ
MI\2_V;O$OA/P%I#:SKVKO;6_D+=0V^V$3))(VZ5T7[J;<9S\U9/[ /P,UWX
M_L[V6@^*-.72?$MYJ%UJ%_9B>.;RV9A&F7C9D.8HHSP3C..N17T?10 4444
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M57V&&X<J8FC"LJB7,K['QF*XEIX:O.BZ3?*[;GZB45^7?_"QO%G_ $,^L_\
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M^#"7_P"*H_X6-XL_Z&?6?_!A+_\ %4?ZK5?^?J^X/];*7_/I_>?J)17Y=_\
M"QO%G_0SZS_X,)?_ (JC_A8WBS_H9]9_\&$O_P 51_JM5_Y^K[@_ULI?\^G]
MY^HE%?EW_P +&\6?]#/K/_@PE_\ BJ/^%C>+/^AGUG_P82__ !5'^JU7_GZO
MN#_6RE_SZ?WGZB45^7?_  L;Q9_T,^L_^#"7_P"*H_X6-XL_Z&?6?_!A+_\
M%4?ZK5?^?J^X/];*7_/I_>?J)17Y=_\ "QO%G_0SZS_X,)?_ (JC_A8WBS_H
M9]9_\&$O_P 51_JM5_Y^K[@_ULI?\^G]Y^HE%?EW_P +&\6?]#/K/_@PE_\
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M\;7TMQ/<:H^H74I9YR3*1&\IC7=D]%& <# KU>OR[_X6-XL_Z&?6?_!A+_\
M%4?\+&\6?]#/K/\ X,)?_BJ/]5JO_/U?<'^ME+_GT_O/U$HK\N_^%C>+/^AG
MUG_P82__ !5'_"QO%G_0SZS_ .#"7_XJC_5:K_S]7W!_K92_Y]/[S]1*\T^,
M_P"S?\._VA(](3Q_X?.OII)E-FOV^YMA$9-F\XAD3=GRU^]G&.,9.?@;_A8W
MBS_H9]9_\&$O_P 51_PL;Q9_T,^L_P#@PE_^*H_U6J_\_5]P?ZV4O^?3^\_3
MC1])M- TFRTS3X1;6%E EM;PJ21'&BA54$\\  <U<K\N_P#A8WBS_H9]9_\
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M$O\ \51_PL;Q9_T,^L_^#"7_ .*H_P!5JO\ S]7W!_K92_Y]/[S]1**_+O\
MX6-XL_Z&?6?_  82_P#Q5'_"QO%G_0SZS_X,)?\ XJC_ %6J_P#/U?<'^ME+
M_GT_O/U$HK\N_P#A8WBS_H9]9_\ !A+_ /%4?\+&\6?]#/K/_@PE_P#BJ/\
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M_@PE_P#BJ/\ 5:K_ ,_5]P?ZV4O^?3^\_42BOR[_ .%C>+/^AGUG_P &$O\
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M_42BOR[_ .%C>+/^AGUG_P &$O\ \51_PL;Q9_T,^L_^#"7_ .*H_P!5JO\
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M!_K92_Y]/[S]1**_+O\ X6-XL_Z&?6?_  82_P#Q5'_"QO%G_0SZS_X,)?\
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M_0SZS_X,)?\ XJC_ %6J_P#/U?<'^ME+_GT_O/U$HK\N_P#A8WBS_H9]9_\
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M$O\ \51_PL;Q9_T,^L_^#"7_ .*H_P!5JO\ S]7W!_K92_Y]/[S]1**_+O\
MX6-XL_Z&?6?_  82_P#Q5'_"QO%G_0SZS_X,)?\ XJC_ %6J_P#/U?<'^ME+
M_GT_O/U$HK\N_P#A8WBS_H9]9_\ !A+_ /%4?\+&\6?]#/K/_@PE_P#BJ/\
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M_B*/^&&O%G_0?T;\Y?\ XBOM2BC_ %BQ_P#,ON0?ZMY?_*_O9\5_\,->+/\
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MO_AAKQ9_T']&_.7_ .(H_P"&&O%G_0?T;\Y?_B*^U**/]8L?_,ON0?ZMY?\
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M#^C?G+_\11_PPUXL_P"@_HWYR_\ Q%?:E%'^L6/_ )E]R#_5O+_Y7][/BO\
MX8:\6?\ 0?T;\Y?_ (BC_AAKQ9_T']&_.7_XBOM2BC_6+'_S+[D'^K>7_P K
M^]GQ7_PPUXL_Z#^C?G+_ /$4?\,->+/^@_HWYR__ !%?:E%'^L6/_F7W(/\
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M_##7BS_H/Z-^<O\ \11_PPUXL_Z#^C?G+_\ $5]J44?ZQ8_^9?<@_P!6\O\
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MR_\ E?WL^*_^&&O%G_0?T;\Y?_B*/^&&O%G_ $']&_.7_P"(K[4HH_UBQ_\
M,ON0?ZMY?_*_O9\5_P###7BS_H/Z-^<O_P 11_PPUXL_Z#^C?G+_ /$5]J44
M?ZQ8_P#F7W(/]6\O_E?WL^*_^&&O%G_0?T;\Y?\ XBC_ (8:\6?]!_1OSE_^
M(K[4HH_UBQ_\R^Y!_JWE_P#*_O9\5_\ ##7BS_H/Z-^<O_Q%'_##7BS_ *#^
MC?G+_P#$5]J44?ZQ8_\ F7W(/]6\O_E?WL^*_P#AAKQ9_P!!_1OSE_\ B*/^
M&&O%G_0?T;\Y?_B*^U**/]8L?_,ON0?ZMY?_ "O[V?%?_##7BS_H/Z-^<O\
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M?]!_1OSE_P#B*^U**/\ 6+'_ ,R^Y!_JWE_\K^]GQ7_PPUXL_P"@_HWYR_\
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M_.7_ .(K[4HH_P!8L?\ S+[D'^K>7_RO[V?%?_##7BS_ *#^C?G+_P#$4?\
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M^L6/_F7W(/\ 5O+_ .5_>SXK_P"&&O%G_0?T;\Y?_B*/^&&O%G_0?T;\Y?\
MXBOM2BC_ %BQ_P#,ON0?ZMY?_*_O9\5_\,->+/\ H/Z-^<O_ ,11_P ,->+/
M^@_HWYR__$5]J44?ZQ8_^9?<@_U;R_\ E?WL^*_^&&O%G_0?T;\Y?_B*/^&&
MO%G_ $']&_.7_P"(K[4HH_UBQ_\ ,ON0?ZMY?_*_O9\5_P###7BS_H/Z-^<O
M_P 11_PPUXL_Z#^C?G+_ /$5]J44?ZQ8_P#F7W(/]6\O_E?WL^*_^&&O%G_0
M?T;\Y?\ XBC_ (8:\6?]!_1OSE_^(K[4HH_UBQ_\R^Y!_JWE_P#*_O9\5_\
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MG+_\17VI11_K%C_YE]R#_5O+_P"5_>SXK_X8:\6?]!_1OSE_^(H_X8:\6?\
M0?T;\Y?_ (BOM2BC_6+'_P R^Y!_JWE_\K^]GQ7_ ,,->+/^@_HWYR__ !%'
M_##7BS_H/Z-^<O\ \17VI11_K%C_ .9?<@_U;R_^5_>SXK_X8:\6?]!_1OSE
M_P#B*/\ AAKQ9_T']&_.7_XBOM2BC_6+'_S+[D'^K>7_ ,K^]GQ7_P ,->+/
M^@_HWYR__$4?\,->+/\ H/Z-^<O_ ,17VI11_K%C_P"9?<@_U;R_^5_>SXK_
M .&&O%G_ $']&_.7_P"(H_X8:\6?]!_1OSE_^(K[4HH_UBQ_\R^Y!_JWE_\
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M_6+'_P R^Y!_JWE_\K^]GQ7_ ,,->+/^@_HWYR__ !%'_##7BS_H/Z-^<O\
M\17VI11_K%C_ .9?<@_U;R_^5_>SXK_X8:\6?]!_1OSE_P#B*/\ AAKQ9_T'
M]&_.7_XBOM2BC_6+'_S+[D'^K>7_ ,K^]GQ7_P ,->+/^@_HWYR__$4?\,->
M+/\ H/Z-^<O_ ,17VI11_K%C_P"9?<@_U;R_^5_>SXK_ .&&O%G_ $']&_.7
M_P"(H_X8:\6?]!_1OSE_^(K[4HH_UBQ_\R^Y!_JWE_\ *_O9\5_\,->+/^@_
MHWYR_P#Q%'_##7BS_H/Z-^<O_P 17VI11_K%C_YE]R#_ %;R_P#E?WL^*_\
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M\,->+/\ H/Z-^<O_ ,11_P ,->+/^@_HWYR__$5]J44?ZQ8_^9?<@_U;R_\
ME?WL^*_^&&O%G_0?T;\Y?_B*/^&&O%G_ $']&_.7_P"(K[4HH_UBQ_\ ,ON0
M?ZMY?_*_O9\5_P###7BS_H/Z-^<O_P 11_PPUXL_Z#^C?G+_ /$5]J44?ZQ8
M_P#F7W(/]6\O_E?WL^*_^&&O%G_0?T;\Y?\ XBC_ (8:\6?]!_1OSE_^(K[4
MHH_UBQ_\R^Y!_JWE_P#*_O9\5_\ ##7BS_H/Z-^<O_Q%'_##7BS_ *#^C?G+
M_P#$5]J44?ZQ8_\ F7W(/]6\O_E?WL^*_P#AAKQ9_P!!_1OSE_\ B*/^&&O%
MG_0?T;\Y?_B*^U**/]8L?_,ON0?ZMY?_ "O[V?,WP1_9;U_X8?$2P\0W^K:;
M=VUO'*C16YDWG?&5&,J!U-?3-%%>/B\96QU3VM9W=K'M8/!4<#3=*@K*]PHH
MHKB.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&3Q=KEPUEIGVA0Z0!5W2SE3][8"H /&YUR",@_GY9^!_VL-<^#4WQWB^(7B
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M;XE:;\2]1M+*6>4V2WGB&YL?M+HVUS;10KY<:AU*_P  RI],T ?L#17YM?\
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M"Y!R,HX(.#[5I5@>/?'.C?#/P;K'BGQ#=BQT;2;9KJYF(R0JCH!W8G  '))
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MKXJC1FM-EWIDSXX1\I)&/JP\W_OBOH/P3\>/#$'_  3KL_$SZQ9H-/\ !?\
M94D;2J&^W16IMQ!MSD.TB@ =PP/3F@#Y _X(\ZG-%^T!XOT]6(@N/#$EPZYX
M+1W=LJG\I6_.OUTK\J?^"./@VXN?B+X_\5F)A:V6E1:6)"."\TPE(!]A;C/U
M'M7ZK4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH K:EIMIK&GW%C?VL-]97"&*:VN8Q)'*A&"K*0001V-<;;^&?AO\
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M*#CG8#73>(=6^&7[*GPWU;6WL-&\#>&(9#<S6^EV<=LD]P4"@)%& 'E8(H
MR=OH":VKKXO^#(/AWJGCN#Q+IFI^$]-MYKF?5=,NH[J#;$"7"M&2&8$8V@YS
M@=:_&_XK?&S7OV]OCQ86&L^)M)\ ^#(97%@NNW\=K9Z;;#[TKEV DG8 < Y)
MPHPHR #K_@=8ZU^W+^WLWCUM.-CHEGJ=OKEZK#>EO:VVQ;:!CT+OY4:'&,_.
MP& :_9*OG+]GG6/V=O@+X-T_P7X(^(_@J62611+,/$-G)=ZC<MA=[XDRSDX
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M95EVAEW;20V-PSCJ.M;%% 'YF?\ #E[_ *K%_P"6Q_\ =E'_  Y>_P"JQ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM/\ ^?\ M?\ O\O^-8/]FVG_ #ZP_P#?L?X4?V;:?\^L/_?L?X4 ;W]M:?\
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MM:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C6#_9MI_SZP_]^Q_A1_9MI_SZP_\
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M_P!FVG_/K#_W['^%']FVG_/K#_W['^% &]_;6G_\_P#:_P#?Y?\ &C^VM/\
M^?\ M?\ O\O^-8/]FVG_ #ZP_P#?L?X4?V;:?\^L/_?L?X4 ;W]M:?\ \_\
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M:?\ \_\ :_\ ?Y?\:/[%T_\ Y\+7_ORO^%']BZ?_ ,^%K_WY7_"@ _MK3_\
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M_P#Y_P"U_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\
MS_VO_?Y?\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\
MA0 ?VUI__/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\
M*/[%T_\ Y\+7_ORO^% !_;6G_P#/_:_]_E_QH_MK3_\ G_M?^_R_XT?V+I__
M #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\
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M_P#Y_P"U_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\
MS_VO_?Y?\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\
MA0 ?VUI__/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\
M*/[%T_\ Y\+7_ORO^% !_;6G_P#/_:_]_E_QH_MK3_\ G_M?^_R_XT?V+I__
M #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\
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M_L73_P#GPM?^_*_X4?V+I_\ SX6O_?E?\* #^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "@ _MK3_ /G_ +7_
M +_+_C1_;6G_ //_ &O_ '^7_&C^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MH /[:T__ )_[7_O\O^-']M:?_P _]K_W^7_&C^Q=/_Y\+7_ORO\ A1_8NG_\
M^%K_ -^5_P * #^VM/\ ^?\ M?\ O\O^-']M:?\ \_\ :_\ ?Y?\:/[%T_\
MY\+7_ORO^%']BZ?_ ,^%K_WY7_"@ _MK3_\ G_M?^_R_XT?VUI__ #_VO_?Y
M?\:/[%T__GPM?^_*_P"%']BZ?_SX6O\ WY7_  H /[:T_P#Y_P"U_P"_R_XT
M?VUI_P#S_P!K_P!_E_QH_L73_P#GPM?^_*_X4?V+I_\ SX6O_?E?\* #^VM/
M_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH_L73_^?"U_[\K_ (4?V+I__/A:_P#?
ME?\ "@ _MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&C^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PH /[:T__ )_[7_O\O^-']M:?_P _]K_W^7_&C^Q=
M/_Y\+7_ORO\ A1_8NG_\^%K_ -^5_P * #^VM/\ ^?\ M?\ O\O^-']M:?\
M\_\ :_\ ?Y?\:/[%T_\ Y\+7_ORO^%']BZ?_ ,^%K_WY7_"@ _MK3_\ G_M?
M^_R_XT?VUI__ #_VO_?Y?\:/[%T__GPM?^_*_P"%']BZ?_SX6O\ WY7_  H
M/[:T_P#Y_P"U_P"_R_XT?VUI_P#S_P!K_P!_E_QH_L73_P#GPM?^_*_X4?V+
MI_\ SX6O_?E?\* #^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH_L73_^?"U_
M[\K_ (4?V+I__/A:_P#?E?\ "@ _MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&C^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PH /[:T__ )_[7_O\O^-'
M]M:?_P _]K_W^7_&C^Q=/_Y\+7_ORO\ A1_8NG_\^%K_ -^5_P * #^VM/\
M^?\ M?\ O\O^-']M:?\ \_\ :_\ ?Y?\:/[%T_\ Y\+7_ORO^%']BZ?_ ,^%
MK_WY7_"@ _MK3_\ G_M?^_R_XT?VUI__ #_VO_?Y?\:/[%T__GPM?^_*_P"%
M']BZ?_SX6O\ WY7_  H /[:T_P#Y_P"U_P"_R_XT?VUI_P#S_P!K_P!_E_QH
M_L73_P#GPM?^_*_X4?V+I_\ SX6O_?E?\* #^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "@ _MK3_ /G_ +7_
M +_+_C1_;6G_ //_ &O_ '^7_&C^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MH /[:T__ )_[7_O\O^-']M:?_P _]K_W^7_&C^Q=/_Y\+7_ORO\ A1_8NG_\
M^%K_ -^5_P * #^VM/\ ^?\ M?\ O\O^-']M:?\ \_\ :_\ ?Y?\:/[%T_\
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M/_Y\+7_ORO\ A1_8NG_\^%K_ -^5_P * #^VM/\ ^?\ M?\ O\O^-']M:?\
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M^_R_XT?V+I__ #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:_P#?Y?\
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M_L73_P#GPM?^_*_X4 ']M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C1_8NG_\
M/A:_]^5_PH_L73_^?"U_[\K_ (4 ']M:?_S_ -K_ -_E_P :/[:T_P#Y_P"U
M_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\ S_VO_?Y?
M\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\ A0 ?VUI_
M_/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\*/[%T_\
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M^_R_XT?V+I__ #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:_P#?Y?\
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M_P#Y_P"U_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\
MS_VO_?Y?\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\
MA0 ?VUI__/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\
M*/[%T_\ Y\+7_ORO^% !_;6G_P#/_:_]_E_QH_MK3_\ G_M?^_R_XT?V+I__
M #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\
MM?\ O\O^-']BZ?\ \^%K_P!^5_PH_L73_P#GPM?^_*_X4 ']M:?_ ,_]K_W^
M7_&C^VM/_P"?^U_[_+_C1_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (4 ']M:
M?_S_ -K_ -_E_P :/[:T_P#Y_P"U_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_
M .?"U_[\K_A0 ?VUI_\ S_VO_?Y?\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_W
MY7_"C^Q=/_Y\+7_ORO\ A0 ?VUI__/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+
M_C1_8NG_ //A:_\ ?E?\*/[%T_\ Y\+7_ORO^% !_;6G_P#/_:_]_E_QH_MK
M3_\ G_M?^_R_XT?V+I__ #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:
M_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-']BZ?\ \^%K_P!^5_PH_L73_P#GPM?^
M_*_X4 ']M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C1_8NG_\ /A:_]^5_PH_L
M73_^?"U_[\K_ (4 ']M:?_S_ -K_ -_E_P :/[:T_P#Y_P"U_P"_R_XT?V+I
M_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\ S_VO_?Y?\:/[:T__ )_[
M7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\ A0 ?VUI__/\ VO\ W^7_
M !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\*/[%T_\ Y\+7_ORO^% !
M_;6G_P#/_:_]_E_QH_MK3_\ G_M?^_R_XT?V+I__ #X6O_?E?\*/[%T__GPM
M?^_*_P"% !_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-']BZ?\ \^%K
M_P!^5_PH_L73_P#GPM?^_*_X4 ']M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C
M1_8NG_\ /A:_]^5_PH_L73_^?"U_[\K_ (4 6+>ZANHR\$T<R X+1L&&?3BI
M:PKQ%L=:T>"V46\$K3&2.(;5<A1U ZUNT %%%% !1110 4444 %<M=?\C->?
M]<HZZFN6NO\ D9KS_KE'0!-1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"&4_@[_P!$T\,_^"V/_"CZK+N'MEV/8?\ A?'PT_Z*'X4_\'=M_P#%T?\
M"^/AI_T4/PI_X.[;_P"+KQ[_ (93^#O_ $33PS_X+8_\*/\ AE/X._\ 1-/#
M/_@MC_PH^JR[A[9=CV'_ (7Q\-/^BA^%/_!W;?\ Q='_  OCX:?]%#\*?^#N
MV_\ BZ\>_P"&4_@[_P!$T\,_^"V/_"C_ (93^#O_ $33PS_X+8_\*/JLNX>V
M78]A_P"%\?#3_HH?A3_P=VW_ ,71_P +X^&G_10_"G_@[MO_ (NO'O\ AE/X
M._\ 1-/#/_@MC_PH_P"&4_@[_P!$T\,_^"V/_"CZK+N'MEV/8?\ A?'PT_Z*
M'X4_\'=M_P#%T?\ "^/AI_T4/PI_X.[;_P"+KQ[_ (93^#O_ $33PS_X+8_\
M*/\ AE/X._\ 1-/#/_@MC_PH^JR[A[9=CV'_ (7Q\-/^BA^%/_!W;?\ Q='_
M  OCX:?]%#\*?^#NV_\ BZ\>_P"&4_@[_P!$T\,_^"V/_"C_ (93^#O_ $33
MPS_X+8_\*/JLNX>V78]A_P"%\?#3_HH?A3_P=VW_ ,71_P +X^&G_10_"G_@
M[MO_ (NO'O\ AE/X._\ 1-/#/_@MC_PH_P"&4_@[_P!$T\,_^"V/_"CZK+N'
MMEV/8?\ A?'PT_Z*'X4_\'=M_P#%T?\ "^/AI_T4/PI_X.[;_P"+KQ[_ (93
M^#O_ $33PS_X+8_\*/\ AE/X._\ 1-/#/_@MC_PH^JR[A[9=CV'_ (7Q\-/^
MBA^%/_!W;?\ Q='_  OCX:?]%#\*?^#NV_\ BZ\>_P"&4_@[_P!$T\,_^"V/
M_"C_ (93^#O_ $33PS_X+8_\*/JLNX>V78]A_P"%\?#3_HH?A3_P=VW_ ,71
M_P +X^&G_10_"G_@[MO_ (NO'O\ AE/X._\ 1-/#/_@MC_PH_P"&4_@[_P!$
MT\,_^"V/_"CZK+N'MEV/8?\ A?'PT_Z*'X4_\'=M_P#%T?\ "^/AI_T4/PI_
MX.[;_P"+KQ[_ (93^#O_ $33PS_X+8_\*/\ AE/X._\ 1-/#/_@MC_PH^JR[
MA[9=CV'_ (7Q\-/^BA^%/_!W;?\ Q='_  OCX:?]%#\*?^#NV_\ BZ\>_P"&
M4_@[_P!$T\,_^"V/_"C_ (93^#O_ $33PS_X+8_\*/JLNX>V78]A_P"%\?#3
M_HH?A3_P=VW_ ,71_P +X^&G_10_"G_@[MO_ (NO'O\ AE/X._\ 1-/#/_@M
MC_PH_P"&4_@[_P!$T\,_^"V/_"CZK+N'MEV/8?\ A?'PT_Z*'X4_\'=M_P#%
MT?\ "^/AI_T4/PI_X.[;_P"+KQ[_ (93^#O_ $33PS_X+8_\*/\ AE/X._\
M1-/#/_@MC_PH^JR[A[9=CV'_ (7Q\-/^BA^%/_!W;?\ Q='_  OCX:?]%#\*
M?^#NV_\ BZ\>_P"&4_@[_P!$T\,_^"V/_"C_ (93^#O_ $33PS_X+8_\*/JL
MNX>V78]A_P"%\?#3_HH?A3_P=VW_ ,71_P +X^&G_10_"G_@[MO_ (NO'O\
MAE/X._\ 1-/#/_@MC_PH_P"&4_@[_P!$T\,_^"V/_"CZK+N'MEV/8?\ A?'P
MT_Z*'X4_\'=M_P#%T?\ "^/AI_T4/PI_X.[;_P"+KQ[_ (93^#O_ $33PS_X
M+8_\*/\ AE/X._\ 1-/#/_@MC_PH^JR[A[9=CV'_ (7Q\-/^BA^%/_!W;?\
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M'O\ AE/X._\ 1-/#/_@MC_PH_P"&4_@[_P!$T\,_^"V/_"CZK+N'MEV/8?\
MA?'PT_Z*'X4_\'=M_P#%T?\ "^/AI_T4/PI_X.[;_P"+KQ[_ (93^#O_ $33
MPS_X+8_\*/\ AE/X._\ 1-/#/_@MC_PH^JR[A[9=CV'_ (7Q\-/^BA^%/_!W
M;?\ Q='_  OCX:?]%#\*?^#NV_\ BZ\>_P"&4_@[_P!$T\,_^"V/_"C_ (93
M^#O_ $33PS_X+8_\*/JLNX>V78]*\6?'+X;S>'[I(_B#X6D<[,*NM6Q)^=?]
MNM9/CO\ #38O_%P_"G3_ *#=M_\ %UX__P ,I_!W_HFGAG_P6Q_X4?\ #*?P
M=_Z)IX9_\%L?^%'U67</;+L>P_\ "^/AI_T4/PI_X.[;_P"+H_X7Q\-/^BA^
M%/\ P=VW_P 77CW_  RG\'?^B:>&?_!;'_A1_P ,I_!W_HFGAG_P6Q_X4?59
M=P]LNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'PT_Z*'X4_P#!W;?_ !=>/?\
M#*?P=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW#VR['L/_  OCX:?]
M%#\*?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,I_!W_HFGAG_P6Q_X
M4?\ #*?P=_Z)IX9_\%L?^%'U67</;+L>P_\ "^/AI_T4/PI_X.[;_P"+H_X7
MQ\-/^BA^%/\ P=VW_P 77CW_  RG\'?^B:>&?_!;'_A1_P ,I_!W_HFGAG_P
M6Q_X4?59=P]LNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'PT_Z*'X4_P#!W;?_
M !=>/?\ #*?P=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW#VR['L/_
M  OCX:?]%#\*?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,I_!W_HFG
MAG_P6Q_X4?\ #*?P=_Z)IX9_\%L?^%'U67</;+L>P_\ "^/AI_T4/PI_X.[;
M_P"+H_X7Q\-/^BA^%/\ P=VW_P 77CW_  RG\'?^B:>&?_!;'_A1_P ,I_!W
M_HFGAG_P6Q_X4?59=P]LNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'PT_Z*'X4
M_P#!W;?_ !=>/?\ #*?P=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW
M#VR['L/_  OCX:?]%#\*?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,
MI_!W_HFGAG_P6Q_X4?\ #*?P=_Z)IX9_\%L?^%'U67</;+L>P_\ "^/AI_T4
M/PI_X.[;_P"+H_X7Q\-/^BA^%/\ P=VW_P 77CW_  RG\'?^B:>&?_!;'_A1
M_P ,I_!W_HFGAG_P6Q_X4?59=P]LNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'
MPT_Z*'X4_P#!W;?_ !=>/?\ #*?P=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;
M'_A1]5EW#VR['L/_  OCX:?]%#\*?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\
M%UX]_P ,I_!W_HFGAG_P6Q_X4?\ #*?P=_Z)IX9_\%L?^%'U67</;+L>P_\
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M\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW#VR['L/_  OCX:?]%#\*?^#NV_\
MBZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,I_!W_HFGAG_P6Q_X4?\ #*?P=_Z)
MIX9_\%L?^%'U67</;+L>P_\ "^/AI_T4/PI_X.[;_P"+H_X7Q\-/^BA^%/\
MP=VW_P 77CW_  RG\'?^B:>&?_!;'_A1_P ,I_!W_HFGAG_P6Q_X4?59=P]L
MNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'PT_Z*'X4_P#!W;?_ !=>/?\ #*?P
M=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW#VR['L/_  OCX:?]%#\*
M?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,I_!W_HFGAG_P6Q_X4?\
M#*?P=_Z)IX9_\%L?^%'U67</;+L>P_\ "^/AI_T4/PI_X.[;_P"+H_X7Q\-/
M^BA^%/\ P=VW_P 77CW_  RG\'?^B:>&?_!;'_A1_P ,I_!W_HFGAG_P6Q_X
M4?59=P]LNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'PT_Z*'X4_P#!W;?_ !=>
M/?\ #*?P=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW#VR['L/_  OC
MX:?]%#\*?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,I_!W_HFGAG_P
M6Q_X4?\ #*?P=_Z)IX9_\%L?^%'U67</;+L>P_\ "^/AI_T4/PI_X.[;_P"+
MH_X7Q\-/^BA^%/\ P=VW_P 77CW_  RG\'?^B:>&?_!;'_A1_P ,I_!W_HFG
MAG_P6Q_X4?59=P]LNQ[#_P +X^&G_10_"G_@[MO_ (NC_A?'PT_Z*'X4_P#!
MW;?_ !=>/?\ #*?P=_Z)IX9_\%L?^%'_  RG\'?^B:>&?_!;'_A1]5EW#VR[
M'L/_  OCX:?]%#\*?^#NV_\ BZ/^%\?#3_HH?A3_ ,'=M_\ %UX]_P ,I_!W
M_HFGAG_P6Q_X4?\ #*?P=_Z)IX9_\%L?^%'U67</;+L>E:#\<OAO'<:J7^(/
MA90UTQ7=K5L,C Y'SUK_ /"^/AI_T4/PI_X.[;_XNO'O^&4_@[_T33PS_P""
MV/\ PH_X93^#O_1-/#/_ (+8_P#"CZK+N'MEV/8?^%\?#3_HH?A3_P '=M_\
M71_POCX:?]%#\*?^#NV_^+KQ[_AE/X._]$T\,_\ @MC_ ,*/^&4_@[_T33PS
M_P""V/\ PH^JR[A[9=CV'_A?'PT_Z*'X4_\ !W;?_%T?\+X^&G_10_"G_@[M
MO_BZ\>_X93^#O_1-/#/_ (+8_P#"C_AE/X._]$T\,_\ @MC_ ,*/JLNX>V78
M]A_X7Q\-/^BA^%/_  =VW_Q='_"^/AI_T4/PI_X.[;_XNO'O^&4_@[_T33PS
M_P""V/\ PH_X93^#O_1-/#/_ (+8_P#"CZK+N'MEV/8?^%\?#3_HH?A3_P '
M=M_\71_POCX:?]%#\*?^#NV_^+KQ[_AE/X._]$T\,_\ @MC_ ,*/^&4_@[_T
M33PS_P""V/\ PH^JR[A[9=CV'_A?'PT_Z*'X4_\ !W;?_%T?\+X^&G_10_"G
M_@[MO_BZ\>_X93^#O_1-/#/_ (+8_P#"C_AE/X._]$T\,_\ @MC_ ,*/JLNX
M>V78]A_X7Q\-/^BA^%/_  =VW_Q='_"^/AI_T4/PI_X.[;_XNO'O^&4_@[_T
M33PS_P""V/\ PH_X93^#O_1-/#/_ (+8_P#"CZK+N'MEV/8?^%\?#3_HH?A3
M_P '=M_\71_POCX:?]%#\*?^#NV_^+KQ[_AE/X._]$T\,_\ @MC_ ,*/^&4_
M@[_T33PS_P""V/\ PH^JR[A[9=CV'_A?'PT_Z*'X4_\ !W;?_%T?\+X^&G_1
M0_"G_@[MO_BZ\>_X93^#O_1-/#/_ (+8_P#"C_AE/X._]$T\,_\ @MC_ ,*/
MJLNX>V78]A_X7Q\-/^BA^%/_  =VW_Q='_"^/AI_T4/PI_X.[;_XNO'O^&4_
M@[_T33PS_P""V/\ PH_X93^#O_1-/#/_ (+8_P#"CZK+N'MEV/8?^%\?#3_H
MH?A3_P '=M_\71_POCX:?]%#\*?^#NV_^+KQ[_AE/X._]$T\,_\ @MC_ ,*/
M^&4_@[_T33PS_P""V/\ PH^JR[A[9=CV'_A?'PT_Z*'X4_\ !W;?_%UU>AZ_
MIGB?2X=2T;4;35M.FW>7>6,ZS0O@E3M=20<$$'!Z@U\Y_P##*?P=_P"B:>&?
M_!;'_A6#^RS-'\#OCKX\^"S 6WA_4A_PEOA2/HB0R$)=VR9/ 20 JH_A#-WK
M.I1E35V7&HI.Q]<T445SFH4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)KW_(4
MT;_KN?Y5MUB:]_R%-&_Z[G^5 &W1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% &+X1_Y J?]=)/_ $(UM5B^$?\ D"I_UTD_]"-;5 !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 8FK_P#(Q:']9O\ T$5MUB:O_P C%H?UF_\ 016W
M0 4444 %%%% !1110 5RUU_R,UY_URCKJ:Y:Z_Y&:\_ZY1T 34444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'S#JW_*1-?^R5_P#N7->]UX)JW_*1-?\ LE?_
M +ES7O=>IA_@.*K\04445TF(4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% &+X1_Y J?]=)/_ $(UM5B^$?\ D"I_UTD_]"-;5 !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 8FK_P#(Q:']9O\ T$5MUB:O_P C%H?UF_\
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MQ!I?A^&X8I#)JE[';+(P&2%+L,D#TKG?^&@/A?\ ]%(\(_\ @]M?_CE?,/\
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ML);B0<94C'6OG#]C7]K6\^'U]8>!;W1)_$$OB+78(QJEQJC*UL)3'%C88VW
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'SW\>+P_!/XS?#SXUP'R=*AF'A?Q
M4PX7^SKE_P!U,_\ LPS8;U.Y1VK[)#!@"#D'H:\7^)'@73_B=X"U[PIJBYL=
M6LY+61L9*%A\KCW5L,/=161^Q+\2-0\:?!M/#WB)_P#BLO!%U)X9UA&;+,]O
M\L4O/+!XMAW?Q,'KS<1#EES+J=E&5U8^@****Y#<**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "L37O\ D*:-_P!=S_*MNL37O^0IHW_7<_RH VZ*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH Q?"/\ R!4_ZZ2?^A&MJL7PC_R!4_ZZ2?\ H1K:
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#$U?_D8M#^LW_H(K;K$U?_D8
MM#^LW_H(K;H **** "BBB@ HHHH *Y:Z_P"1FO/^N4==37+77_(S7G_7*.@"
M:BBB@#\Y?^"P0+6_PJ .#YFI8_*VK*O?V"?VH/%^F_V9X@^--OJ&AW2@3VMU
MXEU2ZC9<=#$\05OH37O_ .WA^R?XN_:@C\$KX5U'1=/.B/=M<?VQ/-'O\WR=
MNSRXI,_ZMLYQU'6OJRWC,5O&AY*J%./84 ?+6@_LRZ-^R_\ L?\ Q/T&PO7U
M?4[[0=1NM2U22(1F>3[(ZJJJ"=J*.BDGDL<\UYE_P21\(Z6GPG\8>(S9POJU
MSK+:<]RT8+B!((G$8;KM+2L2.^!GH*^S/BMX5N_'7PO\7^&["2&&^UC2+NP@
MDN&*Q+)+"R*7(!(7+#. 3CL:\?\ V'?V=?$G[,_PMU?PUXGO=*O[Z\UB34(Y
M-(EEDB$;0PH 3)&AW9C;MC!'- 'S'^P_9P^'?^"@'QHT?3T6UTR&/542WC 5
M%5-0B"  =  2 !7H?@7XS>&]>^-7C1_V=?@A8^(M<3%OK/BR;48],LE)D?#J
MF&WJ[!R2@5GVY(( -=?\!?V2?%WPN_:P^(OQ.U;4=$N/#_B,:@+6VLYYFND\
M^[CF3S%:)5&%0@X<\XQGK7FN@_L&_&?X,?$;Q#=?!_XHZ7X<\*ZX^V<WT3/=
MI#N9E7RS#(CO&&(60.C')^[DB@#A?V X-0L?VZOBK::E'I]I?)9ZFMU;Z.6^
MQ)*+^#<(=V#L!R%R,XH3X/\ [2/[&/Q(\8:[\.?#UKXY\-:O<-,\B6BWDDZ;
MV9%>)&6Y#J&.1&=A)[\8]F_9I_8A\8_L\?M%:IXN_P"$CTWQ'X7U#3I;*XN;
MFXF34Y))!'(\I3RBF3-&?^6F=K9R2.<[4/V-OCO\,?'VOZ_\'?C'#';ZVX-S
M'XM+W$RHI)16=X9UE*[B ^U3@D>N0"G^PS\=?!/BSXJ^)M N?A-9_#OXIW,=
MQ=WUY:Q-_I#!U:>(K+^]MSN(;RAE?E)X( /S1^R/XI^-TOQ.^(GBCX:>!] \
M<>*;B?=JMYX@=$FM/-EE8^67N82-[ [L;ON+G'?[<_9?_8YUSX7_ !)UOXH_
M$CQ:GB_XAZK&\;26BD6T(<C>P9E4N2%55 1%100 >,<CX[_8A^(O@GXO:Q\0
M/@#X_LO!]UKCO)J&F:LA,"L[%GV_NI5=2QW!7C^0DX;H  <9^S;\#OCOH?[8
M0^)?BWX=Z9X.T?6(KB+5TT2_M1:+N@X80K<2.2TT<;'K\Q+<5^A=?/?[-WP9
M^,/@/6-1UKXH?%J;Q?)> G^Q+2)6LXY#CYQ(Z*R@8X2-8U[G/2OH2@#C?B9I
M=G:_#WQS>0VD$-W=:/=?:+B.-5DFVV[A=[ 9; X&>@KX_P#^"1/_ "2/QO\
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M<Z5TSP7X>>%]*\6?\%%M?M-8L8=1M(M5U"Y6WN$#QF1$=D)4\'!P>>X%>_\
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MHTV\L]\TC/ 8W=[CS>69BSGY .<#%5SP2:74GV=5N+DMGY'A?[8MQ%:?MO>
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M5:7KES+//,+3[(55XHTPHWO\RF,,&SP<<<5,9+DL^Y<H2]HI170\&^'?QO\
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M;GO\B+5E#V=OF:O_  3@\%ZAX:^"%]JE_"]NFMZD]U:JXP6A5$0/CT+*^/4
M'O7U:WW3]*CL[.#3[2"UM88[:V@18HH8E"I&BC"JH'     %2-]T_2L)2YI-
MG73C[.*CV/S-_83_ .$3_P"&DM>_X2'[-_:NR?\ L;[9MV^?YPW;-W_+3;G;
MCG&[%=O_ ,%//^$4\[PEY/V7_A,]TGG^3CSOL>/E\W';?]W=_MX[UX[^S;\
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M@DES&5(88G\P#((&"8_SI<T6I1;W9?)4BX22O96.'_X**?\ )>_A[_UXQ?\
MI4U5/^"FAU%?BQX+,K^7I0TL_9WF4-"LWGMYI(P<_+Y.1@\8X-?27[1'[(W_
M  OSQYX=\2?\)9_8?]D0)#]F.G?:/.VRF3.[S4VYSCH:]+^,WP3\+_';PF="
M\36TCQH_FVUY;,$N+63&-T;$$=."""#W' IQJ1CR^1,J,I<_G8^2O$'PK_:
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MB?'G2/CAX$OFT[PW;^%+G2;GRKG3K(+]FW29?S(\*OWCO)!&<YY.<UX7<?\
M!+73VU-G@^(MS'I^_*V\FD*\H7T,@F )]]GX5]3_  1^!?AGX!>$WT+PVEQ(
ML\OVBZO+QP\]Q)@#+$     !0 !]222I*#6]V*E&I&2NK+UN>AT445S':%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?,.K?\I$U_P"R5_\
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MT5L)2,$A2[#.,CIZU*?&?A\:Y::,==TT:Q=Q^=;Z?]KC^T31XW;TCSN9<<Y
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M4 JKL0IQQQVI/A/\1O%FI?M^^(?#UWXHUJZT"*\U)8]*FU"9[5 L;%0(BVT
M$<<<5LZ;3:OL<RQ":B[;NQ]VT55U/5;+1;&6]U&\M["SA&Z2XNI5CC0>I9B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KP?P#9?\+V_;(U#67'G^$_A1:M86F>8YM:N5_?,.Q\J(;2.JOM(ZUW
MGQV^*%O\&OA/XD\6S*LDUA;'[) W/GW+D)#'CJ<R,H..@R>U;_[)/PAN/@Q\
M#]#TG5-TGB;4"^L:[<2?ZR6_N#OEW'N5RL>?2,5Q8F=ERG11CK<]CHHHKSSK
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K$U[_D*:-_UW/\JVZQ->_Y"FC?]=S_ "H
MVZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG7M.LC8VEJ\J?9(5._YPFS=O_>/SNQ\W3I7HE%3S.]R^562ML%%%%24%%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9_%'_P )27_XJCVL.X<DNQ] T5\_?\-E:1_T3/XH_P#A*2__ !5'_#96D?\
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M96D?]$S^*/\ X2DO_P 51[6'<.278^@:*^?O^&RM(_Z)G\4?_"4E_P#BJ/\
MALK2/^B9_%'_ ,)27_XJCVL.X<DNQ] T5\_?\-E:1_T3/XH_^$I+_P#%4?\
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ME)?_ (JC_ALK2/\ HF?Q1_\ "4E_^*H]K#N')+L?0-%?/W_#96D?]$S^*/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B^$?^0*G_723
M_P!"-;58OA'_ ) J?]=)/_0C6U0 4444 %%%% !1110 4444 %%%% !1110
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M]"@"2BH_M$7_ #U3_OH4?:(O^>J?]]"@"2BH_M$7_/5/^^A1]HB_YZI_WT*
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M_P!]"@"2BH_M$7_/5/\ OH4?:(O^>J?]]"@""3_D-:3_ -=&_E775QTD\?\
M;.EMYBX61LG<..*ZK[=;_P#/>+_OL4 3T5!]NM_^>\7_ 'V*/MUO_P ]XO\
MOL4 3T5!]NM_^>\7_?8H^W6__/>+_OL4 3T5!]NM_P#GO%_WV*/MUO\ \]XO
M^^Q0!/14'VZW_P">\7_?8H^W6_\ SWB_[[% $]%0?;K?_GO%_P!]BC[=;_\
M/>+_ +[% $]%0?;K?_GO%_WV*/MUO_SWB_[[% $]%0?;K?\ Y[Q?]]BC[=;_
M //>+_OL4 3T5!]NM_\ GO%_WV*/MUO_ ,]XO^^Q0!/14'VZW_Y[Q?\ ?8H^
MW6__ #WB_P"^Q0!/14'VZW_Y[Q?]]BC[=;_\]XO^^Q0!/14'VZW_ .>\7_?8
MH^W6_P#SWB_[[% $]%0?;K?_ )[Q?]]BC[=;_P#/>+_OL4 3T5!]NM_^>\7_
M 'V*/MUO_P ]XO\ OL4 3T5!]NM_^>\7_?8H^W6__/>+_OL4 3T5!]NM_P#G
MO%_WV*/MUO\ \]XO^^Q0!/14'VZW_P">\7_?8H^W6_\ SWB_[[% $]%0?;K?
M_GO%_P!]BC[=;_\ />+_ +[% $]%0?;K?_GO%_WV*/MUO_SWB_[[% $]%0?;
MK?\ Y[Q?]]BC[=;_ //>+_OL4 3T5!]NM_\ GO%_WV*/MUO_ ,]XO^^Q0!/1
M4'VZW_Y[Q?\ ?8H^W6__ #WB_P"^Q0!/14'VZW_Y[Q?]]BC[=;_\]XO^^Q0!
M/14'VZW_ .>\7_?8H^W6_P#SWB_[[% $]%0?;K?_ )[Q?]]BC[=;_P#/>+_O
ML4 3T5!]NM_^>\7_ 'V*/MUO_P ]XO\ OL4 3T5!]NM_^>\7_?8H^W6__/>+
M_OL4 3T5!]NM_P#GO%_WV*/MUO\ \]XO^^Q0!/14'VZW_P">\7_?8H^W6_\
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M!]NM_P#GO%_WV*/MUO\ \]XO^^Q0!/14'VZW_P">\7_?8H^W6_\ SWB_[[%
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M%_WV*/MUO_SWB_[[% $]%0?;K?\ Y[Q?]]BC[=;_ //>+_OL4 3T5!]NM_\
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M/MUO_P ]XO\ OL4?;K?_ )[Q?]]B@">BH/MUO_SWB_[[%'VZW_Y[Q?\ ?8H
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MMUO_ ,]XO^^Q1]NM_P#GO%_WV* )Z*@^W6__ #WB_P"^Q1]NM_\ GO%_WV*
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M!]NM_P#GO%_WV*/MUO\ \]XO^^Q0!/14'VZW_P">\7_?8H^W6_\ SWB_[[%
M$]%0?;K?_GO%_P!]BC[=;_\ />+_ +[% $]%0?;K?_GO%_WV*/MUO_SWB_[[
M% $]%0?;K?\ Y[Q?]]BC[=;_ //>+_OL4 3T5!]NM_\ GO%_WV*/MUO_ ,]X
MO^^Q0!/14'VZW_Y[Q?\ ?8H^W6__ #WB_P"^Q0!/14'VZW_Y[Q?]]BC[=;_\
M]XO^^Q0!/14'VZW_ .>\7_?8H^W6_P#SWB_[[% $]%0?;K?_ )[Q?]]BC[=;
M_P#/>+_OL4 9>K_\C%H?UF_]!%;=8&ISQS>(M$\N17P9L[2#_"*WZ "BBB@
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M,Z7_ ,^47Y4?\(SI?_/E%^5:=% &9_PC.E_\^47Y4?\ ",Z7_P ^47Y5IT4
M9G_",Z7_ ,^47Y4?\(SI?_/E%^5:=% &9_PC.E_\^47Y4?\ ",Z7_P ^47Y5
MIT4 9G_",Z7_ ,^47Y4?\(SI?_/E%^5:=% &9_PC.E_\^47Y4?\ ",Z7_P ^
M47Y5IT4 9G_",Z7_ ,^47Y4?\(SI?_/E%^5:=% &9_PC.E_\^47Y4?\ ",Z7
M_P ^47Y5IT4 9G_",Z7_ ,^47Y4?\(SI?_/E%^5:=% &9_PC.E_\^47Y4?\
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M&=+_ .?*+\J/^$9TO_GRB_*M.B@#,_X1G2_^?*+\J/\ A&=+_P"?*+\JTZ*
M,S_A&=+_ .?*+\J/^$9TO_GRB_*M.B@#,_X1G2_^?*+\J/\ A&=+_P"?*+\J
MTZ* ,S_A&=+_ .?*+\J/^$9TO_GRB_*M.B@#,_X1G2_^?*+\J/\ A&=+_P"?
M*+\JTZ* ,S_A&=+_ .?*+\J/^$9TO_GRB_*M.B@#,_X1G2_^?*+\J/\ A&=+
M_P"?*+\JTZ* ,S_A&=+_ .?*+\J/^$9TO_GRB_*M.B@#,_X1G2_^?*+\J/\
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MRH_X1G2_^?*+\JTZ* ,S_A&=+_Y\HORH_P"$9TO_ )\HORK3HH S/^$9TO\
MY\HORH_X1G2_^?*+\JTZ* ,S_A&=+_Y\HORH_P"$9TO_ )\HORK3HH S/^$9
MTO\ Y\HORH_X1G2_^?*+\JTZ* ,S_A&=+_Y\HORH_P"$9TO_ )\HORK3HH S
M/^$9TO\ Y\HORK)UC0["WU#2DCM8T268JX ^\,5U-8FO?\A31O\ KN?Y4 6/
M^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3H
MH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HO
MRK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\
MY\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9
MTO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J
M/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?
M*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+
M_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH S/\
MA&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK3HH
MS/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\HORK
M3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=+_Y\
MHORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C_A&=
M+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GRB_*C
M_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9TO_GR
MB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH S/^$9T
MO_GRB_*C_A&=+_Y\HORK3HH S/\ A&=+_P"?*+\J/^$9TO\ Y\HORK3HH Y?
MPUH=A>:4LDUK'(^]QN8>C'%:O_",Z7_SY1?E4'A'_D"I_P!=)/\ T(UM4 9G
M_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT
M4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47
MY5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_
M\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_P
MC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?
ME1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\
MSY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F?\(S
MI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G10!F
M?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1?E6G
M10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_ #Y1
M?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (SI?_
M #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1_P (
MSI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY1?E1
M_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z7_SY
M1?E1_P (SI?_ #Y1?E6G10!F?\(SI?\ SY1?E1_PC.E_\^47Y5IT4 9G_",Z
M7_SY1?E1_P (SI?_ #Y1?E6G10!S5UIEKI_B+1OLT"P[S+NV]\*,?SKI:Q-7
M_P"1BT/ZS?\ H(K;H **** "BBB@ HHHH *Y:Z_Y&:\_ZY1UU-<M=?\ (S7G
M_7*.@":BBB@ HKG/&'Q*\(_#M;4^*O%6B^&1=[A;G6-1AM/.VXW;/,8;L;ES
MCID>M<[!^T?\);J98H?BCX+FE;A4C\06C,?H!)0!Z+13(9H[B%)8G66*10R.
MA!5@1D$$=1537->TWPSI-SJFL:C:Z3IEJN^>]OIUAAB7.,N[$*HR1R30!>HK
M#\(^.O#?C_3Y;_PQX@TKQ)8Q2F"2ZTB]BNHDD !*%HV(#893CK@CUJGXP^*7
M@OX>SVT/BKQ?H/AJ:Y4O!'K&IPVC2J#@E1(PW $CIZT =117F_\ PTM\(?\
MHJO@G_PHK/\ ^.5K0?&GX>W7ANY\10^._#,WA^VF%M/JL>L6[6L4IQB-I0^U
M6.1\I.>10!V5%>;_ /#2WPA_Z*KX)_\ "BL__CE;/A7XQ> ?'>I-IWAKQQX;
M\0Z@L9F:TTK5K>ZE$8(!<I&Y.T$CG&.10!U]%<WX1^)7A'X@/>)X6\5:)XD:
MSVBY72-1ANC!NSMW^6QVYVMC/7:?2NDH **XGQ)\</ASX.UB?2=?\?\ A?0]
M5@VF6QU+6;:WGCW*&7<CN&&001D<@@UF_P##2WPA_P"BJ^"?_"BL_P#XY0!Z
M11532=6L=>TRUU'3+VWU'3[J-9K>[M)5EBF1AE61U)#*1T(.*MT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %23_D-:3_UT
M;^5==7(R?\AK2?\ KHW\JZZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *^!=4^"/ACXY?MG?M P^+5U&ZAT;_A'_L4=KJ4
M]LL?G:<#)Q&PSDQKU]#ZU]]5\A_#3_D]3]IS_N6/_3:];44G-)F=1VB[%#_A
M@WX2?\^&M_\ @_O/_CE'_#!OPD_Y\-;_ /!_>?\ QROH6BO3]G#L<?-+N?/7
M_#!OPD_Y\-;_ /!_>?\ QRC_ (8-^$G_ #X:W_X/[S_XY7T+11[.'8.:7<^>
MO^&#?A)_SX:W_P"#^\_^.4?\,&_"3_GPUO\ \']Y_P#'*^A:*/9P[!S2[GSU
M_P ,&_"3_GPUO_P?WG_QRC_A@WX2?\^&M_\ @_O/_CE?0M%'LX=@YI=SYZ_X
M8-^$G_/AK?\ X/[S_P".4?\ #!OPD_Y\-;_\']Y_\<KZ%HH]G#L'-+N?/7_#
M!OPD_P"?#6__  ?WG_QRC_A@WX2?\^&M_P#@_O/_ (Y7T+11[.'8.:7<^>6_
M8,^$;#!T_6R/0Z]>?_'*7_A@WX2?\^&M_P#@_O/_ (Y7T+11[.'8.:7<^>O^
M&#?A)_SX:W_X/[S_ ..4?\,&_"3_ )\-;_\ !_>?_'*^A:*/9P[!S2[GSU_P
MP;\)/^?#6_\ P?WG_P <H_X8-^$G_/AK?_@_O/\ XY7T+11[.'8.:7<^>O\
MA@WX2?\ /AK?_@_O/_CE'_#!OPD_Y\-;_P#!_>?_ !ROH6BCV<.P<TNY\]?\
M,&_"3_GPUO\ \']Y_P#'*/\ A@WX2?\ /AK?_@_O/_CE?0M%'LX=@YI=SYZ_
MX8-^$G_/AK?_ (/[S_XY1_PP;\)/^?#6_P#P?WG_ ,<KZ%HH]G#L'-+N?/7_
M  P;\)/^?#6__!_>?_'*/^&#?A)_SX:W_P"#^\_^.5]"T4>SAV#FEW/GK_A@
MWX2?\^&M_P#@_O/_ (Y1_P ,&_"3_GPUO_P?WG_QROH6BCV<.P<TNY\]?\,&
M_"3_ )\-;_\ !_>?_'*/^&#?A)_SX:W_ .#^\_\ CE?0M%'LX=@YI=SYZ_X8
M-^$G_/AK?_@_O/\ XY1_PP;\)/\ GPUO_P ']Y_\<KZ%HH]G#L'-+N?/7_#!
MOPD_Y\-;_P#!_>?_ !RC_A@WX2?\^&M_^#^\_P#CE?0M%'LX=@YI=SYZ_P"&
M#?A)_P ^&M_^#^\_^.4?\,&_"3_GPUO_ ,']Y_\ '*^A:*/9P[!S2[GSU_PP
M;\)/^?#6_P#P?WG_ ,<H_P"&#?A)_P ^&M_^#^\_^.5]"T4>SAV#FEW/GK_A
M@WX2?\^&M_\ @_O/_CE'_#!OPD_Y\-;_ /!_>?\ QROH6BCV<.P<TNY\]?\
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M#>PG?"P;^'+#:3Z,:[_]F/XP+\<O@EX:\5RCRM4E@^S:I;E=K0WL1\N=2O\
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M]FW%7=6 (XSW_"NPM;=;2W2%"2J# +=:WGR4ERI79G'FF[O1'S5_P[I^"O\
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M_P )%>D#G_KK[5]-:QKJV'[N$J]PK ,CJ< $9S_*L'2=(DU&16*M]FW%7=6
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M9H !EF(SG/\ ^JKNDZL&589BJ$;4CV@\]N?TH ^:M4_X)W_""US+'8:YY9(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!U96".!+>W!!*1)]<$D_PJ">U 'YQ?MF_LG?!']E_P; MAX@\6:GXWU/\
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MDZ58PVEI<7$BR22Q(@"LS* I) !R !71U6TO3X])TVTL82S16T*0HSD%BJJ
M"<=\"K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)JEQOP&C5P9.<<$\_P!:FG35N>>PYS^S$=I^ESZQ,S2O(JE<^<ZE@V"!C/\
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M /*C3KSUX^OZ54TW5)+.0Q2AF!(7YVQLQQ_GZ5T=8NK:3NS- N#\SR$M^/\
MC0!L1R)*NY&5U]5.16=JFEK<1F2,!'4,Q"IRY_S_ #K,TO5&M'5';$')( YK
MI(Y!+&KK]U@"/QH YJSU"7392LBNP QY3,5QGG./\]:Z.&:.=<HZOZ[3G%9^
MJZ5]J_>0K^^9AN);MC'^%9.GW[V,H7=B(L-XQF@#=U#3$OEXVQONR7VY)XQC
M_/I6%:W,^F3KO60+R3$Q*@Y&,_Y]*Z:WN$NH5E3.UNF?KBJFJ::MY&SJN9P
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M]3T %%%% &+X1_Y J?\ 723_ -"-;58OA'_D"I_UTD_]"-;5 !1110 4444
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M\T;S:A)8_961$W';@RR9)9V8MD9XXXKZ'HH \7_:N_9ILOVHOAW;>&KC5_[
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M#WB+_A:?VW^R=1M[_P"S?\(]Y?F^5(K[-WVH[<[<9P<9Z&OT$HH ^*?VCO\
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MN15?;D@;L8Y%? G[!_[-_A'XVS>*-5\8VTNIV6EF&WAT])Y(49Y Y+LT;*W
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M202!UY_&I;V\2QMVFD#%5QD+UY.**E1S?)'8(PY?>EN)>7D=E"SNRA@I*JS
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M8J"",>_U%9-SKR+]VFANO:XJH;>W8/O4'SHY/N\]./IZ]ZH:3HLNH2&68O$
M0X9T)WYYZG_/-&A:/]O832;6MU8JRDD$\>WU'>NMCC6&-(T&$4!0/85K.:HK
MDAN9QBZCYI"1Q)"NV-%1>N%&!65K>M):1F*(K([AE)23F,]/Z_I1KFM?85:"
M/<MP5#*^ 5'/O]#VK$TO3Y-8NGE9E95<-+N)!;)).,#V-33IJWM)[%3G]F.X
MFGZ7/JTQ:1I%5ESYS*6!QQC/^>E=?;VT=K&%1%7@ E5 S1;V\=K"L42[8UZ#
M)/?-4]8U9=-AVX;S9%;8R@$ ^^?K43G*M+E148JFKL-4UB/38QC;-)N ,8<
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MVGYN.E8/P3\)VOP1_:Z\<?#[PSNLO!.L>'H/$T.CJ[&&QNO/\B3R@2=JOC)
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M5+ 7L.[+;XU8JJ]S_D5B:;J+64BAF;R,DLJ@<\?_ *JZ:*031)(N0& 89]Z
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M"?MR?":?XQ?LV^*-*L+&;4=:L534].@MHC)*\T1R511R6:,R( .3N[U\T?\
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M=N>&3;'B"V&?R<8[J:_1&LZD5&RZFU&<JG-)[7T/,?VBOC7_ ,*!^&\GBO\
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M -=+9W:WD*N,*6&=N<D<T <T!/I-TC,@$@&0&.1@Y'8UT5C?1WL8VMF0*"X
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MIM"I'M!Y[<_I6S7-ZII[6<PDC.0[,P"+C9S_ /7_ $JUI&JEBL$N6))/F.U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;K5-/\+Z9J^F_P!D0Q/(NI6\,2;&)50GEROTV],#M75?\,__  N_Z)MX1_\
M!%:__&ZW/"WPY\)^!Y;B7PWX8T;P_+<*%F?2]/BMC(!D@,449 R>OK55*D9K
M8BE2G3>K/SU_;ST75/A+^T=I?CS0IFL9]6MDN8KB,?=N(E$4@_%/+SZ[C7N'
M_!.'X:KH7P?U3Q->0@W'B2[95+C[UM%E .>Q<R_7BOI_Q3X#\->.([>/Q)X=
MTGQ!';DM"NJ6,5R(B<9*AU."<#IZ5HZ1H]AX?TVWT[2[&VTW3[==D-I9Q+%%
M$OHJ*  /8"AU;PY2HT.6JZE]#\;_ (QZ-JOP7\??$'X>6LK0:1<7\>Z'G]]
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M#RN(P?E'W>HZ+_@F=X+\2Z#X3\5:UJ=O/9:#JTMO_9\<Z%?/9%??,H(^Z0R
M,.#@^E?4,/P4^'EOJ"WT7@+PS'?*VY;E-'MQ(&'0AMF<UV?3@5C*I'E<8K<Z
M8TI<ZG-['YJ?MYZ+JGPE_:.TOQYH4S6,^K6R7,5Q&/NW$2B*0?BGEY]=QKW#
M_@G#\-5T+X/ZIXFO(0;CQ)=LJEQ]ZVBR@'/8N9?KQ7T_XI\!^&O'$=O'XD\.
MZ3X@CMR6A75+&*Y$1.,E0ZG!.!T]*T=(T>P\/Z;;Z=I=C;:;I]NNR&TLXEBB
MB7T5%  'L!3=6\.4(T.6JZE]#\;_ (QZ-JOP7\??$'X>6LK0:1<7\>Z'G]]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-H1P]:A1YGSR6LK7LN]NM_P.F&&JNM3JU+>ZGM?=]O*QX!\*]WB_]I;Q3K+
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M?#=WIWFZ+:[!%:B>1=NT87Y@P8XSW-6IO!6C7'A,>&GL\Z((5M_LHE<?NQC
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MY02&V[F;HO89ZXYX7P5JEEX#_:4\4-XEN4L/M)N!!<W+!8_WCJZ$L> "G<G
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M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#8F$?M2$ED$,3R-]U06./:N2UC6WOF:.)V%LP'R,HSD4NM:L^H7 AB4@1LR
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M.M+.&QC,<";$)W$9)Y_'Z5!JFJ1Z;&-^[<X(7:,\BEU+4H]/MW8E&E !$18
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MJ,C))SG_ /52:9K!@^2=F:, ! JCBN@90PP1D>AK U726C<RQ!I-[$E53[M
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MJ27R'=MCDW8";LD\9S0!B:A9OIUP'&T*S$QX.<8/']*T])U7[1MBE+-,2><
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B:O\
M\C%H?UF_]!%;=8FK_P#(Q:']9O\ T$5MT %%%% !1110 4444 %<M=?\C->?
M]<HZZFN6NO\ D9KS_KE'0!-1110 4444 %%%% !1110 4444 %%%% !1110
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M$6/_ (#)_A1]9GV#V,3Y7_X;F^!?_10K+_P%N?\ XU1_PW-\"_\ HH5E_P"
MMS_\:KZH_P"$7T;_ *!%C_X#)_A1_P (OHW_ $"+'_P&3_"CZS/L'L8GRO\
M\-S? O\ Z*%9?^ MS_\ &J/^&YO@7_T4*R_\!;G_ .-5]4?\(OHW_0(L?_ 9
M/\*/^$7T;_H$6/\ X#)_A1]9GV#V,3Y7_P"&YO@7_P!%"LO_  %N?_C5'_#<
MWP+_ .BA67_@+<__ !JOJC_A%]&_Z!%C_P" R?X4?\(OHW_0(L?_  &3_"CZ
MS/L'L8GRO_PW-\"_^BA67_@+<_\ QJC_ (;F^!?_ $4*R_\  6Y_^-5]4?\
M"+Z-_P! BQ_\!D_PH_X1?1O^@18_^ R?X4?69]@]C$^5_P#AN;X%_P#10K+_
M ,!;G_XU1_PW-\"_^BA67_@+<_\ QJOJC_A%]&_Z!%C_ . R?X4?\(OHW_0(
ML?\ P&3_  H^LS[![&)\K_\ #<WP+_Z*%9?^ MS_ /&J/^&YO@7_ -%"LO\
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M_P :KZH_X1?1O^@18_\ @,G^%'_"+Z-_T"+'_P !D_PH^LS[![&)\K_\-S?
MO_HH5E_X"W/_ ,:H_P"&YO@7_P!%"LO_  %N?_C5?5'_  B^C?\ 0(L?_ 9/
M\*/^$7T;_H$6/_@,G^%'UF?8/8Q/E?\ X;F^!?\ T4*R_P# 6Y_^-4?\-S?
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M[/V[?>_$?3S&5($?V:[W Y]HO3/>OI?_ (1?1O\ H$6/_@,G^%'_  B^C?\
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M=?\ A%]&_P"@18_^ R?X4?\ "+Z-_P! BQ_\!D_PJ')R=V4E961\R:A^WO\
M _4[D;_B-9"(.?+W6EP-JD]\1?2M?2/V[/V>-/C5F^)&GFYP0SK:W9!&?^N7
MTKZ$_P"$7T;_ *!%C_X#)_A1_P (OHW_ $"+'_P&3_"M)592CR[(A02=SPM_
M^"@W[/BJQ'Q)L6(&=JV=UD^W^JKG-8_;^^!VHRLJ_$2T%MD,J-9W (.,=HOK
M7TO_ ,(OHW_0(L?_  &3_"C_ (1?1O\ H$6/_@,G^%3"?([I#E'F5CYVT?\
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MEUT_[]55U/\ X*%? 5862U^(MH9B 5D%G<;1SR.8O3VKW_\ X1?1O^@18_\
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M5G?\(_8?\\/_ !]O\:/^$?L/^>'_ (^W^- &C16=_P (_8?\\/\ Q]O\:/\
MA'[#_GA_X^W^- &C16=_PC]A_P \/_'V_P :/^$?L/\ GA_X^W^- &C16=_P
MC]A_SP_\?;_&C_A'[#_GA_X^W^- &C16=_PC]A_SP_\ 'V_QH_X1^P_YX?\
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M8O\ PA^D?\^G_D5_\:/^$/TC_GT_\BO_ (T ;5%8O_"'Z1_SZ?\ D5_\:/\
MA#](_P"?3_R*_P#C0!M45B_\(?I'_/I_Y%?_ !H_X0_2/^?3_P BO_C0!M45
MB_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\ R*_^- &U16+_ ,(?I'_/I_Y%?_&C
M_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_ )%?_&C_ (0_2/\ GT_\BO\ XT ;
M5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\ (K_XT ;5%8O_  A^D?\ /I_Y%?\
MQH_X0_2/^?3_ ,BO_C0!M45B_P#"'Z1_SZ?^17_QH_X0_2/^?3_R*_\ C0!M
M45B_\(?I'_/I_P"17_QH_P"$/TC_ )]/_(K_ .- &U16+_PA^D?\^G_D5_\
M&C_A#](_Y]/_ "*_^- &U16+_P (?I'_ #Z?^17_ ,:/^$/TC_GT_P#(K_XT
M ;5%8O\ PA^D?\^G_D5_\:/^$/TC_GT_\BO_ (T ;5%8O_"'Z1_SZ?\ D5_\
M:/\ A#](_P"?3_R*_P#C0!M45B_\(?I'_/I_Y%?_ !H_X0_2/^?3_P BO_C0
M!M45B_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\ R*_^- &U16+_ ,(?I'_/I_Y%
M?_&C_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_ )%?_&C_ (0_2/\ GT_\BO\
MXT ;5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\ (K_XT ;5%8O_  A^D?\ /I_Y
M%?\ QH_X0_2/^?3_ ,BO_C0!M45B_P#"'Z1_SZ?^17_QH_X0_2/^?3_R*_\
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M5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\ (K_XT ;5%8O_  A^D?\ /I_Y%?\
MQH_X0_2/^?3_ ,BO_C0!M45B_P#"'Z1_SZ?^17_QH_X0_2/^?3_R*_\ C0!M
M45B_\(?I'_/I_P"17_QH_P"$/TC_ )]/_(K_ .- &U16+_PA^D?\^G_D5_\
M&C_A#](_Y]/_ "*_^- &U16+_P (?I'_ #Z?^17_ ,:/^$/TC_GT_P#(K_XT
M ;5%8O\ PA^D?\^G_D5_\:/^$/TC_GT_\BO_ (T ;5%8O_"'Z1_SZ?\ D5_\
M:/\ A#](_P"?3_R*_P#C0!M45B_\(?I'_/I_Y%?_ !H_X0_2/^?3_P BO_C0
M!M45B_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\ R*_^- &U16+_ ,(?I'_/I_Y%
M?_&C_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_ )%?_&C_ (0_2/\ GT_\BO\
MXT ;5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\ (K_XT ;5%8O_  A^D?\ /I_Y
M%?\ QH_X0_2/^?3_ ,BO_C0!M45B_P#"'Z1_SZ?^17_QH_X0_2/^?3_R*_\
MC0!M45B_\(?I'_/I_P"17_QH_P"$/TC_ )]/_(K_ .- &U16+_PA^D?\^G_D
M5_\ &C_A#](_Y]/_ "*_^- &U16+_P (?I'_ #Z?^17_ ,:/^$/TC_GT_P#(
MK_XT ;5%8O\ PA^D?\^G_D5_\:/^$/TC_GT_\BO_ (T ;5%8O_"'Z1_SZ?\
MD5_\:/\ A#](_P"?3_R*_P#C0!M45B_\(?I'_/I_Y%?_ !H_X0_2/^?3_P B
MO_C0!M45B_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\ R*_^- &U16+_ ,(?I'_/
MI_Y%?_&C_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_ )%?_&C_ (0_2/\ GT_\
MBO\ XT ;5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\ (K_XT ;5%8O_  A^D?\
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MY%?_ !H_X0_2/^?3_P BO_C0!M45B_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\
MR*_^- &U16+_ ,(?I'_/I_Y%?_&C_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_
M )%?_&C_ (0_2/\ GT_\BO\ XT ;5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\
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MK_D9KS_KE'0!-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!4D
M_P"0UI/_ %T;^5==7(R?\AK2?^NC?RKKJ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH Q?&'_(N7?\ P#_T-:V(_P#5K]*Q_&'_ "+EW_P#_P!#6MB/_5K]
M* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQC$DWQ_T-%)V@_\ "&0GG_OKVJ+-NR*/J&BODF#P7^TY<S+%'\<M#+L< ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9^,E:>.2[&98;5F+[R2,[YFQ(?\ 9$?0YH ^TJ*_./\ X)%_\A?XO_[^G?\
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M_'SJ_P#U]M_(5M5B^'O^/G5_^OMOY"MJ@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#$U?_ )&+0_K-_P"@BMNL35_^1BT/ZS?^@BMN@ HH
MHH **** "BBB@ KEKK_D9KS_ *Y1UU-<M=?\C->?]<HZ )J*** /SF_X*_\
M^I^%'_774?Y6U?HG9_\ 'G!_US7^5?*G[>7[)OB_]J*'P4OA34M%T]M%:[:X
M.L3S1;O-$.W9Y<4F<>6V<XZCK7A4W["O[5>L6[Z?JOQQ2?2[A3%<0OXIU6=6
MC(P5,;1!6&.,$XH S_V=[N'QM_P5"\9ZSHS+=:;;RZG*\\62A0((-X//!=AS
MTYX[5B?M,_M)^&O^&^M%U;Q);WNI>$/A[,MLMMIJ)-)+=1AI&8*[HH*SE5.6
MZ0]^E?9'[,?[(.F_LL>"]=70KY-?\:ZI"1+JU\A@A+*&\J)47>8X@QRQ^9CU
M/15'/_L4_LG^)_V?=6\<^(O'.K:7K7B?Q).C&XTN661 @9Y)"QDCC.YW?) !
M'RCGF@#XE\=?M8^#=8_;2\(_&#P99ZOI-B'MHM:BU:"*)W',,K+Y<K@@P$=2
M.5K]?72#4;-D=8[FUGCP58!DD1AT(Z$$&OGS]MW]F34?VGOAGINCZ%=V%AK^
MFZ@MW;3ZE(Z0%"K)(C%$=AD$$?*>5%>E_ 7PKXF\"_![PIX<\7W5C>Z_I-DE
MC/<Z=*\L,BQY2-@SHC$^6$SE>N>O6@#\Q-/_ &8_"<G_  48E^&060>$K?4/
MMXLV ;=$+877V8Y_@R?+SUV^_-?KHT:PVQ1%5$5-JJHP  . !7RG8_LF^+K7
M]NNY^-+:CHI\+2*RBS6>;[;S9"#E/*V?>&?O]/?BOJ^1=T; =2,4 ?G+_P $
MB_\ D+_%_P#W]._]"NZ_1ROR^\,_\$X_VC/ =WJ,OA/XFZ)X8%\X:?\ LC7]
M1M#,%+%-_EVXW8W-C.<9/K7>^ OV/_VJM!\<>'M2UKXV?VCHUGJ-O<7MG_PE
M>JR^? DBM)'L>(*VY01AC@YP: ,2\_Y3 VWT'_IE-<_::Q:_"7_@JQJ-YXIF
M6SL]1O)%@O+@@1K]JM (6W'H-S!,]O;%?1EQ^R7XOE_;PB^-8U'1/^$50 &S
M,\WV[_D'FV^YY6S[_/W_ +OOQ77?M7?L8^%_VI+&SNKF\D\/>*K",Q6NLV\*
MR[HR<^5,A(\Q <D88%23@X)! *W[87_#0?D^%?\ A0_W]US_ &O_ ,@_IB+R
M?^/O_MK]S\>U>'_L-_M%?&;X@?M'>*O 7Q0\0?;_ .Q=,NO/T_[%91^3=Q7,
M,1_>6\8W8W..&*G.>>#7,6_[ '[2EK"N@P_&](?":CR%MX]>U)5$.,;?LP39
MC_9W8]Z^E_V4_P!B7PQ^R_)=:M%J=UXC\6WL!MKC59E\F-8BP8QQ0ACM!*H2
M69B2O! XH ^ ],_9N_X:B_;6^+WA3_A(O^$9^RZEJFH_:_L/VO=LO539L\R/
M&?-SG/\ #TYKH_VAO^":G_"AO@_X@\=?\+&_MS^R5A;[!_8?V?S?,F2+_6?:
M7VXWY^Z>F/>OK3X!_LE^+_A9^UE\1/B?JVHZ)<:!XB%^+2VLYYFND\^[CF3S
M%:)5&%0@X8\XQGK7KG[4WPHU?XX? ?Q1X*T*XLK35=46 0S:B[I NRXCD.XH
MC,.$.,*><4 <%_P3G_Y,]\"_[U]_Z6SU\]_\%9O^1D^#O_7:]_\ 0[:OKS]D
M_P"$6L? GX#>&_!.OW-C=ZKIIN3--ILCO WF7$DJ[2Z(Q^5QG*CG/UKRS]N#
M]D_Q=^TMJ_@*Z\,:CHMA'H,EPUT-6GFC+B1H2NSRXGS_ *MLYQU% 'U9#_J8
M_P#='\J?38U*QJIZ@8IU !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 5)/^0UI/_71OY5UU<C)_R&M)_P"NC?RKKJ "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH Q?&'_(N7?_  #_ -#6MB/_ %:_2L?QA_R+EW_P#_T-
M:V(_]6OTH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &+X>_X^=7_
M .OMOY"MJL7P]_Q\ZO\ ]?;?R%;5 !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\J?M.?\G>?LP?]S1_Z;XJ]EKQK]IS_D[S]F#_
M +FC_P!-\5>RUZ6&^!^IQUOB"BBBNLP"BBB@ HK@_CSXNOO 7P9\9>(-,N!:
MZEI^F336LY17V2[<(=K @X8C@@CV-?#?PW^*'[7WQ<\.G7?">I_VMI0F:W^T
M>1H\/[Q0"PVR*K<;ASC'-:QIN2O>QA4K*$N6S;\C](**\3_9WU3XH:'\.]?U
M'XWSI:ZA9W$EPD\AM L=FD2L6)MOEP"'///X8KYGN/VK/CM^T1XPU.T^"^CC
M3M(T[YL^3;/*8R2$::2Y_=JS8)"+@\$9;!-"IMMJ^P2K**3:=WTZGZ"45\;?
MLW_M@^++_P")[?"_XM:='8>)&E:WM[X1"!_/ W"*5!\IW#[KI@'*\'=FN\_:
M^_:O_P"&>M-T_2]%LX-2\6ZHC2PQW))BM80=OFNH(+$MD*N0#M8D\8)[.7-R
M@JT'!SZ(^C:*_.[5OCQ^U9\(]+L_&?C+3%G\+S.FZ"]LK144/]U7$&)HB<@
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M1C?L)GVM;JQ5E)()X]OJ.]*G345[28YR<GR1&Z3HKZ@Y,HDCC*[EDQP>:[
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MZ?+?^&/A/I7B2QBE,$EUI'AS4[J))  2A:.X(#893CK@CUH _3VBO@SX&_\
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M0!4D_P"0UI/_ %T;^5==7(R?\AK2?^NC?RKKJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Q?&'_(N7?\ P#_T-:V(_P#5K]*Q_&'_ "+EW_P#_P!#6MB/
M_5K]* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B^'O^/G5_^OMO
MY"MJL7P]_P ?.K_]?;?R%;5 !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!\J?M.?\G>?LP?]S1_Z;XJ]EKQK]IS_ ).\_9@_[FC_
M --\5>RUZ6&^!^IQUOB"BBBNLP/%/VKOBQXH^%O@/3QX*TUM0\3ZU?II]HWD
M^:EON!)D*]"> HW<9;)R!@^12?M(_%;]F626Q^-FB'Q;87,1DT_Q)X?CC5#,
M1Q!)\L:#GC.U6&"0)!@C[(HK6,DE9HQE3DWS*5CY1:W^+?QN_8S\0KK.F?:?
M&/B!Q]@T_;%9L+3SHL;M[( 2JR-\QR01ZXKP3PCX7_:S_9\\$R6VC:1)8^&[
M%I+N2SB73;YN>7.%+RGIT6OL[]IO_A:+?#M!\)XXSX@6[CDF?S(UE6!<L1&L
MHV,2P4$$\C( .:^6=5_:$_:MUC3KCPX?AE-:W5Q&UL=3@\/70=<C!82,YA!Y
MZXQ6T&VM$K'+5BHM7<KI;HTU_:LOOC_^R;\4K;4K6+3?%.DV$0N#8Y$5S;R2
M*I=5))7@,K#)'(/? [+_ ()F6UG'\%->GBVF\DUR19SWP(8M@^G)/XFI/V1?
MV0+SX>^ ?%J>/(HQ?^++3[!/I<4BN;:VVL"&=<C>Q?/RD@;5Y)Z>,>'O!?Q_
M_8O\4:U:>#_#;>-?#^I.-DD%A->P3;2=DACA8212 '!!.#_M  U3Y9*4(LE<
M\7&I4703]M58]/\ VS/!USIS&/4&CTR61HOO>:+E@I^NU4_(4?M)+'J7_!0+
MPS;:JQ>P%]H\063[OEED.W_=+,V?J:[+]G_]G3XB_%'XX)\7?BU9MI?V>=;N
MWT^Y3RY9ID $($6<Q1QX!&[DE1P<EJ[S]MO]EO6_BW-I/C3P2%;Q5I4?D2VH
ME$4ES$K%XVC<D 2(Q;@XR&ZY4 M2C&2C?H2X2E&4TNM['LG[3MM:77[/?Q"2
M]"F :-<.-W9U0LA^NX+CWKY[_P""7\\[?#?QC"S.;9-6C9%/W0QA&XCWP%S]
M!7F?C#Q9^U#\??#$?P]U+P+=:;:S-&EYJ#:5+8_:@A!S+-*WE[<@,?+"YQC&
M#@_9W[-WP3@^ GPKT_PR)H[O46=KO4+J($++</C=MSSM4*JC.,A0<#.*R?N4
MW%O5F\6ZM532T2/4*_)KX ?&W0_@'^T-XI\2>(+34+RQD%[9B/38XWEWM.K
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ME^']4U+6;=-+$VG6EE++<1;+8A]T:J6&T\'(X-.35XDQ3M-):6\SF-3^$_\
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MP]J:^&YC9ZOXQ\4SRIIHNOO-:Q)!^\D91@%AP""",;2VMX1_:'\8^$?'VF^
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MKZAKD-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,35_P#D8M#^LW_H(K;K
M$U?_ )&+0_K-_P"@BMN@ HHHH **** "BBB@ KEKK_D9KS_KE'74URUU_P C
M->?]<HZ )J*** /SU_;VM)O@Q^U%\(/C+:(8K-IX[+4)(^"WE2?,">F7@E=?
MHE>._P#!3CQ;>_$?]H Z)I$4E]8^#]$CFN&@RPC\TK+)*>V-LD R/_U?:O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"I)_R&M)_ZZ-_*NNKD9/\ D-:3_P!=&_E7
M74 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!B^,/\ D7+O_@'_ *&M;$?^
MK7Z5C^,/^1<N_P#@'_H:UL1_ZM?I0 ZBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,7P]_Q\ZO_ -?;?R%;58OA[_CYU?\ Z^V_D*VJ "BBB@ HHHH
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MHWU.QMH38*B_?F,C2AO+4\;MOS'&W=N7+46[V)<XJUWN>[T5XK\8OVOOAO\
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MB_WRN0?H,DG).0/^"A'PKCL?L]S'XDM/&&PC_A#9=!NO[3,PX\D#9Y>[(/\
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MN3K'B:739K/3]/LU0O,&DF12\S*-B(HZG=GY:V]VG&S^(C6;OT/3]4L8[/\
MX)_W[(6)E^'N]MQ'7[ .E<'\%?V7=!^,'P5\%^)?C1>7WBHW>E6ATS1(]0N;
M;3M,MA"HA$<<,BDRM& SNQ.2Q&..?0?$EQ%#^P!.CR*KM\.QM5F )_T =*\9
M^"O[5NF_#'X-^#-%^*T6H>%TM])LQIFJK8SW.GZA;&%3"8WB1MLJH0KJ1P03
MGFLH1YY>\RY/E7NG0>&-%U;]GGX[^$_!NFZQJ&K?#KQDES;Z?INJ737#:/>0
MH91'#(YW>4RY 0D\Y.2>3K'P9>?M1?'#QIX:UC6]2TOX:>"7M["YT?2;QK=]
M9OWC$D@GD0AO*C^[L!Y.""#FIOA_/J7[2GQY\)^,M.T74=,^&'@I;JYL-5U:
MT-K)K=[-'Y2M#&WS>2BY8.<<Y& >!:USQ!>_LD_'3QKXHUK1K[4OA=XZEM[V
M75M)MC<2:/?I&(W$\:C=Y3@;MX!P<#!)JJE2_N1V%&-O>EN9?Q8_9UL?V5_!
ME]\2O@C<7WA2Z\/+]NU+P[)?W%UIVL6JD>:DL<KL0X3)5U/&"!@D,*W[5WBY
M/B!I?P#U6T11:7_CG1[FV'<I*"R@\]<$5G?%O]I&/]JCPS=_#WX+VVH>(KC7
MHOL&HZP;2>#3]+MV/[UY6D12SE,@*!D]020%.[^TQX,@\#^'?V>M+MV+0V?C
MS0;6(,FUE6-64 _D/RII*FFWN#O)V#]M[2M9TWP_\))="FBL_$LOCJPALI+H
M"2&*9EE6-V4=0&(.,]JZO5?V"?ACK5K-J>OS^(M7\:&,N_C.XUNY&H+,!D2H
M%?REVG[JA,  #%1?MN,$D^![,0JCXD:023T'+U[;K&LRW\P@@#(JLR?NW)$F
M>!P/\\THQE6E=@VJ:L?.WP'UK4?C5\"=?\#?$:7_ (24Z/JU[X:OKUW>.34(
MX6VJ[.K!LE6 +9#';DG)->5_LT?L7?"3QYXM^+EKXB\*-=Q>'?%4NFZ?"-3N
MHQ# J*0A*2@MR>K$GWKVO]B/24DTWXJ3SJKX\>ZO'Y4B9P=\?/-<9X-^-OA?
M]E/XS?&31_B6^H:!_P )'KYUW1;P:=/<0ZC#)&HV1&)6^=6&#G R<9S2G*-E
M&/0<8N[;/M!$$:*BC"J, 5S.NZZMTIM[<K) Z@LQ4@@@YQS]!563QBFO:79W
M-BMQ;PW$<=PC2AHI=K(&"NA *L-W(/((JYH6A%V%Q<*5"L1Y,L?WN.O/U].U
M:TX*FN>9G*3D^6)\R?%JWN?A+^U)\&O'NFH9+GQ7.W@[4]-@(,MY:R#S(YPH
M/2!\,S'L5%?8-?+'PW0?'C]L#Q7XX*B7PG\,X6\*Z%QF-]2D -],O'#(N(>#
MR"IKZGKFG+GDY&T5RJP4445!04444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8FK_\
M(Q:']9O_ $$5MUB:O_R,6A_6;_T$5MT %%%% !1110 4444 %<M=?\C->?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5
M)/\ D-:3_P!=&_E775R,G_(:TG_KHW\JZZ@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,7QA_R+EW_ , _]#6MB/\ U:_2L?QA_P BY=_\ _\ 0UK8C_U:
M_2@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OA[_CYU?_K[;^0K
M:K%\/?\ 'SJ__7VW\A6U0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?*G[3G_)WG[,'_<T?^F^*O9:\:_:<_P"3O/V8/^YH_P#3
M?%7LM>EAO@?J<=;X@HHHKK,#Y2_X*+?$Z_\ !/P?LM!TR:2VG\2736T\T9*G
M[,B[I$!']XE%/JI8=Z3]DO\ 9'\"Z+\*]#\0>)/#]CXFU_6[2.^D;5K99XK>
M.10R1I$X*C"D9;&XDGG& +G_  4&^$>I?$CX16NJZ-;27FH>';EKM[:)2SR6
M[+MEV@=2N$;Z*U<)^RO^W-X(T?X9:/X5\=WLV@ZGHT"V<-X;:2:"YA7B/_5J
MQ1E4!3N ' (/) ZE=TO<."3BJ[]IVT,?]O']F/PMX+\&P?$+P;IL/ARZL[N.
M&]M-/7RH'5SA)$1>(V5]H^4 '=ZCGZ!^ 7QVM]:_9?TOQ]XLOFC_ +.LY$U*
M\E^](\+%"W^TSX7@=6;%?+W[8O[5FD_'C3-+^'7PXAO-<AN[R*6:\2VD1KF0
M9$<$43*'/S$$D@<J ,\UO_%C]EWXJP_L\?#7X>>$;!M3CMA<7WB"WBO;>!3=
M.RO&K&21=X0O(HQD94$_PU7+>$5-D*7+4E*DKJW3N<;\/;&Y_:[^-NO_ !6\
M>1/9_#?PO&US-#(C21+!$#)':C )? S))M!SDC WK7WI\+OC%X/^,FE7>H>#
M=6_M>RLYA;S2"UF@V/M#;<2HI/!'08K\_6\!?M3_  J^$&L:"--CTCP+;V-R
MU]!&VDR?N&5C,2P)E8E2W();ICH*7]@__A;_ /;MK_PA_P#R3W^V8O\ A(/^
M//\ NKN_UO[W[F/]7_.JG!23=]A4JCA)1<7=[Z?UH:/Q _XQM_;\M-<;]SHV
MK7J7S,W3R+O='.?^ R&4_P# 17:_\%#/$$_CSXA?#SX5Z5(K7-S.ES+QN"R3
M/Y,.<>@\PGV85L?\%-OA^VI>"_"_C&WBS)I=T]C<NHY\J8 H2?0.F/K)7F?[
M&L>K_M!?M/3^/?$9^TOH5A',[\[?.$2P0CV. [_5:(ZQ53LB97C*5%=7_P .
M=3_P3SUNX^'WQ5^(?POU6;_24=I(TS\GG6TC12[?=E93]$K(\ L/VBO^"@6H
M:S+F?1O#L\EQ$K E?+M<10X],RE7_$UE?MB1:I^SW^U1:^/_  ^/(;6;-KN)
MNB>?Y303+[\%'/N]>L_\$T/AV=)^'_B#QG=1G[3K5V+6W=NIAASN(^LC,#_N
M"B5E%U.Z"";DJ+Z,^S:^)/\ @J)_R)/@;_L(W'_HI:^VZ^)/^"HG_(D^!O\
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M,V^CKX*T?6"D866_U>SCNKF9L89R[J2I/7"X [ 5\3?M'> T_8Y_:$\+^*?
M\LUAI5X/ML5F')\O:X6>WR<[HV5AUS]\CL#7U)X/_P""@?PBU[PW;WVKZS<>
M'-3\L&XTVYL9YF1^ 0KQ(RN,]#D'')"\@?*GQ-\4:C^WA^T5HVE>%]/NK?P[
M8(+=;B51F&V\S=-=2=ESD +GG"#J<5I34U)\^QC6=-P2I[]+'6?\%%M%N[CX
M@> _&-[;7%WX,N;"*W(B?:0PD:22/_99HW7![X/]VLC]I[XC?LZ^)OA#:V'P
MZT6Q@\4B6$P26&CO9RVZ#&\32%%\S*Y7J_S<Y[U6_;6DDT7]J;0%\96EW=^
M;..Q-I9Q$A7LEV_:%CY W%@X/(/W>1P:Z3]H[XH?LR^(?A'?V/@O1=+?Q0X0
M6,FDZ$]A) ^1EI)#'&&7&01ELDCCN-([0W,9[U-4O7]#V#X8_!/6_$/[!K^"
MM<@EAU:^L+BZL[6;(>)C*T]LK#J,D(2.VX@^E</_ ,$S_B5%'X9\8>#KZ583
MITHU>'S.,1L DWX*40_\#KTC_@G;-XAE_9]3^VO.-@NHS+I+3DDFV 7.W)^X
M)/, ^AKXT^.K:S^SE^T1\1;/1L6EMKEM=0KM! -I>+O(7TVL<#W2H2YG*!I*
M7LU3JKT.;^(5CJWQSUCXJ?%.WP-,TV^AED5E.3%-*8H0#TRJJF:^V;S]H/R_
MV!X_%<=RSZR^EKH7F$_/]K_X]V<^^ 9/RIW[)?P&MKK]D+4-(U*(1W'C:"XN
M)78<HCKL@;\ JR#W:O@-=:\42>'X_A)Y;!?^$B\_[(3\WVPK]GV8^N?Q-::5
M';LS+WJ*YOYE^)]^_P#!-_X>KX9^"]YXDECQ>>(KUG#%<'R(<QH/^^_-/_ A
M7UE7/?#SP?;?#[P+H/AJS ^SZ7916H8?Q%5 +?4G)_&NAKAG+FDV>I3CR043
M\M_$&M>#_#O[>WB#4/'L=I+X4AU6[^VI?61NX3FW<)NB",6^<I_"<'![9KZ7
MT_XO?LB:I?VUE:Z7X1EN;F588H_^$-<;G8@*,FUP.2.M?+/C[_A!_P#AN+Q-
M_P +'_Y$S^U;G[?_ *__ )XMY?\ J/WG^LV?=_'C->T:??\ [$6EW]M>VK^5
M<VTJS128UL[74@J<'@\@=:[)).V^W0\VG)IRUCOU.@_:D^,WQ"_9K^+7@^72
M]42/X87BP@:+#IULL<20E5F@1Q%O4%-K+AN-Q X&*]O_ &D/C=#\*_@1J7B[
M2KN,WM[ D.C3 !@\TRYC< @@[5S)@C!"8KF/VJ_!6G?M#_LTW&K>'V_M%[>W
M77M(G6)E>550L5"LH;YXRP"D YV^E?"&A^,/$?[2D?PE^$!W16VES/;&=3DO
M&6),I!_YY0*P'/8^M9QBII-]-S:I4E3E)+6^Q[%\8O$'CKQE^PMIOB7Q]K#:
MMJ.KZ_#<6@:UAM_)M0LBH,1(H.XJSY/9A7NOP;^+&E_!3]A_PMXLU9&GAM+)
MUAM8SA[B9IY D8..,GJ>P!/:LS_@H5I5KH7[,>G:;8PK;V5GJ=G;P0KT2-(Y
M%51] !7G/C+P#JOCO_@G'X+.D6[W<^CN-4EMXUW.\*27".0/]D2;C[*:>DHJ
M^UQ>]3G*VK42II7Q@_:V^,%B/%G@W2(M/\-RLS6\%O;V2QR(IQ\OVDF1^A&Y
M>"<XQT'M?[)W[5VH_&B_UCPEXNTF/1O&^D(TDD4:-%'.BML<%&):-T8J&7GK
MD8Y ^*?A#X9_9S\0>$(9/'_BOQ;X9\2QEEN(;9%EMIN3M:+9:R$#;C(<CG/4
M5](?LK^#?A)HT?C'X@_"O4/%.MZ]X?L+J#^R=;:',P*%XV5(XE)$ACPOS9Z@
M@'%54C&S5OP(I3GS)\WKK^A7\1>/OVP?&NM:H_AOPS%X<T^RNI;=8X8+11($
M8KE6O"6E!Q]]  >P'2NC_9'_ &NO%7C[X@7GPY^(UG%#XBA6;R+M8/(E,L1_
M>0S1CY0P 8@@+]P@@DYKP?X6^/O%_P"T+J&OZGXM_:.D^&$EJR&"S^UFTCF5
MMQ/EHLT*87:!P6;GGU-?]E'RQ^VY:"'Q--XSC62^ U^X5P]]BWD'FD.S-S[D
M_6FXKE::6@HU)<T6F[-]7^A^H=%%))(L:,[L$11DLQP /4UP'JGSY^U!]H^*
M'B3P'\#]-DD63QA?"[UR2$D-;Z/;,))R2/NF1E"J3P2".]?6UQ-:>'=-@M+>
M);6&.+RK:&% $C55 50.@ &!BOE;]DEE^(7C3XB?'B^42Q:Q<?V!X7CD.UAI
M-M)M:5,C($LH9B/5#7T-_I&LWA($K(TGNXC#'_/Y5P<OM9N<MD=5^2/*MQG^
MD:U> $AYF&.< <"NMTO38]/@&U=LK*OF<DY('_US2:9I<>G0A?EDD!)\S8 >
M:FO+R.RA9W90P4E59@"V!T%9U*GM/<AL7"'+[TMPOKZ+3X1),2%+;1@9Y_R*
MXZXNKC5[J-'8.Y.U. .IIUY=W&L73F-)&4X80J2P7  S_GUKI-*T5-/4[BLS
MDA@S)@K6J4:$;O<AWJ.RV#1=)73X5=TQ<D%78,2,9_\ U5=NKI+.W::3(1<9
MP,]3BG33QVZAI9%C7.,NP KC]0U.;6)U6))%!7;Y*L6W8).<8_SBL(1E6ES/
M8TE)4U9#=4U2749BN_="')C& .*W=$T,6?[V=!]H5CM96R,$8_QI-%T-;9!+
M-B0R(#Y<D?W#^-;$DB0H7D940=68X%74J*W)#8F$/M2$FE6&%Y&^ZBEC]!7(
MZSK+7TCQQOFVX(4J <XJ36=8DOYA! &559D_=N2),G X'^>:N:'H6W9<SCD@
M@PR1]/?G_"KA&-)<\]R92=1\L0T+0]N)[E 3\KQ$-T[_ .%=#325BCR<(BCZ
M  5S6O:X9&-O;M@*P;SHY/O<=./KZ]JQ]ZO(T]VG$CUK7C=?N[=SY#+APR]\
MTNAZ']JQ-<(&MV4[<-@YS_\ KIVB:"\CK/.&CV/_ *J2/[PQ[UTR(L:A44*H
MZ!1@5K4J*FN2F9QBY/FD.KG=<UXJQAMG(92R297\/\:=KVN*J&WMV#[U!\Z.
M3[O/3CZ>O>J&DZ++J$AEF+Q $.&="?,SSU/^>:5.FHKGJ#G)R?+$31-':^D2
M610UL"5;YL'I_CBNMBC6&-(T&$4!0/841Q)"NV-%1>N%&!65K>M):1F*(K([
MAE)23F,]/Z_I6<I2KRLBTE36HS7-<^R;H8'*W"L,Y7(QC/\ A6+I>FR:I<;\
M!HU<&3G'!//]:73]+GU:8M(TB*5SYS*6!QQC/^>E=?;VT=K&%1%7@ E5 S6T
MI1HQY8[F:BZCN]@MK>.TA6*)=L:]!G/?-4-:UA;"-HD8K<E0R?+D=?\ ZQI^
MJ:Q'IL8QMFDW &,. 1QG/^?6N9L[.XU:X0.TK(?E,S L%P,XS_GK6=.GS>_/
M8N<K>['<;!;W&LW4A7:TI&YL\5V5G90V,9CA7:A.XC)//^13+&PCL8$10I=1
M@R!0":;J6I1Z= SDJ\@ (B+@$Y./\_2E4J.H^6.P1BH*[&ZIJ<>G0_,2)'5M
MF!GD#_ZXKD_](UJ\ )#S,,<X X%._P!(UB\) E9&D]W$88_Y_*NJTS2X].A"
M_+)("3YFP \UM[N'C_>,]:K\A=+TV/3X!M7;*RKYG).2!_\ 7-2WU]%I\(DF
M)"EMHP,\_P"11>7D=E"SNRA@I*JS %L#H*Y"\N[C6+IS&DC*<,(5)8+@ 9_S
MZUC3INJ^:6QI*2@K(XGXX:3K'Q#^%?B_0M,A^W:MJ.DW5G9V^Y(_,D>-E1=S
M$*,DCDD#WKJ/V?\ P3>^!?@WX'TC6+3['KNGZ):V=Y#YJR>7(D2JRY4E3@KC
M()''6NRTG14T]"7*S.2&#,F"M7YIX[=0TLBQKG&78 45*BD^6&P0C97D-NKI
M+.W::3(1<9P,]3BN/U35)=1F*[]T(<F,8 XIVH:G-K$ZK$DB@KM\E6+;L$G.
M,?YQ6SHNAK;()9L2&10?+DC^X?QK6,8T%S2W(DW4=H[#M$T,6?[V=!]H5CM9
M6R,$8_QK6FE6&%Y&^ZBEC]!2R2)"A>1E1!U9C@5RFLZQ)?S"" ,JJS)^[<D2
M9.!P/\\UC&,JTKLT;5-61'K.LM?2/'&^;;@A2H!SBM#0M#VXGN4!/RO$0W3O
M_A1H>A;=ES..2"##)'^O/^%;Y*Q1Y.$11]  *TJ5%%>SID0BV^:0ZN4UK7C=
M?N[=SY#+APR]\U)KVN&1C;V[8"L&\Z.3[W'3CZ^O:DT307D=9YPT>Q_]5)']
MX8]Z=."IKGF$I.3Y8C=#T/[5B:X0-;LIVX;!SG_]=<E^U%\7G^"/P3\0^([-
M#/KCQK8:/;*NYY[^8^7 JK_%ACN([A#7JJ(L:A44*HZ!1@5\L>,'7]H3]LKP
M[X7B*W?@_P"%=NGB#5"OS12ZQ."+.(\$9C3,H.>I8=JYZE1U'=FL8J*L>E_L
MH?"Y?@]\"O#GAN1A+J42O/J5SG<T]Y(Q>9RW5OG) )YVJOI7KU8OA'_D"I_U
MTD_]"-;59%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8FK_P#(Q:']9O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!4D_Y#6D_]=&_E775R,G_ "&M)_ZZ-_*NNH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#%\8?\ (N7?_ /_ $-:V(_]6OTK'\8?\BY=
M_P# /_0UK8C_ -6OTH =1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M+X>_X^=7_P"OMOY"MJL7P]_Q\ZO_ -?;?R%;5 !1110 4444 %%%% !1110
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M ,@5/^NDG_H1K:K T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-IPC:RLO0X;X?_"#1_ASJ6J7^GW=_=W6HX\Z2^D1S]XL<;47J3SG/04OP_\
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MNMM+_-GCTLMDJL:E1QT=]%9M^?\ P"6BBBODSWPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@"I)_R&M)_ZZ-_*NNKD9/\ D-:3_P!=
M&_E774 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B^,/\ D7+O_@'_ *&M
M;$?^K7Z5C^,/^1<N_P#@'_H:UL1_ZM?I0 ZBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\+'\)_]#1HO_@PA_P#BJ+H#HJ*YW_A8_A/_ *&C1?\ P80__%4?\+'\)_\
M0T:+_P"#"'_XJBZ Z*BN=_X6/X3_ .AHT7_P80__ !5'_"Q_"?\ T-&B_P#@
MPA_^*HN@.BHKG?\ A8_A/_H:-%_\&$/_ ,51_P +'\)_]#1HO_@PA_\ BJ+H
M#HJ*YW_A8_A/_H:-%_\ !A#_ /%4?\+'\)_]#1HO_@PA_P#BJ+H#HJ*YW_A8
M_A/_ *&C1?\ P80__%4?\+'\)_\ 0T:+_P"#"'_XJBZ Z*BN=_X6/X3_ .AH
MT7_P80__ !5'_"Q_"?\ T-&B_P#@PA_^*HN@.BHKG?\ A8_A/_H:-%_\&$/_
M ,51_P +'\)_]#1HO_@PA_\ BJ+H#HJ*YW_A8_A/_H:-%_\ !A#_ /%4?\+'
M\)_]#1HO_@PA_P#BJ+H#HJ*YW_A8_A/_ *&C1?\ P80__%4?\+'\)_\ 0T:+
M_P"#"'_XJBZ Z*BN=_X6/X3_ .AHT7_P80__ !5'_"Q_"?\ T-&B_P#@PA_^
M*HN@.BHKG?\ A8_A/_H:-%_\&$/_ ,51_P +'\)_]#1HO_@PA_\ BJ+H#HJ*
MYW_A8_A/_H:-%_\ !A#_ /%4?\+'\)_]#1HO_@PA_P#BJ+H#HJ*YW_A8_A/_
M *&C1?\ P80__%4?\+'\)_\ 0T:+_P"#"'_XJBZ Z*BN=_X6/X3_ .AHT7_P
M80__ !5'_"Q_"?\ T-&B_P#@PA_^*HN@.BHKG?\ A8_A/_H:-%_\&$/_ ,51
M_P +'\)_]#1HO_@PA_\ BJ+H#HJ*YW_A8_A/_H:-%_\ !A#_ /%4?\+'\)_]
M#1HO_@PA_P#BJ+H#HJ*YW_A8_A/_ *&C1?\ P80__%4?\+'\)_\ 0T:+_P"#
M"'_XJBZ Z*BN=_X6/X3_ .AHT7_P80__ !5'_"Q_"?\ T-&B_P#@PA_^*HN@
M.BHKG?\ A8_A/_H:-%_\&$/_ ,51_P +'\)_]#1HO_@PA_\ BJ+H#HJ*YW_A
M8_A/_H:-%_\ !A#_ /%4?\+'\)_]#1HO_@PA_P#BJ+H#HJ*YW_A8_A/_ *&C
M1?\ P80__%4?\+'\)_\ 0T:+_P"#"'_XJBZ Z*BN=_X6/X3_ .AHT7_P80__
M !5'_"Q_"?\ T-&B_P#@PA_^*HN@.BHKG?\ A8_A/_H:-%_\&$/_ ,51_P +
M'\)_]#1HO_@PA_\ BJ+H#HJ*YW_A8_A/_H:-%_\ !A#_ /%4?\+'\)_]#1HO
M_@PA_P#BJ+H#HJ*YW_A8_A/_ *&C1?\ P80__%4?\+'\)_\ 0T:+_P"#"'_X
MJBZ Y3]I#XI2?"#X/Z[KMFC3:W(BV.D6Z+N>:]F/EPJJX.XACNQW"FN]_9C^
M"L/P)^#7AOPRX636(;?SM4N@Q8SWDI\R=BW\7SD@$\[56OG;5O%/ASXU?M>>
M&-'NM=TM?!?PXMQK]W+-=QK!=:K*,6L8).&,:GS,@\'<#7UG<?%KP3:J&D\7
M:& 3CY=0B;^35YE:;E/E1UTX\L;LZ6\NTL;9YY Q1<9"]>3C^M<?>7DVK7BH
M7RAD(B# #:">,X_"N;NOBCX9UJ[0GQ-H0DV[0%U&%1QD]WKI-'\>>"]-AS_P
MEVB^9(JEU;4X" 0.@PWN:T7+05WJR7>H[+8Z/1]%2P17E56N5)^=2>AK0GF%
MO#)*P)5%+''7@9KF9OBMX*MXS))XNT,*.N-1A/Z!JY/5?BQX6U:Z6,>)]#**
M[+&1J$0R"1C.7]A6,8RK2O)FC:IJR.AU?5GU&9@K,+;(948 $'&/\:V]'T 6
MO[RX5))0P9&4GBN<T+QOX-L%$TGBW15N&4JRG4X"!S[-[#O6I)\5/!<<;.WB
MW0PJC)QJ,)_]FJZE33DI[$QA]J1U-<AK.N-?G9"72W*@,C <D'.?Y5SNN_&#
MPG?L88_%&AM;JP96%_$">/=O<]JNZ%XS\'VK"XN/%FBQSHQ"J-4MR"",9X;W
M-5",:2YY[BDW-\L3H=%T ,HFN522.10R $Y'UKHZYC_A:'@W_H;="_\ !E#_
M /%5SFN_&3PC=*;>W\4Z') Z@LQOHP00<XY;V%9>]7D7I31T>O:XTC-;P%T"
MEXY=P&&[<?K3-#T/[5LN)@CV[ C;DYSTKG=#\9>#V=9[GQ7HL>TJ\6-4@Y[\
MC=]*Z7_A:'@W_H;="_\ !E#_ /%5I.HJ:Y($1BY/FD=+&@C144851@#VK#U[
M7&MV-O 7CG1@6; P01G'ZBN:USXR^$/+,%MXJT.3<&23-]'QVX^;ZUG:3XP\
M(7C;[CQ5HL<!4E674X <YQC&[ZTJ=-17/4'*3?NQ.CT31VOW69MA@5]KJQ()
MXKK8($MHECC7:B]!7.?\+0\&_P#0VZ%_X,H?_BJS-6^,W@^S7;;^*]"DG# ,
MK7\9&,>N[Z5$I2K2LBE%4T='KVL?84,$>];AE#*X ('/_P!8U@Z=I\VL7$C[
MD)5@S[R1G)YZ"N;TOQKX2OIE,GBG14M\D,PU. $<>A;Z=JZ^#XE>#+>&.)?%
MVAE44*,ZE#G@8_O5M*4:*Y8ZLS2=1W>QTEK:Q6<?EPIL3.<9)YJIK.J+IL."
M&\R16",H! ('4Y^HKFM4^,7@VRA81>+-#>XP"JF_B(//J&],]ZYJV\?^%M4O
M&D;Q1HBHTFZ0C4H%P"><9?ZUE3I\WOS>A<I6]V)T=O;W&N7C_O%,I7<6?@<8
M'85U]C816,>(T",P&[!)R17-V?Q%\%6-LD$?B[1"BYP6U*#/)S_>]ZCU#XO>
M"[.%C_PENAF4J2B_VA$02!WPU%2HZCY8[!&*@KO<Z?4-0CTV%9959E+;?D )
MZ$^OM7'JUQK5Y&CR!I6&T,W P,GL*YV3XD>&=8O))!XFT/S&&2!J4*C@ =WK
MK-/^('@G386BB\7Z*REMWSZG 3T _O>U:^[0CWDR-:K\CH=+TN/3XE.Q?/V[
M7=22#5B\NTL;9YY Q1<9"]>3C^M<U<?%KP3:J&D\7:& 3CY=0B;^35R%U\4?
M#.M7:$^)M"$FW: NHPJ.,GN]8P@ZKYI/0TE)05D='>7DNK7BJ7RAD(B# #:"
M>,X_"NDT?14L$5Y55KE2?G4GH:YS1_'G@O38<_\ "7:+YDBJ75M3@(! Z##>
MYJ[-\5O!5O&9)/%VAA1UQJ,)_0-55*G-[D-A1A;WI;G33S"WADE8$JBECCKP
M,UQVKZL^HS,%9A;9#*C  @XQ_C7/:K\6/"VK72QCQ/H91798R-0B&02,9R_L
M*V="\;^#;!1-)XMT5;AE*LIU. @<^S>P[U<5&BN:6Y$FZCLMCH]'T%;7]Y<*
MDD@8,C*3Q6U7+2?%3P7'&SMXMT,*HR<:C"?_ &:N7UWXP>$[]C#'XHT-K=6#
M*POX@3Q[M[GM6*4JTM31M4UH=%K.N-?G9"72W*@,C <D'.?Y5<T7059!-<JD
MD<BAD )R/K7/:%XS\'VK"XN/%FBQSHQ"J-4MR"",9X;W-;O_  M#P;_T-NA?
M^#*'_P"*K6I445R4R(P<GS2.GKF->UQI&:W@+H%+QR[@,-VX_6N<UWXR>$;I
M3;V_BG0Y('4%F-]&""#G'+>PINA^,O![.L]SXKT6/:5>+&J0<]^1N^E%.$::
MYYA*3D^6)T6AZ']JV7$P1[=@1MR<YZ5U$:"-%11A5& /:N:_X6AX-_Z&W0O_
M  90_P#Q58>N?&7PAY9@MO%6AR;@R29OH^.W'S?6LVY5I%I*FCI=>UQK=C;P
M%XYT8%FP,$$9Q^HK#@CM[33[K5M0GAM]+L4>:ZDE8@)&B[F8X'0 $_A6+I/C
M#PA>-ON/%6BQP%259=3@!SG&,;OK7E?[8GQ$M_B%X8\-_!_P3KEI?:_\1=27
M2IYM.N$F-GIJ8DO9FV[L 1C;@]0[8Z5K*:I+DAN1&+J/FD3?L2Z+/XT7QM\;
M]6M6M[_Q[J!_LJ&8?-:Z/;DQVL8R."V&8XX;"-7U%6;X;\/V'A+P]IFAZ5;K
M::9IMM'9VL"# CBC4*BCZ "M*N(Z#%\(_P#(%3_KI)_Z$:VJQ?"/_(%3_KI)
M_P"A&MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,35_^1BT/ZS?^@BMN
ML35_^1BT/ZS?^@BMN@ HHHH **** "BBB@ KEKK_ )&:\_ZY1UU-<M=?\C->
M?]<HZ )J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *DG_ "&M
M)_ZZ-_*NNKD9/^0UI/\ UT;^5==0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% &+XP_Y%R[_P" ?^AK6Q'_ *M?I6/XP_Y%R[_X!_Z&M;$?^K7Z4 .HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#%\/?\?.K_ /7VW\A6U6+X>_X^
M=7_Z^V_D*VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#A?B=\#? ?QG_LW_A-_"]CXD_LWS?L?VU2?)\S9YFW!'7RTS_NBN&_X
M8<^ W_1+]"_[]O\ _%5[G10!X9_PPY\!O^B7Z%_W[?\ ^*H_X8<^ W_1+]"_
M[]O_ /%5[G10!X9_PPY\!O\ HE^A?]^W_P#BJ/\ AASX#?\ 1+]"_P"_;_\
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M_P"_;_\ Q5>YT4 >&?\ ##GP&_Z)?H7_ '[?_P"*H_X8<^ W_1+]"_[]O_\
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MM_\ XJC_ (8<^ W_ $2_0O\ OV__ ,57N=% 'AG_  PY\!O^B7Z%_P!^W_\
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M[]O_ /%5[G10!X9_PPY\!O\ HE^A?]^W_P#BJ/\ AASX#?\ 1+]"_P"_;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &)J_P#R,6A_6;_T$5MUB:O_ ,C%H?UF_P#016W0
M 4444 %%%% !1110 5QNJ6,=WXEO [.,1H?E8CM795RUU_R,UY_URCH J_V'
M;_WYO^_AH_L.W_OS?]_#6A10!G_V';_WYO\ OX:/[#M_[\W_ '\-:%% &?\
MV';_ -^;_OX:/[#M_P"_-_W\-:%% &?_ &';_P!^;_OX:/[#M_[\W_?PUH44
M 9_]AV_]^;_OX:/[#M_[\W_?PUH44 9_]AV_]^;_ +^&C^P[?^_-_P!_#6A1
M0!G_ -AV_P#?F_[^&C^P[?\ OS?]_#6A10!G_P!AV_\ ?F_[^&C^P[?^_-_W
M\-:%% &?_8=O_?F_[^&C^P[?^_-_W\-:%% &?_8=O_?F_P"_AH_L.W_OS?\
M?PUH44 9_P#8=O\ WYO^_AH_L.W_ +\W_?PUH44 9_\ 8=O_ 'YO^_AH_L.W
M_OS?]_#6A10!G_V';_WYO^_AH_L.W_OS?]_#6A10!G_V';_WYO\ OX:/[#M_
M[\W_ '\-:%% &?\ V';_ -^;_OX:/[#M_P"_-_W\-:%% &?_ &';_P!^;_OX
M:/[#M_[\W_?PUH44 9_]AV_]^;_OX:/[#M_[\W_?PUH44 9_]AV_]^;_ +^&
MC^P[?^_-_P!_#6A10!G_ -AV_P#?F_[^&C^P[?\ OS?]_#6A10!G_P!AV_\
M?F_[^&C^P[?^_-_W\-:%% &?_8=O_?F_[^&C^P[?^_-_W\-:%% &?_8=O_?F
M_P"_AH_L.W_OS?\ ?PUH44 9_P#8=O\ WYO^_AH_L.W_ +\W_?PUH44 9_\
M8=O_ 'YO^_AH_L.W_OS?]_#6A10!G_V';_WYO^_AH_L.W_OS?]_#6A10!G_V
M';_WYO\ OX:/[#M_[\W_ '\-:%% &?\ V';_ -^;_OX:/[#M_P"_-_W\-:%%
M &?_ &';_P!^;_OX:/[#M_[\W_?PUH44 9_]AV_]^;_OX:/[#M_[\W_?PUH4
M4 9_]AV_]^;_ +^&C^P[?^_-_P!_#6A10!G_ -AV_P#?F_[^&C^P[?\ OS?]
M_#6A10!CR:/"-4T^+?+MD<@GS#GIV/:NA_X12S_YZW7_ '_:LN3_ )#6D_\
M71OY5UU &+_PBEG_ ,];K_O^U'_"*6?_ #UNO^_[5M44 8O_  BEG_SUNO\
MO^U'_"*6?_/6Z_[_ +5M44 8O_"*6?\ SUNO^_[4?\(I9_\ /6Z_[_M6U10!
MB_\ "*6?_/6Z_P"_[4?\(I9_\];K_O\ M6U10!B_\(I9_P#/6Z_[_M1_PBEG
M_P ];K_O^U;5% &+_P (I9_\];K_ +_M1_PBEG_SUNO^_P"U;5% &+_PBEG_
M ,];K_O^U'_"*6?_ #UNO^_[5M44 8O_  BEG_SUNO\ O^U'_"*6?_/6Z_[_
M +5M44 8O_"*6?\ SUNO^_[4?\(I9_\ /6Z_[_M6U10!B_\ "*6?_/6Z_P"_
M[4?\(I9_\];K_O\ M6U10!B_\(I9_P#/6Z_[_M1_PBEG_P ];K_O^U;5% &+
M_P (I9_\];K_ +_M1_PBEG_SUNO^_P"U;5% &+_PBEG_ ,];K_O^U'_"*6?_
M #UNO^_[5M44 8O_  BEG_SUNO\ O^U'_"*6?_/6Z_[_ +5M44 8O_"*6?\
MSUNO^_[4?\(I9_\ /6Z_[_M6U10!B_\ "*6?_/6Z_P"_[4?\(I9_\];K_O\
MM6U10!B_\(I9_P#/6Z_[_M1_PBEG_P ];K_O^U;5% &+_P (I9_\];K_ +_M
M1_PBEG_SUNO^_P"U;5% &+_PBEG_ ,];K_O^U'_"*6?_ #UNO^_[5M44 8O_
M  BEG_SUNO\ O^U'_"*6?_/6Z_[_ +5M44 8O_"*6?\ SUNO^_[4?\(I9_\
M/6Z_[_M6U10!B_\ "*6?_/6Z_P"_[4?\(I9_\];K_O\ M6U10!B_\(I9_P#/
M6Z_[_M1_PBEG_P ];K_O^U;5% &+_P (I9_\];K_ +_M1_PBEG_SUNO^_P"U
M;5% &+_PBEG_ ,];K_O^U'_"*6?_ #UNO^_[5M44 8O_  BEG_SUNO\ O^U'
M_"*6?_/6Z_[_ +5M44 8O_"*6?\ SUNO^_[4?\(I9_\ /6Z_[_M6U10!B_\
M"*6?_/6Z_P"_[4?\(I9_\];K_O\ M6U10!B_\(I9_P#/6Z_[_M1_PBEG_P ]
M;K_O^U;5% ')>)/#]M8Z+<SQR3LZ[<!Y2PY8#I^-:2^%;,J#YMST_P">QI?&
M'_(N7?\ P#_T-:V(_P#5K]* ,?\ X12S_P">MU_W_:C_ (12S_YZW7_?]JVJ
M* ,7_A%+/_GK=?\ ?]J/^$4L_P#GK=?]_P!JVJ* ,7_A%+/_ )ZW7_?]J/\
MA%+/_GK=?]_VK:HH Q?^$4L_^>MU_P!_VH_X12S_ .>MU_W_ &K:HH Q?^$4
ML_\ GK=?]_VH_P"$4L_^>MU_W_:MJB@#%_X12S_YZW7_ '_:C_A%+/\ YZW7
M_?\ :MJB@#%_X12S_P">MU_W_:C_ (12S_YZW7_?]JVJ* ,7_A%+/_GK=?\
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M_GK=?]_VK:HH Q?^$4L_^>MU_P!_VH_X12S_ .>MU_W_ &K:HH Q?^$4L_\
MGK=?]_VH_P"$4L_^>MU_W_:MJB@#%_X12S_YZW7_ '_:C_A%+/\ YZW7_?\
M:MJB@#DM'\/VUU/J*O).!%<,B[92.,#KZFM/_A%+/_GK=?\ ?]J/#W_'SJ__
M %]M_(5M4 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UN
MO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U
M10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?
M\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O
M_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?
M_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_
M #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[
M_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_
M +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M4
M4 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\
M"*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"
M*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/
M6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6
MZ_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_
M[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[
M4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B
M_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9
M_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6
M?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[5EZMX?MK>_TR
M-9)RLTI5MTI)'';TKKJQ->_Y"FC?]=S_ "H 7_A%+/\ YZW7_?\ :C_A%+/_
M )ZW7_?]JVJ* ,7_ (12S_YZW7_?]J/^$4L_^>MU_P!_VK:HH Q?^$4L_P#G
MK=?]_P!J/^$4L_\ GK=?]_VK:HH Q?\ A%+/_GK=?]_VH_X12S_YZW7_ '_:
MMJB@#%_X12S_ .>MU_W_ &H_X12S_P">MU_W_:MJB@#%_P"$4L_^>MU_W_:C
M_A%+/_GK=?\ ?]JVJ* ,7_A%+/\ YZW7_?\ :C_A%+/_ )ZW7_?]JVJ* ,7_
M (12S_YZW7_?]J/^$4L_^>MU_P!_VK:HH Q?^$4L_P#GK=?]_P!J/^$4L_\
MGK=?]_VK:HH Q?\ A%+/_GK=?]_VH_X12S_YZW7_ '_:MJB@#%_X12S_ .>M
MU_W_ &H_X12S_P">MU_W_:MJB@#%_P"$4L_^>MU_W_:C_A%+/_GK=?\ ?]JV
MJ* ,7_A%+/\ YZW7_?\ :C_A%+/_ )ZW7_?]JVJ* ,7_ (12S_YZW7_?]J/^
M$4L_^>MU_P!_VK:HH Q?^$4L_P#GK=?]_P!J/^$4L_\ GK=?]_VK:HH Q?\
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M4 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\
M"*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"
M*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/
M6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6
MZ_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_
M[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[
M4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B
M_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9
M_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6
M?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z
M_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U10!B_P#"*6?_ #UN
MO^_[4?\ "*6?_/6Z_P"_[5M44 8O_"*6?_/6Z_[_ +4?\(I9_P#/6Z_[_M6U
M10!B_P#"*6?_ #UNO^_[4?\ "*6?_/6Z_P"_[5M44 <O-I,.F>(M'\II6WF7
M/F.6Z*.GYUU%8FK_ /(Q:']9O_016W0 4444 %%%% !1110 5RUU_P C->?]
M<HZZFN6NO^1FO/\ KE'0!-1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!4D_Y#6D_]=&_E775R,G_(:TG_ *Z-_*NNH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#%\8?\BY=_\  /\ T-:V(_\ 5K]*Q_&'_(N7?_ /_0UK
M8C_U:_2@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RE^V!K'C&
M[^-7P-\$>%O&^J^"+7Q-_;GV^ZTH(7?[-;0S1Y# @X.X?\#-9?\ PS_\3/\
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M9_T<7XV_[\V__P 31_PS_P#$S_HXOQM_WYM__B:][HH]C3[![27<\$_X9_\
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MH]C3[![27<\$_P"&?_B9_P!'%^-O^_-O_P#$T?\ #/\ \3/^CB_&W_?FW_\
MB:][HH]C3[![27<\$_X9_P#B9_T<7XV_[\V__P 31_PS_P#$S_HXOQM_WYM_
M_B:][HH]C3[![27<\$_X9_\ B9_T<7XV_P"_-O\ _$T?\,__ !,_Z.+\;?\
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M9_T<7XV_[\V__P 31_PS_P#$S_HXOQM_WYM__B:][HH]C3[![27<\$_X9_\
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MJR@8+*,C!P>XKJ;&^CU"$R1AE4-M^8#/0?XT ?+EYX;_ &J[*1E?XE>"MH.
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MD_\ BJKWG@W]JVT167XF^"9\GI'X=D./_'J^B-%UIKAA!.6>9F.UMH QC/\
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M3:C^SG\/=.LO#+1Q^+_$3R16=RZJXLXHPOF3;""&;YU501C+$\[<'YM\,_\
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M?V?_ &WIEMJ/V3_A'_-\GS8E?9O^U+NQNQG SCH*^L/V/OV,?^&4+[Q/<?\
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M_P"NC?RKKJY&3_D-:3_UT;^5==0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &+XP_Y%R[_ . ?^AK6Q'_JU^E8_C#_ )%R[_X!_P"AK6Q'_JU^E #J***
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M":PITW5?-+8TG)05D+<7%QKEXG[M3*5VA4X'&3W-=/HVEKIL.06\R15+JQ!
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M2Z[C\RE>W- '8URNK:.;$[X0S0!069B.#G'^%:FAZI]K00/N:95+,YQ@\_\
MUQ6G-"D\9210Z'J#0!AZ/K@51#<%(T10J$ Y-;]<GJ^F-8R&4%1&[G:JYXK0
MT/6#,PMYB\DKL2&., 8Z?H: (=:T<HS3P!G#%GDR1A>_'ZTS1M8^S;()2B0*
M"=V#G/6NC=1(C*PRK#!'M7-ZUI/V8O<1[$AR $&<T =(CB1%93E6&0:QM:T<
MW#&> ,\S, RY&,8Q_057T76&CD$,Q>3>52/IA>W^%='0!RFCZJUBPB.T0LV6
M8@Y'%=1#,EQ&LD;;D;H:PM:T4*IG@"1QHGS+SDG-5-*UAK%MLI=X0I"HN.#G
M_P#70!K:UI7VQ#,FYIU4*J@C!Y_^N:Q;"^ETJXD3:H)8*^X9Q@^QKKZQ]7T4
M7 \R$)&PW,Y.?FH T[>ZBNX]\3[USC.*JZMIJZA#GYO,C5B@4@9)'?\ *N>T
MS4WL9EW,Q@R2R+WX_P#U5UL,HGACD P'4,,^XH Y"">?1[MOD42@;2K\]<'L
M:ZFSOHKV/,;AF4#=@$8-5M5TE;Y"T81)BP)=NXQC_"N>M+R33[G =@@<;U7^
M( T =5?6,>H0B.0LJAMWRD9Z'_&N559])NXW>,+(HW!6Y'.1V-=;9W2WENDR
M JK9P&Z\'%0:EIJ7T+85?.P KMVY_P#UT &FZE'?1J-R^=MRRJ#Q4]W:K>6[
MPN6"MC)7KP<UR+--I=U(B2;77Y2R]ZZO3[Y-0A,B*R@-M^;Z#_&@#E[NTETN
MZ#%,*')C+$'< ?;\*W]+UA;Y561E6X)/R*#TJS>V4=Y$5=%9PI"%NQ-<K<0S
M:3=[1(!(HSN3WH [":,30O&V0KJ5..O(KD]4TM["5BJL;?("NQ&2<9_QK?TC
M4EOX=N&WQJH=F[G'7]*MSV\=T@65 Z@YP?6@#-TK7!=?).420D*BJ#S6O7'7
MUC+I4\9+KN/S*5[<UMZ'JGVM! ^YIE4LSG&#S_\ 7% &7JVCFQ.^$,T 4%F8
MC@YQ_A5O1]<"J(;@I&B*%0@')K<FA2>,I(H=#U!KEM7TQK&0R@J(W<[57/%
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MJK>ZBNX]\3[USC.*S-7T47 \R$)&PW,Y.?FK'TS4WL9EW,Q@R2R+WX__ %4
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M^'<OQU^'%Q/8_#+XSKI^A2N9"G]IW^DL6]6C@$BL<?Q9[=*_22B@#XI^ ?\
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M'['OB#]I>X\(:MX0U/2])U[13+%++JDTL2/"Q5EVM'&YW*ZG' ^\>>*^LZ*
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\8?\BY=_\
M /\ T-:V(_\ 5K]*Q_&'_(N7?_ /_0UK8C_U:_2@!U%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'RI^TY_P G>?LP?]S1_P"F^*O9:\:_:<_Y.\_9
M@_[FC_TWQ5[+7I8;X'ZG'6^(****ZS **\4_:NU#XD)X#T_2OAC:W1UK5K]+
M6XU"U7+65O@EI-W\&3M&[J!NQS@CR*2Z_:"_9;DEM1#?_'7PY>1$P76)GOK.
MY(_C \V0QYSQE@0!AHR2*UC#F6YC*IRNS3L?9%?'/[<7[2.K^';W3OA?X N[
MA/%VIO%]KN-.D9;FW#L/)@C92"LDA()[A2/[^1MZ=\5/%_[-?[+<OB?XFW=U
MJWC74KJ3[#8W;^8T4LB_N87(X556-I&&>,D?>KYH_9*^(7PT\.^.M9^)7Q4\
M7D^+Y)Y&LK:6PN;@K(XS)<LT<3+N.XJHS\HW''W<:TZ=KRWL<]6KS6@G:_X(
M_0'X$^ =:^'/PVTS3/$GB#4O$OB*0?:-0OM2O9;HB9@,QQM(Q(1<!1C ."V,
ML:^0/VNO%GQ"U_\ :LT;P'X*\9:OX=:]L[2VCAM=3N+6V$SL[&1Q%[$9(!.!
M[5/^RS^W)=WOB77;?XM>-=]I,(8](7^R@,R%V##-M!GIM^_Q^M='^T%^QS\3
M_B7\=M2\>^%?$FBZ(C" 6,KW]S;W<!CA5"=T<)VG<&((8\&G%<DWSDRDJE)*
MG_P2#P7^RY^TCHOC#0]0U?XN?;M*M;Z">[M?^$EU*3SH5D5G3:T05LJ",'@Y
MYKJ_VV_VI-;^$DVD^"_!)5?%6JQ^?+="(2R6T3,4C6-""#([!N3G 7IE@1X)
MKWQ*^/?[&_CS1X/&7B63Q7I-]^]\FZOGOH;N)6 D5'E EC<9&#@=1PPR*?\
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MBO\ P4 T&P\*_LMZ3HNEP?9=-T_4;*UMH-[/Y<21R*J[F))P !DDFLK]BO\
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MVF7[1Z?'K%K+!)]G9%;:HD )0,6QC@9QVI3IJ*N@I5I2ERR7Y_J?3->0Z?\
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MI(64*=WRD5\N?L9>--6TWP7J?P\\13-+XG^'>H/H%ZA8KY\"@_9)P.?E>+:
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M "3:"1SG_/UH -/U"._A!5@9%5?, ! !(]_QJ2\M4O;=H7+!6QRO7K7*_O\
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MKY+R%'!4.1DH&R10!RRK<:/>1N\:K*!D*QR,'([&NGT_4([^$%6!D55\P $
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>W6I26]_]LMWWK+(3&?+60N,@]U&.^*^S**?M'=ON'L8VBNQ\-_%;]CGXB>
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M82TC88* '( 4D<<"N8USP+^V-X)US4%\/^)$\1V5W<27 FBNK25(]S$A%6]
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M1GGGK73Z;J$=]"-K;I%5?,XQ@D?_ *Z-0TV.^A9<*DAQ^\V D5S?^D:/>?\
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MVT?3HK1V4\NR##/CL&;)_&@">:VGTNXC9U"L#N7D'H:Z+2=46^C5';-P 68
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M33D]6>"?'G]OC_A2/Q2U?P=_P@O]M?V>(3]M_M?R/,\R))/N>0V,;\?>/2N
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M:F<.2WF73J*I=6LT%%%%9FP4444 %%%% !1110 4444 %%%% !1110 4444
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M@R(R@$<8[?C6]H^A+8?O)@KW"L2KHQP 1C'\Z9H.C_956XDW"5T*F-ATY_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** ,7QA_R+EW_ , _]#6MB/\ U:_2L?QA
M_P BY=_\ _\ 0UK8C_U:_2@!U%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'RI^TY_R=Y^S!_W-'_IOBKV6O&OVG/^3O/V8/\ N:/_ $WQ5[+7I8;X
M'ZG'6^(****ZS ^>?VW/@;J'QK^$R_V'!]I\0Z)/]MM;=<;KA"NV6)2>Y&&
M[E .]?._[./[>EG\*?!5KX)^(&AZI(^C9M+:\L(T:58PQ'E312,FTQ_=R"3@
M %<C)_0ZO-/BU^SKX#^,NEW\.NZ!9KJEU%Y:ZU;P(E[$1]UA*!DX/\+9!Y!&
M#6\9JW+-:'+4I2YO:4W9GP[^T%^TCK7[8NI:/\/?AUX:U :8]PMPZ7"K]HGD
M&5#2;&*1Q)N))+$9P21BNL_:V_9YU_X?_LQ_#O1]&$NJ:=X8>:76A:AF!FE
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MOCR33_L;7!\O[")2FPSAM^__ &]FSKQN[U]]URD?PE\#QZU_;">#/#Z:OO\
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M-:*K@9"LT5U]Q\=2F>WS'%?7_P"SAX,\=^!?AM#IWQ#\0KXBUUKB2?S-S2M
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ME:FZD.5'Q3%^UI^S L2*WP9RP !/_"+:7R?^_M?3'P-^)G@7]H3X8ZK:^&-
MN-(\+P&31Y=,NK6&V38T8+*B1.RA2LF.W?BND_X9_P#A=_T3;PC_ ."*U_\
MC=><?'BZ\8_ KPKI;?!#X;Z;/')>-/JEOIFF)Y>T)M4&WA*2.S$@[E' C )Y
MJVXRTCN9*,Z?O2M;R1^>WC*?Q?\ !'4/B#\'(&E:RU+488Y(PI\R=8WW0,@!
M_P"6BM&2.<\"OT>\-?"^+X._LFW_ (755%U;>'KR2\=?X[EX7>4Y[C<2![*!
MVKYY^"'P8^)'QV_:"@^*WQ4T!O#]EISI-#97%F;4S2QC$,:0OEPBG#EGSG
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MPRAE8 $#GW^A[5A:;I\NL74DI92%<-)N)&[)).,#V-&CZ.^I2JS*PMLE6=6
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MU'>ET?0FO_WDP9+=E)5T89)!QC^==?6LIJDN2&Y$8NH^:1'#"EO$L<:[448
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M\BM*PVAF&!@9/8?6NKTS2XM/B4A )BH#L&)!/XU)I^GQZ;"T43,REMWSD$]
M/3VIUY?PV*!IGV!N!P3S^%%2HZGNPV",.7WI;BWEVEC;//(&*+C(7KR<?UKD
M+R\FUB\2,OE#(5B# #:&/&<?A3;BXN-=O(_W:F;;M"IP.,GN?K73Z/I:Z;#G
M+>9(JEU8@@$#H,?4UJE&@KOXB+NJ[+8;I&BII\:.ZJ;D9!=6.,5?GF%O#)*P
M)5%+''7@9IMU=16<7F3-L3.,X)_E7(ZGJ$NL721*JD*Y6+:""V2 ,Y/L*QC"
M5:5Y;&DI*FK(-8UA]1E959A;9#*C* 0<8[?C6WI&@+9_/<*KSJV49&/ Q^%.
MT+1_L"B:3<MPRE64D$#GV^@[UIS3);Q-)(=J*,DXS5U*GV*>Q,8?:D25R&L:
MZU_^[A+);LH#(ZC)(.<_RHUS63?L84VM;JP96 ()X]_J>U:.A:$UJPN+@-'.
MC$*H8$$$8SQ]351@J*YY[BE)U'RQ&:+H"[!/<JL@=5>/:QR._/3VKH:1F"*6
M/  R:Y?7-=%TK6\!62!U&6VD-D'/?Z"LK3KR+]VFA^NZZSLUO;ED"EXY=RC#
M=N/UIFAZ$+I5N)PKP,IPNXAL@X[?0T_0M"9V6XN R!2DD6UAAN_/Z5TU:3J*
MFN2F1&+D^:0BJ$4*!@ 8%> _MD_&6_\ AC\(]0L_#AE_X3+7KB+0=%CCQN>Z
MN044ISG<JEG!QU05Z]K6OKY9@MF60.K))N4Y';CI[U\J:3IL_P ?OVOI[B%/
MM/A7X4VWE+R/+FUFY7YCSPWE1#'JKX]:S]GRPYY%\W-+E1])_ _X5V'P3^$O
MA?P3IVUH='LDADF48\Z8_--+_P #D9V_X%71ZIH:W?SP!4F9LLS,>1BLO1]6
M-BPA?:L#,69B"2./;Z"NGAF2XC62,[D89!Q7.:G*:7JKV$BJS,;?)+(H!).,
M?X5U<,HFA2100KJ&&>O(K.UK2?MRF:/<TZJ%5<@ \^_U-8NGWTFDW#QE5 9P
MLFX$XP3G&/QH W=4TE+Y&=%47!P [,<5@6MW+I-XR;\*' D"@'< ><9_&NKM
M[J.[C\R)MZ9QG!%5=6TU=0ASEO,C5M@4@ DCOGZ4 6;2Z6\MTF0,%;. W7@X
MJ'4=-COHVRH,H4A&)( /X5S4$\^BW;_(HEV[2K<CG![&NIM+V&]0M$^_;P>"
M/YT <JS7&CWDB(ZK*!@LHR,'![BNIL;Z/4(3)&&50VWY@,]!_C1?6,>H0B.0
MLJAMWRD9Z'_&N65;C1[R-WC590,A6.1@Y'8T =7=V4-Z@65-X7D<D?RKE9X)
M]%NT^=1+MW!EY'.1W%=+IVI1WT:@,#*%!=0" #^-37=JMY;O"Y8*V,E>O!S0
M!6TG4EU"'&&\R-5WE@ "2.V/I5JXMH[N/RY5W)G.,D5REU:2Z3>*^S"AR8RQ
M!W 'C./PK?TO5TOD5'91<')**IQ0!A:A8R:3<)(&4!G+1[23C!&,Y_"MK1=6
M^VJ(9-S3JI9FP #S[?45HS1B:%XVR%=2IQUY%<IJFEOI\C,JL;?("NQ!).,_
MXT =7-"D\;1N-R,,$5S&L:2;%C,FU8&8*J@DD<>_T-:FEZXMW\DY5)F;"JJG
MD5K4 8NBZTUPP@G+/,S':VT 8QG^AK990RE3R",&N6U;16L?WD(9H%4;F9AD
M'./\*N:/KB[!#<%8PH5(]JG)[<_I0!#K.BBV5IX J0*!E=Q)SG']13M%UIE9
M8)RSABJ1[5&%[<_I715SNM:*RLT\ 9PQ9Y-S#"]^/UH Z*L'6-#7:9K<*@4,
M\FYCD]^/UJ'1M:%NJP3E4@4'#;23G.?ZFNC5@RAAR",B@#EM)UIK+]W,6:!5
M.U549!SG_&NJK%UK16N&,\ 9YF8;EW #&,?T%9^CZL;%A"^U8&8LS$$D<>WT
M% &IJFAK=_/ %29FRS,QY&*Q]+U5["159F-ODED4 DG&/\*ZN&9+B-9(SN1A
MD'%9VM:3]N4S1[FG50JKD 'GW^IH T891-"DB@A74,,]>15'5-)2^1G15%P<
M .S'%86GWTFDW#QE5 9PLFX$XP3G&/QKJ;>ZCNX_,B;>F<9P10!REK=RZ3>,
MF_"AP) H!W 'G&?QKJK2Z6\MTF0,%;. W7@XJMJVFKJ$.<MYD:ML"D $D=\_
M2N=@GGT6[?Y%$NW:5;D<X/8T =+J.FQWT;94&4*0C$D '\*YEFN-'O)$1U64
M#!91D8.#W%=5:7L-ZA:)]^W@\$?SI+ZQCU"$1R%E4-N^4C/0_P"- !8WT>H0
MF2,,JAMOS 9Z#_&G7=E#>H%E3>%Y')'\JY15N-'O(W>-5E R%8Y&#D=C73:=
MJ4=]&H# RA074 @ _C0!S4\$^BW:?.HEV[@R\CG([BNBTG4EU"'&&\R-5WE@
M "2.V/I5F[M5O+=X7+!6QDKUX.:Y6ZM)=)O%?9A0Y,98@[@#QG'X4 =7<6T=
MW'Y<J[DSG&2*Y;4+&32;A) R@,Y:/:2<8(QG/X5NZ7JZ7R*CLHN#DE%4XJ]-
M&)H7C;(5U*G'7D4 9VBZM]M40R;FG52S-@ 'GV^HK1FA2>-HW&Y&&"*Y35-+
M?3Y&958V^0%=B"2<9_QK8TO7%N_DG*I,S8554\B@#+UC238L9DVK S!54$DC
MCW^AK0T76FN&$$Y9YF8[6V@#&,_T-;5<KJVBM8_O(0S0*HW,S#(.<?X4 =2R
MAE*GD$8-<YK.BBV5IX J0*!E=Q)SG']14VCZXNP0W!6,*%2/:IR>W/Z5O4 <
M[HNM,K+!.6<,52/:HPO;G]*Z*N=UK165FG@#.&+/)N887OQ^M-T;6A;JL$Y5
M(%!PVTDYSG^IH FUC0UVF:W"H%#/)N8Y/?C]:IZ3K367[N8LT"J=JJHR#G/^
M-=2K!E##D$9%8VM:*UPQG@#/,S#<NX 8QC^@H VJR=4T-;OYX J3,V69F/(Q
M67H^K&Q80OM6!F+,Q!)''M]!73PS)<1K)&=R,,@XH Y32]5>PD569C;Y)9%
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MSRQ].JL4U\=5I+TOW]+(V6$G3>'3^&FG?UL>0_LF36S>*/%LE[(JZPZHP6;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 8OC#_D7+O\ X!_Z&M;$?^K7
MZ5C^,/\ D7+O_@'_ *&M;$?^K7Z4 .HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&DE=LLI8  8JCHNK?8F$,FU8&8LS8)(X]OH* -/6=(6X3S8@D90,SX7EN_\
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MF0HZAU/56&17)ZII;V$C,%/V?(568@D\?_KK;TG6EO?W<Q59V8[553@C&?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^"G_ $4?1?\ OXW_ ,31_P -E?!3_HH^B_\ ?QO_ (FOH7_A5_@W_H4M"_\
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M ,31_P *O\&_]"EH7_@MA_\ B:/K4NP>Q7<^>O\ ALKX*?\ 11]%_P"_C?\
MQ-'_  V5\%/^BCZ+_P!_&_\ B:^A?^%7^#?^A2T+_P %L/\ \31_PJ_P;_T*
M6A?^"V'_ .)H^M2[![%=SYZ_X;*^"G_11]%_[^-_\31_PV5\%/\ HH^B_P#?
MQO\ XFOH7_A5_@W_ *%+0O\ P6P__$T?\*O\&_\ 0I:%_P""V'_XFCZU+L'L
M5W/GK_ALKX*?]%'T7_OXW_Q-'_#97P4_Z*/HO_?QO_B:^A?^%7^#?^A2T+_P
M6P__ !-'_"K_  ;_ -"EH7_@MA_^)H^M2[![%=SYZ_X;*^"G_11]%_[^-_\
M$T?\-E?!3_HH^B_]_&_^)KV[0?AGX/>XU4-X4T-@MVP&=.AX&!_LUK_\*O\
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MW_H4M"_\%L/_ ,31_P *O\&_]"EH7_@MA_\ B:/K4NP>Q7<^>O\ ALKX*?\
M11]%_P"_C?\ Q-'_  V5\%/^BCZ+_P!_&_\ B:^A?^%7^#?^A2T+_P %L/\
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M  J_P;_T*6A?^"V'_P")H^M2[![%=SYZ_P"&RO@I_P!%'T7_ +^-_P#$T?\
M#97P4_Z*/HO_ '\;_P")KZ%_X5?X-_Z%+0O_  6P_P#Q-'_"K_!O_0I:%_X+
M8?\ XFCZU+L'L5W/GK_ALKX*?]%'T7_OXW_Q-'_#97P4_P"BCZ+_ -_&_P#B
M:^A?^%7^#?\ H4M"_P#!;#_\31_PJ_P;_P!"EH7_ (+8?_B:/K4NP>Q7<^>O
M^&RO@I_T4?1?^_C?_$T?\-E?!3_HH^B_]_&_^)KZ%_X5?X-_Z%+0O_!;#_\
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MA?\ A5_@W_H4M"_\%L/_ ,31_P *O\&_]"EH7_@MA_\ B:/K4NP>Q7<^>O\
MALKX*?\ 11]%_P"_C?\ Q-'_  V5\%/^BCZ+_P!_&_\ B:^A?^%7^#?^A2T+
M_P %L/\ \31_PJ_P;_T*6A?^"V'_ .)H^M2[![%=SYZ_X;*^"G_11]%_[^-_
M\31_PV5\%/\ HH^B_P#?QO\ XFOH7_A5_@W_ *%+0O\ P6P__$T?\*O\&_\
M0I:%_P""V'_XFCZU+L'L5W/GK_ALKX*?]%'T7_OXW_Q-'_#97P4_Z*/HO_?Q
MO_B:^A?^%7^#?^A2T+_P6P__ !-'_"K_  ;_ -"EH7_@MA_^)H^M2[![%=SY
MZ_X;*^"G_11]%_[^-_\ $T?\-E?!3_HH^B_]_&_^)KZ%_P"%7^#?^A2T+_P6
MP_\ Q-'_  J_P;_T*6A?^"V'_P")H^M2[![%=SYZ_P"&RO@I_P!%'T7_ +^-
M_P#$T?\ #97P4_Z*/HO_ '\;_P")KZ%_X5?X-_Z%+0O_  6P_P#Q-'_"K_!O
M_0I:%_X+8?\ XFCZU+L'L5W/GK_ALKX*?]%'T7_OXW_Q-'_#97P4_P"BCZ+_
M -_&_P#B:^A?^%7^#?\ H4M"_P#!;#_\31_PJ_P;_P!"EH7_ (+8?_B:/K4N
MP>Q7<^>O^&RO@I_T4?1?^_C?_$T?\-E?!3_HH^B_]_&_^)KZ%_X5?X-_Z%+0
MO_!;#_\ $T?\*O\ !O\ T*6A?^"V'_XFCZU+L'L5W/GK_ALKX*?]%'T7_OXW
M_P 31_PV5\%/^BCZ+_W\;_XFOH7_ (5?X-_Z%+0O_!;#_P#$T?\ "K_!O_0I
M:%_X+8?_ (FCZU+L'L5W/GK_ (;*^"G_ $4?1?\ OXW_ ,31_P -E?!3_HH^
MB_\ ?QO_ (FOH7_A5_@W_H4M"_\ !;#_ /$T?\*O\&_]"EH7_@MA_P#B:/K4
MNP>Q7<^>O^&RO@I_T4?1?^_C?_$T?\-E?!3_ **/HO\ W\;_ .)KZ%_X5?X-
M_P"A2T+_ ,%L/_Q-'_"K_!O_ $*6A?\ @MA_^)H^M2[![%=SYZ_X;*^"G_11
M]%_[^-_\31_PV5\%/^BCZ+_W\;_XFOH7_A5_@W_H4M"_\%L/_P 31_PJ_P &
M_P#0I:%_X+8?_B:/K4NP>Q7<^>O^&RO@I_T4?1?^_C?_ !-'_#97P4_Z*/HO
M_?QO_B:^A?\ A5_@W_H4M"_\%L/_ ,31_P *O\&_]"EH7_@MA_\ B:/K4NP>
MQ7<^>O\ ALKX*?\ 11]%_P"_C?\ Q-'_  V5\%/^BCZ+_P!_&_\ B:^A?^%7
M^#?^A2T+_P %L/\ \36-KGPS\'KJ>CA?"FA@-,00-.AYX_W:/K4NP>Q7<\&U
MS]MKX,:1HM_?0^.M,U&:VMY)DL[=V,L[*I(C3Y?O,1@>YJM_P3_\9>%;?X&3
M^-]>\2Z1:^+O&^L7^L:N+N^BBD5Q<20QQA6;(14C!4=MYQ7TW_PJ_P &_P#0
MI:%_X+8?_B:\S_X8<^ W_1+]"_[]O_\ %5C4JNI:YI&"CL;NI?%WPQJLH">)
MM)C0K@Q+J<3 X).<;O\ .*V-%\:^"K.,2R^+-!DD<*P#WT ,9Z_W^O/Z5Q7_
M  PY\!O^B7Z%_P!^W_\ BJ/^&'/@-_T2_0O^_;__ !55*LW'EBK(2IZW>IZ6
MWQ2\%QKEO%^@J/4ZG"/_ &:N7UCXP^%KZ3R8?%&D1JI9#LU.(B0'CLW^<USG
M_##GP&_Z)?H7_?M__BJ/^&'/@-_T2_0O^_;_ /Q513FH.]KE2BY*USK="\9^
M#$47%QXKT%BRD>3+?0_+SUY;V].];[?%+P8JDGQ=H0'J=2A_^*KS/_AASX#?
M]$OT+_OV_P#\51_PPY\!O^B7Z%_W[?\ ^*J9S<W=CC%15D=5KGQD\*2,8+?Q
M5HZ!6!\Z+5(OF&.G#>_KVJ/0O&?@YV%Q<>*]#4*Q'DRWT/S<=>6]_3M7,_\
M##GP&_Z)?H7_ '[?_P"*H_X8<^ W_1+]"_[]O_\ %5K[:T>6*L1[.\KMGI:_
M$[P7&H5?%F@JJC  U*$ #_OJL77/C)X156M[?Q5HK%E!$T6J0\<].&]O7O7'
M?\,.? ;_ *)?H7_?M_\ XJC_ (8<^ W_ $2_0O\ OV__ ,5649*+NU<N2;5D
M=!H_C;PE>W!FN/%NBH%97Q+?PGS,G)ZO_G-=5'\3/!4*!(_%6@H@Z*NHP ?^
MA5YK_P ,.? ;_HE^A?\ ?M__ (JC_AASX#?]$OT+_OV__P 555*CJ/448J*.
MXUGXR>#[:+RX/%.ARM(K#?'JD.4/KPW^<5A6/CKPKJMPQG\7Z/&"N?-DOXCG
M&!C)?_.*Q/\ AASX#?\ 1+]"_P"_;_\ Q5'_  PY\!O^B7Z%_P!^W_\ BJN-
M7DC:*U)E#F=VSTF'XD^";=2L7BG0(USG":C !_Z%574OC%X-L8P4\4Z%</NP
M475(<CCK]XUP'_##GP&_Z)?H7_?M_P#XJC_AASX#?]$OT+_OV_\ \56*:O=Z
MFG30V+7X@>&-4ND6;Q=I&TY!FDU")@N 3CE_\YKK;/XA^";*%43Q7H 8* S+
MJ$ +8'4_-7G7_##GP&_Z)?H7_?M__BJ/^&'/@-_T2_0O^_;_ /Q5:5*KJ:;(
MB,%$]"U#XO>#+*W9U\5Z%+(,8C&J0@GG_>KE7^)GAC5KP;_%6D^6TG&[48F$
M8)_WO\XK'_X8<^ W_1+]"_[]O_\ %4?\,.? ;_HE^A?]^W_^*ITZGLUHM0E#
MFZGH&F^/?!.G0*@\6: \@!!E%_ "<G/][_.*FNOBSX+M87?_ (2W0695)"?V
MG""WM]ZO.?\ AASX#?\ 1+]"_P"_;_\ Q5'_  PY\!O^B7Z%_P!^W_\ BJRY
MKN\B[65D;-_\5O#.J7#L/$^D^6<$0C4HF"X&,_>_SFNCTOQQX)TV,Y\6Z!-)
MN)$AOX 1QC'W_P#.:X/_ (8<^ W_ $2_0O\ OV__ ,51_P ,.? ;_HE^A?\
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M.T?QMX2O;@S7'BW14"LKXEOX3YF3D]7_ ,YKG_\ AASX#?\ 1+]"_P"_;_\
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M_HFMC_X&77_QVLHR47=JY<DVK([/1_&WA*]N#-<>+=%0*ROB6_A/F9.3U?\
MSFMO7/C-X!\*^']1U2Y\5:*ECI]M)=2K;WT+-L12[;5#<G . .IKS'_AWW^S
MY_T36Q_\#+K_ ..T?\.^_P!GS_HFMC_X&77_ ,=JJE1U'J*,5%')?L7ZYH;>
M$?$OQ-\6Z_HUGXP^(^I/K%U;7-_$)+6S&4L[8@D':D7(![.,U[7K7C;P<K&>
M#Q7H;!F \F.^A^7CKPWM^M<F/V&_@, !_P *PT/_ +]O_P#%4O\ PPY\!O\
MHE^A?]^W_P#BJR+.NT?XQ>%$803^*M&8,Q/FR:I%\O'3EO;]:WE^*7@QAD>+
MM"(]1J4/_P 57F?_  PY\!O^B7Z%_P!^W_\ BJ/^&'/@-_T2_0O^_;__ !5
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MQ$\$WD+(_BO0"Q4A6;4("5R.H^:N7N/B%X6TVY<1>+M(P,#S4U")<Y&<</\
MYQ6#_P ,.? ;_HE^A?\ ?M__ (JC_AASX#?]$OT+_OV__P 50!Z!I_Q@\&WD
M9+^*="@;=@*VJ0Y/O]ZK,OQ*\$S+MD\5:!(N<X;48"/_ $*O-O\ AASX#?\
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M\=>"=008\6Z!%)N!,GV^ D\8Q]__ #BN!_X8<^ W_1+]"_[]O_\ %4?\,.?
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M,P'DQWT/R\=>&]OUKE/^&'/@-_T2_0O^_;__ !5'_##GP&_Z)?H7_?M__BJ
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MW^_^M1_8_P#T_7G_ '^_^M0!HT5G?V/_ -/UY_W^_P#K4?V/_P!/UY_W^_\
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MGV[?W<TVY#E@.1BM)?#>5!_M74^G_/Q_]:@#;HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\
MA&O^HKJ?_@1_]:@#:HK%_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@#:HK%
M_P"$:_ZBNI_^!'_UJ/\ A&O^HKJ?_@1_]:@ \/?\?.K_ /7VW\A6U7):/H?V
MB?45_M"^B\NX9,QS8+<#EN.36G_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\
MP(_^M1_PC7_45U/_ ,"/_K4 ;5%8O_"-?]174_\ P(_^M1_PC7_45U/_ ,"/
M_K4 ;58FO?\ (4T;_KN?Y4O_  C7_45U/_P(_P#K5EZMH?D7^F)]OOI/-E*[
MI)LE..JG'!H ZZBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?
M^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:
MC_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\
M6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_
M .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI
M_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X
M1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/
M^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:
M@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\
MX$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_
M .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&
MO^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X
M1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J
M-JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@
M1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\
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M7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\
M6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_
M %J -JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI
M_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HK
MJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?
M^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:
MC_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\
M6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X1K_J*ZG_
M .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/^$:_ZBNI
M_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:@#:HK%_X
M1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\ X$?_ %J/
M^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_ .!'_P!:
M@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&O^HKJ?\
MX$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X1K_J*ZG_
M .!'_P!:@#:HK%_X1K_J*ZG_ .!'_P!:C_A&O^HKJ?\ X$?_ %J -JBL7_A&
MO^HKJ?\ X$?_ %J/^$:_ZBNI_P#@1_\ 6H VJ*Q?^$:_ZBNI_P#@1_\ 6H_X
M1K_J*ZG_ .!'_P!:@!-7_P"1BT/ZS?\ H(K;KEYM,_L_Q%H_^EW5SO,O_'Q)
MOVX4=...M=10 4444 %%%% !1110 5RUU_R,UY_URCKJ:Y:Z_P"1FO/^N4=
M$U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?^BF>"?_  GW_P#BJ/[/_:E_Z*9X)_\ "??_ .*H]C4[![2/<^N**^1_[/\
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MWJL:;X5_:KU.,R)\3_ J(K;3N\/R9Z?6K]G)+F:T%S*]CZGHKYE_X0+]JO\
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M^G^#_P!JS4(%F7XH>!4C;/7P_)G@X]:MTY15VB5)-V1]245\R_\ "!?M5_\
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M6M?!/[5EU"DO_"T? JJZAA_Q3\A//XUI*G**O)$J2EL?4%%?,O\ P@7[5?\
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M3_KI)_Z$:VJ^.M ^&_[5\D+P6GQG\*QQQG<=_AV,]23_ ,\ZV/\ A5?[6O\
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M_)GK]: /J*BOD^WT7]J6XF2/_A9_@E6=@H_XIYR.3_O5K?\ "!?M5_\ 14_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&1@Y! (^*]$^"?[;7P%L5\,>!=;BUKP]#_Q[M;7EA/#$O946^ >,?[*C;G-
M%_PG_P %!OCQ'\8O!7@OQO\ #_1/"W]NZG9VLD5]HM_9W/V>:=8FDC$L_P#O
M8;:1E>^,5)^V[_RD$^!GUT?_ -.<E=+\'_V&/BAXR^+6B_$[XZ>-6O=4TFXA
MN[33;6<7$N^*3S$C9MHBBC#\[(@P.6Y7K1^W;^SK\8OB/^T!X/\ &_PQ\/\
M]HG0]-MO*OOMMG%Y-W%<RRK^[GD7=C<AY4J<XYY% 'WU7Q9_P5B_Y-OT7_L9
M;?\ ])[FO,?^-A?^?^$>KL_CQ\&?CU\<OV-O"V@>)-'_ +;^*$/B#[9J%O\
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MK5G2_P!G#XBV_P#P3CO_ (72>'MOCJ61F32OMML<C^T5F_UOF>7_ *L%OO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO8V**P-=^(/A;POJEIIFL^)='TC4KS'V:SOK^*":?+;1L1F!;+<<#KQ5>_\
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M;,DBPQO(YPB@L3["DDE2%"\CJBCJS' KE=8UB2^F\B#<JJS)^[<D2Y.!P/\
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MJ>F26,C-M(@+81B02:V]!\16GB"QAN[>6)HIU#PLD@82(5#!E]00:TI88YU
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M2\"W6FVLS1I>:@VE2V/VH(0<RS2MY>W(#'RPN<8Q@X/V=^S=\$X/@)\*]/\
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M)O"OBCQ#X@^''CM_%WVJTCMUM+O"75G'OW.SKM1B&(3!,:XVD9.:^KJ_/_\
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M&&4,/<9KPC]J3X)R_%7X0:[H%DS_ -K"+[?I=T@VM;WL)\R%@W\.6&TGT9J
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M[/YOF:8D7^LV/MQYF?NG.,>]>B_\/BO^J1_^7+_]R5QGQR^+.D? [_@IQ?\
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MTG_KHW\JZZN1D_Y#6D_]=&_E774 %%%% !1110 4444 %%%% !1110 4444
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M/A>];Q'I=E#+++#8)BXW1IN:+RW*E7QT#8SD'.#FFX2CNB8U82TBSNJ*\B^
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MP;+XD\2S2BU6188;:U"M<7$C'A(U9E!.,L<D !2:FS;L6Y)*[V.XHKB?@_\
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M(5B# #:&/&<?A72:1HZ:=&K,JFYP0SJQ((S_ /JI=&TM=-AR"WF2*I=6((!
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MOB1\0].UWQ<H!DU77_'!BU"*3N=@G14(.,+L.,8YQ7J&D^ ;R]_9G\4R^!O
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MREMWSD$] /3VKHTPZ[R9EK5?D,TW38M/A&U )651(P)() ]_QJ:\NTL;9YY
MQ1<9"]>3C^M-OM0BL8\R.$9@=N03DBN0N+BXUR\3]VIE*[0J<#C)[FLJ=-U'
MS2V+E)05D.O+R;6+Q(R^4,A6(, -H8\9Q^%=)I&CQZ?&K,JFYP0SJQ((S_\
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M.&*I'M487MS^E=%7.ZUHY1FG@#.&+/)DC"]^/UIFC:Q]FV02E$@4$[L'.>M
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MNH0XPWF1JN\L  21VQ]*LW=JMY;O"Y8*V,E>O!S7*7=I+I=T&*84.3&6(.X
M^WX4 =;<6\=U$8Y5W(>HR17+:E8R:5=)(I4*SEH]I)*X/&<_45MZ7K"WRJLC
M*MP2?D4'I5^:,30O&V0KJ5..O(H SM%U;[:HADW-.JEF;  //M]16C)&LT;(
MXRK#!%<GJFEO82L55C;Y 5V(R3C/^-1^(_B9IG@?P;K?B/7YTM=/TFTDO)F4
M')1$+$#U)Q@#N2!0!X3\"8Q\-_VR/C)\/M#Q<^%=2L[7Q=+'"3LTK4)MJ2PM
M_M3#$HQGY57WHK=_8A\':E#\-]4^(_B6'R_%_P 2-0?Q%>ANL-L^19P _P!Q
M(B& /3S".U% 'T91110 5RUU_P C->?]<HZZFN6NO^1FO/\ KE'0!-1110!S
MGC#X:^$?B(MJ/%7A71?$PM-QMQK&G0W?D[L;MGF*=N=JYQUP/2N>M?V<_A/9
M7"3V_P +_!D$\9W))%X?M%93Z@B/BO0+FYAL[>6XN)4@@B4O)+(P544#)))X
M  [USO\ PL[P=_T-FA_^#*'_ .*K6%*I4UA%OT1$JD(?$['21QK%&J(H1%&%
M51@ #L*YW1_AKX0\.^)+[Q#I/A71-,U^^W_:]5L].AANKC>P9_,E50S;F 8Y
M)R0":EL?B!X7U2[BM;/Q)I%W=2G;'#!?1.[GT"ALDUOTITYTW:::]1QG&>L7
M<YJU^&?@^R\6R^*K?PIH<'B>7<9-:BTZ%;U\KM.9@N\Y7@\].*)/AEX.E\8+
MXL?PGH;^*5((UQM-A-\,)L'[_;O^Y\O7IQTKI:*S*.)\2? _X<^,=8GU;7_
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MI(=(L8K5';U(C4 GZUO444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5
M)/\ D-:3_P!=&_E775R,G_(:TG_KHW\JZZ@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBEJZ^9<R2/!'(>AN)W\V8CZ#:/H]??-<]71J/8[,/JG4?5GD'[7G_)M?C_\
M[!W_ +.M?#'P+_:G@^ 7[-6MZ5I!2X\:ZIK4[6<;*&2TC\B!?/<'KR"%7N0<
M\ @_<_[7G_)M?C__ +!W_LZU\2_L??LBZ'\>OA[XKU_6]0FAF6232]-2$$"V
MN!&DGVA\$;P-ZC9TQN[X(UI\OLWS;7,:_/[5*&]CW7]AG]G*WL-+@^+7BBZC
MU[Q1K8:ZL9FF\_[,CYWR,V3F=R6#=UY'4L*\B_;TT&]T+]I#0?%?B?1KG5_
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M+K2LJP3E4*A4CVJ<MVY_2MR@#G-%UAHY!#,7DWE4CZ87M_A71USNL:*8R9X
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M$#[FF52S.<8//_UQ6E/"+B%XF)"N"IQUKE=4TM]/D9E5C;Y 5V())QG_ !H
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MFHVG@35;CP_&VU]3+D*OKG"%0>1QOK-_;!N)H=+\+6$8$5@\LKMM&%#*J*O
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MXC$4B@\^M>C44DVM4#BI*S1X)_PPE\#?^A(_\JU]_P#'ZYWXI>)M"_87\$V
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M1U_^L*V2CAU=[F=W5=EL/TO1X]-C.=LTFXD2% ".,8_SZU<N+F.VC+.ZKP2
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MU8V<BQNP6W));C)Z?_JH U=8TA+J,RQA8W0,Q"IRYZ_T_6L>QU*;2YB'61E
MQY3,5 SSG'^>M=9'(LT:NIRK ,/H:R=8T?[5F:%2T[,,Y; QC'^% &G;W"7$
M89&5N 2%.<55U+28]008VQ2;@3)L!)XQC_/I7/Z;J$FFW&S(5&<"3C/ //\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OC#_D7+O\
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M $-&B_\ @PA_^*HN@.BHKG?^%C^$_P#H:-%_\&$/_P 51_PL?PG_ -#1HO\
MX,(?_BJ+H#HJ*YW_ (6/X3_Z&C1?_!A#_P#%4?\ "Q_"?_0T:+_X,(?_ (JB
MZ Z*BN=_X6/X3_Z&C1?_  80_P#Q5'_"Q_"?_0T:+_X,(?\ XJBZ Z*BN=_X
M6/X3_P"AHT7_ ,&$/_Q5'_"Q_"?_ $-&B_\ @PA_^*HN@.BHKG?^%C^$_P#H
M:-%_\&$/_P 51_PL?PG_ -#1HO\ X,(?_BJ+H#HJ*YW_ (6/X3_Z&C1?_!A#
M_P#%4?\ "Q_"?_0T:+_X,(?_ (JBZ Z*BN=_X6/X3_Z&C1?_  80_P#Q5'_"
MQ_"?_0T:+_X,(?\ XJBZ Z*BN=_X6/X3_P"AHT7_ ,&$/_Q5'_"Q_"?_ $-&
MB_\ @PA_^*HN@.BHKG?^%C^$_P#H:-%_\&$/_P 51_PL?PG_ -#1HO\ X,(?
M_BJ+H#HJ*YW_ (6/X3_Z&C1?_!A#_P#%4?\ "Q_"?_0T:+_X,(?_ (JBZ Z*
MBN=_X6/X3_Z&C1?_  80_P#Q5'_"Q_"?_0T:+_X,(?\ XJBZ Z*BN=_X6/X3
M_P"AHT7_ ,&$/_Q5'_"Q_"?_ $-&B_\ @PA_^*HN@.BHKG?^%C^$_P#H:-%_
M\&$/_P 51_PL?PG_ -#1HO\ X,(?_BJ+H#HJ*YW_ (6/X3_Z&C1?_!A#_P#%
M4?\ "Q_"?_0T:+_X,(?_ (JBZ Z*BN=_X6/X3_Z&C1?_  80_P#Q5'_"Q_"?
M_0T:+_X,(?\ XJBZ Z*BN=_X6/X3_P"AHT7_ ,&$/_Q5'_"Q_"?_ $-&B_\
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M1< G)Q_GZ5RO^DZU>?\ +5HVD]W$08_Y_*O$Y/VTO@SJERAG^)NAAL;=[NP
M')[+71Z;^VC\ M.A 3XFZ")&51(PFD() ]U^M8WC1CIJS36H_(]RTW2XM/A5
M<(\JY_>[ &.34MY>1V4+.[*&"DJK, 6P.@KQ"?\ ;H^ \,>X?$O19?\ 9CD8
MG^5<O??ML_!G5+@"3XEZ*(PYV;W8;03WPOTK&$?:2O)ER?*K11[3>7ESK%RY
MC25DX80J2X7 QG'^>M=)I>BQ:<AW;)Y-VX2% "..E>&:/^V9\ ].B5F^)V@F
MYP59UFD((SGNOTJ_+^W-\!XXV8?$W1'Q_"LC9/\ X[5U*E_<AL*$+>]+<]RF
MGCMU#2R+&N<9=@!7(:AJD^L3*L22*I7'DHQ8-@DYQ_GI7B^K?MP?!?49&4?$
MG1_LVX,B,Q!'&.R_6M'1_P!L;X"6'[R;XG: ]PK$JZ328 (Q_=^M5#EI1YGJ
MR97J.RV/<=%T-+6,2S!96D56VR1\H>N.?\\5KR2)"A>1E1!U9C@5X:W[<GP&
M52?^%GZ&<=A(W_Q-<]K'[<WP6OR8X?B1I"V[*-R,QR2#G^[]*R5ZTKR9II36
MB/:-8UB2^F\B#<JJS)^[<D2Y.!P/\\U=T/00JK<7"ABRD&&6/ISUY^GIWKP[
M1?VP_@-;GSKKXFZ S_*\8$TF5/7GY?I6]_PW'\!O^BH:%_W\?_XFM*E117)3
M(C!M\TCW$E8T))"(H^@ KF]=UTNQM[=BH5@?.BD^]QTX^OKVKQ;6/VZO@K<+
MY=K\2-(1"&63<Q^8'CCY3[U6TG]L#X$,WF7GQ,T$QE2!'YT@8'/?"_7OWHIQ
MC!<\V$G*7NQ/<=#T%I&6>X4H$8CR9(_O#'7GZ^G:NE2-8U"HH11T51@"O#O^
M&X_@-_T5#0O^_C__ !-96K?MW?!/;LL_B5HZNK<ON)4C';Y:S<I5I:EI*FCV
MC7=="*;>W8,64'SHI/N\]./IZ]ZI:1HTNH2F:<L@5E?]XA/F9Y/)_P \UX?I
M?[8/P+DF5[KXF:"L()#1M+(&/'!X7U]^U=1'^V_\!(8TC3XGZ$$4!0/-?H/^
M UM*<:2Y(;F<8N;YI'N44*0KMC18U_NJ,"LK6M;2SC,41621PRDI)@QGI^?/
MZ5XIJG[=GP/2)X[7XE:.9N")%8E>O/5?Z5A6G[8WP1O+HRW/Q-T%%WAI-\K@
MMDY.,+_G-9TX1^.;*G)_#%'MNGZ7/K$S-*\BJ5SYSJ6#8(&,_P">E==!;Q6R
M[8HTC'?:H&:\,M_VV_@%:PK%%\3M"6->@\USWS_=J'4/V[/@7#$RP_$K1WE9
M3M9'8@'MG(I3J.J[+8<8J"N>VZIK$>FQC&V:3< 8PX!'&<_Y]:YJSL[G6+E!
M(\K)RIF8%PN!G&?\]:\3_P"&R_@OJ5R[S?$W0D<C)>21@#C QPE=1:?MK? "
MQC,<'Q-T)$)W$>:YY_%?:M>:-&-HZLBSJ.[V/<;&QBL845$3>%"M(J@%O<TS
M4M2CTZ!G)5Y  1$7 )R<?Y^E>)77[=?P(MU!7XE:/*3Q^[=CC\Q7+2?MI?!G
M5+E#/\3=##8V[W=@ .3V6LJ<5-\TWH7*7*K11[9_I.M7G_+5HVD]W$08_P"?
MRKJ=-TN+3X57"/*N?WNP!CDUX;IO[:/P"TZ$!/B;H(D95$C":0@D#W7ZU8G_
M &Z/@/#'N'Q+T67_ &8Y&)_E3J5.?W8["A#EU>Y[?>7D=E"SNRA@I*JS %L#
MH*Y&\O+G6+ES&DK)PPA4EPN!C./\]:\6OOVV?@SJEP!)\2]%$8<[-[L-H)[X
M7Z5M:/\ MF? /3HE9OB=H)N<%6=9I"",Y[K]*TCRT8WW9+YJCMT/<]+T6+3E
M.[9/)NW"0H 1QTJ]-/';J&ED6-<XR[ "O#9?VYO@/'&S#XFZ(^/X5D;)_P#'
M:YK5OVX/@OJ,C*/B3H_V;<&1&8@CC'9?K6,4ZLKR9HVH*R1[1J&J3ZQ,JQ)(
MJE<>2C%@V"3G'^>E;6BZ&EK&)9@LK2*K;9(^4/7'/^>*\.T?]L;X"6'[R;XG
M: ]PK$JZ328 (Q_=^M:S?MR? 95)_P"%GZ&<=A(W_P 36E2HK<E/8B$/M2W/
M<I)$A0O(RH@ZLQP*Y36-8DOIO(@W*JLR?NW)$N3@<#_/->+ZQ^W-\%K\F.'X
MD:0MNRC<C,<D@Y_N_2I-%_;#^ UN?.NOB;H#/\KQ@3294]>?E^E.$8TUSRW"
M3<WRH]QT/00JK<7"ABRD&&6/ISUY^GIWK>)6-"20B*/H *\._P"&X_@-_P!%
M0T+_ +^/_P#$UAZQ^W5\%;A?+M?B1I"(0RR;F/S \<?*?>LKRK2U9>E-:'M.
MNZZ78V]NQ4*P/G12?>XZ<?7U[4FAZ"TC+/<*4",1Y,D?WACKS]?3M7AVD_M@
M? AF\R\^)F@F,J0(_.D# Y[X7Z]^]=+_ ,-Q_ ;_ **AH7_?Q_\ XFM9U%37
M)3,XQ<GS2/<4C6-0J*$4=%48 K!UW70BFWMV#%E!\Z*3[O/3CZ>O>O%]6_;N
M^">W99_$K1U=6Y?<2I&.WRUE:7^V#\"Y)E>Z^)F@K""0T;2R!CQP>%]??M4T
MXQC[\V5*3?NQ/<-(T:74)3-.60*RO^\0GS,\GD_YYKJHH4A7;&BQK_=48%>&
MQ_MO_ 2&-(T^)^A!% 4#S7Z#_@-4=4_;L^!Z1/':_$K1S-P1(K$KUYZK_2HE
M-UI6*C%4T>UZUK:6<9BB*R2.&4E),&,]/SY_2L33]+GUB9FE>15*Y\YU+!L$
M#&?\]*\2M/VQO@C>71EN?B;H*+O#2;Y7!;)R<87_ #FNHM_VV_@%:PK%%\3M
M"6->@\USWS_=K9RC1CRPW,U%U'>6Q[G!;Q6R[8HTC'?:H&:IZIK$>FQC&V:3
M< 8PX!'&<_Y]:\2U#]NSX%PQ,L/Q*T=Y64[61V(![9R*YO\ X;+^"^I7+O-\
M3="1R,EY)& .,#'"5E3@I>]-Z%RDUI%'MEG9W.L7*"1Y63E3,P+A<#.,_P">
MM=;8V,5C"BHB;PH5I%4 M[FO#K3]M;X 6,9C@^)NA(A.XCS7//XK[4MU^W7\
M"+=05^)6CRD\?NW8X_,45*CJ.RV",%#5[GMNI:E'IT#.2KR  B(N 3DX_P _
M2N5_TG6KS_EJT;2>[B(,?\_E7B<G[:7P9U2Y0S_$W0PV-N]W8 #D]EKH]-_;
M1^ 6G0@)\3=!$C*HD832$$@>Z_6M;QHQTU9&M1^1[EINEQ:?"JX1Y5S^]V ,
M<FI;R\CLH6=V4,%)568 M@=!7B$_[='P'ACW#XEZ++_LQR,3_*N7OOVV?@SJ
MEP!)\2]%$8<[-[L-H)[X7Z5C"/M)7DRY/D5HH]IO+RYUBY<QI*R<,(5)<+@8
MSC_/6NDTO18M.4[MD\F[<)"@!''2O#-'_;,^ >G1*S?$[03<X*LZS2$$9SW7
MZ5?E_;F^ \<;,/B;HCX_A61LG_QVKJ5+^Y#84(6]Z6Y[E-/';J&ED6-<XR[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,7QA_P BY=_\ _\ 0UK8C_U:_2L?QA_R+EW_ , _]#6MB/\ U:_2@!U%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% '"_$[X&^ _C/_ &;_ ,)O
MX7L?$G]F^;]C^VJ3Y/F;/,VX(Z^6F?\ =%<-_P ,.? ;_HE^A?\ ?M__ (JO
M<Z* /#/^&'/@-_T2_0O^_;__ !5'_##GP&_Z)?H7_?M__BJ]SHH \,_X8<^
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M_P"_;_\ Q5'_  PY\!O^B7Z%_P!^W_\ BJ]SHH \,_X8<^ W_1+]"_[]O_\
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MM"_\%L/_ ,373T4 <Q_PJ_P;_P!"EH7_ (+8?_B:/^%7^#?^A2T+_P %L/\
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M^"V'_P")H_X5?X-_Z%+0O_!;#_\ $UT]% ',?\*O\&_]"EH7_@MA_P#B:/\
MA5_@W_H4M"_\%L/_ ,373T4 <Q_PJ_P;_P!"EH7_ (+8?_B:HW/P1^'5Y,TU
MQX!\+SS-]Z231K9F.!@9)3TKM:* .%_X41\-/^B>>%/_  26W_Q%'_"B/AI_
MT3SPI_X)+;_XBNZHH X7_A1'PT_Z)YX4_P#!);?_ !%'_"B/AI_T3SPI_P""
M2V_^(KNJ* /+O"OP-^&\VCHTGP^\+.WF/\S:+;$_>/\ L5K_ /"B/AI_T3SP
MI_X)+;_XBN@\(_\ (%3_ *Z2?^A&MJ@#A?\ A1'PT_Z)YX4_\$EM_P#$4?\
M"B/AI_T3SPI_X)+;_P"(KNJ* .77X6^#$4*OA'054#  TR$ ?^.TO_"K_!O_
M $*6A?\ @MA_^)KIZ* .8_X5?X-_Z%+0O_!;#_\ $T?\*O\ !O\ T*6A?^"V
M'_XFNGHH YC_ (5?X-_Z%+0O_!;#_P#$T?\ "K_!O_0I:%_X+8?_ (FNGHH
MYC_A5_@W_H4M"_\ !;#_ /$T?\*O\&_]"EH7_@MA_P#B:Z>B@#F/^%7^#?\
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MFNGHH YC_A5_@W_H4M"_\%L/_P 31_PJ_P &_P#0I:%_X+8?_B:Z>B@#F/\
MA5_@W_H4M"_\%L/_ ,31_P *O\&_]"EH7_@MA_\ B:Z>B@#F/^%7^#?^A2T+
M_P %L/\ \31_PJ_P;_T*6A?^"V'_ .)KIZ* .8_X5?X-_P"A2T+_ ,%L/_Q-
M'_"K_!O_ $*6A?\ @MA_^)KIZ* .8_X5?X-_Z%+0O_!;#_\ $T?\*O\ !O\
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M;^U-/3[;*6=R ^!E..HKH?[#O/\ H,77Y+67)_R&M)_ZZ-_*NNH Q?[#O/\
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M7^P[S_H,77Y+1_8=Y_T&+K\EK:HH Q?[#O/^@Q=?DM']AWG_ $&+K\EK:HH
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MAWG_ $&+K\EH_L.\_P"@Q=?DM;5% &+_ &'>?]!BZ_):/[#O/^@Q=?DM;5%
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M_08NOR6C^P[S_H,77Y+6U10!B_V'>?\ 08NOR6C^P[S_ *#%U^2UM44 8O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5[E11]7I]@]K(\-_L_\ :E_Z*9X)_P#"??\ ^*H_L_\ :E_Z*9X)_P#"??\
M^*KW*BCZO3[![61X;_9_[4O_ $4SP3_X3[__ !5']G_M2_\ 13/!/_A/O_\
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M_BJ]RHH^KT^P>UD>&_V?^U+_ -%,\$_^$^__ ,51_9_[4O\ T4SP3_X3[_\
MQ5>Y44?5Z?8/:R/#?[/_ &I?^BF>"?\ PGW_ /BJ/[/_ &I?^BF>"?\ PGW_
M /BJ]RHH^KT^P>UD>&_V?^U+_P!%,\$_^$^__P 51_9_[4O_ $4SP3_X3[__
M !5>Y44?5Z?8/:R/#?[/_:E_Z*9X)_\ "??_ .*H_L_]J7_HIG@G_P )]_\
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MV PX_%O>M?\ X0+]JO\ Z*GX%_\ ">D_^*KZ.TW38].@5 %>0 @RA "<G/\
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M)P,XZYJK^QW<#P%KWQ$^ NH2;_\ A$KV34/#DLWSM)H]TQ>/:3][RG8JQ]7
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MLA5**C$YC8$@R?>;/'R;^R;_ ,-"?VIXT_X4/][S(/[8_P"0?TW3>3_Q]_\
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M7^Z:_0;]A'_DTGX<?]>,G_I1+0![U1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!4D_P"0UI/_ %T;^5==7(R?\AK2?^NC?RKK
MJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2P$&6WFD7_7 K\P<\\XZ<5S^]5D:Z01]'ZYKQ5C#;.0REDDROX?XUQVK>*]
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M.2S'J6-<!^R7X7M/A_\ &?X]>#=,1(M TW5K"^LK-8PJ6SW-L9)5C'\*Y"@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 5)/^0UI/_71OY5UU<C)_P AK2?^NC?RKKJ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>XD8;)Y89 '-?85?GI_P4^TFUT_QAX#URV"PZI<6MQ#)+'PY6)XVC.?8R/\
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M<]<5#I:)Q=S15]6IJUE<^RJ*_('2M(\(_$RQ'B3X@?'F73/%4S-)]DN-$O\
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M@$]RN>]4Z?+:2=R%6YVX25G;N=SX'_X7?_PN9?\ A*/[+_X0#^Q(=_V7RO\
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M&^:-P,G!+9"MR, 'E_VG/VROB!\(/C3)X*\+:'H>JPM!;- MU:7$US++*/N
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MH&D?8XUN'WK.RE61L8'/_P!85$8QH+FEN4Y.H[+8=H^A+8?O)@KW"L2KHQP
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M"MI.IKJ$>W#>9&J[RP !/MBK=Q;QW4+12KOC;JN<5R%Y9R:?<9*,$#G8S?Q
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M3:EK.NJJO<:?H=NDSVP897S&>1%4D8.W<6P0<8(-?0U?$'Q,_9[^&/[-&O\
MC[XX_$M)OB9::Q<[8=%OM,@F:WGGE).SS)!&P P 2H**IQDT ?2_P-_:$\$_
MM$>&9=9\&ZDURMNRQW=E<Q^5<VCD9"R)D]><,"5.#@G!KTBOSR_X)8^#4O/$
M7Q(^(%C/8Z9H^I2?9+3PW:WRSS6L9F:13,H.4"@;$+@%@'. ,$_H;0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!4D_Y#6D_]=&_E775R,G_(:TG_ *Z-
M_*NNH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\8?\BY=_\  /\ T-:V
M(_\ 5K]*Q_&'_(N7?_ /_0UK8C_U:_2@!U%%% !1110 4444 %%%% !1110
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M,CP!_+99& &=G[M@6Z#C/6O0?V3/VL[G]H"^OM$N?"CZ*=+TZ.0WT,[3PS2
MA'!/EJ(R<J54EC@-R<5],T5ESIPY6C?V351S3W/SQ_X)T?\ )>/B'_UXR?\
MI4M-_;V_Y.I^'7_7E8_^ELM?HA15^U]_FL9_5_W?L[GA/[<?_)K?C?\ W+7_
M -*X:^>/@_\ !:Z^.O[!;:#IKHFLVVLW&H6 D;:DDR$C83T&Y7=03P"037W[
M14QJ.,;+O<TE14Y\S[6/RJ\%?&:S^ VBKX1^(GP!\/ZYJUHSK%>:MI\5K=NN
MXG]XSV\GF@$X##&1CD]:^P?V/KK_ (3#2M5\1ZC\&]%^'5XLI33]1T[28K,W
M5LXSL'RB0[<+E_N/D8Q@BOI2BG*HI+8BG1<'K*Z7D?GC_P $Z/\ DO'Q#_Z\
M9/\ TJ6G_P#!4#_D=/ '_7E<?^C$K]"Z*?M??Y["^K_NO9W/EO\ ;\^&NO\
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MN]AU/QM8^+[/5I8+1Q++865NK&>2;'W 5(X;&[:<"F_M=>.O'OA_XY_!S0_
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M=RG*]N/UJAH^A-?_ +R8,ENRDJZ,,D@XQ_.E3IJ*YZ@Y2;?+$^9_ ]L/@O\
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MH ZNXM8KN/9*F]<YQFN5O[&72KA'W*,L63:2<8/N*W]+U9+Z-59E%Q@ED4$
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MU/F7,$A\R"X"]Q"X!=B3A=HX% 'UK1110 4444 %%%% !1110 4444 %%%%
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MCKJUJ\,-NPM-,AD((B:5=BKGUC@C53C_ )ZU;_X*K?"S7KB'P9\3]!MY)H]
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M*[$Y+%()$4DGJ<9->H^ /ASX8^%GAV+0O"6AV>@:3&Q<6UG'M#.0 7<]78@
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M , _]#6MB/\ U:_2L?QA_P BY=_\ _\ 0UK8C_U:_2@!U%%% !1110 4444
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MD5YXF\%^&]9U.,)'!>:AI$%Q-QT^=T)';O7HT,,=M"D4,:Q11@*D:* J@=
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M.U=(3=ZM<,VYI[Z8^9.Q;^+YV*@^BK0!ZG1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 5)/\ D-:3_P!=&_E775R,G_(:TG_KHW\JZZ@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,7QA_R+EW_ , _]#6MB/\ U:_2
ML?QA_P BY=_\ _\ 0UK8C_U:_2@!U%%% !1110 4444 %%%% !1110 4444
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M 69&&WH/X@.2N:^Q_%G_  3O^$7B:^:YM+?6/#>YBS0Z3>CRR3UP)DDVCV7
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MWR6QZU^R7A?PY9>#_#>EZ%IL9BT_3;:.T@5N2$10JY]\#FO"?^&%OAX?BO\
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M?;N/_$@M%'8=!'[UZKX5\">&/A?HMY;>%?#FF>'K)F:YEM=+M4MDDD"@;B$
M!.% S[5K?V"MU(_BN_0W;.RCLH41$4,%"LZJ 6P.IJ/4M3CT^%V)5Y0 1%O
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M_P#D8M#^LW_H(K;H **** "BBB@ HHHH *Y:Z_Y&:\_ZY1UU-<M=?\C->?\
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M(KXV%32-.RC9IQT22=U9:[(\M1DZ-+#2AJYZO1IZ[KY'UC1117YF?;!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %23_D-:3_UT;^5
M==7(R?\ (:TG_KHW\JZZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,7QA
M_P BY=_\ _\ 0UK8C_U:_2L?QA_R+EW_ , _]#6MB/\ U:_2@!U%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'RI^TY_R=Y^S!_P!S1_Z;XJ]EKQK]
MIS_D[S]F#_N:/_3?%7LM>EAO@?J<=;X@HHHKK, HHHH **** "BBB@ HHHH
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M_8[\(SG#F2TNB 5^[BXFJC_P3?GT6W_93T1K*2VCN?[0OAJ)5@&^T>>^-_\
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MQOG!STX^GZUB:#'J?@SPKI^AW_B&\\2ZU:+BZUF]ABC>Y8Y8G:@VJ/F   X
M R>INZ%H_P!O832;6MU8JRDD$\>WU'>JITU%>TF*<FWR1&Z5HLNH2,TOF1+@
M,'9"0WXUUZQK&,*H4>PQ211+!&L:#:BC 'M67KNL?8%,,>Y;AE#*P ('/O\
M0]JSE*5:5D4DJ:NQNN:TEK$88BLK2*R-M?E#T_K^E8>FZ7-JDPW^8L; _OBI
M(X[9IVEZ?)K%T\K,K*KAI=Q(+9))Q@>QKKK:VCLX1%$NR,=!DG^=;2DJ"Y8[
MF:3J/F>QXA^UY\3[KX0? N_70?F\7Z_)%X=T&.,A9)+VX_=JR\CE%WN#ZJ*[
M?X#_  NT_P""_P (?"W@O3'2:#2;-8I+B/I/.26FE_X'(SM[9Q7@VJK+^T)^
MV5<&)EF\'_""SP<MF.?6KE<MC!PQBB7'3*N#ZU]&:3K367[N8LT"J=JJHR#G
M/^-<6YTFEK6D"X4S1\,B8$:)][FLBQOY=*N&WHS?+M\MB1CH:Z^LK5=%6\^>
M$*L[,"S,QP1C_P#52 THIHYEW1NLBYQE2"*HZKI2WR!E/ELF3\JY+5A:7JKV
M$BJS,;?)+(H!).,?X5U<,HFA2100KJ&&>O(H Y"UN)M+ND9XW&W)\MLKG(Q7
M5V=VEY"KJREMH+*K9VY'0U6U324OXV9547& %=B0!S_^NN?M;N72;QDWX4.!
M(% .X \XS^- '2:CIJ:A#LR(VW9W!<FN8 FTRZ5F610KY 8%0^#76VETMY;I
M,@8*V<!NO!Q46H:?'?Q'<H,BJ0C$D $_2@ T_4$OH5;*K(028PV2.<?Y^M/O
MK-;VW>,X4L,;\9(YS7*LUQH]Y(B.JR@8+*,C!P>XKJ;&^CU"$R1AE4-M^8#/
M0?XT <K>6DVGS.!Y@0':),%0U=)IFK)J$9W;8I-Q CW9)XSG_/I5FZLX;Q D
MR;U!R!DC^5<I/!/HMVGSJ)=NX,O(YR.XH ZRX@6XB=& ^92 2,XS7*ZAILNF
MS'9YC( /WH4@<^]=!I.I+J$.,-YD:KO+  $D=L?2K=Q;QW41CE7<AZC)% &;
MHVK+<1B*0K&R!57<_+GI_3]:U&17&&4,/<9KE-2L9-*NDD4J%9RT>TDE<'C.
M?J*V=%U;[:HADW-.JEF;  //M]10!D:EI,E@ZM'OE7!8LJ$!:NZ'K"[!;S%4
M"J3YCOUYZ<_7]*VY(UFC9'&588(KF-:TG["QFCVK S!57))''O\ 0T =2RAE
MPP!'H:YO6-'>*0S0AI?,8DJB?=_*K>BZTUPP@G+/,S':VT 8QG^AK9Z\4 <Y
MH>K>2P@E(VLQ8RN_3CI^GZUT0*R(""&5A]017.ZUHJVZF> *D*J-R[B3G./Z
MBG:+K3*RP3EG#%4CVJ,+VY_2@"36M'+%[B+<S$@>4B?X53TC4WL9C%("0[*I
M+MC9@X/\_P!*ZJL/6=%5E:> *FT,\FYCD]^/UH VHY%E4,C*ZGHRG(K)UK2!
M<*9H^&1,"-$^]S6;I.M-9?NYBS0*IVJJC(.<_P"-=50!R%C?RZ5<-O1F^7;Y
M;$C'0UUD4T<R[HW61<XRI!%9NJZ*MY\\(59V8%F9C@C'_P"JL;2]5>PD569C
M;Y)9% ))QC_"@#=U72EOD#*?+9,GY5R6KY+_ &BK.;XS?%[X>? J/S/[,O9A
MXF\51\@#3+9P4B<9Z32@+TX(4U]<WFK6FGZ3-J=Y.EI8P0-<S3S$*L<:KN9F
M/8  D_2OFO\ 8NT^Z^(=UXZ^.NKPR1WGCS4#'I$4P^:VT>V)BMDQGY2Q5F;'
M!PK=Z /I]5"J%4 *!@ =!2T44 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &)J__
M ",6A_6;_P!!%;=8FK_\C%H?UF_]!%;= !1110 4444 %%%% !7+77_(S7G_
M %RCKJ:Y:Z_Y&:\_ZY1T 34444 %%%% !1110 4444 %%%% !1110 4444 %
M1W%O%>6\L$\:RPRJ4>-QE64C!!'IBI**-@/&+_\ 9-\$WEXTT4NJV,;'(M[>
MY0H/8;T9OUKT/P-\.]"^'6FO9Z):>0LK!III&+R2D="S'T]!@#)XY-=)17H5
MLPQ>(A[.K4;CV;.2G@\/1ESTX),****\\ZPHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"I)_R&M)_ZZ-_*NNKD9/\ D-:3_P!=&_E7
M74 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\
M##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_
M *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?
M_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54
M_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\
M+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_
M +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"
M'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP
M&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C
M1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*
MH^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&
M'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)
M_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O
M_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJ
MC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)
M?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\
MP80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/
ML'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-
M_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0
MT:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%
M4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8
M_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_
M '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80_
M_%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?
M,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$
MOT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_
M .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\
M##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_
M *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?
M_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54
M_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\
M+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_
M +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"
M'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP
M&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C
M1?\ P80__%54_P"&'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*
MH^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&
M'/@-_P!$OT+_ +]O_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)
M_P#0T:+_ .#"'_XJC_A8_A/_ *&C1?\ P80__%54_P"&'/@-_P!$OT+_ +]O
M_P#%4?\ ##GP&_Z)?H7_ '[?_P"*H^M/L'L?,M_\+'\)_P#0T:+_ .#"'_XJ
MOG;PEXT\/_%G]K+Q#XNU#7-,C\-> ;4Z%H?VB\C59KZ49N[A,MSM7]UGH00>
MHKW2]_8+^ -_L\WX9:2NS./)DFBZ^NR09Z=ZDM?V$O@'9PB*/X8Z.RCG,OFR
M-_WTSDU+Q'-;0:I6ZG6:'XR\'M()[CQ7HL>TJ\>-3@Y[\_-]*Z;_ (6AX-_Z
M&W0O_!E#_P#%5YG_ ,,.? ;_ *)?H7_?M_\ XJC_ (8<^ W_ $2_0O\ OV__
M ,57/.HZCNS6,5%61UVM?&;PBR&&V\5:%+'(A5R;^/(^GS5GZ1XR\(7C;KCQ
M5HT<!4E674X <YQCEOK6#_PPY\!O^B7Z%_W[?_XJLG6/V)O@7;ZAI21_#/0T
M268JX$;?,,?[U:*MRQY8JQ+I\SNV>Q?\+0\&_P#0VZ%_X,H?_BJR=6^,_A"V
M4+;>*M"EDR5<-?Q''_CU<3_PPY\!O^B7Z%_W[?\ ^*H_X8<^ W_1+]"_[]O_
M /%5C%I.[5RY)M:&SI?C;PE?3+YOBG14M\D,PU* $<>[?2NP@^)7@RWACB7Q
M=H95%"C.I0YX&/[U>;?\,.? ;_HE^A?]^W_^*H_X8<^ W_1+]"_[]O\ _%5I
M4J.H]28043N]5^,G@ZSC80>*]"DG!'RF_B(Q^#5S=KX_\*ZE>%V\4:*$:0&0
MC4H1@$\XRWUK(_X8<^ W_1+]"_[]O_\ %4?\,.? ;_HE^A?]^W_^*JH5?9JR
M6HI0YGJST:S^(O@JQMD@C\7:(47."VI09Y.?[WO4.I?%_P &6<+[/%NAM-MR
MB_VA$0?R:O/_ /AASX#?]$OT+_OV_P#\51_PPY\!O^B7Z%_W[?\ ^*K&^MV:
M6TLC6D^)'AG5KR20>)M#\QAD@:C"HXP.[UUNG_$#P3IL+11>+]%92V[Y]3@)
MZ ?WO:O//^&'/@-_T2_0O^_;_P#Q5'_##GP&_P"B7Z%_W[?_ .*K6I5<U;9$
M1@HZGHMW\6O!5K'EO%VA[B#M']H1')_!JY*Z^*/AG6+M6/B;0Q)MV@+J$('&
M3W>L?_AASX#?]$OT+_OV_P#\51_PPY\!O^B7Z%_W[?\ ^*I4ZGL]4M0E'FZG
M>:-X\\%Z;#D>+M%\R15+JVIP$ @=!\WN:N3_ !8\%6Z;Y/%VAA<XXU&$_P F
MKS?_ (8<^ W_ $2_0O\ OV__ ,51_P ,.? ;_HE^A?\ ?M__ (JLW+F=Y%I6
M5D;.K?%3PMKCB&3Q+H93YD7;J$0R#QR2],^$T?PP^$OA.RT/P]KVBZ7IUL)1
M'9G68Y@F^1I&^9Y&8Y8D\L>M9/\ PPY\!O\ HE^A?]^W_P#BJ/\ AASX#?\
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MX-O$,R>+=%:=5"JHU.#!Y_WO<UD:?\5_"^ES.H\3Z'\Q"ONU"(XP>V'KGO\
MAASX#?\ 1+]"_P"_;_\ Q5'_  PY\!O^B7Z%_P!^W_\ BJ /28?BMX*N%W)X
MNT,C..=1A'\VJIJWC[P7J$.?^$NT7S(U8H%U. 9)'?YO:N!_X8<^ W_1+]"_
M[]O_ /%4?\,.? ;_ *)?H7_?M_\ XJ@#>MOBAX8TFZ9AXFT,R8VD-J,)'.#V
M>NHM?BUX+NH\KXNT/< -P_M"(8/XM7G/_##GP&_Z)?H7_?M__BJ/^&'/@-_T
M2_0O^_;_ /Q5 'HE]\0O!.H0B.3Q=HJJ&W?+J<&>A_VO>N7C^)/AC3+I)/\
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M5RNI>.?"-G,WE^*=%:#("L=2@)/'LWUK _X8<^ W_1+]"_[]O_\ %4?\,.?
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M3P7-&'7Q=H94]/\ B8PC_P!FK-UKQUX-O$,R>+=%:=5"JHU.#!Y_WO<UP_\
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MG?8;_P#Z"7_D!:/L-_\ ]!+_ ,@+0!HT5G?8;_\ Z"7_ ) 6C[#?_P#02_\
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M0!HT5G?8;_\ Z"7_ ) 6C[#?_P#02_\ ("T :-%9WV&__P"@E_Y 6C[#?_\
M02_\@+0!HT5G?8;_ /Z"7_D!:/L-_P#]!+_R M &C16=]AO_ /H)?^0%H^PW
M_P#T$O\ R M &C16=]AO_P#H)?\ D!:/L-__ -!+_P @+0!HT5G?8;__ *"7
M_D!:/L-__P!!+_R M &C16=]AO\ _H)?^0%H^PW_ /T$O_("T :-%9WV&_\
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M5_\ H.?^2B?XT?V7J_\ T'/_ "43_&@#:HK%_LO5_P#H.?\ DHG^-']EZO\
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M7^R]7_Z#G_DHG^-']EZO_P!!S_R43_&@#:HK%_LO5_\ H.?^2B?XT?V7J_\
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MHK%_LO5_^@Y_Y*)_C1_9>K_]!S_R43_&@#:HK%_LO5_^@Y_Y*)_C1_9>K_\
M0<_\E$_QH VJ*Q?[+U?_ *#G_DHG^-']EZO_ -!S_P E$_QH VJ*Q?[+U?\
MZ#G_ )*)_C1_9>K_ /0<_P#)1/\ &@#:HK%_LO5_^@Y_Y*)_C1_9>K_]!S_R
M43_&@#:HK%_LO5_^@Y_Y*)_C1_9>K_\ 0<_\E$_QH VJ*Q?[+U?_ *#G_DHG
M^-']EZO_ -!S_P E$_QH VJ*Q?[+U?\ Z#G_ )*)_C1_9>K_ /0<_P#)1/\
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M6+_9>K_]!S_R43_&C^R]7_Z#G_DHG^- &U16+_9>K_\ 0<_\E$_QH_LO5_\
MH.?^2B?XT ;5%8O]EZO_ -!S_P E$_QH_LO5_P#H.?\ DHG^- &U16+_ &7J
M_P#T'/\ R43_ !H_LO5_^@Y_Y*)_C0!M45B_V7J__0<_\E$_QH_LO5_^@Y_Y
M*)_C0!M45B_V7J__ $'/_)1/\:/[+U?_ *#G_DHG^- &U16+_9>K_P#0<_\
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M:/[+U?\ Z#G_ )*)_C0!M45B_P!EZO\ ]!S_ ,E$_P :/[+U?_H.?^2B?XT
M;5%8O]EZO_T'/_)1/\:/[+U?_H.?^2B?XT ;5%8O]EZO_P!!S_R43_&C^R]7
M_P"@Y_Y*)_C0!M45B_V7J_\ T'/_ "43_&C^R]7_ .@Y_P"2B?XT ;5%8O\
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M]7_Z#G_DHG^- &U16+_9>K_]!S_R43_&C^R]7_Z#G_DHG^- &U16+_9>K_\
M0<_\E$_QH_LO5_\ H.?^2B?XT ;5%8O]EZO_ -!S_P E$_QH_LO5_P#H.?\
MDHG^- !X1_Y J?\ 723_ -"-;5<EX=L-2FTM6@U7[/'O<>7]G5N=QR<FM/\
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M_DHG^- &U16+_9>K_P#0<_\ )1/\:/[+U?\ Z#G_ )*)_C0!M45B_P!EZO\
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M_P"1FO/^N4==37+77_(S7G_7*.@":BBB@ HHHH **** "BBB@ HHHH ****
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M_'SJ_P#U]M_(5M5B^'O^/G5_^OMOY"MJ@ HHHH **** "BBB@ HHHH ****
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M1_PV1XY_Z-U\;?\ @1;?XT<DNP<R[GU/17RQ_P -D>.?^C=?&W_@1;?XT?\
M#9'CG_HW7QM_X$6W^-')+L',NY]3T5\L?\-D>.?^C=?&W_@1;?XT?\-D>.?^
MC=?&W_@1;?XT<DNP<R[GU/17RQ_PV1XY_P"C=?&W_@1;?XT?\-D>.?\ HW7Q
MM_X$6W^-')+L',NY]3T5\L?\-D>.?^C=?&W_ ($6W^-'_#9'CG_HW7QM_P"!
M%M_C1R2[!S+N?4]%?+'_  V1XY_Z-U\;?^!%M_C1_P -D>.?^C=?&W_@1;?X
MT<DNP<R[GU/17RQ_PV1XY_Z-U\;?^!%M_C1_PV1XY_Z-U\;?^!%M_C1R2[!S
M+N?4]%?+'_#9'CG_ *-U\;?^!%M_C1_PV1XY_P"C=?&W_@1;?XT<DNP<R[GU
M/17RQ_PV1XY_Z-U\;?\ @1;?XT?\-D>.?^C=?&W_ ($6W^-')+L',NY]3T5\
ML?\ #9'CG_HW7QM_X$6W^-'_  V1XY_Z-U\;?^!%M_C1R2[!S+N?4]%?+'_#
M9'CG_HW7QM_X$6W^-'_#9'CG_HW7QM_X$6W^-')+L',NY]3T5\L?\-D>.?\
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MJ?I=6Q_DU6(OVM/B),H9/V;?'14C(/GVX!^G-5RM:M"NCZ=HKYE_X:N^(_\
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MJMB1]?FJ2#]K?XA7*AHOV;O'3J>C">WP?QS5<KM>PKH^GZ*^9?\ AJ[XC_\
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MU+PIJG@;Q3X<=6N]%UAD,QAGBWQRJ5."IP1[<>M>^U(PHHHH **** "BBB@
MKEKK_D9KS_KE'74URUU_R,UY_P!<HZ )J*** "BO(?VGOVD-#_9E^'+^(]4@
M;4=0N)/LVFZ5&^QKN;&<%L'8BCEFP<# P20#\4Z'\;/VV_CM8_\ "4^!]&31
M_#L^6MTM[*PAAD7LT9O27D''WE)!.?I0!^FE%?"'[+_[<_C>^^,$?PD^-.A)
MI7B6>0VUMJ"V_P!FD%QMW+'-%]TB0?=D3 R5X(;<-C]J;]HKXA?#G]L/X4>"
M/#OB#^SO"^N'3?[0L?L5O+YWFWSQ2?O'C9URB@?*PQC(P>: /M>BBO.?C_\
M'+0OV>?AGJ'C#7@\\<)6"ULH6 DN[AL[(E)Z9P23V56.#C% 'HU%?F-X?_:"
M_;-_:*MY_$_PYTB+2O#7F/'"MG:6"0O@X^62]):4CH2AQD'@=!Z3^S3^WEXO
ME^+$?PH^-^B1Z)XDFF6SM=16W-L_VAON1SQYV_O,@(\> <KP0VX 'WA17Q/X
M7_:(^(GAW_@H-JOPJ\4^(3?^#KX3'2K26SMXO*WP"XAQ(D2N^ 'CY8Y/4DBL
M/_@HI^UMX[^"OCCPMX7^'FNG1KUM/EU'4F6SM[HNC/MB&)8WV[1%*QQCAN:
M/O2BOG?]GO\ :'NO&W['\/Q*U^Z^UZMIFF7LNIS+&B%YK;S,MM554%@JM@ #
MYJY#_@G3\7?B/\</ /BGQ/X^\1'7(DU);#3X_L5O;"+9&'E(\J--V?-0<DXV
M<8YR ?6]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 5)/\ D-:3_P!=&_E775R,G_(:TG_KHW\JZZ@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,7QA_R+EW_ , _]#6MB/\ U:_2L?QA_P B
MY=_\ _\ 0UK8C_U:_2@!U%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M8OA[_CYU?_K[;^0K:K%\/?\ 'SJ__7VW\A6U0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?,O\ P4F_Y,K^(O\ W#O_ $Y6M>J5Y7_P4F_Y,K^(
MO_<._P#3E:UZI7?A?M'-6Z!1117<<H4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSR<UNW'#JRW,U>J[O86TLX;&,QP)L0G<1DGG\?I46I:G'IL:M(KMN.!L /\
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MQ8Z?K>NWUIHS:[_:Z27,4<DP1<M]D#,JF1B$W <GIFJ7[;O_ "D$^!GUT?\
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M_97T9? L/P[NO%NE68*6,DFD3ZK';QY.!%-:N/EYR%D)*C PN,5U?P%_9/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!B^,/^1<N_^ ?^AK6Q'_JU^E8_C#_D7+O_ (!_Z&M;$?\
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MH.]:<TR6\322':BC).,U=2I]BGL3&'VI$E<AK&NM?_NX2R6[* R.HR2#G/\
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MTG_KHW\JZZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,7QA_R+EW_ , _
M]#6MB/\ U:_2L?QA_P BY=_\ _\ 0UK8C_U:_2@!U%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_:4C2B&?><1QN>/N9W!> =IP,\_<E<]16DT=E&2E3304445D;A1110 4444
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MUQ.+>"24\A%+8]<#-%Q<1VL+2RMLC7J<$]\5R.J:A)K%TD2JK*KE8MH(+9(
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MTA4_+E04X/-?IYX-M=1L?"&AVVKS&XU:&Q@CO)FQEYA&HD8X]6!- &Q1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 5)/^0UI/_71OY5UU<C)_P AK2?^NC?RKKJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH Q?&'_ "+EW_P#_P!#6MB/_5K]
M*Q_&'_(N7?\ P#_T-:V(_P#5K]* '4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!B^'O^/G5_\ K[;^0K:K%\/?\?.K_P#7VW\A6U0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?,O_!2;_DROXB_]P[_TY6M>J5Y7_P %
M)O\ DROXB_\ <._].5K7JE=^%^T<U;H%%%%=QRA1110 445D>)/&6@>#;5+G
MQ!KFFZ%;.=JS:E=QVZ,?0%R :8%G7-!TSQ1I<^F:SIUIJVFSX$MG?0+-#)@A
MAN1@0<$ \CJ!7(?\,_\ PN_Z)MX1_P#!%:__ !NNB\,^.?#?C2*23P]X@TO7
MHX_OOIE['<A>W)1CBMNG=K0FT9:G+>&_A3X)\&ZE_:&@>#M T._V&/[5INF0
M6\NTXRNY%!P<#C/:NIKCV^,G@!=4&F'QQX;&I;_+^QG5[?SMW]W9OSGVQ78=
M>10[]1QMT.=D^'/A.7Q0/$C^%]%?Q$&#C5VT^$W88+M!\[;OSMXZ].*Z*HKR
M\@T^UFNKJ:.VMH4:26:9PB1H!DLS'@  9)-8OA7X@^%O'7VD>&_$ND>(?LNW
MS_[*OXKGRMV=N[8QVYVMC/7!]*6K#1:%./X2^!X]:_MA/!GA]-7W^;_:"Z7
M+C?G.[S-F[.>^:ZNN;N/B9X/L_$J^'9_%>AP^(&=8AI,FHPK=EV *J(BV[)!
M! QSD5T<DBQ1L[L$11EF8X  ZDFAWZ@K=!:^$/A7\-/%-I^WSXCUV_\ "FL0
M^'+B[U(KJ=SITJV<BO&X7$I780V<#GG-?9WA;XC>$_'$MQ%X;\3Z-X@EMU#3
M)I>H17)C!R 6",< X/7TJ_XA\3:/X1TQ]2UW5K'1=.1@K7>H7*01*Q. "[D
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M5NN99$C!Z;V S7(ZAJD^L3*L22*I7'DHQ8-@DYQ_GI3-4U2749BN_="')C&
M.*W=$T,6?[V=!]H5CM96R,$8_P :TC&-&/-+<AR=1V6PNBZ*EG&)90LDCA6
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M>3+'][CKS]?3M4>AZ']JQ-<(&MV4[<-@YS_^NNJK6I-4UR0(C%R?-(: L:
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MRN_>9NK+1'U31114%!1110 5RUU_R,UY_P!<HZZFN6NO^1FO/^N4= $U%%%
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M?E48Q@8'%=3X\\!:!\3O">H>&?%&F1ZOH>H($N+25F4. 0P(92&4@@$,I!!
M(-;]% '#?"3X(^#/@7HEUH_@C29-&TRZG^TR6K7UQ<IYFT*67SI'VD@#.W&<
M#-:WQ"^'GA_XK>#]0\+>*=/_ +4T&_""YM/.DA\S8ZNOSQLK##*IX(Z5T=%
M'-?#GX<>'?A+X/L?"WA33O[*T&Q,AM[3SY)MF]VD;YY&9CEF8\D]?2NEHHH
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M0 4444 %%%% !1110 4444 8OC#_ )%R[_X!_P"AK6Q'_JU^E8_C#_D7+O\
MX!_Z&M;$?^K7Z4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\/?
M\?.K_P#7VW\A6U6+X>_X^=7_ .OMOY"MJ@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\*QXR^#\'BFUA9]2\,3>:Q126-K*564<=@1&^>P5O>OFOXO?M!W_ ,?O@_\
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MV/T Z\BBL3P+/)=>"?#\TK%Y9-.MW=CU),2DFMNN,]-!1112 **** "BBB@
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M37EY'90L[LH8*2JLP!; Z"EO;Q+&W::0,57&0O7DXKD+R\FUB\2,OE#(5B#
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M385DE5F5FVC8 3_.E4J.J^6.PXQ4%=B:EJ4>G0,Y*O( "(BX!.3C_/TKD_\
M2-8O"0)61I/=Q&&/^?RI%:YUR^C1Y%:5AM#,,# R>P^M=;INFQ:=" B@2,JB
M1@202!UY_&M=,.O[QGK5?D-TS2X].A"_+)("3YFP \U->7D=E"SNRA@I*JS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OA[_CYU?\
MZ^V_D*VJQ?#W_'SJ_P#U]M_(5M4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'S+_P %)O\ DROXB_\ <._].5K7JE>5_P#!2;_DROXB_P#<._\
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MAZ?#8Z;9V^GV,*[8K:UB6*.,>BJH  ^E;2J\VMM3FIX=PO%O1GPG_P .L/\
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MV(%W8R<9QTS5^BBH-0HHHI %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<5%1=])-J_DNATE%%%?$GTX4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!4D_Y#6D_]=&_E775R,G_(:TG_ *Z-_*NNH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#%\8?\BY=_\  /\ T-:V(_\ 5K]*Q_&'_(N7
M?_ /_0UK8C_U:_2@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OA
M[_CYU?\ Z^V_D*VJQ?#W_'SJ_P#U]M_(5M4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'S+_P %)O\ DROXB_\ <._].5K7JE>5_P#!2;_DROXB
M_P#<._\ 3E:UZI7?A?M'-6Z!1117<<H4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Q?&'_ "+EW_P#_P!#6MB/_5K]*Q_&'_(N
M7?\ P#_T-:V(_P#5K]* '4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!B^'O^/G5_\ K[;^0K:K%\/?\?.K_P#7VW\A6U0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]A:K_P _MO\ ]^S1_86J_P#/[;_]^S7244 <W_86J_\ /[;_ /?LT?V%JO\
MS^V__?LUTE% '-_V%JO_ #^V_P#W[-']A:K_ ,_MO_W[-=)10!S?]A:K_P _
MMO\ ]^S1_86J_P#/[;_]^S7244 <W_86J_\ /[;_ /?LT?V%JO\ S^V__?LU
MTE% '-_V%JO_ #^V_P#W[-']A:K_ ,_MO_W[-=)10!S?]A:K_P _MO\ ]^S1
M_86J_P#/[;_]^S7244 <W_86J_\ /[;_ /?LT?V%JO\ S^V__?LUTE% '-_V
M%JO_ #^V_P#W[-']A:K_ ,_MO_W[-=)10!S?]A:K_P _MO\ ]^S1_86J_P#/
M[;_]^S7244 <W_86J_\ /[;_ /?LT?V%JO\ S^V__?LUTE% '-_V%JO_ #^V
M_P#W[-']A:K_ ,_MO_W[-=)10!S?]A:K_P _MO\ ]^S1_86J_P#/[;_]^S72
M44 <W_86J_\ /[;_ /?LT?V%JO\ S^V__?LUTE% '-_V%JO_ #^V_P#W[-']
MA:K_ ,_MO_W[-=)10!S?]A:K_P _MO\ ]^S1_86J_P#/[;_]^S7244 <W_86
MJ_\ /[;_ /?LT?V%JO\ S^V__?LUTE% '-_V%JO_ #^V_P#W[-']A:K_ ,_M
MO_W[-=)10!S?]A:K_P _MO\ ]^S1_86J_P#/[;_]^S7244 <W_86J_\ /[;_
M /?LT?V%JO\ S^V__?LUTE% '-_V%JO_ #^V_P#W[-']A:K_ ,_MO_W[-=)1
M0!S?]A:K_P _MO\ ]^S1_86J_P#/[;_]^S7244 <W_86J_\ /[;_ /?LT?V%
MJO\ S^V__?LUTE% '-_V%JO_ #^V_P#W[-']A:K_ ,_MO_W[-=)10!S?]A:K
M_P _MO\ ]^S1_86J_P#/[;_]^S7244 <W_86J_\ /[;_ /?LT?V%JO\ S^V_
M_?LUTE% '-_V%JO_ #^V_P#W[-']A:K_ ,_MO_W[-=)10!S?]A:K_P _MO\
M]^S1_86J_P#/[;_]^S7244 <W_86J_\ /[;_ /?LT?V%JO\ S^V__?LUTE%
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M\_UK_P!^31]EUS_G^M?^_)K:HH Q?LNN?\_UK_WY-'V77/\ G^M?^_)K:HH
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M^RZY_P _UK_WY-'V77/^?ZU_[\FMJB@#%^RZY_S_ %K_ -^31]EUS_G^M?\
MOR:VJ* ,7[+KG_/]:_\ ?DT?9=<_Y_K7_OR:VJ* ,7[+KG_/]:_]^31]EUS_
M )_K7_OR:VJ* ,7[+KG_ #_6O_?DT?9=<_Y_K7_OR:VJ* ,7[+KG_/\ 6O\
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M)K:HH Q?LNN?\_UK_P!^31]EUS_G^M?^_)K:HH Q?LNN?\_UK_WY-'V77/\
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M .!E<,""*SO@;\:=8^+*ZW:Z_P##;Q-\.=9T=XDN+;78XVMY_,#$&VG1BLP
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MV"BLB_[,0/>@#ZPK \'^/O#?Q M]0G\-:W8Z[!I]Y)I]W+83+*L-S'C?$Q'
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M>!_&&C:!\;?A1K7P>BUN<6NG:Y<:C;ZII;3'.V.6Y@^6)CQUR!R3M )KU?\
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MEDE9U154@Y(ZT >[T5\CZQ^VK\2O#VER>)]4_9B\:V?@2&/[3/J9U"U;4(8
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M)7[=_@;P?X"WZ5X"^*6F:@][X7C=GM;.^M(FF%S A)\H, %(''+=@NT ^O\
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MBW&B7#V5[J5Q+%HNG?:5)#1QSW./,P<98+C!!&002 ?25%>!?!#]K.V^)WQ
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M:S:CINC21V]KIJ';C[3=2?)&Q## P>N"5/% 'T917S=\-_VOM0U+XE:5\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSI_[^.^L-4L2%N=/NXR3'/$3_$,LI]5=AD$Y'C5K\#OVI=0TY/#.L?'S1(-
M\L03:]I?AP)K4L>,'!9O+C<@#]X,L"Q/) R 4_V"]3MM8^(G[3UW:2K/;O\
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M2J UJ7'['WQ#^#GBG6M5_9Z^)-GX-T+6[IKZ]\%^(=-%YI:7# YDMV'SP \
MHHZ8YPJJ-OX9?LB^(KKXJ:7\3_C9X]_X67XPT5630[&VL4L]*TC=G,D<(^_*
M>/WC $8'4JI !RO[27ANQ\4?\%!/V6[?4(4N+>W@UV^6.10P\V&W62)N>ZR*
MC ^JBOLAE#J58!E(P0>AKQKX@? F_P#&7[2_PI^)T.J6]O8>#;35+>XL)(V,
MMP;J#RU*,.!M/)S7LU 'Q_\ \$O\6WP&\5Z="JQ66F^-]8M+6%1A8H@Z,%'L
M"QK[ KP3]FW]G_5OV>_A3XT\/W'B2U>^U;6]2UJ#5+> [+,7"KL+*YPQ0KD]
MC5+]@/7O&OBO]E[POKWCS7KCQ'K&J2W5U!?7B!9FM#.X@+8ZY10X]G [4 ?1
M%?"O_!0WP38?$?\ :"_99\,ZG->6^GZGK6J032Z?<-;SJICM3E)%Y4\=17W5
M7S;^UG^S?XT^-7C/X5^*_ OB?2?#.N>!KR\O(9-6M'N(Y'F6%5^53V\ILY]1
M0!B2_P#!-GX6S1O')KWCZ2-P59&\57)# ]01GI7"?#+PI=_L)?M*?#OX0>'-
M7EU_X7_$A-2FM[+4H(?M^EWUO&)7D\^)%,J."B_.#@#@_+SW\?P[_:\,BA_B
M]X!5,_,5\,R$@>PW#-;OPE_91U?1/BU%\5?BC\0+KXE^/[2UDLM+<626&GZ3
M#)D.+>W0GYRK%2Y.2&.03S0!XE^T3K'C/0_^"E_P_NO ?AVP\4>(!\/YE33]
M2U#[#$8S=7.]O-V-@@=L<UL_M!_M+?M1?"/X;W_B>X^%'A#0M+M2D=WJBZS+
MJQL4=@GVAH8T1BB$Y.-V."00#7MVO_L]ZCK'[8?AGXRIJUK'IFD^&)=!?3&C
M8S22/+*XD#?="XD QUXKV?5M*L]=TN\TW4;6*]T^\A>WN+:= \<L;J59&4\$
M$$@CWH \/_8_^ ]A\(? VH:^_BD>/?%7CBX77M9\6* (]0>12T7D@=(55SM'
M^VQX!"CRCX_C_AFC]L_X>_&2'_1O"/CQ%\&>*WQB..X.#97+GL?E52W9(2/X
MJ]D_9@^!.O?LZZ3XA\'MXABUWP#'?O<^%[>8/]LTNWD)9[61SD2(K'*MUY;/
M4!>@_:4^!^G_ +1GP4\3^ M0D2V;4[?_ $2\9-WV6Z0AX9<=<*ZKD#!*EAWH
M \'\19_:7_;VTG1%_P!(\$?!>V75+[O%/KMP/]'0\8)B0!P<\,CCO6Q_P4W\
M)ZIXC_92U;4M)MS>7'AG4K+Q!):C_EK#!)^]R.X5'9SGLAKO/V0?V;Y?V:?A
MC=:1JNL_\)/XMUC4I]6US7F#;[VXD;@DL2Q 0*.3RQ<_Q5[=/!'=0R0S1K+#
M(I1XY%#*RD8((/4$4 8/P[\?:-\4O NA^+?#UVE[HVL6D=W;3(0?E89VGT93
ME6'4%2#R*WKBXBL[>6>>5(((E+R22,%5% R22>  .]?):_L7^,O@WKFHW_[/
MGQ1D\!:+J$S7$_@O7+ :EI"2-]YX-S;X.@.%SG&,A0 (-4_93^-GQNLTT?XS
M_&N)O![8^V^'? VF"P&H#.2DURWS[#T*A<$>AYH I_L"77_"POB;^T9\6K!#
M_P (OXM\40V6D3XPMU%9))&9U']U_-7GN0PZ@U]EUS.A^ ].\$?#V#PEX-@A
M\,Z?8V+66FK;Q[TM/E(1]K'YR&.X[B2QR22237.?L]>!_&_P[^%^GZ)\0O&9
M\>>)X99GFU@P^7N1G)1/5MH.,GGMT H ])KXA_X)GZ7H"ZE^T-J4$<)\3R?$
M;4K>[DVCS5M%8- N>NTNUP1ZD'TK[>KXG\,_L"^+?ASJ/B;QEX!^)2^#OB7J
MFOZCJ#:A%9?:K"^T^XD\R.SNK>0X+(Q8B51E=QX/& #V+]NG2]!U7]D/XL)X
MAC@>SAT"ZN+=IP,+=HA:V*YZ-YPC ]SCO7S9^UK)JVL_\$G?"KZXTG]L76C^
M&_M,DV2Y=GMLL^>=QSD^Y->C7G['_P 4_CGKFE_\- ?%*Q\2>#--NDO%\&^%
M],^Q6=[*GW3<RGYW3IE#GJ<%>I];_:T^ EY^T3\"]1\ Z3J-KH<]Q<V<T=Q<
M1,T2+!.DA7:OJ$P* /5_#GA^Q\)^'M,T33($M=-TVUBL[6", +'%&@1% '0
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MY%#*RD8((/4$5\CG]BGQE\'=>U#4?V>OBG-\/]&U"<W%QX,UJQ&I:0LA^\T
M8[H,^BY)Z;@   #Z\KXK_P""K4MU#\$?A[)8P)<WJ?$#2F@@D?8LD@CN=JEL
M' )P,XXS6E<_LI_'+XQ7%I:_&3XY_P#%*0S)/-X=\!Z?_9OVME((62ZXDV9
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M_&<?BF*R+S#,T>EK&1:!2>0C(@Z<'8O7 K[#EACG4+)&LBA@P# $!@<@_4$
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M>XYK5G_9$^(7P<\2:SJ?[/GQ'L_".AZQ=27UWX*\2:?]LTJ.X;EI+=E.^ '
M!51T[X55'=_!_P""/Q-TCQ\/&OQ0^+5UXNU&&S>RL]!T6S&FZ1;JY!=WB#$S
MR95=K-C;COQ@ E^+W_#3/_"92?\ "K?^%3_\(GY,>S_A+_[3^W>;C]YG[/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH _/?]J:1E_: \2@,0,VG?_IUAK[YT+_D!Z?\
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MRPS(&21",%6!X(()!!J+2=)L?#^EV>F:796^FZ;9PI;VUG:1+%#!$@"HB(H
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M<W,%]I\OV?5-#U2'[/J&F3<_NYXLG:?E;!!*G:0#D$  ]3HKYT_:L_::\4_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M =*^[:\FM3=&HX/H>K3FJD%)'Q#^W-J%K#\4-#MY+J".X;2$80O*JN1YTPR
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MGHUG86OB.48M;'4;55C$$[DXC5D7=N.!\X/1790#J]6_9K^+7P?TL^)_AO\
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MPP^*7B3Q5HOQ4^(OQ&U:UGNH6NH_AUI(6'2+"*:$JD$Q^]<21APQD./WB\#
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M.A\?_L'^)_BIX.O+K1I[[PA<:I9S02[9[*<1-N4./XXY RY'=>*\O^"_PO\
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MW !/:JW_  4,^+WC'X-Z9\(-4\%O=SZC=>-+:T?2;>Z-NFJ!HI-MK*PZH[[
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MRZC(9V(!8G' &;W[*'Q/\?:;\6/B)\#OB;K,?BS7O",5MJ&E^)T@6&34M/G
MVF9!P)$)4$]R3DG&YOJ>OC_P)_RE&^)G_9/['_T?%0!]@4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!\U?%_\ X)__  N^-WQ%U;QKXBDUQ=9U/R?/
M%G>I'%^[A2)=JF,X^6->_7-?1NG6,>EZ?:V<.[R;>)84W')VJ !D^N!5BBM)
M5)S24G=(B,(Q;:6YS7Q&^'/A[XL>#]1\+^*=-BU71KY-DL,@Y4_PNC=5=3R&
M'(->!?#O_@G=\-?A3XOT_P 3>%M8\6:3K%C('CFAU-,,/XD<>5AD8<%3P0:^
MHJ*<:LX)QB]&*5.,G=K4****R-#P7XR?L/\ PB^.&H3:GK?AS^SM;F.Z75-&
MD^RSR$]6< %';_:92?>O'Q_P21^#HDW?V_XU(S]W[?:8_P#26OMJBNB.(JQ5
ME)F,J-.3NXGB/P7_ &,_A/\  F[CU#PYX:2XUJ/[NK:HYN;E/="WRQGW15/-
M>W445E*<IN\G=FD8J*M%6"L#Q]X*T[XD>"=;\+:L9AIFL6DEE<FW<))Y;J5;
M:2#@X/I6_14IM.Z'OHSXY_X=4_!/_GKXF_\ !C'_ /&J=%_P2K^"4<BLQ\22
M@')1M23!]CB,']:^Q**Z?K5?^=F/L*7\J/)?A+^RG\*_@C.EUX2\'V5GJ2C
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M*L>#?'[]B_X>_M(^*K'Q!XN?6%O[.R6PB&GW:Q)Y8D=QD%&YS(W/TKU7X<^
M=,^%W@;1?">C&<Z5I-NMM;FY</)L&<;F &3SZ5TE%#J3E%0;T0*$4W)+4HZW
MHFG^)-'O-*U6R@U'3;R)H+BUN8P\<L;#!5E/!!%?+.G_ /!,GX0Z)X@BUK1K
MSQ5HFH6\_P!IM9;#5@C6S@Y7RV,98;>Q))XZFOK2BG"K.G=0=A2IQG\2(K6%
MK>VBB::2X:- IFEQO<@8W'  R>O  ]JEHHK(T"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "L;Q=X-T'Q]H%UH?B71K#7]'N@!-8:E;I/#
M)@Y&48$9!Y!['D5LT4 >0?#W]D/X,_"OQ FN^%OAQH.E:S&VZ*^6V\V6!O6-
MG+&,^ZXZGUKO? _P\\-_#72[G3?"^D6^BV-S=RWTT%J"%>>0YDD.3U8]:Z*B
M@#S?XJ_LX?##XWR12^.? ^C^([J)/+CO+JW N43GY1,N'"\DXW8SSUK4^&GP
M7\!_!NQN+3P/X1TCPM#<;3/_ &9:)$\^W[OF.!N?&3C<3C)KM** /$?V@OC9
MXE^$.K:/M^$NN?$+P%>P2)K&H>'56\N[)R0%!LL;I8RNXLV0!^&#XG9?M<_"
MOP['='X1? [Q%J'Q FC:W@TS3?!!TYTE/"I<S[%$<>2I8Y. :^VJ* /"?V*?
M@IK7P)^ >E:)XHDCD\6:A=7&M:R(B&6.ZN'WO'N!(8H-JD@D$J<'&*Z[XJ_L
MX?##XWR12^.? ^C^([J)/+CO+JW N43GY1,N'"\DXW8SSUKTBB@#B_AI\%_
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M,2"283^[)R/[O<^IKT?PY\-O"_A#Q)X@\0:+HEIINLZ^+<:G=VZ;6NA;H8X
MW;"(2HP!P:Z6B@#SSXK?L]_#?XY?8CX\\&Z5XFELLBWGO(?WL0)R5612&"D\
ME<X/I6I9_"'P7I_PWD\ 6GAG3K3P7);/9OHEO"([=HGSO4JN/O$DD]2223DU
MU]% %'0M#L/#.AZ?H^EVL=EIFGV\=I:VL0^2&&-0B(/8* /PKR3QA^Q?\#O'
MWB*77M=^&'AZ\U:9S+-<K:^49G.<M($*AV.3DL"3QGH*]IHH S/#?AG2/!NA
MVFBZ!I=GHND6:>7;V&GP)!!"N<X5%  &23P.]4/#_P //#?A7Q+XB\0Z3I%O
M8:UXBDAEU:]B!$EXT2E(R_/\*D@?6NBHH Q_&'@_1O'WAG4?#WB'3H=6T74(
MO)NK*X!,<R$@[3CMP*\7_:X^!<WQ6_9P_P"%8^%]!MYX;F[TNPA!>-$TJSCN
M8A+<+YC#F.!7 "Y8YP >E?0%% %;3=/MM'TZUL+.);>TM8E@AB0<(B@*JCV
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M)&^4=2"K#YNH(!KT[7OA9X1\4>,] \6ZOX>L-0\2Z")!IFISQ!IK7>,-L/\
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MNBHH *YOP)\./#/PQTR\T[PMHUMHEE>7DNH3PVH(62XDQYDAR>K8&?I7244
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>kod-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-09T17:02:57.1064+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="kod-20210930.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany" xlink:href="kod-20210930.xsd#Role_DisclosureTheCompany" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="kod-20210930.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities" xlink:href="kod-20210930.xsd#Role_DisclosureAccruedAndOtherCurrentLiabilities" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="kod-20210930.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecurities" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="kod-20210930.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" xlink:href="kod-20210930.xsd#Role_DisclosureNetLossPerCommonShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1" xlink:href="kod-20210930.xsd#DisclosureSubsequentEvents1" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="kod-20210930.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables" xlink:href="kod-20210930.xsd#Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="kod-20210930.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecuritiesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" xlink:href="kod-20210930.xsd#Role_DisclosureNetLossPerCommonShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureTheCompanyAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="kod-20210930.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" xlink:href="kod-20210930.xsd#Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="kod-20210930.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LiabilityRelatedToSaleOfFutureRoyalties" xlink:label="kod_LiabilityRelatedToSaleOfFutureRoyalties"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="kod_LiabilityRelatedToSaleOfFutureRoyalties" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpense" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_11172.00"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_11192.00"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" order="10612.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" order="10632.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="10752.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="10892.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11032.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_11172.00" order="11172.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_11192.00" order="11192.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_OperatingLeaseRightOfUseAssetAmortization" xlink:label="kod_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AmortizationOfIssuanceCosts" xlink:label="kod_AmortizationOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="kod_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_DepositsOnPropertyAndEquipment" xlink:label="kod_DepositsOnPropertyAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" xlink:label="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" xlink:label="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_11610.00"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_11810.00"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="kod_OperatingLeaseRightOfUseAssetAmortization" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="kod_AmortizationOfIssuanceCosts" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kod_IncreaseDecreaseInOperatingLeaseLiability" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="kod_DepositsOnPropertyAndEquipment" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" order="11372.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" order="11412.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" order="11452.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="11492.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_11610.00" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="11650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_11810.00" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TheCompanyTextBlock" xlink:label="kod_TheCompanyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="kod_TheCompanyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_RiskAndUncertaintiesPolicyTextBlock" xlink:label="kod_RiskAndUncertaintiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kod_RiskAndUncertaintiesPolicyTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedClinicalTrialAndRelatedCostsCurrent" xlink:label="kod_AccruedClinicalTrialAndRelatedCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedLeaseholdImprovements" xlink:label="kod_AccruedLeaseholdImprovements"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedResearchAndDevelopmentCurrent" xlink:label="kod_AccruedResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedLegalFeesCurrent" xlink:label="kod_AccruedLegalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="kod_AccruedClinicalTrialAndRelatedCostsCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="kod_AccruedLeaseholdImprovements" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="kod_AccruedResearchAndDevelopmentCurrent" order="10112.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="kod_AccruedLegalFeesCurrent" order="10191.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10231.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10271.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10311.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10050.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10050.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecurities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTerm" order="10131.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" order="10191.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="10251.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" order="10311.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:label="kod_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_CommitmentsAndContingenciesDisclosureTable" xlink:label="kod_CommitmentsAndContingenciesDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementExpense" xlink:label="kod_ManufacturingAgreementExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ClinicalAndCommercialSupplyMember" xlink:label="kod_ClinicalAndCommercialSupplyMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementMember" xlink:label="kod_ManufacturingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LonzaMember" xlink:label="kod_LonzaMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAgreementsMember" xlink:label="us-gaap_LeaseAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_EstimatedCapitalContributions" xlink:label="kod_EstimatedCapitalContributions"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:label="us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ContractualObligationDueInSecondYearAndAfter" xlink:label="kod_ContractualObligationDueInSecondYearAndAfter"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementInitialTerm" xlink:label="kod_ManufacturingAgreementInitialTerm"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementTermThatCanBeExtended" xlink:label="kod_ManufacturingAgreementTermThatCanBeExtended"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_ContractualObligation" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ManufacturingAgreementExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="kod_CommitmentsAndContingenciesDisclosureTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10031.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="srt_RangeAxis" order="10031.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10031.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="srt_CounterpartyNameAxis" order="10031.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10031.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kod_ClinicalAndCommercialSupplyMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kod_ManufacturingAgreementMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="kod_LonzaMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeaseAgreementsMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="kod_CommitmentsAndContingenciesDisclosureLineItems" order="10621.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_EstimatedCapitalContributions" order="10632.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_ContractualObligationDueInNextTwelveMonths" order="10652.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ContractualObligationDueInSecondYearAndAfter" order="10672.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ManufacturingAgreementInitialTerm" order="10692.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ManufacturingAgreementTermThatCanBeExtended" order="10712.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10762.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="10782.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedRestrictedStockUnitsMember" xlink:label="kod_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedStockOptionsMember" xlink:label="kod_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedEquityAwardsMember" xlink:label="kod_PerformanceBasedEquityAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" xlink:label="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TermOfOfferingPeriod" xlink:label="kod_TermOfOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_NumberOfPurchasePeriods" xlink:label="kod_NumberOfPurchasePeriods"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedRestrictedStockUnitsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kod_TwoThousandEighteenEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedStockOptionsMember" order="10141.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedEquityAwardsMember" order="10161.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10473.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10543.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" order="10583.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10623.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10663.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10733.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_TermOfOfferingPeriod" order="10753.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_NumberOfPurchasePeriods" order="10773.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="10793.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10813.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="10833.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="10883.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10903.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11170.00"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11900.00"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11170.00" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11900.00" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="12660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" xlink:label="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedStockOptionsMember" xlink:label="kod_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_SalesForecasting" xlink:label="kod_SalesForecasting"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LongTermPerformanceIncentivePlanDescription" xlink:label="kod_LongTermPerformanceIncentivePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ConsecutiveTradingDays" xlink:label="kod_ConsecutiveTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis_10031.00"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kod_TwoThousandEighteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedStockOptionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_SalesForecasting" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_PlanNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_LongTermPerformanceIncentivePlanDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_ConsecutiveTradingDays" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AwardTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis_10031.00" order="10031.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="10441.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>kod-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-09T17:02:56.5252+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://kodiak.com/20210930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:kod="http://kodiak.com/20210930" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31"/>
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31"/>
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric"/>
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kod-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kod-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kod-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kod-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" id="Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>100010 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" id="Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited">
        <link:definition>100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
        <link:definition>100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" id="Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany" id="Role_DisclosureTheCompany">
        <link:definition>100060 - Disclosure - The Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100070 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities" id="Role_DisclosureAccruedAndOtherCurrentLiabilities">
        <link:definition>100080 - Disclosure - Accrued and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100090 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities" id="Role_DisclosureMarketableSecurities">
        <link:definition>100100 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100120 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" id="Role_DisclosureNetLossPerCommonShare">
        <link:definition>100130 - Disclosure - Net Loss per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1" id="DisclosureSubsequentEvents1">
        <link:definition>100140 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100150 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables" id="Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables">
        <link:definition>100160 - Disclosure - Accrued and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100170 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" id="Role_DisclosureMarketableSecuritiesTables">
        <link:definition>100180 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100190 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" id="Role_DisclosureNetLossPerCommonShareTables">
        <link:definition>100200 - Disclosure - Net Loss per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails" id="Role_DisclosureTheCompanyAdditionalInformationDetails">
        <link:definition>100210 - Disclosure - The Company - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails">
        <link:definition>100220 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100230 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" id="Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails">
        <link:definition>100240 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" id="Role_DisclosureMarketableSecuritiesAdditionalInformationDetails">
        <link:definition>100250 - Disclosure - Marketable Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100260 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100270 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails">
        <link:definition>100280 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" id="Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails">
        <link:definition>100290 - Disclosure - Stock-Based Compensation - Summary of Restricted Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails">
        <link:definition>100300 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" id="Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails">
        <link:definition>100310 - Disclosure - Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100320 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_AccruedClinicalTrialAndRelatedCostsCurrent" name="AccruedClinicalTrialAndRelatedCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_AccruedLeaseholdImprovements" name="AccruedLeaseholdImprovements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_AccruedLegalFeesCurrent" name="AccruedLegalFeesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_AccruedResearchAndDevelopmentCurrent" name="AccruedResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_AmortizationOfIssuanceCosts" name="AmortizationOfIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" name="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" name="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" name="AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_ConsecutiveTradingDays" name="ConsecutiveTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_ContractualObligationDueInSecondYearAndAfter" name="ContractualObligationDueInSecondYearAndAfter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_DepositsOnPropertyAndEquipment" name="DepositsOnPropertyAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_EstimatedCapitalContributions" name="EstimatedCapitalContributions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_IncreaseDecreaseInOperatingLeaseLiability" name="IncreaseDecreaseInOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" name="IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" name="IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" name="IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" name="IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_LiabilityRelatedToSaleOfFutureRoyalties" name="LiabilityRelatedToSaleOfFutureRoyalties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_LongTermPerformanceIncentivePlanDescription" name="LongTermPerformanceIncentivePlanDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_ManufacturingAgreementExpense" name="ManufacturingAgreementExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_ManufacturingAgreementInitialTerm" name="ManufacturingAgreementInitialTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_ManufacturingAgreementTermThatCanBeExtended" name="ManufacturingAgreementTermThatCanBeExtended" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_NumberOfPurchasePeriods" name="NumberOfPurchasePeriods" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_OperatingLeaseRightOfUseAssetAmortization" name="OperatingLeaseRightOfUseAssetAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" name="PrincipalPaymentsOfTenantImprovementAllowancePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" name="ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kod_SalesForecasting" name="SalesForecasting" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_TermOfOfferingPeriod" name="TermOfOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_CommitmentsAndContingenciesDisclosureLineItems" name="CommitmentsAndContingenciesDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_ClinicalAndCommercialSupplyMember" name="ClinicalAndCommercialSupplyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_LonzaMember" name="LonzaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_ManufacturingAgreementMember" name="ManufacturingAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_PerformanceBasedEquityAwardsMember" name="PerformanceBasedEquityAwardsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_PerformanceBasedRestrictedStockUnitsMember" name="PerformanceBasedRestrictedStockUnitsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_PerformanceBasedStockOptionsMember" name="PerformanceBasedStockOptionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" name="TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" name="TwoThousandEighteenEmployeeSharePurchasePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_TwoThousandEighteenEquityIncentivePlanMember" name="TwoThousandEighteenEquityIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" name="TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_RiskAndUncertaintiesPolicyTextBlock" name="RiskAndUncertaintiesPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_CommitmentsAndContingenciesDisclosureTable" name="CommitmentsAndContingenciesDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" name="ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kod_TheCompanyTextBlock" name="TheCompanyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>kod-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-09T17:02:58.1341+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="kod-20210930.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:href="kod-20210930.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" xlink:href="kod-20210930.xsd#Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="kod-20210930.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10140.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10160.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10612.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10632.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10752.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10892.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11032.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10050.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10050.02" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10050.04" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10100.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10140.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10180.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10180.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10200.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10300.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10320.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateNoteSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10600.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10670.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10750.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10830.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10090.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10090.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10110.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10130.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10200.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10320.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10440.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10560.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10100.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10131.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10191.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10251.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10311.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:label="kod_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_CommitmentsAndContingenciesDisclosureTable" xlink:label="kod_CommitmentsAndContingenciesDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementExpense" xlink:label="kod_ManufacturingAgreementExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ClinicalAndCommercialSupplyMember" xlink:label="kod_ClinicalAndCommercialSupplyMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementMember" xlink:label="kod_ManufacturingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LonzaMember" xlink:label="kod_LonzaMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAgreementsMember" xlink:label="us-gaap_LeaseAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_EstimatedCapitalContributions" xlink:label="kod_EstimatedCapitalContributions"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:label="us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ContractualObligationDueInSecondYearAndAfter" xlink:label="kod_ContractualObligationDueInSecondYearAndAfter"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementInitialTerm" xlink:label="kod_ManufacturingAgreementInitialTerm"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementTermThatCanBeExtended" xlink:label="kod_ManufacturingAgreementTermThatCanBeExtended"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_CommitmentsAndContingenciesDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_ContractualObligation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ManufacturingAgreementExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10031.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10031.02" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10031.04" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10031.06" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10031.08" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kod_ClinicalAndCommercialSupplyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10200.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10220.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10240.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10300.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kod_ManufacturingAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10420.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10420.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10440.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="kod_LonzaMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10560.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10560.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10580.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeaseAgreementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10632.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_EstimatedCapitalContributions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10652.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_ContractualObligationDueInNextTwelveMonths" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10672.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ContractualObligationDueInSecondYearAndAfter" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10692.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ManufacturingAgreementInitialTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10712.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_ManufacturingAgreementTermThatCanBeExtended" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10762.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10782.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedRestrictedStockUnitsMember" xlink:label="kod_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedStockOptionsMember" xlink:label="kod_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedEquityAwardsMember" xlink:label="kod_PerformanceBasedEquityAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" xlink:label="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TermOfOfferingPeriod" xlink:label="kod_TermOfOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_NumberOfPurchasePeriods" xlink:label="kod_NumberOfPurchasePeriods"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedRestrictedStockUnitsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.02" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.04" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kod_TwoThousandEighteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10141.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10161.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedEquityAwardsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10240.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10260.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10340.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10473.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10543.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10583.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10623.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10663.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10733.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10753.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_TermOfOfferingPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10773.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_NumberOfPurchasePeriods" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10793.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10813.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10833.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10883.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10903.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10570.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10770.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10870.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10970.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11070.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11300.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11500.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11600.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11700.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11800.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12230.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12660.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12860.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10100.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10130.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10100.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10130.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" xlink:label="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedStockOptionsMember" xlink:label="kod_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_SalesForecasting" xlink:label="kod_SalesForecasting"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LongTermPerformanceIncentivePlanDescription" xlink:label="kod_LongTermPerformanceIncentivePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ConsecutiveTradingDays" xlink:label="kod_ConsecutiveTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kod_TwoThousandEighteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="kod_PerformanceBasedStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_SalesForecasting" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_LongTermPerformanceIncentivePlanDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_ConsecutiveTradingDays" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>kod-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-09T17:02:58.0027+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedLeaseholdImprovements" xlink:label="kod_AccruedLeaseholdImprovements"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementExpense" xlink:label="kod_ManufacturingAgreementExpense"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LongTermPerformanceIncentivePlanDescription" xlink:label="kod_LongTermPerformanceIncentivePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_SalesForecasting" xlink:label="kod_SalesForecasting"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ConsecutiveTradingDays" xlink:label="kod_ConsecutiveTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" xlink:label="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_NumberOfPurchasePeriods" xlink:label="kod_NumberOfPurchasePeriods"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TermOfOfferingPeriod" xlink:label="kod_TermOfOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TheCompanyTextBlock" xlink:label="kod_TheCompanyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" xlink:label="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedEquityAwardsMember" xlink:label="kod_PerformanceBasedEquityAwardsMember"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedStockOptionsMember" xlink:label="kod_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:label="us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAgreementsMember" xlink:label="us-gaap_LeaseAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LonzaMember" xlink:label="kod_LonzaMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementMember" xlink:label="kod_ManufacturingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedLegalFeesCurrent" xlink:label="kod_AccruedLegalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedResearchAndDevelopmentCurrent" xlink:label="kod_AccruedResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedClinicalTrialAndRelatedCostsCurrent" xlink:label="kod_AccruedClinicalTrialAndRelatedCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_RiskAndUncertaintiesPolicyTextBlock" xlink:label="kod_RiskAndUncertaintiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LiabilityRelatedToSaleOfFutureRoyalties" xlink:label="kod_LiabilityRelatedToSaleOfFutureRoyalties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ClinicalAndCommercialSupplyMember" xlink:label="kod_ClinicalAndCommercialSupplyMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_CommitmentsAndContingenciesDisclosureTable" xlink:label="kod_CommitmentsAndContingenciesDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:label="kod_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementTermThatCanBeExtended" xlink:label="kod_ManufacturingAgreementTermThatCanBeExtended"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ManufacturingAgreementInitialTerm" xlink:label="kod_ManufacturingAgreementInitialTerm"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ContractualObligationDueInSecondYearAndAfter" xlink:label="kod_ContractualObligationDueInSecondYearAndAfter"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_EstimatedCapitalContributions" xlink:label="kod_EstimatedCapitalContributions"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" xlink:label="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" xlink:label="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_DepositsOnPropertyAndEquipment" xlink:label="kod_DepositsOnPropertyAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="kod_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AmortizationOfIssuanceCosts" xlink:label="kod_AmortizationOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_OperatingLeaseRightOfUseAssetAmortization" xlink:label="kod_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PerformanceBasedRestrictedStockUnitsMember" xlink:label="kod_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested, beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested, ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedLeaseholdImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedLeaseholdImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.0001 par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Agreement Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing Agreement Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LongTermPerformanceIncentivePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LongTermPerformanceIncentivePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Performance Incentive Plan Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LongTermPerformanceIncentivePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long-Term Performance Incentive Plan Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_SalesForecasting_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_SalesForecasting_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Forecasting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_SalesForecasting_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales Forecasting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consecutive Trading days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consecutive Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consecutive Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Periods</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options performance period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Options performance period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 LTPIP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Long-Term Performance Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Twenty One Long-Term Performance Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Lease, Liability, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic and Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Allowance for Credit Loss, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock based compensation expense related to ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock purchase price percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_NumberOfPurchasePeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of purchase periods</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_NumberOfPurchasePeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Purchase Periods</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_NumberOfPurchasePeriods_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of purchase periods.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TermOfOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TermOfOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Of Offering Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TermOfOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of offering period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Awards vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period for achievement of specific milestone</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Vesting Period For Achievement Of Specific Milestone</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award vesting period for achievement of specific milestone.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested Restricted Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Performance Period Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options performance period expiration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Canceled</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested, beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested, ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Canceled</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments Debt And Equity Securities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued and Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable And Accrued Liabilities Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TheCompanyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TheCompanyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">The Company [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TheCompanyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure for the company.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of property and equipment under accounts payable and accruals</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Or Part Noncash Acquisition Fixed Assets Acquired1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset obtained in exchange for operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Asset Obtained In Exchange For Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of non-cash investing and financing information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash, at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash, at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Principal payments of capital lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Debt And Capital Lease Obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon options exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Other Operating Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities excluded from the computation of diluted net loss per common share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation weighted-average period expected for recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation cost related to unvested share based awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, options, aggregate intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited or canceled</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited or canceled</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options, granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Plan and 2015 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Eighteen And Two Thousand Fifteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand eighteen and two thousand fifteen equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of common stock available for issuance increased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Employee Share Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Eighteen Employee Share Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand eighteen employee share purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedEquityAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Based Equity Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedEquityAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Based Equity Awards [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedEquityAwardsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance based equity awards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance-based Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Based Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance-based stock options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Eighteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand eighteen equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligationDueInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual suite fees payment for 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligationDueInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contractual Obligation Due In Next Twelve Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets By Major Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LonzaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lonza</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LonzaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lonza [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LonzaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lonza.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repurchase Agreement Counterparty Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Losses, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale debt securities accumulated gross unrealized loss before tax current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale debt securities accumulated gross unrealized gain before tax, current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Amortized Cost Basis Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale debt securities amortized cost basis current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Realized Gain (Loss), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, and Short-term Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateNoteSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateNoteSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Note Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurements, Recurring</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Observable Inputs (Level 2)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Quoted Price in Active Markets (Level 1)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Observable Inputs (Level 2)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued salaries and benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedLegalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued legal fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedLegalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Legal Fees Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedLegalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued legal fees current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedClinicalTrialAndRelatedCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical trial and related costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedClinicalTrialAndRelatedCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Trial And Related Costs Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AccruedClinicalTrialAndRelatedCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical trial and related costs current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents and marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Short Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Options Activity under 2018 Plan and 2015 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued and Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued And Other Current Liabilities Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued and other current liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_RiskAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk and Uncertainties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_RiskAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risk And Uncertainties Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_RiskAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risk and uncertainties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prior Period Reclassification Adjustment Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Common Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LiabilityRelatedToSaleOfFutureRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liability related to sale of future royalties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LiabilityRelatedToSaleOfFutureRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability Related To Sale Of Future Royalties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_LiabilityRelatedToSaleOfFutureRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liability related to sale of future royalties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock pursuant to employee stock purchase plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to employee stock purchase plans, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments for restricted stock units, net of taxes withheld</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock pursuant to employee stock purchase plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ClinicalAndCommercialSupplyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical and Commercial Supply of Drug Substance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ClinicalAndCommercialSupplyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clinical And Commercial Supply [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ClinicalAndCommercialSupplyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical and commercial supply.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_CommitmentsAndContingenciesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_CommitmentsAndContingenciesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_CommitmentsAndContingenciesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_CommitmentsAndContingenciesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_CommitmentsAndContingenciesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_CommitmentsAndContingenciesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementTermThatCanBeExtended_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing agreement term that can be extended</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementTermThatCanBeExtended_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Agreement Term That Can Be Extended</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementTermThatCanBeExtended_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing agreement term that can be extended.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementInitialTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing agreement initial term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementInitialTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Agreement Initial Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ManufacturingAgreementInitialTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing agreement initial term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ContractualObligationDueInSecondYearAndAfter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual suite fees payment each year after 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ContractualObligationDueInSecondYearAndAfter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contractual Obligation Due In Second Year And After</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ContractualObligationDueInSecondYearAndAfter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contractual obligation due in second year and after.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_EstimatedCapitalContributions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Capital Contributions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_EstimatedCapitalContributions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated capital contributions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charges or recoveries related to marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Than Temporary Impairment Loss Debt Securities Available For Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for credit losses for available-for-sale debt securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Allowance For Credit Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized gains or losses recognized on sale or maturity of available-for-sale debt securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Realized Gain Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, effective maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Liabilities And Other Operating Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization (accretion) of premium (discount) on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Principal payments of tenant improvement allowance payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Principal Payments Of Tenant Improvement Allowance Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Principal payments of tenant improvement allowance payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of future royalties, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Future Royalties Net Of Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from sale of future royalties, net of issuance costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_DepositsOnPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deposits on property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_DepositsOnPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deposits On Property And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_DepositsOnPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deposits on property and equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in operating lease liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AmortizationOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AmortizationOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_AmortizationOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of issuance costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_OperatingLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of operating lease right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_OperatingLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_OperatingLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease right of use asset amortization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of common stock warrant, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Exercise Of Common Stock Warrants Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon exercise of common stock warrants, shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon vesting of restricted stock units,net of taxes withheld, shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of common stock warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Exercise Of Common Stock Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon exercise of common stock warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting of restricted stock units, net of taxes withheld</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon vesting of restricted stock units,net of taxes withheld.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in unrealized gains related to available-for-sale debt securities, net of tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per common share, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 6)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_EstimatedCapitalContributions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revised estimated capital contribution</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contractual Obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contractual Obligation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual suite fees payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance Based Restricted Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Based Restricted Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kod_PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Based Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options, vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Contractual obligation under funding agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to employee stock purchase plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Availability of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AccruedLeaseholdImprovements" xlink:to="kod_AccruedLeaseholdImprovements_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ManufacturingAgreementExpense" xlink:to="kod_ManufacturingAgreementExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_LongTermPerformanceIncentivePlanDescription" xlink:to="kod_LongTermPerformanceIncentivePlanDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_SalesForecasting" xlink:to="kod_SalesForecasting_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ConsecutiveTradingDays" xlink:to="kod_ConsecutiveTradingDays_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember" xlink:to="kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_NumberOfPurchasePeriods" xlink:to="kod_NumberOfPurchasePeriods_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_TermOfOfferingPeriod" xlink:to="kod_TermOfOfferingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_TheCompanyTextBlock" xlink:to="kod_TheCompanyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember" xlink:to="kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember" xlink:to="kod_TwoThousandEighteenEmployeeSharePurchasePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_PerformanceBasedEquityAwardsMember" xlink:to="kod_PerformanceBasedEquityAwardsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_PerformanceBasedStockOptionsMember" xlink:to="kod_PerformanceBasedStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_TwoThousandEighteenEquityIncentivePlanMember" xlink:to="kod_TwoThousandEighteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:to="us-gaap_ContractualObligationDueInNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAgreementsMember" xlink:to="us-gaap_LeaseAgreementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_LonzaMember" xlink:to="kod_LonzaMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ManufacturingAgreementMember" xlink:to="kod_ManufacturingAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:to="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateNoteSecuritiesMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AccruedLegalFeesCurrent" xlink:to="kod_AccruedLegalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AccruedResearchAndDevelopmentCurrent" xlink:to="kod_AccruedResearchAndDevelopmentCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AccruedClinicalTrialAndRelatedCostsCurrent" xlink:to="kod_AccruedClinicalTrialAndRelatedCostsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock" xlink:to="kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_RiskAndUncertaintiesPolicyTextBlock" xlink:to="kod_RiskAndUncertaintiesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_LiabilityRelatedToSaleOfFutureRoyalties" xlink:to="kod_LiabilityRelatedToSaleOfFutureRoyalties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ClinicalAndCommercialSupplyMember" xlink:to="kod_ClinicalAndCommercialSupplyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_CommitmentsAndContingenciesDisclosureTable" xlink:to="kod_CommitmentsAndContingenciesDisclosureTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="kod_CommitmentsAndContingenciesDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ManufacturingAgreementTermThatCanBeExtended" xlink:to="kod_ManufacturingAgreementTermThatCanBeExtended_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ManufacturingAgreementInitialTerm" xlink:to="kod_ManufacturingAgreementInitialTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ContractualObligationDueInSecondYearAndAfter" xlink:to="kod_ContractualObligationDueInSecondYearAndAfter_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_EstimatedCapitalContributions" xlink:to="kod_EstimatedCapitalContributions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" xlink:to="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" xlink:to="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_DepositsOnPropertyAndEquipment" xlink:to="kod_DepositsOnPropertyAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="kod_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_AmortizationOfIssuanceCosts" xlink:to="kod_AmortizationOfIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_OperatingLeaseRightOfUseAssetAmortization" xlink:to="kod_OperatingLeaseRightOfUseAssetAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:to="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares" xlink:to="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:to="kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld" xlink:to="kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kod_PerformanceBasedRestrictedStockUnitsMember" xlink:to="kod_PerformanceBasedRestrictedStockUnitsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>kod-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-11-09T17:02:58.1855+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="kod-20210930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="kod-20210930.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:href="kod-20210930.xsd#Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="kod_LiabilityRelatedToSaleOfFutureRoyalties" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_LiabilityRelatedToSaleOfFutureRoyalties" xlink:label="kod_LiabilityRelatedToSaleOfFutureRoyalties"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestExpense" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="kod_DepositsOnPropertyAndEquipment" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="3" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kod_OperatingLeaseRightOfUseAssetAmortization" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" order="5" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kod_AmortizationOfIssuanceCosts" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="6" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="7" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="9" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kod_IncreaseDecreaseInOperatingLeaseLiability" order="10" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_DepositsOnPropertyAndEquipment" xlink:label="kod_DepositsOnPropertyAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts" xlink:label="kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_OperatingLeaseRightOfUseAssetAmortization" xlink:label="kod_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_PrincipalPaymentsOfTenantImprovementAllowancePayable" xlink:label="kod_PrincipalPaymentsOfTenantImprovementAllowancePayable"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AmortizationOfIssuanceCosts" xlink:label="kod_AmortizationOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="kod_IncreaseDecreaseInOperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="kod_AccruedClinicalTrialAndRelatedCostsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="kod_AccruedLeaseholdImprovements" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="kod_AccruedResearchAndDevelopmentCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="kod_AccruedLegalFeesCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedClinicalTrialAndRelatedCostsCurrent" xlink:label="kod_AccruedClinicalTrialAndRelatedCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedLeaseholdImprovements" xlink:label="kod_AccruedLeaseholdImprovements"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedResearchAndDevelopmentCurrent" xlink:label="kod_AccruedResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AccruedLegalFeesCurrent" xlink:label="kod_AccruedLegalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:to="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kod-20210930.xsd#kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent" xlink:label="kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>kod-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:kod="http://kodiak.com/20210930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="kod-20210930.xsd" xlink:type="simple"/>
    <context id="C_cbd92a0e-372f-48a4-b6d5-ce7f82ea665f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_8cafabb9-2fa4-4282-a961-4356c77480d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2021-10-13</startDate>
            <endDate>2021-10-13</endDate>
        </period>
    </context>
    <context id="C_9b59a0e5-e47e-4121-b018-a86d491ac673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_9bdfa9aa-1ba9-4af1-8101-e5969ff5eae8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_a23868ac-4d18-4080-b770-dd5c05f2ac9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_c25a3452-9b30-4001-9008-cd10e3278714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_76b97688-4be3-49e7-81df-21713ee340ae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_68a9be7d-3755-49bf-a2da-42390bcb4eec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_90a0890e-113a-4768-a4d5-8086e659ebe1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_e0805aa0-1dc9-4338-83a1-9f7dc9b4a4d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_1f61b024-5ca7-4987-be9f-a79fc65f9ac7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_60ee5be9-fce8-4ec2-9433-83baa13390dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_58d71972-cf16-407c-92c6-ce1dbf2b12b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-13</startDate>
            <endDate>2021-10-13</endDate>
        </period>
    </context>
    <context id="C_df61c764-a534-4f0b-8ca0-21e84f617033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_bb793a10-451f-4b36-8cb8-5154d0eba3cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_cccca9ea-943c-426b-a949-a6fa3e183830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_132bd18c-61d8-48f7-809f-8bb8b165fbc1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_8ca588ac-2ea8-47e2-9e1e-0d5c0f7bdd04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_28f3dc2d-2645-40d1-8f72-dba22572cd4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_975902bf-d85c-41cd-863e-84e008163d3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_a54f3b91-0dde-44ee-ba4b-942ccb719672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_bba9d155-8973-4881-b4f4-889287f1e62c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_a2ce11da-0bb4-4016-be57-12f7208128b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_195d5ffe-0492-4de0-b82c-488c9ea38019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-13</instant>
        </period>
    </context>
    <context id="C_31399e52-c5e0-47e5-a93a-23ef7ff40786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kod:LonzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kod:ClinicalAndCommercialSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_e95e0f4c-377f-4358-8d44-eaa863f82dcd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_f286752f-3bc4-47a6-a27d-666daa7a6ec9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_1e740a6d-5b59-4139-b143-25fb54883059">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_a5328f00-e330-42c1-80c1-8421c3606923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_93d12b66-9ce5-4317-ac9a-15a39b2600d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_e32f672d-5f84-455b-8c7b-12ed7c65984c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-13</instant>
        </period>
    </context>
    <context id="C_c938c6fd-25b2-418a-ad6d-7089541a671c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kod:LonzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kod:ClinicalAndCommercialSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_20bef648-9662-4045-ac10-f374a4e6dd4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_88e8f9d6-793b-4b92-a798-5c12f7a88303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_458e6e92-7030-4315-9600-616198160fdb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kod:LonzaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kod:ClinicalAndCommercialSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kod:ManufacturingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_e5c59142-312f-4066-abfc-c35cb8d948e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_47fd8490-2f13-4a75-8942-c29752532c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_8656501a-52be-4d70-8809-9957b36d4bee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="C_32f5b3f4-2926-4a41-a753-0315ed597699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_f7a3a9d0-55f0-4f98-bd8e-f8ff83d37aef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_72724aca-fdbc-4107-8023-8e92c79546de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_a0bf9017-3374-4d04-9d4e-2d55c59dd283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_7c0f0042-303e-4491-b1dc-68acfaccacc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_86dc39fd-f86e-42e3-9bd9-ba7b697a9ddf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_baaf78fe-4b36-48dc-ba7a-9a0cd9f14b1c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_9ffaaef7-e461-404c-aa29-30c8c1054bbb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_12553a8d-237a-4ea4-b220-6b9e18798500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_a7ae9458-f493-45a2-8df8-95b502b2f850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_263b39c0-fc6e-4304-804c-806e5d34aa8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_0f217839-80a3-4a6a-bdfd-679c49f63892">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_5c21659f-1cec-4a85-8710-24968233ef93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_0ec927f1-50c6-4660-8fa6-d7393ce25571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_3bb54cbe-545d-4fe0-bcd2-19e483d491f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_4882ce6c-ab65-4041-9b2e-170bdcd25b73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_158eae8b-5b6c-4683-b5fa-33c0622853f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEmployeeSharePurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_63179ee0-98f3-437f-a39f-263cdaf44426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_35c1b8b0-ef41-45be-a72a-9abe398ca0e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_a00f1dc8-2c72-4c4b-a537-1e6bd1510eb4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_e2bbe6b4-f70f-4f1f-81ce-fdcefcfcd7b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_43f639e8-9157-46d6-99bf-779d020c83ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_ca5ad689-4bf0-49c6-bbdf-99985e3228a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_d4d3bdd1-f4a5-411e-b2cd-de5f19a1571b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_add76d56-e3aa-4160-be48-644dc3f7d81b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="C_9a2edcb3-cdb8-4ae3-8ba8-ad3566e86572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_d8945418-7878-462f-88bb-8634543ad049">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_0509b27f-2c96-45a2-b3c6-bd0c582464ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_be29e469-1e89-4c7e-9ad6-caa85930c9fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_3d5599e4-af21-4a80-b2fa-9f50ffb8ff68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_a051b042-5e1d-45e2-b954-e74131ddd0b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_b596f86d-2557-4336-bacd-b0ddf9d1d545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_463882b0-53f7-46b3-9143-d473f7db2d44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_9bb106de-f5c9-411f-80cc-5611a5510340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_7d6f728e-e9d4-4671-bc36-35fc3079d423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_fad684c8-cc78-4067-ab73-24cb363807a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_66006d13-4030-4015-b889-1afb6b097dca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_52fd169e-6778-4b75-87b8-41bfa51538a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_282bfd4f-0e6c-4f01-ad36-409ab1c8d1c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_4724a75b-6bfd-4f43-a79e-256b1d3309c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-13</startDate>
            <endDate>2021-10-13</endDate>
        </period>
    </context>
    <context id="C_dbe6d2e0-e108-4f31-b4a9-aabc9eee0627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_7b2909d7-cea1-4df1-9529-fa4f0d2242dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_00c91e92-2084-4178-8614-66b75d51a63e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f799a588-4775-46ae-b373-fdba49e2b7b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_7f2795d1-2d93-4f05-944e-15b9e4c3cfa8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_ccfa3f6d-89ca-4e36-8c0f-12d38600ca8b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_d7b002c3-ab22-4669-b768-13dd644c4c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_4bf07dd0-aa9f-4e17-a6bc-9b077b5eb34f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_4ed3c78d-73cb-40d0-9e64-ce6ba2494412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_e739ae0c-05c8-4c3a-9039-0e4e7b4f6746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_7dbc5e36-5dc0-495f-8dc7-02933e453b0d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_f3d83275-b94c-473f-9d84-d4f80ce062b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_b4b42d07-b554-47fb-9b37-295ad99f4b05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_508f6cdf-9b62-49da-86b7-10e38cc856c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_d52ced4e-2cc6-4467-a7c6-7247dd7a8166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_63e78694-19d8-46fd-86b4-4a74be843c5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_91bbf1c7-f25d-4226-96c0-0fe81b4ea717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEmployeeSharePurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_83602e3b-403a-43a4-ae96-ae8d95713283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_fb27358c-ef23-4137-acfd-472379d7d8fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-13</instant>
        </period>
    </context>
    <context id="C_be8eee73-1f79-40e1-81dc-2113994bd9a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_e3632781-f643-46dc-88ab-1cd6c0123800">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_6eb21092-7da1-4ed9-b508-b58c034c3e29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_9576e5b4-2d98-4b0c-b5ce-11be9a69984a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_8f8f672c-7b89-45db-8898-94025bfd6f08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_b41ae94c-ea21-43b0-b06e-03ad6d4cf023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_d417aa44-069d-45f0-a7f5-d98db662cdba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_94d38241-9b26-4db5-b401-ca5bf21d7968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_9aef3e3a-3ea0-45c0-bd9f-ebf158d52e18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_a1e4b7dd-9d0f-43db-9195-97483937350d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kod:TwoThousandEighteenEmployeeSharePurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_94e0829a-4192-4195-b797-aa8cc430a181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_7dc99746-dd99-4798-80e9-33bcb72d7ab3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:PerformanceBasedEquityAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="C_520836e4-6ccf-4a48-aec5-56fdd89596cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_5ab89046-dcd8-48bc-ba35-9efd3fc2e6e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_e870a142-80e3-4e6a-82c5-2362dbf0e897">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f34844dd-a0dc-4745-aaa5-323fb87a0df9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_2ca048f5-d8ec-4b11-8cd8-2132a593856e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_b726a636-8b47-460e-ae59-7f6272c15d60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_e681ec89-e92b-43ad-b6d0-5e7aad790ff7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_99a56596-b12a-4053-a88d-44e605f7dfab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_a99bad54-886c-4f22-a572-c4f604a8eef5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_61ad6d79-e0a3-4c3a-9112-71b6fcbfb724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_c04dde98-cf3c-4935-9b98-35dde0c8ff28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kod:TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-13</startDate>
            <endDate>2021-10-13</endDate>
        </period>
    </context>
    <context id="C_b45963b2-ae18-48d6-8992-a6e27e535c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_3cf9ac24-3ded-44bb-ae89-f866105b17ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_abb4f15e-cec6-4695-bd11-ddd8693c1243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_cb05ac74-574d-4580-b0cf-bb252f7fa760">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_c60273c5-32a1-4ece-91e4-ddb660a10670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468748</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Days">
        <measure>kod:Days</measure>
    </unit>
    <unit id="U_CHF">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="U_PurchasePeriod">
        <measure>kod:PurchasePeriod</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      id="F_525f0a1b-b4ec-4a72-98ab-f7443ab418bc"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_43297c36-5cca-4992-b552-762d25eb323d">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_bfb17daa-e5bf-42a6-b0e6-f4661e6df9c3">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      id="F_96f66858-c650-49ce-8733-f803beb8d6ee"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      id="F_0b201eed-5ccd-4cf8-8b7d-2c8eacd321e0"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_6c610b87-5e64-4ad8-a4d1-e933dce4fa66">0001468748</dei:EntityCentralIndexKey>
    <us-gaap:PreferredStockValue
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      id="F_50422e85-346c-4b9e-a26d-7837cf373b79"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      id="F_2f1ee712-59aa-4bc8-a15c-9f4c6b71c5bf"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      id="F_cfc22e00-db77-4e36-b02a-b9cbdc4da455"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:AmendmentFlag
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_491b1780-c8cb-4dfa-9022-3e9b148a4ea6">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_2a306f65-f061-480d-a93e-9adf1883d095">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_b3d4a040-1736-4ad4-bb39-7792d7a25cb7">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_f94fe6f8-80ba-480b-b898-f8f7d70e1f15">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_0be4b659-12f7-4c55-8dc6-58f7d2610e00">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_23267274-8055-48f5-b48f-2fc054c2dca6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_87f1435a-7bf9-42fb-a4ca-49bd3099af5e">001-38682</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_fb9e5051-01cb-4efe-8767-52e22ff9ef43">KODIAK SCIENCES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_c32408b5-0fd1-4442-9573-b54da7eb2872">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_ed8a1601-fce0-4e87-a620-1bccff212085">27-0476525</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_737180e5-3380-4703-b900-0f881c912164">1200 Page Mill Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_15940d3f-3b6e-4dec-aac8-a03d6773461b">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_b7497849-b3ff-4f8a-a69d-1107b734bd0d">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_6493c0e4-fa17-424b-847f-7eadef5a1f5a">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_ec45d39c-9dda-47c3-ba54-a056219028d9">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_4f2f56e7-2b36-4f60-bbd9-53433c2d5a63">281-0850</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_39543fcd-1499-4030-9b4b-d90b46488102">Common stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_2c633fe4-12ef-4bca-b89a-70903abb4157">KOD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_491c43c2-55c6-4d7d-88ab-d92614d92ba3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_588a19eb-ee1b-475c-87c1-40e572fa20b6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_fcf0ca00-9afc-4204-890b-7c5f157c6f4f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_6f89b6eb-f64b-4cd0-9c73-ca2381383ad0">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_3eaaabac-5ed1-4c68-ba71-0a5c86d09b5b">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_856768ee-69f7-4f84-8fe2-c3d863c1cdd5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_8cfd0c21-d6e9-4ec2-bd4d-af5e07078686">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_8656501a-52be-4d70-8809-9957b36d4bee"
      decimals="INF"
      id="F_f09ac071-1680-41ac-b6e5-3afa3ed93651"
      unitRef="U_shares">51717286</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_66e6b67c-557d-46e1-ab4e-cda30959c832"
      unitRef="U_USD">799247000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_9183104e-300a-424d-944d-3d254a128f04"
      unitRef="U_USD">944396000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_8273ff4a-cbb8-406a-9d56-b50b123a0024"
      unitRef="U_USD">24578000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_060b81ad-5932-49db-8d4d-aac1f4a567c3"
      unitRef="U_USD">6259000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_127c16b7-f27c-4379-95a3-f241c780f728"
      unitRef="U_USD">3031000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_f84620b2-6394-465d-956a-a2fce72106c3"
      unitRef="U_USD">805506000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_e378dcfb-5b52-4e98-a1c6-f48fa7e9a579"
      unitRef="U_USD">972005000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_fad4ced4-5c74-439e-9a98-5033489239a6"
      unitRef="U_USD">6324000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_e5204813-03f7-4f56-b2a3-12df7028162e"
      unitRef="U_USD">6324000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_ef9e9043-0716-4bf4-bfa4-ce478e379093"
      unitRef="U_USD">22939000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_3240d88f-f46b-47b4-abb2-51f0ac99ad1c"
      unitRef="U_USD">5136000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_826fdec1-e27c-487e-88b7-bb7772828b3d"
      unitRef="U_USD">68450000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_033a98e2-738f-4a2f-b3d0-7ea46ab9526f"
      unitRef="U_USD">73672000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_c9ec90d7-45fc-47b1-97bd-34d575d14391"
      unitRef="U_USD">54987000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_c0a8b782-d5e5-47c3-b843-7c325c906bc9"
      unitRef="U_USD">10210000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_ee50e1c5-de96-4d5b-93e8-72c040a8e14b"
      unitRef="U_USD">958206000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_c3d0a618-36c9-48e8-b3e8-e1be0fb4286d"
      unitRef="U_USD">1067347000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_ee0e1854-8d3b-4856-a28a-0326721a190c"
      unitRef="U_USD">13761000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_5a8e5c56-152e-47fe-b3d1-2a540564e5d7"
      unitRef="U_USD">8646000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_e4004e5f-d934-4b66-a1e4-a64f91e5d1a7"
      unitRef="U_USD">39016000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_2ede3df7-04d6-4c67-8d24-251851e25012"
      unitRef="U_USD">20402000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_e8efc659-b8c3-4909-9427-ace7832d6169"
      unitRef="U_USD">1619000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_f9fde576-ab9d-41a1-a2a3-3ad5ffdc3388"
      unitRef="U_USD">2374000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_d6b40e12-d41d-49a3-9b32-5ea36f2dc228"
      unitRef="U_USD">54396000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_83c75ea1-faa7-406e-b880-0f8b8191eb90"
      unitRef="U_USD">31422000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_40805e5d-71d1-4e77-8b1c-5e21aee2507d"
      unitRef="U_USD">77338000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_ee3c7b08-d310-434c-bc81-f8641ea0dc4c"
      unitRef="U_USD">75028000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <kod:LiabilityRelatedToSaleOfFutureRoyalties
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_325ae013-ef92-44b1-b6a8-c8e156d3b575"
      unitRef="U_USD">99929000</kod:LiabilityRelatedToSaleOfFutureRoyalties>
    <kod:LiabilityRelatedToSaleOfFutureRoyalties
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_481a935f-55f4-41e5-a5a6-047ccc6473b5"
      unitRef="U_USD">99890000</kod:LiabilityRelatedToSaleOfFutureRoyalties>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_e52ef9fd-7763-4acf-9f2b-fe0e10cd12a8"
      unitRef="U_USD">223000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_efe8e892-1c52-4beb-863a-3cd1ed2f66ba"
      unitRef="U_USD">256000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_5d52716f-4b5c-478e-b697-0f28d1c32eca"
      unitRef="U_USD">231886000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_4c968098-ed84-4d03-9313-bbeb78a2f7b6"
      unitRef="U_USD">206596000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_bfff1a42-fdb4-44d1-afc4-97af41334fb7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_a7233710-d205-46a4-8113-ba636eb31c59"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_c2502c61-12c2-43bc-a004-256f68c76458"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_1a6cc49b-5f34-4cfa-958a-b84a9bed708b"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_50916c3d-d7d9-4780-a686-ff9e3f35956a"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_cbbb80d1-8001-419a-9ffd-e7c3daf2c4bd"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_00100896-3d95-48c1-9370-8e532a501c02"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_32230284-6045-4095-b52f-3e7583e89f17"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_c4631a55-6414-4517-b70c-3fbe44cf0ae3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_ed899a50-0e25-449e-aa03-0254e34cd905"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_90b998ad-fe86-4d33-b805-4371d57cc233"
      unitRef="U_shares">490000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_2117ea6a-0a8a-4ce0-9ef9-99d25ffe1663"
      unitRef="U_shares">490000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_9603a737-4bfa-4312-8b59-0c7caf6f695f"
      unitRef="U_shares">51698775</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_975df73f-7752-4c63-9c49-08bf592d44c2"
      unitRef="U_shares">51698775</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_0d1da0f2-bafe-4c95-8415-66484cd96c95"
      unitRef="U_shares">51112302</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_019ba8c6-2da2-48d9-8801-267530664c80"
      unitRef="U_shares">51112302</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_3e2c8b77-2775-41b4-9f83-3e9a977038d9"
      unitRef="U_USD">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_0a9dc88e-4f43-4082-a598-65acbc0da54f"
      unitRef="U_USD">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_7fc8aae7-6669-4b04-9770-d1fd67df87ae"
      unitRef="U_USD">1191367000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_a59589c6-7b4a-4868-96f9-187285aac15f"
      unitRef="U_USD">1151920000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_aeb35704-123c-4448-af00-a60af770c075"
      unitRef="U_USD">53000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_d2dbe90f-e0eb-40a8-81db-adb7b6a0c869"
      unitRef="U_USD">-465052000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_4f0a319c-5750-46e7-9d9d-3a276bf8dbdd"
      unitRef="U_USD">-291227000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_deedcf78-1a98-4863-9cd7-dfe657dd7a92"
      unitRef="U_USD">726320000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_4395df54-c7fe-4069-ba75-290baedf501b"
      unitRef="U_USD">860751000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_7fda42ed-49b3-4a40-90bb-758073fdf525"
      unitRef="U_USD">958206000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_f07d9939-4f80-4972-919b-2528cfc96716"
      unitRef="U_USD">1067347000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_6993fbc9-4ea1-4c26-9729-44382853ace9"
      unitRef="U_USD">56002000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_5c7c5ea0-7e08-467d-a5b3-39e75204ba7c"
      unitRef="U_USD">29306000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_0c67554a-89ec-426e-bf39-32cd5b0db03d"
      unitRef="U_USD">141743000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_fc3a287c-bb6f-4ac7-8b4a-db57661018bb"
      unitRef="U_USD">70033000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_bc6c6afc-b2f1-4656-aa2c-2ec7c46c59dc"
      unitRef="U_USD">11533000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_50669ace-1303-4619-a848-cc58b459986a"
      unitRef="U_USD">7357000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_50991de3-f35f-4c73-af42-51db0ec457cd"
      unitRef="U_USD">32259000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_218ace46-6f8a-4707-a916-944e0de6f83e"
      unitRef="U_USD">19132000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_aac0af49-648f-4127-83c3-bee96ce4a941"
      unitRef="U_USD">67535000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_074fe34a-fdc4-4dd6-8e22-c7f34f7c47e0"
      unitRef="U_USD">36663000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_61d54eb6-ff0f-4c60-86c7-59679eec8716"
      unitRef="U_USD">174002000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_3462d9f7-ff57-451f-8ae7-aa35e48f0e03"
      unitRef="U_USD">89165000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_1e4062dc-b261-4b3b-ba5d-f4eee490b4be"
      unitRef="U_USD">-67535000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_1b08b0d8-dd34-410e-90f6-99ffb80200d8"
      unitRef="U_USD">-36663000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_2c61b710-4421-436e-a8c5-1d904bdd79d6"
      unitRef="U_USD">-174002000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_245aacdc-248c-4de5-9d29-ebf41a2e14d7"
      unitRef="U_USD">-89165000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_2facd6b8-51d1-43b6-abe7-4583c9f3a35a"
      unitRef="U_USD">40000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_ad7affb9-ee57-47b7-9a33-ea174489e204"
      unitRef="U_USD">645000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_fbc36954-4f4f-4aad-a212-bda614d93643"
      unitRef="U_USD">270000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_56311302-963e-4b23-87e6-7da110262169"
      unitRef="U_USD">2551000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_e4522fd8-0049-4bcf-839c-98b30d0931b6"
      unitRef="U_USD">6000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_7ce03ab7-c61b-40b7-94bf-13365481d8c6"
      unitRef="U_USD">6000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_c2c3614d-c5ed-43e5-a327-cf94406609d3"
      unitRef="U_USD">17000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_a65c5a2e-7d52-4674-9b4d-512e54994f66"
      unitRef="U_USD">19000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_99133f17-6a53-457e-a06d-540008405dcd"
      unitRef="U_USD">-25000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_30aa48bf-5cef-46ec-b3fe-2fbca3da2551"
      unitRef="U_USD">-98000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_672b2efd-765c-4109-bc4a-ea5195e2ff52"
      unitRef="U_USD">-76000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_b67d5586-167e-496b-9be1-5bf1b1345af0"
      unitRef="U_USD">120000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_2f60d510-fa53-4d38-8338-e234d87888b6"
      unitRef="U_USD">-67526000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_2b6e628e-2644-413f-ab94-1717a9dd4729"
      unitRef="U_USD">-36122000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_15c03310-6b69-4d33-881e-9f8525f69708"
      unitRef="U_USD">-173825000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_4dbe3215-5a73-42d8-8776-1a7844c4fbca"
      unitRef="U_USD">-86513000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="2"
      id="F_f6d24125-d340-40a9-a6de-a1608fe3afdd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.30</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="2"
      id="F_a6d607ee-7930-46da-863e-91a4d0ed6138"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.80</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="2"
      id="F_8e49fc7d-2f0a-4a38-a5ed-c1f27d1ea8e2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.36</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="2"
      id="F_f6fef830-67f1-4dd2-b877-2684bae0d1ff"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.92</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="0"
      id="F_2f5d12f5-e1a9-4fe3-b87c-7d1d08954355"
      unitRef="U_shares">51875315</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="0"
      id="F_311c6475-64c4-4586-b7aa-9d0a58d69c1c"
      unitRef="U_shares">45119885</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="0"
      id="F_4b453503-317f-4f72-95ef-61f99ccd0f12"
      unitRef="U_shares">51722611</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="0"
      id="F_2df12904-7b77-4679-a6ed-b44993add364"
      unitRef="U_shares">44972085</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_c25afc90-f5d1-4357-a755-f84b78f0381f"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_527c2f39-4917-4ef3-b6db-c819e45c78f8"
      unitRef="U_USD">-349000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_51a53219-ec23-48f2-bd5e-3a095ed69ddb"
      unitRef="U_USD">-53000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_9b728d84-e211-42af-ae9f-425d1d7d1182"
      unitRef="U_USD">235000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_4928147d-6d23-4d66-8712-5daedb356d61"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_d2905ada-5c44-4443-aea8-6052b44f35b7"
      unitRef="U_USD">-349000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_8a14376f-b405-4575-ad76-eb305d51ff15"
      unitRef="U_USD">-53000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_07c98062-3969-4f9d-83c3-63ee8548179d"
      unitRef="U_USD">235000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_c6117fc6-e425-49fd-997e-5870f32268e4"
      unitRef="U_USD">-67526000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_39aca8c2-44a6-4aed-8261-5e377ff8c19f"
      unitRef="U_USD">-36471000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_e8f841fa-c139-4ba6-a25a-5ccf1461efda"
      unitRef="U_USD">-173878000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_33dd01bd-5c85-495c-b2de-832f4e5a989d"
      unitRef="U_USD">-86278000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_43f639e8-9157-46d6-99bf-779d020c83ec"
      decimals="INF"
      id="F_8fce2638-3770-4593-898f-6d71a1733d0d"
      unitRef="U_shares">51112302</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_43f639e8-9157-46d6-99bf-779d020c83ec"
      decimals="-3"
      id="F_3fa5f83a-43e2-4ce1-b619-f008c4adf168"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_88e8f9d6-793b-4b92-a798-5c12f7a88303"
      decimals="-3"
      id="F_b0baf3ac-14fd-46a5-b91d-b8b0c307848b"
      unitRef="U_USD">1151920000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e2bbe6b4-f70f-4f1f-81ce-fdcefcfcd7b0"
      decimals="-3"
      id="F_bc6df689-7261-4dc8-81eb-7c648540ee26"
      unitRef="U_USD">53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cbd92a0e-372f-48a4-b6d5-ce7f82ea665f"
      decimals="-3"
      id="F_4274756b-06f9-4886-a46b-f9b83eb1ef2f"
      unitRef="U_USD">-291227000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_2e783910-df2a-4834-8af1-eafc08ba2740"
      unitRef="U_USD">860751000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_52fd169e-6778-4b75-87b8-41bfa51538a8"
      decimals="INF"
      id="F_c00c2e19-d47f-4383-9d29-11c45a235b4e"
      unitRef="U_shares">113559</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_94e0829a-4192-4195-b797-aa8cc430a181"
      decimals="-3"
      id="F_f476eef6-5892-4773-a84e-0e1d35656315"
      unitRef="U_USD">1483000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830"
      decimals="-3"
      id="F_5eefa4a5-1783-4eed-b044-bd2e1dafe9cc"
      unitRef="U_USD">1483000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_94e0829a-4192-4195-b797-aa8cc430a181"
      decimals="-3"
      id="F_7d2fa0da-bbae-4c4f-9743-9f7c7b406947"
      unitRef="U_USD">9925000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830"
      decimals="-3"
      id="F_77182f56-d5df-42d0-b589-445d8bc4f5ea"
      unitRef="U_USD">9925000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_2ca048f5-d8ec-4b11-8cd8-2132a593856e"
      decimals="-3"
      id="F_3ca6d097-8180-434d-bbb5-5d94541cc1bc"
      unitRef="U_USD">-35000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830"
      decimals="-3"
      id="F_718a9e4f-70ec-4325-8d9c-6c320209db7f"
      unitRef="U_USD">-35000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="C_e3632781-f643-46dc-88ab-1cd6c0123800"
      decimals="-3"
      id="F_5b13cf4a-4db1-4e69-b4a0-01da14a870ec"
      unitRef="U_USD">-50447000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_cccca9ea-943c-426b-a949-a6fa3e183830"
      decimals="-3"
      id="F_300d4627-d15f-48fc-b57c-dd7fd1d6642d"
      unitRef="U_USD">-50447000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_9ffaaef7-e461-404c-aa29-30c8c1054bbb"
      decimals="INF"
      id="F_a0538bab-73cc-4649-9ce1-1d55120b21e9"
      unitRef="U_shares">51225861</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_9ffaaef7-e461-404c-aa29-30c8c1054bbb"
      decimals="-3"
      id="F_b3427678-63cc-4d59-ba67-050cbb9529a2"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e95e0f4c-377f-4358-8d44-eaa863f82dcd"
      decimals="-3"
      id="F_5fef65f8-ff2e-47c1-9254-b7996b31907c"
      unitRef="U_USD">1163328000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e681ec89-e92b-43ad-b6d0-5e7aad790ff7"
      decimals="-3"
      id="F_ac9ee461-25a2-414d-b8ce-9e8a91e5a776"
      unitRef="U_USD">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a0bf9017-3374-4d04-9d4e-2d55c59dd283"
      decimals="-3"
      id="F_217d7d71-deda-4c41-9a8d-ec72fb5045ae"
      unitRef="U_USD">-341674000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ccfa3f6d-89ca-4e36-8c0f-12d38600ca8b"
      decimals="-3"
      id="F_13d8d845-890d-490d-bb68-fd88111a0b9e"
      unitRef="U_USD">821677000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_a99bad54-886c-4f22-a572-c4f604a8eef5"
      decimals="0"
      id="F_f766e3c1-824a-4492-880a-512bd5d809fb"
      unitRef="U_shares">131276</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975"
      decimals="-3"
      id="F_c62866aa-7519-4836-818c-445bb2018e7e"
      unitRef="U_USD">2228000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e"
      decimals="-3"
      id="F_fa4a3678-f6d6-41c2-a825-3d66c90a37e3"
      unitRef="U_USD">2228000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares
      contextRef="C_a99bad54-886c-4f22-a572-c4f604a8eef5"
      decimals="0"
      id="F_e3f355c5-2cd8-4a97-91aa-a3d4390d84f8"
      unitRef="U_shares">72976</kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_a99bad54-886c-4f22-a572-c4f604a8eef5"
      decimals="0"
      id="F_7d29f80a-44ad-4270-92af-d1cd603bc9ca"
      unitRef="U_shares">4295</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975"
      decimals="-3"
      id="F_4e0c4fd6-b52f-4101-943d-bfe6a2ce0a76"
      unitRef="U_USD">305000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e"
      decimals="-3"
      id="F_fce88acd-5ff3-44c0-a36a-795481408f79"
      unitRef="U_USD">305000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_fa99f658-5fc5-4a2c-8581-53a3fbd56975"
      decimals="-3"
      id="F_a058887b-8e96-4f53-8c12-3d7f95cfd9ab"
      unitRef="U_USD">11087000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e"
      decimals="-3"
      id="F_5b9a6f4b-32b3-49e3-9038-bd06899a4c3d"
      unitRef="U_USD">11087000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_61ad6d79-e0a3-4c3a-9112-71b6fcbfb724"
      decimals="-3"
      id="F_aa768a4a-2f07-4d5f-a132-25be32f81dec"
      unitRef="U_USD">-18000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e"
      decimals="-3"
      id="F_72ce3ae4-2a9a-45b8-bed1-801e4764b49d"
      unitRef="U_USD">-18000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="C_8ca588ac-2ea8-47e2-9e1e-0d5c0f7bdd04"
      decimals="-3"
      id="F_c1777cfb-1084-4370-a139-ef6b78ec580b"
      unitRef="U_USD">-55852000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e2e27f25-598a-4dc3-9fea-0c43c8138a3e"
      decimals="-3"
      id="F_aa6e668e-748d-4142-a8ff-023cce434358"
      unitRef="U_USD">-55852000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_8cafabb9-2fa4-4282-a961-4356c77480d5"
      decimals="0"
      id="F_60b785c8-836a-4b18-810b-20a86ed9192d"
      unitRef="U_shares">51434408</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_8cafabb9-2fa4-4282-a961-4356c77480d5"
      decimals="-3"
      id="F_3ff20ec1-c674-4117-90a7-b863aa336a6e"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_282bfd4f-0e6c-4f01-ad36-409ab1c8d1c5"
      decimals="-3"
      id="F_4cfc3679-9f45-452f-81af-a5c9bddf5fdd"
      unitRef="U_USD">1176948000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a2ce11da-0bb4-4016-be57-12f7208128b8"
      decimals="-3"
      id="F_e3f349dc-3864-4eac-9622-c60810a1539e"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_66006d13-4030-4015-b889-1afb6b097dca"
      decimals="-3"
      id="F_2f9b588e-9c8d-44cf-a643-5becb50cf28c"
      unitRef="U_USD">-397526000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20bef648-9662-4045-ac10-f374a4e6dd4a"
      decimals="-3"
      id="F_59a1897f-8e28-4b1c-a4f0-eef99765e5b3"
      unitRef="U_USD">779427000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_1e740a6d-5b59-4139-b143-25fb54883059"
      decimals="0"
      id="F_eb208561-e29d-46c5-b407-198f4d7c4f18"
      unitRef="U_shares">103585</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_7b2909d7-cea1-4df1-9529-fa4f0d2242dd"
      decimals="-3"
      id="F_74ddde03-e730-44da-b56a-c9e69609f38f"
      unitRef="U_USD">2042000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_745a4aa6-3978-46a1-ada4-76c9d486e166"
      unitRef="U_USD">2042000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares
      contextRef="C_1e740a6d-5b59-4139-b143-25fb54883059"
      decimals="0"
      id="F_245f3589-2232-4d23-90f0-5cd13f81e807"
      unitRef="U_shares">10799</kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares>
    <kod:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares
      contextRef="C_1e740a6d-5b59-4139-b143-25fb54883059"
      decimals="0"
      id="F_e620079a-0cbf-4994-ad8f-3f35d994ac3d"
      unitRef="U_shares">149983</kod:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_7b2909d7-cea1-4df1-9529-fa4f0d2242dd"
      decimals="-3"
      id="F_3fbb225e-e882-4b34-992f-b04b5a8e6f7f"
      unitRef="U_USD">12377000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_79ed73a3-5c9e-418d-ae33-a4fc597b3a35"
      unitRef="U_USD">12377000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_d8945418-7878-462f-88bb-8634543ad049"
      decimals="-3"
      id="F_805cb883-64b5-4fd4-82c6-fb55e368fe72"
      unitRef="U_USD">-67526000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_a9530c25-7079-48bc-af68-1a299df0ea60"
      unitRef="U_USD">-67526000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_a00f1dc8-2c72-4c4b-a537-1e6bd1510eb4"
      decimals="INF"
      id="F_fc9f3630-73f3-4787-9811-1ccf049b770e"
      unitRef="U_shares">51698775</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_a00f1dc8-2c72-4c4b-a537-1e6bd1510eb4"
      decimals="-3"
      id="F_9592aa4e-43e7-4fd8-93ae-0378d3b39287"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f3d83275-b94c-473f-9d84-d4f80ce062b9"
      decimals="-3"
      id="F_21746f78-db09-4c8c-9b51-7132a7b6cbfd"
      unitRef="U_USD">1191367000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_463882b0-53f7-46b3-9143-d473f7db2d44"
      decimals="-3"
      id="F_5425fbd1-6229-4570-bce2-dea283594eb1"
      unitRef="U_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3d5599e4-af21-4a80-b2fa-9f50ffb8ff68"
      decimals="-3"
      id="F_6dda53d6-ed74-4ba5-ba01-52823ffdcbb0"
      unitRef="U_USD">-465052000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_95c78717-066f-422c-a572-3a6080641c97"
      unitRef="U_USD">726320000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_9aef3e3a-3ea0-45c0-bd9f-ebf158d52e18"
      decimals="INF"
      id="F_949a0ccb-6c23-4f3c-a7dd-c203fdf47290"
      unitRef="U_shares">44413404</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_9aef3e3a-3ea0-45c0-bd9f-ebf158d52e18"
      decimals="-3"
      id="F_7e4f3c12-7f7e-46bb-adf4-25a17ea34758"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_86dc39fd-f86e-42e3-9bd9-ba7b697a9ddf"
      decimals="-3"
      id="F_fad37c05-d461-4fe4-a0f5-5eb03eebbb57"
      unitRef="U_USD">503475000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_94d38241-9b26-4db5-b401-ca5bf21d7968"
      decimals="-3"
      id="F_7a3941f3-4435-41b2-9550-396a9456005d"
      unitRef="U_USD">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7d6f728e-e9d4-4671-bc36-35fc3079d423"
      decimals="-3"
      id="F_e9195abf-2259-460b-b574-ff999c73a9ef"
      unitRef="U_USD">-158131000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5c21659f-1cec-4a85-8710-24968233ef93"
      decimals="-3"
      id="F_c51c4c3c-fa35-41e6-ac78-90df270dbcff"
      unitRef="U_USD">345359000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_3bb54cbe-545d-4fe0-bcd2-19e483d491f6"
      decimals="INF"
      id="F_a0144f3d-6c36-4edf-aa8c-807a38675572"
      unitRef="U_shares">39297</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_3bb54cbe-545d-4fe0-bcd2-19e483d491f6"
      decimals="-3"
      id="F_0f1fd432-67e2-4d5d-80d5-88fb67061732"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_9b59a0e5-e47e-4121-b018-a86d491ac673"
      decimals="-3"
      id="F_ddc3caba-9873-46c2-9873-567cb4c32681"
      unitRef="U_USD">159000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_12553a8d-237a-4ea4-b220-6b9e18798500"
      decimals="-3"
      id="F_b9487edd-f499-463e-abad-8d3af2d43489"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_fad684c8-cc78-4067-ab73-24cb363807a6"
      decimals="-3"
      id="F_31859ea7-4441-457c-81bf-f58990aa5799"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc"
      decimals="-3"
      id="F_399141e5-e2b2-4e9f-b350-080dea5d8cfb"
      unitRef="U_USD">159000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_9b59a0e5-e47e-4121-b018-a86d491ac673"
      decimals="-3"
      id="F_b09f2cb2-40ec-4f59-84b2-cb2385ba2eaa"
      unitRef="U_USD">6082000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc"
      decimals="-3"
      id="F_00302626-db3a-4a23-9589-2e2863fda742"
      unitRef="U_USD">6082000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_9b59a0e5-e47e-4121-b018-a86d491ac673"
      decimals="-3"
      id="F_da17cbe4-afea-4d56-bb3f-30f5bcc8dfb5"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_12553a8d-237a-4ea4-b220-6b9e18798500"
      decimals="-3"
      id="F_b863cacc-37dd-414a-b961-533961fe2ac4"
      unitRef="U_USD">479000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc"
      decimals="-3"
      id="F_6ec18cfe-5c47-4ed0-8c7d-6a1182f603ea"
      unitRef="U_USD">479000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="C_fad684c8-cc78-4067-ab73-24cb363807a6"
      decimals="-3"
      id="F_6d3a5c09-4836-426a-bee5-8617904b36e6"
      unitRef="U_USD">-24392000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_520836e4-6ccf-4a48-aec5-56fdd89596cc"
      decimals="-3"
      id="F_95d6b559-ddbc-45ce-853b-e8f90191c1be"
      unitRef="U_USD">-24392000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_508f6cdf-9b62-49da-86b7-10e38cc856c3"
      decimals="INF"
      id="F_9a5de393-44c7-4337-8c1a-74a311315ff1"
      unitRef="U_shares">44452701</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_508f6cdf-9b62-49da-86b7-10e38cc856c3"
      decimals="-3"
      id="F_fa4e1afe-1c57-4981-b3f8-4c6dda8f5ab1"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9bb106de-f5c9-411f-80cc-5611a5510340"
      decimals="-3"
      id="F_0c46c202-2303-4fe1-a04e-ef1062ca7a50"
      unitRef="U_USD">509716000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_60ee5be9-fce8-4ec2-9433-83baa13390dd"
      decimals="-3"
      id="F_5841283e-51a5-4f80-9344-74af393073ef"
      unitRef="U_USD">489000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_dbe6d2e0-e108-4f31-b4a9-aabc9eee0627"
      decimals="-3"
      id="F_b7660caf-d45e-4e68-ba64-c029d7ff817b"
      unitRef="U_USD">-182523000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_68a9be7d-3755-49bf-a2da-42390bcb4eec"
      decimals="-3"
      id="F_ccbbb980-f372-43db-9da9-eddac9c3dcbb"
      unitRef="U_USD">327687000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_4ed3c78d-73cb-40d0-9e64-ce6ba2494412"
      decimals="INF"
      id="F_b37b4ca4-ac7c-4e87-b997-cabf0f769adc"
      unitRef="U_shares">203373</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_c60273c5-32a1-4ece-91e4-ddb660a10670"
      decimals="-3"
      id="F_e0ace173-75b0-4cc6-afa7-92af4a5664a9"
      unitRef="U_USD">720000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_99a56596-b12a-4053-a88d-44e605f7dfab"
      decimals="-3"
      id="F_773ec649-a624-4571-ba1e-fc6af24f8d6a"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_132bd18c-61d8-48f7-809f-8bb8b165fbc1"
      decimals="-3"
      id="F_31069858-316a-4aba-a0a0-6c50956ce949"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672"
      decimals="-3"
      id="F_48b6f12e-fcee-4062-a3c3-c345456ac9c7"
      unitRef="U_USD">720000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares
      contextRef="C_4ed3c78d-73cb-40d0-9e64-ce6ba2494412"
      decimals="INF"
      id="F_ed5f4981-42ba-4d57-92e2-69f34955d680"
      unitRef="U_shares">10942</kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares>
    <kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld
      contextRef="C_c60273c5-32a1-4ece-91e4-ddb660a10670"
      decimals="-3"
      id="F_e71d0a1c-fb2e-401e-a2ca-2950127f384b"
      unitRef="U_USD">-206000</kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld>
    <kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld
      contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672"
      decimals="-3"
      id="F_5a8afb9a-346f-46ad-9efe-a7c362f93296"
      unitRef="U_USD">-206000</kod:IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c60273c5-32a1-4ece-91e4-ddb660a10670"
      decimals="-3"
      id="F_66355f45-b401-4682-be11-90bfb3afc3dd"
      unitRef="U_USD">6890000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672"
      decimals="-3"
      id="F_8603b7e7-6f9a-4fbe-965e-76dc10d0ba38"
      unitRef="U_USD">6890000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_99a56596-b12a-4053-a88d-44e605f7dfab"
      decimals="-3"
      id="F_583b627c-f25d-4c93-b24f-9f8f8a8946d3"
      unitRef="U_USD">105000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672"
      decimals="-3"
      id="F_d6ca8713-51bc-47fc-8198-33f3558f09ad"
      unitRef="U_USD">105000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="C_132bd18c-61d8-48f7-809f-8bb8b165fbc1"
      decimals="-3"
      id="F_dae84e3e-3f1f-452b-b5de-61f85b659e79"
      unitRef="U_USD">-25999000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_a54f3b91-0dde-44ee-ba4b-942ccb719672"
      decimals="-3"
      id="F_c72264d9-32cd-4c46-bf43-39f0ab164de1"
      unitRef="U_USD">-25999000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_63e78694-19d8-46fd-86b4-4a74be843c5f"
      decimals="INF"
      id="F_093fd6e6-bdba-455d-8774-e437c9471ade"
      unitRef="U_shares">44667016</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_63e78694-19d8-46fd-86b4-4a74be843c5f"
      decimals="-3"
      id="F_0b749c87-f2c0-4ef4-9230-d055a98cb1f9"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5ab89046-dcd8-48bc-ba35-9efd3fc2e6e4"
      decimals="-3"
      id="F_b7e91fd6-5e49-4225-a099-457e36c180de"
      unitRef="U_USD">517120000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b41ae94c-ea21-43b0-b06e-03ad6d4cf023"
      decimals="-3"
      id="F_f63116c1-a680-4001-8355-8ec85dcdf38e"
      unitRef="U_USD">594000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7dbc5e36-5dc0-495f-8dc7-02933e453b0d"
      decimals="-3"
      id="F_39292583-01b8-488b-8b85-5e4155735c6b"
      unitRef="U_USD">-208522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1f61b024-5ca7-4987-be9f-a79fc65f9ac7"
      decimals="-3"
      id="F_8babbafc-8cbc-4bdb-a400-12f2064851fc"
      unitRef="U_USD">309197000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_be29e469-1e89-4c7e-9ad6-caa85930c9fc"
      decimals="INF"
      id="F_113423f5-bb68-46e0-8468-82de59cd04d2"
      unitRef="U_shares">93497</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_f799a588-4775-46ae-b373-fdba49e2b7b8"
      decimals="-3"
      id="F_bc8675be-c90d-4eb7-a11c-8e675bdff743"
      unitRef="U_USD">813000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_674db454-f6e3-4468-81ae-1b39fa14fa43"
      unitRef="U_USD">813000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_f799a588-4775-46ae-b373-fdba49e2b7b8"
      decimals="-3"
      id="F_2d160dc6-70f9-452a-a92c-78c33d2fd53c"
      unitRef="U_USD">8241000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_3f480208-6efd-4411-b6fe-abe14b3b7263"
      unitRef="U_USD">8241000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_b726a636-8b47-460e-ae59-7f6272c15d60"
      decimals="-3"
      id="F_c16f876c-1657-4b86-8aaa-15f09293d82b"
      unitRef="U_USD">-349000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_3682616d-1c52-405c-b1e0-0c1c6063c0af"
      unitRef="U_USD">-349000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="C_b596f86d-2557-4336-bacd-b0ddf9d1d545"
      decimals="-3"
      id="F_619f63cd-2341-4adc-ba20-63e5c8adc57e"
      unitRef="U_USD">-36122000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_f5048304-4c72-4870-9f99-67065fdbbe14"
      unitRef="U_USD">-36122000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_be8eee73-1f79-40e1-81dc-2113994bd9a8"
      decimals="INF"
      id="F_144e2c8a-05a5-4ba6-add8-f6c428760acf"
      unitRef="U_shares">44760513</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_be8eee73-1f79-40e1-81dc-2113994bd9a8"
      decimals="-3"
      id="F_20052142-0d69-463d-9187-1bd64617aea7"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8f8f672c-7b89-45db-8898-94025bfd6f08"
      decimals="-3"
      id="F_19caf882-a2f1-45ad-a3fe-439a5ad434ef"
      unitRef="U_USD">526174000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f34844dd-a0dc-4745-aaa5-323fb87a0df9"
      decimals="-3"
      id="F_66b1b4f1-de1d-4a1b-81ea-3112ae99390e"
      unitRef="U_USD">245000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a7ae9458-f493-45a2-8df8-95b502b2f850"
      decimals="-3"
      id="F_5ff4cdef-80d1-4646-8fb3-533c41e70426"
      unitRef="U_USD">-244644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1"
      decimals="-3"
      id="F_b84e934f-34f1-45c5-9d8a-5528c64cd6a1"
      unitRef="U_USD">281780000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_9fde0a87-b6df-48f6-8d60-4dec15aea4d8"
      unitRef="U_USD">-173825000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_4de1c213-0313-4911-8bd9-18b3132f1601"
      unitRef="U_USD">-86513000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_69423c0e-99e1-426b-95f6-73aa7f73ec19"
      unitRef="U_USD">722000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_4e79b431-d646-4164-b0ba-350bf6dea6d4"
      unitRef="U_USD">317000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_eed26ceb-2016-4d50-8080-7e0c3b16e1d9"
      unitRef="U_USD">33389000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_9a314945-e4f2-4d36-94b0-e49c5cf5bb80"
      unitRef="U_USD">21213000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_906bafce-fe3d-47c2-a112-00e338066036"
      unitRef="U_USD">-25000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_1feb9db1-9d82-4ddf-a8be-b27b928c6a04"
      unitRef="U_USD">145000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <kod:OperatingLeaseRightOfUseAssetAmortization
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_29cf547f-faba-434c-98db-97add1d43566"
      unitRef="U_USD">5811000</kod:OperatingLeaseRightOfUseAssetAmortization>
    <kod:OperatingLeaseRightOfUseAssetAmortization
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_6beb249c-0ae0-4fc2-bc0b-6b83bcbbcb86"
      unitRef="U_USD">1793000</kod:OperatingLeaseRightOfUseAssetAmortization>
    <kod:AmortizationOfIssuanceCosts
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_0feb38a4-7606-4b26-989a-7a21808ca0ef"
      unitRef="U_USD">39000</kod:AmortizationOfIssuanceCosts>
    <kod:AmortizationOfIssuanceCosts
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_44b938a4-d55f-4db2-88ca-9a767386f7be"
      unitRef="U_USD">36000</kod:AmortizationOfIssuanceCosts>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_522025a8-979b-4216-a0fa-d47a37639580"
      unitRef="U_USD">3228000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_87a6448f-935a-481f-856d-aff875a2c678"
      unitRef="U_USD">-1518000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_e6ec7e3f-d91a-45d2-871c-0f5519bda65b"
      unitRef="U_USD">936000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_d0f8ec88-e312-41dc-a556-214f064aefed"
      unitRef="U_USD">3654000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_2e359072-2b69-44fb-b7c2-1a7fb0943ef6"
      unitRef="U_USD">3255000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_aba87f53-cffa-42ed-9729-4084a1f1ae89"
      unitRef="U_USD">1616000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_17c8d5bc-cf53-455b-969e-50057f2f8d9d"
      unitRef="U_USD">10547000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_3f3c5396-8670-4dcb-9794-858c5f81b0f6"
      unitRef="U_USD">7566000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <kod:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_cb228352-bfed-4272-8cdc-840259a5e48b"
      unitRef="U_USD">966000</kod:IncreaseDecreaseInOperatingLeaseLiability>
    <kod:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_4ea250a6-1925-411b-9f9c-0cdf71a8fdae"
      unitRef="U_USD">-156000</kod:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_5c3c0dd6-1227-4a19-a493-683446bc8afe"
      unitRef="U_USD">-123235000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_3f5462b6-04fd-4daf-9f91-9307f4b54798"
      unitRef="U_USD">-56409000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_84fec07a-7b9a-426c-93cf-4627db5fefcf"
      unitRef="U_USD">8598000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_7b85dc14-3edc-44d1-9e05-ac0294ca63a2"
      unitRef="U_USD">1855000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <kod:DepositsOnPropertyAndEquipment
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_c07ee7da-eb71-4456-b91c-bf6e3343871b"
      unitRef="U_USD">43841000</kod:DepositsOnPropertyAndEquipment>
    <kod:DepositsOnPropertyAndEquipment
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_f74cb3a3-f286-4f41-9a8a-e66c69c4f0e1"
      unitRef="U_USD">0</kod:DepositsOnPropertyAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_88e8e4c2-b657-4059-8faf-a16f78eacdc8"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_cf4ae4f3-91d1-48fc-afdc-fff6be100870"
      unitRef="U_USD">86317000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_f1c7c061-628c-4e0f-b7bc-9d65752b269a"
      unitRef="U_USD">24500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_46de79ca-c381-45d4-976d-34dba01d1506"
      unitRef="U_USD">134148000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_07953ae9-4313-4589-b0c0-3996dbb20de0"
      unitRef="U_USD">-27939000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_4400157a-9095-42a1-a1b5-6c13126d635f"
      unitRef="U_USD">45976000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_6dc660c7-6f9a-4948-9531-d60e9bbfed62"
      unitRef="U_USD">5753000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_0598dc6d-a571-46ee-af29-54c3a95b9896"
      unitRef="U_USD">1692000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_7a8acc47-231c-4a68-a11c-d47cae272956"
      unitRef="U_USD">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_d749ae71-8fe8-4a7b-9f62-9bb554971cca"
      unitRef="U_USD">206000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_9c05444f-4574-4eab-a510-01d9e1feb3da"
      unitRef="U_USD">305000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_0f4eda1a-8535-462f-8486-3ac64187584d"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <kod:ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_7fc441b9-ebc0-456d-a152-ba0388ab5261"
      unitRef="U_USD">0</kod:ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts>
    <kod:ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_47d679b9-6ae9-403f-b8bf-e5e0b9cca385"
      unitRef="U_USD">99643000</kod:ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_b1c8bda6-82a1-4438-8b55-82afda4eff60"
      unitRef="U_USD">0</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_71abf6fa-798a-4247-9a7e-70333cce5014"
      unitRef="U_USD">5000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <kod:PrincipalPaymentsOfTenantImprovementAllowancePayable
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_38b85174-0568-4741-a6a9-8fb8dfb0e2c7"
      unitRef="U_USD">33000</kod:PrincipalPaymentsOfTenantImprovementAllowancePayable>
    <kod:PrincipalPaymentsOfTenantImprovementAllowancePayable
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_41ddfab1-03ec-46c9-8e78-9243cac1cb39"
      unitRef="U_USD">28000</kod:PrincipalPaymentsOfTenantImprovementAllowancePayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_cd3958e2-4321-48be-9ccb-2dcccd607536"
      unitRef="U_USD">6025000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_a2a6cbc6-07a1-4f91-b694-5aca5b0fb36c"
      unitRef="U_USD">101096000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_7a103223-0cc0-45fc-8826-fec8fee38b90"
      unitRef="U_USD">-145149000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_4ebe5516-862e-41f3-b336-f599bc880d5f"
      unitRef="U_USD">90663000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_6f6558e3-cc7d-4b7c-82f6-13e041b85de9"
      unitRef="U_USD">950720000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_5c21659f-1cec-4a85-8710-24968233ef93"
      decimals="-3"
      id="F_6da4dda5-dd77-4b97-8936-5897c345d01f"
      unitRef="U_USD">211937000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_9b0561f3-5949-497b-9086-658e69d42bed"
      unitRef="U_USD">805571000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1"
      decimals="-3"
      id="F_8e10c4e7-723f-4c04-a834-d895ddda255a"
      unitRef="U_USD">302600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_0af06cbd-2e65-41f0-8c15-df688ba4c5a8"
      unitRef="U_USD">799247000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1"
      decimals="-3"
      id="F_cb001218-103c-44b2-9e5f-9f153c93df6f"
      unitRef="U_USD">291585000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_cdc09aad-5934-4984-ae77-fd7abd84caef"
      unitRef="U_USD">6324000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1"
      decimals="-3"
      id="F_e455171a-3c37-4d9f-a389-d7825f7d5316"
      unitRef="U_USD">11015000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_80322ea3-3216-4177-9994-58e4847622c4"
      unitRef="U_USD">805571000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_a3d0565e-c849-4fd2-8cc7-2152886dd3f1"
      decimals="-3"
      id="F_b7dc9019-6001-47ac-b37f-5a727cf9b2b3"
      unitRef="U_USD">302600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_4d83aba5-f79a-4d7c-bd8e-9a9682fdc3ba"
      unitRef="U_USD">583000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_cc04fd85-0584-43c8-9e11-d262b6edf96b"
      unitRef="U_USD">75545000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_3ac5beb9-f066-4433-8b21-c8ad6fc7f0ab"
      unitRef="U_USD">10730000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_f4a57188-32f1-466c-893c-43de81ff11fa"
      unitRef="U_USD">1034000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <kod:TheCompanyTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_6be47d45-35e2-40a4-9780-c5682380cd12">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;1. The Company&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Kodiak Sciences Inc. (the &#x201c;Company&#x201d;) is a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases in the United States and additional international markets. The Company devotes substantially all of its resources to the research and development of its product platforms and product candidates including activities to conduct clinical studies of its product candidates, manufacture product candidates and provide general and administrative support for these operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021, the Company had cash and cash equivalents of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;799.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million. Although the Company has incurred significant operating losses since inception and expects to continue to incur operating losses and negative operating cash flows for the foreseeable future, the Company believes that the cash and cash equivalents will be sufficient to meet the anticipated operating and capital expenditure requirements for the 12 months following the date of this Form 10-Q.&lt;/span&gt;&lt;/p&gt;</kod:TheCompanyTextBlock>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-5"
      id="F_8f078100-f0ed-46ec-ae10-de9f84903101"
      unitRef="U_USD">799200000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_908d9b1e-feef-467c-8901-4379b414b6e8">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Reclassification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company&#x2019;s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company&#x2019;s product candidates, and begin to commercialize any approved products.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2021, respectively, are consistent with those discussed in Note 2 to the consolidated financial statements in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020, except as noted within the &#x201c;Recent Accounting Pronouncements &#x2013; Recently Adopted Accounting Pronouncements&#x201d; section.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;a&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;ccounting &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;p&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;ronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In October 2020, the FASB issued Accounting Standards Update 2020-10, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Codification Improvements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_2b6efd9e-57ed-4548-bf2d-f56e2a67777e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_90ac75e4-8acf-4c11-9a4c-b5594c043c3b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Reclassification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_cd111f8c-fe0d-4a22-a26a-51634773c499">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <kod:RiskAndUncertaintiesPolicyTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_82b4196d-6dbd-42d8-821b-9e236d3aec55">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company&#x2019;s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company&#x2019;s product candidates, and begin to commercialize any approved products.&lt;/span&gt;&lt;/p&gt;</kod:RiskAndUncertaintiesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_17871a5b-b86c-4b33-a068-c33a05c90335">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;a&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;ccounting &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;p&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;ronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In October 2020, the FASB issued Accounting Standards Update 2020-10, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Codification Improvements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_6ca0a9c3-0093-4898-807e-4cfca0d08a78">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;3. Accrued and Other Current Liabilities&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.562%;"/&gt;
        &lt;td style="width:1.605%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:0.752%;"/&gt;
        &lt;td style="width:1.605%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:0.752%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued clinical trial and related costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,762&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued salaries and benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;39,016&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20,402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_3524c049-7742-4ab9-ba3f-270273a9a475">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued and other current liabilities consist of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.562%;"/&gt;
        &lt;td style="width:1.605%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:0.752%;"/&gt;
        &lt;td style="width:1.605%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:0.752%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued clinical trial and related costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,762&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued salaries and benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;39,016&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20,402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock>
    <kod:AccruedClinicalTrialAndRelatedCostsCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_df762753-0892-4c37-913b-563f969a5639"
      unitRef="U_USD">21762000</kod:AccruedClinicalTrialAndRelatedCostsCurrent>
    <kod:AccruedClinicalTrialAndRelatedCostsCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_c2eea3c4-4c94-44ab-a7c3-af536118e014"
      unitRef="U_USD">11119000</kod:AccruedClinicalTrialAndRelatedCostsCurrent>
    <kod:AccruedLeaseholdImprovements
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_81badbde-d0c5-42bb-951c-fe85c1370127"
      unitRef="U_USD">7470000</kod:AccruedLeaseholdImprovements>
    <kod:AccruedLeaseholdImprovements
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_a5875fa0-b97c-4bec-80a9-10d0875e9b61"
      unitRef="U_USD">19000</kod:AccruedLeaseholdImprovements>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_885df295-5dbd-4f69-86ca-1a2af21cba3c"
      unitRef="U_USD">4790000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_67f3c3cc-0488-4422-82a6-ed62f7bb21df"
      unitRef="U_USD">5094000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <kod:AccruedResearchAndDevelopmentCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_7afdd3f0-638d-4a59-a936-e343d4947b99"
      unitRef="U_USD">3392000</kod:AccruedResearchAndDevelopmentCurrent>
    <kod:AccruedResearchAndDevelopmentCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_e3e265db-d80b-4de9-969e-d0c3e775f298"
      unitRef="U_USD">3082000</kod:AccruedResearchAndDevelopmentCurrent>
    <kod:AccruedLegalFeesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_c4797107-f418-41c2-855f-906f1a98186e"
      unitRef="U_USD">582000</kod:AccruedLegalFeesCurrent>
    <kod:AccruedLegalFeesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_59623464-5808-4087-bc6e-b919743a30a1"
      unitRef="U_USD">252000</kod:AccruedLegalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_16773924-5e8b-494f-965a-db3c9c04edee"
      unitRef="U_USD">223000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_19b7d38b-333b-4b03-a38b-a84ac495fe2f"
      unitRef="U_USD">253000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_f95ea5d2-8d0d-4397-b16b-814bd8adf3c2"
      unitRef="U_USD">797000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_a53312fa-efa2-49b4-a831-f21b01f98d04"
      unitRef="U_USD">583000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_afad6bd3-0f72-426d-a24f-ce1a2d1c8615"
      unitRef="U_USD">39016000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_68e01038-2318-40f6-b61f-14e03a66147d"
      unitRef="U_USD">20402000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_5e42f243-dbf4-4b0f-be40-49ea3fd2f1e7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;4. Fair Value Measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following tables present the Company&#x2019;s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.096%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.072%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.044%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:8.988%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.072%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair Value Measurements at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair Value Measurements at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;917,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;917,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;917,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;942,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021 and December 31, 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (&#x201c;BBA&#x201d;), which are considered Level 3 inputs.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_a90867ad-1e27-46b7-a026-c360bc2874bd">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following tables present the Company&#x2019;s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.096%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.072%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.044%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:8.988%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.072%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair Value Measurements at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;762,550&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair Value Measurements at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;917,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;917,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;917,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;942,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021 and December 31, 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (&#x201c;BBA&#x201d;), which are considered Level 3 inputs.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f286752f-3bc4-47a6-a27d-666daa7a6ec9"
      decimals="-3"
      id="F_b2ef6511-3bc6-43dc-a1fe-ef7233651059"
      unitRef="U_USD">762550000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_b45963b2-ae18-48d6-8992-a6e27e535c56"
      decimals="-3"
      id="F_87ede2c8-15e3-4d9d-a25c-24cd9b977949"
      unitRef="U_USD">762550000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e739ae0c-05c8-4c3a-9039-0e4e7b4f6746"
      decimals="-3"
      id="F_4e67c375-3cf3-455e-9d55-cf6115ad0010"
      unitRef="U_USD">762550000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_263b39c0-fc6e-4304-804c-806e5d34aa8e"
      decimals="-3"
      id="F_1c60fafa-cc92-4e3c-b310-63e1ec5c8f37"
      unitRef="U_USD">762550000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f7a3a9d0-55f0-4f98-bd8e-f8ff83d37aef"
      decimals="-3"
      id="F_572c9b13-3b73-4379-b04c-cba144292737"
      unitRef="U_USD">917485000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_3cf9ac24-3ded-44bb-ae89-f866105b17ab"
      decimals="-3"
      id="F_f58119a6-a9b9-4d34-95cb-bf2ddbb58783"
      unitRef="U_USD">917485000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_abb4f15e-cec6-4695-bd11-ddd8693c1243"
      decimals="-3"
      id="F_9272f959-a2a2-445b-93b1-c09a73744f3b"
      unitRef="U_USD">10006000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_cb05ac74-574d-4580-b0cf-bb252f7fa760"
      decimals="-3"
      id="F_2e878beb-a826-4c39-804b-0c7c9314e306"
      unitRef="U_USD">10006000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e870a142-80e3-4e6a-82c5-2362dbf0e897"
      decimals="-3"
      id="F_b7c20a4e-0a30-443f-a738-b86342c99779"
      unitRef="U_USD">14572000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_76b97688-4be3-49e7-81df-21713ee340ae"
      decimals="-3"
      id="F_a89ea449-866e-4975-88a0-fe0d67260472"
      unitRef="U_USD">14572000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7f2795d1-2d93-4f05-944e-15b9e4c3cfa8"
      decimals="-3"
      id="F_5c48da24-83c8-498a-befa-c1f0201180f2"
      unitRef="U_USD">917485000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_63179ee0-98f3-437f-a39f-263cdaf44426"
      decimals="-3"
      id="F_83c13c3f-64ee-488c-bd34-17e51b675f6f"
      unitRef="U_USD">24578000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d7b002c3-ab22-4669-b768-13dd644c4c23"
      decimals="-3"
      id="F_a5e31074-2b84-4e6a-ad38-7aec2190dc5a"
      unitRef="U_USD">942063000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_925f6ca4-5729-4228-bc66-60671b1da8a0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;5. Marketable Securities&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The marketable securities are classified as available-for-sale and consist of U.S. treasury securities and corporate notes. The fair value measurement data for marketable securities is obtained from independent pricing services. The Company validates the prices provided by the third-party pricing services by understanding the valuation methods and data sources used and analyzing the pricing data in certain instances.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; marketable securities at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the marketable securities (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.91%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.098%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.107%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.107%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.023%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. treasury securities&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total marketable securities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All marketable securities held at December 31, 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; had effective maturities of less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; realized gains or losses recognized on the sale or maturity of available-for-sale debt securities during the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three and nine months ended September 30, 2021, respectively and, as a result, the Company did not reclassify any amounts out of accumulated comprehensive loss. As of September 30, 2021 and December 31, 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; allowance for credit losses for available-for-sale debt securities. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; impairment charges or recoveries recorded during each of the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;nine months ended September 30, 2021 and September 30, 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-3"
      id="F_b7cbe1d0-e260-4397-ac6d-3166f91c1218"
      unitRef="U_USD">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_d0533254-922a-4979-97a1-efa2f7248d67">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the marketable securities (in thousands):&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.91%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.098%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.107%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.53%;"/&gt;
        &lt;td style="width:9.107%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
        &lt;td style="width:1.187%;"/&gt;
        &lt;td style="width:1.521%;"/&gt;
        &lt;td style="width:9.023%;"/&gt;
        &lt;td style="width:0.974%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. treasury securities&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,572&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total marketable securities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
      contextRef="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b"
      decimals="-3"
      id="F_be8b3a12-4687-455b-923d-094b1a12f3a0"
      unitRef="U_USD">10003000</kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent>
    <kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
      contextRef="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b"
      decimals="-3"
      id="F_f378d7f3-6c95-44e6-b1af-3afd8dc30788"
      unitRef="U_USD">3000</kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_c3a73383-ef59-4aa3-a117-ad89a6585b2b"
      decimals="-3"
      id="F_76e677b7-39a0-4b88-8dd8-fdc587a9b63b"
      unitRef="U_USD">10006000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
      contextRef="C_00c91e92-2084-4178-8614-66b75d51a63e"
      decimals="-3"
      id="F_f1814528-27ce-4295-87ce-478c0b502f65"
      unitRef="U_USD">14522000</kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent>
    <kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
      contextRef="C_00c91e92-2084-4178-8614-66b75d51a63e"
      decimals="-3"
      id="F_c7c65538-722c-4113-8982-e95bcf8f25a9"
      unitRef="U_USD">50000</kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_00c91e92-2084-4178-8614-66b75d51a63e"
      decimals="-3"
      id="F_8a03fd40-0c6c-4947-831d-2348d8111342"
      unitRef="U_USD">14572000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_e4368cba-a662-408a-8ec1-437d92a90200"
      unitRef="U_USD">24525000</kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent>
    <kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_a97b57b1-b88f-4f3e-8d7c-78300d398996"
      unitRef="U_USD">53000</kod:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="-3"
      id="F_ddbe9698-979c-4ee6-927e-887c6debcef9"
      unitRef="U_USD">24578000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_4882ce6c-ab65-4041-9b2e-170bdcd25b73"
      id="F_a16567c2-3631-4094-a814-0cd143788c0f">P1Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_c25a3452-9b30-4001-9008-cd10e3278714"
      id="F_adbb875a-1b93-4fb3-b165-a62df0f47e43">P1Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="INF"
      id="F_dcf0d132-6094-46a3-a015-eb0fd07592d7"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="INF"
      id="F_0f2b2167-4b30-4a02-babd-ba5a089e0fb9"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="INF"
      id="F_42056f4b-dde1-4cec-a3dd-f88272a6bcfc"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_83602e3b-403a-43a4-ae96-ae8d95713283"
      decimals="INF"
      id="F_3545ce05-4364-4fac-92e9-6570a9308338"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="INF"
      id="F_5b9430c2-9a32-484d-986b-1bb47cef6b98"
      unitRef="U_USD">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="INF"
      id="F_0e61ce1e-22a6-440a-b706-241bb915b9a1"
      unitRef="U_USD">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_7cfdeca1-bb26-429d-8d62-d54da0c79a89">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;6. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Embedded Lease&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2020, the Company and its wholly-owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd (&#x201c;Lonza&#x201d;) for the clinical and commercial supply of drug substance for KSI-301. A custom-built manufacturing facility is planned to be completed and dedicated to the manufacture of the Company&#x2019;s drug substance. The manufacturing agreement has an initial term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;eight years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, and the Company has the right to extend the term up to a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Company and Lonza each have the ability to terminate this agreement upon the occurrence of certain conditions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In April 2021, the agreement was amended to provide for higher annual manufacturing capacity. The Company expanded and finalized the design and scope of the bioconjugate manufacturing facility with a revised estimated capital contribution of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;75.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million Swiss Francs of which the Company has paid &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million Swiss Francs of the capital contribution, equivalent to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million U.S. Dollars, which is recorded in other assets on the consolidated balance sheet as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Over the period from 2022 through 2029, manufacturing payments totaling approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;150.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million Swiss Francs may be incurred for potential commercial supply of KSI-301 drug substance.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company concluded that this agreement contains an embedded lease as the custom-built manufacturing suite will be dedicated for the Company&#x2019;s use. As of September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company did not have control of this manufacturing space and therefore, did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t record a right-of-use asset and corresponding lease liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Manufacturing Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has entered into service and equipment purchase agreements in the normal course of business with various providers, pursuant to which such providers agreed to perform activities in connection with the manufacturing process of certain materials. These agreements, and any related amendments, state that planned activities and purchases that are included in the signed work orders are, in some cases, binding and, hence, obligate the Company to pay the full price of the work order upon satisfactory delivery of products and services or obligate the Company to the binding amount regardless of whether such planned activities are in fact performed. Per the terms of the agreements, the Company has the option to cancel signed orders at any time upon written notice, which may or may not be subject to payment of a cancellation fee. The level of cancellation fees may be dependent on the timing of the written notice in relation to the commencement date of the work, with the maximum cancellation amount dependent on the agreement or the work order.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Other Funding Commitments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In the normal course of business, the Company enters into agreements with third-parties for services to be provided to the Company. Generally, these agreements provide for termination upon notice, with specified amounts due upon termination based on the timing of termination and the terms of the applicable agreement. The actual amounts and timing of payments under these agreements are uncertain and contingent upon the initiation and completion of services to be provided to the Company.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has also entered into various cancellable license agreements for certain technology. The Company may be obligated to make payments on future sales of specified products associated with such license agreements. Such payments are dependent on future product sales and are not estimable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Indemnification&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at the Company&#x2019;s request in such capacity. The indemnification period covers all pertinent events and occurrences during the director&#x2019;s or officer&#x2019;s service. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not specified in the agreements; however, the Company has director and officer insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.&lt;/span&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <kod:ManufacturingAgreementInitialTerm
      contextRef="C_458e6e92-7030-4315-9600-616198160fdb"
      id="F_a9c9dd2f-66a4-4505-82e1-fb3c3dee57de">P8Y</kod:ManufacturingAgreementInitialTerm>
    <kod:ManufacturingAgreementTermThatCanBeExtended
      contextRef="C_31399e52-c5e0-47e5-a93a-23ef7ff40786"
      id="F_3814bd34-21e5-4c04-a8a8-30d5ad6a384a">P16Y</kod:ManufacturingAgreementTermThatCanBeExtended>
    <kod:EstimatedCapitalContributions
      contextRef="C_c938c6fd-25b2-418a-ad6d-7089541a671c"
      decimals="-5"
      id="F_98a7d114-e677-49b4-940c-6d6a46bf2ff8"
      unitRef="U_CHF">75000000.0</kod:EstimatedCapitalContributions>
    <kod:ManufacturingAgreementExpense
      contextRef="C_a5328f00-e330-42c1-80c1-8421c3606923"
      decimals="-5"
      id="F_3b5b273c-54fb-44e1-b2c3-cc4a1b926d35"
      unitRef="U_CHF">35000000.0</kod:ManufacturingAgreementExpense>
    <kod:ManufacturingAgreementExpense
      contextRef="C_a5328f00-e330-42c1-80c1-8421c3606923"
      decimals="-5"
      id="F_ead942a3-3022-4fb4-b4f1-b03bcfbfeb54"
      unitRef="U_USD">38700000</kod:ManufacturingAgreementExpense>
    <us-gaap:ContractualObligation
      contextRef="C_c938c6fd-25b2-418a-ad6d-7089541a671c"
      decimals="-5"
      id="F_b6a3cbc6-550e-4722-958c-d023d01af072"
      unitRef="U_CHF">150000000.0</us-gaap:ContractualObligation>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b4b42d07-b554-47fb-9b37-295ad99f4b05"
      decimals="-3"
      id="F_b543980e-b078-4066-9cf4-e4a211fb3501"
      unitRef="U_USD">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_b4b42d07-b554-47fb-9b37-295ad99f4b05"
      decimals="-3"
      id="F_bdf38936-674d-4666-9328-2ce5d024f9de"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_3152fdb3-7e92-4524-9d0f-2c32efbe317c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;7. Stock-Based Compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In January 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the number of shares of common stock available for issuance under the 2018 Equity Incentive Plan (the "2018 Plan") was increased by approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million shares, respectively, as a result of the automatic increase provision in the 2018 Plan.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:38.581%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:11.651%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:11.596%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:11.679%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:11.614%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Number&lt;br/&gt;of&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,897,276&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;841,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,478,994&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;94.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;348,420&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited or canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;228,118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,799,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;37.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.74&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;431,288&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Shares&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.942%;"/&gt;
        &lt;td style="width:2.125%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:17.673%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:2.125%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.618%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;Restricted&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;359,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;59.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;170,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,775&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;57.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;61.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;412,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;72.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Performance-Based Stock Options and Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company granted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;669,581&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; performance-based stock options during the nine months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (the "2021 PSAs"). The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t grant any performance-based equity awards during &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.  The Company granted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;170,150&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; performance-based options and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;128,900&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; performance-based restricted stock units to employees in 2019 (the "2019 PSAs").&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The performance-based equity awards granted will vest &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one-quarter&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; upon the achievement of specific clinical development milestones. The remaining shares will then vest ratably over three years thereafter. Performance-based stock options and performance-based restricted stock units are recorded as expense beginning when vesting events are determined to be probable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The milestone for the 2019 PSAs was achieved during the second quarter of 2021. As of September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;42,536&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; performance-based stock options and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;28,905&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; performance-based restricted stock units granted during 2019 have vested. The Company believes that the achievement of the requisite performance condition for 2021 PSAs granted in the first quarter of 2021 continues to be probable.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock-based compensation expense recognized was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million during the three and nine months ended September 30, 2021, respectively, and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million during the three and nine months ended September 30, 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;2018 Employee Share Purchase Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:5.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.62%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2018, the Company adopted the 2018 Employee Share Purchase Plan (&#x201c;ESPP&#x201d;), which became effective on the business day prior to the effectiveness of the registration statement relating to the Company's initial public offering. A total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;460,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock were initially reserved for issuance under the ESPP. The initial offering period of the ESPP was authorized by the Company&#x2019;s board of directors and commenced on January 4, 2021. Each offering period is approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;twelve months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; long, with &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; purchase periods. ESPP participants will purchase shares of common stock at a price per share equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the lesser of (1) the fair market value per share of the common stock on the enrollment date or (2) the fair market value of the common stock on the exercise date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.62%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,295&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares under the ESPP during the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three and nine months ended September 30, 2021, respectively. The stock-based compensation expense related to the ESPP was less than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million during the three and nine months ended September 30, 2021, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.745%;"/&gt;
        &lt;td style="width:1.425%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.258%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.425%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.22%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.258%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.425%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.258%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three Months Ended &lt;br/&gt;&#160;&#160;September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Nine Months Ended &lt;br/&gt;&#160;&#160;September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,759&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,948&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;33,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, total unrecognized compensation cost related to the unvested share-based awards and ESPP was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;122.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_a23868ac-4d18-4080-b770-dd5c05f2ac9d"
      decimals="-5"
      id="F_9143cf37-a135-4d2f-853f-c864a613b2e7"
      unitRef="U_shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_add76d56-e3aa-4160-be48-644dc3f7d81b"
      decimals="-5"
      id="F_9723244e-81af-477e-876b-ca16b04f3748"
      unitRef="U_shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_d65e0367-e1b6-4007-90de-8f77eb9381ee">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:38.581%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:11.651%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:11.596%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:11.679%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
        &lt;td style="width:1.475%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:11.614%;"/&gt;
        &lt;td style="width:0.983%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Number&lt;br/&gt;of&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,897,276&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;841,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,478,994&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;94.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;348,420&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited or canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;228,118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41.86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,799,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;37.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.74&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;431,288&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4"
      decimals="INF"
      id="F_f9241058-4acc-412c-9262-f2048d5e0318"
      unitRef="U_shares">6897276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4"
      decimals="2"
      id="F_179af3b5-c2b6-463d-b923-c35c854732ab"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">24.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_df61c764-a534-4f0b-8ca0-21e84f617033"
      id="F_f1193f78-c376-44dd-a631-f14b691576ad">P8Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4"
      decimals="-3"
      id="F_3bc30fbf-dae0-4b12-a163-d75618c1eead"
      unitRef="U_USD">841704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      decimals="INF"
      id="F_a781319d-7c15-4111-9980-fb96a9c9199c"
      unitRef="U_shares">1478994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      decimals="2"
      id="F_d0cada8e-6f0e-46d6-9ef9-e2d5866565df"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">94.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      decimals="INF"
      id="F_57066a75-360a-4761-8a57-c857bcffc2a4"
      unitRef="U_shares">348420</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      decimals="2"
      id="F_4d99cd0c-dfd5-4d21-8a5d-a20943d64f07"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">17.06</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      decimals="INF"
      id="F_6e769720-3f49-4313-a4df-0220c0ad3a6f"
      unitRef="U_shares">228118</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      decimals="2"
      id="F_7b4949fd-0431-4043-8332-3cb5c137783a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">41.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_a051b042-5e1d-45e2-b954-e74131ddd0b7"
      decimals="INF"
      id="F_c13b317b-afca-474a-a656-ad5f162ad464"
      unitRef="U_shares">7799732</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_a051b042-5e1d-45e2-b954-e74131ddd0b7"
      decimals="2"
      id="F_cb999492-99ba-496d-b36f-062c9eca25c5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">37.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_975902bf-d85c-41cd-863e-84e008163d3b"
      id="F_4b98ccaa-1ad9-4eb4-8838-eacf75455f80">P7Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_a051b042-5e1d-45e2-b954-e74131ddd0b7"
      decimals="-3"
      id="F_3ac7fa92-3244-4efd-ac42-a511243c7eec"
      unitRef="U_USD">431288000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_5896d029-10f0-4c0a-af24-42fa6e3f1454">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.942%;"/&gt;
        &lt;td style="width:2.125%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:17.673%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:2.125%;"/&gt;
        &lt;td style="width:1.531%;"/&gt;
        &lt;td style="width:17.618%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;Restricted&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;359,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;59.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;170,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,775&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;57.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;61.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested at September 30, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;412,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;72.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6"
      decimals="INF"
      id="F_b6fff2b2-2d95-4fd5-b956-328f8ba94d3f"
      unitRef="U_shares">359945</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6"
      decimals="2"
      id="F_7075e91c-1706-4e0d-8afa-acdfc11f0687"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">59.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"
      decimals="INF"
      id="F_7e95f2ed-f52d-4e70-b498-1fa74d818e7f"
      unitRef="U_shares">170150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"
      decimals="2"
      id="F_59325d84-b1d3-499b-9508-fca2b2cce95c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">90.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"
      decimals="INF"
      id="F_4f0b4cf6-49bb-4ed5-9f9c-f6015d4e890d"
      unitRef="U_shares">83775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"
      decimals="2"
      id="F_6a28fa3d-3a54-4623-b964-44ad68b7a816"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">57.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"
      decimals="INF"
      id="F_6ff01a12-64b9-44c7-8d6f-e0d9420b0d12"
      unitRef="U_shares">34033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_dc737b6e-1a18-4671-80fc-b8bcb0d68be2"
      decimals="2"
      id="F_b2447d50-8d0d-43fd-9bcb-9d7022ffb4f5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">61.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_9a2edcb3-cdb8-4ae3-8ba8-ad3566e86572"
      decimals="INF"
      id="F_6d499d88-5d79-4469-b8da-0933216eedd6"
      unitRef="U_shares">412287</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_9a2edcb3-cdb8-4ae3-8ba8-ad3566e86572"
      decimals="2"
      id="F_db1934cd-da6b-471e-9309-9db801522762"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">72.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_d4d3bdd1-f4a5-411e-b2cd-de5f19a1571b"
      decimals="0"
      id="F_0bacd10d-f783-4458-8dc5-b5ae7fa67ac8"
      unitRef="U_shares">669581</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_4bf07dd0-aa9f-4e17-a6bc-9b077b5eb34f"
      decimals="INF"
      id="F_45901ea5-4e4b-436c-bfc4-06865befbcc7"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_ca5ad689-4bf0-49c6-bbdf-99985e3228a2"
      decimals="0"
      id="F_8950b8e5-6d41-4a5b-9f1e-dc4abcd51d5e"
      unitRef="U_shares">170150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0ec927f1-50c6-4660-8fa6-d7393ce25571"
      decimals="0"
      id="F_1b4873cd-af1f-4f78-8fe2-2c55bff69d86"
      unitRef="U_shares">128900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone
      contextRef="C_7dc99746-dd99-4798-80e9-33bcb72d7ab3"
      id="F_28eeb5dd-0467-4d91-8eb3-bd77314ea9cf">one-quarter</kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_d4d3bdd1-f4a5-411e-b2cd-de5f19a1571b"
      decimals="INF"
      id="F_846d77cf-3ed6-4e2f-a63e-005ab55ebaed"
      unitRef="U_shares">42536</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_e0805aa0-1dc9-4338-83a1-9f7dc9b4a4d2"
      decimals="INF"
      id="F_c54c3345-47dd-469e-9dab-e3806ea03e65"
      unitRef="U_shares">28905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_9576e5b4-2d98-4b0c-b5ce-11be9a69984a"
      decimals="-5"
      id="F_a0500ecd-d1f6-40fc-8c01-af05310eeb37"
      unitRef="U_USD">2100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7dc99746-dd99-4798-80e9-33bcb72d7ab3"
      decimals="-5"
      id="F_f8ba3bd2-4746-4702-b52c-915e6fe21005"
      unitRef="U_USD">8300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_93d12b66-9ce5-4317-ac9a-15a39b2600d5"
      decimals="-5"
      id="F_8550edb7-a247-4f88-bcf9-2ae6639fd0ed"
      unitRef="U_USD">1800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_35c1b8b0-ef41-45be-a72a-9abe398ca0e3"
      decimals="-5"
      id="F_1a256f5e-0439-47fd-8340-3443618a02a3"
      unitRef="U_USD">5500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_158eae8b-5b6c-4683-b5fa-33c0622853f2"
      decimals="INF"
      id="F_c2d7d72e-5a50-4b27-be3c-02e813576ebe"
      unitRef="U_shares">460000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <kod:TermOfOfferingPeriod
      contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d"
      id="F_653715a6-27b2-4133-b60d-ffc8da61c329">P12M</kod:TermOfOfferingPeriod>
    <kod:NumberOfPurchasePeriods
      contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d"
      decimals="INF"
      id="F_3b74b73a-1a8f-4142-8aa6-8b896b36ee5d"
      unitRef="U_PurchasePeriod">2</kod:NumberOfPurchasePeriods>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d"
      decimals="2"
      id="F_81881639-bafc-4d09-87ef-7d6891bc4870"
      unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_91bbf1c7-f25d-4226-96c0-0fe81b4ea717"
      decimals="0"
      id="F_11f0c1ee-023c-4d0b-a31b-a213a7c36b69"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d"
      decimals="0"
      id="F_5f8cbed9-e311-4813-a9a7-695235155093"
      unitRef="U_shares">4295</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_91bbf1c7-f25d-4226-96c0-0fe81b4ea717"
      decimals="-5"
      id="F_263ba75e-6985-4575-8e29-f10ea068e630"
      unitRef="U_USD">100000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_a1e4b7dd-9d0f-43db-9195-97483937350d"
      decimals="-5"
      id="F_625d385f-8cd7-4a38-a5d1-8b630a8e5ddf"
      unitRef="U_USD">200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_e0f335ad-301b-48e9-8e33-8ba5d9d4f3d3">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.745%;"/&gt;
        &lt;td style="width:1.425%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.258%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.425%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.22%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.258%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
        &lt;td style="width:1.425%;"/&gt;
        &lt;td style="width:1.528%;"/&gt;
        &lt;td style="width:11.258%;"/&gt;
        &lt;td style="width:0.975%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Three Months Ended &lt;br/&gt;&#160;&#160;September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Nine Months Ended &lt;br/&gt;&#160;&#160;September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,759&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,948&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;33,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_9bdfa9aa-1ba9-4af1-8101-e5969ff5eae8"
      decimals="-3"
      id="F_64182c89-d726-4e46-bf52-689a3efdd049"
      unitRef="U_USD">6429000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_28f3dc2d-2645-40d1-8f72-dba22572cd4a"
      decimals="-3"
      id="F_d5777989-5fc1-4b79-85cd-2ccbd8ff668b"
      unitRef="U_USD">4759000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_bba9d155-8973-4881-b4f4-889287f1e62c"
      decimals="-3"
      id="F_232d4b4d-7f26-43d0-bc7c-474af6585ad6"
      unitRef="U_USD">17598000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0509b27f-2c96-45a2-b3c6-bd0c582464ba"
      decimals="-3"
      id="F_e7b338af-89e1-460c-99c8-427923fe6ed4"
      unitRef="U_USD">11983000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_32f5b3f4-2926-4a41-a753-0315ed597699"
      decimals="-3"
      id="F_c3a0b31c-754f-4f65-9bb1-8c8de2630837"
      unitRef="U_USD">5948000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0f217839-80a3-4a6a-bdfd-679c49f63892"
      decimals="-3"
      id="F_d5819cca-1136-45aa-b1a8-3da88693edca"
      unitRef="U_USD">3482000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7c0f0042-303e-4491-b1dc-68acfaccacc3"
      decimals="-3"
      id="F_7c5b9489-4331-4d22-93b5-46d47f383ed0"
      unitRef="U_USD">15791000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_bb793a10-451f-4b36-8cb8-5154d0eba3cb"
      decimals="-3"
      id="F_35bbac8a-ad38-44fb-bc1b-4a89f9bae7c6"
      unitRef="U_USD">9230000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e5c59142-312f-4066-abfc-c35cb8d948e8"
      decimals="-3"
      id="F_f9dd906e-c134-42f1-a784-1c5fe84c0c31"
      unitRef="U_USD">12377000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_4b9f2c47-4205-4766-9ccd-8ea5abce7f13"
      decimals="-3"
      id="F_b71da40c-1199-4458-96fe-82801f9d3e2d"
      unitRef="U_USD">8241000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="-3"
      id="F_ec51137f-40dc-4443-a7ac-0f07ee342f43"
      unitRef="U_USD">33389000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="-3"
      id="F_ed29dc2f-67fa-434e-a85a-32ca9e797ee6"
      unitRef="U_USD">21213000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_6eb21092-7da1-4ed9-b508-b58c034c3e29"
      decimals="-5"
      id="F_add5a595-e76a-4fb6-92f1-047183155697"
      unitRef="U_USD">122400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_929777e7-b000-4f39-b33a-224aa12e5beb">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_3070f6b5-3c34-46ea-8ab0-d237922d22a6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;8. Net Loss per Common Share&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.859%;"/&gt;
        &lt;td style="width:2.338%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:17.729%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:2.338%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:17.729%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,799,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,238,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;412,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;363,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,212,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,601,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_3414bae1-a268-42c4-b717-387be535d899">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.859%;"/&gt;
        &lt;td style="width:2.338%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:17.729%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:2.338%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
        &lt;td style="width:17.729%;"/&gt;
        &lt;td style="width:1.002%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;As of September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,799,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,238,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;412,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;363,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,212,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,601,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_d417aa44-069d-45f0-a7f5-d98db662cdba"
      decimals="INF"
      id="F_af2eef8e-2b4c-4a15-85c2-5f7a0c34c89f"
      unitRef="U_shares">7799732</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_72724aca-fdbc-4107-8023-8e92c79546de"
      decimals="INF"
      id="F_53b535ea-515b-4ba0-a075-7ea0854a2c5b"
      unitRef="U_shares">7238363</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_baaf78fe-4b36-48dc-ba7a-9a0cd9f14b1c"
      decimals="INF"
      id="F_bb8c34a8-bf81-4174-81f1-752c2b95ec79"
      unitRef="U_shares">412287</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_47fd8490-2f13-4a75-8942-c29752532c90"
      decimals="INF"
      id="F_41756690-952f-4259-857f-c253b893638f"
      unitRef="U_shares">363195</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      decimals="INF"
      id="F_49f666ca-b7a3-4fd4-8089-928ded1777bc"
      unitRef="U_shares">8212019</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_ce6babbb-8299-4dcc-bdd9-a9b7186bec90"
      decimals="INF"
      id="F_70e21e7d-4ac4-4ee2-b911-fcc5b016dc68"
      unitRef="U_shares">7601558</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_90a0890e-113a-4768-a4d5-8086e659ebe1"
      id="F_8ce997ca-1431-4564-9414-439ac9104fcf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;9. Subsequent Events&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On October 13, 2021, stockholders of the Company approved the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the &#x201c;LTPIP&#x201d;) as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on September 13, 2021. Stock options were granted under the LTPIP, contingent on stockholder approval of the LTPIP, to named executive officers and other eligible employees at the vice president level who made a one-time election to participate in the LTPIP and agreed to forgo a portion of their annual long-term incentive awards over the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;seven-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; performance period ending on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;August 11, 2028&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. A total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,502,334&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock were reserved for issuance under the LTPIP.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The options can be earned based on the achievement of the performance-based requirement and/or certain operational milestones. The performance-based requirement consists of seven tranches of options that are earned based on meeting or exceeding stock price goals between $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;200&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;800&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; consecutive trading days.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; billion in a fiscal year.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Once earned, options are subject to a service-based requirement and will vest through the remainder of the seven-year performance period in equal monthly installments.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Performance-based stock options totaling &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,920,625&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; with the same terms and conditions as the LTPIP were also granted to employees below the vice president level under the 2018 Plan. These stock option awards were also contingent on stockholder approval of the LTPIP. As discussed above, the LTPIP was approved by the stockholders of the Company on October 13, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is currently evaluating the LTPIP approved in October 2021 and its accounting impact as a modification of the portion of the annual long-term incentive awards granted in 2021 that were foregone.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod
      contextRef="C_fb27358c-ef23-4137-acfd-472379d7d8fd"
      id="F_69b670ba-d8f5-412f-afcd-527102948be4">P7Y</kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod>
    <kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration
      contextRef="C_d52ced4e-2cc6-4467-a7c6-7247dd7a8166"
      id="F_2ddba57c-c7d3-4de1-b582-51b3a60e8d18">2028-08-11</kod:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_fb27358c-ef23-4137-acfd-472379d7d8fd"
      decimals="INF"
      id="F_f62922bf-1cc0-404a-bbe2-2d5fae586276"
      unitRef="U_shares">5502334</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_195d5ffe-0492-4de0-b82c-488c9ea38019"
      decimals="0"
      id="F_f2bb472c-07fb-424d-8cf6-2d5eea28b167"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">200</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_e32f672d-5f84-455b-8c7b-12ed7c65984c"
      decimals="0"
      id="F_f51bfa4b-a623-46c9-9312-9eac40047447"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">800</us-gaap:SaleOfStockPricePerShare>
    <kod:ConsecutiveTradingDays
      contextRef="C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b"
      decimals="0"
      id="F_101e51ac-e62f-4b52-ae9c-bfd0e5b93623"
      unitRef="U_Days">90</kod:ConsecutiveTradingDays>
    <kod:LongTermPerformanceIncentivePlanDescription
      contextRef="C_4724a75b-6bfd-4f43-a79e-256b1d3309c8"
      id="F_22ba30f8-5ee2-4eee-b2b5-ca47028f5113">Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $2.5 billion in a fiscal year.</kod:LongTermPerformanceIncentivePlanDescription>
    <kod:SalesForecasting
      contextRef="C_c04dde98-cf3c-4935-9b98-35dde0c8ff28"
      decimals="-8"
      id="F_5729954a-98a8-4f2e-85a6-bcff8d40dc54"
      unitRef="U_USD">2500000000</kod:SalesForecasting>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_58d71972-cf16-407c-92c6-ce1dbf2b12b5"
      decimals="0"
      id="F_6e757256-ff66-4be7-9c30-6235aeb4fb7f"
      unitRef="U_shares">1920625</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848279976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KOD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KODIAK SCIENCES INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001468748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,717,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-0476525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200 Page Mill Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">281-0850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847845704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 799,247<span></span>
</td>
<td class="nump">$ 944,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">24,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,259<span></span>
</td>
<td class="nump">3,031<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">805,506<span></span>
</td>
<td class="nump">972,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">6,324<span></span>
</td>
<td class="nump">6,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">22,939<span></span>
</td>
<td class="nump">5,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">68,450<span></span>
</td>
<td class="nump">73,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">54,987<span></span>
</td>
<td class="nump">10,210<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">958,206<span></span>
</td>
<td class="nump">1,067,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">13,761<span></span>
</td>
<td class="nump">8,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued and other current liabilities</a></td>
<td class="nump">39,016<span></span>
</td>
<td class="nump">20,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">2,374<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">54,396<span></span>
</td>
<td class="nump">31,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">77,338<span></span>
</td>
<td class="nump">75,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_LiabilityRelatedToSaleOfFutureRoyalties', window );">Liability related to sale of future royalties</a></td>
<td class="nump">99,929<span></span>
</td>
<td class="nump">99,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">231,886<span></span>
</td>
<td class="nump">206,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,191,367<span></span>
</td>
<td class="nump">1,151,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(465,052)<span></span>
</td>
<td class="num">(291,227)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">726,320<span></span>
</td>
<td class="nump">860,751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 958,206<span></span>
</td>
<td class="nump">$ 1,067,347<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_LiabilityRelatedToSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability related to sale of future royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_LiabilityRelatedToSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848504088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) (unaudited) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">490,000,000<span></span>
</td>
<td class="nump">490,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">51,698,775<span></span>
</td>
<td class="nump">51,112,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">51,698,775<span></span>
</td>
<td class="nump">51,112,302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847914024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 56,002<span></span>
</td>
<td class="nump">$ 29,306<span></span>
</td>
<td class="nump">$ 141,743<span></span>
</td>
<td class="nump">$ 70,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">11,533<span></span>
</td>
<td class="nump">7,357<span></span>
</td>
<td class="nump">32,259<span></span>
</td>
<td class="nump">19,132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">67,535<span></span>
</td>
<td class="nump">36,663<span></span>
</td>
<td class="nump">174,002<span></span>
</td>
<td class="nump">89,165<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(67,535)<span></span>
</td>
<td class="num">(36,663)<span></span>
</td>
<td class="num">(174,002)<span></span>
</td>
<td class="num">(89,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">2,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (67,526)<span></span>
</td>
<td class="num">$ (36,122)<span></span>
</td>
<td class="num">$ (173,825)<span></span>
</td>
<td class="num">$ (86,513)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share, basic and diluted</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.80)<span></span>
</td>
<td class="num">$ (3.36)<span></span>
</td>
<td class="num">$ (1.92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted</a></td>
<td class="nump">51,875,315<span></span>
</td>
<td class="nump">45,119,885<span></span>
</td>
<td class="nump">51,722,611<span></span>
</td>
<td class="nump">44,972,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Change in unrealized gains related to available-for-sale debt securities, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (349)<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(349)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (67,526)<span></span>
</td>
<td class="num">$ (36,471)<span></span>
</td>
<td class="num">$ (173,878)<span></span>
</td>
<td class="num">$ (86,278)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847319416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 345,359<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 503,475<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="num">$ (158,131)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,413,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(24,392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,392)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2020</a></td>
<td class="nump">327,687<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">509,716<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="num">(182,523)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,452,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">345,359<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">503,475<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(158,131)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,413,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(86,513)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">281,780<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">526,174<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="num">(244,644)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,760,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Mar. 31, 2020</a></td>
<td class="nump">327,687<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">509,716<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="num">(182,523)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,452,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">720<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld', window );">Issuance of common stock upon vesting of restricted stock units, net of taxes withheld</a></td>
<td class="num">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares', window );">Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(25,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,999)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="nump">309,197<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">517,120<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="num">(208,522)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,667,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">8,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(36,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,122)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">281,780<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">526,174<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="num">(244,644)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,760,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">860,751<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,151,920<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="num">(291,227)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,112,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">1,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">9,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(50,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,447)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2021</a></td>
<td class="nump">821,677<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,163,328<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(341,674)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,225,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">860,751<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,151,920<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="num">(291,227)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,112,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(173,825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2021</a></td>
<td class="nump">726,320<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,191,367<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(465,052)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,698,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Mar. 31, 2021</a></td>
<td class="nump">821,677<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,163,328<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(341,674)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,225,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">2,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares', window );">Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock pursuant to employee stock purchase plans</a></td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock pursuant to employee stock purchase plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">11,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(55,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,852)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Jun. 30, 2021</a></td>
<td class="nump">779,427<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,176,948<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(397,526)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,434,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">2,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares', window );">Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares', window );">Issuance of common stock upon exercise of common stock warrant, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">12,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(67,526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,526)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2021</a></td>
<td class="nump">$ 726,320<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1,191,367<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (465,052)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,698,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon exercise of common stock warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon vesting of restricted stock units,net of taxes withheld.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon vesting of restricted stock units,net of taxes withheld, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848034600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (173,825)<span></span>
</td>
<td class="num">$ (86,513)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">722<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">33,389<span></span>
</td>
<td class="nump">21,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization (accretion) of premium (discount) on marketable securities</a></td>
<td class="nump">25<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_OperatingLeaseRightOfUseAssetAmortization', window );">Amortization of operating lease right-of-use asset</a></td>
<td class="nump">5,811<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AmortizationOfIssuanceCosts', window );">Amortization of issuance costs</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(3,228)<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(936)<span></span>
</td>
<td class="num">(3,654)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">3,255<span></span>
</td>
<td class="nump">1,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="nump">10,547<span></span>
</td>
<td class="nump">7,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">966<span></span>
</td>
<td class="num">(156)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(123,235)<span></span>
</td>
<td class="num">(56,409)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(8,598)<span></span>
</td>
<td class="num">(1,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_DepositsOnPropertyAndEquipment', window );">Deposits on property and equipment</a></td>
<td class="num">(43,841)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(86,317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">24,500<span></span>
</td>
<td class="nump">134,148<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(27,939)<span></span>
</td>
<td class="nump">45,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon options exercise</a></td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for restricted stock units, net of taxes withheld</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(206)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from issuance of common stock pursuant to employee stock purchase plans</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts', window );">Proceeds from sale of future royalties, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">99,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Principal payments of capital lease</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_PrincipalPaymentsOfTenantImprovementAllowancePayable', window );">Principal payments of tenant improvement allowance payable</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">6,025<span></span>
</td>
<td class="nump">101,096<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(145,149)<span></span>
</td>
<td class="nump">90,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, at beginning of period</a></td>
<td class="nump">950,720<span></span>
</td>
<td class="nump">211,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, at end of period</a></td>
<td class="nump">805,571<span></span>
</td>
<td class="nump">302,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">799,247<span></span>
</td>
<td class="nump">291,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">6,324<span></span>
</td>
<td class="nump">11,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, at end of period</a></td>
<td class="nump">805,571<span></span>
</td>
<td class="nump">302,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use asset obtained in exchange for operating lease liability</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">75,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Purchase of property and equipment under accounts payable and accruals</a></td>
<td class="nump">$ 10,730<span></span>
</td>
<td class="nump">$ 1,034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AmortizationOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AmortizationOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_DepositsOnPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deposits on property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_DepositsOnPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_OperatingLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease right of use asset amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_OperatingLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_PrincipalPaymentsOfTenantImprovementAllowancePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal payments of tenant improvement allowance payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_PrincipalPaymentsOfTenantImprovementAllowancePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of future royalties, net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842633688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_TheCompanyTextBlock', window );">The Company</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. The Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kodiak Sciences Inc. (the &#8220;Company&#8221;) is a clinical stage biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases in the United States and additional international markets. The Company devotes substantially all of its resources to the research and development of its product platforms and product candidates including activities to conduct clinical studies of its product candidates, manufacture product candidates and provide general and administrative support for these operations.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021, the Company had cash and cash equivalents of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">799.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. Although the Company has incurred significant operating losses since inception and expects to continue to incur operating losses and negative operating cash flows for the foreseeable future, the Company believes that the cash and cash equivalents will be sufficient to meet the anticipated operating and capital expenditure requirements for the 12 months following the date of this Form 10-Q.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_TheCompanyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_TheCompanyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847700392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company&#8217;s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company&#8217;s product candidates, and begin to commercialize any approved products.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and nine months ended September 30, 2021, respectively, are consistent with those discussed in Note 2 to the consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, except as noted within the &#8220;Recent Accounting Pronouncements &#8211; Recently Adopted Accounting Pronouncements&#8221; section.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ccounting </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">p</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the FASB issued Accounting Standards Update 2020-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Codification Improvements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">New Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842763992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable And Accrued Liabilities Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. Accrued and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.562%;"/>
        <td style="width:1.605%;"/>
        <td style="width:1.531%;"/>
        <td style="width:12.832%;"/>
        <td style="width:0.752%;"/>
        <td style="width:1.605%;"/>
        <td style="width:1.531%;"/>
        <td style="width:12.832%;"/>
        <td style="width:0.752%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30,<br/>2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31,<br/>2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued clinical trial and related costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,762</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,119</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued leasehold improvements</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,470</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued salaries and benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,790</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,094</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,392</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,082</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued legal fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">582</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">252</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued professional fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">223</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">253</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued other liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">797</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">583</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued and other current liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,016</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,402</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842718152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present the Company&#8217;s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.096%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.072%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.044%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:8.988%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.072%;"/>
        <td style="width:0.974%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">942,063</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (&#8220;BBA&#8221;), which are considered Level 3 inputs.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842732280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Securities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Marketable Securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The marketable securities are classified as available-for-sale and consist of U.S. treasury securities and corporate notes. The fair value measurement data for marketable securities is obtained from independent pricing services. The Company validates the prices provided by the third-party pricing services by understanding the valuation methods and data sources used and analyzing the pricing data in certain instances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> marketable securities at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:12.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the marketable securities (in thousands):</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.91%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.098%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.107%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.107%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.023%;"/>
        <td style="width:0.974%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized<br/>Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Gains</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Losses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,003</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,522</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total marketable securities, current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,525</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All marketable securities held at December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> had effective maturities of less than </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> realized gains or losses recognized on the sale or maturity of available-for-sale debt securities during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three and nine months ended September 30, 2021, respectively and, as a result, the Company did not reclassify any amounts out of accumulated comprehensive loss. As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> allowance for credit losses for available-for-sale debt securities. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> impairment charges or recoveries recorded during each of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">nine months ended September 30, 2021 and September 30, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921844214648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Embedded Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2020, the Company and its wholly-owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd (&#8220;Lonza&#8221;) for the clinical and commercial supply of drug substance for KSI-301. A custom-built manufacturing facility is planned to be completed and dedicated to the manufacture of the Company&#8217;s drug substance. The manufacturing agreement has an initial term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eight years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the Company has the right to extend the term up to a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company and Lonza each have the ability to terminate this agreement upon the occurrence of certain conditions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2021, the agreement was amended to provide for higher annual manufacturing capacity. The Company expanded and finalized the design and scope of the bioconjugate manufacturing facility with a revised estimated capital contribution of approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs of which the Company has paid </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs of the capital contribution, equivalent to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million U.S. Dollars, which is recorded in other assets on the consolidated balance sheet as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Over the period from 2022 through 2029, manufacturing payments totaling approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million Swiss Francs may be incurred for potential commercial supply of KSI-301 drug substance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company concluded that this agreement contains an embedded lease as the custom-built manufacturing suite will be dedicated for the Company&#8217;s use. As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company did not have control of this manufacturing space and therefore, did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t record a right-of-use asset and corresponding lease liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Manufacturing Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into service and equipment purchase agreements in the normal course of business with various providers, pursuant to which such providers agreed to perform activities in connection with the manufacturing process of certain materials. These agreements, and any related amendments, state that planned activities and purchases that are included in the signed work orders are, in some cases, binding and, hence, obligate the Company to pay the full price of the work order upon satisfactory delivery of products and services or obligate the Company to the binding amount regardless of whether such planned activities are in fact performed. Per the terms of the agreements, the Company has the option to cancel signed orders at any time upon written notice, which may or may not be subject to payment of a cancellation fee. The level of cancellation fees may be dependent on the timing of the written notice in relation to the commencement date of the work, with the maximum cancellation amount dependent on the agreement or the work order.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1970833333333335;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Funding Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the normal course of business, the Company enters into agreements with third-parties for services to be provided to the Company. Generally, these agreements provide for termination upon notice, with specified amounts due upon termination based on the timing of termination and the terms of the applicable agreement. The actual amounts and timing of payments under these agreements are uncertain and contingent upon the initiation and completion of services to be provided to the Company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has also entered into various cancellable license agreements for certain technology. The Company may be obligated to make payments on future sales of specified products associated with such license agreements. Such payments are dependent on future product sales and are not estimable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Indemnification</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent permitted under Delaware law, the Company has agreed to indemnify its directors and officers for certain events or occurrences while the director or officer is, or was serving, at the Company&#8217;s request in such capacity. The indemnification period covers all pertinent events and occurrences during the director&#8217;s or officer&#8217;s service. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is not specified in the agreements; however, the Company has director and officer insurance coverage that reduces its exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921844317560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In January 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the number of shares of common stock available for issuance under the 2018 Equity Incentive Plan (the "2018 Plan") was increased by approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million shares, respectively, as a result of the automatic increase provision in the 2018 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.581%;"/>
        <td style="width:1.475%;"/>
        <td style="width:0.983%;"/>
        <td style="width:11.651%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.475%;"/>
        <td style="width:1.531%;"/>
        <td style="width:11.596%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.475%;"/>
        <td style="width:0.993%;"/>
        <td style="width:11.679%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.475%;"/>
        <td style="width:1.531%;"/>
        <td style="width:11.614%;"/>
        <td style="width:0.983%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number<br/>of<br/>Options</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Exercise<br/>Price</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">  </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,897,276</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24.52</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.07</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">841,704</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,478,994</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercised</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,420</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.06</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited or canceled</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">228,118</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41.86</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37.62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.74</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">431,288</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Shares</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.942%;"/>
        <td style="width:2.125%;"/>
        <td style="width:0.993%;"/>
        <td style="width:17.673%;"/>
        <td style="width:1.002%;"/>
        <td style="width:2.125%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.618%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of<br/>Restricted<br/>Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">359,945</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59.54</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">170,150</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90.75</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,775</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57.98</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Canceled</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,033</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61.24</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72.59</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1700000000000002;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Performance-Based Stock Options and Restricted Stock Units</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">669,581</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based stock options during the nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the "2021 PSAs"). The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t grant any performance-based equity awards during </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.  The Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">170,150</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based options and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">128,900</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based restricted stock units to employees in 2019 (the "2019 PSAs").</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The performance-based equity awards granted will vest </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one-quarter</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the achievement of specific clinical development milestones. The remaining shares will then vest ratably over three years thereafter. Performance-based stock options and performance-based restricted stock units are recorded as expense beginning when vesting events are determined to be probable.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The milestone for the 2019 PSAs was achieved during the second quarter of 2021. As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,536</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based stock options and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28,905</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance-based restricted stock units granted during 2019 have vested. The Company believes that the achievement of the requisite performance condition for 2021 PSAs granted in the first quarter of 2021 continues to be probable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense recognized was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2021, respectively, and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2020, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2018 Employee Share Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:5.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.62%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the Company adopted the 2018 Employee Share Purchase Plan (&#8220;ESPP&#8221;), which became effective on the business day prior to the effectiveness of the registration statement relating to the Company's initial public offering. A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">460,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were initially reserved for issuance under the ESPP. The initial offering period of the ESPP was authorized by the Company&#8217;s board of directors and commenced on January 4, 2021. Each offering period is approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">twelve months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> long, with </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> purchase periods. ESPP participants will purchase shares of common stock at a price per share equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the lesser of (1) the fair market value per share of the common stock on the enrollment date or (2) the fair market value of the common stock on the exercise date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.62%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.867%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company issued </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,295</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares under the ESPP during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three and nine months ended September 30, 2021, respectively. The stock-based compensation expense related to the ESPP was less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the three and nine months ended September 30, 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.745%;"/>
        <td style="width:1.425%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.258%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.425%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.22%;"/>
        <td style="width:0.975%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.258%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.425%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.258%;"/>
        <td style="width:0.975%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br/>&#160;&#160;September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br/>&#160;&#160;September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,759</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,598</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,983</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,948</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,482</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,791</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,230</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,377</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,241</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33,389</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,213</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, total unrecognized compensation cost related to the unvested share-based awards and ESPP was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">122.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842684504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Common Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Net Loss per Common Share</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.859%;"/>
        <td style="width:2.338%;"/>
        <td style="width:1.002%;"/>
        <td style="width:17.729%;"/>
        <td style="width:1.002%;"/>
        <td style="width:2.338%;"/>
        <td style="width:1.002%;"/>
        <td style="width:17.729%;"/>
        <td style="width:1.002%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,238,363</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">363,195</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,212,019</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,601,558</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921844659064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On October 13, 2021, stockholders of the Company approved the Kodiak Sciences Inc. 2021 Long-Term Performance Incentive Plan (the &#8220;LTPIP&#8221;) as described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on September 13, 2021. Stock options were granted under the LTPIP, contingent on stockholder approval of the LTPIP, to named executive officers and other eligible employees at the vice president level who made a one-time election to participate in the LTPIP and agreed to forgo a portion of their annual long-term incentive awards over the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seven-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance period ending on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">August 11, 2028</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,502,334</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were reserved for issuance under the LTPIP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The options can be earned based on the achievement of the performance-based requirement and/or certain operational milestones. The performance-based requirement consists of seven tranches of options that are earned based on meeting or exceeding stock price goals between $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">200</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> consecutive trading days.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> billion in a fiscal year.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Once earned, options are subject to a service-based requirement and will vest through the remainder of the seven-year performance period in equal monthly installments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Performance-based stock options totaling </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,920,625</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> with the same terms and conditions as the LTPIP were also granted to employees below the vice president level under the 2018 Plan. These stock option awards were also contingent on stockholder approval of the LTPIP. As discussed above, the LTPIP was approved by the stockholders of the Company on October 13, 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is currently evaluating the LTPIP approved in October 2021 and its accounting impact as a modification of the portion of the annual long-term incentive awards granted in 2021 that were foregone.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842627768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) applicable to interim periods. The condensed consolidated financial statements, in the opinion of management, include all normal and recurring adjustments necessary to present fairly the Company's financial position and results of operations for the reported periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These condensed consolidated financial statements have been prepared on a basis substantially consistent with, and should be read in conjunction with the audited financial statements for the year ended December 31, 2020 and notes thereto, the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 1, 2021. Certain information and note disclosures normally included in the audited financial statements prepared in accordance with GAAP have been condensed or omitted from this report. The results of operations for any interim period are not necessarily indicative of the results for the year ending December 31, 2021, or for any future period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no impact on subtotals in the prior year condensed consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and expenses during the reporting period. The impact of the ongoing COVID-19 pandemic continues to evolve. As a result, certain estimates and assumptions required increased judgment and carried a higher degree of variability and volatility, including but not limited to, the fair value of marketable securities, performance-based equity awards, and research and development accruals for the three and nine months ended September 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As events continue to unfold and additional information becomes available, these estimates may change materially in future periods. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_RiskAndUncertaintiesPolicyTextBlock', window );">Risk and Uncertainties</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health Organization declared a pandemic due to the global COVID-19 outbreak. The significant uncertainties caused by the ongoing COVID-19 pandemic may negatively impact the Company&#8217;s operations, liquidity, and capital resources and will depend on certain evolving developments, including the duration and spread of the outbreak, regulatory and private sector responses and the impact on employees and vendors including supply chain and clinical partners, all of which are uncertain and cannot be predicted. During this pandemic, the Company continues to work closely with clinical sites towards maximal patient safety and the lowest number of missed visits and study discontinuations. The Company has taken and continues to take proactive measures to maintain the integrity of its ongoing clinical studies. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact clinical trial enrollment and completion of its clinical studies. During this pandemic, the Company continues to work closely with its manufacturing suppliers, partners and facilities to maintain the supply of its product candidates needed for the expansion of clinical trials and to retain the number, scale and design of manufacturing runs that regulatory authorities may require to obtain marketing approval, including those required to support a BLA submission. Despite these efforts, the ongoing COVID-19 pandemic could significantly impact the timing or likelihood of clinical resupply and of regulatory filings and approvals. The Company will continue to monitor the COVID-19 situation and its impact on the ability to continue the development of, and seek regulatory approvals for, the Company&#8217;s product candidates, and begin to commercialize any approved products.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ccounting </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">p</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), under its Accounting Standards Codification or other standard setting bodies, and adopted by the Company as of the specified effective date, unless otherwise discussed below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the FASB issued Accounting Standards Update 2020-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Codification Improvements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which updates various codification topics and disclosure requirements to improve alignment with the SEC's regulations. The Company adopted this new guidance as of January 1, 2021, and this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">New Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to monitor new accounting pronouncements issued by the FASB. All other newly issued accounting pronouncements issued through the date of this report have been deemed either immaterial or not applicable.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_RiskAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_RiskAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921846775624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable And Accrued Liabilities Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Accrued and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued and other current liabilities consist of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.562%;"/>
        <td style="width:1.605%;"/>
        <td style="width:1.531%;"/>
        <td style="width:12.832%;"/>
        <td style="width:0.752%;"/>
        <td style="width:1.605%;"/>
        <td style="width:1.531%;"/>
        <td style="width:12.832%;"/>
        <td style="width:0.752%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 30,<br/>2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31,<br/>2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued clinical trial and related costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,762</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,119</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued leasehold improvements</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,470</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued salaries and benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,790</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,094</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,392</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,082</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued legal fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">582</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">252</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued professional fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">223</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">253</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued other liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">797</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">583</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued and other current liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,016</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,402</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842537032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present the Company&#8217;s fair value hierarchy for assets measured at fair value on a recurring basis (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.096%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.072%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.044%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:8.988%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.072%;"/>
        <td style="width:0.974%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at September 30, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">762,550</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair Value Measurements at December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">917,485</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">942,063</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of September 30, 2021 and December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the fair value of the liability related to sale of future royalties is based on the Company's current estimates of future royalties expected to be paid to Baker Bros. Advisors, LP (&#8220;BBA&#8221;), which are considered Level 3 inputs.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842387800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Summary of Marketable Securities</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the marketable securities (in thousands):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.91%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.098%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.107%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.53%;"/>
        <td style="width:9.107%;"/>
        <td style="width:0.974%;"/>
        <td style="width:1.187%;"/>
        <td style="width:1.521%;"/>
        <td style="width:9.023%;"/>
        <td style="width:0.974%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Amortized<br/>Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Gains</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Unrealized<br/>Losses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair<br/>Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. treasury securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,003</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,006</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate notes</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,522</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,572</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total marketable securities, current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,525</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,578</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921844626168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Options Activity under 2018 Plan and 2015 Equity Incentive Plan</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock option activity under the 2018 Plan and 2015 Equity Incentive Plan (the "2015 Plan") is summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:38.581%;"/>
        <td style="width:1.475%;"/>
        <td style="width:0.983%;"/>
        <td style="width:11.651%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.475%;"/>
        <td style="width:1.531%;"/>
        <td style="width:11.596%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.475%;"/>
        <td style="width:0.993%;"/>
        <td style="width:11.679%;"/>
        <td style="width:0.983%;"/>
        <td style="width:1.475%;"/>
        <td style="width:1.531%;"/>
        <td style="width:11.614%;"/>
        <td style="width:0.983%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number<br/>of<br/>Options</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Exercise<br/>Price</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">  </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,897,276</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24.52</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.07</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">841,704</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,478,994</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94.80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercised</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">348,420</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.06</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited or canceled</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">228,118</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41.86</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37.62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.74</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">431,288</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Shares</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted share activity, including restricted stock awards, restricted stock units, and performance-based restricted stock units, under the 2018 Plan and 2015 Plan is summarized as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.942%;"/>
        <td style="width:2.125%;"/>
        <td style="width:0.993%;"/>
        <td style="width:17.673%;"/>
        <td style="width:1.002%;"/>
        <td style="width:2.125%;"/>
        <td style="width:1.531%;"/>
        <td style="width:17.618%;"/>
        <td style="width:0.993%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Number of<br/>Restricted<br/>Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">359,945</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59.54</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">170,150</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90.75</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,775</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57.98</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Canceled</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,033</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61.24</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested at September 30, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72.59</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation for options, restricted shares, and ESPP is classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.745%;"/>
        <td style="width:1.425%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.258%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.425%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.22%;"/>
        <td style="width:0.975%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.258%;"/>
        <td style="width:0.975%;"/>
        <td style="width:1.425%;"/>
        <td style="width:1.528%;"/>
        <td style="width:11.258%;"/>
        <td style="width:0.975%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Three Months Ended <br/>&#160;&#160;September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Nine Months Ended <br/>&#160;&#160;September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,759</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,598</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,983</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,948</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,482</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,791</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,230</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,377</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,241</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33,389</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,213</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921844109128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.859%;"/>
        <td style="width:2.338%;"/>
        <td style="width:1.002%;"/>
        <td style="width:17.729%;"/>
        <td style="width:1.002%;"/>
        <td style="width:2.338%;"/>
        <td style="width:1.002%;"/>
        <td style="width:17.729%;"/>
        <td style="width:1.002%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">As of September 30,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,799,732</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,238,363</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">412,287</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">363,195</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,212,019</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,601,558</span></p></td>
        <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921842392216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Company - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and marketable securities</a></td>
<td class="nump">$ 799.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847840536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable And Accrued Liabilities Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AccruedClinicalTrialAndRelatedCostsCurrent', window );">Accrued clinical trial and related costs</a></td>
<td class="nump">$ 21,762<span></span>
</td>
<td class="nump">$ 11,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AccruedLeaseholdImprovements', window );">Accrued Leasehold Improvements</a></td>
<td class="nump">7,470<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salaries and benefits</a></td>
<td class="nump">4,790<span></span>
</td>
<td class="nump">5,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">3,392<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AccruedLegalFeesCurrent', window );">Accrued legal fees</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other liabilities</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">583<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued and other current liabilities</a></td>
<td class="nump">$ 39,016<span></span>
</td>
<td class="nump">$ 20,402<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AccruedClinicalTrialAndRelatedCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical trial and related costs current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AccruedClinicalTrialAndRelatedCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AccruedLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Leasehold Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AccruedLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AccruedLegalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued legal fees current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AccruedLegalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848076792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 762,550<span></span>
</td>
<td class="nump">$ 942,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">762,550<span></span>
</td>
<td class="nump">917,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Price in Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">762,550<span></span>
</td>
<td class="nump">917,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Price in Active Markets (Level 1) | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 762,550<span></span>
</td>
<td class="nump">917,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Observable Inputs (Level 2) | Corporate Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Observable Inputs (Level 2) | U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,006<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateNoteSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateNoteSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921852380008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Marketable Securities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent', window );">Amortized Cost, current</a></td>
<td class="nump">$ 24,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent', window );">Unrealized Gains, current</a></td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value, current</a></td>
<td class="nump">24,578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent', window );">Amortized Cost, current</a></td>
<td class="nump">10,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent', window );">Unrealized Gains, current</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value, current</a></td>
<td class="nump">10,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember', window );">Corporate Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent', window );">Amortized Cost, current</a></td>
<td class="nump">14,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent', window );">Unrealized Gains, current</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value, current</a></td>
<td class="nump">$ 14,572<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale debt securities accumulated gross unrealized gain before tax, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale debt securities amortized cost basis current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921872135208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Availability of Marketable Securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Realized gains or losses recognized on sale or maturity of available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit losses for available-for-sale debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale', window );">Impairment charges or recoveries related to marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Marketable securities, effective maturities</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847634664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br> $ in Thousands, SFr in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember', window );">Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kod_ClinicalAndCommercialSupplyMember', window );">Clinical and Commercial Supply of Drug Substance | Manufacturing Agreement | Lonza</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Annual suite fees payment | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_EstimatedCapitalContributions', window );">Revised estimated capital contribution | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ManufacturingAgreementInitialTerm', window );">Manufacturing agreement initial term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kod_ClinicalAndCommercialSupplyMember', window );">Clinical and Commercial Supply of Drug Substance | Maximum | Manufacturing Agreement | Lonza</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ManufacturingAgreementTermThatCanBeExtended', window );">Manufacturing agreement term that can be extended</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Manufacturing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments And Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ManufacturingAgreementExpense', window );">Manufacturing Agreement Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,700<span></span>
</td>
<td class="nump">SFr 35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_EstimatedCapitalContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated capital contributions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_EstimatedCapitalContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ManufacturingAgreementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Manufacturing Agreement Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ManufacturingAgreementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ManufacturingAgreementInitialTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Manufacturing agreement initial term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ManufacturingAgreementInitialTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ManufacturingAgreementTermThatCanBeExtended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Manufacturing agreement term that can be extended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ManufacturingAgreementTermThatCanBeExtended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kod_ClinicalAndCommercialSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kod_ClinicalAndCommercialSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kod_ManufacturingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kod_ManufacturingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=kod_LonzaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=kod_LonzaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921840454104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>PurchasePeriod </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,241<span></span>
</td>
<td class="nump">$ 33,389<span></span>
</td>
<td class="nump">$ 21,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,698,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,698,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,112,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock based compensation expense related to ESPP | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost related to unvested share based awards | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation weighted-average period expected for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedStockOptionsMember', window );">Performance-based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Stock options, vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">669,581<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">170,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedEquityAwardsMember', window );">Performance Based Equity Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone', window );">Vesting period for achievement of specific milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-quarter<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kod_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of common stock available for issuance increased</a></td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kod_TwoThousandEighteenEmployeeSharePurchasePlanMember', window );">2018 Employee Share Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock Issued During Period, Shares, Employee Stock Purchase Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_TermOfOfferingPeriod', window );">Term of offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_NumberOfPurchasePeriods', window );">Number of purchase periods | PurchasePeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Common stock purchase price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock based compensation expense related to ESPP | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_NumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of purchase periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_NumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award vesting period for achievement of specific milestone.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_TermOfOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_TermOfOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kod_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kod_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kod_PerformanceBasedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kod_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kod_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kod_TwoThousandEighteenEmployeeSharePurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kod_TwoThousandEighteenEmployeeSharePurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921856928952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details) - 2018 Plan and 2015 Equity Incentive Plan<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance | shares</a></td>
<td class="nump">6,897,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">1,478,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(348,420)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or canceled | shares</a></td>
<td class="num">(228,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance | shares</a></td>
<td class="nump">7,799,732<span></span>
</td>
<td class="nump">6,897,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 24.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">94.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="nump">17.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or canceled | $ / shares</a></td>
<td class="nump">41.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance | $ / shares</a></td>
<td class="nump">$ 37.62<span></span>
</td>
<td class="nump">$ 24.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">7 years 8 months 26 days<span></span>
</td>
<td class="text">8 years 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Balance | $</a></td>
<td class="nump">$ 431,288<span></span>
</td>
<td class="nump">$ 841,704<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, options, aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921847685368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Restricted Shares (Details) - Restricted Shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance | shares</a></td>
<td class="nump">359,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">170,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(83,775)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled | shares</a></td>
<td class="num">(34,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, ending balance | shares</a></td>
<td class="nump">412,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, beginning balance | $ / shares</a></td>
<td class="nump">$ 59.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted | $ / shares</a></td>
<td class="nump">90.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested | $ / shares</a></td>
<td class="nump">57.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled | $ / shares</a></td>
<td class="nump">61.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, ending balance | $ / shares</a></td>
<td class="nump">$ 72.59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848173480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 12,377<span></span>
</td>
<td class="nump">$ 8,241<span></span>
</td>
<td class="nump">$ 33,389<span></span>
</td>
<td class="nump">$ 21,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">6,429<span></span>
</td>
<td class="nump">4,759<span></span>
</td>
<td class="nump">17,598<span></span>
</td>
<td class="nump">11,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 5,948<span></span>
</td>
<td class="nump">$ 3,482<span></span>
</td>
<td class="nump">$ 15,791<span></span>
</td>
<td class="nump">$ 9,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848607528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of diluted net loss per common share</a></td>
<td class="nump">8,212,019<span></span>
</td>
<td class="nump">7,601,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of diluted net loss per common share</a></td>
<td class="nump">7,799,732<span></span>
</td>
<td class="nump">7,238,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested Restricted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of diluted net loss per common share</a></td>
<td class="nump">412,287<span></span>
</td>
<td class="nump">363,195<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139921848397912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details)<br> $ / shares in Units, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 13, 2021 </div>
<div>USD ($) </div>
<div>Days </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ConsecutiveTradingDays', window );">Consecutive Trading days | Days</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember', window );">2021 LTPIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration', window );">Performance expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 11,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedStockOptionsMember', window );">Performance-based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">669,581<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">170,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_LongTermPerformanceIncentivePlanDescription', window );">Plan description</a></td>
<td class="text">Up to 35% of the options may be earned through the attainment of certain operational milestones to the extent that number of options has not yet been earned from stock appreciation. A participant may earn up to 25% upon approval by the U.S. Food and Drug Administration of a Biologics License Application for KSI-301 in the three major anti-VEGF indications and up to 10% from generating sales of at least $2.5 billion in a fiscal year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2021 LTPIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_SalesForecasting', window );">Sales | $</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod', window );">Performance Periods</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for issuance</a></td>
<td class="nump">5,502,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2021 LTPIP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock Price | $ / shares</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2021 LTPIP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock Price | $ / shares</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2018 Equity Incentive Plan | Performance-based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">1,920,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_LongTermPerformanceIncentivePlanDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Performance Incentive Plan Description</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_LongTermPerformanceIncentivePlanDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_SalesForecasting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales Forecasting</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_SalesForecasting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options performance period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options performance period expiration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kod_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kod_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kod_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kod_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kod_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>48
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MEE% ;P3@^T8 7^T'YD9QN$%>_PM02P,$%     @ 5HEI4ZY"U4S5 @  80D
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M":5$U;WFG&6\T0#X?RV$>AWH"8;;L=F_4$L#!!0    ( %:):5.A'W5?2@D
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M\+6&?-7^Y)KM8;\5S[O6X^^]5CL7[]P_79$UCA._1MFH47:^1J#%Y'<EA]U
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MZ<N,_# =ATUT79I(:Q<QW]*RP1\*]B* ^]KAS8X;<;#_B[+X!U!+ P04
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MQ3=1\0L@R6]_5C8$V_#'"L.&<K0 S]<6?)F^T ']Z\"+_P)02P,$%     @
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M:J8E_2?0> #M%UJ[H^$=]'^>U5]02P,$%     @ 5HEI4\')N82! P  - @
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MR\4*2FT,O;T[:._%!P=N>!IZJ#2@/TUO*W4I+IZ;QP7RR/)SH7Z+>B\-@0M
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M3[EK0OK"UC_MOT_>IL]RP_#T<?.S=#LZ-!BUQ=35XM7E++77W4VP+7^DV]B
MPP-?5DJ""C0 [[<6#,LWM$#_U?;F?U!+ P04    " !6B6E3OT':#ET(  ")
M%0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6RM6%MOVS@6?O>O(+RW
M!% 572VI30.D;79V%IAIT+0S#XM]H"7:%BJ++DG%S?[Z_0XI*7)CI[/8OM@2
M>7CNYSN'NMQ+]5EOA##LZ[9I]>OYQIC=RXL+76[$EFM?[D2+G9546V[PJM87
M>J<$K^RA;7,1!<'B8LOK=GYU:==NU=6E[$Q3M^)6,=UMMUP]O!&-W+^>A_-A
MX4.]WAA:N+BZW/&UN!/FT^Y6X>UBY%+56]'J6K9,B=7K^77X\DU"]);@MUKL
M]>29D25+*3_3R\_5ZWE "HE&E(8X</S=B[>B:8@1U/C2\YR/(NG@]'G@_G=K
M.VQ9<BW>RN;WNC*;U_-\SBJQXEUC/LC]/T1O3TK\2MEH^\OVCC:+YJSLM)';
M_C TV-:M^^=?>S],#N3!B0-1?R"R>CM!5LMWW/"K2R7W3!$UN-&#-=6>AG)U
M2T&Y,PJ[-<Z9JSLCR\\OWL"NBKV56\1:<W+7Y84!=Z*Y*'M.;QRGZ 2G@OTB
M6[/1[*:M1'5X_@):C:I%@VIOHF<9WHF=S^+ 8U$0A<_PBT=38\LO/L'O7:W+
M1NI."?9^=6 L^R :;JP'M-'L;L.56%J7W/('9"#6_G6]U$8AA_[]C";)J$EB
M-4E^@-.?YY3Y[!0S]G/+_LG;#J5F/<AX6]%#P#QF-H*UW78I%),KILE>34^E
MW&YQ4A-+QN]YW?!E(QAJG]5:=[PM!>L07F4Y1$&8LYLO76T>(*R$GU!@[+;A
M+3NC_;DEH/?Y.=MSS>JV!'"0HLL'QG<[);_6*"S10$,_0'HWC:U4*!KZ^?CN
M]/.  7HG;!4W#QX#/TY+*#]2G03R#N4"X\M1$H.,^]HB2-T^*DTZ]9YC[W?D
M+=V_R=TC6)!=WUAKC7..#-/OV9X.MM>Z![WZ/[ =BJ]D S34+V>_NB#\;L$#
M>^/#]7JMQ!J^F;WOC#806;=KQ@U[)TIAS\2AY\*Y\/(B\Z)LP?[,HL1/(Y;[
M08:7/ F]+$AF/RG>$L_02[+<*XH$>T7BY\'LYJM094T!.6-QDGL)V)UC-\S\
M8#$#[*U$32<1_Y*"WUC**,J]$,X@R@2!6GRK(RK7]$KVY<LR+RL*+XLCG(DS
M?Q&QS,](D01V1'F.$D1]U25)NW/Y.%FQ&3 &Q:/P-IV5IB9$+FOW7%4N60XW
MNK8V6*?@[82R[0P6O7!U?HKZV?#;M^_&%KDY1'7VJ;V'(*([%L@X+;PB2>&4
MM/#32=RRP O3@*(6^%DZ^\WQ.&-Y[&59:N.09GZ1S]X^!BE.O"".[=XB]*/D
M0/:1 "5AA#A0VF21GQ;L=N(C!RZ'Y4)>F,;,;GXBK[&/<!<A$6\?V+JW8;$H
MO#0/C[A>3^I.LZI3%%8+4, ZMG4]15!/.:;V4&QXO+V[UO-S_T!\55>LE<PX
M/1@M/=5 N#)VF3-H8"/B'[5EB,=33G+BG!!54@3'J(XG&S.2B>VND0]"$%12
MCA6/8%(<V/<](P95]X!01G%GLA4OOJ 9&'BOVTD'AKS<U.)>4(NSC0#P6J\
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M=\9K]WGMD=Q]I/R%*XR25'4K'*7;V)PI]^'/O1BYLQ_;EM(8N;6/&\&!&T2
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MI&4!O%\;X[L'=K#_-CK_$U!+ P04    " !6B6E39(SI_D *   5'   &0
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MAC?CH4=TT^":A55EW52VRF*+JJ<Y_A- .P,\SY2RQX4CZ/XRRW]02P,$%
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MH\[9( !;KXA:(5-48[DTQ$->B1EO5;3>@<]7AKNP57R 9D]/_P%02P,$%
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M;KX<; 9:+-W+]U1H\RKO#A?((I0VP%R?"3-G\H%]GR^^WXS^!E!+ P04
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M7M%NN,*/(E!V SY?2*RJ:F+OZ?HS*_X'4$L#!!0    ( %:):5/KR0E^*@,
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M]08A1+*H'@/50/&=Z:>?N(+NW'QNX0'%A-X ZVO.U6&@%31/LMF_4$L#!!0
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M-L :E65#5TZT*&S'<B<T]C]VF&(3#-( \/^U$/IA8C:HV^KI;U!+ P04
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MS,V;P-TOWE]<=![>W>S;+VO@'0F]I/TC2*\Z]D*9:Q2CCX^C/T2.45\?17V
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
M  @ 5HEI4[JKHZI+ P  R!8   \   !X;"]W;W)K8F]O:RYX;6S%F%MOVR 4
M@/\*\M/VD#EVVO2BIE*O6Z7>-%=]G8A]4J-@R "W:W_]#G:BD;8YV@O*DVV,
M\<>Q.1]P]*+-?*KUG/UII+*3I'9N<9BFMJRAX?:;7H#".S-M&N[PTCRE=F&
M5[8&<(U,\^%PG#9<J.3X:-76O4G#"^V@=$(K+/0%CP)>[+_[_I(]"RNF0@KW
M.DFZ<PD):X02C7B#:I(,$V9K_?)#&_&FE>.R*(V6<I)D_8U',$Z4'XH+#_G
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MTW.&F)1G\LB>":9?;,!.JDKX*EPN5U@A)KEPB6P:>J"'4]F<$DX>63B;!OJ
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M-HO#DG?J[?RCMF[N>:YQ_W=2[<=W[;S]M'S>7'PJ$\X:C@Z/OU!+ P04
M" !6B6E3')H)78P!  #G%   $P   %M#;VYT96YT7U1Y<&5S72YX;6S-F,UN
MPC 0A%\ERA418Z>E/P(N;:\MA[Z FVR(11);MJ'P]G7"C]2*1B J=2ZQ$N_.
MC+W2=\CD?6O(19NZ:MPT+KTWCXRYK*1:ND0;:L).H6TM?7BU"V9DMI0+8F(T
M&K-,-YX:/_2M1CR;/%,A5Y6/7C;ALU.ZF<:6*A='3[O"UFL:2V,JE4D?]MFZ
MR7^X#/<.2>CL:ERIC!N$@IB==&AW?C?8][VMR5J54S27UK_*.E2Q3<6<WU;D
MDGZ)$QEU4:B,<IVMZM"2.&-)YJXD\G65[$0'_<X^W##MGOQJ_TZFSS!4SJTV
M+DS,TN5VAY&TW4,3A,AZU7_$HV.0OOI\U$X[I_Q,[W"]G]HNNWDXUBW7W_'W
M&1_U+\PA0'*D(#EN0'+<@N08@^2X \EQ#Y+C 20''Z$$02$J1T$J1V$J1X$J
M1Z$J1\$J1^$J1P$K1R&K0"&K0"&K0"&K0"&K0"&K0"&K0"&K0"&K0"&K0"%K
MBD+6%(6L*0I9T_\DZX?6R[_^]=:N22U5<_!GW?_-V1=02P$"% ,4    " !6
MB6E3!T%-8H$   "Q    $               @ $     9&]C4')O<',O87!P
M+GAM;%!+ 0(4 Q0    ( %:):5/.E'0N[0   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %:):5.97)PC$ 8
M )PG   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ 5HEI4PYW-KD[!0  <!4  !@              ("!# @  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %:):5.2Z<6FB@4
M $T6   8              " @7T-  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    " !6B6E3KD+53-4"  !A"0  &               @($]
M$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 5HEI4UNS
M#, &!0  *1,  !@              ("!2!8  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    ( %:):5.A'W5?2@D  /\Y   8
M  " @80;  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !6
MB6E3")X'2XT'   3'P  &               @($$)0  >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ 5HEI4QPQ:=L&!   K@@  !@
M         ("!QRP  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   ( %:):5,Y"K A5 H  !H<   8              " @0,Q  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !6B6E3JT="&.4"  "%!@
M&               @(&-.P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ 5HEI4\')N82! P  - @  !D              ("!J#X  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !6B6E3\7M$OT,$
M   H"@  &0              @(%@0@  >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    ( %:):5.('2U5>0@  ,$5   9              "
M@=I&  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ 5HEI
M4[]!V@Y="   B14  !D              ("!BD\  'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    " !6B6E3F#=/:\("  #2!0  &0
M        @($>6   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   ( %:):5.%$/(8R@4  "<-   9              " @1=;  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 5HEI4V2,Z?Y "@  %1P
M !D              ("!&&$  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    " !6B6E3RD@UHO$"  !Q!@  &0              @(&/:P
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( %:):5/E6]T_
MFP,  %\(   9              " @;=N  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ 5HEI4ZLQ+9VE @  LP4  !D
M ("!B7(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !6
MB6E38E@:H*@$   X"P  &0              @(%E=0  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( %:):5.86 V[Y (   <&   9
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M970R-2YX;6Q02P$"% ,4    " !6B6E3Z\D)?BH#  "F"@  &0
M    @($5B@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M %:):5-#,80F& 0   X/   9              " @7:-  !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ 5HEI4VY8JU 5!@  #!L  !D
M             ("!Q9$  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    " !6B6E3%AI'K_<#  ">#0  &0              @($1F   >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %:):5/AI73%40,
M !X*   9              " @3^<  !X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ 5HEI4TSFE_QT P  8@L  !D              ("!
MQY\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !6B6E3
MQB%"7?L"  "M"0  &0              @(%RHP  >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    ( %:):5, 8\@$  4  )X1   9
M      " @:2F  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ 5HEI4Q5;,Z\L P  +A,   T              ( !VZL  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " !6B6E3EXJ[',     3 @  "P
M@ $RKP  7W)E;',O+G)E;'-02P$"% ,4    " !6B6E3NJNCJDL#  #(%@
M#P              @ $;L   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M5HEI4^ ]"5=H 0  2A0  !H              ( !D[,  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 5HEI4QR:"5V, 0  YQ0  !,
M             ( !,[4  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     "D
,*0 6"P  \+8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>135</ContextCount>
  <ElementCount>258</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>32</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Disclosure - The Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany</Role>
      <ShortName>The Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Accrued and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Net Loss per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare</Role>
      <ShortName>Net Loss per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Accrued and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Net Loss per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables</Role>
      <ShortName>Net Loss per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - The Company - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails</Role>
      <ShortName>The Company - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Summary of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Marketable Securities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails</Role>
      <ShortName>Marketable Securities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Stock-Based Compensation - Summary of Restricted Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Restricted Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="kod-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="kod-20210930.htm">kod-20210930.htm</File>
    <File>kod-20210930.xsd</File>
    <File>kod-20210930_cal.xml</File>
    <File>kod-20210930_def.xml</File>
    <File>kod-20210930_lab.xml</File>
    <File>kod-20210930_pre.xml</File>
    <File>kod-ex10_1.htm</File>
    <File>kod-ex31_1.htm</File>
    <File>kod-ex31_2.htm</File>
    <File>kod-ex32_1.htm</File>
    <File>kod-ex32_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img6467664_0.jpg</File>
    <File>img6467664_1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>54
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "kod-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "contextCount": 135,
   "dts": {
    "calculationLink": {
     "local": [
      "kod-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "kod-20210930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "kod-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kod-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kod-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "kod-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 308,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 6,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 10
   },
   "keyCustom": 31,
   "keyStandard": 227,
   "memberCustom": 10,
   "memberStandard": 19,
   "nsprefix": "kod",
   "nsuri": "http://kodiak.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Fair Value Measurements",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Marketable Securities",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Commitments and Contingencies",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Stock-Based Compensation",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Net Loss per Common Share",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare",
     "shortName": "Net Loss per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Subsequent Events",
     "role": "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Accrued and Other Current Liabilities (Tables)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables",
     "shortName": "Accrued and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Marketable Securities (Tables)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_83602e3b-403a-43a4-ae96-ae8d95713283",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Net Loss per Common Share (Tables)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables",
     "shortName": "Net Loss per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "kod:TheCompanyTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - The Company - Additional Information (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails",
     "shortName": "The Company - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "kod:TheCompanyTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kod:AccruedClinicalTrialAndRelatedCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kod:ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kod:AccruedClinicalTrialAndRelatedCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_263b39c0-fc6e-4304-804c-806e5d34aa8e",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_263b39c0-fc6e-4304-804c-806e5d34aa8e",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_83602e3b-403a-43a4-ae96-ae8d95713283",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails",
     "shortName": "Marketable Securities - Summary of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_83602e3b-403a-43a4-ae96-ae8d95713283",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kod:AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Marketable Securities - Additional Information (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
     "shortName": "Marketable Securities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_b4b42d07-b554-47fb-9b37-295ad99f4b05",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eaad1c4-f84e-49b9-8c0d-bf85eb1191e4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock Options Activity Under 2018 Plan and 2015 Equity Incentive Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_975902bf-d85c-41cd-863e-84e008163d3b",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical) (unaudited)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_6eb21092-7da1-4ed9-b508-b58c034c3e29",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Stock-Based Compensation - Summary of Restricted Shares (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails",
     "shortName": "Stock-Based Compensation - Summary of Restricted Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_c515656c-fd5d-4d4d-bb5a-78a9994f0ad6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_9bdfa9aa-1ba9-4af1-8101-e5969ff5eae8",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails",
     "shortName": "Net Loss per Common Share - Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "kod:ConsecutiveTradingDays",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Days",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Subsequent Events - Additional Information (Details)",
     "role": "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_9e4a81b8-d848-4b6b-9f61-d7f1ba8aa59b",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "kod:ConsecutiveTradingDays",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Days",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_e5c59142-312f-4066-abfc-c35cb8d948e8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_5c21659f-1cec-4a85-8710-24968233ef93",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_520836e4-6ccf-4a48-aec5-56fdd89596cc",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kod:TheCompanyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100060 - Disclosure - The Company",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany",
     "shortName": "The Company",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kod:TheCompanyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Accrued and Other Current Liabilities",
     "role": "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities",
     "shortName": "Accrued and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kod-20210930.htm",
      "contextRef": "C_90a0890e-113a-4768-a4d5-8086e659ebe1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 32,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "verboseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "verboseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "verboseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "verboseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "verboseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "kod_AccruedClinicalTrialAndRelatedCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued clinical trial and related costs current.",
        "label": "Accrued Clinical Trial And Related Costs Current",
        "terseLabel": "Accrued clinical trial and related costs"
       }
      }
     },
     "localname": "AccruedClinicalTrialAndRelatedCostsCurrent",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AccruedLeaseholdImprovements": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Leasehold Improvements",
        "label": "Accrued Leasehold Improvements"
       }
      }
     },
     "localname": "AccruedLeaseholdImprovements",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AccruedLegalFeesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued legal fees current.",
        "label": "Accrued Legal Fees Current",
        "terseLabel": "Accrued legal fees"
       }
      }
     },
     "localname": "AccruedLegalFeesCurrent",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AccruedResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development current.",
        "label": "Accrued Research And Development Current",
        "terseLabel": "Accrued research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AmortizationOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of issuance costs.",
        "label": "Amortization Of Issuance Costs",
        "terseLabel": "Amortization of issuance costs"
       }
      }
     },
     "localname": "AmortizationOfIssuanceCosts",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails": {
       "order": 0.0,
       "parentTag": "kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale debt securities accumulated gross unrealized gain before tax, current.",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current",
        "terseLabel": "Unrealized Gains, current"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale debt securities accumulated gross unrealized loss before tax current.",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current",
        "negatedLabel": "Unrealized Losses, current"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale debt securities amortized cost basis current.",
        "label": "Available For Sale Debt Securities Amortized Cost Basis Current",
        "totalLabel": "Amortized Cost, current"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_ClinicalAndCommercialSupplyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical and commercial supply.",
        "label": "Clinical And Commercial Supply [Member]",
        "terseLabel": "Clinical and Commercial Supply of Drug Substance"
       }
      }
     },
     "localname": "ClinicalAndCommercialSupplyMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_CommitmentsAndContingenciesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies disclosure.",
        "label": "Commitments And Contingencies Disclosure [Line Items]",
        "terseLabel": "Commitments And Contingencies Disclosure [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kod_CommitmentsAndContingenciesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies disclosure.",
        "label": "Commitments And Contingencies Disclosure [Table]",
        "terseLabel": "Commitments And Contingencies Disclosure [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kod_ConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consecutive Trading Days",
        "label": "Consecutive Trading Days",
        "terseLabel": "Consecutive Trading days"
       }
      }
     },
     "localname": "ConsecutiveTradingDays",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kod_ContractualObligationDueInSecondYearAndAfter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation due in second year and after.",
        "label": "Contractual Obligation Due In Second Year And After",
        "terseLabel": "Annual suite fees payment each year after 2021"
       }
      }
     },
     "localname": "ContractualObligationDueInSecondYearAndAfter",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_DepositsOnPropertyAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposits on property and equipment.",
        "label": "Deposits On Property And Equipment",
        "negatedLabel": "Deposits on property and equipment"
       }
      }
     },
     "localname": "DepositsOnPropertyAndEquipment",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_EstimatedCapitalContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated capital contributions.",
        "label": "Estimated Capital Contributions",
        "terseLabel": "Revised estimated capital contribution"
       }
      }
     },
     "localname": "EstimatedCapitalContributions",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liability.",
        "label": "Increase Decrease In Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon exercise of common stock warrants.",
        "label": "Issuance Of Common Stock Upon Exercise Of Common Stock Warrants",
        "terseLabel": "Issuance of common stock upon exercise of common stock warrant"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponExerciseOfCommonStockWarrants",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon exercise of common stock warrants, shares.",
        "label": "Issuance Of Common Stock Upon Exercise Of Common Stock Warrants Shares",
        "terseLabel": "Issuance of common stock upon exercise of common stock warrant, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon vesting of restricted stock units,net of taxes withheld.",
        "label": "Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld",
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units, net of taxes withheld"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheld",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon vesting of restricted stock units,net of taxes withheld, shares.",
        "label": "Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Taxes Withheld Shares",
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units, net of taxes withheld, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfTaxesWithheldShares",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kod_LiabilityRelatedToSaleOfFutureRoyalties": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability related to sale of future royalties.",
        "label": "Liability Related To Sale Of Future Royalties",
        "terseLabel": "Liability related to sale of future royalties"
       }
      }
     },
     "localname": "LiabilityRelatedToSaleOfFutureRoyalties",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_LongTermPerformanceIncentivePlanDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Performance Incentive Plan Description",
        "label": "Long-Term Performance Incentive Plan Description",
        "terseLabel": "Plan description"
       }
      }
     },
     "localname": "LongTermPerformanceIncentivePlanDescription",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kod_LonzaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lonza.",
        "label": "Lonza [Member]",
        "terseLabel": "Lonza"
       }
      }
     },
     "localname": "LonzaMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_ManufacturingAgreementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Agreement Expense",
        "label": "Manufacturing Agreement Expense"
       }
      }
     },
     "localname": "ManufacturingAgreementExpense",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_ManufacturingAgreementInitialTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing agreement initial term.",
        "label": "Manufacturing Agreement Initial Term",
        "terseLabel": "Manufacturing agreement initial term"
       }
      }
     },
     "localname": "ManufacturingAgreementInitialTerm",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kod_ManufacturingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing agreement.",
        "label": "Manufacturing Agreement [Member]",
        "terseLabel": "Manufacturing Agreement"
       }
      }
     },
     "localname": "ManufacturingAgreementMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_ManufacturingAgreementTermThatCanBeExtended": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing agreement term that can be extended.",
        "label": "Manufacturing Agreement Term That Can Be Extended",
        "terseLabel": "Manufacturing agreement term that can be extended"
       }
      }
     },
     "localname": "ManufacturingAgreementTermThatCanBeExtended",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kod_NumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of purchase periods.",
        "label": "Number Of Purchase Periods",
        "terseLabel": "Number of purchase periods"
       }
      }
     },
     "localname": "NumberOfPurchasePeriods",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kod_OperatingLeaseRightOfUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease right of use asset amortization.",
        "label": "Operating Lease Right Of Use Asset Amortization",
        "terseLabel": "Amortization of operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortization",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_PerformanceBasedEquityAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance based equity awards.",
        "label": "Performance Based Equity Awards [Member]",
        "terseLabel": "Performance Based Equity Awards"
       }
      }
     },
     "localname": "PerformanceBasedEquityAwardsMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Restricted Stock Units [Member]",
        "label": "Performance Based Restricted Stock Units [Member]",
        "terseLabel": "Performance Based Restricted Stock Units"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_PerformanceBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-based stock options.",
        "label": "Performance Based Stock Options [Member]",
        "terseLabel": "Performance-based Stock Options"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_PrincipalPaymentsOfTenantImprovementAllowancePayable": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal payments of tenant improvement allowance payable.",
        "label": "Principal Payments Of Tenant Improvement Allowance Payable",
        "negatedLabel": "Principal payments of tenant improvement allowance payable"
       }
      }
     },
     "localname": "PrincipalPaymentsOfTenantImprovementAllowancePayable",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of future royalties, net of issuance costs.",
        "label": "Proceeds From Sale Of Future Royalties Net Of Issuance Costs",
        "terseLabel": "Proceeds from sale of future royalties, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromSaleOfFutureRoyaltiesNetOfIssuanceCosts",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_RiskAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk and uncertainties.",
        "label": "Risk And Uncertainties Policy [Text Block]",
        "terseLabel": "Risk and Uncertainties"
       }
      }
     },
     "localname": "RiskAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kod_SalesForecasting": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Forecasting",
        "label": "Sales Forecasting",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "SalesForecasting",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kod_ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of accrued and other current liabilities.",
        "label": "Schedule Of Accrued And Other Current Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedAndOtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, options, aggregate intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options performance period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options performance period",
        "terseLabel": "Performance Periods"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriod",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options performance period expiration.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Performance Period Expiration",
        "terseLabel": "Performance expiration date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformancePeriodExpiration",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, options, weighted average remaining contractual term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kod_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award vesting period for achievement of specific milestone.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Vesting Period For Achievement Of Specific Milestone",
        "terseLabel": "Vesting period for achievement of specific milestone"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingPeriodForAchievementOfSpecificMilestone",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kod_TermOfOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of offering period.",
        "label": "Term Of Offering Period",
        "terseLabel": "Term of offering period"
       }
      }
     },
     "localname": "TermOfOfferingPeriod",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kod_TheCompanyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the company.",
        "label": "The Company [Text Block]",
        "terseLabel": "The Company"
       }
      }
     },
     "localname": "TheCompanyTextBlock",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompany"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kod_TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen and two thousand fifteen equity incentive plan.",
        "label": "Two Thousand Eighteen And Two Thousand Fifteen Equity Incentive Plan [Member]",
        "terseLabel": "2018 Plan and 2015 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenAndTwoThousandFifteenEquityIncentivePlanMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_TwoThousandEighteenEmployeeSharePurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen employee share purchase plan.",
        "label": "Two Thousand Eighteen Employee Share Purchase Plan [Member]",
        "terseLabel": "2018 Employee Share Purchase Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenEmployeeSharePurchasePlanMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_TwoThousandEighteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen equity incentive plan.",
        "label": "Two Thousand Eighteen Equity Incentive Plan [Member]",
        "terseLabel": "2018 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenEquityIncentivePlanMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kod_TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty One Long-Term Performance Incentive Plan [Member]",
        "label": "Two Thousand Twenty One Long-Term Performance Incentive Plan [Member]",
        "terseLabel": "2021 LTPIP"
       }
      }
     },
     "localname": "TwoThousandTwentyOneLongTermPerformanceIncentivePlanMember",
     "nsuri": "http://kodiak.com/20210930",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r36",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r137",
      "r146",
      "r147",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r137",
      "r146",
      "r147",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase Agreement Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]",
        "terseLabel": "Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable And Accrued Liabilities Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "negatedLabel": "Amortization (accretion) of premium (discount) on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued and other current liabilities",
        "totalLabel": "Total accrued and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r29"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r17",
      "r38",
      "r39",
      "r40",
      "r249",
      "r262",
      "r263"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "terseLabel": "Accumulated other comprehensive income",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r37",
      "r40",
      "r41",
      "r71",
      "r72",
      "r73",
      "r191",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid In Capital Common Stock",
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r173",
      "r174",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r148",
      "r150",
      "r178",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r150",
      "r169",
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Stock-based compensation expense recognized",
        "verboseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Anti-dilutive securities excluded from the computation of diluted net loss per common share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r68",
      "r99",
      "r101",
      "r105",
      "r116",
      "r188",
      "r192",
      "r206",
      "r238",
      "r248"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r35",
      "r68",
      "r116",
      "r188",
      "r192",
      "r206"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r108",
      "r112",
      "r118",
      "r240"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Marketable securities",
        "totalLabel": "Debt Securities, Available-for-sale, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r110",
      "r118"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "kod_AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Available For Sale Securities Debt Securities Current",
        "terseLabel": "Fair Value, current",
        "totalLabel": "Debt Securities, Available-for-sale, Current, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r151",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r194",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r23",
      "r63"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash And Cash Equivalents Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash Cash Equivalents And Short Term Investments",
        "terseLabel": "Cash and cash equivalents and marketable securities",
        "totalLabel": "Cash, Cash Equivalents, and Short-term Investments, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureTheCompanyAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r58",
      "r63",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, at beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r58",
      "r207"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosures of non-cash investing and financing information:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r32",
      "r133",
      "r241",
      "r253"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "verboseLabel": "Common stock, shares reserved for issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r71",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock, shares issued",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r14",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r44",
      "r46",
      "r47",
      "r50",
      "r244",
      "r255"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Annual suite fees payment",
        "totalLabel": "Contractual Obligation, Total",
        "verboseLabel": "Contractual obligation under funding agreement"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation Due In Next Twelve Months",
        "terseLabel": "Annual suite fees payment for 2021"
       }
      }
     },
     "localname": "ContractualObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNoteSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest).",
        "label": "Corporate Note Securities [Member]",
        "terseLabel": "Corporate Notes"
       }
      }
     },
     "localname": "CorporateNoteSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r113",
      "r118",
      "r119",
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale Allowance For Credit Loss",
        "periodEndLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Ending Balance",
        "periodStartLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance",
        "terseLabel": "Allowance for credit losses for available-for-sale debt securities",
        "totalLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss, Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale Realized Gain Loss",
        "terseLabel": "Realized gains or losses recognized on sale or maturity of available-for-sale debt securities",
        "totalLabel": "Debt Securities, Available-for-sale, Realized Gain (Loss), Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities Available For Sale Term",
        "terseLabel": "Marketable securities, effective maturities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r61",
      "r126"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "totalLabel": "Depreciation, Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Net loss per common share, basic and diluted",
        "totalLabel": "Earnings Per Share, Basic and Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Accrued salaries and benefits",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Unrecognized compensation weighted-average period expected for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Unrecognized compensation cost related to unvested share based awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "verboseLabel": "Outstanding Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r75",
      "r80",
      "r82",
      "r89",
      "r117",
      "r135",
      "r136",
      "r173",
      "r174",
      "r175",
      "r182",
      "r183",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r258",
      "r259",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r197",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value Assets Measured On Recurring Basis [Text Block]",
        "terseLabel": "Summary of Fair Value Hierarchy for Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r197",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Fair Value By Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r198",
      "r224",
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Significant Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r200",
      "r201",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r138",
      "r139",
      "r144",
      "r145",
      "r198",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Quoted Price in Active Markets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r138",
      "r139",
      "r144",
      "r145",
      "r198",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Significant Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r198",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Inputs Level3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Fair Value Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r224",
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r203",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value Measurements Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r121",
      "r122",
      "r124",
      "r125",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite Lived Intangible Assets By Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase Decrease In Accrued Liabilities And Other Operating Liabilities",
        "terseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase Decrease In Other Operating Assets",
        "negatedLabel": "Other assets",
        "totalLabel": "Increase (Decrease) in Other Operating Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r48",
      "r98",
      "r215",
      "r216",
      "r245"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "totalLabel": "Interest Expense, Total"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r53",
      "r97"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Debt And Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r237",
      "r247",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseAgreementsMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset.",
        "label": "Lease Agreements [Member]",
        "terseLabel": "Lease Agreement"
       }
      }
     },
     "localname": "LeaseAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r27",
      "r68",
      "r102",
      "r116",
      "r189",
      "r192",
      "r193",
      "r206"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r68",
      "r116",
      "r206",
      "r239",
      "r251"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r68",
      "r116",
      "r189",
      "r192",
      "r193",
      "r206"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Availability of Marketable Securities",
        "totalLabel": "Marketable Securities, Total"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r3",
      "r28"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities Current",
        "terseLabel": "Marketable securities",
        "totalLabel": "Marketable Securities, Current, Total"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Text Block]",
        "terseLabel": "Summary of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r58",
      "r59",
      "r62"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r42",
      "r45",
      "r49",
      "r62",
      "r68",
      "r74",
      "r76",
      "r77",
      "r78",
      "r79",
      "r81",
      "r82",
      "r83",
      "r99",
      "r100",
      "r103",
      "r104",
      "r106",
      "r116",
      "r206",
      "r243",
      "r254"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r64",
      "r65",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired1",
        "terseLabel": "Purchase of property and equipment under accounts payable and accruals"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r99",
      "r100",
      "r103",
      "r104",
      "r106"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease Liability",
        "terseLabel": "Lease liabilities",
        "totalLabel": "Operating Lease, Liability, Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability Current",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability Noncurrent",
        "terseLabel": "Operating lease liability, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r29"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Accrued other liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r194",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r186",
      "r187",
      "r190"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent",
        "terseLabel": "Change in unrealized gains related to available-for-sale debt securities, net of tax",
        "totalLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r43",
      "r46",
      "r186",
      "r187",
      "r190"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Noncurrent",
        "terseLabel": "Other liabilities",
        "totalLabel": "Other Liabilities, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Other Nonoperating Income (Expense), Total"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).",
        "label": "Other Than Temporary Impairment Loss Debt Securities Available For Sale",
        "terseLabel": "Impairment charges or recoveries related to marketable securities",
        "totalLabel": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Total"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Payments for restricted stock units, net of taxes withheld"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments To Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities",
        "totalLabel": "Payments to Acquire Marketable Securities, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchase of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r151",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Preferred Stock, shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred Stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Preferred stock, $0.0001 par value",
        "totalLabel": "Preferred Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r21",
      "r22"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Prior Period Reclassification Adjustment Description",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r56",
      "r172"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock purchase plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds From Sale And Maturity Of Marketable Securities",
        "terseLabel": "Maturities of marketable securities",
        "totalLabel": "Proceeds from Sale and Maturity of Marketable Securities, Total"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r172"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds From Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon options exercise"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r24",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r128",
      "r252"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property, Plant and Equipment, Net, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments Of Debt And Capital Lease Obligations",
        "negatedLabel": "Principal payments of capital lease"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r181",
      "r281"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r6",
      "r12",
      "r67",
      "r280"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Shares",
        "verboseLabel": "Unvested Restricted Shares"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r136",
      "r176",
      "r250",
      "r261",
      "r263"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r75",
      "r80",
      "r82",
      "r117",
      "r173",
      "r174",
      "r175",
      "r182",
      "r183",
      "r258",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r219",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use asset obtained in exchange for operating lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Stock Price"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareSummaryOfAntiDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Summary of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]",
        "terseLabel": "Summary of Stock-based Compensation for Options and Restricted Shares Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r150",
      "r168",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationForOptionsAndRestrictedSharesClassifiedInCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r151",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r154",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Stock Options Activity under 2018 Plan and 2015 Equity Incentive Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]",
        "terseLabel": "Summary of Restricted Shares"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested, ending balance",
        "periodStartLabel": "Unvested, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested, ending balance",
        "periodStartLabel": "Unvested, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
        "negatedLabel": "Vested",
        "terseLabel": "Awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized",
        "terseLabel": "Number of common stock available for issuance increased"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Issuance of common stock pursuant to employee stock purchase plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period",
        "negatedLabel": "Forfeited or canceled",
        "totalLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price",
        "terseLabel": "Forfeited or canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Stock options, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "terseLabel": "Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r156",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r149",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRestrictedSharesDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Weighted Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Stock options, vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent",
        "terseLabel": "Common stock purchase price percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r34",
      "r71",
      "r72",
      "r73",
      "r75",
      "r80",
      "r82",
      "r89",
      "r117",
      "r135",
      "r136",
      "r173",
      "r174",
      "r175",
      "r182",
      "r183",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r258",
      "r259",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r89",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r13",
      "r14",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock pursuant to employee stock purchase plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r13",
      "r14",
      "r135",
      "r136",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionsActivityUnder2018PlanAnd2015EquityIncentivePlanDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r13",
      "r14",
      "r135",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period Value Employee Stock Purchase Plan",
        "terseLabel": "Stock based compensation expense related to ESPP",
        "verboseLabel": "Issuance of common stock pursuant to employee stock purchase plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r34",
      "r135",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period Value Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r14",
      "r18",
      "r19",
      "r68",
      "r107",
      "r116",
      "r206"
     ],
     "calculation": {
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r214",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r214",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r214",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r214",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r221",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/DisclosureSubsequentEvents1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r138",
      "r145",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "U S Treasury Securities [Member]",
        "terseLabel": "U.S. Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueHierarchyForAssetsMeasuredAtFairValueOnRecurringBasisDetails",
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted-average common shares outstanding used in computing net loss per common share, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://kodiak.com/20210930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r282": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r283": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r284": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r285": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r286": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r287": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0000950170-21-003800-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-21-003800-xbrl.zip
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MT-\G86%E'L/&SLG.SBG$R\TK]#\]& T /\?1=]P_6%E. T?X65CY61@M  0
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M1F0>'_;X:.0?^,5J^N[J)]U;A*++#5@OV)$@-;5SZ ]0-\5):7U:*E5RWNI
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M!?X9-SH6(7R(NP/PLX%>I+-O-#X*2EP.T6@#0OSNGU@H#X;K4@V8=%Z='&I
MV!VMYR8N8"+W;ME-T]X7K# S8N>WQ.NWM[&"8Y=8A\.0T0$@LJ,CP1>[]3I
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M7F  \P/,_DWAGF$ RZ[:D$?_ZOT+**J(!=T@*SR+Q%?' /K+1E?#D!;,.G!
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MDW'JZA:7IZ9<1A)OK@W;Y&ES4&^AE\M;(=ORJPQ@;TF%'N3$>E",+F&6'O/
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M5E*DN8G\ !^K5#"V[I9EI]%K]%[QHSE?,@"0 Z M(#M!9'GDVG8HT8:PAZS
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MMS+."/N=:4RZQBN/EHFZ!^#R"Y:3R;!H)(-(HEO47V@LD-\BM.=0(T2SSVQ
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M-@TUZ8@.?;E]JG]]M\_=O#GZ'O"<!/^#N\?% :QWTF';= X1;"X"#UJKQ5L
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M[*'R,7Y!"/RFTJD2@_" "/;REI84.YJ>L3!Y&&4F'7A@;55P[J319\!O[B
MC"&!6 BT3[J:%$WH:&>#OGIH@N4I<K(P\\J%JZ-AZ9XGWW)>*ZB^9N?(6Y!J
M1+QF2A/\V[I>"-N8U"I#]D8[BY%.#326>V>?P"B\_B0;C6&_J'ZF^<8',[]C
MRFWSZB?Q*#'8+<HEV!VBTUC6X60'BL^VSN/$M9%2SQ3M ]=[YSOTT&>:\J-
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M8[F6@=N<,D%G7X;G!RM7(U?<9,8#O P-=60#99[]?FD\\VO%3"9C"' *A:G
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M.-DLGM/'.%VM3^KV<IZX),+92*$"PF:-GS+B!Z:%1W)0U88^Z?KBV6&6^&%
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M,#SKN5=XVJUG^JI199D#CRK+O\A57T76'*2X^?+LEJB>,JAL4V 13;Y]XXK
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MB*6Q019-*Q":8 C^)D)8WPQS+_D^J2Y&KYYT^=<A, <=(\'6I^:QH 460(J
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M4UGZ2B3/7I/7J)6P'A[-K/".6Q<8C09%Y==HDPRE_A9IH<6M0$]6:],)B+*
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M2RO @[6BB@-1$3C ^C>5P>:JR)9;C8#^8$]?C\1+BR,<?R>/3>;;.$G:],A
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M9][FI'.*X6X4^Z< $5IJUOWZW<R<CENWIP8N1HIU[#Q4ZU"**!?1%=;(C26
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M0<QU'SE3]XVH'M:H>!CQ/HR9!AF1":AR"U#_<=G:!_KZ_'^F5\$$_A1T+KH
MD4@[0UF<3TR4!&<])D(PGJ43+>=#7X8D6]KP!9.^<=5UZDFSO%+8]B.3A5!,
M&$\8"^UASJR1>F#A\*[: '?F_1>] NW2FON-5;!6_8_<HS__3\F67]$<E,+;
M)$S$3A_RQH_8^T,:"CYUU?5O%Y_%1P *@F=$/,RJBJF7]J"Q>I@N3*E?I4@_
MULN;-=9\A[WCQIG6O=.LL3\,H+L;$991 C<B^23ANT/';X?>\9WM5\PC;F%I
M:P.8_^]YDCEX.OM# .GTCT".VB;W\Z94HGS=?MSP$D\UL/8%FT[S0F?W/G*7
M*VRAVTJ.0)P *BPB?9!!3S^N>E]R2 +_46I,[3JLC4<*RF+,GK^[P?E3[XQ9
M.8>:/[H73)'I0<?1H;1[I&QJ\6C^<.\+.;DK5^R>Q4$BSHD<@=P8C0$8O;YI
M )&&O@53;&"U?FV)D<[P*>>')L-.B67C=74J"F#/\WAH."(+KD<2HIU!<=.,
MT<HCHG<SO.%JFI)F=XY Z;VP#!@+X/:1+19P4QQ7T.?>&TTCRGZ^)[0MFSHX
M@ZX(?T ('+B3.-O Q"Q_UO8FB=ERX+^OI&LAEJEY?=%YW>3](N;M=#H  %B-
M<9H%21MWXK/=FH5^:*MV\55%)[],;#2=I-K17[>+'OY"*P6>]B'\;C4%1C+M
M@G$TWB,4K(E6#<9J>K ]$DKK-,MDID^=$):@Y6J]XUY-!0GLXQDHV%B=B*UM
M:[!@)T_XND7;R]!FK5J9Y]\XXONQ,.1:/3D;&R^Y;3ZZ6;K3I_9;-G-I:T-/
M_-Y'$<5?_B"+A;EV]S=[ #M3'?].RD4J+7E&YH#;E5[?D!)4D'>+3>N?<;G+
MP\IZ3"?8[PGS3A;9?FAI$.D$#A^SX.KTAZM^+ME8+24[=\/:-&D*VUE=5G>@
M518T@3>ZHE[D;+#QZ)D8RWZ%Q3_6[.<,R"X.OD>@$!S&0J)4W5;CP_[KM,OO
M%@AB#^1'@UBO@0X5MN;H[($N*AW<DX4X9'O6]XF8*1L;Q[H)7<(8T7NMYJHA
MSIEY]S;CO.:7"D71,_I4 <XTO(FW^N&YR1M^<!+Z7.-XC'PPV#*?MK83UIPC
M)GF*"(VL K5$I!9:_XFPB^R)?BA-WT?_,DW\3L$"\V9.K(WH.GB4$QOX>5)M
M]Z1 ?5"-[X%C 2O 0'*VXSO]G"M7M,HJBZQ6K!R_;.9LD1TCA-.E'+.C0,\2
M"G^ X-)49WHKXC+)L\.7TD'T?F#M*;ATOJP*ZTU^W-=^F^=Y[?MW(3%?(LPO
M:,K)>0DLCR$!74<X1Y25)R 4X7)!YD/3QX,,<)WN$*/RD<-/ O/01W<L5J8O
MG6L_KWBWXN:JB.VI1R$+IP-CO.4=+S0+2+-(1@1#C ]1R/D"&!?DJML81*(Q
M8;L%(=/H)?"CYLNCTK)SNM()OIK3;T"K&3),R=?0I6Y;UG2.#N)>,X*9!&PL
M3]JYIRZYE$JSA"6\6>TP*/9-B?["G<&RRPVJ[SV8E:J64]$C<\PUN;/LQ/VQ
M*T@W"<CTK.?O3>U>V*6KFPWJ3'6/JI6N2\C=K6^J<T\C#^H,7<DMDD']?)2Y
MC9[4-@OB)@=2LHL,IARKB9V%BDZ:^^%?PY$V]UB7EVF\B28HG%#79LP<K^<[
MC9^U%Q;KVL=KE2[Q;$8)!XG-8AXH;*_1V?!Y7=RM,,G53Z99OF6&KGT)'!T>
M7UGI!M!L1.@ :^\<\0$*D&1BU+/^->HIO75CCC5#GZZN-3T")"3_*W,Y&B_C
MM6L,O;O^^<?!]?1VT>S9SQ/BA%-*X\2.)L/QV48D(\O%M))BC.U_FWSGL(*\
M_"CSWS'R_93=[06 X$R"JJFZC.I5<\T8$.5%UZ))H7/:N]_?NS8;"]10';W@
MSF!ME=/.6LB8*B5#@]%2AZ:A7<X )8]21Q$C>]\+JT%1,D \M>KZW0=FVX<^
MF9D>IK%6C,0RC=M*!19GL9%?J5*5L(1Z6<6$0,2>1,GN4---1I-51!^8V(C@
MZL9)2([WD?S>#AGW/A7>WW#WRIC?T[RWJON0>5,4M(*9S\VY+'GR\!W<2^8!
MX?NH0YAQ&.OF_E#N3\!<VS2V42SX .C^1(31I&$5/:N;DA/P&U]M[0!G(Q[H
M/A+$?'V9I+&_3W(C?V^D5%.E*9S8LA+%H;59\.B':9O+II/N9X(+2B[Y/9'U
MD<:\_QJ@<4"E*O\KY;6^1ER[YDPK+O4Q-L]6C3.1L3="DO9<0;NBM NPR1?^
MK.0_)&@'9<>?=L=^S%=$L53V^\5/\>WO;G:$ULY$1VBN'D?TTSP8:9BHL)PK
M)$VDLHF<04-#U+)(TEE&5LXD5)0B36>;F,^N0?'"GRH&J!FYY4]U)VY$ICU%
M4?C!J2 '9-N2+^K@7 V4<A5)O_2P"XC>%X!,*=+'A#=Q3]FL\D+3^90Z.E;3
M.E_O>W7FYT0RE>S0 ?0O0(9 JU4(,VC+:;A),KXYAS/"'3=Y,#VISVWSX>LK
MF23B+6YE31E6 BP??!S!17&:![?U:;?0!:JHD&S7*]WJ'R[9WKG&K5Y*N_M'
M9!T$?#'7YP9#&"U4WU.&Z:?G)O@ZRAGO,BJ5&'[&=JOD%B/MJAPZG_;ON-&"
M;#*L<2+Q69/4R,;NY9_+SEX>F BE+4C3+OY?]V'1(%0K[!1<)MF)D%ZK]74P
M;+@[WCX.A4;)'6ZY$= 3F\".+J,?I["V/8=><->^617AVPD-6CS_GJYL25=G
M^FMVWR3Y9L3E9 .S>+WGSS5!I_(S0;Z(FXBIS"I,-90P <!<Q.29[5+U;@)-
MQS%RJ2U=S;8G*(^K^2! MBGQL!(YGV<G2?'+=X5P41R1X"B:IY](K59I6+2[
M3^NTAX4([R\FK,49T]FK8EPPHLG<GZ5M+")+KD-%8M(4'%\=-?'B!=IL?TQP
MX]70+;$D]1_;/6C6M"<@R$JH,.%I@G"20XP&6U0>DQD72(%D36ZE#$HR>BH<
M&]6Q>_'0NHJ84.HH+LAKO/@U_GEYVO5F<>ZK,!WP[</"QL9(T\J<59R>0"-/
M5<6M&0&S9RD[QS 7H/,?+GO#'QR6-IV%&_R(_]#EYO?F<7UIQ^)/:=0>2VNP
M!D"RVUK]A[Q38)HXY@@D4N2!F:^8E0H,$)S")F1Q+< 3E4ME8KCKH]ZC?EFL
M.OH#@/R4R-%/?D>1*_._?5_4-0LQD3]C= 125)%F[;VZ+J8DAJP@S/$S$64F
M#0F/@6?G&E:<NF_M>0)^Z8?O^R=BVN?S9MK>]IIZ#TM[G7_'IC"&N78$<N*>
M0+="*\$AAI&-JIQ]7B_-;0T??6_).7BB6E?>6M3-$1;.LBN30L+0>#'XW:6D
M@%(:&\G-R*EXI=+4*Z_-MZVSIXM@_F'7?$9*<NN XU#JXS$&Z:4#R&_'.$>#
MDF^07KC( 2;:V*V@-<CO%UJ*9I]P^Q=#8%,N^C\D&PUZ6D$9QVR-H^(\_0?]
M9TQQW\X?B)+0C/=HQS%A='&*$5AVZV#9+)5I9:&S_ P4!KF#K'<C; ;/_H_3
M,6UN$@$BONJ'X-"D8R?T3;G*!T3!'H!_JDC7?D!?M6(.LYIDW$)-+SBK:W_X
MB#0JN,%O2*<FN2V84J0Q;?XOX,QX3XD^H0.[O"+9).9OBT_#!0T5UOO4PC:%
M=] W@"?]YC_@[TFVIG<9MC=)C;F_Z&'N3M =YT*$?(I#-H>_D:/Q+?^OK@CS
M_F0;5\$AUXH:U08";V,4<G/* ,H!.K@0HQ!)661D4$%/P+UP7G*IRBEYMC/M
M$RW;YK*J(1LP9[ 5B#9[&(G!K2-;#"!G_(<D7Y0^&]/01!5-*-)O&J-LDX]
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M$$8X[YA09R;Y)5^ 8(+ZJ&64D;@R23)[\L3K>.V F%%IBWC6U315X[.G@?
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M>_BHWSTKTZN;]TTPJ! V_';O(WTS_C,^[6X'>E_NGR1KTP8G$\%XL6#&M+>
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M=_+RI0%(M,6_O6AWBP2F==4M;' 'G^F%.!8&N3P4A^PFJ>=P26!:Q<Q,)*B
MJ\G]X3S3MW^Y,I4LNUIDLD+*S\D^+$WBX;XOG0+0OC!VDS$:,BO*A"OI0DRW
M=,&YL+P9R,&VLK9Z1$;CS<,Z.?/J3'&08W.>_VO2^',B@,0R"0%0!O'WV)-4
MED? IN&E]IY\>*>P7]O3+XU>A4UG_)(J.IQ9KS2, /[5RK^UU!?:?@7JNI *
M!5(T/'(1T5JBP7YL'O>NJ&7ORWV<UH>IOQ+/%,G\7D'R;*UD^[8"0HG0.I9
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M<)\/=GT5A.1;,^2B2KLK8N'Z*][^;R7[4US>-(D_S[P!8"8^"A/K*> \W!R
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M1I ,(SX:/MD-_.YSRK_XI(P<;\+!VC0;(\<M2W>^\,MM-CA'DN(DK7.@(D@
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M(N2(D"-"C@@Y(N2(D"-"C@@Y(N2(D"-"C@@Y(N2(D"-"C@@Y(N3_)B$[ZNW
M:3]'P@,<9V>7^I^&O% ?/^'28=M7ZF]P6?S?HL8F1U4L''04!&Q%;B,G0D.J
M,?>Q=QZIS$F?^K9_2JKP<]KB/_"HS)$=V9$=V9$=V9$=V9$=V9$=V9$=V9$=
MV9$=V9$=V9$=V9']_])V$$BN)0;8%\=HB!1N;KQQQNBYMZ#0+:+6ZIN)2QGY
M7UHJK_Y6>D@_+ 7K-8]%6F$LB"%VZ_#S(Y"S<ZN:EB\HIEK-;3UY]\_/M/3%
M"06?J2FJ-'%(:7GYW+YWHXQH!;8ER!"OV9($"$UE#H2GR)U;]J(&G^S(GWX-
MKMTZSFE\F7-(*/L&_[/Z=GZQX_1[-Y((DY13EXD.GE1 +2PF*)TM3-\:0[)'
MJV;!9[\)E,O=/N5BJ16>,A K?EI-HT<7E@(V7D0@^U'N'6] 2['[7:P10?VQ
M3S>OVG;Q<<VVLQ2#<_+G=@2,Y*/=; 7H7CA'LD\GR:PL3*7C<Y[C\PD7>=L^
M&K#"$H-FLD?KK7UZII"6EJY9?.*Q0??]IZ.COE0:X%O(B%8A(NAW<WXB:IWH
MR$FZTMG.^\8;;>TM\=MA.?[4G95]F]FK@%C&1X _/4FD8BK@J1EAO0LB3WZG
MY4ANA'G>^^S'9J9A.],DX:@X-^-:U149KD7,)3KBY\@?"O".!/7SC25Z/).)
M]9>C2E8OWB@NM+F6[6%W3*DTZ<;E:HL?F0"=Z$*$".DB-@_?1,!@D7[)#0[:
M$\4-SP=::D>I@,9-N<I*"_Y-+Z^P+ZE\ 6_*7@R>^*$G\ =$.=E(] J+7C)<
MI@(Z84 'J$=8TK>Q>8_FVE(;>91^F?BM):'W]M_:J[.%:K_]C(S8.3SI]I]N
MX'WB(\K(<\IW*,/YR:#/3I]QYTL"FMVR:UG[A,M3!I05<,?O2(HP\S!&.]*1
M5 B7B;:440IK#MKW#4[R=D-#OHEX==)6EY6:0M#7;NL9P]/;1?9K=UQZFD1?
M_V#<8. Y:#\\[IM<J^6/'DK8!S+!Q>=GO=3GK_?>&%.H\CN7"[AG?=[Y>X%T
M$\OT_9M/KXKY;!&DMC!9Z*WCA,%>%+#3:[INP"WL7<[ML?(;\IW?].*0O,+O
MQ+QXA3-^TP'5=$%7'L)Z%1*RH?6.&\:2<20_-+N(XYK:O=0O5D]]/".N30Y)
MV\W,&5Y VKP ?7]%K*AO!TRNJD<B/"JXNJF FEVHP(?XC3]@3:T_J9@7OLS&
M*G0Q/SYJF[],*<MONCT?J9V?1 K!NB<C/& $*<GTX /PQ269=):'?T+$P\Z.
M_1JM6Q</<>:6_'IKNVEJRNTNZ()X5-(((9!X'>Q%3@$]-(4"P'<GM\"F;_,2
MSL&C;[9Y+39L SA_383KW.<6QGQE]+CU=OLML'+7:@#86((Q"R8J@L\WMOP8
M$="RK[13S7Z%CV7+8+ ?&;Q#QD26 G!-DV=2H@\.W!>AR$X[@JIZ;QC\;%CD
M*D?'?B&0<+7R+J[BYIL=6<"!T]FXRP%L=&>OOF6?_B3S<XL@68)Q_0@9!;+M
MF8*X7MKVZ AG2E5NGM5]NBU 'WX;(\PH(:QHD1)II'X_PEF7@=OBGVRW;;)5
M9;ND2_N<'@'>,EHX9LQ+D0MU-"%S0%$8"8@MZU*'\V$WC#SDY,IA^3V7-G[$
MJ//=OJ(.1_=OD[[P60+V-""2A$2B"170#H*<_YU-D<,%]R;5E8WM3(RLW,F[
M.;KUSJJK-.Z^J.3QE)I/SYK,SRQ&0GJ&'8"X6GS!"(6/\MT,Y]LSZ] ;47)O
M=I4WE%$4/"G]@0<L&JGS"[#BJ<;FM0-%[<=#O1202P:3</'?.EKCZ+KJIJS[
M#<GV!>9<U]_9%-;%:9WYXBIP6:]'G9,5 /EJX4@';5>%>@]Q@AW&5!7BX#JM
M/N8.HQC67V_*[%C,_3DOV9Q[205P52Z?K<ZD]^T3T&HD<7/AVPE17KBXR458
M1_]ZA=C-@;9ZS'PNRD^^LE*?WP?]O%R7,?W7+?[:I3-LNB"34E@O(FF!F=:N
M:>5.M0*.8//$QZG+&9\3[,GI77SJ'?/&DGY(IU=7?)E%$#U-#]8=WQ54NV-X
MU#'*6+7>;L'8UI!F3/'W7+?2#'\A.Z/2F1_ND7WGU-CUK_X$7&5LM7!D@,PZ
M8BV +&&7.S013W4$UT\3HKN;8Q0\_,L\MK<:1L7N6TY+W([/.QX[]:@D,Z#%
M_#)M<(-Q:M5H,W7TN_%Z+\S-3OF78NJ-"FK?*R9"-B4%OJS^EJ+?=?@_.A'J
M'[6ON-#$\E8NE+97EV8R]^ANW@78IHW_,V&+V@;EC0\(L5U@(J(NG7;3T7'U
M[HL+/'8$\RLUMT'3<O47O&5E[[N31ZYA*P_>BS^Z5BUA'?GV/@#2.>R8WJR.
MX< MX4\3ECU0YHGPLW"<0TR'P.8&3"&?HE$^F[53(9&SHJ\&YUL^_HZE;7UK
M:,89_\9ONF3Q&8XW+7L??G:\Q%1$Y/P!FNV;_8?[3+.E2>;OG"*Q#^E_>\K@
MBO2PYAA7G#)*YQWNVRB:K8V<X_M\OI<)Q]#%IZS' 56[*C?*D3#I3'IE/W7Y
M3O00$HB] 4+N6)&+M(#E8= >+D-_-!7 EO!R_E.,%]'J6Z* L=!X#HLN8,L@
MY;DNT'G8,;N@O@3C@7-&;V%$U-NA,8+%F[&LE6^#(O_<H0+<FUM;],$K7K&=
MAH(\#V+O*Z;8:GS9H0*2<A4PYD1FLW=A17<)R<&?5D-S1/7K-+M[BIS<D+9]
MN4*Q]('2#4P.28^^) '(R87PH&&H-ZL:$:]*!<2N^I=X*ZY^W_%(/L\X<]>O
M]D"OJ:-NJET+<]\_7V:1/2Z#,K;0^.$CS.L/J(LYE>O:Z#)'0[#-[IR.!I-L
M53=/<\.O4Q#<K4=&O_I^TN.EDTA%Y%RHYU;R0BT5@+G@A86B?\$BT$)";V[(
MG5_TS %YY0]Z-"1(IJ$2W1*V4C*Z4E,SZ!8IE?^"S,F#M2)QU^*_X]2_$"N
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M;(-_6/OOT+W.8 .2.'E4'Q U"5%;@@;%C0D?>)G/AQUC G<T441Z&W&,6[D
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MD8%Z7_M#^R+0HN(G@H8VBY7^\_^$;OTO=5@]"Y^8]B #,7_@M 2['P]<:\A
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MR/W+-H;;,]&Q9^ANFML]-TN[R:FF]U%5=H7W=->$C#TNT';4?UMQ]5ISU]M
MWN]NBZ<L*YFH6JEY@UF/B'C:;2O2#3(0C5]$//_E.*:JX%MHC-'9;;)1[JD
MO\Z+>,L:L<%)!3#YBNQP+_?O19$!WB8+=%7'F9NH(2'QLI=G?]8_\1A4##I<
M/&PSW;0YWHKAT95-J$W9!VMY(7:K&[D39F:>EUW=77%]_#6W39=)M%_V^B)
M)91W3D*B;5X%C4H6_)K>'GYYI$F#MYY6=C.PXO[S%X.G61PBGX8<6PW"T*8+
M"2!T%)0;<G%JZ.=6GLBKF4MEL;:6[;=##H699U7N0MJGJ'>\\.P4]]162]-?
MMM-@.WCW6F]@O.N,*)&>\08;)XF]E;/$DCB&SU*NS4ZY5:->B!%)K&8X-UTX
M]%Q^0$&SUK?F\5CY2IV.>D0],!;.^5<L=65)"PKMX+)OYH&%_>F?_*6)7?W
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M*/7% K:*!>A3M'#UMS=%HVD*P.*N@A3#/F+8YF@%&T],)0-+X3A\^[SPW_J
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MA-L8]@3DD@1IAH2*O=?23<S%PB2@_5<"CQ"-W-X__ =X,/<'I9]:%@N?'_"
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MXUW"\?N(65PF$YR;DM:D01'R$9C,MJGWX^H2A!O-:+J)>JE'=8;RT72Q5K8
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M]6^'J^G4K5VEM <4?QZ@:!!MP)=@K<PQ\1V(BP-,O9*,(--$JB:2-(_1!ZX
M60O-AAU<.7"V91,.N^P/[#+4\ONRIA$3T+_-P3NVK8LKQIC\7(^  *&%5@->
M;GEI4>9Y>@0^A\<*/&&.#).F3 Y<]U^(LCM]6?E9.^;ZB7/#V50J%ZO/4/#.
M;*3L9TT:Z^<3S8Y@*BCG';3*760OR_2IBW=[[\5H$T7@_2[.]\NAVE>SOI7:
MUI&J(>P89)^J;$O\</+71WI]/,^BJ"DV+$V8$(R(Y]I$9TS[UIS6*'CW]5@^
M1^QAO^H(_0[E_2</T7VO/G(]6Y[(PP"[6N,O!7\1S[<JUMU5YV][(\?Y4;?Y
MC""A@\EIL;Y,!-L)W.64"$B,GM.JL)PH>NK<F]PM6;(]1'F\A=N>7"-Q$T41
M>&S1/#ZOUW(O>U1/M*+@4WW4V:6E!+:;)L-J!E0/UF?LE]Q;R_UUT:G-F&,R
MP##->&*W.];UX'(/38+&_/IS!P71T4M]D&6B,GX/0=/&U<XTW:90(M'X=%R\
M393MCL2:&,7ZQ;8&*>;:FZ!LO.#25Y!N.Y:W&\S\>3JMT6!(S'0_M)(I<Z]'
M7T35@(G' ^9B/N+&X?\&;?0HZ]UT!E*3\Z4[&]1Q77T4H7H0@)L"9O6:=<%5
M)4^*B9JE-0L\F>L[KA[[Z/.\B< 4.V?%X!HL+2X*JS#VDW*\H0VK5ZS1FA_!
MW*TY=.C[V2 @)GGVC[00V&&09&^6:)L TF]XO7W*F9<,N,OLA-.L23W69\:'
M0EA;,J]3M?_X@#S]WK)-7;^T[<$R&2"!H@&MZ;$%^MR5W!TTAO*]GVJ3%.R$
MQI,X:D9EK @-[8%^S7*>$8E3JR);*P VQN85J,A6NX)_G146W*UW&S4<'C!]
M2;]N-ZF[QR+Z;/>M<PXFJFZ?#@Y+.>QX;I]45!8N/FL<;[0?@Q1WVI-(MTJ1
MS/SM>"OL\43O#,L5FXV#G1OW'[\B5 F/WEJZR7N3BKW_5VG\CUO2004%)D8M
M" N5M'[]^3SC9!WW@LP6S1+-9=8NA79:O#+4#M0XX6Q9PF(V;>9@8=&.]P8
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M:PE2R6P@J],Z$6QXAN6^V!M8P7#)0R73ZJQSS6ZJYF+YT/I>W\][V5)+EYN
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MK.OB25RP*(A'^B2C7=C?WJPI]0BB5*#CNN?DN5<]!):]/K!.8R]_2!<78H+
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M!KW$'*^;I^E@%J-]/-RX^%*BE"!OGST:YC![HF8_>NG;T_R3(J!]J^1W1&<
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M 11X*S,L?85<8J&S;ZW-8^UYC2CS)3]Y+OKULZ^RA)<#)?&GZ@;N%!K,77Q
MO+V48LOJ_S8@;YXAM7>AU<GC@":+G?JPJF9[#?G-MD,QO*K+6A\-?+.TWV:!
MY3B"$PK<JV<;U#\"$C/+6-B<BMZK!PG8R&A[#?3_B'EI$AHE5#[TV\+]5[-P
M_T'M[U]I^_YTSP]"7Y,!#3U5T3^4A=&Q@?<R4%N;UZ$,SE(V;DV*[Y)VG]ZD
M9*967E^S4:A X-WH&$AO&[M_$ 4<R !TV5B.T:WP# 41]69KO@T=T?6_)2@F
M R)&1\F C0S(0S*@T]26)-*(J]YS&I#H&WUG-F*+F;5D6;7%F_%>:92C06"B
MM9,/CTKU\:X5?*2WL!Y>HH# 'R"G/;B2=H(HU"$GIVY]2CYT[#8^CPQXG8\@
MFO!BOEMJGEP!1@'Q.KID0(_AKMV\@L"W8\JH(P*)4U2+#,AUPFJ2 =3:4'PI
M$%5;'W]\ \H$Q;Q+(P.B\F:[FCQU:P[IF ]^$65-$\F ^R/H>-+E)#( ^PC:
MY>#,>_B )$0&H(0ER0!F37CDBY4T^PT.T?4??\OBZ3P'QX$;'XB&I],T.IUF
M/(@>]<<LI<U&D'_+XM]-@F>:NRO).C[[>14,\;<L_MTD5,J5(OE;>=7&;(%_
MS^+?S2+0W(]>VU?U56Y[\-_S^%O0OP7]6]#_703-?U)7;V[0!J,+%NP-*Y,+
M=P! ER?_&([W?ZI$?B^]WX+^+>C?@OYW%K2JX&YF;K^Y8)?MVYU'J :\J7'8
M1K"+WV]A__==U>T!)X5Y&>B1F+8S&-E.35IT]%B)_ZM<?C;O0-/+6M2\WOU;
ME_1+ES]I_QVD-["&# C_:<ON/X=F[:VZ\OS7L?BO-Q(:\=F;QQ6M=[R<\^<^
MGC6,,!BZ.C_4/_B,BZ,7;KYO*>FE\P(RXS0IVS#ZW4H=#+Y\YYP07YS0I$CN
MJY!L^A#Z*7$FLW2??TA.]%,0<I]I#+'=3#)I-$__10R7!A_O05, ;F/_@77L
M_OH0,1K%>W2VZ,0[F0RX*P,W;[]$!B2(0&>T@8=\5H_^KW#TMHP,Z._).7$D
M T;5W:9O5)$!?"R1/S/(@#O,C7^6YE]>1;A=4FF$NQ_?/9/QP>R7X4_Y7346
MH6+2&"OQISYAPQ#W!K%>"D7>#>'/S2/<MSV8 O[(T9R]3@9DE9 !032 I*CX
MW4O0D4=D0'LX[_-H4D#1R:'061T18+TZ&:!B3#IF"LJ5/-J"_1K-IOX-^QOV
M'P1+#5R1R2<#9C1()C-FW/Q8,L!UTVU-@D5C8%X>W5+5:$4&C/@C?M2H71DS
M"&I!D@)[3L&B5!? IZR@3Z%Z /KJ=W#;T*,?K"<X(8(/@O@KFD1@.J/"3#57
M00:LM]G^^I:W.TT&'"Q*$G8,SAT^XG5O/.4)"T4^C?^-_AO]WP'=T;^+I#Z$
MP%.1(N UO,?P8U/>Z,J<Y*X9EV2-+[Y/1,\&'T_7VLSMV")[)@CH$#'#_X8R
M^(W^/P?] ^H'_FB*#-C>1214E':,NN?HQCZJ'RL&-?")*; Q5_VER]D $8:_
MC*+Y%XZRJ3>*_VJ4?V$I1# W^R_#_ M'@*RHL+],PO W^F_T?SSZGPH85>C_
MA<9\=G52O&1CU2$F_'W2/7KY;/K0_TQL_T;_C?[_$?WBR(736),9N)T/.[YT
MJKXQ!9.W-C8XGD\>Q7?=Y.T&V?X7LT:_T7^CJ[$'((@QEKS3X)-SI@M/7+SZ
MY-[4ZTNH0]CKZL.(UQLW_G3;HA)H5!>ZW=T8:C[]0",25N#+_%<5URY :W80
MZ]^!(L!_^FQ6!QB3^FK) -@S8O$__U&ZRG1&G\ S1 I*WL_[I\^R=P;G@3N!
MDD<X_<'X?_JL-%1C(@-^(_Y&_%<@4CY*M\Z>JO_63;TZP$?UV ?=8HO7\$8<
M[4?OEVO_U;F) :43D4_1EGBD?F1(!EP83B,#5 V#38K4 8[0SML%IWOBG6T*
M+R9F$WJPRKIJZ?V;_C?]?PYZ3Y+0Z([8H=*'''B<@ID[NR:?V'GGHHCZVM+@
M'E9]G>A>WGT):S+@,_!0IN(-&3!5-1YR&X%B'S\U!(.2@_'_O!LJ%(4H;I,N
M94J2(+G$8C+@M9/NZ;X20HA,Y(;<!OZF_TW_GY=>(8CU7G53TV2JKOF\IF?_
M!VY**N:RO]HE5)&(Y74S,J"J@72WH?B_S+1^T_^F_W^AK_6)I>]$&HPG*9F/
M";PO"U'%]/C(O*V"]AMKD &5ZT<&Y_^"F/?/:&4/HP!?_@KQ7]#J-TXCV-_T
MO^G_\]+3VW99<H>OO:O5 W'%?^I=XXGQL$3\LWMDX*])4BLA ZSYR8#16+?_
M.K[;;_K?]']-[V5FZ5 )0XMS[HR**7UI;?C5&0-5W 3].8WESQDCS:"J(_8J
MX/8[G\D9<1\R@$]F_<0S+N3&_SJ8:1YA@^A@XKO@<%41K&DT*M&OR2K3WC!B
M8G@N=DZYE[.FV2ON P]\N(.@211H^? T$AT?NI;2]"B^FR6F;^/<NS,;]<;7
MTI7>&)EG.D2I7XQ[S?Q$X\XY'V;CQS/UR(N;<HJ%-<6SFXH.I3^R<,<^$6QI
M\D.MC*52FORCY[=$&3I5%3'(^,,C,/$6FDZT._66SI.D;:U/45O\"0 =EM@W
M=!'&<4U\TR7X+G1:*(EGQ(TAJLTV&^\"2I$\%]!;1)>GD[V4<OGF_!F^H@J
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MZ?K/!1]#R\7YLE0&KM9WJX$>Q].R/@Y[>;JE(%/(2'GP9S+@?/F:O_AAA8^
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MM3'[0P^S%!-",?J7:!?+.GB)&8*)):[TU80^'4VXZ6R6?L-%<-4^AP>:?N1
M ^V;L(\FUVA"N33^"']KD2O\M,,43+,UZ;U'6O0I'YLIIQG''-1;XIK'(4EY
MP*EUS%6!O(5Z4/R$ZJ3 8\"4L.@&3IO8L,OM7=7R(03K1*N7G+IDZ7C:=%WI
M].E^T953T2^G9$8%*4FC@C.;#KTQ'Z:P<Q1'<465CKQ3X%UV?Z!*>][S>QR[
MAIG]6F+='P;^OPO1N$L)$D"1CQ@K\Q6XITBTR!Q2[/=*@3:+&KQX\\%WL][V
MYF>N8\50R^*8,\!UQPJ2+CO@W63L)G./W]^>39E"6;&];VH2"TW:W>MR7%<
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MM.6&.^8WW/&DMO@AF07^PFHF_K@!A%0OQH#3#X)Z7!4/MP'IBNA0HQ<:;D9
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M^*6*?EMTU,]1TG#T<%(.?0ACG.Y$:$G05+?ILRA3"/%AD<A\$5/17&8P..%
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M.I6<,/C*$_I[&Q*.QJ]%Z"^0,(Y7N0FI)6T9F"9]*J7Z<G3F#O,TWD.>K-6
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M<:89#=S;9PKZHRX^2/PI[0YGXKWE.62P1-5A4!HLP'EJ9J"9TS=D:EISJ5$
M_@P).JE+5E)OK!IQVC9=X)^;S2-7*<KCO0\4L8Q K(O\:0K+^:I%/8SBF'>)
M[0D/7ET#D!0>!K28 0O&9KUJ9 $+7YVW%1&6O7.J*V!<T$H9GBNV98V)!S;<
ME=.Y\>)$-8B6E;"TMU+(8 K#3:80>HO:EJ_6PK^;1EDC3>BIE\$&G+YBJKC=
M@_BG&33L/7W9ZR%1T2J;VY<,F6BNP\[@18.[\VZ).DTZ"OC#_ G@=NGXUSS
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M?'W/K\W=Z?,/6HC_2+TH!O6$<UN0A0@)2B%D@3H=_'!^<O2ZNM@-TZ+P:M"
MZ*Q'\>JP!XU;CO,;>5ND0GP#.>YN][(,VZ+P.ODN)BP0HM6>N,P[G+^V17(C
M@C ]4#!'L)S"!R^B@^C0<%/$ZNH6*7-WB,B[A\=)-I,); W==H#PI^5=Y] 4
M1;P.('QJ"(SO"T=-(-]WTU=Y73OTY#'DP95FSYA)YT!(\:3MG[5I.G?$8*PW
MYK?,WQ[ M16B.UZ8E=%N?9F%>>%L-:C?>ZK1SL=M9;"=?FB+W2;9X/P2!_$6
MKA F18ZQ0LOO;PQV1TM);P13J+L4[?D_:]&NFY5((HZQ?%%N(*;Y4T]T\T*-
MY_PF1(;ONB'8X0Z50'1, 8@3K5ZBX =WTA1?4VD.44-D$E(,/A(;[0AMJ?_S
M)GE84ZJ^M[OQXA 7@0^[!41A>9$7:HG'RHO%,?=G7MLQI2/K/Y]^2I^]<*;Z
MHL_(2??'8VHMCW\&1+B968(\CA&>(!K;5XJ>O'G2U1 WU21;[/Z,IP54J05P
M]S'S&@2Q;MFO(SZH+SN\09)&)GO\ +$@M#!X)3[T'T%C,'FYD3];/'3<,C"
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M^I+BH1G>+W7ZX4U3(=";!;[@3^JQ!LUQGV9LYK&T\-(M<PNSB*YQV(/X2S,
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MH5*\=+-85A@_D1SL8Y'\\$A#>^*&86V,^BK92T66_H)2!M8&YN.#U0W6:/C
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MZ>58+HC>)M&?( Z0!F*]#T@\!2.GLO^PNPRR^62SG6(GH)@HPE3/Q(+_G1-
M::P=Y!X$U5T,I@8ZD!."I%I:'8R?X=?7OA=@--F=&^>:"BS&QP+\%QK@4SQ"
M#//,XJO.WFW=6&HVI2@MV[/NJ,6,+.\#WL'MTO13ZG/!2DU 8/.-R#$0)]@!
MC(L-S-E=MLQ@4(C6%&*SDXS6]J,B_S;0D_R8-=S,LI1Z-X\8';BY'M5%WWR7
MIZ+.XHS%E",%69.I+"YRS!JB*FJ/)E("%G<R#FLW H&H /3QICJ=+Q_5=-Y9
ML&U@RN*%V[ ;2;B;MFE;-=$?!?K5_=@%;FI6;AV!K^731B<^"A"LQEVB30CN
M:T9'P5B);P%]G3?3-Z.=*;.'P5 3W>P:N/=4?=/*E>5BA1VP"3\B'TU<"%)#
MJK;_?;B7)*QS)=?1[="2KOC'$TJ_G%U'R?XEW_*>OTWRW3U#3$D_HHQ4>MH?
M#)Y_[55WZLD):K1!J=R]S%0,N';]\YDZE1W-U60FCPDE:8^$#L;HMZ796S:O
MRZ_A4P8Z44_3VL+2U&TW)P+Y_ J#>S4;U@]?TZ%]/#U7T9C7\QF3T/T_E^)3
M3;> H:X(8$-7,HP\)*MYX!C/[L0WD53T64H@MU_7N)0<4:;F&^J^NN_K/8_C
MS3:V6TVAC$-Y]]&&"%PM1..?M+#Q,OW&]*3OT(&XQMJ(M(<D3P=<H34"LK@I
M/-'_%I)C.=N;T?0POXZW#NS^-G%6SZDK^UFL2J.'+'L/,+_)-?+/GD;FPZ<<
M[EM]T$(YZ\X>22>A+*\+G8!VY 1[!AT&ZBC2;; ?2O^ ='%943,T115#&3E.
M8E'. +_+UE-0R2F4!U(G(U]A$X)6<G&NDED2N/F%X6K6_*,17!XXV-3]0T!R
MNRO@.N+<82I\O:$D+HA^S[G'Q \5SH93S9N9R40NG_03&%U-"].)"\1H@WS0
M]96_57GT?#W>M[8TV"ZZMQELLL4'+[YACI16-:U/>M4UY-RQRN$2?2V*4(\]
ME/+:N*8=T,&_)M>JCSUYDI.F*PM5;YDD;X%0H ,P1G=8&+O./W>)7 9&2(V3
M"AZ]N[I )<J/!&G"6'F^?RE/ J/K#TT^8'BPH*3^X-JD.#[VK\&V:!'.6&J?
MK<N!QFZ3(06>))2]*?J9::@!*XEO\]!%])1/V6K59TI%"<$AL9&>BY4CH6-F
MFX,YK>R_]N6M+5SG\V G'?4X*>-"-&W_1=9V=VEOL9VH75= 161?Z23@G#T%
M@)NBB)NUP]?U"B12VY:UO -CC> ]>N+!]&6\"LI3B!M62;SUT+<7DM"]47PC
MTS+/+T6\&4!<E"K?TNQD-$H5^ZG%6L;H/>-W')\O'N';6F_(-)6RYLK+>D?M
M/==X[L[\NRU#4!F[##-"&M5H613J%1C4)(=<>9RH1N[X)5!VUZ08P8^"(?B'
M<C^MOTGA 9/X1FX<ADUI6-E6,]8I<&TT8UY0Y86+['8_N"%#>VQTASD*J^+U
MT1F;JS>N?6;Q6FD9ETJ:KU/J^8N/"] =N@4@/G1_]N<,YY,2@:^3&RH4VOLT
M.SGYONB)5GEL^E(BQ,A\:&&<K)O?;;)6:_M2L_9SKKW;CO.-P@RX@?;0;V-]
MZ<IRUF4!;H!D2H[YJ%S;PU52J+SS&9_)RSG*60)"C0!CJ7%EYQJCJ[!R&]FK
MY.K>1"XOCA<0/]3_#^;>,BK*-MX;':64% %I!@GI3FE1^J&[5<H!AI"&(03I
M!@&E!NE&8NB.H;L$I$N0F"&&D8'A\.SWPWGWWN\ZZSUKG;/.^7!]OM<5_U^L
M^Q]K'\;<LTE+<*$*3FM8)O2_8Q889$@0^X-83L0:M R=P"=%5%I]PD)\P)5(
MK'T5L36&8\O51RR(WVE_?TA)$ 7$9/2)S,L-2Y9'E\&T9E9^J;+YC]D:C?0J
MP$G"IDMIC:19E,E#^=GO.$86"BJXDZVF-;2B,-8FZ.C-<9SN.M\1C'%39!^7
M8U/7LG23\K0@'JW[Z+-?>0^&V0#"3CN,#EC"Z'QS)U?2C WI/[?LYD1^[J6%
M%(*79Y]=Y$GN &GN7;!&:#6$YS:UDQQ-BC**,7V<JIOH(_?^!9)\$,^P6&Y)
M2;;B#]E2WV9PY 5P:;+WFG:6SX5/S/(%3X[R2Q;B)CUM&C_B;T")M>Y)!< 1
MU\=>H3W_2%GUU)U86/+4#0UZ=S,QD8D"[-I[10I_=G;B[!*B=EP(5VS&C6,:
M>TR0S1!*D'%#=%L;.3 9:];4=VO<*X^(.6SDDEN0REA^4]>[:27CIQ86/Y[K
MJV\MA>UWE>];7]Z&RQ'7IF6IO0NV1]8_?=24=:5]THU/>P< EY,EZC8=K6,^
M@N2$/OU#IUSF_JSDQ72XT.C7ZL5?^V.N:)IRE/N>^]E4(EA.=7)B#".-2D)?
M.F!D(/+63RU 72L2%):##N"2VX*A<]-/[WV.G 'E@R>Y(3ZE=P#[R404M,$X
M9!])3.> XAN';2_] NWM3PK](!Q90?&_YB';9 B5-AX#-KG42@PD)EB3R5&"
MZFJUA5_R0ZJ]A]TV7['.L^BMJY1#?^06<?1J+U-L$?0>*QK=GJLFB7ZS/%MN
M RC<ZR0)^VO.HJ/%^BZ]CH:.)H&EE;V ]<&:Y0T((SIG\_3A01#E'>!SA>E\
M"FN#H[P=N4S=7W>.ZY)A-HH5'";8A=0^#BM!)\]YV\9+^0:.XZ4:--Q+@LXH
MENW*>S]"LW:+Z!UT&"Y=5C---U%HX-R:I9M=[J%V'$@F=)O?*7:/4Y_0KAPQ
M]YZFJ\G;4@F,DH<%0J7/SUU_W@K-4@5O& ]\0I9L6B5O*\_B1[5&YF2)N.]'
MM;=8R9PNMTR,W4['+2;=>SNEX)V5$_DC+J>;Y4ZASMLRUX;@I8R^8,(;T;,E
MU>E?]]?DB,,]SI#Q]$>3MKVRWIA46!-FWKUD$@]\8J?755\ZU]BT%?@->%Q_
M!W@<#$]$&]\!2-N?K8DII8ZFFF'G,&)U>)+I5L]3A5ZH3$*_(O)V?5RP4\#&
MQ+ @G,/(UREKV_U6[ ;&&=IU;Z-='HW\K<N]CQ^=QSVX(8\F(H^B$?J]ZX^Q
MSPX6,ZEVJ]N"JQ0R?/R/B 8FE TI9"J=LO$D7PXS/U7X*[\]^!EBBB!"E76@
M*P(W4,C$\%PD[%&Q)Y\+CDJ3<P+59VU:>:ZW08?)N1-"GXOL9I&4)49/]ER#
M>YC"-KO0W/S1?J6\_J<A-0VCPFX./^;TC@=O'A3$W@$4:_*QLA!?[=!@0A9D
MNS]#YMS'45>ZGZ/N*..'.JKLC7*/+@9\%V(Q;I GZ/[T9>WX!N/9Q[9V]Y<>
MVBM=H90A T[VH>K!BAO@S!DMWE *;_'4+.7L-26_"-54']].$2>N+''')>_!
MU7.W&/[XT_$CZF-*SJ05&@_I@:5.[+T5@0.7K']V@5-L,=3+0=/UH\FITBA^
MCR9YGPY_1L@JAL1Q08KL*"?OD"YGMS/GG2O[4:JEY4BMTM/8:.&Q(P6<7YF7
MQP+;#GWC'KI-LQ?K3&@;G:X6=X9GC:T#[74C^_GE%2G]UX0CN@V9*DHOU\@_
M^M?OKD=!$7H": 5(X)8 27!O&\8'I?Q=-G&YJ_&F2V(TJ?BVRT':(VZ;@PE&
M$!J\403>%J#](/7P1D)\O-RZY_T+NOVO-N=L!JM-1WW>$@ZTM)<U^5V@Q)A,
M:$]7V'57U(4YU9R8[8?C8YND9X9^-)P?"]()A=W7J1!71RI(CLW;Q(&**NO!
M*XG%X">PK +&A(K2-S5.Q"D,%%W>NVE+C2?<E*3"PD[Y0G%YNR/N$X;/=5]#
M@UE/UA. 3.T\"((^H4,L>ZYRRF:<MW]@>41SJYNP8J@"P-8N&F#KPPS\UBY_
M!\![/54C5KJQ "$** 8Y8S1WJ_.:A#FQR"@X-($&*]8=M!@MT'^Z8MZ[1C)7
M:%,P^"*GI/)YU,.7.59ZLC2GK*R8B@-KTZ!Y:Q)/@2?8<2S7[(HF+)217C-@
M]:5-M(Y9.T\+I)WLRSOU).FGW ;O*%O23LQSU%HDI3FQ;%UT\J!X@<W(G@Z)
MK1?1-M2Q%U6*ON^;GJS>YEC:$ONXG/T*%4\R*&7>82"/.9O\%-QT>L,/C3'C
M" O>Q,7"L3,B9/\.8??#6@U9:;?L\'O4 WV]QN_C+=3>-_W* *VV1<*R]9J]
M.J/<?L5]8B!=<"QLQ8WOTL9*<P/Z5ZUH_S:\Y@YPD6#F2&XQ[63 H>>: OI]
M_/U:0HD*87UOUZ-R!?YMB>P<SW*EA]1J\=H@L;=KQ9#LWIPM*Q&W)-B1IR_+
ME+!WX^S2\SP:A+[Q,B@[FG&U.57GV4U<N=H&WP'Z7"/I[,,W5]7WM9# *'Z5
M#/>2L6EMJG8[TR7:1W:\ ]0)><TUM&@DTFDKH_O^(N[MNY?3E@8FT,=PUN@.
M8(3$+_&T;085IT4F\;-SC*I>/\-](GZ&[Z%;N)-ZXB"%# -5)4XM\VR2$=X0
MWI:V2Y>#Z*H2!TQ@*]*Q7XT\F%KX\Y(5QR2&;%I>T>/I:5&FN,-]:]J^/,FC
M:-ZNJ7J37U#?4O6RY:32SK=^8%G^$T3>K]KI.H[.*-4^:[^UV9D[;H-,3XT9
M\)(MY&5- N3^6/$4IT1O]50ATAL!QX[#:@\/KV^=8[>;7S%D,RTQ7W^::3E%
M<RW&"^S.MU-O_"P4 AW3'WKP;SQ3TZ IX+B=8KL#=$X6!7Y"6&^<1LH1H5_T
MO9ER?AZ^0(FQ_/UJWW(TKG[HUIPMFS3$31#/L8!F0%W]2O!CCEKSJR76L4X\
M["\K//1LI?EO/26/S<0GOQA_F!X25U'U>:ON,CR[ ]B%ID[9=_!L&P^2$=W@
M(_(6(9HR*^RIP[!ZF,+YK^&X8R4V4L"P/3.911+9H/7_KM@:DV^,7)'C")H
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M4T_C\EPN(Y+Z<W]*ZQW 'ITR>&1<]B-M5"6]-S=O/UG?;%7#1CBU_<5'FV'
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MO$NRL"[\)"?O28?J/SX$.BV-2>\V%+^_CX^T)Y0@GZ-FOJC)A%#< ;A$V^\
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MT+.]R]OC=29%+<-?=OQ =&PITBD>2>.ADLL>UE5,=&!E;5*09B5W<>5",OU
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MVE+PQ]P9SE/*>YD8'HBF/,(3=S3>2&82Y3Q$;(NY)'"]I_)>8JX0=1JAO&Y
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ME0A)CO9]P#2X>GTJS/7<=)D9SRT2ERAK,GO&YYCY._?%B<"U26H%A*&CZOQ
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MF6JL0,T&:JL4E".!S PBPA,$);@O#@3'&N9>R+QBG*H+QSU^*PU*LB=+$OY
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M=\OC3*IU>G32MLYK0)5FJYG)ENO\M)F*R:.(+2-Z&4]C<EVQ'S3%$,\$1_0
MZH/'=+5*)"PF:EWX *']:^5%WE")Z9!A4\*N&:TN0RZ4VH>VM(W *!R:37=
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M0) A/#C\!K9V;:C(XG$^*QB.1;A'9MU5^.'$N,L6 1A6?B,^":SW_@<$Q4$
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M6'3Y"MDC*W.7J A 7&L\[$KKB@%E^+]A%^ _[4UTAXLZ0<XO;):9S8L\1!
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MW>S_C&;GR;O#GR3P7;F .^M?_MD M1_"MRYD=>5O%GO8#\@U384C?T\#-"*
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MSLZ7>C4G_P%B_Z<M+J%^EW.M'0+-B:Z3@:=+9-Z<'M/[;VX!+)[7KR'SH[>
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MTV*_5_:&U!0-*/ZAYU_C'P<"5%__'ZOE-NR ND.65QG?Z,^F53":DU<L%K<
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MZ &X%ZOHX@8A:R3)LW3WFBR%\N.GT8UVNE-]%4DE<L!_&EW*8%?@*(,]FF?
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M>UJ56160@.\<J JVU-J"H[W=3-T0242Q<_B=R7(,5#&7?[G.VAH@UUZR+#E
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M+E14A$^D!YQ_[YV)UP)$"#0%ZXHY*SQY2.-K3<%";',W$/8CR"S]JL2O5>X
M0;A@_0A]))A9%.6BH]GQ5+S2EE!N[1#*8=^-3]XC?[;/IYRD7>^I$__-<>R
MB;R/:15K9OJ!B/7\R<Q.*F90>MM+/SE^NU:V+'7C+:\PV<Q<.^=RY/->*?P,
M?0)577B7Q;,DO+V/FY0LEY.*)NH&@C3&C7UD ;Q^;QE<WUR%_1C6R#95_YQ?
M6%[?7%;_Q62 C6G.CR=QC< ".'!2\KF_WT :\5:+)^E>FK3;1MI?X:%%N>LN
M/KMY'12-D1N]_-ZK/>.R=V4YK?/I<IO(XA1MCUE["PN-A3UR<AMCZ^C\^6=
M'IICET\[R<E6YP=MT8, #FH:8KXHY$V!XOM/48K?S!)TXJN7HN][D>SNZP?
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M8J?_YRMP6E;Z0VF.TX:5;ZE7P1T@<EUX&_/0(%QQWND]WC-/FO96]KRU6"4
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M57"(?7;]M=1Q%XUHNWY_F*!T029>@3!MD\W4J0$G#/=FRKA:2+5_533(&9+
M_F5"J^J[DEVS=N3HZ<L6]%I;[$)\PA?C6,EN8)KK:>]O61-<JJ^2H^I&6B,0
MF$5W*0U8:++Q'F()(/FSKPA5^"EV8!AY7^F/U-?Y1Z]KC?^L(9H3XC?9Q_BA
M&OS>;J6EQ1E]]OTGA<:3$\L$OF2AF5N'^?)%_>USS#J3?@RKXK< O,N#X8[S
MDLD#>J(CB*\0>?3./";AU*+]&O)L#B4R"7:G#UY%2EP^[CUJ_:Z]ZC1;.7QY
M4FGOLB2\4NVB;C) .SAA(.->/B'YJ"9(.(E9Y1WT;/ESGC5\P@ML'])O+_U(
M6@UJ'F&C:2#QI/;S<2&@WW>;]B[-V["SNPLQ9'3O#(*7P.D!OQ.X''R]"?]>
MGO3,S@X5&8KY\P:]'4M@L"/P[(90[>[M$W?/,D#+I8;Q7=<VK\9M;4W*_9^J
MO-__M)=)'4)K,P*QHJ>VAA!B'J#F.JF81V;.4AZSKWB+^E/)K<N75W+8.:HO
M1WY]JJ::F;=7S?[TDY9WVD%N@51N=ULJ;EALF'JT,D(_\Y^#AQI"J:[ 8Q6Q
M% @3U]PO.:-]KU"5[AWT24B.27YPYA.@CVD9P#%9U<3#?_U%-6\<\%XV$QNZ
M>0-D7UKX15T\FPXSJ">VN@)[V7*2?AS,K@&OD?PA4K9V7;\19*6RF*'V;Q/#
MD((6.;\5#G8XZH-_GO1U.=745.P($2B\@=:Q0UUJ!")$[ LW$KN&K?%Z7;NZ
MNAL\Z0\FAFHLU9>=XN;1-KFCI[!QXV&]P1CU^G+L^SB24?DYVU0BVZ,9KYGB
M[)EDGT7S0"' X3KZ<+A[)_[:T6 SUG35PE-. >T2 =B$T8GB5/K/R^B>XVH:
M9%0]9,[P(%O)P9D:F]'!2R]M87)"T\DS3K!SF"\ DN LDOZ+J_Q+#'L^WOIG
M^"/.6,"P<EG.3G)6<OQA56]9ZF=>9V&RNE];A;;I7WXQ<Y&-<_2[WP*(^F%0
MC4<G"LXT:3+]U?2_[A"-D0I_2B(BOI"-P7^DYH][\9L<!8]D.<()E5BG9,^[
MP%)*<J3<0X%YM9O./VY[>ATA .8K:(X2^O':R;D?R],/\/K-E@]'.MM4>DY$
M@=.?0]B0Z5+Y-T%8?9F9T2.6*$C^/DC"=YJ.9.(&)]-#;=4\QHYQ=XGPC,?=
MW0'W04G5CW+:-7VZ!J6].#^R2(XM-(Z4ID;==Z;R^B>,9L.$7IB,8AL;+_&D
MD"\V: [5&H5BD:M%!;T43XF]&)$$5XE.8B#56-&$5J7_ZW"'=&E@1YKA2"<=
MX3A,4<*UOJQ9N6INA+*_C_JFMV,F@&C5@!/<=$VXJT7W9+S1YDA9N]8*%A7L
M53BG,\!V>5"5'QH[!H+$)S X9AJ5YME$S_\?.Q",=3)]?EZ5LMRS+W44N,KY
MFZ(([K$'PV5<KDE@&<3=3@K0 OW6BKS+P97$]+R1].=^(B]C2).F)(A&&9,1
M/P<>W8Q5]+'M1U2\Y06B0=9WO_O@2Q45LE1Q&+(6B@_R\%F=*CXBNJGH3<I%
M\WH23>!=JF%P%XYR-E=]DY!QG;Y,;DTIFF- !&78%<+9Y97,X'94?;[#>/E/
M?$BU17=*!A14Z=X*(MAV]BG514;%N+L0V"OPC[+6S'BN\1\##9%786<C<S6=
MY$N 6X!)"]$-_QB3>O.D,>R/41ACL,=S*;Y:6EF[@EQ,_?5TWRV@3-D/MA0"
M@A$%\3?9;20IH7S(AD:K?SA79S,[ET,CB>#F"R-B]$KB#N?AX\_1Y4"'"&I$
M%)R;\:@GF--PZLJ;1<,C+%/!Z06Y)N" 1ZH_7=WI+>4M %;3IC RFXLHW;L%
MK&80L<05>D@9E3<G/ /,)PI)AF"VX^<#,P[]04J^\$7V"N3('N,*Z*G5R(:V
M=;UOFC>6!8JIOL88=6+X!NF.P359)L*_X49*5R(,++J2%I^/GUZ6[.V7ENRG
MLQD*<)8G<$Y&OF4P#F;2^HXB6IGSV,7@1B%9VJ=C"W?H2&JKJB53RZL2CRE?
ML&PM6J.??,+Y 9:X!80+(5IFYU;0M6Q4-NY35'>P?I18'YHO'AJF<VT197W.
M#7?>EA#Q'<MX5O*G>"KTZ*0U*::-_Z.\YP:=MXG;=2C.&+>U64]'-3+IAA@B
MVRPK-E",KY*A%8S%8M24R$;TARE26;E![IK2@VYE]5P4_>O&#$QU<*@S7K*7
M:!/8M&!4%2OSN7-M/>=FO E@A^D 'AO? NZ.D=WT_%M SF2IXAWPE+\%]#6A
MXC#=5BVGB?#&@?,[N\81H0YO ?IGRFC!8H^1O;AK+T@'YXWX1"/W+>"1T W3
MDNW$DLJUUGG+K*!]&.NY[3'3R%71)K!K/ QPL83BF XZ1?R\$4<"OI%H/=,B
M?VD<?4C8Y9A;CC?+*"Y$XRIP 6I?D%_519D@:-_MW\P5-M$->Z;> DBJ6 <A
MO#8G+)VZ&5U$*+;@SB7\=^E/4]HSB*KJB'YX9*\%+ JQFKLX]A:^ZE+'EE*9
M,#5QT=HI2<EMR]H^KQ;,7]?3^U#6&8A2>8L'9&#%6E5&<3R[2?$-O]N@G"V8
MN/GI0+#HW1?G+J#P$5%!C;3&1_VB<POT"C5CB*8X768SCTSMCN]2S9X<:;^N
M5\5W%R'+1:!CNRMN-+3Z%G"E[ )ZCQF$'-L#\6\!>SKC+:?)(H!+? QNYI%)
MMZ $.[*F"T2ZS6<I"%]O:#.S$WN(Y6P6K\B4%W'RRL3Z&Y-QC:,2_,AA1F99
MXV(?JQC\X6A].EP@XS&*4W/1P'#N?<R+E$]Q7]H?P:4U[STT^YSU1$FX%]NW
M90ASMU0+ I=#_S0.X<<+,=<ST#O_C&YVI0\4,6_(LY8@;-;YI+O0BY<ZBRY@
MDX>R1IM8F6$QI#]T% >=%Z!3/Z-BD+ZT%BLMW7/<!#><'H^J_NA>B4MH9VE0
M:'=F_XX)G1]B>U#/JF_BD+8(Z3>R:PZ\!7S,J26B]RB86T[:GULE(@8['6E<
M1/!3;]8:4)I516Z+Q6[9F?HS<]#X/_$T-;4S-[D(9B"_,_@M@ Q^PX.N943Y
M'.UV3R^RH$SRJ4-,3M9>LI5;CMO/P;2\>E/ G1KS]_8<G8%61!16$OSHLD8]
MQ$@4W0NDV[=E/9S7VYKU%&HT^%]YY%42@GKTR\UD/LM' E9N 1TME-94+3>D
MX6V+KY'T0?9@7(O2V"]-0I^@[U_ 4]CL."L:[5Z-^D-=&2DI6*9O 589<+R1
MCI9GW*?*D9![=F>@X#(9)BJ'$$X[J87Y.B,3CQ+][CP*K'H!,S,F9Z?>![>
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M"[VS R,X SWT2^Y"RK+/GC<K'^>YF,PY1"]+/!)43!3GXL^SJVI(\N\%--X
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M]#4-:^UU,<:%2*",OZ]@A46)+EQ?VQ\?@#.&8YD[?3F ONTW!F;]]K$=%S>
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M:A/U9\U1) QUX2"+NJ\Y^!7]!'._KNDZH9:85>>#DON&(R_O$Q^&[Y('(3!
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MDS:3J_2&;\I*MSPTE('7GBH%3NZ[8^&7M@GDD.%W3,[@H?Z#' <?K0X5?7M
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M"*,/A%=A.&X \HH?;P!A^%!4">^[_Z&W?OPFR<7]]080'K\&NJ(3ML30R-\
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M5T]K&0RII-C710-D5-LA"%4,]^K1<<Q=1@.@'U0MU>&J[37/F)\J8QTUGEY
M1CBVC;WTKFY\,I]K(,Q."L0A\D>%U[W>?NN7VC,Q^*VT>#E_3IXK4:$7MZIT
M>UQG,[-GT/&Z:@[F#^P"UEEE,]Z&<W384N%$T'15.ZPN>F#(2N?-*VTT8$P3
MQHTB&P?!M4_*OM9ZQK_/,4ZHD$H$96A.\\M,O.[]<[YXZ9L"#BD*6$G_1:X&
M;'1?J8 ;2"Z&SYP6^*P\\"J<:D00E#YY7X(!67R8IZT:(7'[APHA&!;;K^4?
M8'?NZ^L;XWFDNO XS7%EM'T5N_)2U]S6\DZT):-RI(K\@!B*OW:5P&Y4QYI*
MT7'7?&,4(0FQ@URR!]S$*/I6%<5>O$-_#UGDCM 'KU0$W0[$BT.1GA.ZNK3/
MHUQ,E>VHW[U]P\%9_"V__CJ0[#O8U&Z-O-QC:&ML32<I[/NWIT]Y?(G+E-F-
M%D[JV=W6QQR]^=NBKK2-)7ZT,7MS70"28'OA5*<7)>8H$FYH!2H2' 2"97Y
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MFA$4<RVQ1 1<*-.&L>UK[5 %L'N3?XP.%A-G)4:)FQR6V90X?O&^D<>>ZWK
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M.Z!C,PA<NY5%/*S,?4:!+'57%IA1G6@3Z'C]VOYNAY.]_<JP@5!VC"PYZ7T
MN20 < M O@/!10.L(%#5]E3NN!4X1<]M()D==6\X:T8N$M)-'3HGX/5D]W-_
M,ED#/N2FE'#[ED)%76$6<2;0#/@S31WYJ8UBAUJ@R<<<5+%C$+5@K/JE_Q @
M69R0D_*"#4M!6'THLVX -<]0=?@>:.L;AV>W0#)Y\I7-9.QEE=*3(KXJILX>
M?<]:EZ:Y\@):XE:?E;::G$ )/L34%>/U<T0'?':9N_MVC&97/%LXYTGW],J5
MUHJ"=?#ZE_39.";" I?9UB+Q]F*&^H:]!RNJT.<KY5$K$,*=U"=I!'IRYD6L
M!7QC_;/,5KIQ%BKXT#6WN&:._>)'V)C9G34_XX6S[>/G7XM7PI3/HO)G$5;X
M^YGB!K9FIES)Y-&,D6Q;#X5'1,W:ZL?W3?I>UC:XYB^',IE]Y;F''5GW^[S;
M_^'S;O^%UKX</4"[_><KTM[$JN-ME-!Y.GL=B))AC/24Z[0.@B5O_II*5/8@
MR[%/B*D_KQF9!;%L8JDC6;SV@*VOO>CPB,B\'%F+6\4>CN]+AR?C8(5%)W+H
M=7UV-&=/+Q\69;#0[0,V4.PSE2 \SU40IDNW6][!/;_ _<M751*2-^9$B5GQ
M?LIS,+\+]@UENKJ@>>O5HTJ!&@95S[6Q(=*\/$J\9S2:/^P)"#IM\&GT0YI"
M^Y>U=002PKP'&-ZVV2 3VQ[X\<$.8^O $:;D8B:J46N9LM7UR9T;2Z6QO"Q#
M?"X\!Z*1A:.#@K3^<_8J&15<>VY3)<,V;/8H/"06@FR)SGYYM,N!]R6<[3T_
M]UU$I-19C/25QM?DK8A/A'TT\MWOC&Y2M@MQ15=5Q /M*^[[2<^@ 7;#-.T!
M!/#DBN7IKS6U];$TQBHKTS]>[NU9N%!443&2!>UKHH: #2SSAQ$>LZ H$_Y%
MVZ=AX@] U8'?0G\\':ZEVFXXA%_.R%U)!?0!R5 LUYZ3K;[+IG=MFA\^#=0;
M/#\7.'>F7-9B<W?.*' VPS/O*" ?$!QYF5>LH0B^ODM\$S4$KHV-6KU#K#:%
M>N+?HEC7%NS;8HI0\'@LMJ4C8ZU<1J(S&/S46WBC&3+K=)8WC;JKG(?@[F#1
M[3$H#?!KD'[ F3S&>R_&7!J/1_36VB;66\L@>OP*/T7$^14-XE@NI->$Y4//
M6^7S0[^TDLVVL .65\Q:/I+)@E240G1RA#R/T0"&.@Y]B",:<&N7(CM%OJ5Q
MS.F!3QA6:+2WH^\M7.!SW2$?-B[UM-1HVM?N!PU/O+LZ077$[=R$<O#;&O"I
MZ7S[V[+GJ;YVU8O^'X6Q[W:Q7_BZ2H,YZWG3ERS\,ZX$_=Z$K"YV?@5V=U+N
M\Y-[UDYRF3&7ZN+'S+J-3&,"[O1;V&Q4!0$3#0+)D)K%;K:O[(PB_)UWYN?C
MBXG+5QK/*S+1@*44F KDSK4Y+T>4]52NEOFY$I[LDCA,%ZBN#PQ(^V"0ZUV@
M6!S\EL_?9565:@L-(/;C!:TPD)CXA\A529Y32&@.5"G=Q+6[T9<H@FU*>LV&
MA+ T(@8JNE;!=Z&S?D#3.I#5Z/V4!U[=65()U%3"<6SQXA<5#6*V2_,,*Q1A
M3M?B*[>!#5OG_7=79H>]SPM?M3M*4[KB2G,<*YW9(SB61AE0DPM\L+"ON?Z0
MKF;06=S/-Z@IO@#3)-<BAI%8VF4%V@^9%SFI(=%-P:W%CWNDP-D+;(C%I8I;
MU\ )/X=2>U-S6&]>95W9^4]KT%/%M-4+\MO1%6*%?7XZ1L#:OBZ.F.==GJ3>
M]=.&: "IC^G/^H0>#F6VM#C.9IQYDC?1/D%O9R(Q'EF2CX:8 #7T5B4JO^/,
M6%!U\DV90];"Z'IW0G]QRZ=$9P 5<^H@$O-+2R"V,FRQ$TQRZONXSI1L3AF9
M[2 Z-T3KZ4!;2O*0";#H3 ;Q5*U3C/81_NR8KVK;GRB1#S_O/B2XYAI/48>;
MM%AG0X5G:8PEZ#5$WDDEN_*.294;+J,!^^*PEI7D0K[1.XC>P6-U\WI1I7?)
MT_HJO.^G+:4W <BYDXI1TQ@3]DF)1ZAIU(,H/5A]V>JN,OO9JDH=;"'!A=F5
MC^2^&GENS(\G4I[0IK4CD2F&]V@ D8<JR1.P8##0VI36#SCI8+DP0ZI0:,H<
MZ$KTDY&P' ^'I_&P8RE&F]S2TPS.T[)NP*UYRM0+(?'CAVTJHL;A$DWFV3_O
M:EM\_:SY[15O'=;Z+-U',A.OY<59LJ7-R+KW)RW$M#^1U7(_@@_P]\VMM@")
M>E/"^Z/\JQ":.NYPD<T.8"@&)>AIM*KA?#H#+L@T6S*Y0B-@\GT+#\9[&AWZ
MU9KQ /XCU3[BNWXX<-RP?;DN!@)$2A?U"6_(@TE:!0<Q9KJ.!J/!P?:EX"RB
MK+.'KQ64?),T21^)<UV"\X"U#7WBW$MQ725731Y:$ZW/_>V=FQ\.V#/O\@^R
M:M$5:Q$F7:T18188-0BJ7X^+X51)@C-UQ\NLS"*U.4^&#/T%U*ISWVG1Y$9G
ML<J^3F8Z*B;S5E5 U%T!MDT>P(U+[*"CX2<T/]UG"S)?/&VU7)5]0(G;V1VR
M@>-R6JZ*PM^%"7;0B\,R-J,\YLGV%QC'ZJ8$!,'VF4#F/EH-MOY8\LI-X%.)
M\$B[IVI>6VPBB27TQJD2'?#-OHH;?L_@$DG+AV3VN2^G3B6_C,Q!51GC>?=,
M,TB3 APES(#LF]S -\0AR1+,(O<6Q":FD19'49RN=8U.OH&9:O17<%-F4(=B
MZ4@^/*U#(*B>)H;+C-#7L=$%/-T\"HTZXT5XP"!G/I/\A\0_C6=W+Y\V<!<J
M^3"'';L7T5R\5Y#*N+@@=Y;<[U!,YZ+Y.IADEY+"KA-Q*MC-#15<KNB<:8CK
M;GM2596ZPI_ZZ &Q&X?L7,E>A'YPYC=98KM%A"_\>2>8O-:\&*%J5#>]EQ3<
M__TN/:M8J/LK*B+1I[?:6)!1((M%K&L#A*;'"ICJIVJ9B;'Q@/V;X ,;':C0
ME!;I>O7!F\U#"\ ]\S*S@)[ZFFL>9*78ZZ4AT2*VB8=*5Q0+H.G;/B#//1%'
M&E7DB:V(2XW"3C!_@7<3%[/_*)QIU3JHC:2+,),;SI(9/7%G3.J!+5L"J+6*
MT9HIVH+0JMA/ )DE0>]G_'D)!HXLK3.LNQGSF?AF[]C4.XWB)O6$8ZQ8^V-L
M*3C+9@^&%R\PP;DC).AWP>2;&9E6XWQI1<M'%-Y:<]^[#]=SE@$TOF[0NFOU
M)1"%U.H=BFX0D<1-Q.;R_$;ZBBF7QB62,%)*5P/&4>'<7G,#;\DM[8S#ZI3W
M<C*MV<#O$"6WK1LG(>Y-MIP2<0(F]DXSIK:J*@X5\-P8]WD1!#:[WHHN.78Y
M)KW0%2Q"_3#%Y8LCH;N_V>?)X*A[-/3\WG@[S8+[<\KSB\9#4P8,/LGD@(T0
M!;!+X0][#8*IG(H[@R#/0UX+TIE@D.+):)QI%7&7*19J]'*A)%??N&M%_&ZW
M$<8YBZ^5SKS\M+@AJQ!]BVI9V]EEU*BSX+9<6E%NB?J@XF-]!C4_643'LFG8
M C8]^]1IH4.M;V"1K3^ADQMM^9:!>)M&O52OV\1"FQPR%>24[>]3'A>%8JVO
M#-5@V%NLV7:EVU.Z^'QD[AAB;>11LE@U\\X=',-0;56%@3,J:%M=WK;(<)>^
MX=?N*A^95PH4A-$%6/ENT:L;VR8*5]C7Q##5WABE7G7$D SJA[((AVX=@UTF
M,6>+4B-J>T88^M5MO/SI.W.6)V&N11H:(>&FNYHG^WKRV1_7]2QTB>%*JU[!
M;;<-MX\10P:HWDCD/%?:7LWHUX\WNL[E?[2_GJ&S;]0F+=2FU*8DARU>DS.@
M9!8!H)GY1500G=M$Y,=$:V/;9F=7N>\+CY#E;20(4:TXE2DQ)VNZ5<!+3YBR
MR_IFS:>$8'H?0BFZGK=>X7X*^=XM,G53)\K2L]H33U+<!3T3\9E<TFE)MZ1P
M/!DC+VYW02K!7?85/U>@J)WQ'1"YT5:N.NJGX8!ZHE7X, '3:$KE78HD-KKC
M83<T /:2@<1(( 1._+*E&0V(D$F#SG.Z"1ZL6.N_BQD%D%);(Z'C:G$<+KY4
MLJ47DU;)!>,F3Y%E$J3>9!H?5*>N75XU)%0I/*R.->RB(5S7:X^]%^U*_+ %
M&(X&W/-C@^LJ^,MUOCW]TF 7_B9L'N4=L46'1_AN-:;="@+DS_ ]DX;5MY1(
ML86WJJ_R\D]61[5048MZ\W1?.,=)T.9L I+>!$U.R^W)5>C;@NNJH=Z*OHA6
M[J(^'T+GG0<XAXY,MDSZTHDM20D^N U-Y(Z)ZPY&PV8L(SE[AS].&>[ZD<)N
MI91XAR^3HP&]Q@:S/6TL\#OU)>0EMKI$V9^>R<^%K/=_8\;I-_9YP>S76%'8
MR@4_7CZ=B65"V-NNV#I>&YLW#^\=[#^YJ^NMEL(J%\TD<*_^N=ND59LD H(&
M/&:&S2!!VZ!++O;S_?GEJ,5W0)I6&GB(]/O'J3:A?9:":J_*#]XJD,S&R8^6
M"=+;LYZ_*+KB?RQCD]$F-R<A!C\+@?5UG@<\A MD-9O$V*@INXZUIBD]E<%2
M5[JK'[A$G;U<$95) K<.[(MQ1[IB+1L)HR9;Y6K?XYA%JZ872Q+B#5 .^]E>
M.?FI :GYN<- 1*T,SD]69U"CQ0)=YZE^+)5.+SE$2?RE]HTJ]G==@$%IRWV=
M#APC:, [:Z7QUXU7G'?"6E)\N_&7KG_$O-_]%M/SPM9DX&#8^KV+J[WE!=AD
M&U*OVQ&C:T!M1"]>I93H&=X8YLV(!D!&*>-^96A:AMD</% P\TA^?(]'A+;D
M!@^>>$^ #N)#NTYSP;O-"?>*GZ9]!D\JS6:):KE/\=?T<66]4V>&7JEJ8[GR
M!G^UWX7\(&*@WC;%XW8'4MF*U"="+:_D"OI*#89PP-86.M <27S)GJK86R[0
MC]N%)5GY!AHIG"F;E^"7,_';:$!=0Z>XQHQ^8U1O<E57;A)%C)N#& W5YX_L
M%PD5G[I+_(H:X2;-B^Y(CJ.:,V4$V?)A+)A63,EVQ<O'O8S+JL4>[\LS\0FJ
M^D!]YXY;"J+RPK.C_'RK5*SKWYOK6*ADGQF"LS!<!6(;%V9*?OK\B[=ISW3*
M91P,JDQ;/S[0J]+SF:0-E\W1Q43PRCI@NOKZ@9(R=L?;J583WK = 4A-8Y7/
M#4.QEX,=GSWO*JA$JP(-8.!9WS.,$]Q#+=R%ZP:VC66)S<B2637P*&KHM2>P
MQLQ'!>-M)DH</!MQ!SK$W=EJ8T2PP Y7\E+-GJ\"[[+$G87NN2GJR-@_O'IA
M6?\(AT@ZI,\ ^C1T8FOD;9*=ZR"W;%PQT H-@%IW8J#N1)Q!(<[$6*Z/=%O!
MIQ@J9\G'01,3]9A035;2"YN@KX+\NY\T\@N*XIIKBN8EG#N:<\_C'AJ@;TOH
M.J]$X2?26:ZVFBX@$KD"LC -:L.'.75!"+QG9,<">E;\#:5"G9S:9D0OVLQR
M(?TCZJZ#!>OJ$Y$7M_J6E!<[%R--'H)7T(#.PWM^S\?*J?5?3UY+6'EG0*7]
M-FP^N^JYU67(#PRFPPE(/G[.+=)X&AMY.(DD0+C ^]I!%#@AG29L5=.L,7Y]
M];(V!^3>%]$JY)UK0>GF;.1S,P-H0!5RL]VGU;QB%#;"I20#OS-5G'=)7VLX
MW!!*>7 41<'&J>M\3'-0@0V9)H\>CZH6L1T8% 0%JLN0WPKZ?Y'N@SL*KDLJ
M.P\"+A,AQK(EQW<6L"#'3CG1?C,B6HC8 QY<HQN4UJ%=U)=,73.DB/';#CJ=
M+YHG#G5$\QM#PZ8CI9KTW29)7#E$#<;VKF5R%[<-HF][%"Q*L=1U$_%4R^YH
M?[PBD:]XB@RMNXHC1GCU@'!/B_R&0<L'66^R4R5Q4@R,FA('S7>/[JL(8:EY
ME1M4GSD,< TO-9WX$W\I+1WOG7\=7:4]<MMC;2-GLNY1[9:"YPU9G6=%.,&2
MVWW+RI.G>B=;2G[5\GCT)C!B_B%0GKU@(!D'D\+!RM.^:Y3VD$I:VF9F[SB8
MNX6NMWIN-V5<1+:,XTZ/UM*K5UY Q=U:I(BXP/U85BL=ASX?'#2 75E0.4XE
M2.VF#X!QD.2&JQLJX./N+F+OE9=9_J2%K-X-FR+U2;_X'TSTIF\-XUI:PWJ?
M,1]6X4.)\#=AE[IT+BXNY0MR5W6\#E!R(5J+<Z"!X=!0C,'R(&=I^ 9)$2<%
M-E7?Q:ZQ0$INWY=>MWI;P;O,C[!HS1DVI^L47J]ZP7GXB_?J[S H& O0_702
MD#'>Z28AKI>H<UU9$=4ST#>TL)]<RD3DK&R(V@R)%L/D"=NMFNX\UP+K?.*T
M?\CQ1"S)K'TU??7ZI/0UODX*+]_')'Z+)T6%"J7&S(K%@^4Z7%G!F!!D[8I@
M]ON):67Q*.MZ([OV!\;"S=DMT;$<FR);RF2U:M%09WH)<W%0Q;9!M6)\^3:=
M^EO+V)O&BJF^0F]>,IWE-U;+5_8>"7<^XE2M+%<RGI98Z*4\JVNNM'R%QQ8'
M*MJ7+2M3*I1_^$Y,\FZH^L Q;Y\4RJ?DDBBL.'AE^?FAAMAGIJO6T\WM[85B
M$BU=L?-[OY)X8K^?W&^PS%SB<\NE*Z8DD05>;C0453SLS<\(+MS16]+E+=L=
M9:HEN1]GC@:4Q:JV/MO79Q$YXI[_$F(\H[.M_+5)_U>+KJ)?S?\"@E.>?S>0
M9FN\0TECPE4JX7B-^F@C0I40VM.YQ$%^9!%WZ#(#KBBPVY;]D=O>^3 N"Z!3
MQ\YN_W/BX3/77YW742WEQ1R&LTFN':LIKND5CD #93?CV38H]@ @(O=#00/#
MJM:) [W21?1QLK:.+G+E+O/ P!H2:/!'6L^S04?59"9W?_P*-,#GJ46#)8LQ
MI<6O! 1CUY@L OE5>35FF\*0G,+V4G][(T.+9\\C"-_+?:8%.Z/(T_/9CZH?
MLR@33_-/52+G6$R6]6[):0;BC8"27MM<BNYHE/#\D5GP"D]H%-09 WR9II>1
MJIL@9;S@]MCA!Z,Y<#/?DZ2+KCDIDC_&+?UA((>M@GH<IQ>OPJ27[\U6#@<<
ME\<LZM+1IRN%N]2=MF,\)8^;VBUE-:2H^A#C=LWCMCL"H9\'V+5-;]JGU=0U
M3C^)ES_B22_Z'/2J$6?U^G+:?7MQ,;-G\%>F3[VGFSU%'./+['B^?'F:YW_D
M]E]Q\%4VZ)ES:KL%S_L(Y]74Q Z2O] FO'?+4NWV*P]^HH+BO@)IP_5$2<FC
M\T"??.'FBF11'+.L\CX[@X\&[LPM6$P<E)/!4HSNJ[!RA>1-H[:$<7Y;/4?V
M FQL[*9+3<@X?UH[?E)"WKD+I3D*Q+YS,B\@+G)3DGP-$/)($G]@].)2I_GU
MS/G[Z9(C"M4)\PDSFQ6K5\.-A_^#O?>,:JH+NT6CB'1!%.F@%$&J=! D B]=
M!.F]2"?2E!)J$ 2DAB(@-2*]B_3>>^^=0$*O"340"!?/.?=\]<<9]WSCEC'N
MC_S9(SO)7L^><SYS9ZZU;L5<)>[@B)ZF,[ZYD\-.G /6L?VVN26ZF\"#RT3A
M'^N YW7<_PE _\[S;;;_:/^"D_O9WV#"0N\-P"/7L4$V#R\R8W/71!J:79KZ
M9*\FE:7T] ,AP0*SH7 3TVM1H?0*Y=K89V\(D30W@+^H_5<X35=)6UX3??QL
MX%#5I;8V>OI)HNX<W:DX1S-W[)0(D4A$=IB.@4Y_5R6%$=N=-)B%<KY#_,X$
M?I25O'5/7+$^P^<T2$9"W7^"406NP(W$-=$=2=X@N3'_]B*IU,25 MVW@5DP
M9W/)Z<HX'H'&:)=PDD=[+]@2GIF,O_IU,L! O';JZ& B*_/X&0+PG2M:/3GC
M%?GQD"5-?V7I$+WV5 RHOF=AMH-IND:7M/C./?3AZ>LBQ5M0+27Z!(P-1WKD
MF\O<7M]NBE-09N'/VEH-["3TN1+N\+77I;=GR6:LI>9PF[8[CPNW2L)CO8HO
M E%PX5 ]_M+=(K?<Y<7BO]MT:@<22O0 911JRJ2B1]\8OH;BJB6D43U5?$&9
MR33&QGQWR\UN/_"<T>ORTB./V"%E\T<.A]@ Q2U)Q(0=X"G<GXD D:>V '/<
M3L:J.5$OOV5M :B^E((:/!?>>#U]*/S)[0QY!>+W;HPXM^\T\331UJVIX5H/
MZN%;ES!=]*^24QQ-N0&<Q]]7]=#4&0M1)J#!N>W3*\;A+*76$W02;@#@KV&"
MG[R ZM/UM?^"V!)K$?E/<I]8J=\?*^G0OZ&*+P8566!K59K:?Y-&YP$>_DU3
MV525\OZAR>P,^8=U,%J]%D+<-7'25Q4VE^/UF&II4S!Q*?"^$,Y;>R*[9.1U
MZ(OK'P=TTM&7WPL'BWG_Z*3KWWT@!$>5MB]350>*?X_+SU3P1O_SLL<IYT.4
MI?$FX4_BS,)=Y;S\^2>V; 4ZOE3Y:>N&NO(*7"D-U/K3C]Z%)1BH#>-Q"<81
M#@.[ZQHD):HB>F*>:_32:6:394+%1Y#*MB#78I.GL6O6$EI"=]M<B'HN3DN;
MAX<E.74>:K_4H$UXPWMK0X8*B?]')/9C\7C[_Y[T)KQR<L[PH7YQA"U?!/$.
MU_FQ9CO\C>^]NW^?X/-):<._Q^G_6Y27]_]6Y9U]<&*7PF6HP/Z=)WK5F #Z
M8\1L]U*W."Z;NUY1VS39\HN>9F[&,/TCPNL")YY_03/WFMG\KF[2*K23'W#E
M-FY)1A["IQ!;1C-6(1WK)EON.GFA^=L:CZ'N=='6DI%ADD:,/"$X@)TX*W[#
M-CKHZEA'!!)2[PR5HB^V\]Z3]D\MUA^R='7:#M%QT?[-D76G]W4T&=.0+-F(
MR^:GA%\>K_QS'(L,<X;2!ER=5JABI7?OWKGG'?E0_@S&E$F7'?S]Q=)1K!F?
M?[>I\%0E''\'0BXE+Z2*@(1Z!VU1Y^N7P>X&G2FW;JZ#JP/4.08XFOP4K7V3
M8K(",WO[WLRQU)$-&^@B%1NCED4,WO3J2M#\S3==^F<R7CTMPF,IO BX"V#S
MP0D[T/EZHO[$%#T#$(D&*DK< ("&&Q!(]A(%:?B7ZTFE.[<'T@'N>HD%/DZC
M=>8ET7IEANNE)>SCSE1G%G+QM!\>K)#3]JR:,*47L%_)-.LOQDDUS8F(+&5[
MQOQY5? AFULP4(\U_V_4J3 )75C!6=O&$TX(L&5>U>/X:BR+%GAF3"6^:YRP
M5'RI-O#5ZVXDN8B,QB<AZ/&VR?WDHIRCF+8/YF^(S=CS\4BTQ^'JL<DZ4<UO
M]#X0<=#> .CFQ]USFJX7NW0]+*MTWA%V0[HKK4,DDCY^^\/W.000OLY?>5&9
M_+W[H)7/=TJSMH_U]IS7=G@EK$_#UZL<J8HA7H0V7[2=;"QB/D-1);RL!D;!
M#U6_<F9M>F)[T"7VK ;:187U&84=+ $";B;V!KI$_9D:!4Q3$DZ+N(0ZX^:2
MG*;(=CO5ES:V%X^83!\HLEZA=2L=01X#7M"GE#9QZNB?A*=1C[O?HNZ[>$JE
M_G"%0Z=3?^VJ.OTBZL_FR@,YLFU*X'+K^1/_:>O((L]GJ;L&*0J49]R)&22(
M9X!X1C?Z 0T!6T6/],?4.FA72(^%R/KU[T1"+@NKH252'Y_]J$Q=N+:*\QN#
M>F\E3,N3%M.JRSZ0!WRZY"LY>T[15V5NPS,4J(1<V.+.CY9/%'&7T 4$[8&H
M#<<28D;N!L__]'K?,Y/1Z =1R<IU.)KMM?PN'+ JVQ!;P03?S $X[+Y27Z#*
MA7Y^!] Q#B"7O@%HZ5\ZGJ3H3'2WR58$Q[NP13*Y0@M*"R4H=1:C2U]9OP,)
MZ8]3[@CQ6%BZD79R?=HL.[FVPU-91DCFZ^JG?A*3B_3143-Z:R+[>LY94,0Q
M/!N@W@RZVZ.9JOHCU(#V3<_W06W2XULEKII<6&3OM(A-J+T7+-$%^.2B+AWA
M<0-@"?/8YUJ,=O&AV]EW0C1&-O(WR;2)L\*ZBQP,WWH'DCJ&J[4FB]Y5I^FY
M."GU&#_PXW/C82.6MGS(+N<:>0. J0!V^"LQIX13;#R9[PZ_AZ\G. G[]"XA
M=;Z3!EO&!L7.SFC]:^2DYMNCX>W]LL5? 6SS1 R;5]=V@(E3PL-5?'U:*KU!
M ,4=5CBZ@)]7\VPI\U.;$4.9:54_[@:@7/^4E@H/FQ^#AX.\VA;>5^9'D!UU
MK\6N'_3]?/!I9]SD.=K,YK&$0.+3 P ZS9]JU-Z[T*R[</ 7\MX?SJ=WTB#!
M!@V5T4=/%'5XM(-M-%36W*GZE^9'LA=K%6,X6X^UJ0A8Q6_;G^]WID<(:X,1
M'V1KN5RGZTRT5/VD%:S_>Q"0+<WV"N3Y=FK\0LF\_.53?/ZX*6]]RV2/W@B6
M37%SPI^D^QR&1O"E01U;&TD=[97(VW>_C0SDCFN>V!BWT:)O -0=ZZ@@V6Z/
MGY8X_EM _"1=,I(',2_+TO[4H4_^8<6 O.(ZBRCAYFJ3T.:B8IW/XUV C5=G
M1UEKEA;N>!>1AF^X._+NV3R2-0@2 O;^.$)]DF#># ?L<*=/"VO1"K72MBT>
M.5GT^ ,-XQ6F:S[6_#BZ\]R>[1;5BQ=6;QE>O;P,Y,1+'W//J7E_;UV32JNJ
M.N[S;2N@9<+^-YIE:2F%]^P'^7-QW"$C^-*_<HG9$#PK)V O5G/9QX;-8CJY
M8_L?<!,24>07]E7049\V0L@\3OSLDGCGX?\ 3AY+N7L)K0$IBM.DD""!P<]K
MMV?FY"=9_IJ!I9Y6@CFA='>%2#K'?OB$8ET>@*OT#0$,4E!<(J27V"W'D)E-
M0$RU&/7C[)9<N/.BM9,]68NBD[52 .MN"]O"17E1@<&V),]7E&FDD,Q:)FI-
MG9X:Q>6B:TZA-&?%2Y9*JOF#Y<%1HT(4!0,9+1.GQ3Z,*HY\'QBMK/&8M 0T
MA(9=<=ZC]W$EN7R93'LUR73579H #KC(<)O4)>_"53C[0F71)XFV/5!Q3:WJ
MMPY6;A<BXL_A107V CN$ M4OQ.Y:S1))W6KQ> #/_%*7%RW8S#LHT$41&"6(
M58=J1&G*]C\^N% J-?U/(+/#4Q9W]-A%6X*6DYY-@X"GR#5K6>&0KOBG%3=#
M)$-T=[T?4",:1Z'S)5;'M_4.@/+O&FLB9-*2& ,EG9B >ZDRK+?E@I5\!K:,
M.WV[+_\&M\,&N#TP'/"J:$"[J<;.^+=N#_=,R:<9W;AML7#LR\R^R'("%X+(
M6Z,"?3<9AWL*YW%29C+=2TDY&)?L-6#4+M>D2I;ACIW4("!#\[>],NOA#_9G
M0[TKU58LGNUS6GLFK7H:_3XCAX$5ZD[5Z=\-I*QB9KJBK1EO5/R.A@4=Y*"&
M&TC2?M=52^+!3+;+:]S8:G*\1?ZC[IA)&^\$K<#VLW)W9?S[5M4C1(MR3*/@
M;(93?VX 64I^4K-]D0")#\K"=TYS_A>F]/;!:Y+VK1$W@#D/9GRQ8.$E:@U'
M^]+I%1"%&A^<4Z[&-HD'//)C;MC[0<+*.:S&<U\K<ZXYJ^CJ8<B$:O#;>&.U
M53_=>]IX;,ETCH62:].A5U0W@&OU=NCE;OX-@-OA^E'%#0 J#MQ-^;LA \IY
MCN.L>13BX$P.%VF*V#)]/MX.L;,75-[@F^XU^.!+UJOT=.UN7E";)IS-]^^<
MT?2K=QA/=%#7,DTEZ@;PM=2MA-J@[G?89F7]\3)GKA7^#V/\Q3<[U+3[\\E8
M\>VS9;S;<V#@'MG1,4?A@NS)%5&TU=/(GS!SIB^3KJ.6T5-K26;D6@C/?36L
MO-VRD:I+]?*SQNI_:'FEQ.XJM3+M_?07OG/9@C@,IW,.P9$[P"@^N-5-\+K9
M3C^[^/U<G6/P#3G6C/,*M#HR%XHC%D)S(/5ZU(DQ_,9C4MR@G)T__?%#>?/&
MV3M/:-GH51<%HS7<M;I! 6CR?7S@MQO 2FHS%<J]N, 5P;UO(<5SAH8MTYB[
M"II;8D/F7I\SY]CZOD"9M'3 ,"]"0WT%' 0>Q*$-'WSNWW[Z"%9JA[?08G<#
M6,A"''9 YN4,,;8K0$*[C.=8P59'WN%D+T\_T5VK9)R^K<GL !-U,,/)\SHH
MQM%L_ASW#8@SN.SY^U#[U76.E#WB,+0%I4EFULET;[1EE1VMD[)P#57%,LSX
M>^P+/+P!N),0?&25],V+JI/",XVX 9 584UO &,$-X !H/X- #EYY[RF'4H!
MRN#"V*Y&V7;..Y\!OSE7;CGQG]S*H)+TB.13?N:D9WP_)&@^*!V:JF&=_4<S
M6*]3<)3;.$Y45V*27[ZQ UI?RKM24YDBZE="WUT)BH-!$)PA@WOIQ*@H8HFN
M'7' SW(  J^E\.9X2&@8N'C12-"(H$?^XYSIWGV@L]E\QJY"J"%TI:FD.XR-
MVZT&A3'3>2G%YD3)T^QEDN-%UMLC<M*R!\+:S.$FO:5+[/UR>C+!-4KRB1OC
MM"1MKB0NSR,SWI"U::59^UMF2*MB/&\ ^.H-*.H.9C+PJX[5[YXU]=))SCD=
M/L\K5?K1"N6A+R-\C_0DY<Z[?68R;P!MPOZDX.Z>+E-13!$B_;GC_07C&C!/
M25Y J]/;/V'9"0^;K2,=-;(C10^(%MXPE6%)<-.F?-=Y_(V>Y.%N^Y1M;D^J
MGO0H!=H-7.2Z+%SUF0%WDFAZM&9JIG4P6"SA%7'S]4_WLF\9#/5HFXK5%OS"
MA8&B!;M/;%H.E$X_9.B5^EN?#A9K!Q+UT *@&M?)CN[.<Q%G%Y/^I-LI!YGY
MF%<7UC(@SZ=<GVW/\G.X7OZ2B<KY3AH(IFT%7 O^:F:[+FRQI6EF\S4+-<"4
MH:L'.H DIG=YA9\T0]437U I/!%X89?]P5-(1<8IG)IF8>5VZ&\ X?O^-+C%
MAU?2&'<DZ/#1E<!D5*? Q=&CQ[.5]C6.\T5-5FK-'[@. &?B3YD+W?36RO:?
M(<DXNF'5U!&^$FADIRG?:".)^08CUXP<L>47EY 7*H*_9W<3>?+WE-^W,O@<
M[DFBSE5OL=Y%9GJ^"NV1A%#Y"E.L^W)X;;R^T/SI%2>+X']:_*,S@GFPY06>
M%,!O0=Y?QW\,3N?&' VK4FA9:0G+>#W92()*ZM!4M>&MG'V>4'KPS#Q2I8<A
MR$?B$^-H8;;YG?@X6 6\VQ%OQ6Q?:[6%T/<E)K0 C%P%AEF%]!N9&+[(%$VB
M+(]R^:-(LUS**CD&L/;+MK("^!?I#=P JO7V$SCVX,_#5D?(MNP19@R[H TC
M@Z'&+E+K:FY!CA%6R<#"< 6/&E8 <S[WB)0CRJQ=^BG:$0;=0%4U%R%+*)\X
M\IWTH_N:=!HKV5X5D99WX^Y\1$\'2%M<IP&=#Q]C&A#K>1UF$1G$Z@3@T/?.
M?,/ZCGF5"\],^AA^OQO<;<0+)>OC$CV./2?S-\.8Z<Y ]V=6(12X"5%*C&IG
MG!PQV'M"+?#Y!&FR^U>I/IY0.P_Q]>$SD[W"EQ -3L"O\/^2U]ULV!'=.&0W
M"\*U6Q3[K[*/_\_LO/KOMYK7!?['_>@!K_X+ Y;D"<!_GVP4P;Z#]"W[#S*?
M"T.VF[G.#$]^P_%.Q7=]9>0?ZQD$_(U(]OJJ8917@9'>[,VQ2#)NK-F[FC03
M1?)YZZ"/7PSD;#@TP38K:9]-S5RQ1+X/L5+->H% G\J]&T!8U;FQZPV =Q>^
M5:09-Q?+Y1+?H-C:\J=F3\S+&L'["8G8#*PVDOW=EUUS5IBFPAC!8*2>D>I_
M V N<8,\;'[B/[E,A0E# "DP]%VNNZ)T50OJC&EB+PL[F%PBUDR@O,3Y.OUQ
M2N_CU/S*Y.WWK9;FPCO:%!-$H2/[_&=RF GT>?>E1P6ZS,#HM>@((>H");5/
M(_&"U /9#_7T&/9F$!4PA6.-_'O1OMYC;D5P\L6%;6F.L4SLZ_+:>W*?G2=E
M]^Y8<WW2J>O>N/<Y]B3A<;J!B72']M-?B-.ZBZ4B7X+K(FD^>P]_4G1B[F^P
M*;7:Q/+RO.!+]?IA\\'QV( WOL>!+E[,'WVI,*HY5P\QGW/!ZBH>M=&3U!G[
MD]R+@SW\S_!RU0&? QY;(446QU1T&!+"@VDF?!=:7I8%-#_U[[_M^IJIKYRG
M?5U1@>!#+9T,A'LL'V^<W1,;.)MFS^>OUHM@5L\W8)'S_<=98F2AFBD%H!-I
M#0P:E8<HZS*;D^MH9FR9R)R6?MKE13J#EO&\RWWO6.%H[[V8XXN8/%H.6JH]
M8 4PR!T:"K][Q;JZ[S^R1]<55='CZKB1G4K3OW=_C5W]GMOSIE?A# O&F70.
M@IN[(&9&W#BP'!XN4A8FAW!N3S<0;GDD%';@2/<93[C-XR*F;X)'W.KCB[7-
M..X,5%D Y",Y+2952?HY^A7F0\>[VFCD_B-5&\VW3#J_*C><A(Z49&'OIYO7
M?Q7--QC$;"F<JV6ME2T8G1FAU;O5M#IP/*B@>3CHE3:S3:IJ@_L_Z7*'NI'*
M1[8\"PF]]RSC(YDX$#,!-P#[VR[-C.S@]H8!6W;,\Y:DQ0P\B,\=(LRX[@ \
M.*MUDY?G@7LI/R5E0)^;/.:*8FNXEZ^@UE#UN;V9[(IV<O4Z?E^:'E-*,%9%
MGRYZT+[-&B>10BZJ[-(6&UZ-%]1V5I;<3.=[YSJO^=[N^%8&A8\H:KWK1(]:
MC,C3P=%V7D&9$BHA^)/[HX;2:6O9Z ZG#EW+#Y5(:T?#<C1L/QTKC;D!($:Z
M6N[OFCX9!58)+TF/BQ_D4E>C+CYRV+)2*A7[:V7@^^3MZZPX.B/46\T>8SYW
M))K-OQK:68CP<19A@5<CQ)R3Y[0MM#/4'4[#N?RR)GK+K)E]L#TA_MUF9+[*
M*-A*5/471(DDEE]7=3<L!3X2_9'U)9>GPF#C-:BOF10WD@%$P?83$#"&G7J"
M.5]>'_<"96?(V8#G\I_>M[8#!B2104L*DHCFP5^P2D_G6A^:>>YR%+S+>783
MP1& XS0#W[9_(<75?Y:EXJ53SX)#[)*'346.@>YL\LV.I0KB-.+W:_S),>1G
M.3/2[';SM[5H?,\4D6W_YX,/;<:\?$-8Z' @O=E2G&O4@8QIEG@;EBG<?ZK*
M)NSLX;OMJO51S,39R#7,%X*V1&P&N9<1;S'/U]O 0 R>0M=_EIEYO^ZM.<;)
M6Q[%@.\W1US_E.(M!"^LU$2Z,3Z9V:^OSLQ3QJ]J^5%^$:V(]SDF:T>):NNQ
M]G&35(3V^">_D=26#\Q!S2\PZJA0XU$IVQQ&ELMCW13WK\9= G:&A%H>6^D!
MZ_KF:6@SJ6WXGYE]<A1>MW?_%7=]]*[R),3-G9#/D=KM670;CR>S^R13_@-!
M%Z^R,6^N!-U4OUXW%D3"<HAS"*0*N$H_WE+SA&K:?X!Z07>I1H%C5FHH#X_5
MP[7+=PCKX_L07=:=3MU. 1:3Q\TFMB-6#_3V-63*#31>7.^6?I+9SD@X-:%Z
M&!^QH1 ?6,"DX#I/'7JXAR.WOV08_3C%,FKY!RQ6T-F^^,RD=1^[:"M^7O:C
MY<.MX<GJAI%?2:#%Y-'+L<^_.",DQ7E6$^E[GW]JX'LBF\OAF$U$7?IJ9FY2
M2\M>9/%=FM4D3&Z%_RL<_P9@!Y^#&LQ4'N)CS#JDGT^<2K"2%2X-T9@4-8
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M:];_,!K\38&$+\;,_I#;5U*VTK?T8EA]_(1C5H^]9)?,C[6+_G[U/<&KVM?
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MU!"KEJKR0]B9E=/XHC]'=BTV\@:047EG2I4F12RJ>?=NWA8H::HRL2)V+4K
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MH':TF,'*%* WT(9/NSA<^BVG9.U^ROD-H+*S^@9@9TOT8&A]=@6_^Y.?>)D
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MO/5*U?-<&EEB!&W _L-6*FX:!,FX0<B1$Y#DMH8&$RTG*:].DENF@-A<F#S
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MF5-04=H"8,!,\_@MS#A.Z' +S:3(I1LB__R1ZCE%X*,K6P7L[C:_GZ0,O_X
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M$+%OKE;@O.GZ+\1-_W=Q9JGG?#+OKE;<)'H (YDME7W_AU(L<^5]]O$]QPL
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M,<.J=J>6#S33D?]N6"H75^$A\:LPLL#$W($0+/VQ;?\P/QS(UT5L#^=^(JY
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M6EG#,&JZ3\#%9XB2,X:VZ7[:!5<(+2@:9LMLH5T1^21NX$:TJ@KT9 1M9F1
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MDO)GM4UM,HG!(2./=6OU4MO6Z%X:((A=QI$X[Q.)RT$9P.O?7Z%8\&6]-Q7
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M>M3RO:4K=%05,S!<M ],]K';<7Q^H'H6(?D9PS):RJA05%Q6=%>9Z5!)09]
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MSQ%,(HZ46V],AK8SA_FV*07HOX+NN;VQFA/0 UA,S:G\B:CQ]NW_2S;K/WB
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MX_5TRG49N8$$+' 4>T[IJ09D,%B!D!;C-CYL%G[E=G1Z.GE(QIF2LEXK ZY
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M_9 HA6:\]/D8TDG/-MV7GH/L[[ZN^Z[T:+)?.\C650(5OG$AW:Q98,)2E-W
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M3./KR?FWDTC\H<M4='FYG3#/DV;<B!!.LB\GEM&'+K.9Y?EVSSO?F$Z:_R7
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M Y4Z,9\^$[>2\R3@280WGJO+G7_"T+]#M2I?==KO]%>C2M)BU#JE\9Y7V9_
M'^9Q13*4 (*MIE:^U]&JL/W%Q@Z>ANU8M2GW@3.DIHQ>@NQCDP"!P?&K:^VD
MI,K?+PX.LH(2M:T =5BR:GD*8%=)#//A0Q47IT.F2IB2Y/X+S^ @'Q0HX1^<
M>%(L*MR2JU;'F];B4GAO>#C]W>:(+1<['I.6,>]CH>A3>),)G_S#H,%UMJ).
MQ*2 *('HTSU#UHK=PS4+R6E/([P)=X^I=0-]P;'!SUJRZ"GM+BYT)3S<I57
MW??J?EK_C&NNF&F@TGE8PCLE,N7U07EN&HRT==19"81*-^%W;FYA,1-0]86J
MX0Y$HZ1HO]*1DI6DS^V,K#KK#]3BM]30X/O<R.9 RIVYS.P_8?:4B6^K6@+U
MN?I'K,O$K^\2BED+<2AB9T@]K,3(/#AM]U<K^3_/Q50I5O2=B'=Q<*M7E*D8
MP_%1D7B6AHOZ@G63V.O+N[9S?97/SI9>T23H)(,]-\)<WXLQ;*<T9]G(DAH;
M<_QM"<0-]<IHN966G'G!&;Z=L?8U76&8J(DW8*(B9=-0G"B8$>\)<.*-02*0
MNX>S8) ]@"MUUF-RWQ'QJT 7:RQ<O;5?#=366LSGWQ)Q:9N5<M# ^[73:9@5
M+\?-D7&#]O(:1Y5!QCYSR;B85>XE"Q>!G2KN"]ZNM57ED'=2R9";!8_MO9VY
M)CF=R!<%.$7\ ,I'M>ERJJYOF 7<_";IC.]:RS!UZ^LM75_V<UB*TS7<VLQZ
M_ Q_&%O \N_8S>-JH(S6W<3HG,&/HIF@31U+Z!(3LW%:AOK5U@.>R!!LXDJ#
M)SU6T=FMI]QQ.;A66-NZ5 -E=1P] JSVE]J85!?98G&DV-2<''^*^+FX#.&3
MDT*D<A9>>'EQ:A!IH?[9LX)_<.6LA<45_P=>6/G_HA?&'GSR_9]%9X[_C.DW
M<*#[U)JE+H-MA^5?T5D_<G(W9>2#P]O(:J5F6Y@8ALM?"9?A5LG^@4?$5V*I
MDK3"Y,#W#51]T''#L720L[\OQ7.C!R3QE++/'.2ZJ_[^..G("&%?:L:EH3Q#
MOM8DYTI?%AC,JZ[ZGZ(S+HF"!Q^7$JTUO3ZUZOG,5 .-R!DM2@T\/IF@'%6\
M&=5)6<!5,7W.<894LL;EXO)Y^P^A"]D@?R/\T&0"_77W,^T ?@#=*/B6W;#E
M'I!82J-TL,;8C[K3F;%MLOC@Q_&=:^A[,&\'Y<8VZI;+A'_OIL=>YPIOZNR+
M V(CVM9%,)!9*10K2F$JY2K_0CVV#1^EAHP\(D8D<]>D!J^IXWS^<ZTZ%3>1
M7R-$G'MI[:Q\[7ER(<EALCC-KS4$ZR#O^,.U 9Z[MC_$1$9T9M*>?;$F08H<
M&=D+S,>-\D:_?_4F.'"L[VV'.^:WBS(G U7Q:B=+FE?7=[N+3BO>F4Q&91*S
MSPMWXO0'1FN^X)I3QBB5MF+UZ&8P5H8>+.FG/)^6XHY[3,RDT9DT_=1>61^2
M+A,'C/'H!M@SCRRR&U!D-B=_51OQ+"K<@(#7#;7DV2(GFO@Y70Z-2R]211+X
M;9;D-1I/$Y1#!EG^"B7LS13@Q+L"M'D0=YRL]"NW.V@ZP-)N3M*@6LJN;P'M
M5 AOJ]RF:<!2G]U22R17_\VX$U1Y/DXX6;FIN/".G(IL9'?N=>(;GY\'EE;6
MMW-/63H'-J 9'.@%9?:Z/T?;#WEF4OCSTJH).,<B2A]K8NR3%L5O*[$O;>>#
MS2;KDG7E.#L$8X,(&7]B26;O,2^^$JK*Q?D/'A-Q#IS4DRRUR=,??Y2(U^$C
MT'_IO=<_=9XC!P^O"/+DI@H[S8T_.)[*S-^3(;:[IHJ%U>V.LPA88P8\*OS3
M5/XK38Y)I]Z*>S1(7?VNHBS+P$)CZ.5S*@Q7_'=[AAR60AU9R@7TKUUN#SX\
M^#L.=#MQ<OV9Z4W]1X25)>D0A1O=G2R\TTITIY7'7&"EF=SJU,%4-R[!_$/:
M0'H"0BS4L8FP*^L0%96)^O'S@>\$ZJIM\2J-%F^+2E8M!L8 4NL,D1ZZET2+
M+ZIZYF.;:"%SU1Z1=+PY@J_(165&=$B2P!O^M;&00M6\U[JO8K_R2B6^RW*5
M_1N^ >9G:O+:7C+B6>ET%3"B&Z-(QG,6P4/9&B(Q"^>=^_;EX3;;6I!8"SK!
M7.K\0EN!7>R^7[F+\8PR2NL/7@OT%<T*?L U,-QU,TU+$B2.LJ-348O6@#DO
M-J)QU:RG;"%XRX13/RU5<9[TD3][:0$1^RN4*:QIB3HAL[#DUB;7>:N\7?F=
MX#5N)/TQ50QWD2 Z;92K)/6N\.T+R3^RNHO,15<!C_@5[P'G$P6VQ\LOAEZ4
M? 8HU1"+C[J9[5!+;Z-JM D/LF4(KU!_T M:JZ+NB&A#@K:]AER,2WM+KDU&
MG ;K\1L%9<<(:]VO_7/HSC@[B@9<7_L&LJ1I)WFZ++T8V,T+CRD9PC:^)$4S
M4IHAO@;JFE_ B(>^!SR&WNHX_3,\O.Q=<A?$Y&/U0D@X.&E8Q,:O=DP(4HL5
M"M@EW\5[8EAVLO\--32PI/\%1_^.CV[:78S8DN R2O3_-4!LT(OB!(2=(B<"
MWT1_V#QWI"OYG0&$. &NDD/=#)M %4F:7S:Y:+[KX!T.9YZB]K04)RW_<OQ(
M?0N-QVP1):$Z09XZ+'9R(5)_=2]S#P=@4WG>\L=+L%KH#O&$:&7#%3Q.YB8'
M#^8(\L3147I8U(=N4YGE.S)DM8YX\W<GBP8Y. ;#_&M)<G"YIB_6EHID:O Y
MI3&W^5W[;$L#TF+ D/P3J6#CN]KL!(@4CO[?S@8,B^OE#.KP  G.SIDS(18J
MQYD,^7=CN !,A>P].7U927*\GJM)I4OOG?&I\[+ _T0&P/6:M_B"G4A1Q_%W
MA-#;^*E[0 E7091<(M!#7!<0O&]/83CQ\GD&)HZ.S DD^M!M]B$)U#Y+-U01
M;TFN%ZSF]#\>(%I9.8*.DZ)EE=C< ^P6A9DR/!D=%P"]%COUD[9>W# RG33N
M9*H.K#3(<5F5.+$E'NSA3GW=T#6MS,F;ME(,ZOM#%9[MNHV*A@<(EQZP-(58
MAM6SN(OUUVK^%V#H)TI\G=/NM5"B>K$^:,5)P4J[CCHO*WJ>DZX4)1?C/A1C
M@QX3Y'/FFW^EK?QXDB:C03K2(['>Q53^?Y+^X^LZM3QLTK)B\Z2I519/L*4>
M<I_)QCV5XDBV5=&2\);*D#"-WW\3*F7 #I!'0OJ%0+OG!D;95)3]MT?K"BWR
M%KB<L(!^EK2HOJ9AE8%#)EUYK5Y92UV,,E_J:(VI];:0KR$&!(!X&U:W%,"_
M@V?JT"&G_9,"T]O&Q9,T/;Z[V)PEZ+"<S-TNZT/>GSG69 +6C+HF>ZMC(<XF
MW?%78_.MH393I3'RM\AJ/9NB>.=%6<2_@</J8$QRP(!.NU*++%F6*V.MT;[9
MZ.%BNH3#6SB2935^__7$RH#=@U+X 5;8"5G3>JEK2D;R,QAL7C&@CB@,(^6/
M^Z*AM*SXPPVI8.'%EK(&;T^6J>"Y%1#+5Q$TO,4'6.U(#+3<+HQD>T)J==3_
M(H-Z\I]PX5SSNZ8P6/Y$,&0\K4B;5XER_&K/\/I?T?$'G4MW8FXT>5U79(4P
M^9LUT%<._I*S4Y(SMI:Y*\/7[5IW(39W2&?&1/VH8J#,6G?2HBIU[+,;EQ#X
MX.>#Y55@01W+T*/?O'F.Y#KV7>WO]]5X-^6P14]^#.'HD+"<BN:TO@=847UQ
M=AW@VM5Y.T2ER"DO2X?O<QC9(I"'TD>ZK1%B[*U K7<O2 Q5I&"XSYV;]C+7
MM%X2>I!U^O>"GP+Y2/V8G'&]$^X!:]5'SS8R*.%$8=P(K&&\;JD$[SJZY9Z7
MU(#K_YT-:;0OOZ(J!^]]]9B>_<_.%P%L_V"*VEQN*]H=&) 62#_.>\!1&+3K
MS6W#+%<T@J_RBEXQXN[;8#/(N4[D<M1O&0M%SLR6_&H9.T.L/2SG^*D5@XRC
M/%0"<$N?W9)_X7.;UT)SH^*MZVC654\BYV8U3'>7Y)W%ZT@7R-7P2%:W<ZXC
MYKT"QE.0*3+^'H"I%;TZWG-([*UL%JKJ2QY1I)XO?;(WCY?]7)D* VHEQDXU
MWSPO_0?]\ -7YC%?E/ R'A+KS;'?B4^3:E0J6\$XU1A22XA-89H 5'M\#^A@
M0#[_C.+CBUBB.P*CN*+WU1$^K-&(>\!\N\U)W:L3Z^$;0:>QD8^K\("_Q3Z>
MW^:TK^1"C\;O 93 ]D?W@*[FNZ6[47V:O_^ 6IU*#6B9G4.M_2#^H.,Q(<3?
M5DV$X?> (H5[0!+?/<!5 VL'GVS(C^-X%L5]#PCUISSV^@6MAM:=_7&^Z]^Z
M:E/_%ECG/-=<F6:-#DKH\(>;U7Q&"=X#NGWYR![&DKP'8(O.>7"<'5;>UN^G
M>O6S'"YO#J;Y>/=)GJ\%2!>%HY;5D=PODC0>?H=3YL.U]CH&E&E17O*P9,!S
M_5V9M5BAAX?N^KS"I1!53KXSW[XWK$:!G'^Z/\-B.D30AM("^V2DZ\*O^B_D
M'F9VM8A/RAP+Q6QV!(-V@>#K7A=)<ZA[@/ 0>!OFZ[+IN^WEX';VKYR@*?Z-
M]MWL$N5MHGNDU*[NF[VFNURJDIH( PS+6&];UIC@2D&9,6SV[V*L -]1LA/P
M?O_#A)(=U2.PUCE:GA4@_=<[EYB:\1P@<?LF\PL))KT8@4^+5P0 903+K6GH
MY[W_;;2B]C_QFJZ"T %[I7M 622JN.S_EVU(>&:4T(%&KWO @WG\":]CN0?H
MMBOW'W]&121!CPAO\>W?@<_MS[YC_7<6[SO)1XC? ]A];OBA"Q/W@!_(XM_V
M?>W_RGPFTJSXY],Y?^'(#M_CEWIS48:L7(L.:4.?Z@^J@4]+J9>:_<BT65)/
M2;P)9'O1BKW"L=AGQ,[X]HHTLR:ZU_EWHI*#OXC-Y]XZ"@$JX7L L;>_V Q>
MCPM&)K>-^+JD3BCV(]D@T$!V+2Q.UZ9/>V-9,"$Z58KP1@89T=%>K=K?XQPA
M^W;ZP#JV9E%,AF<S61\-PP@PIE]<I[BJMMY1G@*V3#S:[HF.:*KOO0=$T ./
M;M//6R<2^U5G/,28?'AE,%E/%COULTVR'DL$!I^X73+TJP=*8"'05WVEL7KT
M/B0DI)?.+;'LQ/73AG0) E1R8.;CSFKV74[@E>1,/$A]POJLE/%8D7+Y'$)-
M38SA&&'8IU']Y_>X5KJ:S;QV\(7I;3TOB-,[N(?<["D?BGTUPE<[XD8:#K%Q
M,DD/U+!*#D[#7/UH__DVIPW#SVD6:ML\SH#$ZKY9KR9?_MT4UEI%:1&B$YTD
MG/ZMX2KIZ- 4>L-QUW<)DCX&52T_=3<C]];%YY>5_A1IY]#;?>@09/7I ,!Y
MU" U6^XGCTRX>8,20H:M20X3/NE?<\9;-*FVA===*&B$4\K.I?J%&@1RHC$=
M"<4!1DV^6EUQ6Z3EJ_H:'?Y<*X7:MT>9 ?Q<\G>@E#4)[5,'7VREAFV8DX86
M0[V?U?<XZ36E71,WCKZ[^SFKV\9\V]K"ZFQU(Q\+A$=NDF]2DPM4H-_&C4"%
MM.R6<4&2_K\S)":<4&ZKZRN+!!V4L*G?TBE&??I4>"[*?09T%0*928%#X1?1
M\UP7KV?:6 R1T)X[-+E[P*=HV3H5(>NM+[D-04+?8$Z*CUY)-JTS-6W* +W[
M5'(LYG)7$)[QNFW;=?Y3=? DL^KE'M96G+?4P.[(Q72-*H:RE8;+\HQ[P$K2
MZ=@R/@J"*Y1J,9-C\>;R):7\FO01!5C6U'J=D-Q_&LS@)\#0O:C246_H6#)*
M;6J'GZ<"N?C^B798N'03,8#G5]'8)Q <?.&UOWBD1AB0B7-V#\ +RVF>-I@[
MU&CZ\K1J 23J."ZIS5DP)DA*B[=6Z;\I2GYN_<JH6$>5AU@B,ZR=T/TP? ES
MIN5YL:J'<[Z=9HF;BL5N-0=>Z4FB+F!30</^E'"%?7]OM3W<K$8O'(5>M+1;
M=PV*OSAD]A5_9Q1ZXD0NO#!*\WQ :E4!E'#=;Y9&SX%T.TZ]L+[-;I%;!V,B
ME:'DAG93B](M\&N_^I^#>(=;I+%,3.N6#GAQC5Q]LOGR:J-LW*]UUMG*FC(Z
M;[R0IK.=#%56P:M[5&R)P\JME95!*J'X+*PN$L_? 3!6\%;0$,9)^[XWS+9W
M'$?+P7?/D?$]AK5CQ:03B[:)GB?Y\7@:BKK",4W5_%>@W03 >VG[@MM\;A3T
MV/X"?+21=$<X_1FVW5Z?>*,PM9]A .':*H3RB H6TAAAQ3:@C_JJ[Z=FVX%H
M;]-19#]VX12&ICG.=GO ]'T>O(E,B9>A\H#@($*65MHQX?U,#8TWI9XUE4=@
MA-RQZ_R:-8*N: <D,@U,54?W_G!A N+B(1?;^$8Y*.^A1/?&MT'<+8X"'8NR
M7/S8L_5HK^M#:&PIBFG&S^V'?:+;521;.UT18CTT2I&!\8)3(XCR1"#X/!J!
M>2/V !6OXR;UB,PG68XO[),-=W?[,.43J0P4O_HHW#JX6L11<./2BSW.7#6+
MS*R%]CB3V)+7W0'JCQ"UM3VNBX,?<\?-,8ZM\:JDNP7FH]HTEO](ZNZJ)+@B
M=EV'4K?LC)9KQS+7/9-6&:*7 7>4R.(UALBDCDHE4J]JA&3(E-3+4<75<;Z&
M1Y1<9)@-6VVOD#.K#$'TM#\=:AE"P$3 2'NC\,U7=1()N0.]_(IQXJ#QIUJY
M!-CBXQB0S()VY\- $! 96.H-Z6VCF[0Z!B:F.CB6G?DZ3DHP"/EORC$M@#S3
M,_E_$=(I)*(,)_P,CB&KK2/TM+??LI#^W!:A2H<\9SFW6>^],(DZ(IQI/_G-
M?UL-)=T(AMLVLQ[H6,S;EOI_R,A<=\9^>?/*OT<"*Q*E!_6?._PL;#\\8%&7
M\&AAF/Y/MVHC9=TK3C6<.*6MEM,+_-N4%H'CEZKTDC/.M?8?S;KGSASM\=,F
MN DWN;7*OY72"%Q%$5"Z[,#;8I'L1_UZL^!WQ<[HN[JS$H_+H;G+!L(2(<V]
MK(2L<0A>&#K:*?I45GDRZ/&B_\_V:MT\CQ6$Z&K>4G[^DIWFN!N+;=4XY4W1
M%M=7\Z=XX8_U8P1^;>6)#G/TGO-J*FND)9RA5!Z"3BV+QOAUO<#),=T@1$WO
MTP&8]L,57\0HO" 0_W$W85:1$784L1*Y#.-N42BR,[Q(,W>4,?ER-^ZRI5A9
M&?DB5#VY\RKY&M*F8'#C[2=^[ SS!WH3WP-DC^IJ2PV,?O=4+]@^H(ZHIVOU
M6ZB%%EJ_5$;"&1@1^7W7G^,V3<K\A\V<QU)IH5IB%Y<D);5M;N_(:\_L(#4
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M:8B#'B-?WTC7$_7TUWE>0J+H,(*N9AH5,0>(0$?JT_0>BPPH0YY(5R^WXZ1
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M6"B:M71Y7'O[6XAR?5L&C;!E"/TKO$YTH:>-4A;QAPH]RY2#WY$*QDT51.K
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MJY]J)S;C=YY:2KW4!>WVQ3OU_X7Q*6M;6I+4U^5(<K#_:9%Q5<:UDO%Y'4J
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M'P33P@$;[HMJ*E1D7K%H#DT!V,"9N06>!6Q.:WOW<<,1>$W@^Q\V2(O73R9
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MU,?G=;;8HP_CQ%N)%4R,*A[#1\-TC[X3F,\,.ID]3Z4L9_MC?#N:_QY]Q4Y
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M,B</>Q[$"A&,6AV.>#E>\=6BE#_FSV Y;=E!-PHX9&C57-/<!WT+C('=:WN
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M6;9,MRAG3%<O.2HQQ.'- ^4U:U>,V*-I^!PU/YD.;(/8$S.VVP0A%*U8-;3
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MC VYAF,OK3^8+ZOXLF%S K:9>B!=ZUE2\L>+EYW 9N+7:UJ]1@#;Q'<>XM>
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MS/(7UD[WZN<=N#3@W#ZX=^E$M-%>U2@186FZE12K?[?-2:RY%K2%V]!.,1;
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M3"KDU2HF7)_-AMQAM%^-'Y4;H'2W^#I#)_&7/TYZNG#DL+"4!2Q00@_B5A/
MP,.R,.OOZ1MC+C\K:E_:PZY/V-Z.5=B\7[,FRU+Z]'/Z(/!3UET<[M>[N5OE
M2U28(P) ?W&  '*71YX.( #\P;EDOW"OBM,W$DE$@G#L\90L$O[) NWO68IW
M20B@52*R=#@"]OP2K=,.=3OWTN1A%UNZ6Z3VS[+N,;TC8#K-F(M7D%\;(W?W
M_&%X851"I:N\TZNPV5L:=N[ B4:&1I9A+S*Z;9J+?6V0Q0OB/0F4NS2^4FHO
MU*;R8VA Y]K6$<Z+-S7A;#],VS$:Z^CZ8TU5W% #MM-+!4+N25W[%1$ !,45
M'B@"G3#&+FDF\7H'X\USTVZMH;$[UA XM2@EB?T4@-\7G;[ XO#RTVO'8>&U
M JVPE+3!;TN6W7OW^M%P--BB^0G%"G72>HK:GM!&Y2_(8= G(AD^3*\M6FS@
MY?+G4:[2%!]TN!DLXN2W#&R@=%^D P]%UU)P3&?WP_#BJSY&V['<Q#RJQMIN
M7&6FR<1KE_TUM*#[QS#M-;NVOBRVNXP\QB>*O<\WRPF)41U^I4>D'=U9GZ.M
MEK:GP=1;RH^R,A1)X@L4TI>,K:A;+.(>FZG?[\RE'6/F2ZE#FSM?91=4-G!X
M*U/\:>ZP]#H7)KC&/S48@E-)\G1\@.$3@9:P'/,,DD;5B[FD]8C#1VO%>M"5
M@  ./AS^RY#N@(4!^FB7R@@'KRIVHDA?$^Q3CRD\&#,""#0_"6R#A,[A5!2Y
MBN34S[XY'--3<!]]<AAC+.K%?!S8P6;\Q-H#K=MSY(F;_.6P,NOSRJE742+1
MC.$FIR9>VZ2LW%#QBEQ6QQC/'V?]?*M$!RGPEB?[?PHUJG([[="\M">:R>$V
M8]'C"$#%8K5ZZBECL"2CW[<!=_/^: &[>*=W[[:%MZG,#S'61^;8[I^^O7\*
M,U[]IBZGH'/T83J.=*&O%K\MNY:>B.XKS@^.5F':M4;EE=_MQK.%#VD<J5,Q
M27LJUTG*9?''OCQ= \,?'ZKKXIXM?: HCCU%/J+U1T7YFNC:51IZ+PSSOU7>
MNP>:8/$OVE]@ZRPJV!"O]4[W%P35&2X:8I%QH2_2EY""1WM8M\:<^+:C_7,X
MZW7O?T;X(0#KTE#(8PE6RV9BV(0IY65\*7ZB',=*N 6]R]RSH,.>>/JOR:&4
MAPRTP7?(^[VEO7AS*(HA,C#_=-W<KMUF+C$K_PL,1G<U*(\]8>^$?'%JKK7]
M@O;^@?'>Q Z;R)C\D+- 1[]B/\>!2#!+";B2)3,8^.\>MNT1WR>E71$12R!8
M@Y!EI2&5R;&KOX%#X !=*:=V,M4XE^8[8349JQT$8#42Y/J0P>,;ASUQ2F6#
M_HQX-;H:5LZP9$ 5K)U:("ATI6H(;4WS<T$ V!(4;G9M<PY!')5)%JNU*5S-
M)J$*"IQX+@Z'L&EB#F;S7_QATX6.%35?O,W.+"/)=,P=;[6-WX.I0NE4B0WR
M< <6/B. _=Q9W9RP^@ZR#X7)3_?[AJ3RK50M1Z,/4$.+P&H8J)\G(MIK"S2<
MC=E=1!B('[EP9N7)_&S_U5O4KV]+4OH*DF._-[$'595A;,BV^\Y[F<NSL!\_
M+B)=S(;3I;'R[ITK2'Z_\DY$7.!I^#,S+9L>=U0$P I=[.CYZVK.&P^CN$2O
MY['&(%2^D.5D!."OT]2@3Z&=TL%3PD-2RDPS'=+0^Q%,J'2+GY*^D@K!R[&'
MDI"0'VY &M0%%C/4/W<K.UX49:!IGBE\V&1Z9,*T>5 ?.XU5'EIW.M7B]\20
M,R*S)/5SCH9[!R&CP3%Z#VSBW)O):<;5M'&6V+40_Z7$S,W40,BWP_>6IC91
MI>I?/-=2Y).7-@2(Z.P\7HUPU03(Z1#FY7RC<B,K$=2:2E-)N*P(<9#4F:^A
MN:_WR<^3*S)DE"_H+]'B2/\R2XN]<8LY/WIN7%8P\FRSEE4SAC9O>WY'=#HJ
M.+TNIXZC/GS@?2)G0/7 UC!#;#@T-'33\V&]-A,F4>_#-AS]5'32WAO$-11Y
M-X5R'UH[O^MOQ5>F1@#J<^6AID;:9F$%%K;EQ56WA_XIM*PH#."8:$=XP5%@
M1F%>JCUEN6P:ZUFDH[J%!Y;^KY%/Y,)CX5/8Z PT=X[Z4SGRP6S1"01?[1(E
M#9J;BBNC26G-(]Z;Q/RDJ(&-E>P7.OU<6BB*%/DRJ/$%7;@')*F0L<-!]V3A
M<2A.Z=-I&D$?B+S3RG_TLY5)WUFV>N[XK.<K(Y'PD#-W9G=PL$!!*-+.\ZF1
M_?J]S*JF.FUV:F'7Y_V7ZQ=%2;'N)$<3DFLXEAE@&R2W+6G4VF[T;ON;X.$Q
MI[A))L+HGWSV3?IB$Y7>&*4(P)W+I,:4R9#4)-(^8MO0(2P=<TY=0YM1D#?4
M4&:(+K(][N3;NLJW)B(MK9;"NW"!&L5]4193YVXTT!U8:9I_JNQN@<EH5>>Q
MC+HO^C D]KW%C>B>6B%/676?EO,[=*$12'MF"NC:73SX>_.@M.7E$VL20JK]
M6J]!XQ;^6?VY+BM_.DGRF&BT8HY&-AM4^^=,JJ]"+];R]LG;+<=X"I_7_<?T
MY,EAAV).#8T/?XUMEII8F0\X8])"'PA'IX+H;7&LI.DVSID\UB);N)^\%16N
M"NF)?*;22ZZ6C9,1\4=J]XY-U-$OXHYCK6NS;4R>+BX@^+4P/%S8,&/J'^K"
MY?]&TR%=](4#&@(HB5']ZQ:<R9];<%C0#-!XC-IDYD0&TPP&F4YW-B$&2BZ-
MO\/;&I'-\_"H0OD.>TTA4E*JD?&_II]/_'WZN6;N5$EFN)RK[#*+^:&A67S.
MSS1,4^V1-ASZJVW0JIKES4>/CXJ4;P?):J@V:';5#)=>@TFC76?\#M%0SV#>
MSR<+]CS+9NAP#4U(:JS!5F>U9IK=KRXVUF^@%.Z>G#G.7P[ G%Y5=JNHXPL&
M!M8U4?>';^==_)70R,1'INN]:>0,!3AF[02D#/<Z\?&J):HR53L*FWI="PZJ
MR;)V"G/3+36I/W4&D8@A<]_S9XBU+Y$QO9//C*-U7C&+7EL3U='3U3>QGEQ)
MA97(:$PR3G-&,VF::K,]'97\&/G8P=L?3-I?63+$Q*2H2R/LI7AB?/AH?>3P
M]V-=-S;I,:<[:5V.E9/O>G-B3Z=#97$NU9HMOTO;IR:%OT1N]H?)'=<HP8Q7
MO)]T5,M1S.ZZE$O:WG[JL=@<N7T["SY2=/*@#KDDUMU8J'DD_\N$F/+6$VFI
M*OL?&%5R5%CTS:+8IYOJL2:?-VZ>T1U'3N<1$!9F!O6GE.S3V(&Q/?_,2"]#
M?=+3,GE93(4G:>VB>X0B(\(]E_$9%?QPN-:R4JH&9PL)<I->Y72CY_S.3X89
MXIX_V31RP+7.SJSS=C74SQ&XW#3Y//GT0S:^Y+#P#>; 4BG]>2X^M*HZ^C4J
M]LD!>[13QT, (#?[FN6=ES.81(T=J;+-_RPPO=)/^1,YET"COH[7XO4=6VZQ
MN:JZ023]G]:P%.3L%GE95GFMU%_*O"2+^=AMTE]0]K;&D[:1#H-4I1M*"MCT
MYV,=VM;C'9)+;4%Z&5D[BI#;OJ],#<]9=SH8OX9"1#1V\THM59B>W<VD/C\Y
M6S4.DGAFX,63]'(B((<Z9-U05&-28X322+/(-#3:ZZ"A#/U:F]VQE?^\DBNG
M\8/0)/T+*:(+BI?$,476A>]O:^6;VLNPPW,!@@?>9^U7TLS)L&2UG[3]%WCK
MB'C[S75U!GH<T?"2_!X"R8PMJ\7JQOI7RU<4 I+=GO?$,_KMU:,RA-&:1"PC
M1FSN<BH&Y0M#4I.NGAAVUL0%1/ZH5DJRU%4*>E,DRE]M*09C=1@XA6B=[RRF
M^?TF,DVUU!U]^T.SO_!&G)38#@_;?#C9P/C.\_A[/HH%>)@7-NVT>^9Y-E,G
MOW3@2F:'>C.T-4'+4S:\?5G2W-XM2OHJD[5.A2J^#@4!0)5_52A@.0?P=&D+
M<4!C$D/^%;.LL53:?^\$NR?BY_&1C3UX,*=ZU>.<^4:;NEBBV)G(0:%>^OHU
MR,J18[C.FR';:KQL05/I3U'R>4F#\@1XXH/%FMF[H=K?M A _O]V'*WY/Q='
M9W OLC_D<5K:*ORI1S8+R2C^=5WQ;1-<M<X@;(0 5O6=9AEUP.Z4JT1/F6>T
MAT#5N5W%KSM &$=\QCBQ\9U+SQM".F[(?VJ]MO^$27(YXS\OM.)? O$H=#"K
ME]0EA51TE=^E-_-[R<*@7&=\;C3W!#3HE<FEL[3>4$&L/:;OR02]%/[>P)!
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M4,Q9E UZ!C7^_NNJI%2Y6?'5$WHV%IR:K1N\D\Q;Y0B5,+57_41'U[+_ZMB
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MX3;)T2#6\_KGDX/<_.[7FR?9J2$:U;NYO2IMH[D# S0!AU8WO^]X$V&?CQ&
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M_XBU-A;UY'K=3#_8B^D+;:(E5"YZ0-O!QX<TE]TPC/>W?0_4B/>I2+Y>\1G
M0+-X,UWALY"&%/OPNNB?EI'L0BCX@#0]C;SB/N4/='A5'",.T6_\L7K[OXE4
M4&)N\H=]4-AM_";(6LCC<]A'N+'R"33"OW;S[WF*59'DL@.&8^NU7QI4CP+J
M/_G,EZ .38O?52((XQ_A:%<<.LU:<!)'92WN:@]@SR8UC<@5=[_Q<"U>^P_>
M*<5]<,5U& X"D'K]"@&T1"" SFGJ\EMG+^):8T[HFG3DM]?L23_@K2<]_=[[
M;/V55::[BA:>2@TE\6 [VZY791).:MY'(O87%X=R&3L<#.Q7F"H,!!M]-$ND
M^R/0B2HWEYC;=U[H9F<O))Y9/./)1H?OHJ \G&FIS\4X NBPAS]& )D9&9#E
MGH<@;JT[J0%EXA7JZGN@1J)_\%29\Z(3?9*G"[:NY%EFS-'91$1NJ<>)M_[E
M$8RYQC2MLYC*4#]^03XJ?)G#U/*_Y1V^==+;,U-YQ=MR\0[9L9Q))EXE7>1?
M+;_QTWC%4I6OM^KS,F2U/UJ4EUYIO-,.Z/DW)*7AK/Q  !YO3N;@\F.#"P3T
MY6S0U,([5B9!/2U6;HVQ0X_IZCC['YELC.%D<G)<8'&0!$2^<^*\[B(H(<>=
M6'Y[V)F= A7;''Y>2EAY5]Z,OF1(9NOS;(>EH4.N6?O1+P=[?P0@7)+Y[\BG
M.#E+6JSLKXOP<3UU;?]$5OE[B9T>'\$49C&?'G.M$'0[WGM;=U;]6ZK:0@"K
MO^ZQ]K0YS[P41Z-Z^]P9W^%R<;=K::SD_%;<,<B>CI*IUIU=V"=A8737%5;G
M15[]Q/N''JNF9V:ZP)BL]':8Q-F:0$U=*6[E754SH-,-_KIFZ_=-:4T,*G;/
M=JC@?.L,1Z]1T5[3BG@NYG,XLWY&I)'W$)V_<*D\T(!M3KY,[LMA^49?9'I.
M)&&A/P56FY!QY\*1:ZNQRM0C>FS(R*81\[^EJIWSY7F9E:<IZ!@G@I*$/'E1
M?N/XLM3[%\5VY-P36M)5-%%'>K;Q3],P2P@V#>ZOWF$[6.D/]!YDF+NHM,EI
MF@'5:))&=*##L6-JTBN\( _VEH,>AB?PPOC_AG/ Z+=R1F_K)*0LLN;L7G Z
MA\1S9Q<E<_G+?:HE'0:-Z.WR-3WE$%8ZC.EK^/2GF&N\D5?FKD(":7>,3;#S
M$'5AI5!DB [57!RZJ[UY5]>,TD/!!4O*E #YFWQ,@[N4Y"C<1LZH^#?MVGI^
MG^BQS<B) ANL<[9B_E76]<%4)UI*K?94->1Q&_,?+8NMZ\)N_NM*<Q8#"RPF
MZR[IDXGT!_1UJOA]/1'08=@Q8<=5C)?2*/6J3JQ3XEM &M1P41#(P7(FKLO3
M)&-:?B3"&1!7'F2&Q29;,&\2\5W<?N1ZK6HCBN[5*4\F;E$/<B-_BZVR;W\V
M F@?&1T6Q:!  $$EGCH/9F,9QU"""/G\:TPIHGYL1#K>+>>8E.IIQ_"-)XY1
MCQ59$QHK;DC6:>K&7-G^/^R]=UA3[;8O.A$%! $!D4Z0JE0!$:FQT41 D-ZB
M B)=FG2"2)$: 0$!(4J13D0(77JOTKM4Z9$@& )I)W[[KKWV^K[UW'O/O6OO
M?9YS_&/^P209&>]X1_F-=\PYAF:J".5SHE]Q'6\HJ_'RTJWS!F=DND:S&@@J
M2I.13YJJ0,U.GNM69+7C()K$GL[MS6K -]T9&P>[,3[G=,WP>=;$?"6F*I3M
MM<5L165BLL&S@MD^[@>,]\F.,KOV4@+[U:-<]R8N 3<8%"GU(IC#(OBPS9HR
MS+>M7;3X=>(NE[/$RY\<,BZKOT[6:;L,,NZ\*8D2N&CI)]YQ<_7%KU+(WL).
M .YNH# :$=:@L0+BPM\<%E>&KI2:N]@;5R4:VU?"W+6=+,-QY5W=/+%ASQ".
MXTW.B)#JIH9(,N2LJ*#O']4*E8:1H>&KN6/F2SEI/NK;_.L<!C1%YBD)/,=Q
M]0^#IB7/,CNM9TIA%K$2#_D+L<DY07"A-*,>$=AA</*7+IQG(%7BY:YEUY=I
MQ/,)G\![,\"!A79QG/"2?$ET0WEXU+WI7XIU9\M%2J AW(I#V^54LBES+0^]
M+V\ASCZ0LBDN+5CD"?\*(%8Y E"1=Z+4UHPX"SEU,!O*LFP=\RV%"U//T\P[
M#2D%@G@*',H7;O:%:S& _3XRBV60 ,WA7?"W['=0;V8 .K1N[<[XRQ">'(*B
MTL6A.PUQ< +5NS&PBUZ("?K5 HL7"W^QL[ )P*R2NGF==SU_BVFAM82V)(S9
M9NXT]PJ>X'"8XO[U=F]O?>^K,D/FICM'9>#9^XN-&4\[R=&5P]G&7^FL!G7=
MI(8;.8S0I&FY1?E?N0T=TG@([[Y'G3L_,^<@S\"4:[1TNY<VHGM0ENAO<NO#
MUO 6C6?5)?FS E]/*]N#UT<:C+<Q4UA*/W:M1N$-W7>KC')=X-!)<NBDST2;
MZ-68Q"P_"_M.=:M+X*QLPOP3RLVTTI4:2RW.&E3MC0Z/R1GG&<.6'#^.F^N#
M1J)L?U0@$5+EA+K&4WV<)0O,![8)AJZ/GP%P9]KT%<P<EMJ;3DV*[&P3ZF!R
M74V'3RBG*H,>NN8PW3&6OUY$IZJ=!5_?-C>XG20YS605Q&YKTG\(J=)KH;-X
M+]1$!IJI?K;38K^&S(A9F+NAIM$*.8:UY-V/\NL/[X8,0_, _\'"W!X;OG3F
MP=/VA!FF;RL)W62,;#3 9GXF^_34)2.1P42]ST.ZP4UY?E?@U=3-6C:V;E''
M3,8GF=::R#DQ19FG :$\^%27F$HU&>ZW:]+&B*5P>XX'D9=MKY9PYU/$_;'+
MW7)#VYQB AR+!BUO&(6O$7=Y?(^#D2O^]F2&-%S[FJ+,E11<0>X (S2EDAP%
M:HB4T.%[7YIV5\C)]!6*+47)2J,PEO('_7J9@G"?^+<$L/D&A=G9L[?$& OX
M&UW&P<YZSRFJ9P+O?KEYBD-/\6;[^GQPLLT=LD1/SR)2/?=$-+PHC*Z6'[EO
M_R!<I)S]F7E.IA(M.?*.S,KQ_B0,L6ET)=-<6Z$AK5JF0C1XKYMI<1%-3L_6
MX.@Y*$731L$3R.$>"<"FMY/-#AHR"KHZN^P:BMB777.0Z4* I"9"5&/CU9)O
M"8@5;O1ZB$D9#R<NRPK>L+$U5C)0M22"UM/1.F*8->PEN[#49=WX+Q>O&=F\
M70>3L=<6D8R]TF[\@;U@-@)_K'8#H_AZQK##5HOCYDK/8[)^</]ZL*CH/U@U
M(HOL<,46)79W+Y 1I_A.F^>5D0>Q-KBF.^_SB.0<M430",Q<Z5:Q6B%:*[A'
MW!T)48T8JWRY.^8R2_>]YVE(DB4A;[PSZ6G&A)JU:6M[@7.L/1DV^HU!J^6;
M'03.D&-^%'S)@8O,#D^18CXJ$\U O&I'_J686*!L5!/@&#H,KJ3834E-^'JS
M+#:O*K2WY+1E?$3VV)6IW?=VK;F1H(:ITZS[<7 4$@W1J;F@*K31:/:PR:E\
MC@*5?#RI\5?K#E$!$00T&DA 2O1SPI@F!3GR9GK5_7J+7;2YJ/N&L$IS MGY
M3#3(WB,@52D@K;?(COIN=.G'-$M $P/)>]"%<PQD&W5E;]F3OR41ZZ;QB&;Q
MT!PX-O@QJ-2=9F;B9\#:&VJR:?EYOI2\ZB5.->MS=]^15[T")J\:V80:1_/;
M"34*;0PSD:,93P3T@MHDJAQ-]>-R$OEW,F]T\SK%0T^]8W0<]7[R\Z3"[+F,
METR[)[-DX?N;QFO5\4ON@HXK5=^H6??E\5=]6JQ4EZREHF98:C@8N6.O#VIX
MEX5V8;:P;.*.%>3T(U%-OS9MZD30QXN48U*5TY6%+]1_R(0/O2TRE-1B'SK:
MMN!4_5BM_S)/C.N=T2FXT)#>_D\$3PVA6I5B_N:P]I[235O7G 'W7<+,VO<F
M9WCH^>J;VM"H.CK)'SV?3(2>^@X:AZB^211,>]8=O;W1QE];>E\KL?/&%:&W
MS$.X2H&^+H$$HB]">!3J.O1\@#-OJ+V46WO05O(F,88@NOK/;/L=H]FP][M>
MOLS09(/ 34'<W,'Z]K'Q:'9WGMFM2UOLMIQ'^?_<^)VT[Q+J56E0TSYDB&<O
MT?:=CV+WQQ?J3TY_\0*53^J&C<_J=KR05O5*#/JJZ'E <.IK^D<7(#?D"*\2
M:0Z919%Q^H43L?F9%QYY?F^Z QQKLB90G)3Y>!PJQF(V?$M,[P1*%/AA T.H
M^!X3DY<Y3<A[JSL?6 ^/4E1Z1UN(A/7!(*F;%N _V35P\%G$.''03=BEOZ07
MWN!QTO>:,FB_PVNX^U.!K9VW"H>N6N!Z<? 462(?5%VJR5X5LF;?/V('LU:%
ME,K>(4,16K.'0F3P4TG+P&JZKO!O!N)?%9O*E,9/Q\5?/I/P8QU-]JH3:O%Y
M5Y.ES9C5[]7\,(L.[Z'^XV&@03;,*O9,+R->G' F@ -$!C@E Q:87BQ= *Z;
M'%;IE"[/#5QY(\#^ARF'13]9LQJNZZ[M- P53<G+U0C.<9V"/-,..YE^M*Y-
MJ%&E,]4L"A9ZLF#?\]C(0VN%C(J\I(ES"Q2YL=)DD"<,#<]UAN&?A:B<']E:
MT:K1V>9'B#]\9'A571:V/U*7H=V]>\%$W6#VAIWQR3*-6];41<'3"\#NRF-(
MU Q-33,MZDH(Q5L2X+-M=AY:-=D2='4Q#)N:?60702CK>DI=9;)]':3AR.GL
M\^73DL$MV%?GD]%HR QT.2('#5Z2K"YRL/;TC=B;O/-E*?;LI/RH?"K#,%Y-
M2RI^B:8839P'4:S!W+%IV5W$ONYI$O#%:<!KE_T)'$D"4'9+]3 &2$<97@%K
M8T] "*T";R21,;&E=3^H G-O\0GD7.+9H/P*M8>$&9. $\0S6$A+.6O*6N>8
MW,_6_?7Y6BGEM"U/@:NRLY1(?[5S]RC^=OW]D88MI[^WD[C.\M]0*?WWBJG!
MWTNVX]T]).!"J0BQ3OY'6=V_K$#Z/W-)!_YE"I(8Z*_#DD)X_J-8_W]>U'1[
M2HMN(419$O"8#/S=E@) S-#'1TTV.,>DU:,,Y8$: 41*&@GP,J$G 6<4T%S$
MJ&!R>AJ\0 *B$9[9(<JR1';/17D",X&.2&CZXX#_\GJSV['0,1L!!R6*?AZ,
M!M!#V(=#(0L'V@=2. P)^%4K:(.3W4+J!N00178+18>*%RG;P$N1JF17)$5V
M1;-_'.VW,03^.A: O(<N5/\:,3>W\8[Q# F(X/YU3G&[Z=<YA=N_E0K^3^1K
M/8@-(X1E<W<O%(>?.9!GFOLD;!-,10WR1T+_D6&C;55>$@#+A! ;9X]H9W[+
M\#=?O_GZS==_)E]FBET[.FC)A7LCB> (?T[!"M:G FYO; A;Q\+E<KM'M$\6
M?LZ1 #* A/Z)67^=IE;8R9D6[LM8\(WXBV/\_)NO0HJH )!4GK?A/6II$D#;
MU-)T<.D)!"L1249O.416Z OHAL&7)K0%(PE@L5(Y1]$/;46@W0BTYFQ$.G(\
M77Y"3OH@BPO'YRJE\.?;2$#[I)X:X E"%^.Y2,#-%/)"0J>@V'3PD@E6GA@N
M04<"3GW\!85'AZ]S=^%%20!9,%_RWD,7JT!$81C6B$B6R'MMLD1:G,%X':^#
MWVS]9NLW6_]"MG(\T1I+XZL#<ETA@5+* X>Y2>I5CZ^Q<PBIB"&S0ZY!L/H@
M>O!&EN]]$G R90&O!D)GJW)"AY71^<33$DW8Z.\%[QC8B.<TVO2.1;+.D9D6
M(KLT)@W\15@$_$!/^1+Y9[3=B/SU11<I^QK$T/)+#3.*5^",#>*H-7#_C$0Y
MV)<$E)N3@#^1W5 6( %\AB2@+!&ZH5Y50$GF-YP)/4J,6@\'H[5<R.LANT=:
M@:5\ LL0+70QD>Q97Y9M10/?)I?<7C#=1(1YL=Z[#(Q> * KE4U_7O3FQCL&
MFS_)4.//6U'G?Y'RS9^%./SGK2C+B@;6_KRW5_ZT%T[YV2$*?]G:O^S%;[9^
ML_6;K?]TMI1)@#'6?O'G'E5T3FLZN[&L+;TB-^@UM,(J.&YI7J2M7.M\T@>S
M37?-V4QQU,C9K@^:]V0<RQ D0.!\Y,\,$G"#M?H?QSZ[U^65I/(*-4P_11-1
MC'VP.SO%_^',A15:X0K>N""_>I$X4$,"WH4MO"JEO4@)QEU=(8:R!-^$[<S"
MCFETCFB_9(?(DH#?'_[]X?]%/LRKH^J&TE%1G;UD[T&Y:'=M2^P]L:V!_/^.
MR55DJ@@^HA)^O+'06[<%=/S[_4KHPZ_0+X^V?YC/9(=(0S_N@C>DO8\D0%,^
M\ /V.GQ*5<&[,Y =I:'C,U;!VAH8GG4"E6234"D9'K#A&/:)+]@@B<.$2#^R
ME<4@>IP<HW^3_DWZ_QMI!2EF!_FK,Q+]B8[WY_A1_:Y4C/VG'"0C_2JA[<NK
M[AN7_GH ?)$2]+\*][])_R;]_Z#?$B"MVO2@V\)YRFJ2'*8%((7F5=P$_&\$
M<]H6]O:+2<#D+/2"A2%%S+^3?/)W'XY4 QZ1@+_1!/^-51?]Z^Q-?V,7]C=6
M+0SO44G]._6_L3HQ?NXW[=^T_U6T^\8KB]^X';2[W/$SU](T?B#SUIMUTECX
M,PFXH,-%K(=_NT[WO^_B?]/^WY,V=VJD5T9&G(2URAU?MH"XEU2J>VN5).!O
MG^!E(@&O1*&36N #@=^>^C?M_X5I>^R;#M@O2X &&E)VW5-Y'X DSWD=DX [
M6V(L)B0@(>;6\0#YP]&S__CR?JT3XH@# =Y^[3TV*>%- @3DU@D>\2'"V=$7
M@?^FZT0N_ ?G"'0[!RJZ79R01+QEKD?P<OMFY0V<TU?[+[\>8=N(:GU-6&IB
M!+(<=(P\-@;'@E<MZTE "'3#R8+L'XHA>8#BO["9 F/:KS&YT6!F9:D][27&
M4%4>QV/C&.]E$H""5<X[5D$<U'""9_O?<)Q\:LOM#[NS3@(JR-^ '%_*.DT"
M6H-^%3?K<;K0GJ_!_:##*]#-1E&,.>K]'=FX5<^QM]D[,'KB$*$0NO'!5X0$
MG#[\];;HGV\4SQ64P8I'=^Q0MKYN&"A*FP2HR;: L7I_%%O_?,/ZFQK()']*
MI>3_'>6<K0,<-3)AJ6F:!""E".>&3I* )=4_2K1_N1.0?"[(&OX \TE9'@?&
MY)& [+1%.%[D5\$UY\\W$![9OWCFG="(( 'VQ+&F@_O*+"0@#/='8?=/-XR^
M&^K_] ]Z,=.-7M@A 3.IQ&C[4"@:#B6*PO[T]^?>:%6$WL< ,UXN AQG0 *&
M[Z+UB"R[O\K ?[YA4JNO,;Z)8702:(/^95/ ?[ES*'KQ^+-JR_^DE$\AOT =
MZ>0S<["IB^\>O^H^^L+] [IH9/-_K$!^J]UO*?^6\O]V4FZ1\M*;*=JV3]ZS
M;ST?X D7:7OW_7B7_MBFU -"$^B T\6K[T7&-X!$VN&G';[RH>-6G\ZI!;VS
M*W/Y9H6V_-!*U0GLQ<;+3C06(#(;Y;8DT*"5W1!5F>OU5RQ62 !-:C2@9+*S
M?W7;8?:+QL5OL&LSR#AS)OT&[7#U^5QO'^(Y0N&552I(="/5F>9D"%;#]JA\
MMM2@\@MYG^LWSSP-U$)KUW"])#8_[%K^^G,7NJDXOHY'/IG1\V&B J__*"O6
M&;49?6=(87V=1B8,>/N6!,#S["_>?.L]GLIQQTT']A:Z=()01 (V"K%LY)W=
M!&.+<HH"P80"IM(R5Z(HED<YM=_6]QFD0:,<@\C?1627AT_/RX>+EU< %E,F
M0O^D/<&$UZ;"%D;4\]NPJR]](PQG.'^W7&U/K$5*P LTQ:!DCQLO!X60N>^,
MTP[41\M(<X@&*J_S+O@WQHP<^!Y,#3X;$%Z^'0X(Q-K@C\=[ROBK+?OXU1EU
M=J@<[7OGWT7'H?Q LI:^8IA\9'A>ZC+BN;'<%G2)Y]5AUV&QH ,8>27UQ,5&
M82S_S0&D'E[@N[SG\_'B#9Y;AG#3-&/!!,,RY=>/6CYJ_7JG:W;8R[#B5Y-8
MP:<EE%TO.+:/]H^-OPY>6?'[;M^_BN*!9;U'2Z&L!!_"EZ'/EUVW E7704D&
M/8MN,Q_8OVI@"Q?O1=.1M9!F)Y,:3]N8EF(;[J.YS4D"_.)/>=1U5DC@6VDH
M^?_MA6'[Y\V_GH(WW*R#Z<2\?JV_WS!CC]+@#K^_'!DJI#_<%9G+@1]PLL""
M,(ADK:1EM^>+"KC2I4.%PZ7BA0,)&OZ8F/ S9IH_[&#?]R?A^?G^7_W.RXGO
M,&D8VX1<&EO52Z%@L"^!D0';7_:RLV:$+&KVMS3$BUA>NTX?1H9N,(-.$$>9
MTX  N\34.V/JP6B]!NE1& +A:$5W4[)U>>E.^"/E-!O<W!^-"2KC+G8JC]-X
M>@1^5*;M:VE">L\]G%VV?[ZD3O&Z*F3]*5B]&(Q^'CP./3#$TY$M\@".-PJZ
M?*(S!/C5V)WU19E3BU$I:DK:[J3.N4R%S:[1R<\V['6)E?HYJ:)C1ZTX-4)!
MJ>"/R>74YVO>0J92D;9<FL?I%?E8;4S9&*LMB!G/Q"W.(*A(R;VXPCZ??I@)
MTD@\=E,-ZBWJ)0$--V_7*BC#]P>\W3M?O=,<UJ=6TW]N;G@OL@YIV])K_OF?
M"F1@3!F,T]_\;@,^AV<4++I^45F)KU/=\^W*2&/2!+(=&=MQVLQ<S6Z>^^W[
MS2SP$&M,_J;G-HOLG1^BR4-OMTROTK /'6WJ9@JY^F?0WO?Y%K\>YD!D(Q1[
M2Z6#HZQIF.P=7FW0MW3ZNPX\@;:>PAF17<I]M!21902Z9W10>;G+->]1G(WE
M.LT[VIPB)WV'[JL[Z3JS=Q\V"\0CXVJ_/>'?[44(!XX68.TQN:/!)F0=>YQ*
M$6;3]LE#-KZVJ_26S=+"3,6]1Q>P28N)Y^(&""%M'+N'Q5_%=[Y[Q[QF5BYY
M6YCV_&D-1R=TR'R[9&?E4[@^ZZU3%&F&)Z9X=%P,+G\HK>>7>3U_#+I*C@Y_
MXLZ8? N.%'X;TK=GTMSRAKGXEV;#KRIY(_)^2AA(J)YWSNFM(4R@V5<G)8A)
MI=;0/N.XW$/WLS9$J&BZ5^WG36>%H52UVL64=!#*).A"/&.4ZFD?2G?0U)EK
M>(NOR'^R%<=*_\0WJ1X?B[%;98[Z&O1Q73[U.?QVK9W8#5:N/#_9M9@F:N)8
ME724"+9TT?#FLQ=D!E<CX<TX8ZM_ZF5V)U-3%3OZWHP8Z[+?S*WYOZ8]U/UU
MVL.,X9*N*F;-T2#C\)FJ%ZP9BG12SVN\B.5@CS?$^@VJ-/Z\NM("0:J42(@W
ML0;2EB/N_Q)-9"/X,^3N@#MKW9H9\V5_MP>REO'_K"N!O6Y& 3[F]9%)VCYZ
M!.KH('E2/U '?3L\PQ&.U9AS7:<L-I'>>S2$J<-"T"OMJG(D(#QUJ=3NRA-.
MH@OOY/4XJ_?J5#HEANC"VKIU6K^!H,CLC4)[]I1[GS273*EA5+*3^^L'I70;
MJ \5Z5P=42B[^]Q15VD5$T)S>6D$D*)O4RO/:J1/)OQ@BW"%.L#9??74]H13
M]S1:6#85.W)]JCRAK:K3OO.WSH1T49^18;R5,%.]HRR%,W $B08:HB\G<5P,
M5!*AO+:=7HSCF6.D<%I@4CVQQ>Q&MO0[&)U;;8D#^Y7I*J-L, =P0.\ST:[Q
M9A3DNM5?WR4UUM/A>+_<]&=/H=^(1J L\O%#>U(M5,HHABM4JRNCWD'2'[;V
M%@KGJ]CF0\);A,OZ_M[K^5S(T>.N-CA2:/\DZ!R>(3'Q^JVE:0;?0<]T,GRA
M84.9D-&,7G,35D_K5PBO6G"H<+A/%;=J1P=7,"RP3)2&[T\@#S+M) 68>HVO
MJNG7+J2"84=K(:I/&]&1*(M'>4/M0Y0-=Z@L?8.PZSSR1@$JU)B<NB2;P/MH
MY;N:M(R1M@HB&TY;M?_0"%<KL==-D:>_I)\$U-\\Z:O #=OO 'S=\'P0)(3
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M"[7%?SW*6^ND>7"2O<1.OZZJX<TIWG5VWMQH[.0B!'\U'R^!H"=[SVX2D""
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M*^49ZDH:3<T@E?_;^__071I4X.CIQ%+4GGA1K+K'6*+^Y-L5T#KK:P'1D;4
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M-!GH@&=P[7 VHN!V(^U>9VKNQLSG$DE,87Z'N& /2W*Z"+/FT0,: ?9F]<$
M7Y&=K"2\"0$I!^;:4'2NX@5%K.$,WK)2/(JW2Q!0%_L1^?CI,Q+PJ>LMBPG8
MB?[\+L:54%P)BE*\(JQ$;V W%MUYM?A.KM"<I<UNL>T^"9#0N1_F]Y9YGKEH
M*,'0[39J"_;%C=NWKJM9E7$B4*.PL8]'<D*[T ]X5:0[G+6ZR.@AU@*U@<\P
M=L$KK_#RCS=H?7B2_NQ%?IV%A6J&FXR6^/K: [-O3V]^F%ND3&5=!Z'OP>-2
M)A?HE266P(Q60278TD=C"]U*,=.Q5P0 $L#U2@.1XE0WJ<SDC5,FMOH/)CV@
M;ZPX'V^->>+K5JG;*^S\'/Y:X9[_$G6>;7:MW'Q&;XXW3U7TV+=&*6C+39O1
M0!.I\$8VK">1A4=?Z.HR4>?'#?&<HI9S4.4V9=>Y=XN+E_DF)1QPT$ =-$.>
MHZH(7L)%5J_66>"6O7>^=KS,/<OSS$Q#')""TB&L,#BTTA8M%:5LMGI+\K-P
MMM>NRO]@[RV#VORBN,$ I=!B;;'BM%CQXEI2:/'B[A0MI$#Q4 *AN+NT6%K<
MW=TI7ER">Y&2("% ",O_W?VP[[N?=F9G=G9FGP^9Y\,S]YQ[<\[O_,[<<\\-
M-7].);YFR?'3SDU=\MCTO+((*XSF5T)_0]3V+?$U$[L9CEES7R627? 5&;$1
M5.OCU![K\2F-)/;)ZQ4S.8Q9O]N8Z#,CVFP,YI%6W1CI]BTPY^3J<P(O?/E]
MB.$A>P!]+5N1VO'P'I=-#]/*^>/JO+R=)*CFCI_ 4MC8Y:W>+.!/W 1V7)4Y
M*B:J<\C39D\]_O J)W)TX?X'< I;\MWP'.R/"VKIR"B@BNKSPA=QHMH$=E*>
M$T#D-:P6.&&*(OMW@%JQ/E6R:(N'$/XMD(WAB0BW6F-U,;"Y68%3V/"-:$L5
M#7TTXX5_&\LZ7S%3%VS)99")A"_3!&P_X+C*A_CW[YD4K-7/N;TVGO6QN)[%
MUZT^^26D)*>(K]!A1D3JZB,V2Y6<5/'#?M?K@:KKZ+*24=X:&JUD7%(!.++
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MO#R7XQ&R,F:5=-[390EOO3"B[I!<)FD#-6>BV?)LH-/^[)A*7'W.<BQM:X>
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M\/(?D/OA\1C 0[(@-3WX\W )WVO<UF< F@GT/!#DS9<$'NI\3/\(-\ ;X#,
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M6 [((^1>%Q '!'QR_Q8UL+3:_*MK*6LU8;-TNWW:Y5<<B2"A%W]*,JFL3D(
MCD7;F^,VLV+,>S1;(3JH)SVF,_3"Y8G#:W.'2V_4P*Z4?KK(%^/7"ILXXA,T
M>,RQ7(5Z,Y=6=126N:52\)&ZZ@:?;6(MU_AV'W%L_:"YN6JI.5?:, UA^&N\
M3QS16XC*K NR1>B \>6UAP6#/_/(YFU(;E9EKIKP,([T(A?^(FQ]9:K]'<H(
M'52,44$_)0@7^3Y']I3%S.'Z6\ W.@T7ECZ;#QXDC5Y2SUS[39UDS56US0Z<
MJ@_392)3"2NY2DV+@9))?^:"SXC -BG?N"(-MRKQ1!#W$ O[B5%"(Q%AO:NL
M2%C?'8#\DPSM=(5-[  #U7G4L5YND]6TV8JX#PV1W8LG77 &;WT9WCEIEAM]
M$..361&38\7>5<$&["QBO:/%1WMIES]U=XYW;T?[ERVAN/F7AZ!7A?H&J?T-
M/\OB/&<O[&?L+/_'SO5S@.P <*#AW _?">KSI9CU6Q +I[1!J/_D=4-]X:<.
M:@1U2#W1&,? JN2,@7KLZ8!ED@-*JRKUWU^5>(6%-&?9<9OU( NY7OJOML&N
M)PDYC=%\5UEY;A36/(-L<?1)B2"5%.'MPFJ!L*4$JV82>U/06<VSO\ZZ#Q7P
M$DG=,47SGG&-U:%ORIW+: QQ'VVM'?CJQX;\$BDEB@J8'(^6*[*4?6 M[:>F
M^[*HPN<?I_(,I/KEI >E#;EIB3)]) V @^70C(%#'?1]WG.V1<?%65^)0=:.
M2_8!_1;L9UG[P2G_2D'(?/U 0OHJ[CY%F]L_/!)XW-R/7_M0QT77UXJ-E@K+
MF7OYRK\^?3AJI,:)YU1^N=1+L@:;:G&<\Z04&<)EH>88>U'],X:2XJ.N)9EC
M[_U0C=8N.. ]!?P,O =/,_US,BI PT5SJ!V;95H);\YAU-9%":U,\/P=H.V[
MH$E-8D6TH)+XX%F^>GKD7I&$<N,(^2X4#TX6> >HGZO=N'KR;@,:F3I1XA#;
M%[XQ5S[C5R"P0&,M\Y$C$?ZV,I^F<,IY^WT\3Z1HJKFB^)M^'XWCE8UOO@BJ
MRWZ4=_Q??Q8$VXP,QQ1_@92<!EZ@]80VJ_9O:O3W M!"VXMR121+%R/]?%Y]
MT[2!?E7#C/_0*SB/S&=9U&N6HI6@\PHC&;O%.KV4F$.Z_0O"#PFA>B2-NWAO
M"-!3JX;]OHRL;_MEX8D*)&XEC;1OMIV1)<,/Y:I_=_\^ A5.7Q">Y- 9TE#*
M>@("'EW/1.]R!/HQ'OM[/OO6).@^S])4$:<\DZ89]MQ%4$1S)V [ 7Y:*N95
MZN.,:+8LCTXY[!YS:]1/_"L6>?/ZUU!T-<$7@GN'^TE:L3G'W812R9B7& "E
M=%:GJ30I+N?R&(DFN@;]XX:JSB9>B^C;4C]G2Y %_+?)75JKP!ZR]3G$D\MU
M/N$M30M?.:KO2<=NEFZM !X!#-M4SOE+-7Q)@MI-3,NTH#B_ \8B6$H'":CH
M>Z8NA!6IS0>I^IQ^T+.W>Z&GNQX-O=['XS"<2N^/+JV3&PO15%>D[%5$'IB1
M;7DE("XM)I>F)LQK$_WH^I@<2!AF^ZP%C85]'PX^)L)K^K=N+7*4LM%95]AU
MB<Y"H#8G/B0O'J:#!HOW6S(H5QR@Y,X1WP8!F9SKB(& -SWR1D]30O5"R:;:
M5#?F^V;1]<7@GDOYR;FU[FN^W-LTZW*1(9=CY7@<J7[&4<*4\3\;<"\RO <&
M\>;^,Y*-_2=!6 :$1ACA))837++1)N'K_#/"0R'<:8;/U(9R(;/@M?O+K03S
M221='ZW%4=*-Q%:OL?9R0933P[1<AS*-:_G1V.KW]-OV?#?+V^1GWC_)WD]Z
M!D97J1OU4BHA'E(W O,]]$ZC835Q<?7'HB30?B!MFP-!]*Y"4TM4;V/UD@-5
M#=-WA=16(#A2F<:**&0(3[RB$^6$KMUD4(!2@,D&W98F-BL))NC)#[SBOV_-
M_/P!&?'-"OA(D_;%EOZA3BPI@* *1,NL)V12HA">G_G,S;$@J8R.O,9J#*!-
M24%*ZHX5V99,.QK9LF R75E##V[!8CY7Y&4MS4UT73[*-8++)U4_#O&._Q9=
M*^K?-&8#(9J1ML[#?$#> 7HF*$%)X.'#7@=[OX+#2QSM35^ID,^*P,L\N9_.
M6#[EX[=,&G,*I3E$E=GX[^.K[>TXTM&=\C,=K!"YVT(9'C2Y*G(@?\/B(5P&
MYNI7!%>R:ZE7J >8+);N6 I6>SE0NDE7HV^3UBU(*H.E7^1_&BIS3+]>[&&A
MS6YT1T6-Q!9":BR=G;^N:Q(D0-ZC?R$YNB2SHF4>HS_> 1YALWC4>$?7$/$F
M#AT??G2IU13S#I J,I26WV;*"(L=XR#25)&EGSH1<?5'C4\9@,<6#J>CVG70
M0U%V]T:@=^?7XXMCCN.J(4%GAUG1DFV S^5U^E48]M%>L2CL1G2?A6AGR.\K
M?15K -_.W[AR@)]BB0,1I&RRI+R;9<_JJSY^_G*+V:0F6G-=B0*O">\$/6_B
MXLHP(Z>4X<88]D!/S43-3(Y^I^WW; ,^,Z[2"2P?8%378C+B\0,/__.ZF#DI
M%XFJ6NRUJ)3!.#S$CB-R=SW;C^H8*__L>$FOF7X=)3*[M/H.'++A=T#ZJ)MI
M/$""W>$\H_DI*]'+F/RTA'$R5S.]F/.OP>Q*O5RA\#.<["#,IX[J.,U@Q1>V
MFO .;:$_=X 8M^'_!6 ^X96T54>BI)6^108ULD;3[MC_+^@"TYAAZ0AWLK31
MPY_!!7 <:J\LE>^T]NP$-@@:5!((XR2X@@K1\-Z6V)AB$[^*@=/9<OX7WTEJ
M!E]2>EX_4<* NH%69HXW/2W J ZBP[.VI9/>F/>+)JIB:RU3!:.I.M"U!Q4$
M "[2BV/J_PM*569W"!U$(.9116B1K5N!E!.,@1":VV3J>.8J[;42Y#<?[N63
M)OR%I) E<0J<B_+_+W;[]7>'=EM*A&TH2<>):6/U9P\ZZ]..N#<TPF&/QW,1
M9[VT%J'2#GGRJ%;YR<];=28(:EZ\LH^ZU0=E"N\ @C@B)VO/@?9Q86N,\\J,
M4O>,!K4_%1UCC\UP==FA$3VY ^B\M)>BKG"-E9K/R2&<U%*@5 #\)(N"KF<!
MZ^^5ZJ\D6T7C#:25BT774:PXN;KWS<_]/):ZM0G?4#[02\Z,'VBJ1'/9![E(
M"Y1@)-#M.?Q)Q9\N2VUY#F0.<Z]0HWY!/+G8!]P'MU(H/;1)+D8'&KX$#<%V
M;W$T^3;,.'D2%04IK8>QLR4K>.-ZDS1)L :E'_FS0000$P-DA"M@Z_YKXT-:
MAA&6$<>I(2JCYX+QR)J:^+?[BH7OWC(1^_<\7?:?M*B[[.N,;:DO[25I)5(3
MI"%\R9[BQ;4W)\ZB)WX'R*YWP3XN1]2:-X5UP\C/Z7S8X]ZN@*#"A$;'WQ)L
M G6P77[K25T\'?6HPI[.8)FG:(X-*%H10IU;$9'[8W4;7G8Z:JS09<?/(D0>
M@I>T8&#@"2*Y*)N;?SWHZB+X?#M4CS@VS[(4K_N!ES#.J=A_G5$*800BG0],
M'!E99RHA$IL4P7Z%BDXR/B,JU+NG>3&/*3FD5"EE?AJ, Q_R7T#AJBA4W*9:
M=I*KPP89V03EW$U"@@OQ*_D: 2;^'ZQ!_LN9M@@E4UAM?>4"QSIC>YER\3)&
MHCIR!^ZJRMV:82B4B236+K/TQ>_W)0N2)MI8"_M*;RP6<J[*@*<:_<_$3&;E
MH]P"H/JQC)TXC76B;SI@I7+T#H!^11!VG_I1^R];$)R_,5X[_FJ>[U)@M (_
ML3E[D:25PN#-22R8%QU(> 0Z[VE;&[@#U%;VKH7? 9YX\-.AHWKO $LRK_Y@
M8$<W)PW+\MM7VC^L;Y>4BA:\.'9U,M>W7=_2,\;= 1[<"\+Y=?#4W 0B69_X
MZ;>MR<C-R/=Q0NE!GM%H\7W9$HO&VTQ:Z!%H*\/$D*6A/I#H54XH!6%"SDH7
MI9XBX/XQF!(9A\BA?3;N )&K9#/2O)M9P!L=V4Y"/B?IOR_.1"5;,,B:JEZN
M;,*_;QDI[R4>ZEDL['6_?X4?<R7.H 'GH*E,A:ZGR[ U(^Q#H)_,_,<G;N1.
M5*:/3W[5[5U.T)JW%.))I^#%&=\^1WLCUGIACS!TUAL6C_^N+1KCI_U ^6K(
M*#>X>'E?;=M9I]I)9U],0%ANL_P9,8_2#).Z5IFP?7ZF RX:<&<^Z35^_XF+
M*9EEG[A+U\RSI0 @$$N T4=,#+H\ O?VWP&8_(4/-2=LOW1+DX/*&03'_RTH
MT'C!Y>L+V*+86:1")ULE'M8!UY.OQ]-^_072>9*H::#4ZO-3^OODJ++:0JAM
M!U-_UF+: UCG%Y#8/BB>%=(5R861F+H#U(T6..7OB/YJER^&LI(Y?:^HW+@\
MNKCW\PV+J(L3<K2!K*1,?860:*ZP=R,9_4Z>(/F.=*C(502+8[3-MP"EGV3C
M$C(/L",P>CKCN382I)U&B Y\]8GP'8!B"%=. 8^@09DU5BYXF_CW*.%-;O2E
M1=5)5!L4Z;UQ,D@61IW-VH+TBG@8)9*:4&Q.G:#MH/TIF>6W]%@L;I4"\)4Y
M[O;>(?"Y?R\,3]JS7+7D8(V,1P;.R<MB:&IJQ%TMP:/]Z*DR1_& VM>X !EZ
MM/6&?9C5GS:V7XO[M!\^FYH8#=8)Q>-XOS$+!U!9*7?M10(P(;<I_@004G1"
M/CIR9',MUI,)!URIVF:C:E1/9R9#'?SJ@=TFU6@4\Q==4=>XM.+*ADZKSD H
M3AO=%J]U'XP0^^+ GW?&OP]%[6706-44RYY"-RK \[1S-1IP!_ (=,T,,N]$
M<J/>H*60WGW/0-F<B#=9J$K^:_B(;\31]O?SE1>![U<7 +8UX(JMC8D>* 'F
MY62&"L(E[#/DC34+00+/9J]*EZ5PK-OXVRT>Y9^D-1WT""B& H1]"HU>%4)8
M#&1)3G3KIW^HQ,]:B<D:'36COP.4/S8+]WCU>_C[@7LHY26#CTM_W&+0AO<@
MT;Y+&VC]YHVU9H@<[\$0;WVWUJ2QDAE-LLVZ +-])  -10G-O43_N/$#GPR8
MXU3!5!&L\:9#;E%/8L6414N<S2-M4C[\^AHM]JMRFFNG@Q[#BX#U ,DJ(M:/
M<2=ZK^U.!'[5?:!A K@DC!O! 22CREUXT@8Z_W\+YO^76S"WM0ZNU1/T3(1^
MS?W;\0*9%5/QB\XI=6[%IB65'7M8QK5#5FLY#\.NW %H/9F"H836]7_^Y=7,
MB]S$5;_S)')*))3[E_(']=E)4Y'%7_;!X].U17<4-2(L0H;A;P<?.H1DH+,(
M%!_U^[/\3-6[!_RA<L:B!MX?SYZ9,(D*#*@C@WU\"JO')!/W4!YSA;-,I!V2
M:(+-;LX-#8H%Q\O'K3$EU9'K_)=MA8_1E_#(XTI^YNECNY:6="G0)ZV\5(?,
MEPH!-K4"ZX"'RB)7\!MS_^$YIMKC[!](IHWZE7]1^.5'KF..C7PG#B\FTGBT
M!7BC8_($.'BD; Q,;MY#U)$$ Q8+!KVK'#7/J)O:0X%/B'2YFJ)_1QN2AML9
M9ORQ=;@1/MH\M[EQ4/RAYEC_!GN#FD+S%AZ4%ZINC8@UZ2^8$X$B?DW4%=/(
MO;FT:A<%,H+]M[K/T 7S^HTSTD"2MC0-:&'CDL[(6]64TTLJ9KRN!\AHNTZ@
M/R5&Y#:]7F-QTM."'(2J0O<M?;CD%RW[L]HM/D[%K8G^(F,*B6D%!AP"U[][
M7=?OIB!QB9(3-8A5G":UWWY0^Z+7]\W7WFYL%2ZTE%G<SSY[SDY9L)W4T-ZI
M<P@+Z:3'D"%+WLAC:"HJ:H1/ _?]TC_1OKEI0')Q,A\[*WS5O<=9&4&TU/IX
MACUTB]?6P]=D*/J)V.).9FL(SUO#A%@ @]*@AI;%(^P0]3,,_FU5FR(">[O(
M>Y*^I1J3N2[%XM-P$@L3) 4>YIO<MGN2*&X1'./<LP!S1EEOWWPCB5/O=9IM
M#8G!&7EZ:!;0IOGXCX5A6LUN8[LO$Q2LV+^D&"<M5GAX3;)Y0"N/\?>L'\YE
M]AQB\@RP="/L!D0;L&V2+1%U,5*C(VS7U53-3R$&8,0@:19#5E]^NDYXMT=T
MSI[$3B@!!VX;'O91*Y+VS;MU5.L&_##%2%KBZS17)Z-9W<_.;5:CN"UST U[
MSQV \0[PF9\:HM1J(3CR0<@,_@]+E?0:7O$FA]B_A,LO7=U@WZ+!^?7.O7E_
MN"6IE$3#;MY!@&B18L,%\* %=K"U/7S,A6FA@F/U6T/2]UQ+B8O^K[S^'G>
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MM2D5_"X$?+I^1KH7,?8:B/MLO>@@;6[)&>;<NMO:EF(5*7)A;P5@TC'@/LM
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M($U0Y%//9\ 0LC+$, @#N"8+?PY="<EW%-665UHN=1IIR&_]?I-0Z;A^\[M
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M1R='AOY:RH*C#[!I3[K/MJ_R!"9PLG9]6&F_=H#@/!3CIO?$OA]XAS/:]HD
MB-4!4[S#A_/ I,NE2W_/&]NF0IK0:QMF=A1:1[MR:&EI'2B_%]*1HI%=X]HJ
M1!J-EU\,A;H%GRTK6I/QH#YV9Y7OIQ.22$S/)6?N,[-53F_(%3X>^]RVF@0Z
MD*#WYT,"[NO+6VW[6U$0PP$O[C/(]27(VZ9/VB#=M* CW>P$Q\0VAZ6X/.",
MP!]A1Y\C)046I1I##!&W*;, 3\2XUM$==\"<$14LTA)5)NM Y6HHCF0MTH*M
M!^ NJJ,P=BIN@^B[=7N(U6W68V1^AM,T%I45<=$10^=V25)51#MW7UDHW!B4
M_,U/)U?Q0D%6P*>Z5@B&^-MY45$P1,HUKS]N.+JFT*"1:UYJT[3BHAC\. #;
MRW<5^ D]M%EHUF6>OVM)T=EO_WR([@-!CZ8<5E$.P"GG0,]79L"AB:2(YRKY
M3A0^EHR@\Q.'.1+WE8*ZC;!A*[;0NCZ/\[JK7,A909UUAK20!IOL3^Z;[Q92
M315T1/IK<D?&&]'$5\&3$N0'".9?K4R[U]>8-JG'T00O9=T'JVH^J@4C <^Z
M/&^J<'V0@.ZQWW)KCMU' 0=ZF2OO?T'8!C+7]^VI#IDS984MS!+-5!5VMK"G
M9JX[VN:PU\8Z<-7X_9^K-$[Q]W>]\LDK%4JU^H0CT%Y4\#,J*F04D[2C1\++
MY:"@)4/9MT\F  G(.N*_R3AUN3V_,KUOD(NZQ-;-'R_G?/HSFIK1UOI7'Y=1
M8-4+/\X[MH11VXO>^K$(,#J<Y32G*TSFU"@I-:2J%F:NKF[KB;AP$-8X^'U!
M$\/&ZJ+F<SARH.%.L+5$,@.J&>N,/'KL_@7QTLO;;IZ;<<YQ(\8)@QX5&Y_&
M#O4L<:GO+4P7DM)F>[)@^I =@/;.2  & NQL3Y.IT\]B:=<Q+X<XOEXDI#IC
M%MO.O_\)_("KO]8380O"2U,[U8J)")@UYRE)_N7:52!CS,T]:[-I*D1'KP-#
MOU.W,7H.F1 CADZNEE;9)AATW9<S0+HGAWR(*C:/#<?=[?CB>>02>MGRN-64
M5:?6"]75XT,,B;==P36RX:>^ZP^YO>C@NNTIY&$@]E*U?LS<VN?L>KKH#-@2
MYIO  QVT>[=?MMKWH>&@# 5,&1-+,,&5PKI4_62@ZC#QARD//,1JU)R.32>1
MI3#QM._P8%KJY1U3,R[#K_2:3L'B!B3:F?DZ&\F=GE]]A-8=$=ZR><4C 3I5
M(O+?I.X3^=2.SP4<EEJ9QA9)>D6G9*L:&W]/Y)%I^54M=MS'!3#Z2<.BU_S?
M>=UU@J%1N&+ZTOF@[L;UR2-N0KNZDY2Z^^DM)^'K\L]PR[(_4*$/"0B?-TI
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MD\+CENREDH;!Y2-U5[]*ZBPKF=\&!BRJ)7()KT"^,<WW_J+:\D65!9HHFK(
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M=-0E\C;%)LBJXDX'929.SR^R+V*R6MJZC>D5%EM;^Y/S%-S) K1,)%&!B$9
MM;4WY29K_Z!.P:NB]L0Q4[5],C_/7U5?BU^V$]BCQ;@:]+1,W1H.?RFOPX5
M44;Q6H#KZ-U+=&MC72!\K['W%DJ\,M5)QYHF1.G96VJ@>8OYG*D*0I3SV"]\
M5["U._-=*KP!<"<8>T,%WV8#QC!-CZ;3VR6NYLJ,! 1AW5ZU^M^'-Z,6PES7
M*#(Y3GEV>@,D6A*Z;YNXA*6!(SAT8B'RM1]!GZNQ;K'^:1[RWU6X^4$W)#7
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MZ(&C,,I;Y^IC25D<#Q.$GCD&4Q&=/E[Y4G9$(>J?K5L"']!\^49<2K+[K ]
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M"OA2Z[&M=(?',WW$<B:-H;7IG:L7[5R-6;U&TZ @[L[A&.GR4^=1(-D^XGG
M(!@: 5NFIH3=]<PB ?AP5YMHHNC+305[ZP]133H+\_E#Y%S]3$P+Z/27*^02
M *LV,KJ)DP=/4(7.1O)I6[O%/K>:N-%.>M>%\^/BCPB[%TUFRHCPE#&.V^LH
MG^IBV/=Y5KC(J?#IR\]6U'-UCY" (Y(S>"Q[W8[$7'D0W+-@7Q (55PBP)44
M&<)-_/%Z<RM+<&!STU?V.=7TH5[?X<D&WI=,K;13T0W&RHTQ3!G:83<V?ZH%
MN9BUQ*IB)RC!)!.6<Q^=F':^G\%]QBIL &JL!A73BY(@KVM65+-U?5R>7CM
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MM%'\GST=A^=(=XR\G)XM=:M/&"$^H20<(9=7-FOL%O^U*\,^!#(#AL1!RM&
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M5WCA).PBP0!A<? %$P);I8C\YIFBV")^S7Y<(D9MCM+^TG@Y6XZ6D&BU+_]
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ML^L0^6IJOW&JP#S!9+<VJ8_ZH6M1?7_5A-I;3;8J /;/XA<HO#&X\RJHBQB
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M *[8@C+2=A(@@15@.IU7]0%OQ[C2=(+!!4Z$M*4_>LM2EGUTASH5@ZEEFM$
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M+GOY3Y"?%1J ?^^L'I[3EB,AX]?X4'J1\_#R1/8@QJH):N#4'(_ME7_30\F
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MKOT]><P-[J/(]L?J6?/>/*H>R\"9DV0F."OC=/5_6ZAQE7D7?X40X%%R18'
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M.3T9_?H)X%MP7U.5O^GQ=,3T"\I>0Q?QXV= 9<]Q3*1LVLX!.O,=\R1T%YQ
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M$*,"HS\OWEEOXQ(G*A0#L#^^$=&#%6K[4AW23S7<)U<W[&7_:ZVY>VR/'G:
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M%ACVR.:RL]4%+-(WQIDV.ER._Q=$\1-YRF^-QK_GL+$-$H_Q4T5/>W3*E6,
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M7I2<JXY)>4;"]4ZOXMEM++Y3CH*L-!-U@OD47"#9NMT6][O[C$6RPN\^?0?
M6G'RNS6/YK\+PW =KNG,5XT_X*CK,VI*U2AXFW;2:1+FH;7Q9'/#5:VRD=TD
MN[ 2H'_O>QDCJA(^W;ONAF0136T((_DPUUQ3;T/Q.73HUUURR8V/F0M.?D1U
MI2,G)S9_5"OB^"B^/+_WP:S' :6MD+6SF]M5/)"[?5]WZBN6)6A5[Z0GS(Y+
M__%1UH0I?QH%_]F3@:&-((+^3]6^5NNU:N-]Y:4.B2;WJ<BXFDC_29H8LGX>
M;GI.HZOU3=^<+XL=B]ZL=EWW%6D)9Z6"PEOPRWQK)PA985<,.V=M/YBK$2MU
M';A-4?EC!_+QDV[YH^B7)QN11\">[+\#$H3,3]E0L7 A#LE*?*6QH, BK]84
MEA]0Q-M6^E9WFJ7UVTN A=9[U<7ZQV]2'V)?;*7\%^R)K7_3HBA\KJDM_IO\
M3\?X:^:.OJO!B A3 $$TN@D#"+2+*9>+_2P#E +D:?/>8L(CB)=CWX.=?_(A
M_G41)E7:"$809G,X?T='*(T^PRLBU<?'2^-#,G[?OOAJU@P&L)<=>4S@-9;Y
M0<GYQ]K*LRC1J$+J3SC"HT!I0QF(:$CRAO\_N!(G9<)?_0A4_W4+ @Q>!EK2
M=K;MO_,EG1U]EO[1,%:!"6S5FMG9ZHF,!6UQX# S8@#JNG.4D4@DF4)UR51(
M1<Q+<2\?.4_-W?PR*]X!Y1:=H-@?@_GR%M^:I(A7TW"7TSTS3H==HKNB2F?&
MU#U79>\_<RCFS?[P/.2N_P$GF\%T2T<)EE?"2KZ%]]VL#&CFX5^SF3%_I%T\
MQ_5DWWTICEB-BXO]-JJZ?PEFS,@9+7JC)QNME2CI]-3$H><%VE-CU],[N7MB
M8*BX<#5G09XK1J$'N[RTX=\PI"3GR4O'7B?^/U2C^O-R$&I-&2/ $TV"*8FW
M.I'*868?QVT!?R[*C4!'2VC_,]Q _@MZ4TN5#*'6/RHO/C-'E*YNM-4=V%:Z
M1 /O371X_MD\_LA<[D_R*E$]@$D--^\_Z3YQ2$BK1RH'FL?KQJ=\F+D#&OEK
M5/,?M^62$W(8T^Z)<)P <+[486VL7]]PQF( \M,\N'?!LK&+7::1%]<%?^<F
M_O\O:Q!G1@XAMDH<5O15L5".LI'=QL0\6?"C%&)'[[BX^W6IEQPRC<]X:]TE
MBG9&@UNP)R1IW>E>PG/#@?&Y'Y#JNE*\_9IJ0D)%I+AL]2RP8>B#LS%$$;(&
MX1;)@N^PVAK,"PIT5B!/B#"4N6A)4RU\2HQH)R#T@:B#%36J7&5>\E<OL/\(
MZ?KU?T<M*6P705LWYDN.BG&<?Y.0N^BQ9_X(A+2^6%_-.!CEZ>+!GH-40#"
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M)9X@5#25X&']*%,8?4!?K\#I]D%S+1CA%GZM+HQ'C0$4VW;(>=!EH'"*,8
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MD67Q)$4JHWU?'-?"R_+1V.C1%C+4G=6K<*%.M3>GAA7-6YGNJT?<NDZU#@
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M).0+A"%P#>1P((.*CV(&^ZO4Z-0YH+CE/@XHIF-VV![*59?9T+T?Q1K9-<*
MD3#%V*-8?TQ@E1QEY_EB?5PRVUQKMPX&"?IEB')ZO>MEP G6!^]&9C/PT"R^
M<\"X+.!T.D:X'V>/559> <Y10[DHI8)HS0. S*866OF82 310$#_ZQ''@8:(
MV;HPM[6OS,, _W7Z63X-.R<^^X=/33\F (B*;[:8KYP#$*HY.!V,.AP8PQI>
MB+N113SA7FE7.U6Y)RV*2&EFD YY0!GSO8R0LD](78"> /'&>&#.'?$1Q=1G
M1-1M37T.<*!FP&1W_)"&EEL[UZ?;]RQ8YH>.ZSU/9"MYYT?,*6$UC.1"!R/[
M$%=A >7F74-!MGZ%"W4)I3D[C!OS3R=N&^^KR#_,+-^[2IKUF@S *$^.VH%F
MTRK>\)V!LE+EBLY$!7*)/-U&*M0FEFESNS9;!E,/?I794[A?J5+)C=%!)6NA
M?O="8O'4-<@Y)VD\9=/$2LL4PVBFQ@A1?YS24[6.?#_1F3J_S6B@.R53USF
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M3\%1P,O-U4^F7KK6B2JN6DW1NFCU&YGD6]^>CU COKZK"@@(KT1D(CD/O"*
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M)$<G(6@H ")Z#@C-,^D2@%I'>'L*S+G.PQDA=/E]^_(]!WL$E,URU;*;Y8
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MTF5-HLC@8LTL,+K'.J(_A=A''+7>9 O'CN8OG -$DL1>Y;+'T:5OX<E!4ZE
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M#ER.WMFDG><ZWJYR>5:#;(G&1\'\Q(<X/V>\A1$C'O2ZRS1!^[/W42X*[/-
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M5D.N91G44[)1'@K@JAR/;+\P'1EGHT(!!^%GX993#A"GL:>=\W]=->H8?MG
MZX3 "?!Z@P%H(C?R%&32U JG!U[<_L+GZ^2S'!-4U"278G!\KEJ/4JY#OT(=
MA[-=G*AW=T2HX$:D'S;,ULN]*G-X&L#X[OSKL>7K"J+S8C.39'K P!$OO;X6
M069R$!_-EHN[J?*U:JW^L4C[@4/C7^LUR*XI4P_JLS>Z7A8-1K@$KP<I1![S
M\R,5IM%V.?U^-@F![Z;5JM_6QCR3"6')V *2;YD$H@9A8= &Z. :^.>B_6<T
MDW=L?>*S*=O/,\K#NU:[EEF<.M^=AY=2F 69DH[6_$E$(X).-$'3%DC$0W%,
M9)EJ3B!,+\M^8G_'\MAP1E*0<J"7XI"5*36G+GFXW/?3GVG=:2#8=C ;'(>4
M03RU);GSZ;<TXC'A+^_G.LA^*_9Z?>79P0!/"E>(H/J8J:XZ&K@\,1BNP\[=
M=0J*+,T_!:G__FWS![J83@RJHY3H<-OYWPJV"::G:G[T$56R:C+9=?)CY1;)
M>:/&QF=^_<:SFXP,UJ<@!@2$,'=K=K,9*".P]G9>FL35JH[/_\R^TAA0(E_T
M>/B*!!L/[WP<S[YTV%E=[=I.BW$:ON['8\14,+R0,!JK90,&-Z=+)N;Z\E1G
MY,7M;FWST3]@XR,H,0IBWR9L:7%:=GZJ_J<>O9"%PW1#>/S?45G]#WH;[=D)
M',6JU0K16G9%P]ZMP=_F#VQ6'SW7O^I_43BTGN.-"2A M5*AOX$&L#'(41CA
M/OC,XLJ(0W6_RRGHW//C-[*IK,S6$;2AZ&FI3K9YD:VKCKLKG2!D7F&< .%*
MC.O8^C 8T-.9UD<.I1(+SJ+B1\YS-[UGUO2H= <3E0C/J%-PCDYE_U*<.%#7
M%RBT?6V[K2*QB)UMMOI,0\=[EF^?![DR]9]]LQZNXTX/G:=.KIU!"B#>$ PB
M#H.#^MEIEAM+?&:\S[;=JO,A,[OOIH#G-89OL6V,5>!;#Y-,0$&-M2>(0.T#
MUX$%[X:PV[YSD7?H14L#TOV&ZSR\\JZ]G^N&?G:?:*!$(94>^X._/1"KP:DK
M0V0T!^12EMSWT2U)1S]UQ"DI1SG)',O0 <RB3+^8/.!5TKVU+70OI;MHZ;&>
M((?>\L3Y/X,T2[]_EIUV'<.>_"SI);JTS."F1C-*@/B^UKR:4IL ^T=)$]^9
M.2UVFN.37SK$@?Y@YCV@BV)C1%N\&EDF&+I^ )C;!CB&V5D>/#!>D%2"9GLP
MFF8<J$4Q,1XR:%D5^,>O1^^*$C0WI'L\!?SK$3(3&WC+!N)<&_[[CR)/Q[J4
M<WON<R/A+F Q?RG]H"0W2]0"-XZ_>^R\FP9ZYR]!;*Q'0ZS&1^IH+:S=J)12
M=S<)V^(BMW ?H.LZ\]![/])"=*V;-G8HMW<R!"ST[\M0?'"[^L)JM77CWK;7
M2G[Q;6_R^\5<4QK*L*N87THB/Z&'QZ_AIZ#X=T:G():F?_>_%D?>"X)B%:A3
M)+^<Y%6GG5/0I>4-48K;1[P5618-/&P=),O! 3T4]NJ?JCI:\O@M(GLW_Z*D
MR0@$B4H,\NX/='\P^]+VX<1^Q4R82M_Y6X*M]%_U43:@OU949EML#@1,[>L\
MU](0*=$\4XK!M*4^9)#%N&5>&)R.P24BXV2&VW77>.51ZR50+DF\7%/8WM$P
M]-RC2V\[;V3O*2?#/&6_S:[>>>E%C'JU0"4<B7=64OY!LJY2QZ"TP41TBFUK
M)'96!WP8?)5F;U,H^28@Z_HW1>'4T N02 <D36JUNYB!1$]=0G(TV2083\)Y
M1IMM3"(>E.C7U@XLK# 25!G'<T?^G-<Y\'W!R!!)^QK*#2+J#[/&_Z@N)+.W
M3!ZYJ;^L>N:V\C@JZ<[598%KX[-.\50A(&=]G\S-WR_&3(@J</SD=@()5]@I
M:9WZ'G#AVL?TH8=.=Y[Q*<@%F!VCA-J\\!#B6R#TQ2)_(E+#14@A6DI&='F5
M;9PZ4F;7.S-]?Y>:-)BQ'$(851?O:-M0ZQE.CD71D:WP)\/FSO(^P>?M+LG=
M-GWQ+ES9EC%-K"(H??K].%,63<6BRIB%*:(@X+-A8OYUPT(1L+W34#<E9WA^
M=<78C46/)>W<X_2A[B[&]<,K'"TD.S?+S.-&*B]P&WOT3BU7S7)612;^+;/T
M=[\HL&S*M=RB9.3,I'\OT78**8D<%N*G917GMGFO_+LB%^*KWQK^O=U^+B)N
MHGU/B,MH[R-+B0M_U-V@D9#ZT9IB5(\:#IR0QU\W\36 FS85T9(FKO[)7Y>,
M1S9[+YKUQ258O$WA. -ZC<$;1TUG89/[O_B\=LY.@'#[Q&S%PUZH3@Q]M\EZ
MY =:M?^S]$8I?$RECL2$!BI.02XU:U2^O#)R6EOU_#[1T7/!JANIB/_J:K9M
M@RS#Y8QXPA;:.SHJ:KI%3+^,#+?&!'C\K1)^1,FDF;\.,+B!$B3S ?&%_D'W
M".V_@RM^YDE,9N_=\.A)\;C@J#XD.U*__OR@^0R((8TFH!14CY$/@97XLF;"
M86*K*:=_[Q<X9M%B2G*:5X(DM"PPD\-8W_7$"WUOKB2XE-A#(RL_6M$@@V>A
MP(C?*8@;XT11V&CJMD71(?0[@M_\>M(4X#,LD#GJTQG[2N&"6?,=4I-HH03'
M\)<;U>(U@ S) D"N>(M"-]:BJP\-NPU]1AQZQ=VM.8/'>_VR))Z\KQ/)S3]6
MILO"-ZV/]5>'GH(X4"[:*'A.K^I)==R3UKG#8*5NK\=#9ZH*B.H1%>7*AMVY
ML_37VB3%W@KN8-;?V[P(+Z$.0-ES= WO6%F^>6QOQ"E<U'Z]^7V+Z".-C*T4
M3HX0JTHR/^#D@T=WJ79"IK6L*X UL_-#7GZ5;G4!Z3#E!'N3PJ+7>](OGZ04
M)N0U' Q3!^%<G:Q G<WT*<@)'>MK#\;_:/*>F\MC(?!E*RC/5W'X:;>!\WBU
MV..8;AYP?N)A0-.FM=HED&V-!2D"7S, S562W9[RY5QA&%W$?OL"MHNXFKYT
M.6_F^ SB&D&"RGR\49UHV8B\ ,03K+6L-DB:PU93:R3H3J!EAFNZ;+H!(]?[
M^EIW4\>7(J!SZT*DO!"M!\394U"Z =!Q"GHV<DR-<VTA08 WPSV86DR/NTX/
M3]1_+<M%_=>RG$?:5T!T866>E/V3JH50;P$Z\/"!3I:Z]G@8;3;+$S5DRJ9K
M[TQ>-/W&),E&K%2(% /G8-=ZUIC\+7$XS;9$L'[=E&1S#&=:O:*D8Y=6R-TM
M-,W@;/M7F2=]%  9_G 5]4IQMW)XM/GVU7ZZ;[]]M%BE23WJY\8^Q)U8;5#1
M[N4(9B#>*8#EL2T,NW)3,NEF2M>2T>/. OPEZC&Q=;)34;[,H]4='2&)7W(I
M43W(UF]5"BAH=>\>T/C1(3&X*IH^(':&(!;.-NRI6E:R/%\T26\A].@= Z<F
M_4(^^#WJ^2DH+MNO%P)(H\(0KW'6SS7L([%->:@K?H83?7LQ<9HU+)\TGR=E
M*$12I9#3:)YVA1*@M#>/"7#":D,L8CUV=K0L*M9&@HE^IA/*:*?P9VFE-T;U
M7^F*MT&CT'7L>=$D29KE,&K9^6;WITQ>FJSVV/'BP^_M=FHOE\NOZWM]36KH
M ]36T;M7UB$<"X#,7: ;*]A^K;2KT5?H1R$V5GIF=W?"=Z"8\3=K;=79'Z.^
M]('9(!SJR0^".74:WO!81\E$#,P5OWO6=AZA]:<C[.OL\9VW"?GJ7R-&U]5'
MW%'="KN[6X#2AK;]$6^[VT?_L8>>Y[]M*%$^W]4Q8MZ*?**KS5JSY]9$R40]
M?W<*>H&)6>,]6@.,7A!$LQ+0)KE2F!=IAR.,7L$?7);Q([)U;>1FAAN'%>@8
M>"TDKAX>ESW75QV*YHSN3>;R#REW.]$^"EO]I5$1LC7J/';-^#C6AS'M/LO>
MFRZ(F1';&RT/0GF]TQLET-WW7*D_7QF231"QZS.J*/S#ZAAFM;W5 ^Q(<1\+
MZGN1F\]Y)7#A:SNUWK6%+=QJ#4'F)J&I_Q04GU@I>B;/3K.'RM7HKF;"K<'C
ME!NZ]DKQ&_WGP4[!?W:0$^C:W:U^3P' "2<=2K95ZZ5=77NAV-V*AJ)&V[?R
ME8_39N>NB7@FRP);X1(B8HIT2\@IH=S&9)(ZV:RC+>-I4W3/28Z2&B7P"TAL
M<YUN.=4^F'01-11'UCX%U1BA#A]8L6\H+!AO. UB6+?M(4 ;P?-N,YYT4SJC
MP-_JKML-3P]Z=-V0GY+J@9#A^=OG$ZZ)^O/NT0CN_ I9CI)'5L'O;5.%?Z](
MZPLYK/9$.J2&\:[2;8F,,X51>S%<]<D14+P)ZAPP91_ ;SA^.'*7N'ZK+3=L
M[3&6Q^_%#;,]/6\=?B"#9(XPQW?FX- <_A LFH:%EE)M=9\)EG4HE>.%E=MW
M)H/SV./NOM]0%^P&Q?VB@JE???.X*<D5U#- #U';X]NOX^S@W>\ASN$54\.7
M_8_?5'0^6W__IS/CZ_^^-'1%#B,%:]#$/Y1RQ&W)RR>)%8MR$?_UOP;;9W\^
MZB0\C:<"O*O486CMO5-0';S/,^YDGRQ9YY\T/  K&4U;JS,*?!&FWCFAO.?_
M(M-ZA?J8[GV@U0-\^+_/C?3"$T]!@F0OKT^VJS;^?_;O-S?6QZE:R^G5@[F9
MI,.;&_6U+S,L?/P/GJ#[/SW(QY2R(D=*OM9=!DXEES5J[M/J3F^%OW2_3D%'
MNQ!JF,PZ;!%-O<_0MV8+HTA%=3@1$RGY.<;CE61>;%ORX6!#DO;=/Q)H61[!
M2,,]5 R1U.&5//ZZ6:.9K,.2"/T^0[1,*MT2$/&1Q7 G5UK]K;=;4ZY7A-+<
M;Y&9;!VL$$Y6>F5K%$M<6;F%VMC316ZC]QA.0<%<>2'<OS!U"CLG6JP._+&(
MVQPT@'I\Z7=0@#ZR+\*G^]=%IKQU$9]++? %!V* (B5K8%6JZ5MBK/>2NL%]
MG!_D4S+ ?VP2;&OOX9A8&EE,R0U#;@-HOQD4>J5FV]%?J/GKVJ+_]WUHI*\=
MY&\P*3( /CB62,0P(:"0M%B_:OLP.;FWY$],UA!*ZKP?]);!)ZLM@]TS.+=D
M$<2+N?L_,N3VDM >X8#EI2NA1T]&CAP>JU^B%]@Q^42^9H4,3OWIM!"!%["=
M!#9WVMMJ381IAL-)XR\P%^Q-[5B9!F35;L6H=G59K+<VF?@0*>HV:4L4F.L<
M;$$8E I7H,JO7* E?$<"->,(T@MG6"!KX.W?%5@/E!/]0_/T1(:O,02AR\@A
M# W>1RNQN*O;I9>X+G>[?Z!V;HSUX%=%IQX,J%U-#K8_!55_(_^<4:Z.@=9%
MQUU,+6Z>NN30JKX>3#R^JI&L+T*9%1049(@C2:Q#!\KA"?;" 7;GIVSJ>NQM
MROX&_!)'U;[RW]'79EX&.M8UX3%KX"-W<9Q4P#<YN8H(+Y%M9GVF)BV(J>$^
MG)LZ3+V$IC&<8/WSQ'G;M9::=ZCV:MKG#1(8:S>9H77,8%[Q(<,UV,H>DX@N
MO"$A].ZL3J[ 4*N*ADXNE+7Z(3)RCIM0EQQAKTCSTSKI4] XN^],'\+C(I(3
MZ$H#48?1Z51L=0+MB.T/CN#OB #F.!"-1:7BF7H5HDX&^U%<.HF%R[:]WBDJ
MW6XMUMRN&4PI15L_1,NGBRCQR L#D9G'!BG)6..6Z\AW">#9<FK?,9<1(>R[
MN?,*IK9$TZ(;BM19J&Z3V3M(V.(-[0^Z*F<SM(-$I6V^O>?+O61Y_]A-'^FM
M? HZ#W4*#E1.W:^WE&O6MPUNZ&)"/T1-)Q!5B I=R4E\<(%Z==:!3)OO;R%N
M]0_^I 0:OMMRT6X-'WP%,R,H=:E"SK<+?W3.FB@4-&UH_Z8>]81CD&G^Z(@Q
MZ0BOT 45O;T.3[0YGWAK1<BM?ZKJ(O\Y8]D$B:OZ =T7-F;TO%K,QEYE7+U[
M5:5@QN<4%-W0GI0AM Q-*+U__4VA3G(I667_1_+DW2VD!&I(FP"EA.UA#HVM
M]![O]WG^E>ZD3>EGNSD:T0%QT/[D3SI_FO#%/\?B4<\-7@ ++FFP/7D-],F+
MF>-B!"_IPBEHR*U!NST^F<(W<UP9#.5&=5;CJT?05WHP>V R[,]-/=XN\AL@
M#LV&%-FVJ6VV_<N_,WLW\-U[$1&_13I/@!W1+V1>;:Z<W^ Q.#-;R::M;O'Q
M,*[EP&D0FNRGBA%3;JN\"KL^V',@<*L,9R7-SZ!=JP29>*,Q-Y\M7^.&8Q<?
M?E"3-5K7'BD==7/E$3TT%^GV$\6A@N;S5^NSEPT1E#W,2AY;9G9A?2]:VKG*
M?,@H=.)'E ,R*)58TAC3JG%.I::::DZR'*O::"%E3OT4U$B#8L%1V[LW#+]&
M566U4@.I'J<@502?T;N9S.MF?<[E01-_74J';#>32VA^"' ?*N'02Y%Q9(.)
M&$E47[$&:LZE_%=R".:/ 8(VD?;&Y!'$".DU:DA_ K5S'GVBX?JK83\Y'C^V
M#HWT-A%S].2V=_GD5P5>D%#_.T9R @P\2C]#@VS9K00SGSI/6KF?@O)*M^I?
M/_QL727?8?4\:ZTQ9I+R">H,W7GDH26(;4,#;PU57?E3Q9X^F)6"KD+[@KQ_
MOW>D5<&ZA69;3R'_/'H"X5*.@^(7#YP34].Q ;+C6AZ<Z (P*/29&/K7]4VT
M9TN:9R9=J34YS#]X?Z0;>)*G_9HX^3'QUD>63XH@ 9"5/)07)EM 08<CCY>R
M?E%>UJ]N6<(CRK/GJ),#U7X[!D?4IL#=I\ZTN>C=^\]WC)+9PLQ';UC%=FJ2
MI6:U;N+*W$NFW1$&'UU2&RKHI?X\]3EW3A1_'Q8(.CG_/ST6MEV-D-Z+O J4
M;8"C&\\OJ\609=B+3OYY<\M2RO8M^4LCE(#H"+YZ"NK7)X0A-.?&0KA-T@=0
MCIX[#3/#K'#-1DK[AN#@RPVM%R$:GV1R =_52YYT  (8>6G57S( V;684@M^
M^WA'S"DKSW=O5.;#_^OG 106O/N.0'.PP0C;?C%F@/6#:R#_XH\ZX]AVN&@;
M?^+G7H<!=N_%TMT, @RK!5V$\F.<3#Q[\_BBJ3H(/6RPZ]KCI&6G=U)1BI4B
M3\2L<YI A_G@JH\58#K@X-^-3]HE2OP+>Q8K.YORM\T"9IMF*_])?7-3Y,^Y
M"V%%].<NA.CY1R63'%T>(!=6)0"&<I>:7UF^C::/?VF4+JJQ_K595-^,*)FH
M"=/DW=S47^&@ YUHQ,GTG8+<QA:##"GI5/ *,&C::/? +.UYW>0A6FU8+8M]
M=&5>T^*A4MT3?/.V;C[XY8>6M6B=JRA1LC8>$_N\T59MUKO-3J]RYC@F8;PB
MDN&)DW#->]_J%"0G=0$-H6KYZ[6;K:-#6B^5%@17N2DWY_03EFK\E]A4M9Z,
M,RWS6(W8<P,UI'NN]E<G*E7V0Q;%D@N6[7MYJ87@A">YN^Z+>N>_UD0,9]SZ
MQN,SH#DW60\RT^.A!>*8Q$EV):@-HB):!V.T+.3J%Q.K8X[8KZLVA-SIO"=?
M0,?0R3RTKPNY96;OA%>%Q4VZ4"6AO!_P9"OT$C?*(1F<=86"COQ#'AG<W_+K
MO)9]^)4&->VLQL 0SABS%&\#V$DV;O5D=IZ-AR==.W?0.3T7SR5UDC$/&_ZM
M*T;2XS&EHP6CFF^**U^=S<IMT9'Z+Q/#;%\$)6\I6H2NAS$S"L4;3;Y$0(L7
M?F7;973FE"ST9!)G?5-E3;O/@S[&Q($L0*!_-27A14M87[3@#I7?2*Z+8#<;
MMT@VBX&E$RW>]ADA0YL8_IQ865>JYK=J_YVT7&FXZ7FQWK9CU2C'91[BJ>GG
M<&-+,)^UWHH.+]4I >V5DR5;F8A!13QR=N,+^$BJ:]?:*YPZ1UH&!:NH(2R7
M/_S_1#4]D$M([\OCI50A61':GS-7$.JX<KD7P7?5+[++J#1@WO$-4B$YU96@
MH-W_X?4B5F-(96 &YPXFS@-^^*^SMD^Q[IZ]68NYF^X@)<$/\ISE1PS?14R9
MQO\QTP/Q_ \!EP0VB'7 Q[7ZZ,1.'K(J "OQ'_5D7;1>?6QO[Q_YDMD(FZ3K
MV^H0E>[)>#@""C:N]/>[2Y!4G7!==,PKXZW\9I4BM=MZKP8F[)'TD(UC3A]4
MSG%3\&R]V^;OZD5-8CJ^XL4^G)*58S;%S:[<*4R(K)SI<UES[!SYT_2A2J?A
M]QH(ZJ)PACHI)MHVW2[CY76&B%98.#(!/XS>.8EZIP9MRY/-+?W^DO-N;A%#
MBB[H2$-F"[981\PFP+HP_(AK>$PXF==EP\YOD-_/UW>6QA?SEFJ13R]X7N[]
M<0![[.#9\035<TSYJ/S9:1KZPEA4?^&F?+954@7Y.^CY9RL8ND0UR4@\1.?3
MA_8L8C"EB*Q&NNT2V#SU\D@![)]^JYDO<"W*YXM6/$7UV76&DH '48N]X?6'
M%T)_/_QO.H!K4Y?6A-I-\!)8^60<F&78G:/0!Z<-O9=:E7^^.EWI\RNZ_1#%
M(*L@P@DLCHNLT0P]YS#^G9"U>)$KF9./;_7^_BKDG^0<L8ZZ-1ZZGX</+3M1
M"T])L"QB;OR/O]8+;2*[8S?&[DW35/=0Y?>0,@5LUAH1*LLW>3<G2O^[N<&V
MS!?H,TR\T"EH4&$AN5OL!N%.YI_?B_5^<F^(GV,*I>1_Q+XJ+!T6&F=J^F^R
MI<5CM>[D?S>'.%H7A@D YK:Q];9E)6&JK1']EWX6.:]=12T^L$8+2@(5V=%A
MT;TWVG6([A5ZIR!FP3G6:#NH!"JUGD+V.!Y=]LL'W_L0=QGTWV.0$!U7H<6.
M%?7LRRXTS'Z1[*!3X#UQZ9BS7]AP4\&K <9#5Z/GA0%K^14C8'CY2-P*^_=T
M@]F*C<YZEXT_RWW;@L8*#N&3+7"!(<(CQ O\77]7!3 ZZH5,,F"XV:% )%R:
M^AYPX\: +Y%*##)E*OE_3NG_#DO? NR*C.5T_8@^Z5Y=^[1R4\!+^3VYB>_U
M?K>2)M0%;WWI-S*_SLP4;J-,<X]7<U!!+3470MX8UCMM&<R[XEQ9W2\0\1?J
M:)UP)^NG\"NH0K&/S=%F-C+ZX\HMW4Q6%RF37HDW91)'/'3(. )DOAHW@"$,
M$QWP!DE:9E+MK<1*T>'''17BEX>,6SX\OOSKST##[O1_'^!C3+^"(+07$Z4C
M3WCL6QY\*;)PU37>=>SSO2>1W\_9,H%V!UZ]SO[KA!W<-2,9(:SP_Q=[[QG5
M5/>]BP:1(H(TI4-40%1 ! 2D!D2:"*B\="$JTJ4I)4!,*-*D"2B("!$1 2E1
MJD),**&)] Y2D@A(B224L#6%F_=WSQWCCCO&&??__W;.'??#_I:,O?:<:\[G
M>=:::RZC#.*6 &NHY<1*8E7;A4"EW.X;^,$GV3DU$O(EZV<Y-]>55P] B3A1
MB*^:$&SK^A@CE *UH* 25W80,]6NP ?I&56J: ,L\1^Q^9-FI#?W8IP,J5NT
M]]3]6*1O("=!IW,Q65ON\F2X.VBC9"N\I'S3X97SS,/>?Y;,!6\7S5]^(UCA
MBWZ^PGP+\0/SMRNNID"\12O\/JD57"J6H6:437SWUR,WGVMQU"78%RO/8KD9
M$91RLL"2,\.!H)RZ,#88XU:E/XTI;)5^ C$0[<G]U&W2;7DR_@C/)8Y?_SBE
MLH:0#5H]W5L2#+<1I9'3H_9M"XJ%QIF^O_G?DV^^C'IW0OK(W+YY]![ZP;\,
M91F9 A8W4H%;,LNTMI[@^+3 @L"ML8YH]]H2-"S9[5/,FFM K*O$J2=ZM=IW
M4STW>MOX_VU217!M@#28HPA9R=HT)P_>B<;ER4- "\740,BH6.&D5HN8@J5G
M>S"-]6O.8^/_RJ8"%$^24A++$,8]UFUT/(\8*+;N]R:CMD3=JN6<E,XW%.WY
M,,^C?^''PX=:2@L$@NDF+K.F)-Q1UPU[E]>S4.6O7^<_#2(C#:[7G1T\-C^M
MP)_@46 &@K<&'X .DP 3Q>_@.0$B^OA:WN@1U=W 2'R^D[;ZG?CC5V][F?1U
MBARS?02][A?M7IS\?M9O-OR=F-3C=U9<7VL:[ETNR3!VN'KC/[BUQ.%8\1^V
MY?<OV^*@[L=A9*NL0UY-I;]O2;!R+E&3UL($*!3. 0A'B;W:E5@^Y>\L[CZJ
MJPT$GTQL\  _W:'?"]X,)6PO0^HI6&C!9R;C]WZWID?!_ZUE52?\$M!'8">7
MY/0'#(@J/A>P=RTT'D_$G[G8?-,3=@6QO6WD_]L7]!9#(NVBCLL#X2$(H9Z2
M?I):PQ5YN9,JJIBB10SD'%C;,,8'JSQ< S\ U76RDSM97WQ@N[X^0G>N.+2X
MX,T1W_\%EE+^=WH8N\P/^9$]6Z*9!=JE!R#%N]5#<G#-2=91H/#Z5TQSVC^?
MLDM;&K_DR5)N<R1-K\?0O""]\?!<VE]@IA;F1"NGUF:\=YO!-RW>[<)7W(^8
M]PQB:L9E3#.4]WB<*&>RJ6X$0UPRPY1SR+/"CWI$2ES=6EJB6R&CYVS;ZWBC
MU_%FB*2=BJ5?=]_F7XH*5-QVB_9'A#(3#-SAUW_^\1J ??W[=:HX$9J E+R$
M3'O%-^3K..009]PZYH*%9=GTKR=_8@AJ_7( JJBY!#7\UK0XR2PY9?>QZ^\8
M[H)"*RK/]Y'YGHF:W\=?!_7P)\?KRBV^Q]5ED3T)N-F$=IQ_O?I:\;E/9E*U
M*4-YB2U1V:OYJ5FFTZ_E0E%9W3?B@YID8[)6/<D?7_@__."<'(5^,12.[D'-
M*I,2>SJ0L]+=4OJP\)4O8WNI7H*ACS[=MT!J:X/.+956,@)H4EC> U#\<T1/
M2SZ^]S10N-3*@YW:I8=RU[R?J_5J;;[^_)46./JJ)%=T'0D<R0-'2QHHFK\E
M#Y0D><65IS]Y_"[XV];4KM$2)?EIV %(!N9D23WV0N.'7TO9.Z>\[7.#GMFF
M@CW<C1O4'IHA$[>7-=-C)R=,-2J"I&#$ZNH[C]N*;=EZ*WQ.B^1_DG--1%<A
M7L.$[H5;JH >RK>FWQC?RT<%(3HN->]@"Y2\D4L.?4X\CJ]K3H1%C.''7@?-
M%^PFX]%2TPQ= $E4.^Y_JUK;U>;)U$--&1]_D>/1>9=OZ.=P(=01W?G8<T B
MW0%NU/ 8>K/5<L\,5^1*^!85PJEYWT>BPQ-U0[F"B48&S2-I*&?,.0)3@V1"
M"2ZN5;$.;AE7X/FI&4@"D81KS4.L[HF#[R#;+Q^ /.ELL[6H+F89>'H'&KA7
MSZ6HAOU)WE)1/<(?F3EJ>27GZS]G>0Y_E!W_\]$Y2E=?-^SR^EGBAOFW=4.[
MIJH^2$#6'VWP4PA-S0/YZSW:#:W K(7\G$:</0!-?XTZ +U]A8F&XK,^&%Y#
M<4*TD4NYZSQD0WCH$$.^&?I7CX\9A^X4G$;1XH:1WD/I;'R@RF:65#A;E=G<
M^^27DG$V,N?,X>1PB0XY9M?CH? #$%<8P!:!C;A$ Y=+TW]N6=9D6^V?]LSJ
MG:K**'$L\_ U_[5#:2SAB\@U&J%&/FU8Y 3<'*G'/H4TM7CD!RC.?_\.<QZQ
M!O=D\CR*@R9"ZU>RPJE.M%K*G:98E;_)J27C"O](SD@-K7Y#'G:")$8KD4WI
MX; I6JDS0ZU\K:=SX7B.UURI2ZN=X68<UDZW3?I/.^\'[A#$/0[PW0-0NQ[.
M4\!T:1Z#$V($LTWI4N'V4N52G\50^5S3T4L)#>A8]0FGD]O?N>R3QW]]<S!2
M&BZPWM Z75)GM%PK3\IG9$-2P#0U?_!?&\6(/3S\X0$H1XG*P^HBFQZ K-ZA
MI< BAKIP%481VUUWAY01DZYZDO?9 BQF.U\!66E81?/&21R EEXBMR->Z3 3
MMI"[5NB9;[N/P"0UNYW+(=!.1 DT]P!$N1$\6PIEJ[ZX)13W0M"8@1ZBC=K#
M-T KI,D/M,DK^<U)@!?,]]##[)^1PL#U[.\2%(9];$'Z*4"]1HD(^%P?AS!_
MY-'^;.:X/V.$/9A ^ D428G,H9:^UQ SH-RQJ:6[@E)=7=07!2GLG4KH1SEW
M1T\L!5L4GHAY2-Y@^NW(2YYP5]%WLGNTN[44V3%%@;0;@CMF_YI&5MYV\7&9
MCKOEL@Q=J.6YH?E1CF"&"(#EDGI2</>AL_[[5N.[QS]GF8T;N;PIRJ[=1+T(
MX957%0T;Y+P?@9[R9S#9H_D(YSD /4EH;X%TR6HLAO]^ZF0WP:>F&B"/6!NB
MYZA#Z8%DUZ70"4_'T.<-E;B")#6UDLM7KDF-S<ZZ_3;:IK"^WB46\=BR!7DB
M9BS\*.PWN5:>7G=U75+BL0EW@S)!#5"$]J"!ZUAI?[# GG[&7W12UJR*3O.
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M<6UON-#/6;KP&]0#4)=@UN0B!_9$P"= +\!0/1PM!L.XU>!I8H/M]YJ:S/_
M5WOULT[=/B'OAZY2WLFE/0,<*%,=J&;WGE26CE^S(&6CYZ_A5RR*R%'I/N/F
M-UO6HN(M^;/YA795E\1)K).*($@7)%=.0L_LDP3;H/Q0@$1 =V]) (L.(X2
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MOE3,WEW*_X=^-5 J6$:SVG+=4DG.7K!\&,K!$@>&"*\1%Z 2#+.O0'QXH'<
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M< *4KU;UT@$HQ4A3]'9?K<>5^JZW?L/Q7E^VAP1/=1X6>*'(:Y#M$<S.$H<
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M\^YQ^=I 87TJWQCUUWM@K]$>,>+Z.Z6W2*+JH>;P&/(N)%WNZ"3D_F*B(P5
M665N+]HTCI0UO*(I%*B)[U\126SF\8:^",WCLN0Y_0FAB_QF"O$.IG/#<@]
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M%$CS"?"D6K3IK+T/2,+?6R#?OS6Y'YK9X>!X>0G^A<.4"VI^ $IZ MPW.'H
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MW/UFV?+&M5=_O;] Y!A.%&3'UN9=XJ*PLR^/,\;=J)-<QYX7Y!%Q1C1_>G%
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M#WE=Q/6?/PLQOJSU9_Z_5;WWUPRJ"!?XSYW28Q :/V61E3U\&->P\HFH]D2
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M3'0:1JO*UZG;Q+-RUL8+DC,'[<_FTQZ;)F0*^(W8?[(81'$A[QR DE <\)A
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M=6)M8@)*J<QE,X<KVKVEOIG1[(R'QZ,'QP^AY)GGO&3KJZ2!Q* 2<HKYA[G
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M?^/?^#?^C?^?8?![X;\ 4$L#!!0    ( %:):5/_5:*",^0( ,UG"P 0
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MRBZA>)/$?S>@C^.XI!)!BOR7:__P[#_G6/1_R;/_R['_VZ]1X @S$V/QF'D
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M/PI4)4SF).?9/MN(^ 599N7?@Q\<1@W#3FC*H@;$^$BX)'7?T-(%FW2GJIV
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MY,'A@WCTA,]Y&/G%S0&,<H_1'(TVY[5\\,7.8TTZ8,-80J124<R8UU!RNP>
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MT+M#&QIR-91ZS*TB:13_,6HZ,WKXZWBJ[&8<HW'<(ZNU(:K=.D0E=, 4XKB
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MR+"2Z>,%4U2W5M1ILDK4?)+!@6;EFT6AZLZJ0RO79^J?C>B4G+S.J\(=]\X
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M-Z*/"O#9=*!K>BE\UO@I[G+_J31F1C:B+J5 QGP^;7@'C7\3M'POWBU_6"V
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MQ$,T)]H[C=$?LP?+? K"BGKF9GVL\U :#PAIKGG*_='ZJA'SKZ=G(Y>WSL+
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M -3__-(-(^*NF%'4^@Y#N#Z:M_I]#C5"E',V<E0SR= Z<NFW(+/@2UA3%;=
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M40F'>;.SP>/ Y?WZ>8RU[.J\NU2XA>V.523#9"PR(HUP>V9/M0="NA'A&W1
MQP;33P= B:&=MC3R*<I-'^MSJ2H2'S&$S.F& O19[3D-6 3L).V\ Y;?%UWH
MA6WQ-/#,MX\OZ^="/1CYHA58<M8_W0,P'84&$S$SRJT+KF14MLB%PFW1K&S!
M(0;]A=GRPIJ93TM4B]2?G'A\_\B9,)-YABU?P4=#LP?Y#DK-SJQ+$%OIB78J
MB^) W! N_ZR8T&IU)$+$_-(=LS"QU*Q>YE6F##(3A7'0S24'VVQP7N+Z!ZZ)
MI*>?GUFIVU>YHK)&_LRLC9!/85<Q^$+EW9LU58.UG(5\%I)%X4EK.89LFF<
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M#K]LBC@I__7F+7[6],> FKR1(?.6IH^-2\XTPLZ=;6+*XF>?/OLWX]A!W/O
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MC!IPBW8ABU[LRL"BWMY49[99S7)AV1C!,^%@I',$5.P2LP1?$,!_(&AH+NZ
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MU:R,4!CD]9STN)B/2=)"N13_/6SGH\K$-]HNVQX<=5F]^G/B YGAP/V5+;8
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MV?XFV+@?7E)%F9Z#2VE+?4AZ?1]@H$YMBT">3/=)AVSI8PVYGZ9D=!HGQW6
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M7(4G5X_.&.IRGAI(WC'I[B&I]3DC0*[+13)4RQ(DP%NTJ#\I*$+"<Y_&.L7
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MNFO>'8'XH,(9Q-,HC$/Q-Y]/\3K/2%21$ID,'5G8-X;M1A90]UEU +IL#,F
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M]/>5,VWUE:EJ-K5)'1^'.I\ISE2JU)!QTT<74J623Q3)!OB?WY+VVO*:V>Z
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MAQFSHLJKA3YXDO0\ZRC9Q5%VI#K!U<*WVF5>L[Q3IHVC?$/&I=/Y;+\UQZO
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M\E#%YUWUE[T&CK'NI)=BV*E:]M0(8J]RJS.T(L3"<>2DR.C@Z!F6(+&9QZ;
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M023HIX;]#UUKO1S7A^VOEO[\L[RPIX<W5O3AU0TAY7<'CR1JCH'&@WA2\7N
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M\:SYP*:.^ZIB;?FQDV5Q%3:<]H<_:=)[J[:N=CS64:,>-UFN)4(BL:+5V.@
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M/[ZJ4UEYZ)/A#T-=)4)7"HCQ^,G8#PW&>!2+I[9^K>NMT8E162X9I83$A-K
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M*Y7)5VJ2\$$-F1N"LS]J2_BJ4G,+F-D$.N[_LV;&?[NR0V:',^V3/83B$T:
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M ^,<Y0\)3+#)K9$ZQ4RY->AZ9G?<D26=2CK1)B<<//4I3"OZ##-E<*<2HUO
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MRRS%.6X)/9H=/29Q^%6LDOX?P1\L?N/_^*(!N.<GHA_9Q+2(F;Z _=.G$WO
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MK2%^S+X',9OV:6?]AOB,;+J,D+[OS$)_KC'8]\[+<ZO^B_KCXPDIG;S/LJ]
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M)6_#N8D]B>!/ULV@9+&G=<6Q<$4)^QG,LH:WBDW5UY1I4?\\I>ABE0\PH;6
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M^"9F9$UU IN+=BR+3LB[>>=_L/?>84U^Z[9H$!60)@A(#PH("H*"2"<JTD5
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M4B(D8D<[&GE1X4\JL='O5MW@7QR>C[JT_^*^*&@$W:X(T.E"G?O'PB! J5E
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M2/]GC:X7+8"V%?!;R(G-'BLCF]XMJ_#S_LPV?9"Z\RDX\,'YNGT*-PR@=?
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M_S_')'8O$DSJV;IY!,@1($> ' %R!,@1($> ' %R!,@1($> ' %R!,@1($>
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M[H#X/[8#K01VJRFC<<FD,UH+V=&DHJM8?"+*P61K*6$I(*3O)E)#5N;EN+C
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MS.97<=!$7R!+B7>7IF;W5EIP(IXAIX@M@%WM0\N';KOKJ%Q<* \M%JJ0/[_
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MIC5R^4#-; 8IL0T'^^7PD\: "062/:%B#+(A8$T%96@$ "7PQ(V!#5%RLD>
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MT]1Q;8VL)QO]#!AA)POC?P@XYWH6M9^H[M=9OY2[-T0(YK]RD[]=B&1CH/#
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MPA3C-65C;Y)#Y-@IH,8\>2M@),'"V9OG1DG*06OP0.;VI;-T*KR^.\=Q)<\
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M S'9J(MZ$A![HO^B.2_Y)EY^LAFL>S*][OM;G\M%-5Y9+MI%(5@EH6658H=
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M-7(:7EO8L"V! S_XN60TWAVDV3KZ D[GU@D[?$HP/O^ P&^]ZE$UV$6CP%-
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MM[>=S[!5^9M=#+!9-/GBPO#X#'V(=X?C>4Q^G5V78I=GGYAWHH9"IVQPFT.
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MEZKI6=2TPMI*\:3?;RO%RP&[A%:=\TOJT0!KG_<<78.U&\8YH?ZI,Z\^(V'
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MP(BT%6" B]?Q[626<U3]S9T9EKDO+./0AU!(P7L_30*^3"%JKPT+98HB7L>
M#Q=Y9Z4%P=#W?-TNP^(LVE/0<A[+RU#H6++9^VW>8FZO11I/M2BP<=7>J1OK
M*+<B]8P-X!>1J]QX&2)AA=\=NTHL9N"MCE6/H4QLDT\D)%Q)[:8OF+,2,B/K
MB!_4W6I;Z\LB'2>NLH&:M'8V,#Y&9[&DV, N/<91+1C+WP4[-P12^/O;D0:L
M[!O(16Y(9V\VT+_R6W:O __M?]);S7@&MAT#,2]!ES'(;GJ[V,"V:#V(/23.
MT6EHA@Z,G+4(KJQ40L:#S%:'<-&!3<6MP5' JKS&Q": N)5]_Z+3/;](M/F\
M!\RQ$&!N:%Q=":6R?D/4]9=>C7\1ZKEH_$^ZP-8U6==D79-U3=8U^;^@B9NM
M.EDG.GAQ^D&XQ5T)'\GYIE<O(JXF-VM)XZ4?T3ZS@?T:\%4:&^BUK+1Z0G,Y
M7#U""Z.A-.U4\X0G<[0JGJM]E1>*%#9U4MF[A!3'T'IO%_I_47]T]KUI^YWO
M=ICFZ^(KB*_P36S 88X7I4L^:_DMPR>[VKWSRRX#"[LK-<FJM[Z/4S#9V@K@
ME\PI))7S(QOH,QV%?< Q8AZ J_3$E3#FLD0]HIK\U2$T7GHLK).Q9?EX;XBT
M+.F'X1U)O:U^U_&VKFP@X"98>X"FP0JT'&>R@5"(KT#&VQY*G%O=ZH1>9L%8
M2K8D'3>(BH +3+0TZZ,#>I%?;GK$&V2<@ 5A)R3S00(-I'7#R$W^/&S@35PI
M&P!);&#8].<>8^;G5VP 1X5-W_1A Z<NLRKUH/[_?6FP_EXTA-"U=6'KPM:%
MK0M;%[8N['^-,,0S%$@[D\8XRJIF?2FM_$0'^S0)'YLB(Y-ME6=U6"O?W/HJ
M6S$)V#O8E>=L8':!#=Q"M(T(?=3@?W5YK3:W^8F=[<$5D'@.M+KV#FS7EMIU
MY+0UWB@OY1!VCQ^>]%T'&[K8]"*FH*\N3>O>SFUM.99RC(?OX-.#<.9&TSZ:
M&N,"(^YMX6]'';[Y^J^=8#BB?9P-?!&G8'__M/I".6NK&QLX*!#)!F:D>%EA
M2JOBE%"6/FSM=RX_-I ^ATPBD W0*SLK7""SJ8*+QIC;H8SP:=\Z4C9KP:@=
M[6RLPS^45/T?../[_[,+>1"LO@B.!$[ J2?ZV<"D3+>?UQ_;?"U<Z*-PD^?\
MC*UB)5E@\[%.5IT@=O$\/@&L5H:/#-X%9]0@FZ22, 9=\-&]$,^\OAVY*NG4
M"B<FPN9=5.#4?9!OM-_#^QDMJQ.6R./1E$DV\&@U/^PP)EGK>&K88> ??6%"
ML<1L^/QA&C<+FX]=M$3\4"(O,_BE6#HP#A"_A&>%GU_Z@%[N ^%?7IOCB :K
M4W[/*4B6H5@CJSH!N1!2BGF(G;^PB%E^"RF*L9&K!U<4'\#HFQW!;\)CE9LA
M%U+HP XFL@'=SP\4($K-R08P!/HU"L248ZK![RJL$8V^PZF5)YD[_[-';OY7
M7-*U\%MR*\(5<A GGZC'N&&V,]]@1VZ3L<-L(&UO)28$/N+(JP].'H,"0Q0;
M&-%!],!6K8W>K'VN\^\N=76Q.I#S1N*0TA/818%\JVKL_-%)<*G:B6(-9\2^
MC%Y=@#$/,_-+&(\=07SCBHBBL8[?ROS#?_3T6+NLI>KG5CAZ(9T:6<W= _BM
ME >LDY[@$H4-?"A&>0F"3:'\+%@W3*>6,*^4,KVJ4$QK90.'T-G@=QYH^C@B
M7OBWP.?U9]G ]$^7,>ENUK]1A:C(0.Y@"1^.9CV-SLAF Q+?I%@U<&HG_E9J
M&!GW;4/8X3?_\*OR-O,#&Q@S8@,E.&8*\CR^%?D1R?C"!J@K;*!(>DK5@:7;
M!<[.,0_I#=Z38[Q0=:&#;.#<LV7/<*C.<^)=78Z&,@*_9_8M[/SF]Y!'>+.!
MQ5T(IS%[B@)I"N72!3G@\W\M)G ^I=5"9HEN@,1Q0B5LAQ?FVQQ-$L=X;*O"
M!MZ_AJ\>QD]$-\!6)/S7?A==9CW_[.\%5LN"(Z>A$/X(2D_MNI]S8/-R>=-\
M(9GT5KBN7['.'D28U[^UI?J_[5K;$;!)#?(!;F@J?6^!\D=ZB>G2P-]MGK3'
MSKU@7KR ($OX#J:P@<.%1O2=UR']I-<^.;KQ.QMX[@-%W?>C.%9XR&>Y2VS@
MA44F\[$\.!&[]I6@P#O@EXH?4'?WQ]F 3JW-$OS'-(BO388W9K+XILJ@6.2]
M6/./]K7?_$T,&FPZ&VA*(\JMLLH@!1V1]_"U!/(5],H>%%3T(_'(51GIGF:0
MX B%HT.N=O"'<M/95*-_(P2[8_FAJ-4^ \X(9; !5:<$F@CD5;CS;,#7A2F\
M-(-CG>5E8<'9T#H]E@$DXBJ!_G0.FH,KG(LG_W1&B=%6!JM/%;&!(-@>)=QF
M0V)NDIF-3*J)C]B;@F.)0_JJ)D(-*L.8VZN#6%$V<#=Z11TK!N*MD$SQP #M
M5S"RJ;.4.)QG#H PS $I.;,, <@+Y&AV0]QU'WMFE-#;[[*!^-S'9D.;QDLC
MXA=9O);]9-X9-;*!)5DN5$F$L,D''^_K7%S7 =XFR*Z(2=Y4Y0-.Z!.W(UZR
MVD#R1=$-\&VVT\CM"=1.LP_!&:RZ3R]^Z'D+Q!04HEH.*43$;22ZOF[CZD_@
M?:R(X[]%+<N/!EUR'$OTQTYY.>Z/41/H.CY4>1:"YJEWX9!<,$..%$).ZLE\
MZ^VI+\7JKNRP&?9XNG$^1N\"_VG-6OS&*-]M*UCJ!MI"%DJ%5IQ)TYV:3:P5
M._3)"E'R-*; YGW_]L<:>YT+T)=JX>YV,YA^(VH,165F^ WM^G*MF;KA8EG&
MU[:O9>].-.5DA>D29,]6CRRU G9@M29#G\)9A]U6K,]P<LU".DYZ9Z<-W@Y.
M\!'OI5<)5=Z,4&[;BM,(T+SJ9V++2Q=!>>,A%ND2HHY^S-!S>-N+M)S>/3DI
M%K_G68.=^?ZGNT5__/R:1Q#DC$:*,5/@Q%0! G>%7R[MS$DR\M6#C(M7DQ<L
M7^24 SR7)492-IXH<'UZJNH-[\=;F*^1"JQM3R@'16J66<+D^H&"JQ<NG7'E
MYFCDB&B=\ WZPI">Q?7BJ#'DN5E1TH,D@W,A-BJ7"SR@W'F^U,-Q_[$3[P3]
M1NX<W_&P^?7#,(#,!OJ?4],I^"JDB+?;!7)2?81R2=\#ZZ^R>6?3/SV+#S3B
MW/ 91S6C1;]C6-&X2>!>[X>DYX@N[>[QXHKKBMHV7>VR>]Q7C)V&>6E''1@O
MYB#G_P[YV**;&5<MO+]OFIA9A=Y"DZYAB95T*25N+'=J:;U2TMN>7I9P]LK9
MJ[CYLA@#.<VK2V]XNVY++\1#09/!+U)W::I=;QBYS3$^P>XX(O',POYDR9_]
M-[P0\)E1[>)ER!,J'-,89\CYB4,R&Y:4=HA?>FRX<;)![_06S9"-.T^-[#SU
M9D>9] BZSX"UC2.% </G,^1)SLKP/=YA[1%>;OI'# STN<B[-]]P;<O:S]DP
M$\@5,(DEF^">>,8__7$[68 \T)-T !>[46"GPF'5 Q(G/BV-Y+JM7.*:S+@'
M\E>J>XL3(RN3X)$>V!GSXLWNQ2X?C. O+QVY1D^_8W=_J=%R''1 ]CG4PHI<
M0L?*._8::I@7<E.98J-!^IM]3[RG3YQ3O<KUB2N,,<<LQ#K*& P;/>FO]2I3
MRD_D"BXVF/9V*'GV*E.DSN>JKZN@IF\;UY1 +3PL>2^MEM2#KSB0 SI-&FA8
MB407MO#.[3EBWW\P]YZ03X,:1H3Y6?/4,($'M4M >^.#:0>G$<.+<P8_9/<7
M?V=D(U]=J:PROZ\P88C2H6NQ^A,(,\M$-4VY3)J347?>(-6 4&1S<:(_R?@\
MR;NQ":Y.)U 3: OY#!$:G]VP\[:6BY^Z\J6*(ZJS&B6>!L=RJVR9N"_?J,@Q
MA"0;H@51YRBG*"<IHJS<7&_=PVG*\;[OHF7[8WZD7U:3""P]QK%?-#/R![,1
M*<>JPQ;SAF$=Y6@7V #I4.?B ]@,LL /33\D9#<P[D,O68FI=!V5E8_*Q-P=
MID8Q<S2EZ:J3]W882G17G/(.,= 2[JZI".-1:1K9)>P@+K'[G"H7%R#6KN-O
M-X4F7X$_X2,4)7B%:LH[W!1\$3@D\@2]CZCP)!X>&(4.?@"53-U04 ,Z_(][
M1W765![M2"/C'[L(ZCFXNAQY8%#*RRA<J;P%I;(MD@\U;^SF %;'_B.IHT*!
M&KBV0ZV&#42S(BR7U<FX/FZ6+H:;!5^5=YJBV;%TGR[&LV)P.-H<ZZRIWS4V
MD%&WRDN-@5*M#XP)ZD!5[>?[@SN@/A &;""?V\9H5A)*%//PU;7'U:=\1RN@
MO'$P/YX-6._%\D/,Y(O%8XC1R$/$)+IO&FP*B6>BP&>%$,$@H _O,=8!_M$7
M?PW*E@T\%45#XYK)LQFXAQ; CG Y0$D41I=&-+J&,AZ[(DE,XT5K+38@;BF&
M3=- 1A#F'5?CF0&S6&JLC]Y,(62 9 *K<HQU_3-R6(61X ^ET*L:+LP,6V/Z
M,<@$4B60"4JQ+S&=]PDKDFDL5:B&W+)JB9Z_, 3.0"6 LY8G5/=M9Q#_4'6,
MSD6A2T*"R')#NBE$^ASW;?6DUM?WFO#*"PU9@S=N$P$?HK+TE# #(I"!CR!)
M'=[1K,]WH*K\,.>2' E79\@WA E2Q/'1?&=L)KTH<V?:A^]&BD1]R]P?;6R,
M,J$PL36$T+*Y<-D\B<J2#N?6VOZ::MN36P0WDM7QHZ$S7G1C&W]<Y0GZWFR)
M0IJ4V3/$I1+KDEYT@.PEWX>U',LOO XX+>I1WW4Y>X"]=HTJ/2J[;'JM)UCN
M*CL_N3\3S#:[K+H_D.<6YPMF,J1E*Q_U$64D6:"3H93EJ++57G*N3S93SR:K
M*>->Q?@X+-9/"AG+!LB&L!757#2=PP:<:'):=!I:;I#;CMI)?C1XD&(X^;'(
M;#XE1)*@]#5]MWCD@X+JZ0#@R_Y+7,XZ_JZT3-:V5T,6Q5Q0)>U2[6N:]/BJ
M /VRXUW):\GZW^V 9\EJ#;[)3'PU@78D__F0S'6" 845! LU\]Q2UH"6UK_[
M:'%!_%HI@OG&"K-_>P) #PO+QS^K3+X[.R#UN'ZL8:(_MN'$%O$LI94Y(IQV
M='.QQU"N*@-)&CB*JRVW=\HN^C3V(%G\>KB@H_+HZX,+C9K/>@+@9P]COHD^
M8&U+''KB<<(=N<EQ;]^]IR2Y\3A'"PU4TZ4C#-XE3!IHC^TW.,M,F9-L<W$?
M)LWM/<-M1$4JZF_Z>EMWF&^?:*W:8=V3(WQ! ;SI$.4"%N3Z^(:3HJ'0J,HP
MSG*,%RXN'VRTISY 7''^EE_]X8?="#P)!95GO!?)&.:6U4;6)AV;4,:><I9A
M3S^K]B-V5?;V2B9K*YTL7D40P6C>2U9J8P,?XPVCON3I]8T'M9P0@G)7CL<W
M3SGKQ:$ K>DU3I/"@%=\"M,RJM7>WVF<N$/QNE W5[9(%^O, B;+7YAQA8RI
MG^.5+2;)W-QAVZB!;&G^PFVG(7$F1)>ZWS=*>IPW'$:^"(:481X5JZ%@3CZD
MS_<%;:T,2SX8<3;MB=7?>[G145QHXZ[7"QV5&LP0;8G;MAS,%(::H[-&I(KM
M2\?XGOZH+V<"Q:]KF38_]5/A&0N ([,P+]G '5Q?9AVLT![_**UM,5+EBG"-
MC6+CI=VH9./'L@,1ZBNA:HO\PU P(E\YXHSB3-<J"9&1JW"X)^G419 P4PXX
M-RT(Q,S+GXPXN7_'@-M30)L-I%9D$ET:'*!:MDI4?$@NS+)1QX)86EIQRTNR
M8E>]9C;ZU1-ZUM;QYZ]]$2T$/C9 S+KW?:K3@L9=TWY;V56[/7MZM_K6T)R:
M3_9BP8G:.8<YYWRE%\JKUH;0:JMU6I!A1VP1FC%_*+$J@=GS;/5]U.GJ<D9Y
M_#32BZ%-"WZ#NDQ.BGZBJ91U*"-]\,B1HX%"YOM.G$@V?4@,.@G;Z=\)*]&K
M Q^!^S2-2#(\.W8LYBD1S2U_M@XBDP?5>,9V _X.6F4(*(,(,DR'6N%4+[P2
M&]A:Y4!!4$];][_;-6=_<]L-]XOWFX._\]R_<L]I08HZ 95%N91QID<Q%*-5
MI9<$ZBIE2\E<55 <Y[.HY:\?C"8U5(8)+8R6-[I4;*[FVAC5$*"]FQGLKXBR
MI(0VYFJ=6*X3QC^IT%)TJWR7D%07+V^U/[)95=;H!:HJ;,.P6H.6=@\S W[+
M3XKJ1CXX[=73>+DK?Y2NC7[[+E!!\^47R?>>J5'ZU5-<KK9\]$/^?8.':+,4
MBPJ9'&^OLQUY$H7)2V.=/<;BY\KU-%X'O5YH\.:?A\^:THV1K [+N$>R1:I%
MJN[P(KU]KM:O'D6*'QI3,VW<A<D#?/<0R)>-(E3P,;9]DPD;/8UA"8-:VHC'
M//TO6\KACZ>1&97<74HVB.I5R9_ECOPAA6[VV_%Q3\=O*)S8,*& :];?MXH8
MDYI9IKO"(?!"E<6V%9,EX]XFHSY8$_11=BHRXLD6FH7MVS)-:L*8 (U)U_,V
MH7J19Q"KC _64P(/@D.>.P5IM6R_L5#SIJE%[-6P%!#@F\&_4I##!JI--!UE
MW^#>TE1.%1?\\*SUD.@T*'DO^RY(2ZT?>9+U#592$E*I[!0W*-RS.$PRXK-&
MQ>5T^GPL<8DNBPXPQ=E?PYVL>WJ8<^JV= UX!];':<%,\H<YJK.>9)I/(502
M4K]7(.C4HX(9J,@('C=!1BMJ-GWM,*N,4!*SOB>;%&Z %=2:KG>QNS%_QDGT
MT[FF.+WK=3%?B4?9@%M2Q0W.N57I<63O'#6E2UL2Q4F!UT7S3>ZJ*Y,9:/Z<
M',RM4;2S>L^C8"^-Q/&[Q*N\%]!)*%.(L1CU9)2]0JD0G;BM[KGN2<CK_#JC
ML??*%JXV^=4VK@E(\06(P[.VQ;KWI>^D]5=3IS.Q+9*#H=);Q>&#N\Y=),U6
MP##G5_%#C8W2<$[4IB[M0Q.7:H>DM\SF_9PU:95/GSQ6\$;C_7FB_FL[-4%%
M#F0]NMBK)GH#+8Q^"H^R<\J<HLJ-_K#\7#%C=X<ST'3+A-X9VSP7=9M3^]J5
M:2.7I@;?1 0A0T!![8-?*$Y#9I^'5NX@#)^;O;[0DWW@J5ZP:=7US?YSF;Y,
M@/F*#;APLX$(D$]3@ZA6 7/)J'7;F..2AG440F6)-C;9B7K:87R!!5[:8:X&
MB/%RTUKWOGKKU-<8HGDB[FE+IG*\J^0'FYC2V%=MD2/:"$=5CBO#K]$?L/:$
MG=XE]; -FD>R:4-J)G6(G6JO,J-;XL[511U\AN?<WOY(>P7G2R;TT:DM%*DJ
MV),>,:&."GCJ5$^,X_NI@\XZ-QPLA"T0D?E<8N;B$?.W"?6XON'&9 X:'WE\
M2#N1-+N7BJ\[_C"K4;WU8Y^G3?NCVNC8P"_X%&.<(L?2 #^1#7R S1Z1FCU
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MFRF"T\<0M.$@Z*V=S9AY@4O0<"UN5#M=*B6@\K-]@HQK0!RZ;L:%FCL7>O5
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ML*97V6T;\6.*>P\3)6K*MJ++?[XW3 _R8?W_:Q=R6S Z!Q\#OACB80>[Y8?
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M@?0SH5I(AK:D@SWU,^"D'X/MZ?;#A>@]T"I5]%J_%S[:':&IAJ&5I_5^%/G
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M-E'[ >2.[,PAX.&F;CYZ"#A ^?7S]*6:+&<&_)(6RVH,'[['^IWB"GF=_8:
M6;M/5,'!VD">U1'$G>&<NN"W6&'W7-\GI,EUO_1MO>:O#ZI--SCNG$A0Z3XJ
MN/Z0&(P;Z+1V-!C7X,&)H#A6E/*25_0,GL1<^["U;URM)OD<UR)E%Z;)&E+
MX+'[,7U=F/+OF>*-!=.KP@]+T-Y.SZJ.F078W>ZZS)5P3$(C8]%7"/T:XV:2
M*,Y&[@C.F0I@OFEI+&.H7-7YJ5K6C11]EK/J1NAQ(+Z)Q"Z%_<>.9LY8M>L0
M2 T>@ZT]_9N+/[G#1$A?M__H/"=*^]C@]6E9[62]399'4"%WUFM9+B7%UU$<
M,0"SU([8ZFYN,_P8@AWWUB<+KD\PC_+)>GS-_CQHFW^=:[5>0TWJ 9<R.UOV
M==7]1$H(66&O%5-9\VKC=TW*-3'G)YC*C*B^,V^3I5I(R:*VRRNRJ_-A4(*I
M(EO ]@."?KC#L*HK=[ ICX65]9TR^8\F2]AG3TX[0"0> I\I"\.A6AX,A_(>
M[&EU!DD*,^ ?2LQ!W]^L%9;<16$G@ZW/O^Q/S(F]FC:@'MLP]8BLF&1[.% F
MV8A@P!96!MY,C1@^!-:LJQF[W1/8BUI#,<SP)V&5WDPX!"X U%4: [*;$*)(
MKRJ'?97'TZXNJ,4&\T>)6RUAGAOL\H9FMTPW"M(YW(C>E."NQ^IME/,UCYV\
M:-7[#PCN^?!DD_J;UZ&[DQ,,#LMZA'Q?I@V:>"\@W$2O9J3A-F;:LP?:5[YL
MP!<:XN^6"ML9+P4=X$==P,JN=4UG$"_HIJ?D<[!1H8+N_1-WZK286L7;$0][
M&;%SS&MP#O*=39(U+=RWZ+.DJPF?E?-S%\%[3%$Q*XMRSN3.8F&::2890@HB
M%H1I0:EZ4>WBFH/N#<:?IF\.>!0T)W<7>QI,;\G%,5^([Q*ESH3(DA3QB2_<
MZ-+4JT1HI#NJ-]:L+&W4Z!#0F$I?!,F<;AZMF#-4@9* <)(^>4J9G-Y*.HCO
M>!MLM"YS-^Y4R3]/M0+>%XJ^X2H'],5:&% C@=Q(\42(D%NPFCIMF36AJFG;
M\E-R&PVQ'LH_K,12]%IOEXQ?:5Y1/G[]3$,;G;UO@1,#H0^-/]:XE^R,MIB=
M'A!T4.H<*0K1?ZT7<NI@HL(%0S %(WC^>$B_(Y0$[B;*K=?4EU7$S(/_V-WK
M3PQYLPXK&^A,A%"#"8WCGYL@(U1-?,B9Z]P+DQ8LH9O<51]3A81,K]]XKMER
ME/%L_\M,^+^V\@U7;9NOIQ\"RB"M"5SG.$@0.@22JZ"4X$/ ,'GO/><A</:X
M"'V>X:>E0GY^/ 2ZA=OHC0N'P*"N];]V\NUG(&Z3@U BNPR&GO?_TD8^N 2#
M>1C11<%68X+C'>)M'H]OA)\$Y:8K)T?PZHR]A4';5'=WO3$\#2)N1+YFF].$
MCCD6X:JX<?NWCD]\3EL%%YZ.JLV!1#%80!J&I[IG 7+$RJB-9?S9(&KO*<.:
MG)!ZC>IT#F.B#)T'%J8V)UR3;K\9C3YYTM03V<_.:Z!/A?3 <X7)CB07XIN!
M%NBT25NZ<)H;:TG>M%F!B#B/E+20.EA[9Y/,&@2A\O-U55 -:+DB;=/(U<^7
M3CT=SHG1\I^MFY>&3<^N,HZIQ(=INR8"<?US %M'-I1X-L]#8"QR]'%DT>4+
MY8'/?X?_])<\O]XB0,G'S9]X1$:UU3O4V$H$<]\8O]8MU?WKRHFKJ.X8ZA_:
M-YAC+5*(>I[\L-#B9@%%O >A^?E6>%1280:<F+HN1:DM0>'\U\5HC!-AV2.>
M<"W.W(BQ(RS5]%/:?J-FZP^!;Z*)B0=8)^9?(-3%'*S<7#<))LDXPGE<H^V=
M)7[;?W["[['#<\YV1Y7"YW$\"P>#='!47D6F?IJ.X)9D23AF>]LNM?GAPY4@
M)G@FE'#[$(AB:\><VH4)#)Q<-3G^B$>$9_@7XB.XJ*2^#-<&6XR:SL #S+'T
M5-PJ>^8L.8;<]?Q/^\F::!UEK\D*?=0_^D'  /D#PP>I$1(CJYPK&<0T(.AW
M!_[DN8.(FC,_IEYM0KO7%K0^>$\N'/V"N,IPJ#D!MC9C3\J)_I'N5!6NR/N4
M&\-_;-HC=AVM7_5B-C:UQK83UQ(73%Y@(/*^\G"\.TJZ"B^(ZBNO>G>'8EW5
M</KZ?"4U?RIZY?A@^*F>8OAT'YZM&1J=+1)^EQQ28/@AH'[.GE7>!U-N^;/U
MSJFKZ+Y:SY:R[&-7%@#H1Q2_EK(SC)M^8IZJ$PVKV7$-D*B+75,N49!,NZEK
MY_Z6AKVR@^Y")<!YY.ER" NB3&RQ_-G2ZC%WEAXWE:,^3 *>!@MDU_5-LHQ#
MKC/1%HN*:Q(C?QK7=-49491(EE>(MM_Z)"^1*$3Y:"#4]4V8O$G*)_Q(Q\Y/
M,W=F,OYX\EW^HSDY/U)IG)3KTH=FJF$.!(-QG)^IN$%N6\AB;DY#"H[Z4+Z]
M%=.=W>X<2KQPU+OY=U($4G77+="QS61J%=<5)CU$U?D0H'-G1+6V^(71)$]$
MC(TF>K[V*4QX]RH@BS<AGT=W0M<469>A$#G'&?_BRTVC B9GQM5HTRC'UXX,
M<OB8\GAC183S48F[O8$\3B_%T.[R U-EB^QF)G@\E!?Q1&;]&N66E<T >#*C
MP%7XO9_?A'JYG-?4U/EC"1T)@CSQO\=B@P;9SN/1$7,2!%AH@]#"M<EIL6OM
M'P/E,JYS"T6W4N?>O>!JRDT>QEB!]INQ/<0*+#J*JBM5)/VYC!9[_VY<\>@_
M;%+'W[V< G:2S%\CQZZ:M,'%D?W^V8*##0]Q9=ZX5:>-2M> *LOGS3.?AGCC
MJ6FQ04RSI>@L&#83<PK$\9$S0*SK,FEY3BKQ>Q47\D%#M"'@)[(P!RDTZ !"
M<BD,5MY32M5FT&U61N@MA">#W'0)EWE.A%=N0-'-]-Y1GY[VGA2_[D9QM4/
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M87:NZINS<->#E^+\=T+%5J[)%LG:5AO\%D)#_EZ;AR32!60B:@X!!O D_=X
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M$\-;)N=IGCT$\BJVZ=<8/PC +<!E+ZUP6AYF,5O_$( /@7\4K6K"P<6'PX?
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M^K=OA]H>J^U*WQPOQ6 _PK>>7>VB@5.'P)\A&^@AP%)P""1%M6,.E@K :YD
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MDTG8;_9>^RG9ZUT+WC^N\7#GV2<S7H_PBYCF:&/J'O8(+5L<I-I9N7&8RQF
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M-EF,W\8GY[_565@3.6(*;XF4EUI%Q<.QYO/1(%:DT9&*ARQ).E2=5TQ-H%]
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MAOVIJ9)IVK1>U('4SYVTWBX.@6<"/Y:$N9K!4'5SJNWZ@8K7D! J#RGO+-[
MMF5EK4#;4&Y)T3RT#/5M*:_RF7*L?L]C31 GTG-B5"SS-R=?JT7\T+KAGAVP
MPTF\2D \Q%8'9%EFYZ4I=A993#<]4&^;QI\7R6B^BI+1V38-"PGK0/'[>D7
M>%%(Z)U]G<]NEFRNM=QR!;"JW<#9%]=5A6\]$_")D<BQ#P<;P]R!)TI[<2@\
MW:<3JW\][._"3E1,'U M+IP,\GHZ1GQ&F0(!C^:C&E#1&OS?@:QN4\ONGGM>
M3/&<U:)EZ@IJ296T+O?3Z56[5'&0_U+#.Y\EEL+P\0P@IMY*_?\PLL#8$7B;
MG>JA/RU B&%46B0FG#C\EW<<@K;+$'.!5OB+/\8/":1ILK+1N)?T4E> D>#
M]-=NZ'L.FJ[ $;P>&=[$B:.U&V\*69(*U=*T7*G8T0 K%0BF3Y=!?Y^+6E7;
MG8U4"K]DRQ[UE)EH 54CYVU#><E(;&&GTM"6_\'GWL^=0=)MMG>ZF:P&^B]:
MZ! G6C0"$-*$"Y@S !#J3-AP]<#)=O@\F=CT4NP<(QU+\<_,//M9:'S"8->8
M]^LB/><>!#E/G:_),P &V.[Z#)M3"D[Q=$Q0-RP_<FX(?*=6G6[\J>>1) ]3
MB@D3"PM '480@Z?((GSA_($6JZM&+U\^G3OMXU)]G)1G_YLN7\Q!92,G;[5)
M@L) 77,)S>\P=#2<DL"Y05T1X_D3 8W0,\!3+M2IW-9O\+\"'SY3W>3 )U16
M*] 6*B3*_SMU\S6/FV?Q17 3YA^/+E#&4W>4LCTSA[I_LH7IITU"U&,'HFD!
M*3YOP;K5TSR'O[3&^P2[^ ,S.69>^W\%.,^?JX--+M-@Z3!?+H(7/XZ #S/5
M#AD )_,4!AKJ@I4N4KEVZU];U+?HU:R6^03X92V.K>#DO7;,-51#[>69$\MS
MVR?/(T#7++N%?2#%*.P]X(FB.?<9 &T#(M^(:;Y)W21A4%ML:AM(B)!W!N@\
M';46*Y[[\$/W1F4/9L:X/#7-_)G+.1CAI=<4A%@+)YB6G 'X$$TP1[!@8-DB
M=ZN@Q%-<S1%Z-7O%^<!#KY+AY\\O]P!T?71N?\X ,5,$D3. [A&<<FX&AFO8
M:A8@A1!"<0FGQV;8K+@%M(Q'P4'%E03>!R]?[/3.%=9W<]"<*"Z!6=U12(.=
M2Y =WD;<Q:^9:L%_NON1M:Y*'7E]":^]1W<U34/WJ.KW/)KP@#LZ)E<CN^.T
M-BMF_,(<^D#N^$W@Q$78FZ@C3?>#4Y4CK\D,_)LW<U.W:N<XQRUU&5>T1MBT
M=.A^]H*$3V\JGOJY$[VA/ W8NO'!I.<1T%\[)?WG(W=L>"=7+HC6!/;T$9>R
M :1B0CUV]0 #ZH!?#KQ]ZEA?-UQQ]ZHO#UL!32'4?R:I1+ J@:Q$+M>2<0-?
M@CEZ:*WIY^XH)MM+F8I/;2K$1D'%EKW7H76S.@*1+7C$ "QEGAV,\8;:XI23
M+C1:MY?.[$;RLCRY<N?Q$C-EO,-V*6D5I0?V,(^AZM'+J!>S,DMW(RJ\;M&X
MEO$X6/S!?F<6R _E,EV;4M &<8?U:9TGZ"V:/G@P%B9-R)XW&]EAZ'8M['V%
M_=0EG!G@>Q(IV<V@(WK4TKI'=1=>L6> JBJ"N)T7QCG>ERA[>;*!>VBG8B5;
M?6(RLF;HBIB=SFPK(%J$5QC],:Q_ /N4^'C4%Y&(#V#5\ZZL)ENKQR\EB/,R
M"WP6:5&UX.?A415).)7J#J,*OB;FPMX0?"9ZC6=_VU?3.N1CD>@AS]OKY">Q
M^QPTH]0]($>1VM02P<+BFEA+S8[EUDTY_^3M"[R+L6A=I,)*!75KVUU:OP!U
M)CZ&]?:0]*A(W#'_!V6&<H*_ =.3Q I3>4@RT5/]=LA'RM)!-Z;?*OF_]U?G
MM1%.N20<!?F 0L:2<E([($0F4](Z+=7&QZ*PIJ#S ]C]#D+A@[%EG.;LMWX-
MO(^HMW5/'TO'[=A7%MZ98"6%_37:@ZWN//9&0M#2WF6"TY,DM)HIN2MGY Y#
MO+^Z^((F#]/27_3N3I@LY2]HW^_I/P&;[44&:8-< LVIE+7@AQ5L$A(>0P;@
M'HYOCLQ9WTUD;NI\_4CD>L#UC!0S&\\P6QQ.MMUFY\$"9$>ZJ*/627V6K@,R
MB7ZM^_9G5]4'9UN87U;@*1_Y&Z(S-0&R[]<L2QUA_. ,8)(7#K;64H>*##<K
M0^7&2-?*S&Y\KGN4R;\3,5#4$W CGTTA18>7UZ)=1'$_-*LE=9*Q52G6' UU
M=$"X26J4>KY /_Z14<_HV6HE>-,G)58<>098^*JE,EX-HB&8M(^S#W@5;P4H
M,X?9J[#%W=%7F3BV>"&=LD)7'"2[[4/4A/(0<K&[Q[:XKIKTK5=V1@)3+QL^
M3Q97"S.G:%^)>YG1J+(DF**M%4K8P,S30\&$XNM099RZ>S.(D7/E_:'%JHUS
M[V_'%EY'QQX5N@LA!Q#$_'D-.^^EP:AF1MR%Y1B;65W#FKS5VX!9N61H>\0F
ML6S? /]YF,*_#N'TO#48/; 6Z/]G\DHVQM-Z\5J%KEQ:8=J'75L.VZC(ATLB
M&:<?B1)4QU;[KSW-#PUP7[BF_?^P>O-_SH0\5L,.3C%2]!&,%/"IG/LFP8&B
M__8PBY(^.$C8H]QY%$HU9,4=IT!\.M68!8'(,&H<YO]Z/4=5V6E6)F> "D8[
M\_]Q]VH4)]77]3Z)HWH!.2J#IDYMP7IBLLA06%J5'H?5/%SRO_=T___;U__G
MFOE*+9\!"-<"2)_*:\FQ'E2[-W84#:7Z] LR5(_D1S62/W80E,3L< TXA=[\
M#' %& \[ZC>C!"B>LD(^@K%FL,0\%L*CH"4TSBONQB%G<TJ'#7^-R("D\VP2
M[<AKBM\1.@'F"8^<XZ[,?+YX.+;V4"8SVZZZRN@:9=VC@ :\<U/HD.9?A2Q.
M==U*)*XDPL_%4G%4]J7GL[JI.B?#7";'5-A1!=WPKRH*_<A7V[FP_N/+@XU]
MU6.RSZ.\>R;N"RQ-^Z"V( S0,,(@(FP,PBV])^T[^5[T6HG+E :X*>UA+6W$
M@7JE*%E[_4)8 640?&FP%12A9A"]>GWJG>6PK1M+<KWI[X^N ,VV94G-MJBY
M<# 5 AS,3U3WJ&!]1)D_O;9U!,1G$(#%87\A+"_^*O)W#GM*KYDTFM[K$%7Z
M7K*FTK?,<>-2CT#4%$H6_)\_N DF7)?M8/8RK<'"WI3+."&'D.?S]G$BZGK]
M(E<_R^URW_ _%(O0O B02,0[DS.:%!WPS%:+@N\I!<FIKRFB;PQ3Y.JV4U>>
MAMP$CS?+$6)+)D@"A%Z?,\ E[H0,F\KABL^-P\A^U4>]F!>V[T],KJF;\XB9
M\Z@@OJ)>#$YR8Y0[O=[XSUW'*?WR"2HS/&#LYY%=JDUIN1'-H=*U_9YA.IZ6
MY:8Z/ OE(BC1JD;7F>QSEQ#B([86O3TI'+-H!!T230@W?G0&B _8;5W7[NEI
MS0>.(1)/"3C(]OO%7Q[>M198W^,H+_,Y:ZJ8F2S;3UR0:.-'I< XJKTN6<\D
M<C0ZI2]N5^R)<UC\:7TM_^HF72GG:2B"&I\Q@V> %SC8X9S400#^ :'5&0M>
M<DI<M+-0!1E.BQ7OI2NKZ5W=F:,++4=6SEP[%ZXUB[,BL4M@5N:CQ6NPE-+O
MKJ?[=Z")6_W1V<H9M=D1='W!T#H1U;5B: !1DF0P'G:!,F2MEX,0^X5<S6\0
MJG1NO-XW'/0B;S*YYYG!L>&Z&4R_Z1'1F70%._AF%7T5EPG_?C.IFB\,+O'1
M3\'AS3ZN7CZD#A" H-K]2#6A$EP[/N=OG@JC>:D[:@K=J..8<$49KL"^$:[]
M1]Y0<)UV'42X!N^2-C[H"O9J_Z3^\<K0=GDAJCF>Y?PQR^-\KWMQ-+1?("H+
M?%XMLI&0*EL(R^'T&2 N3W'HR)QMDVO+6[-PRVGR1@!37&37ILE7$?]%_87
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MM]2?L8[(M$QD($>2J0)Y&=U$!:IGDF> 0W;(A_G*;S'DDC#0.7FM.7/*[6
MD?$^E>[L" J4RY//*G%:U=![/S($=]KO2%N_]'5Y$Q+)/J'Z/*^D&)I*!!':
M+0A>Q+N!QI)KZ:,0-ZG/<VU -M$_(A/MS2"'T(=6VZ%A-Z#25/U8CHTEI]3
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MG\W.?%2B.9[:+'=A;(>.6L86S9N)!5\J%>JD_(0;OC1[>S$!]KW40!*QSE*
M]-93\-G]6;!&)>9.?9]>M?O1.COR6'78T\?1.P6$"0/#Y2\9&7CK4IBPZ+1=
M?U%=&,L^\++M5'F]D9>M?*&+Q\+; GZ@HJAA\&>Y%PE-YVW9[N1PO,QPQ-4K
M[?RJ2JS%ZR"=EQ(L$3TS]=-^ISQ.36Q:H?,)#DY/QDJ4DD4O%_0>AI,U[X^C
M\:ZCLJR*X39W/V#7;@WDKQC:4KVJUIR?+IT4%]7*#4:US=RX)I=Y0TB[]3R
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MD 0[&0?YGT32!>#ZALP/5GTI5V8"W^IL88U+06AO,9CM8C&R@E]0@5I3>ID
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M*L/_JZKH"W" 5\2"Z[[[',P27F&PZZZ']T_<K\KL_U75\B@XWGR5_C88[-Z
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MDE4)L=ULTC3<#XO^?*V2\/X'T5Q+C? X>M-Q@2L)C\]SX*4ZJ3"_8:.1G+^
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M]:%BU1:/C_WR/76#H>$!5S31_B4["MXG>:]F^OX0XTH;A%:0I(.-#"QX$Q]
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MFU^0+G\B<$_GUE!S^[_^5C_[! M1OYY:0!'$>;E>)=R>Y2'H1H8R/:OR.BO
M93Q>+F7\U/O2/7.F<(VOH/TMDNQLX?RJ/%QD//HYY8Y0IG+Z]:"/;I?94?66
M<UX#^U#A]37L>!SV9BWU)?S,^_="]G20BX^%J.B!O,2K8.)VK],4S_9R.X0D
MI;,Q>P%I0RI:<-LC&R]:A0BK][LK*@TZYUU71O.+RD@^?;@.?5M[\>ZAU^NF
MUP6<4[937157F,[S2!CPW[EY">!$C$-A$&UM?;(G[ %IAJSG 3T%/VZSTG"=
M=WC@1,#A"X_MZ\E"VK\'TF]+W1B]+1\E;&Z.HH-\=*07[F:&SE41,FWPM-(
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M0E0B-Z3?PD>@#-[:E[4-_.=17+:>F;Q0-^NC(UQMY2UKI9S.8A%:L-9HEN3
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M. BA*/H*I]_A9LRT)\TH]UAIE0[BTV:D@]C,YY%QVF+$K8V!S29=3_;:(-V
MM"49![*ZPH;K>Z.?8;I'@3NGZU:;Z@"[.3K+[;ERR[PF[L$[/\.E^=?ZZU%*
M7<8 >0FV6M6!+9-%X%\A^![B[/EX&A>6= U1YSA:AW"A(K]N7WU'"^[YHNM3
M>W%_ &SX[SY7^S<&5:&-8K<O!4*H8P#EB85>_[>=[$;QW91$L55%JA0*1<!2
M8CX=MM-!IK$;F.I,2MI7@!X=*E*/KNVW^QQP["H>[EU[]_?;U'4^IH.V[SZ
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M6,'-%\^R@RY,!8+"/DN0(N$OIJ8Z/7V$. R3V\^\,%ZX^>D3,PCT%/0,H,\
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M%'S$"I((*\JGM380,\F.)H1(RJTBW>S)F:YB:G:YR;)7\B76+^\-MX;"= =
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MV-!4GJ,!0#P_*078\"G@[HJ@2.;E'_+C#A:&_W(9WM^[SSYQX%.[V'@H^]X
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M*%DMFAK230>]B?L"55&,1;'?6H"_->"^G?7W5F8(1?]ED_70L;]8/^LXRG[
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MNZK#1FNR_$ ;@FZ; VB#7L'L\A5C3V(6K_S K(_*$NPAE/17R,,=,/4<M0S
M=7?$6/>!L#RW!10.>_/?[8Z_N>0E?!"\+>>.V0-*>J5:<%.0T28G<,U=.4!L
MH\@25MV^T9087^@\U6+77@?PC*T(YITBS 406.8CF T60(Q6%V=0$Q&+L9,
M!=_KIKV0_?@72+[ZV8>2.D@'"2%V7X3*FQ^<]840@?^LS?L%Z/ H^./_;G;S
MOV^#F?RX19H<S' 8SDE1)_ E^+L<Z3:J"LFX/M>[$+/ ,CK]"?F,FV';:M.=
MC B,F$-T*9*N-H+?K#;04.]L6_UQ&F7S6;/L2L/'DE+/=V_W<$S/1ZW>=DH
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M"%)$0'HG*"@J*H(T$1(4:2("*M*$J!0I H)2#01!0.E%0 $)TI$2D::4A(Z
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M&% ]WT[@$N_#UEY)G2C+V%5+8,YB"=LX9WCIKM)BID4_&0PV"DC58HHH3 [
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MZWSZ,PIW]MK@HUQ>F_&)#IFXXY(A4/07V=%W?V_)2LRTH0(@]V!I)$T4CCD
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M<]U^-E3VT:_N**7JW10IRKQEY%#7#':PV>NR\'L"2X]1\&&K5BM@D4PS_09
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M4*PM_K10XU83=O5LEH;.POU^^')T\O=4%@]YBZ42XU+&/<^>><S:M@J8&$J
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M^69JQIM7I-BO9_PKJ33I7O/[!]HZ\F^'K"L.3.AL;(NTJ\.FE&1\!#Y'2>;
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M0$93^<XL=).1'Q9BSI)*,>&IKN/U>^/W?Z0W+SG>WD\ZOU,4_ >.1D$7G[E
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M1;_RFB\$J1JI8DT<6*PUNAI-Y96Z.'[GTU.54"5V\UI,J^VYUDJ#BI_NAHC
M'13LPC?6-S#$'!W4.J'R((I_\0@0B[).[(7)K%PG^B5.YF4W1AR[./#Q#PMG
M>9UK01MX<Y X;Z5]^<FE:K.W\SX3&#&4\:<:IV@SZT\?N5Q]'KN%=B-;'M0*
MK#"SK(BW$/O^+KC[+AH*=F$$&V(G+]4U_A.W\0O(?_3< ASQ@MK3G!,,4V(P
M6Z-6P6(P?Q07R>,IA\LYV)FU@SO91CS6WD/WS[9\,$L/+"IR14;&0+Z^3OD-
MFW'J<<R,A7K\W92XE;4M4.[V^D>_OP8R4G;G,P\H=&B[,T8G\PQ]!L-!W$Y5
MH:KBVMA[8+R:<SH;F$;BU2?^$X.UIM/@ .'/$IMS#)8D,1E/GUZHSX^GJR(&
M(%K?'RR.4W7QA<(;,LW$A>3WCGW74]1#A7@B[F<-Y.C:!&:_N&_W'5R#[-H$
MM4/K_!\A:ZJ*,YQ=+S>.H[=*P(:#7TF*&4-S%B*-:;NG6(70?_/3ET?I?VM
MQWCA9U/M74E<J='^_ VK0D]Q3\FMTG]NOZ08GEH*U04.16S'WX>(*6_;C%7C
M/HQN2GIM*5??Y^[C\U;[^A4.,+THV&>XFC^(P]O& IH $:>:D^:3>&LA;;@%
MSM8),S]C^8U?5T^N2 3NVWILT@QFAAX1F]IWAL]5)^&/@#->!RY5DKK.Y)[]
MM*Q('I-H5S&%M4&0R2A5O63:2\_JB5[8<P^>#G^?!X^D4C2%3KT* :ZQGB4B
M"?EQ&#U/=6\,]SADJG$D0CLON/=N<UTN*L>^</E&QTIQ1X=.M1.^:=,!!T[
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M\K1JS::A[8 "L_"J>K]L8YSB\*S"=G&70[TWN,<G2HKV+DJ;9-9K)\[>]MW
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MKR>BWM-4?T F&^G[E-^HF"U-'=R] ENJ1,N0N>@%?5@(Y0J4!;+T55X!2[%
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M.,^G+NM^Y.AFP)_'TF7@@\PIA'0SV34;CY:D6G>"N8/";9X^YB&4@N7&5P9
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MTC3H)ZA9>,@4A%#_K%76:;I?,:ZL3%I+<I]AS_!)GF\7#^+J!.I.?67SR=J
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M<?Y0/,-FV_D<8!E'&4R^.OP?-H\I^4^0?.63'SUMB 620FX_#5>UWCWN#Z$
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M,[/_AW7)JFAC(,><1;!&1\'>W;@/H=I)< CA!$>H:WW1JN 6K2GL1? \XWF
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M2+Y(_7&CH5?M7HV81DO%?0!]V?]OV^=FLW8<W9^>CW-](^##D1XPLG@-68A
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M'BMS:W9JLC#H2<SDS#2<EYHHG%@,*:C:O?&L+V_4IYS&6&?\EBUZ8_M.Z\V
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M//;\JOTI4D4JKH]MS&,W1W9*QO,;"*?#PZO9LZ:_D**_#LK%D"P&#L_3I$\
M%=;P'639'?=TJ3L&R;[JJ]O.:8<K.'AS22U&<<5[$KB?2 81;\Q#V=SITC"C
MI'7C4?/Q:T7WAV3;V.JN5SLN3(P@2=$T-CVZOO&_$R1*\*,;4IM'A#]NG>F2
M/A%5H 7/#ZEI/+^-GR(^ KT1T]6=F&I#;(0H*<':-K[L)L&68>=LE.KE>1X2
MI]=A>XFYS:7K1[2_C "'AG;KX5R.?4=/ #GE;FDC'SQL;YC8J=.?9-L67%3X
M9 >GL?]_;=\*8GJ'((8]33]%R6BOE5M<E^&;7"VO$:Q3R"FA:(1%^NVT3"7M
MDC^_(0]_T[<FWJ0P781OK'W':@\ W?YKJTJK<#7]FTIT3:DQQ8 &NC:CF<!^
M^-1*X$VFK4K?R,)3XV)[*3S\*K3%F*[L?J"@F7 D%,TNG"ZEJ:I?XTC^8K5S
M A@GVNM356CL8U"WK83]7 'P:K(L2V84HKA!P4#@XJ_>6T:^&W]*+M#%SQX@
M)K9.07JP%[0$5GZN3KN\W;7)B>'<4E97W=QTONX[(!9G+)[-PGI?:J:4Y9QY
MFEI;K@O\PBOYP$].O>SSP.@3 .DY(B93]FL\OH]9EWPK>R"#*JF<\QL17G9)
M?-Z4C!AB?0<51MV@:@?=!]/9F]VX[EZ;G;1]FW'75P#G=-](,>+!V<C(R):N
M+[3 XW=TGC#'H25ZW] &C1U_[0]?1;Q[I6QH[ N[XNM:*)5\?^8QR 7:51+B
M%_#L# 7<6FNOTT@[4/%],1 L>\<IK;)7N/L*X#0JV\GCLOMCL^L$K=DKTU?;
M37-*'I/5$-/+^,XZDO:\< S*"3>*#+=O(9IS-B?T<(G5)]W]'7665A&ZA\@$
MOL+,1.+EB*?(!6%2^* WEKMM1;9VSJU#^-00CJY;NH0ES=(IX'P^:-O57HDA
M[UKA(QNF,'X&$PV,2RL!IZV\_*76/;5FJ'S$L/5B<[$>^7FG&-Z*/T)":4\:
MR_5UMRVJ#T4O[KD(F(GD9@I7<F[+$0^III2!?=<3P'MV^C6>F@9@+1J[CR!*
M!60(&4_M>_ZK6P1#MZM0BI4] ]N_%>DP_'8"D/8<$@IML=8P^!X43^<$[9N7
M.A4? J?1+I.;;'9?J$(JGN*\+>LKX('>VY*?ZQ]^]T+2OHS$_R#H&K&"*.)#
MH)_>Q)MX[+1!JY;$*,I**$>P,RM<$"4\-:AD@,S_&WBZ+S43!_7:FN'OPE3#
MVHU95W+9H_52^JF/J1Y%)LA@T)^=[T;G_7^U)HW%_N>49B5>+AK-10X?M;AW
M$%43[H47VR9DF?R,PPWY&@W:Z9\1RPX=GXS6O@2#*\EQCBSH -UL+O,_'F@X
MM#@!L!K]NQ5-:XZ;<9EOX+00&"4DL-/[<)^$H5_ZSK">8WLJ- X#'"P2)4>]
ML\Y]I/)^5_/6H??&F%?9F\F7G\[</GON.?-9B]\,:1I@+ZZ@92G'B*GU1ITH
MI&LN;_T7F3U^QUSEU_ZN9YA\[JLZ\ZY'A(-GOY.>^U1U2%X<6@D>.6J7DK0?
M\8/^@I),C>/GQ,A=T6_BF[POQ]L<Z\Z-.PB^?U>K45(>N43R,8246@AZDUQP
MQSGMIBWSH,L/-)X(J3D,RXPEO^M^\=#Q:NB$ T@F ?&P*?Z;<4H7XF'.8S>J
MONWMO ;ON!%WAC6_A'*0_6CG[[H+[JR63^%Y<MU/2+X_T*' 1\=/*2E]HR+L
M-=4 VF(D31<.2CD!M E?4<HRO@J:[!ZT7;\765EMQ<Q2*7)U^,6"U]_\ZP2?
M);2S-T6BJ$LTI#K1]-&U4Y$>2O6TZH%GD .ZYC0:2C$&1LG0Q8/LO?GR>W%*
MHR\]39[*W_JKBOV(D>=9X\YV$9@@;K7M4;0) Y<+,)%?29#JO WAE4Q;KF'=
M^ 3 T(_#1P(OWXJ@1]B-+Z7KRK\)WAK+Y90P[Z@]+I)+)GO_ E$DN>-H)@09
MT39[69)=8:5L:2!G6@U=4.8L;N%%Z>>% (N%?<=?B*&U;77@%!!GGD96>4S>
MS\#QRPBW6_NIMQ\%W;G_I[NWX2MH=I,_EH5#8"?UG36VQ@*&!'[ G U[B>_C
M]9PQ&_:PQL]Z?40Y19[: 3P0A5L?_C7[\<J]Y>7+WO!C8Z.XXL>7Q],V@IF[
MH)3;XI'H4V&/1S6XRX+\;$>]-PA1%O655P^?B"7:GFIHF;]#M-\CE>)O9G0@
MHD-8$Y36P?'J@J\F;3N8QK'R'"EW9O1Y"96(5DP"G!N)38)H-9.C8X:'E,'=
M^"2=RI@N+M'[\1^DC74$U^<@%QABO:\E'L3ZB 1[]Z9;B6O(8X[_?&:HN!NJ
M^CJSM-@9H/PRYZ9%#_ UJV,SO?$03,D-UX!N"0/;!H^C\N)H/XZ_ KV]$^9.
M468)L"NN<S=JZH;?--OCA\?%1V3^?G==N"W=K3_OK[PSJ<'YQ"/;#5GD-U)N
MK\3FMP8I';*<NSA:H8PXMW+OPPAS8]//NEQS , NW]SAW4@*&,]*N<U-=")+
MS0MWA#-KDYPKO8O<)D)$['L%QN_T/RD,_IC=F*)E9J]9<H=BA2^A\EC3'4JM
ME;X-R,#0MQ'GCF,A4I14@MXO&<4.(2E4$M4J=WN-._,V&Z=D"J<)$B H-8*6
M"#,:U+I"X7Y.]H[U0O<6N)&WPK_RWG1H[>);\ I0!81NW^\I*S')N5>1M&TT
M'2BK+'I;8O?OVCJ<\D$C'7V*K#38/60H],5W5<SC>=K[)P_.OKD^L1C=P4J1
M9.T <8!-X<Q(6,3N!U\9@L&CBDTKQ9;D)?-GD_2UMXK8<CT<*T7"HGV&W]-
ME[P1,"<QO+51B$S^\#T@T.>+Z U'4[Z2JRHN;O9Z#Z5FDO3C]0UGAH]. !EX
M'XW6^+#&;(L-.-F[Z]X 492TUO64#(_Q+BL:OZ%?7N%OM9"D(Y[F)/M J!/C
M+D5"[&O^^\2$XG(">/D#F ,9#',&<4%;R\EBN>>:N.QE(OJ*1G*^ZD?^A@,S
M*M\Q!SW+496^[)UK"AN7Z+QK 2K.!8EO?)]KS"G@/ RFRC/4HHT6#8HD1$>]
M <;P]94O1^W9P'X:U';RL"ATWVVE)C_XE>JJIMK&/HUYNM[>,;\V7_C-%.&
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M]2I]L2K5Q.;S#Q-A1VZ@I] 6Z=W0',5]I_J&;-5XDXG-S:]_56^+1HG"/,E
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M[>^_<CTTE<-@TO"%$C #QGUAGSGQJ)H"6*Y: %7F$UFRP/BV1<M]6C_#IQ1
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MZCGX'&WT_IZWN*KKDLOMN:M,SY\5A-__)Y0GMAD]C,+@0*'P(PD\F@( O*$
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M>%'EWPM+U#JOM[VW_5.)(@/%'Q2 @-W']P51T6#+X#<=5,WH0O2G +[;]E(
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M\DMW!W)R./,%Z^OKCRV3?V9'_=Z@%?V:LN0;NCC*U4%4_5&RU+M2>6?5EV9
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M634GSWF9'CY1JAP8JN)@6$_%U8M:>#NH68VNC!S<?AX]EEL*:Z$ &*;PURB
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MU'K$* M$O195^!2VO<L,@:E"4/?E%NL"8?N-8A##KQD(WZ&5,'G9$"2'\71
MJN8)D_>O_T;!^(.:P-O" 4H_S;O%C*V&G_WS,8Z8]2"F#ACXQQ4V?T#,UF#L
MB%HAQ$RR-XU9]P6Q$&LSP+'-/4@*J3=FS"'3-;8 46I4??&K<> W1OJ+?32*
M_V+'C<UODUMM 5FBDI1CJ@)7F8;V2/*I1N#93;] IN(AQ(<8&/F<-6(A6Q)Q
MBP5Z:Y[%"#Z/6(C+XZ"(1-$_*&(8X=PPJ@3[6@YSWI)9P[_.5(<0D'<--3DW
MFC-_]7+;;TMNVS]=:P\@.-&R6 SCE0R@/%8>U!TP) M$@,*VCS$%$$-7UE@@
MS6:;$F,FS6!^6SZ,A[X?86V0$P"8L#5]")@V\KK,QP/=PRCF];D0)J.9&>6;
M];<K4)A"R/81")4!.#3X*'A;BIOQ$K%ZM6\!P-==FY=^-1;]AD9_I.7,/YWP
MLT2Q96J]V4Q@QG1W4]:8UV[[WV6!,AK(L!%=ILX,@L3@9KX@^6%+Z<&^W S?
M#$/&)_1,BC8@3#V(!5EH#1^B)2@5@?D,Q94AMB7/@TES$*HAS1H0\EY KJ.(
M%RW$TVKHV_\.:X@STB S9O]KJWJ2+S%J1(BI&:'$1$/(6JC(:8[M(SAT/35]
MH<R/J56DCM"RH72R0*+(',3084",'*'2-%[ 48X7 X^V',78!S7^1]E&]3V9
MW!9)9RH#Z<0^J@62>!.'6!$"&%6]+50<=9 ^]:MQYC>D^?V2_\0?6@*RL<AM
M/D/@"KWY'NSS'4V\A44#H,TXHSU<\=]7_#-^WPZ >I_0T!V4LXZ^E18J<;/N
M;Z3K\-7_C,4UR_]Y!T"G('K8LF\#-H>Y8="#] /8")=<^ZLAX#<T^JLE_Y&X
M/S4'^)J[TF8AQK&<]/T"D?^(QNAL1)M4'[/A)'KSQB ;_5@S4R]QF=ET ,7@
MW./5SP*YYP/.=QC(9@21%(,OV8 43??]7=[R/SK^:K&?\9>- 99 =/;/VJ"_
M;PQG[D879/6C 2O.]*P@5G@  E)VFE\!.%/8_1H+%  XFW:U,04%3-(H($&Y
MTRF[70^%V*.WA1+%:%M@JOKR,)(>#&8$ +[-$1Q%CS_ K$5OG5[<--2$/Z>>
M^M50]!L8_0F6^S@W('@@M1 * G+'<03C9!P)?AZXO.ZK"\P1AWDZ8*8S$C5
MUMJ+\Y/%BP#&($*H3 "E+OM6$T:9U]0/,*N-LIF],*(!H#:H!?0F=^[D(?3,
MU1_HY0')=2L(/>Y=%'4#S!!G% "Z[HC -&\+2)\PA 7 /_YJ<_QFDM\?Q.!;
M_<>C&IK=@NC!;C LPW#32AVPC(4@.ET6_H_]O#G_0<D7RUWI,3TL$#]B\Y6_
MM,&VJ!N$#/S-DI19( \/#'C\J^GF-\(A:N/762 Y60::!<)7^[O"A ,FP1MG
M .<&TM)13/_C;GI$-G U2;T9534%VQ9_/ GP-C-::&6<FWEI$$Q: S-?2."-
M>A SAX H;P-\V<*9 DQ'.\ZAOI\RF0W G.C=O]$RMM/_ 9!A'G3@.V.TIQ&T
M'9.(155,'9)P?7);S$8#"(]Y8*HPIO@J4Y-4?>\Q(%,^60O=U0 HK>M/_6HJ
M^(T,0H$$/@]!?%0CP )]_0R8\_J:)/X&!<5D!_(,T67L)(TW'[T92:R6*F40
MD3FMH<S=D<W_A,F3_[QY7>42HGP0\+T@-424 5ULR 00I/7%O\M?_D=' .+G
M(=F(&5T*<+=W#Z 9W (!SZ#S+!"=$\.\A@Z"D8_\[$MRP^2_98%J^K:9-W%-
MB)TPC/$2[!\;LG+^J0*RTLV\QL%$(_!!#=I,W3V E$_2WFQ2 7:\Q#CRJQ'I
M-TSZ=YZ,^4M-\O^)ES+^Q\?_#_;+_F5@\!<U9W+&7Y2G;>(MF=L&_3.-B)W:
MMO] S*[_J>/6F@096T9@ZE,@S5G,XRL2@"!Y;_Y=.O,_.OZBYHR^])?UZ<$V
MQ*0C,$5%W6PASV67<TBRC8AM!3\P;:\CHHNW_+>M /A[(),_MP)8,V'^0RF$
M[ !\,Z" ,#2Y'@>@I<@+X$^[,EI\_0%X/!40_*L!Z3=(^B,\;S;"NVE01 MV
MB@7:@K% 6B+^L(.(EEY!0)-[S0'"!$)^2R@J#[)9EM+^MW7GSY"_*573H0"X
MB]@+,:L 4K@!<0;RKS.\,-(Z4UL7(,=)I/BO-LAO1OE= =H&]8<"]?H80&YG
M^*$4A(D_-P>B93 (M= ^R8.>Z2/)TG:,(O 2LVA;V/893S2) <3R5/:E@']2
M<>HC2T"#BA#-8,9IL*XQ4R?)@/$*@<\J!_@2BTSZY83SVYK6[\O/EI@_U*?Y
MY0$?<H*0MYBQ0FO*W,P;_$H_J?O3=9K2[RO0)D7_O3R](4=Y3R!I*"T!5M=Y
M]S<ZMJ,%_A](>1QQ$C$339ED?O>:I.J3"%GT8TI,'4P4>D62C1FBB ?(,]K?
MU2Q)$3+A2)5?\Q5/JS(N^]4\\!L3_)LV>O[UY9\_EYYA'_^Z3KUL!UDK8B)B
ME;\BOR>0^JD)?[\D^!GQS_40/\!UHW<!HC5)N[L.Y+ QM8@A)>:,N@: CF\@
MUWXY(/T&27]DYWM_[/1 !4)F'#ET$(M20.B*!!Y8$SH(IEH9V/U- ?HV^*\+
MU@&208 )"@$[V !NE0$N!M*NZ$.R5(#1A#( ;%SK?OO+K?%S_+X6#?U#K9JR
M"C!;]&%).N2S1E@0>L;Y*F;3;NT?3IST@/R#?#.4@-D78P&9CF*^B<K( ;RG
M2XQ9!R'WC66GA1*ZNWXYW/RVK/6_WTW[?PD&_O>[:;^K_?S[WDW[Y73T&R']
MD9K/_['1 UH/)BH$?4)OQ@<@FA'$,[G+' P9L6]_4WB6B/J[4C6:$\A96\T!
M0Z#. _,W:F09T1*8P( CHGM[-#FWYMM^N2U^CG_Y><&_A&]^7W\>)/VA0*U]
M$/#SD2A&-0#.+;2N/<!C!!WZ#;D7CVET_KX*/2#]WTO4\(X:4;BZ003U]0E#
M(_N_4[(GX'_$Y"W8?VS[\#.!S, L!\4.&6PE!H33)@!9.K'Z_R1NJ\B&3AY_
M&O42R4%R/;G<_H2J_^YKT;+#R1A8RK5P%Z-+$/E(AKQI #^%=I.2/N7/U^@K
MUU5ADPLJ*[7\M/^4T?7M9\*[FO-]./" #XF&K;,QRRT0BP\YBVDG 0?(_WG>
M\!<CP#YZUOQA0QND:O0N00>\BJ\9.90("484;;VL$:1K]53M[EFR.;T>F*V=
M\&G!=-E-ZA(QTZKBU6Z[<C5QJ<?G#+AIT( !64)<'IUC*DP>!PE-7#CJ2'VX
M?\[_#>2 PLORI=L<5H\>BL]-KF31I)H)^DT;#37B%8)G*,D%]BY0\_?A$8(;
MY:D14<K=$X_RM#^"E/O"[W8;%[2CZ3M4RG7CP?(+9T6OWW6\?_>8Q*K]$] M
M%>'$;21.C'X".M5<C[_AHJ[HMW;"^LJ-=A9H'^-+BN+=H1LKT>@!LRA?(*%^
M\9XR;TIP71F3?IKSJ81W-?]P@I?"M1R:2JBYM=S%1^<EHL=U=]6BC!@?F#LH
M8H <U2?O4(-\,FM%J+^5'UO6$O$+*^>YRBTWK?I$?X!_1SA[=MW1S,\F@[33
M-XS>;I_.B)(!_.+$Y%1IB$SO@=;BR4.!+FG6E@9[-#Y])T[Y.R]V'Z#D:JV7
M!+GD+?!F9'[-L"I8<)7*-+=%- BFIPI<GAJ \,#5".@&=?45N &6H613;#<Z
MN\25<X&-)A)HLK7[SLM;<$6*,W;R5<#1(D+SZ[R]'])&JJ(X:\AO7JQV#=N+
M?(A7B]$'">2J5.C9[,_:2N!48,P_?<*48Z1524[!PFU.4IQSM+.5@JNN'NNT
M_W$I_Q%GRC6^L2^GYD07.)Q([!3HS^KQVT@X!^ +<##5T OF89R[9U]M0?9I
M,3%AZKG/(_&I7+&9XQ,=)^M=CG?0M/0'C/35"1*=0N)V$O6G")<+W(UGP!1?
M[5KT-FD=PCR 8X&F^Q'UO1K 7.Q&A0 Y"HR;!1)$Y2*P?+V0!4X[%NC9(I.3
M&(2/6/=9(1W@> DY^#17=S)$0[1!KM6%W4&OU*V=:]>,IU42"[1S)QV>6;GX
M65&D[2,3B*1LPHQ/G&-H#HI8 1S$R*WBI.G8.)M.' NZ':DG<B9F:NE"^Y&&
MUR_P(WADF;_DT$STO8CDH3/B[?+\('4]']@*AJ:Q@"Y$UCL;''9,?>3!<UXC
M)\>EWGKL:+O?J87<(0XC'0)BE(8#!WO@G6LA.^G@QRZ*KKPW\[.MA.+N%\L]
M-%%F[CVCY4J^UWPZ.*\ZR6E@-NMKEEJJ0:)?LD.#+$5\JQ8)6NIS_#&Y9".1
M>+Q$1PWR,/8*G_KNF(N2#)/H-6O7VJA18RRL6=I(7>SJ8$8?J57_="\I.*!;
M;<QART&$GQ!P^][8TX+"*=3*UA3JV01/<2]<_I-ELQLO1Y%3X;5\+\\I_JH8
M6_6N$X_E+OULUVY@Q&S*AMKL0Z]# I]2BB#!%L):U/I;?6\OB[0&/R(F9?,(
MR[:,WWY!W'NYF.2CH0=%TG?"2D+G>K8%\>O:.*U80MAW"W08J1$PEV[$_607
M(8ZS!Y=>.L7LF WRW<YE"D837)G^< -@)E'0%)(O>,5N_;/!"-^4:'+.\A75
M?*<ZTUZ2WM2Y1+.ZN#=1Y)[H*)?&K[WE:(JX?4B6.;,UX'S\1-W@?E-+?AU^
MB3Q(WVF!2VG)RA(I;9\\JDOWM^D+]G+H@J]0Q!H'-30(GB$XZW,W*SR_VATB
M?2F[]6W?S*7ELIV/'VMIZ;E@WC$[P,1'D(.0%0L@$]],ENS+C7>.UQ/RKFP$
M2$^"_?^VKOYYW:VF_R^7Z'K;$9-GJ4GO4%/75SS^L4J0S_BGCK>:+%JR*Y7B
MWDS99('J_%\#&-8M^'?EF[\LZ4Q#BA.:@5QD&(-56?=,SAA=VCK#Y#,H'+_>
M\N[QL(K-DPN83Y0##4;>Z.\U IC,URYS PJCSO.!<C?2=8Z5WS*X8\FYH40_
M06/JA:!7%!WIGU ? ]B_P%XP=]DK[ZHG[XX% F4/YF9:=;C=X$JM#@TJ&*^J
M(FR6[N"Y+U2NHQG$80R3!Y3B_V#OO:*:@+:UT2@H34$0I!,5$)3>.Q&5+B"]
M$Y$. M);2!0$I$L7!*)4Z2)-BH1>I?=."*#TA!(B).'&_9_[LL\9_SC[ONU[
M#F\\9(QDK3F_,N>::U5/0\4AODWH@(X+ -W<CC+]6!];;VQ5H9='E!?Y(^:H
M84I=Z LJI-KVD4C<"HNBYKDM[@RU.M-!TU./3FNVZ^82CH/S?AYFXY\-79?E
M!FP:B(JQ.'I6*-_ <Z-7VH&79P--.[ PQXF]R%]I:(?&5,*6PTO(\.P9X.]?
M,>58_.:/7Q,-'YDE2D0"'' 9RKP0+?1IA][5;2Y^C-JG+/\D^\8@%H><1!HV
M$1-_10 H70<"=SCW@%C@*C:7\'PXSI!2YSOSLG[6-B]*I*G:42^N71J(9B=/
M"/4!K98:ZK9RXFR9D!\"C>M*+ T.VWM6HVN*,4&.*&!\: F2M5:S1:00%#D_
M=$Q7HR9(FVNZ2]1X=D.](?Z3'4NI?H2\_L?X!43>UX^IFZLYR<J/OQ,:6N_C
M)>@7\4:XFZ5;\G>_6N: -=,*$H"0&\^.%5E-=\!F>!!F.@,CT1ZL'N/[6,'%
MHN#RVN+2P]$^HW7O<G%YO]]JE#PWW* :X\[+<O3V\>TF)JSD7)\2M1QR"MA"
MRZ7KO_:ZNU\6U'],3:XQIL9DK/YWE4R8^*A$_*4=J^/R3M+&5F]")^2S8?4\
MP*N1L<Z^_8+*TWX@J995Z+!#STIS7)SI:!JZ8@9?Z#]";"LFQ3Q7ZW99%1.7
MMI]&EH'W)N)5N0B7ZWQ]^&I.B,&H[\A>CL=XC\MN[6X2-C.-2N.(. $ L2WE
M-4YO]OX=IY] U*X0V&>(ZC!,^07@!G1FI58]0E)[R<X,1W_U8^'<DXG%I<4E
M>76&2\F:0N!7ONLS[2M,$/U2XA*<-:H#0;$\Z(8NZZPI)_+,""4.!F\OWI51
M8[WRS)OJ^CU*U:I'J9_U=\B3EW:(3IRJ_$(\^P2Z $(BPEF$ 3I&O#*)UZD,
M= 326:@'8=V8&P+LFZ@1"I>7'E4O)/6H<*KT%N/U<)^1B/#EZS\PH)@ZQHG:
M,OWXWHRL1U1F^3;E>^&OE:A6+ZOU1BI*%.(D.N?](_+F5(M=Y"$"GNYNE!T]
M,:(4C2=\R9I\6;AP[-MZSWDW[!HZHT.[Q!H/1+K9EKA.][WB>=]S[Y7&-JO%
MLHCQ$9#3C:6'J50Z+:_N#YN603%Y@V-=U5XC!K8&^_@%+X1C#RG!N5B]J^,T
M7F2/X/3?FW^]RL4$I^ ,-C5'P[&'=5,M7A1OH/=Q:J=(6"S?G=OR;^Z..X)\
M/?P,N5 =*6F@Y7X P=#.SKUPSG)N;J';S<63K?O:C4]/XAEMC8U>D>+@2B#%
M7B]:0A?7CQ:Q;CR_"Z3'0:>M]9XV&UU]9F=]^(C.^MN#I(2/];E3^CELR>NO
MOH4&I_!/QFP:-"LQHXKC(+:K8,!@*8Z] X'^L#/HQ>%6N"_0),WGLQYLV@^[
M ?* )<"HCS5.$F]!&.M':_OY+.T;F[Z_OY.4]D&$_/!1-5Y@!?0"&&L*8D$X
MZ=&Z9L5W6KM)LQ^7_?EXH/C^/5/T_A!K=/2)G0U)H5\A*= 4KW'8KL/?BFY(
M5I-8G.LY:[<2I%N_06]>S63T[)?*I*79Z/'.J0K[DJ6ZPMUC@P%VLJ.RD]A5
M^)^;DG3G%"2X_EU74;H:DJ/]/"_F_K7_=CWYWWC@@IPY*Z(RMW3&5'1!@.-J
M9L?E4+F2'208)P#")U>17P!F74@D^7AFR;BVY' B[H!DDLADAX^\]IZ7CF^;
MO+?FK6UXUOL*MT"C058?_-SI7HL3-I_P11(V-]-1_3;>+Y%U.WQ@K);_<$3R
M[1Z#K,T3V^^H=-"#HV39Q#DPUF%:,C3XU]I*=V9"'4;/[&<TQ[JXBYAH6SQ@
M5;-AXT^@ZA_31B&#4Z6"G P],;GSQ>H91-*)E)/K,L^X+R=B/K@P/:=YGU")
MO#MB\_'=,2@-TG[N@P_$>(;QH)TZ85$UH8D]RE)-YP_ X5'U<7U)E3W$6P$0
MSU_.)MP4Y/:!ZD2JE%61;[R_$J6&0GJ@/-D4+2TAG8RZ.-9Y4:M$?V^]!JWO
MXS%A.9H6YWZ\DRDI<4R[H6^<0MV_+%1T%W:9/I-92F>F+?ZMSJ0$L5P#XNY-
MPY%!H'KE&[CS+F4*#(^ZKV-(/@^#W?N(?.IM)4UA,3Q?UCE9IXGIF6>49)F.
M"7Z[J?!'N;[U"J.1S,T'@$/W9X#%MFP 8$1KN,"6,9O7&W5?B:?<,O%97=;6
M7GYCQ+X=:Z!QNQ^'M[K^)-1/"2)P3@JO@:=$"=(>W?(D<-J"_?1-X#4N8-\/
MAG#YEP\48M]5W'%Q2KL3#3U.%C4&&KAJK;<*0,3'E<7PH*D6SBJI 1?YK)Z:
MNNPP.:@F@TK=N]N0/@7?(?L*O]#8@/K(%3Q/DSKARDL$^@ZH)Q&GZ9MX1CT'
M6WT$BX<47@!H&W DUP>RX;L M+\%XQU;O0EE%P"'Q @@I>.8(NNJ6<OC-9$8
MKMM9DE\GN,[D&"@'[7XF/;$[>!Y!_J933-8FQ%8M7M.[QW/_[YMC6H4: M^K
M$,1+9_%NH9XPUN3YP$IN"I? ;-&1(E4=&]#Y?3RYWMS(*B$J(O=@;SY[O(Y8
M* ]?^IC)]%@0MLNOJI^KNXC)IN,A?%56QK6W^'V"T./T1&-[Y<\.?DSJ8UOA
ME\CC*_#7]*WGFDH!#P<OB\8+!R?<" X@Z%CKFOEH HVVE>^-2X:\VSLXL62_
MOWZ;QY29BEU."4"^/OW66["Z+)]"C=7$\+WZEZKX%B62.V_#A=[+<L)DO(.H
MKB4R6,6?9GUHIK_Z'B58:OP1X__"YT_0K^AC$ =I:63QQOD[%M+-,!1=V%G:
M:%W+>!7<-_UI%SR5+@WL+%CY^3'3@S9(P?:7B8\;Q0H(;:NAR6R_;%^0RH'(
M7BUN:K_R;KV:['6)M^1G/L;JT9+IMZ\;])%$EAX546H3P=Q*A>/#?D4#HU#3
M(IX>D@R8[6D9>:,=^E3%)]P.:=\*>4;TM'#<V)^$%$7Z<])V=;3^0&<WE:>X
M9I4]!F'C!P8N%Z>K+7WY+F>GRB9:.FE53J P*/C4F-QT C+ZDA>#DO_72N'_
MIE.PM")KB!X]"CP=>J^U&>4./F?6^MYDR5^I/"1Y7F0?0%//XP@4]/!6D]WI
MJVSJ.>34&E[>7\(/!J',[2#TC6;V'%SJ%#\@;B0&LB)A>< _CG=< ,XT@\"6
M@7S$)T-DQ'8LZ7\AMR!#K52GJ<4!"0\/I?C2HQ^/L6'HJQ\QCQ:0DR1LAZ.T
M7Q?ZEBDHQ&8\#5MI"439)U++<.Z*?N<#A-OHG9M )S.(9)."1#:\9-T%X&W4
M6FOCN^?UKZFN9I6+\[[GDD%M4B\"9! # (\,K#DA8Q=ZZ7> 16Z9SP6 BJ)+
MZ&7F247P"^NYV7WG?,=?CON:BLV07MRC\:)\VN <?W#5I\;%PD':C[D[/+&,
M+_?;Z=7,/ZQ>VG;K@-B>^T#HT#K'TZ:MBK7-S>^0^>-[FS^LPL,4^Y)2N G[
M4^MPM/X!VTX##?H7TB86>F:E+#.I\X,PGNT1IWG-A571@4:G,5+-'Q!X[T<S
MLF'W#3H%F1[N5CP7R*<Q)7SW(<]D7:SL@7#12]OLEM=[(Z 'R*!58[4<V7;=
MPI.YNU:_[LMV?EJY0IP#7<'#@JX7)6'(GC+[W&#@?*AI_[,7IYY;DK(K3Y3:
M;8L$A+]WZU+FAG;#*)1Y76HLK7%\NF,>0%[/8TJ&'E\[O'G\H^I?N*FHNN#B
M-RU .S0I.YOX(FM'1+?.=+)-GDD.-<[I/XJT6TH0#QUR,)R;/SXXDDP$+52'
M.V ZV^6CNF,O )'I9S.9*#<6U>Z>#*QF3]]/E]N>DL7I4/,;JV**9^'64Q"!
MU9$_6@>)H%T:(/&]N>F2T8ZAT1_W*;[3F.S% VA\Q O<1(\%J'.%QM6&&W/E
MUZRDNSRWTM1(ZF&0,R7K_.OJ;7DR2V-MBS') P:7 'G'"ENW4I>&^QLC3B'4
M0]?*"--JY*+8N]4FK44)V%$T$!=HNONW _#XE*A?1T=4SR=R,?UEA5'"!2#5
M_?$%(&EG#('\2&2 C0FAP<2;TW"\1^LC0H4D[ HNMB?+LPWQ%D2KR-4J/Y6I
M6U)F\=N_.N?>2B2HQ>PPOF'3D:-T]5I-7(!A!'7RAB9A!Y]@/E#.M !._ -W
MA/#AQE97$MBN3]>MYMB=N^G4-4K[Z&'-*[ #]%:5<_J:?ZQU'_8JN=5DV3=$
M;*1-RR9I2S1V?.%(UK.UHFA+#,MB;@-&G@6\K65<X0#]:&[QZ\K(N';U#WQQ
M%:# KS_?^H)0#7%8 \6OL+?(G,L'@IZE:->W&#=C>(_5"W@A(T+5B6DOV >2
MR6J3$L3,>K)=C;S"3T-:>[Y]?'LS_0)0LIM[G]"L?!6G;A(J?]2;/L,LUK_1
MY[MC&?M]8O)/DEK?PPN ?<J>31)Z B43IBSF,A*RNL(PNS.F3JQ7"+CK_$.F
MJTW>J7Z#M5*A#59]VO[W3BU@E%8=^E9LZ=[#;\L[)OI@JV&O08F!8E;%/2N1
M3TQ'X#V'<QF1W<WI%7;B-8% FPN :@YM6:'%3:SY;7]JJSN*PEIE/<H&%>\9
M2_@T.B+4^Z].',U&/?AJ-:Z9O^L9 V=1Y$;K=;[:69:<0E379GJ8# F3X.=/
M6EJFZ4N-H3&67RRHBB 9O*( %G8!^$R2??SS41< [IF\0 4#=.*>"#JQT^;V
ME"*H:"=+NH0\8*=X>[K:NI=\55RTL\2Z;_F%1V]5!22 !%$R.,-5. #/AZ[X
M%:D(_!3HO>_^4E6H)Z5(Q8V[..G^_!!;F-I#6>6P&,:M8=?L ]A[XVP45^!\
M[V]K1GTK=8W_20?DO1!,RJ*!ZJOP2.1,BTL9S,Y%?+$BRRHTR^5(0$"\<C;I
M8Y[8L%BOQ;;OTJ,5TXD*SPJ>(W>//'-DBHMU7YMX-GW2>W6+/V1$:I)<NH<J
M(,FTP;^' 4^E3D0Z87_XH+=(HM^XBAAML6PT7LAZXIYYOT&_MWIL)F=[I9;Y
MM20X>AI,NR]U 9#I"0B!_+@W/+RV,?.*)RB>\64U/M]K68UY4Y9C)ATZ!:^3
M6NG\6 :*@M-6P)!W<565+]@M91DU)$]LN[[1?JP>*'L%6%[A[W0G#JQ\VZMJ
MR^$ZL)@1AB'OX!(K;RK75#Y]FM@XO!DIK;BWU.]1N9A[.:)01XWC1'X7 5;Y
M/X7SY:5I*4='ZE)Q\P0 5QW21HS0J$P9R$5T8[\ <)DOV:B^']MZI1/<2$$>
ME,1]3_VSZZ$G[CY?@M3&.)$++S$F\O&I'H>KCGN(;T'E"_6(6^*!?VAT62/5
M'@$"^91'T(-819PV&J%2-[&GR%RP?>IU-]I/QW%8H3D3SN*T=%M!8F3@@TWP
M/W-"[C5"#90F\/"074=@[>J'#,,;);2?>+[Q)J+#Y3_QU5_ZU6"!C7@^P*JK
MLDYOPX=AQHK@Y# "3W.GC]K9/!*][FEMLUVCLGL5YW/D*,J4R'=01J=O U\5
MN6H&44";1"'C17[*0Y.<F+*%)#S\C9XU?SBUBX/[F!MA37XHX(>X1T)T>Y@0
MO73D2Q"S1IS+K;KFGNG1V&A?Q#==Z1X[<XG-W<.1ONU7[(IG,P%@ZM_ P[0#
M!E( ,(&.PY9;MXLMLHH'/4K$##^F'8Q%V.$ZN^?U7K>(E>!BK9O/:1.+.F:8
M394M^S=Z?EBZ7N[]?4FJVN@D'JB'H<WP*=JNEY[/S?&-O+][<,?<-HW.V/?Y
M8[H7 DQNV\X'HVBZ_T^4H$:HE$20N^8*3D I(-PXMU4L[DV%>/QC@[K1O6=;
MTNL>)$HX8D_[$^OW9.M('-64S6^4\4#O +SN/6S\O'(>#_MYSHZ4Z1FY@O<>
M\Y3R)'<#+02'YO3..7W<K5G837%V_Y[&F,O"\2;!K3[Y2:1,LKH9ZJ%Y9@*
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MO?DLY4</=!Q\F#3RY@* I2-AE);PSK[VX&"H\K3EQQ)4?7UT@*;D,/V-X.3
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M78D[&3)L0S I \VER]9 5Q;_C+N,J=FG.W=%WQ6_O8']]KY/[@[NMRLXX@*
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M2%\[C4 WO)-<N3&7[QY4NU#P@3M8>MP?;A=3A:J*L;F!L[N>W2J$N?<1.7O
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M@'5P":185.+W@\3EF(MO!2"V^T#4*X?6M^CIU%6AL=%%0Z+M;H;0IFX,)]K
M/0),#5'US%^L+U\K*=\\^M,XAHC5\N7"+]H%WE54,.7*(>S-$DF(X];DA#QQ
MU@3=3L8C36Q\:>!K?\Y4;V=+.?\*C2Y7Z3<\;#1983<U$S3Z,O3'BJ<B<@6#
M<KZH!L[V7M&/]E5 K9DO-;.+D(T;.4.]WK>T/QN)S=QL"'_;2&9F[@=M01-
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MV*,Q0'R0SCZD7!00:-82<=LN;9O.+C@)3Y^W( >D@(@U1/H]H^_9=\RO?H\
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M_X9M?D.4(@]NL-MTH2_&G<ME+ULBU6(Y[0^I2:R]AX7:HL"2UQ,O&;9<EBL
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MTCLJ?;D=9\\MG87>!AHWQFJD>Q /#-3(V/TJ@B@(5#B^*_'JT [& GY>:=>
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MFN'+A0)Q(2BD(3S/]:GNU6#H3*%$\C]6N0W]'HH%C2QW_)0C[7.^:":2;R'
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MSD3N<>24Z(E6F/: .":&<0!"/'SE>\--\4!'QV5S%<=;/CT;"7<>-GR6:!_
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M[\DM<??G$;N&,)RX7X_C"3V"-NC6Z&R5E+W/I'3E"F7.3 I_G1F_CHCFW"7
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MCV@<<[S_V^0TZA+>]SV.H_H''F:OF?N<&=R[>'H8G%@$XQ^6E7 !R'Z3F0=
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M%/+8B!U9 ANX/4[LYD(>/YFB)K#V$?4R=XF]](@+=DJ_B4N %ZF*(%=);4@
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MMFC+BH/@90V/(#5KG()6F,YO[Q8UWJ?O7DFH<'%PI4S3?:';3;C)MOU]7/_
MZ_-8ZF:A0I[<3GIC01?"H?'<KDOY0:";<%T\-UEH<YH0*\TP4Z%UWO>KM:N7
M )P/\ ?XG*O5\1+P?@I.B-4B*">NB%XPV,A= CIVP40-1)U8%;+2E/CFY4D
M9. U%-1UKYT.G1Z]LLLMDCZH4QWZ@U:*YJZ<AV9)812 XX:F.V#DI86IR;<E
MBR$7+U:PVUVN]1B-?XRWE+KD^AJ[)/M@L*O;>A!L%8@3'NF\<+9*)TX==6<*
MUR58;4]Q5G-=FV6H5GE_8HLS_=U^$R>XO,05)%N#YD 62#6NS*DX5'Y).)O=
MC-/,8IFR.F"E7(->/PS6\_,VJ:DT]-U,[_4HIED<]%K3 2VG06B!S_$/=VUN
M)TS['E17[K<O?MEG>+'0R,WO=0!Y2I# /5J1#FWGTB/O/%=5UGCG<N@BO)%S
M"4 *Q:?[GHJ^[^A8;1$7RW%*8R^6^.#XXRKF@=4E(%&5;.4@>I&S%7T0(U<B
M'\^S]\K2L;-72].$2[SCD%M;L/K?7,Q[.:.!?T;BY*5QPN ?68,GF=/6&./P
MIK=M-=;WUP1BAF@%,0L0S2!.'/4RXITZ,$,'[9M\.WDE;,'ZUZ9E;#IW9]*(
M*+<B.=U==RJ] '[VNMW)DB8[B7S%L0_\JZ'M ;AM/!..$QN*.1:0PG!4KDI(
M/N$UJ^20E-JD69GEE;UU8\4KNVE$/>U8DCU;_ D)XCY[QF36)26M,3&@<-,_
M+)8B$069$I(6O8&TZXW7M:L'>079A9BYJ!1_"JK%^X/V=O&"4!#6KFU:JE6Z
MU#GCT G3P[=FFLM])6J0?7:C^Q-(:=@+U=8>P[;!];TXGYH-E6*1W_4/UJD[
ME^JFBO,AT'S#Z=LB8U^3:3BU<[DFTV9D)#<?GRD9C+/OH$!AWD.BG??4V:":
M^?FH;<QV!.^&>1".549 B(MNUF"$2TG59(-M04>QI#&/DJMH/;WBC+,7B'X*
M#".*3 DCJ[.Z!7AT(%[FCGY)61[#^J.W]0=SE^Y1OT2U09;!>UGH72STR%55
MNG!0'7'7W]"9)SLTL$%_APM0PN0>T[2FU(&PS:LRWAE0K4FIIDN]^3>]."ID
M%%*C0)+'CN4+5W=[>-*;7HHD\55WR$6OQ-WY6.I"? U..62PY=^=4@6N9$$H
MH;J/T2=Q*;IV!3.=+RDR*+AY%/.-#+L!],SYB@#[;Y4!$@I*3\0E_\0:Q+CJ
M.(WDM@.)741*G!>F!AS#XUJY>NODM+FEY=ZTZ1WY*GQXTFM>$_:W9!*V6WNR
MF<?@>/@552#^/M38&\@YHS;4>M=_:OK>(5>59$$G[QKLZSJS$>:CN\1OAS(?
M^UNW%,J$G\?HWW((&D>#L)0X&)JS#[MX9U0>Q@K922\5<A?YZL<2;?P[W]5L
M5:^/XD3QC\='1@<"Z"*20(_>6GL-9Y-;L.Q^OGO@X^?K4E7UPMGZE/[FSWL5
MXC-73/I&9NSE2>M'OTW'NLGM2YJ8A/E;=SBO^E42.5 76((J0)J0M>/20C$Z
M(N.O'W_BFE=>;E9>$Y<]/*YZOH+8RUEVBT!2GR B//C!UNB&:B_AH?6 RI]'
M5LV]A8]^5*_ O(L3O'*=9TM*C$7R!W+#%37:W]2KRT^1JA9)*T^/4!XQQ9AD
M<+OKM2I\5*;L%Y+"F;_?3P;K1[05+X/V\M%'6!_.:SA3O4QKBU60N O$,&.X
M&7IXM>,^78PVQ0?C82JO]XDO\ZK,8FJM2'F6*=27VJ9D,S#C"?_W&./?%32"
M-X7]7%F^!)Q"+@&:PL$R$%GBY-*A(A1T0:)EH]$0TR[@H5QD ?(X/036!SN\
M6;[+="$E6D,<@QR"!4DL[0_RF+-\B1&Y_N@W<G=2/'%?F,3F#D'GQ-A+P(.
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M/LO3=K7-^Y=:O(]=):+=B-7:Q5:-[+B8:>)JU2G(-,9C^G?SHM6V^KOFIB[
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MF%B\8MY*S-7R4R!^;33C6Y@_#U"@^DUG#TADQSQWN2I+\:P8DB42JI;WR/6
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M&B7YUQE@\Z_TZ>6-/VWNQ]<.I/\>/LDYT8-WJR*HV.PSP&];%/3?;&)Y= 9
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M!)N=KD]$ :_^6:; +H6_1YTKTHMJ52<,-M8V6O-#LLYU^)-TUI-T^#-F2\I
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M[UI4RU!Q?".:0PS]O7KDU4N6;O<!P>6OIO8@N2<I/#LE> Q9HZB@)0C,3!>
MQP(:%P Z*>S)9I?MG<EC%?7NC)/JRL6*BMFHXVQMF^V8ZXFO%KF3;C\>,,H2
MU.;G/(:RPL0F6AVPE7_;V1K9$M_\M7PSL>S+<Z4]\I9U^%US;VJ;'R>%HP9W
M;R1HP?L5'(4$S_(3\7KD?XQ:'27<*$<>+:?TDSFCLIWV!> 5\+)DL=G'E=H;
MO\X1JZ](@"!3C"H/EC<7E1NAZ!B">=V4K#=Y5%SG^RW]T\C+^!LW:Z]_]<$
MDICI3C 6%X#_MVE4^VGR0YH/_&<]:R';/#P1158V1KRJ#/CG\5=Q01EJ1Q<
MJR?G];&D:SC'#F1TLJ6^'VJ%:L<]SL9EK$7MRF!O3M#XE$C"H0//SD*0%(QM
M7%7!U[E+?;:RGE9/3TR7WEANLN#QQR%6S)<T+2Z#M<180G3RFF%W%2U,!,LR
M4[\F+_@#NYNDY>B9."^S@/F$$7P,(.U3[HVRKR4]E#,H;+II[D_B'P0RN2X&
M4:NC1CG>!(ECEY"1TBZ6DT;CKG<.UQ A3^WF8Y,,WS)\68W'5R58H6<B<,](
M- ]6O;#KN&U%VYB\E>>R)=3#]-TDD]$[O6L1)K]";ZT)M+S(U@,'7P"J-Z/3
MCPE*Y'V.$9$=EFE5%0H(</./PY[N_%X#>8;U%5E".X;@]$3C\XJ*X_T(Q<!R
M$'T0+]ZK#A*PR XKTZEZ[7/OUBKT$D_-4O^(P;'0<\WKQLX$E>ER1Q%=ZY)%
MS\!DL"1Y2]7JAII4K_TY.V^K2TM%L.'$<RM6K+I;TC%KXG%];G2EAB\N";T'
MZYO(I7J?Q66=I+EI>4&479B_/WD_\?AEN-FS#LJ;5U4\K#TW=S<*Y[:R_/+0
MCGC#G@RM>)A"T<X"PU>&D@)PMV!#2^/;_!+28^X0QELA#%>K$B\ 3HR1EL!(
MN MC<!#;9&5>Z[0GCR;:1FM0"3'BJ$W\,1<?^_A)C_]J587/1%!G$,/D?M4K
M;%4L+'"51Q$W-)R/!W?3N[SN/M]/3(QG_.9&#:#Y(PV>VT2MA'LQ4MG^P8*W
M9E79IP2F^3*4PI+T"%$LICE;ZV9^\K;WS3GD*R,53=;7,P-(FI*F@N6S]L'X
MT3)+F,1Y(X+#=[;[F5A"N R4\9?O.QF.'R$+NSK\,6W-@K@[Q4*_CB@3RO@S
MY%_ZO?**YS?^N>OVA8%<,ILN )$@!J("[EEG8Q WSBR%JCI_B3%G^87OR_'I
M<)K[NX-JO/4H?<(5O!E$8*(RZ#9,MQ4[V$B,\<!_S 8YOB%6LRN]ZUL>;=-
M&8NFSU?0UN6MW&W[F3"?;!R*-L1HX$;1JA_0\*N_N.AY9\Y!T\OZE'=K:GAC
MJ3I&\ZLJ/"V+=D-1+E9FS3AH%YC+-P*UM%R^XI1D>&V;CZ"(B8?[CKE7Y3Y\
M1#!OP(/;>7FPX ]B1+&O?TZ:H1&K85_TKCZ[L?MV;\3/;IZ_FDSJ^9-M;Y.#
M3FBU37#;2?DV>H67J-*8,E2?&]:J(="JH.+&8[UZ[GQ>ZNZB]+;E3TOB[H*.
MC =H]0+0;1A)HC[/%T?0X_>[67.4&Y,?*R[GHJ^^G9G9YK_Y]F#O!L/X>-/.
M8%;V'*\2@9?(:0/1PAF&2"!$\.0X)(EC$=4>T, O?YI;S;Y_'OHM;BS[/LI\
M4RQYC)="/*@6KT)0\M5:K1@I+':B>#H-4RN]8G4!N Y)<_&!>^;GU<7%,F0)
M U8=Y=E'\!V$>WC@FFRU2^4V;?$?7I$&L+C$#5_OW?D5RE[9-$ X^ZJK\<-^
M2E/"&YO"/.^9)?-$U1$S_1WHCL<'W.QN[A=;W\"C43:B&_[C@FS)/6_-13,<
M2W'XAM;+FGLJ"([TX,YCP3:VOI5+L$LXVG8$$$L=]6E9/-LYJM#@[R,53=#M
M&W3CBJM[%*_15,N:6FK6R'"D'9)B*TCH.XXZT@O. M.8]CRE;$CV'7H..0[K
M8'^1::K#SO[KZMJ<.1B7?.*!->_3G*Q4UG/RXBW[%LZJ6)GI(U _W8"^MC#H
MYI& IJKU8IE%'!V(J6OMY8CBF%!"/8SSF^UGLS%$1ER9Y?01AFI&[]13@JO<
M/\1:G3/U3?<F71$%0)@2>XGE"-2!Y-7#J:/,PY2M5-)./,]ZL^G74[\D\3D^
MU3;V$\U:_4MIGL@XY]B9$:-.UA=>.+;>9GY7[C>JMW!\PW;:"D^-C RH"=-'
M*G%QB'0'J*,CI7=#*J[\:0<-I?:X)HNI%H#\\NRY6QN;E[K?5J[X[IW//-.X
M!LN@*\LA"&-S >"+()/])?@Y>\I1SW\R9 33P?LG>),N !,6IQ< G@M ?W15
M.>CH1\[0?SOG7@KZ;T;CB>:,%P"!UWRDUG]J$P2I(!-_3O QCJ2EI\%LOI(K
MS'(H@<&4@[?@## AND:?#)^0JE9]!PBZ95@EVR%!_[7JBWNMI4S!VOMU'BW4
M6Z55Q4XGS?6?3GP:QI8M#<(57/;X&+FC_<M$5A/L+9^E\4]EW'FW$:,US-GW
M'N[ >-E7H+XLFZ_=^,_)F%_B8-657[6QK*:/+'+,7;OX,SK(*OGM -T*8Q#_
M@,LWU1A7DDS;FZ,!)GM+D6BZ1^;5:@=K#:++RDH$!:(X-K6T.2<!2^A*Y0R1
M3U+Z7#?7VO_94UB7&''^R]P*A:1^$\1(FB!U3U1(5V%$FR3V58>N&]99J\H-
MXK?[*/C/S [*L[C%EPCI=Z'I>AKVFQ+S$B2]%8SH!<!> $D*E=$@0&TT4+FL
ML&LX[[P5QS%I,%NW%VVOL?$2T(EAW?,IGRMDBYZQPY\QW$L?;#3A&:.B> %X
M_MG:F8T51QE00N5V<.-O@E#RCEG]/N-6SMWQO;H*1X/Z:<^A@GF5['71>\82
M^:*7Z0T;;*<-5J;+0:]/%> 5>Q[/?!L[<IEWO> T3CDB$UZ0&(RLD0PB,Y"E
MNP1ZY_2U?FG?[],^H7@-F -!'@]=189@Q!%L,$=L45B=860&_<]J>G5P0[3\
M<<#KQ R1M>QV,U1(L('V4TV#AP3U]EPJ(BVV%[T!OX;7T\:>]_0O2I^P1G''
M-XU,M#NZPB/DRX+D\"]1P"BS<34TDF[+]G8\TV=DG<M->R"A,-P<6T13'8:N
M<OS[X<MO)R4;H.HO)U!-+E%P@?I#W0HM'M3M?U*K$"[J0FT838[0SB1;C^LO
M;](Q6'US#WJJ#2<R7WH<= UO7"I;2E2?>$CQ_6 /LMQ*CTWK ---]X4IB^3C
M_=8-Q74\"<+H5(T1MSVJ#8X^8W^SM&AEMB_XA>5!>KAV[<SMZA:]G3?[=VY>
M=;U^/:G2_S[=G.I&F*E(B?/$'N_PC_IOWZ;_V=UOI@>- >NHPY&.<(J!*LC$
MZ:P'$VMVX:-VPT!95;2_</^O<V;>]6 8:-4&&>XEP2K7@XP) F%SON(8#E2:
M@U*;AVLM\?YSF]<[E3N5?P+3S_L'!-(12;B53C@5\2F!D2B X)A4UCH!2NTB
M%\R&Y)*1KN<M$1QSY(KG:2[T'PT6380,[C<T!GS6E?I4-;9'5%JKHL=WZDRJ
MX:A2*EH!'.8&;=&KO0QN5O;<CM15A:[F?*O@#[8T>'N9=<1-;$,::EZ"Q0Q5
MMV/Z89!-0/V%1VSN2//V9DK5WN[;*A?#5*1=PBGW!>!- D$X(X$4Z_SG @ =
M/94&1X*.!R<O 'HOJMY@]T..@%=_.=?^:=;(29.M\/X[>V#9??W7KP=#NGC"
M3YWUC,P>7M8)9<A7FS?-)YDN95MR:H]/S!.C[GP4I>+ZA'4;9)RB65FH<B[U
M;EQUV%VI=3L6ALF1I;@/"DJX8GD!^)-2E0LC2RR1&WBRJK0+VR1%J 2J.3G1
MAY7+SHS?8\7F]7$;Q=X59@<PM%^R,%>E'8,JFSNBG8YB%&#JCA26B]O0ZU(]
M3*]J1(]I?'A5MF_+L*YX7@!N%G(5M#P_34/WEI#7=(GPW))H-O/B,Q&$>_TQ
M@[6B1)U)6WJQP.N!SBVC[-CBF%R?(P !&'D!<);X0&+#_FP^7NEF9!RVJSZ-
M;O#_8,ZDU_NH0+LG/>$+T/(H\UQUUK0V8^1D@6M(YU-!P]\;$?$:*NK_4,O6
M+Y_TDZSMC^A?RMB 4+/A&.AX:)^D4W40)N)1*/NS/4#9YH>D38.=:N6:&%B;
MH<QY#%&JPE:B&Q3-N9$M&R/736]/>#2D_\-:CSXVH/M*W^L7F&/ C2XS^*X1
M&>AS__FS.3"1/X['@8UG)")@Y/C67#/-U9BX=]14#VE$()-F;H5OH.(MS?N6
M[0SYQ^_^^C5KM8B]8IB6NL2H>%Z%7)]#",#G6.&_GQ(?3&S.@NQSKVW-E"$V
M#MO-4G'">_M%=XJ)_55FLW4\2CV<*AO)9?-J)4YIB9\KQ<2?*KM_W2XO*BZ1
MSA8<59MX6S>L.",JICI(V=!0__Y1'YWV5R-FAF  @'>:IO!+_J9[4^ >E._W
MRESN&NA]'7 ^H#/#NQH]#-2<\DQ0'3D;-6Z+7WXC0'C\093OHQ_=U;6LLU S
MD-/HJ2)R/H+4R=E'BFJH>C4-<D2&6ZY$+79;1@2WJOA5U.5X+ \7/1XY</-I
MT.3X 7RPT1QH3X;22)D*KN=3=3%*F&>:3D"#UISK$Y92P=R]?7M[-$U]7RH"
MRU7RBY-G+@#14NMI=V*VH.T+5:G(_[V34U4"8=/"VH:B,%"+&>GA.R-]IC.6
M<E/06Y'W&M\&?Y"\_SLZ_*WC-WU[CH->/>3I-XCP4M'<Z>3J"C$W%W/E O#B
MG.T"H(VN "WJ=36>\8:AX#'+P/??<-1=;0^=;VH!EYLF"VZ+H\]<NF[Z"\,M
M3Q83Z/_8,D\I:ZS12C#V";;YO.4]07?^XAI"T?G&*\?;?/]J$G@%-HH3/6D.
M1?<%'X,N$Y6P"5%50;=\0Z:/5G;;#+5]F?0/-0=L?^>N7V+)S#&7'[GBV3%8
MJ"%<P9),*/_)_^G%FE#;L&&PXB=0'11#C4;&ODO-[<R@I.BR996\_7371&6Z
MW?@291H-HY<[*!Q14@E<3>M<!(:LT! 55I>4H_@F,"%Z]]D/O]G96H!6#7Z^
MF[NN9/[N7T-(PL>ANE[^1Y]-)X(L8$,"_[CA\T\>Q&@VV36<Q3:G%,3F?ZQ1
MNLV'E3ENL\-KD3<HV%/["$Z_Q>HOF,(E59@=^T@XY?/O2*->G4*.@XZ^%G!8
M1^^!X>R1JNUY$ND!&8BH6\6#:&&Z4Q4POC5&FF'IZ[(EPHV-4RZ<6DDB7U/Z
MC>]WVRNT4\^R@B"&<0O [H0KAM@(U,A7QS40MV]3?LUSZ?2P;MFG;&:I3NM/
M2H6-X@TT,=TOS,>#Y/$V*,:HU&HK?%67(CC2[L.&!(;K<7K^J$VLICGV3CH9
M0$ET>'NZ:KQAYYEYQ(?V:U:&==HY#Q5=7\C)H?5=,$Z' 7H09,K/4Z&A@4 0
MTR9TX:QW'X5L!X?GL!,"CZO>N]2[B&KB-//M+ 0X+6_%_67Y;=00F[CB?-A"
M;?X<*['[==60LJ'>H\"7QH9W@5%2P72U)?5=R&"QGM0@9NY5,EAOFS.PLL)!
M)1M3)Y>:_#7>*B"RJ^].3NF@+]_<[!74ROPHRN=#O>G4$3QBF?O[U(WNQ%\]
MWWHV'G=]?62^#MI#?X*(FV1")HN7Y(:]H.F'542F"X!6+<ZG(S=FX>EDP5BY
MC"&+LQER?I3=O#9>S]=\4'3NB\N/"\#K.N0K:.P"J%."Y@+0^1F?5FR)!_6J
MLF2\N4V:_F3546Q9E\#OH2Z*>OXRDD+AUF6I$=7"?QX*(&JR](3;.9EEF)^D
M_$K[F^L0*;0@#N3Z#?.R?Y\4*"K7]V_0!*>X+ RS0,6)=HLPP/*++?DK_OFK
M2B+?LQA7< Q:#VD*3[[3'36!=1#>!8V3.&=4&?#)[<LT4RZM8#2/[MB WWG"
MW5_J11::CY/UI:-UJP:_/DI.LGXWJ9I0 A\$[2%W/S>2,N+\76.PYO^FMT:^
MHC 2'0OBN7G;(K^7YZWF-:,\$4FKL L ]M[L(Q+K!#^VQ=>E;O'U&.<H07GK
MVX-U+I<<<$KMM^%<<96[@07,)G8-/D#^3/?D)5ZG_WVDOG63=(U,?05+R,QY
M[M%?\N)RGEG]GQPC2WW_CPE0DO)X*LT'/DH<?.K4<P)>AVU= *Z(_#M[.H/<
MO>UP <@/\P0WR'7!;^+SNW*8<&DA_VXE)9JOVMBI."_J<]?OZB7(LE D]3EG
M,6@;4^FP8%3%R2BVAKFI#^S.T,AI+-0>W'<,O)XJZ*!@;(+["!%"CT8KZZVN
M7%[9)MTD+T.?9>.;>>D/3<\YG_]-N%]V/>A%9B3@IH&\BDAGONZ#^"UD;_<@
MFSNTZH^?>1B9(0!#FV<CD@BF.$5?L'$<:%+:Q?*:\?;,4U7?P0^G_2JS"F<X
M6Q$7G*,1?IC@"6/%T2GR;"2N(OF>-XY5RES]^<SY;L,S#M?'CE?L7<;#1I\6
M_+WE?R^W0:ZS):9XK]4*2Y:]&8Q10=:+SLNLCDV2XE13;D7R*M?Z#*9@8O4X
M"0PU07N.:#,%DRG&ZW6H<DUL3!)!5-57HP](%HWWDC\?Z(K/\(T1?PAM]#VQ
M*RG1Z5U06?$:ZQD8&<HXJ]K*-9T-#UH TGHEQ  O>;F NJJY$JYO-5YWGF'=
MEIS4H7U%WM.ZIPAJC_?+;2/1JQ^R^ N:>=RCD]XY1A,%SRM5N6%/L-D-7]^A
M R6Z,GZ^83(:KX^IJ_M1F_7N#LO'D(<OW+IN$;C?'T9@KN F]?!=! W8]6IL
M* ^XLYDQ]AZZ>7:5HR[G3,=>E$YB0C\Q_X%#_VF?BM3Q:,P%P'$E/$=U.KX$
M#;S\1[&AH)NM]4=U[) @"#$W%*10D88'HZAJQS @%/N$\>2C'U9MXLM*\A-*
M(I_6=6X&7[ZOTN.I62BLERYH+VR2]/LM%KA0NG !0$%[]L-7N%]\_S%U!&04
MZTU!"U<\@WVT&+EJT1G_E>-7;F!;%-^,W?DW!),^JKI*HAM,3X8!/UO7DRE[
M"\#1 Z96.9<6'\=8\T(=SF$NOM+F^W<'NVZ%3MVP=13:[<+&Z[_:KL"N=(G!
MP#\EX:\UZAH\?GQ;:AJ%F7AT&NGZ3%9;U\2XJACRG:</S_:,QJ_<4%6(43A:
MH7%F??=&%0CY\1/JYW)#,W73:5WDS129IKV)+X5H&>/ NRV$)U;96E8(;%")
M_Y?.T3+=C*"\TB)V@9\>+ARKFV3^-S'6Q=/ZH(<9PFQ4;!('H"FE(DMDE@Y\
M[0D<[[16-MLV2[R"PAB?:=+]]=@:]]OSR,UXV)(PEE$%81-W]%KH7'>6'3_+
ME2+2)FA@@9BW"'J\"CJ@(@!5]J=F:<??&2QS'I[FSI'Z@*Z[88;_ENB/'"O^
MU2N_5;GP0)1<!SAZ60H?@,OO/*,3"RP=+L4[=I\=YP7F' P^L6-2HB\>3R0^
MIJMEW-O<,Z3VI>X",WIV%?G:JTVV@NR&V[Y,NAA?>7W\XLLK0@8\II41M0)T
M<M3'B4<4[9QP+)T$:LX+/0PDQU%@GPS\N7G _#FI@,##!F\_K>HADY<:\(?7
MDQ4)$4262F?+L"FSU 7'B-VO4ZY+V2&AO]6;0N(-M#<IZ;(H=N W$'=@=_&@
M;[X^';8/,G7'I<7LV+Y7?T?4+[W\_;B8SMWAR9M@R?=(VE.SS9 @*J(*_IW?
MR0J=KZCZN 3BK:W%G&9R\-+#9*[@DQ'10AQ;V!&4S:FJ"-*L'U]?A!1S*EX4
MZ-8_UJ($#M:D:#=4+MH6%M?ES*I*XA>Q0R<OQUL9R_&-7;R"8T0@&J)G(2[=
MIM>IB+>(:S<>O^?6<]N,KMVME$$JI$UK8J76M1X-OP&[AC4H6KLM1.1/LW37
M\9[4JM$:4.*8I: ;^)Y#S3^>'S0,HE$&E0N6%<&4L$N%1.B&EK3_6XNXMJ?V
M-$&?JW2+C$L_F9BN%'^EYO!P^<-LI.'!%?8?W8S+9O]WOV.8#SN\/X*%!)P&
M:G2M',A\W3F3_-L+/94^UR.U>Z\0=)N@<[,D[>RJ<[@U_,^CYMS_PZT%09FI
MY HA!L3UD0F@UL046=\XDJON2R#!:<_$2,/7<?,_'RR2(JU8-N07$H6P!S$M
M2TJ=YD'\U0TX_8V<Y_JLGWM:1TQ>B2A=XBNYVQI^!_&Y6*+<I5Y/87=?#-U2
METWGWJ%(':_!=\7"D/+&W,RGWP,R@@W_LU<BE\MX 7AU :#"2SL?;N4 7%BO
M*G<W.=UN23+M?6ALD6.F$CS$N0E?S7*W'$:MQ-Q\ON7^QMMP3:\A5"]50F1W
M33CSY2O2S5#:^+F>@-D(,BQ)A.6P3*<]FPCBQ;OV/=6ZJ>7!FLZ*_U_:)?M4
M?X*8,DW2-"=<I =D]!J1",CS$*[,B-^_88$;*@,5ORW<=>5<SW^FR/TLS*L^
M3-NMN@ (B1#TX7,00[*0\6%AQ(Q[ 2-DX.])HD@QAK \WX4)ET>'3J)0CEO[
M;ST!?'#QXZ/XF-4VZBY_1'7IEK]&=GAAN7;-MIP9CC(),W6]XC;0-[B/XU@&
M:CLF/<KLQ&9I5EVTZ)SA,,&^6=L:Y1"MH9+^_+IS8,U)J3>IXB5!;F#H'.J1
M!>;TE4";*$:$__L-9\_P2:ZHCDL16$,Y;ZE=77#:_H"$I3M:-^]!UN:&!]'[
M,BBMA.5RMHJ@ KGZSGA^EK"65%GV<5OVE/5;BN3G/&2)YWI#N1YF_6J/ @.\
M#./ "G71QL0D_,]VR7#[XKT3V?^[71+@R*-R=S\.P8'70YN6FY%$L3-I:/:7
M2GDVNN."#W)^ZUW^3PT3E64G9,TG5:DQ99$BO'T'Z<YL?69";9?3%R<<^+/O
M@%^LVH<W\@.NP9M[(1I5BQ/L*#P<.\*LH9W6U_SH[J7VI[6 !UNVO\G<5O4J
MWJ$5_^S?G5;KG@?KF88U\2*OK#<9;W%]?L50<%0!9<++J>,*ZPL1;04+SEB+
M):T *,_Z(XUHSY$!9MY82;? /R<E^GIF:6XG+CT5,K+">=&_Y91;T(T8GM7]
MD"#A,>D$=KV @H4=D=L1%@%:D*O9VI=%! "8UP-\(0#KZJ=J4N"@2>"UNG/Z
MXR@$O^^+N;M[*ZQE=)6_')WSJE^[(H4I<1,M2Q#U29C.M^$BY[/ RI*B$=DA
MIX#+P\RAXXGOJ7$L&S.@FH2.)243TE@HJBI\9M/M98NAE@;?UZMJ1GB:!=7!
MY>.]5Z?[A0GWSL-<7.N'JF+ UV]5YS[!5L4JZPF<Q$#=<JQT:-*65)<[AMYO
M?9+? IL^LXNZ%<47QRH_=L7$*/B+&X G3/%;P7E!5O0'/S[[#=#<"DFK:H&-
MU$=8V7!2O4G.]1.BMPH91?['Z-$96Q>)?HPHZE'ZZ\V9_K=,U3+/V<8)J\<W
M*AVA;7R)?S^?9=R#<7W=RA&8(JH[%2Q8[61D:/'L?>5^J.]6'5?,T_SQ"T!J
MHC[%Y%=VX[^AF>%G3AK>\ U]-/B4S0M\=I1V 7@HL[J"-02?2ET  !> 7^H7
M  ,VF:/'8X7=$LS1O'+&Y>625Y6O0Z0Z$4QD]/VR\"<'."GFZ7)GUB?1P?%Z
MO/!?!>^%_/>IKX5^90SK_77EA1Q? *0,P(%Z9W]@AQ< RDTRW7281.Z*PLET
M<Z%I_SWB_AB)BS0#KA-/1&?;CG;]S:A8SBV>@SL9-&QY7(TV_AF[3M7WN0EP
M=L8=J(<"D3& <GQ2![N7[)2W%8VYLV#QF"]6BKMZ02EYV Y_N+KR'B&L[R(7
MHRQ4@ \)>!GY&EFGPZ_VT3N<3[Y_*XMS<:'W66: 'G'/<7<AUGB)5XG@XINL
M@_/9M5FK,%>?JO *E/3%?#!/E;KW?:"!Q.Q261 :;BR_=W<%HU+NFZ]V'NN5
MN7]UX!U5!6N"8W/ D]-QJ^3KV6/Q:C?8!'XLR%U78]E- ]+#A+Q6\U=/E16^
M 6EVGU\ JL-*:6U*.]H/VA?_!KMF:T*^A,]P!3S'Y$49+TO?*-=5??KE!9V_
M79X,LXFQE1()O"Y'+;@84 84\V5$Y>Z64'=E*YE'KW28G[VLM_@]=9SYV>''
MZ[MRTL.BK.8C[D7L"NP\HO'GD1)$F=*@"2!W92M/ 3UCYT1784/VZX;>I2>J
M5I@4^ULN%J"9*NZH2_M@[1Z"-%$PXGF@:1 7'HSYV?.SHO"1)MKCAX@U1<[J
MZQ9ZJ0Y_AA@TSS.;[Q/W=H^SC>ST=OZ\I!7K[/[*Q]"5Q/*08LPLON9W4HO/
M_O:C;WO92=6'++-1TL@((-:(WNRP>R$,$66/9KS2!RU:!FO?"7<R\QV(57KI
M8R>TIA*\K1D8@QZ-]01R!HTBF<5AH/(YB/?,&4.1B_19X*!!E'"=M["%#E>P
M@_Q?EEG??53"!X30%L["M[8K QKI\M4.)_C5M>;TB>:U1YHF:S_N9'\ERF!S
MPV&B'JALH:Z,U^FH_XN]]PYKJENW1X,-! 6E%R$** @B*E4I$94F4J4C1$6D
M2:]"8 E("TVZ4I4BTD5Z#;V*2)> E-";)-1 "G?I/??>\WWGTWU^9]]GN\\Y
M^X_Y^"PB(>O-?,<[QIASOHN0$75U<U1%._RHKCQZ:N"8^*2]TX#V[0RSSKU<
M[\/O.HR=S6G^*+,JH/_W 8W4_^> QN"FJ]_KQ7&6WI7-9.[.XQ)WBD/E[2R?
M^/ $4\KK<![6Q:;Z.<,.6"QFX-V42WJ=6UPC;2ZDG6QE"]=?Y>R8>ZO#H&7\
M=1\"VV#W4Q/^L _AF4?]:?M<?L\HRU1AL+3Q%.R8>VY#G!_(17VVWKDLJTIO
MU2CUK)V!ZTK>#2<HG8HTZ<5,@%->^O-<;XUB!MK:4/MC_MGDS1M*2=G',K*G
M?2F(@H(8\)V4IZ 'EJZ5/R=>0<#S1Y^XE[A4&CE=6^-Z?,JO7;7Y&+T2Y* .
M=1C_NV^)Q"?G;Q"[M^"1,W7TI)HZNN4ZKO =?1RWN[I.F(-GVM+GSGCQ#SX;
M;6&ILG0W:KTH)MWSYUMRUT+W(64]]?N0$P8+.V@[GQBK(333W)N3 :KR<;T?
M=V@X$%UL7^FS95P9&MJYPB16P[!E&/<"A"EVISF!,OC2:_02F=GRHG3+:1M%
M:K?[*:#(\LOD:_($Z+U[X27A$;B'A";#^.<UQZ=4KV'ZY4(,G]]T>Z<N^2C*
ME,LQN"B<#G'Q:)?IV\O:NQG3-EQK76_\HI/CQ;;@_;)Y!1S3J4V[L@((* YX
M_CKR8=5@R4C^ZKAZU;G1EQW;XRRR@V.])LY&(:J<8<8&J2+?]XR5H/P?X9TR
MW45:/4JS?(DN4T;ZFV'J2L/F1LH2-]+$(H\]ISR6PS'+=RCE"U\;:O(UO$3<
M9[HG<'FRY]#7-HQSZ8"0G5CW734[\4^ME\]]2;\2$9OQE,U;AX^"0W;"U'UY
MLO!9'9\Z(UAL R(*[S6+9[:L)DCGU/G@JKE&6@2(+%AZ]UMX VG.-/FIUEAS
MFXM2K$-'(I4$9B$-]Z]?E1Y^9-47)J_UB13^]&[2FPZGCGV(#>S(<CF9!>L6
M7B.6U9&[-'Y@^/6PD=ISAK/='X""6P>COE#;2QU9<C N]]N'6-GY<XEC:]A7
M4\,WI:3,(SY&';]-%C0*<3QB\"CLRY7(GJ)6.9Z$+<,-X 2Y&T5-U,N7S<\E
MRF)7R9D\=E$88UF9OJ)O>.C5G2=# @XQVN;]1>FA,4GI SBZ \O*!%7OX3CH
M"834J2@$#$N;Z)!EN$S'<<$CC+C4<3KPM!G3J=G '45SIE'W8HS$RBHNW7"P
M1F2:8Q]"#;=",PTD(%ZX!RG:2*O1GI+CK59F,[EC,YJP8\.G7/39>=0+=N=#
M>7^>T/ C\;+("YH*=<@<R,$OU'/2EECS>OC)3!'WU(8JKFI'/3NT71YWU'V9
M0_YN=/6#GDJ5<.VX(;XH9;>Z^;;E=+S(%,OJ>6S;;3P%QKQ"U6JWOSF%K6]+
M8> )??-A(:G9)(4&E<BXGCLV;%^%PZ6ADU"_[WV\D5MT(2E,_2["!]PW.JKZ
M$/+9(T>G^M<T'2[0B]/6SQ0_PCT+?(N1;<1*- )'$%>4AQN]F?L0,O,XP<7M
M8(9VRNL?C^@[C V-UTZ1A%NN:>\]+GZ+MD(_F7Y2YO;Y0J^2#!OK"6OU/,^O
M-M9/(U><B8B(ES7F="N!DP!M1^ZXY02=7=K1*@[C\T*%%VV5%XKDV2XTSSA]
M-H^B%%OR2(WP9B'WH&A$I:JK+1"<DU]OZT^5E; [-1?5-I:\C#I1'0V[;-/5
M\,G:J E:7-@($G*K[.R%% CV6_*[5HS2M[3^M(V'#SZGGXR1!F@%JP=*JF6L
M6JV%;O31+%\-&!'Z]M" QV&AL]Y7MC0I1T%7S\8C04'(>"$B!N& S=U6PMDF
MRI:XV%%:7%$(N#4H+5;09,8K1)I1>O3%2 ;)Y?FX&OI%L85+ &=7+V4]P0@?
MMYH2XW@IFJ]&8C.O>7\C[3S<C3>ZYM',)*VJ:_JV$?YZU0L4/,";627V3,!7
M@1//_%ZX'A[=T\N2.^;ZONW8Y3R-UC?TD@,".3[/()P0QGF=VZ>0:\.OTU6S
MG:2$Y38UY1T3_1DUKQ_^]P,124  'T/V(7;[$((=W&BX UK>1FQ';7\_.5&V
MM74*9#(\5K#M'7(TSYHD"_GV*0D2:A^2H420D-^'O! +)'F"F/P:6:U= M\]
MJ \,UP![5+FE&U?PK[!;LA)+H,93?JDISPCYBT'1CG@ *C#%:8! ,0$L2@TW
MIF*5)G;Y3&3!RI('W>,=_@JP C.1^ ERO=O$GMH6-HM(+T%6'HX "1 E.5AL
M56,?$NEEIY\D!ANWW!-9\^!/J[E;\;/.$/_(\:_#.?_\AW/XTY[]5P=W56G
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M+\^HU\/UL_+]#QUZ\_L0(M,P^18J$+Y]HAK$'H?AA</>P#ZDP1B84<&#-_>
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MLPE>W5O2#5>-4!B8Z9LS-OQRHX<;HG*.%==S,X"S'E/+GJ/IX/I05=GX\(_
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MWSUEZR?*^I&F4=V]U&W^G9N[E3/1.UM,I0)]F=XF;^^^S3$DT87L0Z9TR:/
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M;Z2HV0U]G..8.SX.=[A7F!J=>+/;FYJ(P/E/M,BH3*FWV-"I]1)M[,Q)Z:9
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M7/TR[R$NX/4<ICWC^U=MQ8S:!GF*^E=L,X(?10V>BZ&35>JRL:E *_4X:%D
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MT)Z&LH.*QNKE@(76HTTR#E#KW4XU7-4KF#J8?[P(FVUR$9==ZL)-#);A?3>
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MU0T]\KC4&73EIEXH!T&5-#0"$:H;@DBA&Z^!V8AJ6*[*8/THFM>&N?L&4A>
M*VYX)\I/%/=G\EDS;J440TN/I.+47;0;)4B:%</@!RAKZ/@"SY]TZ\\JW/B$
M'@,% [JI_#D3K5S!KAO%G:0VKRX@/)_(<O[](3 .2+NG9.Y^XTQQL_\N)S(U
M6%(ETXMQ30OU+H-.M;E;Z:WW->.\I=JDNH.'IDS^P;QP=4CN(B@&Q$OFC\4L
M#0Z+3S"P,"4FGX>_\C5+U97'CV<T!?@3#>[N/K+0:EYYL:PDB3,(JTOH<(&;
ME^$S\P+]YW>?PEZ--\C["#R&</GOSW7+=IK3)&KU>%R[YIPL3#-?^#U.7?SS
MYC/SO]X0/WPZMJTC;2(58_)TR%U)(F=>.FX]5NFI?:"'!]M^EQLSI&HNX>L*
M\'5LCQ.V:\FS!<[N;"G;&2>L5H=9J_>M8E6YC^GYS/=^E;1B+JG=NT?"MR9
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M!M$!&Y_N68JWPT%KZC'CO='%0!.L<G'RZMC=!XG7+0Q2N^0$5QC"^D/H6R\
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MB>&?2J57@-GGEU?P\K:-DSHVFFY447M1._R2-09$_YBYO,PQNL^@U1S+G-0
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MO9FFL8A;!@38J\9Y5*6 CK\W;=J9FJ7M "^1E@@Z+DAF4&-C<&)WL1KI&T'
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MH;IC@OFZ,P W$ 8:[-A$+\6QP[ZN1)DV&8F.Z: (F&_=O"25Q7='E!3</6;
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M4+^1#YH[E5 X:HB4]7;^/;A#;*VV05;?%]9:-OV5K_K>*I@#9=:-2Q@<?]4
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M5?)5T^MT*E$#>B%-:\Z<>X"$]^^V HNJ5_<CS@&-T!X:*[0&O,(WL#<^!O_
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MKFYFAQ#VRM;7(K,H@E"R4-8RC,9/U_*7D0TJP-+*E:_1')[5,G=A8YPCP'V
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MS'MKZ!.>R=1#JZ?7QIOWW:X /NP4.Q"6W7^D1=4"N@+<W.Q48C)(.5NLL')
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MR%$OX7/[>622/)J>H+_#%0MEK5"D_;7SI+.3U1"QO"->]_.QY^/V#R(I/2R
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MO@Z,(V1T\9](C10(ZVM,4YM:$/:G$KI)++J2,R- 9^#V3_.&[7*)RBR'YSY
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M0QK6"8U_>*Z;XI<&\;=X->C.CK29'Z+8[C_FBJ3?CVOXOOI;6J#%IW0D9ZT
M8B'7Y%254S0$LUM*M#RMYM+OP.9+1QDD8+/K*J92I_?2<^'U#?N!F5\4#8J(
ME@I&TZ+(@0:#&T^4S9";2C0#=/*^BL#0)@)WIR7;U,.>*X!AG-",]<\E:1#[
M@[&[/W D3W,^G(A4!IEUW/XSUOB$T>Z1X\:-KE#X#$06XY"(693G]K=U+W6>
ML#'+WOW557689QPQVS9:LCK,*"D\@G2T$FOON6GP+G@"&:>Y;7?B7MS/6]DA
MI\@HS"AL^42_92%3L$&]=6Y<M'GI\@Z.KSL+V%#F+.^:B\X.*:F?_V8J^RJ&
M)^PN"[LO"X>2*AB= B&%=:"(WW\2FZX/*[R[ KR8TMB2^VM,!G!=.%HV&E,O
M:- F;,(#_[K)%S\I"I9YS*O_M;)X1,Q8&WAFJN3_=J7GXT<UAO+WKAW.Y\=@
M3;&T^?X"(7T",+-PES4TW==W?8=I[3*/.G$!*9_SZQ&]=U+,!+R\G\PN0$!W
MW?'O\4J< 6Y>J.B,ZA0<R)U'7@&2X8'=BB4<!N)%BF]3WWD%9RQV@X:N %V3
M8%=AX5!69OF4G]D;FMX!FKOV6Q70W(Z6,VQRDEM=K2MFE#Y9I0L![;_[C[@X
MMP+[0NC- ZWS%G#!KPG3L$]U#UM2@B_Z]3)!SLK'$WY<+Z>@.ZJVP2)XD9&D
M!N7'Z&P<Y]-IY8#OYVTQA;:3]2'/ -NCU^UCR^-AE^D1Z873F[RGCR["0LW4
M:UH0W.74:GF<F6B"(,%43658C*RF%+3G2E+!*\$^'3/O?53V'8H90B!4 D'T
M!L=[-"?#/M,=*HF^U,16KNA7G9<Y,RI.?!^/9+V7E>2.JV9V#FG9_/\/T^FU
M\E0Q&N5XZ;4&/G<UYW'2BF;TZHCWP+E97 &4SG,@?VPX#('-+66\8BAWHHWS
M($&MXIPI^L1"37J9MZBBMBSE/ZU2;N591B[24U;ZR^O'RR3:9)+S^O&,Y#;3
M?0M-6E#-BV'AA,Y!<<:UM$GF XMTH5=P@3)&QKT3A-_1\U7=#SNJTY'PF8SE
MOL.PSU< NF,4XY8XL:1+\[*IS%F,.P-AT\],9T3A'7D6=+PE'K>E^!%OVRE?
ME>SA<DSTR=[ZKT466# XUV9G1W=C='5+-0 =?@)[ &)"UX=2U$&[E%E-F+M\
M^3]K).:]>NZ9MY0;NK7CTQ*"M?IR"/)Z6;JU_ <A]=VLO/*9R%#YO8M%KO"$
M*X#_KE4JQC/@K42H%I%%5]-4_\/?KT4SH6BP+$Q6!LI]L(LA' X%E-I\,/#7
MSAH1*@R0'0>!G?VN )0M>D%8*,5+Z8LZM,R14O5W\G'XBT=0@VA*)8)EN#FL
MD_]8+IBII!>SC1PO$4S9D%T6RZDGS-8$ABC8(,HN97D3->P;(=._2GAO+&DN
M*BF<G.PV$9Y_S1>V-S&($=P(='4-\CG>LB.&=9M:Q14TA8CNXI[,&5"U]1!J
MY'9N6-\!&WW=MB7?34Y$SUAYZQ)XN$#Q8^:BVO2E?T=)=\ _B:U8-?QHN/O:
M9VC]HLW('[$E49+G/I,G22B>/D=N!8P5CQ48\];7=O<W!"]>C*^#I[8K,TOB
MBM3I*YQ_-2Z/!ITKE&RY$L$]K"H)CQLSU5O-IAK2!O\KD\"Y.!(_]9VQ X<A
M,>''SY7OD=Y,2I6:7R9;3HZ;Q/Y5G:#_1M\K=P6HBFBEQT)CDS^3Z$N7U.;=
M<I5'W9.0MJ0?R9Z#86U@X>;GI8J(*C[QN"@MQ85MEXJF=)A_A2EX.#-A,)_=
M7EY.9OU6QKK[J$X(QW 8/1'ZEO"6Z0'(7P4<?3/K)L^]FD^K+(#?+#O/6=BG
MN>X'O\%O?K:_YXRHD)E,@?*^UGS$$6M(%7[".$BZ M"0:=T2 :B&!JHUQ\LG
M:BQ\4T*R:W ]3%A4\//B+;_SJDIOVU^[<Q&TV?'Q_>\7:4GS+VP\U *4-(>]
MM65Z^\?;NU])KU,_;[+*N+F5:M22N]]@)KOF]IO9N.Q;['-Y+?-JK86)!K.Y
M?K/^ ]MJ_'(7] X$X<ZM/9V?M\IR5\YI3;D1"(!V2D\:?0O6P"='![_^N6#Q
MQQQTRKI>QH)SJ[376$ <,N"XG_=(3CD^J2.Q$:CA*E&V79F1(=V5=94>-&Q+
MS\*.A2F):. #Z7*]>\)/K5=]F:3YK=*[04+%\SH6OOYO.Y#7<K9Z[WW6KTV-
M3VC0P975@';'30KR"7R)/BHW>BK+=][-/F0Q_I/AQYG/\) ;7S%,@^W]3-+T
MJZ^7'Q+QZJ5E'QA_^'Q%%"\1$B/=$2PP[A/B-J/W$)*W,_ANYN0FR[08AT8X
MA2#@E8>\9R\EP+^JN9O\ .\>7]?D6ISVMJ%I[HVL1PN81R>)[B4+9V\<IN#[
M1N, +=OK6;7[1@D\RY(68CRXAVA=(_#.2-DW83K.\D[#__U>$O(JF1E @_P1
MJ-?-L*=X=5*F.UL8^L85X*MO)5Z]FRGT$;ZB'O$YSY><J6#2+XKK406XV@3E
M%2@1LKKQP80YD@=A:E*C6I6CSN7P.<4'P.=4O9<FJ^)31]3IJP+;+!^0K2K^
M^MOG2K<Z,8Z?(0N*)YY1K2'$^0,ESV^"J;J M33C/"Y"?2*VO+Q1*GNT'EXZ
M+]G[X*_UYC\( I%NGL">32L:!A'*+:&=H9R("YJ8?#88["B6[^WJC5:_M%Y4
MJ)QR+6:9[@_$2#-&=])U9FGF<1N'\9F#4O\)S)8ZRW!8G,Z8!PEC*Y$]79]C
MK60R42@^UB[=Q'H\:QNOYT6Y"DDSGAH%!"!C79OW# A\2<?T-W"LR-([V;\'
M>KP.[^W"7\J===MMA[$HLE7H_FZO>I4JWL9T Y\\W,95^0_Y#J28E7DAOXFM
ME9.FX X1,WW*P7OKO^\V4"8VCKK8M@;V%*V,WB863S+)6R2NZ?1E2+T+H[$,
MX[:TI)48.C(>0-[_D*J?NI8IF5H+7G*VW/5K;;)(V_&W\3 6IDT4?N,PKWDD
MY+4#^PG^@.I"JK^HX'@M<+O0[M[8Q*1MHDWB>X8G_!UE"0":C[JP1J/ZDL$H
MAO=O_Z_M%37!)E@P%S41K(_V?7[;CS7XCJ<D_^#= CG*)KY/"JE"IBTTITLM
M>>@5G2F/_<-],1PV&T0&:!_AFAXVXYE]X[OU\_GLGZ;LVLO);;!$W>;)_;J6
M=NQNU;8:_ !_8'%9[I:<0 H+\K5=.1)*Y.ZLKV&>'F-WM]V>]Y,5IZ'^  B)
M4YG-Q/CX01TX;T\.07HVEJR*E?^Z+E?ZY=V<Q/E KV\!@5KECNZV5.^BF-G>
M.--LFQG.QPV+/_BU^DJ78;70]N&$]GKS_E*#TMM.Y9X/%9BH7]OZ\74?'V)3
MS5S_/:^$"D(N,'35%])_EQ2(5B%>4F ;GNF6Y[Z/,_@^<WV?RM.@+'UNS_*X
M.L5*%4+9,Q?6Y4X#LN2>I U)(G.)OR<@9*BBU7I]K5^> Z=/$EAS$[MSI\#2
M\"Y7ANK??3[6+VG^1( W5?[([Y@H,^P"B^;,P!;.=A&O(',V7_Y3JO'^YZ*K
MXN"<MI]R ^>F"K%-B,:!<V6<-/)406@FP_OK5#?6M_+5>_-%>Y9%7M%]$:>E
M>L>:[?\-V?"6Z6 U,#,KR>1[_<&)0.UT"#<\N&:E^5/)UX_I/)[[0LE6<Y,8
M!2NVE]@_#9')S^;,;_SOMKO,!L*(TFZ',@M)+!(+Q;$09- FJ9HD\>)=24OS
M[;)N6T3C49'QZU666[=+CK=T0@P#\"7M_N<&H%J(@9J,<)%B>G7BJP3;]8[$
MD@7KN$G&SX._I1GEJ[Q<5;<FX!,A0!A,1Z2TZF/F6I.AO5ISJ<PJ2U"54&:6
MP,Z"E>0NF"<=[K;YNF@G(W &2GT*];US\G47*10?0-FSN\/LH6KB<*_4X;&A
MFB8?X-;?S%-0A'L,%PN2FR09%\ S7A&W WS6GVH#G%U>Y/W"9=%T4GX%J-N
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M:ST,[,[N+,\7[4-_:^L,.CN7'"_6'=XJ4O?Z^@<-?\<DNQ=Z9]H^NQ;TG0<
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M3C8 ]?>(1U4MN [-@PK3)V;K+^DNVOYY>R:">*ZB-);-0LN'.FMY(\ZZH#S
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MZ1U"J[MD^]X&>0.BX"XGRGZ31=HAHNK#>OCU!^<XNSAZ82]:#>:K. W:XCS
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MLFG TKMSQ@)[6.>#')Y\ SKB9I<==[6_F,>=7TYJV:M<EF&()<(4 A;=>ND
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MO35NFO^&YU'=-'STWP,OC)#7?@P5QG<%<+X0-!L78#/#0/?M=X6.U[00[ZR
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M(R%!6MTP-)\&40LK&@8T&O?:%<R=])S2?9[UN ;Q8N>%SV?0EZ^,YM^;]WN
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MS?T>Z:F[IL%-\_-F>@M(!*^31]Q1920[3M .C?3TM#Y8-O)8"*E/.P4R0/N
M_V"(WQBFZK"BO4UX9$IQG_B!2F]_YJZ#X])'WYF&?G:RV N\Y-SPA]K^X6D@
MUI"@^NE*"NDA:H5IP^Q&?-PU;7E'GK=+%?7/+^Q?A1=1XH)U%ENCO&HAXH_#
M=$1+3B30UN]I^P9BLA[QM/J#%#>;U3'GH&XK@9U/Q>B"G9P@IE@7?FXI^)+6
M<ZW;;S6"B<W[,_9.2R=KNOJVM3M-.J>%+:2D_ 'YPDV. G.Y;<GD8QM9FY:Q
M=>E#HWGRXTXL@RQ.W=9-Z<PG7Z85'4GX>#4TIZFYH_?MK]5[OY)80VF(W@3)
M'%U#_&'D$DI]X"PLY8N=S1XP](G7:?8D&$"BJ<1[O3T$4RVX-4#OX@<Q7O>'
M#JZX,"5:LHY$A+\.>;&4^./7&@7@X$)2M A4P@)CF\6OO>J8$FV58OWSYY+F
M0%+1O68T'8-F_IR8;H2!9LIDT(S)V;I]9T?I+<XZK>A>G12#N>3X4MQJWTG*
M3BG*Z37L1C.+W%85UNOJ1BX5@3KO2-S:2%<IZ;K=,X%$/WYFDQ?>0[.?/MK<
M@&QN$(:IH ,(P>A00R^L;8#5E#*D8H9[QA:23FWZ-C'2Y)BG6O_Z54#LD:+E
M#Y%< 6/#=.7O.:L0'TAA5D- D<+12RWNGST/CVK"0R>Y@VS*#VP71,9VS6X:
M:@1J]?U?-_7-XTB/SXND&:-5)2>4E4+R-\SES*!V)QY=(5RAD-L]%KR)(!'
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M(2D@$@8E%Y+L:C*7:TO &5!]-;2"D0#4Y\A- FTZC' $ZTK @9;I@5M.$R3
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MJW])N]YT6+HM%2=D7#5%(W]X.7-(KUJASR<E=N7X2*8 ])E<5S0E3Z]"34B
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MJ5.Y'=^;))$^//@G)MC$[9;U PL>-4.\#FYQ13^D0)];&J,>$6%A<$A;O*1
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M"06G<"OB.)P6*H<!KU1$M<BA6HV7'XUM!NH@>G^(Y(=&=N9^2K-E-::X53G
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M9ING(9.E8=%>\\U%(2/NGX3$"C%",6QMCB@"FZTJ)'>A!S-%,VD!4\ _3B0
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M8(>V?C^ $M:$E04Q[,#K(O:\43PL 3]@5TO%RC/T6S!UZ2?I1],%/Z1*!=Y
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M*OG?@K>>5,/1VFL C5S\63F!_LSO<ZPUPGLG)EU2\H4RN6$D:#>7A1*[@@K
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M&?1P*+;3YQ]^GYR=5-W?(744N$*=OMDB!COHSF:JGYCHA(*0JB_3+OP.D/#
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M_[EB?#-2U*D5VE]6[EU8[0+'TRY-U>]R4KC[;MBA"1#VPU=F?B[IWI^Q_>!
M7R%D2XC2 4/*^T[\%MR3=)&<0"IM]UY.#@;34_5^[2Q9>K[6-MVI^JO]5@(6
M!_Z1GKH;S#DMJ0 AAG1VT-60^N+.K!DKI?P!"1(GAQ=2*_;]O'GF.EAV;!E"
M/A2\>:W!"-M@JI(F:Y/.(R,]J2;$'+NLESJ.11[3#RKK5J%.<Z9=8["!X^6H
M LVNAXOA&KO8A#X\ @V*6I1HF(3?TA.G:#\*MQL)]',3K=S)D3#ML,\$#<J]
M[+S:S\ G6KX!B8'L65"ES]Q:GN4)5Q8>V6C2TPY"(\[75U^L*P_ B[[B-0_5
M$^\PBI>TSG"CW_GXM< 2'BP2 OG?1Z( ]00(OSN-CIA2C==]/*MRHC2[4XI5
MZGWDYI&R=1<@]LDZFB)A1NDEU9HD]K8@D^=PF)S/U<B2-:V[2+:>>*].@95<
M6SJI=T^VZ5'$U1<'"EB7KL!3 $<' V708&RT9,)+CMI_V;)=UGA3)BFD80B5
M;'8,IC[X1;L&5QZMKDM\-]1;66'5.*4K59?/(8L9G'C%#O2-E*%/(()[4H7@
MVI1:%^(TWF*[H5VLGB<3%M++1Y2O=7PW(2B>*Z7]N'-'5W\U4 #)V7$%;IQ*
M_I#3*<96,%]5A%LKB__+P.99VIC[Q[X4X/4:6\3K%SG<3%!!<JOF01)!]=)H
M2W;**YN_C,27TUI5S4%,\]GA7QGBF@A^O%WW3W!KOK4EF,KC .CU1WR0<QBZ
M@R'\GW!EJN?R4C*"E:H<@F^7QI=1KZAK.5@$!7[<R)5OXW#$A-<EQ(#?LX]V
M,GYPT9FNIZJ0>AM[J@%K>C)U\97+DYY<*S=[N(4Y]\5UB;."Y'(QO5- .G</
M@LS6_+^*HJ''0J> @5H8/ZV]]!0P%O^"'BO[!Q@3W-CCC7TP:$5ZC.RQ(AI'
MB17I9J4D?UK_9:D"%>P,6GG+W1;)_@N 8<+X0NZV5KP8WN)]]+\6#(1V]74B
M8L[PH?IZ&V39DMM#3+1]0OAGTP25LR*(6>>]Y'O.0'')50E @=_P"_HRXBD@
MG"9IA*M$&$V'250>C N@OO_=U+TFH^#9Z3G&S/TN[])Y$3>&#+\DF/K6/R*J
M]VBJF62E#4S0&DX@A\FW-C1G+&)FA[:*O=Q"^U_7!E]GY%T'TU&=\>7 )#U5
MBG<E+!_N=Z9-WYSL-[VYI'K8Q %S=Q[&.&>\"CJTK.)%?=]>X:-I40BE9M>D
MJ&&*+:W0UT]$#"\)@T1]7A>\H'<A?R,UH(@$'%M'2:%'ALV&X</:!FC)K>>N
M;NBD&Q+(DA!/F,)VY:?Y360MIC*DS'BZS**I?E+-<-\[0?-1*^MK%G/NM4_3
MU3 _#)8_44?6$V^A\*BA9=1+?'^*],PQH6E@WF\O_==9YHP:"]<A=#FI3?VU
MQ$+QX)BJZD5/H/EXW6'%UH_/-@6W!M/T!P;^7FG>Y8/?(HWT>B<*H="G@)BC
M:%1,737P*UM([T/[RI_I/Y?3O1D\][([-:6+V/H[%R*.]2AX-%YZ^S$IRG;,
M]=CX[=1K#GL'F4,WFPF,Z\,%<UD.=.0-C^FN:@Y;JOQ)48<,3+KG054^ N]H
M?8PP:FK2?G!TU6!!2''Y>\&Y?^*DL7!!DHLAI?HLI0:3JPIN(.+%Q-24>[^Z
MYV8EJ4VK$>M>5OHRU$2T/@_D<4XN).3^(":O)JI 9MRZ@_]%*11,VXS*&W_Z
M=4VV\G>;GV8N'X,8BRMI^!$@J-KAI$1/:NT4P$[CV1Q$7!O\XI']<,:]Y:4+
M?-IO0/CRU\*5\+LV9#'*A=2M9"&+8Q68T']5G]^>_5?YD+7'5 @T)5HF5NB$
MX$1!/<$NN]\FY5U:$G4?*475'4>EF3QE"ZKN/@4(0Y'<>DJPW7N-J  B*';6
M7U;VL='>SF[:3A/RM=)K+HXGVY>BDJ:3L%33EI-W_HAX)*OSTI42J-("Y;)8
MI8[U2+V$?O"A4HVT[MV-(\OE:C1,CXNJ^ NN+,AEZ7YAL_EXR&<57F4);W[I
MUL#H =CRKBX<?UFE<+W$1MZ3X/XL:YB7TT"N;P8 _;-+OXG@0;A#ZF!E=TC:
M<%7BQ3ND=0ZL3:]OZ.?+RE=SK3+%+QATBN5KL"[^)6R?\^:E</<$2[7&E4W4
MS>5IK$C3V9F^IQN9+.]'N2!![MB1[E#U;J7T,DIU=S_6ZTOQR)[E1>.MHH:"
MK\::(FX2]0!8W[;%*> BJ),F^@NNCF]_H" $>W4*</B>W=?S=%+>Z\E[D4QO
M'?>]!FLIAU>OU4([WE+^DEZMXB"Q_C-UGKJJJ7S0Z2\E:UAX<KUD_BD@>=CO
M]^<5P@1KTLI9SY,D!1-/=;03<UV6=SVZTG9IH8]I4:[0^IK038T'/S< NL:A
MM<W''B^N*!,W,=8/-JR.@+$!KQVM"";O<<T-C1\NOQ\=_R-\FRY]9)@Q&+ (
M>8,0LK<4BJ*^F,.S!I4.^&O[E5WH.ZK*([]>F.Y0M@>SA6DYPJ)P(XGU($YW
M<V<\ZL))*9OWG09XL1GK,W1/D+;D_;U5W3Z-@<H2*A]QN/ZC8<4,_ YIZ$^F
M2MC+P%^4X?4B5QK1A])K2S$LHJH3$;%46_PN$%;@Z7=[0B3?Q78R0*WM@6=4
M.5_Z\7GIS#1K=T&!0G9I7$HFR9(0&*ER%DB6)/<VC9;O@MO^E4"SQNS%474.
MSH([M=_Z-'5$4J S.J)EE$%T&/-$$0D1)T<U*C=85>TH<7.5-^_A7E&Z)!6X
MHJBM+\K8'C14O36R7&FL&3 20U.8UA$\3P@M@G3;H:CF*T\9KRB\9SDX-&8<
M*SY!AEV"9?;: 7ORZ7NT>E$)"!Q_>\[=!A)OF[E AZ5\_#S_[\4FP;Y_L0ZN
MX8X4"5("'C1K<H<22S _#&#>WJJJJK[^6B;#,_/'UT( OR_+5RV_A&ZB5Q2I
MG*"6Z8T?LNPKQF'R/YNLKM- 8_[]7JXI_ #,OKFT5%R7;,HIH-.,_@,%LJR]
M%(\B6MI#V-;G-_AS0\?MK_C^,1/=RKCLUH"/>!4*':4QT<:<+I(@D2J;CI9V
MWXDC<0<S?",/1O\FOJDO8/YX[[NS0Z2UA*:H<E0D4R$[?2^20T^6JDR))XYT
M.8E/XB>WZSW#>"VY;>U-O$^*H/^>-12P<HJ$?^?H]_D1:E U3JZAE. 5HM7T
MSK+^6BX>BN+HA>HAV7]YIV%6#+(9O?ZP*&E6JU,F29DFE'12*^Y"#BZ&-CNF
M@N+1]ZJ?\RX8JA(6?I)P'_W-\>?<JPO6!4T'0.QWU;P>,,/DA-(IH#O@B4^P
M;],OAFUB-<&I]L51_BI&X,#"P^#/E?>E+WS,G%_.:*3ZOP^ZX+NOKM>7L'B2
MKW=M$\'IKQMRA^3XB:] @8CY>&151H;\558ZF;WG%H[6FQ448*2?EEU%SO;1
MS!%]N\=LV%/ 6K,,_5@'+PS19\=">0-;ZLGNN Q-OFU6M_1]+JYCQ"-LRS/:
M >GE>T(HT/XQ- JW^ 3+W$;,:I5D?R%K8K&K6X',"IG73M:6W+5M AES?P7:
MC.;/7/L\\%P#$/R+\2>$]:]WW%)=278EOAP<5[F<?$'W9HBLJ+#9>&'!BRGE
M\/T!&>D@!M%"NB3.)'Q[#@X1J^.'RYJHA#OCYR "]CN&98O7/S3DB/L$QM\4
MC:7H=XXP9(Z(A>G14]4I64$!9QQ[#I9WC[B]4[CX#%.VG.S2;[8R(-F?V,PL
MK2G L%_@][B#GH+NM0()P*'$)3N2%F758E3^25OCU**D>9S03;J&=V6L:,F5
M_3VD@PSC.RKHI!!.3_3&QV(&P0+0I5E^]0[YYER&8]&>XU_:D7X\+QGUZA=@
MJ^1URMU%X;;Z7W]M=<R_+-Z:^F63J.E9[.9;#Y^5?G3K3H%-P06/D:WB4X 4
M(V'D)$4==,0]W4SI7D(W"IV?)=T)AJY]C=UF?,SY[MR_!=1O^DU]$>NMP67A
MD1@$O<Y5W.9QD[?7]G*&K53#6W.^9UF_L4D:3^@CTKLP)KR=M,ZE/?V'M.Y_
MJ".!+XBGFF*6L1U7^2RT848Z%O "D?U_B+[P9[/?&J646VGG6SZ>1*!6PLM.
MHG<1!XKZ(!/K"-ID;N]2W!95F5AF_/[C9)MG\*7F#,7LQO&/Z/F![4[Z@F)8
M=<ASED^9X9J2TWT%;,3=5#T]^#V2=.\2$Z5J$"WD_VH =\)G/B3G%#1U_\:"
MG',<BYA%G^XK&Q^M\( E09562#B$2T\,;CKVA,]))$:#*EW5"V(6S7QB_V-Q
M]-M*P5T.ZU;8'MIQ2H>_' N#/(PUG5YM>%:#>L^0CA874130"5DF:':M.PD2
MO,-1 C1QF/5]XDX[R=ZD8\R;L+<:3O%0G:=C91+_SO2$2:+H7 MP-A7OYP27
M:AUO<PSB0U91+KNKA'K8#]R\Q@0S>Y\'NJJOYS)1+O1?$='ZT9^LY1.QD9Z6
MMW8=*+;O4ML'G'%C[OJ'[UC9P70%3:+7$'S0=9PERZ;6?%I]3[#GV^EDEM!5
M3LSPHY#\IO+_W^+0:[K>#[Z-^H?,G5CAA1V5L/S9?Z"1#.X"##5/81AE?9 6
M7'$L["K5BVB,)+C3Y-5C^:T,=:NRBM;5]N:P5_#GE >R7PNL2D>E#P57)7L2
M(,Q4)1(C5<KI<NWTWW+3ZZ[UDW);T>4J4#X7=PF&JI/.S+KS:YJ;#E+_(]$N
MHM#C=[FHM_[[H1V*<?-H$A6?=[,MQZ2>)'\FVNW6R;$_R_=V[BJG[K(W#0"V
M4,]!?!Z+6A0@3C[0L=W3T*HMTJ3@]^2C9F[30IR^*$"$?3*?E(G!+L70KL/%
MQOSG_M6/UU?>WA&]>?[Q97_3QV^Y#"08,C&R0+(D235KM[-=&IU\K0L/9!_T
M=?ZRGB%BZ7FIX*:Z^,HYIM520_;":052,9XO"Z^ K5T>B549_+SKI9*X^<5[
MD;M=/,,TW#21G1XGD+5!![$#;**@P(2CU6YM$-U&L )6FE],/&%QT[+A8L>1
MA##R$A^C\#N9_C]Y4.(@P23AI;W59)@LDGEC6F(HT6C,/S%H6TZY/SZ?YAZW
M9B^A\U>@"D'&30-C7M)XH>?&S$\!6[L"=DZAV3S7]^(FY[]&3.0W\>[2>$D-
ML00(ZQPLUFAB>_<@)*YMHB49\ZMI8 '98N+C8ZQ9"%2B"),@/2V-"6T&Q'W\
M^?H*,;5?Q?99K37"GG]EU2[)=RNX9!3%WOFV+!*Q6HP/[ 7RP8,HZ<3-[L::
M.?GVH8KTS9Q?DM_6LCMNY\SR,>9)IJ ]:B2BYM)KB--V#93F8SM*#J:%/K2L
MFP8B[E&\CV_K'%H'&A.&G\12NB,-)$8M;S*O=@A2[XQ2N8^=J9#1O^^MNE0W
M\_6TS==C9L)&19LO<YWPYCLF1 ;-Z*_RT$W 6KL10AT\:WN4O)N4R"4.:\O4
MX78BN:;4$(A]ZN30*PE[YD/7_>_?)?IFDGH?]NR&9X&]8M?&&B^*6J(;E2_K
MJ1O/"3H*BTY&7?UWH74D$<FK HJB,:.F_\Y]+DK1F+&?4SSY/=%T^-1HH^=#
MZ 6S3H;I*(IWEUU..'@9J5656=Y#/HH@GIQ,9.^=$Q)7-KOVA;&(93-]YD^X
M-H5VS98J?)(%OXJ'MKYNSQ:EMX@9PRC'MC3!)&P(H >O[K(#I!D%*A84<#D8
M%/=Z>?DFA ^,XYNZ_NAVBUIF\=R0^[."6T:?#C])%$G2)%_!=I,[N%$D]2W[
M9?-V/=G$>!5A>9!MMK")ZWM<PL*M/*857FN%@CEE;*LW/?4&,;7'F]4.%G6&
M,]PZ(9_=<YA$S$&).P-)!"D1[T.;P(?]A6PCD0ANJD$E=%&"*)WRI#X6TR&Z
MMY+QI^_RTOWZM+ =O"K8G_QLC5E4.6*5#\D1)@,;)TSWH&)I0I/+XW);U^6?
M.[XBSTH[7IOO_M3'HW'.3/*UI+<&G3"V_>+ROP@XO0LAE0-*$R19E>!1'+8]
M*I[&A/M3KA-"O//?F?YIZC)M^;"3)CAMP.=<()07N]AS%L6(.96LA270\\P$
MP&J8E,<2+_AYHK:EL(>8.B*N@R/ACTQ I=J^1>04S.4UDU1T<9_V.[9/$1G-
M_0/"8<+$$0PX,5>W,6%73_S,=;0W3'RTSP>CCYRRV$9FBYX(*:M\W]NQ9J@&
M<,^EJ8$]4P]53P$BB&EMR(EL3#L"[5NA)SI&,&))A')]30EG$."A6T$":%*P
MZH<DDR0],<K?;6^=Q[C8:,P7-XX$[6-;:_]7/"*RP<MT^W1)41^6>&#[&!2?
MGLRF$STEJ-R> KE-W,"HCG />#4J'>XP\TV1&@?3E)M3;P+OL$U2>4\!THTD
M?EIO*^A/UFH'/_%NYB?:&(23*H]/Y:%D=D]CR86J[9QU[:]"]=B,-5\Y7L#0
MK1AKZV_N-6CPT,W#NG?QJ5N;SSOD4:00N!GQ65N<:N+%.:;*:D_GISPC]'WA
MQV8,Y;ZIO;'FQX_@MR?@0"+7;F^!P$3NHK/JV[2%N:\-%-?WRLF=24J*VXO?
M]2[!A8G 6']?;P(H7NQ&XWB M+U"K4>!?/.+G3NQ+Y**%>?9@P@ UP\ B_LG
MW^N$+=EI/_S6&A+^8'H/YC2LC.<7[2RXKEOZA6L6LLFK=R$$]21G>O&BAGAU
MZJ5S?_E"+('K6G?4+P^KH65R;</<)>?0=.'LOGV\141AO'6B0ILS?B36"0RU
M'^&!^1CI!-=_N"GS]Z*M\8.;4='.&'T ? 9C(#WW^.9GP!-V ._^=#1BY5#'
M\Q3P-+^:EIP2KK/[B.*"QQT[N.>:49 5HG<MF0?\<T=F*MO6\,</@9>N#)7X
M[;LF_>DH^J6BP &#='';=+0L7IW&ISR// 4\3G;FZG_E8LN@#RA<=F5=#IY.
MIV3LB2J35XBU"Z;?I/Y%/:]K<!>@D_SX^T/AR,,Z-]YUE)".>^@RY U-@<2>
M+.2X$?PXJ=9(3/U-VO57Z%&#>9/"0G864#18L+[U84@YW-51^%'FJCT;]\U&
MJ.SS_D-ZL_T?Q:(V42.K)<>Z9_@$2JB".^- @J&Y9S1Z\U#^>G7%N*MUNFE)
MT3L%8NWYI_H _V5_$11Z-X(,Y@@36PN3F@Z3I PZM4Y4<AV%M'ISF'N_3%D3
MG-(H%G=YK"FP'84T^!F&L?B(3$2)Y*"QR8O5Q5+#.:+M?[?1EG*X![_-!85S
MSD>@ P7Z>.AFJ<RG@,R$DT+PYO'M4\"86S6B&D#A/@M.WF-]Q#0YZQ3P:<3I
M%* /N@)_04G'+44C&F+?_-WEV0#/!M^&W3:U(_1GO-2VO'&_0?7YZKIC_=+V
M+/'!(M;,A>2?<[?XLH!_>>?NEOHM?O #6>V>I;VP,. IH$;+^T14-937E^?A
MS74ER73.?;EP7HDE%;K]I:TR>DIM#XBS0\9HQ6[=2;&],4143S;N=X;,LK'C
M/H.D9&H;U_O^554@&G*H6YUX"B SC2,.[CS.(S8>"X'FA'N_P>BW-G$0BHE+
MJ*=*IUZ/J@*8.1EU*7-PY"[M>="0._SLG<_$4E"G@"?)ZJ> 6[W_^<B+)!3>
M <Q$XX<N2ON(_9EBR_9)1ZK]'NY_*&IZW=AWAAO;^O70A5"?TDKZ1TC)/#,>
MW4<E'5F>R_V$Z;^RFWF0NN[&"I/9CR\&Z.)NVM!WL<X.*^IS0"&UPV6%83_(
M%WZBJ'*A?,LP]';X<UO52_#9MX1L*64!T1]7H&N6T2@.N8ZK5-U?\,=EVQP>
MK\N5C87U'N5+)B$?^PQ2K-^=7:R)\O<48!1K=G;X5(%VK1DR6S!M1>$G@7L@
M3' C!-M!( G1;?C1R1"8SEJ4<OWRK8&Y&$$F()T-*1=PE/ _66OM_[$#<SL4
M3@%=8!H_W(N26 Z;[GD 3:S8"+,LD-M]H($*9+G5^@CCNX=I/_K3D3Q>X3)V
M<&RO$1BD1I*[VK2R?0\P\+>SG,<JXXOFIT\[Z9QOGLZ9^^52DHFKZ"4^'=!G
M"J17ZZ5=53(\3RK&X <2Y^_U=2.(5?-"VT7<$I6[%5?=C>1?IUTA-M3@AZ1M
M:M)T_ R_E H@N#3VOO6C(\LBV4*-C#0F/W G.24]*!/4KO]\WX@WO6@9)0AV
M/@6\@8BH,M?K>J.1L]CY/O^6TF3I6;>T@HKE<RE+VTJ9NTYZX.4,,..M/%0C
MU<,X;'=N6_$LONO)D[RC(D8VY5>5!>^720=R]X1=I&$0S#2&A;[/,#^TF6^E
MR;\ S_M#0S]"BKRSE7<2RG+)&S(5)9H6BW>WQA3O6R5\LV),;>,M@YL2[S;B
M/&U^J@P]'3.7S?3"2>XMW&X8,^CJ.J@\NO;0?0$8*D@:H6J5+2.I?TGJ-%:7
M4P#AT1IJ.0O!4)QNFQHO!5@I]C"+VO(5 %>&QAOYGWB@]FM!SN:']U=0S(AG
MX&@$@YMY-3-,[\?(@_L17QRRFUL$-QO,+O*.?%RVKKQOY/?C05Y;_I ++Z]K
M9*W.?=PQA!\&M?I5G139][ N]P="J@&5<YG'LZP&+2(T_K'L:6J^'@NMZQ3
MIG>.0I[KI0EFVGO:+5X5-PB%?3=J,+HV>U]@*Q2ZUB)3*?W@L>B?G?XDE_,O
MRL4,CPW"?HIQGY14^H=8\B]".6?7O26_8=<;H:R>$N$7FV3FWM&%AUSP?FBW
M=$X/0#$G^Q/A-!'B&WYF-U__Z<RA()EL=]=GCP=OT(=_!0@02*KK//>WI0<'
M0NDS=.:G)F1!&#WN<9T@G 4$G3O9U#(68&\KMU,TK&Z\\6B9K+,BUD-OS_-(
MVO.^V] 2(^+)?\/BYZBASF<$S;)(26"S&G75KUTJ1E_3RG)-O^7R:O^#VV?&
M^E )(UZ_+]=2]@-=C3DCZQZG7J"<'/-3=4\^P1^[X('\>M\:R:_-G3G&=Z8D
M]WI2")>*_=X+(TN"J]%(P#KR8AO;1XJEL7*^K%FC/=3O%6YE1CGY)V!@=:SE
MMDR M,QG]8_GF4I7LDM$O6^-4\V*%]WM*M\*I>0%<1OX0OT$8+^38UB^%S!=
M[K =/P4LOP<S^5MR&%6^F"ZX-JIZ,8@V#I6/J>"L_"!2G8U10GL_-=,)4/U;
MPH.S\M\IW+KZ,(DF:02]:#]GQ&TAA3:.N#-&"$E3;%JFRYS^O]H[KZBFOF_?
M;P2)TD6D0Q!04*1*D1I0:2(=Z45ZB1'I 0((2) N(*!T*0+2I1=I 6G2$9":
M -(#B;1(O>'_?SGCCG'O^3^=E_,;(_-M[XR5N>?\SL]<:^VLUZ :#6(&9.LJ
M,P#_G1G2QC93?CIY@BO="9=3M3_-S;7<VL4V3T8%=ILPK:@8,MOIMV/7S<9U
M0*)+<<A -J+>:Q-43I0_"^7F;,>$53U9#PG_?3,IE"K =Z6135;-\UA-$)9C
M#,,HQSX8MM8U>$ZR!1059E.8SL<X+@HRG@/JX];'*EE!KK=*.V4_^GS?>#9Y
M5XF%+#J$^MG%UM1R4OA+E-*(8&!7WI3J\HS9W[C;G8-N#;VVDPT2Y<J /2&W
MX\@H1@X2]&G36W=#YMF>"EN4257-^'&L$HB,3HGLTA7N%)0"VU@S&',J^VA4
M\*PW?QTG6%/-]NND?MS:R(.^F[2!=R*#@:0+H4(016=%&>*[%A=H3#;);]9*
M+U.SX\L\:NP?EN7*A]HTT%*==9\#5Q!\7U0+?Q$DY_WKI\1AA>::WD5QC9>>
M;#6[Q=YO6_F6$ DH7GH-M)7Y]6/.@@O@"[KX@&_A*8N"#Z=E-8J'9!ZM//XP
MW43Y@KEM&8#FY+RFV!5^&U1EA0J*]*O_B5#%P(5JS*W+2U>2)QS1M!DY]@MM
MW0/I-)?]8 PDO2>R!'V,\)LC@U2?-]4",,8)%6KAQ(:\]]'HYFB-%C&W^G2'
MQC[^_\2Y1KBZL+VARP0?[>%JJ&OENBE"X')-ZX=17R<9ZA\:X,Y$TVH=$"E>
M  UY?2:L[BH<>2+M6C1G%E-I*=#,=(5<S4I2TO#N53YG7KM5AG, V4J*H,:%
M8JDQPK1FZ_JSU%463+X%;NE8L9X?,^[WZQX,N6RO_:MPT/BT!='NT2(M.35I
M48;@7XVF3W8%6S-XZWU@/WS4?LPF;IJ#HR!VK6&!XOC+VW5?X%;>^8@5C8;2
M\FU85SMO\GQESQ=W+?7OFG[[%YLY(00+C':8G]GZ&<-PJ;B9\Q6Q@ QU7[4U
MBZED=[% O#PTG9!T+(60(7PK?U1"J$-U&XY_JC,S2,-.BF!C3#X(32T_V]CR
MB-ZU_*@,P"$G(D/MX"/ZH#^E >= ]^9$,R7:@A93'O:B61K3+[R%9>T/BH>M
M-#=)-:DMW*\2[9?EU YZ,I_S6BZK:^%K:\<"&U2*M;8 HV:DUP ;FS6>'7!R
MZ/U;]S;CT<MMM=[-R52L' BW@()0>;INE5,ZU38*QF('.!HS1J4.,P9-AIKH
MH7DYKZ6%WUI=/;F)-_W.ILWHQ)@ZKI,P(MY6$K]:-JG'XK$ 2J=815 >BR,D
M"1ZE954Y<!N&GXFG%MC?G9/NW>L5?=B*X.]&(([-L;5L&C-+@C4FC@&.>HC7
M*LKK]BEW"@X+FY$-I=ENY9<U&W\) L5';CCEO'X@' F^=$*+SZ@>6Q*DVP1I
MT5-:[?6BK^W,M)[JEWE4^JWFO\K"H2!D06M$NNBK.3P'P.5PXL\^1"T B,L8
MJ_"CUA#/;R2P9M%BM3_SQC7C?R(L1JZE^3?8/XB1N1;3P#YI@0FB<LZDQ.TC
MPW.F!6.3K.E"YN>NWJ3S[N5-W-;2=-%59*CYQCK4:2IXEEB(.HA1.)O7,'OK
M([83,UY<9A B=I6%C+48 Z%PMB3'S2%#<TQ/H]0KXGIKZW8Y-2/2ESP2NLO=
MH9:10#]>-6ROG!4>> X\FMC*'?<L7HN68JQRA!8=LH?07.$*N4)&IRR,1$@5
MP(D]GW=XGMEIHL88V@SJ)%7UUZVPHVSE5BS(7;U4AI\TDL@CMNT0QM*EJ*X6
M]JH)JD<O/'I8I9?,5UWZPBQ4_,F[W#E93N/.Z C:!G&Z53A8\Z%;A=.,3GTJ
M5A_L29;T"[[$[A@\X'^+ 7A]&2 )-M]/09V2:N%;<A>/_6F%.TW#JKU3C#(]
MPW]$B-9X,TZ)!O< D\K*P(T5*[J+ERV)]8IAW^T+(:X#9^%2C[(R&Q L&6H#
MRS[N;PV.2WO 3K$WS4^:2/#!%7187=TK$M^YZF0X+5@2S6K%YZ%^AZ7=ESD%
M8;?D]F# Z_U_XMURC"OE.O$);6=]<II8L!VM)AA20H-$\_X,>[)]2(9$W*YQ
MRJ:E'X?8G .AC4E;AV*$1_U2M"N:5*PQL[IJ<Q'*[_F[*SB@X\U@="FHC?6>
MGVJX>)H%FV;T-N-!_!N];A:'[1^OQ+IY%VO7LJF&KA%<G^ #8SSR-OT"6HH^
MFY?]*GV92Q.K$%XO%SK.">W;"K(M#ST*S*=>#J1!ZE.Z1LZO_%F$>KY8CJ?L
MT5FMYXJ5,:H:4:1",F,Q:CG*D?SC=[FI[KX6 3C"%"+Y23-P!417MS.E8N>C
MK \$8MSW]SF43M9Y=\O8=A0XWIH?"8%J9+^? ;B=SA@:37#GD7Q958'TW/+L
M9V_)*[/1"G8OKN_> 24.>#+H@!+A? ?/"":X0XMPDQ$$'YE?.AFSD-#V[4:1
M^.'LI*D['!^HXDSW4XE(S(T';:7A<CM3FZ<SNM_D5'_[6*=Q^Z.7?$*KM+2:
MW;/5AN^^?-(KC5GAK>2(:[B\IX@[F"8.5I,4N\3.L,]>@]X?F9-YY)8>E(U&
M KL[$5; R56\W\'H89<I_0;30?Q?PT.WV0'7>] $16JV(BY&/A#/[4\$GV/9
M$QF"?F%M+B:+RLS$13-]09,WY7YTM.2O6P[V0P%YCA)K>SH@*3PI9B&\Y0[\
MI06H\\A](]4@@;>45 U_TN>>)T:'PLGWE&[^/TLUN2:%^6/\DRC>E_DF['8B
M<G2J;I8298'?SP$00LGOT(B3LJXN6>7>8L>*O\&+]'=Z=VZX92E9CB@#'I:D
M!"@F+NQ(>O1$(,=TK?;I3(;@Y$I\XTL?:4>%+?7"$TH<"@6F9GK&R3IJ.WH.
MU A-'^S:-OE^K=/?O1Z\E@O8H8WTB1DQ0- F#K^9MA Z.7T[ZT"@U!M?0ZVB
M+:,N]W<JP8JF4UB_ ^UOI$Z\\@<<C,E"!K)V?U'%9-R6YQ;4PI:7Y83-YCYM
MN]17HJ;T6N$9B<J#&V,CBLQG=W'(B*483@N^3M9GGZL*U-PG)M]%7.?)!?RN
M3<4J^_*"*\'M_OZ=&0A6YINS%;V%<\U*31F?]6C@S'*O'I1[Y+SF7TOES,"4
MWIUY.OH"MC<G,^?]".I,W\T.76.@HNC'2Q%C\#MK;7#1Q@$8VC)<ICF?(9S!
M[4O_CN2% #!+@KHD<%']EQ5X$#RXH*YOD@)@)B?)QG&1!!MG']Y*1Y9?W'2;
MZ53H:+1#XQ$_Z4 @^]D@A*:%82.NB !%B9BZ1.<'SLF-SO[(CN8H%Q!]&DLS
M:^=5_B0G$A#X3^+?TT"''!333(R+M],"SIRW1[!>&?(?((F>'Z=1N7<V"F;I
M?"7:"- #38(N1MZ%VK2[0Z?7_V5[Z?31BG]>*(<D;UF?B"^['6=&\:13]J6&
M!> $,JS #'=80,VS5)P-C&!_S0L$R:A[I]A<U/5NWL3>LLA(8-6.$)2MN;36
M['+ @A<W#3HPM?(==8,U]_[>FJO:$96M7<VL+Y+S(I;=1:,P5X3THJPPEH/U
MT#&+6';-#F1Z6L7$*E#<F;2N%V573&+HREK+[6'PXY][31;ZZI[7:C*6'QKW
MD)(BAW@J-V0F$S6.&4Y84@GF6>0JK9*[%%9S]VZ%/ZK0J!NW95[&6V*((8I%
M@VF#.I@@;VQ'2[$(*8GB7PI93E37_@KE6ZAT4"Q?[^':35]ISCIC=D3'G5Z%
M_#5L(39C^SM$84@@,!WH$X5ALLO0D@>W&G8.5-6D"9XI#QV$C3=)Y:HL"/3U
MN9>AXA<FOKD0-0G<E4DW@O#*GEUKX1H3W(<)+=N8F;V?+6 /D;\B%R*BM&X.
M1D+LB2@5>&V\U'6/V&V!&JIE2TV/#A:QL$&9[U][VM5ZN8+?:7E8%A''W4)-
M="0"@@NH"_.DI*UPDNSG5G9>5;\]PE-5/[]E_#LCCB\:KP_G:Y<11I533A%\
M4!-6OXXDWEJ[7@ ,J:PL8O!'][T?OGRE+W45V7<B%<!KG.+CU6RG#BALBA_'
M5,O8\FZ>-K?U"*Z$U'/M%^?/_')XD"9>*\XK'\K(>)29YIEVNZ8Q6IVMO!ZR
M;%--E#_6T2#;A3<R"@4W]CAID$9(;4D!_^*FJ*@+T:9*8-B<BC;*@3L2D1A]
M:F8^7AT@9V()]2@=.(D2J$A5MOCB7457SVZM>&-X1/&RAX\5S8F\[](,A%6S
M8 <OF)'FC"/&"?4[1H<[%9*H?JE;'D.FZ_S$L LC.&(^G'%)Q5Y7CX4P?"N8
MLM)5]7(,Y\+:@Z#@))5%RN<DZ51&VLJ LMO%"Y(5YH\3V^^^3[CS[Q<DB5+F
M@@^P/1 B2)2ZT,]KH.MA>4E5O-Y2*8PC(F<[*>R17^Z'AI&^$YAQRJ:Q:H-0
M(01PK4\#(!V--S(C8#?)E5YFR>5Y"JW>6_:KE/BT1'ME74$.-W<67#8=T*36
MHBVTN/ #?EBF]'WY9CB7)W<M$<P;'=)<<]=KDQG=_DHF5^31==?7CC^CR.5-
M> 5L#ACAF9![Y4Q.AS):=05F+HWV?=C4B>V;O"_OQ[_S#PVAU5'DKB[,IF49
M;K5M#3WCF. :+Y5C(9U5G%G4Z"^.^J"SORC-:R>WVR.Q55VM0V*.[4:=7MKL
M]IZ_GXSRB8"5Q&;<V,G@FGEIW*"95@O^D)C0<'B1DN5!!3,NM?=_S<]T^3C+
M,/^NRR#MYHX/*2D(N;(%[;8[C0FDZ8<+T8;F/EM88;-K:3!SG[6.?JB9.?5=
M>MWRIS)@,%J=)DBI63>V-Z-V[QYL6)6ZIMKFP9+N\-U8X,@H\^31:>H9VXG^
MS^_%BQ#*=J\O2]0!KN*U51  @;TN=$:N\ +]2F",Z%^BQ'=D747PC>:--=_Z
M9.94^U7$&9$QP)OG>'G9Q@*?&-.Y)+[P%GSEA .O-\^,,,)L"CHI9=U5'X[@
M&=+Y>H>*9(^\<8.?M+M9\)@;P8L+K*0I*B#(S&M,&8L+!WC(3W?'-=7<\K:4
M9;?SF_1?.@?"%=@)^9B#X1/]?-7B=1A72D_\G B:CL5$S9Y+=)ES?U17D5,:
M<P[\ F' R'TG+X$@$,K+Y^KIF(N4_CPWR3!9LHJEK)V=484&E<=#O%H4KU:^
M";.]\;60*WL%(XJ<PO]MA0Q'0Y MS 2KW SACL9;95%V PVC<X'.;)]7/9(]
MMCM3UXE.<>U:H$'(+C5A:78LQUJK'4:$NDY?^^891+K%E.D:"\3'2ET"*=2,
MZBH#[@NX$CD1A9M9[.> ';%-O:I;?<QT@#P<2EJOD_6(E;)]0$2+S_\^A.P_
M J2+C;9(3F9<753- H.SWU/OU.UZ@X5Y@8;[L/5V7N&B:7)M/HGQ?[+U?S9;
MET\"B, /9A"T#NVRY*R<F&#_J^T&WB&F0)E('VWE7AD3ZARH7+B8K=L8<9',
MI*I+76&<HVMIS-QX@.^Y)&UGOSG$M2^Q-:Y#KATI)Y!'&$,=IG+6V3+FYLT5
MJF/M![L!)&G<0Y*ET>9<[=.H,QKGNG?F?*')2SW22+;^X^*W^N.^KG?TKJY2
M4?O#&$@N?XOYEO'>VQNGZ@IEL.''A#WDYF*FR/8$7@'KEIQ!UJTA]]05*'K/
M@8I_=XT^Q*[13/$TIH668&4QYI5QOP/L,%Z]^6$;ZW VUAPD9#PE(SGQ(10)
MH$-HI,N=B3"#PM>%>%J];6%JP>V\?=%:+0Y%YRS.#,#KPKR\_L8G(5D,<*I/
M)JIJ(CM&*9VNV]'E=+,NI_,SD_)-&8SK@&3SB%@B#F&&MMRMK/@C@76SUGRX
M,QC?C*<@BWYQ[]FK;-KW5(<#[A ZB$-<./AZL^+1SELY^8,8YY^ZY:4[?'7Q
M[X%LJ>0-VCY@F5-@G#^;!HQI;0>3(KC5P]\T2SGG]HK,W.I(3O8Q7W5.?CAH
M1,3WXC/IBZX[0C,/3.\LNI'U2PKJ[[@B6Y["OQ:H)T7S4?_=*S&!HIQ_G8$G
MX&(*^UQI*Y]T6B(UH?\I%NK_H3.^I^#+UW=*G-^;H7JG48'4+BDJOG),#+=:
M3KSKZD14SKKH%65VVS@$9@JSJ2#D!+ BP3]'-0_NJEXS4CW5:^T*9=8QWG>0
M-XD%\?%%YJ.MB"E,<&HLQ$TD<J:<%GE/UJ5QS PD-69]2*=5)GKI4F,J/U#F
MVA%$3&%TP"/+EA%Q8OQ80.MB"EW$?$?55P<[$PC>-_TRF4BG&Y\0+[5M.P>H
M3N[C)N3U(%3KHNO77'Q@ 5X,0K]9'0#&9S8/J4C^%%*(MI5E1@+=>*,WXMKL
M3G_6%;A&2R4R9!XEUS:_4?O(P4PZ'-OI+M#+=?KVC')FGG<3/=Q.\QNIJ8)=
MI)[%BKWS:&M?"N[RSV @47T\O+=#[6PX[9!HZ_IY?6+S*YN96O*#)2O%[.>&
M5A$M1&H1^5E-K6U4<6QQ$.;^<F\=L7Z]Y_UK2FMC<C0-\S6+&PR T4T\&P8<
M>B:X7FE,:%*JF?CT)O&Z1L.MJ >#O73AYFA',D=2B4FB9$-QJP=N!"]<@4&
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M%V+)BZGKOO'S=R>N7)JGSY?B6F;G-<LALFO3*':1[Y6/6-^H+>E\^4(. )Z
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MZ: ;@T8<()$=PU&!BNQBD_M^5:"C1"5M:ESG+FKGDWZ57\+P[/"0J3/P2M4
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M%6"';)[KE][M. QI6)KZTHG(OA?_,I*$*3"-Z[OG]:F@L9H]S(4Y[R$0I%[
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M5I/0T>Y3>^+<CHJ!Y\/.@G-^L;/L;]W.LJ.XLR0+DBQ(LB#)@B0+KI<%%^;
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MYIEDG_# UVP]#],%=TJ'&@^I//S,WN\XQ:2+;;>.P''L<L.1#=H4LUPC29U
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M;F9_N@B3KOZL5Y[M^E9H_4%>=US/1#V8[BJ$I;KY!V.$\46CDPKW1-&9UQ^
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M1$^3QICHJ7%Z(N<@ IHRQD1 #1+0_FBS\W#HIO5S<ICC. PM;S1C"L)X$OI
MRQMWK"0O^UJ@6[8[I!GTZ1 ;F86X\*%SX>-]120YW;B<CLS2I%F("T?-A4_"
MV:*?8R"O&Y77D5F:- N1X:C)\'PC_>S;_K2/\1S/- H+$R4^4+,0)8Z:$G_
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MU=U0W<U'ZFX2M]:F$H$SIT!)R_K]$!ZPF&@=)NW801]YEX+NC[ $@<&!LBC
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MLWJ3LVZ]7.39AX.(L#\>]I36CF@+UV?-*K2>7_ZK<))OM6&$T3G9).U">M,
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M*62)SM9GB[\GS1:*<FQ2"K+"**Q >DUZ?12];L:B4Z]=U*6HE+& 8YF#,LJ
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MHO_/4V1XIF=711!JW!.P9SI"Y:KJ[3W5;9^R:W:<7QVX6CE%D>Q,TK;FZ0^
M3%*4*)5EB1*1%"JB;)-,,I%K =_ZU@58,UM-&Z6;:3FFN1RSFI$=/C3=*<(>
MA[ S$FW!CS*EB[!SIJ$W9G_PG@@H+@3TJTI^U[J%:FSEOL0-Y:[GG_/EF6LK
MLVK;(+.!F!87+Q<@*S+-1*;C,POYX,[Q[])A&$/,E "REAI0C#A0T"M@::U(
MS8EDNZ>"W&>G[)N9:6/9S8^N__O-;,#T'YUW <'M3SVTG\[LVXCKJ2AG3Y'
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M#D.4T%TF,?UR2,TXI#\^DG=4+,HC4QO($>!8&$ =]$#7V@!I.:L9UIA+M9=
M1CLWSMGNYW9^_CXPH].9'3#XXJU_-$:%Z23,O'+:<<&CHH91J*$8Y2RD7XSR
M89L/<.MJ:10P1"! F:5 UMP"0JU6$%G$X%Z:.Q[&*"-")XCN:_=E,0=C+J_8
MEF1I(7" %@*+X4#&2E]4WPW]!+[?XTELQQN&/#0%* ?X/A,=C(^,Y8-SQY\&
M@[5D1+E ^0@B@2L*"30T$! IN=4:0^MVTF![;"CP9FTI'NL 7UQ/)"D'^!XU
M&RG]!(HI+'1D)#H8'QTY*GM/*82(U0I(*!F@6"&@D&: &T00YI83MG,@UQX/
M['^0O?^C':1L(NM]]:4LAF&$D:%2[?)$Q^S[9J9FIARS7P[.SL0^'YHV%3'G
M*^:,A%K0HDSC(N;<:&/9K_W8^[6'(H&A1U/7K0)[3+NWS?S\?!Y'/#>_5ZO%
M/#8BCUY;5[DOKC5-YTK.,"_L*I+-4++CLPU'%5#CUG .30VXCR?<2RJ 9 0!
MRZ&36GMG^<ZQN ^N@(Z0^;8'RY\&K+1[B:.Q2<W(X<-H&<W@(T.+(MDBV;%)
MMEBXPY:(,"F"D;- L7C(*'<.*(\E8-00)9F60NZ_G/C1+!R:<(F+A2M9GSP%
MGP\8K \NB(NI:EVW;!NS=';MKX>5V$VJF5M&5WZIOH1O?VZ69V=N:DM\-Q>C
M6V2:B4P+A3EL[QHEE#&T!I@@ ZB*#C<*_[*T-LKA&DNV0V$><M[:KVZJ E9^
MF']07_YO1,7YU#:SCS_/V_=GJG4_J,!F7L_/%V[6J3C,S(Y@*["1"6P4F1:9
MCD&FXS-O^5BLX]]C8FLJE:L1$-Z)8'UK#:3G&$BM&:.R1L;L'!+RD*/6GL;Z
M7M]H O=5?GJ,J);/%'WD0]=*/4$>]02+51L_65;+>>7.%]/YA7.7'_4GR"^F
M:E;V)6?&/XID,Y3L^/C=41$H:2"CE'I 64T!=4H#Q1 $$%GID'>:V+V?LO9F
M0-:W/I&F[K>@W_;-+*J_^12/>KF92\4FO?O9TD-@:<M[Q)!2)%LD.S;)%C-X
MV$($3YU52 '!" .48P\$%1P093A%HF:"VGT7(CR]&2R-53*#E%*M,+JP0!>6
M60P)^-5RU;JJG5^H:=RGNBE8V,0-S+Q;ENVKV1CG(M-,9%JHSF$+%KRA%&D)
MG#8PN/VQ^A(Q#+2"1 BE&>8[/6V_M;'[]>-;W_J?$US^ND;+O[OE6[\F0*\C
M4&;&: I:9((61:9%IF.0:;%JASU\JK:\EL&J\73B)"0>:*$]<,Q!+8U11+"'
M=FI_,JMV+5PMY833?6V=*X!13@0X8E>]F9EFH:;58KW%(&;OU:)9AO>F3I6-
M_[D9VR+9#"5;R,Q!R8Q&1FBK>" F"@%*B0!",Q9?>JNH\Y[OY>3L7]T:)M_Z
M'YU>GL[LZQXK?XE0^58'>:><0V[>>0&-#$&C2+9(=FR2'9^AR\=V'?_N@AHI
M[;E7H)8BV%1,:R!5[4 -"2'&.!9,VCZJ A[;#E\_B:=8X=%XM*61^U@U=W,L
M8NEF<>M <Q[;F[GX=J6FT_GG5#$0+HQ=#4M@+Q=F<2^9EJ8AXY!^X7Z%^]W.
M_8C0@J&: LBX +2F""BN)!!>"^LU=-C4#R^3&$S$NPW]^Y#LPYM+\W"ZM@[O
M>N.PGPT0!\TF'5\GDWPF\ST;EA4]/@>+5Z1?^$;A&X=^EEL*6)"U7FD$('$&
M4&X"U7"U !)38I1!1A/Y\ *6 _$-+ K?>$9\X]$J9K950?I?NE?@:A!Y%.WZ
M=XJ6_T#+?W?+RL1F;8NAZ6*E+_;8K>UX \F'IC2E]^TST<'XR.51L3=CB63"
M84 )1H *[8 T1@,<.)FQ'-:,[.44T%MZW_Z\AN(]][[E$X@SR!8>'X$[9DPJ
MRLA(&<5(9Z2#8J0/:J055MQHPP&L8UFMEPAH+BE@RBBFH=>$FT=L4/]81AI!
M-(&R=*@?'2J5,IZ1A#Z:F6EC(5[U75ATZ5_?A_=21&32QT7</U?-I[!R8Y6/
MFMGMIB;Q\U+1DXN=+S+-1*;CXT+Y8-+Q9\,"08,$8P*@28>4> .$P!QX9X1W
MC@@M][(#*O*T^/]/E_C]ZP:ZXP>G,WOUC:TKW[FVF0=BUYN$'P?3\-,7,UW%
M0^'#/\[4[*/[52W=3SZ,?'EWNM>%61C^]<>\C[()HK+L"Q\!BWC*LIS,E3)*
M:U5D6AC D9E8&NPA8X@#P;$#%'D"-"'!Q#(IM1$"6N;W$0W)U<3^T8$K<,)Y
M.7!E_'&1<N#*(T/+ZSN'0":56E;:A4>=Q9*1N:\6:6V7BI&\3'E)1CT3'13Z
M=5#ZQ3UG3#@"C*DMH+HV@51Y#A!QD"(MF'4[];Z"<(@=T?%\.P4H410H)WGX
M0UC):D2P('NE7X%X]43KQZ9;S#LU_6N0Z")\([R.0VMF*V??!B#?X^YTR>"D
MQK"DLPJN%66,5!G%T&>D@V+H#VOHK:+6*@:LK>M@Z&4-A"0<,"%K0RBS$.W$
M69C!B#/I 3)Q,Y 2#(@:08"IY (3XKP<OZ''"$TDJ8NA'QNNE;J5XXO,N/#^
M V,R)="926+E*I[A$\PBGMGY2D_=N/A9/LOI7_/47^%VA^V>JR'C,7/&))6
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MP>;I:%?^"B]T[J!TCCI>&U(S0(P/=(XQ!Z1E#!C/$6+*0HC@=3KG:B*5@P9
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M9XR.RJ77M<%040>@(A!02CQ0-1% "TXH-E+6M;SNTCM10X4H#LZ_(X ZKH#
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M\2: 9M.>NUF:P7\\ZQ^7W#F.C$,.X !?@%*H@*XA!Y@&(4@4)*30CB?G>""
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M>!Y_]]%R4=)(:[$'G <GG;+@YPOL$/":&&*=8[5U.[DH)AR/IS+4,$:%"6)
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MFEI >7Q $EO>&L>"S:->[B;0'_Z OS1#[FL_CS;^ZMCE0*!CE"S^#)A[L$H
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M*++(-0+XGR V;">VN;5W0O[%>I.76\X_\.H\B_EAG?:FE(PY)5Y0R=+X[\^
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MX;EBM5:4C;;EC1@,(M]*LTF$G8D!8, $>@.Z^'T0%IZ*2\4[M)8^QH*/:3<
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M-U4&U-YB*37E?[3SK,[(4ROCF"IU9<E[B]6JTJ=#%=,?V*.J[Z)LJ5:XI.2
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MNUH.3Q^6ZZT8_7NQ*G-8W ?.Q1PV>3Y1'!?,&NP>TT4:WF?U)^TEHR*G/KI
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M!7FS*M'^W;(*E)96II)$KPKM?UMXJ*#I!< BO*9<@PPD=%N:576C;5B3P1[
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M]% :^P5&Q?OD">[T <][4;G$CFEC^C3Y\>@O_P#89EG1P'_[PH)16B@>TWH
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MJ,RG'M(-A+VI4DOP\,O9\$]!BM@PZ,J=O*=20MG;NC%RUC52>A606]N<4?^
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M2" X"JIKEY^%@[#H:3H7/T9BJ-BKN(]BI)BV;='+?V,:4Q0A!JZ*KW33.CN
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M)N?^)D)F,P]RZ4-V$Z1C&0+-:03D.W&WL:B.0&V0X)?,,GV.GH+BN*XO-UW
M91U0_J&/'&CP$O_S9'-B$_JIE?6+0?MG-CGT/#QD9C//_[Y8+I_ )_BB%PW*
MZNLA+F5DANJI2\5##ZR&Z(H1)-'%MX/D8SG5#%(3))#T[.1)PK=:THKU9[E
M':T"\\R(R4/*;=8_4W2\X4%EP4N/IL#=0;^]0*?N4DQ"Y_RTZ&:>CY,0R K2
M:>RZ)'OVZR,_ED7D_S:Z]#K&4PHU%Y>K,BLR2?(B1\JBLSXWG^L=>UI:?KE'
M5RCA;[?'<A#<Z;M22L\LR,QN3NB"W:Q/T"S0(#5,726ALR-@2?(M]*\YY>1K
M-H;5#-@5)OFB4:?YB,F)=(1W3%:O/M*H9.(X<S#CHC15$B]P\',@TQN3%L\D
M=)=(ZVXOX8\GCDTHA><P@UBF(!U(T$]8@\*A%]8X0A ]F+ CB!<_+[>684.,
ML3ICH+R$D&5U[FU\!)D8N":#M&S#V-Y#_C.D8](*JR_"9BN%+*$ ?/8S+"-:
M-MX?G:(J[DW35L4-[9</5Z]\'!0['$Z:>;6/32Y<., FE/V@=98=)$[%^P$<
MM?%WE3CH.*PKY<\YMN6U )@UH&O:'0WD_[0XQ#-E&4K[3"83=\PY0ZNBL$&P
MW8!6]+VJRM=-FVNJN86'/7BX>KA<9!Q0<JX'9'(9+9/-&\N]V-F7'HT91]!*
MF!BK6%:H2HY7RZ4EXG? S= J"(O/:):2'1W0O#.9#9VEMI"$STEY%%]2I+23
ML\2L1JS'V=S01GGUXOML]?V+9W_\_K48\.M_O7RX>JHE8ZO11FN:KYLD0#R$
MX?+H)X&_N386X[%)T9.0'F03IQ8/_76SV=,O7CMN:]#RZC\H)FG[\LS]SS_M
MCZR9P!$/#^;&T8DD!F&FO:H2+!5,&V]XS/4IHIK)HDX;#M'*MG@ D,])$^!Q
M>,/GN;(/A-Y<JZ%Y%-"LZU1^P7GQNSAMWM$VLMEKSX]6UNCUI?:G<PRI8OE7
M./3IH[$I>UC.V,;H*[EWX[($HDT ^U@<X898*2HO23&FL_=F;RI;?9>?@(+!
MJ[!WF:VNUNM_E>Z/5U7EX.*SU8L3BTB]:/ R<WEU;_)#-] 3?%<V[EBF&M<&
MBK3-5EI=Y& =YL8S2=@#)P" :$.>Q(F^(C39UJ,[ 79FM0XQGS />-0'#H/U
M[\#,2X^L%6U$+=^QW/RV ;Z_[5V$UD/;]0'J33N%\9K<D"%XY]D#2 Y$KZW"
M?[ZY"GC>I(ZIQR ]ZA2G.@<9H3;ZGU@ML"J9[R<Z.\$G>@?!RS FB9U4/K=Y
M2Y<XY.N,APEX8)$4\S',%S28)X^>/):=1_PK#X-<K.5JPL87R7Q$I7^% [(C
M_@G.K>+3IK]_&*7/:AI<T5KZQ =Y_TLWZO=#5^;=03L7$:ROVYR+I &4SXDG
M<[\YR]@W+9)/0:Y1WH1,-+,TAAJOAS$@-F17+WY GG \5E^4M^JZ9I[LN'JF
MSZ,+AV/L-MUX-Y9>#M]+2N, ;A5;UI8>ES:&3M.0=GR@9W2(Q8OF:"<9>Q!+
M_R9MEV7'BBU\OF_=F@OVBROX&%?P(L(NZ)H08<^9@Q.]R5+H,BIM:HV42:P"
ML.&X@'9,^KB@91/!)>-/G]F. PU87PJ,P!^IHIK4[!$GQO]JET)FAZX9&J?W
MY)3UI#=.4L>A)*>$&+7T</6"H@'5:Y3<K$!T?-SRWKA<T<5!:-AZ>QFPQ<FH
M,$G"9L(0QIJGO%#T=K[J#NBU;J.#P61=OM&/8'E&30PA^O A!#\QUN9Z/E/(
M]A 4N)#?UY5ZX=#*]B*A6G+0=448@@6^DQ.[4L;)189.#(3YYRP'+UE$_/2_
M RV^+?A>H@2EO-0ZE]$ 0=(U=>VJ="Q3>V'69]O(!*</S#U;/ =7S9PD5"<!
M>ZYJ/LC9<U05EY $8\?1(Z.N.+-9.^0-\0NZ<'86G_3R?!(_PL6A#L8Y38>4
M?LWV4DZ/3^=+";')3[.F?A_0Q;YU-V)=7//J@"5W24TIXTM(,WQ3DWV7O)ZQ
M']*O^%NAMXA761+PVL$ABGIILQE:N"5<-(LV]NFJ]?/"&\BU4PB:X&@#5$T.
M:A<.B><AN;O2BSG835-D6W VWL.@MTFJ5I[<J&$,_B54F7__Z1K!O"@CS _?
M4Z#V[ 7]YQ\O7EUYA;'9A+F>3,LV#%O<#K+^O+3%W4673[Z+Y/@8<.VOA&O'
M1J_O38ZG\\4 7U.]6,@<:*4T=7/@=8=1:,U5W/?-!>A%Y-IOEX#?Y4@/)KYT
M.?K<QW@G 41[W5H^+U<E4Y9R_&F+A5N\''([W20U[A&;Y+YN$/#LRV.VHB51
M%J50"D"^V=6T0#9NS"; F=].J<@D3S):"H$4S1:25QD<K1=LZ3LW:<W&QK/%
MGD,#/)1=S+Z:R U>ETVE69VR98PV78]"*UET",=.$M"S2RCQ/ =3_-B!ZR-!
M)8"-:.A=9UT6W# Z=TW.@<LD#NM.\M^2EB@Q+PS:I8?$ 4^F8O/M:ZZIOP[*
M/_"!S^.+O[(!RU>*;^_#*EV@FA.HYI\7J.:7@6K>"]?_:4K3/W(.Q<Z1Y_'V
MXQJJD6<H.*A+T$&5RPMI5N\;PZ']GFKR]\)^/CI5$G(.Y_OWKIOJVA_MW@7F
MK+A.%%4Z-K1Y<8R,?ZRZ4P>&Q,AXK".903?9BJ:"&R?D$$W'W+J7+AQK+>'K
M202\S]MKI6Q0%*9B".-+VGTX&@> S\[?@?++H^"D,$\3QA$3 AJN'NC:\!I]
M;7[CFQ*[N&@NTX5]?B-T*"6WEE\A2RE9#VW80.LRIR'#ZLS#B,M.:<-0YMOF
M+0^ U6_!0]'F'OO&"1$*6R@Z&"IPT;F#!Q+ HCH/5O(7[]+4DLT"[LF'4S2"
M<994\\A)?8RB%EWQJ^^4/T_KHV8-0;PS#M0X$C5VFH:;.)VF>!/W=  (Z%C)
MY9I:Q*D$A2IO"#URT@/ZMFYN*'0B&UGGVDT:OSZ?^^"JG.40TD?O:*K<@^$H
MDL7H(35T8)2_-X5J6(]O1.WVR%CO8!ORHO6M*Z^=M/?0>?L$S!CZT)4DT%F'
M?*IJ[+D8=E6SQN7C[_I[67.]5SF*3KRL)+QDB#_.[5'4#YO,%,D;EE&:V-1F
M*ZEW&##7?U3B<G54T5JVRN,9=QK6>6@<-_8D,0&%([-1MZ4T1*1VS*7Z,L+"
MCCP.<DQ=EY]LK=)G$Y(CZ<'L8_I(9I7LL"I]=Z5]F,LW]*R, M<,L.=F.J##
MO:7[L[@W6D1/O/:1\I)#I2,_T9S"2J?MX"ATDCUM#,?>.D7:IN(YF_=6^'PW
M&1__Z:9IWT9^SX;=S$P_'OQ L[T2N:_JI.G!NBN[7G)LI:B?DD^,A<KM9O?A
M\+4L^,MQ3M@80Q3<#1WW7FJUT RG:CKOA6&C.2><I?6<]B>!$RD</D/-CYV"
MD )55<B\& <!4Z38%[/5-:VAI@V?0'*E;9$B]Y?JZ)=*RD1Q0-UQHIK"+C/9
M#5OLJ715(=O0B&S(+X&TS4'+J_0X@B<N#=D$5(5,\K@B5: \4*X'>R@;68BJ
MQKRREJN/HB09J$^E0C?9^400;VVZ%=+=VN&H1'1OP+1DN*PD%/-]U]I]-N\\
M!(K3EM=<KZ4GC)CUM I%-X'?'@5ZK4O#(5R00S=.=6M=:9U0^"5F(M5<N@W(
M.Z;11#8V*OFL?,LK$AH<28.O,'9,DSZ5'M@B4J;;G0/EE2G-1@3\;NT%S. L
MC3A)[3GJS&!$C1]* -G8C=_;69Z0#L\>0D>%^*@V4I\8?L#'B <<Z5&@V--^
MW<7%]QNU48TN>UR90O/'3RBHKOM]-PK2&>S$O=_76CB)BQ^)FQ";,-.) L:;
M&>X9W\]EO(D4'4KY_^S4-%$:U"B+O6/)A0MRR>'?SPU*ZWU<8SU#0QIJ3)<H
MPIB*"R.<H\VCO][D;=&]AZF7R<Y+H5XP97?L*B"1RY4&2)UQC*I58I$ O4M]
ML30%:K4TAR(KZOQ5H^'L37ZR-AUN(.9SXQ%UQ/^+MYB(W$<]ME'*;?*V/?D^
MM8@%U3/N6W^-8#U]!-NPZR8OJC&D.BCYE+\ZNPT] ,^O3ZQJ#9(]A80&F'*D
M'%.67&"'NL0,M2SQ>[G$?W)&9R,X90\VYK:').R )U<08+J&/*SPIUF,F]6Q
MQWM* N[V8)20H6#\0L[;FD^:";-1[3>7),L3IRL4+9#%N,<L9)+?%Q)(^*5A
MF5(,R>_D+B5P2/S'IWL*D[+5?^5'()09N%FCHW/UW_2MHCDDOWO3>_[^-W2&
M^S_7TF(K1L%#?W=$IV.X*0/J!4 1\T_BXCSM2%1J O2[_[FR'U-+X;YL3F9^
M<7?Q*W:\W@MW\<E:7!G44S>1KNCXI5\,K9E?*V9@1XAL;=II8!XW4D3!< MI
M&X:I@J/+SD6**PZ'/,8^&2,'=")I1]XUX*!E;#*#!XH8M,,LH A,LG''*<(4
M0*W4\L\_W Q@36.%&!I4^0Z>5/)#OF^])!F3F2G4*HL@5LCU"O2,SK['(_[(
M<.QI>!_ZW>(IIR=0Q@8N!T@6&2YYJ:;=K27[T4"<I@7,*R)PNS4M-IN2[:L1
MCY>OIR0V.>;_CP_[3%F!,@*7BK (QI4U0=J=6^3D9S1)VM2(7XTY(>[.:_KD
M4(UV61$"*/C;B$OX"O IT=/@>\+=/9NGT75L5Q5_Q^2]:Q!A P:-,T,_\6)Q
M[I<3/@Q9,D0/1R)\1/E*-NGP"WE3(?D;5RB5#7'"F[P#13B^/'22=[+Q2N;8
M!A85,CFYM;5J(GV)L;S]2<@76W=TC/Y9YYTJ%!3-9A"M=*3&@CLL&HJ-_N"G
M^.1ZF1EA.J0KRYL=3:Z"UZ=>*F7C4-6E4?*("[H4<FTPA/?G;Q!^2G5-&>FZ
M_D&@'9!B@6!C^Q5GQ1+TFLV+L$1+AJT%H*L8U>^B\ 8;V$SFSQ[Z O^(F,YP
M_(!T&;,O^IJ)#1>O3%_W*1N?BS,O,I#/B(]<SH2EF\[:B=) O:7WA$QU-K/%
M*0ED J2N\J%&%[>HK80@U>XZO16LRVCO4SAPVOLPD:R2U<V,]$(7(_FVG/V:
M-M_KR6)<G(WK[]V>OW8S[K8O: 45@N$?RJHX=RDSV"\>^RY8N8_"ROW'@I7[
MI5BY)3R[B).>;G(6.M@>=ZE!@]ER0\EGU)>0BX;1.8+ATYP&H9:A09>(-"LC
M9O"LG.I)0CTNE>=<EN_WH]/9S;YA_1$^=''T)V<>['X?.L@H3$HU0U <9\P5
M#\ Z['9-4TQF%-OT1F/;S=]>O,*_.,=KJ10.>:(SZ.7#9[J7*VXI!&WAC34>
MN:7'O4B((A!!O[>7)&;=C7HO-,W&V3F5)^9XT<N=1="GM/,H::,)':XWIC%S
MMI/E_73,GEB;41*<:V/#U?[&,+U/7[P,X@*A.S8Y/TP:C7Z5*8W*8&4_#:TL
M>K8DPBAV#^03 :D? IT(")(IIRA?)'S61Q0'3@RF<;-9&]=W7;VC7:>8%E8U
M0^?S@:W"^*]I;AA<9KQAROL0.K BN(J&I*8>*N.Q9T,OP_LO1H^6UVQVUD^A
MM1AY"&VN0(B%,^8F;R>9(]^,R?XF+P]\VK""OXN/.#GJ3MN2]8V[$S=CJ 24
MB;N&P!-MZ,W0G\M7>PED&?+XJB'(3XX5T2'BQBB?D&M"0Y96Q5-Q#]_R-'./
MI%E?W)#5AN74?-U4PT%*R+LJQ]%2FB'GN\R%0CT5YC5 PPC+9\82T'[^%@SC
M4%6?43'*4O82C(LPITZCEN,G;9OV/.NV+'8SK<,K748XARJW!ES->8W?+)P5
M1UVEK-%K>J'O9:1GE$M>SFCN&(EP=">QK(Y+\-AK/"#X6O4'/U@H))M7">'+
M I/<[X/LR6_C(/%[SZ$_WV9CHJ,)0VG(W(JH<]HVCX/E6D^IW(+,J7 * FC?
MW;4N[@E/BWSL&S0=ISVRM^K3'#N:M.ESS!)[5FNTE,WE9N]J*8KSYJ:;_))^
MOF/6_M$%YJ)A.U$5)54E;R/[1?MD[NL.P8.F5263]<N18@I?%E!8A '<CI.C
M(;3]L?%PBSA9J[&.A;23,#,A5E,&U;EUB)Y5Y&W7/F-D0L$:[X8]?^[K,9^A
MQ,6]UIQEH]U2&*E<ATVZD#T>+'(@6)Z;?:.:-9*8RNE1-IP@YOO'TYAB;KR:
MR^C5J,/@,,?+%O9N%28D1$?L;V2#-)X*--(RUT*GT,ES"<W/XQ@6I,D78524
M%*PV<!5B)RQGG5"#,)#P)BE>)/L<<XE@H]/&YV:& 66RVQD42A84!*"872T%
M8(S(3KA]JA3B%[9Q+A4+&K8\K <*\+@J8FT_G9#!ILJ]W*F(HLYP"*LM!,OQ
MKBO'18[[^U2=/,J8SS01C+P4/\-HS"GI:;KX/3W>*.A-)AV-6"$?7S1.2CZB
M(&S^4]J I!P8]//(E X,UZE4AM/H5THI\R!C4]B18AIZ\VP*:4WIRQ (O45S
M4 Z89%/T>/PV;JP^7B$\EW2&MK:H!^<7Z'6^TC.BW3:T;_V&G<[OA][Y!VEP
M6WDUA;+>TV[=3R5BQMSADYA 308>2JDQ_WK'3*0HKVT4^M+P<O[Z]<.O822@
MCZ"%_-=MY=Y]L('\3#%-N3T]0-87AH>+ -S;]M^R&3PHT5S[5W1$XDJS1D-^
M\,%-6?1[^OG)-V5]5ZWHS>E !P@_7V7-<[.NFLW;6WWQPEQ-I@"EE'?;1^L_
M^V)*]!+3$=R5Z9G:H3CB"!_@]R+/'!; H(+>Z%2D60ORX^ T2W=:]%=T9$AH
MRY$=G#X+@71 Q[?;O&S'G3N(9+TK_S8L%)I=_>^R8)8%\Z46C.":(^(B"=D"
M;5X$HMY8VVF@F^:,CQ)&SZVK^)-3!FGPEV[H\&Q(32U 3#C=EE6SK)J[O6K2
MTQB(=VFI<)\ +YC:[9J>2;DF\@XX$H);\Z3K:[+?A-U$ZXO(1ZV-SGU9&LO2
MN,-+@PO:Y<:ET'(1SP[U0/D(ZP)'K MYW+>#EC$OKK>J'#>.;(7BNM>[+6MA
M60MW:BU8.Y-DK#95@^QW4C! ,R5%63XK,*/'$6$.DD7$Z?"=;"0&[U#BXF-S
M'(1J85D2RY*X4TL"9EK1:!B7D1!CQX:]1H%FR_W0%.F,CB2Q@LUQ0-.!;^0R
MZ3,L&L^TK/RKUQY@$XG'"+\U1.PY6^[3X,!(?,N[SK)^EO5SA];/@&9!UZ'%
MA:%%7D^A9LQLUS6;DD%4 D4%($Y.UZ S=T?'R?HY6<&H_OOPG-$OB?^/0EES
M_2?&Q=R^5CC-1L[4R1G1%T<55EM,=05:$+8,SL!M2>@<2\_;YTPEN+DQVD6I
M9-VX-M:/8:(_ ?*<%ZT"=[P#9>:HO>D2E.>#"ZQIY>0\9\RDZXN;R#A!Y=I#
M)(*PS:^;UCXT=!ZTR35%FK:>^U:5I^V:\[V;T;C&!!J'")[)BIJ-D')'@A"I
M5@HHX6K3%1L#II* ,)+K,>"FHE]BK<F+)=:X&<P+P435IJ85C)77_C QT=$S
M^V;,VT"T+N P[A/J8FE:FC0M_65I6OHR!-_W<7/]-$A):R Y#R6U+:DEARL=
MN*D"5%YE@ON*'75$E$07 *Z5J7IU!TSSLC-:G)DRJ6Q8;Y03MR&O&_CIM(X(
M!RD:/XE*T QL\/>$4[V/-OWQRHTS$%%M5CZ/7.0M5X+\U7"DK1EEMH^RUJEL
M[&W,-;1OW4YPYU8KL&YJ""TR+[>MQEV>MD;]DG68W>[)?GS/PF]N^= ):\5D
M53.\.'Z-3(<06"8\2;9O/ER /TM>9,F+2%[1P2'D&V&?@("=(AJB%M.1PFGA
M#J)1T$LSHXG#SO$F'0=3,<0'G6L?T$&Y=#?TBY_)(:/4NV3;EU5QYU9%Z.]E
M*Z:MQC$_<JQ$F(84$4T\G?,=RUMRWERE%)FJM-:4NF^Y78Q_,?X[9_P1#H$+
M2E.*NX[)LOJD>L1XA,6@%X.^!P8=*SY:_5^1FD9Y$/BG-PT=ZB#F#GXWG%L6
M&U]L_,[9.-?C&?LBA?X(1-PZ/BX'3@\/&5!E8SWH+W:]V/6=LFNO@VZ=D+E(
MEQ1-9TV0>7& *)4)SB\1]Y=^BXN1?X3S]JF3LBX\,U9H#X[ER!(-,I\379]N
M19NUHZ54+D'ZL@;NV!I(,B?*$>(U!NO.M7U*V:;0W7,F+[L 8U N<!.6J?(L
M*A%,42W++U.&Q'A%8D'F+-S>B>(6>&V-S(Q':]+TT=*T9UH6W;+H[M2B2W1#
M*';:-S?)3L,:O@:C+Q;S7<SW3IEO*F^CQ>42N,)(5#!-4"Z-L8LE?_'IF8E^
M4"1E801ZY(WC "--U0CB0=E70T<@<QTM!]O%K._ ],P[: H?7+WK]\%%6^(F
MQ=X+*'\QX<6$[Y0)Q\+V$;IO@[X%5=-.B >6[K?%B.^<$<N9SEWGE4^D=U##
MT@XFY#TZJ.&HA.72R/:I&]G>#ZO7EB,#S,<D#IZU(>!FDPZPG:M!.>YF!<6U
M*TW@NDG;&$M 63=;]0FE ^\<,?E]-+5/V]:AY.217,*(*W%."R31&-'N/S::
M2+!FJ$.S'^ _0JF\4QJ%$21^S/:CHB[80R-\>>NXA;.L2U#_B)JV<J0J,^E8
M*6SIYKC3IOQQ_N![T78NO4*QH7,:G)2=;SKXY\,W#^7OZ[;)"^70SEGV@WY;
MNUTNS9TFBJPB'2%/'W420%25@4(/5Z_:YLC$(WQ#N^9$RCF2@2$S?L$=$-+G
M&\BKN-63M:H379B,Q\H%A[%:;92T8EDB\/QX<9$?AA8UCJ2GN63N'Y5FE$N.
M4$UT5=->"=18ZS9GY7I1@RF=JNY%*UBZ>G<(=^N9CA,TB43O*%WAF)&:7BD>
M'4J:[8FFHL 3L0PWZ_^V^KS\3\^)GFAO,[NSJ&JZ.F=:F,KMRDY&R$^<:@GJ
MZX^EE-+B$9D.VB;EV8336:FM?8^U:9 ([7,^=*IJR%\69K]D'AZNWC1,%XT'
M@7F:6$HL7F)<^$;N!%)HMHLU?!YSV$!T:VV]/9#A?(XG9/%3O7*F*7ISM@#3
M Y]<-N!.I@5/8T9O:,JW'R@Z-B#MB(:.+/^.[,#NQCSO5C23:_!;9L[!HU L
MC\GZ;2R0L4H$S52)#'\5&V+:DLJW?R,ZT>&*PZ_FQW75L;XI5%8D]H%G,8;%
MJ5D*KW540,0/S'T/SC@SMXRV$%:#JJ7;VH]:7L]D%0CO]TB9Z(Q2%/D.*&M*
M!V+%&9"3,(K+J](&JJE[$@$=H1(8;=L^T./EXXTIO;7X1;%K65-7JFACKRDJ
M<4I;/K:D=NR" !D;CF.*;AA_I.<S%S:X#VIF._L*[T4\NNSB[YG%EZE1):JY
M9Z/0>:5$5E"+F_S03T1KVAA2Q_#'Z5XD1/5)\MRTLR()-*]H=YV7E2 (L-R"
M^])@=0P\2T %M-:NL5+UH[8]Q[24,74,;1]_"]>/KJ1:;>.VT@!-/G,C$621
MW[&VH*NEWS*^:68JN$H,Y0+.@?M(>28 ?!:5@%B'()U</J%"8PS#.6"?1]*W
M2$*T*,*GQ3-TV/GYFE7G;DQUD'6Y%%>!*W_@M*A>3=^[P[&/1"X;V\S7&AR)
M_*2F\$P_+S_ 8TYI2;=>.(4WCVB:S@Y/M2S%JT/.!5)\@CTIRHX]LZ"[-JYE
M_V?!&E;M,7J]%E!F^J^RX.'^BV*#%L#>*^'.9G&7?UUEJWW3'7$044OCV,BY
MMY@)+X#&UP[#R$5 "GL38DNF$@Y;GR0,9G<I'\3$A:JD41?Q!-^4YKLZS?='
MMZ:3)Q$UMEE$1(%P#)=BJ6:PP' H3?ZIP 0<&'P332C6*<0\M!-%C@5MD+NC
M6]R'766A1!E/V]>/%DJ47YT2Y?<=J7B/UL%=M#NE&3!.@R!(]I,7I>%#0ZOR
MN.F>,1-$I&K0$8K7@IUQ/%2P+TVO"\2O73*3;S(UI*6(YT<1BEA+5/U;L-77
MR5MF49RP+0?=WRQPULE.G9VQP$2&ZOR)#-F!IL59D0^C(YO/XH8CB1HD!.L$
M5IC[E)3&:=W 1^$V!-^0ST.&.1*B\]%ZW->!)KPB;PO&=V&#YPQ3G)IC]KT'
M_-R%G)O+S8JET!GJN#US"2: FZPX+LSXA0PRMR[^N::P*.\EL.3<%(+AL[J^
MMSH!?=R[F<F<U4C1EYQ0USPF0^*BR'<FUO7,>.]8&(WB8@[-9KEM+EQ+)B*]
M)-);H&D&Z5^2L^/8C:_+"1C\8Y3U$6$UO9O%?RKYU3:<XRSQ:GMG$L\3\38H
MC_D/>T$IR]0-G0J)<[C9L;_$ .7+UI]A[)&F&3YTDQB8R=AS%$_X>3H'*'KO
M$ &S74^UU9-9](6_,UO*\5B5KN"'H_<CQPP W]<!C<ZZDG0N8.P\5PP7Q_];
M</PBR*A$G'&Y=RXW/9N,KR)=-/6:R3+6:W-VSSP:DYCR/C*T.,V.&Y,X1J(W
M,NY'^B0-&@]7+^CO&%ZV<O2*2LTF;2=BCE[:D#9#2+?O]63+YTE;/4<<H;="
MR$F'0G)(G50@F0N[]?$83TCGQ<*3S05$PGF[V6>6FY+M+RKN9,I)-8:YP4V#
MG?5PWE7Z@HF=I,EK2[2'5\-),!][!FA2(P,.X_7'?_WP@;P*4L\T2,ZKI"%$
MRZE9?/Q:)55HG^<#>1,[.0XO,)N6,@E>T?4J"ZQV4?+."=W:S&P*V".FYII]
M]KRB**! ND)L5?AS.2$D]2-[H#422#2^8V/\0W"WV*H8&IN?@DB,JHEYR=!_
M.)\:P)_ENGK-%GI,8K=SR1JVMC5/D^X7_-%)5E HTI1!0 HODJ"+]LSU*99M
M0@KR76YP]2J_T:T)%1=Q[M:FP<FD5IJ?9.Q1'8VYV=D]> XXV$@#">%>9U.?
M74B)9^(%5NH<[_*RH[(&*+/C^1JG]QD:63!/CDQ_4F, Z9R:AW2;@Q)WA 70
MHFY2W(RO?C;G-[I0,&2K <?9+7:?<#>A2A'@"Q<B&=I"^X'#B[R7339;*;/>
MY-O)<,\-#C9L)/[1CLT&\7#U<JS&1_9T./(VKY)BO!1*3I.FXPYX'O\JY*YL
M*:S8&TSVP7;@ZJ]\,3'3<[K:D_K-)JC%YO0'.#?4\+3D)( R3X5\1/E*/2C%
M=$JT'1>=\A)2LCGG,/D 85G<.%">JSJ9G"Q/!OGU;8F$=RFE1BGIWHL0:$$X
M?1C8YN4\IZ>0T&Y<0%*0#<H:*&FPNR2G$YC+Z8\=>2ZD^<$4P\3S9'?L2GA1
MC<^E\3V[IJF-\IUB,M59_X0LW L\Z4Y%XJOOU)2ZU2M.L#R-; W^Z'E=T]F<
M?[S:<&'IR:-'?^&LS'>OGCZGF)B%)M@#DQ=< \LA/QJ,@0QH?Z,%N$]@N'0;
MBL<?" ;$87N"6 P3OTXN_I!" T[UX$%EM!BEQ*.RG!AC$=W9UD0B3;"F0$!K
M<7H>6%&X4@*B0<OH1($T=IN* A2#5(6DJ& A;(QV^9N\T\.M?Y!PV!@))208
M(,;;7!XOA\E!U39<5P?]^(D-V2 8/-JFCHY#MQGQP]7W@U:\**IX_.0!KFHH
M'@CKOJ/#1E=>T[Z(>8_.3+7$=A3MTBYGA+I1;Y@FN2Q<GPZF])WSMKLCRX*$
MU.J[_[GR>8U)MYG59>TU=10,=DT;<'0(ZVB%^3,!S4PN)R#\@R<L$::[<57U
M0.NSE2LF[*$L].")1A7O G;2# =11 P<N " MS&=B+(-]OLC:R;=2%T9T=8[
M_@+]*).W=JJ2X5H:=J^!4!R7Q6:5Y*+ $$W_* _,PL&YURQ\,_<>X.!R@8FU
M(]2LUGW[T[T(2I;=X#VS^!,$>BNENM<CQWG"<1]4YYTXI)'K70WL>7->C]V>
M(VQ:-E6Y/?GE>=%E/%S]G<Y[G#+I#5I!QEMV;\VOEEW\>8WBX:_W=,!T7%8?
M%"I>[UH395WEVE:M1^L;BM:UR*#>&E[%2YAPAK)(V2/C>1#%LHF'ZHS?>]3M
MF@6P+7+GIM&$VS:<DQ7R?WS9,OYQ]'<N/%N]%)78[N@V@5A$MSP&0]*O@G1:
M5&GASR3SR,GC3K U<B9"OF8-V2EV7^H"N%"WD7-R7^Y4/2KDN>;@3/'.17/.
M?3QJ1UE4Z%N3;^O!UN"/<(S7$UN<F6J&1B+$X%<(WQC""/*['@QK,^KO8!%
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MV?6SRR.E[S V+W!WT(M#TD"R^1RF\RO<'..4YOLT/MW%ZM>KJN;"%[V/U7@
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M8"3UD6$X!:L/VU)VM%,H@8+I^H=W(?NM/H=H<+<'EOP,\\!DF_Z!173<HH/
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M\V);25> &MROQLN6Q=JG;@T!G8FY(Y\,]BG<Q/HRK6W,M3S!LFGIEC1#:VK
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MC=^H[4TX;*77E.%C'0B]6YH ?]'=49[W& F>Z5)8;B:&91(E:"!4WO^7%HG
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M),V[-Q)>8Q: =0<*,5P>;B@-E5FWV2=>O'K)80F<.JN,EH4K!?EG54\1GC&
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M8H,&.6D"'78"Y:=AQ32"\"UWSCO]5*_,YF5^)C+>'$0.VORQ#]6&-BA,)]/
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MT@5B$Z;7BG=")QK[?3;3'?)W.Z7V#<"@?R1$*(H46C;CLAD_=-P?"CZ!X47
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M6&,\=5[<1;E6""2BZLCI'ME")HQ?L2B"<6&?W*M6BIOT\L:!%H/XM_R"(N'
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M,70IJSV7B8RX)8%:NG 8-HY#;%(9 3@&7^I#"#P*_,6O<&*&C\\RG:Q0.D9
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M_IE(]RVHH2(BUL\DTRNT7:*!R+&F8M)$FG4WF]7C"94J#Q+H7+0+3Q<N7C5
M2M"S^3<"__NL\WS>86;%QJF_3&L(\;/6[I)V/JT-!'4![)X-0RKV5/SN?,P3
M,[=&=%9Y,;%U6(JZLTS6/%=8$%GC%7-X LVAY1XQ;?V9E"&6-ZA#8<9X@Y]=
M/Q3&( \@(#M,CB%?IC<J)[+9J*&*;[2N0R.9T/IH4,NDJ5!A]X?"%FJ9-L"B
MWGF;NXTRMMX@(OYKZ<J-SE?OAV&!/M-'TJ1/N4GT',I*%V?G@UO@V+#F_<L8
MP.[,4U%0UP2M \XO+6?VNY_96"9URZ@Z/]EWD&7&2WSMM\*_7%?[?U^LOD.>
MB7-;S(U+IJKR9RL#0>+QIIFW $TITD/&H$G-2*0&3 =R$<Y5/4O5"V"(Y_SA
MG\$\_:T8,B(*G=<FFVBI$S=\-'12/<B.P[[=<SJN/D/>FPJMA@;D4"+B%!VF
M=-8?F,LSL27OG9FB(DN7[&F!(.W#Y6$:(TV0GTS&U>'HV%3=9MP3O_7&S93C
M5=HV.5WY6,?7I9K-YV@<\E(=^2CMPJ\N\N0"/@)^7GJOAX[*EEJM@Y9>@W*(
M7_S?O_JI4'R)K78PY$)1I+UPIXL0I)QX:7=ET!"J]I C$.YP,E?^)GH/:MX@
MKB2 +-K<(S '6MAJZ[9]H^W*Q-RKJ"%W* 48&?T1H)"5M%SH7$5?V>\;(8['
M[EW7]&!!K\B,, ).#(;6GZ*=MU;=N)&^F<0ARD.H." ]]D,DE+M6/AKX&+;;
MTMYU2P+BI36\59]$O)+_+Y $Q](WQ;BC"3F%.F"&#:EK5)5E)A6]Y& >QTIZ
MN#]W8N7,KP<3[:<NAZZ1^GBQ>@WG1GH.-7$C&1I-'Q#((B%/29Q)!2.37_]+
M@RZ\UX.X1)9"/4DL9M8N.APE FG'L<5.^XD6$M^%Z.+S)KK0PX'2DV^FH/Q=
M'0 1X?! ,M" #M /LQDI]=2TS9-?+EY?Z)D30)C=&[?0_RZK_4.O=NZNTO81
M@ 4X:1V<H;26[R.7C7ZZ<]5^3?VXB-_]5W!UO_[#HH>GWRULP<M"_^ +W2_M
MNG: PC#X*[2N&&R@)EY.BR@X N(S< T95JK,413KUT=<[9P*WP),"!5Y[5%1
M;-FY>V@5I"_W(;U-V*+<Z5NVU+*E/OS9$1B#4<G;^Z@&V5*$1>$8($"OI;>C
MZ&99OLOR_> G@B(CPTHU"Y0=(C\I+6%"_3SXU=XKK8B/PM=EUU4+7?RRD!_E
M0A;0!ZD&2L=O%TA&P]]4'WU9PLL2?C1+N%S!Q?:>A3C4QTCACFKVI;?.\5<Q
M"4/%<LW=&!Z'97$OB_L#*Q3 7S#=<)%ID/HJNH%Q'OA75/Q+^K*F +3K"/E9
M'U>P^:U)-T;(VV+=EPWP@3= XRZYMD589+^L'= Q3/X0#?]0OD6DN*S79;U^
M8&\D2V3XE5E([S\K3U?[?7791=I'E&\YS4'H[\@S55?7PF?B#X%K6DJ7JW+=
MM>5V6>7+*O^PJYSXR] %;60QCIS'TSSV#5JQ>76/#?D>A(= NRK!0ADUWRB%
M\9*>7M;W(UK?9P7M_(,SI:I0(I677-Z?!W;E.GE<,>5]$? ZRXI?5OR'7?&1
M[BZ25C XG<SS#R]^>LZ=^OM#R=3.6KEDMWN1&5J6\(=>PO,MG()C)*.+J/'2
MM4]BXD_R(-9(WY0=EVK %5[U )'G?2Z+&M [OJP?VKIN;[17+=+Q$J<N.)NW
MX!)9??W5TW\KK(OX-_^=;;M'O\,O?RM6])CX^_<C@2'\L_H/BL[#][\0+^3J
MO\IFI-[#;YX6_GI??U6(!PH&%W\SH4(M^]5?._>V&BY6JY](KK/D[D"P(.$A
M0Z,LK9RNH_0#Y]C*RXXX5M9NN*&6! SW;Z&_CH8AO[HI$TRP*!YQUR5W:7FK
M.U3UZCNW<?NU-[]QT-)W^G/\QD_X1K':,B$C=P1^_\NJ&VO7!S(;?KC#@9#$
MJ^=2@F3P<'!3^ DX0HWWD<^],)]['C\G[#M##8V.*$2".W :,L*1T[E)7F6<
MI^0-,B>8V[(^2B]@:-[$^D9Y;IY*HP;>$1%\T_YG';%VQ6&*O]S?R_#Y3Z-+
MX_/C8/EFX6!Y5PZ6Y23*Y^YU!7+ A'..<'5MH-KB$RJ@6G==N7=@<-?DA3^&
M*A)DZ*IK;W9@H;P5WE:=J@]F *9"#AHT=>94M]Q=S5WPV9T9)VO)$J7K;C[<
M1+2J&,)I?QZWSL_JAIYNH=5G_OZ7C([A/]$>_M>NPD7]=#3MJF[]"=EQURMW
MCJ"OG#I^B=C329OA%G2$E/V,W?S?_T(>JA.T.Z)M:1DNHPYW<FC\G7KF<10]
M)_[#(WL ?W_.AX-_O]1C2$1PIRZIC'&6'IT_>V8NDL>^6#TGU0GT)Q-IFCX-
M\\(UJ0@F_Y7Y\,V0]!44PCBH5;O\[4TT-%D)\:IRU\)@X?U_Z6[>5=IBL+3I
MOX,RRQV\(A5SX^4,F1.@OY[L_ ?$]2):7EZKC.!E"=.3OB/]1T1-C 8$56OY
MTI%^''W@? ]V!?TZ%2;ZJJ>A530F=FA!6;&;=RB]F_@#\_(2D0E6H8P*%,.7
MSNR^7T2[U9H1HD$^1.$6=0-9FC5_\(B/"XUFAW%@WXWI6!*5.S^V7YU\%!-#
M>8ABY9<5@49O!(:=R.+MZ"+6NIMI##JB7]Q<N4;R&[SUP?&BS(5WGKLO3\MC
M6<6+E$V>$XF!UI1Y<Y3HX)9]CP*_[OMDK^>,[VR=E''95$_3U"46D+X5GD\@
M#?X@,(,$YYAJJ<BIEBCL0<(5&B8^LJ'I!AG1=@0C=V_Q"69)*T"2_/:1Z5KZ
MG%CE! U/I"G:I_PY-)!TVCL'@O[+NEWK<]/S%FD?5J&@3;-!^8PF)48#^)0]
M\B,*':#+]D_=@^02(S-GOE:U4U(>VSL_H+% '(=4@:8P@ZN/VD@0=^1BXQ]D
MXWF-W=:_#4^ .!=$IWHNY8]7/*4I/O>R[4%-I*B_05_X0BCP> @%&$8[&.((
M2<C("6@73S.E\'+9&:>>M?!@D_T3%C#*SR LIOZCA!=/6:"2B,%28)F+S=)'
M,8G6E%5*TTXL;L#!3"H9%)[TEL><A#:&TX2&%"G3$A(E.?8,(9GJIIP0V%4A
M1V]!;R(GVR(W]?Z8$.ZQL/U2OG)E[5](7*\<I>+E,JQ 999 >4;19'CSF520
M]\VL?O IZ0S+-F4]1:.=)!LN76>6WC%9;QPAT))#'*]KB_CMIC2&?P?%%B=Y
MZ1Z_MIT?S?_A67AIM#>]![2IV3^U6T_WN/?%XN;\L4'H3ZBY@M45O3,)P^'=
MU=*F-KQ71H)9\.#^]OK')]]\]71UJ*[;@>5#M[1#2"&U<>!-)/H=3L)Z?X[V
M^&OO?G&NFAX!@6^'PB'X]VFVK[QCOB8$" 2XFFKO5Y'QH^C&\6&:_!W*AKQ8
MY:1(S% :"-O#WP+-HVNN"(G%.7I$%);QB)Z-FAS<9M3PY,K5!_\M,!1R(^5.
M6"X.?LJDC?GJV/L8IB2#Q)>@1<:H (SI;^VV\B_#K)3!E7L?^M <]9JLOX6M
M,K7)(Y.XBMP@WW7?^C?9TK4^"A]AL9 S#N=MQR?17-7;($,ZT2B0-9"3K%9Q
M[U]PN!R_TJY)8]A98M,.++T^JA67<_7_17I4Y#&F?*.B;BR&4[9QE$LN!W/"
M'C/=L(0HCX.X5(J>R5]9OHB/BQ ]<TY,U9 "'PZT"2G_QHF:?<)5&RZB''J<
M>>.S!H T(-'(OBFY#K$[^5 W2J7$J,"RN&:EY0EIIMKE*F1R >$G]L(33T /
M#X;5$\G:GM2<-V2)S&/M9 5LN_$RY%5\M-^K++6_P$U)9&M15FG5>P/KGHR'
M&6$WH_J&K-(!D_'7_WY.I<M]U?>HKW):JNHM3VM0?$(ZU9]>8>4H>^UUN:$D
MK0;,?B<Y;WTW48=0=.O,</2K7U1?FH=F142\@XH)HHG$%S;9?X)B[M$?.0X6
MN_*#\G9SJ [],W\9?YVX5/4ZLBJ/B=2VDF"#*PXUR>B!4A0XA$_S&J')1E\G
M_>!O1'?B]T%?[NMVX&[G__S[3V8;+![F@^QGPKL-.@:.JK@8/*\!*1;@3F[H
MO(^592-?T]EO?"H.K> K^+71M76]Y\V*^T:Y,W;&A$L5V45_B2AU=M7V!XH>
MHRR;[.'Y40E%F#HIG&,26F$I$UGQILS!HO:BUK^XGI1&#34VV76W#9?UMI*)
M(%5C#Q@;\=8WE)\6]7HABC36RY\PW5@EZ:PP5B:W(+FY ^B0KKV%)>DH):$W
MWI5WHQ$$FEM*OKT302Y$!;SX'5EXB/.)?)7.6B$FSR9F3)R:38Y)Q:AG%UR]
M/XCA]8Y^4.J:FWL&\,.8!H>1.[A*IG[3==&GJTGI*I^PN3(N'RAO<2W(I?F7
MANK.ZB4N(^.\]D=ZRTE4#4"8K+H(5B\Y>]".T%Y6?OXW?7P@I:*M0([KEQO<
M4@8+A!TE!YH39R5S2")CIO)D8H5$RFX),WC'Q+7AA\VO%%#$^HCC@"2MA70N
M/(=_DR4+[9*:T=616%&H&8YWY!^@&EFNW0!@>DS#JUH947,C*T 2NYJCEOFM
M>G&?>'.&7FBZ*!V&=*A5_L7)7RIU.^("[^:80D]:F(O5SRK\>Y.Z;KTC0K\;
M/VJ_FGH3E23CH),_T=9#ECRZES,BN&ZK.Q3;F_R,*9WRY&5QNIV,;,AFR56@
M!Q4"IET,=VEV4#,PW5P:AH8A)A-'.XG<7E&.!0.R:V3RJBY&8SC#.UP3>35F
M:N=W& V<U':7$_?!$8M42\)Y:&/W)';QMZRVA,:Z;NMKQ]E"\I;I[#6!__PI
M2TLO:#!D^2#R.6>Y] VPCJM;'T5@O."\)CBO/RXXKP7G]5L8KSG)#ZGSD= ,
M6:J[E#Y.EC62<S+7-#8("166OUU ))ZRM\B'!,V0P"N\(_WFC8O.WF M\'8T
M3:BY5DC,0YHT4<#*A^NQ6VM3(D42/^#2+=(-WHTB98.<G: P-0)-ME@U)BLO
MI#5V?CN5]VZ1R=]%_9+RC8L=A41E(&@05;<*''M1Z(1)F5PYJ/PM5<WR]&MZ
M1WS%'TWLA6M"(R0P\OO?4#:?L&RG"F:(1(+H?;P?XD )9>AF)JN5E*BWKM]T
MU5J+@OYT9(J3S;-7Y"K_P*XR_V[[C%2($V&(I;#[CH5=$^>.(E[54#6%PQ]J
M]FMI>9===_2[GA-QV+NRCZ4B6;X%ZJ-:CQ1&2%B%7.#[E!58V.$_I.8YS-5,
M:P=.&<*>-93"V*[^GV^_NGCJHSH?]W ^:.=\_"LLH__/TS\]O?C*_A5*&3.+
M#OGU_WGYW[TT:Z@DG)4U;G<[JOUIZT;Y5C2"-SX"])'D*L-!ZT#\5;,EO7:7
M%8IH/H F370T[WSS;3#;/,@[?Z^@6)'.MG&H@!6^6/V"?L373LS]-W_^&A?_
MYL_?Z.B2-O+5CZKP_DH@LB]:AE\^_?<__QL22>4> DFA#D$?P(W+((I$SX[L
MPV6+$RT8U_:&LB/4VL+!1C"P7S!$CY*+6[=#H0$Q[R4=,YIE^/:K)T"N-:1^
M^.305J1T/NZ!K*/"-A.O?>'CW.NR'MV7>JS0V4GG=+@YU;S%D/0^R'T3].:A
M-+2B? H?8YUS3X[.AU/<9_1EH?4*?<Q(C)59--+\HET@@YJ^PE@>,1_+#%I<
M:KA<VP_F@V;-X564;Z<FD I9X:BD)(T_RI$^R-Y#GV%C,HRB#Q(Y\T :B-5N
M"/+6F+UXM4)R(#NCX*8J"H'[MZU19M'K%WG51L\#,RUW.AKN/IGWF$@3'F-.
MRT4?ZJ,]2<B3_-FOB>?0X2->C6VUJTQ6T90AGU?>P+UR=>5VG)S]7JGNO"D=
MX?;[RZR^H.^I<7OQ_-7WK^G7:M6^7+FF5.29!:P8$4!R/IO+ "BC\K#L2+_D
MX _KZ4'+.9)*(@I#RR)'&[0Q)D;F8O5#/'HH-UCU3+N BY%ADZ,$7T=R(#]I
MG_Z)%5Q=YU>_2&GZ?;$!V!C]@ZBPT*+;41+>4?;4;S@>"+U\-B#^V3$&[VE'
M4Y]<%3$4(.,[LN:Z,7F4:#S=R<F</8CY6'R8-4#NW+F8JLW&#OVSBT%?)IO\
MK4-!,H+$=W9B_;L;NTZ"B1,#.C6[5:_6^M[?_OHKQD6QER 6C-[L8>P(/-YK
MP5F,F4H:)JVO!BISJYF%.$]_8('$!+$NCY "]GV4YVI!]>,(]?N0,\U!M9:'
MSB:WO:$3*P%Z&<W&SFWDNP#&;_F6015V[ V"WWSME)N7' C9(7!V?]!QSVJ'
M885]PU$JR<W%0T)P^)A8+)(IEMYD1.SYQ[X;?HTOGAVG*:O^[W6W^L-_R/_/
MG%"/-R)\,66E$^[1T#414CK:X1RK0_ 95E)69 9I+;+E?8+RI9 L:+)VDTW9
M7Y&H]LW]-'YG'8+'<_#]ODOB86-<LK0/G[O_@<HQF03O@)<UV?V195]CFH3V
M5 %K.**.#M^A2+88?9Y$S5A,-92?U8>1/J&AHMLD9OZ<6/9I'7/_>[ /^+M=
MQ-XYM-TA^'JG05<L^^EP)K%'Y?\1#GDJE<W;D>P ,FY"F CD%"WBV7AL(8NI
MPZ='0TAU.59;4!P&V-LDU'[-4! 3S2"$X8;;"+HWW<EV>(CS^ 6,(L,9LM[X
M0LC-ZS?";'7NX/RZP;R$.:I";KWV1V#/$SXS/<93"M_5&P<:BLF]19[%'^4$
M,8*=#B?\FJK5>^H?\Y=XX5WECA;2%[SF\%'*<1S=P)^4]X(NPN!8V+R+\8S@
MC*2]X$')63_'2)<W+MT]\2W32<13=^IXT8.=&_$2[[-"IULL2%2,?T9UI1RT
MV*)@[)Z3,HIAI?V2O?;L'7#3-#7+W8#4@U>L#2&2EVD.WC@-(= H!(%)?><!
M946NU#8PP-#Z[ DQ*!VKC#C(>U"XI_=MN(;R8'D'J^'H1T.:B9\=FDTG;CL]
M:I!=Q,R81SOQ@N*+H0LA2Z10C1//54S0'W;GM_Z$(8-(BZ.[=+KM&."K2]'H
M0P;3((]U\6D=S4OI(YFX5R@UO1(HKM\75/GX:W V?PA'X8O@8:(%IOS_V_O2
M)K>1(^WO^RL0>M<;]@9%]:ES[8@>'5ZMQS,*:6SO-T41*#;+ @$:1[>XO_[-
MHRZ Z$.ME@A2Z8C=:763.)[*K,KS22YC?!_E_+:8RQAM2<9XEW[(Q_D'TQ%8
MGRTJ#,,"06P^Q$+T?OK;[E]PJJQ]E"#XL0LPE=S\Y*(,M C,A\'1F4[YNLJ]
MZ<;MMI\P4)UXYD[**."NZ!KQ775P)V%OL^;QOE:W:>K^?&'ZO!F2@!N'(-^1
MQ\/R:/1E=F;*%;(NP.U:)@9,;38.1<Z']7#B/(8^B=+%RG=H$W"R:?Z/3 =D
MAB"G@!(Z4:\#&]=4<X U'2B#(*>4RZB0!(:K)?"XK6WW#C;GI$%=;(L/]=\=
M'1P\FSA#\G9J$[0134_')Y&1K65)):;)J[X*(Z?!9@T*63*-^N10, 55^^%G
M,='2*.84S302I% +&YPCT^3U9^1LH(>S'8<3W].)#V5+H-'Z[A7PSZU1:"T=
MERCI4_-TBVC]=:D(7M/+^A;'[ATFH3MHDY3'WWWSAI.X_S.C_&&WU<9]9\+]
M3=32B$7&Z.-&<WU[_3>%QKT(J>[PUG9KFK=Y>()([*PAC"?S-1LLE]^R=%/5
M$[%(7+UWT\Y*'Z9F3FX F-^X8\;IIMC,C C#2;K)'P#QQN*<P+I09$F'@SFJ
M[ VI/PIPT^,_O%Z-[9#!3D4JE=T;G6>U;Z_KN&.97E+CCU6-.*H9E@$NAAD+
M<K4H+S#\^. WS:GZGL=Z@@=%7B#7B5_QQO%-)MTP!$&&G6"ZVHGTG52X;E2X
MGDJ%JSAHW]Y*IQW-9_3B;1A#!#9WA-Q""O8NRS];$Q\B-?P4CEF)FN3@*,<>
MK<;2&0WU(].MNEQ;A8\>X(X;W=81I&$ I=::2<4Y_2/&]KCD\<[&=E?^!F2N
MTE1?AOU"5TI?7(T;70)LD'\_?'(\?>HKX9Q$%5B/"Z=WL\".,LSO!HJ*XP-+
M 9QP,=[F7ZS%R(=^:FNRL%=38^<UV3[_?O+X--3G[<09+.)YM7ABQVEO>PRI
MG=" RZP*Y "RN18'.+S)'DNK:\P?H YUW0)G/[U,WH& H:=(]K"U$;D+<9#H
MDY(N[I+L/Y!S@#7\\,"4ZN<BQ@;[]SBAKY9H8/<,]TB;HDX$SW\W<<%E:CCL
M?9>BOIEI C_"]3R%T^2OL-&CM3SQ,6I[;XS?S/,61]HWNE=70"_K:&?@LNY'
MO"-5,\+O\+^V*X%3ZW8S :E^:+<5)G8T-<?L\?Z#R>].\VYR7I94#03/XJ+]
M$0!QSD]V@!W= 8*:?8D9@QR=W#'L4SJD ?VJG&M,'%3UOD6%PN4O2 H9:HM"
M, 6+;3C11F04ST<F>S+N1<:]?)^)1=AP1549/>H/12RWO$=O'KS- IZ>HZX^
M\D?QVX&V/1G+)4*^_4&+@7B6>@X4U<?$7(,8DJ00<[NBXZ9+GT04^_XXNL(<
M+:M)GS8;C&(XL$R]B,XV+D 8(/-:BZJ(JFQ[\JXUX*QU'SEJ2.%">>?@IHF\
MBKR.1%ZY5BS$$JR;&4<&1%I%6K<KK2XC[R@1R8"(!FE$YO0DV-*^;-MQ1LU]
M:\,M[?47B8B^B/YV-VKNKL72CRR+9?X*<[RL/(^LF!DBO5N6WEKK3\,SWGI%
M1_$LM.M\Q3C!88NW1,I%RK<KY2%889O&(L%F#Y"Y$WB2P[Q23.ELF6'C(CH=
M%_BQ'ECJ<4<<[E5(Q%[$?KMBKU)JJV!"YH>Y23%W=,6>W>@\UYACI>)1),A=
MVSGGZ:(HD?=7HB(BT=N6:*HVAK_!AEX6>I)4Y5KE/!3"UGJK-1,C(G<Z-])1
MG;YU*$,C'3QTKF:.PHGF*K!Z^%'G(NXB[EL6=S<$>(D%\?23_KRB&93(6:UM
M<[$N[!3[MKIB(\<JNGF9FU)$6D1ZRS8)CRZ=) NT3**)#S2D@%KJ_?05D5:1
MUBT[CH%(4+G9[13""RU);'>8ND9B^RIT0'>9 424192W;#IKW5B6B]!L;RN5
MX1,9U;K.-,5$DE4[RVD<"#4"\L J$6 1X&T*,%*68#[P'*R%NNDTVN:^K33-
ME5E&(UV1F*@US<;.'.;@72'64B1]ZSF^3&5IBYK)(7$SDARK$O^)IV\I'LVZ
MT1S&!!#%%<1U,7FQ8R)V;,=NM![-G6)&$:8B0@G!&<YIBW-B7&] Z7^L)_$I
M3;,'N.K?TT7--$Y4(F9E>J<PV[=F<E1#KZSR==W4'&?#=I&RJKO$83P[./ (
M V0IO75&>?'=:!&0ELH;.@&_+2N"ZT@JL)-GF)AAH/G'MZ]3[TKGJ_Y;.%*#
MXL)S@WD2Z; <FWA^70O;/3)_# A8W)86M:S8K[.,7_=]4(?&Y)9RUM$L=#@4
M BW'-<-S4FTN=#:4RO9]-OW7Q=DPF]D0ZHU#/=F)/5FD?L@BN:;1D&O*TH6!
M?_HMCS_-_8UUK\601C)C#1H/RHGJ&Z2W2CRQ'](3&]J=K?D<RNIOTT'EBIF'
M"CLEW"!"OOW<&XOU7<KC!MJH.M5"@R;.U19.C^E,]$/T8]OAN$!PB+,R4%NH
MA9W&.H*DTC\&FPVO+1^EMO4\Q__ZLCWG*;L\.$5ZO#4/^H.\<KEV\\J9H!D4
M<6%6EDF\69@JXVB0)[96A9L/GZA,_XOH)8*C1',O>6 ]L[JM,(L>]#"BX7-M
M"I&#P3'U:UY4%%@4>,L].^A PAL372FS-_*/5#5H50['V$>:CH-?1)9%EL<F
MRX4^+[$!C7O.+\J*1Q[HBB?N\N8<%?Q-;+D?3>EUN2)55=C*PXE1.&C*8*QA
M\)1)([\H7R34EAO4EH^%VO(+J"UE Y4-]+OH9:[:(O5V=M\W[5"7W^38VC:8
MV&LNANBR)XDVM._..ILSCNM#BUV1M5Y0PI9B\OR(FB<PTF0^C,].B.6YXRA\
M<9./=!&+_HTFVM3W<ZDDPGNG6#9PG?<,TK)P5#W=<=><:?8#B:A\L:))6S0X
M,RZ*H2D(G:ZW3$Q\T9#1:(A3!Y#DY:RM:C+9K^.OXJRS6I?2<B^"/!Y!9@.%
MA@>O&IJ8>&4^#,.A-LA)LV$X>[:2VG(1Z1&(M!U9XHI],)O%AG?H'G9I8"OS
M47I+Y%?D=]N]$<'>]JV5]#.W6SJSG!LM*6:(F[1KJL1=>[COLL)GZE"B8&U<
M@;]J*ISZ6NNTTC;;]*DH+Q\NRDOIMA"5V+Y*V#Y-TH*%3P?99DW\UT"_IC13
M?!WF/VG;)\ #I(L6''"<C1QF@(7Q:)1WKNLRY4%X%#+K#V>C627HR[>%&P'M
M)EK2G&*SM/F/[O@'1S)/L^@N%[KPPWQP[H&]D*^KQ -_J17*!$Z>BVK*794E
MCMJV&VRWXC*4VG8G1W>8[GLCAF=Z7=IQ$H[4H=.:8>;NI6V?&XV!P]=]\^J,
M^!]L "2.3\++I#2< Q'BP0V>D]"$)^.!U&4=1AS91\"!\+[TF6 SM(25'2@9
M6D=M,LK-)ZSBD1$A"%I&32[]$8>VF+E711===&C<X6M8%'RFLN#E**OK? US
MXV#5SG0"GN"#HM09%5]B2TQ?1/O!9)H<Z.ZU\2C,+5V<E[;@8Y4;<I/T'!ZK
MJ?>Y0OOHY/3I<?2__=WUG&Q:M=W88#JM RCZOGA_0';JB>]UH3DM-'LQ=+;X
M;AC:S@IM&P(M<5?@;IRW;/6Y<0"QWF1Z1D0RMOO,S@(JSDFYRRKC232!;]KW
M@$^3]]>]RJ;TA[3*4%L#:*D?1NIV9Y\8B:;TM"L[IP>7Q)TM[(;5+E3<:%!@
MN+SI)W/.^ZD<G[S!KW'D@M!W@6G\M9]E2I^):_&;7LQ.N3Y.D[*RPW%#.2',
M(UT6_;8-MJ?M?>"[[K'7-$+3GIDXK0LA99^4Q FV*<-9_9K[5.KN^):ZNZ/Q
M@T>C?;R4S=8=,+CJD\YBO+*JJO)2T[/1F<D'T\1MV7B E7@2KR/@RE7+Q6K\
M5CZV$ZZ7<8*,7&H^'U>+=0V/"C=)%R4BU_GF>6LR,MB[NN#U*7[SCFYQ.P[V
M-N*LI*!0VBJH0R$<)SRT=+";HJ>'7JUMI2#W2MHSO=N&@7B[#LV<J)U44:!;
M!8Z(D3U_+_9\;-*9*Y-;AD6[3[.#L8SMQ%Q; S#35EA0DW!PNS=@XFG%UEB$
M7YBJ/W*L4@:^;AN$G6O?&9T;B)8&I@1$]I8U/R8)^#?@^X!?R):469'>X8,-
M#M&(#H4..0@_.IG^RG4$NYVY_ZK+LN >X@E.;TO"O.LP[-YV4.,V8WNHX:O?
M8%;]Z%J-=U%_[J=#E@=(HT9=8<\X(\5OR[/8*_3M!WW/@KC&HJU_LCE1_!JW
MXP=J(]Y%T;O[UAUM7=2NZUWMN'^=@PID4*0*J7=I=JN?VSI-?BL3;KAU7;]H
M=>NLOSF"<0B P<-X:SRVG*T5'N@8ILFK4*]\M8/+\078O[U+<.6P/SYWB+R!
MAEJBVTH6HQMT@,_S;H$?.MYPUUU6VG)A;SY-QYI"!R@47^$9D-WT,I/D%IU*
MW?*N(2=\T_L@G\*N;'=A-_RDG3A31+-OH=FZ;D#;,/)"72^+\C+)2RS)\_K!
MP3E3-TRW4B\FK-XH*"!OGE6*/4QNRPE<*63L)>H"3BIW^* ,]74>%!33#ADY
M W7=+CG3S5X?'E]T'(%^X CFBC81J\7.6N3SC$Q ?S-K^T5#>^NR+"*'+83S
M^&5[<4D:]4"O;:JT7=:4L^>IL&R]M?756T9O<*VJF\$;QUYHA[F#0Q5T.8Y#
M@"6HUWR%_G.CSQABR=VGC0.H( Y5F1.#0WP3MI1[:KX!5AP!I,T+G%&*C9;.
MMJ;'!-DT6;[V7UNA6=U[U:GH[SWH[S]Z>W8\B\1*OA\YVU849KD_6R\YV[Q;
M[/Y[)70)!1(V8Z=(4Z.&K8.QVT)+'I,;4OV/6$<<JPD^GVEH.#?ILPW[]!Z#
M8D.^9LP]FXL$Q3L1WA*##[ %HO=$\8;88/9F#BIB1YTINC^Q<Q91(O#9:;#<
ME5/G(N1I5JE:^MC^(.Z#AW3=6S%F\HD->W?_*G9XHYW6=;]<1LXQQ0F+CFL,
M7\%\=UO8*>9P/&2Z1C"Z1%=X=E3<DQDYG\'!#I/3T7CBK J[_4/SMH-?S&%%
MDPZZPGM'I/7CM04]D;:@+V@+DIC)?;"UL8/'F9$X).Z,0[_=SX=SKE=VL-/V
M[NP^NY%&@4A%_EV(1.(!T]8-\RC"EOA_&W=RS'%#Y^Y?P<C"\:7^H"+/EO?Y
MW"RI!2"\4SET$3:K+8?7VFC8QU7LAKIO4$>[C3%UCXKA<&?(H$26^TRS71A%
M>#DK;\\13IL3<]XYYC20Q--\TKD!ZS*SV0E\,(DNC5M)[W80?#.E=$H&=@(2
M/K"L#=594YM,)+=ELFJKVA&'91>JL*E*2F[ZPIGPA*CA>5ZF:&VB+Z32Q31!
MWQIO7=-%P?8!E2XXPZS=QZVAY\S$2;>4I]>_#'"I<^WI88)=%3_(I7*D%TR!
M.JRFJ'%JI5OX% :@5.T-]URKS"W'0,&)+4B/$K3Q3H$7H01)O'P*SF[.-LYT
M0VRLL5TY33[ C@5/BGU]7&.)U79,J.' (V./S&UT&^"]&\VY%8>/'J+\H#1V
MS1&,ZS94>FR,=H&<63<UKTL;;^#H!?P5*^^7CM@J8GCE ,#2P/:.B1O>W;IO
MR*%Z&F1CBK0$GR9%J73O0J]8Z7-8.2<>/G7#E514/QV N:GXA[YDZHJ6LB*"
M.YM:FIERM5"@I2FM/3I%108Z4JU]]8"5&]2U"BNZ<2' 45!<'?85EKUGV(T=
MAE[>"C/-9W@.\"7\ 3=\!%TIC(1 =-I8!'L.3<^]PRJQ\Y*\.)0UW@,,[S#Q
M%UG4[.RA0>SY;PXUUXK*>6_5+-"6#8=C3N>=%S9R=-TI&+^97WV*JG!-6B<"
MPWL6.805)B7AS>I%D$E;2$'Y^.%]T,7:;Z9-<#.8>O0)&!5DO>.]%L"[I$6G
MEYII7?!NVL VAD6.*&,N?H8<RK$GW]E<[;R0NLPW<E4#GC._Z7ZXA4-.R[<V
M#6[R88Z^KP^S#0C&X<(\^--[*@-^'XCL?[TL8,-<F!5N2VAAO.2@R <,BFS1
M//Z689 ?8[&''(S??-G>-9$PZV%=E%A41J6Z47".SU'<DN-TGF7GG\?L]7A^
MI M%&WT--L*/E<S?":&ZVT%T%R'J66'KLATL[$/2OO7&M135RH(%<1$'<<G@
MP0NME&%7CNP0*VK)!ZP&LY6JEG<YV$@A('SCBZ AER/'ARU3S]M,"VNS='3]
MD!U=%%/AV!D5SK@</B@?TOKY"N,+W?&<9 "P"/&XA-CVK?6""U<57KDNL2MB
M?43MS_U75P7&;=C!^IJB Z(#V]4!"G(4*0=_:8?VH4-2A#AB<QW7LM">B2AO
M691=#TBG6J93\B(3(D1X1P'/U<)+"2FR#4A4SWYZF;P#SQF[R$5(14BW*Z21
MA1Q/Y+'L!I,A>H'!+H(K>MI""Q[ZCC0?BQLVR]9:*#4&?]J&?$Q? 1E7/-[J
MLJ)(HDC;5B2O%3CM5I]WA_345[.N<IK4$ZZ**(LHCV)T#XLMF]ZKMM&=NB0F
M*L,#('>U4)/$U'6+I 5,8A9* )#P#$0;('.<9R+D(N3;CQ2"P5.UIG&!DDQC
M35/+W$>?]#HPEXFXBKAN7UR[@;UYDIO&G-/>*_(I\KE]^<S1;N#<H27GJT(Q
M4A2LVW#S)I);$3'?&3&/*Y:QV9W9?N(P7U2:.ESTZQ+H(M BT%OF\65*:@K*
MN7;[C)D,N#K;,3[4EO*ATTF">M#I0^'>:"SYYT@AFRR9S37.8B(6N*'*U[4H
M@2C!UI4@BD?;5GC'&-SC#/!$66[;%^$5X=VN\'I:SHWR5MAN6]N'98K:9-JF
M7S@H1Y]9E#G^6J18I'B[4@Q;KJG\CFLKM[$'(2OG<\JH '0/6["MSRNM92Z,
M".T(A/9"5<8QDC&-PX9US W4I67:(BI:XX(;R.:WTE6JS07'2+!YF!N<F6Y(
M)%PD?,NUI$..X*T].V:?*K 5'^4]11X29KU#VT.D6Z1[--)-W2]NX#/NU0NM
M\F:1TAZMUN09UB#3("PBMR*WVYY'1^:Q)]+P$MSCZ\#JHIDI?8L6;=+7ELL)
M']WM^.B>"A_=%W YR,8H&^-WT4L>8I,G8)T6Y=*DDXBR*)HN&S;.>/:F:P5G
M:M&FJ<RL]72SN+NZ26,O?_W[VU</#Y\E2)BJETB+Y<LX6YP!JFNMF6THIE:6
MP9VB(MM7$1)D$E7'G)#I.@591[IEM"),G?!PP?0%,LHD;_AC_+OL!9D0-)]!
MAGE^S3J\1<(YM'.2M588F&</A/DU:)>"U;#[V<03"MH_8=/FC;9>B#9UV-HF
MR4+Q?(O*8#59UF%2#*/6+LJ\7>KNKDAN/!%TE6#;%$S3U1:NS,?6"E<E,J!A
MPHPI#GMNEJ5YPR)BGJ7I1MO;&C?[T)<4-6-$3/3 3'M7UOKZ9YTF/U6E\EN^
MY6VDL\!+/G'YP57+M@Z$U+=A#IE8"K[<DB40@ZO-I ^]W31Y4^9Y>6E_;<HL
M#%*S-"K(WV<!ZM]=N1E6;NAG'05;)G'@)<U5C43I%$</Y8&TXM&*S8B[#4#!
M\7UUXZ(S= _ K3MF-I#)14]JWYE7AQXT(D*G85W4B0\*JJE4,7K&Z+'L^W)_
M_33Y,/BAZ[B)[!!1XLPC)LE >QFP@J,<7R#P#5JN.**9C$D*]X,%;I#&^?#9
MDX.(%^MT%_;5^R&">J\,T50-3#L(;$&9R5LWP;<SP"1.DJ+2P_9A+&E]ER3?
M#55H+0>AYU0,5(KXI9@M9;BY[4<BTMI%J?RZV1O@&'P:$L7>(%G:\6<1:<.J
MG>76SX#=]@(/5CO9JH13"X<K4QW6K(GFS4XPH F?/(<OXO%OR0 MKTG.LY+M
M_"=/VQFS=.)8C8EG/$8B6L>[VU4+.UU6N>D4-6WYV SD>%C@D+TP='(SCU<T
MC<N?-A$#,K%\8B]1?YAN=(S82=F6F\6AP,_"[.K(^KH9*0NNFK,"-B?>T%F6
M8E50XR>BE]'PHT#M/(FFI,-JV=CQP(/5-,\,OP@B2X5RMKQY8YA.7R2NG68V
M84JUTC,]&@R<(3VJ'_F+6QN.X7 F) ]3P;W/,I[!ZL-E,RMKH6=+PY-K$A'.
M5O;'1M*=[?:FD $ND@IXVX6;_*VM>8=[Q0P>A>:%7/9.=3<4":FJ/U,/&<?<
M2Y#[\WC<AQWW#K8(#9;C#1E)J3"[!**/62<2,E4SO[W;HS=X]NGI8N3Q\28W
M?$FEM,]/F,\.ZQ)(=30!G^>:C4 T@<$<67MXO- %\] _NS>L^=T"SCBGU!XV
MT1.XJ7(=RR4:KY-3K&.].36>;H2#NE!$\'G+(2)L-ST+6=#],!RVTPI2<1 ?
MN&_#./58N&G2UQP,76MJ\?3@GIG'#-=7#)%R4O^56]? FWD#E?R7[B$]0'Q\
MN].:ZJG.*_2<K"#486!16\S5!2#OQP>)@3FJH_Q^#*1?B7X&-A.S(N*$<#+2
MB'+5=:^QW(,XK8?=RIB.E15LW=^ @I=:MDUJF3"Q6Q$TIJC9]^O$-95UP+D"
MA4>ZB9$Y:LF\^X!&MM.(:$-_!C.!CD8P0F!SPM_%LNBE% 6QH5H[&E[8H6=E
MH\%4;CH"7@Y$$,212D%FNM!SG#6/!/V;XA[F7_1%O4<:"_=PP1YO5AJ*/ZPQ
MG &"?Z[Q_/3&IN>5-<4\;]G$:*O^V MX4F4J?VS@-($&7YF]M9Z#Y]E,8N4A
MBRWGD">^A\>7KVF_02&.Z+W3LEKQJ(E8*=$H,K:+OFA"M6.PWL+QA+>U ]+F
M/&/ 6IDK.E6;CF(CFSXK]M#0\Z6A6,_MHUM[?$SM1$#YGN97@=!<8OD*_,<Z
MCF#5U7&U(HXY(9%MK('NY-8%RV9K^')M)8@8V-H*]&OB)JP$>;R-,.(4EA *
MWE37"0]WP@0:W@$G@=;LLE2*E/$[2.SXS[.=$.&[*?Z[NTLH#1.Z7CZ7NCK'
M$X1<N-K.[/7^[J;TDD_6L><H8%AR*T7B;?O.<1%M]V&V"5&BDPZ%69J8_*'#
M%)]P:=HE)77(VF.:\^%3\S<Z*"-5QF>R(XCX17%:6M6R_T2Q[^6JH0+-?N"&
M?:!5KE+-$<PEDK!WU9)NZ%2RZ=^[[[!&9\S5JIJ<+7%B-*/>+#A219^"UT;/
M-"O3EIPXH6*7'/T/F:-W\1?:@2Y4B@%=[:-1LQ+'MG5L43N1 <SRG(:BXW3B
M-6YYZI\X,G+=_72#(Y9Q@R6W !P%V#<PI8IQEYS/7(66_+_:LFJ%HU+48=N]
M81@)H6(".!B09 _/S8N2?" ;6QQTT41R17*WW%C>PK9:T03"X8W;)[J"S<>)
M%YPS&$(P;OYC/",GY!0XVDSE&E0R0Y>*K=(XE\/E,IR!H&#WA&+E2,$Z% L1
M'1(=&H<Q=(4&V40/YE5!W&L\&DBN:;8NG@I@R+A/,W])GL.OV*I:V^DV8"^E
M-$8S"U=>&.&;$N'?MO#CMM]LN.UDX3<X(]C%&A3)>8N"K,@)4$5AB7TP;H_)
MV:76C2O(H.%LZ^02G .L"L2@!N I\B[ROO7-?F%F?8FG2DV4:\YZ] 4:DR]"
M9B)2/!HI=L6@FQ'D<PKYXEQKL.!A$Z9AEV6"S4KDX :[AF9>SG#SIWKZVLTL
M<_%G&P+O6NU6(T0%1 5&[OE.>@%*<$DQPU F"EDER*#GU,ZU77/2KGR[=N5G
MTJXL[<JR28Y-+X.=P$55< T7V^8Z\B;)M:J;Y/'CY.C1\>_0*%B6E6_-BLNV
M0@"Q/^*:=]2E)>#F *)/X8;F3YK!+5V=7]W5Z4J:)]C/1D;:T<&Q0_[/MD']
M953&\+.Z='^FJ4#X#U>\0P4*K_[\\F>B2"?7",OFN!TD7P.F>>8_G,3%$>0S
MZ>)<G=LTB?+5XIWF$HJ?J<(W#KBX,UN4$]>"BME].P_#%C6XDCR^ CU7J LL
M+PNNC<8_VAQ-KJC5L-*:6UZY*_&RP.:$P]/?N6(!&YRV!;%SZH;AGDE&*7R?
M#BRZ=&9AL\5"K@0C5&"0U//3SW0*&G'=*[=%[BJ/!B$SM0V/<\LT57 X+0(Q
M +QVHH).M+</VUFQ#GNC+UZYI@1I8HU45M.XX,YV2M=WK^2,B\"Y;1J[JML"
MK64WM'>SG&>HJ(@+>'M51;:U(^28;#$/EA)MU/&P(XNUYJ:X (VA^M>*>]JH
M[*G$AITP4WO72_.DN/0630^V]*Y3K((B\Q)$@(3]Y0+#'-7ZRM/-]Z3-=4;'
M(AANW&"+A7Q-[;[8G9D'OSQ;PH&0*E\,WLW_S+%LA:,E4;,XGF!Y'H:9S71S
M2?0%MCUKLZUQHQ>C_QG78Q[W9Y2S1M&A$'I__MEF5"+/#T;/Y9^"#L^69Z5U
MR_=#T3ZV'BY7>;G6/U9[\$[HT]U;->Y!?ZZ1?_S_4D ICO4/Z5BCKPL;-#;*
MDSF4NMYF4+94:W*8'0F*JZK4"Y7/)7 NHKM]T;7RJNH:?0_V#W)EEKCW8ZP6
MS!+X:6ZR%LP*.!^RMEF+Y(KDCEAR'=446ML5,_+ (]OP#0>X;G:VK9%\B\20
M"+T(_:B$GJQ[4R?GR(%?:&Q<(]&G&&2A\H>N53DK4W"!"XG$WY^'-0=_RHXA
M[WI:?YM^F%X9>[C!MR(BN?R""^J8;!'6'!L-8S%P1'I.1#:VOHCS[HQ#A(?/
MCH\G1*B#>1N=;3V6+"[^G7#C3DTO.0]9<GJ=FQQ7ZE G1<2%(:HTJ^)]A>)+
MO:@2;S#$_Y754?#I+M$F;BOP,2<7"NLVV6*8NVXI[Q.=[3:2-GCET+$0PEG(
M!J18Y9)+76D[8C)+M.%/7H6?ZQ"V.L[3<TRA5JL<S =\\Q+9F#7R,:?,QDR4
M8585/1O0!@N4Y92LZS(U5!%.H 5MIWP3 TK/0(_Y3U#B.C..?"4.'0:"421L
M[=$VW;1+V534I8XZAVVQ+B6W<.LHSB?CW,VFR3\6)N=[1CE*>AYBN?!M+9G-
M,"!O5[HH;>OPAL;@]^?*LHU<P": M&;= CA8T4(C%>A"$W)$N#>L0$Q.Y?J0
M56';9S*-3!ZT\JZYK(=7>"(0WX*?&A4 HW4D5TQNQE,D\>87YKRL+,DLX4F7
MI1= _4:]\'+J^56OO[-GG>5#PE&;-CR^]1HKVI*0(%"N_*##V')[16"6-9]H
M'5 $%]^OB$T/Q:\H\8*P?Q1I= Y'K^7DU.*1<9D8[P_&+=' K;9^2DI:Z0NS
M"0_^Y(HA8IKQ>X%Q9RV-^\G)O)T/#>,"SX+:/JAVI"9%UJK"4!+N_BN:8:YF
MV <8'U'X5T?$Y+Y9Z'..JVKBS6OB_<B6;6Q00'">F4_$3*>X-I+*&IGTW=G.
M]00]$3W]QC1:VMDKXK5D.GHB2ESH((A\AK$DLCGK"-O+>+*B%V@GCRRUP:P-
MYA5H@F74C<OF_ 5H(!U58\02GY67Q3F\D+:%$U\IY<,/4<>/@<2G3.W9&9#'
M-+2<?\9C#\_(V1!3?*<<Q%F?^)&V<OSI@60WXFS'>]Z[,GY++U,.T!OVL#=,
M^GKU3&@W*(SYI#T]<D]$%C3VKB<BEBC$S+OJ8E!CB'I9YX%84O;0+Y'^#VZ]
M5&>\0=$N9[@AS*^AA!I<T0F/G;7C95=,;6^M[=J)AV6D2L%2F/@]*Y"NW<02
M&-,Q+U?*5'VB8F;XO8[..G(V-IBMD7R<'+ZV<%2/CHH[*JECMQ%?9Q*-.($S
MAE_1LEY=2XK)!.61"]2M O*4C/:TPJH]9?+HM+N.ZBKW)'BWJ-6FBBB\N _<
M$%##"PQR\D\J*J16X-*=I(%2&J[^OH6O'YZ<7!UOM-=.5>W?(%3QDG<;RIEI
MY8:?W#T,\2:']RQ7_"A\>QJLP,MLB $35V&5J^ GNLNC15!A=2UB8'FLD2:#
MO,:;+D:Q4]R+\+_V@O1E!+5=P3-C!:/M&W6(>;8-K*],,%*1!6)[(MG5L(V8
M&]>ERW4]B8%!IQPKPW*PGG.K/,@"RHSA$>MX#W;WO0Y=:T\5/6<H41]T;HLS
MJLNV[E/@1_>;<.7HOUJBC=>>%GZP;+2W\U3ZW-2.RI2B#Y9^FX-K<PS_T'0@
M6R5*ITNDXQ3^\XT)74)P>V?4BAK>?6)=$4-YE&ANMMW7UCYVP)\>5IM;[6S#
M;LJX7-*Q]YP]/I">LR_H.1-S]R[F[EDRA^.RY;3!$@/6BH/\;![@F<!#FSD,
MRJG60$^+WE;P*]GU9 KL[G *'/I1$>, '"1AD[-;1[A"]#?XECVXW+POGC^Y
MOL)8HHC[.K#9J#1%ZFS'UQ&>S09M^2Y1M@/M(][J_ BU:?*&<PI+HN^,K?9)
M]-2KTI&AVB RO#6_7)APQ(C,] ;99Y2?%)/_BWI-0A^7(T@F?Y^.NW!\AX6/
M9HA$,U&"9??ZL^TA ;NNSV#>$1I8V0^__J_O3CLY.'$A Y<0L-PQ,3MS78/4
M^.\'"QQ4K(B&X-U:Q[8>;Q"IO6NPKVK1M>)"%B=@9/*CT<SFV+(%4Q)VBZ4-
M3D621/&$P&:GFB^3&QH%Z3=W3BC"SJD_V\UK,Z/EZ(1M#5ECC7]B1"_KFFQZ
M5(W,*#<"#FDT.,^KX4#)R3EP[Q<4CG"8)J_:RJ& :2IVI# M;N\TZ3.=TR&
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M,/FY!-1_T]4R>:<KZNE&OKFWGD3_7:Y"S8P:VXDGFB>P"JP"J\ JL JL JO
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M[.^M<'E?ED8D?L\E_LFCH^-'Z#](3<4>>@("O\#_X\(OP04!54 54 54 55
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MJ5I+;GT'=$I@%5@%5H%58!58!5:!56"5W/HN16T$?H%?X)= L( JH JH JJ
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ML=QM?4\<&6/1C\>#==+#[;8\6/_U:%9FZS_]VW\]6C3+_$__'U!+ P04
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MD=RE0%<$5-'S]Y &CY(-K$TP*J2_MCJ9XKBP_+%)HM_J1>SR]Q8965(FWX)
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MB&XT'9Y70L7?A*GO1;)SBC],MTB@B$,MVIOXIC;D:&1$;E#P5^R1T9<!@)X
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MN1$2HPIU,RUUYC:9$:(J'M?2TOD%<2F;PF"*<&/<$>R,X8U>[I)X=7Y'U4%
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M6B=1@$DJRM3T(ZKU6]OBUMAMSHEN<N6M^@ 52>9+:E0QY+KW=N4#ZR',TM\
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M.7 _<&.7Q>RNU(#=O2>E!XP'ST:PRV@<2V^DKW'C58*D4@,4VBLD\O(9Z*)
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M+X:XIY(Y/>S+D,EX";_9!R8_P!2XV5L/*-\+9C+X!O]\/D#WSCS*<[3=DK3
M1,%:[&B!1RE4'/I@L8A5\>HG<9G[WM:+@0I.LGO&5^TBI*K(I&0[Y;FADBS1
M(5\:4B4OLTR2K2DQ5J7W4WF5VE+/2@,4JKX'J9W>7A>&=7JO;Y9OBNHZK6W3
M+S'W!/XH8TR6);X@P@N9Y72]@(KT*X0[;)E["]5K\OWN3$.#*?F*&GBXHI>#
MQA6KNMQ6?:N*WWGC+/TFLVV14T9OZ&W!B^B.& %(%[! 2+V1,-V3Z_J+&9#6
M=&;6\?2O+^'Q@1?-%S'94>WWPPE@HXGR#YHT8DHU][9>#?#Y!"Y=OQL^_%7U
M1F 4JA\3[Z>%\T0LN"IZ^R@)M59A<D.\?8N'VGH]4 Q^/K;Z&]1Z(*@-Y#;5
M.?MM'5X>6O:;SI]R<O&1&BD'K1J!=FZ R<&+F8=R<K>BX>ZL6RU/.'L=/^$E
M<R4&M9XF\HJQ=J=/<6<12>P$V-0*3Q&VDJDT.A0!-0%"&3;>)!.!YAV"69'#
MZ\=JD20-;4*E8%4X0245ME!4PCK?IV9" K%(6^J:'6Y%B6DR,>_6$Q#_N-?$
M$A NG;-1A,0"_SM0'[')@PF*J/@5L<HVU*\Q&.Y7C8DF)?;):8A6H_< 9< _
M%BH4V#2@HMRN%BG2*>L/W!^LDK?X-W;^(.H6WV4^&'H?[-?:&JNJ+[J)(E %
M %=3>$T'Z*!PD\O/45EU<!V77%29PK*6HZEO7SVHN$<BYE6?-:O'"#4XFE#&
MD\RMO5C/^->M@?NTVHODB[3,I:^75D6 W8!HK8V-F\A#[BW@U-10ZD+"W<)=
MX>?C.,IGBKNQ.J7;*HUE(B=1L6I_C<^J%!TF)[A"C 7G=G>JN12)ZJ=SE'"R
M&%[XP7!WN"4&J/G"-]3AZFS[M15_.I-!F0&SA\LZ"(!/?P5\CVM&0&9N9PL3
MVE#)!V710(@@!M8#61-)@;F3O*-QFG[+F[F\:<;,/2SCI8UWW'P.=>ZI3(K&
MKP986N=12VVDGHNTD!R:YJ8Z841["NE.Z25$/?0\23!1:YI#*">_(XTTZ=(Z
MMM7,J+(BDXXF7S9:&[K@,'O51"R.&89D0 0""TBYB)LA.ZA926A%+@J$#^;U
MK& 3V'$,#*<_R[R82]WC1[<&8W&JX6+,#@5"_+;B0!EV? S98HSPY1%B:UJ9
MD9VXX",R@X7'?9B4Y0>HV)G2X(3X(W7:C-JN%FW3PP.)-$X<,,%%OJJ; 2JT
MC.KB0D0QBCH?N$=!4ERWW6RKL/AE+F*[%%N1J>),K3?9_HP55.4P]?[KN'\&
MIAZAT+'%;( (J5MI@+$ALPM4)K\P+\O\EEQ&W<KP>KM_&^-<W6-R0>J)KP4T
M<?>J-(K=\*@=U;N>=:E56YB1!=^! )07^ $FB&<<@.(7+J)Z^RX=S;<\=M@T
M[QH+;4 =YI3$L>J[6FW>4LG]\E;"HM4SLSICMU)5[8:XA7Z[](TNI.C7ZGC2
M=$=F )RLGAGH,H[7,\RV-YN2]UQ&](]E1#N':E-ZR8>N8EMGE[^KEA#:X]N'
MNKNA=]!MQS+G[NH<B^Q;=[^H539=ZV)T&<EWAFNOL#6H-BWSM]Y[#&K&I>XE
M\BF">PD%!]4^RVS*H:U#T$FFU+'Z$%;/4C<QYO[SF7\6-[+08[/5!5!KE:),
MVC,'I\$^;3M'0M1(<9X"8KF)X2IF8](-1#[S38">?Y@;%YI?K89.,=!(T7>5
M2:#>J #4^X_@9NSDC@*].(X*GU777#8_3+.I2,POYD1E/KESTU@1G\]/;Y<+
M_!?@>SJ9^'80%M<!^SG $0^T-_D]8"*MC&*SX^H8#?>;=:K D#A^'Z1@FF?H
M(S+5J:W:?>[$K7QE^I4!O"GO2#HB!VN:D3F?4OT^E=Q&\(AA/C*)@;C9.%(O
M4]Y4.LLB10,,.XR;3[%R,0G9A:\]9,;3T$C%]]F<8,>:[46@ME&QR/,5%3BA
MC".V3AJY_?##7Y3_EY?R>1U?94U$M<![LZEC6A;&VVA%'-1J8%%BEW!.**1^
M'KGMA'MQ'QV=GYAN.!X\6RW]>L7Z%"X@8THQSA36CQ57QVK1_XKL0 S 39;M
M?O,K>O377,O5)*0J5PF=)'IW5FW\L%&"'Q4T]X.#R#*Q^WP81Y[?"#$9IX(7
MS><RQ&A%O*SO"%EK.9\;"-3WH[;BB&C-BH.6<M@WVA%M_=9?P:--,*;())7/
M=/G?K+BNLV3N#?5^'3X[%]^=(;*F(?)'E7&PV?3Z8&7@ZT#RU/)C;#88AU@0
M9L5_6:E=ZF22RF1 .\BS.R$:<;M5I6!+CNVEDP'^A"=WB2R.9&9"(#1,1GRO
MI;:D8Z -W7D$%-NP5"U7:_%T,Y5B@1,WC%9LL@1 X2^Q8TMFUE;U['07C6@0
M/ _W$Q7M5&/08N:8E S;GTPBG'9:V UXO@[/AMY$8H)-['.U)+TF3E$QIR0=
M3!M(MNE!];<QI^AO3%JRD],['68?C@X/+, ,:EW0QBHU".<C-5,:K$!)Y\TX
MC69=L\#BC=Y!EJ%NT L*;U5:K!H:QP:J1>-:(PZ M%0\/2JN3JCS>: =)8^U
M:4Y3$:>BKF0#M,'+&>XN)8\,S2D&$WD+GP?UR^IN/*#DP(584A4!>6LH/8^&
MEZBT6,,Z["E_^-HJ.U^S/M+/B-FEF55\01D/W@3++^9<?G%!Y1?< 9QR8W+C
M1M&]/*K"?L525M P,0C8-.Q:[<)*YS6.E1ATRW"YG5YB8NX#[8R1I[UXO6RD
MP9&H-D,[1ZIL3Y-4+,QV5+J1&OW(S%%D<N5N'.M:UQ@#)(HCJOE +E8YC';>
M'&PZ^U)]92M$R@'BJ@8)7:ZZ7P'Q%*'SD#16+0FA9$3B5S7G,RF_RB13#@ B
M0QQ^'C.#\%6ZG!63LGKX(.@4'],(3 G[OLZR]=$$+&+EN$2:F$B0&G%5%-4.
MA%FS@9$[$O,#NI%Y89N/['"T-V)GY]DLS="<LD&;#+]S:AG1O,FZLHJBJR25
M=M\AV^>*HQZOAYVI&1U+TT0\K'>>XXUSA0,A;S54D-Y7W/&Y:UXG%3FH^N6;
M>U7>W177JQ0MG[)]VB.FZ>R-#)AJ@A9B3Q1JU FKA14H:NA-O[T1L/V-P53R
MLYC<)G;565)N2V7T@MZ@-G-6CO,HC 0;)75=/;?>A1IR-!^75%=8TSLF:DV6
M+]&<_7M5B"/-R8L>E 1E2A]6Y8H-*#XB/\V#29_7_>P_=X#]U$V9PWE]C+/F
M>YOL@NA1GSQ-8GL\"=ROR94J;%"IC?5IOY4@P8ZZ45*2QU8U"N?$>)TA"7P=
M&W8,:,QN?N4,81]X%W?^T(&$T/@R.F12@4F1^B"O682^2W7Y&_?I][E+/\L/
M$YZHXH8<IV8CJJ,2G!91VHI:2C/L]H!O9-H!;B_&D'!8!K+R0I",5"78L8[8
M,E-G8Z VJ<@*MM@Z?%+5)Y(S:-D,"-DJOEKPJF/XC7-P*BV:>CI48X6T[%>I
M:[H-B**\9F' XA3M-S<!GS6*GGO1I^5:R;,)WNR?SMG?#)\=I]['4A#V$FZ.
M:+HIEZWV(<ON6)DS!F$3I>'867:(U? ,5>*)#1<&-CWWX0*H.)7\SDWOJQ)!
M5[IV>=@6<+19M&!ULUV,D)A16F3#DFX-UREUM<VE6)HN$8^"-[F\^TW;WW.7
M=W_/G<A_HCS^>;RSFR42,U5^%?5'/:\0W0Y&9R9EK\Y&;>69&*.* Z(&2?6W
MM^G-=#>&OE.W<)[!SO#9X2Q528\ W'ZH6.=HSU7-4[BO0H&= K(<7<I< XO(
M!:>B*+,>H)FR+4B_-?4.4_PA-U3Q]4!2Y?!L&Y-L )/(1_=:# AI BZ%,J<.
M<0Y-FB61J PE'O.I+1K 9]H<_!S3WA(@N5BGL%ZF91PV>W+5?.'T$?Y4Q:UU
M]2%]M'(OCX=N'HX^=OOI('LO)U'"/8,V?0+.AQ5%Y;Y*]-=.H+ ZDJ)<I(GE
M$!!<9?.COX"Z*Y7H0=9S%>W P\2..E2MWDT 6G7MP%!ZD$5C-=RI&E:L?CGZ
M=XG#%>\RC?M)4=7FSPA@W2=X^\"[I/L+L0,(<?I]"M @4MS:>DD2["_YZ?SH
MMM6)/P_:X5NBOYR2O'C_<9I,:;PI!H"PC@3H5#+Q"7*FV"4?ML.SYH-L>@%0
M>$YAJ<2;1#GFA:&_V0O+:I2@-0G\"[4)<+D-CW/<0N_IO$?$C<W>B+XI9V'E
M9)75=-PUZ;L7KG_'&#J2GOJ M3UG#%5*4!^ 79/_)I=I+(M+K"H3G5WYM/])
MM<'3 IRU=67)Z]ZI=D,XGU/2QE@HA-6I\;(J*Q9% 0Q*=79%)I2O$Y_YZ2;@
MZ/LL&D>%M^D9A(Z!]Y&!AXZ!/P0#/Z:>NGV M.'>R$<U\(]-2^":AO<Q,^$%
M^)D>4$"L/)+YVMUD')7^4"<E1Z6WI])1K)+*L)5O'T!=(]/:[BD9[PP+AT2L
M/9RFA>C34)7>;?8-.B:X%A.<."9XSTRP"H?T = U%OC/-(S$-^\,*XEQMM%1
M$@P]>.BU9H%'QO',02G,")MS+4U'=:7*],O+ .OZ,+(5<V@6V:.CW[7H=[KI
M].OUG8 MS\IF0[KM*.+D8-EJ='8YXT(WIG()6 X2/D:"7MW%4A<(['I<(\9M
M"&BH :>%X*+8ZDB/*:NZ&CG27HNT9YM.VKVG[%8DLP_P!@+G# \D<VXJPLW:
M@W0^5V[>JH;EO4IT(J\"%\5R\R><MU).L7'@[JX/0GWO]5M3N>-7U99M&%5C
M3E75[ T:MKO^YH\SS_J%R[.^YSSK.S_S6BB_,4Z(@SX!]1I4>O44,>GAJJ"[
M8[Q] *'#FS;>T.]Y\!I(JOUR 4I/('+Y< C5Y0S9S)SQS29,4#5WO4\GQQ^W
MST>GG[TOH],/)Z>?#XX/1]X1_-?Q^='O(^_+IX-C!]S; _?L_.3PG][)E_.C
MDV/OX./I:/09(/KD[>_UM-NO7)[?SI%'#TBD<O YFZ:1/;_"<8J(CTF[V).C
M9EG5_:C>EATFQD^TY3=HI.3G.-M3O]ODY],FL*>#'58VDM!70^6XD:.**%\5
MBZYOIWJR%J@>,#3.36[182VWJ&/5NPF/;80CH2?91.RG4\4AZ 9 U"27 .\_
MK^Y$.>6]+2KC5C-^_5KZ0A.O#"9LJK'_H,Z^.\.MXY/S(Q"-)Q^\&F__>'K@
M^/I:(M+RY^\[ *XU3B?,0"XZX*U;GJMZRZE>D';F+L9/:$R$3O,'94#Q69PQ
MHZ;C8!QG#A^Q4 7IVJENU*2VBOQ8TKK1$^^JI. ?U&8Z!+W)*;E*U>$T9M!C
MVAJ,T VP;H:%C]RS6%#QOWJ+VAAN +;U,DK>CFE($;T8U,/]G;?T_'8LEFE9
M[$^B[S)\>QF%Q6S_%0%*/0\D$8M%+O=SN1#8J91]M_ ZX^2]B'(5.-S73ZN'
MX*G0G)O6?O%\^/K-F[\A4'XIPA4/[0Y_?77=,WO#W6N>>+DWW'N^5WL(_I$U
M=Z]OFN'>WO<U+.,2P,0>[GWV<^,';W&R*\XY4G@ R(7;6(65^KY_)EIN#F>L
MQ:ILPNZ\ZR=R/??"->H !?#!^LG__LO>7^X:N(J7F ._W('=>C05[FD#OI\,
MZ:GI:L<\3Z\:>?>1];(>,*>'N2K'G1XGY!U[Z@-[&ND!.5]H,N="JK$?CCT]
M''MZ8A#='.3_ZT-=B9,23DKTF5#.TP*+UFJRPDD()R$>/>(["?'3"<!)B#X0
MROER08Y7#K0XV? HG!N;#MW-0?^5W=8<1^OKE6),^I?1]T7$Z3=4!N7XVJ/@
M:T[9ND[9@O_%"/^3S8=8-Q.IMSQRK>;MPV>_RYSZ_I]A=DX9;W@G+1Y,IW*!
M].A1*7 T@>]=T/#.)(3/@G0N]>AX2HP9"YJ9R9G9F(P4)7-[(%N5N;3]CAX]
MK8K@:4TUXJC]+24BA5*W0Q_+.+W5C(B'O_7__G!RZAV.3KR3XT__VM_L"\>D
M=.Q.C;V50MV\$JY*3E/XBY.1&^@0S><RC$#6Q\L:"C2;XYX"NF11@!EVK.]]
MT:EUU9Q@O'D:C0$/A6E0<D\$D\QF9;&]]QHM3#;QYO_G)DQR]_GP^?/G+E_S
M)_?COX\.!VWNM=G4/_3.ZAFJ=IZL/:HN1<)OSZ&#W\ YIC-NJ&W-=0YI0FH'
M\V!9@H1-;?#MWV"Q(4!,3$TK%?7;FFQ1K(1BL=A>A=HL9#3F6QH&!I>*W?93
M9FGV3SZF(E9#7U5'!WA7 K=>++VM-SL#GB0:E)196V2"%@C%,K^Z.[^W13,Z
MU.D6:6:/ N9CU L[1OPD?V5E#'>.CH6=L) EV=>'=K6/7/E=F0PLRB*]12[P
MFZMS@=7*-.^,E_ZA[."]-V#'O;XN._CE\,6OKZY+#_YU^.+E=2O!0R]?_OKC
M&<(,'48:VPZ]"UN7L>E*<[<#QS8EHW+3.ZLH_GV> 3.KQI"N] RYB^[K13<E
MK+OJ1WO5BI@]5&!0'_IBM#9WZ8_VT@_+>8GS*R_,O=N7[:!X8T/Q"E*YNYC7
MWLX+7_]G]_$4Z6R*DT=SP-WU0EWKWHYC7^OG*.WM[+C+ZLEE@=7X-W=9/;^L
M?B9P/$DQMO=0&1N.S-878,_7%6#NFA[PFG;WUI9=[IX>\)[V=NY9:#D+[$%$
MUW.G)_:$XO[ZPEE@O;FLO9?#;@;I;FL#;^N%L\!Z+L9>.)5QXZGLKR^=!=:#
M:_H!T>7NZ2']ALX">Q2BZZ53$WM"<7]]Y2RPWES6WHZSP/IS6V_N6Y@Y"^R>
MQ=@KIS)N/)7]]5=G@?7@FIP!UHMK>G/?7L-U]9 >-[/>-*GVZ\-JD"[W^G[D
MWNN'-MS<16Z89'07N5$7N;MSM<'G6L.L<V8W>'[3]O>R<:]N\/PM<?XFG3Z>
M6J./<7\;?:QL4;399#ST/M 8-]V]HMV=J=4@HZ,+Q9D,J)A[=TL,/#%.+U1_
MCUHC"]/FPQI\)T*>= ?+%K"W;>[F<:':8F$#(/H1-9>"]\(OL1=1$8D8^PO]
MNX3?S>%\,_@KPA:2<<Q-@E0_D$F4P0]#L<3#4!N2()TO8EE(#Y0AF80BX]_#
MTP).' 1E5FOF4;]5;N?1FMQW5WU1]+&Q/\J-1KBZ9D$=/"3H+P\Y64A> M":
MVIX!CN;>YPC^NT@3F6\X*^E#[YF]GZ!J;CC!1(-GS3YO7?S\GIC>_36#JDU<
M??,V!ZDUB^2%M(5;O1>437^&ZK"!5(,0KV[W=*,^3=Y!LO2H+51G/RB61U&N
MH; 1!^L^%XZY-^@2# "=O'R&0\NQ6581%24(VVN;6U'7K469+=)<JJFW'6-G
M[V:N>;]MB;OJ+O7JY4-VEWJY,WSU^M=K>D*]>#-\OOO<]81ZNLXSBT_]TF!-
MKH',4[]U!\Z;@?-FS9=^?C!W@RADDP.V'\B'T:G!N23 GI#DKBO#ZBGU@6D#
M-M1=DI_+9'K(*-6&)C)MT!5N,O6=SZ+L3HG/R;Y'1X*WYZ<NB_#'Q>(MC?,'
MN#E'HC^0L_044I;V[C1]X_I 4F\9PKIQI&CP[+ID@AL'(JY,,N H@\LS>*@\
M@^MQ_=63P_6.J*E(EL4,_X'#J "+U+7A564B6S*J7A/N@\-'>$=\J5W1OSI1
MB>3F-,5A.1S2E01QF6/#[G3B$_8G*>&])A-X/7Z^O&JW<\#VCBU>GT T],X9
M,'#;-.9KQ5MXD%QW"'1M(/ E('T#5>//"ZZ'V,H'ZUW)#1*F#-PS&98!_GBI
MSA_(//>]"$\ Z*%^GY3S,5"OF09M( #L+JN%4MN=URVGKPFMYK+ \"HPGRBQ
MXM#P1SO,C^E@]4 LL,4R+]00US2)89];!P/<\T1>TGX ^GLO_]: WDSD<&*9
M=-Y>$T)T*8E7+A#&[;6V;'RMH260]$64ECDRZ1N\9U!=Q:UOM1/!<B*>K7<$
M#UP96*Y<_6PF=:@^A!O1DO(&&(31\4)W%@=X#.70][!Q]< ;EP6 (<('TMLN
MM6>6>HY+93(O8Y(,R J\*[%+"<6N^U*WN74TN(+AW8#1=24>5CMO$14L]!^9
MI7PC1_?Y\N>=+]_;^1L^1!8*W06H+V52,,!QRRV\)@Z#A&*A,<KF&B+64SNN
MPS$:T9E+Q(@$-(588=VD!/*';1EBEF&=&50\HCY&S"5:_'"BQ<..\=I]/7R^
M\^:ZX5LOACMOKAWC]6;X\N7>=0^]'NZ\V',I&T_7=\"\;(-2/]W-W:X2V"76
M/-H;=I/7GLQ5-R:O.7[<ORMTP_*>P"6O'I;G2+4_M^A2*S?.D>^&]3T%PG/#
M^GIT66Y8WR.X+)>CO/%B;$6XZ4"%FGXP.:O6<. U;>?.Z7%;+;S  '0R93^[
M^LQ1J775VR[G?./O:'=]N>?NZ0'O:<\5!_1:[/W@C%JG8SZ\];;VI%IW63]^
M6<TV1706E2-ZNYODAW'#^U$!IPG>_M!X6W>YFWZY]SX3U]F&FSD-URFD#RD>
MUYZ#ZZYI@WFGW=I[,Q&/\Q]_8*Z4P[\'O*U[G^GK[-8'$<EK3O9UVO+#"^:U
MY_NZR_H);CTW'K$_MW7OLWZ=9;F94WZ=ROB0 FSM^;[NFAY2=#D+K!?W=.\S
M?9T%]B"B:\W)ODY-?'@!MO9\7W=9#WY9S@#KT67=^ZS?VVLFKC_?G4FX-:?\
MWNV=.>I<7^ZM/=_77>&&7.%#SKQW5^AF^OZ$5CENIN_-@+?I,WU?->[5S?2]
M)<Z_&KYZ]>LC'>F[CAJZ-WQV#DA34/NRKXLT\<YE-H\2H9NRC>:+.%W69KO9
MYWBPC=YH=J0;M]K1"57T=]RJC8O8I>]0E+G<; X]](ZX;9^\H.:EV$&PT1JX
M&@LI#7%5,RC5[$AL;%JHXU<-2?67!AC<+?5KHKH2JKZ%W/TPFL]E&,'/XV6U
M%'5?'$M<82(C_ V^.2VI87&.78D)W+T8%>O(O8/<>SRA_?<T+I-"9$OO5.8
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M4V,,=8[4P03RZ+NW]:J#![2, 4>B3R_HV5,OZ\/39M/?NB91UJQ[GAZ_M?O
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ME,,G]NU4<@T5@TM4H13GIO65XJ4J,@0*++Q\BKM<4-RE%EY!L,_+N;Y'DA6
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M,C"Q@/K8?6>5*)EL%V!#+](@SX6L)D(HM5/(.ESJY:+/3B'JU,>J"J&$:)3
MKB64KI+X5'5)F")-4+-R8#A?)?#%^ P>$QX;WYQF,0E9NQ ECRV_Q*?%!#)L
M^"RZP+@U[HO.CM;<@D+;\!D5J.I,!#WA5?L!YU9F_JE(HJ*0QQ8 K*$Q6Q(K
MS?5J#CLCJV5U-ADX[_<;\A5#J6C/;1X.=::OGL8"A:VC>8T!6CD@LR@Q$5&N
M8*[HD.!5M<0),P[&'BAXPAA;0-GPH'!IN"3G-\59%(%7ZU'J-,P+D^VB*)0R
M?V3^F2.$;PS&FS 813*\0);C8"A@D^ST#WV0)0[%!+/YL>%6*DXE@SP *8#T
M@N4KG+&:2A ]'DAV,$ QE0U7#[R+I"MZ\ LKE:RS9D S)2EJ+8-BPE3' 5(L
MR64;BCXC)@VI##D'H.OX:NH]JK2*RZ\JJ)+Y;=D>QK0&ROT<1A>!],_89THP
M&PO?1=,(25KG_U<L[E:DL5S8>V7?GK0W['V$A0W)3"TZXK>(Y.T)U2QTQ&&&
M/-EL"Q2]D9I6%\P>>F0$4H8(6/C"8T:/BL<]Y\?5)1IYNKMX[=,&E,(:'9 <
M$[E(T9A!$4'&#580&0-*-^<X1FXG(^^VEY'?2;#/_!;P:TV<2$ADGG!2-0J3
M)-,LQ4&_W/C,@T%YT*A(U@>T$6(#.=\OJO]1"NB/<I]#-R\6UHFQ23B>@2NK
M6">;^XZSUFR#[8O1F]Y)'YMAC^&O_A"[85]]$M0@>] _&0]>#PYZX[Z +XG1
MAU>_]@_&8GQ$'_4&P[R'=G T'(D/QT=#,3[I#4>O^R>B-SP4)X-?WHQ'XN@U
M7C_OKAV)47\L7A^=C-\(N$9O:#7<ONJ//_;[<!E8VL'1^^/>\!-=B9:*7;IO
MCMX=]D\ZH@<?'W_"2W]\,SB "\%MAN+UX%U??!S A>D'_8.3_KAW0E^SKN@J
M"=:CE[WV2N*>_T>6I&2.H'?,K6XCD#%ITX5S+PB*5K_$A)V*$E(KVDO^5JFL
MMNHI7M*&#-(;!&X<P6] OH+IY-%V<0\AW)R*OJA:DO8MP7WKZ!>^(CWA%]8:
MW#\\DR8B8&)ZG"_GDFO=-']YGL1DDI[FO074(8F)TE+WP!K1)L?7*T3VM+U\
MS;&#QEM8>IF%E5-C/YVI<QDBU^@L:&T#A.%_C_&P2XX07 K+S'6?1HR[ZU=3
M,SI*7<IMZI8;%9L8"\X* %$ MM\"["Z=C3R7NF(Y<6RV'AD\:R^;C;+X7)U[
MU.J% R8:SW"U(0AT*I;L=_CB5)63E)4>#_VZPA18Y)IRU[\9O6*7#5!=/_X(
M_@JHT07?8 :*\$W/GZL0^!G. \O]\;?<VI)D$^"L!-YTW+7>F3]O,7=I:^?Y
MDXW33='7_>]-9['5$I\BPIYPJA+X*2^%5"%.I$&3$C[IK,3TJ\DC,/>.BJ[7
ME0PQ?)S/"2@7 >EWBS$=VN2<JN#2W *^-<!21^QZ/9&@AS-I&GD[ICD!_A=C
M,\(3TXM@A@88BUN_+FH^S6)YI=C>6&/B\J'G6MJGCEU8;^I]@4MPKR7FO",.
MFOIJJGV!TGB1>K._NA1+JKWVX'_OO?BS3,5O7@#/J^T&8UJ;*X('@D<PQ_?,
MYE;JO?@15%)7_%,43NS22>:N3"O"L?=_VM%7[IJ)XIR(WL';X=''=_W#7_HC
M,7[3&XO!&*,P^3=,_<1(C([>]3%4='PT' U>#=X-QAS4&1Z-[;!,\8/Q$4=R
MQH/W_7>?Z#O]=WT*,XD/PT.X^TB_8M++PSN'_8[H_]8?BL'K8B%PZW]^Z(_&
MHU)4Z>@$%FP%OGHTJ1#N_+[WML\!,%C#8/@+QI5J'NI5_TWOW6NGK=>CHQ?M
MU=8G5O=T%#;>$B[/AHKEN9(7)DAO]<ZCYP@J!RS4<X5F* ?P.?3>X;@[V+31
M1 ?B091++)K%GTQ@%\"OY?B4"<HHTMAYZRAUZZ&5[.G*!.S^PF;8HLJW%,FQ
MEJUPU<&2*K:B0+(JI*J#?*UX!\PO:AU)J\7+)-S/73JOFIY:^HOK5:BL..E6
MQXC!%4._,&JP#@/^VC#WM:ZW63CT:-W #94IR:G9;2S8X:IMNC2:*EY,O;LX
M2@0ND 5IW9;J*J"OV=&&JCO78O*-+29/*@?K6DR^LL7$:>?585Q;[57/_3!5
ML2P$WTOQ2W0.GAWJCW=>T[M%*1=_]3C(TAQ(/;;$'@=97(,+J5?'\-54WYGJ
MY5+4#!5[JE(>KH<)?MI9+__\FJEY5&6G*P+GX!KJ2($N 4PRC'.#@:$31>".
M\@U &7*QMXJT]DV]SSP;%V=JF+M?TW1PX\7PDZ/FY7&78AZ!CZTPQN>?XPJ#
MY4JM=WF0#U9<FAHD. @<Y4N+\_)Q0!0K7&UFLA>\$K*$%V=$N,4/E0E1P(.@
M14(Q2:R $*=9FALBDUFD0P#PD8BS0 _Y!,$#5DBHO*:: LV6B05IY09E.<H%
MBG:%@Z@R.A%T4>5IJD0[DZ<ZTU"5O$"V+J2&5Z*DKS<Q-6X8N :BZB![3H(L
M02(@DUPA:2#K@!C5);<X*!R)9H$- 27S]U7DQ7J0)=(BF.\)?X[V)])LW128
MIE).DZ?X\Y=Q1?LT&7P"R_SWB/H;L7T3C31=*)7\IYD(*7=OHKEGOF=L=$]]
ML5WGB]T'1F\.10V&6,TX[(]&XN.;_DG_Z'6G:F(H!(>0<ZH/\65UPNI4Q6"<
M%K/9:1K7[:CQ=I-?JCN?^, 9_!9O Z;/_M9+^O1QX"VC+-V?JB_2?WFA_'2V
MO[>-VZ*_#X00>(M$[B<2?"#8;F9G&RD633N.\.V;;[]<Q8OE:^_N=9]M;_\5
MMZ .LI._]+2[>\TW=I]UG[\H?>>'0=@NL+@[/'N,)XGG^VQ/A5\+-FRN03T?
M^47N#F=T9[==(B-/57T7"-A;.&%!]]G9V^N8_^ ZL!]-._BG=R:?&G5<[3R7
MYO#C54"#]HKOJ/3!*8F'J"3R^$-3I4Y;E,3-#MYIB88>3',X\M72">4'3@+'
M,8[7&GIS)Y6=5'8LV7R6=-+9\>B#D:DN''+_CJLY@G:LTJ =,K9I!]TVE7HB
M$YHK(T6/>YCOE-/;>9KW1,RZS;]<WL'?F(-\L/G9NWGFEFG-0ZP!WB_ W:M_
M.O11(W;V(5)3&Y_9594U;7T[>ZZJK&V,_H,+DF^O>>9?;P:O!F,;\N*;-O9I
MRS?V:T7):#3X94B##$?]X]X)3DY\?7+TWAZEV% IW6Q#Y_71B?BM]^X#CA$X
MZ ]^ZQ^*04?\IA U5QP#K<=1.NN8KHEK8'W>1K[R/HO11''+\B"<=,M#1$H@
MN3A#I&15\:S4O,YR$LWGV)%,T_ J/4G4-ZP'YL^7C "MOW(:19]K>YCR]A)N
M_#FP1K(.HRXNA9[SPDS>]R/SW"J.Y7F$4U.7=N\6M4TQ_%(]!' !G5>%ODL\
M94!D]'B0VF736J89=FU%%SR6D%J4\/[8>Z9' <)SS1%_I*EM),WF >H/X\&5
MO0+01T^WR7#(2Q3"P5\"OWJB80%P%@Q=P_0:6:7$]D"9RAPLW0;/?6P^M1[6
MN1J_E_DHOW3.2?>H]'BGY39*LZG]<M?V45Z\M'_7=73VGT8<<LOB%X\PL[I?
MU>.-V,G;$!%/[Z&$:-8C/[EU!^,!>*MW)B36<:D&P]'XY -/F&]VG&:_M>"&
MQX%$0Q <"9PA,%5@QVN(%@+U3/1<[W3FL6V8Y-W+>#>>-['(8H27RH<569B3
MBAK894@=5[9MB>^:,138%&_,1@N)-F)H0F,_$L9+WLRFW0IKL@6:NU&6ZCG+
M!.NDX29P:H)9=F*<&9Q<D4\8SR<Q-());R28[J!GP,BQQN]-PX2VBZLW;7T[
M3UU<O>&6REV'?[]#7+TZKLW%U6^P?;\>#89CT1\=G!Q]%'468;,VD^I9FBN8
MOV>9P$,+RAZ846Q%$+V9DK/9VUB7DG'[> NLW:KR'[>/+G/1?MHYE%Z\FK=P
M&)5K>I%)&>L>!VG#D\RJ6?QK,OB=VD3F(I^WB!GKN@1^Z:*5^9]TV664T516
M,[ Q2V=1#$_G<VY>Q7*B<?0(+9T&,T63C">8^C)0YX3M!9_CE6R $!KP36,B
M:4U>2NBLG@IOE,N])@][TUQOY[)\<H'MJD)83<9#R!V5KSEPN?MHP&>!X#-I
M]51^UD/J#>K4"I72\%]-1SAGBO&J@B6QRR0*X:+$)F9>L,?S_2^M=S%AV:2^
M8&0E0'ME4+94$$/#\1'J#I=:AM\B5J*9N2D09DASB36B]]*@$!>XET41#C,N
MH^:8=?F=&EB<0@BD< *T-YZ8!!'-.RT0^1@.ST+ 8]R[RJ9WKP /JZG'R06#
M)1?HB?'$ HR<5P;ZK\SS)\@#O2N7,&4N+JANA[_K$$K6# ]V'_7T0&6FD$+6
MYU)]P]O$\Z-)>Y08(4HL4A^)""7"NF%IU=3&;,#Z*CA#,W6W(Q#%!JYD<B^U
MI'XJB0OT[V.D<:2EC0DO@G5)_3J &Z(S25F<G%BNP/JNYZW2G2L0DCAH.$UR
M 04K._-0,>A\T3P+4B^449;KO*51>544+0:PV@""GWC)K(,<.I.3SQT"W8CF
M5&]WJD*/,<1YAO=FOKN7RP?>O5P^K*A:&WSL9D+/<=9ZG/6D^\A"=ZF3D26U
MP\2] !Y,F7B)#>%]BX 3FX+KJ7<F Q*C^&M+UF-M)&I6G29,]&SZHGB1DI=<
M!ZDQU)"&IPKMQZJNLW6"'\%W;UZ820^5U(V8]^",XU N@:)@3R>I'H-OC&$C
M]_/,JV1SF9.K$[Q/=18^:9($/L/Q]/A$.#,\-TH+D87ZL8"%QE_.O<]RY>>A
M/ --0]E=#2X+++H()#WALJ33M/EAJS:T,"=!1E6R9HQ]H.9*6\UD:ZH /]45
MKTO"\503/< 35W:*^'7)YYR"TB5#""X+P%W]&SY1;14E9&I%)%JT8L5-- (:
ML0%(?.6/VA4C#2&@5U8,;\^W'R>!G@&CS,233@F;%W<Y%S+X@L+$9@B\.E>!
M/),:.( (%QT&EF6E6MN9"FQMHQ*;M)U,6D\F[78??<!9^,;Z1+I!6(=J<4!'
MTZB81['DBH@(3; %XIY[@0Q]</Z7TH,O9F& ",TW-*!SG,P<LY'M#::;7+F7
M;.:2"D>2M@5B7D;.P%G NFQ^ET0CPDS!<VCHB#!'R"AK]ZMTH/BHT3$OP,.%
M@T1>V]C9,AB9#-E. H4>T\:K+BZ+\D"%&9H'*!:B)9<CDP1*&(8SJ:RI8X"[
M@-\T(A9*;>4KDEP5T.O;VTD"WSX#@8_HOJOF!K$B&D-)DM48&65D"-SVPB"I
MH(-4+*JD="UGK/PHP; 'GOG4N(3D-N*6(PYTF%.TK7:9TJ(,R&#FG9.G!F_%
M NP7<*=153",JU&W'4N]$$USK15J78EPLZ<RB,(SHKS(%D.K%(W_UN208)_)
MBG^= ]/Y*H&WXS-L&9C2[Z993+>-3N%(M)+,C21'.NN1SM/NHT]X]'Y&9E)A
M=.J>#2] ["#TXH 2?/Q'#CU$L(7GT6?3U(&1Q1HT(>O(#0@3(^^Z(UOOR)[1
MD16<HOG!'(.QMX$U$1*9@B_4ZP0&L3YEK5$Y;(7S+H*E%1PSX3>-.(6XEF76
M!+Y/.;:@PASVDF&38W"H\=4TCN;"8T!I+4TX!$MZ)99>$H7D:8#H4/)<YEX/
M^T'@.&1PG,94)R%%AH<FJPB%C]5_ILU<-'"0QD@Q:6+KBF*S-'@68GIAL27<
M/F"78&IBESK>A<_M1R3IP,@GYRZR';)*O#^BMU9\(+RJ!?9%-K'>$]BXLRCR
MQ=13V!.8>WCP*S\*I;ES6FQ,54LCKBB?+(EN!.LT"TB*H[+@E[3S61!#L8"F
M]KJYZL%O# \^<]6#WY8W=NIG9?.>L_JQ\HGR"PKC)"AE%E%FJ@1=D%C+-I1Q
M()4N/,*Y3"C!0JB0&MIXU4) ,6@^9XN3)#<Y/[JFB0+3C&O(N@:AEW$P7L)*
M(D*W#J\^ 2G)>(R(.$B+N?X)*$:T%'D;<W0JS>4[XH_,/\L!G'VLK-*1$0S[
MX=VZ8A!B@%AR#)E_6[FF3IG0-8M+%E>TC6BMOK3.0KR]JS;.?&YM7 >A=N:5
M[6-<3B]A-X%60TM4:#ET\*:XU+Q)_/HEZR@V>KJ$N)T&> ."J;3,1U1Z818$
M^"^T/3R<N-81Y]Z$39D8U&=65?^D#S0P.+90_ %.2>*KB7,>U^?G%[8Y628Q
MW6!CHK(1)_2R E45+8I4I<M.'M1$&D13D,.&%>+D6*^V%K5+J%]1:TZ<:A_2
M!(6+KU4B$]I>*P+"9/ AE9LP/-,0VK;29V1SYRI^.^#R991BG Y@2A"O=*8Z
MMLV$8( ZI1BE'N45X/-W&$'7CGP-%"[(S5\I[:!M[8%5P[%* ,6QF_R+.^<U
MSWF[XF 2CP>L$3GTR1H@ .4>H*H+$QFP?B1E ]I4QA06+)PIX%LK:<.^&H,6
MHR.C521G74+)>1ASCI=$?#J%=TH(L66G2.LQ6EJ!GKSPEJ5/"D^44K8+&296
MSA:(VM'0FC2TH^-*R-)P;(POIV,/)=^Y\*J9WDS8$I3+U+)])M3]R=$!S&=0
MM4M,8N#,@OFV ]/VSV$9.&<'3)U*Z0Z2M <$06$#,MB* B<MPHA@K&AJ7;&0
MR9!Z^&VD<EB _9B.CM:DHR<4VL:#M()&.F&JQ0V:BCHT7,28DCIA<@.E8HL:
MBFZQ1F*SFD_>$F-EHYM)X0^X//X4UA2J9,:F\&1FK\U1PYK4L O40+W:7/V9
M8@2+*PW ,/2Y %4G-L@Z4,F":AABU# U)D91Z*,+&*.+$*X[4XO<B$4I8.5%
M3/*BJ"RHK=DHZK"N*+;%5ARFE6KVQ?@W:%T1,*?VYC T2/'T/*V8YI5TUI+
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M*'TJ.LP2FLLD1ERQ)X[)7@>1L4$J?FI*L?$0T=[<%+J6NVCD96KBKHL->."
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MW1=H&R63"7SN)(LEJ<X%P0!W"G'I)4DVYU9:D>%["_A"3-&7'!.W@Z$?]#E
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MI?E1AB&."5 !RL*.40V6)"MI=]B 4IWA2LBBO#5DA5\O-3<X-ZF-#$J,T1I
M!*(<+78CO8"K-!;EWM72?6,MW1-72]>Z M*V*74K.>0M,(]/$V/JT-B=+K^=
M2)G1:);A3CI!!Z4YP0O?1NV1AZ7G4I)QKI7(2D;,ND*BK;&9#*@H)XDHC@,J
MQYND^GR+BJI2BJZX7KX*?4,[[&Z\DDIQS4"[,G:$/;^,+M^)3HV'"1<(KU#W
MH!:G4J7:FLSS:R8'M[U5V MY;)?<GQL!T=J&P\[6SK8+]+=/F'V<16@0B0%Y
MO!XSDBDU _%6U)A=41+F9-HZY&KJ!&0(AG(,I@A9]KZ*49P5^P[OV7SU54_S
MG58.8NR?9GW_.PBG*H3;]/_,5+KL3J*\NJ319B'E-C7)_QK-0O$JBL]D@D(^
MM96#4>) 5:9,D*LL;\H<SJ^XIW[%[EI^Q=]_/HW\Y3_^Z^\_S])Y\(__!U!+
M P04    " !6B6E3?9E]S\@(  !W3   #@   &MO9"UE>#,Q7S$N:'1M[5QM
M<]NX$?[>7X%Q)ZT\0\EZL2\-I7I&L94[3Z]VSI8[Z4>0!$74(,$#0,GJK^\N
M0$JR)<=R[IJ3;,83V207P&)WGWTCJ4%B4G'Z)S)(&(W@-QD8;@0['7UI]CJM
MSN#('0+!44DQ"&0TMY0YT68NV-\/#+LW39Y%+#-^N]5^UX]E9IJ:_Y?Y'3C.
M33^E:L*SII&Y[TX(GK%FPO@D,7ZGU7,C8IIR,??'/&6:7+(9N98IS:K!@31&
MIN5XNR05?)+Y@L6F?W ZP"DJCF8)-ZRI<QHR/U>L.5,T7^?J:XL>G/[ESYT?
MVOW!$5*=#H[R7=JSPDD>;SJ@X=U$R2*+FJ$44OEJ$M!&V[,_A_VU<YW#_M-R
MFCD^ RFBEPIN=)_P@!OB#.AW$%^G^WO++X1UF=I5 9Z-KL<7GR[.AN.+JTOR
M^?;ZYG9X.2;CJ]TTQMT6YO7MSZ,;TNG19N>X00_)\/*<=$ZB\NCV\GQT3<8_
MC<C-Z.SV^F)\ <2C+V<_#2]_')'AV9A<?2*=#[UCKY;]RV4_O"'#\ZO/X]'Y
MJA6CJ*UE]]I=%*^5_O#ZX_!R=-.\^O+SZ-^5X+OM=G='/<BFJ//_$'LF54K%
M2P5_X9%_\=!(13XS)90TB4?^V3IO>21DRO!X3DQ"C?](MA&?5EN)N,X%G?NQ
M8/=;"/(_A<998=M@CJ 0'-;4ABK3M^)JPBY3[0=4,QRZ4;@IG)CQR"1PW#MN
M=]\O__V-9_LB^TIP/+,R"H0,[UXVPU=D^8R(#DX[K4JE&W3I6-I5P8'1DH1.
M&5%LRMF,16"B7)-?"M@XV/"<7+-<*D-D1C[!]*33;OY"9$S^(2-.[\A-R%D6
MPHP76=A:9FT@AO*S-O#78.#=?3;PCV =$1IP.B=WF9P)%DV8Y^Q<.>N.)(S)
MI"$H',HS0K,Y*3*C"@;[H6!D(#$T>TI2.%*<"A+3$$XI(E-(NHUT=&L$&0-T
M:*KF2)+2.P;KKLRIX5P$S,"2 K>(:R!!R%58I$!FP05"9(J >,*$Z (_EN-G
M3+%R$MQ RK6 BI%G$S+C)H$-ZIR%ED&<-P?69 3;G,*PB 3S53'4^'VM^.V]
M2OPR$O,,$()@6R+" _ ".5Q6*]=Y%N/BAL,\/ M%$<&<@+H5\_< L1Q#'O"N
M$>_H!X18 KK$DGZT-"@DXCBQAQ2%  ) L02HV>6TY2>D.B&QD#-=05RQ"==&
M45B(XDG'-W#IK2!55\RL<5N#];6"]7B?P3I^8-E_U240R_H'PY*,8PZ'UMHO
M"%7,X@IPP@/!T/X) T$%@NL$R9$LA9",81F/01"AD+J <2A<)84#6*YDR"(X
MK4D#\!0Q *@#S>@^3&@V860(<?"Z$$!A^Q(G#79HA]J^!!ZY0XZU?>: C?,3
M#)8K>'?X0UZV7BA^L% ,"^$^'WL!H,!4W'\>V27T$$/^<>NDUWO7K\&^EV!O
MT,,]1OLYTZ!>L'Z;E3X/30\3YI 6>OLAF+D&#&!6KN1R85DHF !BY)1K&WF!
MBF5V'FRQ+&/V:MQ73%"+VS(97F+/*W,"O,@A?@,O6@H>46,9#32':E=QW !W
M*;O-1#*<J="81ELWIVW.;>.TU P8,I 7X* <;(&'A:"87L"V+!/+=!Q&N.1^
MM2:!OP*&A* O&,^B+2)^[1=>C5\(7H]?V#J@KKF'[4/QUEX"/,N41PA^JF5&
M,>>@&AP'5MKH$:B**G2"O^ TX(*;.2;MFY9%7V6!;#'JW,P#TI5*W:8V]^6&
M\D+EX".T+3+"4*K(,F!K]@G+H'80X"K@"LO1!R%)D1GG#L!7\1RRB]HAO"6'
M$.ZS0QA-J2AL-$6TL#B&.II/P<[UAGH8JH8M\@)WN+DXMLB'@1#3M2O! UF8
MI]?>)G.A"VJ&_87X^7X:":K.A75FS,D ^.GCY#5XWQ!XHWT&[[E#QSK*L$M>
MEKSVRB,0OR!Z8\XNP[!0B**5!/G!?*G4!L[@S7>818<PQ:_N/A5IK!''X (@
MECZB*]D,P>!M.Q\[_5FQX.70<9)0O:@@, I;E\$BFY[8W9>IPYP(?L=$V=M_
M1._]!H%LZ2!J;["7WN#D333X&OJP[/'9^\M1Y42\95C$*+T*ZF6$1'"^H&Q8
M*^B!+PKEO)%*+W)T>P(F2U-N#&,;\XY 0OZ/5R(./-GA#0 ]A'F-:03\QG9"
MY9W8KP4'EJT_*K+0=OL/Z_;=&X+R?K?OA@(*5% P!\!B!QI[V?:!#E[FUXLV
MVHS1.TR87<%J4V9;:ML;X-6=KA>!MNQXN?[_AGA*(QBHV2*<;@!X69H#,6 5
M*FC/Y>L:DG5=I&#R( B[C3)=V7@WL,[%WQID][JS-H24.U80RCP $+.A%R!H
MG_PHL>JY')9G4RFF#!/9C$[*!UA4&:U9F@LY9W!UED@7G^D#3P#(_8TY?>L)
M3&U\DK1YW'I__.%=/Z<1=M\>P&Q-0*_FK09CNX\;' PMC.P'X-&8LNN"2/QV
MWY(WP4AE 1;/[UG4=X;>:=LG<<L!8(R"YIKYVK4D%Y[$OKW@YC[ ]8$!5:V.
M#5+G3OUJ?$D$5-%"$G:YXY-6NPW* C$=F>@)(J#IO7^&IK<%S?$/K0^=AT3P
MAWK,?Z5]IXMUSC<#N'MRXE7_ ;*5]966U6F#OYB!4)L!1*@[WWXV\41_BMDN
MU)6EU3AK6HQW@JYF ,Z?>GJZ,IL_TKIWQ[6=@ZWZY!(<2AJ 3_G@D6Z[N_HJ
MRT8SJ37[E&:_H^I(J:7*S?TANH(!^ZFHW8'@Q[F_$W@K0]E"B-T3X)W86_+D
MH2 V*WR#P'?% +[?JT/?9@)'^NCQ2RR;3*(.PK6KKG7U%G25\B@2[ WIZEM>
MN=P)37T5575(_$;5;GRCLPZ).PG=/7:SM:YJ7>VLKNJ06(?$U6]*22@'\&;V
MYMI9PEE,1O<L+/"Q.G+E;O^O1LA:JMM(M?'9/=E+Q;HT#[^6<,!OO#6P2U^0
M\A:_'>J[[CE9I)@YG3#G!YLT!O/VJ9C1N;;)YN#(?6W8X,A^X=C_ %!+ P04
M    " !6B6E3S:JBQ<@(  "!3   #@   &MO9"UE>#,Q7S(N:'1M[5QM<^(X
M$OY^OT*5J[DC54!X279N#)<J)F%V<[>5S";D:NZC;,N@BRQY)1G"_?KKEFP@
M@4S([-XL)$XJ$-LMJ=7=3[_9T)_85)S^B?0GC,;P3OJ66\%.AU\:W7:STS_R
MAT!P5%#T0Q7/'65&C)T+]O<#R^YM@\N821NTFJUWO41)VS#\ORQHPW%F>RG5
M8RX;5F6!/R&X9(T)X^.)#=K-KA^1T)2+>3#B*3/DDLW(M4JI+ >'REJ5%N/=
MDE3PL0P$2VSOX+2/4Y0<S2;<LH;):,2"3+/&3--LG:NO+7IP^I<_MW]H]?I'
M2'7:/\IV:<\:)WF\Z9!&=V.M<ADW(B64#O0XI+56W?T>]M;.M0][3\MIYOD,
ME8A?*KCA_82'W!)O0+^#^-J=WUM^$:S+]*X*\&QX/;KX='$V&%U<79+/M]<W
MMX/+$1E=[:8Q[K8PKV]_'MZ0=I<VVL<U>D@&E^>D?1(71[>7Y\-K,OII2&Z&
M9[?7%Z,+(!Y^.?MI</GCD S.1N3J$VE_Z![7*]F_7/:#&S(XO_H\&IZO6C&*
MVEEVM]5!\3KI#ZX_#BZ'-XVK+S\/_UT*OM-J[:H'V11U_A]BETJG5+Q4\!=U
M\@\UD>2CTF-FE*R3B&G+DSFQ$VJ#1S*-^;3<0LQ-)N@\2 2[WT* _\D-S@K;
M!3,$1>"PAK%4VYX34P-VEYH@I(;AT(U"3>'$C,=V L?=XU;G_?+G;USNB\Q+
MP7'I9!0*%=V];(:OR/(9$1V<MINE2C?HTK.TJX(#8R43.F5$LREG,Q:#B7)#
M?LEAXTR+.;EFF=*6*$D^P?2DW6K\0E1"_JEB3N_(3<29C&#&"QDUE]D:B*%X
MK0S\-1AX9Y\-_"-81XP&G,[)G50SP>(QJWL[U]ZZ8P5CI+($A4.Y)%3.22ZM
MSAGLAX*1@<30["E)X4AS*DA"(SBEB4HAV;;*TZT12 ;H,%3/D22E=PS679G3
MP+D8F($E!6X1UT""B.LH3X',@0N$R#0!\4038G)\68Z?,<V*27 #*3<"*D4N
MQV3&[00V:#(6.09QW@Q84S%L<PK#8A+.5\50X?>UXK?[*O'+2,(E( 3!MD1$
M'< +Y'!9KUSG,L'%+8=YN(Q$'L.<@+H5\Z\#8CF&/.#=(-[1#PBQ!'2!)?-H
M:5!(S''B.E+D @@ Q0J@YI8SCI^(F@E)A)J9$N*:C;FQFL)"%$]ZOH'+^@I2
M3<G,&K<56%\K6(_W&:RC!Y;]5U, L:A_,"RI).%PZ*S]@E#-'*X )SP4#.V?
M,!!4*+B9(#F2I1"2,2SC,0@B$LKD, Z%JY7P ,NTBE@,IPVI 9YB!@#UH!G>
M1Q,JQXP,( Y>YP(H7#_BI,8.W5#7C\ C?\BQII<>V#@_P6"Y@G>//^1EZX62
M!PLEL!#N\[$7  I,Q8/GD5U #S$4'#=/NMUWO0KL>PGV&CW<8[2?,P/J!>MW
M6>GST*QCPAS1W&P_!#/7D ',BI5\+JQR#1- C)QRXR(O4#'IYL$6RS)FK\9]
MS01UN"V2X27VZD5.@!<YQ&_@Q2C!8VH=HZ'A4.UJCAO@/F5WF8C$F7*#:;1S
M<\;EW"Y.*\. (0MY 0[*P!9XE N*Z05LRS&Q3,=AA$_N5VL2^"]D2 CZ@O$L
MWB+B5W[AU?B%\/7XA:T#ZII[V#X4;^TEP+-,>8S@IT9)BCD'-> XL-)&CT!U
M7*(3_ 6G(1?<SC%IW[0L^BH'9(=1[V8>D*Y4ZBZUN2\VE.4Z Q]A7)$114K'
MC@%7LX^9A-I!@*N *RQ#'X0DN;3>'8"OXAED%Y5#>$L.(=IGAS"<4I&[:(IH
M84D"=32?@IV;#?4P5 U;Y 7^<'-Q[) / R&F&U^"ARJW3Z^]3>9"%]0,^PO)
M\_TT$I:="^?,F)<!\-/#R2OPOB'PQOL,WG./CG6489>\*'G=E4<@?D'TQIQ=
M15&N$44K"?*#^5)E+)S!F^XPBXE@BE_]?2I26R-.P 5 +'U$5[ 9@<&[=CYV
M^F6^X.70<S*A9E%!8!1V+H/%+CUQNR]2ASD1_(Z)HK?_B+[^&P2RI8.HO,%>
M>H.3-]'@JYG#HL?G[B_'I1.I+\,B1NE54"\C)(+S!67#6D$/?%$HYZW29I&C
MNQ,P69IR:QG;F'>$"O)_O!)SX,D-KP'H(<P;3"/@'=L)I7=BO^8<6';^*)>1
MZ_8?5NV[-P3E_6[?#004J*!@#H#%#C3VLMT#';S(KQ=MM!FC=Y@P^X+5I<RN
MU'8WP,L[72\";='Q\OW_#?&4QC#0L$4XW0#PHC0'8L J5-!UGZ\;2-9-GH+)
M@R#<-HIT9>/=P"H7?VN0W>O.V@!2[D1#**L#@)@+O0!!]^1'@=6ZSV&YG"HQ
M99C(2CHN'F#11;1F:2;4G,'5V43Y^$P?> ) [F_,Z9M/8&KC$Z2-X^;[XP_O
M>AF-L?OV &9K GHUGV:PKONXP<'0W*I>"!Z-:;<NB"1H]1QY XQ4Y6#Q_)[%
M/6_H[99[ K<8 ,8H:&988'Q+<N%)W*<6_-P'N#XPH,O5L4'JW6E0CB^(@"I>
M2,(M=WS2;+5 62"F(QL_000TW??/T'2WH#G^H?FA_9 (_M&/^2^U[W6QSOEF
M '=.3NKE'T"VM+["LMHM\!<S$&HCA AU%[C7!I[H33';A;JRL!IO38OQ7M#E
M#,#Y4T]-EV;S1UKW[KBV<[#5@%R"0TE#\"D?ZJ33ZK17,+/13"K-/J79[Z@Z
M4FBI='-_B*Y@P'XJ:G<@^'$>[ 3>BE"V$&+G!'@G[I8\>2B(S0K?(/!=,8#O
M]Y&A;S.!(W/T\,,KFPRB"L&5HZYT]19TE?(X%NP-Z>I;/FBY$YKZ*JJJ@/B-
MJJU"X>Y#=H_=:Z6K2E<[JZLJ%%:A<$6U-TQRI<F_>,3(9\T,1S&Y^VMG$\X2
M\FEQ$^#*/P&P&BXK$6\CXMIG_W OR'"P?.(71;PFW,.O)2/PCC<+=NFK4M[B
M]T1]USU/%NEG1L?,^\@&3<#: RIF=&Y<(MH_\E\@UC]R7SWV/U!+ P04
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M-%<4F*1<3F#$<LNRB&GHH'C:?CL 8B#A@M&K<$8LGFIN.7HEDL+P,DZ)G#!
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M-#8W-C8T7S$N:G!G4$L! A0#%     @ 5HEI4\F:_06QBP( (RDD !
M         ( !PR\0 &MO9"TR,#(Q,#DS,"YH=&U02P$"% ,4    " !6B6E3
MVM<):DP-  "T?P  $               @ &BNQ( :V]D+3(P,C$P.3,P+GAS
M9%!+ 0(4 Q0    ( %:):5.X ?$(30L  +*,   4              "  1S)
M$@!K;V0M,C R,3 Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( %:):5.^/5Q!01D
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M97@Q,%\Q+FAT;5!+ 0(4 Q0    ( %:):5-]F7W/R @  '=,   .
M      "  7D6% !K;V0M97@S,5\Q+FAT;5!+ 0(4 Q0    ( %:):5/-JJ+%
MR @  (%,   .              "  6T?% !K;V0M97@S,5\R+FAT;5!+ 0(4
M Q0    ( %:):5-<I<M08P8  "DR   .              "  6$H% !K;V0M
M97@S,E\Q+FAT;5!+ 0(4 Q0    ( %:):5/2P]WA9@8  #LR   .
M      "  ? N% !K;V0M97@S,E\R+FAT;5!+!08     #0 - "P#  ""-10
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
